title,pmid,abstract,keywords
Disentangling Association Hydroxychloroquine Treatment Mortality Covid19 Hospitalized Patients Hierarchical Clustering,34336157,efficacy hydroxychloroquine HCQ treating SARSCoV2 infection harshly debated observational experimental study reporting contrasting result clarify role HCQ Covid19 patient carried retrospective observational study 4396 unselected patient hospitalized Covid19 Italy FebruaryMay 2020 Patients characteristic collected entry including age sex obesity smoking status blood parameter history diabetes cancer cardiovascular chronic pulmonary disease medication use used identify subtypes patient similar characteristic hierarchical clustering based Gower distance Using multivariable Cox regression cluster tested association mortality modification effect treatment HCQ identified two cluster one 3913 younger patient lower circulating inflammation level better renal function one 483 generally older comorbid subject prevalently men smoker latter group increased death risk adjusted HCQ HR CI95 = 380 308467 HCQ showed independent inverse association 051 043061 well significant influence cluster HCQ interaction p 0001 driven differential association HCQ mortality high 089 065122 low risk cluster 046 039054 effect survived adjustment additional medication use concordant association disease severity outcome finding suggest particularly beneficial effect HCQ within low risk Covid19 patient may contribute clarifying current controversy HCQ efficacy Covid19 treatment,
Risk factor mortality hospitalized patient COVID19 three hospital Peru retrospective cohort study,34211701,BACKGROUND Peru one country highest COVID19 mortality worldwide first stage pandemic relevant evaluate risk factor mortality patient hospitalized COVID19 three hospital Peru 2020 March May 2020 Methods carried retrospective cohort study population consisted patient three Peruvian hospital hospitalized diagnosis COVID19 MarchMay 2020 period Independent sociodemographic variable medical history symptom vital function laboratory parameter medical treatment evaluated Inhospital mortality assessed outcome performed Cox regression model crude adjusted evaluate risk factor inhospital mortality Hazard ratio HR respective 95 confidence interval 95 CI calculated Results analyzed 493 hospitalized adult 728 n=359 male mean age 633 + 144 year COVID19 symptom appeared average 79 + 40 day admission hospital mean oxygen saturation admission 826 + 138 676 n=333 required intensive care unit admission 33 n=16 admitted unit 602 n=297 sample died adjusted regression analysis found 60 year old older HR=157 95 CI 114215 two comorbidities HR=153 95 CI 110214 oxygen saturation 8580 HR=252 95 CI 158402 le 80 HR=459 95 CI 301700 middle HR=165 95 CI 115239 higher tertile HR=218 95 CI 151315 neutrophiltolymphocyte ratio increased risk mortality Conclusions risk factor found agree described literature allow identification vulnerable group monitoring early identification symptom prioritized order reduce mortality,adults;covid-19;latin america.;mortality;sars-cov-2
Inflammation COVID19 pathogenesis treatment,34367415,coronavirus disease 2019 COVID19 declared pandemic March 2020 World Health Organization date 163 million confirmed case COVID19 disease claimed 33 million life globally many disease inflammation key feature COVID19 inflammation overwhelming may lead unfavorable outcome even death Scientists world working tirelessly search therapeutic strategy suppress modulate inflammation COVID19 review give overview role inflammation COVID19 also critically examines various treatment approach target immune system inflammation COVID19 well highlight key finding numerous study conducted thus far,covid-19;sars-cov-2;cytokine storm;inflammation;pharmacotherapy
Antimalarial drugsare beneficial rheumatic viral disease considerations COVID19 pandemic,34218393,majority medical fraternity continuously involved finding new therapeutic scheme including antimalarial medication AMDs useful combating 2019nCoV coronavirus disease COVID19 many decade AMDs widely used treatment malaria various antiinflammatory disease particularly treat autoimmune disorder connective tissue review comprises vitro vivo study original study clinical trial consensus report analysis available medical database eg PubMed manuscript summarizes current knowledge chloroquine CQ hydroxychloroquine HCQ show difference use activity recommendation dos adverse effect two group patient rheumatic viral disease including COVID19 case connective tissue disorder AMDs prescribed prolonged duration small dos effect observed week whereas case viral infection prescribed larger dos short duration achieve quick saturation effect rheumatic disease AMDs well tolerated side effect rare However viral disease effect AMDs questionable noticeable suggested initial prognosis mainly used additive therapy antiviral drug recent study shown AMDs diminish efficacy antiviral drug may cause respiratory kidney liver cardiac complication,antimalarial drugs;covid-19;rheumatic diseases;viral diseases
Integration virtual physician visit provincial 811 health information telephone service COVID19 pandemic descriptive study HealthLink BC Emergency iDoctorinassistance HEiDi,34131026,BACKGROUND British Columbia like many jurisdiction health information telephone service 811 provide caller information registered nurse help decide whether attend emergency department primary care clinic manage concern home describe new service HealthLink BC Emergency iDoctorinassistance HEiDi partnered physician available videoconferencing 811 registered nurse support caller METHODS Apr 6 Aug 2 2020 caller 811 telephone service available anyone BC categorized `` seek care within 24 hour registered nurse eligible referral HEiDi HEiDi physician `` virtual physician connected directly caller via desktop videoconferencing software assessed health complaint provided advice suggested care disposition conducted descriptive study collected demographic characteristic health concern disposition determined virtual physician RESULTS HEiDi virtual physician provided 7687 consultation patient n = 4439 578 2064 age range 4814 629 female Common health concern related gastroenterology n = 1275 166 respiratory n = 877 114 dermatology n = 874 114 7531 call available data 2548 338 caller advised attempt home treatment 2885 383 contact primary care physician within 1 week 1131 150 attend emergency department immediately 538 71 attend primary provider INTERPRETATION found virtual physician able advise nearly 3 4 721 patient away inperson emergency clinic assessment 1 7 150 seek immediate emergency department care Virtual physician provide effective complement provincial health telephone system,
Human Defensins Inhibit SARSCoV2 Infection Blocking Viral Entry,34206990,Innate immunity acute infection play critical role disease severity severe acute respiratory syndrome SARS Middle East respiratory syndrome MERS likely contribute COVID19 disease outcome Defensins highly abundant innate immune factor neutrophil epithelial cell including intestinal Paneth cell exhibit antimicrobial immunemodulatory activity study investigated effect human alpha betadefensins RC101 thetadefensin analog SARSCoV2 infection found human neutrophil peptide HNPs 13 human defensin HD 5 RC101 exhibited potent antiviral activity pseudotyped virus expressing SARSCoV2 spike protein HNP4 HD6 weak antiSARSCoV2 activity whereas human betadefensins HBD2 HBD5 HBD6 effect HNP1 HD5 RC101 also inhibited infection replicationcompetent SARSCoV2 virus SARSCoV2 variant Pretreatment cell HNP1 HD5 RC101 provided protection viral infection defensins effect provided postinfection indicating effect directed towards viral entry Indeed HNP1 inhibited viral fusion binding spike receptorbinding domain hACE2 antiSARSCoV2 effect defensins influenced structure peptide linear unstructured form HNP1 HD5 lost antiviral function ProHD5 precursor HD5 block infection SARSCoV2 High virus titer overcame effect low level HNP1 indicating defensins act virion HNP1 HD5 RC101 also blocked viral infection intestinal lung epithelial cell protective effect defensins reported suggest may useful additive antivirus arsenal thoroughly studied,sars-cov-2;antimicrobial peptides;defensins
Occurrence SARSCoV2 RNA Six Municipal Wastewater Treatment Plants Early Stage COVID19 Pandemic United States,34201687,study investigated occurrence Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 RNA primary influent n = 42 secondary effluent n = 24 tertiary treated effluent n = 34 collected six wastewater treatment plant WWTPs AF Virginia WWTP Florida WWTPs B C Georgia WWTPs E F United States AprilJuly 2020 100 wastewater sample analyzed eight 19 untreated wastewater sample collected primary influents contained SARSCoV2 RNA measured reverse transcriptase quantitative polymerase chain reaction RTqPCR assay SARSCoV2 RNA detected influent wastewater sample collected WWTP Virginia WWTPs E F Georgia WWTP Florida Secondary tertiary effluent sample positive SARSCoV2 RNA indicating treatment process WWTPs potentially removed SARSCoV2 RNA secondary tertiary treatment process However study needed understand log removal value LRVs transmission risk SARSCoV2 RNA analyzing wastewater sample wider range WWTPs,covid-19;sars-cov-2 rna;transmission risk;wastewater;wastewater treatment
Predictive Score Risk Associated Progression Patients COVID19 Pneumonia Wuhan China ALA Score,34221844,Background Coronavirus Disease 2019 COVID19 become Public Health Emergency International Concern 90 million confirmed case worldwide Therefore study aim establish predictive score model progression severe type patient COVID19 Methods retrospective cohort study 151 patient COVID19 diagnosed nucleic acid test specific serum antibody February 13 2020 March 14 2020 hospitalized COVID19designed hospital Wuhan China Results 151 patient average age 63 year 64 patient male 424 29 patient 192 classified severe group Multivariate analysis showed age 65 year odds ratio = 972 95 CI 2923231 P 0001 lymphocyte count = 11 x 10 9 L = 342 95 CI 124941 P = 0017 AST 35 UL = 319 95 CI 111919 P = 0032 independent risk factor disease severity area curve AUC receiver operating characteristic curve probability composite continuous variable age + lymphocyte + AST 0796 Finally predictive score model called ALA established AUC 083 95 CI 075092 Using cutoff value 95 point positive negative predictive value 541 38701 921 872971 respectively Conclusion ALA score model quickly identify severe patient COVID19 help clinician better choose accurate management strategy,ala score;covid-19;risk factors;severe pneumonia;wuhan
NOX2 Activation COVID19 Possible Implications Neurodegenerative Diseases,34208136,Coronavirus disease 2019 COVID19 rapidly spreading contagious infectious disease caused pathogen severe acute respiratory syndrome coronavirus 2 SARSCoV2 primarily affect respiratory tract well central nervous system CNS SARSCoV2 infection occurs interaction viral protein Spike angiotensin II receptor ACE 2 leading increase angiotensin II activation nicotinamide adenine dinucleotide phosphate oxidase2 NOX2 resulting release reactive oxygen specie ROS inflammatory molecule purpose review explain SARSCoV2 infection determine neuroinflammation induces NOX2 activation microglia better understand role NOX2 inflammation overview involvement neurodegenerative disease NDs Parkinson s disease PD Alzheimer s disease AD amyotrophic lateral sclerosis ALS provided write manuscript performed PubMed search evaluate possible relationship SARSCoV2 infection NOX2 activation microglia well role NOX2 NDs Several study highlighted NOX2 activation microglia amplifies neuroinflammation date clinical treatment capable counteracting activation however NOX2 could promising pharmaceutical target useful treatment prevention NDs COVID19 treatment,covid-19;nox2;central nervous system;neurodegenerative disease;oxidative stress
Adaptive social contact rate induce complex dynamic epidemic,33566839,Epidemics may pose significant dilemma government individual personal public health consequence inaction may catastrophic economic consequence drastic response may likewise catastrophic face tradeoff government individual must therefore strike balance economic personal health cost reducing social contact public health cost neglecting risk infection increase potentially infectious contact people deliberately reduced either individually decree must balanced social economic cost fewer people contact therefore active labor force enrolled school Although importance adaptive social contact epidemic outcome become increasingly recognized important property coupled humannatural epidemic system still well understood develop theoretical model adaptive optimal control effective social contact rate using traditional epidemic modeling tool utility function delayed information utility function trade populationwide contact rate expected cost risk increasing infection analytical computational analysis simple discretetime deterministic strategic model reveals existence endemic equilibrium oscillatory dynamic around equilibrium parametric condition complex dynamic regime shift small parameter perturbation result support supposition infectious disease dynamic adaptive behavior change may indifference point may produce oscillatory dynamic without forcing constitute complex adaptive system associated dynamic Implications epidemic adaptive behavior influence infectious disease dynamic include expectation fluctuation considerable time around quasiequilibrium balance public health economic priority show multiple peak surge scenario implies high degree uncertainty mathematical projection,
Evaluation government strategy COVID19 pandemic using qrung orthopair fuzzy TOPSIS method,34226821,COVID19 outbreak emerged China continues spread rapidly world brought increasing number case death Governments suffered serious damage loss field health also many field directed government adopt implement various strategy community However country succeed partially strategy implemented country failed context necessary identify important strategy implemented government decision problem based decision many expert contradictory multiple criterion taken account order evaluate multiple strategy implemented various government study decision process considered multicriteria decision making MCDM problem also take account uncertainty purpose qrung orthopair fuzzy set qROFSs used allow decisionmakers assessment wider space better deal ambiguous information Accordingly two different Technique Order Preference Similarity Ideal Solution TOPSIS approach recommended qROFS environment applied determine appropriate strategy result proposed approach determine A1 Mandatory quarantine strict isolation strategy best strategy Comparisons qrung orthopair fuzzy MCDM method intuitionistic fuzzy TOPSIS method also presented validation proposed method Besides sensitivity analysis conducted check robustness proposed approach observe effect change q parameter,covid-19;mcdm;q-rung orthopair fuzzy sets;strategy selection;topsis
Appendectomy COVID19 pandemic Italy multicenter ambispective cohort study Italian Society Endoscopic Surgery new technology CRAC study,34219197,Major surgical society advised using nonoperative management appendicitis suggested laparoscopy COVID19 pandemic hypothesis significant reduction number emergent appendectomy observed pandemic restricted complex case study aimed analyse emergent surgical appendectomy pandemic national basis compare period previous year multicentre retrospective observational study investigating outcome patient undergoing emergent appendectomy MarchApril 2019 v MarchApril 2020 primary outcome number appendectomy performed classified according American Association Surgery Trauma AAST score Secondary outcome type surgical technique employed laparoscopic v open complication rate One thousand five hundred forty one patient acute appendicitis underwent surgery two study period 1337 868 patient met inclusion criterion 546 408 patient underwent surgery acute appendicitis 2020 791 592 2019 According AAST patient complicated appendicitis operated 2019 303 v 399 2020 p = 0001 observed increase number postoperative complication 2020 159 compared 2019 96 p 0001 following determinant increased likelihood complication occurrence undergoing surgery 2020 + 67 increase unit AAST score + 26 surgery performed 24 h admission + 58 open surgery + 112 conversion open surgery + 166 Italian hospital March April 2020 number appendectomy drastically dropped first pandemic wave patient undergoing surgery frequently affected severe appendicitis previous year s timeframe experienced higher number complication Trial registration number date Research Registry ID 5789 May 7th 2020,appendectomy;appendicitis;covid-19 pandemic;machine learning
COVID19 Vaccine Acceptance Hesitancy Resistancy among University Students France,34203847,objective explore among university student level COVID19 vaccine acceptance hesitancy resistancy determine motivation barrier reason may change student vaccination decision making online observational crosssectional study conducted among student French university January 2021 question intention vaccinated COVID19 motivation barrier convenience sample included 3089 student mean age 203 SD = 19 question intention vaccinate COVID19 580 student reported would choose vaccination 170 reported would 250 sure main motivation vaccine acceptance `` nt want transmit COVID19 others main barrier vaccine resistance hesitancy `` prefer wait experience new vaccine Age female gender first three year study studied science course neither science healthcare course study significantly associated higher risk vaccine hesitancy resistancy Selfestimated knowledge conventional vaccine COVID19 vaccine confidence efficiency safety conventional vaccination associated lower risk vaccine hesitancy resistancy relevant disseminate evidencebased intervention promote COVID19 vaccine acceptability college student especially student neither science healthcare course study college student soon eligible receive COVID19 vaccine,covid-19;university student;vaccine acceptance;vaccine hesistancy;vaccine resistancy
Increase SARSCoV2 infected biomedical waste among low middleincome country environmental sustainability impact health implication,34293833,Studies shown severe acute respiratory syndrome corona virus2 SARSCoV2 highly infectious disease global death rising 360438 28 May 2020 Different country used various approach lockdown social distancing maintenance personal hygiene increased establishment testing isolation center manage pandemic Poor biomedical waste BMW management treatment disposal technique especially SARSCoV2 infected BMW may threaten environmental public health developing country extension impact economic status individual nation large may increase potential transmission airblood body fluidborne pathogen increase growth microorganism risk mutagenesis upsurge virulent strain contrast uncontrolled substandard burning could increase potential spread nosocomial infection environmental exposure toxic organic compound heavy metal radioactive genotoxic bioaerosols might present gaseous liquid solid byproduct paucity understanding pathophysiology management SARSCoV2 pandemic also necessitated need put place appropriate disposal technique cater sudden increase global demand personal protective equipment PPE pharmaceutical drug manage pandemic reduce risk preventable infection waste Therefore need adequate sensitization awareness environmental monitoring impact improper handling SARSCoV2 infected BMWs Hence review aimed address issue relating improper management increased SARSCoV2 infected BMW low middleincome country LMICs,sars-cov-2;biomedical waste;environmental impact;low middle-income countries;public health
Delayed presentation child emergency department first wave COVID19 pandemic Italy Areabased cohort study,34214214,AIM ascertain delay attendance emergency department ED 2020 lockdown METHODS Areabased cohort study paediatric 015 year attendance resulting hospital admission Tuscany Italy FebruaryMay 2020 corresponding period 201819 analysed time symptom onset arrival odds arriving late 90th centile time paediatrician judgement late presentation logistic model RESULTS expected ED attendance fell sharply 62 2020 v 201819 case studied 455 2020 1161 201819 documented delay arrival ED 2020 versus 201819 several group diagnosis namely gastroenteritis sepsis wound burn infection overall Time presentation 90th centile also higher 2020 odds ratio 144 95 confidence interval 100 206 paediatrician judgement late arrival 189 case 2020 vs 134 201819 158 114 219 CONCLUSION populationbased cohort delayed attendance ED ascertained subjectively objectively convey message family paediatrician seek hospital care case severe unremitting symptom wait longer normally would,covid-19;delayed attendance;emergency medicine;epidemiology;public health
habit fingerlicking getting solution pandemic,34211670,habit fingerlicking insanitary habit observed everywhere including hospital ward medical facility among provider staff member enduring habit present pandemic continue unless serious notice taken Herein illustrate risk imposed everyday habit individual practicing surrounding people describe challenge prior attempt defeat habit explain face mask eliminate everlasting habit,covid-19;finger-licking;sars-cov-2;coronavirus;habit;mask;pandemic
Overlapping Independent SARSCoV2 Nosocomial Transmissions Complex Outbreak,34346709,SARSCoV2 nosocomial outbreak first COVID19 wave likely associated shortage personal protective equipment scarce indication control measure covered limitation update current SARSCoV2 nosocomial outbreak required carried indepth analysis 27day nosocomial outbreak gastroenterology ward hospital potentially involving 15 patient 3 health care worker Patients stayed one three neighboring room ward severity infection six case high fatality rate made clinician suspect possible involvement single virulent strain persisting room Wholegenome sequencing WGS strain 12 patient 1 health care worker revealed unexpected complexity Five different SARSCoV2 strain identified two infecting single patient ruling relationship outbreak remaining three strain involved three independent overlapping limited transmission cluster three three five case Wholegenome sequencing key understand complexity outbreak IMPORTANCE report complex epidemiological scenario nosocomial COVID19 outbreak second wave based WGS analysis Initially standard epidemiological finding led assumption homogeneous outbreak caused single SARSCoV2 strain discriminatory power WGS offered strikingly different perspective consisting five introduction different strain half causing secondary case three independent overlapping cluster study exemplifies complex SARSCoV2 transmission nosocomial setting second COVID19 wave occurred lead extending analysis outbreak beyond initial epidemiological assumption,covid-19;sars-cov-2;genomic epidemiology;nosocomial transmission
Impact COVID19 Pandemic Perception Health TreatmentRelated Issues among Patients Phenylketonuria PolandThe Results National Online Survey,34199184,agreement pandemic affected healthcare system behaviour patient study aim identify problem encountered patient phenylketonuria PKU parentscaregivers sixweek pandemic lockdown Poland 15 March 30 April 2020 determine factor influenced health treatmentrelated issue well respondent perception impact pandemic study participant asked complete nonvalidated online questionnaire comprising 31 question including 27 singlechoice two multiplechoice two openended one total 571 patient parent completed questionnaire 95 respondent performing blood phenylalanine Phe test analysed period 213 declaring blood Phe increase 153 decrease Increased problem contacting doctor dietitian reported 261 subject whereas 393 felt restricted access dietary product 634 participant satisfied remote contact PKU clinic Better compliance associated higher odds acceptance remote contact reporting fewer problem contacting doctor lower odds missing Phe testing Selfreported high stress associated higher odds reporting limited availability lowPhe product Phefree formula well increased Phe concentration nonPKUrelated health problem patient also poor dietary compliance experienced problem contacting specialist Health treatmentrelated problem experienced pandemic lockdown related higher intensity stress patient s family worse therapy compliance pandemic Previous experience remote visit resulted better perception method contact seems form communication popularized improved increase therapy effectiveness case different limitation future Special attention paid vulnerable patient may extra risk provision standard care affected,covid-19 pandemic;pku;compliance;phenylketonuria;remote medicine
Low level plasminogen increase risk mortality COVID19 patient,34354045,pathophysiology coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 especially complication still fully understood fact high number patient COVID19 die thromboembolic cause role plasminogen precursor fibrinolysis hypothesized study aimed investigate association plasminogen level COVID19related outcome population 55 infected Caucasian patient mean age 698 + 143 418 female Low level plasminogen significantly associated inflammatory marker CRP PCT IL6 marker coagulation Ddimer INR APTT marker organ dysfunction high fasting blood glucose decrease glomerular filtration rate multidimensional analysis model including correlation expression coagulation inflammatory parameter indicated plasminogen tended cluster together IL6 hence suggesting common pathway activation disease s complication Moreover low level plasminogen strongly correlated mortality COVID19 patient even multiple adjustment presence confounding data suggest plasminogen may play pivotal role controlling complex mechanism beyond COVID19 complication may useful biomarker prognosis therapeutic target extremely aggressive infection,
Systematic Review Antiphospholipid Antibodies COVID19 Patients Culprits Bystanders,34218350,PURPOSE REVIEW COVID19 patient procoagulant state high prevalence thrombotic event hypothesis involvement antiphospholipid antibody aPL suggested several report reviewed 48 study investigating aPL COVID19 patient RECENT FINDINGS Prevalence Lupus Anticoagulant LA ranged 35 92 ICU patient Anticardiolipin aCL IgG IgM found 52 40 patient respectively Antibeta2glycoprotein abeta2GPI IgG IgM found 39 34 patient respectively 1 12 patient triple positive aPL profile high prevalence abeta2GPI aCL IgA isotype Two cohort study found persistent LA persistent solid phase assay aPL time aPL determination potential role real challenge treatment disease,antiphospholipid antibodies;covid-19;lupus anticoagulant;thrombosis
impact COVID19 pandemic addressing common barrier pharmacybased pointofcare testing,34130575,Introduction Pharmacybased pointofcare testing long potential improve patient access timely care adoption slowed financial regulatory barrier COVID19 pandemic reduced temporarily eliminated many barrier pharmacybased testing review examines change brought may impact pharmacybased testing pandemicAreas Covered review searched peerreviewed lay regulatory literature explore implementation pharmacybased COVID19 testing includes review regulatory financial change removed barrier testing Additionally review literature related growth pharmacybased testingExpert Opinion clear COVID19 pandemic created awareness opportunity pharmacybased pointofcare testing change made response pandemic potential increase role pharmacybased testing additional regulatory change wider pharmacy adoption still needed maximize value service,clia-waived;covid-19;pharmacist;pharmacy;point-of-care testing
Preventive Practice Associated Factors Toward Coronavirus Disease 19 Adigrat Town Northern Ethiopia CommunityBased CrossSectional Study,34211282,Purpose global coronavirus disease 19 pandemic unprecedented crisis unlike since end Second World War Yet successful vaccine treatment reported Even though increasing practice community critical prevent coronavirus disease 19 pandemic limited study Ethiopia particularly study area Therefore study aimed ass practice associated factor toward coronavirus disease 19 Objective ass prevalence associated factor practice toward coronavirus disease 19 prevention Adigrat resident Northern Ethiopia 2020 Methods communitybased crosssectional study design carried among 421 Adigrat Town resident September 10 20 2020 Households selected using systematic sampling technique identify determinant factor binary logistic regression analysis employed confidence interval 95 identify statistically signi fi cant factor adjusted odds ratio AOR used Statisticalsigni fi cance determined Pvalue 005 Results prevalence poor practice 322 95 CI 315385 Age 2029 AOR=21 95 CI 1965 occupational status unemployed AOR=15 CI 95 1419 marital status unmarried AOR=19 95 CI 12125 educational status read write AOR=21 95 CI 2093 statistically signi fi cant factor toward COVID19 prevention Conclusion poor practice toward coronavirus disease 19 prevention significantly high Age occupation marital status educational status significantly associated preventive practice toward coronavirus disease 19 would helpful health professional volunteer inform community continuously giving health education regarding preventive way increase practice,covid-19;ethiopia;practice
Online Media Attention Devoted Flour FlourRelated Food Safety 2017 2020,34347869,light extended stayathome period COVID19 pandemic recent societal trend revealed increased use online medium remain connected Simultaneously interest athome cooking baking particularly comfort food increased Since flour crucial component many product analyze US public social online medium space reference `` flour use also quantify share medium mention flour devoted flourrelated food safety risk andor risk mitigation found volume mention flour use fluctuate seasonally often increasing ahead winter holiday season NovemberDecember time period volume interest rapidly increased March 2020 stayathome order issued share medium devoted flourrelated food safety risk associated illness extremely small generally corresponded flour recall announcement public risk communication Overall interest flour use remains seasonal predictably related societal trend increased baking home holiday 2020 stayathome order However awareness flourrelated food safety risk seems largely absent based online medium data collection analysis except immediate reaction flour recall study suggests flour safety education program may desired support consumer informed decisionmaking,foodborne illness;data analytics;flour;food recalls;risk communication;social media
Understanding small Chinese city COVID19 hotspot urban epidemic hazard index,34282250,Multiple small middlescale city mostly located northern China became epidemic hotspot second wave spread COVID19 early 2021 Despite qualitative discussion potential socialeconomic cause remains unclear unordinary pattern could substantiated quantitative explanation development urban epidemic hazard index EpiRank Chinese prefectural district came mathematical explanation phenomenon index constructed via epidemic simulation multilayer transportation network interconnecting local SEIR transmission dynamic characterizes intra intercity population flow granular mathematical description Essentially argue highlighted small town posse greater epidemic hazard due combined effect large local population small intercity transportation ratio total population population outflow could serve alternative cityspecific indicator hazard effectiveness good EpiRank contribution city determining specific city s epidemic hazard captured via network approach Population alone city GDP valid signal indication proposed index applicable different epidemic setting useful risk assessment response planning urban epidemic hazard China model framework modularized analysis extended nation,
Combined Effects Masking Distance Aerosol Exposure Potential,34218858,OBJECTIVE quantify efficacy masking `` social distancing transmission airborne particle phantom aerosol source simulating infected individual nearby target simulating healthy bystander wellcontrolled setting METHODS aerosol created using monodisperse polystyrene latex bead place infectious respiratory secretion Detection aerodynamic particle spectrometry reusable cloth mask disposable paper mask studied Transmission simulated indoors 3minute interval eliminate effect variable ventilation rate aerosol exposure study commenced September 16 2020 concluded December 15 2020 RESULTS Compared baseline 1foot separation mask employed particle count reduced 84 3 foot separation 97 6 foot modest decrease particle count observed receiver masked substantial exposure reduction occurred aerosol source masked party masked source target masked particle count reduced 995 baseline regardless separation distance type mask employed CONCLUSION result support principle layered protection mitigate transmission SARSCoV2 virus causing COVID19 respiratory virus emphasize importance controlling spread aerosol source combination masking distancing reduced exposure exhaled particulate individual measure Combined measure remain effective way combat spread respiratory infection,
Agricultural worker meatpacking plant presenting emergency department suspected COVID19 infection disproportionately Black Hispanic,34133805,OBJECTIVE Facilities process package meat consumer sale consumption meatpacking plant early site coronavirus disease 2019 COVID19 outbreak aim study characterize association meatpacking plant exposure clinical outcome among emergency department ED patient COVID19 symptom METHODS retrospective cohort study patient presenting single ED March 1 May 31 2020 1 symptom consistent COVID19 2 COVID19 test performed primary outcome COVID19 positivity secondary outcome included hospital admission ED ventilator use intensive care unit ICU admission hospital length stay LOS 48 =48 h mortality RESULTS Patients meatpacking plant likely Black Hispanic ED patient without occupational exposure Patients meatpacking plant exposure likely test positive COVID19 adjusted relative risk aRR = 237 95 confidence interval CI = 159 353 similar rate hospital admission aRR = 094 95 CI = 082 107 hospital LOS aRR = 076 95 CI = 045 123 significant difference ventilator use among patient meatpacking nonmeatpacking plant exposure 82 vs 111 p = 0531 ICU admission 41 vs 120 p = 0094 mortality 20 vs 41 p = 0473 CONCLUSIONS Workers meatpacking plant Iowa higher rate testing positive COVID19 likely hospitalized illness patient disproportionately Black Hispanic,
Insourcing scaling telemedicine solution 2 week Lessons digital transformation health care,34293616,Covid19 pandemic required rapid scale telemedicine well digital workflow maintain access care reducing infection risk patient clinician nt used telemedicine suddenly faced multistep setup process log virtual meeting Unlike inperson examination room locking virtual meeting room errorprone posed risk multiple patient joining online session administrative burden practice staff generating manually sending link patient educating patient device set timeconsuming unsustainable solution deployed rapidly systemwide without usual roll across month answer design implement novel EHRintegrated web application called Switchboard two week Switchboard leverage commercial cloudbased video meeting platform facilitates endtoend virtual care encounter workflow previsit reminder postvisit SMS text messagebased measurement patient experience tool extend contactless workflow inperson appointment first 11 month pandemic inhouse platform adopted across 6 hospital 200 practice scaled 8800 clinician peak conducted average 30000 telemedicine appointmentsweek enabled 1000020000 text messagesday exchanged platform Furthermore enabled organization convert average 75 telehealth visit conducted via telephone 75 conducted via video within week,connected health;digital transformation;health it;informatics;innovation;telemedicine
Subtotal colectomy refractory ulcerative colitis COVID19 infection first case report Japan,34213760,report 60yearold male transferred hospital operation refractory ulcerative colitis UC diagnosed infected COVID19 SARSCoV2 PCR test positive time transfer determined emergency operation general condition poor malnutrition ADL decline due exacerbation UC air embolization central venous catheter removal underwent subtotal colectomy sigmoid mucous fistula ileostomy well postoperatively first case report Japan underwent operation UC COVID19 infection,covid-19;colectomy;ulcerative colitis
Population Pharmacokinetics Favipiravir Patients COVID19,34292670,antiretroviral drug favipiravir inhibits RNAdependent RNA polymerase developed treatment novel coronavirus SARSCoV2 infection disease COVID19 However pharmacokinetics patient COVID19 poorly understood study measured favipiravir serum concentration liquid chromatographytandem mass spectrometry conducted population pharmacokinetic PPK analysis Thirtynine patient enrolled study 33 administered FPV 1600 mg twicedaily BID first day followed 600 mg BID 6 administered FPV 1800 mg BID first day followed 800 mg 600 mg BID median age 68 year range 2789 year male 31 795 median body surface area BSA 172 2 range 11122 patient requiring invasive mechanical ventilation IMV start favipiravir 10 256 Twohundred four serum concentration available pharmacokinetic analysis onecompartment model firstorder elimination used describe pharmacokinetics estimated mean clearancebioavailability CLF distribution volumebioavailability VF 511 Lh 416 L respectively Covariate analysis revealed CLF significantly related dosage IMV use BSA Simulation study showed 1600 mg600 mg BID regimen insufficient treatment COVID19 targeting EC50 97microgmL especially patient larger BSA andor IMV higher favipiravir dosage required COVID19 dosedependent nonlinear pharmacokinetics may cause unexpected significant pharmacokinetic change drug toxicity study warranted explore optimal favipiravir regimen,covid-19;favipiravir;sars-cov-2
Right ventricular dysfunction right ventriculararterial uncoupling admission increase inhospital mortality patient COVID19 disease,34286870,BACKGROUND Coronavirus disease 2019 COVID19 frequently involves cardiovascular manifestation right ventricular RV dysfunction alteration pulmonary hemodynamics evaluated application critical care ultrasonography ORACLE protocol identify frequent alteration influence adverse outcome especially involving RV dilatation dysfunction METHODS crosssectional study included 204 adult patient confirmed COVID19 admitted three center Echocardiography lung ultrasound image acquired admission using ORACLE ultrasonography algorithm RESULTS Twohundred four consecutive patient evaluated 22 119 demonstrated fractional shortening 35 33 171 tricuspid annular plane systolic excursion TAPSE 17 mm 26 135 tricuspid peak systolic wave tissue Doppler velocity 95 cmsec 69 375 RV basal diameter 41 mm 119 583 pulmonary artery systolic pressure PASP 35 mm Hg 14 11 TAPSEPASP ratio 31 inhospital mortality rate 376 n = 71 Multiple logistic regression modeling showed PASP 35 mm Hg RV FS 35 TAPSE 17 mm RV wave 95 TAPSEPASP ratio 31 mmmm Hg associated outcome PASP TAPSEPASP ratio lowest feasibility obtained among investigator 622 CONCLUSION presence RV dysfunction pulmonary hypertension alteration RVarterial coupling conveys increased risk inhospital mortality patient presenting COVID19 upon admission therefore searching alteration routine parameter obtained quickly safely ORACLE protocol,covid-19 disease;critical care echocardiography;right ventricular dysfunction
Prevalence Factors Associated Reuse Mask COVID19 Pandemic Nationwide Survey Taiwan,34360358,Mask usage effective measure prevent severe acute respiratory syndrome coronavirus 2 SARSCOV2 infection however mask reuse recommended Studies examining factor associated mask reuse coronavirus disease COVID19 pandemic limited nationwide survey aimed determine prevalence factor associated mask reuse among Taiwanese citizen pandemic 18 May 31 May 2020 computerassisted telephone interview system used randomly select Taiwanese citizen interview regarding COVID19preventive behavior knowledge mask usage total 1075 participant overall mean age 574 year 822 participant reported mask reuse COVID19 pandemic controlling covariates participant greater knowledge mask usage high supply mask le likely reuse mask pandemic Moreover generalized estimating equation GEE analysis showed compared participant maskwearing behavior COVID19 pandemic likely reuse mask pandemic Thus imperative educate people correct usage mask Furthermore government provide sufficient mask general population reduce mask reuse,covid-19;sars-cov-2;knowledge on usage of masks;reuse of masks
Intense Mild First Epidemic Wave Coronavirus Disease Gambia,34286683,severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic evolving differently Africa region Africa lower SARSCoV2 transmission rate milder clinical manifestation Detailed SARSCoV2 epidemiologic data needed Africa used publicly available data calculate SARSCoV2 infection per 1000 person Gambia evaluated transmission rate among 1366 employee Medical Research Council Unit Gambia MRCG systematic surveillance symptomatic case contact tracing implemented September 30 2020 Gambia identified 3579 SARSCoV2 case including 115 death 67 case identified August Among infection MRCG staff accounted 191 case asymptomatic mild cumulative incidence rate among nonclinical MRCG staff 124 infections1000 person 80fold higher estimate diagnosed case among population Systematic surveillance seroepidemiologic survey needed clarify extent SARSCoV2 transmission Africa,africa;covid-19;sars;sars-cov-2;the gambia;coronavirus;coronavirus disease;disease burden;severe acute respiratory syndrome coronavirus 2;severity respiratory infections;transmission rate;viruses;zoonoses
HD5 LL37 Inhibit SARSCoV SARSCoV2 Binding Human ACE2 Molecular Simulation,34363600,coronavirus COVID19 pandemic still spreading world reported angiotensinconverting enzyme2 ACE2 receptor SARSCoV2 spike protein initializes viral entry host cell Previously human defensin 5 HD5 experimentally confirmed functional SARSCoV2 present study proposes human cathelicidin known LL37 strongly bind carboxypeptidase domain human ACE2 compared HD5 Therefore LL37 bear great potential tested antiSARSCoVD2 peptide investigated molecular interaction formed LL37 ACE2 well HD5 ACE2 tailed thermodynamic stability MMPBSA free energy landscape analysis outcome confirmed possible inhibitory effect SARSCoV2 result obtained could help propose promising therapeutic strategy havoc caused SARSCoV2 infection,human ace2;mm-pbsa;molecular simulation;sars-cov;sars-cov-2
COVID19Related Pericarditis Pericardial Clotting Hallmark Two Cases Review,34221878,prevalence pericardial effusion clinical significance well understood COVID19 patient report two case COVID19related pericardial effusion complicated intrapericardial clot formation final outcome favorable intrapericardial clot remained mostly unchanged 6month followup treatment approach longterm consequence still unclear propose review particular cardiovascular complication COVID19 patient,cardiovascular complications;covid-19;echocardiography
Management liver disease Italy one year SARSCoV2 pandemic webbased survey,34219343,,covid19;hcc;sars-cov-2;cirrhosis;liver transplant
coSIR model predicts effective strategy limit spread SARSCoV2 variant low severity high transmissibility,34334951,Multiple new variant SARSCoV2 identified COVID19 pandemic spread across globe However epidemic model view virus static unchanging thus fail address consequence potential evolution virus built competitive susceptibleinfectedremoved coSIR model simulate competition virus strain differing severity transmissibility various virus control policy coSIR model predicts although virus extremely unlikely evolve `` super virus cause increased fatality rate virus variant le severe symptom lead potential new outbreak cost life time present model also demonstrates protocol restricting transmission virus wearing mask social distancing effective strategy reducing total mortality combination adequate testing strict quarantine powerful alternative policy mandatory stayathome order may enormous negative impact economy addition building Mobile Cabin Hospitals effective efficient reducing mortality rate highly infectious virus strain Supplementary Information online version contains supplementary material available 101007s11071021067058,covid-19;covid-19 control strategy;competitive evolution;sars-cov-2 evolution;sir model
Rare cutaneous adverse effect COVID19 vaccine case series review literature,34363637,Among vaccine coronavirus disease 2019 COVID19 BNT162b2 BioNtechPfizer mRNA1273 Moderna mRNA vaccine targeting Spike protein Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 ChAdOx1 nCoV19 AZD1222 OxfordAstraZeneca based adenovirus expressing fulllength Spike protein Clinical trial reported different cutaneous adverse event mainly local injection site reaction either immediate delayed onafter 8 day,covid-19 vaccines;cutaneous adverse effects
Determining Incidence Asymptomatic SARSCoV2 among Early Recipients COVID19 Vaccines Prospective Cohort Study Healthcare Workers Vaccination DISCOVERCOVID19,34363462,impact COVID19 vaccination viral characteristic breakthrough infection unknown prospective cohort study incidence SARSCoV2 infection decreased following vaccination Although asymptomatic positive test observed following vaccination higher cycle threshold repeat negative test inability culture virus raise question clinical significance,covid;sars-cov2;incidence;pandemic;vaccine
SARSCoV2 Seroprevalence Neutralizing Antibody Response First Second COVID19 Pandemic Wave Croatia,34203060,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 novel coronavirus pandemic spread far total 349910 SARSCoV2 case 7687 death reported Croatia analyzed seroprevalence neutralizing NT antibody response Croatian general population first MayJuly 2020 second December 2020February 2021 pandemic wave Initial serological testing performed using commercial ELISA confirmation reactive sample virus neutralization test VNT significant difference overall seroprevalence rate found first ELISA 22 VNT 02 second wave ELISA 251 VNT 187 Seropositive individual detected age group significant difference according age lowest prevalence NT antibody documented youngest 10 year 161 oldest 606970+ year 160 128 respectively age group However age group showed highest median NT titer 3264 group seropositivity varied 193 215 significant weak positive correlation binding antibody level detected ELISA VNT titer rho = 0439 p 0001 observed SARSCoV2 NT antibody titer seem agerelated highest NT activity child 10 year individual 50 year,covid-19;croatia;elisa;sars-cov-2;vnt;seroprevalence
Acute Bronchiolitis Covid19 Pandemic,34219854,INTRODUCTION autumn winter bronchiolitis epidemic virtually disappeared first year COVID19 pandemicOur objective characterise bronchiolitis fourth quarter 2020 role played SARSCoV2 METHODS Prospective multicentre study performed Madrid Spain October December 2020 including child admitted acute bronchiolitis Clinical data collected multiplex PCR respiratory virus performed RESULTS Thirtythree patient hospitalised bronchiolitis study period 28 corresponded rhinovirus RV 4 SARSCoV2 1 type infection SARCoV2 bronchiolitis comparable RV bronchiolitis except shorter hospital stay significant decrease admission rate bronchiolitis found RSV isolated CONCLUSION SARSCoV2 infection rarely cause acute bronchiolitis associated severe clinical course COVID19 pandemic period marked decrease bronchiolitis case,covid-19;sars-cov-2;bronchiolitis;children;pandemic;rhinovirus;sincitial respiratory virus
Ig vasculitis nephritis henochschonlein purpura covid19 case series review literature,34366528,COVID19 related glomerular disease date seems collapsing glomerulopathy mostly young Afroamerican patient APOL1 gene risk allele However population predominant elderly Caucasian patient biopsied pathology since beginning pandemic IgA nephritis SchonleinHenoch purpuraSince description first case entity SARSCoV2 infection research group three case arisen described following article contrast rest IgA vasculitis case reported patient presented renal function deterioration required immunosupresive therapy Moreover showed incomplete recovery renal functionThis case series strengthens hypothesis SARSCoV2 infection may another trigger pathology,covid-19;iga vasculitis;nephropathy;sars-cov-2;schonlein-henoch purpura
Pulmonary embolism coronavirus disease 2019 silent killer,34334899,Background Pulmonary embolism PE identified one deadliest complication coronavirus disease 2019 COVID19 especially patient admitted intensive care unit ICU Western literature reminds u high prevalence PE COVID report series 13 case PE diagnosed managed hospital Methods Retrospective analysis medical record 13 case PE admitted hospital February 1 2020 September 31 2020 done clinical laboratory radiologic data assessed detail Results Computed tomography pulmonary arteriography used make diagnosis eight patient 6153 clinical finding corroborative ultrasound laboratory parameter used label PE five patient 3846 Five patient hemodynamically unstable requiring thrombolysis recombinant tissue plasminogen activator four patient 3076 suffered fatal outcome Conclusion COVID19 highly prothrombotic state physician keep high vigilance PE hospitalized patient COVID19 especially admitted ICU prophylactic anticoagulation worsening started therapeutic regimen Patients time discharge switched oral anticoagulation continued least 36 month,covid-19;pulmonary embolism;sars-cov-2
Cellular humoral immune response mRNA1273 SARSCoV2 vaccine liver heart transplant recipient,34291552,Recently published study found impaired immune response SARSCoV2 vaccination solid organ recipient However study assessed immune cellular response liver heart transplant recipient prospectively studied heart liver transplant recipient eligible SARSCoV2 vaccination Patients past history SARSCoV2 infection SARSCoV2 detectable antibody IgM IgG excluded assessed IgMIgG antibody ELISpot protein 4 week receiving second dose mRNA1273 Moderna vaccine Side effect troponin liver test antiHLA donorspecific antibody DSA also assessed total 58 liver 46 heart recipient received two dos mRNA1273 vaccine Median time transplantation vaccination 54 year IQR 0327 Sixtyfour percent patient developed SARSCoV2 IgMIgG antibody 79 SELISpot positivity Ninety percent recipient developed either humoral cellular response 87 heart recipient 93 liver recipient Factors associated vaccine unresponsiveness hypogammaglobulinemia vaccination first year transplantation Local systemic side effect mild moderate none presented DSA graft dysfunction vaccination Ninety percent patient develop humoral cellular response mRNA1273 vaccine Factors associated vaccine unresponsiveness hypogammaglobulinemia vaccination first year transplantation highlighting need protect patient,t cell biology;basic (laboratory) research/science;clinical research/practice;heart transplantation/cardiology;immune regulation;infection and infectious agents - viral;infectious disease;liver transplantation/hepatology;monitoring: immune
Perinatal health care access childbirth concern birthing decisionmaking among pregnant people California COVID19,34215218,BACKGROUND public health emergency including COVID19 pandemic access adequate healthcare crucial providing health wellbeing family Pregnant postpartum people particularly vulnerable subgroup consider studying healthcare access perinatal people likely higher risk illness mortality morbidity COVID19 infection also higher risk negative outcome due delayed inadequate access routine care METHODS surveyed 820 pregnant people California two wave COVID19 pandemic 1 nonsurge wave June 2020 n = 433 2 surge case December 2020 n = 387 describe current access perinatal healthcare well concern decisionmaking regarding childbirth time also examined whether existing structural vulnerability including acute financial insecurity racialethnic minoritization associated access concern decisionmaking two wave RESULTS Pregnant Californians generally enjoyed access fewer concern perinatal healthcare winter 20202021 despite surging COVID19 case hospitalization compared surveyed COVID19 lull summer 2020 However across surge nonsurge pandemic circumstance marginalized pregnant people continued fare worse especially facing acute financial difficulty racially minoritized individual identifying Black Indigenous CONCLUSIONS important clinician researcher policymakers understand whether shifting community transmission infection rate may impact access perinatal healthcare Targeting minoritized financially insecure community increased upstream perinatal healthcare support promising avenue blunt negative impact COVID19 pandemic pregnant people California,covid-19;california;childbirth;decision-making;financial insecurity;healthcare access;perinatal;pregnancy;racial/ethnic minoritization;sars-cov-2
role Tcell exhaustion Long COVID19 severe outcome several category COVID19 patient,34288064,Unusual mortality rate difference symptom experienced COVID19 patient postinfection symptom called Long COVID19 also widely experienced substantial percentage COVID19infected individual specific health category virtually asymptomatic several individual health category exhibited several unusual symptom yet individual health category fatal outcome hypothesized difference mortality rate symptom could caused SARSCoV2 virus infection acting together one latent pathogen infection certain patient mutually beneficial induced immune cell dysfunction including Tcell exhaustion latent pathogen infection likely involved protozoan parasite Toxoplasma gondii infects approximately one third global human population Furthermore certain infection cancer cause Tcell exhaustion also explain severe outcome COVID19 patient several disease cancer comorbidities,sars-cov-2 mortality;brain infections;latent infections;protozoa;protozoan infections
COVID19 Community Transmission among Healthcare Workers Tertiary Care Cardiac Center,34209161,Aim determine frequency mode transmission outcome Coronavirus Disease 2019 COVID19 among healthcare worker HCWs tertiary care cardiac center Kingdom Saudi Arabia KSA Methods retrospective study Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 infected HCWs conducted 2 March 31 December 2020 Data related presence COVID19 symptom mode transmission hospitalization mortality collected patient medical record Results 4462 patient tested COVID19 realtime reverse transcriptase polymerase chain reaction RTPCR 203 45 HCWs positive 125 616 male common age group 40 year commonly encountered health professional nurse 74 364 followed therapiststechnicians 48 236 housekeeper 25 123 physician 21 104 majority 184 906 HCWs contracted COVID19 community 19 94 healthcareassociated infection infected HCWs 169 833 mild symptom managed home isolation common symptom fever 128 631 body ache 124 618 headache 113 557 dry cough 123 606 sore throat 97 478 body weakness 97 478 fatigue 94 463 Comparing male female significantly higher number female nurse contrast higher number male physician housekeeper therapiststechnicians specialty HCWs significantly lower number nurse therapiststechnicians infected =40 year age group compared 40 year Furthermore significantly higher difference observed among nonSaudi nurse compared Saudi nurse mortality documented among included HCWs Conclusions largest tertiary cardiac center KSA HCWs contracted COVID19 developed mild symptom nurse aged 40 year commonly infected infection acquired community HCWs adherence mitigation measure outside workplace vital curb current pandemic decrease nosocomial transmission risk,covid-19;kingdom of saudi arabia;cardiac center;community transmission;healthcare workers;mortality
possible protective role Bacillus CalmetteGuerin therapy urinary bladder cancer era COVID19 brief report,34222132,Given systemic immunogenic effect Bacillus CalmetteGuerin BCG therapy patient bladder cancer nonspecific immunogenic effect viral respiratory disease aimed study severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection bladder cancer patient history BCG therapy present study bladder cancer survivor history BCG therapy identified included study according data recovered UORC UroOncology Research Center registry database patient followed term acquiring coronavirus disease 2019 COVID19 Among studied patient 102 eligible bladder cancer patient history BCG therapy entered study male constituted majority patient 863 half study population 559 65 year old Among understudy patient 127 confirmed COVID19 study result show statistically significant association time number BCG therapy course SARSCoV2 infection Although statistically significant association observed receiving BCG therapy developing COVID19 infection rate patient recently received BCG therapy lower received therapy year ago,bcg therapy;covid-19;urinary bladder neoplasms
Adopting medical technology case fasttracked approach,34338021,NHS always struggled effectively adopt innovative medical technology report Medical Technology Group argues new system widespread adoption technology needed report argues considering growing backlog procedure caused COVID19 pandemic medical technology increase efficiency deliver better outcome patient helping NHS recover,
COVID19 Ocular Prophylaxis Potential Role OzonatedOils Liposome Eyedrop Gel,34351367,Purpose ass whether ozonatedoil liposome eyedrop gel OED could used prevent severe acute respiratory syndromecoronavirus 2 SARSCoV2 infection vitro infection model Methods First tested efficacy OED vitro cell regeneration dry eye resolution human corneal epithelial cell hCE2 Second assessed vitro antiSARSCoV2 infection efficacy OED using Vero E6 cell Tissues examined ass different parameter morphology histology mRNA expression 24 hour treatment Results OED could restore 50 scratch monolayer hCE2 cell vitro compared 25 obtained phosphatebuffered saline solution PBS 24 hour treatment OED number microvilli mucin network restored observed using scanning electron microscopy Vero E6 cell infected primary SARSCoV2 strain treated OED two timesday viral replication found inhibited 70fold reduction observed 72 hour infection compared untreated PBStreated condition Conclusions SARSCoV2 transmission ocular surface ignored Although prevalence coronavirus disease 2019 conjunctivitis infection low need barrier prevent possible viral infection warranted OED treatment may prevent risk SARSCoV2 infection 72 hour twicedaily application Translational Relevance Dry eye condition might risk factor SARSCoV2 infection OED treatment may preventive role,
Viral Load SARSCoV2 Respiratory Aerosols Emitted COVID19 Patients Breathing Talking Singing,34358292,BACKGROUND Multiple SARSCoV2 superspreading event suggest aerosol play important role driving COVID19 pandemic better understand airborne SARSCoV2 transmission occurs sought determine viral load within coarse 5mum fine =5mum respiratory aerosol produced breathing talking singing METHODS Using GII exhaled breath collector measured viral RNA coarse fine respiratory aerosol emitted COVID19 patient 30 minute breathing 15 minute talking 15 minute singing RESULTS Thirteen participant 59 emitted detectable level SARSCoV2 RNA respiratory aerosol including 3 asymptomatic 1 presymptomatic patient Viral load ranged 635821 N gene copy per expiratory activity per participant high persontoperson variation Patients earlier illness likely emit detectable RNA Two participant sampled day 3 illness accounted 52 total viral load Overall 94 SARSCoV2 RNA copy emitted talking singing Interestingly 7 participant emitted virus talking singing Overall fine aerosol constituted 85 viral load detected study Virus culture negative CONCLUSIONS Fine aerosol produced talking singing contain SARSCoV2 copy coarse aerosol may play significant role SARSCoV2 transmission Exposure fine aerosol especially indoors mitigated Isolating viable SARSCoV2 respiratory aerosol sample remains challenging whether easily accomplished emerging SARSCoV2 variant urgent enquiry necessitating largerscale study,covid-19;sars-cov-2;aerosol transmission;airborne transmission;respiratory virus transmission;severe acute respiratory syndrome coronavirus 2
Stem Cell Theory Cancer Implications Viral Etiology Certain Malignancies,34205851,1911 Peyton Rous Nobel Prize winner 1966 demonstrated virus ie RSV caused cancer chicken 1976 Bishop Varmus Nobel Prize winner 1989 showed cellular origin retroviral oncogene actually normal cellular gene ie protooncogene article revisit role virus play genetic origin cancer review link virus cancer autoimmunity alternative stem cell origin cancer propose virus likely cause cancer infects progenitor stemlike cell rather progeny differentiated cell postulate known eg HBV HPV novel virus eg SARSCoV2 pose imminent threat emergence chronic viral disease well virally induced malignancy Knowing origin cancer profound implication current conception perception cancer affect conduct cancer research delivery cancer care would ironic virus turn useful tool ideal mean quest verify genetic versus stem cell origin cancer pertains oncology recapitulates ontogeny although genetic makeup pivotal cellular context may paramount elucidating stem cell origin cancer,covid-19;hbv;hpv;sars-cov-2;autoimmunity;cancer stem cell
RNA sensor MDA5 detects SARSCoV2 infection,34211037,Human cell respond infection SARSCoV2 virus cause COVID19 producing cytokine including type III interferon IFNs proinflammatory factor IL6 TNF IFNs limit SARSCoV2 replication cytokine imbalance contributes severe COVID19 studied cell detect SARSCoV2 infection report cytosolic RNA sensor MDA5 required type III IFN induction lung cancer cell line Calu3 upon SARSCoV2 infection Type III IFN induction required MAVS IRF3 contrast induction IL6 TNF independent MDA5MAVSIRF3 axis setting found SARSCoV2 infection inhibited ability cell respond IFNs sum identified MDA5 cellular sensor SARSCoV2 infection induced type III IFNs,
Preterm birth associated asymptomaticmild SARSCoV2 infection per se Prepregnancy state matter,34351922,Evidence real impact severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection preterm birth unclear available series report composite pregnancy outcome andor stratify patient according disease severity purpose research determine real impact asymptomaticmild SARSCoV2 infection preterm birth due maternal respiratory failure casecontrol study involved woman admitted Sant Anna Hospital Turin delivery 20 September 2020 9 January 2021 cumulative incidence Coronavirus disease19 compared preterm birth case group n = 102 fullterm delivery control group n = 127 woman spontaneous medicallyindicated preterm birth placental vascular malperfusion pregnancyrelated hypertension complication included Current past SARSCoV2 infection determined nasopharyngeal swab testing detection IgMIgG antibody blood sample significant difference cumulative incidence Coronavirus disease19 case 21102 205 control group 32127 251 P= 050 observed although case group burdened higher prevalence three known risk factor body mass index 249 asthma chronic hypertension severe Coronavirus disease19 Logistic regression analysis showed asymptomaticmild SARSCoV2 infection independent predictor spontaneous medicallyindicated preterm birth due pregnancyrelated hypertension complication 077 95 confidence interval 041143 Pregnant patient without comorbidities need reassured asymptomaticmild SARSCoV2 infection increase risk preterm delivery Preterm birth severe Coronavirus disease19 share common risk factor ie body mass index 249 asthma chronic hypertension may explain high rate indicated preterm birth due maternal condition reported literature,
Improving Emergency Room Utilization COVID19 Pandemic Telemedicine Social Determinants Health Outreach Approach,34211654,Highrisk patient age 65 chronic medical condition yet primary care visit within 2020 identified subgroup patient participated survey ass social determinant health SDOH setting pandemic Outcomes participated survey participate compared Notably surveyed lived within zip code low socioeconomic status significantly decreased emergency department visit defined discharge emergency department without hospitalization compared receive outreach Rates inpatient hospitalization differ significantly finding suggest patient outreach evaluate SDOH pandemic lead appropriate emergency department hospital resource utilization finding particularly impactful given current pandemic may place strain emergency department healthcare resource,covid-19;social determinants of health;outreach;telemedicine
Safety Precautions SelfPerformed Severe Acute Respiratory Syndrome Coronavirus 2 Tests Case Swallowed Swab,34221756,Oropharyngeal nasopharyngeal specimen collected swabbing pillar severe acute respiratory syndrome coronavirus 2 SARSCoV2 diagnostics Commercially available rapid antigen test selfsampling polymerase chain reaction service made specimen collection available anytime anywhere nonmedical setting study report case 45yearold man accidentally ingested swab selfperformed SARSCoV2 rapid antigen testing Imaging study revealed elongated foreign body stomach Urgent gastroscopy confirmed presence swabbing applicator gastric lumen retrieved using loop without complication Millions SARSCoV2 test performed daily increasing proportion performed laypeople Foreign body account particular set complication avoided cautious sampling using correct technique Radiopaque labeling instrument would useful Otherwise rare serious event occur may require immediate medical intervention,adverse event;computed tomography;covid-19;foreign body;gastroscopy;sars-cov-2;self-testing
Knowledge attitude practice second wave COVID19 outbreak crosssectional study various perspective,34212710,Aim investigate knowledge attitude practice towards COVID19 among selected population Methods anonymous online questionnaire based Chinese study distributed via online social medium platform among general population Bosnia Herzegovina Germany India Kosovo Romania Results total 1032 subject predominately female 615 596 mean age 3123+1294 year single 705 683 high school degree lower 469 454 student 528 511 living urban environment 824 798 completed survey median knowledge score 100 range 012 male beta 0437 p=0003 older beta 0028 p 0001 associated lower knowledge score single beta 1026 p 0001 mental labour employee beta 0402 p=0032 associated higher knowledge score vast majority subject visited crowded place 630 610 wearing mask going 928 899 female OR=0731 p=0022 higher knowledge score OR=0929 p=0017 mental labour employee OR=0713 p=0031 decreased exposure crowded place High school lower education level OR=0616 p=0024 decreased action wearing mask public place higher knowledge score OR=1112 p=0013 increased Conclusion study suggests resident selected region good knowledge pessimistic attitude relatively appropriate practice towards COVID19 second wave outbreak,covid-19;attitude;epidemiology;knowledge;public health
COVID19 dermatological personal protective equipment consideration,34219927,Cutaneous injury irritation among health care worker substantially risen COVID19 pandemic field already laden skininduced injury irritation due high level handwashing glove wearing increase reported handwashinginduced xerosis irritant dermatitis contact dermatitis N95 respirator surgical mask Masks goggles face shield glove potentially create abrasion long hour use leading itching pain aggravation underlying skin condition Personal protective equipment PPE related skin injury serious American Academy Dermatology released recommendation preventing treating occupationally induced dermatologic condition COVID19 pandemic reviewed discussed conjunction overarching guideline mitigating spread virus,covid-19;cutaneous injury;personal protective equipment
Nine Months COVID19 Pandemic Europe Comparative Time Series Analysis Cases Fatalities 35 Countries,34205809,1 Background describe dynamic pandemic across 35 European country period 9 month 2 Methods threephase time series model fitted 35 European country predicting death based SARSCoV2 incidence Hierarchical clustering resulted three cluster country multiple regression model developed predicting threshold COVID19 incidence coupled death number 3 Results model showed strongly connected death incidence wave spring fall corrected casefatality rate ranged 2 207 first wave 05 42 second wave incidence stay threshold predicted regression model R2=850 COVID19 related death incidence necessarily coupled cluster represented different region Europe corrected casefatality rate cluster flipped high low vice versa Severely le severely affected country flipped first second wave 4 Conclusions COVID19 incidence related death uncoupled summer coupled two wave countryspecific threshold infection reached death number start rise allowing health care system country prepare,covid-19;sars-cov-2;corrected case fatality rate;death threshold;flip effect;multiple regression;time series analysis
Impact ReninAngiotensinAldosterone System Inflammation Coagulation Atherothrombotic Complications Aggravated COVID19,34220496,Atherosclerosis considered disease caused chronic inflammation associated endothelial dysfunction several mediator inflammation upregulated subject atherosclerotic disease Healthy intact endothelium exhibit antithrombotic protective surface vascular lumen vascular smooth muscle cell vessel wall Oxidative stress imbalance anti prooxidants subsequent increase reactive oxygen specie leading tissue damage reninangiotensinaldosterone system vital importance pathobiology vascular disease Convincing data indicate angiotensin II accelerates hypertension augments production reactive oxygen specie lead generation proinflammatory phenotype human endothelial vascular smooth muscle cell upregulation adhesion molecule chemokines cytokine addition angiotensin II also seems increase thrombin generation possibly via direct impact tissue factor However mechanism crosstalk inflammation haemostasis also contribute prothrombotic state inflammatory environment Thus blocking reninangiotensinaldosterone system might approach reduce inflammatory thrombotic complication highrisk patient COVID19 reninangiotensinaldosterone system may activated level angiotensin II could contribute ongoing inflammation might result cytokine storm complication significantly impairs prognosis outbreak COVID19 concern raised use angiotensin converting enzyme inhibitor angiotensin receptor blocker drug patient COVID19 hypertension cardiovascular comorbidities However present evidence favor continuing use drug Based experimental evidence blocking reninangiotensinaldosterone system might even exert potentially protective influence setting COVID19,angiotensin ii;antihypertensive treatment;coagulation;haemostasis;hypertension;renin-angiotensin-aldosterone system
Bioengineering Progress Lung Assist Devices,34203316,Artificial lung technology advancing startling rate raising hope would better serve need requiring respiratory support Whether assist healing injured lung support patient lung transplantation entirely replace native lung function safe effective artificial lung sought 200 year bioengineering progress artificial lung closer ever meet demand risen exponentially due COVID19 crisis review critical advance historical development artificial lung detailed current state affair regarding extracorporeal membrane oxygenation intravascular lung assist pumpless extracorporeal lung assist total artificial lung microfluidic oxygenators outlined,artificial lung;lung disease;membrane oxygenation;respiratory failure;ventilation
Investigational study clinical characteristic confirmed COVID19 case,34211647,Background COVID19 emerging infectious disease impacted HealthCare System worldwide patient undergoing elective surgical procedure associated high mortality rate complicated perioperative course Methods retrospective observational study research design conducted utilizing RedCap ACS COVID19 Registry Cerner EMR intent design create statistical information confirmed COVID19 case admitted academic institution Brooklyn New York March May 2020 Results total 1413 patient included final analysis 1413 patient 520 Expired 405 male 33 female p = 0004 Male patient high mortality rate statistically significant race Expired 383 white 342 Black 282 Asian Unknown 436 showing statistical significance p = 0050 common comorbidities notExpired versus Expired DM 446 expired versus 556 notexpired HTN 771 versus 229 CAD 479 versus 521 Comparing data COVID19 patient without surgery surgery observed 53 surgery went Home versus 386 surgery could examining without surgery versus surgery 34 versus 133 discharge Rehab Other discharge destination 59 versus 145 Expired 371 versus 313 Overall presence surgery significant impact COVID19 patient discharge destination p = 0001 Conclusions implication change setting current clinical practice therefore require forbearance training preparedness education efficiently maintain essential surgical service,covid-19;peri-operative testing;surgical practice
Plitidepsin Mechanisms Clinical Profile Promising Antiviral Agent COVID19,34357135,Current standard treatment COVID19 lack effective antiviral option Plitidepsin cyclic depsipeptide authorized Australia patient refractory multiple myeloma recently emerged candidate antiSARSCoV2 agent aim review summarize current knowledge plitidepsin s clinical profile antitumour antiSARSCoV2 mechanism correlate available anticipated preclinical clinical evidence drug s potential COVID19 treatmentPubMed Scopus CENTRAL clinicaltrialsgov medRxiv bioRxiv database searchedPlitidepsinexerts antitumour antiviral property primarily acting isoforms host cell s eukaryotictranslationelongationfactor1alpha eEF1A inhibiting eEF1A therefore translation necessary viral protein behaves `` hostdirected antiSARSCoV2 agent respect potent antiSARSCoV2 property drug demonstrated superior ex vivo efficacy compared hostdirected agent remdesivir might retain antiviral effect transmittable B117 variant wellstudied safety profile also combination dexamethasone may accelerate repurposing chance COVID19 treatment Preliminary finding hospitalized COVID19 patient suggested potential safety efficacy plitidepsin term viral load reduction clinical resolution However still incomplete understanding exact integration host cellSARSCoV2 interaction intravenous administration exclusively purposing hospital setting precocity clinical data currently considered chief deficit phase III trial planned compare plitidepsindexamethasone regimen current standard care moderately affected hospitalized patient Despite plitidepsin s preclinical efficacy current clinical evidence inadequate registration COVID19 patientsTherefore multicentre trial drug s efficacy potentially also studying population emerging SARSCoV2 lineage warranted,covid-19;sars-cov-2;antiviral agents;aplidin;plitidepsin
Methyltransferaselike 3 Modulates Severe Acute Respiratory Syndrome Coronavirus2 RNA N6Methyladenosine Modification Replication,34225491,coronavirus disease 2019 pandemic caused severe acute respiratory syndrome coronavirus2 SARSCoV2 ongoing global public crisis Although viral RNA modification reported based transcriptome architecture type function RNA modification still unknown study evaluated role RNA N6methyladenosine 6 modification SARSCoV2 methylated RNA immunoprecipitation sequencing MeRIPSeq Nanopore direct RNA sequencing DRS analysis showed SARSCoV2 RNA contained 6 modification Moreover SARSCoV2 infection increased expression methyltransferaselike 3 METTL3 also altered distribution Modification METTL3 expression short hairpin RNA plasmid transfection knockdown overexpression respectively affected viral replication Furthermore viral key protein RdRp interacted METTL3 METTL3 distributed nucleus cytoplasm presence RdRp RdRp appeared modulate sumoylation ubiquitination METTL3 via unknown mechanism Taken together finding demonstrated host 6 modification complex interacted viral protein modulate SARSCoV2 replication IMPORTANCE Internal chemical modification viral RNA play key role regulation viral replication gene expression Although potential internal modification reported SARSCoV2 RNA function SARSCoV2 N6methyladenosine 6 modification viral life cycle unclear current study demonstrated SARSCoV2 RNA underwent 6 modification host 6 machinery SARSCoV2 infection altered expression pattern methyltransferases demethylases expression level methyltransferaselike 3 METTL3 fat mass obesityassociated protein FTO linked viral replication study showed METTL3 interacted viral RNA polymerase RNAdependent RNA polymerase RdRp influenced distribution also posttranslational modification METTL3 study provided evidence host 6 component interacted viral protein modulate viral replication,n6-methyladenosine;methyltransferase-like 3;respiratory syndrome coronavirus-2;viral replication
Solar UVBA radiation highly effective inactivating SARSCoV2,34285313,Solar UVC photon reach Earth s surface known endowed germicidal property also effective virus effect softer UVB UVA photon copiously reach Earth s surface virus instead little studied particularly singlestranded RNA virus combine measurement action spectrum Covid19 response UV light Solar irradiation measurement Earth SARSCoV2 pandemic worldwide recorded Covid19 mortality data `` SolarPump diffusive model epidemic show UVBA photon powerful virucidal effect singlestranded RNA virus Covid19 b Solar radiation reach temperate region Earth noon summer sufficient inactivate 63 virion openspace concentration 15 x 10 3 TCID50mL higher typical aerosol le 2 min conclude characteristic seasonality imprint displayed worldwide SARSCov2 mortality timeseries throughout diffusion outbreak temperate region showing clear seasonal trend equatorial region suffering average systematically lower mortality might efficiently set different intensity UVBA Solar radiation hitting different Earth s location different time year result suggest Solar UVBA play important role planning strategy confinement epidemic worked set springsummer month fully implemented lowsolarirradiation period,
adapted inpatient service COVID19 pandemic physician associate support orthopaedic team,34286200,Introduction March 2020 due COVID19 pandemic increasing demand medical intensive care department UK Medical staff surgical department redeployed aim study determine whether department able maintain standard use physician associate medical doctor PAMD model care Methods mix questionnaire audit data collected prospectively compared preCOVID general surgical team PAs Results Sixtyfive per cent response indicated improvement compared preCOVID condition 35 indicated care electronic discharge notification audit showed 89 completion rate orthopaedics compared 73 general surgery Venous thromboembolism assessment compliance better compared general surgery Conclusion Overall study support hypothesis PAMD model care noninferior MDonly model care effective,covid-19;adapted;pandemic;physician associate;trauma and orthopaedics
Simple RTPCR Melting temperature Assay Rapidly Screen Widely Circulating SARSCoV2 Variants,34288729,Background increased transmission SARSCoV2 variant concern VOC originated United Kingdom B117alpha South Africa B1351Beta Brazil P1Gamma United States B1427429 Epsilon India B16172Delta requires vigorous public health response including real time strain surveillance global scale Although genome sequencing gold standard identifying VOCs time consuming expensive describe simple rapid highthroughput reversetranscriptase PCR RTPCR melting temperature Tm screening assay identifies first three major VOCs Methods RTPCR primer four sloppy molecular beacon SMB probe designed amplify detect SARSCoV2 N501Y A23063T E484K G23012A mutation corresponding wild type sequence RTPCR VOCs identified characteristic Tm SMB Assay optimization testing performed RNA SARSCoV2 USA WA12020 WT B117 B1351 variant strain assay validated using clinical sample Results limit detection LOD WT variant 4 10 genomic copiesreaction 501 484 codon assay respectively assay 100 sensitive 100 specific identifying N501Y E484K mutation cultured virus clinical sample confirmed Sanger sequencing Conclusion developed RTPCR melt screening test major VOCs used rapidly screen large number patient sample providing early warning emergence variant simple way track spread,
Safety Immunogenicity mRNABNT162b2 SARSCoV2 Vaccine Hemodialysis Patients,34220867,Background Hemodialysis patient high risk severe COVID19 SARSCoV2 vaccination related safety immunogenicity data patient rare Methods observational study SARSCoV2seronegative hemodialysis patient vaccinated two dos PfizerBioNTech mRNABNT162b2 vaccine COMIRNATY R 30 microg followed 90 day Local systemic side effect assessed every dialysis session first postvaccination week first second vaccine dose Immunogenicity determined four week vaccination quantifying antiSARSCoV2 spike protein IgG antibody LIAISON R SARSCoV2TrimericS IgG chemiluminescent immunoassay expressed binding activity unit per milliliter BAUmL adapted International standard Results Fifty patient 32 woman 68 men mean SD age 676 148 year included Mild local reaction occurred 38 first injection 292 mild 21 moderate 21 severe degree second injection Systemic reactive event occurred le often diarrhea 4 mild 4 moderate fatigue 8 mild frequent one first injection 42 patient developed positive response using assay specific cutoff value 338 binding activity unit per milliliter BAUmL median Q1 Q3 antiSARSCoV2 spike IgG concentration 200 117 510 BAUmL second injection percentage seropositive patient increased 979 antiSARSCoV2 spike IgG concentration 1075 2908 1735 BAUmL Higher age immunosuppression associated lower calcitriol treatment prior seroconversion hepatitis B vaccination significantly higher antibody concentration Conclusions mRNABNT162b2 SARSCoV2 vaccine appears safe welltolerated show high immunogenicity hemodialysis patient,bnt162b2;covid-19;sars-cov-2;hemodialysis;mrna vaccine
Evaluating Epidemiological Risk Using Open Contact Tracing Data Correlational Study,34227997,BACKGROUND 2020s extensive debate possibility using contact tracing CT contain SARSCoV2 pandemic concern raised data security privacy Little said effectiveness CT paper present real data analysis CT experiment conducted Italy 8 month involved 100000 CT app user OBJECTIVE aimed discus technical health aspect using centralized approach also aimed show correlation acquired contact data number SARSCoV2positive case Finally aimed analyze CT data define population behavior show potential application real CT data METHODS collected analyzed evaluated CT data duration persistence frequency contact several month observation statistical test conducted determine whether correlation index behavior calculated data number new SARSCoV2 infection population new SARSCoV2positive case RESULTS found evidence correlation weighted measure contact number new SARSCoV2positive case Pearson coefficient=086 thereby paving road better accurate data analysis spread prediction CONCLUSIONS data used determine relevant epidemiological parameter used develop agentbased system simulating effect restriction vaccination demonstrated system s ability identify physical location probability infection highest data collected available scientific community analysis,bluetooth low energy;covid-19;sars-cov-2;contact tracing;digital apps;infection spread;mhealth;mobile apps;mobile phone;transmission dynamics
Drug interaction profile TKI alectinib allows effective safe treatment ALK+ lung cancer kidney transplant recipient,34339964,ALK targeting tyrosine kinase inhibitor TKIs highly potent treatment option therapy ALK positive nonsmall cell lung cancer NSCLC However pharmacokinetics TKIs lead clinically significant drug interaction interfering comedication may hamper anticancer therapeutic management present first time drug interaction profile ALKTKIs crizotinib alectinib immunosuppressive agent cyclosporine kidney transplant recipient diagnosed ALK+ lung cancer Based therapeutic drug monitoring cyclosporin plasma level dose cyclosporine adjusted achieve safe effective therapeutic level term cancer treatment kidney transplant condition Particularly 15 year upon kidney transplantation stage IV lung cancer patient treated 1stline chemotherapy 2ndline ALKTKI crizotinib followed ALKTKI alectinib successful therapy ALKTKIs continuing 36 month including period patient treated COVID19 bilateral pneumonia Hence therapy ALK+ NSCLC ALKTKIs organ transplant recipient treated cyclosporine may feasible effective,alk+ nsclc;alectinib;crizotinib;drug interaction;kidney transplant;cyclosporine a
Epidemiologic immunologic virus characteristic patient paired SARSCoV2 serology reverse transcription polymerase chain reaction testing,34216468,BACKGROUND natural history clinical progression severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection better understood using combined serological reverse transcription polymerase chain reaction RTPCR testing METHODS Nasopharyngeal swab serum collected single timepoint patient urban public hospital August November 2020 tested SARSCoV2 using RTPCR viral culture antiSpike panIg antibody testing Participant demographic symptom collected interview Chisquared Fisher s exact test used identify association RTPCR serology result presence viable virus frequency symptom RESULTS Among 592 participant 129 218 evidence SARSCoV2 infection RTPCR serology Presence SARSCoV2 antibody strongly associated lack viable virus pvalue=0016 COVID19 symptom frequency similar patient testing RTPCR positiveseronegative patient testing RTPCR positiveseropositive Patients testing RTPCR positiveseronegative reported headache fatigue diarrhea vomiting rate statistically significantly different testing RTPCR negativeseropositive CONCLUSIONS patient testing SARSCoV2 seropositive unlikely test positive viable virus therefore lowrisk forward transmission COVID19 symptom common Paired SARSCoV2 RTPCR antibody testing provides nuanced understanding patient COVID19 status,covid-19;sars-cov-2;serology;viral culture
Statins COVID19 Therapy,34208435,Inhibitors 3hydroxy3methylgultarylcoenzyme reductase statin one main group drug used preventing treating cardiovascular disease worldwide widely available cheap welltolerated Based statin pleiotropic property including improvement endothelial dysfunction antioxidant property atherosclerotic plaque stabilization inhibition inflammatory response hypothesized use statin least adjuvant antiviral therapy may justified effect might especially beneficial patient COVID19 suffering endothelial dysfunction microvascular macrovascular thrombosis cytokine storm review recent data regarding pathophysiology SARSCoV2 activity host cell proposed COVID19 therapy pleiotropic activity statin statin clinical trial respiratory infection According guideline European American Cardiac Societies patient cardiovascular disease high cardiovascular risk concomitant COVID19 recommended continue statin treatment However initiation statin therapy de novo COVID19 treatment done part clinical trial,covid-19;sars-cov-2;pleiotropic effects;statins;therapy
Virtual Handover Patients Pediatric Intensive Care Unit Covid19 Crisis,34211276,Objective key measure mitigate coronavirus disease 2019 COVID19 social distancing Incorporating videoconferencing application patient handover process healthcare worker enhance social distancing maintaining handover element study describes pediatric intensive care unit PICU physician experience using online videoconferencing application handover COVID19 pandemic Design Qualitative content analysis Setting PICU university hospital Riyadh Saudi Arabia Subjects PICU Physicians Interventions Due pandemic hospital s PICU used Zoom R remote conferencing application instead facetoface handover Following institutional review board approval data collected two week 1 Jul 2020 14 Jul 2020 Measurements online survey conducted using openended question capture demographic data perceived efficacy remote handover Thematic framework analysis process included open coding creating category abstraction Main Results 37 PICU physician participated handover completed survey participant comprised six attending nine specialist 22 resident 20 541 physician reported attending 15 Zoom handover time study n 6 162 ten virtual handover variable previous teleconferencing experience physician 784 comfortable conducting remote handover found SituationBackgroundAssessmentRecommendation handover element properly achieved remote handover process perceived advantage online handover included fewer interruption time efficiency facilitation social distancing perceived disadvantage paucity nonverbal communication teaching virtual meeting Conclusion Videoconferencing application online handover could supplement traditional facetoface intensive care unit patient handover outbreak infectious disease use video streaming emphasis teaching encouraged optimize user experience,covid-19;picu;physical distancing;physicians;tele-icu;zoom for remote handover
Association heavy metal highsensitivity Creaction protein 10year risk cardiovascular disease among adult Korean population,34282223,prevalence cardiovascular disease CVDs Korea tends increasing worsened COVID19 pandemic Increasing evidence show heavy metal associated increased CVD risk aimed determine association serum heavy metal level 10year risk CVDs predict risk CVDs based marginal effect Heavy metal measured graphite furnace atomic absorption spectrometry direct mercury analyzer result show significant relationship increase cadmium lead mercury hsCRP level 10year risk CVD adjustment serum cotinine age group sex body mass index family history CVDs diabetes hyperlipidemia highrisk drinking physical activity diabetes doubling serum cadmium lead mercury hsCRP associated increase 10year risk CVD 014 010 011 022 respectively Therefore special concern given harmful impact heavy metal 10year risk CVD important develop prevention strategy targeting highrisk population slow progression risk factor related heavy metal reduce prevalence Remarkedly hsCRP validated widely used inflammatory marker could potential clinical value predicting monitoring CVDs,
Trust expert trust national leadership lead greater uptake recommended action COVID19 pandemic,34226844,Evidence suggests people vary desire undertake protective action health emergency trust authority may influence decision making sought examine trust health expert trust White House leadership COVID19 pandemic impact individual decision adopt recommended protective action maskwearing mediation analysis conducted using crosssectional US survey data collected March 27 30 2020 elucidate individual trust health expert White House leadership perception susceptibility severity COVID19 perceived benefit protecting COVID19 influenced uptake recommended protective action Trust health expert associated greater perceived severity COVID19 benefit taking action led greater uptake recommended action Trust White House leadership associated lower perceived susceptibility COVID19 associated taking recommended action trust health expert greater predictor individual uptake protective action trust White House leadership Public health messaging emphasize severity COVID19 benefit protecting oneself ensuring consistency transparency regain trust health expert,risk communication;risk perception
Considerations resuming global surgery outreach program coronavirus disease 2019 COVID19 pandemic,34130811,BACKGROUND coronavirus disease 2019 pandemic disrupted delivery safe surgical care worldwide One specific aspect global surgical care severely limited ability physician trainee participate global surgical outreach program low middleincome country METHODS narrative review literature regarding global surgical outreach program coronavirus disease 2019 pandemic performed Factors must considered reinstatement global surgical outreach program identified suggestion address provided based available literature experience senior author RESULTS global surgical outreach program canceled start pandemic many academic surgeon turned digital solution continue engage low middleincome country partner advent coronavirus disease 2019 vaccine improved access testing treatment worldwide recommencement global surgical outreach program may begin considered Important consideration initiation include vaccine testing availability visiting provider local staff patient local hospital capacity staff equipment shortage characteristic patient population visiting provider Region countryspecific factor including local infection rate concomitant health crisis must also taken account Expansion digital collaborative effort may deepen international connection promote sustainable model care CONCLUSION careful consideration global surgical outreach program may begin safely restarted near future current article evaluates individual factor must considered safely restart global surgical outreach program coronavirus disease 2019 pandemic better controlled,
healthcare provider system preparing health emergency situation,34226853,Natural disaster disease outbreak famine human conflict strained community everywhere course human existence However modern change climate human mobility factor increased global community s vulnerability widespread emergency midst disruptive health event COVID19 pandemic testing health provider system globally study present qualitative analysis published literature obtained systematically examine approach health provider taking prepare respond mass casualty incident around globe research reveals emerging trend weakness system disaster response highlighting proposed solution others may better prepare future disaster Additionally research examines gap literature foster targeted actionable contribution literature,disaster;emergency;preparation
Delays thrombolysis COVID19 associated worse neurological outcome Society Vascular Interventional Neurology Multicenter Collaboration,34333701,INTRODUCTION demonstrated multicenter cohort COVID19 pandemic led delay intravenous thrombolysis IVT among stroke patient Whether delay contributes meaningful shortterm outcome difference patient warranted exploration METHODS conducted nested observational cohort study adult acute ischemic stroke patient receiving IVT 9 comprehensive stroke center across 7 US state Patients admitted prior COVID19 pandemic 11201902292020 compared patient admitted early pandemic 3120207312020 Multivariable logistic regression used estimate effect IVT delay discharge hospice death treatment delay admission COVID19 included interaction term RESULTS 676 thrombolysed patient median age 70 IQR 5881 year 313 female 463 median NIHSS 8 IQR 416 Longer treatment delay observed COVID19 median 46 v 38 min p = 001 associated higher inhospital deathhospice discharge irrespective admission period per hour 108 95 CI 101117 p = 003 effect strengthened multivariable adjustment aOR 115 95 CI 107124 p 0001 interaction treatment delay admission COVID19 pinteraction = 065 Every onehour delay IVT also associated 7 lower odds discharged home acute inpatient rehabilitation facility aOR 093 95 CI 089097 p 0001 CONCLUSION Treatment delay observed COVID19 pandemic led greater early mortality hospice care lower probability discharge homerehabilitation facility effect modification treatment delay admission pandemic indicating treatment delay time contributes similarly shortterm outcome,covid-19;mortality;outcomes;stroke;thrombolysis;treatment delay
New Status Parasitic Diseases COVID19 PandemicRisk Factors Protective Agents,34200502,possible parasite may influence course COVID19 infection either risk factor protective agent current coronavirus pandemic may affect diagnosis prevention parasitic disease elimination program present review highlight similarity symptom human parasitoses COVID19 discus mutual influence study evaluated selected human parasitoses similar symptom COVID19 examined potential influence SARSCoV2 virus invasion available data suggest least several human parasitoses could result misdiagnosis COVID19 disorder malaria schistosomiasis soiltransmitted helminth increase risk severe infection COVID19 also suggested recovery parasitic disease enhance immune system protect COVID19 infection addition COVID19 pandemic affected parasitic disease elimination program endemic region influenced number diagnosis human parasitoses,covid-19;sars-cov-2;diseases;pandemic;parasites;parasitosis
Genomic Association vs Serological Determination ABO Blood Types Chinese Cohort Application Mendelian Randomization,34202464,ABO blood system inborn trait determined ABO gene geneticphenotypic mechanism underneath four mutually exclusive collectively exhaustive type B AB could theoretically elucidated However genetic polymorphism human population render link elusive importantly past study using genetically determined rather biochemically determined ABO type could evaluated inference error Upon bloodtyping genotyping cohort 1008 people Han Chinese population conducted genomewide association study parallel binomial multinomial loglinear model Significant genetic variant mapped ABO gene quantitatively evaluated binary multiclass classification performance Three single nucleotide polymorphism rs8176719 rs635634 rs7030248 would together sufficient establish multinomial predictive model achieves high accuracy 098 F1 score micro 099 macro 097 Using set identified ABOassociated genetic variant instrumental variable demonstrate application causal analysis Mendelian randomization MR study blood pressure onesample MR severe COVID19 respiratory failure twosample MR,abo blood types;chinese cohort;genome-wide association study;mendelian randomization
Detection coronavirus2 realtime reverse transcription polymerase chain reaction conjunctival swab patient severe form Coronavirus disease 2019 Sao Paulo Brazil,34287482,OBJECTIVES test conjunctival swab patient laboratoryconfirmed severe form coronavirus disease 2019 COVID19 presence SARSCoV2 realtime reversetranscription polymerase chain reaction rRTPCR METHODS Fifty conjunctival swab collected 50 inpatients laboratoryconfirmed severe form COVID19 largest teaching hospital referral center Brazil HCFMUSP Sao Paulo SP sample tested SARSCoV2 rRTPCR primer probe described CDC protocol amplify region nucleocapsid N gene 2019nCoVN1 2019nCoVN2 SARSCoV2 RNA compared nasooropharyngeal swab collected within 24 hour conjunctival swab RESULTS Five conjunctival sample 10 tested positive amplification N1 N2 primerprobe set two conjunctival sample 4 yielded inconclusive result amplification N1 primerprobe set nasooropharyngeal swab positive SARSCoV2 rRTPCR 34 patient 68 negative 14 28 inconclusive 2 4 5 patient positive conjunctival swab positive n=2 negative n=2 inconclusive n=1 nasooropharyngeal swab rRTPCR Patients negative inconclusive nasooropharyngeal swab diagnosis COVID19 confirmed previous positive rRTPCR result serology CONCLUSION first study present conjunctival swab rRTPCR result SARSCoV2 Brazilian population sample 50 patient severe form COVID19 10 positive conjunctival swab correlated positive nasooropharyngeal rRTPCR result,
Evaluation SARSCoV2 Vaginal Secretions Women COVID19 Prospective Study,34205751,OBJECTIVE aimed investigate likelihood vaginal colonization Severe acute respiratory syndrome coronavirus 2 SARSCoV2 pregnant nonpregnant woman Coronavrus Disease 2019 COVID19 MATERIALS METHODS Vaginal swab taken woman diagnosed mild moderately acute SARSCoV2 infection Wolfson Medical Center Israel March 2020 October 2020 COVID19 diagnosed realtime polymerase chain reaction RTPCR performed nasopharyngeal swab Vaginal swab tested presence SARSCoV2 reverse transcription polymerase chain reaction RTPCR RESULTS total 51 woman diagnosed COVID19 included study 51 woman COVID19 enrolled study 16 314 pregnant enrollment 35 686 nonpregnant Mean age 435 + 153 year range 2174 year Compared nonpregnant group pregnant group characterized higher white blood cell absolute neutrophil count p = 002 p = 0027 respectively nonpregnant patient likely chronic disease p = 0035 hospitalized p 0001 one patient 19 aged 60 year tested positive SARSCoV2 vaginal secretion Mean gestational age diagnosis COVID19 pregnant group 323 + 78 week Thirteen patient delivered study period delivered term without obstetric complication neonate healthy CONCLUSIONS Detection SARSCoV2 vaginal secretion patient diagnosed COVID19 rare Vaginal colonization may occur viremia phase disease although infectivity vaginal colonization need proven,covid-19;sars-cov-2;vaginal secretions
Disability among Older People Analysis Data Disability Surveys Six Low MiddleIncome Countries,34209792,analysis survey six low middleincome country LMICs aimed estimate prevalence disability among older adult ii compare experience participation key life area among older people without disability may show vulnerability COVID19 pandemic Data analysed districtlevel national survey Cameroon Guatemala Haiti India Nepal Maldives across six database totalled 3499 participant aged 60 year including 691 people disability Disability common among adult 60+ ranging 97 80118 Nepal 392 India 95 CI 341445 Mobility commonly reported functional difficulty setting older people disability significantly le likely working reported greater participation restriction environmental barrier key life area compared people age category without disability p 005 Disability common population older people disability may greater difficulty participating COVID19 response high economic vulnerability imperative prioritise need older people disability COVID19 pandemic including ensuring accessibility health service community general,covid-19;disability;older adults;participation
Bilateral post fever retinitis retinal vascular occlusion following severe acute respiratory syndrome corona virus SARSCoV2 infection,34228600,Introduction world fight pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 several report retinal manifestation disease emerging Post fever retinitis well reported ocular inflammatory reaction multiple invasive agent virus bacteria microbial agentPurpose report interesting case bilateral multifocal retinitis multiple vascular occlusion patient three week febrile illnessResults Investigations ascertain cause fever resulted identifying ephemeral seropositivity several different Ribonucleic acid RNA virus retinitis managed systemic steroid doxycycline anticoagulant improvement visionConclusion High persistent seropositive response SARSCoV2 helped u narrow causative agent cross reactivity SARSCoV2 virus misleading need careful interpretation,covid-19;ig m;igg sars-cov-2;multifocal retinitis;rt- pcr;sars-cov-2;vascular occlusions
Molecular epidemiology SARSCoV2 Cyprus,34288921,Whole genome sequencing viral specimen following molecular diagnosis powerful analytical tool molecular epidemiology critically assist resolving chain transmission identifying new variant assessing pathogen evolution allows realtime view dynamic pandemic Cyprus first two case COVID19 identified March 9 2020 since 33567 confirmed case 230 death documented study viral whole genome sequencing performed 133 SARSCoV2 positive sample collected March 2020 January 2021 Phylogenetic analysis conducted evaluate genomic diversity circulating SARSCoV2 lineage Cyprus 15 different lineage identified clustered three group associated spring summer autumnwinter wave SARSCoV2 incidence Cyprus respectively majority Cypriot sample belonged B1258 lineage first detected September spread rapidly largely dominated autumnwinter wave peak prevalence 86 month November December B117 UK variant VOC20201201 identified first time end December spread rapidly reaching 37 prevalence within one month Overall describe changing pattern circulating SARSCoV2 lineage Cyprus since beginning pandemic end January 2021 finding highlight role importation new variant travel towards emergence successive wave incidence Cyprus demonstrate importance genomic surveillance determining viral genetic diversity timely identification new variant guiding public health intervention measure,
Successful control COVID19 outbreak tracing testing isolation Lessons learned outbreak control effort made metropolitan city South Korea,34364306,first surge coronavirus disease 2019 COVID19 case began June 27 2020 Gwangju metropolitan city located southwestern part South Korea population 1501000 Local government Korean Center Disease Control Prevention immediately started epidemiologic investigation traced contact patient using wide variety data source including location data mobile device credit card transaction closedcircuit television footage July 16 2020 138 community transmission case 10 infection cluster identified across city contact tracing epidemiologic relatedness found 136 986 138 case investigation showed extensive meticulous contact tracing suppressed COVID19 outbreak populated city,covid-19;contact tracing;isolation;sars-cov-2;testing
Use local perforator flap closure thoracoomphalopagus conjoined twin defect separation COVID19 pandemic,34226881,Introduction Conjoined twin rare medical phenomenon pose unique challenge surgeon Separation conjoined twin involves multidisciplinary teamwork complex medical management surgical planning multistage operation often still high mortality morbidity rate time COVID19 pandemic separation conjoined twin pose even greater challenge Aiming best outcome possible minimizing risk COVID transmission ensuring safety personnel paramount case report present thoracoomphalopagus twin successfully separated 4 month age preoperative planning operative detail postoperative followup outcome discussed Methods absence tissue expander inability acquire due travel restriction COVID19 complicated management patient Routine Polymerase Chain Reaction PCR swab test performed patient personnel Standardized personnel protective equipment PPE worn ward surgical care separation twin cardiothoracic pediatric surgeon one twin underwent immediate skin closure using double keystone perforator island flap lower abdominal perforator flap Due extensive defect closure delayed second twin series dressing change eventually local perforator flap could raised close defect using staged tension suture skin graft secondary defect Results twin discharged significant morbidity personnel exposed COVID19 infection management Conclusion Preoperative coordination planning multidisciplinary effort adherence screening protocol COVID strict use standardized PPE contributed successful separation thoracoomphalopagus conjoined twin COVID19 pandemic,covid-19;case report;negative pressure wound therapy;perforator flaps;thoraco-omphalopagus conjoined twins
LongTerm Persistence AntiSARSCoV2 Antibodies Pediatric Population,34199852,BACKGROUND Antibody dynamic time SARSCoV2 infection still unclear data regarding child scarce METHODS prospective cohort study performed including child infected SARSCoV2 March May 2020 Patients categorized 3 group child admitted COVID19 outpatient child mild COVID19 seropositive child participating seroprevalence study among cohabitants infected healthcare worker HCWs Six month infection new serological control performed RESULTS total 58 child included 50 male median age 83 IQR 28135 year median time two serological study 186 IQR 176192 day 86 4856 child maintained positive IgG six month infection percentage 100 admitted patient 78 among rest included child p = 0022 diagnosis lower respiratory tract infection multisystemic inflammatory syndrome associated persistence IgG p = 0035 child HCWs seroprevalence study lost antibody often p = 0017 Initial IgG titer child remained positive six month infection significantly higher p = 0008 CONCLUSIONS child infected SARSCoV2 maintain positive serological response six month infection child lost IgG titer frequently asymptomatic mildly symptomatic presenting low antibody titer infection,covid-19;sars-cov-2;antibody;children;pediatric;serology
Chronic Back Condition Level Physical Activity Well Internet Addiction among Physiotherapy Students COVID19 Pandemic Poland,34206426,Objectives aim study ass back pain relation physical activity well Internet addiction among Polish university student COVID19 pandemic Methods research conducted via Internet student group three university Poland 141 people Back pain examined ODIThe Oswestry Disability Index NDINeck Disability Index Polishlanguage International Physical Activity Questionnaire IPAQ used ass physical activity level Internet addiction tested using Kimberly Young Questionnaire Results respondent mostly suffered pain originating cervical spine study group every fifth person high level physical activity Sex differentiates level measure considered Sitting front computer affect pain spine Conclusions Research result suggest pandemic negatively affecting student Frequent occurrence back pain observed simultaneous low level physical activity Maintaining regular activity pandemic least home indispensable preventive measure physical health,covid-19;ipaq;kimberly young questionnaire;ndi;odi
highly potent stable pancoronavirus fusion inhibitor candidate prophylactic therapeutic COVID19 coronavirus disease,34367893,development broadspectrum antiviral human coronaviruses HCoVs critical combat current coronavirus disease 2019 COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 variant well future outbreak emerging CoVs previously identified polyethylene glycolconjugated PEGylated lipopeptide EK1C4 potent panCoV fusion inhibitory activity However PEG linkers peptide protein drug may reduce stability induce antiPEG antibody vivo Therefore herein report design synthesis series dePEGylated lipopeptidebased panCoV fusion inhibitor featuring replacement PEG linker amino acid heptad repeat 2 Cterminal fragment HR2CF HCoVOC43 Among lipopeptides EKL1C showed potent inhibitory activity infection SARSCoV2 spike mutant well HCoVs bat SARSrelated coronaviruses SARSrCoVs tested dePEGylated lipopeptide EKL1C exhibited significantly stronger resistance proteolytic enzyme better metabolic stability mouse serum higher thermostability PEGylated lipopeptide EK1C4 suggesting EKL1C could developed candidate prophylactic therapeutic COVID19 coronavirus disease,coronavirus;fusion inhibitor;lipopeptide;polyethylene glycol;sars-cov-2
Impact Covid19 Visit Pediatric Patients Injuries Emergency Department Korea,34356547,total number pediatric emergency department PED visitor decreased worldwide since coronavirus disease COVID19 outbreak hypothesized might also affect number PED visit due injury Therefore investigated change PED visit COVID19 outbreak longterm multicenter observational study assessed change proportion injured pediatric patient weekly visit trend rate change since COVID19 epidemic began segmented regression analysis also evaluated weekly change distribution detailed diagnostic code among pediatric patient injury COVID19 pandemic proportion injuryrelated PED visit increased COVID19 first confirmed Korea COVID19 epidemic proportion foreign body ingestion fracture patient among pediatric patient injury increased significantly every week change proportion injured pediatric patient COVID19 outbreak may result social distancing prevent spread virus risk pediatric infection decreased risk injury remained Therefore parent take precaution prevent infectious disease careful prevent child s injury home,covid-19;emergency department utilization;injury;pediatric emergency department
Abdominal imaging COVID19,34367509,Initially thought respiratory infection coronavirus disease2019 COVID19 recognized complex disease wide clinical spectrum including digestive involvement several study evaluated chest imaging finding COVID19 paper looked abdominal imaging feature patient Liver biliary pancreas bowel involvement reported COVID19 infected patient review aim summarize currently available data related abdominal imaging technique COVID19 accordance relevant clinical laboratory workup patient Underlying mechanism indication imaging finding related COVID19 discussed based published data Also practice point clinician highlighted order adequately recognize digestiverelated injury severe acute respiratory syndrome coronavirus 2 infection s steady accumulation data respect abdominal imaging finding COVID19 currently available recommendation based limited research wide spectrum abdominal imaging finding COVID19 includes hepatobiliary pancreatic luminal pathology,covid-19;computed tomography;digestive;features;gastrointestinal;imaging;ultrasound
Clinical variant myocardial involvement COVID19positive patient cumulative experience 2020,34215924,Myocardial injury diagnosed troponin elevation common COVID19 patient cardiac involvement clinical manifestation occurs le frequently analyzed literature COVID19 2020 systematically reviewed case individual patient data presented searched PubMed Google Scholar `` COVID `` COVID19 `` coronavirus combination `` myocarditis `` heart failure `` takotsubo `` cardiomyopathy `` cardiogenic shock identified 90 case COVID19 myocardial involvement mean age 529 + 183 year 545 male 55 survived 611 20 died 222 15 167 outcome unknown time publication Among patient known outcome mortality 26 nadir LVEF 317 + 131 recovered 501 + 160 Pericardial effusion common finding reported 21 233 patient including moderate size effusion 89 large 78 effusion caused tamponade 11 122 patient 83 patient experienced decrease LVEF 30 could classified takotsubo syndrome takotsubo patient older myocarditis relatively high proportion male one third case complicated cardiogenic shock Myocardial involvement COVID19 patient often present new rapid decrease LVEF although normal LVEF takotsubolike wall motion pattern rule myocarditis Moderate large pericardial effusion common cardiac tamponade occurs 122 patient Cardiogenic shock develops one third patient Mortality appears high 26,aortic pulsatility index;covid-19;coronavirus;heart failure;mortality;myocarditis;takotsubo
Interventions prevention persistent postCOVID19 olfactory dysfunction,34291812,BACKGROUND Loss olfactory function well recognised cardinal symptom COVID19 infection ongoing pandemic resulted large number affected individual abnormality sense smell many condition temporary resolve within two four week However significant minority symptom persist present known whether early intervention form treatment medication olfactory training promote recovery prevent persisting olfactory disturbance OBJECTIVES ass effect benefit harm intervention used proposed prevent persisting olfactory dysfunction due COVID19 infection secondary objective keep evidence uptodate using living systematic review approach SEARCH METHODS Cochrane ENT Information Specialist searched Cochrane COVID19 Study Register Cochrane ENT Register CENTRAL Ovid MEDLINE Ovid Embase Web Science ClinicalTrialsgov ICTRP additional source published unpublished study date search 16 December 2020 SELECTION CRITERIA Randomised controlled trial including participant symptom olfactory disturbance following COVID19 infection Individuals symptom le four week included review Studies compared intervention treatment placebo DATA COLLECTION ANALYSIS used standard Cochrane methodological procedure primary outcome presence normal olfactory function serious adverse effect change sense smell Secondary outcome prevalence parosmia change sense taste diseaserelated quality life adverse effect including nosebleedsbloody discharge used GRADE ass certainty evidence outcome MAIN RESULTS included one study 100 participant compared intranasal steroid spray intervention Participants group also advised undertake olfactory training duration trial Data identified two prespecified outcome review data available primary outcome serious adverse effect Intranasal corticosteroid compared intervention using olfactory training Presence normal olfactory function three week treatment selfassessed participant using visual analogue scale range 0 10 higher score = better score 10 represented `` completely normal smell sensation evidence uncertain effect intranasal corticosteroid selfrated recovery sense smell estimated absolute effect 619 per 1000 compared 520 per 1000 risk ratio RR 119 95 confidence interval CI 085 168 1 study 100 participant lowcertainty evidence Change sense smell reported selfrated score sense smell reported endpoint study visual analogue scale three week treatment median score endpoint 10 interquartile range IQR 9 10 group receiving intranasal corticosteroid 10 IQR 5 10 group receiving intervention 1 study 100 participant lowcertainty evidence AUTHORS CONCLUSIONS limited evidence regarding efficacy different intervention preventing persistent olfactory dysfunction following COVID19 infection However identified small number additional ongoing study area living systematic review evidence updated regularly incorporate new data relevant study become available first version living review identified single study intranasal corticosteroid include review provided data two prespecified outcome evidence low certainty therefore unable determine whether intranasal corticosteroid may beneficial harmful effect,
diabetes mellitus wrongdoer COVID19 severity,34217771,coronavirus disease 19 COVID19 turned pandemic short period time due high transmissibility causative agent severe acute respiratory syndrome coronavirus 2 Various report suggested promising link overexpression angiotensin converting enzyme 2 ACE2 COVID19 pathogenesis severity COVID19 pathophysiology greatly depended several comorbidities like hypertension diabetes mellitus DM respiratory cardiovascular disease DM emerged major risk factor current review focus link among expression ACE2 use ACE inhibitor ACEIs angiotensin II type 1 receptor blocker ARBs risk COVID19 pathogenesis DM review also emphasizes synergistic detrimental effect DM COVID19 immune system provoking uncontrolled cytokine storm eventually lead lethal consequence Finally several possible therapeutic strategy highlighted reduce excess risk associated COVID19 people DM,angiotensin converting enzyme 2 (ace2);covid-19;cytokine storm;diabetes mellitus
Changes family medicine visit across sociodemographic group onset COVID19 pandemic Ontario retrospective cohort study,34131028,BACKGROUND suggested COVID19 pandemic worsened socioeconomic disparity access primary care Given concern investigated whether pandemic affected visit family physician differently across sociodemographic group METHODS conducted retrospective cohort study using electronic medical record family physician practice within University Toronto PracticeBased Research Network evaluated primary care visit fixed cohort patient active within database Jan 1 2019 estimate number patient visited family physician visitor rate number distinct visit visit volume Jan 1 2019 June 30 2020 compared trend visitor rate visit volume pandemic Mar 14 June 30 2020 period previous year Mar 14 June 30 2019 across sociodemographic factor including age sex neighbourhood income material deprivation ethnic concentration RESULTS included 365 family physician 372 272 patient Compared previous year visitor rate pandemic period dropped 345 357 visitor per 1000 people 292 visitor per 1000 people Declines visit volume pandemic le pronounced 218 fewer visit mean number visit per patient increased pandemic 164 196 decline visitor rate visit volume varied based patient age sex socioeconomic status INTERPRETATION Although number visit family physician dropped substantially first week COVID19 pandemic Ontario patient community low socioeconomic status appear disproportionately affected primary care setting pandemic appears worsened socioeconomic disparity access care,
Mutation hotspot spatiotemporal distribution SARSCoV2 lineage Brazil February 20202021,34363852,COVID19 pandemic already reached 110 million people associated 25 million death worldwide Brazil third worsthit country approximately 102 million case 250 thousand death International effort established share information Severe acute respiratory syndrome coronavirus 2 SARSCoV2 epidemiology evolution support development effective strategy public health disease management aimed analyze highquality genome sequence Brazil February 20202021 identify mutation hotspot geographical temporal distribution SARSCoV2 lineage using phylogenetics phylodynamics analysis describe heterogeneous sequencing effort progression different lineage along time evaluating mutational spectrum frequency oscillation derived prevalence specific lineage across different Brazilian region found least seven major 17 two minor clade related six prevalent lineage country described spatial distribution dynamic emergence recent frequency shift lineage P1 P2 carrying mutation concern spike protein e g E484K N501Y draw attention due association immune evasion enhanced receptor binding affinity Improvements genomic surveillance paramount importance extended Brazil better inform policy maker better decision fight COVID19 pandemic,covid-19;high-throughput nucleotide sequencing;infectious diseases;molecular epidemiology;phylogeography;severe acute respiratory syndrome coronavirus 2
Plasma convalescent decrease mortality COVID19 patient systematic review metaanalysis,34337734,OBJECTIVE investigate role Convalescent Plasma CP reducing mortality COVID19 patient MATERIALS METHODS systematic literature search conducted PubMed Embase Medrxiv Google Scholar April finalized December 2020 using following term covid19 convalescent plasma cp ccp copla study screened extracted evaluated two author independently Comparative retrospective prospective study control group included Mortality defined outcome interest Research article published English language available full text review article measured outcome interest excluded study RESULTS Eighteen study included metaanalysis 5658 patient 2092 patient treated CP 3536 patient control group Forest plot showed CP use associated decreased mortality = 064 95 CI 049 084 p 0001 heterogeneity I2 = 2762 patient experienced adverse event fatal case reported CONCLUSIONS Convalescent plasma effective reducing mortality severe critical COVID19 tolerable adverse effect,
Protective Boxes Prevent Airborne Transmission SARSCOV2 HospitalBased Experiences Narrative Literature Review,34349570,Objective Occupational safety healthcare setting integral part treating COVID19 growing body evidence suggests inhalation respiratory droplet 5 microm tiny aerosol 5 microm possible route virus transmission Recently innovative barrier enclosure aerosol box designed cover patient head allowing implementation airway management procedure fitted hole initial design undergone series modification improve staff safety operator ergonomics efficacy airway procedure Methods reviewed literature concerning different box modification provided insight experience using box Aerosol box garnered attention clinician frequently exposed aerosol performing aerosolgenerating medical procedure particularly endotracheal intubation Current evidence come simulationbased study rather reallife clinical investigation Results report indicated box significantly reduced diffusion aerosol room however operator experienced difficulty maneuverability airway device Conclusion Aerosol box used patient necessitating simple elective intubation healthcare provider adequately trained Customized design made based clinician experience,aerosols;healthcare;occupational safety;severe acute respiratory syndrome
Patient s point view use telemedicine multiple sclerosis webbased survey,34283343,Restrictions access healthcare facility COVID19 pandemic raised need remote monitoring chronic medical condition including multiple sclerosis MS order enable continuity care circumstance many telemedicine application currently tested physician preference commonly investigated data regarding patient point view still lacking built 37 item webbased survey exploring patient propensity awareness opinion telemedicine aim evaluate sustainability approach MS Analysing 613 questionnaire 1093 sent person MS followed Multiple Sclerosis Center Tor Vergata University Rome found half respondent 54 open televisit Propensity toward telemedicine significantly depended higher income p = 0037 living farther center p = 0038 using computer tablet p = 0010 using Internet remote activity p 0001 conversely influenced specific disease characteristic ie degree disability main advantage disadvantage televisit reported participant respectively saving time 70 impossibility measure physical parameter 71 Although majority respondent favour televisit far approach restricted displaying better socioeconomic condition higher familiarity technology Implications study telemedicine platform better tailored patient demand order spread use telemedicine enhance usability increase patient adherence,covid-19 pandemic;multiple sclerosis;remote monitoring;survey;telemedicine;televisit
Identifying Patients Highest Risk Remaining Unvaccinated SARSCoV2 Large Veterans Health Administration Cohort,34293247,Since start Coronavirus disease 2019 COVID19 pandemic patient cirrhosis demonstrated higher rate hospitalization decompensation death setting severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection 1 Given higher risk severe COVID19 course patient cirrhosis 1 vaccination utmost importance,covid-19;cirrhosis;coronavirus;sars-cov-2;vaccination
One half year COVID19 pandemic Exit strategy efficacy SARSCoV2 vaccine holistic management achieving global control,34284531,pandemic unfolded past one half year data show SARSCoV2 higher mortality compared influenza people sequela infection need treated health care system Evolution new virus variant discussed global expansion delta variant demonstrates new variant higher transmission potential also pathogenic easily arise far roll vaccine efficient tool control pandemic evolution new variant vaccine efficacy must closely monitored zoonotic nature virus mean cross human animal reservoir back surveillance SARSCoV2 virus animal close contact human needed certainly new wave coming year possible booster vaccination needed increase population immunity reduce circulation SARSCoV2 vaccination probably expanded child,covid-19;vaccines;surveillance;variants;zoonosis
COVID19 Vaccine Male Fertility,34346045,world going COVID19 pandemic mass vaccination newly approved vaccine COVID19 begun around world concern among vaccine recipient regarding potential effect vaccine male fertility COVID19 affect male reproductive health COVID19 vaccine impair sperm parameter,
Longitudinal observation antibody response 14 month SARSCoV2 infection,34343708,Better understanding antibody response SARSCoV2 natural infection might provide valuable insight future implementation vaccination policy Longitudinal analysis IgG antibody titer carried 32 recovered COVID19 patient based Umbria region Italy 14 month Mild ModeratelySevere infectionTwo FDAapproved immunoassay SARSCoV2 Nucleocapsid protein NCP antispikereceptor binding domain SRBD used sequential serological test different time point demographic clinical history symptom profile associated magnitude longevity antibody response also analyzed AntiSRBD IgG persisted 968 31 32 subject 14 month Patients reporting loss smell taste clinical course disease developed significantly higher antibody titer AntiNCP IgG seronegative patient n=7 10 month tested positive antiSRBD IgG 1213 14 month emphasizing higher falsenegative rate NCP proteinbased antibody assay study also highlight importance adopting specific immunoassay routine estimation antibody titer decreased rate reinfections recovered patient,coronavirus;covid19;humoral immunity;sars-cov-2;neutralizing antibodies
Polio Supplementary Immunization Activities COVID19 Pandemic Experience Penampang District Sabah Malaysia,34218701,BACKGROUND Polio Supplementary Immunization Activities SIAs carried State Sabah response Vaccine Derived Poliovirus outbreak declared December 2019 Prior Malaysia poliofree past 27 year paper reported successful implementation SIAs district Penampang Sabah adapting vaccine administration COVID19 pandemic METHODS series meticulous planning healthcare staff training advocacy community engagement activity conducted Penampang District Health Office Bivalent Oral Polio Vaccine bOPV monovalent Oral Polio Vaccine administered period 1 year via method house house drivethrough static mobile post targeted group 22 096 child aged 13 year RESULTS Polio SIAs Penampang managed achieve 90 coverage bOPV mOPV overall vaccine wastage reported 163 major adverse reaction reported CONCLUSION High vaccine uptake Polio SIAs Penampang attributed good interagency collaboration community engagement intensified health promotion activity drivethrough vaccination campaign,malaysia;sabah;supplementary immunization activities;collaboration;community engagement;drive-through vaccination;health promotion;polio
Diagnostic Performance Radiology Residents Thoracic Ct Imaging Emergency Radiology Covid19 Pandemic,34225625,BACKGROUND COVID19 pandemic workload radiologist radiology resident well clinical physician increased INTRODUCTION study aim determine diagnostic performance radiology resident effectively contribute diagnosis COVID19 METHODS thoracic computed tomography CT image 135 patient aged 2083 diagnosed COVID19 evaluated retrospectively five radiology resident radiologist 10 year experience diagnostic performance radiology resident evaluating COVID19 assessed according year residency patient age gender Receiver operating characteristic ROC curve analysis performed determine sensitivity specificity radiology resident RESULTS radiology resident performance determining COVID19 using CT finding evaluated follows sensitivity 9722 specificity 8889 positive predictive value 9091 negative predictive value 9655 accuracy 9333 According year residency sensitivity specificity radiology resident determining COVID19 using CT image 923 100 7143 100 respectively CONCLUSION high sensitivity specificity radiology resident evaluating thoracic CT image COVID19 diagnosis indicate radiologist important clinical physician diagnosis COVID19,covid-19;chest;computed tomography;pneumonia;radiologist.
Global burden acute myocardial injury associated COVID19 systematic review metaanalysis metaregression,34336202,Background body evidence showed strong correlation acute myocardial Injury COVID19 infection However link acute myocardial infection COVID19 prevalence reliability diagnostic modality independent predictor clinical outcome still uncertain topic debate current study designed determine prevalence determinant outcome acute myocardial injury based systematic review metaanalysis global published peerreviewed work literature Methods comprehensive search conducted PubMedMedline Science direct CINHAL LILACS December 2019 May 2021 observational study reporting prevalence AMI included case report review excluded data extracted two independent author customized format methodological quality included study evaluated using NewcastleOttawa appraisal tool Results total 397 article identified different database Thirtyseven Articles 21 204 participant included seven study excluded metaanalysis revealed pooled prevalence myocardial injury COVID19 pandemic 2233 95 CI 1786 2681 37 Conclusion metaanalysis showed mortality among patient acute myocardial injury COVID19 four time likely compared without AMI necessitates mitigating strategy prevent manage clinical outcome getting worse,mortality;myocardial injury;prevalence
Rhinovirus spread child COVID19 pandemic despite social restrictionsA nationwide register study Finland,34228369,Social restriction coronavirus disease 2019 pandemic strongly affected epidemiology influenza respiratory syncytial virus RSV rhinovirus seemed spread despite restriction aimed analyze rhinovirus epidemiology child pandemic registerbased study used data Finnish Infectious Disease Register Nationwide rhinovirus finding July 2015 March 2021 included stratified age 04 59 1014 Cumulative 14day incidence per 100000 child calculated Four thousand five hundred seventy six positive rhinovirus finding included 3788 828 among child aged 04 highest recorded incidence 362 among child aged 04 October 2017 highest recorded incidence pandemic period 136 November 2020 impact restriction mostly seen among child aged 04 year age week 1422 2020 incidence since remained near reference level age group Strict restriction temporarily interrupted circulation rhinovirus spring 2020 Rhinovirus incidence returned normal level soon harsh restriction lifted looser social restriction prevented RSV influenza season failed prevent spread rhinovirus,epidemiology;nonpharmaceutical interventions;rhinovirus;surveillance
Impact Prophylactic Hydroxychloroquine People High Risk COVID19 Systematic Review MetaAnalysis,34199214,proven prophylactic intervention COVID19 systematically reviewed efficacy prophylactic hydroxychloroquine COVID19 Studies evaluating hydroxychloroquine prophylaxis COVID19 searched several engine 8 December 2020 Primary outcome included RTPCR positivity COVID19 infection positive RTPCR compatible COVID19 symptom allcause mortality Random effect metaanalyses performed outcome Five randomized controlled trial RCTs n = 5579 one cohort n = 106 included Placebo comparator four RCTs usual care one RCT Compared control five RCTs showed hydroxychloroquine prophylaxis reduce RTPCR positivity RR 101 95 CI 088116 COVID19 infection RR 098 95 CI 078122 allcause mortality RR 073 95 CI 027199 difference effect pre postexposure prophylaxis Prophylaxis hydroxychloroquine increased risk diarrhea abdominal pain vomiting RR 456 95 CI 1581319 effect hydroxychloroquine secondary outcome Quality evidence low low outcome Hydroxychloroquine efficacious prophylaxis COVID19 infection defined either RTPCR positivity composite RTPCR positivity compatible symptom Hydroxychloroquine reduce allcause mortality clinical worsening adverse event,covid-19;efficacy;hydroxychloroquine;prophylaxis;safety
Outpatient Practice Reactivation Integrated Community Practice COVID19 Pandemic,34292775,Introduction coronavirus disease 2019 COVID19 pandemic impacted health care organization throughout world Southwest Minnesota Region Mayo Clinic Health System communitybased health care system immune March 2020 outpatient service deferred decreased 90 Method article review approach used safely reactivate outpatient care tool developed outcome reactivation effort novel Outpatient Practice Reactivation Framework established used included Outpatient Clinic Appointment Dashboard Decision Matrix Access Management Virtual Care Patient Safety framework guided patient demand care safety principle recommended state federal agency internal infectious disease department guideline Results Conclusions course 9 week ambulatory visit volume clinic utilization rate returned preCOVID level PreCOVID fill rate range 87 94 postCOVID fill rate range 86 89 exceeding target fill rate 80 result establishing initiative shared priority committing robust schedule decisive action creating maintaining welldefined structure taking inclusive approach overcommunicating providing sufficient data transparency developing guiding principle training educating staff,covid-19 pandemic;health care;public health;virtual visits
Ant colony optimization Cauchy greedy Levy mutation multilevel COVID 19 Xray image segmentation,34293587,paper focus study multilevel COVID19 Xray image segmentation based swarm intelligence optimization improve diagnostic level COVID19 present new ant colony optimization Cauchy mutation greedy Levy mutation termed CLACO continuous domain Specifically Cauchy mutation applied end phase ant foraging CLACO enhance searchability boost convergence rate greedy Levy mutation applied optimal ant individual confer improved ability jump local optimum Furthermore paper develops novel CLACObased multilevel image segmentation method termed CLACOMIS Using 2D Kapur s entropy CLACO fitness function based 2D histogram consisting nonlocal mean filtered image grayscale image CLACOMIS successfully applied segmentation COVID19 Xray image comparison CLACO relevant variant excellent peer 30 benchmark function IEEE CEC2014 demonstrates superior performance CLACO term search capability convergence speed well ability jump local optimum Moreover CLACOMIS shown better segmentation effect stronger adaptability different threshold level method performing segmentation experiment COVID19 Xray image Therefore CLACOMIS great potential used improving diagnostic level COVID19 research host webservice question http aliasgharheidaricom,ant colony optimization;covid-19;diagnosis;image;meta-heuristic;swarm-intelligence
Evaluation COVID19Associated Myocarditis Via PointofCare Ultrasound Pediatric Patient,34225328,ABSTRACT Coronavirus disease 2019 COVID19 associated myocarditis reported onset pandemic presumed etiology direct damage myocardium severe acute respiratory syndrome coronavirus 2 Common finding include electrocardiogram abnormality elevated cardiac marker diminished cardiac function lead heart failure cardiogenic shock resultant poor perfusion Thus myocarditis recognized cause death patient COVID19 Unfortunately difficult predict prevalence myocarditis patient given relative novelty pandemic lack available data Pointofcare ultrasound POCUS shown useful modality investigate lung pathology patient COVID19 Bedside cardiac POCUS also used investigate cardiac pathology case describes pediatric patient COVID19 evidence myocarditis POCUS pediatric emergency department,
Clinical epidemiological characteristic outcome Coronavirus disease19 patient large longitudinal study,34285686,Objective study aimed determine clinical epidemiological characteristic outcome Coronavirus disease COVID 19 patient Methods large cohort study 15409 confirmed patient COVID19 different severity followedup three specialized COVID19 hospital March 18 October 11 2020 Iraqi Kurdistan predictor mortality severity examined binary logistic regression analysis Results incidence rate severecritical status 123 median age 360 case fatality rate CFR 198 incidence rate severecritical condition CFR rose increased age group except 014 year 119 incidence rate severecritical patient CFR 83 05 211 40 237 87 1549 year 5064 year 65 older age group respectively severity disease CFR associated coexisting chronic disease cardiovascular disease 182 31 diabetes mellitus 198 34 asymptomatic patient 8400 545 statistically higher CFR 23 versus 16 P = 0006 common symptom diagnosis fever 319 cough 235 loss smelltaste 163 sore throat 157 shortness breath 98 headache 95 result showed older predictor mortality severity COVID19 patient Conclusions region low incidence severecritic status CFR patient coexisting medical condition likely severe condition die COVID19 older age predicts severecritic status higher CFR,covid-19;case fatality rate;outcome;severity
Compromised Lung Volume Hemostatic Abnormalities COVID19 Pneumonia Results Observational Study 510 Consecutive Patients,34209720,BACKGROUND Hemostatic abnormality described COVID19 pulmonary microthrombosis consistently found autopsy concomitant severe lung damage METHODS retrospective observational crosssectional study including consecutive patient COVID19 pneumonia underwent unenhanced chest CT upon admittance emergency room ER one large academic hospital QCT used calculation compromised lung volume CL Clinical data retrieved patient file Laboratory data obtained upon presentation ER AIM aim study evaluate correlation hemostatic abnormality lung involvement patient affected COVID19 pneumonia described using computeraided quantitative evaluation chest CT quantitative CT QCT RESULTS total 510 consecutive patient 68 male aged 67 year median diagnosed COVID19 pneumonia underwent unenhanced CT scan upon admission ER included 115 patient CL 23 compared CL 23 showed higher level Ddimer fibrinogen CRP greater platelet count longer PT ratio Via multivariate regression analysis BMI = 30 kgm 2 Ddimer level 500 ngmL CRP 50 ngmL PT ratio 12 found independent predictor CL 23 adjusted odds ratio 95 confidence interval 21 1140 31 1658 24 1345 34 1485 respectively CONCLUSIONS Hemostatic abnormality patient affected COVID19 correlate severity lung injury measured CL result underline pathogenetic role hemostasis COVID19 pneumonia beyond presence clinically evident thromboembolic complication,covid-19;d-dimer;sars-cov-2 pneumonia;hemostasis;lung volume measurements
ECMO Used Conditions Severe Scarcity Population Study Public Perception,34218997,OBJECTIVE ass societal preference regarding allocation extracorporeal membrane oxygenation ECMO rescue option select patient coronavirus disease 2019 COVID19 DESIGN Crosssectional survey nationally representative sample SETTING Amazon Mechanical Turk platform PARTICIPANTS total response 1041 member Amazon Mechanical Turk crowdsourcing platform included Participants 379 + 126 year old generally white 65 collegeeducated 661 Many reported working healthcare setting 225 friend family member admitted hospital 438 died COVID19 299 MEASUREMENTS MAIN RESULTS Although reported unwillingness stay ECMO one week without sign recovery participant highly supportive ECMO utilization lifepreserving technique policy level majority 967 advocated continued use ECMO treat COVID patient period resource scarcity would prioritize highest likelihood recovery 50 followed sickest regardless survival chance 317 Patients 40 year old likely prefer distributing ECMO firstcome firstserved basis 215 v 133 p 005 CONCLUSION Even though participant expressed hesitation regarding ECMO personal circumstance uniformly support using ECMO treat COVID patient policy level others might need even setting severe scarcity,covid-19;ecmo;bioethics;justice;resource allocation
Clinical characteristic outcome critically ill COVID19 patient Sfax Tunisia,34380191,Background Africa like rest world impacted coronavirus disease 2019 COVID19 pandemic However study covering subject Africa published Methods conducted retrospective study critically ill adult COVID19 patientsall confirmed severe acute respiratory syndrome coronavirus 2 SARSCoV2 infectionadmitted intensive care unit ICU Habib Bourguiba University Hospital Sfax Tunisia Results total 96 patient admitted ICU respiratory distress due COVID19 infection Mean age 624+128 year median age 64 year Mean PaO2FiO2 ratio 105+60 =300 case one Oxygen support required patient 100 invasive mechanical ventilation 38 40 Prone positioning applied 37 patient 385 Within study period 47 96 patient died 49 Multivariate analysis showed factor associated poor outcome development acute renal failure odds ratio 67 use mechanical ventilation 58 serum cholinesterase SChE activity lower 5000 UIL 59 Conclusion retrospective cohort study critically ill patient admitted ICU Sfax Tunisia acute respiratory failure following COVID19 infection mortality rate high development acute renal failure use mechanical ventilation SChE activity lower 5000 UIL associated poor outcome,covid-19;intensive care unit;prognosis;respiratory distress
Effectiveness safety acceptability notest medical abortion termination pregnancy provided via telemedicine national cohort study,33605016,OBJECTIVE compare outcome implementation medical abortion termination pregnancy without ultrasound via telemedicine DESIGN Cohort analysis SETTING three main abortion provider POPULATION SAMPLE Medical abortion home =69 day gestation two cohort traditional model inperson ultrasound n = 22 158 January March 2020 versus telemedicinehybrid model either person via telemedicine without ultrasound n = 29 984 18 435 notest telemedicine April June 2020 Sample n = 52 142 comprises 85 medical abortion provided nationally METHODS Data electronic record incident database used compare outcome cohort adjusted baseline difference MAIN OUTCOME MEASURES Treatment success serious adverse event waiting time gestation treatment acceptability RESULTS Mean waiting time referral treatment 42 day shorter telemedicinehybrid model abortion provided =6 week gestation 40 versus 25 P 0001 Treatment success 988 versus 982 P 0999 serious adverse event 002 versus 004 P = 0557 incidence ectopic pregnancy 02 versus 02 P = 0796 different model telemedicinehybrid model 004 estimated 10 week gestation time abortion completed safely home Within telemedicinehybrid model effectiveness higher telemedicine inperson care 992 versus 981 P 0001 Acceptability telemedicine high 96 satisfied 80 reported future preference telemedicine CONCLUSIONS telemedicinehybrid model medical abortion includes notest telemedicine treatment without ultrasound effective safe acceptable improves access care TWEETABLE ABSTRACT Compelling evidence 52 142 woman show notest telemedicine abortion safe effective improves care,abortion;ambulatory care facilities [n02.278.035];health planning [n03.349];induced [e04.520.050];mifepristone [d04.210.500.365.415.580];misoprostol [d23.469.700.660.500];pregnancy complications [c13.703];telemedicine [n04.590.374.800];termination of pregnancy
Pilot Study Assess Feasibility Mobile Unit Remote Cognitive Screening Isolated Elderly Rural Areas,34198917,BACKGROUND Given current COVID19 pandemic situation ever remote solution assessing monitoring individual cognitive impairment urgently needed Older adult particular living isolated rural area socalled medical desert facing major difficulty getting access diagnosis care Telemedical approach assessment promising seem well accepted reducing burden bringing patient specialized clinic However many older adult yet adequately equipped allow proper implementation technology potential solution could mobile unit form van equipped telemedical system come patient home aim proofofconcept study evaluate feasibility reliability mobile unit setting remote cognitive testing Methods analysis eight participant aged 69 86 year old city DigneLesBains volunteered study basic neuropsychological assessment including short clinical interview administered two condition telemedicine mobile clinic equipped van participant home face face specialized clinic administration procedure order randomized result compared Acceptability user experience assessed among participant clinician qualitative quantitative manner Measurements stress indicator collected comparison RESULTS analysis revealed significant difference test result two administration procedure Participants overall satisfied mobile clinic experience found use telemedical system relatively easy CONCLUSION mobile unit equipped telemedical service could represent solution remote cognitive testing overcoming barrier rural area access specialized diagnosis care,cognitive assessment;dementia;mobile unit;screening;telemedicine;videoconference
Glycophosphopeptical AM3 Food Supplement Potential Adjuvant Treatment Vaccination SARSCoV2,34220861,world currently experiencing coronavirus disease 2019 COVID19 pandemic caused Severe Acute Respiratory Syndrome2 SARSCoV2 global spread resulted million confirmed infection death global pandemic continues grow availability drug treat COVID19 infection remains limited supportive treatment Moreover current speed vaccination campaign many country slow Natural substrate biological immunomodulatory activity glucans may represent adjuvant therapeutic agent treat SARSCoV2 AM3 natural glycophosphopeptical previously shown effectively slow side effect progression infectious respiratory disease regulating effect innate adaptive immunity experimental model clinical study however exist use AM3 SARSCoV2 infected patient review aim summarize beneficial effect AM3 respiratory disease inflammatory response modulation immune response attenuation muscle also discus potential effect immune system adjuvant treatment COVID19 infection adjuvant SARSCoV2 vaccination,am3;covid-19;cytokines;food supplement;glycophosphopeptical;immunonutrition;muscular damage;vaccination
Tonic pupil COVID19 infection,34217472,latest global health threat ongoing outbreak respiratory disease named COVID19 multiple everevolving neurological complication since reported present case patient bilateral tonic pupil postinfectious context COVID 19 Brain magnetic resonance imaging laboratory test normal 0125 pilocarpine test confirmed diagnosis,bilateral tonic pupil;covid-19;pilocarpina;pilocarpine;pupila tonica bilateral
Side Effects Reported Jordanian Healthcare Workers Received COVID19 Vaccines,34205917,Background Distribution COVID19 vaccine surrounded suspicion rumor making necessary provide public accurate report trustworthy expert healthcare professional Methods distributed questionnaire Jordan among physician dentist nurse received COVID19 vaccine explore side effect SE encountered first second dose one three vaccine namely AstraZeneca Vaxzevria AZ PfizerBioNTeck PB SinoPharm SP vaccine Results total 409 professional participated Approximately 18 31 participant reported SE first dose second dose respectively remainder mostly local side effect related injection site 74 Systemic side effect form fatigue 52 myalgia 44 headache 42 fever 35 prevailed mainly first dose significantly associated AZ vaccine age = 45 year p = 0000 001 respectively serious SE reported Conclusions conclude SE COVID19 vaccine distributed Jordan within common range known far vaccine study needed include larger sample size longer followup period monitor possible serious longterm SE vaccine,astrazeneca vaccine;covid-19;pfizer-bionteck vaccine;sinopharm;dentists;healthcare professionals;nurses;physicians;side effects
Lessons COVID19 pandemic response appraisal guidance public health management Invasive Meningococcal Disease,34218099,BACKGROUND COVID19 focussed public attention management communicable disease like never Surveillance contact tracing case management recognised key component outbreak prevention Development guidance COVID19 drawn existing management communicable disease including Invasive Meningococcal Disease IMD IMD rare severe outcome Neisseria meningitidis infection prevented vaccination Cases still occur sporadically requiring ongoing surveillance consistent management end national international public health agency developed published guidance identification management IMD case AIM ass national international guideline public health management IMD focus recommendation identification management `` close contact IMD case METHODS Guidelines six national international public health agency assessed using modified version Appraisal Guidelines Research Evaluation AGREE II Instrument four key domain stakeholder involvement developmental rigour clarity applicability direct comparison terminology recommendation identification management close contact IMD case also conducted RESULTS Guidelines Europe United Kingdom rated highly using AGREE II Instrument presenting clear critical assessment strength available evidence risk cost benefit behind recommendation management close contact Direct comparison guideline identified inconsistency language defining close contact IMD case CONCLUSION Discrepancies guideline could due limited evidence concerning mechanism behind disease transmission along lack consistent process development review guideline recommendation COVID19 management demonstrated international collaboration development public health guidance possible practice extended management communicable disease,covid-19;communicable diseases;contact tracing;guidelines;meningococcal disease
Collapse public health system emergence new variant second wave COVID19 pandemic Brazil,34222607,worldwide spread severe acute respiratory syndrome coronavirus 2 SARSCoV2 caused severe public health crisis since 1918 Spanish influenza pandemic introduction public health intervention aimed reducing number COVID19 case many country across world obtained success containing fast spread SARSCoV2 first wave pandemic However SARSCoV2 resurged many country causing even devastating second wave Brazil one affected country currently facing one worst public health crisis history discus unprecedented challenge faced Brazilian public health system midst second wave COVID19 pandemic particularly regarding collapse Brazilian health system emergence new variant concern VOCs Finally suggest insight using one health approach help country face overcome current COVID19 crisis,covid-19;coronavirus;one health;public health;sars-cov-2;variants
COVID19 Pandemic Huge Stress Test Health System Could Great Opportunity Update Workflow Modern Surgical Pathology,34209009,BACKGROUND December 2019 outbreak atypical pneumonia known COVID19 identified Wuhan China disease characterized rapid humantohuman transmission severe acute respiratory syndrome coronavirus 2 SARSCoV2 spread rapidly 200 country Northern Italy s region hit hard term death report experience Pathology Department Fondazione IRCCS Istituto Nazionale Tumori INT Milan first Italian public cancer center period lockdown took place Lombardy March May 2020 METHOD variation term exam calculated two different timeframes December 2019February 2020 preCOVID19 MarchMay 2020 COVID19 period TurnAroundTime TAT metric released Lombardy Region calculated ass change applied guarantee safeguarding worker affected average diagnosis time RESULTS COVID19 period decrease performed exam considerable decrease observed PAP test 816 followed biopsy 488 second opinion 417 surgical 315 molecular 294 cytological 181 test Measures applied within Pathology Department digital pathology remote working rotation change operating procedure improved diagnostic performance required guideline Lombardy Region term TAT time measure applied safeguarding personnel turned feasible affect overall performance Pathology Department CONCLUSIONS sharp slowdown cancer screening first wave COVID19 could seriously endanger cancer prevention near future,sars-cov-2;cancer screening;health management;preventive measures
Genomic Surveillance SARSCoV2 Viruses Collected Ending Phase First Wave COVID19 Pandemic Bangladesh,34292071,Mutations deletion emergence new variant severe acute respiratory syndrome coronavirus 2 SARSCoV2 may pose serious health threat report genome sequence SARSCoV2 virus collected SARSCoV2infected patient end phase first wave COVID19 pandemic Dhaka Bangladesh,
LungCentric Inflammation COVID19 Potential Modulation Vitamin,34203190,SARSCoV2 infects respiratory tract lead disease entity COVID19 Accordingly lung bear greatest pathologic burden major cause death respiratory failure However organ remote initial site infection eg kidney heart spared particularly severe fatal case Emerging evidence indicates excessive inflammatory response coupled diminished antiviral defense pivotal initiation development COVID19 common finding autopsy specimen presence thrombus lung well remote organ indicative immunothrombosis Herein role SARSCoV2 lung inflammation associated sequela reviewed emphasis immunothrombosis much vitamin touted supplement conventional therapy COVID19 impact vitamin various juncture COVID19 pathogenesis also addressed,covid-19;sars-cov-2;acute respiratory distress syndrome (ards);coronavirus;cytokine storm;inflammasome;neutrophil extracellular traps (nets);vitamin d
Effects treatment COVID19 convalescent plasma 25 Bcell depleted patient,34293119,25 Bcell depleted patient 24 following antiCD1920 therapy diagnosed COVID19 symptomatic median 26 day remained antibody negative treated convalescent plasma high neutralizing antibody titer 21 84 recovered indicating potential therapeutic effect therapy particular population,b-cell depletion;covid-19;sars-cov-2;convalescent plasma;immunodefiency
CHOROIDAL CHANGES DUE LONGTERM USE N95 FACE MASKS,34303028,PURPOSE aimed examine change choroidal stroma vascular system due longterm use N95 mask healthcare worker METHOD healthcare worker included study age 1850 best corrected visual acuity BCVA 1010 spherical cylindrical refractive error le 3 diopter intraocular pressure IOP within normal limit axial length AL le 25 mm choroid imaged enhanced depth imaging EDI technique using SDOCT choroidal vascularity index CVI total choroidal area TA luminal area LA stromal area SA measured subfoveal 2 mm area Measurements first made wearing N95 mask least 2 hour without removing repeated 1hour removing office working RESULTS study included 62 eye 62 participant 32 woman 5161 30 men 4839 mean age patient 3381+ 888 year 2050 year difference subfoveal TA LA SA 2 hour N95 mask use 1 hour removal mask statistically significant p 005 However difference CVI mask use removal mask statically significant p=0537 CONCLUSION Due CO2 retention hemodynamic change choroidal vascular flow choroidal vascular area choroidal stromal area may affected prolonged use mask,covid-19;edi;n95 mask;optical coherence tomography;choroidal vascularity index;eyes
Increased susceptibility human endothelial cell infection SARSCoV2 variant,34224022,Coronavirus disease 2019 COVID19 spawned global health crisis late 2019 caused novel coronavirus SARSCoV2 SARSCoV2 infection lead elevated marker endothelial dysfunction associated higher risk mortality unclear whether endothelial dysfunction caused direct infection endothelial cell mainly secondary inflammation investigate whether different type endothelial cell susceptible SARSCoV2 Human endothelial cell different vascular bed including umbilical vein endothelial cell coronary artery endothelial cell HCAEC cardiac lung microvascular endothelial cell pulmonary arterial cell inoculated vitro SARSCoV2 Viral spike protein detected HCAECs SARSCoV2 infection endothelial cell tested Consistently HCAEC expressed SARSCoV2 receptor angiotensinconverting enzyme 2 ACE2 required virus infection Infection SARSCoV2 variant B117 B1351 P2 resulted significantly higher level viral spike protein Despite intracellular doublestranded viral RNA detected supernatant contain infectious virus Analysis cellular distribution spike protein revealed colocalized endosomal calnexin SARSCoV2 infection induce ER stress gene EDEM1 responsible clearance misfolded protein ER Whereas wild type SARSCoV2 induce cytotoxic proinflammatory effect variant B117 reduced HCAEC cell number different tested endothelial cell HCAECs showed highest viral uptake promote virus replication Effects cell number observed infection variant B117 suggesting endothelial protection may particularly important patient infected variant,er stress;endothelial cells;sars-cov-2;virus trapping
Prescription Drug Dispensing US Children COVID19 Pandemic,34285080,BACKGROUND US coronavirus disease 2019 outbreak overall prescription dispensing declined rebounded Whether trend occurred child unknown METHODS Using IQVIA National Prescription Audit contains monthly dispensing count 92 US retail pharmacy assessed change monthly number prescription dispensed US child aged 0 19 year 20182020 compared dispensing total April December 2020 April December 2019 overall drug class among drug class typically treat acute infection eg antibiotic chronic disease eg antidepressant RESULTS January 2018 February 2020 median monthly number prescription dispensed child 25 744 758 Dispensing total declined 25 684 219 16 742 568 March April 2020 increased 19 657 289 October 2020 decreased 15 821 914 December 2020 Dispensing total April December 2020 160 630 406 271 lower compared April December 2019 220 284 613 Among 3 drug class accounting prescription 2019 corresponding percentage change 556 antibiotic 118 attentiondeficithyperactivity disorder medication 01 antidepressant Among drug class typically treat acute infection chronic disease percentage change 513 174 respectively CONCLUSIONS Prescription dispensing child declined onequarter April December 2020 compared April December 2019 Declines greater infectionrelated drug chronic disease drug Decreased dispensing latter potentially concerning warrant investigation Whether reduction dispensing infectionrelated drug temporary sustained important monitor going forward,
Lagged meteorological impact COVID19 incidence among highrisk county United Statesa spatiotemporal analysis,34211113,BACKGROUND association meteorological factor coronavirus disease 2019 COVID19 discussed globally however short study period lack considering lagged effect different study area result literature diverse even contradictory OBJECTIVE primary purpose study conduct reliable research evaluate lagged meteorological impact COVID19 incidence considering relatively long study period diversified highrisk area United States METHODS study adopted distributed lagged nonlinear model spatial function analyze COVID19 incidence predicted multiple meteorological measure March October 2020 across 203 highrisk county United States estimated spatial function smoothed within entire continental United States biharmonic spline interpolation RESULTS finding suggest maximum temperature minimum relative humidity precipitation best meteorological predictor significantly positive association found 3 11 lagged day lower level selected meteorological factor particular significantly positive association appeared minimum relative humidity higher 8836 5day lag spatial analysis also show excessive risk northcentral United States SIGNIFICANCE research finding contribute implementation early warning surveillance COVID19 using weather forecasting two week highrisk county,covid-19;lag;precipitation;relative humidity;spatial;temperature
Janus kinase inhibitor dermatology Part II comprehensive review,34228996,Janus kinasesignal transducer activator transcription JAKSTAT intracellular signaling pathway implicated pathogenesis number inflammatory dermatosis Clinical trial study demonstrated efficacy JAK inhibitor treatment variety dermatologic condition review JAK inhibitor currently investigation treatment alopecia areata vitiligo sarcoidosis necrobiosis lipoidica granuloma annulare systemic lupus erythematosus special emphasis safety implication JAK inhibitor novel coronavirus 2019 pandemic,covid-19;jak inhibitor;jak-stat pathway;janus kinase inhibitor;janus kinase-signal transducer and activator of transcription pathway;coronavirus;dermatology;immunodermatology;immunology;review
Cutaneous reaction inactivated SARSCoV2 vaccine ChAdOx1S recombinant vaccine SARSCoV2 case series Philippines,34363713,Philippines remains one country highest number new COVID19 case Western Pacific region Philippine government granted emergency use authorization inactivated SARSCOV2 Sinovac recombinant ChAdOx1S AstraZeneca vaccine Early trial vaccine described reaction ranging injection site reaction generalized urticaria,astrazeneca;covid-19;sinovac;delayed hypersensitivity;exanthems;vaccine
Impact Deranged Glucose Metabolism Diabetes Pathogenesis Prognosis Novel SarsCov2 Systematic Review Literature,34365925,BACKGROUND novel coronavirus disease COVID19 declared global pandemic World Health Organization March 11 2020 constituted one serious health challenge century globally causative organism initially named 2019 novel coronavirus 2019 nCoV subsequently renamed Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 pandemic far infected several million killed million people worldwide Diabetes mellitus DM one leading cause morbidity worldwide OBJECTIVES examine critical role diabetes play pathogenesis prognosis COVID19 ass emerging therapy available fight pandemic METHODS Authors conducted systematic review literature examine role diabetes comorbidity pathogenesis prognosis COVID19 RESULTS experimental observational data early 2020 suggested people COVID19 comorbidities dominant diabetes cardiovascular disease hypertension Empirical evidence indicates diabetic patient infected COVID19 disease worst outcome concerning morbidity mortality CONCLUSION combination underlying chronic condition hypertension obesity cardiovascular disease together altered ACE receptor expression immune dysregulation via cytokine storm alveolar endothelial dysfunction increased systemic coagulation may put individual diabetes risk COVID19 severity study needed elucidate glucoselowering drug may modulate host immune response diabetic individual especially following administration potential COVID19 vaccine,covid-19 disease;coronavirus;diabetes;hyperglycemia;metabolism;pandemic.
Outcomes Extracorporeal Membrane Oxygenation Acute Respiratory Distress Syndrome COVID19 Patients PropensityMatched Analysis,34207573,remains unclear extent outcome complication extracorporeal membrane oxygenation ECMO therapy COVID19 patient acute respiratory distress syndrome ARDS differ nonCOVID19 ARDS patient observational propensitymatched study outcome ECMO support compared 19 COVID19 patient suffering ARDS COVID group 34 matched nonCOVID19 ARDS patient NCOVID group historical cohort 12 propensity matching performed based respiratory ECMO survival prediction RESP score age gender bilirubin creatinine level Patients characteristic laboratory parameter adverse event 90day survival analyzed Patients characteristic COVID NCOVID group similar ECMO initiation fibrinogen level significantly higher COVID group median 493 vs 364 mgdL p 0001 Median ECMO support duration similar 16 vs 13 day p = 0714 respectively ECMO therapy patient COVID group developed significantly thromboembolic event TEE NCOVID group 42 vs 12 p = 0031 mainly pulmonary artery embolism PAE 26 vs 0 p = 0008 rate major bleeding event 42 vs 62 p = 0263 similar Fibrinogen decreased significantly COVID group NCOVID group p 0001 whereas Ddimer increased COVID group p = 0011 Additionally 90day mortality differ 47 vs 74 p = 0064 COVID NCOVID group Compared nonCOVID19 ARDS patient ECMO support COVID19 patient associated comparable inhospital mortality similar bleeding rate higher incidence TEE especially PAE contrast coagulation parameter differed COVID NCOVID patient,covid-19;sars-cov-2;acute respiratory distress syndrome;coagulation;extracorporeal membrane oxygenation;thromboembolic events
Serology COVID19 Comparison Two Methods,34208607,BACKGROUND aim study examine performance two assay detecting SARSCoV2 antibody METHODS total 127 COVID19 disease contact Infectious Diseases Department included Two serological test used SARSCoV2 IgG CMIA Alinity system Abbott LIAISON R SARSCoV2 S1S2 IgG CLIA DiaSorin RESULTS assay exhibited 9685 123127 patient test result agreement two case positive result obtained SARSCoV2 IgG CMIA Alinity system Abbott negative based LIAISON R SARSCoV2 S1S2 IgG CLIA DiaSorin test two case negative result LIAISON R SARSCoV2 S1S2 IgG CLIA DiaSorin test positive SARSCoV2 IgG CMIA Alinity system Abbott CONCLUSIONS Based result study conclude population medicine assessment antiSARSCoV2 antibody exposure SARSCoV2 virus based spike protein nucleocapsid protein show comparable effectiveness,sars-cov-2;chemiluminescent immunoassay;nucleocapsid protein;serology;spike protein
New Impedimetric Sandwich Immunosensor Ultrasensitive Highly Specific Detection Spike Receptor Binding Domain Protein SARSCoV2,34292712,impedance sensing platformcombined conducting nanocomposite layer fabricated develop effective rapid method detection coronavirus infection COVID19 specific spike receptor binding domain RBD protein precious antigen marker COVID19 disease Coronavirus infection spread globally swiftly major impact health economy quality life community Fast reliable detection COVID19 significant issue effective treatment bad illness aim first Epoxy functional groupsubstituted thiophene monomer synthesized electrodeposited singleuse indium tin oxide ITO platform presence acetylene black employing cyclic voltammetry technique thus conducting nanocomposite CNC layer high conductivity obtained composite electrodeposited first time ITO surface generate facile costeffective impedimetric biosensor addition composite provided proper attachment point antibody binding also supported biosensor construction immunospecific biointeractions antiRBD RBD protein hampered electron transfer ITO substrate surface electrolyte reaction caused variation impedance signal signal proportional immobilized RBD antigen amount asprepared immunosensor showed wide linear dynamic range 00012120 pgmL ultralow detection limit 058 fgmL added superiority great selectivity suitable repeatability multiple reusability excellent reproducibility,conducting nanocomposite;impedimetric analysis;single-use electrode;spike receptor binding domain
Optimal quarantinerelated strategy COVID19 control model,34226756,time paper written quarantinerelated strategy full lockdown relaxed preventive measure available measure control coronavirus disease 2019 COVID19 epidemic However longterm quarantine especially full lockdown extremely expensive measure explore possibility controlling suppressing COVID19 epidemic lowest possible cost apply optimal control theory paper create two controlled SusceptibleExposedInfectiousRemoved SEIR type model describing spread COVID19 human population model solve optimal control problem find optimal quarantine strategy ensures minimal level infected population lowest possible cost property corresponding optimal control established analytically using Pontryagin maximum principle optimal solution obtained numerically validate analytical result Additionally controlled model find explicit formula basic reproductive ratio presence constant control show epidemic eventually stopped longterm quarantine measure maximum strength full lockdown strength quarantine reduced optimal quarantine policy behavior appropriate optimal solution dependence basic reproductive ratio population density duration quarantine discussed practically relevant conclusion made,covid-19;pontryagin maximum principle;seir epidemics model;nonlinear control system
NLRP3 Infections betaAmyloid Inflammasome beyond Neurodegeneration,34209586,Amyloid beta Abeta induced abnormal neuroinflammation recognized major pathological feature Alzheimer s disease AD result memory impairment Research exploring lowgrade systemic inflammation impact development progression neurodegenerative disease increased particular research focus whether systemic inflammation arises secondary effect disease also cause pathology inflammasomes specifically NLRP3 inflammasome crucial component innate immune system usually activated response infection tissue damage Although inflammasome activation play critical role various pathogen host defense overactivation inflammasome contributes pathogenesis inflammatory disease including acute central nervous system CNS injury chronic neurodegenerative disease AD review summarizes current literature role NLRP3 inflammasome pathogenesis AD involvement infection particularly SARSCoV2 NLRP3 might represent crossroad hypothesized neurodegeneration primary COVID19 infection,alzheimer's disease;covid-19;nlrp3;infections;neurodegeneration;neuroinflammation
Microstructured Surfaces Reducing Chances Fomite Transmission via VirusContaining Respiratory Droplets,34339604,Evaporationinduced particle aggregation drying droplet significant importance prevention pathogen transfer due possibility indirect fomite transmission infectious virus particle study particle aggregation directionally controlled using contact line dynamic pinned slipping geometrical gradient microstructured surface systematic investigation evaporation process sessile droplet sprayed microdroplets laden virussimulant nanoparticles Using mechanism designed robust particle capture surface significantly inhibiting contact transfer particle fomite surface proofofconcept interconnected hexagonal inverted pyramidal microwall fabricated using ultravioletbased nanoimprint lithography considered promising scalable manufacturing process demonstrated potential engineered microcavity surface limit contact transfer particle aggregate deposited evaporation microdroplets 93 hexagonal microwall 96 inverted pyramidal microwall particle capture potential interconnected microstructures also investigated using biological particle including adenovirus lungderived extracellular vesicle finding indicate proposed microstructured surface reduce indirect fomite transmission highly infectious agent including norovirus rotavirus SARSCoV2 via respiratory droplet,directional particle aggregation;fomite transmission;microstructured surfaces;nanoparticles;respiratory droplets;virus particles
Clinical Presentation Management InHospital Outcome COVID19 among NonHealthcare Personnel Healthcare Personnel Tertiary Cardiac Care Hospital,34226467,huge number nonhealthcare personnel nonHCP get infected corona virus disease 2019 COVID19 paralyze health care system also put health care personnel HCP potential risk globally Objective study compare Healthcare personnel HCP nonHCP COVID19 case prospective observational study carried National Heart Foundation Hospital Research Institute Bangladesh March 08 2020 July 20 2020 study period admitted nonHCP subsequently diagnosed COVID19 positive rRTPCR HCP hospital experienced fever respiratory symptom came close contact COVID19 patient home workplace become COVID19 positive included 320 infected patient 181 566 patient nonHCP 139 434 HCP NonHCP older HCP Mean age 5295+1382 year vs 3408+1111 year p=0001 NonHCP predominantly male HCP predominantly female 735 vs 41 265 vs 59 p=0001 NonHCP risk factor comorbidities HCP p=0001 Typical symptom COVID19 fever cough prevalent HCP aggressive treatment required nonHCP NonHCP severe disease higher case fatality rate 94 vs 07 p=0001 HCP Disease severity 003 95 CI 001015 DM 009 95 CI 001094 independent predictor mortality NonHCP older age predominantly male comorbidities HCP Typical symptom COVID19 prevalent HCP NonHCP severe disease higher case fatality rate HCP,
Inter IntraRater Reliability Measuring Photometric Craniovertebral Angle Using CloudBased Video Communication Platform,34345337,Objective Due social distancing guideline Coronavirus COVID19 pandemic provider patient wanted avoid close contact make physical therapy PT assessment difficult lack empirical evidence reliability various clinical measurement performed virtual environment One procedure photometric measurement craniovertebral CV angle Craniovertebral angle measurement usually performed outpatient setting defined acute angle formed straight line connecting spinous process C7 tragus ear horizontal line passing spinous process C7 Although photometric measurement CV angle considered valid reliable clinic empirical evidence exists CV angle measurement reliability performed virtual environment Thus purpose study ass inter intrarater reliability photometric CV angle measurement using cloudbased video communication platform Number Subjects 66 subject 57 female Methods measurement performed two final year PT student completed musculoskeletal part curriculum blinded s measurement subject photographed two posture HIPAAcompliant videobased telehealth platform 1 normalrelaxed posture 2 ideal posture posture subject considered good Student researcher 1 measured CV angle relaxed posture ideal posture student researcher 2 measured CV angle relaxed posture subject s CV angle measurement performed three time three separate day mean used analysis shape CV angle frequency distribution assessed using kurtosis skewness value Rater reliability assessed using intraclass correlation coefficient ICC interpreted based guideline provided Portney Watkins 2009 Results CV angle normally distributed relaxed ideal posture mean standard deviation SD relaxed posture 507o + 63o kurtosis skewness 067 074 respectively mean SD ideal posture 555o + 54o kurtosis skewness 01 054 respectively ICC interrater reliability relaxed posture 088 ICC intrarater reliability relaxed posture 091 Conclusions Craniovertebral angle normally distributed sample acceptable level inter intrarater reliability attained measuring CV angle using cloudbased video communication platform,craniovertebral angle;forward head posture;physical therapy;posture;telehealth
Replicative Fitness SARSCoV2 20I501YV1 Variant Lineage B117 Human Reconstituted Bronchial Epithelium,34225487,Since emergence 2019 circulating population new coronavirus CoV continuously acquired genetic diversity end 2020 variant named 20I501YV1 lineage B117 emerged replaced circulating strain several region phenomenon poorly associated biological evidence variant original strain exhibit different phenotypic characteristic analyze replication ability new variant different cellular model using comparison ancestral D614G European strain lineage B1 Results comparative replication kinetics experiment vitro human reconstituted bronchial epithelium showed difference However virus put competition human reconstituted bronchial epithelium 20I501YV1 variant outcompeted ancestral strain together finding demonstrate new variant replicates efficiently may contribute better understanding progressive replacement circulating strain severe acute respiratory CoV2 SARSCoV2 20I501YV1 variant IMPORTANCE emergence several SARSCoV2 variant raised numerous question concerning future course pandemic currently observing replacement circulating virus variant United Kingdom known 20I501YV1 B117 lineage little biological evidence new variant exhibit different phenotype present study used different cellular model ass replication ability 20I501YV1 variant result showed variant replicates efficiently human reconstituted bronchial epithelium may explain spread rapidly human population,20i/501y.v1;b.1.1.7;sars-cov-2;ex vivo;in vitro;replicative fitness;variant
Performance Comparison Five SARSCoV2 Antibody Assays Seroprevalence Studies,34374351,Background Seroprevalence study coronavirus disease 2019 COVID19 case including asymptomatic past infection important estimate scale disease outbreak establish quarantine measure evaluated clinical performance severe acute respiratory syndrome coronavirus 2 SARSCoV2 antibody assay available Korea use seroprevalence study Methods sensitivity specificity crossreactivity interference five SARSCoV2 antibody assay evaluated using following 398 serum sample confirmed COVID19 patient 510 negative control sample 2018 prepandemic 163 serum sample patient SARS Middle East respiratory syndrome MERS viral infection five sample interference study Results sensitivity five assay ranged 922 98 specificity including crossreactivity interference ranged 975 100 agreement rate excellent kappa 09 Adjustment cutoff value could considered ROC curve analysis positive predictive value individual assay varied 35 100 01 prevalence high =95 two assay combined Conclusions prevalence COVID19 Korea considered exceptionally low present thus recommend using combination two SARSCoV2 antibody assay rather single assay result could help select SARSCoV2 antibody assay COVID19 seroprevalence study Korea,antibody;covid-19;sars-cov-2;seroprevalence
Ovarian Vein Thrombosis Pelvic Surgery Patient Recent Coronavirus Disease 2019,34375739,abundance literature demonstrated Coronavirus Disease 2019 COVID19 contributes hypercoagulable state associated venous thromboembolic event Data postoperative complication following mild COVID19 infection limited report case ovarian vein thrombosis OVT following pelvic surgery patient recent mild COVID19 infection patient presented complaint fever worsening rightsided abdominal pain postoperatively found right OVT Thrombophilia workup negative hypercoagulable state patient diagnosed COVID19 may implication postoperative complication gynecologic surgery even case mild infection research needed determine optimal thromboembolic prophylaxis patient undergoing pelvic surgery COVID19 infection,hypercoaguability;hysterectomy;robotic surgery;septic pelvic thrombophlebitis
Knowledge awarenessbased survey COVID19 within eye care profession Nepal Misinformation hiding truth,34288939,BACKGROUND Nepal severe lockdown several month 2020 due COVID19 pandemic concern regarding misinformation circulating social medium study aimed analyse knowledge awareness COVID19 amongst eye care professional Nepal first wave pandemic METHODOLOGY invited 600 participant 12 ophthalmic centre across Nepal complete qualitative anonymous online survey Altogether 25 question open closedended used overall performance score calculated average 12 `` Knowledge question participant RESULTS 600 eye care professional invited 310 51 participated survey symptom COVID19 known 94 whilst 49 participant aware disease transmitted 54 aware anyone infected SARSCoV2 Almost 98 participant recognized World Health Organization s awareness message surprisingly 41 participant felt consumption hot drink help destroy virus contradiction information Importantly 95 participant aware personal protective equipment PPE acronym stand Social distancing felt key limiting disease spread whilst 41 disagreed PPE mandatory eye care practitioner mean overall `` Knowledge performance score 6965 SD + 2281 CONCLUSION still considerable scope improve knowledge COVID19 amongst ophthalmic professional Nepal Opinion also split measure prevent transmission misinformation potentially fuelling confusion recommended follow national guideline whilst seeking published scientific evidence behind unofficial statement accurately inform one s clinical practice,
Effectiveness Covid19 Vaccines B16172 Delta Variant,34289274,BACKGROUND B16172 delta variant severe acute respiratory syndrome coronavirus 2 SARSCoV2 virus cause coronavirus disease 2019 Covid19 contributed surge case India detected across globe including notable increase case United Kingdom effectiveness BNT162b2 ChAdOx1 nCoV19 vaccine variant unclear METHODS used testnegative casecontrol design estimate effectiveness vaccination symptomatic disease caused delta variant predominant strain B117 alpha variant period delta variant began circulating Variants identified use sequencing basis spike gene status Data symptomatic sequenced case Covid19 England used estimate proportion case either variant according patient vaccination status RESULTS Effectiveness one dose vaccine BNT162b2 ChAdOx1 nCoV19 notably lower among person delta variant 307 95 confidence interval CI 252 357 among alpha variant 487 95 CI 455 517 result similar vaccine BNT162b2 vaccine effectiveness two dos 937 95 CI 916 953 among person alpha variant 880 95 CI 853 901 among delta variant ChAdOx1 nCoV19 vaccine effectiveness two dos 745 95 CI 684 794 among person alpha variant 670 95 CI 613 718 among delta variant CONCLUSIONS modest difference vaccine effectiveness noted delta variant compared alpha variant receipt two vaccine dos Absolute difference vaccine effectiveness marked receipt first dose finding would support effort maximize vaccine uptake two dos among vulnerable population Funded Public Health England,
Coordinate Induction Humoral Spike Specific TCell Response Cohort Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine,34208751,Vaccination main public health measure reduce SARSCoV2 transmission hospitalization massive worldwide scientific effort resulted rapid development effective vaccine work aimed define dynamic humoral cellmediated immune response cohort health care worker HCWs received twodose BNT162b2mRNA vaccination serological response evaluated quantifying antiRBD neutralizing antibody cellmediated response performed whole blood test quantifying Th1 cytokine IFNgamma TNFalpha IL2 produced response spike peptide BNT162b2mRNA vaccine induced humoral cellmediated immune response spike peptide virtually HCWs without previous SARSCoV2 infection moderate inverse relation age antiRBD response Spikespecific cell produced several Th1 cytokine IFNgamma TNFalpha IL2 correlated specificserological response Overall study describes ability BNT162b2 mRNA vaccine elicit coordinated neutralizing humoral spikespecific cell response HCWs Assessing dynamic parameter easy immune monitoring protocol allow evaluation persistence vaccine response order define optimal vaccination strategy,sars-cov2;coordinate immunity;health care workers;mrna vaccine;whole blood t cell assay
predicting role carcinoembryonic antigen underlying mechanism progression coronavirus disease 2019,34217339,BACKGROUND coronavirus disease 2019 COVID19 induced worldwide epidemiological event high infectivity mortality However predicting biomarkers potential mechanism progression COVID19 well known OBJECTIVE aim study identify candidate predictor COVID19 investigate underlying mechanism METHODS retrospective study conducted identify potential laboratory indicator prognostic value COVID19 disease prognostic nomogram constructed predict overall survival COVID19 patient Additionally scRNAseq data BALF PBMCs COVID19 patient downloaded investigate underlying mechanism important prognostic indicator lung peripheral respectively RESULTS total 304 hospitalized adult COVID19 patient Wuhan Jinyintan Hospital included retrospective study CEA laboratory indicator significant difference univariate P 0001 multivariate analysis P = 0020 scRNAseq data BALF PBMCs COVID19 patient downloaded investigate underlying mechanism CEA lung peripheral respectively result revealed potential role CEA significantly distributed type II pneumocytes BALF developing neutrophil PBMCs participating progression COVID19 regulating cellcell communication CONCLUSION study identifies prognostic role CEA COVID19 patient implies potential role CEACAM8CEACAM6 progression COVID19 regulating cellcell communication developing neutrophil type II pneumocyte,carcinoembryonic antigen;carcinoembryonic antigen-related cell adhesion molecules;coronavirus disease 2019;developing neutrophils;type ii pneumocyte
recombinant spike protein subunit vaccine confers protective immunity SARSCoV2 infection transmission hamster,34285130,Multiple safe effective vaccine elicit immune response severe acute respiratory syndrome coronavirus 2 SARSCoV2 necessary respond ongoing coronavirus disease 2019 COVID19 pandemic developed protein subunit vaccine comprised spike ectodomain protein StriFK plus nitrogen bisphosphonatemodified zincaluminum hybrid adjuvant FH002C StriFKFH002C generated substantially higher neutralizing antibody titer mouse hamster cynomolgus monkey observed plasma isolated COVID19 convalescent individual StriFKFH002C also induced Th1 Th2polarized helper cell response mouse hamster StriFKFH002C immunization protected animal SARSCoV2 challenge shown absence virusinduced weight loss fewer symptom disease reduced lung pathology Vaccination hamster StriFKFH002C also reduced withincage virus transmission unvaccinated cohoused hamster summary StriFKFH002C represents effective protein subunitbased SARSCoV2 vaccine candidate,
Diabetic Retinopathy Screening Registration EuropeNarrative Review,34204591,Diabetic retinopathy DR leading cause preventable vision impairment blindness European Region Despite fact almost European country kind prophylactic eye examination people diabetes examination properly arranged organized according principle screening medicine 2021 current COVID19 pandemic moved telemedicine forefront healthcare service Due lot patient could benefit comfortable faster access ophthalmology specialist care study aimed conduct narrative literature review current DR screening program registry European Union last 20 year implementation telemedicine daily medical practice performing screening program became much attainable Remote assessment retinal picture simultaneously save country time money resource,diabetic retinopathy;population screening;registry
Forecasting MultiWave Epidemics Bayesian Inference,34335019,present simple nearrealtime Bayesian method infer forecast multiwave outbreak demonstrate COVID19 pandemic approach us timely epidemiological data widely available COVID19 provides shortterm forecast outbreak s evolution used medical resource planning method postulate one multiwave infection model convolved incubationperiod distribution yield competing disease model disease model parameter estimated via Markov chain Monte Carlo sampling informationtheoretic criterion used select use forecasting method demonstrated two threewave COVID19 outbreak California New Mexico Florida observed SummerWinter 2020 find method robust noise provides useful forecast along uncertainty bound reliably detected initial singlewave COVID19 outbreak transformed successive surge containment effort state failed end Spring 2020,bayesian framework;covid-19;incubation model;infection rate;markov chain monte carlo;pseudo-marginal mcmc
Effects remotely supervised motor rehabilitation program individual Rett syndrome home,34282992,PURPOSE study effect remotely supervised homebased familycentered individualized rehabilitation program motor activity individual Rett syndrome RTT evaluated MATERIALS METHODS Thirteen participant classic genetically confirmed RTT followed threemonth program motor activity home total 47 rehabilitative goal set Goals achievement motor function parental satisfaction evaluated program carried participant s parent remotely supervised via Skype call twice therapist experienced RTT rehabilitation RESULTS Thirtyseven 787 rehabilitative goal achieved overachieved Ten participant 769 significantly increased gross motor functional level medium size effect 0604 Parental report involved family suggest average high level usefulness program 445 adherence program 445 general satisfaction 455 CONCLUSIONS finding strongly support implementation program population program remotely supervised implemented child away referenced facility long duration long holiday Covid19 type lockdownImplications rehabilitationA remote supervised motor activity program carried primary caregiver support motor functioning RTTTherapists consider family member motivation carry activity integrate family s daily routineThe program flexible adapt sudden change medical environmental condition functional ability family member motivational level,exercise therapy;rett syndrome;patient-centered care;physical therapy specialty;telerehabilitation
impact COVID19 pandemic hospitalization plasmapheresis therapy multiple sclerosis neuromyelitis optica spectrum disorder nationwide analysis Germany,34285719,Background Many country worldwide reported side effect coronavirus disease 2019 COVID19 pandemic influenced care patient disease acute elective setting Patients multiple sclerosis MS neuromyelitis optica spectrum disorder NMOSD represent major patient population suffering autoimmune inflammatory demyelinating disease central nervous system aimed analyze MS NMOSD hospitalization application plasmapheresis therapy dynamic different period COVID19 pandemic Germany Methods conducted nationwide retrospective crosssectional study using administrative database hospitalized patient main diagnosis MS NMOSD including information application plasmapheresis therapy included fullyear data 1463 hospital MS NMOSD patient hospitalized 2019 2020 Germany n = 87453 compared case number plasmapheresis therapy rate different pandemic period 2020 corresponding period 2019 Results observed substantial decline MS NMOSD patient hospitalization different pandemic period remarkable decline first wave pandemic First diagnosis MS 168 relapsingremitting MS 340 secondary progressive MS 489 primary progressive MS 438 NMOSD 192 Treatment rate plasmapheresis increased MS NMOSD patient 2020 compared 2019 18 versus 16 p = 0003 140 versus 93 p 0001 substantial increase first wave pandemic especially NMOSD patient 197 versus 84 p 0001 Conclusion marked decline MS NMOSD patient hospitalization different pandemic period 2020 substantial reduction pandemic s first wave progressive MS patient MS NMOSD patient needed rescue relapse treatment continued receive plasmapheresis therapy Germany,covid-19;germany;sars-cov-2;multiple sclerosis;neuromyelitis optica;plasmapheresis
Comparison Vaccine Hesitancy COVID19 Vaccination China United States,34198716,OBJECTIVES investigate difference vaccine hesitancy preference currently available COVID19 vaccine two country namely China United States US METHOD crossnational survey conducted China United States discrete choice experiment well Likert scale utilized ass vaccine preference underlying factor contributing vaccination acceptance Propensity score matching PSM performed enable direct comparison two country RESULTS total 9077 5375 3702 China United States respectively respondent completed survey propensity score matching 820 respondent China positively accepted COVID19 vaccination 722 respondent United States positively accepted Specifically 319 Chinese respondent recommended doctor COVID19 vaccination half US respondent recommended doctor 502 local health board 594 friend family 648 discrete choice experiment revealed respondent United States attached greatest importance efficacy COVID19 vaccine 4441 followed cost vaccination 2957 whereas China held different viewpoint cost vaccination covered largest proportion tradeoff 3066 efficacy ranked second important attribute 2634 Additionally respondent China tended much concerned adverse effect vaccination 1968 vs 612 lower perceived severity infected COVID19 CONCLUSION Although overall acceptance hesitancy COVID19 vaccination country high underpinned distinction country observed Owing difference COVID19 incidence rate cultural background availability specific COVID19 vaccine two country vaccine rollout strategy nationdependent,covid-19;global health;health policy;public health;vaccine hesitancy;vaccine preference
Exponential Amplification Using Photoredox Autocatalysis,34288684,Exponential molecular amplification polymerase chain reaction powerful tool allows ultrasensitive biodetection report new exponential amplification strategy based photoredox autocatalysis eosin photocatalyst amplifies activating nonfluorescent eosin derivative EYH 3 green light deactivated photocatalyst stable rapidly activated lowintensity light making eosin amplification suitable resourcelimited setting steadystate kinetic study reaction modeling found EYH 3 either oxidized eosin via oneelectron oxidation triplet eosin subsequent 1e H + transfer activated singlet oxygen risk degradation reducing rate EYH 3 degradation successfully improved EYH 3 toeosin recovery achieving efficient autocatalytic eosin amplification Additionally demonstrate flexibility output signal coupled eosin amplification photoinduced chromogenic polymerization enabling sensitive visual detection analytes Finally applied exponential amplification method developing bioassay detection biomarkers including SARSCoV2 nucleocapsid protein antigen used diagnosis COVID19,
Making trial part good clinical care lesson RECOVERY trial,34286192,COVID19 hit UK early 2020 known treatment condition result death around one four patient hospitalised disease Around world possible treatment administered huge number patient without reliable assessment safety efficacy rapid generation highquality evidence vital RECOVERY streamlined pragmatic randomised controlled trial set response challenge April 2021 39000 patient enrolled 178 hospital site UK Within 100 day initiation RECOVERY demonstrated dexamethasone improves survival patient severe disease result rapidly implemented UK internationally saving hundred thousand life Importantly also showed widely used treatment hydroxychloroquine azithromycin meaningful benefit hospitalised patient possible randomisation large number patient adoption streamlined pragmatic procedure focused quality together widespread collaboration focused single goal RECOVERY illustrates clinical trial healthcare integrated even pandemic approach provides new opportunity generate evidence needed highquality healthcare pandemic many condition place burden patient healthcare system,covid-19;recovery;evidence-based medicine;quality-by-design;randomised controlled trials
IntentionBased Critical Factors Affecting Willingness Adopt Novel Coronavirus Prevention Pakistan Implications Future Pandemics,34200335,Since human being long tradition coexistence pandemic may profoundly impact adopting preventive measure crucial humankind s survival study explores intentionbased critical factor affecting willingness individual adopt pandemic prevention end representative sample 931 Pakistanis filled online questionnaire However 828 questionnaire found complete valid path modeling analysis core finding follows Firstly peer group belief selfefficacy perceived risk pandemic knowledge ease pandemic prevention adoption riskaverse behavior revealed driving force individual willingness adopt pandemic prevention Contrastingly lack trust political mythical attitude towards pandemic uncovered inhibitor Nevertheless moral value depict neutral role Secondly peer group belief highest ranked followed lack trust political mythical attitude towards pandemic prevention Finally moral value determined lowestranked critical factor Based result government promote awareness campaign lethality fatality pandemic centralized decentralized level win people s trust grassroots level overcome mythical attitude individual societal level Besides access personal protective gear made feasible since easier pandemic prevention adoption would increase individual willingness adopt preventative measure,covid-19;pakistan;hybrid theoretical framework;intention-based critical factors;novel coronavirus;pandemic prevention;path modeling
Systematic Review Impact COVID19 Pandemic Neurosurgical Practice Indian Perspective,34211863,Objective study objective systematically review impact current pandemic neurosurgical practice find safe way practicing neurosurgery amid highly infectious patient COVID19 Materials Methods review PubMed EMBASE database performed literature systematically searched using keywords `` COVID19 `` Neurosurgery Results Among 425 record 128 article found eligible analysis article described perspective neurosurgical department pandemic departmental model organizational scheme triaging emergent nonemergent neurosurgical case optimal utilization limited resource solution continue academic research activity Triaging system help u optimally utilize limited resource available Guidelines developed safe neurosurgical practice continuation clinical academic activity pandemic various national international neurosurgical society Key change telemedicine regulatory guideline would help u continue provide neurosurgical care Videoconferences online education program webinars could help u overcome disadvantage brought upon neurosurgical education socialdistancing norm Conclusion unprecedented time like single algorithm going clear ethical dilemma faced u Individual patient triage way maintaining ethical practice time efficiently utilizing limited resource pandemic progress new guideline protocol continue evolve better neurosurgical practice,covid-19;impact;neurosurgery;triage
PORTABLE SINGLELEAD ELECTROCARDIOGRAM DEVICE ACCURATE QTc EVALUATION HOSPITALIZED PATIENTS,34223287,BACKGROUND Many commonly used drug prolong QTc interval QTc lead potentially lifethreatening arrhythmia current era COVID19 pandemic worth mentioning disease several drug used treatment associated QTc prolongation OBJECTIVE evaluate agreement clinical precision portable singlelead ECG device measure QTc interval compared standard 12lead ECG METHODS sequential test QTc ECG recording obtained device KardiaMobile KM1L AliveCor R compared QTc obtained conventional 12lead ECG Agreement evaluated using BlandAltman plot Lin s concordance coefficient Consistency two device determining QTc prolongation QTc =470 m male =480 m female evaluated kappa statistic RESULTS 128 patient presumed confirmed diagnosis COVID19 admitted University Hospital included QTc interval measured KM similar QTc measured conventional ECG 44245+405 vs 44165+403 m p015 BlandAltman analysis showed significant difference QTc value average difference 0797 95 Limits Agreement 13179 11585 Lin s concordance coefficient showed excellent agreement 0988 p 0001 Concordance two device determining QTc prolongation excellent Kappa 090 CONCLUSION ECG recording obtained KM1L allow accurate QTc interval assessment Considering simplicity use approach advantage conventional ECG provide alternative evaluation QTc hospitalized patient current time pandemic COVID19 beyond,covid-19;electrocardiography;kardiamobile;mobile applications;qt/qtc interval;smartphone;ventricular arrhythmias;single-lead ecg device
Topological data analysis model spread coronavirus,34347838,apply topological data analysis specifically Mapper algorithm US COVID19 data resulting Mapper graph provide visualization pandemic complete supplied standard method allow easy comparison feature pandemic across time space encode variety geometric feature data cloud created geographic information time progression number COVID19 case Mapper graph reflect development pandemic across US capture growth rate well regional prominence hotspots,
Appointment impact orthodontic emergency occurrence coronavirus disease 2019 pandemic retrospective study,34376339,INTRODUCTION retrospective study aimed quantify impact coronavirus disease 2019 COVID19 orthodontic appointment make analysis orthodontic emergency OEs occurred pandemic METHODS total 628 patient randomly sampled 3489 subject undergoing active orthodontic treatment fixed appliance medical record reviewed OE occurrence analyzed 617 patient explicit returnvisit record COVID19 outbreak Wilcoxon signed rank test chisquare test binary logistic regression performed RESULTS returnvisit 986 patient delayed significantly increase 898 + 476 week P 0001 general 323 patient suffered various OEs waiting first returnvisit bracket band debonding frequently reported category OEs receive timely treatment lockdown incidence nearly 2 time higher normal appointment time correlation found OE occurrence different demographic clinical characteristic patient therapeutic progress patient especially stage 3 postponed occurrence OEs CONCLUSIONS Regardless limitation study suggested highly possible COVID19 pandemic delayed appointment fixed orthodontic patient OEs bother minority patient could settled time lockdown negative impact nearterm treatment progress prevented study required investigate longdated influence COVID19 orthodontic practice,
Statistical Modeling Prediction Infectious Disease Dissemination Special Reference COVID19 Spread,34222166,review discussed different statistical modeling prediction technique various infectious disease including recent pandemic COVID19 distribution fitting time series modeling along predictive monitoring approach epidemiological modeling illustrated epidemiology data sufficient fit required sample size normal distribution general theoretical distribution fitted bestfitted distribution chosen prediction spread disease infectious disease develop time data single variable number infection happened therefore time series model fitted prediction done based bestfitted model Monitoring approach may also applied time series model could estimate parameter precisely epidemiological modeling biological parameter incorporated model forecasting disease spread carried came improve existing modeling method use fuzzy variable detection fraud available data Ultimately reviewed result recent statistical modeling effort predict course COVID19 spread,distribution fitting models;epidemiological models of disease;estimation;parameters;prediction;time series regression models
role remdesivir patient COVID19,34353998,PURPOSE REVIEW COVID19 represents unprecedented public health crisis caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 antiviral remdesivir one component treating COVID19 Unfortunately trial evaluating remdesivir reported mixed result leading uncertainty use remdesivir review discus trial evaluating efficacy remdesivir COVID19 supporting data help inform role remdesivir patient COVID19 RECENT FINDINGS Since start pandemic four randomized trial remdesivir treating patient hospitalized COVID19 Since extensive observational study provided supportive data SUMMARY majority trial evaluating remdesivir suggest remdesivir effective treatment patient hospitalized COVID19 Although may benefit subgroup others insufficient data make definitive statement benefit lack benefit particular group Remdesivir demonstrated clinical benefit decreased time hospital lower progression mechanical ventilation decreased utilization hospital resource unclear reduces mortality one randomized controlled trial suggested possible survival benefit Based data available remdesivir approved authorized early use 48 country,
Treatment DPP4 inhibitor time hospital admission COVID19 associated improved clinical outcome data COVIDPREDICT cohort study Netherlands,34222054,Purpose Inhibition dipeptidyl peptidase DPP 4 could reduce coronavirus disease 2019 COVID19 severity reducing inflammation enhancing tissue repair beyond glucose lowering aimed ass prospective cohort study Methods studied 565 patient type 2 diabetes CovidPredict Clinical Course Cohort whether use DPP4 inhibitor prior hospital admission due COVID19 associated improved clinical outcome Using crude analysis propensity score matching age sex BMI 28 patient using DPP4 inhibitor identified compared nonusers Results difference found primary outcome mortality matchedanalysis = oddsratio 094 95 confidence interval 069 128 pvalue 0689 secondary outcome ICU admission invasive ventilation thrombotic event infectious complication Additional analysis comparing user DPP4 inhibitor subgroup nonusers subgroup 1 user metformin sulphonylurea subgroup 2 user insulin combination allowing correct diabetes severity yield different result Conclusions conclude outpatient use DPP4 inhibitor affect clinical outcome patient type 2 diabetes hospitalized COVID19 infection,covid-19;dpp-4 inhibitors;mortality;type 2 diabetes
Modulation Viral Programmed Ribosomal Frameshifting Stop Codon Readthrough Host Restriction Factor Shiftless,34202160,product interferonstimulated gene C19orf66 Shiftless SHFL restricts human immunodeficiency virus replication downregulation efficiency viral gagpol frameshifting signal study demonstrate bacterially expressed purified SHFL decrease efficiency programmed ribosomal frameshifting vitro variety site including RNA pseudoknotdependent signal coronaviruses IBV SARSCoV SARSCoV2 proteindependent stimulators cardioviruses EMCV TMEV SHFL also reduced efficiency stopcodon readthrough murine leukemia virus gagpol signal Using sizeexclusion chromatography confirm binding purified protein mammalian ribosome vitro Finally electrophoretic mobility shift assay mutational analysis show expressed SHFL strong RNA binding activity necessary full activity inhibition frameshifting show clear specificity stimulatory RNA structure,shiftless;frameshift;readthrough;ribosome;virus
Functional binding dynamic relevant evolution zoonotic spillover endemic emergent Betacoronavirus strain,34286673,Comparative functional analysis dynamic interaction various Betacoronavirus mutant strain broadly utilized target protein ACE2 CD26 crucial complete understanding zoonotic spillover virus cause disease COVID19 employ machine learning replicated set nanosecond scale GPU accelerated molecular dynamic simulation statistically compare classify atom motion target protein presence absence different endemic emergent strain viral receptor binding domain RBD spike glycoprotein multiagent classifier successfully identified functional binding dynamic evolutionarily conserved bat CoVHKU4 human endemicemergent strain Conserved dynamic region ACE2 involve Nterminal helix well region transient dynamic encompassing residue K353 Q325 novel motif AAQPFLL 38692 appears coordinate dynamic interaction viral RBD N501 also demonstrate functional evolution Betacoronavirus zoonotic spillover involving ACE2 interaction dynamic likely preadapted two precise stable binding site involving viral bat progenitor strain s interaction CD26 SAMLI 2915 SS 333334 analysis indicate human endemic strain hCoVHKU1 hCoVOC43 evolved stable Nterminal helix interaction enhancement interfacing loop region viral RBD whereas highly transmissible SARSCoV2 variant B117 B1351 P1 evolved stable viral binding via focused interaction viral N501 ACE2 K353 aloneCommunicated Ramaswamy H Sarma,covid 19;molecular dynamics;molecular evolution;viral binding
TuberculosisAssociated Hospitalizations Deaths COVID19 ShelterInPlace San Francisco California USA,34287142,mandated shelterinplace restriction associated coronavirus disease pandemic precipitated decline tuberculosis diagnosis San Francisco California USA Several month pandemic severe illness resulting hospitalization death increased compared prepandemic level warranting heightened vigilance tuberculosis atrisk population,covid-19;california;sars-cov-2;san francisco;tb;united states;bacteria;coronavirus disease;deaths;epidemiology;hospitalizations;mortality rate;respiratory diseases;respiratory infections;severe acute respiratory syndrome coronavirus 2;tuberculosis and other mycobacteria;viruses;zoonoses
Assessing Orthopedic Patient Preferences Mandated Virtual Care COVID19 Pandemic Elective Virtual Care NonPandemic Circumstances,34292825,purpose study compare orthopedic patient preference mandated virtual care coronavirus disease 2019 COVID19 pandemic elective virtual care nonpandemic circumstance orthopedic virtual care questionnaire administered adult orthopedic patient undergoing first orthopedic virtual visit March 15 2020 May 18 2020 questionnaire 13 item rated 1to5 Likert scale `` strongly agree `` strongly disagree Responses compared using KruskalWallis nonparametric Wilcoxon ranksum test Patients showed higher preference mandated virtual care pandemic compared elective virtual care nonpandemic circumstance 225+131 v 410+125 P 0001 also preferred virtual visit specialty compared orthopedics 217+135 v 279+142 P 0001 Patients older 50 year likely view virtual care best option pandemic 206+125 v 248+135 P 0165 equally effective inperson visit nonpandemic circumstance 245+136 v 283+118 P 0150 Female patient likely pursue future orthopedic virtual visit 261+137 v 307+145 P 0203 view virtual visit equally effective inperson visit 247+133 v 287+118 P 0181 Orthopedic patient preference mandated virtual care COVID19 pandemic seems higher elective virtual care nonpandemic circumstance older female patient appear favor virtual care Orthopedics 2021 44 4 e471e476,
Veterinary Vaccine SARSCoV2 First COVID19 Vaccine Animals,34200587,coronaviruses wide range host specie many animal harbor pathogen however handful become severely infected,
Coronaregionalism Differences regional response COVID19 Italy,34366171,paper discus response COVID19 crisis acute phase first wave pandemic FebruaryMay 2020 different Italian region Italy decentralised healthcare system consider five region Lombardy Veneto EmiliaRomagna Umbria Apulia located north centre south Italy five region differ healthcare system extent hit first wave COVID19 pandemic investigate different response COVID19 reflecting seven management factor 1 monitoring 2 learning 3 decisionmaking 4 coordinating 5 communicating 6 leading 7 recovering capacity light factor discus analogy difference among region different institutional choice,covid-19;health management;health policy;italy;regional responses
analysis mortality survival COVID 19 patient admitted tertiary care hospital Maharashtra India,34334904,Background nine month responding coronavirus disease19 COVID19 pandemic scientific fraternity yet unravel mystery risk mortality Despite resistance wear mask global public health response beaten grimmer projection million death present study seek analyze survival COVID19 patient tertiary care hospital identify risk factor mortality Methods Medical record 1233 RT PCR confirmed COVID19 patient admitted tertiary care hospital 01 April 30 September 2020 retrospectively analyzed calculating overall survival investigate independent predictor survival COVID19 patient Results 72 58 death occurred 249 elderly age 60yrs people P 0001 760 people multiple comorbidities one comorbidity P 0001 756 people diabetes P 0001 755 people hypertension P 0001 significantly higher risk mortality observed elderly patient patient comorbidities patient requiring oxygen admitted hospital Conclusion Survival reflects cure rate used health professional policymakers plan implement disease control measure insight provided study would help facilitate identification patient risk timely provision specialized care prevention adverse outcome hospital setting,covid risk factors;india;mortality;survival
Combining IL6 SARSCoV2 RNAaemiabased risk stratification fatal outcome COVID19,34379684,BACKGROUND coronavirus disease 2019 COVID19 pandemic rapidly increase use mechanical ventilation MV case require extracorporeal membrane oxygenation ECMO high mortality OBJECTIVE aimed identify prognostic biomarkers pathophysiologically reflecting future deterioration COVID19 METHODS Clinical laboratory outcome data collected 102 patient moderate severe COVID19 Interleukin IL 6 level severe acute respiratory syndrome coronavirus 2 SARSCoV2 RNA copy number plasma assessed ELISA kit quantitative PCR RESULTS Twelve patient died required ECMO owing acute respiratory distress syndrome despite use MV Among various variable ratio oxygen saturation fraction inspired oxygen SpO2FiO2 IL6 SARSCoV2 RNA admission intubation strongly predictive fatal outcome MV use Moreover among variable combining SpO2FiO2 IL6 SARSCoV2 RNA showed highest accuracy area curve 0934 patient low SpO2FiO2 261 fatal eventrate MV use 30day significantly higher patient high IL6 49 pgmL SARSCoV2 RNAaemia 15 copiesmuL compared high IL6 RNAaemia without high IL6 RNAaemia 88 vs 22 8 logrank test P = 00097 P 00001 respectively CONCLUSIONS Combining SpO2FiO2 high IL6 SARSCoV2 RNAaemia reflect hyperinflammation viral overload allows accurately intubation identifying COVID19 patient high risk ECMO use inhospital death despite use MV,
Impact PostCOVID19 Syndrome SelfReported Physical Activity,34205086,Background subgroup patient recovering COVID19 experience persistent symptom decreased quality life increased dependency others personal care impaired performance activity daily living However longterm effect COVID19 physical activity PA subgroup patient persistent symptom remain unclear Methods Demographics selfreported average time spent walking per week well participation activity preCOVID19 three six month followup assessed member online longCOVID19 peer support group Results Two hundred thirtynine patient confirmed COVID19 diagnosis included 83 woman median IQR age 50 3956 year Patients reported significantly decreased weekly walking time three month followup three month 60 15120 min vs preCOVID19 120 60240 minweek p 005 Six month onset symptom walking time still significantly lower compared preCOVID19 significantly increased compared three month followup three month 60 15120 min vs six month 90 30150 min p 005 Conclusions Patients experience persistent symptom COVID19 may still demonstrate significantly decreased walking time six month onset symptom research needed investigate longterm consequence possible treatment option guide patient recovery fromCOVID19,corona;exercise;persistent symptoms;physical activity
COVID19Related Reduction Emergency Health Care Utilization Among Febrile Pediatric Oncology Patients,34224515,severe acute respiratory syndrome coronavirus SARSCoV2 pandemic disrupted normal health care utilization pattern worldwide including decreasing emergency department ED visit various medical emergency examined whether pattern present febrile pediatric oncology patient singlecenter cohort study conducted retrospective chart review ED visit febrile pediatric oncology patient first 4 month global SARSCoV2 pandemic compared data time period previous 2 year first 5 month pandemic 25 pediatric oncology patient fever visited ED 65 child visited time period 2018 60 visited 2019 Compared 2018 2019 encounter 2020 decreased 62 58 respectively significantly higher percentage febrile pediatric oncology patient 84 admitted hospital pandemic compared previous year 58 concern possibility fear exposure coronavirus disease19 COVID19 health care facility prompted caregiver pediatric oncology patient avoid seeking care child fever Consistent communication family lifethreatening nature fever prioritized among pediatric oncology provider,
Immune Response Vaccination COVID19 Breastfeeding Health Workers,34204501,BACKGROUND Initially data safety COVID19 vaccine lactating woman aim study evaluate immune response COVID19 vaccination breastfeeding woman METHODS study included 32 breastfeeding woman regardless study decided vaccinated Maternal serum breast milk sample simultaneously collected day 8 + 1 22 + 2 29 + 3 43 + 4 first dose vaccine immune response assessed determining presence antiSARSCoV2 IgG IgA RESULTS breast milk IgG level detectable 650 + 674 median 47 maximum 342 BAUmL highly correlated serum IgG level rS 089 p 0001 breast milk ratio IgA cutoff value higher serum IgApositive 418 + 326 median 28 maximum 10 serum IgAnegative woman 056 + 037 median 05 maximum 16 p 0001 highest concentration serum breast milk antibody observed day 29 + 3 decrease day 43 + 4 CONCLUSION immune response vaccination SARSCoV2 strongest 7 + 3 day second dose vaccine Lactating mother breastfeeding child vaccination SARSCoV2 may transfer antibody infant,covid-19;anti-sars-cov-2 antibodies;breast milk;breastfeeding;lactation;mrna vaccine;vaccination
Clinical outcome hospitalised COVID19 patient Mthatha Regional Hospital Eastern Cape South Africa retrospective study,34212748,BACKGROUND Coronavirus disease 2019 COVID19 public health crisis threatens current health system sudden expansion need inpatient intensive care facility raised concern optimal clinical management resource allocation Despite pressing need evidence make contextspecific decision COVID19 management evidence South Africa remained limited study aimed describe clinical characteristic outcome COVID19 hospitalised patient METHODS retrospective crosssectional study design used evaluate clinical outcome hospitalised adult patient = 18 year old laboratoryconfirmed COVID19 illness Mthatha Regional Hospital MRH Eastern Cape RESULTS 1814 patient tested COVID19 20 March 2020 31 July 2020 MRH twothirds 654 female twothirds 242 392 patient 216 tested positive disease hospitalised onethird 150 quarantined home mean age patient tested COVID19 426 year difference male female mean age hospitalised patient 555 year mean age hospitalised patient died 613 year much higher recovered 495 year Overall 188 776 hospitalised patient clinical comorbidity admission Diabetes 368 hypertension 331 common comorbidities amongst COVID19 hospitalised patient CONCLUSION majority patient hospitalised COVID19 elderly high baseline comorbidities Advance age underlying comorbidities diabetes hypertension HIV associated high mortality hospitalised COVID19 patient,"covid-19, diabetes;co-morbidity;hospitalised;hypertension"
French survey lockdown consequence COVID19 pandemic Parkinson s disease ERCOPARK study,34293534,BACKGROUND 2020 coronavirus disease 19 COVID19 pandemic imposed total sudden lockdown aimed investigate consequence first COVID19 lockdown midMarch midApril 2020 motor nonmotor symptom NMS cohort French people Parkinson s disease PwP METHODS PwP enrolled either online survey sent national France Parkinson association FP reach French community PwP part outpatient telemedicine visit followed hospitalbased Parkinson Expert Center PEC patient evaluated using standardized questionnaire assessing motor NMS including list disabling new worsened symptom Patient s Global ImpressionImprovement scale PGII psychosocial query quality life RESULTS 2653 PwP included 441 166 PEC group 2122 834 communitybased group Physiotherapy interrupted among 886 patient 409 referred clinical modification symptom Based questionnaire pain 93 rigidity 91 tremor 85 three frequently new worsened reported symptom Based PGII motor symptom affected domain followed pain psychic state PwP communitybased group tended frequent worsening motor symptom motor complication pain confusion PEC group CONCLUSIONS first COVID19 lockdown negative impact motor NMS PwP Efforts allocated avoid interruption care including physiotherapy physical activity implement telemedicine,motor symptoms;non-motor symptoms;pandemic;parkinson's disease;sars-cov-2 lock down
impact COVID19 related national lockdown ophthalmic emergency Italy multicenter study,34219482,PURPOSE ass ocular pathology admitted Italian Emergency Eye Departments EEDs COVID19 pandemic national lockdown 2020 comparison period 2019 METHODS Electronic record patient presenting EEDs two tertiarycare Eye Centers COVID19 national lockdown Italy March 10May 3 2020 compared equivalent period 2019 Main outcome patient age gender diagnosis Statistical analysis included unpaired Student ttests Poisson regression chisquare test RESULTS Overall EED visit significantly decreased 541 2020 lockdown compared 2019 851 v 1854 p 0001 lockdown patient showed comparable mean age 528 year 2020 v 533 year 2019 p = 052 significant male gender bias 611 2020 v 558 2019 p 00001 frequent pathology eye inflammation traumarelated incident spontaneous acute vitreous detachment Patients inflammation headachehemicrania spontaneous subconjunctival hemorrhage significantly le whereas traumarelated diagnosis significantly higher lockdown compared 2019 p 005 proportion nonurgent visit decreased 17 2019 8 2020 p 0001 CONCLUSIONS 2020 lockdown significant reduction access EED especially nonurgent pathology Potentially visual function threatening condition traumarelated pathology retinal detachment rupture wet AMD showed lower number case higher stable proportion relative total caseload suggesting correct efficient access ophthalmic health care pandemic period,covid-19;sars-cov-2;eye emergency;lockdown;pandemic
Acute autoimmunelike hepatitis atypical antimitochondrial antibody mRNA COVID19 vaccination novel clinical entity,34293683,Autoimmune phenomenon clinically apparent autoimmune disease including autoimmune hepatitis increasingly reported natural infection SARSCoV2 virus also vaccination report case 63year old man without history autoimmunity SARSCoV2 natural infection experienced acute severe autoimmunelike hepatitis seven day first dose mRNA1273 SARSCoV2 vaccine Liver histology showed inflammatory portal infiltrate interface hepatitis lobular centrilobular inflammation centrilobular necrosis absence fibrosis steatosis Serum immunoglobulin G slightly elevated Autoimmune liver serology showed indirect immunofluorescence pattern triple rodent tissue compatible antimitochondrial antibody AMA unexpectedly pattern mirrored positivity primary biliary cholangitis PBC specific molecular test indicating antibody different classical AMA Antinuclear antibody ANA also positive rimlike indirect immunofluorescence pattern liver HEp2 cell substrate similar PBCspecific ANA however antigp210 large panel molecularbased assay nuclear antigen negative suggesting unique ANA patient carry HLA DRB11101 allele protective PBC Response prednisone treatment satisfactory clinical significance novel specificity need evaluated emerging condition,atypical anti-mitochondrial antibody;autoimmune-like hepatitis;sars-cov-2;mrna vaccine
COVID19 complicated immune thrombocytopaenic purpura internal jugular vein thrombosis,34285032,61yearold woman tested positive COVID19 community 5 day prior admission presented new onset severe headache mild shortness breath acute reduction platelet count 153x10 9 L 5x10 9 L diagnosed immune thrombocytopenia purpura treatment intravenous immunoglobulin platelet count increased 15x10 9 L Due nonresolving headache magnetic resonance venogram showed bilateral internal jugular vein thrombosis discharged hospital followed Haematology Neurology clinic platelet count returned normal range 7 day later commenced anticoagulation thrombosis,covid-19;haematology (incl blood transfusion);thrombotic thrombocytopenic purpura
Transmission SARSCoV2 household setting prospective cohort study child adult England,34348116,OBJECTIVES measure secondary attack rate SARs prospectively followed household contact paediatric adult case SARSCoV2 infection England METHODS Selftaken nasal swab household contact PCR confirmed case COVID19 blood sample day 35 tested evidence infection SARSCoV2 virus RESULTS secondary attack rate SAR among 431 contact 172 symptomatic index case 33 95 confidence interval CI 2540 lower primary case without respiratory symptom 6 CI 014 v 37 CI 2945 p=0030 SAR index case 11 year 25 CI 1238 SARs ranged 16 428 contact 11 year old 36 CI 2845 contact aged 1954 year p=0119 proportion infected developed symptom 78 similar age p=044 though 19 year old fewer mean number symptom adult p=0001 fewer reported loss sense taste smell p=00001 CONCLUSIONS high risk transmission SARSCoV2 virus home including infection introduced child risk child acquiring infection lower adult fewer developed typical symptom Covid19 infection,sars-cov-2 transmission;households;secondary attack rates by age
New development perspective acromegaly,34344028,Acromegaly rare severe disorder usually due excessive secretion growth hormone GH pituitary adenoma Screening mainly relies measurement insulinlike growth factor 1 confirmatory diagnostics includes GH suppression test delayed diagnosis result increased morbidity mortality discus recently published suggestion regarding biochemical workup suspected case followup comorbidities Moreover new analytical tool automatic identification typical facial change using artificial intelligence presented hopefully allowing earlier diagnosis future far surgery still regarded therapy first choice case without postoperative remission new imaging approach combining sellar magnetic resonance imaging position emission tomography may improve result repeated surgery pharmaceutical arsenal includes first orally available somatostatin analogue recent data possible drug combination outcome radiotherapy presented Finally special attention paid older pregnant patient well certain consideration COVID19 pandemic appropriate diagnosis management acromegaly particularly challenging,
challenge screening SARSCoV2 variant concern RTqPCR One variant hide another,34332998,INTRODUCTION Following emergence SARSCoV2 variant concern VOCs worldwide important monitor local epidemiology better understand occurrence cluster reinfections infection vaccination Detecting mutation specific RTqPCR rapid affordable alternative sequencing However care must taken ensure technique used uptodate adapted variant circulating studied population MATERIAL METHODS sample tested positive SARSCoV2 screened detection mutation spike protein using Novaplex SARSCoV2 Variants Assay week 11 2021 Target sought deletion H69V70 mutation N501Y E484 K week 18 used addition new Novaplex SARSCoV2 Variants II Assay sample target found Variants assay mutation E484 K alone order screen mutation L452R K417 NT W152C RESULTS week 11 25 2239 positive sample 54317 tested Variants Assay week 18 25 94 sample met criterion tested Variants II Assay 47 L452R mutation without W152C mutation typical B1617 variant week 25 profile found 455 sample frequent CONCLUSION According observation variant B1617 become predominant institution probably region absence use Variants II Assay would considered wild,covid-19;rt-qpcr;sars-cov-2;variants of concern
Identification SARSCoV2 E Channel Blockers Repurposed Drug Library,34201587,SARSCoV2 etiological agent COVID19 pandemic member Coronaviridae family enveloped virus ion channel membrane characterized E protein Therefore attempt identify blocker E channel screened library 2839 approvedforhumanuse drug approach yielded eight compound exhibited appreciable activity three bacteriabased channel assay Considering fact E channel conserved SARSCoV2 protein inhibitor activity may provide option curb viral spread addition inhibitor also enhance ability understand exact role played E protein infectivity cycle Finally detailed electrophysiological analysis alongside vitro vivo study needed establish exact potential blocker identified study,covid-19;antiviral drugs;bacterial assays;channel blockers;viral channels
Natriuretic Peptide Levels Clinical Outcomes Among Patients Hospitalized Coronavirus Disease 2019 Infection,34291225,OBJECTIVES increasing evidence cardiovascular morbidity associated severe acute respiratory syndrome coronavirus 2 coronavirus disease 2019 ProBtype natriuretic peptide biomarker myocardial stress associated various respiratory cardiac outcome hypothesized proBtype natriuretic peptide level would associated mortality clinical outcome hospitalized coronavirus disease 2019 patient DESIGN performed retrospective analysis using adjusted logistic linear regression ass association admission proBtype natriuretic peptide analyzed cutoff 125 pgmL log transformed proBtype natriuretic peptide clinical outcome additionally treated body mass index confounder proBtype natriuretic peptide level coronavirus disease 2019 outcome ordinal variable SETTING reviewed hospitalized patient coronavirus disease 2019 proBtype natriuretic peptide level measured within 48 hour admission March 1 August 31 2020 multihospital US health system PATIENTS Adult patient = 18 yr old n = 1232 confirmed coronavirus disease 2019 admitted health system INTERVENTIONS None MEASUREMENTS MAIN RESULTS adjustment demographic comorbidities troponin level higher proBtype natriuretic peptide level significantly associated death secondary outcome new heart failure length stay ICU duration need ventilation among hospitalized coronavirus disease 2019 patient significance persisted adjustment body mass index ordinal variable adjusted hazard ratio death log transformed proBtype natriuretic peptide 156 95 CI 123197 p 00001 CONCLUSIONS investigation warranted utility proBtype natriuretic peptide clinical prognostication coronavirus disease 2019 well implication abnormal proBtype natriuretic peptide underlying pathophysiology coronavirus disease 2019related myocardial injury,biomarkers;coronavirus disease 2019;heart failure;natriuretic peptide;obesity;pandemic
Variant Analysis SARSCoV2 Genomes Belgian Military Personnel Engaged Overseas Missions Operations,34372565,year first identification severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent 2019 coronavirus disease COVID19 China emergence spread genomic variant virus travel raise concern regarding introduction lineage previously unaffected region requiring adequate containment strategy Concomitantly introduction fuel worry possible increase transmissibility disease severity well possible decrease vaccine efficacy Military personnel frequently deployed mission around world part COVID19 risk mitigation strategy Belgian Armed Forces engaged mission operation abroad screened 7683 RTqPCR test pre postmission presence SARSCoV2 including identification viral lineage Nine distinct viral genotype identified soldier returning operation Niger Democratic Republic Congo Afghanistan Mali SARSCoV2 variant belonged major clade 19B 20A 20B Nextstrain nomenclature included `` variant interest B1525 `` variant monitoring A27 well lineage B1214 B1 B11254 pangolin nomenclature internationally monitored due specific mutation harbor contact tracing phylogenetic analysis show isolation testing policy implemented Belgian military command appear successful containing influx transmission distinct SARSCoV2 variant military civilian population,covid-19;sars-cov-2;genomic epidemiology;military;outbreak;variants
Use Telehealth Provide Continuity Cancer Care COVID19 Pandemic Advantages Disparities Implications Promote Health Equity,34218752,Perceptions oncology health care provider use telehealth provide care patient COVID19 pandemic explored qualitative study using semistructured interview purposive sampling N = 30 conducted Four theme emerged 1 telehealth provided continuity cancer care used decrease risk COVID19 exposure 2 advantage brought convenience inclusion family caregiver 3 telehealth revealed geographic aging racialethnic disparity digital illiteracy 4 rapid implementation challenging Telehealth provides number opportunity support care vulnerable cancer patient health crisis however disparity must addressed,covid-19;cancer;coronavirus;disparities;telehealth
Comparison SARSCoV2 Detection Rapid Antigen Three Commercial RTqPCR Tests Study Martin University Hospital Slovakia,34280974,global pandemic coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 tremendous impact global economy health care system life almost people world Central European country Slovakia reached one highest daily mortality rate per 100000 inhabitant first 3 month 2021 despite implementing strong prophylactic measure lockdown repeated nationwide antigen testing present study report comparison performance Standard Q COVID19 antigen test SD Biosensor three commercial RTqPCR kit vDetect COVID19MultiplexDX gb SARSCoV2 MultiplexGENERI BIOTECH Ltd Genvinset COVID19 E BDR Diagnostics detection infected individual among employee Martin University Hospital Slovakia Health care provider doctor nurse classified `` critical infrastructure doubt huge impact incorrect result could patient 1231 sample 14 evaluated positive SARSCoV2 antigen presence confirmed RTqPCR kit 1 kit 2 another 26 sample signal E gene 40 sample reisolated subsequently reanalysed using three kit detected virus 22 23 12 case respectively result point divergence antigen RTqPCR test also within `` gold standard RTqPCR testing Performance analysis diagnostic antigen test showed positive predictive value PPV 100 negative predictive value NPV 9810 indicating 190 individual negative result fact positive data extrapolated national level mean daily number antigen test 250000 April 2021 point 4700 people per day misinterpreted posing risk virus shedding mean Ct value sample antigen RTqPCR positive 20 kit 1 2047 2016 Sarbeco nbsp E RdRP kit 2 1937 1999 Sarbeco nbsp E RdRP kit 3 1747 ORF1bRdRP mean Ct value sample antigennegative RTqPCRpositive 30 kit 1 3067 3000 Sarbeco nbsp E RdRP kit 2 2986 3101 Sarbeco nbsp E RdRP kit 3 2747 ORF1bRdRP confirms advantage antigen test detecting infectious individual higher viral load However reporting Ct value still matter ongoing debate conducted without normalisation standardised control known concentration,ct;npv-negative predictive value;ppv-positive predictive value;rt-qpcr;sars-cov-2;antigen;sensitivity;specificity
cell epitope SARSCoV2 spike protein conserved surface protein Plasmodium malariae share sequence homology,34222663,Since emergence late 2019 severe acute respiratory syndrome coronavirus 2 SARSCoV2 spreading remarkably fast worldwide Effective countermeasure require rapid development data tool monitor spread better understand immunogenic profile However limited information available tool target immune response SARSCoV2 study excogitated new approach analyzing phylogenetic relationship using whole prototype proteome sequence Phylogenetic analysis whole prototype proteome sequence showed SARSCoV2 direct descendant BatCoV closely related PangolinCoV BatSLCoV SARSCoV pairwise comparison SARSCoV2 BatCoV showed unusual replacement motif consisting seven amino acid NNLDSKV within spike protein SARSCoV2 replaced motif spike protein SARSCoV2 found 12 specie including conserved surface protein malariacausing pathogen Plasmodium malariae identified B cell epitope sequence homology SARSCoV2 spike protein conserved surface protein P malariae using Immune Epitope Database Analysis Resource IEDB shared immunodominant epitope may provide immunity SARSCoV2 infection previously infected P malariae,sars-cov-2;malaria;phylogenetic analysis;proteome;prototype;spike glycoprotein
Challenges Perspectives Prevention Infectious Diseases,34205856,world currently engaged ongoing battle COVID19,
Identification novel inhibitor SARSCoV2 main protease pro Withania sp molecular docking molecular dynamic simulation,34287986,Since December 2019 coronavirus disease COVID19 claimed life million people across globe date medicine available responsible virus SARSCoV2 3CLpro 3chymotrypsinlike protease main protease pro important role cleaving pp1a pp1ab polyproteins pro serf important target drug designing COVID19 Herein study includes investigation screening identification potent lead Withania sps SARSCoV2 using virtual screening molecular docking molecular dynamic MD simulation Seventythree natural compound important medicinal plant screened Binding affinity used identify probable target inhibit pro compound 27hydroxywithanolide F W32 115 kcalmol withanolide W56 114 kcalmol withacoagulin H W30 111 kcalmol showed highest binding energy Lipinski s rule followed druglikability likeness screening resulted 36 molecule MD simulation 50 n predicted withacoagulin H possessing strong binding affinity hydrogenbonding interaction active site binding free energy calculation showed negative energy withacoagulin H 63463 KJmol compared selected compound study also compared bonding energy already reported repurposed newly synthesized drug absorption distribution metabolism excretion prediction made found good balance potency Hence following screened compound Withania sps could serve potential lead drug development COVID19,"covid-19;mpro;sars-cov-2;docking, molecular dynamics simulation;pharmacokinetics;virtual screening, withanolides"
Protective Action L salivarius SGL03 Lactoferrin COVID19 Infections Human Nasopharynx,34200055,study used live viral particle oral secretion 17 people infected SARSCoV2 17 healthy volunteer plated suitable medium complete microorganism minimal Lsalivarius growth type medium also contained appropriately prepared vector system pGEM5Zf + based lactose operon betagalactosidase system Incubation carried type medium 24 h addition 200 muL Salistat SGL03 solution order test inhibitory effect coronavirus contained oral mucosa nasopharynx visible light blue virus particle test plate gradually disappeared material collected infected person time Regardless conducted experiment swab additionally taken nasopharynx infected healthy people rinsing throat oral mucosa Salistat SGL03 type experiment 24 h incubation appropriate medium biological material find virus particle Results also confirmed MIC MBC test Results prove lactoferrin one ingredient preparation probably factor block attachment virus particle host cell determining antiviral property conducted preliminary experiment constitute promising model research antiviral property ingredient contained Salistat SGL03 dietary supplement,covid-19;l. salivarius;salistat sgl03;human nasopharynx;lactoferrin
Altered Vascular EndotheliumDependent Responsiveness Frail Elderly Patients Recovering COVID19 Pneumonia Preliminary Evidence,34207876,evaluated vascular dysfunction single passive leg movement test sPLM 22 frail elderly patient 84 + 31 day hospitalization COVID19 pneumonia compared 22 age sex comorbiditymatched control CTRL rest COVID19 patient stable clinical condition without severe comorbidities Patients aged 72 + 6 year 73 male moderate disability Barthel index score 77 + 26 hypoxemia normocapnia arterial blood gas analysis mild pulmonary restriction spirometry Values circulating marker inflammation Creactive protein CRP erythrocyte sedimentation rate ESR coagulation Ddimer 2713 + 3752 mgdL 6424 + 3237 mm1 h 1043 + 729 ngmL respectively rest femoral artery diameter similar COVID19 CTRL p = 016 contrary COVID19 infection deeply impacted blood velocity p = 0001 femoral blood flow p 00001 sPLM peak femoral blood flow dramatically reduced COVID19 compared CTRL p = 0001 blood flow peak p = 005 area curve p 00001 altered vascular responsiveness could one unknown component long COVID19 syndrome leading fatigue change muscle metabolism fiber composition exercise intolerance increased cardiovascular risk Impact specific treatment exercise training dietary supplement drug evaluated,covid-19;endothelial dysfunction;inflammation;nitric oxide;single leg passive movement
COVID19 Lockdowns May Reduce Resistance Genes Diversity Human Microbiome Need Antibiotics,34206965,Recently much attention paid COVID19 pandemic Yet bacterial resistance antibiotic remains serious unresolved public health problem kill hundred thousand people annually insidious silent pandemic contain spreading SARSCoV2 virus population confined tightened hygiene measure performed study computer simulation using mobility data mobile phone Google region Lisbon Portugal comprising 37 million people two different lockdown period scenario 40 60 mobility reduction simulation assumed network physical contact people small world computed antibiotic resistance human microbiomes 180 day simulation simulation show reducing human contact drive reduction diversity antibiotic resistance gene human microbiomes KruskalWallis Dunn s pairwise test show strong evidence p 0000 adjusted using Bonferroni correction difference four confinement regime proportion variability ranked dependent variable accounted confinement variable eta 2 = 0148 indicating large effect confinement diversity antibiotic resistance shown confinement hygienic measure addition reducing spread pathogenic bacteria human network also reduce resistance need use antibiotic,antibiotic resistance transmission;computer simulations;contact network;human microbiome;social distancing;transmission
Potential Vitro Inhibition Selected Plant Extracts SARSCoV2 ChymotripsinLike Protease 3CL Pro Activity,34209659,Antiviral treatment inhibiting Severe acute respiratory syndrome coronavirus 2 SARSCoV2 replication may represent strategy complementary vaccination fight ongoing Coronavirus disease 19 COVID19 pandemic Molecules extract inhibiting SARSCoV2 chymotripsinlike protease 3CL Pro could contribute reducing suppressing SARSCoV2 replication Using targeted approach identified 17 plant product included current traditional cuisine promising inhibitor SARSCoV2 3CL Pro activity Methanolic extract evaluated vitro inhibition SARSCoV2 3CL Pro activity using quenched fluorescence resonance energy transfer FRET assay Extracts turmeric Curcuma longa rhizome mustard Brassica nigra seed wall rocket Diplotaxis erucoides subsp erucoides 500 microg mL 1 displayed significant inhibition 3CL Pro activity resulting residual protease activity 00 94 149 respectively Using different extract concentration IC50 value 1574 microg mL 1 calculated turmeric extract Commercial curcumin inhibited 3CL Pro activity fully account inhibitory effect turmeric rhizome extract suggesting component turmeric extract must also play main role inhibiting 3CL Pro activity Sinigrin major glucosinolate present mustard seed wall rocket relevant 3CL Pro inhibitory activity however hydrolysis product allyl isothiocyanate IC50 value 4143 microg mL 1 current study identifies plant extract molecule interest search treatment COVID19 acting basis future chemical vivo clinical trial,covid-19;fret assay;sars-cov-2 3clpro;allyl isothiocyanate;curcumin;mustard seeds;natural compounds;plant extracts;turmeric;wall rocket
Impact Covid19 containment community pharmaceutical spending Andalusia Spain,34221202,Background field health year 2020 remembered testing stressing health institution form management centralised decentralised everyday activity primary hospital care significantly altered introduction telephone consultation reduce number visit health centre hospital still relevant today face successive wave pandemic Objective analyse whether population confinement due COVID19 pandemic impact dispensing medication community pharmacy associated spending period MarchJuly 2020 Andalusia Spain Methods time series analysis applying econometric model analysis technique confirm rule whether lockdown caused COVID19 pandemic impact dispensing medication community pharmacy associated expenditure variable used number medication container dispensed community pharmacy charged public fund Spanish National Health System expenditure prescription drug relation population analysis performed within region Andalusia 8464441 inhabitant Results data obtained time series confirmed significant difference studied period number medication container actually dispensed number would expected dispensed according trend variable sample period expenditure result followed pattern Conclusions health crisis produced COVID19 lockdown impact medication consumption Andalusia,"covid-19;financial management;government programs;health expenditures;interrupted time series analysis;models, econometric;national health programs;pandemics;pharmacies;prescription drugs;spain"
Characteristics clinical outcome risk factor SARSCOV2 infection adult acute myeloid leukemia patient experience PETHEMA group,34292118,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection produce higher morbidity mortality hematological malignancy evidence acute myeloid leukemia AML scarce multicenter observational study conducted determine clinical outcome ass impact therapeutic approach adult AML patient SARSCoV2 infection first wave MarchMay 2020 Overall 108 patient included 519 active leukemia 704 therapeutic schedule AML Signs symptom SARSCoV2 present 963 patient 824 received specific treatment SARSCoV2 mortality rate 435 correlated age gender active leukemia dyspnea severe SARSCoV2 intensive care measure neutrophil count Ddimer level protective effect found azithromycin lopinavirritonavir normal liver enzyme level SARSCoV2 first wave finding suggested increased mortality AML short period SARSCoV2 management could guided risk factor AML patient,covid-19;sars-cov-2;acute myeloid leukemia;hematological malignancies
Diagnostic yield bacteriological test predictor severe outcome adult patient COVID19 presenting emergency department,34289966,BACKGROUND Guidelines recommend maximal effort obtain blood sputum culture patient COVID19 bacterial coinfection associated worse outcome aim study evaluate yield bacteriological test including blood sputum culture association multiple biomarkers Pneumonia Severity Index PSI clinical microbiological outcome patient COVID19 presenting emergency department ED METHODS substudy large observational cohort study PredictED study PredictED included adult patient blood culture drawn ED Haga Teaching Hospital Netherlands substudy patient tested positive SARSCoV2 PCR March April 2020 included primary outcome incidence bacterial coinfection used logistic regression analysis association procalcitonin C reactive protein CRP ferritin lymphocyte count PSI score severe disease course defined intensive care unit admission andor 30day mortality area receiver operating characteristic curve AUC quantified discriminatory performance RESULTS included 142 SARSCoV2 positive patient presentation median duration symptom 8 day 41 29 patient severe disease course 24 17 died within 30 day incidence bacterial coinfection 2142 14 None blood culture showed pathogen growth 63 contaminated AUCs predicting severe disease 076 95 CI 068 084 070 061 079 062 051 074 062 051 072 072 063 081 procalcitonin CRP ferritin lymphocyte count PSI score respectively CONCLUSION Blood culture appear limited value procalcitonin PSI appear promising tool helping physician identify patient risk severe disease course COVID19 presentation ED,covid-19;bacterial;clinical assessment;diagnosis;emergency department
Investigation Epidemiological Situation Incidence Covid 19 Disease Area Markazi Province Iran Country,34211742,INTRODUCTION Coronavirus emerging virus caused many casualty Therefore purpose descriptive study investigate epidemiological situation coronavirus Khomein city province Markazi Iran METHOD crosssectional descriptive study performed people coronavirus disease first date admission positive PCR patient coronavirus 21 September 2020 Information record definitively discharged deceased patient due coronavirus positive PCR extracted 2022020 2192020 demographic characteristic age gender area residence occupation past medical history assessed patient coronavirus disease RESULTS range age study 2 month 95 year old mean age 529+192 year old mean age men woman study 5236 5384 year old respectively showed significant relationship T=0966 N=691 PValue=0335 df=689 521 death rural area 479 urban area CONCLUSION observing protocol people well traffic restriction social distance gradually experienced decreasing trend positive coronavirus case hospitalization case due decrease people s sensitivity false confidence second outbreak disease began reached peak May July,coronavirus;covid-19;epidemiology
Identifying factor associated issuance coronavirusrelated stayathome order Middle East North Africa Region,34226851,COVID19 pandemic spared Middle East North Africa MENA Region MENA one politically socially economically heterogeneous region world characteristic reflected government response COVID19 twothirds government issued coronavirusrelated stayathome order SAHOs one effective tool public health official slowing spread infectious disease SAHOs effective term countering infectious disease extremely disruptive nonhealth domain objective study identify reliable factor related health care policy making shaped decision MENA government issue SAHO response COVID19 result identify specific political social medical factor played important role provide look early government response global health crisis heterogeneous region world,covid-19;mena;coronavirus;lockdowns;pandemic;policy diffusion;public health;stay-at-home orders
Highresolution HLA genotyping identifies allele associated severe COVID19 preliminary study India,34289534,INTRODUCTION Human leukocyte antigen HLA variability demonstrated associated susceptibilityseverity COVID19 Highresolution HLA genotyping identify allele associated severe COVID19 Indian cohort performed METHODS Quantitative reversetranscription polymerase chain reactionconfirmed SARSCoV2positive patient mildmoderatesevere disease n = 54 asymptomatic n = 42 recruited genotyped 11HLA locus MiSeq using NGSgo R MX113 analyzed NGSengine GenDx RESULTS significant difference allele group identified HLAC04010101 HLADRB501010102 HLADQA103010101 HLADPB104010141 HLADPA101030102 Alleles namely HLAC04010101 571 95 CI 122714 p = 02 HLADRB501010102 294 95 CI 11784 p = 03 DQA103010101 2247 95 CI 1283935 p = 03 HLADPB104010141 944 95 CI 0517581 p = 13 HLADPA101030102 827 95 CI 2263021 p = 001 associated severe COVID19 CONCLUSION Genotyping allele enable identification individual risk severe disease stratification preferential vaccination,covid-19;hla genotyping;sars-cov-2;severe covid-19;vaccination
observational cohort study incidence SARSCoV2 infection B117 variant infection healthcare worker antibody vaccination status,34216472,BACKGROUND Natural vaccineinduced immunity play key role controlling SARSCoV2 pandemic SARSCoV2 variant potential evade natural vaccineinduced immunity METHODS longitudinal cohort study healthcare worker HCWs Oxfordshire UK investigated protection symptomatic asymptomatic PCRconfirmed SARSCoV2 infection conferred vaccination PfizerBioNTech BNT162b2 OxfordAstraZeneca ChAdOx1 nCOV19 prior infection determined using antispike antibody status using Poisson regression adjusted age sex temporal change incidence role estimated protection conferred one versus two vaccination infection B117 variant identified using whole genome sequencing RESULTS 13109 HCWs participated 8285 received PfizerBioNTech vaccine 1407 two dos 2738 OxfordAstraZeneca vaccine 49 two dos Compared unvaccinated seronegative HCWs natural immunity two vaccination dos provided similar protection symptomatic infection HCW vaccinated twice symptomatic infection incidence 98 lower seropositive HCWs adjusted incidence rate ratio 002 95 CI 001018 Two vaccine dos seropositivity reduced incidence PCRpositive result without symptom 90 010 002038 85 015 008026 respectively Singledose vaccination reduced incidence symptomatic infection 67 033 021052 PCRpositive result 64 036 026050 evidence difference immunity induced natural infection vaccination infection Sgene target failure B117 CONCLUSION Natural infection resulting detectable antispike antibody two vaccine dos provide robust protection SARSCoV2 infection including B117 variant,sars-cov-2;antibody;healthcare worker;immunity;vaccine
Natural Products Alone Combination FDAApproved Drugs Treat COVID19 Lung Cancer,34207313,public health emergency international concern highly contagious coronavirus disease 2019 COVID19 pandemic identified severe threat life billion individual Lung cancer malignant tumor highest mortality rate brought significant challenge human health economic development Natural product may play pivotal role treating lung disease reviewed published study relating natural product used alone combination US Food Drug Administrationapproved drug active severe acute respiratory syndrome coronavirus 2 SARSCoV2 lung cancer 1 January 2020 31 May 2021 wide range natural product considered promising antiCOVID19 antilung cancer agent gained widespread attention including natural product monotherapy treatment SARSCoV2 ginkgolic acid shiraiachrome resveratrol baicalein lung cancer daurisoline graveospene deguelin erianin combination FDAapproved antiSARSCoV2 agent cepharanthine plus nelfinavir linoleic acid plus remdesivir antilung cancer agent curcumin cisplatin celastrol gefitinib Natural product demonstrated potential value assistance nanotechnology combination drug therapy codrug strategy `` natural remedy could serve starting point drug development treating lung disease,sars-cov-2;united states food and drug administration-approved drug;lung cancer;natural product;natural remedy
COVID19 Diabetes Understanding Interrelationship Risks Severe Course,34220706,relationship COVID19 diabetes mellitus complicated bidirectional one hand diabetes mellitus considered one important risk factor severe course COVID19 Several factor often present diabetes mellitus likely contribute risk older age proinflammatory hypercoagulable state hyperglycemia underlying comorbidities hypertension cardiovascular disease chronic kidney disease obesity hand severe COVID19 infection treatment steroid specific negative impact diabetes leading worsening hyperglycemia increased insulin resistance reduced betacell secretory function Worsening hyperglycemia turn adversely affect course COVID19 Although knowledge gradually surface pandemic progress challenge understanding interrelationship COVID19 diabetes remain,covid-19;sars-cov-2;comorbidities;coronavirus;diabetes;mortality;severity;treatment
Antimicrobial Peptides Physical Activity Great Hope COVID 19,34209064,Antimicrobial peptide AMPs alpha betadefensins posse antiviral property AMPs achieve viral inhibition different mechanism action example bind directly virion ii bind modulate host cellsurface receptor disrupting intracellular signaling iii function chemokines augment alter adaptive immune response Given antiviral property fact development effective coronavirus disease 2019 COVID19 treatment urgent public health priority derivative explored potential therapy COVID19 exploration using various strategy range direct interaction virus using vaccine adjuvant However AMPs work isolation specifically role potent immune modulators interact tolllike receptor TLRs chemokine receptor receptor shown play role COVID19 pathogenesis addition known healthy lifestyle accompanied controlled physical activity represent natural weapon COVID19 competitive athlete increase serum defensins shown function selfprotection attack microorganism consequently controlled physical activity could act support therapy fighting COVID19 Therefore including information player interaction would produce complete picture AMPbased therapy response,covid-19;antimicrobial peptide;cathelicidin;chemokine receptor;defensin;physical activity;toll-like receptor
Effects Patient Characteristics Diagnostic Performance SelfCollected Samples SARSCoV2 Testing,34286681,evaluated performance selfcollected anterior nasal swab ANS saliva sample compared healthcare workercollected nasopharyngeal swab specimen used test severe acute respiratory syndrome coronavirus 2 SARSCoV2 used PCR diagnostic panel test selfcollected healthcare workercollected sample participant public hospital Atlanta Georgia USA Among 1076 participant 519 men 571 50 year age 812 Black nonHispanic 749 reported 1 chronic medical condition total 80 tested positive SARSCoV2 Compared nasopharyngeal swab sample ANS sample sensitivity 59 saliva sample sensitivity 68 Among participant tested 37 day symptom onset ANS sample sensitivity 80 saliva sample sensitivity 85 Sensitivity varied specimen type patient characteristic finding help physician interpret PCR result SARSCoV2,2019 novel coronavirus disease;covid-19;georgia;sars-cov-2;united states;anterior nasal;coronavirus disease;coronaviruses;respiratory infections;saliva;self-collected;sensitivity;severe acute respiratory syndrome coronavirus 2;viruses;zoonoses
Influences weatherrelated parameter spread Covid19 pandemic scenario Bangladesh,34226864,Objective Weather parameter temperature humidity air quality index wind speed important factor influencing infectious disease like Covid19 Therefore study aim discus analyse relation weather parameter spread Coronavirus disease Covid19 perspective Bangladesh Methods Correlation among weather parameter infection death rate established using several graphical plot wind rose diagram Kendall Spearman correlation appropriate discussion relevancy reference Information presented study extracted 1st April 2020 30th December 2020 Results Analyses show decrease temperature infection rate increased significantly Also number infection increase wind speed increase absolute humidity rate Bangladesh almost constant therefore author unable predict relation absolute humidity number infection prediction number infection based wind direction several region seven division Bangladesh vulnerable upcoming several month Conclusion study analysed dependency weather parameter number infection along predicting upcoming danger zone,bangladesh;covid-19;humidity;temperature;weather parameters;wind speed
Colorectal Cancer Care Patients Perceptions COVID19 Implications Subsequent SARSCoV2 Infection Waves,34373848,Background Changes colorectal cancer CRC care planning coronavirus disease 2019 COVID19 pandemic associated healthrelated quality life HRQoL wellbeing patient CRC unknown report change CRC care patientreported outcome including HRQoL distress loneliness first wave severe acute respiratory syndrome coronavirus 2 SARSCoV2 Methods April 2020 4984 patient included nationwide Prospective Dutch Colorectal Cancer cohort invited complete COVID19specific questionnaire together validated European Organisation Research Treatment Cancer Core Quality Life Questionnaire QLQC30 De Jong Gierveld Hospital Anxiety Depression Scale Clinical data obtained Netherlands Cancer Registry Scores compared year prior COVID19 age sexmatched control population COVID19 Results total 3247 651 patient responded April June 2020 patient 17 canceled postponed changed hospital visit telephone video consult 53 adjusted postponed canceled treatment Compared control patient reported worse HRQoL comparable distress le social loneliness patient = 212 control = 329 Compared preCOVID19 clinically meaningful deterioration HRQoL prevalent patient change cancer care planning patient without change Prior undergoing currently undergoing treatment infection worry associated lower HRQoL Conclusions CRC patient reported equal anxiety depression worse HRQoL control population Changes care planning associated deterioration HRQoL increased anxiety case 1 risk factor healthcare specialist discus mental health status possible support future SARSCoV2 infection wave comparable pandemic,
National Collaborating Centre Methods Tools NCCMT Supporting evidenceinformed decisionmaking public health Canada,34220355,National Collaborating Centre Methods Tools NCCMT part network six National Collaborating Centres Public Health NCC created 2005 federal government following severe acute respiratory syndrome SARS epidemic strengthen public health infrastructure Canada work NCCMT support evidenceinformed decisionmaking EIDM public health Canada accomplished curating trustworthy evidence building competence use evidence accelerating change EIDM Ongoing engagement target audience ensures NCCMT s relevance ability respond evolving public health need particularly critical coronavirus disease 2019 COVID19 pandemic saw NCCMT pivot activity support public health response conducting rapid review priority question identified decisionmakers federal local level well create maintain national repository inprogress completed synthesis effort along partnering COVID19 Evidence Network support DecisionMaking COVIDEND sought reduce duplication increase coordination synthesis effort support decisionmakers use best available evidence decisionmaking Data website statistic illustrate successful uptake initiative across Canada internationally,covid-19;keywords: public health;evidence;knowledge mobilization;networks;partnership;synthesis
Seroprevalence SARSCoV2 Antibodies HIVInfected Patients Rome Italy COVID19 Outbreak,34202510,BACKGROUND study aimed determine proportion people living HIV PLWH antiSARSCoV2 IgG antibody large sample single HIV referral center Rome Italy timeframe included first second wave Italian COVID19 pandemic Methods conducted crosssectional study stored cryopreserved sample 1 March 2020 30 November 2020 Total antibody SARSCoV2 preliminarily tested using chemiluminescent immunoassay Positive result retested ELISA assay IgG confirmatory test Results overall 1389 sample analyzed 1106 PLWH 69 male median age 53 year 94 antiretroviral treatment 93 HIVRNA 50 copiesmL median CD4 cell count 610 cellmicroL analysis revealed total n = 8 patient tested IgG positive study period Seroprevalence equal 0 first month MarchJune started increase July reached maximum rate 159 October 2020 overall seroprevalence 072 81106 95 CI 037142 CONCLUSION finding setting show low IgG SARSCoV2 prevalence among PLWH compared data available general population,covid-19;hiv;sars-cov-2;antiretroviral therapy;seroprevalence
ScreenPrinted GrapheneCarbon Electrodes Paper Substrates Impedance Sensors Detection Coronavirus Nasopharyngeal Fluid Samples,34205178,Severe acute respiratory syndrome SARSCoV2 causative agent global pandemic resulted one million death ten million reported case requires fast accurate portable testing mechanism operable field environment Electrochemical sensor based paper substrate portable electrochemical device prove excellent alternative mitigating economic public health effect disease Herein present impedance biosensor detection SARSCoV2 spike protein utilizing IgG antiSARSCoV2 spike antibody labelfree platform utilizing screenprinted electrode work principle redox reaction impedance probe detect antigen spike directly nasopharyngeal fluid well virus sample collected universal transport medium UTM High conductivity graphenecarbon ink used purpose small background impedance lead wider dynamic range detection Antibody immobilization onto electrode surface conducted chemical entity biological entity see effect biological immobilization enhance antibody loading thereby sensitivity case able low limit quantification ie 025 fgmL however linear range 3 order magnitude wider biological entitybased immobilization specificity sensor also tested high concentration H1N1 flu antigen appreciable response optimized sensor used identify negative positive COVID19 sample great accuracy precision,covid-19 antibodies;graphene/carbon;sars-cov-2;electrochemical sensors
Investigation management outbreak COVID19 infection acute admission unit District General Hospital lesson learnt,34337381,Background SARSCoV2 outbreak difficult recognise control due high infectivity wide range clinical manifestation infection outbreak Watford general hospital provided opportunity recognise complexity involved COVID19 outbreak investigation Methods outbreak control team OCT convened term outbreak case significant exposure defined per Public Health England PHE Guidance context local outbreak Root cause analysis RCAs carried case identify possible cause possible route transmission learning point contact patient staff screened RT PCR genomic sequencing performed set positive specimensIn addition active contact tracing screening cohorting patient staff standard transmissionbased precaution reinforced control outbreak Findings Fifteen patient four staff member identified outbreak investigation contact tracing screening strict infection control measure outbreak brought control Conclusion could successfully contain spread outbreak following PHE outbreak control guideline local guideline recognised several challenge investigating COVID19 outbreak hospital setting Problems arising variable sensitivity test difficulty differentiating COVID19 related symptom underlying disease problem related establishing route transmission issue contact tracing discussed Additionally importance limitation genomic study COVID19 discussed,covid 19;infection control;isolation;outbreak;pcr;screening
Clinical Epidemiological Characteristics Paediatric Patients Diagnosed COVID19 Tertiary Hospital Mexico City,34213541,COVID19 affect paediatric population le frequently adult retrospective study performed tertiary paediatric hospital Mexico City child 18 year age hospitalized positive reverse transcriptionpolymerase chain reaction SARSCoV2 Included study 86 patient median age 10 year old IQR 26143 year classified three group previously healthy chronic disease immunosuppressed patient principal sign symptom fever 81 cough 51 headache 35 total 20 patient 23 required management paediatric intensive care unit PICU 17 needed mechanical ventilation average 127 day IQR 229 day statistically significant difference three clinical classification group patient admitted PICU previously healthy patient mortality rate 5 four patient Given paediatric population susceptible infection potential transmitter clinical presentation variable degree severity important continue reinforcing social distancing measure,covid-19;clinical-epidemiological characteristics;comorbidities;paediatrics
Left ventricular longitudinal strain alteration asymptomatic mildly symptomatic paediatric patient SARSCoV2 infection,34219155,AIMS Compared adult patient clinical manifestation child s coronavirus disease2019 COVID19 generally perceived le severe objective study evaluate cardiac involvement previously healthy child asymptomatic mildly symptomatic severe acute respiratory syndrome coronavirus2 SARSCoV2 infection METHODS RESULTS analysed cohort 53 paediatric patient 29 male 55 mean age 75 + 47 year confirmed diagnosis SARSCoV2 infection asymptomatic mildly symptomatic COVID19 Patients underwent standard transthoracic echocardiogram speckle tracking echocardiographic study least 3 month diagnosis Thirtytwo age sex body surface area comparable healthy subject used control group Left ventricular ejection fraction within normal limit significantly lower case group compared control 624 + 41 vs 652 + 55 P = 0012 Tricuspid annular plane systolic excursion 201 + 3 mm vs 198 + 34 mm P = 0822 left ventricular LV global longitudinal strain 219 + 24 vs 226 + 25 P = 0208 comparable two group Regional LV strain analysis showed significant reduction LV midwall segment strain among case compared control Furthermore case group 14 subject 26 regional peak systolic strain 16 25 Z score healthy cohort least two segment subject show difference regarding symptom serological finding CONCLUSION SARSCoV2 infection may affect left ventricular deformation 26 child despite asymptomatic mildly symptomatic acute illness followup needed verify reversibility alteration impact longterm outcome,covid-19;sars-cov-2;longitudinal strain;paediatric cardiology;speckle tracking echocardiography
Two novel nomogram based inflammatory cytokine lymphocyte subset differentially diagnose severe critical NonSevere COVID19,34282057,intend evaluate difference clinical characteristic cytokine profile immunological feature patient different severity COVID19 develop novel nomogram based inflammatory cytokine lymphocyte subset differential diagnostics severe critical nonsevere COVID19 patient retrospectively studied 254 COVID19 patient 90 severe critical patient 164 nonsevere patient Severe critical patient significantly higher level inflammatory cytokine nonsevere patient well lower level lymphocyte subset Significantly positive correlation cytokine profile observed significantly negatively correlated lymphocyte subset Two effective nomogram developed according two multivariable logistic regression cox model based inflammatory cytokine profile lymphocyte subset separately area receiver operating characteristic two nomogram 0834 95 CI 07790888 0841 95 CI 07560925 bootstrappedconcordance index two nomogram 0834 0841 training set 0860 0852 validation set Calibration curve decision curve analysis demonstrated nomogram well calibrated significantly clinical net benefit novel nomogram accurately predict disease severity COVID19 may facilitate identification severe critical patient assist physician making optimized treatment suggestion,covid-19;sars-cov-2;cytokine profiles;lymphocyte subsets;nomogram
Clinical utility rapid ondemand laboratorybased SARSCoV2 diagnostic testing service acute hospital setting admitting COVID19 patient,34337384,Background onset COVID19 pandemic 2020 hospital clinical team realised need rapid accurate testing facility allow move patient quickly isolation room specific COVID19 cohort ward soon possible admission Methods Starting July 2020 PCRbased test platform could test 48 sample parallel turnaround sampletoresult time 5080 min placed satellite laboratory laboratory floor within walking distance acute respiratory admission ward staffed team three midBand 4 staff split 07002200 hwork day 7 day week 2 senior supervisor Urgent sample testing decided upon clinical team requested phone test result entered manually realtime became available sent electronically requesting ward team Results dailymonthly PCR positive test number approximately followed local national UK trend COVID19 case number daily case number reflective November December 2020 surge Test result used rapidly segregate positive patient dedicated COVID19 ward area minimise risk potential nosocomial transmission crowded waiting area Testing capacity sufficient include case uncertain diagnosis likely require hospital admission Following completion admission process based rapid test result patient allocated dedicated COVID19 positive negative cohort ward Conclusions rapid testing facility reduced unnecessary lengthofstay busy acute respiratory ward current absence treatment mildtomoderate COVID19 patient could discharged home complete rapid test facility become successful aid patient flow reduced exposure nosocomial transmission,covid-19;diagnostics;infection control;nosocomial transmission;patient flow;rapid testing;sars-cov-2;triage
Evaluation Patients Suspicion COVID19 Pediatric Emergency Department,34349593,Objectives Coronavirus disease 2019 COVID19 different clinical presentation child symptomatic child suspicion COVID19 fever respiratory symptom retrospective study aimed describe demographic feature clinical characteristic outcome confirmed probable COVID19 patient admitted pediatric emergency department ED Methods identified 135 child aged 1 month18 year suspicion COVID19 admitted ED March 11 May 12 2020 urgency patient evaluated according Pediatric Assessment Triangle PAT Emergency Severity Index ESI score Patients divided two group confirmed case Group 1 probable case Group 2 Clinical laboratory radiologic feature disease severity patient analyzed Results According PAT evaluation 82 patient 656 nonurgent frequent ESI triage category level 3 n=102 761 Fortyone 304 patient identified laboratoryconfirmed case Fiftyfive 407 patient 28 day 4 year age Fever cough frequent symptom onset illness COVID19 positive patient n=16 39 Sixtyfour 474 patient mild disease 40 296 patient comorbidities Group 1 neutropenia significantly higher Group 2 p=0024 Mean procalcitonin erythrocyte sedimentation rate level Group 2 significantly higher Group 1 p=0012 p=0028 respectively Twentyeight 51 patient chest computed tomography finding compatible COVID19 Fiftyone 378 patient discharged ED 81 60 admitted ward 3 22 admitted pediatric intensive care unit Conclusion study confirmed diagnosis 45 135 probable case SARSCoV2 polymerase chain reaction test Among confirmed COVID19 case patient mild moderate disease clinic confirmed three patient classified severe disease critically ill patient,covid-19;children;turkey;pandemics;pneumonia;severe acute respiratory syndrome
perspective hospitalacquired nosocomial infection control COVID19 usefulness spatial separation ward airborne isolation unit,34293732,coronavirus disease 2019 COVID19 pandemic imposed considerable burden hospital healthcare worker HCWs worldwide increasing risk outbreak nosocomial transmission nonCOVID19 patient represent highestrisk population term mortality HCWs Since HCWs interface hospital one hand community potential reservoir carrier victim severe acute respiratory syndrome coronavirus 2 crosstransmission addition paradigm shift management viral respiratory outbreak widespread testing patient HCWs including asymptomatic individual hospital risk aerosol transmission poorly ventilated space performing aerosolproducing procedure imperative take measure aerosol transmission particular spatial separation inpatient ward nonCOVID19 patient designated patient suspected confirmed COVID19 well negativepressure isolation floor ward using airborne infection isolation device could help prevent nosocomial infection,covid-19;sars-cov-2;airborne isolation unit;airborne transmission;hospital-acquired (nosocomial) infection;segmentation
SARSCoV2related Multisystem Inflammatory Syndrome Children case series,34221480,27 April 2020 National Health Service England issued emergency alert new condition owing observation increasing number case COVID19related hyperinflammatory syndrome termed multisystem inflammatory syndrome child MISC presenting symptom appeared similar Kawasaki disease toxic shock syndrome report case six child fitting criterion MISC admitted Royal Hospital Sohar Hospital Oman month June July 2020 Four patient required admission paediatric intensive care unit inotropic support two admitted paediatric ward suspicion appendicitis MISC reported small number individual age 21 year median age 910 year Five current patient aged le median age reported existing literature patient showed complete recovery supportive management intravenous immunoglobulin steroid one patient requiring interleukin6 inhibitor tocilizumab,covid-19;case report;kawasaki disease;multisystem inflammatory syndrome in children;oman;sars-cov-2;toxic shock syndrome
Surgical oncology operative experience highvolume safetynet hospital COVID19 pandemic,34291824,BACKGROUND coronavirus COVID19 pandemic led disruption operative hospital capability country triaged resource canceled elective procedure study detail operative experience safetynet hospital cancerrelated operation 3month period height pandemic METHODS Patients operated diagnosed malignancy abdomen breast skin softtissue September 3 2020September 6 2020 identified operativeclinic schedule Sociodemographics tumor treatment characteristic COVID19 information identified retrospective chart review prospectively maintained database Descriptive statistic calculated RESULTS Fifty patient evaluated within window underwent oncologic surgery Median age 61 interquartile range 5368 56 female 86 White 66 Hispanic majority 28 colon cancer two patient tested positive COVID19 preoperatively within 30 day operation mortality 1year study period CONCLUSION COVID19 pandemic many hospital operative center limited intervention preserve resource oncologic procedure continued many largevolume academic cancer center study underscore importance continuing offer surgery pandemic surgical oncology case safetynet hospital minimize delay timesensitive oncologic treatment,clinical outcomes;coronavirus;surgical oncology
COVID19 Health Care Personnel Significance Health Care Role Contact History Symptoms Test Positive SARSCoV2 Infection,34366140,OBJECTIVE identify significant factor help predict whether health care personnel HCP test positive severe acute respiratory coronavirus 2 SARSCoV2 PATIENTS METHODS conducted prospective cohort study among 7015 symptomatic HCP March 25 2020 November 11 2020 analyzed association health care role contact history symptom positive nasopharyngeal swab SARSCoV2 polymerase chain reaction test result using univariate multivariable modelling RESULTS symptomatic HCP 624 89 positive study period multivariable analysis health care role physician advanced practice provider contact family community member known suspected coronavirus disease 2019 COVID19 seven individual symptom cough anosmia ageusia fever myalgia chill headache significantly associated higher adjusted odds ratio testing positive SARSCoV2 increase symptom number odds testing positive nearly doubled odds ratio 193 95 CI 182 207 P 001 CONCLUSION Symptomatic HCP higher adjusted odds testing positive SARSCoV2 based three distinct factor 1 nonphysicianadvanced practice provider role 2 contact family community member suspected known COVID19 3 specific symptom symptom number Differences among health care role persisted controlling contact may reflect influence social determinant Contacts COVID19positive patient andor HCP associated higher odds testing positive supporting current infection control effort Targeted symptom contact questionnaire may streamline symptomatic HCP testing COVID19,
Comparison myocardial function assessed echocardiography hospitalization COVID19 4 month followup,34286449,patient hospitalized corona virus infectious disease 19 COVID19 currently unknown whether myocardial function change recovery whether related elevated cardiac biomarkers single center prospective cohort study consecutively enrolled hospitalized COVID19 patient 1 April 12 May 2020 patient underwent transthoracic echocardiography TTE evaluation hospitalization median 131 day IQR 116136 followup 51 patient included baseline 40 age 62 year IQR 5468 78 male available followup TTE baseline 68 patient normal TTE regarding left ventricular LV right ventricular RV volume function compared 83 followup p = 007 Median LV ejection fraction 60 vs 58 p = 054 tricuspid annular plane systolic excursion 23 v 22 mm p = 018 comparable hospitalization followup significantly lower RV diameter 39 vs 34 mm p = 0002 trend towards better global longitudinal strain GLS 185 v 191 p = 007 found followup Subgroup analysis showed relation patient without elevated TroponinT andor NTproBNP hospitalization myocardial function followup Although significant difference individual myocardial function parameter 4 month followup compared hospitalisation COVID19 overall trend towards normalization myocardial function predominantly due higher rate normal GLS followup,covid-19;echocardiography;myocardial function;sars-cov-2
Case Report Liver Cysts SARSCoV2 Evidence Virus Cystic Fluid,34222319,Background December 2019 outbreak pneumonia caused new type coronavirus named severe acute respiratory syndrome coronavirus 2 SARSCoV2 quickly spread worldwide resulting pandemic clinical manifestation SARSCoV2 range mild nonspecific symptom severe pneumonia organ function damage addition 60 patient liver impairment dysfunction confirmed several study presence SARSCoV2 liver tissue Methods report two case symptomatic liver cyst requiring fenestration recent SARSCoV2 infection patient hospital admission due documented SARSCoV2 infection Recently infection developed symptom caused enlarged hepatic cyst one abdominal pain jaundice underwent surgery two negative swab test SARSCoV2 Results Cystic fluid sent microbiological test realtime fluorescence polymerase chain reaction COVID19 nucleicacid assay cyst fluid found negative case Discussion Although current data document viral contamination cystic fluid data document hepatotropism COVID19 virus Herein report viral clearance pharyngeal nasal swab evidence viral load potential viral reservoir,cov-2;fenestration cyst;jaundice;liver benign disease;liver cyst infection
Immunogenicity BNT162b2 COVID19 mRNA vaccine early clinical outcome patient haematological malignancy Lithuania national prospective cohort study,34224668,BACKGROUND Haematological malignancy treatment likely affect SARSCoV2 vaccine efficacy aimed evaluate serological response BNT162b2 vaccine patient haematological malignancy type treatment METHODS national prospective cohort study done Lithuania assessed serological response one two BNT162b2 Comirnaty PfizerBioNTech vaccine dos healthy healthcare worker patient haematological malignancy Eligible participant aged 18 year older received vaccine dos available biobanked blood sample vaccination second dose Biobanked sample health data obtained Vilnius University Hospital Santaros Klinikos Biobank Abbott Architect SARSCoV2 IgG Quant II chemiluminescent microparticle assay used quantify serum antiSARSCoV2S1 IgG antibody antiS1 IgG antibody concentration 010 day first BNT162b2 vaccine day second immunisation around day 21 7 21 day second immunisation Adverse event assessed standardised questionnaire Breakthrough infection characterised clinically SARSCoV2 genotyping whenever possible study registered ClinicalTrialsgov NCT04871165 FINDINGS Jan 8 April 21 2021 885 participant haematological malignancy included study 857 patient antiS1 IgG seronegative timepoint 0 constituted main analysis cohort agematched comparison made 315 patient haematological malignancy aged 1860 year 67 healthy healthcare worker age group Patients aged 1860 year haematological malignancy lower median antiS1 IgG antibody response two BNT162b2 vaccine dos healthcare worker age group median 6961 AUmL IQR 129220 672 v 21 395 AUmL 14 83133 553 p 00001 Compared untreated patient haematological malignancy n=53 median 5761 AUmL 62916 141 patient actively treated Bruton tyrosine kinase inhibitor BTKIs n=44 0 AUmL 07 p 00001 ruxolitinib n=16 10 AUmL 045 p 00001 venetoclax n=10 4 AUmL 01218 p=00005 antiCD20 antibody therapy n=87 17 AUmL 12319 p 00001 showed particularly poor antiS1 IgG antibody response following two BNT162b2 dos Patients treated tyrosine kinase inhibitor n=41 10 537 AUmL IQR 233519 388 patient received autologous haematopoietic stemcell transplantation HSCT n=192 6203 AUmL 145116 834 allogeneic HSCT n=122 6304 AUmL 112016 913 among subgroup highest numerical response Nine SARSCoV2 infection three COVID19 death observed among fully vaccinated patient haematological malignancy INTERPRETATION Patients haematological malignancy mount blunted heterogeneous antibody response full course BNT162b2 mRNA vaccination Patients actively treated BTKIs ruxolitinib venetoclax antiCD20 antibody therapy seem negatively affected might left unprotected SARSCoV2 infection Breakthrough severe SARSCoV2 infection fully vaccinated patient haematological malignancy emphasise importance ongoing strict adherence nonpharmacological intervention household vaccination SARSCoV2 circulating community FUNDING Vilnius University Hospital Santaros Klinikos TRANSLATION Lithuanian translation abstract see Supplementary Materials section,
Moderate acceptance COVID19 vaccination patient pre postheart transplantation Experiences German Transplant Centre,34216078,INTRODUCTION OBJECTIVES Patients awaiting heart transplantation HTx increased risk developing severe coronavirus disease 2019 COVID19 Patients supported left ventricular assist device LVAD face additional risk due coagulopathies COVID19 Following HTx elevated risk factor severe COVID19 persist due chronic immunosuppression frequent comorbidities Taken together COVID19 vaccination critical importance three patient cohort report experience deliver COVID19 vaccination German transplant center METHODS RESULTS screened 211 patient contraindication offered remaining 186 eligible patient COVID19 vaccination 133 patient 71 accepted offer vaccinated Acceptance vaccination differed HTx recipient 84 113 74 patient waiting list 34 47 72 patient LVAD support 28 50 56 LVAD cohort demonstrated lower acceptance level vaccination compared HTx recipient patient awaiting HTx 74 vs 56 p = 0028 CONCLUSION demonstrate first time moderate acceptance level COVID19 vaccination HTx recipient candidate waiting list compared general population despite perceived highrisk severe disease Additionally supported LVAD even lower adherence Efforts may need made increase acceptance vulnerable well costintensive patient cohort,covid-19;lvad;heart transplantation;vaccination
Pharmacokinetic profile SARSCOV2 neutralizing antibody BD604 cynomolgus monkey,34215019,BACKGROUND Currently severe acute respiratory syndrome coronavirus 2 SARSCOV2 spread worldwide severe pandemic effective therapeutic medication urgently needed reported previously BD604 fully human monoclonal antibody strong vitro vivo neutralizing activity SARSCOV2 OBJECTIVE purpose study characterize pharmacokinetic propertie BD604 cynomolgus monkey METHODS analyze concentration BD604 cynomolgus monkey serum ELISA assay established systemic validation performed including accuracy precision dilution linearity hook effect selectivity specificity stability parallelism test six naive cynomolgus monkey 3sex administered BD604 single dose 10 mgkg via intravenous infusion 60 min Blood sample collected various time point 0672 h analyzed serum concentration BD604 RESULTS data validation experiment assure reproducibility reliability established ELISA assay validated method used measure BD604 concentration cynomolgus monkey serum pharmacokinetics parameter including terminal halflife t12 peak serum concentration Cmax area curve time zero last timepoint infinity AUClast AUCinf apparent volume distribution Vz clearance rate CL mean residence time MRT calculated reported BD604 showed marked sex difference dose 10 mgkg comparing AUC0last Cmax female male cynomolgus monkey CONCLUSION cynomolgus monkey BD604 posse pharmacokinetic property similar natural IgGs,bd-604;sars-cov-2;monkey;monoclonal antibody;pharmacokinetics
Pattern Visits Metropolitan Emergency Department Lombardia Italy January 2019December 2020,34202591,Coronavirus disease 2019 COVID19 general decrease presentation emergency department ED reported However suspect lower number unchanged pattern ED visit urgent condition 2020 compared 2019 retrospective study assessed change number presentation ED tertiary level university hospital Milano Lombardia Italy Compared 2019 significant drop ED presentation occurred 464 recorded 157 difference proportion patient admitted white code pattern hourly presentation ED unchanged overcrowding working daytime COVID19 changed ED flow likely causing overall reduction number deferrable condition However pattern associated urgent condition change abruptly 2020,covid-19;italy;emergency service;overcrowding;primary care
Severe feature outbreak low mortality observed immediately MarchMay Covid19 outbreak Stockholm Sweden Mortality COVID19 outbreak,34375761,OBJECTIVES aimed estimate well excess mortality reflected burden COVID19related death whether excess mortality outbreak might resulted compensatory reduced mortality MarchMay Covid19 outbreak Stockholm Sweden METHODS Using previous 10year 5year average mortality baseline compared excess mortality estimate MarchMay 2020 outbreak Stockholm RESULTS Weekly death estimate revealed immediate preoutbreak postoutbreak allcause mortality exceed excess mortality regardless using previous 10year 5year average mortality Fortythree day start outbreak 744 total excess mortality reportedly explained known COVID19related death update 15 week start outbreak reported COVID19related death explained 99 total excess mortality CONCLUSIONS Exceptional outbreak feature rapid excess mortality observed However excess similarly low mortality observed immediately prior outbreak postoutbreak thus emphasizing severity first wave COVID19 outbreak Stockholm,"covid-19;mortality;sars-cov-2;outbreak, public health"
Brain Mechanisms COVID19Sleep Disorders,34203143,2020 2021 unprecedented year due rapid spread modified severe acute respiratory syndrome coronavirus around world coronavirus disease 2019 COVID19 cause atypical infiltrated pneumonia many neurological symptom major sleep change exposure people stress social confinement change daily routine accompanied various sleep disturbance known coronasomnia phenomenon Sleep disorder induce neuroinflammation promotes bloodbrain barrier BBB disruption entry antigen inflammatory factor brain review finding trend sleep research 20202021 demonstrating COVID19 sleep disorder induce BBB leakage via neuroinflammation might contribute coronasomnia phenomenon new study suggest control sleep hygiene quality incorporated rehabilitation COVID19 patient also discus perspective strategy prevention COVID19related BBB disorder demonstrate sleep might novel biomarker BBB leakage analysis sleep EEG pattern breakthrough noninvasive technology diagnosis COVID19caused BBB disruption,covid-19-sleep disorders;brain mechanisms;the blood-brain barrier permeability
Bioaerosols mouthbreathing Underrecognized transmissible mode COVID19,34220352,whole world affected coronavirus disease 2019 COVID19 pandemic many researcher racing understand disease course undertake risk analysis formulate effective treatment strategy Severe acute respiratory syndrome coronavirus 2 SARSCoV2 highly transmissible coughing sneezing breathing talking may account viral transmission asymptomatic carrier Bioaerosols produced mouthbreathing expiratory process habitual mouth breather considered addition nasal bioparticles potential transmissible mode COVID19 Oral health professional justifiably apprehensive exposure risk due close facetoface contact mode transmission aim commentary summarize research conducted area suggested strategy limit spread COVID19 especially dental office,covid-19;keywords: bioaerosols;coronavirus;mouth-breathing;oral diagnosis;transmission risk
Isolation Viable SARSCoV2 Virus Feces Immunocompromised Patient Suggesting Possible Fecal Mode Transmission,34207314,1 Background Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 excretion stool well documented RTPCR evidence stool contain infectious particle scarce 2 Methods observing Corona Virus 2019 Disease COVID19 epidemic cluster associated ruptured sewage pipe search viable SARSCoV2 particle stool inoculating 106 sample 46 patient 3 Results successfully obtained two isolates unique patient kidney transplantation immunosuppressive therapy admitted severe diarrhea 4 Conclusions report emphasizes SARSCoV2 enteric virus infectious virus particle isolated stool immunecompromised patient like case kidney transplant recipient Immunecompromised patient likely massive multiplication virus gastrointestinal tract report suggests possible fecal transmission SARSCoV2,covid-19;sars-cov-2;cell culture;organ transplantation;stools
Heart transplantation complicated COVID19 infection,34283959,influence COVID19 heart transplantation considerable Reports COVID19 infection recently transplanted patient scarce present 60yearold patient COVID19 infection diagnosed six day transplantation clinical course revealed two phase Initially mild respiratory symptom treated remdesivir noninvasive respiratory support second phase clinical deterioration postoperative day 22 respiratory decline led administration convalescent plasma satisfactory response improvement condition,covid-19;heart failure;heart transplantation;lung disease
dilemma treating infected versus wounded Gaza s healthcare system choked,34212406,Gaza facing persistent disturbance since last 14 year Even pandemic Gaza faced dire healthcare consequence prevalent instability lack adequate medical resource limited healthrelated infrastructure Gaza continued struggle responding pandemic nearby country However challenge compounded onset conflict affected Gaza s infrastructure displaced ten thousand makeshift shelter testing capacity Gaza alarmingly low make outbreak difficult document Additionally medical centre affected ongoing conflict centre directly impacted severely overwhelmed injured conflict shifting focus resource away coronavirus Vaccinations Gaza cover 19 population great number unvaccinated people may act vector transmission overcrowded shelter Furthermore nonavailability clean water maintain hygienic condition heightened risk explosive surge case Hence beyond ceasefire step need taken strengthen Gazan response COVID19 pandemic,covid 19;challenges;clean water;healthcare system;testing capacity;vaccination
COVID19 Vaccineassociated Anaphylaxis Allergic Reactions Consensus Statements KAAACI UrticariaAngioedemaAnaphylaxis Working Group,34212542,era novel coronavirus epidemic vaccine coronavirus disease 2019 COVID19 recognized effective public health intervention control pandemic adverse event following immunization AEFI defined untoward occurrence following immunization majority AEFIs caused protective immune response stimulated vaccine reported AEFIs serious many immunologically mediated even reproducible reexposure However uncommon severe allergic adverse reaction anaphylaxis allergic reaction occur vaccination Confirmed allergic reaction vaccine may caused residual nonhuman protein preservative stabilizer vaccine formulation also known excipients 2 main potential allergenicimmunogenic excipients COVID19 vaccine polyethylene glycol PEG polysorbate 80 PEG also known macrogol ingredient various laxative injectable formulation depot steroid Polysorbate 80 present various medical product cream ointment lotion medication tablet Contraindications administration COVID19 vaccine include previous history severe allergic reaction first dose COVID19 vaccine proven hypersensitivity vaccine component PEG polysorbate 80 Anaphylaxis allergic reaction following immunization cause fear loss confidence safety vaccine among public better understanding event thought help alleviate concern current COVID19 vaccine provide reassurance general population analyzing exact incidence anaphylaxis potential risk factor COVID19 vaccineassociated anaphylaxis could prevented managed risk stratification based local global experience,covid-19;anaphylaxis;hypersensitivity;immunity;immunization;pandemics;preservatives;public health;vaccine
Summary SARSCoV2 Vaccines Technologies Available Development,34206507,Since beginning 2020 world race develop vaccine control COVID19 pandemic 250 project initiated purpose 14 authorized use despite phase 3 clinical trial 40 vaccine also phase 12 clinical trial show promising outcome Regarding appropriate choice vaccine country region reviewed currently used vaccine light different influencing parameter factor include mode action dosage protocol age group vaccinee side effect storage condition mounted immune response cost Technically seven type vaccine developed SARSCoV2 messenger RNA mRNA nonreplicating replicating vector inactivated virus protein subunit virallike particle DNA vaccine live attenuated vaccine mRNA type used first time human Unfortunately mutated variant SARSCoV2 started appear worldwide researcher investigating effect currently used vaccine many concern regarding longterm protection afforded vaccine side effect whether require future modification effective mutated variant development new vaccine using advanced technology paramount overcoming difficulty controlling COVID19 pandemic across world,covid-19;sars-cov-2;immune response;vaccines
RAS Link COVID19 Increased Stress Head Neck Cancer Patients,34336866,COVID19 pandemic emerged largely unexplained outbreak pneumonia case Wuhan City China rapidly spread across world 11th March 2020 declared global pandemic resulting restriction contain spread demanded momentous change lifestyle general population well cancer patient augmented negative effect mental health patient head neck cancer HNC already battle stress cancer diagnosis treatment causative agent COVID19 SARSCoV2 gain entry Angiotensin converting enzyme 2 ACE2 receptor component Renin Angiotensin System RAS RAS shown influence cancer stress progressive suppressive effect review provides overview SARSCoV2 look RAS provides mechanistic link stress cancer COVID19 probable activation RAS axis increase stress anxiogenic tumor progression tumorigenic ACE2 hijacked SARSCoV2 mental health crisis brought pandemic highlighted many study emerging link cancer stress make important ever ass stress burden cancer patient expand strategy management,ace2;covid-19;cancer;head and neak cancer;oral cancer;renin angiotensin system;stress
Innate Immunity Children Role ACE2 Expression SARSCoV2 Infection,34287338,COVID19 Coronavirus Disease 2019 emerging viral disease caused coronavirus SARSCoV2 severe acute respiratory syndrome coronavirus 2 lead severe respiratory infection human first report came December 2019 city Wuhan province Hubei China immediately clear child developed milder disease adult reason milder course disease attributed several factor innate immunity difference ACE2 angiotensinconverting enzyme II receptor expression previous infection common coronaviruses CovH literature review aim summarize aspect innate immunity focusing role ACE2 expression viral infection child modulating antibody response SARSCoV2 infection review conducted using Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guideline Articles deemed potentially eligible considered including dealing COVID19 child providing uptodate significant data term epidemiology prognosis course symptom focusing etiopathogenesis SARSCoV2 disease child bibliographic search conducted using search engine PubMed Scopus following search term entered PubMed Scopus COVID19 ACE2 Children COVID19 Immunity innate child search identified 857 record 18 study applicable based inclusion exclusion criterion addressed issue COVID19 concerning role ACE2 expression child scientific literature agrees child develop milder COVID19 disease adult Milder symptomatology could attributed innate immunity previous CovH virus infection yet fully understood differential expression ACE2 child could contribute milder disease,ace-2;covid-19;sars-cov-2;adolescents;children;coronavirus
Assay System Simultaneous Detection SARSCoV2 Respiratory Viruses,34199257,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 trigger disease nonspecific symptom overlap infection caused seasonal respiratory virus RVs influenza virus Flu respiratory syncytial virus RSV molecular assay accurate rapid detection RV SARSCoV2 crucial manage infection compared analytical performance clinical reliability Allplex SARSCoV2FluAFluBRSV SC2FabR Seegene Inc Seoul South Korea kit four commercially available RV detection kit Upon testing five target viral strain SARSCoV2 FluA FluB RSV RSV B analytical performance SC2FabR similar kit significant difference p = 078 zscores efficiency SC2FabR Evalue 81104 enabled reliable SARSCoV2 seasonal RV detection 888 nasopharyngeal swab specimen processed using fully automated nucleic acid extraction platform BlandAltman analysis revealed agreement value 954 SD + 196 kit indicating statistically similar result five conclusion SC2FabR rapid accurate diagnostic tool SARSCoV2 seasonal RV detection allowing highthroughput RV analysis efficiency comparable commercially available kit used help manage respiratory infection patient coronavirus disease 2019 pandemic,sars-cov-2;influenza virus;respiratory syncytial virus;simultaneous detection
Increasing postpartum IUCD coverage QI initiative step towards reducing unmet need postpartum contraception,34344746,BACKGROUND Unintended pregnancy negative impact health economy nation prevented effective family planning FP service Postpartum intrauterine device PPIUCD safe effective FP method allows woman obtain longacting contraception discharge point delivery observed poor coverage delivery PPIUCD facility trigger initiate quality improvement QI initiative increase PPIUCD coverage current rate 45 10 3month period METHOD fishbone analysis problem done following cause identified lack focused counselling FP lack sensitisation training resident doctor inconsistent supply intrauterine contraceptive device IUCDs QI team constituted representative faculty member resident intern nursing officer FP counsellor point care quality improvement methodology used INTERVENTIONS Daily counselling antenatal woman started counsellor intern antenatal ward WhatsApp group resident made initially sensitise later parking problem trouble shooting resident provided handson training skill lab Uninterrupted supply IUCDs ensured provision buffer stock IUCDs respective store keeper RESULT PPIUCD insertion rate improved 45 192 3 month sustained current 30 35 1 12 year initiation project tiding turbulence COVID19 pandemic using QI technique CONCLUSION Sensitisation training resident well creation awareness among antenatal woman targeted counselling helped improve PPIUCD coverage facility QI initiative potential facilitate effective implementation FP programme strategic utilisation resource,maternal health services;obstetrics and gynecology;quality improvement;teamwork;women's health
Extended Ecological Restoration Bacterial Communities Godavari River COVID19 Lockdown Period Spatiotemporal Metaanalysis,34219185,unprecedented COVID19 pandemic major impact human health worldwide Whilst national international COVID19 lockdown travel restriction measure widespread negative impact economy mental health may beneficial effect environment reducing air water pollution Mass bathing event MBE also known Kumbh Mela known cause perturbation ecosystem affecting resilient bacterial population within water river India Lockdowns travel restriction provide unique opportunity evaluate impact minimum anthropogenic activity river water ecosystem change bacterial population including antibioticresistant strain performed spatiotemporal metaanalysis bacterial community Godavari River India Targeted metagenomics revealed 087fold increase bacterial diversity restricted activity lockdown significant increase resilient phylum viz Proteobacteria 706 Bacteroidetes 225 Verrucomicrobia 18 Actinobacteria 12 Cyanobacteria 11 observed minimal incorporation allochthonous bacterial community human origin Functional profiling using imputed metagenomics showed reduction infection drug resistance gene 071fold 064fold respectively observation may collectively indicate positive implication COVID19 lockdown measure restrict MBE allowing restoration river ecosystem minimise associated public health risk,antibiotic resistance;bacterial populations;covid-19;kumbh mela;lockdown measures;public health;targeted metagenomics
InHouse Filtration Efficiency Assessment Vapor Hydrogen Peroxide Decontaminated Filtering Facepiece Respirators FFRs,34281105,cope shortage filtering facepiece respirator FFRs caused coronavirus disease COVID19 healthcare institution forced reuse FFRs using different decontamination method including vapor hydrogen peroxide VHP However healthcare institution still struggle evaluating effect VHP filtration efficiency FE decontaminated FFRs developed lowcost inhouse FE assessment using novel 3Dprinted air duct Furthermore assessed FE seven type FFRs Following 10 VHP cycle evaluated FE KN95 3MN95 mask 3MN95 BenehalN95 mask showed significant lower FE 804918 fine particle size 031 microm compared FFRs FE = 981 p 005 Following 10 VHP cycle FE KN95 mask almost stable FE stability 991 particle size 3MN95 mask stable 2 5 microm FE stability 980 Statistically FE stability 3MN95 mask 03 05 07 microm significantly lower p = 0006 2 5 microm inhouse FE assessment may used emergency procedure validate decontaminated FFRs well screening option production control FFRs Following VHP cycle mask showed high stability 5 microm size suspected droplet implicated COVID19 transmission,covid-19;ffrs;kn95 masks;n95 masks;decontamination;filtration efficiency;vapor hydrogen peroxide
Cardiopulmonary exercise capacity limitation 3 month COVID19 hospitalisation,34210791,RATIONALE study aimed describe cardiopulmonary function exercise 3 month hospital discharge COVID19 compare group according dyspnea intensive care unit ICU stay METHODS Participants COVID19 discharged five large Norwegian hospital consecutively invited multicentre prospective cohort study total 156 participant mean age 562 year 60 female examined cardiopulmonary exercise test CPET 3 month discharge compared reference population Dyspnea assessed using modified Medical Research Council dyspnea scale mMRC RESULTS Peak oxygen uptake VO2 80 predicted observed 31 n=49 Ventilatory efficiency reduced 15 n=24 breathing reserve 15 observed 16 n=25 Oxygen pulse 80 predicted found 18 n=28 Dyspnea mMRC =1 reported 38 n=59 participant similar peak VO2 p=010 lower mean peak sd VO2kg 1 predicted compared participant without dyspnea mMRC 0 76 16 versus 89 18 p =0009 due higher body mass index p=003 participant treated ICU versus nonICU mean peak sd VO2 predicted 82 15 90 17 p=0004 respectively Ventilation breathing reserve ventilatory efficiency similar ICU nonICU group CONCLUSIONS One third experienced peak VO2 80 predicted 3 month hospital discharge COVID19 Dyspneic participant characterised lower exercise capacity due obesity lower ventilatory efficiency Ventilation ventilatory efficiency similar ICU nonICUtreated participant,
Thromboembolism COVID19 vaccine patient preexisting thrombocytopenia,34344867,vaccination single effective intervention drastically reduce severe disease death following SARSCoV2 infection shown UK Israel serious concern raised unusual adverse drug reaction ADR including vaccineinduced immune thrombotic thrombocytopenia VITT concurrent low platelet well capillary leak syndrome fact overall safety vaccine highlighted low frequency ADR considering UK early June 40 million first dos 29 million second dos injected nonetheless 390 thrombotic event including 71 fatal event reported Interestingly case reported low platelet count presence antiplatelet factor4 PF4 antibody indicating abnormal clotting reaction three referred case report postvaccine clinical case fatal thrombosis postmortem examination whole exome sequencing WES analysis whose pathogenesis appeared associated preexisting condition thrombocytopenia due myelodysplasia,
PostCOVID19 Pulmonary Fibrosis Novel Sequelae Current Pandemic,34205928,Since initial identification novel coronavirus SARSCoV2 December 2019 COVID19 pandemic become leading cause morbidity mortality worldwide effective vaccine treatment begin emerge become increasingly important identify proactively manage longterm respiratory complication severe disease pattern imaging abnormality coupled data prior coronavirus outbreak suggest patient severe COVID19 pneumonia likely increased risk progression interstitial lung disease ILD chronic pulmonary vascular disease paper briefly review definition classification underlying pathophysiology interstitial lung disease ILD review current literature proposed mechanism lung injury severe COVID19 infection outline potential viral immunemediated process implicated development postCOVID19 pulmonary fibrosis PCPF Finally address patientspecific iatrogenic risk factor could lead PCPF discus strategy reducing risk pulmonary complicationssequelae,ards;covid-19;sars-cov-2;coronavirus;interstitial lung disease;mechanical ventilation;pneumonia;pulmonary fibrosis;venous thromboembolism
Lessons Cadaver Dissection COVID19 Pandemic,34227264,rapid increase coronavirus disease 2019 pandemic midFebruary 2020 led anatomy department Korea University College Medicine cease dissection laboratory However handson anatomy laboratory experience paramount maximizing learning outcome paper share experience lesson learned facetoface cadaveric dissection experience disruptive situation minimize infection risk following strategy applied first student oncampus attendance reduced second body temperature symptom checked entering laboratory personal protective equipment provided participant third negative pressure air circulation system used dissection room suggest conducting facetoface cadaveric anatomy dissection feasible daily count newly infected case stabilizes ample provision safety measure facilitate handson education,covid-19;covid-19 symptom screening;dissection laboratory operational strategy;personal protective equipment
TBK1 TNFRSF13B mutation autoinflammatory disease child lethal COVID19,34210994,Among child severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection typically mild describe case 35yearold girl unusually severe presentation coronavirus disease COVID19 child autoinflammatory disorder unknown etiology treated using prednisolone methotrexate parent half cousin Turkish descent 5 day nonspecific viral infection symptom tonicclonic seizure occurred followed acute cardiac insufficiency multiorgan insufficiency ultimate death Trio exome sequencing identified homozygous splicevariant gene TBK1 homozygous missense variant gene TNFRSF13B Heterozygous deleterious variant TBK1 gene associated severe COVID19 variant TNFRSF13B gene associated common variable immunodeficiency CVID suggest identified variant autoinflammatory disorder treatment combination factor probably predisposed lethal COVID19 present case,
Nucleocapsidspecific PDL1+CXCR3+ CD8 polyfunctional Tcell abundance associated survival critical SARSCoV2infected patient,34283810,RATIONALE importance adaptative cell response control resolution viral infection wellestablished However nature cellmediated viral control mechanism lifethreatening stage COVID19 yet determined OBJECTIVE aim present study determine function phenotype cell population associated survival death COVID19 patient intensive care result phenotypic functional profiling mass cytometry FINDINGS Increased frequency circulating polyfunctional CD4+CXCR5+HLADR+ stem cell memory cell TSCM decreased proportion GranzymeB Perforinexpressing effector memory cell TEM detected recovered deceased patient respectively higher abundance polyfunctional CD8+PDL1+CXCR3+ effector cell CXCR5+HLADR+ TSCM well antinucleocapsid NC cytokineproducing cell permitted differentiate recovered deceased patient result principal component analysis showed imbalance cell compartment allowed separation recovered deceased patient paucity circulating CD8+PDL1+CXCR3+ Teffcells NCspecific CD8+ Tcells accurately forecast fatal disease outcome CONCLUSION study provides insight nature cell population involved control COVID19 therefor might impact cellbased vaccine design infectious disease,adaptive immunity;immunology;t cells
Contribution rapid lateral flow assay capillary blood specimen diagnosis COVID19 symptomatic healthcare worker pilot study university hospital Paris France,34229244,BACKGROUND study aimed ass rapid test immune status COVID19 among Healthcare Workers HCW history symptom SARSCoV2 detection either documented negative METHODS Whole blood finger prick serum sample taken HCW use 2 rapid lateral flow test automated immunoassay RESULTS Seventytwo HCWs included median duration symptom onset serology sampling 68 day AntiSARSCoV2 antibody detected rapid test 11 HCW 153 confirmed 10 available serum automated immunoassay frequency ageusia anosmia higher participant SARSCoV2 antibody P = 00006 P = 0029 respectively CONCLUSIONS study among symptomatic HCW first wave France showed 15 IgG antiSARSCoV2 higher seroprevalence general population Rapid lateral flow test highly concordant automated immunoassay,sars-cov-2;healthcare workers;rapid lateral flow test;serology
Management Outcomes Coronavirus Disease 2019 Infection Series Neurosurgical Patients,34211871,Background coronavirus disease 2019 COVID19 pandemic impacted neurosurgical practice worldwide Iran hospital halted routine activity hospital bed assigned COVID19 patient share experience 10 neurosurgical case confirmed COVID19 Materials Methods February 24 2020 April 20 2020 able obtain clinical data ten neurosurgical patient COVID19 predefined electronic form Results 10 patient COVID19 neurosurgical unit eight underwent surgical intervention age patient ranged 21 75 year 70 male diagnosis COVID19 based chest imaging finding reverse transcriptasepolymerase chain reaction coronavirus infectious disease specialist pulmonologist confirmed diagnosis two case significant decrease O2 saturation intraoperatively Three patient series died assessment period One death due respiratory failure induced coronavirus infection cause death two patient cardiovascular failure related COVID19 Conclusions hope provide reference future study help develop clearer understanding neurosurgical practice outcome patient COVID19 time COVID19 pandemic dealing neurosurgical emergency conservative approach recommended Using committed personal protective equipment shorttime operating procedure minimally invasive surgery must considered management emergent patient Resuming elective surgery need defining measure needed ensure patient healthcare provider safety Reorganizing healthcare system telemonitoring released patient lessen hospital visit,coronavirus;coronavirus disease 2019;neurosurgery
Challenges interpreting cytokine data COVID19 affect patient care management,34358229,Challenges using cytokine data limiting Coronavirus Disease 2019 COVID19 patient management comparison among different disease context suggest mitigation strategy improve accuracy cytokine data learn experience gained COVID19 pandemic,
Testicular Pain Mesenteric Adenitis Atypical Presentation COVID19,34211816,21yearold Caucasian male past medical history presented emergency department right lower quadrant pain radiating right testicle two day reported occasional dry cough day denied fever infectious symptom patient afebrile normal physical examination CT abdomen pelvis showed prominent right lower quadrant lymphadenopathy Viral panel common respiratory pathogen returned negative nasopharyngeal swab SARSCoV2 Xpert R Xpress SARSCoV2 reverse transcriptasepolymerase chain reaction Cepheid Inc Sunnyvale CA positive patient remained quarantine 14 day reevaluated seven week later spontaneous resolution abdominal pain continued absence upper respiratory symptom repeat CT scan seven week later showed persistent mesenteric lymphadenopathy Repeat COVID19 testing performed time frequency atypical presentation COVID19 remains unknown healthcare provider must continue remain vigilant consider COVID19 differential diagnosis patient presenting emergency department despite lack respiratory gastrointestinal symptom research warranted examine possibility asymptomatic spread asymptomatic patient persistent radiologic finding ass whether repeat COVID19 testing warranted patient,asymptomatic covid-19;covid-19;mesenteric adenitis;sars-cov-2 (severe acute respiratory syndrome coronavirus -2);testicular pain
Rhinoorbital mucormycosis following COVID19 previously nondiabetic immunocompetent patient,34338124,PURPOSE report series 13 immunocompetent patient developed newonset uncontrolled diabetes mellitus DM following COVID19 infection presented rhinoorbital mucormycosis ROM METHOD Retrospective study RESULTS total 127 patient COVID19 Associated Mucormycosis CAM evaluated four centre India patient underwent endoscopic sinus debridement surgery received systemic amphotericinB therapy Five patient 513 384 received retrobulbar amphotericinB injection Orbital exenteration performed advanced orbital involvement progression orbital disease spite maximal medical therapy cohort 13127 102 patient presented new onset DM one patient bilateral disease mean age 359 year range 2051 year mean duration diagnosis COVID19 diagnosis mucormycosis 142 day 713 538 patient received systemic corticosteroid course treatment COVID19 six patient received steroid immunomodulators mean followup period 92 week range 318 week following discharge Life salvage possible 100 case overall globe salvage possible 428 614 eye globe could preserved 45 patient received retrobulbar amphotericinB injection CONCLUSIONS involved care COVID19 patient aware possibility recentonset DM even patient without history corticosteroid therapy Rarely recentonset DM following COVID19 may present rhinoorbital mucormycosis requires aggressive surgical medical intervention,coronavirus;rocm;fungal sinusitis;immunocompetent;rhino-orbito-cerebral
Prevalence Clinical Features Skin Irritation Caused Infection Prevention Measures COVID19 Mecca Region Saudi Arabia,34285535,Purpose Due COVID19 pandemic recommendation prevent infection suggest increasing frequency handwashing disinfection however measure negative implication skin study aim evaluate whether measure correlate newonset skin damage exacerbate hand eczema among general population Materials Methods descriptive crosssectional surveybased study including general population Mecca region Saudi Arabia achieve study s aim online questionnaire general population comprising 25 item distributed via social medium apps pandemic October 23 November 21 2020 Data automatically collected Excel entered SPSS analysis Results total 783 participant included study 695 888 female history hand eczema reported among 123 157 participant 270 345 history atopy COVID19 pandemic 86 130 participant noticed newonset skin irritation 81 313 participant reported exacerbation earlier hand allergic dermatitis frequent symptom dryness feeling tightness Additionally participant among group noticed skin lesion appeared le 10 day frequent handwashing statistically increased following onset pandemic p=0001 association newonset symptom frequent handwashing well use hand disinfectant pandemic p=0001 Conclusion study suggests general population s skin negatively affected COVID19 precaution particularly history hand eczema recommend spreading awareness skin protective modality use new infection prevention measure regular skin moisturization hand protection possibly using le damaging skin disinfectant like ozonized water provided scientifically proven effective disinfecting COVID19 virus,covid-19 pandemic;general population;hand eczema;precautions;questionnaire;skin
Effects COVID19 prevention procedure common infection systematic review,34217366,INTRODUCTION Since outbreak severe acute respiratory syndrome coronavirus2 SARSCoV2 began necessary measure prevent virus transmission reduce mortality implemented including mandatory public use mask regular handsanitizing handwashing social distancing avoidance crowd remote work cancellation public event introduction COVID19 lockout performed systematic review available published literature investigate incidence seasonal influenza respiratory viral infection METHODS PubMed Embase Web Science Scopus Science Direct Google Scholar Research Gate World Health Organization database website systematically searched original study concerning impact COVID19 prevention mean measure common respiratory infectious disease pandemic published March 2021 RESULTS finding showed adherence health protocol prevent COVID19 could help reduce incidence infectious disease influenza pneumonia Mycobacterium tuberculosis CONCLUSION implemented prevention measure protocol might reduced incidence influenza common respiratory infection However controversy exist matter future large populationbased study might provide information address controversy,covid-19;infection;prevention;sars-cov-2
SARSCoV2 Variants Immunocompromised Patient Given Antibody Monotherapy,34352197,72yearold immunocompromised man infected severe acute respiratory syndrome coronavirus 2 received bamlanivimab monotherapy Viral evolution monitored nasopharyngeal blood sample melting curve analysis singlenucleotide polymorphism wholegenome sequencing Rapid emergence spike receptor binding domain mutation found associated compartmentalization viral population,covid-19;sars-cov-2;bamlanivimab;compartmentalization;coronavirus disease;coronaviruses;immunotherapy;monoclonal antibody;monotherapy;respiratory infections;selection;severe acute respiratory syndrome coronavirus 2;variants;viruses;whole-genome sequencing;zoonoses
Associations COVID19 transmission rate park use landscape structure,34210524,COVID19 pandemic severe impact global public health England social distancing measure nationwide lockdown introduced reduce spread virus Green space accessibility may particularly important lockdown could provided benefit physical mental wellbeing However association public green space use rate COVID19 transmission yet quantified size accessibility green space vary within England s local authority risk benefit public using green space may contextdependent evaluate green space affected COVID19 transmission across 299 local authority small region England calculated daily case rate metric based upon sevenday moving average day within period June 1st November 30th 2020 assessed baseline health mobility variable influenced rate Next looking residual case rate investigated landscape structure eg area patchiness green space park use influenced transmission first show reducing mobility associated decline case rate especially area high population clustering accounting known mechanism behind transmission rate found park use showing preference park mobility associated decreased residual case rate especially green space low contiguous patchy result support reduction overall mobility may good strategy reducing case rate endorsing success lockdown measure However mobility necessary outdoor park use may safer form mobility associated activity eg shopping officebased working,covid;coronavirus;ecosystem services;fragmentation;green space;health;park use;public health
Direct Comparison Clinical Characteristics Outcomes Risk Prediction Patients COVID19 ControlsA Prospective Cohort Study,34204453,study investigating early risk predictor coronavirus disease 19 COVID19 lacked comparison control aimed ass directly compare outcome risk predictor time emergency department ED presentation COVID19 control Consecutive patient presenting ED suspected COVID19 prospectively enrolled COVID19patients compared patient tested negative overall control ii patient tested negative respiratory infection respiratory control Primary outcome composite intensive care unit ICU admission death 30 day Among 1081 consecutive case 191 18 tested positive severe acute respiratory syndrome coronavirus 2 SARSCoV2 890 82 tested negative overall control 323 30 respiratory infection respiratory control Incidence composite outcome significantly higher COVID19 23 compared overall control group 10 adjustedHR 245 95 CI 161374 p 0001 respiratory control group 10 adjustedHR 293 95 CI 166517 p 0001 Blood oxygen saturation age highsensitivity troponin creactive protein lactate dehydrogenase identified strongest predictor poor outcome available time ED presentation COVID19 highly comparable prognostic utility overall respiratory control conclusion patient presenting ED COVID19 worse outcome control even adjustment difference baseline characteristic predictor poor outcome COVID19 restricted COVID19 comparable prognostic utility control therefore generalizable unselected patient suspected COVID19,covid-19;sars-cov-2;characteristics;comparison;controls;outcome;risk prediction
SARSCoV2 Spike Protein Receptor Binding Domain Interact Effectively DPP4 CD26 Receptor Molecular Docking Study,34209788,ACE2 established main receptor SARSCoV2 Since human coronaviruses known use coreceptors viral cell entry suggested DPP4 CD26 could potential additional binding target coreceptor supported early molecular docking simulation study However recent biophysical study shown interaction weak conducted detailed molecular docking simulation predict potential binding interaction receptor binding domain RBD spike protein SARSCoV2 DPP4 compare interaction observed experimentally determined structure complex MERSCoV DPP4 Whilst overall binding mode RBD SARSCoV2 DPP4 predicted similar observed MERSCoVDPP4 complex including number equivalent interaction important difference amino acid sequence SARSCoV2 MERSCoV result substantially weakened interaction DPP4 shown arise difference predicted proximity nature secondary structure binding interface RBD SARSCoV2 finding support DPP4 significant receptor SARSCoV2,covid-19;dpp4;sars-cov-2;molecular interactions;receptor binding domain
Impact COVID19 Pandemic Gastroenterology Department Activity Gastroenterologist s Perspective Nationwide Real Impact Portuguese Center,34373841,Background Several gastroenterology society created recommendation order reduce nonessential exposure severe acute respiratory syndrome coronavirus 2 SARSCoV2 virus aim evaluate national gastroenterologist perspective impact COVID19 impact reorganization gastroenterology department COVID19 pandemic Methods first purpose online survey distributed gastroenterologist nationwide second purpose author conducted analysis endoscopic procedure performed Gastroenterology Department Centro Hospitalar Vila Nova de GaiaEspinho CHVNGE March 16 May 8 year 2019 2020 Results Sixtyseven gastroenterologist answered survey 149 resident 866 worked hospital COVID19 patient 164 assigned assist patient department suffered modification Ninety percent resident affirmed activity changed Ninetyfour percent declared nonessential endoscopic procedure postponed 851 maintained inperson medical visit 881 already remote consultation 119 clinical visit gastroenterology unit number endoscopic procedure decreased 731 2019 2020 2020 proportion urgent procedure higher compared 2019 Conclusion advent COVID19 led important change gastroenterology activity Portugal national gastroenterology unit complying recommendation Furthermore Portuguese gastroenterologist believed decrease endoscopic activity compromise resident education training gastroenterology department CHVNGE shown significant reduction number endoscopic procedure,covid-19 pandemic;endoscopy;gastroenterology department;medical education
Risk severe illness COVID19 patient NAFLD increased NAFLD fibrosis score,34213039,BACKGROUND still little knowledge association liver fibrosis clinical outcome COVID19 patient nonalcoholic fatty liver disease NAFLD aim study determine association NAFLD fibrosis score NFS determined liver fibrosis clinical outcome COVID19 patient NAFLD METHODS NAFLD diagnosed Hepatic Steatosis Index HSI absence cause chronic liver disease NFS used evaluate severity liver fibrosis RESULTS total 86 COVID19 patient NAFLD included median age 435 year 581 patient male Thirtyeight 442 patient advanced liver fibrosis according NFS Multivariate analysis indicated concurrent diabetes odds ratio 8264 95 confidence interval CI 120256830 p = 0032 advanced liver fibrosis 11057 95 CI 1193102439 p = 0034 independent risk factor severe illness COVID19 patient NAFLD CONCLUSION NAFLD patient NFSdetermined advanced liver fibrosis higher risk severe COVID19,covid-19;fibrosis;non-alcoholic fatty liver disease;severe illness
Fomites environment important role COVID19 transmission Brazilian midsized city,34354189,clear COVID19 indirectly transmitted possible conclude role environment transmission SARSCoV2 without studying area people transit great number work aimed better understand role environment spread COVID19 investigated presence SARSCoV2 fomite well air sewage using RTqPCR studied reference market area COVID19 reference hospital Barreiras city Brazil collected analyzed total 418 sample mask front cell phone paper money card machine sewage air bedding ascendant phase epidemiological curve COVID19 Barreiras result detected human RNAse P gene sample indicates presence human cell fragment specimen However detect trace SARSCoV2 sample analyzed conclude far environment inanimate material important role COVID19 transmission Barreiras city Therefore similar result probably found city mainly COVID19 epidemiological scenario similar Barreiras city study small piece indicating possibility fomite environment important role COVID19 transmission However study necessary better understand world scenario,
Usage eHealthmHealth Services among Young Czech Adults Impact COVID19 Explorative Survey,34281084,Various mHealtheHealth service play increasingly important role healthcare system personal lifestyle management Yet relative popularity service among young population Czech Republic known Therefore carried online survey convenience sample n = 299 young adult aged 1829 living Czech Republic end adapted survey instrument previously used similar study conducted different cultural context Hong Kong study found health tutorial activity ie acquiring information diet exercise fitness common among respondent = 281 SD = 114 followed health information seeking activity ie acquiring information medical problem = 263 SD = 089 medical service ie eHealthmHealth service provide infrastructural support ePrescription doctor appointment organizer = 218 SD = 097 Based grouping according gender existing health condition pairwise comparison showed statistically significant difference also briefly analyzed influence COVID19 pandemic examined activity Based relative popularity suggest leveraging potential health tutorial activity improve public health,consumer health data;consumer health information;mhealth apps;personal health informatics;quantified self;self-tracking
Case Series Multisystem Inflammatory Syndrome MISC Children SARSCoV2 Pandemic Latvia,34208057,total number COVID19 positive case Latvia escalated rapidly since October 2020 peaking late December 2020 early January 2021 Children generally develop COVID19 mildly adult however complicated multisystem inflammatory syndrome child MISC case study aim ass demographic characteristic underlying medical condition clinical investigative treatment data among 13 MISC patient using electronic medical record 13 acute illness contact someone COVID19 positive two six week MISC onset five 13 symptomatic acute COVID19 phase median age 88 year 1113 patient male 1013 previously healthy 13 patient tested positive SARSCoV2 RTPCR antibody testing commonly involved organ system gastrointestinal 1313 hematologic 1313 cardiovascular 1313 skin mucosa 1313 respiratory 1213 one median hospital stay 13 interquartile range 11 18 day 713 patient received intensive care 613 oxygen support 513 received inotropic support death occurred current pandemic every child fever clearly defined epidemiological history COVID19 careful clinical assessment possible multiple organsystem involvement special focus child severe abdominal pain andor skin mucocutaneous lesion,covid-19;sars-cov-2;multisystem inflammatory syndrome in children (mis-c)
multiclass COVID19 segmentation network pyramid attention edge loss CT image,34226836,end 2019 novel coronavirus COVID19 broke Due high contagiousness 74 million people infected worldwide Automatic segmentation COVID19 lesion area CT image effective auxiliary medical technology quantitatively diagnose judge severity disease paper multiclass COVID19 CT image segmentation network proposed includes pyramid attention module extract multiscale contextual attention information residual convolution module improve discriminative ability network wavelet edge loss function also proposed extract edge feature lesion area improve segmentation accuracy experiment dataset 4369 CT slice constructed including three symptom ground glass opacity interstitial infiltrates lung consolidation dice similarity coefficient three symptom model achieve 07704 07900 08241 respectively performance proposed network public dataset COVIDSemiSeg also evaluated result demonstrate model outperforms stateoftheart method powerful tool assist diagnosis positive infection case promote development intelligent technology medical field,
COVID Obesity OneYear Narrative Review,34208529,11 March 2020 coronavirus disease 2019 COVID19 declared pandemic World Health Organization study focus narrative review illness first year pandemic relation obesity Databases used search study published 8 December 2020 total 4430 article scientific literature found 24 article included oneyear narrative review mean BMI value severe COVID19 patient ranged 245 334 kgm 2 versus 185 243 kgm 2 nonsevere patient Articles using term obesity overweight without indicating BMI value patient common useful anthropometric parameter defined index confusing due classification different West compared among Asian Korean criteriabased adult proposed new term called COVID obesity define importance anthropometric parameter among others relation pandemic,bmi;covid obesity;covid-19;nutrition;obesity;overweight
Automated Reverse Transcription Polymerase Chain Reaction Data Analysis SarsCoV2 Detection,34292929,BACKGROUND severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic current public health concern Rapid diagnosis crucial reverse transcription polymerase chain reaction RTPCR presently reference standard SARSCoV2 detection OBJECTIVE Automated RTPCR analysis ARPA software designed analyze RTPCR data SARSCoV2 detection ARPA load RTPCR data classifies sample assessing amplification curve behavior evaluates experiment s quality generates report METHODS ARPA implemented R language deployed Shiny application evaluated performance ARPA 140 sample sample manually classified automatically analyzed using ARPA RESULTS ARPA truepositive rate = 1 truenegative rate = 098 positivepredictive value = 095 negativepredictive value = 1 36 sample correctly classified positive 100 sample correctly classified negative two sample classified positive even labeled negative manual inspection Two sample labeled invalid ARPA considered performance metric calculation CONCLUSIONS ARPA sensitive specific software facilitates analysis RTPCR data implementation reduce time required diagnostic pipeline,
Time series forecasting new case new death rate COVID19 using deep learning method,34221854,first known case Coronavirus disease 2019 COVID19 identified December 2019 spread worldwide leading ongoing pandemic imposed restriction cost many country Predicting number new case death period useful step predicting cost facility required future purpose study predict new case death rate one three sevenday ahead next 100 day motivation predicting every n day instead every day investigation possibility computational cost reduction still achieving reasonable performance scenario may encountered realtime forecasting time series Six different deep learning method examined data adopted website Three method LSTM Convolutional LSTM GRU bidirectional extension considered method forecast rate new case new death Australia Iran country study novel carry comprehensive evaluation aforementioned three deep learning method bidirectional extension perform prediction COVID19 new case new death rate time series best knowledge first time BiGRU BiConvLSTM model used prediction COVID19 new case new death time series evaluation method presented form graph Friedman statistical test result show bidirectional model lower error model several error evaluation metric presented compare model finally superiority bidirectional method determined research could useful organisation working COVID19 determining longterm plan,"anfis, adaptive network-based fuzzy inference system;ann, artificial neural network;au, australia;bi-conv-lstm, bidirectional convolutional long short term memory;bi-gru, bidirectional gated recurrent unit;bi-lstm, bidirectional long short-term memory;bidirectional;covid-19 prediction;covid-19, coronavirus disease 2019;conv-lstm, convolutional long short term memory;convolutional long short term memory (conv-lstm);dl, deep learning;dlstm, delayed long short-term memory;deep learning;emro, eastern mediterranean regional office;es, exponential smoothing;ev, explained variance;gru, gated recurrent unit;gated recurrent unit (gru);ir, iran;lr, linear regression;lstm, long short-term memory;lasso, least absolute shrinkage and selection operator;long short term memory (lstm);mae, mean absolute error;mape, mean absolute percentage error;mers, middle east respiratory syndrome;ml, machine learning;mlp-ica, multi-layered perceptron-imperialist competitive calculation;mse, mean square error;msle, mean squared log error;machine learning;new cases of covid-19;new deaths of covid-19;prisma, preferred reporting items for precise surveys and meta-analyses;rmse, root mean square error;rmsle, root mean squared log error;rnn, repetitive neural network;relu, rectified linear unit;sars, serious intense respiratory disorder;sars-cov, sars coronavirus;sars-cov-2, serious intense respiratory disorder coronavirus 2;svm, support vector machine;vae, variational auto encoder;who, world health organization;wpro, western pacific regional office"
Emerging Evidence Pleiotropism Eosinophils,34209213,Eosinophils complex granulocyte capacity react upon diverse stimulus due numerous variable surface receptor allows respond different manner Traditionally believed part parasitic allergicasthmatic immune response scientific study arise paradigm cell continuously changing adding layer complexity role homeostasis disease Developing principally bone marrow action IL5 granulocyte macrophage colonystimulating factor GMCSF eosinophil migrate blood different organ performing multiple function tissue homeostasis gastrointestinal tract thymus uterus mammary gland liver skeletal muscle organ lung gastrointestinal tract eosinophil able act immune regulatory cell also perform direct action parasite bacteria novel mechanism immune defense extracellular DNA trap key factor Besides eosinophil importance effective response viral pathogen nuclease enzymatic activity lately described involved severe acute respiratory syndrome coronavirus SARSCoV2 immunity pleiotropic role eosinophil sustained eosinophil also detrimental human physiology example disease like allergy asthma eosinophilic esophagitis exosomes significant pathophysiologic unit eosinophilic pathology require specific treatment eosinophil control new monoclonal antibody like mepolizumab reslizumab benralizumab review describe role eosinophil effector regulatory cell involvement pathological disorder treatment,biologic treatment;eosinophil;eosinophil extracellular traps;sub-phenotypes
Signatures Venezuelan Humanitarian Crisis First Wave COVID19 Fuel Shortages Border Migration,34358135,Testing isolation crucial controlling COVID19 pandemic Venezuela one weakest testing infrastructure Latin America low number reported case country attributed substantial underreporting However Venezuelan epidemic seems lagged behind country region case occurring within capital region four border state describe spatial epidemiology COVID19 Venezuela relation population mobility migration pattern nonpharmaceutical intervention fuel availability impact population movement Using metapopulation model SARSCoV2 transmission dynamic explore movement pattern could driven observed distribution case Low withincountry connectivity likely delayed onset epidemic state except bordering Colombia Brazil high immigration seeded outbreak NPIs slowed early epidemic growth subsequent fuel shortage appeared responsible limiting spread COVID19 across country,sars-cov-2;sei models;venezuela;drivers of transmission;metapopulations;spatial incidence
Rapid determination infectious SARSCoV2 PCRpositive sample SDSPMA assisted RTqPCR,34293609,ongoing COVID19 pandemic generated global health crisis need well management patient also environment reduce SARSCoV2 transmission gold standard RTqPCR method sensitive rapid detect SARSCoV2 nucleic acid answer PCRpositive sample contain infectious virion circumvent problem report SDSpropidium monoazide PMA assisted RTqPCR method enables rapid discrimination live dead SARSCoV2 within 3 h PMA photoreactive dye react viral RNA released inside inactivated SARSCoV2 virion assistance 0005 SDS viral RNA inside live virion Formation PMARNA conjugate prevents PCR amplification leaving infectious virion detected optimum condition RTqPCR detection heatinactivated SARSCoV2 resulted larger 9 Ct value difference PMAtreated PMAfree group le 05 Ct difference observed detection infectious SARSCoV2 ranging 20 5148 viral particle Using cutoff Ct difference 86 method could differentiate low 8 PFU live virus mixture live heatinactivated virion experiment showed method could successfully monitor natural inactivation process SARSCoV2 plastic surface storage comparable result gold standard plaque assay believe culturefree method established could used rapid convenient determination infectious SARSCoV2 virion PCRpositive sample facilitate better control SARSCoV2 transmission,covid-19;inactivation;infectious particles;pma;rt-qpcr;sars-cov-2
Current Understanding Multisystem Inflammatory Syndrome MISC Following COVID19 Distinction Kawasaki Disease,34216296,PURPOSE REVIEW article reviewed current report explore difference similarity multisystem inflammatory syndrome child MISC known multisystem inflammatory disease seen child particularly Kawasaki disease RECENT FINDINGS Severe acute respiratory syndrome coronavirus 2 SARSCoV2 human coronavirus causing COVID19 disease emerged China December 2019 spread rapidly entire country quickly country Currently pandemic SARSCoV2 infection result 20 patient admitted hospital illness 3 developing intractable acute respiratory distress syndrome ARDS high mortality However pediatric COVID19 still reported mild disease affecting 8 child Pathogenesis child comparable adult suggested impaired activation IFNalpha IFN regulator 3 decreased cell response causing impaired viral defense yet clinical course mild almost child recover infection without major complication Interestingly subset patient develop late marked immunogenic response COVID19 develop MISC Clinical feature MISC resemble certain pediatric rheumatologic disease Kawasaki disease mucocutaneous lymph node syndrome affect smallmedium vessel feature MISC resemble macrophage activation syndrome MAS However recent research suggests distinct clinical laboratory difference MISC Kawasaki disease MAS Since start SARSCoV2 pandemic MISC become candidate common cause acquired heart disease child,covid-19;kawasaki;mis-c;macrophage activation syndrome (mas);sars-cov2
COVID19 positivity rate hospitalization mortality adult without intellectual developmental disability Ontario Canada,34340949,BACKGROUND Across within country need understand COVID19 pandemic impacted population individual intellectual developmental disability IDD OBJECTIVE Rates COVID19 positivity adult IDD including syndrome relative adult without IDD Ontario Canada compared Health profile casebased rate hospitalization intensive care unit admission mortality within 30 day testing positively compared IDD including syndrome versus without IDD METHODS retrospective cohort study linked health administrative database using unique encoded identifier describe populationlevel COVID19 positivity related hospital use mortality January 15 2020 January 10 2021 Incidence rate ratio RR 95 confidence interval calculated RESULTS Relative adult without IDD COVID19 positivity rate 128 time higher adult IDD 142 time higher adult syndrome Compared adult without IDD adult IDD twice likely hospitalized following COVID19 RR221 95 CI 193254 die RR223 95 CI 186267 RRs greater adult 65 adult syndrome mortality rate 659 95 CI 451962 time higher without IDD DISCUSSION Ontario Canada hospitalization mortality rate associated COVID19 higher adult IDD adult finding inform vaccination strategy often prioritize older adult general population resulting people IDD often younger age group overlooked,covid-19;down syndrome;hospitalizations;intellectual and developmental disabilities;mortality
Impact sewer overflow public health comprehensive scientometric analysis systematic review,34216613,Sewer overflow attracted global attention pose serious threat public health ecosystem impact public health via consumption contaminated drinking water aerosolization pathogen foodchain transmission direct contact fecallypolluted river beach sediment recreation However study attempted map linkage public health including Covid19 using scientometric analysis systematic review literature Results showed country actively involved research relation public health Furthermore renewed call scale environmental surveillance safeguard public health safeguard public health important public health authority optimize water wastewater treatment plant improve building ventilation plumbing system minimize pathogen transmission within building transportation system addition health authority formulate appropriate policy enhance environmental surveillance facilitate realtime monitoring sewer overflow Increased public awareness strict personal hygiene pointofusewatertreatment boiling drinking water go long way safeguard public health Ecotoxicological study health risk assessment exposure pathogen via different transmission route also required appropriately inform use lockdown minimize socioeconomic impact guide evidencebased welfaresocial policy intervention Soft infrastructure optimized sewer maintenance prescreening sewer overflow recommended reduce stormwater burden wastewater treatment plant curtail pathogen transmission marine plastic pollution Comprehensive integrated surveillance global collaborative effort important curtail ongoing Covid19 pandemic improve resilience future pandemic,covid-19;public health;scientometric analysis;sewer overflow;systematic review
Characteristics Survival Intensive Care Unit Patients Coronavirus Disease Osaka Japan Retrospective Observational Study,34204934,epidemiological clinical characteristic treatment outcome patient coronavirus disease 2019 COVID19 admitted intensive care unit ICU adequately evaluated Japan analyzed registry data 205 patient COVID19 admitted ICU February November 2020 Osaka Prefecture Japan Cox proportional hazard model used ass association epidemiological factor mortality among ICU patient 205 ICU patient 161 785 men 149 727 older 60 year total 117 patient 571 comorbidities common symptom diagnosis mild n = 131 639 total 187 patient 912 received mechanical ventilation 32 patient 156 required extracorporeal membrane oxygenation Patients followed median 25 day ICU admission total 147 patient 717 alive discharge 58 patient 283 died hazard ratio mortality among patient aged 80 year 602 95 confidence interval 2101725 multivariable model higher among aged =59 year result useful recognizing clinical course infection ICU patient,covid-19;japan;age;intensive care unit (icu);mortality;survival analysis
State art nonthermal plasma processing biomedical application help fight viral pandemic like COVID19,34220401,Plasma processing find widespread biomedical application design biosensors antibiofouling surface controlled drug delivery system plasma sterilizer present coronavirus disease COVID19 situation prospect applying plasma process like surface activation plasma grafting plasmaenhanced chemical vapor depositionplasma polymerization surface etching plasma immersion ion implantation crosslinking plasma decontamination provide timely solution form better antiviral alternative practical diagnostic tool reusable personal protective equipment worth exploring Herein role nonthermal plasma contribution toward healthcare timely reviewed engage different community assisting healthcare associate clinician combat current COVID19 pandemic also prevent similar kind future outbreak,covid-19;antibiofouling;biomedical applications of plasmas;biosensors;plasma decontamination;plasma-enhanced chemical vapor deposition
Implementation lung ultrasound low middleincome country new challenge global health,34216270,Pneumonia remains leading cause death globally child age five poorest child one risk dying recent year lung ultrasound widely documented safe easy tool diagnosis monitoring pneumonia several respiratory infection disease pandemic played primary role achieve early suspicion prediction severe COVID19 reducing risk exposure healthcare worker positive patient However innovation improve diagnosis treatment allocation saving hundred thousand life year reaching need paper discus advantage limit different tool diagnosis pneumonia low middleincome country highlighting potential benefit wider access lung ultrasound setting barrier implementation calling international organization ensure indiscriminate access quality sustainability provision ultrasound service every setting Known Pneumonia remains leading cause death globally child age five poorest child one risk dying recent year lung ultrasound widely documented safe easy tool diagnosis monitoring pneumonia several respiratory infection disease pandemic played primary role achieve early suspicion prediction severe COVID19 reducing risk exposure healthcare worker positive patient However innovation improve diagnosis treatment allocation saving hundred thousand life year reaching need New discus advantage limit different tool diagnosis pneumonia low middleincome country highlighting potential benefit wider access lung ultrasound setting barrier implementation calling international organization ensure indiscriminate access quality sustainability provision ultrasound service every setting,alrti;children;global health;lmcis;low- to middle-income countries;lung ultrasound;personalized medicine;pneumonia
Neutralising capacity Delta B16172 variant concern following Comirnaty BNT162b2 BioNTechPfizer vaccination health care worker Israel,34212838,SARSCoV2 Delta B16172 variant concern VOC VOCs spreading Europe Microneutralisation assay serum obtained Comirnaty BNT162b2 BioNTechPfizer vaccination 36 healthcare worker 31 female demonstrated significant fold change reduction neutralising titre compared original virus Gamma P1 23 Beta B1351 104 Delta 21 26 reduction Alpha B117 variant significant Despite lower remaining neutralisation capacity conferred Comirnaty Delta VOCs probably protective,b.1.617.2 (delta);bnt162b2 vaccination;covid-19;neutralizing;variants
Insilico study effect SARSCoV2 RBD hotspot mutant interaction ACE2 understand binding affinity stability,34217923,fall 2020 brought several new variant SARSCoV2 circulating across globe steadily increasing COVID19 case responsible emergence variant SARSCoV2 variant reported date multiple mutation spike protein specifically receptorbinding domain RBD employed integrated computational approach involving structure sequence based prediction study effect naturally occurring variation SRBD stability ACE2 binding affinity hotspot stabilizing residue mutation N501I N501Y Q493L Q493H K417R strengthen RBDACE2 complex modulating interaction statistic interface Thus report critical mutation could increase binding affinity SARSCoV2 RBD ACE2 increasing viral infectivity pathogenicity Understanding effect mutation help developing potential vaccine therapeutic,covid-19;hotspot residues;mutation;rbd-ace2 interactions;receptor binding domain;sars-cov-2;sars-cov-2 variants;spike protein
Placental expression ACE2 TMPRSS2 maternal SARSCoV2 infection placental defense mediated fetal sex,34293137,BACKGROUND Sex difference vulnerability severity SARSCoV2 infection described nonpregnant population ACE2 TMPRSS2 host molecule required viral entry regulated sex steroid expressed placenta sought investigate whether placental ACE2 TMPRSS2 expression vary fetal sex presence maternal SARSCoV2 infection METHODS Placental ACE2 TMPRSS2 quantified 68 pregnant individual 38 SARSCoV2 positive 30 SARSCoV2 negative delivering Mass General Brigham April June 2020 Maternal SARSCoV2 status determined nasopharyngeal RTPCR Placental SARSCoV2 viral load quantified RTqPCR performed quantify expression ACE2 TMPRSS2 relative reference gene YWHAZ Western blot performed placental homogenate quantify protein level impact fetal sex SARSCoV2 exposure ACE2 TMPRSS2 expression analyzed 2way ANOVA RESULTS SARSCoV2 virus undetectable placenta Maternal SARSCoV2 infection impacted TMPRSS2 placental gene protein expression sexually dimorphic fashion 2way ANOVA interaction pvalue 0002 observed impact fetal sex maternal SARSCoV2 status placental ACE2 gene protein expression Placental TMPRSS2 expression significantly correlated ACE2 expression male Spearman s rho=054 p=002 female rho=023 p=034 exposed maternal SARSCoV2 CONCLUSIONS Sex difference placental TMPRSS2 ACE2 observed setting maternal SARSCoV2 infection finding may implication offspring vulnerability placental infection,angiotensin-converting enzyme 2;covid-19;sars-cov-2;type ii transmembrane serine protease;infection;placenta;sex differences;transplacental transmission;vertical transmission
Artificial intelligence Potential tool subside SARSCoV2 pandemic,34366689,Artificial intelligence AI method simulating human brain order complete task effective manner numerous implementation field manufacturing sector digital electronics Despite potential AI may obstinate assume person administered society would rely solely AI example healthcare field everexpanding discovery made regular basis regarding growth various disease preservation utilizing brain power may deemed essential nt leave AI redundant asset year accumulated data regarding pattern analysis various medical circumstance algorithm formed could assist situation diagnosis support population health management matter becomes even relevant today s society currently ongoing COVID19 pandemic SARSCoV2 uncertainty pandemic strain variant rolling speed vaccine AI could utilized advantage order assist u fight COVID19 review briefly discus application AI COVID19 situation various health benefit,artificial intelligence;coronavirus;deep learning;epidemic;machine learning
Characterization Fed Cattle Mobility COVID19 Pandemic,34208118,COVID19 pandemic significant consequence cattle slaughter capacity United States Although industry stakeholder implemented strategy minimize cattle welfare impact increased weight day feed DOF increasing temperature concern mobility challenge would observed slaughter facility objective study characterize mobility fed cattle recovery period identify factor impacting mobility total 158 group cattle 15388 animal one slaughter facility included study 4point mobility scoring system used ass cattle mobility Cattle facility normal mobility score reduced historical average 9619 7455 increase highly elevated mobility score observed Mobility impacted weight temperature humidity index THI distance hauled sex DOF result differing mobility category Weather key contributor mobility challenge relative risk observing elevated mobility score 4576 greater THI changed Stress Mild Stress Despite challenge industry faced period effort minimize negative effect cattle welfare enhanced focus lowstress handling effective,covid-19;cattle;days on feed;feedlot;mobility;welfare
Respiratory Protection Effect Earlooptype KF94 Masks according Wearing Method COVID19 Pandemic Randomized Openlabel Study,34282608,BACKGROUND Earlooptype Korean Filter 94 mask KF94 mask equivalent N95 FFP2 broadly used health care setting Korea coronavirus disease 2019 pandemic METHODS prospective randomized openlabel study designed identify difference fitting performance mask wearing method three different type KF94 mask ear loop January March 2021 Generalfitting involved wearing earlooptype KF94 mask tightfitting involved wearing mask aided clip connecting ear loop 30 participant wore three type mask according randomly assigned order method performed total six quantitative fit test QNFTs according occupational safety health administration protocol RESULTS fit factor FFs measured QNFT significantly higher tightfitting method clip KF94 mask P 0001 However total FFs low median interquartile range 6 323 29 9116 generalfitting tightfitting respectively wearing tightly horizontal 3fold type mask adjustable earloop length highest FF median 125 QNFT pas rate FF = 100 increased significantly 4 13 18 60 CONCLUSION Even sufficient filter efficiency earlooptypeKF94 mask provide adequate protection However relatively lowrisk environment wearing faceseal adjustable KF94 mask tight wearing clip improve respiratory protection healthcare worker TRIAL REGISTRATION ClinicalTrialsgov Identifier NCT04794556,covid-19;infection control;kf94 mask;n95 filtering facepiece respirators;quantitative fit test;respiratory protective devices
association ABO blood group asymptomatic COVID19 case India,34366234,COVID19 pandemic resulted multiple wave infection worldwide large variation case fatality rate among different geographical region suggest human susceptibility virus varies substantially Several study different part world showed significant association ABO blood group COVID19 susceptibility demonstrated individual blood group lower risk coronavirus infection establish association ABO blood group SARSCoV2 susceptibility first time analysed SARSCoV2 neutralising antibody among 509 individual collected three major district Eastern Uttar Pradesh region India Interestingly found neutralising antibody significantly higher percentage people blood group AB 036 followed B 031 022 lowest people blood group 011 estimated people blood group AB comparatively higher risk infection blood group Thus among asymptomatic SARSCoV2 recovered people blood group AB highest whilst individual blood group lowest risk infection,asymptomatic;blood group;covid-19;coronavirus;india
Prioritizing pregnant woman COVID19 vaccination,34227102,Despite emerging evidence safety efficacy country offer COVID19 vaccine pregnant woman even though higher risk complication COVID19 performed web search COVID19 vaccination policy pregnant woman two category country bearing high burden COVID19 case country high burden maternal underfive mortality top 20 country affected COVID19 11 allow vaccination pregnant woman two deemed safe vaccinate pregnant woman highrisk group contrast five 20 country high underfive mortality maternal mortality allow vaccination pregnant woman none country included part highrisk group vaccinated India Indonesia onefifth world s population fall category include pregnant woman priority group COVID19 vaccination prevent COVID19 aggravating already heavy burden maternal underfive mortality strong case including pregnant woman highpriority group COVID19 vaccination recommend including COVID19 vaccination routine antenatal care country particularly India Indonesia view high dual burden,covid-19;dual burden of disease;maternal mortality;pregnancy;under-five mortality;vaccination
Acute graftversushost disease liver transplantation close contact COVID19 case report,34216759,Acute graftversushost disease aGVHD rare complication liver transplantation characterized high mortality presented case aGVHD orthotopic liver transplantation OLT hepatocellular carcinoma HCC patient suffered fever oral ulcer rash diarrhea coinfection Cytomegalovirus CMV Short tandem repeat STR analysis cluster differentiation CD3 cell skin biopsy indicated aGVHD regimen included high dose steroid ruxolitinib basiliximab local liver radiotherapy antibiotic prophylaxis withdrawal tacrolimus MMF Unfortunately developed acute rejection followed cytomegalovirus infection lung infection Soon afterwards sent `` isolation ward due high suspicion clinical coronavirus disease 2019 COVID19 Fortunately excluded COVID19 nucleic acid antibody test Though closely contact COVID19 patient month patient affected COVID19 careful protective measure Finally patient recovered antiviral antifungal treatment knowledge first case report patient recovered aGVHD close contact,covid-19;close contact;orthotopic live transplantation;agvhd
iceberg COVID19 Results rapid literature review,34291001,Background Given various report clinical spectrum disease aim present study determine possible scenario Coronavirus 2019 COVID19 iceberg using published article Methods present study rapid review international database including PubMed Medline Scopus Web Sciences Embase Cochrane Library January 1 October 30 2020 Results review 7 scenario considered COVID19 iceberg range fatality percentage estimated 05 7 range asymptomatic case 1 886 range case mild symptom 8 78 symptom 1 90 range intensive care unit ICU admission 05 142 finally intubation percentage estimated 02 122 Scenarios Diamond Princess Cruise Ship Iceland closer reality clinical spectrum COVID19 around world represent 06 05 death 07 1 intubation 25 97 ICU admission 11 6 hospitalization 15 31 case mild symptom finally 569 75 asymptomatic case COVID19 respectively considered basis clinical knowledge disease Conclusion Understanding clinical spectrum natural knowledge disease paying attention asymptomatic mildsymptom case help make better decision develop effective intervention control COVID19,best estimates;covid 19;clinical spectrum;iceberg;natural knowledge;rapid review
FirstDose Coronavirus 2019 Vaccination Coverage among Residents LongTerm Care Facilities France,34380133,BACKGROUND Longterm care facility LTCFs experienced severe burden Coronavirus 2019 COVID19 vaccination SARSCoV2 major issue resident OBJECTIVE objective study estimate vaccination coverage rate among resident French LTCFs METHOD Participants setting 53 medical coordinator surveyed 73 LTCFs firstdose vaccination campaign using BNT162b2 vaccine conducted health authority January early February 2021 MEASUREMENTS resident LTCF beginning campaign investigator recorded age sex history clinical asymptomatic COVID19 serology SARSCoV2 severe allergy current endoflife situation infectious acute disease refusal vaccination resident representative person vaccine final status vaccinated RESULTS Among 4808 resident average coverage rate COVID19 vaccination 69 46 LTCFs coverage rate 70 Among unvaccinated resident observed frequently history COVID19 positive serology SARSCoV2 446 vs 112 among vaccinated resident p 0001 history severe allergy 37 vs 01 p 0001 endoflife situation 49 vs 03 p 0001 current infectious acute illness 196 vs 03 p 0001 refusal vaccination resident representative person 389 vs 04 p 0001 CONCLUSIONS 3 10 resident remained unvaccinated half LTCFs coverage rate 70 suggests COVID19 remain threat many LTCFs vaccination campaign,coronavirus-19;long-term care facility;vaccine coverage
Impact COVID19 Pandemic Trauma Encounters,34219502,OBJECTIVES Coronavirus Disease 2019 pandemic affected health care system significantly compare 2019 2020 evaluate trauma encounter changed pandemic METHODS Retrospective analysis using large US health care system compare trauma demographic volume mechanism injury outcome Statistical analysis used evaluate significant difference comparing 2019 2020 RESULTS Data collected 88 hospital across 18 state 169 892 patient included study 63 fewer trauma patient encounter 2020 compared 2019 Mechanism injury significantly different 2019 2020 le blunt injury 8964 vs 8839 P 001 burn injury 184 vs 200 P = 021 penetrating injury 858 vs 975 P 001 Compared 2019 patient 2020 higher mortality 262 vs 288 P 001 longer hospital LOS 392 + 690 vs 406 + 656 P 001 CONCLUSION COVID19 pandemic significantly affected trauma patient demographic LOS mechanism injury mortality,special topics;trauma;trauma acute care
Prediction model spread COVID19 outbreak global environment,34226882,COVID19 long become worldwide pandemic responsible death two million people posed economic recession paper study spread pattern COVID19 aiming establish prediction model event harness Data Mining Machine Learning methodology train regression model predict number confirmed case spatialtemporal space introduce innovative concept Center Infection Mass CoIM adapted field physic empirically evaluated model western European country based CoIM index feature showed relatively high accurate prediction spread obtained contribution twofold first introduced prediction methodology proved empirically prediction made even range month second showed promise adopting CoIM index prediction model model adopt CoIM yield significantly better result discard applying model better controlling inherent tradeoff lifesaving economy believe decisionmakers take close optimal measure Thus methodology may contribute public welfare,covid-19;data mining;decision support systems;machine learning;prediction methods
Imatinib STI571 Inhibits Expression AngiotensinConverting Enzyme 2 Cell Entry SARSCoV2Derived Pseudotyped Viral Particles,34203261,group clinically approved cancer therapeutic tyrosine kinase inhibitor screened test effect expression angiotensinconverting enzyme 2 ACE2 cell surface receptor SARSCoV2 show receptor tyrosine kinase inhibitor imatinib also known STI571 Gleevec inhibit expression endogenous ACE2 gene transcript protein level Treatment imatinib resulted inhibition cell entry viral pseudoparticles Vpps cell culture FVB mouse orally fed imatinib tissue expression ACE2 reduced specifically lung renal tubule parenchyma organ heart intestine finding suggests receptor tyrosine kinase play role COVID19 infection therapeutic target combined treatment best conventional care COVID19,ace2;covid-19;imatinib;tyrosine kinase
Generating hardtoobtain information easytoobtain information Applications drug discovery clinical inference,34286302,Often biological entity measured multiple way distinct category information information easytoobtain information EI gathered virtually every subject interest information hardtoobtain information HI gathered propose building model make probabilistic prediction HI using EI feature mapping GAN FMGAN based conditional GAN framework us embedding network process condition part conditional GAN training create manifold structure readily present condition experiment generating RNA sequencing cell line perturbed drug conditioned drug s chemical structure generating FACS data clinical monitoring variable cohort COVID19 patient effectively describing immune response great detail,clinical data monitoring;conditional generative models;drug perturbations;generative adversarial networks
Supervised Molecular Dynamics SuMD Insights mechanism action SARSCoV2 main protease inhibitor PF07321332,34289752,chemical structure PF07321332 first orally available Covid19 clinical candidate recently revealed Pfizer information provided interaction pattern PF07321332 biomolecular counterpart SARSCoV2 main protease pro present work exploited Supervised Molecular Dynamics SuMD simulation elucidate key feature characterise interaction drug candidate protease emphasising similarity difference structurally related inhibitor Boceprevir PF07304814 structural insight provided SuMD hopefully able inspire rational discovery potent selective protease inhibitor,covid-19;pf-07321332;sars-cov-2;sumd
Differential Diagnosis COVID19 Pneumonia Influenza H1N1 Pneumonia Using Model Based Clinicoradiologic Features,34211983,Objectives coronavirus disease 2019 COVID19 pneumonia influenza H1N1 pneumonia highly contagious disease aimed characterize initial computed tomography CT clinical feature develop model differentiating COVID19 pneumonia H1N1 pneumonia Methods total enrolled 291 patient COVID19 pneumonia January 20 February 13 2020 97 patient H1N1 pneumonia May 24 2009 January 29 2010 two hospital Patients randomly grouped primary cohort validation cohort using seventothree ratio clinicoradiologic data admission compared clinicoradiologic feature optimized least absolute shrinkage selection operator LASSO logistic regression analysis generate model differential diagnosis Receiver operating characteristic ROC curve plotted assessing performance model primary validation cohort Results COVID19 pneumonia mainly presented peripheral distribution pattern 262291 900 contrast H1N1 pneumonia commonly presented peribronchovascular distribution pattern 5297 536 LASSO logistic regression peripheral distribution pattern older age lowgrade fever slightly elevated aspartate aminotransferase AST associated COVID19 pneumonia whereas peribronchovascular distribution pattern centrilobular nodule treeinbud sign consolidation bronchial wall thickening bronchiectasis younger age hyperpyrexia higher level AST associated H1N1 pneumonia primary validation cohort LASSO model containing eight clinicoradiologic feature yielded area curve AUC 0963 0943 sensitivity 897 862 specificity 897 897 accuracy 897 871 respectively Conclusions Combination distribution pattern category pulmonary opacity chest CT clinical feature facilitates differentiation COVID19 pneumonia H1N1 pneumonia,computed tomography;coronavirus disease 2019;differential diagnosis;influenza a (h1n1);multivariate analysis
Association Caseload Surge COVID19 Survival 558 US Hospitals March August 2020,34224257,BACKGROUND Several US hospital surge COVID19 caseload effect COVID19 survival rate remains unclear especially independent temporal change survival OBJECTIVE determine association hospital severityweighted COVID19 caseload COVID19 mortality risk identify effect modifier relationship DESIGN Retrospective cohort study ClinicalTrialsgov NCT04688372 SETTING 558 US hospital Premier Healthcare Database PARTICIPANTS Adult COVID19coded inpatient admitted March August 2020 discharge disposition October 2020 MEASUREMENTS hospitalmonth stratified percentile rank surge index severityweighted measure COVID19 caseload relative preCOVID19 bed capacity effect surge index riskadjusted odds ratio aOR inhospital mortality discharge hospice calculated using hierarchical modeling interaction surge attribute assessed RESULTS 144 116 inpatient COVID19 558 US hospital 78 144 542 admitted hospital top surge index decile Overall 25 344 176 died crude COVID19 mortality decreased time across surge index stratum However compared nonsurging 50th surge index percentile hospitalmonths aORs 50th 75th 75th 90th 90th 95th 95th 99th greater 99th percentile 111 95 CI 101 123 124 CI 112 138 142 CI 127 160 159 CI 141 180 200 CI 169 238 respectively surge index associated mortality across ward intensive care unit intubated patient surgemortality relationship stronger June August March May slope difference 010 CI 0033 016 despite greater corticosteroid use judicious intubation later highersurging month Nearly 1 4 COVID19 death 5868 CI 3584 8171 232 potentially attributable hospital strained surging caseload LIMITATION Residual confounding CONCLUSION Despite improvement COVID19 survival March August 2020 surge hospital COVID19 caseload remained detrimental survival potentially eroded benefit gained emerging treatment Bolstering preventive measure supporting surging hospital save many life PRIMARY FUNDING SOURCE Intramural Research Program National Institutes Health Clinical Center National Institute Allergy Infectious Diseases National Cancer Institute,
Benefits risk associated different us COVID19 vaccine Vaxzevria modelling study France May September 2021,34212840,Thrombosis thrombocytopenia TTS identified rare adverse event following COVID19 vaccination Vaxzevria modelled benefit risk Vaxzevria distribution May September 2021 metropolitan France vaccine available considering French hospitalisation data European data TTS Across different scenario benefit Vaxzevria distribution people 55 year older exceeded risk death COVID19 young adult risk least similar magnitude benefit,astrazeneca;sars-cov-2;vaxzevria;benefit-risk balance;thrombosis;vaccine
Modulation Gut Microbiota Prevention Treatment COVID19,34209870,gut microbiota well known exert multiple benefit human health including protection disease causing pathobiont microbe recognized healthy intestinal microbiota great importance pathogenesis COVID19 Gut dysbiosis caused various reason associated severe COVID19 Therefore modulation gut microbiota supplementation commensal bacterial metabolite could reduce severity COVID19 Many approach studied improve gut microbiota COVID19 including probiotic bacterial metabolite prebiotics well nutraceuticals trace element far 19 clinical trial testing efficacy probiotic synbiotics COVID19 prevention treatment ongoing narrative review summarize effect various approach prevention treatment COVID19 discus associated mechanism,covid-19;butyrate;intestinal dysbiosis;nutraceuticals;probiotics
SARSCoV2 Infection Health Workers Analysis Verona SIEROEPID Study PreVaccination Era,34198715,BACKGROUND report baseline phase SIEROEPID study SARSCoV2 infection seroprevalence among health worker University Hospital Verona Italy spring fall 2020 compare performance several laboratory test SARSCoV2 antibody detection METHODS 5299 voluntary health worker enrolled 28 April 2020 28 July 2020 ass immunological response SARSCoV2 infection throughout IgM IgG IgA serum level titration four laboratory test Association antibody titre several demographic variable swab test performance test sensitivity specificity agreement statistically analyzed RESULTS overall seroprevalence 6 considering either IgG IgM 48 considering IgG Working COVID19 Units associated statistically significant increase number infected worker Cohen s kappa agreement MaglumiTM VivaDiagTM quite good considering IgG Cohen s kappa = 781 95 CI 740820 lower considering IgM Cohen s kappa = 133 95 CI 78187 CONCLUSION large sample size high participation 847 biobank longitudinal design significant achievement offering baseline dataset benchmark risk assessment health surveillance management SARSCoV2 infection hospital workforce especially considering ongoing vaccination campaign Study result support national regulator guideline using swab SARSCoV2 screening health worker using serological test contribute epidemiological assessment spread virus,sars-cov-2 infection;health workers;serosurvey
Challenges HospitalAcquired COVID19 Surveillance Attribution Infection Source,34338172,performed surveillance hospitalacquired COVID19 HACOVID19 compared timebased electronic definition realtime adjudication likely source acquisition Without realtime adjudication nearly 50 HACOVID19 case identified using electronic definition misclassified electronic traditional contact tracing method likely underestimated incidence HACOVID19,
Adherence COVID19 Nutrition Guidelines Associated Better Nutritional Management Behaviors Hospitalized COVID19 Patients,34204893,Good nutritional support crucial immune system fight coronavirus disease 2019 COVID19 However context pandemic highly transmissible coronavirus implementation nutrition practice may difficult multicenter electronic survey involving 62 dietician conducted order understand barrier associated dietician adherence nutrition guideline hospitalized COVID19 patient Indonesia 69 dietician felt stress performing nutrition care 90 took supplement boost immunity coronavirus concern related clinical practice included lack clear guideline 74 lack access medical record 55 inadequate experience knowledge 48 lack selfefficacyconfidence 29 performing nutritional care Half 52 dietician performed nutrition educationcounseling 47 monitored patient s body weight 76 monitored patient s dietary intake adjusted linear regression showed guideline adherence independently predicted dietician nutrition care behavior nutrition counselling s 024 0002 008 p = 004 monitoring body weight s 043 004 011 p = 0001 dietary intake s 047 003 010 p = 0001 COVID19 patient Overall adherence COVID19 nutrition guideline associated better nutritional management behavior hospitalized COVID19 patient,covid-19;indonesia;guidelines adherence;length of stay;mortality;nutrition care
Generalized form fractional order COVID19 model MittagLeffler kernel,34226779,important advantage fractional derivative formulate model describing much better system memory effect Fractional operator different memory related different type relaxation process nonlocal dynamical system Therefore investigate COVID19 model fractional derivative paper apply effective numerical method obtain numerical result also use Sumudu transform get solution model Sumudu transform able keep unit function parity function many property valuable present scientific result paper also prove result effective numerical technique helpful understand outbreak COVID19,covid-19;mittag-leffler kernel;sumudu transform;numerical methods
Assessment Impact Coronavirus Disease COVID19 Pandemic National Antimicrobial Consumption Jordan,34207567,Coronavirus disease 2019 COVID19 overlapping clinical characteristic bacterial respiratory tract infection leading prescription potentially unnecessary antibiotic study aimed measuring change pattern national antimicrobial use one year preceding one year COVID19 pandemic Annual national antimicrobial consumption 2019 2020 obtained Jordan Food Drug Administration JFDA following surveillance method Access Watch Reserve AWaRe classification used Total antibiotic consumption 2020 268 DDD per 1000 inhabitant per day decreased 55 compared 2019 284 DDD per 1000 inhabitant per day increase use several antibiotic 2020 compared 2019 third generation cephalosporin 19 carbapenems 52 macrolides 57 lincosamides 106 2020 marked reduction amoxicillin use 53 use azithromycin increased 74 National antimicrobial consumption Access group decreased 18 2019 2020 591 vs 481 total consumption use Watch group increased 2020 26 study highlighted increase use certain antibiotic pandemic period known associated increasing resistance Efforts enhance national antimicrobial stewardship needed ensure rational use antimicrobial,aware classification;antimicrobial consumption;antimicrobial resistance;antimicrobial stewardship;drug utilization
Risk factor death due COVID19 state Acre Brazil 2020 retrospective cohort study,34287555,OBJECTIVE analyze risk factor death individual severe acute respiratory syndrome due COVID19 METHODS retrospective cohort study comprised adult individual COVID19 March September 2020 notified Epidemiological Surveillance System state Acre Brazil Cox regression used RESULTS Among 57700 individual analyzed incidence 27654100000 inhabitant mortality 618100000 inhabitant risk factor death male HR=148 95 CI 125 176 age =60 year HR=1064 95 CI 884 1281 symptom dyspnea HR=420 95 CI 344 512 multimorbidity HR=223 95 CI 177 281 emphasis heart disease diabetes mellitus Sore throat headache symptom present mild case COVID19 CONCLUSION male elderly heart disease diabetes mellitus dyspnea characteristic associated death due COVID19,
Return Basketball Play Following COVID19 Lockdown,34204988,Due concern regarding spread coronavirus COVID19 major sporting event activity temporarily suspended postponed new radical sport protocol emerged sport recommendation based scientific evidence returning teamgame activity following lifting COVID19 restriction extended duration lockdown selftraining detraining COVID19 environment especially true basketball postlockdown return basketball court ultimately depends teamscoaches trainer player medical staff Nevertheless current scientific knowledge evidently insufficient far safety returntoplay timing concerned situation present major challenge basketball competition term organization prioritization maintaining physical fitness decisionmaking preparing adequate basketball return program player health major priority article briefly discus topic propose multiple strategy,aerobic;anaerobic;detraining;fatigue;fitness training;injury;performance;recovery;testing
ABO phenotype clinical correlate COVID19 severity hospitalized patient,34290882,Aim study investigates association ABO blood phenotype COVID19 severity measured intensive care unit admission need intubation hospitalization length death explores clinical predictor COVID19 severity within primarily Hispanic demographic San Diego County Materials method retrospectively reviewed 942 total patient 473 available blood type hospitalized five Scripps Health hospital COVID19 Results significant association found ABO phenotype COVID19 severity multivariate analysis diagnosis anemia male sex associated severity outcome exploratory analysis Conclusion result provide relevant clinical correlate COVID19 severity help better elucidate association ABO phenotype COVID19,abo blood type;covid-19;hispanic;san diego;anemia;male
Higher COVID19 mortality lowincome community City Cape Town descriptive ecological study,34286217,Background Cape Town South African city high level economic inequality gone two COVID19 wave evidence globally lowincome community experience higher level morbidity mortality pandemic Methods Agestandardized COVID19 mortality eight subdistricts Cape Town compared economic indicator taken recent Census unemployment rate monthly income Results overall Standardized Death Rate SDR COVID19 Cape Town 1 640 per million wide variation across different subdistricts linear relationship seen subdistricts high poverty high COVID19 SDRs Conclusions Lowincome community Cape Town experienced higher level COVID19 mortality continue contend COVID19 community need prioritized access quality health care,covid-19;low-income;mortality
Data Sharing Southeast Asia First Wave COVID19 Pandemic,34222173,Background new pathogen emerges consistent case reporting critical public health surveillance Tracking case geographically time key understanding spread infectious disease effectively designing intervention contain mitigate epidemic paper describe reporting system COVID19 Southeast Asia first wave 2020 highlight impact specific reporting method Methods reviewed key epidemiological variable various source including regionally comprehensive dataset national tracker dashboard case bulletin 11 country first wave epidemic Southeast Asia recorded timeline shift epidemiological reporting system described difference epidemiological data reported across country timepoints Results finding suggest country Southeast Asia generally reported precise detailed epidemiological data first wave pandemic Changes reporting rarely occurred demographic data reporting shift geographic temporal data frequent country provided COVID19 individuallevel data daily using HTML PDF necessitating scraping extraction data could used analysis Conclusion study highlight importance nuanced analysis COVID19 epidemiological data within across country frequent shift reporting government continue respond impact health economy data sharing also need prioritised given foundational role policymaking implementation evaluation intervention,covid- 19;southeast asia;data sharing;emerging infectious disease;epidemiological data
Selfreported Changes Energy Balance Behaviors COVID19related Home Confinement Crosssectional Study,34340742,Objectives Crosssectional report weight gain COVID19 shelterathome raised concern weight increase pandemic continues examined behavior impact energy intake andor energy expenditure among adult United States shelterathome Methods Crosssectional data N=1779 April 24 May4 2020 collected demographic diet physical activity sleep food purchasing behavior Percent participant reporting increase decreaseno change behavior COVID19 shelterathome assessed analysis followed comparing whether increase decrease likely health behavior participant across sex 4338 male Results Increased consumption healthy food energydense unhealthy food snack increased sedentary activity p 001 reported Physical activity alcohol intake declined p 001 Females likely male p 001 report ultraprocessed foodshighcalorie snack intake fruitvegetable intake p 001 increase p 01 sleep sedentary behavior Conclusion Acute behavioral change supporting greater energy intake le energy expenditure especially female underscore significance COVID19related increase unstructured time Longitudinal assessment body weight health behavior warranted understand impact pandemic,
Reactivation Mycobacterium simiae recovery COVID19 infection,34222683,limited study coinfection coronavirus disease 2019 COVID19 nontuberculous mycobacteria briefly describe reactivation Mycobacterium simiae infection patient recovered COVID19 October 2020 Iran pandemic COVID19 infectious agent ignored,covid-19;mycobacterium simiae;sars-cov-2
Impact COVID19 lockdown child asthma Jordan parental questionnaire,34222681,Objective evaluate impact 10week lockdown child asthma aged 417 year term presentation emergency department ED frequency admission compliance medication change pulmonary function testing result Design setting questionnairebased crosssectional study using Google Forms collect parent caregiver response consented participation Results total 374 parentscaregivers contacted 297 79 responded majority child male 188 63 498 aged 712 year half participant 194 65 reported improved compliance medication spacer use significant reduction number presentation ED 137 80 admission hospital 56 24 10week lockdown period compared time period previous year p =00001 Around 25 participant used telemedicine phone social medium application communication treating physician 59 80 described easy smooth Conclusion national lockdown Jordan due COVID19 pandemic associated fall emergency presentation hospital admission acute asthma exacerbation Parental response indicate fear focused around COVID19 associated enhanced compliance use preventer medication lockdown,covid-19;adolescent health;virology
Neurodegenerative proteinopathies associated neuroinfections,34223998,Infectious agent including virus bacteria proposed involved pathogenesis Alzheimer s disease AD According hypothesis agent capacity evade host immune system leading chronic infection inflammation subsequent deposition Abeta phosphorylatedtau brain Coexisting proteinopathies agerelated pathology common AD brain elderly individual whether also related neuroinfections remain established study determined prevalence distribution neurodegenerative proteinopathies patient infectioninduced acute chronic inflammation associated herpes simplex virus HSV encephalitis n = 13 neurosyphilis n = 23 mean age death HSV patient 53 + 12 year range 2465 year survival 9 days6 year following initial infection mean age death survival neurosyphilis patient 60 + 15 year range 3686 year 15 year respectively Neuronal tauimmunoreactivity neurites observed 8 HSV patient 19 neurosyphilis patient approximately half found region associated inflammation expanding beyond region expected Braak stage neurofibrillary degeneration Five neurosyphilis patient cortical ageingrelated tau astrogliopathy Abetaplaques found 4 HSV patient 11 neurosyphilis patient Lewy body observed one HSV patient two neurosyphilis patient TDP43 pathology absent observation provide insight deposition neurodegenerative protein neuroinfections might implication COVID19 patient chronic andor postinfectious neurological symptom encephalitis,alzheimer's disease;herpes simplex virus;neuro-infection;neurosyphilis;proteinopathy;tau
Selfreported change physical activity sedentary behavior screen time among informal caregiver COVID19 pandemic,34215246,BACKGROUND Informal caregiver providing unpaid assistance may vulnerable change health behavior due modification caregiving COVID19 pandemic Therefore crosssectional study explored selfreported change physical activity PA sedentary behavior screen time among informal caregiver providing care older adult aged 50+ pandemic METHODS Study participant recruited via Amazon s Mechanical Turk reported perceived change increased lot increased little remained decreased little decreased lot moderateintensity PA MPA vigorousintensity PA VPA sedentary behavior screen time weekday weekend pandemic analytic purpose response category categorized threelevel ordinal variablesincreased increased lot increased little change remained decreased decreased little decreased lot Multinomial logistic regression model assessed likelihood change vs change MPA VPA sedentary behavior screen time weekday weekend based caregiving demographic characteristic RESULTS total 2574 individual accessed study link 464 meet eligibility requirement addition people completed 80 le survey n = 1171 andor duplicate IP addresse n = 104 excluded resulting analytic sample n = 835 sample 69 male mean age 34 SD = 97 48 reported increased VPA 55 reported increased MPA majority also reported increased sedentary behavior well increased screen time Respondents living care recipient likely report increased weekday screen time Odds Ratio = 155 95 CI 111216 sedentary behavior = 180 95 CI 128253 respondent living care recipient living care recipient also likely reported increased MPA = 164 95 CI 116232 VPA = 153 95 CI 109215 also likely report decrease VPA = 175 95 CI 114270 CONCLUSION majority respondent reported MPA VPA PA sedentary behavior screen time changed pandemic Living care recipient associated positive negative change behavior Future research explore factor associated reported change behavior,covid-19;informal caregivers;physical activity;screen time;sedentary behavior
Leveraging Massachusetts perinatal quality collaborative address COVID19 pandemic among diverse population,34226648,OBJECTIVE leveraged Massachusetts perinatal quality collaborative PQC address COVID19 pandemic goal 1 implement perinatal practice thought reduce mothertoinfant SARSCoV2 transmission limiting disruption healthpromoting practice 2 without inequity attributable raceethnicity language status social vulnerability METHODS Main outcome cesarean preterm delivery roomingin breastfeeding examined change time overall according raceethnicity language status social vulnerability 03200720 11 hospital RESULTS 255 mother SARSCoV2 67 black Hispanic 47 nonEnglish speaking Cesarean decreased 49 35 roomingin 55 86 breastfeeding 53 72 increased change differ raceethnicity language social vulnerability CONCLUSIONS Leveraging Massachusetts PQC led rapid change perinatal care COVID19 crisis short time representing novel use statewide PQC structure,
Biochemical composition transmission diagnosis SARSCoV2,34291285,Coronavirus disease 2019 COVID19 lifethreatening respiratory infection caused severe acute respiratory syndrome virus SARSCoV2 novel human coronavirus COVID19 declared pandemic World Health Organization March 2020 continuous rapid spread worldwide Rapidly emerging COVID19 epicenter mutant concern created mammoth chaos healthcare sector across globe 185 million infection approximately 4 million death globally COVID19 continues unchecked spread despite mitigation measure effective affordable antiretroviral drug made available population large vaccinated timely diagnosis infection adoption COVIDappropriate behavior remains major tool available curtail still escalating COVID19 pandemic review provides updated overview various technique COVID19 testing human sample also discus brief biochemical composition mode transmission SARSCoV2 Technological advancement various molecular serological immunological technique including mainly reversetranscription polymerase chain reaction RTPCR CRISPR lateral flow assay LFAs immunosensors reviewed,covid- 19;elisa;rt-pcr;sars-cov-2;transmission
Challenges dental professional COVID19 pandemic prepared,34222503,BACKGROUND emerging knowledge understanding novel coronavirus infection dentist must capable resuming practice necessary precaution near future hence aim present study evaluate knowledge attitude practice along felt challenge dentist concerning practicing dentistry pandemic India MATERIALS METHODS online crosssectional questionnaire study conducted dental practitioner Uttarakhand India dentist approached obtaining Email address head dental institution dental association branch state knowledge attitude practice along apparent challenge practicing pandemic assessed using closedended questionnaire relationship mean score demographic variable determined using Student s unpaired ttest keeping significance level 005 RESULTS 759 respondent total 458 respondent male 60 whereas 301 40 female mean knowledge score higher female 1106 + 212 compared male 972 + 453 statistically significant P 005 mean practice score lower male 1749 + 647 compared female 1926 + 669 likewise lower score seen graduate compared specialist difference statistically significant P 005 Majority study participant felt following various safety guideline feasible 9697 expensive 9644 considered challenge CONCLUSION imperative dentist fully prepared resuming service reach right kind awareness limit spread disease,covid-19;dental practice;pandemic;readiness
Morphological alteration tongue epithelial cell infected SARSCoV2 casecontrol study,34342110,OBJECTIVE aim present casecontrol study evaluate morphological aspect epithelial cell dorsum tongue expression SARSCoV2 Spike protein cell patient without COVID19 infection METHODS 24 individual least one symptom COVID19 recruited among inpatient Hospital Universitario Pedro Ernesto Rio de Janeiro Brazil 14 patient tested positive COVID19 RTPCR included case group 10 patient tested negative included control group Cytological smear dorsum tongue obtained patient analyzed using immunohistochemistry directed SARSCoV2Spike protein Morphological change epithelial cell analyzed using light microscopy RESULTS Immunohistochemistry showed 71 COVID19 patient presented epithelial cell positive presence SARSCoV2 Spike protein cell coming patient control group negative Cytological analysis showed significant difference comparing epithelial cell COVID19positive COVID19negative patient CONCLUSION COVID19 may generate dimensional change tongue epithelial cell however study necessary understand happens,rt-pcr;sars-cov-2;epithelial cells;spike protein
COVID19 plastic surgery lesson national speciality review United Kingdom,34130913,BACKGROUND Ramifications coronavirus disease 2019 COVID19 restructuring healthcare widespread including delivery surgical service across specialty including plastic surgery Redeployment personnel cessation elective service commonplace However continued need emergency oncological surgery national review practice conducted COVID19 pandemic ass impact service staffing training METHODS Key aspect current plastic surgery practice United Kingdom examined crosssectional study operating capacity location theatre list national health service outsourced private institution PIs difference across subspecialties change anaesthesia practice staffing redeployment oncall provision impact training RESULTS Threehundred fortyfour plastic surgeon United Kingdom provided practice data across 51 unit Theatre capacity outpatient service markedly reduced Outsourcing operating list PIs widely utilised Increased use local anaesthetic hand procedure prioritisation shorter operation reduced microsurgery head necklower limb almost complete cessation breast reconstruction noted together marked regional variation Redeployment occurred staffing level whilst telemedicine played critical role patient management training CONCLUSIONS COVID19 enforced unprecedented change surgical care delivery training identified examination plastic surgery nationally United Kingdom Novel mean support continued elective emergency service including oncology identified Lessons learned allow phased return service improved preparation future,
Clinician Perspectives Implementing Video Visits HomeBased Palliative Care,34223480,Background Despite increasing use acceptance technology health care limited evidence usefulness appropriate use telehealth homebased palliative care HBPC part process evaluation pragmatic trial video visit HBPC assessed clinician experience video visit implementation Methods assessed clinician experience perception usefulness appropriateness video visit using anonymous survey brief qualitative interview subset survey participant Qualitative analysis guided sociotechnical framework emphasize technology s `` value proposition end user key adoption Results Clinicians 36 physician 48 registered nurse generally favorable attitude toward video visit telehealth Respondents felt confident skill needed make role video visit successful Clinicians neutral whether video visit useful practice enhanced patientcaregiver experience Clinicians found video visit appropriate followup care opposed start care interview yielded two theme complemented survey finding 1 factor enhancing value proposition positive response patient family convenience 2 factor diminishing value proposition issue related technology scheduling Discussion finding provide insight clinician experience implementing remote video physician consultation facilitated nurse patient s home preCOVID19 era Clinician view video visit may shifted pandemic occurred data collection complete Clinical Trials Registration NCT 03694431,adoption;clinicians;implementation;palliative care;telehealth;video consultations
Telehealth Multidisciplinary Target Delineation Radiotherapy COVID19 Pandemic Review Case,34217435,Like medical specialty radiotherapy deeply influenced COVID19 pandemic pandemic severe influence entire patient trajectory oncology diagnosis treatment followup Many example deal patient staff safety shortness staff resource quest continue highquality evidencebased treatment presented use telemedicine telehealth frequently presented part solution overcome challenge available presented solution apply acute local setting whereas others might inspire community improve quality costeffectiveness radiotherapy well knowledge sharing future unresolved issue many available technical solution related data security public regulation example GDPR General Data Protection Regulation EU HIPAA compliance Health Insurance Portability Accountability Act USA Using solution involves supplier s server nonEU country problematic within EU paper shortly review influence COVID19 radiotherapy describe possible solution telehealth target delineation crucial part highquality radiotherapy often requires multidisciplinary effort handson corporation highquality multimodal imaging Hereafter technical solution presented case,
Evaluation central venous catheter risk factor mortality chronic hemodialysis patient COVID19 Brazil,34132971,PURPOSE Hemodialysis patient COVID19 increased risk death aimed describe characteristic cohort Brazilian hemodialysis patient COVID19 ass mortality rate risk factor death METHODS Retrospective cohort study 741 Brazilian hemodialysis patient confirmed COVID19 FebDec2020 52 dialysis center country analyzed comorbid condition sociodemographic factor dialysisrelated parameter detect risk factor mortality hemodialysis patient performed multivariable Cox proportional hazard regression analysis Survival analyzed KaplanMeier RESULTS 9877 hemodialysis patient 741 diagnosed COVID19 Mean age 57 + 16 year 61 male 51 white frequent symptom fever 541 cough 509 dyspnea 372 142 asymptomatic 139 death 188 66 within disease s first 15 day 333 patient 449 required hospitalization 211 285 admitted intensive care unit cumulative probability survival 90 day diagnosis 79 95 CI 7682 fully adjusted multivariate model risk factor significantly associated death diabetes mellitus HR 152 95 CI 105219 P = 0026 use central venous catheter CVC HR 179 95 CI 122264 P = 0003 age HR 103 95 CI 101104 P 0001 origin North vs Southeast region HR 260 95 CI 101668 P = 0047 CONCLUSIONS Hemodialysis patient using CVC vascular access aside diabetic elderly one closely monitored due high risk death course COVID19,brazil;covid-19;central venous catheter;hemodialysis;mortality;risk factors
Systemic Adverse Events Use Antipyretics Predict Neutralizing Antibody Positivity Early First Dose ChAdOx1 Coronavirus Disease Vaccine,34199053,Vaccination considered crucial eradication coronavirus disease COVID19 medical center Korea health care worker HCWs vaccinated ChAdOx1 COVID19 vaccine vaccination many HCWs complained adverse event AEs However remains unclear whether production neutralizing antibody NAb affected Therefore aimed evaluate AEs early NAb production relatively healthy Asians received ChAdOx1 vaccine determine effect AEs antipyretic early NAb production COVID19 182 Korean HCWs received first dose ChAdOx1 vaccine 172 945 experienced =1 adverse event 148 813 tested positive NAb 3340 day vaccination NAbpositive vaccine recipient reported systemic AEs consumed acetaminophen frequently NAbnegative recipient identified association antibody response COVID19 vaccinerelated AEs conclusion ChAdOx1 vaccine recipient reported AEs medical center,sars-cov-2;health care workers;neutralizing antibodies;vaccination
Viral transport medium COVID19 testing,34226865,Precautionary measure physical isolation social distancing mask aided controlling spread COVID19 However detection virus crucial implement isolation infected individual paper present innovative repurposing lab material workspace personnel response COVID19induced shutdown consequential shortage commercially made virus transport medium VTM method VTM production highlight ability standard research lab fulfill need affected pandemic potential recurrence outbreak collaboration various entity Ohio State University Wexner Medical Center OSUWMC allowed efficient production distribution VTM tube facilitate mass COVID19 testing propose implementation process university research lab would enable quicker intervention potentially better outcome prevention spread disease,covid-19;pandemic;supply chain;viral transport media
Inhalable nanocatchers SARSCoV2 inhibition,34292870,global coronavirus disease 2019 COVID19 pandemic caused severe acute respiratory syndrome SARS like coronavirus SARSCoV2 present urgent health crisis recently increasing number mutated strain SARSCoV2 identified globally mutation especially spike glycoprotein render higher binding affinity human angiotensinconverting enzyme II hACE2 receptor resulted higher transmission SARSCoV2 also raised serious concern regarding efficacy vaccine mutated virus Since ACE2 virusbinding protein human cell regardless viral mutation design hACE2containing nanocatchers NCs competitor host cell virus binding protect cell SARSCoV2 infection hACE2containing NCs derived cellular membrane genetically engineered cell stably expressing hACE2 exhibited excellent neutralization ability pseudoviruses wildtype SARSCoV2 D614G variant prevent SARSCoV2 infection lung vulnerable organ COVID19 develop inhalable formulation mixing hACE2containing NCs mucoadhesive excipient hyaluronic acid latter could significantly prolong retention NCs lung inhalation Excitingly inhalation formulation could lead potent pseudovirus inhibition ability hACE2expressing mouse model without imposing appreciable side effect Importantly inhalable hACE2containing NCs lyophilized formulation would allow longterm storage facilitating future clinical use Thus work may provide alternative tactic inhibit SARSCoV2 infection even different mutation exhibiting great potential treatment ongoing COVID19 epidemic,sars-cov-2;hace2-containing nanocatchers;inhalation;mucoadhesive;virus inhibitor
Persistent Symptoms PostCOVID19 Patients Attending FollowUp OPD Sukraraj Tropical Infectious Disease Hospital STIDH Kathmandu Nepal,34203115,longterm effect COVID19 among survivor matter concern research aimed study persistent symptom postCOVID19 patient attending followup clinic tertiary care hospital Nepal patient presenting outpatient clinic study duration six week history positive reverse transcriptase polymerase chain reaction severe acute respiratory syndromecoronavirus2 SARSCoV2 least two week prior presentation included duration followup ranged 15 till 150 day mean duration 28 day diagnosis COVID19 118 patient 43 364 history mild COVID19 15 128 moderate 60 508 severe time presentation 97 822 patient reported least one persistentnew symptom beyond two week diagnosis COVID19 Dyspnea fatigue chest heaviness cough commonest persistent complaint 48 407 39 331 33 28 32 271 patient respectively finding study highlight need extended monitoring postCOVID19 patient following discharge order understand mitigate longterm implication disease,covid-19;nepal;post-acute covid-19 syndrome
Learning Crisis Multicentre Study Oncology Telemedicine Clinics Introduced COVID19,34213751,COVID19 pandemic necessitated adaptation cancer patient care Oncology patient contract COVID19 poor outcome Telemedicine clinic teleclinics introduced cancer patient reduce risk horizontal transmission St Bartholomew s Hospital Royal Free Hospital London Teleclinics become routine many speciality however inclusion oncology care standard prior pandemic mixedmethods survey designed delivered cancer patient n = 106 St Bartholomew s Hospital Royal Free Hospital transitioned teleclinics March 2020 survey explored patient perception format total 96 905 patient consented take part across range tumour type Overall respondent reacted favourably format teleclinics 906 respondent 8796 stating would utilise teleclinics beyond pandemic Additionally survey distributed clinician delivering teleclinics n = 16 explore previous training perception lesson learned introduction telemedicine Results suggest patient accepting teleclinic use clinical purpose Teleclinic implementation affords benefit cancer patient care COVID19 urgent need telemedicine education oncology specialty training,covid-19;cancer;evidence-based care;patient experience;telemedicine
Discovery Antivirals Using Phage Display,34200959,latest coronavirus disease outbreak COVID19 brought attention viral infection posed serious health threat humankind throughout history rapid global spread COVID19 attributed increased human mobility today s world yet threat viral infection global public health expected increase continuously part due increasing humananimal interface Development antiviral agent crucial combat existing novel viral infection Recently growing interest peptideproteinbased drug molecule Antibodies becoming especially predominant drug market Indeed remarkably short period four antibody therapeutic authorized emergency use COVID19 treatment US Russia India November 2020 Phage display one widely used screening method peptideantibody drug discovery Several phage displayderived biologics already market expiration intellectual property right phagedisplay antibody discovery platform suggests increment antibody drug near future review summarizes common phage display library used antiviral discovery highlight approach employed enhance antiviral potency selected peptidesantibody fragment finally provides discussion present status developed antiviral clinic,antigen-binding fragment;antiviral;bacteriophage;intrabody;nanobody;peptide;phage display;single-chain variable fragment;transbody
Possible Targets PanCoronavirus Antiviral Strategies Emerging ReEmerging Coronaviruses,34361915,Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 caused Coronaviruses Disease 2019 COVID19 worldwide pandemic seventh human coronavirus crosstransmitted animal human predicted continuous contact human animal virus spread animal human Therefore imperative develop universal coronavirus pancoronavirus vaccine drug next coronavirus pandemic However suitable target critical developing pancoronavirus antiviral emerging reemerging coronaviruses review discus latest progress possible target pancoronavirus antiviral strategy emerging reemerging coronaviruses including target pancoronavirus inhibitor vaccine provide prospect current future research treatment disease,epitope;inhibitor;pan-coronavirus;target;vaccine
Janus Face Thrombocytes COVID19,34211762,55 year old patient COVID19 known comorbidities presented fever myalgia headache presentation leukopenia thrombocytopenia however bleeding manifestation patient s inflammatory marker including ferritin Creactive protein elevated admission Later course illness went develop severe thrombocytosis leukocytosis discus course outcome illness unusual case COVID19 severe diametrically opposite haematological abnormality,covid-19;hematology;platelets;sars-cov-2;thrombocytopenia;thrombocytosis
Increasing adiposity presence cardiometabolic morbidity associated increased Covid19related mortality result UK Biobank,34217276,BACKGROUND Although obesity defined body mass index BMI associated higher risk hospitalisation severe course illness Covid19 positive patient amongst British population unclear translates increased mortality Furthermore given BMI insensitive indicator adiposity effect adipose volume Covid19 outcome also unknown METHODS used UK Biobank repository contains clinical anthropometric data linked Public Health England Covid19 healthcare record address research question performed age sex adjusted logistic regression Chisquared test compute odds Covid19related mortality consequence increasing BMI sensitive index adiposity waist hip ratio WHR percent body fat well concomitant cardiometabolic illness RESULTS 13502 participant tested Covid19 mean age 70 + 8 year 489 male 1582 tested positive mean age 68 + 9 year 528 male 305 died mean age 75 + 6 year 655 male Increasing adiposity associated higher odds Covid19related mortality every unit increase BMI WHR body fat odds death amongst Covid19positive participant increased 104 95 CI 101107 1071 95 CI 1577306 103 95 CI 101105 respectively p 005 Referenced Covid19 positive participant normal weight BMI 18525 kgm 2 Covid19 positive participant BMI 35 kgm 2 significantly higher odds Covid19related death 170 95 CI 106274 p 005 Covid19positive participant metabolic diabetes hypertension dyslipidaemia cardiovascular morbidity atrial fibrillation angina also higher odds death CONCLUSIONS Anthropometric index sensitive adipose volume distribution BMI well concurrent cardiometabolic illness associated higher odds Covid19related mortality amongst UK Biobank cohort tested positive infection result suggest adipose volume may contribute adverse Covid19related outcome associated obesity,adiposity;covid-19;mortality;obesity
Natural killercell immunoglobulinlike receptor trigger difference immune response SARSCoV2 infection,34352002,BACKGROUND diversity clinical course COVID19 related difference innate adaptative immune response mechanism Natural killer NK lymphocyte critical protagonist human host defense viral infection would seem reduced circulating level cell impact COVID19 progression severity activity strongly regulated killercell immunoglobulinlike receptor KIRs expressed NK cell surface present study s focus investigate impact KIRs HLA Class ligand SARSCoV2 infection METHODS KIR gene frequency KIR haplotype KIR ligand combination KIRs HLA Class ligand investigated 396 Sardinian patient SARSCoV2 infection Comparisons made 2 group patient divided according disease severity 240 patient symptomatic paucisymptomatic Group 156 hospitalized patient severe disease Group immunogenetic characteristic patient also compared population group 400 individual geographical area RESULTS Substantial difference obtained KIR gene KIR haplotype KIRHLA ligand combination comparing patient Group Group Patients Group statistically significant higher frequency KIR AA haplotype compared patient Group 346 v 238 = 17 95 CI 1126 P = 002 Pc = 004 Moreover KIR2DS2HLA C1 combination poorly represented group patient severe symptom compared asymptomaticpaucisymptomatic group 333 v 500 = 05 95 CI 0308 P = 0001 Pc = 0002 Multivariate analysis confirmed regardless sex age patient latter genetic variable correlated le severe disease course ORM = 04 95 CI 0307 PM = 00005 PMC = 0005 CONCLUSIONS KIR2DS2HLA C1 functional unit resulted strong protective effect adverse outcome COVID19 Combined well known factor advanced age male sex concomitant autoimmune disease marker could prove highly informative disease course thus enable timely intervention needed reduce mortality associated severe form SARSCoV2 infection However larger study population well experimental functional study needed confirm finding pursue effect KIR receptor NK cell immunemediated response SARSCov2 infection,
Importance Apolipoprotein AI AII Composition HDL Potential Studying COVID19 SARSCoV2,34357154,composition property apolipoprotein apo AI apoAII highdensity lipoprotein HDL might critical SARSCoV2 infection via SRBI antiviral activity COVID19 HDL containing native apoAI showed potent antiviral activity HDL containing glycated apoAI apolipoproteins However report elucidate putative role apoAII antiviral activity HDL,covid-19;sars-cov-2;apoa-i;apoa-ii;glycation;high-density lipoproteins
InfectionMediated Clinical Biomarkers COVID19 Electrical Biosensing Platform,34205852,race towards development userfriendly portable fastdetection lowcost device healthcare system become focus effective screening effort since pandemic attack December 2019 known coronavirus disease 2019 COVID19 pandemic Currently existing technique RTPCR antigenantibodybased detection CT scan prompt solution diagnosing infected patient However limitation currently available indicator enticed researcher search adjunct additional solution COVID19 diagnosis Meanwhile identifying biomarkers indicator necessary understanding severity disease aid developing efficient drug vaccine Therefore clinical study infected patient revealed infectionmediated clinical biomarkers especially proinflammatory cytokine acute phase protein highly associated COVID19 biomarkers undermined overlooked context diagnosis prognosis evaluation infected patient Hence review discus potential implementation biomarkers COVID19 electrical biosensing platform secretion range biomarker reviewed based clinical study Currently available electrical biosensors comprising electrochemical electronic biosensors associated biomarkers discussed insight use infectionmediated clinical biomarkers prognostic adjunct diagnostic indicator developing electricalbased COVID19 biosensor provided,acute phase proteins;adjunct diagnostic biomarkers;cytokine storm;electrochemical sensors;electronic biosensors;pro-inflammatory cytokines;prognostic indicators
Seroprevalence SARSCoV2 Antibodies Symptomatic Individuals Higher Persons Increased Risk Exposure Results SingleCenter Prospective CrossSectional Study,34207919,present study aimed ass antibody seropositivity prevalence among symptomatic individual individual high risk occupational exposure SARSCoV2 Participants Chelyabinsk Russian Federation increased risk exposure SARSCoV2 highrisk group n = 1091 participant either symptom consistent COVID19 suspected experienced COVID19 past symptomatic group n = 692 enrolled 28 September 30 December 2020 Blood sample tested enzymelinked immunosorbent assay D5501 SARSCov2IgGEIABEST D5502 SARSCov2IgMEIABEST AO VectorBest Novosibirsk Russia overall seropositivity rate 28332853 SARSCoV2 antibody detected 1723 adjusted prevalence 17171729 participant highrisk 4595 adjusted prevalence 45914624 symptomatic group Higher IgG IgM titer observed woman compared men well participant symptomatic group compared highrisk group result indicate seroprevalence among resident several Russian region low 2838 inadequate provide herd immunity lower seroprevalence among participant highrisk group may attributed enforcement healthcare protocol use adequate personal protective equipment,covid-19;antibody;focus groups;global health;high-risk groups;seroprevalence
Investigation Four Clusters Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 Rwanda 2020,34209123,reported finding first Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 four cluster identified Rwanda Caseinvestigations included contact elicitation testing isolationquarantine confirmed case Sociodemographic clinical data case contact collected confirmed case person laboratory confirmation SARSCoV2 infection PCR contact person contact SARSCoV2 confirmed case within 72 h prior 14 day symptom onset 14 day collection laboratorypositive sample asymptomatic case High risk contact come unprotected facetoface contact closed environment SARSCoV2 case 15 min Forty case reported four cluster 22 April 2020 accounting 61 locally transmitted case within six week Clusters B C associated two nightclub one house party different family household living compound multifamily dwelling Thirtysix 1035 contact tested positive secondary attack rate 35 Positivity rate highest among highrisk contact compared lowrisk contact 10 vs 22 Index case three cluster imported international travelling Fifteen 40 case 38 asymptomatic 1325 52 825 32 symptomatic case cough fever respectively Gatherings closed space main early driver transmission Systematic caseinvestigations contact tracing testing likely contributed early containment SARSCoV2 Rwanda,covid19;rwanda;cluster analysis;infectious diseases;transmission
Concerns Knowledge Practices Dentists Mexico Regarding Infection Control Coronavirus Disease Pandemic CrossSectional Study,34198601,Dentists highly exposed vulnerable coronavirus disease COVID19 pandemic physical proximity patient necessary effective dental examination treatment objective study describe concern knowledge infection control practice dentist Mexico COVID19 pandemic crosssectional study conducted 22 May 2020 8 July 2020 anonymous survey distributed dentist covered information regarding dentist sociodemographic professional characteristic clinical practice pandemic perception regarding application infection prevention control guidance dental setting COVID19 pandemic 703 respondent 731 n = 514 woman 536 n = 377 dentist 110 year experience Regarding statement issued World Health Organization Centers Disease Control Prevention CDC response 11 survey item total agreement rate 90 high frequency seven nine item moderate low frequency total agreement respectively dentist study agreed CDC statement concerned regarding possibility infection despite using protective gear,covid-19;sars-cov-2;concerns;dental practice;dentist;infection control practices;knowledge;pandemic
Antimicrobial Activity Curcumin Nanoformulations Comprehensive Review,34281181,Curcumin CUR natural substance extracted turmeric antimicrobial property Due ability absorb light blue spectrum CUR also used photosensitizer PS antimicrobial Photodynamic Therapy aPDT However CUR hydrophobic unstable solution low bioavailability hinders clinical use circumvent drawback drug delivery system DDSs used review summarize DDSs used carry CUR antimicrobial effect virus bacteria fungi including drugresistant strain emergent pathogen SARSCoV2 reviewed DDSs include colloidal micelle liposome nanoemulsions cyclodextrins chitosan polymeric nanoparticles metallic mesoporous particle well graphene quantum dot hybrid nanosystems film hydrogel Free nonencapsulated CUR CUR loaded DDSs broadspectrum antimicrobial action used alone PS aPDT also show low cytotoxicity vivo biocompatibility improved wound healing Although several vitro vivo investigation describing nanotechnological aspect potential antimicrobial application CURloaded DDSs clinical trial reported study translate evidence clinical scenario infection,antimicrobial agents;bacteria;curcumin;drug delivery systems;fungi;microbial drug resistance;photochemotherapy;viruses
Persistent decline hospitalization acute stroke acute coronary syndrome second wave COVID19 pandemic Greece collateral damage unaffected,34285718,Background alarming cerebrocardiovascular collateral damage reflected decline admission acute stroke acute coronary syndrome ACS observed initial phase COVID19 pandemic thereby leading redesign public campaign However limited data regarding ACS hospitalization rate second wave pandemic followed reimposition lockdown Methods calculated rate ACS hospitalization three representative tertiary care hospital Greece 2month period NovemberDecember 2020 second wave COVID19 pandemic compared corresponding control period 2019 three representative tertiary care hospital Greece followup study identical design previous report evaluating ACS hospitalization first wave pandemic MarchApril 2020 Results Compared 2019 34 relative reduction hospitalization incidence rate ratio IRR 066 95 confidence interval CI 048092 p = 0013 33 relative reduction ACS hospitalization IRR 067 95 CI 054083 p 0001 second wave COVID19 pandemic relative reduction smaller reach level statistical significance respective syndrome haemorrhagic stroke IRR 087 95 CI 041182 p = 071 STelevation myocardial infarction IRR 081 95 CI 057114 p = 022 Conclusion ACS hospitalization persistently reduced second wave COVID19 pandemic compared 2019 Greece decline similar observation first wave despite large difference epidemiological COVID19 burden Lockdowns common characteristic wave appear detrimental indirect impact cerebrocardiovascular disease general population,covid-19;greece;acute coronary syndromes;admissions;intracerebral haemorrhage;ischaemic stroke;stroke
Severe acute respiratory syndrome coronavirus 2 SARSCoV2 testing essential food production worker evolving thinking pilot testing lesson learned,34343819,essential part US coronavirus disease 2019 COVID19 critical infrastructure country s foodproduction workforce Keeping foodproduction worker safe COVID19 pandemic meant added workplace protection Protection guidance came early Federal Government Absent guidance strategy screen causative virus Without viral screening food company outbreak facility close Companies interested viral screening devise strategy One company devised strategy three main goal 1 detecting asymptomatic infection opportunity spread 2 identifying workplace cluster indicate potential protection breakdown 3 comparing company result community infection rate company decided pilot screening two US production plant Screenings involved mandatory viral testing reverse transcription polymerase chain reaction optional antibody testing immunoglobulin G Pilot screening showed benefit along limitation 1 detecting asymptomatic infection questionably relevant time point 2 identifying infection cluster uncertain site transmission 3 showing relatively low rate infection absent detail meaningful community comparison Establishing worker screening process enormous undertaking Company employee stretch job role distracted form usual responsibility Whether company would find sufficient benefit justify similar screening unclear Moving forward new Federal leadership could provide greater support assistance worker screening addition new technology could make future screening feasible valuable worker screening experience pandemic offer learning next,covid-19;critical infrastructure;food security;occupational health;public health;sars-cov-2;testing;workers
First Dose BNT162b2 mRNA COVID19 Vaccine Reduces Symptom Duration Viral Clearance Healthcare Workers,34204252,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infected one hundred million people since beginning worldwide pandemic study data large hospital central Italy used evaluate impact first dose BNT162b2 mRNA vaccine SARSCoV2 infection term prevalence symptomatic case symptom duration viral clearance timing vaccinated Healthcare Workers HCWs positive RTPCR nasopharyngeal NP swab divided two cohort positive RTPCR within day 12 positive RTPCR day 13 day 21 first dose administration compared presence duration symptom timing viral clearance variable evaluated across HCWs positive RTPCR within 6 day first dose administration nonvaccinated HCWs positive RTPCR 1 October 2020 28 February 2021 Eighteen HCWs tested positive RTPCR NP swab day 1 day 12 1st dose administration incidence rate 62 x 10 4 5 HCWs day 13 day 21 incidence rate 23 x 10 4 Symptom duration viral clearance timing significantly shorter cohort HCWs positive RTPCR 12 day first dose BNT162b2 mRNA vaccine administration first dose proved effective reducing presence symptom duration viral clearance even HCWs vaccinated le 6 day result could implication public health postexposure prophylaxis,covid-19;sars-cov-2;first dose administration;healthcare workers;mrna vaccine;vaccine
Mesenchymal Stem Cells Gene Delivery Tool Promise Problems Prospects,34200425,cellbased approach gene therapy arises promising strategy provide safe targeted efficient gene delivery Owing unique feature homing tumortropism mesenchymal stem cell MSCs recently introduced encouraging vehicle gene therapy Nevertheless nonviral transfer nucleic acid MSCs remains limited due various factor related main stakeholder process eg nucleic acid carrier cell review summarized main type nucleic acid used transfect MSCs pro con application emphasized efficient lipidbased carrier nucleic acid MSCs main feature application myriad study demonstrated therapeutic potential engineered MSCs therapy various illness optimization clinical use ongoing challenge way improvement genetically modified MSCs combined various novel technique tool eg exosomes spheroid 3DBioprinting etc aiming efficient safe application biomedicine,3d-bioprinting;covid-19;cell therapy;gene therapy;mesenchymal stem cell;niosome;non-viral gene delivery;transfection
Pregnancy Opioid Crisis Heightened Effects COVID19,34282083,opioid epidemic continues affect pregnant woman opioid use disorder adversely unique enduring way onset coronavirus disease 2019 COVID19 pandemic necessary public health measure implemented slow transmission increased barrier care woman commentary explores implication measure discus strategy developed manage challenge based work clinical trial providing patient navigation pregnant mother OUD believe solution applied medical behavioral health research setting pandemic beyond increase quality care resource vulnerable population,
Clinical trial enrollment rural satellite hospital COVID19 pandemic,34367680,Introduction Controlled clinical trial CCTs traditionally limited urban academic clinical center Implementation CCTs rural setting challenged lack resource inexperience patient care team member CCT conductance workflow interruption global inexperience remote data monitoring Methods report experience coronavirus disease 2019 COVID19 pandemic activating remote monitoring multicenter clinical trial Study Efficacy Safety Canakinumab Treatment cytokine release syndrome CRS Participants COVID19induced Pneumonia CANCOVID trial ClinicalTrialsgov Identifier NCT04362813 rural satellite hospital VCU Health Community Memorial Hospital VCUCMH South Hill VA part larger VCU Health network lead institution VCU Health Medical College Virginia Hospital VCUMCV Richmond VA used local resource facility remote guidance oversight VCUMCV resource using closedloop communication network Investigational pharmacy pathology nursing essential operate work coordination lead institution Results Fiftyone patient COVID19 enrolled May August 2020 35 69 VCUMCV 16 31 VCUCMH Among patient enrolled VCUCMH 375 female 625 Black median age 60 interquartile range 5668 year Conclusion Local decentralization trial experience gave rural patient access novel treatment also accelerated enrollment diverse participant representative target population,covid-19;sars-cov-2;canakinumab;clinical trial;telemedicine
Metagenomic identification new sarbecovirus horseshoe bat Europe,34282196,source COVID19 pandemic unknown natural host progenitor sarbecovirus thought Asian horseshoe rhinolophid bat identified sequenced novel sarbecovirus RhGB01 British horseshoe bat western extreme rhinolophid range result extend geographic specie range sarbecoviruses suggest presence throughout horseshoe bat distribution Within spike protein receptor binding domain excluding receptor binding motif RhGB01 77 SARSCoV2 81 SARSCoV amino acid homology apparently lacking hACE2 binding ability hence unlikely zoonotic without mutation RhGB01 present opportunity SARSCoV2 sarbecovirus homologous recombination finding highlight natural distribution sarbecoviruses opportunity recombination intermediate host coinfection underestimated Preventing transmission SARSCoV2 bat critical current global mass vaccination campaign virus,
Advancing lung organoids COVID19 research,34219165,COVID19 pandemic emphasised need develop effective treatment combat emerging virus Model system poorly represent virus cellular environment however may impede research waste resource Collaborations cell biologist virologist led rapid development representative organoid model system study severe acute respiratory syndrome coronavirus 2 SARSCoV2 believe lung organoids particular advanced understanding SARSCoV2 pathogenesis laid foundation study future pandemic virus develop effective treatment,
Current perspective COVID19 neurology mechanistic insight,34353250,SARSCoV2 novel coronavirus causative organism Covid19 pandemic wreaked havoc worldwide producing asymptomatic symptomatic case leading significant morbidity mortality even infection country reported mortality rate 23 majorly due cardiorespiratory failure Recent study highlighted neurological involvement playing key role cardiorespiratory failure symptom headache anosmia ageusia observed Covid19 patient Studies suggests SARSCoV2 entry via olfactory epithelium OE expression type 2 transmembrane serine protease TMPRSS2 addition angiotensin converting enzyme 2 ACE2 facilitate SARSCoV2 neurotropism virus either travel via peripheral blood vessel causing endothelial dysfunction triggering coagulation cascade multiple organ dysfunction reach systemic circulation take different route blood brain barrier BBB disrupting BBB causing neuroinflammation neuronal excitotoxicity resulting development encephalitis encephalopathy seizure stroke SARSCoV2 invasion brain stem believed responsible cardiorespiratory failure observed Covid19 patient Apart viral invasion via hematogenous route SARSCoV2 neural invasion via PNS nerve terminal resulting viral replication retrograde transportation soma leading invasion CNS including brain producing neurological manifestation disease either initial stage course disease even long period post infection many case ACE2 receptor expressed brain glial cell SARSCoV2 act via neuronal well nonneuronal pathway exact cell type involved trigger inflammatory pathway need indepth study development targeted therapy,covid-19;sars-cov-2;neurology;post covid-19 syndrome
Promising Enzymes Inhibitors Development COVID19,34353251,Since outbreak COVID19 epidemic nearly year COVID19 brought painful disaster people world threatens life health also induces economic crisis present promising method eradicate COVID19 mainly include drug vaccine Enzyme inhibitor always reliable strategy treatment related disease Scientists worldwide worked together study COVID19 obtained structure key SARSCoV2 associated enzyme reported research inhibitor enzyme article summarizes COVID19related enzyme inhibitor recent development mainly including 3CLpro PLpro TMPRSS2 RdRp inhibitor hoping provide valuable weapon ensuing battle COVID19,3clpro;covid-19;dpp-4;inhibitors;plpro;rdrp;sars-cov-2;tmprss2
Comparative Study SARSCoV2 SARSCoV1 MERSCoV HCoV229E Influenza Host Gene Expression Asthma Importance Sex Disease Severity Epithelial Heterogeneity,34198852,Epithelial characteristic underlying differential susceptibility chronic asthma SARSCoV2 COVID19 viral infection currently unclear revisiting transcriptomic data patient Th2 low versus Th2 high asthma well mild moderate severe asthmatic characterized change expression human coronavirus influenza viral entry gene relative sex airway location disease endotype found sexual dimorphism expression SARSCoV2related gene ACE2 TMPRSS2 TMPRSS4 SLC6A19 ACE2 receptor downregulation occurred specifically female Th2 high asthma protease broadly assisting coronavirus influenza viral entry TMPRSS2 TMPRSS4 highly upregulated sex Overall change SARSCoV2related gene expression specific Th2 high molecular endotype asthma different asthma severity airway location downregulation ACE2 COVID19 SARS ANPEP HCoV229E viral receptor wascorrelated loss club ciliated cell Th2 high asthma Meanwhile increase DPP4 MERSCoV ST3GAL4 ST6GAL1 influenza associated increased goblet basal activated cell Overall study elucidates sex airway location disease endotype change epithelial heterogeneity potential factor underlying asthmatic susceptibility lack thereof SARSCoV2,covid-19;hcov-229e;mers;sars;allergy;asthma;epithelium;gene expression;inflammation;influenza;sexual dimorphism;virus
Concurrent COVID19 infection child acute appendicitis report three case,34221211,Literature describing patient concomitant COVID19 infection acute appendicitis pediatric patient growing understanding clinical picture patient relevant treatment report 3 male child surgically treated acute appendicitis concomitant SARSCoV2 infection first patient 12yearold male presented symptom indicative appendicitis respiratory symptom associated COVID19 eg cough shortness breath Laboratory evaluation revealed leukopenia elevated Creactive protein imaging consistent acute appendicitis acute pulmonary viral infection Though lacked diffuse peritonitis physical examination leukocytosis found perforated appendicitis operating room second patient another 12yearold male whose suspected appendicitis confirmed via ultrasound surgery tested positive COVID19 1 month prior continued test positive infection admission without associated respiratory symptom third patient 13yearold patient also presented symptomatic acute appendicitis without apparent COVID19 manifestation case provide example pediatric patient concomitant acute appendicitis COVID19 infection namely unusual presentation perforated appendicitis asymptomatic COVID19related pulmonary infection common acute appendicitis asymptomatic COVID19 infection,appendicitis;covid-19;pediatric;sars-cov-2
Viral Dynamics RealTime RTPCR Ct Values Correlation Disease Severity COVID19,34203738,Realtime RTPCR considered gold standard confirmatory test coronavirus disease 2019 COVID19 However many scientist disagree essential understand several factor variable cause falsenegative test context cycle threshold Ct value utilized diagnose predict SARSCoV2 infection practice significant clinical utility Ct value correlated viral load addition Ct value strong correlation multiple haematological biochemical marker However essential consider Ct value might affected preanalytic analytic postanalytical variable collection technique specimen type sampling time viral kinetics transport storage condition nucleic acid extraction viral RNA load primer designing realtime PCR efficiency Ct value determination method Therefore understanding interpretation Ct value influential factor could play crucial role interpreting viral load disease severity several clinical study consisting small large sample size several discrepancy exist regarding significant positive correlation Ct value disease severity COVID19 context revised review literature conducted fill knowledge gap regarding correlation Ct value severityfatality rate patient COVID19 Various database PubMed Science Direct Medline Scopus Google Scholar searched April 2021 using keywords including `` RTPCR viral load `` SARSCoV2 RTPCR `` Ct value viral load `` Ct value COVID19 Research article extracted selected independently author included present review based relevance study current narrative review explores correlation Ct value mortality disease progression severity infectivity also discus factor affect value collection technique type swab sampling method etc,covid-19;ct values;rt-pcr;sars-cov-2;mortality;severity;viral load
Sweden s coronavirus strategy Public Health Agency site controversy,34226854,contrast vast majority Western country Sweden left large segment society open instead imposing lockdown combat spread coronavirus result Swedish COVID19 measure largely devised expert agency health garnered widespread international attention Despite global interest corona strategy Public Health Agency Sweden PHAS currently systematic study COVID19 policy present investigation focus controversy characterized PHAS work reference risk assessment facemasks voluntarism testing protection elderly pandemic Overall inquiry demonstrates PHAS risk assessment initially overly optimistic facemask recommendation conflict large segment scientific community extensive period Yet voluntary measure worked moderately well testing PHAS manage deliver promise time whereas several measure implemented protect elderly deemed inadequate late,covid-19;sweden;controversy;facemasks;pandemic;public health agency;risk;testing;the elderly;voluntarism
DEELIG Deep Learning Approach Predict ProteinLigand Binding Affinity,34290496,Proteinligand binding prediction extensive biological significance Binding affinity help understanding degree proteinligand interaction useful measure drug design Proteinligand docking using virtual screening molecular dynamic simulation required predict binding affinity ligand cognate receptor Performing analysis cover entire chemical space small molecule requires intense computational power Recent development using deep learning enabled u make sense massive amount complex data set ability model `` learn intrinsic pattern complex plane data strength approach incorporated convolutional neural network find spatial relationship among data help u predict affinity binding protein whole superfamily toward diverse set ligand without need docked pose complex user input model trained validated using stringent methodology feature extraction model performs better comparison existing method used widely suitable prediction highresolution protein crystal 25 nonpeptide ligand individual input approach network construction training proteinligand data set prepared inhouse yielded significant insight also tested DEELIG COVID19 main proteaseinhibitor complex relevant current public health scenario DEELIGbased prediction incorporated existing database including RSCB PDB PDBMoad PDBbind filling missing binding affinity data proteinligand complex,binding affinity;pdb;convolutional neural networks;deep learning;drug discovery;protein-ligand binding;supervised learning
Sensitive Specific Immunohistochemistry Protocol Nucleocapsid Protein Common SARSCoV2 Virus Strains FormalinFixed Paraffin Embedded Tissues,34287344,Human coronavirus disease 2019 COVID19 lifethreatening highly contagious disease caused coronavirus SARSCoV2 Sensitive specific detection SARSCoV2 viral protein tissue cell COVID19 patient support investigation biologic behavior tissue cell tropism virus identified commercially available affinitypurified polyclonal antibody raised nucleocapsid spike protein SARSCoV2 provide sensitive specific detection virus immunohistochemistry formalinfixed paraffinembedded tissue Two immunohistochemistry protocol presented mutually validated matched detection pattern two distinct viral antigen virusinfected cell within autopsy lung tissue COVID19 deceased patient Levels nucleocapsid protein lung COVID19 decedent measured quantitative histocytometry immunohistochemistry image showed excellent loglinear relationship level viral nucleocapsid RNA level measured qRTPCR Importantly since nucleocapsid protein sequence conserved across known viral strain nucleocapsid immunohistochemistry protocol expected recognize common variant SARSCoV2 Negative control include autopsy lung tissue patient died nonCOVID19 respiratory disease control rabbit immunoglobulin Sensitive detection SARSCoV2 human tissue provide insight viral tissue cell distribution load patient active infection well provide insight clearance rate virus later COVID19 disease stage protocol also expected readily transferable detect SARSCoV2 protein tissue experimental animal model animal suspected serve viral reservoir,sars-cov-2;immunohistochemistry protocols;nucleocapsid protein;spike protein
Cardiac involvement MRI young population COVID19 single tertiary center experience,34286876,BACKGROUND Coronavirus 2019 COVID19 cause morbidity mortality increasing number people worldwide Although mainly affect respiratory system influence organ including heart associated broad spectrum widespread cardiovascular problem ranging mild myocardial injury fulminant myocarditis aimed evaluate presence prevalence cardiac involvement asymptomatic symptomatic patient recovered COVID 19 infection METHODS total 100 consecutive patient COVID19 proven reverse transcription polymerase chain reaction RTPCR 40 year age without known additional chronic disease analyzed retrospectively cardiac magnetic resonance CMR result symptom RESULTS Cardiac involvement detected 49 100 patient CMR imaging cardiac involvement group number patient chest pain andor dyspnea 41 84 statistically significant p = 0001 Twentyfour patient 47 without cardiac involvement group asymptomatic also statistically significant p = 0001 LV ejection fraction statistically significantly lower group cardiac involvement 61 v 66 p = 0001 LV stroke volume tricuspid annular plane systolic excursion TAPSE statistically significantly lower patient cardiac involvement p = 0028 p = 0019 respectively CONCLUSION Based single center experience myocardial involvement common symptomatic patient COVID19 study needed longterm side effect clinical result patient,covid-19;cardiac mr;cardiac involvement;chest pain;dyspnea;myocarditis
Temporal variation COVID19 epidemiological discussion practical application,34369194,OBJECTIVE aimed characterize temporal variation coronavirus disease 2019 COVID19 infection mortality possible tool monitor control spread disease METHODS analyzed cyclicity synchronicity case COVID19 infection time series death using Fourier transform inverse method statistical treatment Epidemiological index eg case fatality rate used quantify observation time series possible cause shortterm variation reviewed RESULTS observed shortterm longterm variation COVID19 time series short cycle 7 day synchronized among country periodicity believed caused weekly cycle community social factor combined diagnostic reporting cycle could also related virushostcommunity dynamic CONCLUSION observed synchronized weekly cycle could serve herd defense providing form social distancing time effect temporal distancing could enhanced combined spatial distancing Integrated spatiotemporal distancing therefore recommended optimize infection control strategy taking account quiescent active interval COVID19,covid-19 epidemiology;covid-19 weekly cycle;coronavirus disease 2019;fourier transform;epidemic disease temporal variation;time-series analysis
Description Analysis Cytokine Storm Registered COVID19 Clinical Trials Systematic Review,34199506,purpose systematic review describe characteristic clinical trial focused COVID19 patient cytokine release syndrome CRS variability CRS definition Two author independently searched three clinical trial registry included interventional clinical trial COVID19 hospitalized patient required least one elevated inflammatory biomarker Relevant data including type cutoff measured biomarker oxygenrespiratory criterion fever radiologic criterion medication summarized total 47 clinical trial included included study considered following criterion oxygenrespiratory criterion 42 trial 89 radiologic criterion 29 trial 62 fever 6 trial 18 Serum ferritin measured 35 trial 74 CRP 34 trial 72 Ddimer 26 trial 55 LDH 24 trial 51 lymphocyte count 14 trial 30 IL6 8 trial 17 cutoff value variable included biomarkers commonly used medication tocilizumab 15 trial 32 anakinra 10 trial 244 systematic review found high variability CRS definition associated biomarker cutoff value COVID19 clinical trial call standardized definition CRS especially COVID19 patient,cytokine release syndrome;cytokine storm;definition;systematic review
Hyperimmune plasma three immunodeficient patient affected nonsevere prolonged COVID19 singlecenter experience,34210259,BACKGROUND Convalescent plasma CP hyperimmune plasma HP passive immunotherapy consisting infusion plasma recovered people infected patient Following preexisting evidence many viral disease SARS MERS Ebola CP HP also proposed treatment COVID19 Nevertheless due lack large welldesigned clinical trial clearcut guideline exist subtype patient CP HP administered CASE PRESENTATION reported case 3 patient immunosuppressed affected nonsevere prolonged COVID19 treated HP whose neutralizing titer higher 180 first patient 55yearold male undergone lung transplant therapy Tacrolimus developed nonneutralizing antibody SARSCoV2 second patient 77yearold female affected follicular lymphoma tested positive SARSCoV2 6 month third 60yearold patient affected chronic leukemia develop antibody 2month disease 3 patient received HP tested negative SARSCoV2 within 2 week CONCLUSION Despite encouraging initial data strong evidence exist support CP HP treat COVID19 experience although limited due reduced number patient found good safety efficacy HP 3 immunodeficient subject data needed order ass whether subtype patient may particularly benefit passive immunization,covid-19;convalescent plasma;hyperimmune plasma;immunodeficiency;sars-cov2
Impact Coronavirus Pandemic Substance Use Disorder Treatment Findings Survey Specialty Providers California,34285496,Background coronavirus pandemic public health emergency begin ebb United States policymakers provider need evaluate addiction treatment system functioned public health emergency draw lesson future emergency One important question whether pandemic curtailed use addiction treatment extent telehealth able mitigate access barrier Methods begin answer question conducted survey specialty addiction treatment provider California June 2020 July 2020 survey focused specifically provider organization served Medicaid beneficiary Results 133 respondent 50 reported decrease patient since stayathome order March 2020 largest decline among new patient 58 said patient relapsing Eightyone percent provider said telemedicine use increased since stayathome order said telemedicine moderately 48 completely 30 addressed access barrier Conclusion effort needed ensure patient particular new patient receive addiction treatment public health emergency,covid-19;substance use disorders;addiction;telemedicine
Pathogenesis Diagnosis Treatment Hemostatic Disorders COVID19 Patients,34377558,novel coronavirus infection named COVID19 first detected Wuhan China December 2019 responsible significant morbidity mortality score country time article written number infected deceased patient continued grow worldwide patient severe form disease suffer pneumonia pulmonary insufficiency many case disease generalized cause multiple organ failure dysfunction physiological system One serious prognostically ominous complication COVID19 coagulopathy particular decompensated hypercoagulability risk developing disseminated intravascular coagulation case local diffuse macro microthromboses present condition cause multipleorgan failure thromboembolic complication cause pathogenic mechanism coagulopathy COVID19 remain largely unclear associated systemic inflammation including socalled cytokine storm Despite relatively short period ongoing pandemic laboratory sign serious hemostatic disorder identified measure specific prevention correction thrombosis developed review discus cause COVID19 coagulopathies associated complication well possible approach early diagnosis prevention treatment,covid-19;anticoagulants;coronavirus;cytokine storm;hemostatic disorders;thrombosis
Eating Habits COVID19 Lockdown Italy Nutritional Lifestyle Side Effects Pandemic,34209271,limit spread coronavirus SARSCoV2 nationwide lockdown started Italy March 2020 unpredictable situation crosssectional study using online questionnaire carried Observatory Food Surplus Recovery Waste CREA Food Nutrition Centre aim work evaluate Italian habit changed period determinant change effect food waste prevention sample 2678 respondent 62 showed low Adherence Mediterranean Diet AMD lockdown many participant improved quality diet increasing consumption fruit 244 vegetable 285 legume 221 nut 12 fish shellfish 14 Unfavorable change observed excessive consumption sweet pastry 369 comfort food 227 lack physical activity 372 main novelty study examination dietary change identified cluster analysis Respondents generally high AMD improved eating habit habit respondent generally low AMD remained unchanged addition nearly 80 respondent sensitive food waste study provides useful contribution debate nutritional recommendation case lockdown,italy;mediterranean diet;sars-cov-2;eating habits;food waste;lifestyle;lockdown;physical activity
Delayed RTPCR TimeToPositivity adult SARSCoV2 Infection,34343115,Early diagnosis among crucial measure control spread SARSCoV2 infection date reverse transcription polymerase chain reaction RTPCR gold standard COVID19 testing various factor affect performance leading false negative result Hereby present patient high clinical suspicion COVID19 multiple negative RTPCR result 5 day 22yearold woman presented fever dry cough nausea myalgia headache mild dyspnea Eleven day close contact father tested positive COVID19 RTPCR nasopharyngeal oropharyngeal swab performed day 8 9 12 illness came back negative even started worsening dyspnea showing increased lung opacity radiographic finding day 11 illness Interestingly rapid antibody test VivaDiag COVID19 IgMIgG rapid test VivaChek Biotech HangZhou China positive antiSARSCoV2 Ig Ig G Due worsening condition referred tertiary hospital RT PCR result positive day 13 illness 28 day first symptom discharged hospital improved symptom chest Xray conclusion patient high suspicion COVID19 repeat swab test mandatory previous test negative diagnosis treatment plan COVID19 solely based RTPCR also consider patient s history symptom laboratory result radiographic finding,rt-pcr;sars-cov-2;false negative;time-to-positivity
Gastrointestinal symptom healthcare utilization increased among patient functional gastrointestinal motility disorder COVID19 pandemic,34378840,BACKGROUND coronavirus disease 2019 COVID19 pandemic led unprecedented disruption healthcare Functional gastrointestinal motility disorder FGIMD associated significant healthcare utilization clinical implication healthcare disruption due COVID19 pandemic clinical outcome patient FGIMD unclear METHODS performed retrospective study patient three common FGIMD irritable bowel syndrome IBS gastroparesis functional dyspepsia FD tested SARSCoV2 describe alteration gastrointestinal symptom medication use healthcare utilization pandemic factor associated COVID19 KEY RESULTS prevalence COVID19 pandemic 032020092020 320 832592 among patient FGIMD 362 IBS 571574 307 gastroparesis 23749 244 FD 291187 institution Patients FGIMD increased abdominal pain nauseavomiting diarrhea constipation weight loss p 0001 along increased proton pump inhibitor H2 blocker opioid use p 00001 inpatient hospitalization outpatient visit p 00001 number diagnostic test including crosssectional imaging p = 0002 upper lower endoscopy p 00001 significantly higher pandemic compared 6 month prior Diarrheapredominant IBS positively 237 95 CI 134419 p = 0003 associated COVID19 whereas functional dyspepsia negatively 046 95 CI 027079 p = 0004 associated CONCLUSIONS INFERENCES Patients common functional gastrointestinal motility disorder reported gastrointestinal symptom COVID19 pandemic concurrent increased medication use healthcare utilization,covid-19;sars-cov-2;functional gi and motility disorders;functional dyspepsia;gastroparesis;healthcare utilization;irritable bowel syndrome
machine learning based exploration COVID19 mortality risk,34214101,Early prediction patient mortality risk pandemic decrease mortality assuring efficient resource allocation treatment planning study aimed develop compare prognosis prediction machine learning model based invasive laboratory noninvasive clinical demographic data patient day admission Three Support Vector Machine SVM model developed compared using invasive noninvasive group result suggested noninvasive feature could provide mortality prediction similar invasive roughly par joint model Feature inspection result SVMRFE sparsity analysis displayed compared invasive model noninvasive model provide better performance fewer number feature pointing presence high predictive information content several noninvasive feature including SPO2 age cardiovascular disorder Furthermore invasive model able provide better mortality prediction imminent future noninvasive feature displayed better performance distant expiration interval Early mortality prediction using noninvasive model give u insight intervene Combined novel technology wireless wearable device model create powerful framework various medical assignment patient triage,
Epidemiological coinfection characteristic common human coronaviruses Shanghai 20152020 retrospective observational study,34350810,coronavirus disease COVID19 pandemic major challenge worldwide However epidemic potential common human coronaviruses HCoVs remains unclear study aimed determine epidemiological coinfection characteristic common HCoVs individual influenzalike illness ILI severe acute respiratory infection SARI retrospective observational multicentre study used data collected patient admitted nine sentinel hospital ILI SARI January 2015 December 2020 Shanghai China prospectively tested patient total 22 respiratory pathogen using multirealtime polymerase chain reaction 4541 patient tested 4037 18334541 tested positive respiratory pathogen 359 1634541 tested positive common HCoVs HCoV infection common nonendemic season respiratory pathogen odds ratio 233 95 confidence interval 164331 HCoVOC43 4172 68163 common type HCoV detected coinfection rate 3129 51163 among 163 HCoVpositive case HCoV229E 5313 1732 HCoV type frequently associated coinfection Respiratory pathogen responsible coinfections HCoVs included parainfluenza virus rhinovirusenterovirus influenza virus adenovirus Furthermore identified one patient coinfected HCoVOC43 HCoVNL63HKU1 prevalence common HCoVs remains low ILISARI case Shanghai However seasonal pattern HCoVs may opposite respiratory pathogen Moreover HCoVs likely coexist specific respiratory pathogen potential role coinfections HCoVs pathogenic microorganism infection pathogenesis ILI SARI warrant study,sars-cov-2;co-infection;human coronavirus;respiratory pathogen
Mild COVID19 disease healthcare worker German university clinic `` first wave University Medical Center HamburgEppendorf,34374799,BACKGROUND Healthcare worker among exposed potentially threatened population ongoing COVID19 pandemic Despite report number infection SARSCoV2 German healthcare worker course clinical presentation affected COVID19 well described OBJECTIVE contribution characteristic progression infected case among healthcare worker University Medical Center HamburgEppendorf first wave COVID19 pandemic presented METHODS 1 July 28 July 2020 67 healthcare worker previously tested positive SARSCoV2 via PCR invited via Email participate anonymous online questionnaire 39 person participated RESULTS Participants 58 mostly =39 year old 64 female 70 healthcare worker involved direct patient management 85 including contact SARSCoV2 positive patient 62 participant reported acute symptom median duration 19 day frequent symptom fatigue 85 anosmia 67 cough 64 headache 62 shortness breath 51 disease course mostly mild low admission rate 5 Ongoing symptom lasting four week postsymptomonset particularly anosmia fatigue shortness breath reported 38 group frequently preexisting condition 53 vs 12 p= 0010 specifically hypertension 27 vs 4 p= 0062 DISCUSSION Healthcare worker reported mostly mild course COVID19 despite increased contact SARSCoV2 patient However reported persistent symptom month infection,covid-19;course of disease;healthcare workers;infections;sars-cov2
Hereditary Chorea Associated Aggravated Systemic Lupus Erythematosus,34336483,Chorea caused number condition including genetic metabolic derangement infection drug toxin tumor disorder immune inflammatory system body Huntington s disease HD common genetic cause chorea Systemic lupus erythematosus SLE autoimmune condition Common symptom include oral ulcer joint pain malar discoid rash photosensitivity blood dyscrasia involve heart lung kidney brain SLE cause neuropsychiatric manifestation like psychosis seizure headache confusion stroke Chorea known symptom SLE HD recognized involve one system associated number comorbid condition report first case hereditary choreiform disorder associated aggravated SLE also first case report probable Huntington disease Balochistan Pakistan report 19yearold girl choreiform disorder family history chorea Choreiform disorder present paternal grandmother uncle presented fever cough aggravation choreiform movement upper lower limb 10 day also complained pain small joint hand foot oral ulcer hair loss aggravation choreiform movement two half month Probable differential diagnosis HD Wilson s disease type hereditary chorea aggravated infection SLE Covid19 made initial lab result revealed pancytopenia increased Ddimers serum ferritin positive antinuclear antibody ANA antidoublestranded DNA antidsDNA C3 C4 complement factor low rest lab test result including polymerase chain reaction PCR coronavirus disease COVID19 blood culture malaria negative Thus diagnosis hereditary chorea associated aggravated SLE made Hereditary choreiform disorder associated aggravated autoimmune condition like SLE Thus recommended vigilant low threshold diagnosing coexisting autoimmune condition like SLE patient hereditary choreiform disorder,case report;chorea;co-morbids of huntington's disease;comorbids of sle;hereditary chorea in balochistan;huntington's disease;inherited choreiform disorder;pakistan;sle
Role Multifunctional Cytoskeletal Filaments Coronaviridae Infections Therapeutic Opportunities COVID19 Nutshell,34359986,novel coronavirus discovered 2019 new strain Coronaviridae family CoVs previously identified human known SARSCoV2 Severe Acute Respiratory Syndrome Coronavirus2 whilst COVID19 name disease associated virus SARSCoV2 emerged one year ago still haunt human community throughout world causing healthcare socioeconomic problem SARSCoV2 spreading many uncertainty treatment prevention data available limited randomized controlled trial data efficacy antiviral immunomodulatory agent SARSCoV2 mutant considered unique within Coronaviridae family insofar spread rapidly severe effect health Although scientific world succeeding developing vaccine medicine combat COVID19 appearance spread new aggressive mutant posing extra problem treatment Nevertheless understanding pandemic increasing significantly due outbreak leading development many different pharmacological immunological treatment Review focus subset COVID19 research primarily cytoskeletonrelated physiological pathological process coronaviruses SARSCoV2 intimately involved discovery exact mechanism subversion host cell SARSCoV2 critical validation specific drug target effective treatment,covid-19;sars-cov-2;cytoskeleton;drug targets;filaments
Validation onscreen applicationbased measurement shoulder range motion ROM telehealth medium,34352402,INTRODUCTION Shoulder range motion ROM assessment vital followup evaluation operated patient outcomebased research study aim study investigate accuracy reliability remote onscreen application app based method shoulder ROM measurement telehealth medium MATERIAL METHODS consultant shoulder surgeon boardcertified orthopedic resident medical graduate doctor served examiner cohort consisted 24 healthy volunteer 16 symptomatic patient expectant shoulder ROM deficit shoulder ROM first examined physically using goniometer clinic Zoom remote conferencing using protractor extension app chrome browser RESULTS Instrument validity examined comparing goniometer method protractor appbased method expert shoulder consultant using BlandAltman analysis showed minor mean difference healthy volunteer patient elevation 20 degree 50 degree abduction 20 degree 30 degree external rotation elbow adducted ER1 19 degree 02 degree external rotation elbow abducted 90 degree ER2 04 degree 4 degree internal rotation elbow abducted 90 degree IR 23 degree 12 degree respectively limit agreement LOA wellestablished minimum clinically important difference MCID value intraclass coefficient correlation ICC value varied 083 096 volunteer 090 098 patient meant excellent correlation two method interobserver reliability two examiner protractor appbased method evaluated ICC score excellent ranged 086 098 volunteer 088 099 patient Comparison protractor appbased method gold standard goniometer method resident graduate doctor showed excellent ICC value CONCLUSION Protractor appbased method measuring shoulder ROM telehealth medium accurate reliable compared clinical goniometer method validated method used remote telehealth consultation significant benefit saving patient travel time COVID19 even later,covid-19;goniometer;intraclass coefficient;protractor app;shoulder range of motion;telehealth
Improving Efficacy Regulatory Cell Therapy,34224053,Autoimmunity caused unbalanced immune system giving rise variety organspecific system disorder Patients autoimmune disease commonly treated broadacting immunomodulatory drug risk severe side effect Regulatory cell Tregs inherent capacity induce peripheral tolerance well tissue regeneration therefore prime candidate use cell therapy patient autoimmune disorder Pre clinical study using Treg therapy already established safety feasibility show clinical benefit However Tregs known functionally impaired autoimmune disease Therefore ex vivo manipulation boost stably maintain suppressive function necessary considering autologous transplantation Similar autoimmunity severe coronavirus disease 2019 COVID19 characterized exaggerated immune reaction altered Treg response light Tregbased therapy currently investigation treat severe COVID19 review provides detailed overview current progress clinical challenge Treg therapy autoimmune hyperinflammatory disease focus recent success ex vivo Treg manipulation,autoimmunity;covid-19;cell therapy;gene editing;rna interference;regulatory t cells
Association Low Vitamin K Status Mortality Cohort 138 Hospitalized Patients COVID19,34207745,recently hypothesized vitamin K could play role COVID19 aimed test hypothesis low vitamin K status common characteristic patient hospitalized COVID19 compared population control low vitamin K status predicts mortality COVID19 patient cohort 138 COVID19 patient 138 population control measured plasma dephosphorylateduncarboxylated Matrix Gla Protein dpucMGP reflects functional vitamin K status peripheral tissue Fortythree patient died within 90 day admission patient level dpucMGP differed significantly survivor mean 877 95 CI 778 995 nonsurvivors mean 1445 95 CI 1148 1820 Furthermore level dpucMGP pmolL considerably higher patient mean 1022 95 CI 912 1151 compared control mean 509 95 CI 485 540 Cox regression survival analysis showed increasing level dpucMGP reflecting low vitamin K status associated higher mortality risk sex ageadjusted hazard ratio per doubling dpucMGP 149 95 CI 103 224 association attenuated became statistically insignificant adjustment comorbidities sex age CVD diabetes BMI eGFR adjusted hazard ratio per doubling dpucMGP 122 95 CI 082 180 conclusion found low vitamin K status associated mortality patient COVID19 sex ageadjusted analysis analysis additionally adjusted comorbidities Randomized clinical trial would needed clarify potential role vitamin K course COVID19,covid-19;matrix gla protein;sars-cov-2;elastic fiber;thrombosis;vitamin k
Restoring NK cell functionality via cytokine activation enhances cetuximabmediated NKcell ADCC promising therapeutic tool HCC patient,34284214,Natural Killer NK cell considered first line defense viral infection tumor Several factor affect NK cytotoxic activity rendering dysfunctional thereby impeding ability scavenge abnormal cell part immune escaping mechanism induced different type cancer NK cell play crucial role augmenting activity various type anticancer mAb since dysfunctional NK cell main reason low response therapy light examined phenotypic character circulating NK cell isolated HCC patient compared healthy control dysfunctional NK cell HCC patient reactivated cytokine cocktail cytotoxic activity antiEGFR mAb `` cetuximab investigated showed downregulation patient NK cell activating receptor NKP30 NKP46 NKG2D CD16 well CD56 upregulation NKG2A inhibitory receptor also reported increase aberrant CD56 NK cell subset peripheral blood HCC patient compared healthy control Thus confirming dysfunctionality peripheral NK cell isolated HCC patient Cytokines reactivation NK cell lead upregulation NK activating receptor downregulation inhibitory receptor Moreover percentage aberrant CD56 NK cell subset reduced proved advanced HCC patient increased percentage immature noncytotoxic NK cell subset peripheral blood might account low cytotoxicity noticed patient significant improvement cytotoxicity HCC noticed upon using reactivated NK cell combined cetuximab Therefore study highlight potential recruitment NK immune cell along cetuximab enhance cytotoxicity HCC,adcc;covid-19;cetuximab;cytokines;nk reactivation;tumor
Comparative performance SARSCoV2 lateral flow antigen test association detection infectious virus clinical specimen singlecentre laboratory evaluation study,34226893,Background Lateral flow device LFDs rapid antigen testing set become cornerstone SARSCoV2 mass community testing although reduced sensitivity compared PCR raised question well identify infectious case Understanding capability limitation therefore essential successful implementation evaluated six commercial LFDs assessed correlation infectious virus culture PCR cycle threshold Ct value Methods singlecentre laboratory evaluation study headtohead comparison six LFDs commercially available UK Innova Rapid SARSCoV2 Antigen Test Spring Healthcare SARSCoV2 Antigen Rapid Test Cassette E25Bio Rapid Diagnostic Test Encode SARSCoV2 Antigen Rapid Test Device SureScreen COVID19 Rapid Antigen Test Cassette SureScreen COVID19 Rapid Fluorescence Antigen Test estimated specificity sensitivity LFDs using stored nasooropharyngeal swab collected St Thomas Hospital London UK routine diagnostic SARSCoV2 testing realtime RTPCR RTrtPCR Swabs inpatient outpatient department St Thomas Hospital healthcare staff department household contact SARSCoV2negative swab population confirmed RTrtPCR used comparative specificity determination sample collected March 23 Oct 27 2020 determined limit detection LOD test using viral plaqueforming unit PFUs viral RNA copy number laboratorygrown SARSCoV2 Additionally LFDs selected ass correlation antigen test result RTrtPCR Ct value positive viral culture Vero E6 cell analysis included longitudinal swab five infected inpatient varying disease severity Furthermore sensitivity available LFDs assessed swab n=23 collected Dec 4 2020 Jan 12 2021 confirmed positive RTrtPCR wholegenome sequencing B117 variant dominant genotype UK time study completion Findings LFDs showed high specificity =980 except E25Bio test 860 95 CI 779999 test reliably detected 50 PFUtest equivalent SARSCoV2 N gene Ct value 237 RNA copy number 3 x 10 6 mL Sensitivities LFDs clinical sample ranged 650 552736 890 814938 sensitivity increased greater 90 sample Ct value lower 25 test except SureScreen fluorescence SureScreenF test Positive virus culture identified 57 404 141 sample 54 947 positive culture swab Ct value lower 25 Among three LFDs selected detailed comparison test highest sensitivity Innova highest specificity Encode alternative technology SureScreenF sensitivity LFDs increased least 947 including sample detected viral growth Longitudinal study RTrtPCRpositive sample tested Innova Encode SureScreenF SureScreen visual SureScreenV test showed test identified infectious sample positive Test performance assessed Innova SureScreenV affected reassessed swab positive UK variant B117 Interpretation comprehensive comparison antigen LFDs virus infectivity found clear relationship Ct value quantitative culture infectious virus antigen LFD positivity clinical sample data support regular testing target group LFDs supplement current PCR testing capacity would help rapidly identify infected individual situation would otherwise go undetected Funding King s Together Rapid COVID19 Medical Research Council Wellcome Trust Huo Family Foundation UK Department Health National Institute Health Research Comprehensive Biomedical Research Centre,
Role Therapeutic Plasma Exchange TPE Multisystem Inflammatory Syndrome Children MISC,34208141,Multisystemic inflammatory syndrome child MISC new potentially lifethreatening disease related coronavirus disease 2019 COVID19 aim study reveal clinical laboratory result MISC role therapeutic plasma exchange TPE treatment Clinical laboratory radiological characteristic patient admitted pediatric ward pediatric intensive care unit PICU tertiary hospital diagnosis MISC April 2020 March 2021 included study Fortyone patient admitted hospital diagnosis MISC Twentyone 512 patient admitted PICU Six patient needed invasive mechanical ventilation 146 10 patient 244 TPE 3 patient 73 needed extracorporeal membrane oxygenation ECMO patient grouped according need PICU admission Group 1 need PICU Group 2 need PICU admission Group 2 significantly higher level Creactive protein CRP alanine aminotransferase ALT ferritin Ddimer proB type natriuretic peptide pro BNP lactate p 005 Hyponatremia found independent risk factor inpatient MISC PICU think dynamic laboratory trending beneficial determining need PICU admission TPE may effective critically ill patient,covid-19;mis-c;therapeutic plasma exchange
Monoclonal Antibodies Early Treatment COVID19 World Evolving SARSCoV2 Mutations Variants,34291118,Monoclonal antibody targeting receptor binding domain RBD severe acute respiratory syndrome coronavirus 2 spike protein important outpatient treatment option coronavirus disease 2019 mitigate progression disease prevent hospitalization impact different RBD mutation efficacy available monoclonal antibody process incorporating impact treatment algorithm ill defined Herein synthesize data surrounding impact key RBD mutation efficacy US Food Drug Administration Emergency Use Authorized monoclonal antibody describe approach Michigan Medicine monitoring mutation frequency circulating virus developing algorithm incorporates data outpatient treatment pathway,covid-19;sars-cov-2;bamlanivimab;bamlanivimab and etesevimab;casirivimab and imdevimab;variants
Suspected SARSCoV2 Reinfections Incidence Predictors Healthcare Use among Patients 238 US Healthcare Facilities June 1 2020 February 28 2021,34351392,retrospective cohort study among 131773 patient previous COVID19 reinfection SARSCoV2 suspected 253 02 patient 238 US healthcare facility June 1 2020 February 28 2021 Women displayed higher cumulative reinfection risk Healthcare burden illness severity similar index reinfection encounter,
Principles practice deploying flexible physician workforce COVID19 care ward Dutch hospital,34286205,COVID19 pandemic attainment required hospital workforce extremely challenging requirement create surge capacity COVID19 care ensure sustain regular hospital care ongoing COVID19 pandemic demand deployment flexible physician workforce cohort ward hospital successfully organised managed key principle followed Physicians ability practice general specialised medical skill COVID19 specific medical education re upskilling necessary approach future physician workforce may applicable several national healthcare system Solidarity flexibility transparency within medical staff cornerstone successful deployment physician flex pool hospital dealing pandemic,covid-19;capacity;workforce
Review early report epidemiological characteristic B117 variant SARSCoV2 spread worldwide,34218651,variant B117 severe acute respiratory syndrome coronavirus 2 SARSCoV2 RNA virus causing pandemic year worldwide reported United Kingdom UK late December 2020 reported mortality increase 65 transmissibility increase 70 may result increase reproduction number 113155 075085 analyze global increasing trend variant B117 extracted result B117 GISAID May 11 May 12 2021 conducted doseresponse regression took 47 day reach 20 121 day reach 50 among sequence submitted UK Korea case B117 increased since first report three case December 28 2020 Positive rate B117 Korea 216 week May 9 May 15 2021 Detection rate variant expected increase new variant SARSCoV2 emerging close monitoring control would maintained month,epidemics;epidemiology;sars-cov-2;variant;covid-19
Acute Pulmonary Embolism Thrombus Entrapped Patent Foramen Ovale Patient COVID19,34221885,61yearold patient presented syncope 1week history fever diagnosed COVID19 infection without pulmonary injury associated intermediaterisk bilateral pulmonary embolism Computed tomographic scan transesophageal echography performed confirming mobile intransit embolus originating right cavity extending right ventricle patent foramen ovale patient underwent surgical embolectomy without complication COVID19 found current risk factor patient could warrant consideration extending thromboprophylaxis indication COVID19 patient certain criterion even without hospitalization indication pulmonary injury,covid-19;cardiac thrombus;echocardiography;patent foramen ovale;pulmonary embolism
Awake Venovenous Extracorporeal Membrane Oxygenation Coronavirus Disease 2019 Acute Respiratory Failure,34286281,Implantation venovenous extracorporeal membrane oxygenation alternative invasive mechanical ventilation `` awake approach may facilitate lung diaphragmprotective ventilatory strategy without associated harm endotracheal intubation positive pressure ventilation continuous sedation report present characteristic outcome patient treated awake venovenous extracorporeal membrane oxygenation approach DESIGN Retrospective case series SETTING Monocenter study PATIENTS Severe acute respiratory syndrome coronavirus 2 patient acute respiratory failure treated venovenous extracorporeal membrane oxygenation instead invasive mechanical ventilation March 2020 March 2021 INTERVENTIONS None MEASUREMENTS MAIN RESULTS Physiologic laboratory data collected admission ICU prior venovenous extracorporeal membrane oxygenation implantation decannulation Seven patient treated venovenous extracorporeal membrane oxygenation instead invasive mechanical ventilation due hypoxemia median Pao2Fio2 ratio implantation 76 interquartile range 5992 Four patient awake group subsequently required invasive mechanical ventilation one patient 143 died significant complication attributed venovenous extracorporeal membrane oxygenation CONCLUSIONS report demonstrates selected group patient `` awake venovenous extracorporeal membrane oxygenation approach feasible may result favorable outcome,acute respiratory distress syndrome;coronavirus disease 2019;mechanical ventilation;mortality;noninvasive ventilation;venovenous extracorporeal membrane oxygenation
Role ACE2 pregnancy potential implication COVID19 susceptibility,34338772,time coronavirus disease 2019 COVID19 impact severe acute respiratory syndrome SARS coronavirus CoV 2 infection pregnancy still unclear presence angiotensinconverting enzyme ACE 2 ACE2 main receptor SARSCoV2 human placenta indicates organ vulnerable viral infection pregnancy However happen additional molecular process critical allow viral entry cell replication disease manifestation particularly placenta andor fetomaternal circulation Beyond risk vertical transmission COVID19 also proposed deplete ACE2 protein biological action placenta postulated effect may impair essential process placentation maternal hemodynamic adaptation COVID19 pregnancy feature also observed several disorder pregnancy review gather information indicating risk protective feature related ACE2 change COVID19 pregnancy First describe mechanism SARSCoV2 infection ACE2 main entry door current evidence viral infection placenta discus central role ACE2 physiological system reninangiotensin system RAS kallikreinkinin system KKS active placentation hemodynamic adaptation pregnancy Significant knowledge gap also identified urgently filled better understand fate ACE2 COVID19 pregnancy potential associated risk Emerging knowledge able improve early stratification highrisk pregnancy COVID19 exposure well guide better management followup mother child,covid-19;sars-cov-2;angiotensin converting enzyme 2;cardiovascular disease;placental biology;pregnancy
Characteristics Angiotensin Iconverting enzyme 2 type II transmembrane serine protease 2 4 tree shrew indicate potential animal model SARSCoV2 infection,34227905,Angiotensin Iconverting enzyme 2 ACE2 type II transmembrane serine protease 2 4 TMPRSS2 TMPRSS4 important receptor SARSCoV2 infection study fulllength tree shrewACE2 gene cloned sequenced biological information analyzed expression level ACE2 TMPRSS2 TMPRSS4 various tissue organ tree shrew detected result showed fulllength ACE2 gene tree shrew 2786 bp CDS 2418 bp encoding 805 amino acid Phylogenetic analysis based CDS ACE2 revealed tree shrew similar rabbit 8593 human 8547 far mouse 8281 rat 8258 silico analysis according binding site SARSCoV2 ACE2 receptor different specie predicted tree shrew potential SARSCoV2 infection possibility similar rabbit cat dog significantly higher mouse rat addition various tissue organ tree shrew expressed ACE2 TMPRSS2 TMPRSS4 Among kidney highly expressed ACE2 followed lung liver esophagus lung liver intestine kidney relatively high expression level TMPRSS2 TMPRSS4 general reported first time expression ACE2 TMPRSS2 TMPRSS4 various tissue organ tree shrew result revealed tree shrew could used potential animal model study mechanism underlying SARSCoV2 infection,ace2;tmprss2;tmprss4;tree shrew;tissue expression
BlockchainBased Traceability System Ensures Food Safety Measures Protect Consumer Safety COVID19 Free Supply Chains,34199825,world facing unprecedented socioeconomic crisis caused novel coronavirus infection COVID19 virus also spreading import export food supply chain Chinese authority discovered COVID19 virus various imported frozen meat package Traceability play vital role food quality food safety Internet Things IoT provides solution overseeing environmental condition product quality product traceability solution traditionally based centralized architecture guarantee tamperproof data sharing blockchain emerging technology provides tamperproof data sharing realtime article present blockchainenabled supply chain architecture ensure availability tamperproof audit trail tamperproof audit trail help make sure safety measure undertaken minimize risk COVID19 bacteria fungi parasite present frozen meat supply chain,covid-19;blockchain;cold supply chain;food safety;hyperledger fabric;meat supply chain
Measuring impact COVID19 pandemic organized cancer screening diagnostic followup care Ontario Canada provincial populationbased study,34217413,essential quantify impact COVID19 pandemic cancer screening including vulnerable subpopulations inform development evidencebased targeted pandemic recovery strategy undertook populationbased retrospective observational study Ontario Canada ass impact pandemic organized cancer screening diagnostic service ass whether pattern cancer screening service use diagnostic delay differ across population subgroups pandemic Provincial health database used identify ageeligible individual participated one Ontario s breast cervical colorectal lung cancer screening program January 1 2019December 31 2020 Ontario s screening program delivered 951000 41 fewer screening test 2020 2019 volume program remained 20 historical level end 2020 smaller percentage cervical screening participant older 5059 6069 year pandemic compared 2019 Individuals oldest age group lowerincome neighborhood significantly likely experience diagnostic delay following abnormal breast cervical colorectal cancer screening test pandemic individual high probability living First Nation reserve significantly likely experience diagnostic delay following abnormal fecal test Ongoing monitoring management backlog must continue evaluation required identify population access cancer screening diagnostic care disproportionately impacted quantify impact service disruption cancer incidence stage mortality information critical pandemic recovery effort aimed achieving equitable timely access cancer screeningrelated care,covid-19;cancer screening;diagnostic assessment;disparity
Ischemic stroke coronavirus disease 2019,34338841,article report two case patient coronavirus disease 2019 COVID19 occlusion large cerebral artery occurred occurred female patient early stage COVID19 second case late stage One female patient could successfully treated iv thrombolysis mechanical thrombectomy Coagulopathy course COVID19 result severe stroke poor outcome even younger patient respect etiology arterial occlusion COVID19induced hypercoagulopathy cardiomyopathy vasculitis necessity research,coagulopathy;embolism;large vessel occlusion;thrombectomy;thrombolytic therapy
Grip strength predictor disease severity hospitalized COVID19 patient,34217985,BACKGROUND Grip strength one main component physical functioning sarcopenia physical frailty OBJECTIVES explore role grip strength measurement admission predicting disease severity COVID19 METHODS Demographic data smoking status comorbidities COVID19 related symptom grip strength laboratory computed tomography CT finding admission noted Using Smedley hand dynamometer maximum grip strength value kg three measurement dominant side recorded Low grip strength defined two standard deviation genderspecific peak mean value healthy young adult 32 kg male 19 kg female Patients categorized three group according clinical CT finding Severe illness group pneumonia respiratory rate 30min oxygen saturation =90 extensive lung involvement CT Moderate illness group pneumonia CT score =11 Mild illness group normal CT finding RESULTS study population included 312 patient 140 F 172 distribution mild moderate severe disease group 369 510 122 respectively Cough fever dyspnea hypertension obesity cardiovascular disease CVD chronic obstructive pulmonary disease COPD frequent Creactive protein CRP ferritin Ddimer neutrophil level highest severe group p 05 Absolute grip strength value lowest frequency low grip strength highest severe group p 01 Since found significant difference stemming severe group combined mild moderate group nonsevere compared severe vs nonsevere group binary logistic regression analysis age gender body mass index smoking status presence comorbidities low grip strength abnormal laboratory finding taken analysis age odds ratio 1054 95 confidence interval CI 10201089 obesity 2822 95 CI 11436966 COPD 5699 95 CI 123126383 CRP level 1023 95 CI 10101036 low grip strength 3047 95 CI 11468103 observed independent predictor severe COVID19 disease p 05 CONCLUSIONS addition wellknown independent risk factor ie age obesity COPD CRP level low grip strength independently increased three time severity COVID19,coronavirus;frailty;hand;muscle;sarcopenia
Cumulative Adverse Event Reporting Anaphylaxis mRNA COVID19 Vaccine PfizerBioNTech Injections Japan FirstMonth Report,34347278,INTRODUCTION midFebruary nationwide immunization plan prevention coronavirus disease 2019 COVID19 started Japan first primarily focused health professional using mRNAbased vaccine PfizerBioNTech phasein period February March attention focused postvaccination anaphylaxis anaphylactoid symptom viewpoint ensuring safety vaccination program OBJECTIVE aim report provide update status anaphylaxis anaphylactoid symptom occurring vaccination COVID19 reported Adverse Event Following Immunization AEFI reporting system Japan METHODS Pharmaceutical Medical Devices Agency PMDA received AEFI report health professional manufacturer reporting system AEFI vaccination COVID19 operation since midFebruary 2021 Reported AEFIs anaphylaxis anaphylactoid symptom assessed using Brighton Collaboration Criteria ass diagnostic certainty RESULTS 1month since Japan started vaccination program COVID19 February 2021 578835 dos administered health professional PMDA receiving 181 suspected event report anaphylaxis anaphylactoid symptom 171 181 case woman developed symptom Among 181 case evaluated according Brighton Collaboration Criteria 47 case 26 classified level 13 reporting rate 81100000 dos CONCLUSION result appear similar reported AEFIs foreign study coronavirus vaccine administration health professional although reporting rate higher work needed examine causal relationship anaphylaxis reaction coronavirus vaccine administration Issues multiple reporting possible sexage bias also remain analyzed,
Case Immune Thrombocytopenia BNT162b2 mRNA COVID19 Vaccination,34285180,BACKGROUND Immune thrombocytopenic purpura ITP immune response destroys platelet increase risk bleeding range bruising intracranial hemorrhage ITP known complication coronavirus disease 2019 COVID19 first study BNT162b2 messenger RNA mRNA COVID19 vaccine report ITP incidence serious adverse event AEs low overall present case ITP complication BNT162b2 mRNA COVID19 vaccine CASE REPORT Three day receiving second dose BNT162b2 mRNA COVID19 vaccine 39yearold woman presented petechial rash trunk leg arm fatigue muscle ache time hospital admission platelet count 1000microL peripheral smear showed profound thrombocytopenia course patient s hospitalization treated 2 unit platelet 2 infusion iv immunoglobulin iv methylprednisolone platelet count increased 92 000microL day discharge prescribed tapered dose oral prednisone One day later rash resolved platelet count 243 000microL patient recovered completely complication CONCLUSIONS ITP considered severe AE BNT162b2 mRNA COVID19 vaccine Knowing early sign symptom ITP become increasingly important population receives vaccine Quick diagnosis management essential avoid lifethreatening bleeding,
photoelectrochemical aptasensor determination severe acute respiratory syndrome coronavirus 2 receptorbinding domain using graphitic carbon nitridecadmium sulfide quantum dot nanocomposite,34219971,Herein photoelectrochemical aptasensor quantitive measurement severe acute respiratory syndrome coronavirus2 receptorbinding domain SarsCov2 RBD reported first time purpose first graphitic carbon nitride gC3N4 cadmium sulfide CdS quantum dot fabricated characterized gC3N4 CdS mixed well fabricated nanomaterials characterized scanning transmission electron microscopy CdS QDsgC3N4 nanocomposite added solution containing chitosan aminerich polymer generate ChitosanCdSgC3N4 nanocomposite Subsequently surface ITO electrode modified ChitosanCdSgC3N4 amineterminal aptamer probe immobilized surface ChitosanCdS QDsgC3N4ITO electrode using glutaraldehyde amineamine crosslinker electrochemical performance electrode studied using cyclic voltammetry CV electrochemical Impedance Spectroscopy EIS photoelectrochemistry PEC surface coverage immobilized aptamer probe founded 262 pmolcm 2 obtained result demonstrated proposed photoelectrochemical aptasensor used measurement SarsCov2 RBD within 05320 nM limit detection LOD obtained 012 nM 3sigmaslope affinity AptamerChitosanCdS QDsgC3N4ITO also founded 34 nM using Langmuirtypical adsorption system proposed photoelectrochemical aptasensor applied measurement spiked SarsCov2 RBD human saliva sample two concentration effect interfering biomaterials human immunoglobulin G human immunoglobulin human immunoglobulin human serum albumin also studied,aptasensor;cadmium sulfide quantum dots;coronavirus disease 2019;graphitic carbon nitride;photo-electrochemical method;syndrome coronavirus 2 receptor-bonding domain
Previous SARSCoV2 infection linked lower vaccination intention,34289169,,
Plant Survival Severe Stress AntiViral Human Defense Perspective Calls Common Efforts,34211468,Reprogramming primary virusinfected cell critical step turn viral attack harmful human initiating superspreading cell organism population level develop early antiviral therapy proactive administration important understand first step process Plant somatic embryogenesis SE earliest studied model de novo programming upon severe stress contrast virus attack promotes individual cell organism survival argued transcript level profile target gene established vitro SE induction reference compared virusinduced profile identify differential virus trait link harmful reprogramming validate hypothesis selected standard set gene named ReprogVirus approach recently applied published resulted identifying CoVMACTED complex trait promising support combating SARSCoV2induced cell reprogramming primary infected nose mouth cell perspective aim explain rationale scientific approach highlighting relevant background knowledge SE emphasize role alternative oxidase plant reprogramming resilience learning tool designing human virusdefense strategy present list selected gene outlook announce wider data collection ReprogVirus Platform support antiviral strategy design common effort,reprogvirus;sars-cov-2;aerobic fermentation;alternative oxidase (aox);early cell reprogramming;somatic embryogenesis;stress tolerance;viral diseases
Using Bus Ticketing Big Data Investigate Behaviors Population Flow Chinese Suburban Residents PostCOVID19 Phase,34199900,Largescale population movement turn local disease widespread epidemic Grasping characteristic population flow context COVID19 great significance providing information epidemiology formulating scientific reasonable prevention control policy Especially postCOVID19 phase essential maintain achievement fight epidemic Previous research focus flight railway passenger travel behavior pattern China also numerous suburban resident nothigh economic level investigating travel behavior significant national stability However estimating impact COVID19 suburban resident travel behavior remains challenging lacking apposite data submit bus ticketing data including approximately 26000000 record April 2020August 2020 2705 station result indicate Suburban resident Chinese Southern region likely travel bus travel frequency higher Associated economic level find resident economically developed region likely travel carry various social activity Considering perspective traveling crowd find men young people easier travel bus however exactly main workforce indication finding suburban resident travel behavior affected profoundly economy consistent inherent behavior pattern COVID19 outbreak use typical region verification indeed case,bus ticketing big data;chinese suburban residents;population flow;post-covid-19 phases;spark distributed computing
Could Exogenous Insulin Ameliorate Metabolic Dysfunction Induced Glucocorticoids COVID19,34220705,finding highdose dexamethasone improves survival requiring critical care due COVID19 mean much greater usage glucocorticoid subsequent wave coronavirus infection Furthermore consistent finding adverse outcome COVID19 individual obesity hypertension diabetes focussed attention metabolic dysfunction may arise critical illness SARS coronavirus may promote relative insulin deficiency ketogenesis hyperglycaemia susceptible individual conjunction prolonged critical care component promote catabolic state Insulin infusion mainstay therapy treatment hyperglycaemia acute illness effect insulin admixture glucocorticoid COVID19 article review evidence effect insulin clinical outcome intermediary metabolism critical illness,coronavirus - covid-19;critical-illness;dexamethasone;glucocorticoid;insulin
SARSCoV2 Brain Know Causality Cognitive COVID,34362224,second year COVID19 coronavirus disease pandemic seen need identify ass longterm consequence SARSCoV2 infection individual s overall wellbeing including adequate cognitive functioning Cognitive COVID informal term coined interchangeably refer acute change cognition COVID19 andor cognitive sequela various deficit following infection may manifest altered level consciousness encephalopathylike symptom delirium loss various memory domain Dysexecutive syndrome peculiar manifestation Cognitive COVID well previous major outbreak virus like SARSCoV MERSCoV Influenza attempt understand underlying mechanism describing causality similar symptom following SARSCoV2 infection review therefore attempting highlight current understanding various direct indirect mechanism focusing role neurotropism SARSCoV2 general proinflammatory state pandemicassociated psychosocial stressor causality Cognitive COVID Neurotropism associated various mechanism including retrograde neuronal transmission via olfactory pathway general hematogenous spread virus using immune cell vector high amount inflammation caused COVID19 compounded potential intubation associated deleterious effect cognition well Finally pandemic s unique psychosocial impact raised alarm due possible effect cognition Furthermore surfacing report postCOVIDvaccination cognitive impairment vaccine containing mRNA encoding spike glycoprotein SARSCoV2 hypothesize causality way mitigate risk potential impact quality life individual fact even minor proportion COVID19 case developing cognitive impairment could significant burden already overwhelmed healthcare system across world make vital gather evidence regarding prevalence presentation correlation causality event reevaluate approach accommodate early identification management rehabilitation patient exhibiting cognitive symptom,covid-19;sars-cov-2;brain;cognitive;diagnosis;neurotropism;prevention
Evaluation potassium peroxymonosulfate MPS efficacy SARSCoV2 virus using RTqPCRbased method,34216737,,
Kinetics seroprevalence SARSCoV2 antibody comparison 3 different assay,34290329,Comparing seroprevalence antibody kinetics three different commercially available assay SARSCoV2 Serostatus COVID19 patient analyzed 5 month 10 month infection using three different assay Diasorin LIAISON Euroimmun Abbott Diagnostics ARCHITECT Seropositivity baseline differed significantly depending assay Diasorin 81 Euroimmun 83 Abbott 59 followup antibody level detected Diasorin assay stable significant loss seropositivity Euroimmun Abbott assay significant difference SARSCoV2 antibody kinetics based specific assay used,
Radiotherapy based management Covid19 pandemic systematic review presented consensus guideline,34214608,Treatment management cancer patient radiation oncology department current COVID19 pandemic challenging systematic review published consensusguidelines role radiotherapy prioritization suggested treatment protocol set management undertaken based PRISMA protocol PubMedPMC Scopus Google Scholar Web Science database 01202021 One hundred sixtyeight publication regional consensus included Summary recommendation contained 1 using hypofractionated HypoF regimen therapeuticpalliative indication 2 delaying radiotherapy several week pandemic 3 omitting radiotherapy replacement alternative therapy active surveillance 4 applying safer patient setup preparation protocol 5 developing telemedicinetelehealth service conclude essential carefully weigh risk exposure COVID19 infection benefit treating cancer patient pandemic Trying global guideline facing probable crisis crucial health care service,covid-19;oncology;pandemic;radiotherapy
Increased incidence postoperative respiratory failure patient preoperative SARSCoV2 infection,34225188,OBJECTIVE study reported increased postoperative pulmonary complication SARSCoV2 infection many limited use historical control focus le severe respiratory complication characterized association preoperative SARSCoV2 infection postoperative respiratory failure PORF DESIGN SETTING single center retrospective cohort study New York City March 14June 14 2020 PATIENTS Exclusion criterion age 18years obstetric procedure absence SARSCoV2 PCR testing preoperative respiratory failure total 778 patient met criterion 87 SARSCoV2 MEASUREMENTS primary outcome PORF included inability extubate =24 h unplanned reintubation within 5 day Multiple exposure measured including SARSCoV2 infection 4 week 5 day surgery Multivariable logistic regression performed adjust preoperative hypoxemia oxygen use pneumonia well tachycardia gender Charlson Comorbidity Index CCI Surgical Mortality Probability Model SMPM index perioperative blood transfusion MAIN RESULTS SARSCoV patient higher CCI P = 0007 SMPM score P = 002 incidence PORF 16 versus 7 uninfected comparators P = 0001 Amongst infected individual 39 exhibited symptom COVID19 PORF common patient compared asymptomatic individual 26 vs 9 P = 004 Adjusted analysis revealed increased odds PORF infection 28 95 CI 1262 persisted even adjusting probable mediator preoperative hypoxemia Infected patient also demonstrated increased adjusted odds 30day mortality 35 95 CI 1491 CONCLUSIONS Detection SARSCoV2 infection within 4 week 5 day surgery associated increased odds 5day PORF 30day mortality support delaying elective surgery question remain regarding applicability recommendation asymptomatic patient needing urgent semiurgent procedure oncologic surgery,coronavirus disease 2019 (covid-19);invasive mechanical ventilation;perioperative care;pneumonia;post-operative respiratory failure;severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
Rapid decline antiSARSCoV2 antibody patient haemodialysis COVIDFRIAT study,34211708,Background Coronavirus disease 2019 COVID19 patient haemodialysis HD high mortality investigated value reverse transcription polymerase chain reaction RTPCR dynamic change antibody enzymelinked immunosorbent assay immunoglobulin IgM + IgA andor IgG large HD cohort Methods conducted prospective observational study 10 Madrid HD centre Infection rate antiSARSCoV2 antibody dynamic incidence asymptomatic SARSCoV2 infection defined positive RTPCR IgM + IgA andor IgG assessed Results 1 March 15 April 2020 136 808 168 HD patient diagnosed symptomatic COVID19 RTPCR nasopharyngeal swab 42136 31 died second fortnight April RTPCR antiSARSCoV2 antibody assessed 763 surviving patient point 6991 758 symptomatic COVID19 patient antiSARSCoV2 antibody Four week later 154 1065 initially antibodypositive patient become negative Among patient without prior symptomatic COVID19 9672 13 RTPCR positive 101672 patient 150 antibody positive Four week later 6286 721 initially antibodypositive patient become negative Considering IgG titre serology remained positive 4 week 90 5460 patient symptomatic COVID19 525 2140 asymptomatic patient probability adequate serologic response defined development antiSARSCoV2 antibody persisted 4 week higher patient symptomatic COVID19 asymptomatic SARSCoV2 infection odds ratio 404 95 confidence interval CI 204799 corrected age Charlson comorbidity index score time HD Living nursing home 59 95 CI 23151 main risk factor SARSCoV2 infection Conclusions antiSARSCoV2 antibody immune response HD patient depends clinical presentation antibody titre decay earlier previously reported general population inadequate immune response raise question efficacy future vaccine,covid-19;sars-cov-2;antibodies;haemodialysis
Latin American ophthalmology practitioner s perception current COVID19 pandemic,34287515,PURPOSE ass perception Latin American ophthalmology practitioner regarding coronavirus disease 2019 COVID19 exposure risk knowledge personal protection measure prioritization patient METHODS Selfadministered voluntary anonymous survey Google Drive form distributed via text message ophthalmology practitioner May 01 May 05 2020 RESULTS Three hundred seventyone practitioner 45 response rate comprising 118 276 resident 111 405 ophthalmologist 142 328 subspecialists completed survey Among 106 326 thought high risk acquiring COVID19 course work Furthermore 273 691 believed current guideline insufficient identify COVID19 patient survey also revealed 265 595 trained use personal protective equipment PPE even correct use 341 915 still felt risk acquiring COVID19 Moreover 80 respondent view staff member knowledgeable national protocol attending COVID19 patient However 9 2 considered changing profession ameliorate COVID19 contagion risk CONCLUSION survey revealed issue faced ophthalmology practitioner Latin America routine practice concern anxiety COVID 19 pandemic seem worldwide important reinforce confidence ophthalmology practitioner current guideline attending COVID19 patient also necessary conduct training program PPE usage ensure PPE item available time enhance quality care minimize spread disease,
Understanding COVID19 Epidemiology Implications Control Experience Greek SemiClosed Community,34201868,BACKGROUND aimed estimate SARSCoV2 antigen antibody seroprevalence one worstaffected pandemic semiclosed community Greece Deskati evaluate sociodemographic clinical correlation functional antibody response METHODS Ag2019nCoV V1310V1330 Rapid Test Prognosis Biotech Greece used antigen detection Rapid Test 2019nCoV Total Ig V1210V1230 Prognosis Biotech Greece SARSCoV2 IgG II Quant method Architect Abbott Illinois USA used antibody testing RESULTS None participant positive antigen result SARSCoV2 seropositivity ranged 13 45 study population depending method Onethird participant known past infection positive antibody test result 77 + 13 day infection Twofifths infection determined serology asymptomatic advancing age hospitalization predicted seropositivity among patient past infection Half participant tested positive antibody aware past infection CONCLUSIONS Highburden context Greece Deskati far herd immunity threshold highlighted value lowcost serosurveys targeting symptomatic asymptomatic population evaluate natural immune response SARSCoV2 nonvaccinated susceptibles design evidencebased policy lifting lockdown,coronavirus;semi-closed community;seroprevalence
Role Threat Coping Appraisal Protection Motivation Adoption Preventive Behavior COVID19 Pandemic,34291027,100 million case 2 million death globally COVID19 pandemic continues remain major threat Identifying behavioral factor influencing preventive behavior COVID19 crucial devising public health policy promote essential strategy combat pandemic efficient manner current study therefore conducted estimate prevalence COVID19 preventive behavior measure association behavioral construct like threat perception response efficacy selfefficacy per sociodemographic background regionstratified online survey focusing construct protection motivation theory example threat coping appraisal preventive health practice COVID19 carried among adult user social medium India Generalized linear model clusteradjustedrobust standard error used analyze response model preventive practice among study population Analysis total 2646 response revealed proper perception regarding cause symptom transmission COVID19 prevalent majority respondent majority participant reported frequent use face mask 9320 followed frequent washing hand soap water 8490 majority respondent affirmed though frequently sometimes avoid touching face unclean hand Frequently covering mouth crook elbow sneezing coughing maintaining physical distance outside noted among 7414 8384 respectively proportion participant frequently using sanitizers clean hand infrequently practicing comparable Selfefficacy preventive practice threatappraisal COVID19 illness identified important determinant selected COVID19 preventive behavior independently analysis confirmed practice behavior mostly synergistic Current finding highlight formulation precise risk communication strategy improve perception regarding threat appraisal selfefficacy could facilitate desirable practice also effective prevention airborne infection hence may contribute toward broader policy direction evidence urge implementation precisiondriven risk communication diffusion practice attain behavioral herd immunity,covid-19;behavior;prevention;protection motivation theory;response efficacy;self-efficacy;threat appraisal
COVID19 Impact CranioOroFacial Trauma Care Italy Epidemiological Retrospective Cohort Study,34281002,coronavirus disease 2019 COVID19 deeply modified organization hospital health care center patient s behavior aim epidemiological retrospective cohort study evaluate COVID19 pandemic determined modification cranioorofacial traumatology service METHODS dataset included hospital emergency room access sixmonth prepandemic period six month pandemic outbreak variable collected patient age gender type emergency access relative color code Glasgow Coma Scale Score type discharge RESULTS 537 vs 237 prepandemic vs pandemic patient accessed hospital emergency room mean age decreased 6079 + 2534 5675 + 2450 year Yellow green code access went 289 661 375 577 prepandemic vs pandemic Glasgow Coma Scale GCS show increase 166 vs 278 15 grade score 287 vs 285 14 grade score reduction 13 12 grade 402 145 vs 371 97 prepandemic vs pandemic CONCLUSIONS Since COVID19 outbreak continues epidemiological data still necessary perform public health intervention strategy appropriately predict population need order properly manage COVID19 related oral pathology well common health problem,covid-19;cranio-oro-facial traumatology;retrospective cohort study
insight novel coronavirus disease 2019 COVID19 Current understanding research therapeutic update,34353275,BACKGROUND Humans infected various coronaviruses cause serious illness death One pandemic strain coronavirus recently identified December 2019 lead devastating outbreak Wuhan city China caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 highly contagious cause symptom fever cough shortness breath OBJECTIVE objective review highlight current understanding research therapeutic update novel coronavirus disease 2019 COVID19 METHODS thorough literature search conducted research paper patent context COVID19 article respect subject taken various public repository Google Scholar Pubmed ScienceDirect Elsevier Springer Web Science etc Results present analysis showed key area invention vaccine diagnostic kit apart composition treatment CoV also observed specific vaccine treatment available treatment 2019nCov however developing novel chemical biological drug kit early diagnosis prevention disease management primary governing topic among patented invention present study also indicates potential research opportunity future particularly combat 2019nCoV current focus research turned towards developing four potential treatment including development candidate vaccine development novel potential drug repurposing existing drug development convalescent plasma therapy PCR based diagnosis gold standard COVID19 testing require resource time expertise high associated cost hence researcher also developing different diagnosis method COVID19 Although vaccine developed various company passed preclinical stage still exists guarantee become effective vaccine current treatment used COVID19 patient well established limited success CONCLUSION pandemic challenged medical economic public health infrastructure across globe urgent need explore available possible methodsapproaches study disease drug vaccine development earliest,covid-19;sars-cov-2;epidemiology;non structural proteins;pandemic;pharmacovigilance.;variant
Lowdensity lipoprotein cholesterol level associated poor clinical outcome COVID19,34353699,BACKGROUND AIMS Severe acute respiratory syndrome coronavirus 2 SARSCoV2 sole causative agent coronavirus infectious disease19 COVID19 METHODS RESULTS performed retrospective singlecenter study consecutively admitted patient March 1st May 15th 2020 definitive diagnosis SARSCoV2 infection primary endpoint evaluate association lipid marker 30days allcause mortality COVID19 total 654 patient enrolled estimated 30day mortality 228 149 patient Nonsurvivors lower total cholesterol TC lowdensity lipoprotein cholesterol LDLc level entire course disease showed significant inverse correlation inflammatory marker positive correlation lymphocyte count multivariate analysis LDLc = 69 mgdl hazard ratio HR 194 95 confidence interval CI 114331 Creactive protein 88 mgdl HR 244 95 CI 141423 lymphopenia 1000 HR 268 95 CI 191378 admission independently associated 30day mortality association maintained 7 day admission Survivors presented complete normalization lipid profile shortterm followup CONCLUSION Hypolipidemia SARSCoV2 infection may secondary immuneinflammatory response complete recovery survivor Low LDLc serum level independently associated higher 30day mortality COVID19 patient,covid-19;coronavirus;high-density lipoprotein;inflammation;low-density lipoprotein;sars-cov-2;total cholesterol;triglycerides
Repurposing Siddha mercurial drug mild moderate COVID19 Case series exploration chemical profile,34226805,Background Vajra kandi maathirai VKM mercury based traditional Siddha drug used treat various type fever inflammatory disease report experience using VKM successfully treat 5 severe acute respiratory syndrome coronavirus 2 SARSCoV2 infected patient chemical profile Case report family 5 member age range 13 77 male female one preexisting renal impairment SARS CoV2 positive mild moderate category treated VKM along specific dietary practice drug consumed home quarantine RealTime RT PCR oropharynx swab XrayCT scan chest hematology renal function liver function body temperature oxygen saturation assessed Blood parameter repeated completion therapy ass safety aspect mercury drug Chemical profile drug done using Gas chromatographymass spectrometry inductively coupled plasma mass spectrometry Results first dose oxygen saturation improved Within 3 day therapy symptom fever body pain cough loss taste normalized render RealTime RT PCR negative COVID19 observed side effect damage renal liver drug contains 22 mercury along 9Octadecenoic acid E 1HImidazole 45dihydro2 phenylmethyl 912Octadecadienoic acid Z Z major organic compound Conclusion Vajra kandi maathirai might safe drug manage COVID19 patient Rigorous research required discover new antiviral molecule formulation,ayurveda;covid-19;sars-cov-2;siddha;traditional medicine;mercury
Detection SARSCoV2 point care,34289741,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 etiologic agent COVID19 Testing SARSCoV2 infection critical element public health response COVID19 Pointofcare POC test drive patient management decision infectious disease including COVID19 POC test available diagnosis SARSCoV2 infection include detect SARSCoV2 antigen well amplified RNA sequence provide review SARSCoV2 POC test including performance setting might used impact future direction optimization validation new technology well study determine clinical epidemiological impact SARSCoV2 POC test needed,covid-19;poct;sars-cov-2;home testing;nucleic acid amplification testing;pooled specimen screening;rapid antigen testing
Study Development Antiviral Spandex Fabric Coated Poly hexamethylene biguanide Hydrochloride PHMB,34203388,spread COVID19 brought huge loss around world study aim investigate applicability PHMB used developing antiviral spandex clothing coronavirus PHMB qualitatively determined surface spandex fabric using BPB antiviral analysis show PHMBtreated spandex fabric kill 99 coronavirus within 2 h contact suggests spandex fabric treated PHMB could used developing antiviral clothing coronaviruses containing transmission COVID19 highrisk place Furthermore PHMBtreated spandex fabric shown excellent antibacterial activity grampositive S aureus gramnegative K pneumoniae hand feel property Spandex fabric significantly affected PHMB coating addition wrinkle recovery obviously improved PHMB coating,phmb;antiviral clothing;coronavirus;protective spandex clothing
Advances computational landscape repurposed drug COVID19,34339864,COVID19 pandemic caused million death massive societal distress worldwide Therapeutic solution urgently needed de novo drug development remains lengthy process One promising alternative computational drug repurposing enables prioritization existing compound fast silico analysis Recent effort based molecular docking machine learning network analysis produced actionable prediction predicted drug targeting viral protein pathological host pathway undergoing clinical trial review work highlight drug high predicted efficacy classify mechanism action discus strength limitation published methodology outline possible future direction Finally curate list COVID19 data portal repository could used accelerate future research,covid-19;computational drug repurposing;docking and molecular dynamics;sars-cov-2;structure-guided machine learning;virus-host interaction network analysis
Severe reinfection severe acute respiratory syndrome coronavirus 2 nursing home resident case report,34284812,BACKGROUND topic natural immunity related severe acute respiratory syndrome coronavirus 2 remains controversial Although evidence suggests postinfection immunity achieved reported case reinfection similar milder symptom Information severe disease manifestation reinfection known present case reinfection severe presentation compared initial infection CASE REPORT describe white male patient nursing home reinfected severe acute respiratory syndrome coronavirus 2 severe disease manifesting dyspnea fever encephalopathy hypoxemic respiratory failure requiring intubation elevated inflammatory marker lung infiltrates imaging initially testing positive mild symptom 2 month prior presentation Notably severe acute respiratory syndrome coronavirus 2 antibody detected indicated coronavirus disease 2019 reinfection treatment remdesivir dexamethasone convalescent plasma subsequently extubated discharged home 2 week CONCLUSION clear whether initial infection severe acute respiratory syndrome coronavirus 2 recovery provides prolonged immunity beyond 2 month Furthermore even antibody present guarantee attenuated course reinfection Therefore vaccination play important role prevention Longterm cohort study needed study factor behind reinfection,covid-19;immunity;reinfection;sars-cov-2
Coronavirus disease 2019 vaccine update,34349402,Coronavirus disease 2019 COVID19 infectious disease caused coronavirus people infected COVID19 virus experience mildtomoderate respiratory illness recover without requiring special treatment Older people underlying medical problem likely develop serious illness December 2019 novel coronavirus designated severe acute respiratory syndrome SARS coronavirus 2 emerged city Wuhan China caused outbreak unusual viral pneumonia highly transmissible novel coronavirus disease also known COVID19 spread fast world overwhelmingly surpassed SARS Middle East respiratory syndrome term number infected people epidemic area Currently definite treatment COVID19 although drug investigation Infections caused virus enormous global health threat Hence government established fasttracking research develop rapid diagnostic test kit vaccine low cost review highlight vaccine available COVID 19 worldwide implication,covid 19;corona virus;vaccines
Telemedicine Time COVID19 Pandemic Results First Survey among Italian Pediatric Diabetes Centers,34203306,BACKGROUND Use telemedicine child adolescent type 1 diabetes beginning COVID19 pandemic investigated METHOD 68 Italian pediatric diabetes center invited complete survey telemedicine usage pediatric patient allocated notech group multiple daily injection selfmonitoring blood glucose tech group insulin pump andor flash continuousglucose monitoring RESULTS 603 center completed survey notech tech group used way communication generic download portal instant messaging personal physician mobile working email phone call physician mobile difference except use email higher notech group p = 003 Seventyfour percent center systematization andor reimbursement significant difference among region p = 003 CONCLUSIONS Almost Italian pediatric diabetes center use telemedicine semivolunteering manner lacking proper codification reimbursement system legal traceability accreditation system,continuous glucose monitoring;continuous subcutaneous insulin infusion;insulin pump;pediatric diabetes;telemedicine
Assessment potential risk factor coronavirus disease19 COVID19 among health care worker,34281792,BACKGROUND Understanding COVID19 infection among health worker risk factor adverse outcome important characterizing virus transmission pattern risk factor infection also preventing future infection health worker patient reducing secondary COVID19 transmission within health care setting aim identify risk factor infection among health care worker limit adverse event health care facility SUBJECTS METHODS total 336 HCWs COVID19 treatment hospital took part study varying COVID19 exposure risk depending job function working site participant asked risk factor COVID19 infection RESULTS Among participant 426 medical doctor 286 nurse 74 assistant nurse 214 others Forty four percent participant work experience 510 year half participant received training Infection Prevention Control IPC 568 COVID 19 91 hand hygiene facility 69 admitted availability PPE half participant admitted always follow IPC measure Two third participant 667 close contact patient since admission 423 present aerosolizing procedure patient Forty two percent participant respiratory symptom common sore throat representing 324 highest frequency respiratory symptom among nurse assistant nurse 51 Frequency respiratory symptom higher among contacted patient directly prolonged period compared admitted contact CONCLUSIONS Risk factor COVID19 represented smoker nurse assistant nurse liable catch COVID19 doctor contacted patient directly prolonged period hisher body fluid material surface around,covid-19;egypt;ppe;pandemic;risk assessment
Exploring Mystery AngiotensinConverting Enzyme II ACE2 Battle SARSCoV2,34285711,COVID19 newly born pandemic caused SARSCoV2 virus recently emerged betacoronavirus cross specie barrier predominantly infects pneumocytes respiratory tract due presence angiotensinconverting enzyme II ACE2 cell like surface enterocytes upper esophagus colon also considered primary site infection ACE2 receptor served cellular entry point SARSCoV2 expression ACE2 receptor regulated several factor age tobacco smoking inflammatory signaling ACE inhibitor angiotensin receptor blocker comorbidities chronic obstructive pulmonary disease COPD tuberculosis cerebrovascular disease coronary heart disease hypertension diabetes Therefore scientist trying explore indepth knowledge ACE2 considered potential indirect target COVID19 therapeutic focused review discussed detail ACE2 expression regulation different factor primary vulnerable site SARSCoV2 infection Clinical trial rhACE2 COVID19 patient ongoing outcome trial prof positive breakthrough management COVID19 Finally suggest targeting ACE2 master regulator balanced way could serve potential option management COVID19,
Molecular evidence suggesting persistence residual SARSCoV2 immune response placenta pregnant patient recovered COVID19,34291856,OBJECTIVES Recent study shown presence SARSCoV2 tissue clinically recovered patient persistent immune symptom discharged patient several month Pregnant patient shown highrisk group COVID19 Based finding assessed SARSCoV2 nucleic acid protein retention placenta pregnant woman fully recovered COVID19 cytokine fluctuation maternal foetal tissue MATERIALS METHODS Remnant SARSCoV2 term placenta detected using nucleic acid amplification immunohistochemical staining SARSCoV2 protein infiltration CD14+ macrophage placental villus detected immunostaining cytokine placenta maternal plasma neonatal umbilical cord cord blood amniotic fluid specimen delivery profiled using Luminex assay RESULTS Residual SARSCoV2 nucleic acid protein detected term placenta recovered pregnant woman infiltration CD14+ macrophage placental villus recovered pregnant woman higher control Furthermore cytokine level placenta maternal plasma neonatal umbilical cord cord blood amniotic fluid specimen fluctuated significantly CONCLUSIONS study showed SARSCoV2 nucleic acid one patient protein five patient present placenta clinically recovered pregnant patient 3 month diagnosis immune response induced virus may lead prolonged persistent symptom maternal plasma placenta umbilical cord cord blood amniotic fluid,covid-19;sars-cov-2;cytokine;immune response;placenta;pregnant women
Wastewater Sample Site Selection Estimate Geographically Resolved Community Prevalence COVID19 Sampling Protocol Perspective,34222738,Wastewater monitoring virus infection within community complement conventional clinical surveillance Currently SARSCoV2 severe acute respiratory syndrome coronavirus 2 clinical testing voluntary inconsistently available except occupational educational setting therefore likely underrepresents actual population prevalence Randomized testing regular basis estimate accurate populationlevel infection rate prohibitively costly hampered range limitation barrier associated participation clinical research comparison communitylevel fecal monitoring performed wastewater surveillance effectively surveil community However epidemiologically defined protocol wastewater sample site selection lacking Herein describe method developing geographically resolved populationlevel wastewater sampling approach Jefferson County Kentucky present preliminary result Utilizing site selection protocol sample n = 237 collected 17 wastewater catchment area September 8 October 30 2020 one four time per week area compared concurrent clinical data aggregated wastewater catchment area county level SARSCoV2 RNA consistently present wastewater studied period varied area Data obtained using site selection protocol showed variation geographically resolved wastewater SARSCoV2 RNA concentration compared clinical rate finding highlight importance neighborhoodequivalent spatial scale provide promising approach viral epidemic surveillance thus better guiding spatially targeted public health mitigation strategy,covid-19;gis;sars-cov-2;environmental surveillance;epidemiology;wastewater
new application mTOR inhibitor drug potential therapeutic agent COVID19,34218545,Since December 2019 COVID19 emerging pandemic caused SARSCoV2 resulted one important global health threat Concerning absence approved effective vaccine drug treatment outcome improvement COVID19 patient role SARSCoV2 activation mammalian target rapamycin mTOR pathway decided review previous data regarding therapeutic effect mTOR inhibitor drug COVID19 patient searched scientific database Web Science Embase Medline PubMed Scopus Google Scholar using appropriate keywords find suitable study suggestion October 2020 finding current study confirmed mTOR inhibitor drug suggested mechanism cell adjustment induction autophagy without apoptosis reduction viral replication restoration Tcell function decrease cytokine storm moderation mTORPI3KAKT pathway activation bring therapeutic impact COVID19 patient Taken together necessary find suitable therapy COVID19 pandemic emerging regard clarify valuable consider therapeutic effect mTOR inhibitor drug metformin mTOR inhibition property treatment COVID19 patient,covid-19;sars-cov-2;coronavirus;mtor inhibitors;metformin;rapamycin;sirolimus
Coronavirus Disease 2019 COVID19 Crisis Losing Immunity Need,34207024,ongoing coronavirus disease 2019 COVID19 crisis led new socioeconomic reality acquisition novel habit Measures imposed government health authority confinement lockdown important consequence including mental health problem economic crisis social isolation Combined newly acquired habit hand washing sanitization face mask directly indirectly led reduced immunity effect immune system impact epidemiological profile respect COVID19 infectious disease also limit efficacy ongoing antiCOVID19 vaccination campaign Therefore need review approach optimize measure towards better population immunity much needed epidemic,coronavirus disease 2019 (covid-19);immunity
Telemammography breast cancer screening costeffective approach Argentina,34281995,OBJECTIVES Argentina low middleincome country LMIC highly fragmented healthcare system conflict access healthcare stated country s Universal Health Coverage plan telemammography network could improve access breast cancer screening decreasing mortality research aim conduct economic evaluation implementation telemammography program improve access healthcare METHODS costutility analysis performed explore incremental benefit annual telemammography screening atrisk Argentinian woman 40 year old Markov model developed simulate annual mammography telemammography screening two hypothetical populationbased cohort asymptomatic woman Parameter uncertainty evaluated deterministic probabilistic sensitivity analysis Model structure uncertainty also explored test robustness result RESULTS estimated 31 100 new case breast cancer would detected mammography 39100 telemammography model returned incremental costeffectiveness ratio ICER pound26 051qualityadjusted lifeyear QALY lower WHOrecommended threshold pound26 288QALY Argentina Deterministic sensitivity analysis showed ICER sensitive uptake sensitivity screening test Probabilistic sensitivity analysis showed telemammography costeffective 59 simulation DISCUSSION Telemammography considered adoption could improve access expertise underserved area adherence screening protocol poor Disaggregated data province needed better informed policy decision Telemedicine could also beneficial ensuring continuity care health system stress like current COVID19 pandemic CONCLUSION 59 chance telemammography costeffective compared mammography atrisk Argentinian woman 40 year old adopted improve access healthcare underserved area country,bmj health informatics;covid-19;health equity;information systems;public health
Kidney Transplantation COVID PandemicA Review Guidelines,34209504,paper describes problem transplantation process COVID19 pandemic Transplantation procedure program impacted COVID19 number transplant fallen noticeably first part paper point change service organization particular donor recipient pretransplant peritransplant management patient pretransplant evaluation need attend facetoface appointment blood testing investigation risk contracting spreading COVID19 minimized `` Clear green area COVID19free pathway highly recommended hospital transplant procedure Diagnostic procedure concerning donor including CT scan coronavirus testing nasopharyngeal swab necessary transplant surgery COVID19 symptom risk transplant population described Detailed guideline transplant society concerning change immunosuppression infected recipient discussed Management infected suspected medical staff mentioned paper end guideline concerning vaccination COVID19 transplant recipient,covid-19;sars-cov-2;renal transplantation guidelines;solid organ transplantation guidelines
COVID19 social distancing negative effect people Parkinson disease association confidence selfmanagement,34284733,BACKGROUND purpose study describe effect COVID19 social distancing function health wellbeing people Parkinson disease PD test association effect patient activation level ie skill confidence managing health METHODS Communitydwelling individual PD answered anonymous webbased survey Part 1 included 27 multiplechoice question regarding change function health medical care wellbeing Part 2 consisted Patient Activation Measure enquired skill confidence managing one s health RESULTS Respondents N = 142 reported decrease various function 248 373 health 338 43 wellbeing 261 471 domain Rehabilitation ceased 612 Among reporting worsening health 678 associated cessation rehabilitative treatment decrease physical activity Patients activation level inversely correlated increased assistance activity daily living increased tiredness worsening symptom lack support family friend CONCLUSIONS Social distancing major negative impact health function people PD PRACTICAL IMPLICATIONS Supporting people PD skill confidence managing health may preserve physical mental health period dramatic change life s circumstance,covid-19;parkinson disease;patient activation;self-management;social distancing
SARSCoV2 spike protein detection plasmonic Dshaped plastic optical fiber aptasensor,34215035,specific aptameric sequence immobilized short polyethyleneglycol PEG interface gold nanofilm deposited Dshaped plastic optical fiber POFs probe protein binding monitored exploiting sensitive surface plasmon resonance SPR phenomenon receptorbinding domain RBD SARSCoV2 spike glycoprotein specifically used develop aptasensor Surface analysis technique coupled fluorescence microscopy plasmonic analysis utilized characterize biointerface Spanning wide protein range 25 1000 nM SARSCov2 spike protein detected Limit Detection LoD 37 nM Different interferents BSA AH1N1 hemagglutinin protein MERS spike protein tested confirming specificity aptasensor Finally preliminary test diluted human serum encouraged application pointofcare device since POFbased aptasensor represent potentially lowcost compact biosensor characterized rapid response small size could ideal laboratory portable diagnostic tool,aptamer;plastic optical fiber (pof);polyethyleneglycol (peg);sars-cov-2;self assembled monolayer (sam);surface plasmon resonance (spr)
COVID19 Ghana challenge countermeasure maternal health service delivery public health facility,34281582,provide situational update COVID19 Ghana seventh African country reporting case modification occurring within health system curtail outbreak potential impact delivery antenatal care service also highlighted discovery Delta variant Ghana current attention prevent third wave infection also control manage existing case Efforts procure vaccine vaccinate special population sensitize public implication vaccine hesitancy ongoing Amidst activity suggest innovation countermeasure safeguard primary healthcare service potentially reinvest effort towards achieving sustainable development goal three within context maternal healthcare citing example specific developing country,covid-19;developing countries;ghana;health services;maternal health;pandemics;public health
Protein function regulation clinical perspective,34224431,PURPOSE REVIEW Protein PS essential natural anticoagulant PS deficiency major contributor acquired hypercoagulability Acquired hypercoagulability cause myocardial infarction stroke deep vein thrombosis million individual Yet despite importance hemostasis PS least understood anticoagulant Even 40 year since PS first described still uncovering information PS function purpose review highlight recent finding advance understanding function PS explain hypercoagulability caused severe PS deficiency RECENT FINDINGS PS long described cofactor Activated Protein C APC Tissue Factor Pathway Inhibitor TFPI However recent report describes direct inhibition Factor IXa FIXa PS activity PS completely overlooked Thrombophilia becoming frequently reported disorder Hereditary PS deficiency anticoagulant deficiency result eventually thrombophilia addition PS deficiency predisposing factor venous thromboembolism VTE effect PS deficiency arterial thrombosis arterial ischemic stroke uncertain Plasma PS concentration decrease pregnant woman Inherited thrombophilias important etiology recurrent pregnancy loss anticoagulation therapy benefit woman recurrent pregnancy loss documented PS deficiencyHypoxia risk factor VTE hypoxia downregulates plasma PS level Importantly COVID19 lead hypoxemia lung damage IL6driven inflammatory response viral infection hypoxia decrease abundance key anticoagulant PS surmise IL6induced cytokine explosion combined hypoxemia cause drop PS level exacerbates thrombotic risk COVID19 patient SUMMARY review intended advance understanding anticoagulant function important plasma protein PS Despite 40+ year research complete description PS biology pertains control blood coagulation However picture PS function become sharper recent discovery FIXa inhibition PS Hemostasis mediated PS includes regulation FIXa activity alongside cofactor activity PS TFPIAPC pathway addition direct inhibition FIXa PS suggests PS particularly small derivative PS could used treat individual PS deficiency abnormality cause thrombotic complication,
VirusNegative Necrotizing Coronary Vasculitis Aneurysm Formation Human SARSCoV2 Infection,34202646,report case myopericarditis associated SARSCoV2 infection necrotizing coronary vasculitis intramural vessel giving rise biventricular apical microaneurysms electrical instability Negativity myocardial polymerase chain reaction common cardiotropic virus SARSCoV2 suggested immunemediated myocardial pericardial inflammatory disease High dose 1 mgKg daily prednisone antiviral Remdesivir IDA Business Carrigtohill County Cork T45 DP77 Ireland therapy led resolution cardiac inflammation ventricular arrhythmia Morphomolecular characterization endomyocardial tissue may improve outcome subject SARSCoV2associated myopericarditis coronary vasculitis,sars-cov-2;myopericarditis;necrotizing coronary vasculitis
Antiviral Activity Licorice Help Fight COVID19 Infection,34201172,phytotherapeutic property Glycyrrhiza glabra licorice extract mainly attributed glycyrrhizin GR glycyrrhetinic acid GA Among possible pharmacological action ability act virus belonging different family including SARS coronavirus particularly important COVID19 emergency urgent need compound counteract pandemic antiviral property GR GA pure substance component licorice extract attracted attention last year supported launch two clinical trial silico docking study reported GR GA may directly interact key player viral internalization replication angiotensinconverting enzyme 2 ACE2 spike protein host transmembrane serine protease 2 3chymotrypsinlike cysteine protease vitro data indicated GR interfere virus entry directly interacting ACE2 spike nonspecific effect cell viral membrane Additional antiinflammatory antioxidant effect GR excluded multiple activity GR licorice extract critically reassessed review possible role spread SARSCoV2 feature COVID19 disease discussed,covid-19;sars-cov-2;enoxolone;glycyrrhetinic acid;glycyrrhizic acid;glycyrrhizin;licorice;liquorice;virus
Emergency department impaired adherence personal protective equipment donning doffing protocol COVID19 pandemic,34281594,OBJECTIVES Coronavirus Disease 2019 COVID19 highly infectious viral pandemic claimed life million Personal protective equipment PPE may reduce risk transmission health care worker HCWs especially emergency setting study aimed compare adherence PPE donning doffing protocol Emergency Department ED v designated COVID19 ward score adherence according step protocol DESIGN Prior managing COVID19 patient mandatory PPE training undertaken HCWs HCWs observed donning doffing COVID19 restricted area SETTING Donning doffing observed COVID19 designated Emergency department compared COVID19 positive ward PARTICIPANTS HCWs working aforementioned ward time observation RESULTS observed 107 donning doffing procedure 30 observed ED 50 HCWs observed donned PPE correctly 37 doffed correctly ED significantly lower mean donning score ED 78 Internal 95 ICU 96 p 0001 significantly lower mean doffing score ED 72 Internal 85 ICU 91 p = 002 CONCLUSIONS hypothesized HCWs assigned designated ED wing made protocol deviation compared HCWs positive COVID19 ward Time management acuity lack personnel stress known COVID19 status may explain lesser adherence donning doffing protocol study ass correlation protocol deviation use PPE morbidity well improvement implementation required Resources invested ensure PPE properly used,covid-19;emergency department;personal protective equipment
Chronic fatigue syndrome emerging sequela COVID19 survivor,34341960,SARSCoV2 survivor may report persistent symptom resemble myalgic encephalomyelitischronic fatigue syndrome MECFS explored MECFSlike symptom prevalence b whether axonal inflammatory andor lung change may contribute MECFSlike symptom SARSCoV2 survivor clinical neuropsychiatric neuropsychological lung function assessment serum neurofilament light chain axonal damage biomarker MECFSlike feature found 27 sample MECFSlike group showed worse sleep quality fatigue pain depressive symptom subjective cognitive complaint Borg baseline dyspnea 6min walking test vs without MECFSlike symptom preliminary finding raise concern possible future MECFSlike pandemic SARSCoV2 survivor,covid-19;cognition;fatigue;functional neurological disorders;mood alterations;viral infection
Management outcome mucormycosis COVID19 patient preliminary report tertiary care hospital,34334896,Background Coronavirus disease 2019 COVID19 continues significant health problem worldwide unprecedented surge mucormycosis patient COVID19 new emerging challenge Although study documenting high incidence mucormycosis COVID 19 patient recently emerged literature data pertaining treatment outcome cohort lacking report experience management mucormycosis COVID19 patient tertiary care centre Method clinical imaging histopathological treatment data 20 patient mucormycosis setting COVID19 analysed Results 35 65 case developed mucormycosis setting active recovered COVID19 infection respectively Diabetes mellitus documented 80 case 55 demonstrating HbA1c 10 Steroid administered 80 COVID19 illness Imaging demonstrated paranasal sinus PNS orbital intracranial extension 100 55 20 patient respectively received amphotericin underwent endoscopic debridement 20 underwent orbital decompression 5 maxillectomy orbital exenteration 620 30 patient died 4 rhinoorbitocerebral disease 1 extensive orbitomaxillary involvement 1 sinonasal disease 6 patient received steroid documented poor glycaemic control Conclusion strong association hyperglycemia steroid intake mucormycosis COVID19 case warrant judicious use corticosteroid optimal glycaemic control study highlight good clinical outcome achieved invasive mucormycosis provided prompt treatment instituted aggressive surgical debridement antifungal medication,covid 19 associated invasive;management outcomes;mucormycosis;mucormycosis
Behaviors Experiences Nurses COVID19 Pandemic Turkey Mixed Methods Study,34369037,AIM present behavior experience nurse Turkey current coronavirus pandemic BACKGROUND coronavirus pandemic lead difficulty healthcare worker especially nurse mostly accompany patient front line METHODS study parallel mixed pattern converging quantitative qualitative research method used RESULTS model revealed 41 year old older diabetic female single professional working pandemic department took personal measure Five main theme appeared regarding experience nurse pandemic period 1 Psychological mental strain 2 Personal protective equipment 3 Organizational physical social strain 4 Change professional value 5 Turning crisis opportunity CONCLUSIONS Personal measure associated risk status need protect nurse significant measure providing psychosocial support meeting basic need preventing complication likely occur due increasing workload IMPLICATIONS NURSING MANAGEMENT effort made ensure good work fair treatment tolerance discrimination equal compensation condition,covid-19;coronavirus;coronavirus infections;epidemics;nursing
Impact COVID19 Care Patients Noncommunicable Diseases Low MiddleIncome Countries Online Survey Patient Perspectives,34368433,sought gain insight impact COVID19 associated control measure health health care patient low middleincome country cardiovascular disease diabetes mental health condition using online survey COVID19 pandemic common concern 1487 patient took part contracting COVID19 accessed health care infected COVID19 half said health worse since infected Collectively people reported increase feeling stress loneliness COVID19 pandemic led range health care impact patient noncommunicable disease including constraint access care health effect particularly mental wellbeing,covid-19;anxiety;cardiovascular disease;depression;diabetes mellitus;patient perspectives;survey
Silico Identification miRNAlncRNA Interactions Male Reproductive Disorder Associated COVID19 Infection,34204705,Coronavirus disease 2019 COVID19 global pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 Angiotensinconverting enzyme 2 ACE2 receptor SARSCoV2 transmembrane serine protease 2 TMPRSS2 facilitates ACE2mediated virus entry Moreover expression ACE2 testis infertile men higher normal indicates infertile men may susceptible infected SARSCoV2 may cause reproductive disorder pathway induced ACE2 TMPRSS2 Little known pathway regulation ACE2 TMPRSS2 expression male reproductive disorder Since regulation gene expression mediated microRNAs miRNAs long noncoding RNAs lncRNAs posttranscriptional level aim study analyze dysregulated miRNAlncRNA interaction ACE2 TMPRSS2 male reproductive disorder Using bioinformatics analysis speculate predicted miRNAs including miR125a5p miR125b5p miR5745p miR936 regulator ACE2 miR2045p modulator TMPRSS2 associated male infertility lncRNAs tissuespecific expression testis including GRM7AS3 ARHGAP26AS1 BSNAS1 KRBOX1AS1 CACNA1CIT3 AC0123611 FGF14IT1 AC0124941 GS124F42 predicted identified miRNAs lncRNAs proposed potential biomarkers study possible association COVID19 male infertility study encourages study miRNAlncRNA interaction explain molecular mechanism male infertility COVID19 patient,covid-19;interactions;lncrna;male infertility;mirna
Predictors survival older adult hospitalized COVID19,34216306,OBJECTIVE study designed investigate clinical characteristic associated mortality predictor survival older adult hospitalized COVID19 focus neurological comorbidities presenting neurological manifestation METHODS compared clinical characteristic age gendermatched sample 75 deceased 75 recovered patient MAge = 78 hospitalized COVID19 developed logistic regression predict likelihood survival RESULTS Deceased patient like dementia altered mental status AMS acute respiratory distress syndrome ARDS sepsis mechanical ventilation balance difficulty higher heart rate respiratory rate blood urea nitrogen creatinine absolute neutrophil lower oxygen saturation absolute lymphocyte shorter length hospitalization Logistic regression based three mortality predictor ARDS AMS length hospitalization correctly predicted 87 outcome 89 sensitivity 85 specificity CONCLUSIONS Dementia AMS strong predictor death older adult hospitalized COVID19 finding add rapidly growing neurology COVID19 literature underscore importance early recognition incorporation mental status examination medical assessment COVID19,covid-19;delirium;dementia;neurology;neuropsychology;psychiatry
Neutralizing AntiSARSCoV2 Antibody Titer Reported Adverse Effects Sample Italian Nursing Home Personnel Two Doses BNT162b2 Vaccine Administered Four Weeks Apart,34203652,BACKGROUND immunization healthcare worker HCWs play recognized key role prevention COVID19 pandemic Italy vaccination campaign began end December 2020 better knowledge onfield immune response HCWs adverse effect main factor involved fundamental METHODS performed study worker nursing home Northern Italy vaccinated JanuaryFebruary 2021 two dos BNT162b2 vaccine four week apart instead three week provided original manufacturer protocol One month second dose serological titer IgGneutralizing antiRBD antibody subunit S1 spike protein SARSCoV2 determined sociodemographic clinical characteristic subject adverse effect vaccination collected questionnaire RESULTS worker high antibody titer ranging 20 760 time minimum protective level observed Titers significantly higher subject previous COVID19 diagnosis Adverse effect vaccine frequent second dose severe adverse effect observed CONCLUSIONS two dos BNT162b2 vaccine even administered four week apart induced high titer antiSARSCoV2 neutralizing IgG operator included study,bnt162b2;covid-19;sars-cov-2;adverse effects;antibody titer;health surveillance;healthcare workers;vaccines
Reduced pediatric urgent asthma utilization exacerbation COVID19 pandemic,34289526,COVID19 pandemic profound impact healthcare access utilization could important implication child chronic disease including asthma sought evaluate change healthcare utilization outcome child asthma COVID19 pandemic used electronic health record data evaluate healthcare use asthma outcome 3959 child adolescent 517 year age prior diagnosis asthma history wellchild visit encounter within healthcare system assessed allcause healthcare encounter asthma exacerbation 12months preceding start COVID19 pandemic March 1 2019February 29 2020 first 12 month pandemic March 1 2020February 28 2021 Allcause healthcare encounter decreased significantly pandemic compared preceding year including wellchild visit 481 pandemic vs 666 prior year p 01 emergency department visit 97 vs 210 p 01 inpatient admission 16 vs 25 p 01 though 100fold increase telehealth encounter Asthma exacerbation required treatment systemic steroid also decreased 127 vs 504 exacerbation p 01 Raceethnicity associated change healthcare utilization asthma outcome COVID19 pandemic corresponded dramatic shift healthcare utilization including increased telehealth use improved outcome among child asthma Social distancing measure may also reduced asthma trigger exposure,asthma and early wheeze;biostatistics;epidemiology
Case Report COVID19 New Orleans Louisiana Highlighting Complexities Prognostication Critically Ill Patient,34223481,Palliative care team intensive care team experience providing goalsofcare guidance critically ill patient family Critical coronavirus disease 2019 COVID19 infection defined infection requiring intensive care unit care respiratory support often multiorgan involvement case present 53yearold critically ill COVID19 patient multisystem organ failure appeared hour death despite best medical effort Comfortfocused care compassionate extubation offered medical team felt near certain death imminent Overnight option considered family patient began markedly improve hemodynamically extubated several day later Weeks later patient survived hospital stay discharged rehabilitation rehabilitation returned home able walk communicate freely independently perform activity daily living Dialysis longer necessary stopped challenge assisting goalsofcare conversation patient serious COVID19 infection discussed,covid-19;intensive care;palliative care;prognostication
Surveillance testing SARSCOV2 infection asymptomatic athlete population prospective cohort study 123 362 test 23 463 paired RTPCRantigen sample,34221445,Objective ass diagnostic accuracy antigen compared reverse transcriptase RT PCR testing asymptomatic athlete screening programme monitor infection college athlete Methods Quidel Sofia2 SARSCoV2 Antigen Tests performed daily sport participation football basketball wrestling water polo 29 September 2020 28 February 2021 Paired RTPCR antigen test performed least week Positive antigen test confirmed RTPCR Results 81 175 antigen 42 187 RTPCR test performed including 23 462 weekly paired antigenRTPCR screening test 1931 athlete One hundred seventytwo athlete positive screening RTPCR 04 83 48 occurred paired testing day sensitivity antigen test varied frequency RTPCR testing prevalence COVID19 sensitivity antigen testing 357 95 CI 17 60 specificity 998 95 CI 997 999 onceaweek RTPCR testing adjusting school prevalence Daily antigen testing similar RTPCR testing two three time week identifying infection Antigen testing identified infection next scheduled PCR 89 occasion resulted 234 day potentially infectious athlete isolated would isolated RTPCR testing alone Two athleticrelated outbreak occurred 86 total infection community acquired Conclusion Antigen testing high specificity short turnaround time sensitive RTPCR Daily antigen testing RTPCR testing two three time week similar benefit drawback testing approach,covid-19;athlete;infection
COVID19 Tests Limits Biodiversity Laws Health Crisis Rethinking `` Country Origin Virus Access Benefitsharing,34369124,COVID19 pandemic raise serious question operation international agreement accessing sharing virus potentially delaying emergency response access benefitsharing ABS framework United Nations Convention Biological Diversity Nagoya Protocol apply collection use COVID19 pathogen SARSCoV2 framework aim ensure country origin reap benefit use resource Using realworld example demonstrate conceptual definitional ambiguity relating `` country origin make operationalising ABS scheme biodiversity conservation sustainable use objective difficult may also undermine public health emergency response Understanding COVID19 fit fit within ABS law valuable exercise international policymakers trying determine best operationalise pathogen ABS issue currently examination World Health Organization critical responding pandemic,covid-19;convention on biological diversity;access and benefit sharing;country of origin;genetic resources
Functional Consequences Novel Ribosomal Pausing Site SARSCoV2 Spike Glycoprotein RNA,34204305,SARSCoV2 Spike glycoprotein protein acquired unique new 4 amino acid PRRA insertion sequence amino acid residue aa 681684 form new furin cleavage site protein well several new glycosylation site studied various statistical property PRRA insertion RNA level CCUCGGCGGGCA nucleotide composition codon usage sequence different rest SARSCoV2 genome One feature two tandem CGG codon although CGG codon rarest codon SARSCoV2 genome suggests insertion sequence could cause ribosome pausing result rare codon Due population variant Nextstrain divergence measure CCU codon extremely large exclude divergence might affect host immune responseseffectiveness SARSCoV2 vaccine possibility awaiting investigation experimental study show expression level original RNA sequence `` wildtype spike protein much lower codonoptimized spike protein studied cell line Interestingly original spike sequence produce higher titer pseudoviral particle higher level infection mutagenesis experiment suggest dualeffect insert comprised combination overlapping translation pausing furin site allowed SARSCoV2 infect new host human readily underline importance ribosome pausing allow efficient regulation protein expression also cotranslational subdomain folding,sars-cov-2;codon usage;ribosome pausing site;ribosome stalling;spike protein
Radiomics Effective Distinguishing Coronavirus Disease 2019 Pneumonia Influenza Virus Pneumonia,34211951,Objectives develop validate radiomics model distinguishing coronavirus disease 2019 COVID19 pneumonia influenza virus pneumonia Materials Methods radiomics model developed basis 56 patient COVID19 pneumonia 90 patient influenza virus pneumonia retrospective study Radiomics feature extracted CT image radiomics feature reduced MaxRelevance MinRedundancy algorithm least absolute shrinkage selection operator method radiomics model built using multivariate backward stepwise logistic regression nomogram radiomics model established decision curve showed clinical usefulness radiomics nomogram Results radiomics feature consisting nine selected feature significantly different COVID19 pneumonia influenza virus pneumonia training validation data set receiver operator characteristic curve radiomics model showed good discrimination training sample area receiver operating characteristic curve AUC 0909 95 confidence interval CI 08590958 validation sample AUC 0911 95 CI 07531000 nomogram established good calibration Decision curve analysis showed radiomics nomogram clinically useful Conclusions radiomics model good performance distinguishing COVID19 pneumonia influenza virus pneumonia may aid diagnosis COVID19 pneumonia,covid-19;computed tomography;influenza;nomogram;radiomics
Increased Levels serum Pentraxin 3 Critical Coronavirus Disease2019 Patients,34212320,Pentraxin 3 PTX3 ficolin plasma phase pattern recognition receptor PRRs activate complement classical lectin pathway respectively may contribute disease severity study aimed investigate association PTX3 ficolin disease severity patient coronavirus disease2019 COVID19 Seventythree COVID19 patient 25 healthy control enrolled study participant divided three group follows 14 patient intensive care unit ICU group 59 patient nonICU group 25 subject healthy control group serum level PTX3 ficolin measured enzymelinked immunosorbent assay ELISA kit Patients ICU nonICU group significantly higher level PTX3 compared healthy control group p = 00002 p = 00072 respectively Patients ICU group also increased amount PTX3 1957 + 1769 pgml compared nonICU patient 1220 + 1784 pgml However difference significant hand serum level ficolin different among three group PTX3 acute phase protein may contribute disease severity probable inflammatory role could result high activation complement system hand could suggested ficolin crucial role disease severity COVID19 patient,covid-19;coronavirus;ficolin;pattern recognition receptors;pentraxin 3
Impact SARSCoV2 Pandemic Bronchiolitis Hospitalizations Experience Italian Tertiary Center,34203542,SARSCoV2 pandemic restriction deeply altered common respiratory illness burden aim paper clarify measure may influenced bronchiolitis epidemiology exploring possible explanation studied 342 infant hospitalized bronchiolitis center four different epidemic season OctoberApril 20172018 20182019 20192020 20202021 MarchApril hospitalization rate RSV respiratory syncytial virus infection pediatric intensive care unit PICU admission oxygen therapy administration data compared among different season outline change SARSCoV2 outbreak MarchApril 30 231 28 246 5 51 infant hospitalized bronchiolitis respectively 20172018 20182019 20192020 lower rate MarchApril 2020 p 0001 hospitalization bronchiolitis occurred epidemic season 20202021 significant difference RSV infection oxygen therapy administration PICU admission across season outlined conclusion report severe decrease hospitalization bronchiolitis center throughout entire SARSCoV2 outbreak rather lockdown period seems suggest pivotal role systematic implementation costeffective nonpharmaceutical intervention NPIs compulsory face mask hand hygiene deployed entire pandemic reducing circulation infectious agent,covid-19;coronavirus;infants;non-pharmaceutical interventions;pediatric emergency department;respiratory syncytial virus
presence antileucocyte antibody plasma convalescent woman SARSCoV2 infection reason disqualification plasma therapy analysis based literature review,34218245,According data November 29 2020 SARSCoV2 coronavirus responsible 61 866 635 case infection 1 448 990 death worldwide number still growing rapidly main problem rapid increase number patient pneumonia complicated respiratory failure treatment COVID 19 patient significant effect convalescent plasma CP therapy convalescent patient SARSCoV2 IgG neutralizing antibody indicated procedure total duration infection shortened clinical condition improved faster patient receive form therapy aim study explain cause disqualifying woman antileucocyte anitibodies CP plasma donor COVID19 patient However according literature 2 patient received plasma convalescent developed Transfusion Related Acute Lung Injury TRALI common cause TRALI antileukocyte antibody directed Human Leukocyte Antigens HLA class II Human Neutrophil Antigens HNA Therefore patient COVID19 may transfused plasma convalescent woman history pregnancy testing negative antileucocyte antibody preplasmapheresis blood sample,sars cov-2 coronavirus;convalescent plasma;neutralizing antibodies
Covid19 Parkinson s Disease treated drug brain stimulation,34366530,PURPOSE Covid19 affected people especially chronic disease including Parkinson s Disease PD Covid19 may affect motor neuropsychiatric symptom PD patient intend evaluate different aspect Covid19 impact PD patient METHODS 647 PD patient evaluated term PDrelated Covid19related clinical presentation addition past medical history pandemic online questioner compared agematched control group consist 673 individual sample normal population consist 1215 individual RESULTS prevalence Covid19 PD patient 1128 mortality 123 among PD patient prevalence Covid19 PD patient undergone Deep Brain Stimulation DBS 1818 significant association found duration disease prevalence Covid19 statistically significant higher prevalence Covid19 PD patient direct contact SARSCoV19 infected individual found statistically significant association found worsening motor symptom Covid19 PD patient normal population may differ prevalence psychological disorder including anxiety sleeping disorder Covid19 may affect psychological status CONCLUSION PD patient possibly follow tighter preventive protocol lead lower prevalence severity Covid19 consequence patient Although seems Covid19 affect motor psychological aspect PD much expected accurate evaluation suggested order clarify effect,covid-19;deep brain stimulation;pandemic;parkinson's disease;sars-cov-19
FIB4 Predicts Need Mechanical Ventilation Multiethnic National cohort COVID19,34222739,Background Simple test routine data needed coronavirus 2 SARSCoV2 2019 COVID19 help identify may need mechanical ventilation MV Objective determine FIB4 associated need MV multiethnic national cohort patient COVID19 determine optimal FIB4 cutoff Patients Methods retrospective national cohort study adult seen ambulatory emergency department setting diagnosed COVID19 identified using TriNetX platform Measures included demographic comorbid disease routine laboratory test Results total 4901 patient COVID19 included mean age 56 48 female 42 obese 38 White 40 Black cardiac disease 15 diabetes mellitus DM 39 liver disease 20 respiratory disease 50 Need MV 6 optimal cutoff FIB4 need mechanical ventilation 304 AUC 0735 sensitivity specificity positive negative predictive value 42 77 11 95 respectively 93 accuracy stratified race increased FIB4 remained associated need mechanical ventilation Whites Blacks Conclusions FIB4 used front line provider identify patient may require MV,covid-19;fib-4;mechanical ventilation
Multiple sclerosis neuromyelitis optica spectrum disorder COVID19 pandemic year Czechia,34216998,BACKGROUND novel coronavirus disease 2019 COVID19 appeared concern course patient multiple sclerosis MS neuromyelitis optica spectrum disorder NMOSD arose study aimed evaluate incidence severity risk factor severe COVID19 course among MS NMOSD patient METHODS March 1 2020 February 28 2021 12 MS centre representing 70 Czech MS NMOSD population reported laboratoryconfirmed COVID19 case via Czech nationwide register MS NMOSD patient ReMuS main outcome COVID19 severity assessed 8point scale cutoff 4 radiologically confirmed pneumonia according World Health Organisation COVID19 severity assessment RESULTS identified 958 MS 13 NMOSD patient 50 MS 4 NMOSD patient pneumonia 3 MS 2 NMOSD patient died incidence COVID19 among patient MS seems similar general Czech population multivariate logistic regression determined higher body mass index BMI 107 95 CI 100114 older age per 10 year 201 95 CI 141291 highdose glucocorticoid treatment 2 month COVID19 onset 283 95 CI 010748 antiCD20 therapy 704 95 CI 3101587 independent variable associated pneumonia MS patient Increase odds pneumonia antiCD20 treated MS patient compared patient diseasemodifying therapy age sex BMI highdose glucocorticoid treatment 2 month COVID19 onset presence pulmonary comorbidity confirmed propensity score matching 890 95 CI 3043324 Reports COVID19 infection patient NMOSD scarce however data available suggest high risk severe COVID19 course well higher mortality rate among NMOSD patient cohort 4 NMOSD patient 3077 severe COVID19 course 2 patient 1539 died CONCLUSION majority MS patient mild COVID19 course contrary NMOSD patient however higher BMI age antiCD20 therapy highdose glucocorticoid treatment 2 month COVID19 onset associated pneumonia Based study already started early administration antiSARSCoV2 monoclonal antibody preferential vaccination risk group patient,b-cell depleting therapies;covid-19;disease-modifying therapies;multiple sclerosis;neuromyelitis optica spectrum disorder
Representations Psychoactive Drugs Use Mass Culture Impact Audiences,34204970,Drug use increasing worldwide recent decade Apart determinant drug initiation established numerous study author wish draw attention equally important factor may contribute augmenting phenomenon article aim draw attention content mass culture especially representation drug use mass medium may influence liberalization attitude towards drug use role mass culture impact audience discussed present overview drug representation content mass culture eg film music literature occurrence drug reference everyday product eg food clothes cosmetic Attention drawn liberal attitude celebrity admission drug use particularly impact presented position attitude audience especially young people musician actor celebrity regarded authority Indications preventive action also presented Attention drawn need take appropriate action due time COVID19 pandemic many people staying home due lockdown quarantine possibility much frequent contact mass culture content may distort image drug,covid-19;alcohol;illegal drugs;marijuana;mass culture;youth
Two dos SARSCoV2 BNT162b2 vaccine enhances antibody response variant individual prior SARSCoV2 infection,34376569,Understanding impact prior infection severe acute respiratory syndrome coronavirus 2 SARSCoV2 response vaccination priority responding coronavirus disease 2019 COVID19 pandemic particular necessary understand prior infection plus vaccination modulate immune response variant concern address sampled 20 individual 25 individual without confirmed previous SARSCoV2 infection large cohort healthcare worker followed serologically since April 2020 45 individual received two dos PfizerBioNTech BTN162b2 vaccine delayed booster 10 week Absolute neutralizing antibody titer wildtype SARSCoV2 variant measured using enzyme immunoassay pseudotype neutralization assay observed antibody reactivity lineage B1351 P1 variant increasing antigenic exposure either vaccination natural infection improvement confirmed neutralization assay using fixed dilution serum sample impact antigenic exposure evident enzyme immunoassay measuring SARSCoV2 spike proteinspecific IgG antibody concentration data show multiple exposure SARSCoV2 spike protein context delayed booster expand neutralizing breadth antibody response neutralizationresistant SARSCoV2 variant suggests additional vaccine boost may beneficial improving immune response future SARSCoV2 variant concern,
Dogs Cats Passively Carry SARSCoV2 Hair Pads,34372563,epidemiological role domestic animal spread transmission SARSCoV2 human investigated recent report aspect need clarified date rare case dog cat living COVID19 patient found harbour SARSCoV2 evidence pettohuman transmission aim present study verify whether dog cat act passive mechanical carrier SARSCoV2 live close contact COVID19 patient Cutaneous interdigital swab collected 48 dog 15 cat owned COVID19 patient tested SARSCoV2 qRTPCR time elapsed owner swab positivity sample collection pet ranged 1 72 day median time 23 day dog 39 day cat sample tested negative suggesting pet passively carry SARSCoV2 hair pad thus likely play important role virus transmission human data may contribute confirming direct contact hair pad pet represent route transmission SARSCoV2,covid-19 patients;sars-cov-2;cat;dog;hair;skin
Assessing ratio new Covid19 case new test SarsCov2 Italy fractal investigation,34212925,AIM processing heterogeneous data Italian Covid19 epidemic fractal investigation trend curve ratio new Covid19 casesnew SarsCov2 test METHODS New case Covid19 disease new test calculated raw data freely available Italian governing website effectiveness Italian government Decrees aiming obtain lockdown assessed fractal investigation Selfsimilarity parameter presumed fractal shape obtained 6 day Decree estimated possible Selforganized criticality also assessed check chaos involvement disturbing fractal shape Shapes compared used estimate number new test SarsCov2 Italy would able perform RESULTS full lockdown changed biocomplexity Covid19 epidemic Italy biocomplexity Covid19 change lockdown Italy able perform least 25490 test daily +8940 average real data show larger number test done p 0001 thereby obtaining lowering contagion biocomplexity observed full lock Italy would able perform 7088 test daily +5163 average real data show lower number test done p=0029 thereby observing worsening contagion CONCLUSION case heterogeneous data fractal investigation would prove useful assessing estimating trend,
Potential molecular mechanism zinc coppermediated antiviral activity COVID19,34284268,Novel coronavirus disease 2019 COVID19 spread across globe surprisingly potentially protective therapeutic antiviral molecule available treat severe acute respiratory syndrome coronavirus2 SARSCoV2 infection However zinc Zn copper Cu shown exert protective effect due antioxidant antiinflammatory antiviral property Therefore hypothesized supplementation Zn Cu alone adjuvant may beneficial promising efficacy favorable safety profile mitigate symptom well halt progression severe form SARSCoV2 infection objective review discus proposed underlying molecular mechanism implication combating SARSCoV2 infection response Zn Cu administration Several clinical trial also included use Zn adjuvant therapy dietary regimensantiviral drug COVID19 infection Overall review summarizes nutritional intervention Zn Cu may offer alternative treatment strategy eliciting virucidal effect several fundamental molecular cascade modulation immune response redox signaling autophagy obstruction viral entry genome replication SARSCoV2 infection,copper (cu);coronavirus disease 2019 (covid-19);gastrointestinal system;severe acute respiratory syndrome coronavirus 2 (sars-cov-2);trace elements;zinc (zn)
Case report cerebral thromboembolism unconscious COVID19 patient intensive care,34367452,Although severity coronavirus disease 2019 COVID19 frequently related acute respiratory distress syndrome acute cardiac renal injury thromboembolic event increasingly reported Acute respiratory distress syndrome due SARSCoV2 Severe Acute Respiratory Syndrome Corona Virus 2 often requires intensive care followup well respiratory failure SARSCoV2 may cause central nervous system CNS involvement pandemic raised many challenge managing critically ill older adult population preferentially killed COVID19 mortality morbidity rate extremely high critically ill patient COVID19 Recent study reported potential development hypercoagulable state COVID19 Viral infection hypoxia may cause state increasingly reported thromboembolic event associated poor prognosis Due thromboembolic complication COVID19 patient often neurological symptom symptom may observed intensive care patient sedated report one case sedated COVID19 pneumonia later diagnosed cerebral venous thrombosis cranial imaging could awaken even though sedation discontinued Since COVID19 cause intense thrombotic susceptibility due cytokine storm cerebrovascular thromboembolic complication associated COVID19 infection considered first foremost unconsciousness ventilated patient Severe potentially cerebral thrombosis may prolong patient stay intensive care,covid-19;case report;intensive care;pneumonia;tromboembolia
Aerosol Generation Ear Canal AirFluid Interface Suction,34286175,Objective identification aerosolgenerating procedure AGPs important current SARSCoV2 pandemic due aerosolmediated virus transmission Aerosol measurement clinical procedure using particle counting may confounded variable natural background aerosol level limited partial volume sampling study objective quantify significant aerosol generated simulated suction clearance procedure Study Design Prospective quantification aerosol generation clinical suction simulation Setting Clean chamber Methods created clean environment particle counting transparent neutralized polypropylene chamber Air passed HEPA 14 class filter maintain constant chamber inlet pressure optical particle counter connected line chamber exhaust vent measure vented particle chamber background count 1 particle =03 microm per 15 minute flow rate 1 chamber air change per minute used system quantify low aerosol count generated suction clearance silicone ear canal open airfluid interface Results clinically significant aerosol generation found particle counting whole chamber air volume simulated suction procedure Conclusion Simulated ear suction clearance airfluid interface suction generate significant aerosol appears likely aerosol potentially generated suction tube tip entrained incoming air flow first study quantify aerosol generated suction controlled environment research required determine clinical implication,agp;covid-19;aerosol-generating procedure;aerosolization;airborne;ear suction;microsuction;suction
BNT162b2 COVID19 vaccine correlate humoral immune response dynamic prospective singlecentre longitudinal cohort study healthcare worker,34224675,BACKGROUND Concurrent PfizerBioNTech BNT162b2 COVID19 vaccine rollout Israel initiated Dec 19 2020 assessed early antibody response antibody kinetics vaccine dose healthcare worker different age sex different comorbidities METHODS prospective singlecentre longitudinal cohort study Sheba Medical Centre TelHashomer Israel Eligible participant healthcare worker centre negative antiSARSCoV2 IgG assay receiving first dose intramuscular vaccine least one serological antibody test first dose vaccine Healthcare worker positive SARSCoV2 PCR test vaccination positive antiSARSCoV2 IgG serology test vaccination infection COVID19 vaccination excluded study Participants followed weekly 5 week first vaccine dose second dose given week 3 Serum sample obtained baseline weekly followup antibody tested 12 week first vaccine dose week 3 administration second vaccine dose week 45 ie 12 week second vaccine dose Participants comorbidities approached participate enriched comorbidities subgroup least two neutralising assay done 5 week followup individual IgG assay done entire study population whereas IgM IgA neutralising antibody assay done enriched comorbidities subgroup Concentrations IgG greater 062 sampletocutoff sco ratio IgA greater 11 sco titre neutralising antibody greater 10 considered positive Scatter plot correlation analysis logistic linear regression analysis linear mixed model used investigate longitudinal antibody response FINDINGS Dec 19 2020 Jan 30 2021 obtained 4026 serum sample 2607 eligible vaccinated participant 342 individual included enriched comorbidities subgroup first vaccine dose elicited positive IgG neutralising antibody response week 3 707 880 803 individual 264 710 372 individual respectively rapidly increased week 4 ie 1 week second vaccine dose 1011 984 1027 357 965 370 individual respectively 4 week followup vaccination high correlation r=092 detected IgG receptorbinding domain neutralising antibody titre Firstdose induced IgG response significantly lower individual aged 66 year older ratio mean 025 95 CI 019031 immunosuppressed individual 021 014031 compared individual aged 18004599 year individual immunosuppression respectively disparity partly abrogated following second dose Overall endpoint regression analysis showed lower antibody concentration consistently associated male sex ratio mean 084 95 CI 080089 older age ie =66 year 064 058071 immunosuppression 044 033058 specific comorbidities diabetes 088 079098 hypertension 090 082098 heart disease 086 075100 autoimmune disease 082 073092 INTERPRETATION BNT162b2 vaccine induces robust rapid antibody response significant correlation receptorbinding domain IgG antibody neutralisation titre suggests IgG antibody might serve correlate neutralisation second vaccine dose particularly important older immunosuppressed individual highlighting need timely second vaccination potentially revaluation long gap dos country Antibody response reduced susceptible population therefore might prone breakthrough infection FUNDING Sheba Medical Center Israel Ministry Health,
ALLERGIC REACTIONS COVID19 VACCINES,34333906,Coronavirus Disease 2019 COVID19 affected whole world short time One influential public health initiative modern medicine offer vaccine become even important COVID19 pandemic continues worsen worldwide Many vaccine trial launched COVID19 pandemic vaccine widely used around world offering realistic hope ending pandemic Allergic reaction vaccine reported shortly approval reaction general rare circumstance serious Allergy vaccine occur either active vaccine component vaccine ingredient spectrum reaction may local hypersensitiviy reaction may severe anaphylaxis acute severe lifethreatening systemic hypersensitive reaction requires quick intervention allergy suspected correct examination followed algorithm important true diagnosis treatment decision regarding revaccination Patients experience allergic reaction first dose covid 19 vaccine directed allergyimmunologist evaluation atrisk patient individualized Finally point benefit current COVID19 vaccine go far beyond side effect vaccine important way recover pandemic,covid-19;allergy;hypersensitiviy;polyethylene glycol;vaccine
Range Varicella Zoster CoInfections COVID19 Singapore,34216133,recent description novel coronavirus disease 2019 COVID19 presenting varicellalike exanthem report three case patient VaricellaZoster Virus VZV COVID19 coinfections presenting three varied way case highlight need heightened alertness coinfections present pick overlapping dual pathology current pandemic given infection control measure including airborne precaution crucial COVID19 VZV,covid-19;chickenpox;coinfection;communicable diseases;public health
Group Vaccinated First Systematic Review,34216120,BACKGROUND Since supply coronavirus disease 2019 COVID19 vaccine limited worldwide essential prioritize vaccination based scientific evidence Although several framework study vaccine distribution published published systematic review evaluated prioritization COVID19 vaccine MATERIALS METHODS searched 4 different database PubMed SCOPUS Web Science EMBASE article published January 2019 December 31 2020 Studies included contained primary search term `` vaccine `` COVID19 `` prioritization addition manually included report national international website RESULTS Thirteen study met inclusion criterion study older adult frequently mentioned group healthcare worker HCWs mentioned 1st priority group HCWs patient comorbidities 2nd 3rd frequently mentioned group reviewed paper Reducing severe COVID19 frequently mentioned goal CONCLUSION Since vaccination program initiated several country scientific evidence vaccination prioritization needed increase knowledge general vaccine prioritization improve vaccine acceptance result showed HCWs older adult frequently valued study,coronavirus;prioritization;vaccine
Inflammasome activation crux severe COVID19,34373622,COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 result lifethreatening disease minority patient especially elderly people comorbidities obesity diabetes Severe disease characterized dysregulated cytokine release pneumonia acute lung injury rapidly progress acute respiratory distress syndrome disseminated intravascular coagulation multisystem failure death However mechanistic understanding COVID19 progression remains unclear review evidence SARSCoV2 directly indirectly activates inflammasomes large multiprotein assembly broadly responsive pathogenassociated stressassociated cellular insult leading secretion pleiotropic IL1 family cytokine IL1beta IL18 pyroptosis inflammatory form cell death discus potential mechanism inflammasome activation clinical effort currently way suppress inflammation prevent ameliorate severe COVID19,
familial cluster COVID19 infection northern Chinese region,34343962,OBJECTIVE Currently coronavirus disease 2019 COVID19 spread worldwide become global health concern report familial cluster six patient infected severe acute respiratory coronavirus 2 SARSCoV2 northern Chinese region share local experience regard control COVID19 METHODS demographic data clinical feature laboratory examination epidemiological characteristic enrolled case collected analyzed Two family member Cases 1 2 Hubei exposure history admitted hospital confirmed diagnosis COVID19 eight familial member contact incubation period underwent quarantine hospital closely followed family member analyzed clinical outcome RESULTS Case 3 negative SARSCoV2 reverse transcriptionpolymerase chain reaction RTPCR result suspected COVID19 radiographic abnormality Cases 4 5 developed symptomatic COVID19 Case 6 considered asymptomatic carrier SARSCoV2 RTPCR result positive four family member close contact COVID19 patient evidence SARSCoV2 infection CONCLUSIONS finding suggest COVID19 infectivity incubation period preventive quarantine effective controlling outbreak COVID19 infection,coronavirus disease 2019;family cluster;incubation period;quarantine
Evaluation AntiSARSCov2 SRBD IgG Antibodies COVID19 mRNA BNT162b2 Vaccine,34206567,1 Background evaluation antispike protein receptorbinding domain SRBD antibody represents useful tool estimate individual protection Severe Acute Respiratory Syndrome CoronaVirus 2 SARSCoV2 infection 2 Methods evaluated anti SRBD IgG level indirect chemiluminescence immunoassay Maglumi 800 SNIBE California 2248 vaccinated subject without previous SARSCoV2 infection 91 vaccinated individual recovered COVID19 268 individual recovered COVID19 vaccinated Among healthy vaccinated 352 subject performed redosing 72 day first measurement 3 Results Anti SRBD IgG level lower subject previous infection vaccinated subject without previous infection p 0001 difference observed vaccinated subject without previous SARSCoV2 infection Overall antiRBD IgG level higher female male 2110 vs 1341 BAUmL p 0001 well subject symptom vaccination asymptomatic one 2085 vs 1332 BAUmL p = 0001 lower older younger subject Finally significant decrease antiRBD IgG level observed within short period complete twodose cycle vaccination 4 Conclusions result show efficacy antibody response vaccination age time sexrelated difference,covid-19;s-rbd igg;sars-cov-2;antibodies;immunosurvelliance;kinetic;spike;vaccination;vaccine
New Zealand maternity midwifery service COVID19 response systematic scoping review,34215539,PROBLEM COVID19 guidance professional health organisation created uncertainty leading professional personal stress impacting midwife providing continuity care New Zealand NZ COVID19 pandemic resulted massive amount international national information guidance guidance often conflicting suited New Zealand midwifery AIM examine map national international guidance information provided midwifery regarding COVID19 foreground learnt lesson future similar crisis METHODS systematic scoping review informed Arksey OMalley s fivestage framework range source grey empirical literature identified 257 source included FINDINGS Four category identified discussed 1 guidance provision maternity care community 2 guidance provision primary labour birth care 3 Guidance midwifery care womenwahine confirmedsuspected COVID19 infection including screening process management neonate infected womenwahine 4 Guidance midwife protecting self family whanau extended family COVID19 exposure CONCLUSION Guidance mainly targeted tailored hospitalbased service odds NZ context primary continuity care underpins practice evident providing continuity care constantly needed navigate evolving situation mitigate interruption restriction midwifery care often without fully knowing personal risk family key message need single source evidencebased guidance regularly updated timestamped show advice change time,covid-19;guidance;lockdown;midwives;new zealand;practice
Acute Retinal Necrosis presenting ophthalmic manifestation COVID 19 recovered patient,34228583,Purpose Infection SARSCoV2 virus result immune dysregulated state predispose reactivation Herpes virus report describes development Acute Retinal Necrosis ARN two patient recovered SARSCoV2 infectionMethods Observational report two consecutive patient presented ARN recovered SARSCoV2 infectionResults Case 1 5yearold child extensive peripheral necrotizing retinitis Case 2 61yearold gentleman bilateral retinal detachment sievelike break optic atrophy patient recovered SARS Cov2 infection 1 month ago PCR vitreous sample patient positive Herpes simplex virus Case 1 treated oral valacyclovir Case 2 underwent surgery eye retinal detachmentConclusion Immune dysregulation COVID19 infection result reactivation herpesvirus may lead development ARN,covid-19;acute retinal necrosis (arn);herpes virus;immune dysregulation;reactivation
Neurochemical sign astrocytic neuronal injury acute COVID19 normalizes longterm followup,34333238,BACKGROUND Neurologic manifestation wellrecognized feature coronavirus disease 2019 COVID19 However longitudinal association biomarkers reflecting CNS impact neurological symptom known sought determine whether plasma biomarkers CNS injury associated neurologic sequela COVID19 METHODS Patients confirmed acute COVID19 studied prospectively Neurological symptom recorded acute phase disease six month followup blood sample collected longitudinally Healthy agematched individual included control analysed plasma concentration neurofilament lightchain NfL glial fibrillary acidic protein GFAp growth differentiation factor 15 GDF15 FINDINGS One hundred patient mild n = 24 moderate n = 28 severe n = 48 COVID19 followed median IQR 225 187262 day acute phase patient severe COVID19 higher concentration NfL group p 0001 higher GFAp control p 0001 GFAp also significantly increased moderate disease p 005 compared control NfL r = 053 p 0001 GFAp r = 039 p 0001 correlated GDF15 acute phase six month NfL GFAp concentration normalized persisting group difference Despite 50 patient reported persistent neurological symptom commonly fatigue n = 40 `` brainfog n = 29 change cognition n = 25 found correlation persistent neurological symptom CNS injury biomarkers acute phase INTERPRETATION normalization CNS injury biomarkers individual regardless previous disease severity persisting neurological symptom indicates post COVID19 neurological sequela accompanied ongoing CNS injury FUNDING Swedish State Support Clinical Research SciLifeLab Sweden Knut Alice Wallenberg Foundation provided funding project,cns;covid-19;gdf-15;gfap;nfl;sars-cov-2
Differential Antibody Response mRNA COVID19 Vaccines Healthy Subjects,34346750,Knowledge development duration virusspecific antibody COVID19 vaccination important understanding limit pandemic via vaccination different population society However clinical utility postvaccination testing antibody response selection targeted SARSCoV2 antigen established result testing clinical team independent vaccine manufacturer also limited report initial result ongoing clinical study evaluation antibody response four different SARSCoV2 antigen first second dose Pfizer Moderna mRNA vaccine later time point revealed peak antibody induction vaccine boosting dose gradual decline antibody level later time Antinucleocapsid antibody induced spike proteinencoding vaccine may continue serve marker previous SARSCoV2 infection difference two vaccine term antibody response revealed Age gender dependency determined minimal within healthy adult aged population result suggest postvaccination testing antibody response important feasible tool following people vaccination selecting individual might require third dose vaccine earlier time point person may need second dose due previous SARSCoV2 infection IMPORTANCE authorized vaccine COVID19 widely used important understand induce antivirus antibody antigen targeted long antibody circulate personal health condition age may affect humoral immunity report induction time course multiple antiSARSCoV2 antibody response healthy individual immunized Pfizer Moderna mRNA vaccine also determined age gender dependence antibody response compared antibody level response seen recovered COVID19 result suggest importance screening antibody response multiple antigen vaccination order reveal individual require early late additional boosting may need second dose due prior SARSCoV2 infection,covid-19;sars-cov-2;antibody;humoral immunity;vaccination
SARSCoV2 Entry Crossroads CD147 ACE2,34201214,late 2019 betacoronavirus SARSCoV2 identified viral agent responsible coronavirus disease 2019 COVID19 pandemic Coronaviruses Spike protein responsible ability interact host membrane receptor different protein identified SARSCoV2 interactors among Angiotensinconverting enzyme 2 ACE2 Basigin2EMMPRINCD147 CD147 CD147 play important role human immunodeficiency virus type 1 hepatitis C virus hepatitis B virus Kaposi s sarcomaassociated herpesvirus severe acute respiratory syndrome coronavirus infection particular SARSCoV recognizes CD147 receptor expressed surface host cell nucleocapsid protein binding cyclophilin CyPA ligand CD147 However involvement CD147 SARSCoV2 infection still debated Interference function blocking antibody expression knock CD147 showed receptor partakes SARSCoV2 infection provided additional clue underlying mechanism CD147 binding CyPA play role CD147 regulates ACE2 level receptor affected virus infection Altogether finding suggest CD147 involved SARSCoV2 tropism represents possible therapeutic target challenge COVID19,ace2;cd147;covid-19;emmprin;sars-cov-2;basigin;entry;infection
DICLike Syndrome Following Administration ChAdOx1 nCov19 Vaccination,34205940,recent week adverse reaction reported administration OxfordAstraZeneca chimpanzee adenovirus vectored vaccine ChAdOx1 nCoV19 AZD1222 particular thrombus formation led several European Countries discontinue administration vaccine March 8 2021 European Medicines Agency Safety Committee confirm probable association report case patient developed disseminated intravascular coagulation first dose OxfordAstra Zeneca vaccine resolved day administration dexamethasone enoxaparin work demonstrates safety OxfordAstra Zeneca vaccine development side effect easily managed prompt diagnosis short time commonly used drug,sars-cov-2;chimpanzee adenovirus vectored vaccine;disseminated intravascular coagulation
methotrexate influence efficacy vaccination SARSCoV2,34132881,question whether ongoing treatment methotrexate MTX actually impairs protective immune response SARSCoV2 vaccination answered certainty basis available data However view fact short discontinuation twice weekly MTX treatment patient stable disease situation probably associated comparatively low risk inducing flare underlying inflammatory rheumatic disease short discontinuation treatment considered according individual decision involving patient treating rheumatologist Nevertheless discontinuation MTX treatment appear absolutely necessaryespecially since discontinuation would occur twice within short period time COVID19 vaccine circumstance longer period discontinuation treatment considered could result flare underlying disease detailed assessment data situation resulting consequence also respect DMARD follow soon updated recommendation action German Society Rheumatology DGRh management patient inflammatory rheumatic disease context SARSCoV2 pandemic especially COVID19,flare;protective immune response;recommendations for action;stable disease situation;treatment discontinuation
Acute Necrotizing Pancreatitis Cystic Lesion Concomitant SARSCoV2,34377701,SARSCoV2 cause severe acute respiratory distress clinical complication thromboembolic event gastrointestinal tract disorder generally present abdominal pain case report describe patient severe viral necrotizing pancreatitis associated COVID19 infection LEARNING POINTS patient COVID19 gastrointestinal symptom raise suspicion pancreatitis additional evaluation carried outFurther research investigate COVID19 associated acute pancreatitis warranted,covid-19;amylase;lipase;pancreatitis;pandemic
Bradyarrhythmias patient SARSCoV2 infection narrative review clinical report,34219243,Several cardiovascular disease arrhythmic disorder described COVID19 era likely related SARSCoV2 infection prognostic relevance bradyarrhythmias infection yet described data available longterm heart conduction disorder review literature concerning association hypokinetic arrhythmia COVID19 January 2020 February 2021 performed keywords used research `` sinus node disfunction `` sick sinus syndrome SSS `` sinoatrial block `` atrioventricular block AVB `` bradyarrhythmias `` COVID19 `` SARSCoV2 Excluding `` relative bradycardia total 38 case bradyarrhythmia related SARSCoV2 infection described even young people requiring many case definitive pacemaker implantation Furthermore report case nonhospitalized 47years old man SSS developed consequence mild SARSCoV2 infection described case heart conduction disorder found presentation infection hospitalization COVID19 case diagnosis SSS made resolution infection Although rarely heart conduction disorder may occur COVID19 present case highlight cardiological follow may desirable even resolution infection especially presence symptom suggesting possible heart involvement,sars-cov-2;atrio-ventricular block;heart conduction disorders;sick sinus syndrome;sinus node dysfunction
Characterization lowdensity granulocyte COVID19,34228753,Severe COVID19 characterized extensive pulmonary complication host immune response believed play role major arm innate immunity neutrophil one first cell recruited site infection excessive activation contribute lung pathology Lowdensity granulocyte LDGs circulating neutrophil whose number increase autoimmune disease cancer poorly characterized acute viral infection Using flow cytometry detected significant increase LDGs blood acute COVID19 patient compared healthy control Based surface marker expression COVID19related LDGs exhibit four different population display distinctive stage granulocytic development likely reflect emergency myelopoiesis Moreover COVID19 LDGs show link elevated recruitment activation neutrophil Functional assay demonstrated immunosuppressive capacity cell might contribute impaired lymphocyte response acute disease Taken together data confirms significant granulocyte activation COVID19 suggests granulocyte lower density play role disease progression,
Returning Workplace COVID19 Pandemic Concerns Australian Workers,34131836,Purpose determine nature prevalence worker concern regarding workplace reopening pandemic identify characteristic worker industry particular concern common Method Prospective cohort study 1063 employed Australian adult enrolled start pandemic Data attitude workplace reopening collected 1 July30 September 2020 frequency concern describes infection risk change work impact home life Regression model examined association demographic industry factor reopening concern Results four five 824 worker reported concern workplace infection risk half 534 reported concern impact work home life Concerns prevalent worker reporting psychological distress financial stress among exclusively working home Concerns regarding infection risk common worker health care IRR 116 95 CI 101 133 retail IRR 131 95 CI 106 161 accommodationfood service industry IRR 125 95 CI 101 155 Concerns regarding change work home life common female worker IRR 124 95 CI 107 143 partnersspouses dependent child IRR 144 95 CI 116 179 Conclusion Concerns COVID19 infection workplace common Many worker also concerned change work home life prevalence concern related nature work responsibility home Actions reduce risk workplace transmission coupled effective communication infection control may alleviate worker concern whilst recognising worker family social circumstance,covid-19;hygiene;infection risk;social distancing;working from home
Dengue fever outbreak Cook Island rising concern effort challenge future recommendation,34289153,Cook Island government made several effort ensure zero confirmed case transmission COVID19 especially among visiting traveler However Cook Island ministry health deal new strain dengue fever outbreak known dengue fever type 2 DEN2 adopting several measure control spread especially affected part subtropical country paper aim describe dengue fever response taken Cook Island suggest recommendation control risk transmission endemic part world,covid-19;cook island;den-2;dengue fever;endemic;outbreak;travelers
COVID19 pandemic Stay Home policy exposure risk infection among Nigerians,34226855,global threat continues accompany SARSCoV2 led global response adopts lockdown stay home policy mean curtailing spread study investigates compliance Stay Home policy exposure COVID19 Nigeria survey conducted April 4 May 8 2020 using crosssectional mixedmethods approach elicit response 879 participant across six geopolitical zone Nigeria Descriptive chi 2 multiple regression test used analyze survey data using SPSS whereas NVivo v12 used thematic analysis qualitative data States complete lockdown 724 respondent complying fully policy compared 442 respondent zone partial lockdown Market place classified highrisk zone visited n = 505 710 Though compliance influenced nature lockdown enforced chi 2 = 70385 df = 2 p 005 female widow unemployed associated increased compliance Exposure COVID19 associated married unemployed income Fear anxiety misperception play major role compliance author conclude compliance uniform nuanced targeted approach required government continues respond COVID19 global pandemic,covid-19;nigeria;stay at home
Antigenbased rapid diagnostic testing alternative diagnosis symptomatic COVID19 simulationbased net benefit analysis,34292212,BACKGROUND SARSCoV2 antigendetection rapid diagnostic test diagnose COVID19 rapidly low cost lower sensitivity compared reversetranscriptase polymerase chain reaction PCR limited clinical adoption METHODS compared antigen testing PCR testing clinical judgment alone diagnosing symptomatic COVID19 outpatient setting 10 COVID19 prevalence among patient tested 3day PCR turnaround hospital setting 40 prevalence 24hour PCR turnaround simulated transmission case contact relationship time viral burden transmission case detection compared diagnostic approach using measure net benefit incorporated clinical public health benefit harm intervention RESULTS outpatient setting estimated using antigen testing instead PCR test 200 individual could equivalent preventing symptomatic transmission one person COVID19 one `` transmissionequivalent hospital net benefit analysis favored PCR testing 25 patient PCR instead antigen testing achieved one transmissionequivalent benefit setting antigen testing preferable PCR PCR turnaround time exceeded 2 day test provided greater net benefit management based clinical judgment alone unless intervention carried minimal harm provided equally regardless diagnostic approach CONCLUSIONS diagnosis symptomatic COVID19 estimated speed diagnosis antigen testing likely outweigh lower accuracy compared PCR wherever PCR turnaround time 2 day longer advantage may even greater antigen test also le expensive,
Toward Smart Diagnostics Pandemic Scenario COVID19,34222208,incredible spread rate coronavirus disease 2019 COVID19 outbreak shocked world ever dramatic scenario proved significance diagnostics cornerstone make lifesaving decision context novel diagnostics generates smart data leading superior strategy treatment control surveillance prediction prevention management pandemic disease vital Herein discus characteristic met COVID19 diagnostics become smart diagnostics enabled industry 40 especially Internet Things IoT challenge ahead recommendation moving faster pure diagnostics toward smart diagnostics COVID19 possible epidemicpandemic disease also outlined IoTFogCloud model based smartphones IoT gateway smart diagnostics unified strategy data collectiontransmissioninterpretation also proposed integrate new digital technology single platform smarter decision Last least believe `` smart diagnostics perspective realized sooner encounter pandemic far worse present one,artificial intelligence;biosensors;internet of things;point-of-care testing;smartphone
Immune cell profiling antibody response patient COVID19,34225645,BACKGROUND Although growing number study evaluating lymphocyte subset count prognostic factor COVID19 disease severity lymphocyte subset analysis IgM IgG responder nonresponders period onset symptom conducted yet study aimed evaluate immune cell profiling COVID19 patient without antibody response METHODS crosssectional study level peripheral lymphocyte subset measured using flow cytometry 53 patient positive SARSCoV2 RTPCR antibody testing COVID19 performed RESULTS white blood cell neutrophil lymphocyte count consistently decreased IgM IgG nonresponder group difference median value two study group found statistically significant term neutrophil count P = 0024 IgM response pvalue = 0046 IgG response respectively Moreover level neutrophiltolymphocyte ratio observed significantly lower IgM IgG nonresponder group compared IgM IgG responder group 36 + 31 vs 63 + 42 pvalue = 0021 patient IgM antibody response significantly lower CD20 + lymphocyte 11 versus 15 group without IgM antibody response pvalue = 0031 percentage NK cell CD4 + cell significantly increased patient IgG antibody response compared without IgG antibody response 13 versus 10 pvalue = 0028 415 versus 34 pvalue = 003 respectively Moreover patient produced IgM IgG antibody significantly higher percentage total lymphocyte 64 versus 54 pvalue = 0017 CD4 + cell 41 versus 34 pvalue = 0038 NK cell 13 versus 9 pvalue = 0023 compared group serological response significant difference observed percentage lymphocyte subset including CD8 + cell Treg cell CD19 + B cell CONCLUSION result suggest total cell CD4 + cell NK cell percentage linked serological response Moreover finding suggested neutrophil absolute count neutrophiltolymphocyte ratio may valuable predictor IgM IgG antibody response,antibody response;covid-19;lymphocyte subsets;sars-cov-2
Peripheral central smell region COVID19 positive patient MRI evaluation,34282630,BACKGROUND Coronaviruses may lead invasion central nervous system PURPOSE investigate effect COVID19 infection smell using cranial magnetic resonance imaging MRI MATERIAL METHODS Cranial MRI scan 23 patient COVID19 patient group PG 23 healthy control HCs evaluated Peripheric olfactory bulb OB volume olfactory sulcus OS depth central insular gyrus corpus amygdala area smell region measured RESULTS Smell loss present nine patient 391 PG mean disease duration antiviral treatment 300 + 235 565 + 172 day respectively OB volume PG significantly lower HCs bilaterally However significant difference observed OS depth insular gyrus corpus amygdala area group left corpus amygdala area increased increased disease P = 0035 r = 0442 treatment duration P = 0037 r = 0438 PG longer treatment duration increase Creactive protein CRP lymphocyte count decrease positive thoracic computed tomography CT involvement related OS depth decrease Right corpus amygdala area increased patient COVID19 increased Ddimer value thoracic CT involvement detected CONCLUSION COVID19 disease affect peripheric smell region OBs affect central smell region insular gyrus corpus amygdala area importance study detect MRI finding patient COVID19 leading odor disorder finding may help diagnosing disease early stage,covid-19;corpus amygdala area;insular gyrus area;olfactory bulb volume;olfactory sulcus depth
Assessment Prostate Cancer Treatment Among Black White Patients COVID19 Pandemic,34292311,Importance Early COVID19 pandemic racialethnic minority community disproportionately experienced poor outcome however association pandemic prostate cancer PCa care unknown Objective ass association race PCa care delivery Black White patient first wave COVID19 pandemic Design Setting Participants multicenter regional collaborative retrospective cohort study compared prostatectomy rate Black White patient untreated nonmetastatic PCa COVID19 pandemic 269 patient March 16 May 15 2020 prior 378 patient March 11 May 10 2019 Main Outcomes Measures Prostatectomy rate Results 647 men nonmetastatic PCa 172 266 nonHispanic Black men 475 734 nonHispanic White men Black men significantly le likely undergo prostatectomy pandemic compared White patient 1 76 13 v 50 193 259 P 001 despite similar COVID19 risk factor biopsy Gleason grade group comparable prostatectomy rate prior pandemic 17 96 177 v 54 282 191 P = 75 Black men higher median prostatespecific antigen level prior biopsy 88 ngmL interquartile range 53152 ngmL v 72 ngmL interquartile range 51111 ngmL P = 04 linear combination regression coefficient interaction term year demonstrated odds ratio likelihood surgery 006 95 CI 001035 P = 002 Black patient 141 95 CI 081244 P = 23 White patient pandemic compared prior pandemic Changes surgical volume varied site 33 increase complete shutdown site experienced largest reduction cancer surgery caring greater proportion Black patient Conclusions Relevance large multiinstitutional regional collaborative cohort study odds PCa surgery lower among Black patient compared White patient initial wave COVID19 pandemic Although localized PCa require immediate treatment lesson study suggest systemic inequity within health care likely applicable across medical specialty Public health effort needed fully recognize unintended consequence diversion cancer resource COVID19 pandemic develop balanced mitigation strategy viral rate continue fluctuate,
Evolution Nutritional Status Early Nutritional Management COVID19 Hospitalized Patients,34209229,Background Aims SARSCoV2 infection associated increased risk malnutrition Although numerous screening nutritional management protocol malnutrition study reported nutritional evolution COVID19 objective study describe evolution nutritional parameter admission 30 day hospital discharge determine predictive factor poor nutritional outcome recovery adult COVID19 patient Methods observational longitudinal study report finding discharge 91 114 patient initially admitted COVID19 received early nutritional management Nutritional status defined using GLIM criterion compared admission day 30 discharge Baseline predictor nutritional status day 30 assessed using logistic regression Results Thirty day discharge 286 patient hospitalized COVID19 malnourished compared 423 admission Half malnourished patient 53 admission recovered normal nutritional status discharge Weight trajectory heterogeneous differed patient transferred intensive care unit ICU hospitalization p = 0025 High oxygen requirement hospitalization invasive ventilation p = 0016 83 16612 andor oxygen therapy 5 Lmin p = 0021 32 1289 strong predictor malnutrition one month discharge Conclusions early nutritional management patient hospitalized COVID19 improved nutritional parameter discharge finding emphasize importance nutritional care COVID19 patient hospitalized medicine department especially transferred ICU,covid-19;sars-cov2;albumin;malnutrition;nutritional management;pneumonia
ReDuNing injection ameliorates LPSinduced lung injury inhibiting neutrophil extracellular trap formation,34229173,BACKGROUND Acute lung injury ALI acute respiratory distress syndrome ARDS lifethreatening disease could occur severe COVID19 patient ReDuNing injection RDN tradition Chinese medicine preparation clinically used treatment respiratory disease including COVID19 PURPOSE elucidate potential mechanism RDN treatment ALI METHODS Female C57BL6J mouse used establish ALI model intraperitoneal injection 10 mgkg LPS RDN injection intraperitoneally administered dose 5 10 mlkg cytokine measured ELISA qPCR data related NETs analyzed ELISA immunofluorescence Western blotting network pharmacological approach RESULTS RDN robustly alleviated LPSinduced ALI Meanwhile RDN downregulated expression proinflammatory cytokine IL1beta IL6 TNFalpha Specifically RDN treatment inhibited formation neutrophil extracellular trap NETs remarkably suppressed protein PAD4 active compound RDN decreased phosphorylation ERK12 CONCLUSION finding demonstrate RDN ameliorates LPSinduced ALI suppressing MAPK pathway inhibit formation NETs,ali;ards;mapk;nets;re-du-ning injection
Identification special cell type determinant kidney tropism SARSCoV2,34228902,kidney tropism severe acute respiratory syndrome coronavirus 2 SARSCoV2 wellvalidated clinically often lead various form renal damage coronavirus disease2019 COVID19 patient However underlying mechanism diagnostic approach remain determined interrogated expression virusrelated host factor singlecell RNA sequencing scRNAseq datasets normal human kidney kidney preexisting disease validated result urinary proteomics COVID19 patient healthy individual also assessed effect genetic variant kidney susceptibility using expression quantitative trait locus eQTLs database identified subtype tubular cell named PT3 cell vulnerable SARSCoV2 infection kidney PT3 cell enriched viral entry factor replication assembly machinery lacked antiviral restriction factor Immunohistochemistry confirmed positive staining PT3 cell marker SCL36A2 kidney section COVID19 patient Urinary proteomic analysis COVID19 patient revealed marker PT3 cell significantly increased along elevated viral receptor angiotensinconverting enzyme 2 found proportion PT3 cell increased diabetic nephropathy decreased kidney allograft lupus nephropathy suggesting kidney susceptibility varied among disease finally identified several eQTLs regulate expression host factor kidney cell PT3 cell may represent key determinant kidney tropism SARSCoV2 detection PT3 cell may used ass risk renal infection COVID19,covid-19;sars-cov-2;chronic kidney disease;diabetic kidney disease;scrna-seq
Impact Coronavirus Disease 2019 Pandemic Neurosurgical Practice Feasibility Safe Resumption Elective Procedures Era Large Referral Center Tehran Iran Unmatched CaseControl Study,34284156,OBJECTIVE coronavirus disease 2019 COVID19 pandemic considerably affected surgical practice present study aimed investigate effect pandemic neurosurgical practice safety resumption elective procedure implementing screening protocol highvolume academic public center Iran one country severely affected pandemic METHODS unmatched casecontrol study compared 2 population patient underwent neurosurgical procedure June 1 2019 September 1 2019 period 2020 prospective part study patient underwent elective procedure tested severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection postoperatively evaluate viability screening protocol RESULTS Elective emergency procedure showed significant reduction pandemic 594 n = 168 vs 713 n = 380 increase 287 n = 153 vs 406 n = 115 respectively P = 0003 proportional distribution neurosurgical category remained unchanged pandemic Poisson regression showed reduction total daily admission category including spine trauma oncology infection significantly correlated pandemic Among patient underwent elective procedure 0 00 26 1625 positive test result day 30 60 postoperatively respectively Overall mortality comparable preCOVID19 COVID19 period yet patient concurrent SARSCoV2 infection showed substantially higher mortality 65 CONCLUSIONS implementing safety screening protocol proper resource allocation emergency care capacity maintained risk minimized hospitalacquired SARSCoV2 infection complication mortality among neurosurgical patient pandemic Similarly elective procedure according available resource hospital bed allocated patient higher risk delayed hospitalization concerned risk hospitalacquired infection reassured,covid-19;neurosurgery;pandemic;sars-cov-2
Modelling conformational state dynamic role infection SARSCoV2 Spike protein variant,34351895,SARSCoV2 Spike protein need openstate conformation interact ACE2 initiate viral entry utilise coarsegrained normal mode analysis model dynamic Spike calculate transition probability state 17081 variant including experimentally observed variant result correctly model increase openstate occupancy infectious D614G via increase flexibility closedstate decrease flexibility openstate predict effect several mutation glycine residue 404 416 504 252 well residue K417 D467 N501 including N501Y mutation recently observed within B117 501V2 P1 strain knowledge first use normal mode analysis model conformational state transition effect mutation transition specific mutation Spike identified may guide future study increase understanding SARSCoV2 infection mechanism guide public health surveillance effort,
Modeling Provincial Covid19 Epidemic Data Using Adjusted TimeDependent SIRD Model,34207174,paper develop forecasting model spread COVID19 infection provincial ie EU NUTS3 level Italy using official data Italian Ministry Health integrated data extracted daily official press conference regional authority local newspaper website data integration needed COVID19 death data available NUTS3 level official open data channel adjusted timedependent SIRD model used predict behavior epidemic specifically number susceptible infected deceased recovered people epidemiological parameter Predictive model performance evaluated using comparison real data,covid-19;eu nuts-3 regions;italy;sird-derived models;epidemic data
CO2 concentration monitoring inside educational building strategic tool reduce risk SarsCoV2 airborne transmission,34224708,order avoid SARSCoV2 transmission inside educational building promote safe reopening school Italian Government line European country accordance recommendation adopted contingency plan including action able guarantee adequate air ventilation classroom Therefore pilot study surveillance activity based realtime monitoring CO2 level proxy SARSCoV2 transmission risk conducted inside 9 school 11 classroom located Apulia Region South Italy reopening school lockdown due COVID19 pandemic specifically monitoring activity data treatment conducted evaluate initial scenario inside classroom first stage evaluation potential improvement obtained applying detailed operating protocol air ventilation based specific action simultaneous real time visualization CO2 level nondispersive infrared NDIR sensor second stage evaluation Although first evaluation stage air ventilation opening window door guaranteed 6 54 classroom showed mean value CO2 higher 1000 ppm classroom exceeded recommended CO2 concentration limit value 700 ppm development implementation tailored ventilation protocol including real time visualization CO2 level allowed depict better scenariosAn overall improvement CO2 level indeed registered classroom teacher compliant helpful management air ventilation strategy Therefore study report first evidencebased measure demonstrating exception environment affected structural limit realtime visualization monitoring CO2 concentration allowes effective air exchange implemented contributes prevent SARSCoV2 transmission Moreover basis monitoring outcome order ensure adequate air ventilation educational building 4 levelrisk classification including specific corrective action level provided,co(2);covid-19;indoor ventilation conditions;ndir sensor;sars-cov-2 transmission risk mitigation;school re-opening
adaptive capacity public space COVID19 Exploring urban design intervention sociotechnical system approach,34220186,coronavirus disease 2019 COVID19 pandemic dramatic impact way community interacts within public space Consequently design urban environment requires new approach view Human Factors Ergonomics approach used provide insight article explores opportunity making public space safer accessible community use pandemic condition study utilizes sociotechnical system model archetype public space developed preCOVID19 explore infrastructure activity impacted introduction virus public space system aim identify element system completely unavailable pandemic condition element become limited use remained unaffected presence virus finding show pandemic condition preCOVID19 public space surprisingly resilient proportionally element within model completely unavailable also demonstrate overall public space system still operating significantly constrained achieving optimizing community individual health wellbeing insertion five 5 urban design intervention within system model presented unique insight possibility optimizing adaptive capacity intervention revealed design opportunity across several level system model insight argued assist reestablishing community access pandemic condition also inclusive access broader range community condition,covid-19;adaptive capacity;public space;sociotechnical systems;urban design
Safety biologics inflammatory bowel disease patient COVID19,34131784,BACKGROUND Patients Inflammatory bowel disease IBD remain highly concerned either disease medicationsnamely biologicsmay increase risk severe coronavirus2019 COVID19 aimed ass safety biologics Inflammatory bowel disease IBD patient COVID19 METHODS systematically reviewed multiple database find relevant article reporting effect biologics `` severe COVID19 IBD patient form case series 10 patient casecontrol cohort study included Severe COVID19 defined intensive care unit ICU admission mechanical ventilation andor mortality Pooled analysis multivariate regression performed RESULTS total 12 study 2681 patient included proportion female 483 95 confidence interval CI 470495 proportion UC patient 448 95 CI 410485 Overall IBD patient need mechanical ventilation intensive care unit ICU admission mortality 51 61 45 respectively Use biologics show moderating effect mechanical ventilation p = 068 ICU admission p = 027 mortality p = 020 CONCLUSIONS finding advocate continued biologic therapy IBD patient COVID19 pandemic Nevertheless incidence severity outcome related COVID19 IBD patient need reassessed data continues emerge,biologics;covid-19;inflammatory bowel disease;mortality;sars-cov-2
COVID19 Motivated Reasoning Influence Knowledge COVIDRelated Policy Health Behavior,34226771,Objective spread misinformation COVID19 severely influence government ability address COVID19 pandemic study explores predictor accurate belief COVID19 influence COVIDrelated policy behavior Methods Data original survey collected Lucid July 2020 used Ordinary Least Squares regression OLS used predict accurate belief COVID19 Ordered logistic regression model estimated examine relationship COVID19 knowledge policy preference health behavior intention Results Ideology education found positive effect knowledge COVID19 Moreover low level knowledge COVID19 found reduce support mandatory vaccination policy willingness get coronavirus vaccine available Conclusion finding help policymakers develop communication strategy public coronavirus vaccination,
SelfMasked Aldehyde Inhibitors Novel Strategy Inhibiting Cysteine Proteases,34288674,Cysteine protease comprise important class drug target especially infectious disease Chagas disease cruzain COVID19 3CL protease cathepsin L Peptide aldehyde proven potent inhibitor protease However intrinsic high electrophilicity aldehyde group associated safety concern metabolic instability limiting use aldehyde inhibitor drug developed novel class selfmasked aldehyde inhibitor SMAIs cruzain major cysteine protease causative agent Chagas diseaseTrypanosoma cruzi SMAIs exerted potent reversible inhibition cruzain Ki = 18350 nM apparently protecting free aldehyde cellbased assay synthesized prodrugs SMAIs could potentially improve pharmacokinetic property also elucidated kinetic chemical mechanism SMAIs applied strategy design antiSARSCoV2 inhibitor,
effect orally administered lactoferrin prevention management viral infection systematic review,34133812,demonstrated lactoferrin LF play role host defence evidence potential antiviral property clinical study fragmented systematic review aimed identifying effect orally administered LF virus infection systematic search conducted PubMed Scopus Web Science BioRxivorg ClinicalTrialsgov database inception 7th January 2021 Eligible article investigated virus family provided data effect orally administered LF origin prevention andor management confirmed viral infection people age narrative synthesis result performed Quality assessed Cochrane RiskOfBias ROBINS1 tool total 27 record included nine registered protocol found data Flaviviridae n = 10 Retroviridae n = 3 Coronaviridae n = 2 Reoviridae n = 2 Caliciviridae n = 1 published trial high risk bias finding heterogeneous across within viral family regarding virological immunological biological response clear conclusion weak positive result reported decrease symptom severity duration reduction viral load Despite high tolerability effect LF oral supplement still inconsistent preventing managing viral infection Small sample size variety recruitment treatment protocol low study quality may contributed heterogeneity Betterdesigned study needed investigate potential benefit viral infection including SARSCoV2,covid-19;sars-cov-2;lactoferrin;systematic review;viral infections
influence preadmission antiplatelet anticoagulation therapy illness severity hospitalized patient COVID19 Japan,34340930,INTRODUCTION Many article reported coronavirus disease 2019 COVID19 cause coagulation abnormality pulmonary thrombosis contributing poorer prognosis study aimed evaluate whether preadmission anticoagulation antiplatelet therapy prevented severe COVID19 illness MATERIALS METHODS conducted study determine whether taking antiplatelet anticoagulation agent admission affected severity admission using large nationwide cohort hospitalized COVID19 patient Japan analyzed large nationwide cohort hospitalized COVID19 patient Japan February 9 July 31 2020 RESULTS CONCLUSION total 4265 patient 342 facility Japan included use associated slight reduction disease severity admission propensity scorematched analysis controlled underlying disease However difference statistically significant,anticoagulants;antiplatelet therapy;covid-19;japan
SARSCoV2 neutralizing antibody Longevity breadth evasion emerging viral variant,34228725,Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 antibody neutralization response evasion emerging viral variant variant concern VOC unknown critical understand reinfection risk breakthrough infection following vaccination Antibody immunoreactivity SARSCoV2 antigen Spike variant inhibition Spikedriven viruscell fusion infectious SARSCoV2 neutralization characterized 807 serial sample 233 reverse transcription polymerase chain reaction RTPCR confirmed Coronavirus Disease 2019 COVID19 individual detailed demographic followed 7 month broad sustained polyantigenic immunoreactivity SARSCoV2 Spike Membrane Nucleocapsid protein along high viral neutralization associated COVID19 severity subgroup `` high responder maintained high neutralizing response time representing ideal convalescent plasma donor Antibodies generated SARSCoV2 first COVID19 wave reduced immunoreactivity neutralization potency emerging Spike variant VOC Accurate monitoring SARSCoV2 antibody response would essential selection optimal responder vaccine monitoring design,
Prolonged detection complete viral genome demonstrated SARSCoV2 sequencing serial respiratory specimen,34351998,Accurate timely diagnosis severe acute respiratory syndrome coronavirus 2 SARSCoV2 clinically essential required also monitor confirmed case aiming prevent spread Positive realtime PCR result late time point following initial diagnosis may clinically misleading methodology account infection capability existence whole genome sequence study 47 serial respiratory sample tested AllplexnCoV test Seegene triplex three assay targeting SARSCoV2 RdRP E N gene subsequently assessed next generation sequencing NGS COVID19 patient tested early stage disease viral gene target positive advanced stage N gene target positive AllplexnCoV test corresponding NGS result showed presence complete viral genome copy early advanced stage disease although total number mapped sequence lower sample advanced disease stage conclude reduced viral transmission late disease stage may result low quantity complete viral sequence solely transcription favoring N gene,
They re getting taste world qualitative study people multiple sclerosis experience accessing health care COVID19 pandemic Australian Capital Territory,34227728,BACKGROUND People multiple sclerosis MS often immunocompromised require complex care engage variety healthcare provider manage health OBJECTIVE elucidate people MS experience accessing health care COVID19 pandemic Australia DESIGN qualitative study involving semistructured interview thematic analysis SETTINGS PARTICIPANTS Eight adult clinical diagnosis MS participated telephone video call interview June July 2020 RESULTS Participants aware MS made vulnerable contracting COVID19 case usual care postponed sought circumstance warranted risk facetoface consultation Benefits telehealth consultation included improved access convenience contactfree comparison video consultation via telephone considered le personal limited capacity read body language physical examination participant hoped incorporate telehealth future healthcare routine DISCUSSION CONCLUSION Personal risk assessment trust healthcare professional determinant mode people MS accessed health care COVID19 pandemic Telehealth valuable tool mitigate COVID19 transmission enabling contactfree consultation People MS may find specific value video consultation enable visualization physical function need training support clinician conduct remote consultation PATIENT PUBLIC CONTRIBUTION study conducted team comprised four people MS neurologist four health service researcher,multiple sclerosis;pandemic;patient experience;qualitative;risk assessment;telehealth
Disparities among RaciallyEthnically Marginalized Groups COVID19 Pandemic Persist Regardless Statewide ShelterinPlace Policies Analysis Northern California,34215866,measure COVID19 disparity among racialethnically marginalized group hospitalization ICU Intensive Care Unit transfer prepost implementation California statewide shelterinplace SIP policy retrospective cohort study conducted healthcare system California COVID19 patient 112083120 identified electronic health record examined hospitalization ICU transfer raceethnicity pandemic period using logistic regression Among 16520 people COVID19 mean SD age 466 184 year 542 woman PostSIP period patient average younger larger proportion Hispanic adjusted model odds hospitalization 20 lower postSIP compared SIP yet nonWhite group higher odds ORs 1621 compared NonHispanic White regardless period Among hospitalized patient odds ICU transfer 33 lower postSIP versus SIP Hispanic Asian patient higher odds compared NonHispanic Disparities hospitalization persisted ICU risk became pronounced Asian Hispanic patient postSIP Policy maker consider way proactively address inequity risk considering future populationlevel policy intervention public health crisis,covid-19;disparities;policy
Previous SARSCoV2 Infection Increases B117 CrossNeutralization Vaccinated Individuals,34204754,spread new variant severe acute respiratory syndrome coronavirus 2 SARSCoV2 need ass protection conferred previous infection current vaccination tested neutralizing activity infected andor vaccinated individual pseudoviruses expressing spike original SARSCoV2 isolate WuhanHu1 WH1 D614G mutant B117 variant data show parameter natural infection time infection nature infecting variant determined crossneutralization Uninfected vaccinee showed small reduction neutralization B117 variant compared WH1 strain D614G mutant Interestingly upon vaccination previously infected individual developed robust neutralizing response B117 suggesting vaccine boost neutralization breadth conferred natural infection,b.1.1.7 variant;sars-cov-2;humoral response;neutralization;pseudovirus
Musculoskeletal Disorders Pain Medication inHospital Mortality among Patients COVID19 South Korea PopulationBased Cohort Study,34202825,aimed investigate whether comorbid musculoskeletal disorder MSD pain medication use associated inhospital mortality among patient coronavirus disease 2019 COVID19 Adult patient =20 year old positive COVID19 diagnosis 5 June 2020 included study based National Health Insurance COVID19 database South Korea MSDs included osteoarthritis neck pain lower back pain rheumatoid arthritis others pain medication included paracetamol gabapentin pregabalin glucocorticoid nonsteroidal antiinflammatory drug NSAIDs opioids strong weak opioids benzodiazepine Primary endpoint inhospital mortality total 7713 patient COVID19 included inhospital mortality observed 248 32 patient multivariate logistic regression analysis MSDs p 005 significantly associated inhospital mortality However inhospital mortality 1273 time higher user strong opioids odds ratio 1273 95 confidence interval 2441664 p = 0002 use paracetamol p = 0973 gabapentin pregabalin p = 0424 glucocorticoid p = 0673 NSAIDs p = 0979 weak opioids p = 0876 benzodiazepine p = 0324 associated inhospital mortality South Korea underlying MSDs associated increased inhospital mortality among patient COVID19 However use strong opioids significantly associated increased inhospital mortality among patient,analgesics;musculoskeletal diseases;opioid;pain;population
COVID19 Delayed Cerebral IschemiaMore Common First Meets Eye,34208470,Since arrival global COVID19 pandemic scientist around world working understand pathological mechanism resulting infection gradually understanding COVID19 trigger widespread endotheliopathy result widespread thrombosis particular microthrombosis mechanism involved microthrombosis confined infection evidence patient aneurysmal subarachnoid haemorrhage SAH also suffer endotheliopathy microthrombosis article attempt shed light similarity underlying process involved disease suggest potential treatment option,covid-19;delayed cerebral ischemia;microthrombosis;subarachnoid haemorrhage
Inactivated SARSCoV2 vaccine influence profile prothrombotic antibody increase risk thrombosis prospective Chinese cohort,34336365,presence antiphospholipid antibody shown associated thrombosis coronavirus disease 2019 COVID19 patient Recently according report several study vaccineinduced immune thrombotic thrombocytopenia mediated antiplatelet factor 4 PF4 polyanion complex adenovirusvectored COVID19 vaccine recipient impendent explore whether inactivated COVID19 vaccine widely used China influence prothrombotic autoantibody production induces thrombosis prospective study recruited 406 healthcare worker received two dos 21 day apart inactivated severe acute respiratory syndrome coronavirus 2 SARSCoV2 vaccine BBIBPCorV Sinopharm Paired blood sample taken vaccination four week second vaccination used detecting prothrombotic autoantibody including anticardiolipin aCL antibeta2 glycoprotein abeta2GP1 antiphosphatidylserineprothrombin aPSPT antiPF4heparin seroconversion rate SARSCoV2 specific antibody 9581 389406 four week vaccination None subject spontaneous thrombosis thrombocytopenia minimum followup period eight week significant difference presence ten autoantibody sample collected vaccination aCL IgG 7 vs 8 P = 076 IgM 41 vs 44 P = 073 IgA 4 vs 4 P = 100 antibeta2GP1 IgG 7 vs 6 P = 078 IgM 6 vs 5 P = 076 IgA 3 vs 5 P = 072 aPSPT IgG 0 vs 0 P = 100 IgM 6 vs 5 P = 076 aPF4heparin 2 vs 7 P = 018 antinuclear antibody ANA 18 vs 21 P = 062 Notably seven case presented antiPF4heparin antibody range 118179 UmL vaccination none exhibited sign thrombotic disorder conclusion inactivated SARSCoV2 vaccine influence profile antiphospholipid antibody antiPF4heparin antibody increase risk thrombosis,anti-pf4-heparin antibody;antiphospholipid antibody;inactivated covid-19 vaccine;thrombocytopenia;thrombosis
impact Covid19 pandemic breast cancer early detection screening,34217412,COVID19 pandemic affect mortality morbidity disruption expected continue time access timely cancerrelated service concern breast cancer early detection treatment key improved survival longerterm quality life Health service generally strained many setting population breast mammography screening effort diagnose treat breast cancer earlier paused reduced capacity resulting delay diagnosis treatment may lead intensive treatment requirement potentially increased mortality Modelled evaluation support response pandemic estimating short longterm outcome various scenario Multiple calibrated validated model exist breast cancer screening applied 2020 estimate impact breast screening disruption compare option recovery range international setting behalf Covid Cancer Modelling Consortium CCGMC Working Group 2 Breast Cancer summarize provide example range setting internationally propose priority future modelling exercise International expert collaboration CCGMC Working Group 2 Breast Cancer conduct analysis modelling study needed inform key stakeholder recovery effort order mitigate impact pandemic early diagnosis treatment breast cancer,breast;covid-19;incidence;modelling;mortality;screening
Prevalence Anosmia Ageusia Patients COVID19 Among United Arab Emirates Population,34226066,OBJECTIVE aim research determine relationship prevalence taste smell dysfunction patient COVID19 United Arab Emirates UAE population METHODS Enrolled participant interviewed online via phone call obtaining informed consent Quantification smell taste sensation COVID19 infection correlated severity COVID19 symptom RESULTS total 500 patient mildsevere COVID19 completed survey total 264 asymptomatic 214 classified paucisymptomatic le severe symptom Almost equal proportion studied population experienced extreme taste sensation reduction 43 loss smell sensation 44 Statistically significant drastic decrease smell taste sens seen among younger individual magnitude reduction sense change increased steeply asymptomatic group paucisymptomatic group symptomatic group CONCLUSIONS Sudden anosmia ageusia need recognised early detection COVID19 infection identify otherwise hidden carrier thus favoring early isolation strategy restrict spread disease,ageusia;anosmia;covid-19
Nanotechnology Shield COVID19 Current Advancement Limitations,34202815,coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 global health problem declared pandemic COVID19 resulted worldwide lockdown threatened topple global economy mortality COVID19 comparatively low compared previous SARS outbreak rate spread disease morbidity alarming virus transmitted humantohuman droplet close contact people age susceptible virus advancement nanotechnology remarkable property including ability amplify signal used development nanobiosensors nanoimaging technique used earlystage detection along diagnostic tool Nanobased protection equipment disinfecting agent provide muchneeded protection SARSCoV2 Moreover nanoparticles serve carrier antigen adjuvant thereby making way development new generation vaccine present review elaborates role nanotechnologybased tactic used detection diagnosis protection treatment COVID19 caused SARSCoV2 virus,covid-19;sars-cov-2;detection;nanotechnology;treatment
Multisystem Inflammatory Syndrome Children Adolescents MISC Setting COVID19 Review Clinical Presentation Workup Management,34220204,Earlier course SARSCoV2 primarily identified cause acute respiratory illness adult elderly immunocompromised child known afflicted milder symptom However since midApril 2020 latent effect virus begun emerging child adolescent characterised multisystem hyperinflammatory state thus term Multisystem Inflammatory Syndrome Children MISC introduced CDC syndrome manifest approximately 4 week COVID19 infection symptom mimicking Kawasaki Disease Kawasaki Disease Shock Syndrome Demographically MISC peak child aged 5 14 year cluster Europe North Latin America seen later followed Asia Although exact pathophysiology behind syndrome unknown recent study proposed postinfectious immune aetiology explains increased level immunoglobulin seen affected patient Patient presentation includes limited persistent fever rash gastrointestinal symptom cardiac complication including myocarditis patient also raised inflammatory marker including C reactive protein ferritin interleukin6 poorly controlled patient syndrome lead multiorgan failure death mainstay treatment includes use intravenous immunoglobulin steroid immune modulators aspirin Adjunct therapy includes use low molecular weight heparin warfarin long term anticoagulation Currently little known syndrome highlighting need awareness amongst healthcare worker parent Moreover increased case COVID19 result second wave essential keep MISC mind attending patient past history COVID19 exposure infection Additionally patient identified treated strict followup must done order carry long term study identify possible sequela complication,covid-19;infectious diseases;kawasaki disease;management;multisystem inflammatory syndrome;pandemic;pathophysiology;pediatric;workup
Management SARSCoV2 pneumonia intensive care unit observational retrospective study comparing two bundle,34225084,PURPOSE compare effect two therapeutic bundle management SARSCoV2 ICU patient MATERIALS METHODS retrospective observational study performed university ICU March June 2020 first wave September 2020 January 2021 second wave first wave patient received bundle 1 including early invasive ventilation hydroxychloroquine cefotaxime azithromycin second wave bundle 2 included noninvasive oxygenation support dexamethasone main outcome inhospital mortality Secondary outcome included ICU hospital length stay ICU supportive therapy viral clearance antimicrobial resistance emergence RESULTS 129 patient SARSCoV2 pneumonia admitted ICU Thirtyfive treated according bundle 1 76 bundle 2 Inhospital mortality similar two group 23 p = 1 hospital p = 0003 ICU p = 001 length stay ventilatorfree day 28 day p = 003 significantly reduced bundle 2 Increasing age vasopressor use PaO2FiO2 ratio 125 associated inhospital mortality CONCLUSION Within limitation study change therapeutic bundle SARSCov2 ICU patient might effect inhospital mortality associated le exposure mechanical ventilation reduced hospital length stay,bundle;covid-19;dexamethasone;hydroxychloroquine;intensive care unit;treatment
Potential Mechanisms Action Chinese Patent Medicines COVID19 Review,34335247,Coronavirus disease 2019 COVID19 emergent infectious pneumonia caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 highly contagious pathogenic COVID19 rapidly swept across world since first discovered December 2019 drawn significant attention worldwide early stage outbreak China traditional Chinese medicine TCMs involved whole treatment process indispensable part TCM Chinese patent medicine CPMs played irreplaceable role prevention treatment epidemic use achieved remarkable therapeutic efficacy period medical observation clinical treatment mild moderate severe critical case convalescence order better propagate make full use benefit TCM treatment COVID19 review summarize potential target SARSCoV2 well theoretical basis clinical efficacy recommended 22 CPMs National Health Commission Administration TCM local province city treatment COVID19 Additionally study analyze drug composition potential active ingredient potential target regulated signaling pathway possible mechanism COVID19 antiinflammatory immunoregulation antiviral improve lung injury antipyretic organ protection provide meaningful information clinical application CPMs,covid-19;chinese patent medicine;sars-cov-2;review;traditional chinese medicine
way communicating pandemic meme sticker COVID19 systematic review,34211702,Background midst coronavirus disease 2019 COVID19 pandemic many way communicate hygiene measure meme sticker widely used social network carried systematic review order determine impact sticker meme tool face COVID19 pandemic following PRISMA guide Methods search carried scientific database MEDLINE PubMed ScientiDirect Scielo LILACS Latindex public prepublication server bioRxiv SocArXiv medRxiv Preprints publication identified using term meme sticker COVID19 SARSCOV2 WhatsApp corresponding translation Spanish Portuguese Results initial search 8434 study obtained 7749 Preprints 446 SocArXiv 145 ScientDirect 82 medRxiv 12 PubMed study found LILACS Latindex Scielo bioRxiv 51 study included eligible eliminated meeting study inclusion criterion majority 40 study eliminated study publication related social aspect related COVID19 develop analysis sticker meme Conclusions study identified met inclusion criterion related role sticker meme tool face COVID19 pandemic study needed estimate role mean communication health,covid-19;cell phone use;health promotion;sars-cov-2;smartphone;ehealth strategies
Remdesivir MD Simulations Suggest Favourable Binding SARSCoV2 RNA Dependent RNA Polymerase Mutant P323L WildType,34206274,SARSCoV2 RNAdependent RNA polymerase RdRp protein target antiviral drug Remdesivir RDV RDV clinical trial COVID19 patient showing reduced hospitalisation time spread virus RdRp developed several mutation frequent A97V P323L current study sought investigate whether A97V P323L mutation influence binding RDV RdRp SARSCoV2 compared wildtype WT interaction RDV WT A97V P323LRdRp measured using molecular dynamic MD simulation free binding energy extracted Results showed RDV bound WT A97VRdRp similar dynamic motion internal residue fluctuation whereas RDV interaction P323LRdRp exhibited tighter molecular conformation high internal motion near active site corroborated RDV showing higher binding affinity P323LRdRp 241 kcalmol comparison WTRdRp 173 kcalmol study provides insight potential significance administering RDV patient carrying SARSCoV2 P323LRdRp mutation may favourable chance alleviating SARSCoV2 illness comparison WTRdRp carrier thereby suggesting scientific consensus usage Remdesivir clinical candidate COVID19,rna dependent rna polymerase;remdesivir;sars-cov-2;molecular dynamic simulations
SARSCoV2Receptor Axis Heart Blood Vessels Crisp Update COVID19 Disease Cardiovascular Complications,34372552,SARSCoV2 virus causing COVID19 disease emerged expeditiously world declared pandemic since March 2020 World Health Organization destructive effect SARSCoV2 infection increased among patient preexisting chronic condition particular review focus patient underlying cardiovascular complication expression pattern potential function SARSCoV2 binding receptor attribute SARSCoV2 virus tropism physiopathological state heart blood vessel precisely described note atheroprotective role ACE2 receptor reviewed detailed description possible detrimental role SARSCoV2 infection term vascular leakage including endothelial glycocalyx dysfunction bradykinin 1 receptor stimulation concisely stated Furthermore potential molecular mechanism underlying SARSCoV2 induced clot formation association host defense component including activation FXIIa complement platelet endothelial dysfunction immune cell response cytokinemediated action well elaborated Moreover brief clinical update patient COVID19 disease underlying cardiovascular complication new onset cardiovascular complication postCOVID19 disease also discussed Taken together review provides overview mechanistic aspect SARSCoV2 induced devastating effect vital organ heart vessel,covid-19;sars-cov-2;blood vessels;bradykinin;cardiovascular disease;glycocalyx;heart;thrombosis
Improving pandemic mitigation policy across community coupled dynamic risk perception infection,34284634,Capturing coupled dynamic individual behavioural decision affect disease transmission epidemiology outbreak critical pandemic mitigation strategy develop multiplex network approach model adherence healthprotective behaviour impact COVID19 spread shaped perceived risk resulting community norm focus three synergistic dynamic governing individual behavioural choice social construction concern ii awareness disease incidence iii reassurance lack disease show policy enacted early broadly cause community become reassured therefore unwilling maintain adopt action Public health policy success relies collective action therefore exploit behaviourally receptive phase period generation sufficient concern foster adoption novel action relaxation adherence driven reassurance fostered avoidance negative outcome time,behavioural epidemiology;behaviourally receptive phase;disease risk perception;social norms
SARSCoV2 Plasma Hypercoagulability,34221178,Hypercoagulability emerged prominent consequence COVID19 present challenge clinic also thrombosis research Health safety consideration status blood plasma supply infection status individual donor mechanism SARSCoV2 activates coagulation concern review discus topic basic research perspective respiratory illness blood plasma COVID19 positive patient carry minimal risk infection practitioner researcher currently special regulatory mandate directing individual donor research purpose blood centersservices vendor blood product research test bloodplasma SARSCoV2 antibody discus current theory SARSCoV2 lead hypercoagulant state severe case COVID19 current understanding mechanism behind COVID19 associated thromboembolic event centered around three different pathway 1 direct activation platelet enhancing coagulation 2 direct infection indirect activation eg cytokine storm endothelial cell SARSCoV2 shifting endothelium antithrombotic prothrombotic state 3 direct activation complement pathway promoting thrombin generation investigation SARSCoV2 affect thrombosis COVID19 patient may bring novel antithrombotic therapy combat disease,covid-19;complement;endothelial cells;platelets;thrombosis
Retinal detachment COVID19 era review challenge solution,34226798,Background Since beginning Coronavirus disease 2019 COVID19 pandemic obstacle proper diagnosis management many disease evaluated change retinal detachment RD presentation surgery COVID19 pandemic propose solution minimize detrimental effect lockdown RD diagnosis Materials method PubMed Embase Scopus Web Science Google Scholar searched relevant article keywords `` Retinal detachment `` Coronavirus COVID19 SARS MERS Results COVID19 lockdown associated 5366 reduction RD presentation decrease rate maculaon RD increase mean duration symptom rise number patient proliferative vitreoretinopathy suggestive delayed presentation RD Moreover drop 5662 RD repair surgery observed However frequently performed ophthalmic surgery changed cataract surgery April 2019 RD repair April 2020 Using phacovitrectomy instead vitrectomy alone reduce number operation ophthalmology center decrease use personal protective equipment 50 cut cost per patient 1720 Also developing wellorganized telemedicine system decrease unnecessary visit delayed presentation Conclusion Delay RD presentation surgery associated poorer prognosis Optimizing guideline RD management developing wellorganized telemedicine system minimize impact lockdown RD management,delayed diagnosis;macula-on;presentation;telemedicine;vitrectomy
Clinical characteristic gastrointestinal manifestation outcome COVID19 patient Iran location matter,34222432,BACKGROUND Coronavirus disease 2019 COVID19 started Asia Iran one first epicenter AIM study gastrointestinal GI symptom comorbidities associated pandemic four different region Iran METHODS analyzed data severe acute respiratory syndrome coronavirus 2 positive patient evaluated four hospital Iran n = 91 including South Shiraz Southeast Dezful Rasht North Northwest Mashhad April September 2020 Demographics comorbidities clinical finding including GI symptom collected Statistical descriptive analysis correlation analysis symptom comorbidities mortality performed RESULTS average age COVID19 patient 511 year 56 male Mortality rate 17 Cough 846 shortness breath 714 fever 527 loss appetite 439 main symptom Overall cardiac disease common comorbidity average 285 followed hypertension 285 diabetes 252 highest comorbidity North Rasht diabetes 30 South Dezful hypertension 37 Shiraz lead cardiac disease 434 reported GI symptom included nausea diarrhea vomiting abdominal pain 428 318 268 12 prevalence respectively addition albumin alkaline phosphatase aspartate aminotransferase alanine aminotransferase elevated 263 CONCLUSION result show hypertension diabetes common comorbidities distribution different COVID19 patient four studied region Iran Nausea diarrhea elevated liver enzyme common GI symptom also high mortality rate associated high infection rate Iran beginning pandemic,covid-19;gastrointestinal manifestation;iran;pandemic
Deleterious Effects SARSCoV2 Infection Human Pancreatic Cells,34282405,COVID19 pandemic infected 154 million people worldwide caused 32 million death transmitted Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 affect respiratory tract well extrapulmonary system including pancreas express virus entry receptor AngiotensinConverting Enzyme 2 ACE2 receptor Importantly endocrine exocrine pancreas latter composed ductal acinar cell express high level ACE2 correlate impaired functionality characterized acute pancreatitis observed case presenting COVID19 Since acute pancreatitis already one frequent gastrointestinal cause hospitalization US majority study investigating effect SARSCoV2 pancreas clinical observational utilized human iPSC technology investigate potential deleterious effect SARSCoV2 infection iPSCderived pancreatic culture containing endocrine exocrine cell Interestingly iPSCderived pancreatic culture allow SARSCoV2 entry establish infection thus perturbing normal molecular cellular phenotype infection increased key cytokine CXCL12 known involved inflammatory response pancreas Transcriptome analysis infected pancreatic culture confirmed SARSCoV2 hijack ribosomal machinery cell Notably SARSCoV2 infectivity pancreas confirmed postmortem tissue COVID19 patient showed colocalization SARSCoV2 pancreatic endocrine exocrine cell increased expression pancreatic ductal stress response gene Thus demonstrate SARSCoV2 directly infect human iPSCderived pancreatic cell strong supporting evidence presence virus postmortem pancreatic tissue confirmed COVID19 human case novel model iPSCderived pancreatic culture open new avenue comprehension SARSCoV2 infection potentially establish platform endocrine exocrine pancreasspecific antiviral drug screening,covid-19;sars-cov-2;acinar cells;ductal cells;ipscs;islets;pancreas;pancreatitis
Early determination case fatality rate COVID19 pandemic ongoing Yemeni armed conflict,34343468,OBJECTIVES determine casefatality rate CFR coronavirus disease 2019 COVID19 associated determinant order understand true magnitude problem ongoing conflict Yemen METHODS CFR among confirmed COVID19 case Yemen calculated data retrieved national COVID19 surveillance April 10 first COVID19 case reported May 31 2020 RESULTS total 419 confirmed COVID19 case reported 141 57 case required intensive care mechanical ventilator respectively total case 95 death reported giving CFR 226 much higher compared country CFR significantly higher among elderly compared young adult varied governorates Mortality associated preexisting hypertension 230 95 CI 158 354 diabetes 168 95 CI 108 261 CONCLUSIONS Elderly comorbidities particular hypertension diabetes higher risk poor outcome therefore receive attention clinical setting Preventive measure also prioritized protect group order reduce severe case deathsassociated COVID19 armedconflict,cfr;covid-19;sars-cov-2;yemen;comorbidity
Deep learning model forecasting COVID19 outbreak Egypt,34334966,World Health Organization declared COVID19 global pandemic early 2020 comprehensive understanding epidemiological characteristic virus crucial limit spreading Therefore research applies artificial intelligencebased model predict prevalence COVID19 outbreak Egypt model long shortterm memory network LSTM convolutional neural network multilayer perceptron neural network trained validated using dataset record 14 February 2020 15 August 2020 result model evaluated using determination coefficient root mean square error LSTM model exhibit best performance forecasting cumulative infection one week one month ahead Finally LSTM model optimal parameter value applied forecast spread epidemic one month ahead using data 14 February 2020 30 June 2021 total size infection recovery death estimated 285939 234747 17251 case 31 July 2021 study could assist decisionmakers developing monitoring policy confront disease,covid-19;deep learning;egypt;epidemic model;long short-term memory network
chronic oral anticoagulation reduce inhospital mortality among COVID19 older patient,34216379,BACKGROUND Patients hospitalized COVID19 experienced increased risk venous thromboembolism AIMS evaluate effect chronic oral anticoagulation OAC therapy vitamin K antagonist VKAs direct oral anticoagulant DOACs prognosis COVID19 older patient METHODS Singlecenter prospective study conducted Emergency Department ED teaching hospital referral center COVID19 central Italy evaluated patient = 65 year consecutively admitted ED confirmed COVID19 compared clinical outcome chronic OAC ED admission using propensity score matched paired cohort control primary study endpoint allcause inhospital death Patients matched age sex clinical comorbidities clinical severity presentation based NEWS = 6 Study parameter assessed association allcause inhospital death multivariate Cox regression analysis identify independent risk factor survival RESULTS Although overall mortality slightly higher anticoagulated patient compared control 633 v 435 p = 0012 multivariate adjusted hazard ratio HR death significant HR = 156 078312 p = 0208 DOACs HR 146 073292 p = 0283 VKAs HR 114 048273 p = 0761 alone affect overall survival cohort CONCLUSIONS Among older patient hospitalized COVID19 chronic OAC therapy associated reduced risk inhospital death Moreover data suggest similar outcome patient VKAs patient DOACs,covid-19;direct oral anticoagulants;older patients;oral anticoagulation;vitamin k antagonists
Conventional Unconventional Approaches Innovative Drug Treatments COVID19 Looking Outside Plato s Cave,34281262,Thousands drug nutraceuticals along combination used select candidate therapeutic targeting transmission proliferation fatal severe symptom severe acute respiratory syndrome coronavirus 2 SARSCoV2 order reduce unacceptably high mortality rate observed coronavirus disease 2019 COVID19 pandemic associated negative effect daily life worldwide,
Notable Emerging Variants SARSCoV2 Virus Quick Glance,34219999,Severe acute respiratory syndrome coronavirus2 SARSCoV2 etiological agent coronavirus disease2019 COVID19 highly contagious pathogenic coronavirus emerge spread human population Although substantial exertion laid avert spread COVID19 therapeutic preventive countermeasure emergence SARSCoV2 variant result mutation make infection ominous New viral confers higher nasopharyngeal viral load increased viral transmissibility higher infectiousness immune escape increased resistance monoclonalpolyclonal antibody convalescence seravaccine enhanced virulence Thus pertinent monitor evolving mutation genetic diversity SARSCoV2 decisive understanding viral variant review provide overview colloquial nomenclature genetic characteristic different SARSCoV2 variant context mutational change circulating strain transmissibility potential virulence infectivity,genomic surveillance;notable variants;sars-cov-2;sars-cov-2 nomenclature;transmission
Development Promising Method Producing Oligomeric Mixture Branched Alkylene Guanidines Improve Substance Quality Evaluate Antiviral Activity SARSCoV2,34200418,paper report synthesis branched alkylene guanidines using microfluidic technology describe preparation guanidine derivative lower temperature significantly le time required previously applicable method Furthermore use microfluidics allows attainment highpurity product low residual monomer content expand range application class compound sample obtained molecularweight characteristic calculated based optimal condensation condition established Additionally work antiviral activity alkylene guanidine salt SARSCoV2 virus confirmed,antimicrobial resistance;antiseptic;antiviral activity;microfluidics;microreactor;polycondensation
Thermotropic effect PEGylated lipid stability HPPHencapsulated lipid nanoparticles LNP,34220293,work demonstrate enhanced thermal steric stability lipidbased formulation presence encapsulated HPPH demonstrated potential cancer application previously presented vivo study Differential scanning calorimeter DSC used study phase transition domain formation qualify thermodynamic property associated change lipid bilayer behavior due presence PEGylated varying concentration size encapsulated HPPH molecule Thermal instability quantified dramatic change calculated enthalpy shape melting peak calculated half width melting peak systematic study focused understanding effect varying molecular mass concentration PEG polymer photopolymerizable lipid DC8 9PC lipid bilayer matrix four week room temperature 25 degree C major finding include increased thermal stability lipid bilayer due presence PEG2 K HPPH resulted van der Waals force various molecular specie change bilayer curvature confirmed via mathematical correlation demonstrated encapsulation therapeutic lipid formulation alter overall thermal behavior therefore imperative consider calorimetric effect designing lipidbased vaccine presented research methodology finding presented predict stability lipidbased vaccine development COVID19 storage transport distribution,cancer;lipids;thermal analysis;thermodynamics;vaccine
Targeting 3CLpro SARSCoV2 RdRp Amphimedon sp Metabolites Computational Study,34205768,Since December 2019 novel coronavirus disease 2019 COVID19 pandemic caused tremendous economic loss serious health problem worldwide study investigated 14 natural compound isolated Amphimedon sp via molecular docking study examine ability act antiCOVID19 agent Moreover pharmacokinetic property promising compound studied docking study showed virtually screened compound effective new coronavirus via dual inhibition SARSCoV2 RdRp 3CL main protease particular nakinadine B 1 20hepacosenoic acid 11 amphimedoside C 12 promising compound demonstrated good interaction pocket enzyme Based analysis molecular docking result compound 1 12 selected molecular dynamic simulation study result showed Amphimedon sp rich source antiCOVID19 metabolite,amphimedon sp.;covid-19;coronavirus;molecular docking;sponge
Reduction emergency activity Covid 19 Italian lockdown s lesson learn,34373110,COVID 19 pandemic declared 9 th March 2020 health crisis affected whole world high unexpected number infected people situation forced declaration lockdown worldwide health system reorganization Surprisingly social distancing law caused reduction urgent hospital activity COVID 19 related aim manuscript analyze reason fewer emergency described 2020 Italian lockdown Data reporting urgent Emergency Room ER activity first three week Italian lockdown Group 1 analyzed compared period 2019 Group 2 study period 2020 465 reduction ER activity compared 2019 Nevertheless hospitalization rate higher 2020 2019 p 005 present data showed almost half basic ER activity araised mild health problem could followed territorial health service strengthening territorial medical service would allow hospital handle critical situation easily focus activity reducing waiting list,
Supporting Feeding Late Preterm Infants Hospital Quality Improvement Project,34334658,ABSTRACT Background Feeding difficulty common cause delayed hospital discharge readmission late preterm infant Frequent adequate feeding birth protective dehydration hypoglycemia jaundice National Perinatal Association s feeding guideline provide foundation late preterm infant standard care Feeding least every 3 hour promotes nutritional status neurologic development One feeding assessment every 12 hour hospital stay ensure quality infant feedingProblem large urban hospital medical record review completed evaluate nursing care practice consistent hospital s late preterm infant care standard policy Feeding frequency nurse assessment feeding effectiveness far acceptable target quality improvement team formed address inconsistency expected practiceMethods project included investigation using define design implement sustain method quality improvement Parent education nurse education visual cue developed sustain enhanced nursing practiceResults Late preterm infant received feeding least every 3 hour increased 25 1 40 27 11 40 = 0275 SD = 0446 p = 0001 Documented breastfeeding assessment increased 2 5 264 8 10 126 p = 0001 Documented bottlefeeding assessment increased 15 39 264 31 53 172 p 0001 Intervention time cut short due reprioritization effort response COVID19 pandemicConclusion Interventions implementation process improvement easy replicate attainable sustainable goal directed toward improved outcome late preterm infant,
Diagnostic delay acute mitral regurgitation coronavirus disease 2019 pandemic case report,34281499,BACKGROUND Diagnostic error delay cause serious consequence patient safety especially emergency department Anchoring bias one major factor leading diagnostic error coronavirus disease 2019 COVID19 pandemic high probability COVID19 febrile patient could major cause anchoring bias leading diagnostic error addition certain evaluation auscultation difficult perform casual basis due increased risk contact infection lead inadequate assessment patient valvular disease Acute mitral regurgitation MR could fatal disease emergency department especially diagnostic error delay diagnosis often reported diagnosis difficult even though treatment emergent surgery diagnosis acute MR become difficult coronavirus disease 2019 COVID19 pandemic could affect daily practice especially febrile patient report case diagnostic delay febrile patient anchoring bias COVID19 pandemic CASE PRESENTATION 45yearold man presented emergency department complaining acute dyspnea fever Based vital sign computed tomography chest acute pneumonia due COVID19 suspected Auscultation avoided facility rule based concern contact infection admission intensive care unit Doppler echocardiography revealed acute mitral regurgitation transesophageal echocardiography revealed mitral valve tendon rupture confirming negative result polymerase chain reaction severe acute respiratory syndrome coronavirus 2 mitral valvuloplasty performed third day admission patient discharged 14 day admission without complication CONCLUSIONS COVID19 pandemic anchoring bias suspecting COVID19 among febrile patient becomes strong heuristic factor thorough history physical examination still important febrile patient presenting dyspnea ensure correct diagnosis acute mitral regurgitation,bias;covid-19;diagnostic error;dyspnea;mitral valve prolapse
Clinicians patient experience managing heart failure COVID19 pandemic,34353790,BACKGROUND SARSCoV2 Coronavirus Disease COVID19 resulted unprecedented societal healthcare provision change implemented pace Little known indirect impact change future effect may AIM explore patient clinician experience managing heart failure HF COVID19 pandemic DESIGN SETTING Qualitative study three region UK Cambridgeshire Greater Manchester West Midlands METHOD Semistructured interview n=30 conducted older adult established HF healthcare provider primary secondary health service involved care Interviews analysed thematically RESULTS Compliance government guidance Stay home Protect NHS Save Lives COVID19 pandemic perception relating risk COVID19 underlying morbidity drove being careful behaviour organisational change Enacting behavioural change implementing organisational change resulted opportunity challenge health healthcare practice CONCLUSION Perception risk led significant behavioural organisational change pandemic change described patient clinician enhanced relationship selfmonitoring present opportunity consideration given maintain develop Equally indirect impact COVID19 associated lockdown disengagement withdrawal fallout reluctance access health service acknowledged intervention address challenge needed,covid-19;heart failure;qualitative research
high COVID19 spread impact neighbouring country Evidence Ireland,34355116,Background Coronavirus disease 2019 COVID19 necessitated public health response unprecedented scale Controlling infectious disease requires understanding condition increase spread Prior study identified sociodemographic epidemiological geographic association Ireland offer unusual opportunity quantify high infection rate one country impacted case neighbouring country Methods analysed official statistic confirmed COVID19 case island Ireland 52 week March 2020 main research question higher case Northern Ireland NI impact number case Republic Ireland ROI used least square regression compare confirmed case ROI county border NI rest state included model sociodemographic epidemiological geographic factor employed latitude county town instrumental variable isolate quasiexperimental estimate crossborder spread Results quasiexperimental framework controlling population density age distribution circulatory disease prevalence border county extra 210 95 CI 84336 confirmed COVID19 case per 1000 people equates estimated 9611 additional case ROI 4 national total first year pandemic result substantively similar nonexperimental framework alternative additional predictor sensitivity analysis Additionally population density ROI county positively associated confirmed case higher proportion resident professional class negatively associated Conclusion island Ireland first year COVID19 pandemic high infection rate NI increased case neighbouring ROI Maximising coordination pandemic response among neighbouring country essential minimising disease spread associated disruption society economy Socioeconomic disadvantage appeared confer significant additional risk spread,ireland;coronavirus;epidemiology;instrumental variable;policy;population density;public health;socioeconomic
Risk factor associated SARSCoV2 pneumonia pediatric population,34351892,INTRODUCCION Hasta ahora existen pocos estudios sobre la caracteristicas clinicas de la poblacion pediatrica con neumonia por COVID19 El objetivo de este estudio fue analizar los datos que se asocian con el desarrollo de neumonia en ninos adolescentes con infeccion por SARSCoV2 en Mexico METODOS Se llevo cabo un analisis secundario de la base de datos de la Direccion General de Epidemiologia del Gobierno Mexicano Se incluyeron menores de 19 ano con infeccion por SARSCoV2 confirmada mediante la prueba de retrotranscripcion acoplada la reaccion en cadena de la polimerasa RTPCR La variable dependiente fue el diagnostico de neumonia Se calcularon la razones de momios RM los intervalos de confianza del 95 IC95 Se realizaron modelos de regresion logistica multiple para ajustar los factores asociados neumonia RESULTADOS Se incluyeron 1443 ninos con diagnostico de COVID19 La mediana de edad de los participantes fue de 12 ano rango intercuartilar 2575 516 La neumonia se presento en 141 ninos 98 Los principales factores de riesgo fueron edad 3 ano RM 35 IC95 245503 diabetes u obesidad RM 126 IC95 4623491 e inmunocompromiso RM 703 IC95 3971361 CONCLUSIONES Los ninos con COVID19 menores de 3 ano con comorbilidad especialmente diabetes u obesidad los inmunocomprometidos presentan mayor riesgo de desarrollar neumonia BACKGROUND Currently study clinical characteristic pediatric population COVID19 pneumonia study aimed analyze data associated development pneumonia child adolescent SARSCoV2 infection throughout Mexico METHODS conducted secondary analysis database Direccion General de Epidemiologia Mexican Government included child age 19 confirmed SARSCoV2 infection reverse transcriptionpolymerase chain reaction RTPCR test dependent variable diagnosis pneumonia Odds ratio 95 confidence interval 95 CI calculated Multiple logistic regression model performed adjust factor associated pneumonia RESULTS total 1443 child COVID19 diagnosis included median age participant 12 year interquartile range 25 75 5 16 Pneumonia occurred 141 child 98 main risk factor age 3 year 35 95 CI 245503 diabetes obesity 126 95 CI 4623491 immunocompromise 703 95 CI 3971361 CONCLUSIONS Children 3 year COVID19 comorbidities especially diabetes obesity immunocompromised patient higher risk developing pneumonia,covid-19;factores de riesgo;neumonia;pediatrics;pediatria;pneumonia;risk-factors
Upsurge human rhinovirus infection followed delayed seasonal respiratory syncytial virus infection Thai child coronavirus pandemic,34350701,BACKGROUND Respiratory syncytial virus RSV human rhinovirus HRV commonly cause influenzalike illness young child global coronavirus pandemic beginning 2020 altered seasonality prevalence respiratory infection Thailand aimed characterize upsurge HRV subsequent RSV infection observed among young child sought medical care hospital Bangkok METHODS July December 2020 nasopharyngeal swab child =5 year age presented influenzalike illness tested RSV HRV using reversetranscription polymerase chain reaction Positive sample Sanger sequenced Genotyping performed using sequence phylogenetic analysis RESULTS Upsurge HRV infection began July subsequently replaced surge RSV infection September onward 6 month HRV detected 275 158574 sample 44 69158 HRVA 7 11158 HRVB 36 57158 HRVC Meanwhile RSV detected 404 232574 sample 78 181232 RSVA 6 14232 RSVB RSV peaked October 2020 approximately 2 month later typically seen previous year RSVA subgenotype ON1 Codetection HRV RSV found 51 29574 CONCLUSIONS HRV RSV infection among young child coincided relaxed local coronavirus public health measure including return inclass schooling delayed RSV season 2020 predominantly associated RSVA,children;coronavirus;infection;respiratory syncytial virus;rhinovirus
Guillain Barre syndrome complication SARSCoV2 infection case report,34377452,Introduction Covid19 infection usually manifest respiratory symptom neurological sign might mean symptom revealing infection Guillain Barre syndrome GBS COVID19 associated GBS seems severe nonCOVID19 GBS Case management reported 49 oldman admitted intensive care unit bilateral ascending symmetrical paresthesia associated lower limb numbness sphincter disorder two week upper respiratory infection diagnosis postCovid19 GBS maintained evolution favorable Intravenous Immunoglobulin IVIg plasma exchange PLEX second therapy Conclusion case report suggest probable causal link COVID 19 GBS severe association prompt u research may help professional early diagnosis early treatment thus improving morbidity mortality,a case report;covid-19;guillain barre syndrome;immunoglobulin;plasma exchange;sars-cov-2
Tolerance BNT162b2 mRNA COVI19 vaccine patient medical history COVID19 disease case control study,34210574,INTRODUCTION Studies evaluating BNT162b2 mRNA Covid19 vaccine safety excluded subject previous history COVID19 infection aim study focus tolerance vaccine population METHODS anonymous selfreporting survey related safety tolerance vaccine completed subject 21 28 day first vaccine dose two vaccination center RESULTS Subjects prior COVID19 disease history n = 61 higher systemic reaction subject without previous history n = 1987 459 v 297 p = 001 Asthenia headache fever significantly frequent COVID19 + group negative group 256 v 152 p = 0045 197 v 93 p = 001 65 v 09 p = 0003 respectively Grade severity higher COVID19 + COVID19 group p = 003 CONCLUSION study confirms higher risk side effect patient preexisting SARSCoV2 disease good overall tolerance,covid-19 infection;tolerance;vaccine
Safety Efficacy Anakinra Interleukin1 Antagonist Severe Cases COVID19 Systematic Review MetaAnalysis,34216117,study aim ass anakinra s safety efficacy treating severe coronavirus disease 2019 COVID19 Numerous electronic database searched finally 15 study total 3530 patient 757 anakinra arm 1685 control arm included pooled adjusted odds ratio mortality treatment arm 034 95 confidence interval CI 021 054 2 = 48 indicating significant association anakinra mortality significant association found regarding mechanical ventilation requirement anakinra group compared control group 068 95 CI 049 095 2 = 50 safety anakinra evaluated thromboembolism risk liver transaminase elevation Thromboembolism risk 159 95 CI 065 391 2 = 0 elevation liver transaminase 135 95 CI 061 303 2 = 76 statistically significant control group Anakinra beneficial lowering mortality COVID19 patient However nonsignificant difference safety profile anakinra control group may result baseline characteristic intervention group study essential evaluating anakinra s safety profile,anakinra;covid-19;il-1 antagonist;kineret;sars-cov-2
Acute Respiratory Distress Syndrome Time Weaning Invasive Mechanical Ventilator among Patients COVID19 Pneumonia,34208922,Acute respiratory distress syndrome ARDS due coronavirus disease 2019 COVID19 pneumonia main cause pandemic s death toll assessment ARDS time invasive mechanical ventilation IMV could enhance characterization outcome management condition citywide retrospective study hospitalized patient COVID19 pneumonia 5 March 2020 30 June 2020 Patients critical illness compared noncritical illness examined severity ARDS factor associated weaning patient IMV ii mortality citywide study Louisville KY 522 patient COVID19 pneumonia 219 419 critically ill Among critically ill patient median age 60 year 53 male 55 White 32 African American critically ill patient 52 ARDS 38 severe ARDS 25 patient weaned IMV severe ARDS weaned within eleven day versus five day without severe ARDS p = 0023 overall mortality critically ill patient 22 versus 1 critically ill Furthermore 14day mortality 31 patient severe ARDS 12 patient without severe ARDS p = 0019 Patients severe ARDS versus nonsevere ARDS needed twice long wean IMV eleven versus five day double 14day mortality patient without severe ARDS,ards;cap;covid-19;imv;sars-cov-2;pneumonia
Screening Diagnostic Prognostic Tests COVID19 Comprehensive Review,34198591,molecular testing realtime polymerase chain reaction RTPCR remains goldstandard test COVID19 diagnosis screening rapid affordable molecular antigen testing option developed affordable pointofcare antigen testing despite le sensitive compared molecular assay might preferable wider screening initiative Simple laboratory imaging clinical parameter could facilitate prognostication triage comprehensive review summarises current evidence diagnostic screening prognostic test COVID19,covid-19;crisp;pcr;sars-cov2;coronavirus;diagnosis;immunoglobulin;prognosis;screening
DIC SIC CAC haemostatic profile COVID19 patient hospitalised intensive care unit singlecentre retrospective analysis,34284551,INTRODUCTION Infection SARSCoV2 severe form lead acute respiratory distress syndrome requiring mechanical ventilation condition Intensive Care Unit ICU state hypercoagulation described COVID19 may deepen respiratory failure leading increased mortality aim presented study characterise haemostatic profile based result clotting system parameter risk assessment thromboembolic complication patient hospitalised ICU MATERIAL METHODS retrospective study covered first 10 adult patient hospitalised ICU Hospital Infectious Diseases Warsaw second quarter 2020 Demographic clinical laboratory parameter coagulation system risk thromboembolic complication assessed Well known criterion haemostatic disorder used classify observed derangement RESULTS frequently observed deviation coagulation system high concentration Ddimer fibrinogen select case clotting time prolonged severe thrombocytopenia observed patient presented high risk thromboembolic complication assesed Padua score observed clotting abnormality meet criterion DIC disseminated intravascular coagulation SIC sepsisinduced coagulopathy diagnosis CONCLUSIONS main element coagulopathy observed case differ usually seen patient recognised sepsis unique haemostatic profile COVID19 patient treated ICU described CAC COVID19associated coagulopathy, cac; d-dimer; dic; sars-cov-2; sic; coagulopathy; fibrinogen; haemostasis; thrombosis;covid-19
Antigenicity Epidemic SARSCoV2 Variants United Kingdom,34220844,determine whether neutralization activity monoclonal antibody convalescent serum vaccineelicited serum affected top five epidemic SARSCoV2 variant UK including D614G+L18F+A222V D614G+A222V D614G+S477N VOC20201201 B117 D614G+6970del+N439K pseudovirusneutralization assay performed evaluate relative neutralization titer five SARSCoV2 variant 12 single deconvolution mutant based variant study 18 monoclonal antibody 10 serum convalescent COVID19 patient 10 inactivatedvirus vaccineelicited serum 14 mRNA vaccineelicited serum nine RBDimmunized mouse serum four RBDimmunized horse serum four spikeencoding DNAimmunized guinea pig serum tested analyzed N501Y N439K S477N mutation caused immune escape nine 18 mAbs However convalescent serum inactivated virus vaccineelicited serum mRNA vaccineelicited serum spike DNAelicited serum recombinant RBD proteinelicited serum could still neutralize variant within threefold change compared reference D614G variant neutralizing antibody response different type vaccine different whereby response inactivatedvirus vaccine similar convalescent serum,b.1.1.7;monoclonal antibody;mutation;neutralization;pseudotyped virus;vaccine
Acceptance COVID19 Vaccine among Healthcare Workers Eastern Cape South Africa Cross Sectional Study,34207018,BACKGROUND study ass perception acceptance severe acute respiratory syndrome coronavirus2 SARSCoV2 vaccination also examines influencing factor among healthcare worker HCWs Eastern Cape South Africa METHODS crosssectional study performed November December 2020 total 1308 HCWs two large academic hospital participated Eastern Cape Healthcare Workers Acquisition SARSCoV2 ECHAS study Validated measure vaccine hesitancy explored using questionnaire Logistic regression used identify determinant vaccine hesitancy RESULTS majority nurse 452 risk unfavourable Covid19 outcome due obesity 629 direct contact individual confirmed Covid19 771 overall acceptance SARSCoV2 vaccine 901 differed significantly level education Individuals lower educational attainment primary secondary education prior vaccine refusal le likely accept SARSCoV2 vaccine However positive perception SARSCoV2 vaccine independently associated vaccine acceptance CONCLUSIONS high level acceptance SARSCoV2 vaccine reassuring however HCWs lower level education prior vaccine refusal targeted engagement address concern fear,eastern cape;sars-cov-2;south africa;healthcare workers;vaccine acceptance
Systematic analysis SARSCoV2 infection ACE2negative human airway cell,34214467,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 spike variant govern transmissibility responsiveness vaccination disease severity screen new model SARSCoV2 infection identify human H522 lung adenocarcinoma cell naturally permissive SARSCoV2 infection despite complete absence angiotensinconverting enzyme 2 ACE2 expression Remarkably H522 infection requires E484D variant virus expressing wildtype infectious AntiS monoclonal antibody differentially neutralize SARSCoV2 E484D H522 cell compared ACE2expressing cell Sera vaccinated individual block alternative entry mechanism whereas convalescent serum le effective Although H522 receptor remains unknown depletion surface heparan sulfate block H522 infection Temporally resolved transcriptomic proteomic profiling reveal alteration cell cycle antiviral host cell response including MDA5dependent activation type interferon signaling finding establish alternative SARSCoV2 host cell receptor E484D SARSCoV2 variant may impact tropism SARSCoV2 consequently human disease pathogenesis,ace2-independent;covid-19;rig-i-like receptors;sars-cov-2;clathrin-mediated endocytosis;heparan sulfate;proteomics;spike variants;type i interferon;virus-host interactions
Hospital admission care home England COVID19 pandemic retrospective crosssectional analysis using linked administrative data,34286106,Background Care home resident complex healthcare need may faced barrier accessing hospital treatment first wave COVID19 pandemic Objectives examine trend number hospital admission care home resident first month COVID19 outbreak Methods Retrospective analysis national linked dataset hospital admission residential nursing home resident England 257843 resident 45 nursing home 20 January 2020 28 June 2020 compared admission corresponding period 2019 252432 resident 45 nursing home Elective emergency admission rate normalised time spent care home across resident derived across first three month pandemic 1 March 31 May 2020 primary admission reason period compared across year Results Hospital admission rate rapidly declined early March 2020 remained substantially lower 2019 end June March May 2960 admission residential home 162 3295 admission nursing home 237 suspected confirmed COVID19 Rates emergency admission decreased 36 residential 38 nursing home resident 13191 fewer admission total Emergency admission acute coronary syndrome fell 43 29 105 fewer admission emergency admission stroke fell 17 25 128 fewer admission residential nursing home resident respectively Elective admission rate declined 64 residential 61 nursing home resident 3762 fewer admission Conclusions first study showing care home resident hospital use declined first wave COVID19 potentially resulting substantial unmet health need need addressed alongside ongoing pressure COVID19,covid-19;administrative data;care homes;hospital admissions;linked data
Smart sensor pregnancy Narrative review use smart home technology routine prenatal care,34215532,INTRODUCTION Today s routine prenatal care Germany includes regular inperson appointment pregnant woman doctor midwife Considering increasing digitalization healthcare sector view global COVID19 pandemic frequency inperson visit could reduced remote monitoring using smart sensor technology aim give overview current international research use smart sensor prenatal care benefit cost resource consumption METHODS narrative review PubMed Science Direct searched clinical trial using smart sensor prenatal care published English German language 12016 122020 included study addressed benefit cost resource consumption innovative technology RESULTS identified 13 project using smart sensor field basic prenatal care prenatal care patient hypertensive disease pregnancy prenatal care woman gestational diabetes project detected positive effect smart sensor health care cost resource consumption least equal benefit pregnant woman DISCUSSION CONCLUSIONS current COVID19 pandemic underline need introduction smart sensor technology German prenatal care routine Remote monitoring could easily reduce frequency inperson visit half Smart sensor concept could approved digital health application Germany order increase user acceptance additional cost pregnant woman health care professional using modern healthcare apps However health insurance provider need invest smart sensor technology order eventually benefit,digitalisierung;digitalization;mutterpass;pregnancy;prenatal care;remote monitoring;schwangerschaft;smart sensorik;smart sensor;vorsorgeuntersuchung
SARSCoV2 Induce Uterine Vascular Anomalies Poor Contractile Response A Case Report,34209533,reporting case 36 yearold Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 positive hypertensive primigravida postpartum uterine atony required emergency subtotal hysterectomy Saint John Hospital Bucur Maternity Bucharest maternity designated Coronavirus Disease 2019 COVID19 Maternity Bucharest Ilfov County since March 2020 patient mildly symptomatic SARSCoV2 infection confirmed reverse transcription polymerase chain reaction RTPCR caesarean section performed live male fetus born 2630 g Apgar Score 9 male fetus negative SARSCoV2 Postpartum hysterectomy adnexal preservation performed uterine atony postoperative evolution favorable patient discharged baby 10 day birth Given limited resource placenta umbilical cord uterus tested SARSCoV2 pathology exam revealed maternal side specific uterine atony lesion well endometrial miometrial ischaemia placenta nonspecific finding chronic ischemic lesion small villus fibrin deposit maternofetal interface peculiarity case report morphological finding placenta uterus resulted intrapartum uterine atonia patient gestational arterial hypertension premature birth COVID19 study required characterize pattern intricate condition,covid-19;sars-cov-2;atony of uterus;gravida;hypertension;postpartum hysterectomy;pregnancy
Acute Kidney Injury Pediatric Diabetic Kidney Disease,34211943,Diabetic kidney disease DKD common complication type 1 2 diabetes often present adolescence young adulthood Given growing incidence type 1 type 2 diabetes child adolescent DKD represents significant public health problem Acute kidney injury AKI youth diabetes strongly associated risk DKD development review summarize epidemiology pathophysiology AKI child diabetes relationship AKI DKD potential therapeutic intervention Finally appraise impact recent COVID19 infection pandemic AKI child diabetes,covid-19;acute kidney injury;diabetes;diabetic kidney disease;pediatric
relationship serum testosterone level clinical course prognosis COVID19 disease male patient prospective study,34288536,BACKGROUND potential role testosterone among sex hormone hypothesized identifying sexrelated difference clinical consequence severe acute respiratory syndrome coronavirus2 SARSCoV2 infection Due high global prevalence hypogonadism relationship hypogonadism SARSCoV2 infection outcome deserves indepth study OBJECTIVE present study aimed investigate relationship serum testosterone laboratory parameter prognosis coronavirus disease19 COVID19 male patient COVID19 diagnosis MATERIALS METHODS prospective cohort study included 358 male patient diagnosed COVID19 92 COVID19 negative patient admitted urology outpatient clinic control group COVID19 patient divided group according prognosis mildmoderate severe group lung involvement chest computed tomography 50 50 intensive care unit need survival RESULTS measured serum total testosterone level COVID19 patient group found significantly lower control group median 140 ngdl range 021328 322 ngdl range median 125674 p 0001 respectively serum TT level statistically significantly lower severe COVID19 patient compared mildmoderate COVID19 patient median 851 ngdl range 021532 median 315 ngdl range 088486 p 0001 respectively COVID19 patient need intensive care compared COVID19 patient need intensive care median 640 ngdl range 021337 median 286 ngdl range 088532 p 0001 respectively COVID19 patient died compared survivor median 829 ngdl range 263165 median 166 ngdl range 021532 p 0001 respectively DISCUSSION CONCLUSION data compatible low TT level playing role pathogenesis disease Covid19 patient poor prognosis mortal course may guide clinician determining clinical course disease,covid-19;sars-cov-2;hypogonadism;mortality;prognosis;testosterone
Assessment serological assay identifying high titer convalescent plasma,34216156,BACKGROUND COVID19 pandemic accompanied largest mobilization therapeutic convalescent plasma CCP century Initial identification high titer unit based doseresponse data using Ortho VITROS IgG assay proliferation severe acute respiratory syndrome coronavirus 2 serological assay nonuniform application led uncertainty interrelationship purpose study establish correlation analogous cutoff multiple serological assay METHODS compared Ortho Abbott Roche antispike ELISA virus neutralization assay Relationships relative FDAapproved cutoff CCP emergency use authorization identified convalescent plasma cohort 79 donor April 2020 RESULTS Relative neutralization assay spearman r value Ortho Clinical Abbott Roche antiS ELISA assay 065 059 045 076 respectively best correlative index establishing hightiter unit 387 signaltocutoff SC Abbott 1382 cutoff index Roche 11412 antiS ELISA 1219 neutralization assay 159 SC Ortho Clinical assay overall agreement using derived cutoff compared neutralizing titer 1250 785 Abbott 747 Roche 835 antiS ELISA 785 Ortho Clinical DISCUSSION Assays based antibody nucleoprotein positively associated neutralizing titer Ortho assay although ability distinguish FDA hightiter specimen imperfect resulting relationship help reconcile result large body serological data generated COVID19 pandemic,covid-19;sars-cov-2;convalescent plasma;serology
Modelling spread covid19 capital Brazil using numerical solution cellular automaton,34352565,novel coronavirus disease 2019 COVID19 still challenge researcher due spread death Hence classical epidemic SIR SEIRD model inspired epidemic s outbreak widely used predict evolution disease addition classical approach describing complex phenomenon Cellular Automata CA highly effective way understand iteration populated system present research analyzed usage CA generate epidemiccomputational model micro perspective based parameter obtained statistical fit macro perspective validating SIR SEIRD model government official data Brasilia Brazil author applied obtained parameter Cellular Automata model CA model simulated spread virus infected uninfected people restrained environment ie supermarket several varied condition applying approach never adopted manner applying CA research proved represent essential tool predicting spread coronavirus confined space random movement people CA numerical opensource presented purpose clarifying spread occurs mathematical curve organic way numerical simulation CA model allowed author conclude market store relevant place might infection Thus every local store market owner reason aspect could avoid spread disease coming efficient solution environment specific feature know one capable managing,covid-19;cellular automata;federal district;seird model;sir model
Impact Computed TomographyQuantified Emphysema Score Clinical Outcome Patients COVID19,34285557,Background Chronic obstructive pulmonary disease COPD considered risk factor poor outcome patient coronavirus disease 2019 COVID19 However data prognostic impact radiological emphysema extent patient COVID19 limited Thus study aimed examine whether computed tomography CT quantified emphysema score associated worse clinical outcome patient COVID19 Methods Volumetric quantitative analysis CT image performed obtain emphysema score COVID19 patient admitted four tertiary referral hospital Daegu South Korea February 18 March 25 2020 Patients divided three group according emphysema score emphysema score =1 1 emphysema score =5 emphysema score 5 Results total 146 patient confirmed SARSCoV2 infection included median emphysema score 10 interquartile range 0518 Eight patient 6 previous COPD diagnosis Eighty 55 55 38 11 8 patient emphysema score =1 1 5 5 respectively number patient received oxygen therapy two week admission significantly higher group emphysema score 5 group p=0025 frequency death three 27 group emphysema score 5 tended higher group Multivariate analysis revealed age COPD serum lactate dehydrogenase level associated greater risk inhospital mortality patient COVID19 Conclusion current study demonstrated patient CTquantified emphysema score 5 tended progress severe disease time however exhibit increased risk mortality COVID19 cohort study consideration emphysema extent airflow limitation degree warranted,copd;covid-19;computed tomography;emphysema;mortality
Aerosol Generation Laryngology Procedures Operating Room,34213770,OBJECTIVE Severe acute respiratory syndrome coronavirus2 spread respiratory fluid aim quantify aerosolized particle laryngology procedure understand potential transmission infectious aerosolbased disease STUDY DESIGN Prospective quantification aerosol generation METHODS Airborne particle 0325 mum diameter measured livepatient laryngology surgery using optical particle counter positioned 60 cm oral cavity surgeon s left Measurements taken procedure compared baseline concentration recorded immediately procedure Procedures included direct laryngoscopy general endotracheal anesthesia GETA direct laryngoscopy jet ventilation carbon dioxide CO2 laser use without jet ventilation utilizing intermittent suction RESULTS Greater 99 measured particle 03 10 mum diameter Compared baseline direct laryngoscopy associated significant 671 increase cumulative particle primarily 03 10 mum particle P 0001 10 25 mum particle significantly decreased P 001 Jet ventilation associated significant change cumulative particle analyzing differential particle size 10 25 mum particle exhibited significant increase compared baseline +4240 P = 002 Significant increase cumulative particle recorded CO2 laser use +1470 P 0001 specifically 03 25 mum particle Overall difference comparing CO2 laser use jet ventilation versus GETA CONCLUSIONS CO2 laser use laryngology surgery associated significant increase airborne particle Although direct laryngoscopy GETA associated slight increase particle jet ventilation overall increase particle aerosolization LEVEL EVIDENCE III Laryngoscope 2021,co2 laser;covid-19;aerosol-generating procedures;direct laryngoscopy;jet ventilation;optical particle counter
Early treatment combination two potent neutralizing antibody improves clinical outcome reduces virus replication lung inflammation SARSCoV2 infected macaque,34228761,urgent need effective therapeutic intervention SARSCoV2 including new variant continue arise Neutralizing monoclonal antibody shown promise clinical study investigated therapeutic efficacy combination two potent monoclonal antibody C135LS C144LS carry halflife extension mutation rhesus macaque model COVID19 Twelve young adult macaque three group four animal inoculated intranasally intratracheally high dose SARSCoV2 24 hour later treated intravenously high 40 mgkg low 12 mgkg dose C135LS C144LS antibody combination control monoclonal antibody Animals monitored 7 day Compared control animal animal treated either dose antiSARSCoV2 antibody showed similarly improved clinical score lower level virus replication upper lower respiratory tract significantly reduced interstitial pneumonia measured comprehensive lung histology conclusion study provides proofofconcept support clinical development monoclonal antibody COVID19 early infection,
Antiviral Effect Budesonide SARSCoV2,34372616,Treatment option COVID19 disease caused Severe nbsp Acute nbsp Respiratory nbsp Syndrome Coronavirus 2 SARSCoV2 infection currently severely limited Therefore antiviral drug efficiently reduce SARSCoV2 replication alleviate COVID19 symptom urgently needed Inhaled glucocorticoid currently discussed context treatment COVID19 partly based previous study reported reduced recovery time case mild COVID19 inhalative administration glucocorticoid budesonide Given various report describe potential antiviral activity glucocorticoid respiratory virus aimed analyze potential antiviral activity budesonide SARSCoV2 circulating variant concern VOC B117 alpha B1351 beta demonstrate dosedependent inhibition SARSCoV2 comparable viral variant tested cell viability remains unaffected result encouraging could indicate multimodal mode action budesonide SARSCoV2 COVID19 could contribute improved clinical performance,sars-cov-2;antivirals;budesonide;corticosteroids;variants of concern
Adverse Effects Personal Protective Equipment Among Intensive Care Unit Healthcare Professionals COVID19 Pandemic Scoping Review,34212076,Introduction avoid exposure SARSCOV2 healthcare professional use personal protective equipment PPE treating COVID19 patient Prior study revealed adverse effect AEs PPE healthcare worker HCWs however review focused AEs PPE HCWs intensive care unit ICUs review aimed identify AEs PPE HCWs working ICUs COVID19 pandemic Methods scoping review conducted MEDLINE CINAHL World Health Organization global literature COVID19 Igakuchuozasshi Japanese medical database Google Scholar medRxiv Health Research Board HRB open research searched January 2528 2021 extracted data included author name year publication country language article title journal name publication type study methodology population outcome key finding Results initial search identified 691 article abstract Twentyfive article included analysis analysis comprised four key topic study focusing PPErelated headache voice disorder skin manifestation miscellaneous AEs PPE majority AEs HCWs ICUs induced prolonged use mask Conclusion AEs PPE among HCWs ICUs included heat headache skin injury chest discomfort dyspnea Studies focus specific disease skin injury Moreover many AEs induced prolonged use mask,covid-19;healthcare worker;intensive care unit;occupational health;personal protective equipment
Impact proactive lowmolecular weight heparin therapy outcome COVID1,34282625,OBJECTIVES Low molecular weight heparin LMWH may provide beneficial effect outcome COVID19 aimed examine impact LMWH treatment clinical outcome duration hospitalization admission intensive care unit requirement mechanical ventilation death COVID19 patient normal Ddimer level admission BACKGROUND Coronavirus disease2019 COVID19 predisposes patient arterial venous thrombosis METHODS retrospective multicentre observational study analysed data 308 confirmed COVID19 patient normal Ddimer level initial admission propensity score matching PSM patient grouped Group 1 patient received LMWH Ddimer =05 mgL Group 2 patient received LMWH Ddimer level exceeded 05 mgL Group 3 patient receive LMWH RESULTS PSM group comprised 40 patient patient Group1 best clinical outcome compared group Group 3 worst clinical outcome p 0005 benefit LMWH increased early prophylactic therapy especially started Ddimer level =05 mgL CONCLUSION result strongly suggest proactive LMWH therapy improves clinical outcome hospitalized COVID19 patient even normal Ddimer level = 05 mgL Tab 3 Fig 2 Ref 34,covid-19; sars-cov-2; thrombosis; antithrombotic therapy; low-molecular-weight heparin; d-dimer; enoxaparin.
Albumin Infusion Critically Ill COVID19 Patients Hemodilution Anticoagulation,34281177,Hypercoagulation one major risk factor ICU treatment mechanical ventilation death critically ill patient infected SARSCoV2 time hypoalbuminemia one risk factor patient independent age comorbidities Especially patient severe SARSCoV2infection albumin infusion may essential improve hemodynamics reduce plasma level main marker thromboembolism namely Ddimer plasma level suggested recent report Albumin responsible 80 oncotic pressure vessel necessary keep enough water within systemic circulatory system maintenance sufficient blood pressure well sufficient blood supply vital organ like brain lung heart kidney liver reacts decrease oncotic pressure increase albumin synthesis normally possible use amino acid protein introduced nutrient reaching portal blood sufficiently provided diet amino acid delivered liver muscular protein systemic circulation liver also source coagulation protein fibrinogen fibronectin v WF VIII physiological component extracellular matrix vessel wall albumin main negative acutephase protein fibrinogen fibronectin v WF VIII positive acutephase protein Acute illness cause activation defense mechanism acutephase reaction may lead increase fibrinolysis increase plasma level fibrinogen breakdown product mainly fibrin Ddimer measurement plasma level Ddimer used marker venous thromboembolism fourfold increase Ddimer plasma level used negative prognostic marker critically ill SARSCoV2 hospitalized patient Increased fibrinolysis take place ischemic peripheral site mentioned coagulation protein become part provisional clot eg lung Although critically ill SARSCoV2infected patient considered septic shock patient albumin infusion considered hemodynamic resuscitation anticoagulant role coagulation factor provisional component extracellular matrix case generalized peripheral ischemia due hypoalbuminemia hypovolemia discussed review,covid-19 hypercoagulability;d-dimer;albumin infusion;fibrin;hypoalbuminemia;ischemia;lung injury kidney injury;provisional clot
Annexin A1 potential prognostic biomarker COVID19 disease Casecontrol study,34228870,BACKGROUND Annexin A1 AnxA1 important endogenous glucocoticoid protein contributes suppression inflammation limiting production neutrophil proinflammatory cytokine study aim determine clinical predictivity value blood AnxA1 level patient mild severecritical pneumonia induced COVID19 METHODS study employed prospective casecontrol study design conducted Ankara Training Research hospital 10 February 2021 15 March 2021 total 74 patient 42 moderate 32 severecritical case COVID19 disease according World Health Organization guideline 50 nonsymptomatic healthy volunteer participated study Blood sample taken patient time hospital admission serum isolated Following isolation serum AnxA1 level evaluated using enzymelinked immunosorbent assay method RESULTS serum AnxA1 level measured 255 186386 ngml control group 212 14732 ngml moderate disease group 148 97268 ngml severecritical disease group Serum AnxA1 level significantly lower severecritical disease group compared control moderate disease group P = 01 P = 0001 respectively Using receiver operating characteristic analysis larger area curve AUC serum AnxA1 level control group AUC = 0715 95 CI = 06260803 P = 0001 calculated compared COVID19 patient group diagnosis COVID19 disease AnxA1 level found 80 sensitive 541 specific cutoff level 185 ngml diagnosis COVID19 disease Moreover AnxA1 level found 698 sensitive 581 specific cutoff level 172 ngml predicting need intensive care unit ICU treatment CONCLUSION AnxA1 level may beneficial biomarker diagnosis COVID19 pneumonia predicting need ICU treatment patient COVID19 pneumonia time admission emergency department,
Directacting oral anticoagulant use prior COVID19 diagnosis association 30day clinical outcome,34218058,BACKGROUND unclear directacting oral anticoagulant DOACs use hospitalization due COVID19 diagnosis would potentially impact severity clinical outcome thereafter compared 30day hospitalizationrehospitalization clinical outcome patient chronic DOAC therapy patient oral anticoagulation OAC therapy time COVID19 diagnosis METHODS used data TriNetX global federated health research network Patients aged =18 year treated DOACs time COVID19 diagnosis 20 January 2020 28 February 2021 included matched patient OAC therapy period patient followedup 30days COVID19 diagnosis primary outcome allcause mortality hospitalizationrehospitalization venous thromboembolism VTE intracranial hemorrhage ICH RESULTS 738423 patient included propensity score matching PSM 26006 patient remained study 13003 DOACs 13003 OAC DOACtreated patient mean age 671 + 154 year 522 male higher relative risk RRs lower 30days eventfree survival compared patient OAC allcause mortality RR 127 95 CI 112144 LogRank test p = 0010 hospitalizationrehospitalization RR 172 95 CI 164182 LogRank test p 0001 VTE RR 451 95 CI 391582 LogRank test p 0001 ICH RR 090 95 CI 054151 LogRank test p = 0513 CONCLUSION COVID19 patient previous DOAC therapy time diagnosis associated improved clinical outcome lower hospitalizationrehospitalization rate compared patient taking OAC therapy,anticoagulant;bleeding;coronavirus disease 2019;direct-acting oral anticoagulants;mortality;sars-cov-2;thrombosis
ROMANOV study found impaired humoral cellular immune response SARSCov2 mRNA vaccine virus unexposed patient receiving maintenance hemodialysis,34284044,Patients maintenance hemodialysis MHD high risk infection SARSCoV2 virus death due COVID19 prioritized vaccination However excluded pivotal study weakened immune response known whether patient protected `` standard two dos mRNA vaccine answer antispike receptor binding domain RBD IgG interferon gammaproducing CD4 + CD8 + specificT cell measured circulation 1014 day second injection BNT162b2 vaccine 106 patient receiving MHD 14 history COVID19 compared 30 healthy volunteer four history COVID19 vaccination 7280 90 patient receiving MHD naive virus generated least one type immune effector response weaker le complete healthy volunteer multivariate analysis hemodialysis immunosuppressive therapy significantly associated absence antiRBD IgGs antispike CD8 + cell contrast previous history COVID19 patient receiving MHD correlated generation type immune effector antiRBD IgG antispike CD8 + cell level similar healthy volunteer Patients receiving MHD naive SARSCov2 generate mitigated immune response two dos mRNA vaccine Thus good response vaccine patient receiving MHD history COVID19 suggest patient may benefit third vaccine injection,bnt162b2;covid-19;hemodialysis;sars-cov-2;mrna vaccine
Always Better One NTerminal Domain Spike Protein Another Emerging Target Hampering SARSCoV2 Attachment Host Cells,34208755,Although approved vaccine proving utmost importance containing Coronavirus disease 2019 COVID19 threat hardly resolutive new severe acute respiratory syndrome coronavirus 2 SARSCoV2 singlestranded RNA virus variant might insensitive immune response induce scenario developing effective therapy still dire need Different target therapeutic antibody diagnostics identified among SARSCoV2 spike glycoprotein particularly receptorbinding domain defined crucial context aim focus attention also role played Nterminal domain S1NTD virus attachment already recognized valuable target neutralizing antibody particular building cavity mapping indicating presence two druggable pocket recent literature hypothesizing presence gangliosidebinding domain perspective aim proposing S1NTD putative target designing small molecule hopefully able hamper SARSCoV2 attachment host cell,cavity mapping;galectin inhibitors;spike protein
Lack N2gene amplification Cepheid Xpert Xpress SARSCoV2 assay potential novel causative mutation case series Auckland New Zealand,34336597,describe three case viral strain demonstrate impaired N2gene detection Cepheid Xpert Xpress SARSCoV2 assay two previously undescribed single nucleotide polymorphism SNPs C29197T G29227T propose SNPs likely responsible since close proximity previously described C29200TC29200A SNPs already shown abolish N2gene detection Xpert assay Whether SNPs abolish N2gene detection Xpert assay individually combination requires work elucidate,covid-19;mutations;pcr;sars-cov-2;single nucleotide polymorphisms;xpert
Severity mortality COVID19 infection HIVinfected individual Preliminary finding Iran,34211935,Background Higher mortality due coronavirus disease 2019 COVID19 reported among immunocompromised patient however relation immunosuppression due HIV infection severity COVID19 infection remains unclear aimed investigate severity mortality COVID19 infection HIVinfected patient Methods retrospective cohort study COVID19 suspected confirmed case hospitlized Iran Febuary 19 epidemic onset date April 8 2020 whose data recorded national database Medical Care Monitoring Center Hospitalized patient followed admittion deathdischarge Patients HIV status recorded based self report Logistic Cox regression model used evaluate association HIV infection severity according GlascowComa Scale situation need intubation hypoxemia mortality COVID19 infection respectively Analyses performed separately COVID19 suspected confirmed case Results 122 206 severe acute respiratory infection SARI case 90 HIVpositive 007 similar mean age Pttest= 0750 distrubtion gender PChisquare= 0887 nationality PChisquare= 0202 HIVnegative patient comparable proportion HIVpositive HIVnegative case tested COVID19 p= 0170 however frequency positive result lower among HIVpositives p= 0038 frequency COVID19 HIV coinfection lower expected among confirmed case adjusted OR= 054 95 CI 029102 suspected case adjusted OR= 068 95 CI 045 102 mean frequency COVID19 infection lower among HIVpositive case HIV infection decreased risk death among confirmed adjusted HR= 033 95 CI 005232 suspected case adjusted HR= 081 95 CI 033194 among SARI case adjusted HR= 073 95 CI 035154 Conclusion finding support concept HIV infection risk factor increase severity risk death among COVID19 infected patient,covid-19;hiv;severity
Redefining Relationship Palliative Care Critical Perinatal Neonatal Cardiac Patients,34201973,Patients perinatal neonatal congenital heart disease CHD represent unique population higher morbidity mortality compared neonatal patient group Despite overall improvement longterm survival often require chronic care complex medical illness hospital discharge placing high burden responsibility family Emerging literature reflects high level depression anxiety plague parent starting early time prenatal diagnosis current era global COVID19 pandemic additive nature significant stressor medical provider family catastrophic consequence communication coping Due high prognostic uncertainty CHD data suggests early pediatric palliative care PC consultation may improve shared decisionmaking communication coping minimizing unnecessary medical intervention However barrier pediatric PC persist largely due perception PC consultation indicative `` giving review serf highlight evolving landscape perinatal neonatal CHD need earlier longitudinal integration pediatric PC order provide highquality interdisciplinary care patient family,congenital heart disease;neonatology;palliative care;perinatology
Risk COVID19 Related Hospitalsation Intensive Care Unit Admission Mortality People Underlying Asthma COPD Systematic Review MetaAnalysis,34222281,Background Several underlying disease associated unfavorable COVID19 related outcome including asthma Chronic Obstructive Pulmonary Disease COPD however study reported risk adjusted confounding variable study aimed examine adjusted risk COVID19 related hospitalsation intensive care unit ICU admission mortality patient vs without asthma COPD Methods systematic review major database undertaken study published 1122019 1942021 Studies reporting adjusted one confounder risk either hospitalsation ICU admission mortality asthmatic COPD patient control group = asthma COPD identified Risk bias determined via QUIPS tool random effect metaanalysis undertaken Findings 37 study eligible analysis total 1678992 participant pooled ORs COVID19 hospitalsation subject asthma COPD 091 95 CI 076109 137 95 CI 129146 respectively ICU admission subject asthma COPD 089 95 CI 074107 122 95 CI 104142 respectively mortality ORs 088 95 CI 077101 125 95 CI 108134 asthma COPD respectively pooled risk mortality measured via Cox regression 093 95 CI 087100 asthma 130 95 CI 117144 COPD finding moderate level certainty Interpretation COPD significantly associated COVID19 related hospital admission ICU admission mortality Asthma associated negative COVID19 related health outcome Individuals COPD take precaution limit risk COVID19 exposure negate potential outcome Limitations include differing population type adjustment differing cofounding variable Practitioners note finding dealing patient comorbidities Review Protocol Registration http wwwcrdyorkacukprospero,copd;covid-19;icu;asthma;hospitalsation;intensive care;meta-analysis;mortality
Digitally enhanced recovery severe COVID19 new frontier,34286209,first wave intensive care unit admission COVID19 response constraint social distancing introduced new digitally enabled critical care rehabilitation pathway Using smartwatch technology pathway rapidly enabled multidisciplinary team observe recovery COVID19 cohort across eight NHS acute hospital across south England represents one geographically largest smartwatch study kind,covid-19;digital assessment;digital rehabilitation;smartwatch technology
Decreased human respiratory syncytial virus activity COVID19 pandemic Japan ecological timeseries analysis,34344351,BACKGROUND Nonpharmaceutical intervention NPIs sanitary measure travel restriction aimed controlling severe acute respiratory syndrome coronavirus 2 SARSCoV2 may affect transmission dynamic human respiratory syncytial virus HRSV aimed quantify contribution sale hand hygiene product number international domestic airline passenger arrival HRSV epidemic Japan METHODS monthly number HRSV case per sentinel site HRSV activity 2020 compared average corresponding period previous 6 year January 2014 December 2020 using monthly paired ttest generalized linear gamma regression model used regress timeseries monthly HRSV activity NPI indicator including sale hand hygiene product number domestic international airline passenger controlling meteorological condition monthly average temperature relative humidity seasonal variation year 20142020 RESULTS average number monthly HRSV case notification 2020 decreased approximately 85 p 0001 compared preceding 6 year 20142019 every average yen1 billion approximately pound680000 9000000 spent hand hygiene product current month 1 month 029 p = 0003 decrease HRSV infection increase average 1000 domestic international airline passenger arrival previous 12 month associated 38 x 10 4 p 0001 12 x 10 3 p 0001 increase monthly number HRSV infection respectively CONCLUSIONS study suggests association decrease monthly number HRSV case improved hygiene sanitary measure travel restriction COVID19 Japan indicating public health intervention contribute suppression HRSV activity finding may help public health policy decision making,covid-19;epidemics;hrsv;npis;sars-cov-2
COVID19 vaccineassociated cerebral venous thrombosis Germany,34288044,OBJECTIVE aimed estimate incidence cerebral sinus venous thrombosis CVT within one month firstdose administration frequency vaccineinduced immune thrombotic thrombocytopenia VITT underlying mechanism vaccination BNT162b2 ChAdOx1 mRNA1273 Germany METHODS webbased questionnaire emailed Departments Neurology asked report case CVT within one month COVID19 vaccination cerebral event could also reported Incidence rate CVT calculated using official statistic nine German States RESULTS total 45 CVT case reported addition 9 primary ischemic stroke 4 primary intracerebral hemorrhage 4 neurological event recorded CVT patient 35 778 female 36 800 age 60 year Fiftythree event observed vaccination ChAdOx1 855 9 BNT162b2 145 none mRNA1273 vaccination 7126434 first vaccine dos incidence rate CVT within one month first dose administration 055 95 CI 038078 per 100000 personmonths corresponds risk CVT within first 31 day 055 per 100000 individual vaccine 152 100221 ChAdOx1 2320535 ChAdOx1 first dos adjusted incidence rate ratio 968 3463498 ChAdOx1 compared mRNAbased vaccine 314 1221065 woman compared nonwomen 2645 patient CVT 578 VITT graded highly probable INTERPRETATION Given incidence 002015 per 100000 personmonths CVT general population finding point towards higher risk CVT ChAdOx1 vaccination especially woman article protected copyright right reserved,covid-19;sars-cov-2 vaccination;cerebral sinus and venous thrombosis;incidence study
Evaluation rapid antigen test detect SARSCoV2 infection identify potentially infectious individual,34213977,identification isolation highly infectious SARSCoV2infected individual important public health strategy Rapid antigen detection test RADT promising candidate largescale screening due timely result feasibility onsite testing Nonetheless diagnostic performance RADT detecting infectious individual yet fully determined study RTqPCR virus culture RTqPCR positive sample used evaluate compare performance Standard Q COVID19 Ag Test detecting SARSCoV2 infected possibly infectious individual end two combined oro nasopharyngeal swab collected routine SARSCoV2 diagnostic center total 2028 sample tested 118 virus culture inoculated SARSCoV2 infection detected 210 sample RTqPCR representing positive rate 1036 Standard Q COVID19 Ag Test yielded positive result 92 454 sample resulting overall sensitivity specificity 4286 9989 adjusted Ct value 20 n=14 25 n=57 30 n=88 RADT reached sensitivity 100 9825 8864 respectively 29 culture positive sample detected RADT overall sensitivity low Standard Q COVID19 RADT reliably detected patient high RNA load Additionally negative RADT result fully corresponded lack viral cultivability Vero E6 cell result indicate RADT valuable tool detection individual likely transmit SARSCoV2 RADT testing could therefore guide public health testing strategy combat COVID19 pandemic,
Imaging Multisystem Inflammatory Disease Children MISC Associated COVID19,34284918,RATIONALE OBJECTIVES retrospectively evaluate imaging finding multisystem inflammatory disease child associated COVID19 MISC MATERIALS METHODS radiological imaging finding 45 pediatric patient aged 52 day 16 year diagnosed MISC according World Health Organization criterion evaluated patient underwent chest Xray echocardiography finding obtained 25 abdominal radiograph 24 abdominal US 7 abdominal CT 16 thorax CT 21 cranial MRI one spinal MRI MR cholangiography MRCP cardiac MRI examination categorized evaluated according affected system RESULTS common finding chest Xray perihilar opacity peribronchial thickening pleural effusion finding thorax CT Echocardiography finding myocarditis observed 31 case common finding abdominal radiological evaluation hepatomegaly splenomegaly edema gallbladder wall periportal area mesenteric lymph node right lower quadrant thickening intestinal wall free fluid Reversible splenial lesion syndrome RESLES common neurological finding Acute disseminated encephalomyelitis ADEM like lesion acute hemorrhagic necrotizing encephalomyelitis radiological finding consistent GuillainBarre syndrome found one case CONCLUSION Radiological finding seen MISC pediatric case correlated affected system According system involved specific finding disease Radiological finding primary diagnostic tool assist evaluation affected system guide treatment,covid-19;children;imaging;multisystem inflammatory syndrome in children;radiology
role teledentistry oral cancer patient COVID19 pandemic integrative literature review,34219196,OBJECTIVES integrative review aimed ass benefit use teledentistry patient undergoing treatment oral head neck cancer COVID19 pandemic MATERIALS METHODS searched PubMed Cochrane Scopus Web Science Lilacs Embase Open Grey Google Scholar Jstor database study referring management control assistance teledentistry patient oral head neck cancer COVID19 pandemic RESULTS found 356 reference database 209 duplicate removal 23 met criterion fulltext reading 11 study included qualitative synthesis four category virtual visit use remote technology patient s satisfaction multidisciplinary approach teledentistry found 78 patient currently preferred teledentistry 92 patient would recommend use video consultation patient continuity dental care reduction patient visit hospital reduction risk infection coronavirus limitation facetoface consultation protect health professional benefit reinforce use teledentistry health institution Two study showed patient satisfaction use teledentistry monitoring cancer patient showed improvement quality life CONCLUSIONS teledentistry remote technology monitoring patient oral head neck cancer well accepted patient preliminary study Although study pointed benefit using remote technology care cancer patient robust scientific evidence still needed regard,covid-19;head and neck cancer;integrative review;oral cancer;teledentistry;telemedicine
Delayed Breast Cancer Detection Asian Country Taiwan Low COVID19 Incidence,34349563,Purpose ass whether COVID19 pandemic delayed breast cancer diagnosis Taiwan Asian country low COVID19 incidence Methods monthly volume breast biopsy breast cancer COVID19 pandemic January 21 July 31 2020 compared period 2019 preCOVID19 Results Taiwan recorded lower COVID19 incidence rate 202 case per million population Asian country screendetected lesion accounted 55 36 2019 2020 total biopsied lesion respectively Total breast biopsy mammographyguided ultrasoundguided biopsy decreased 17 23 14 respectively preCOVID19 COVID19 Monthly difference significant total biopsy p=003 mammographyguided biopsy p=004 benign pathology result breast biopsy p 001 Nearly 46 decline noted biopsy result noninvasive breast cancer 2020 number total breast cancer early breast cancer stage 0 1 decreased 10 38 respectively pandemic Individuals early breast cancer accounted 71 49 total diagnosed breast cancer preCOVID19 COVID19 period respectively p 0001 Conclusion pandemic significantly delayed early breast cancer detection Taiwan despite low COVID19 incidence Clinical Trial Registration ClinicalTrialsgov NCT04750018,covid-19;breast biopsy;breast cancer;mammography;pandemic
Flavor Future GI EndoscopyNew Solutions Shape Field Modern Gastrointestinal Care,34208440,Gastrointestinal GI cancer remain high list leading cause death worldwide however recent emergence new ongoing global healthcare threat COVID19 pandemic led temporary reduction elective endoscopic procedure,
Cardiac rehabilitation COVID19 pandemic Germany quick poll German Society rehabilitation Prevention Heart Circulation Diseases DGPR,34226141,BACKGROUND Germany COVID19 pandemic significantly changed cardiological care outpatient inpatient setting including cancellation elective intervention investigation presented carried order obtain information extent also applies cardiac rehabilitation facility METHODS August 2020 107 member institution DGPR contacted asked take part online survey containing 12 set question topic RESULTS end August data available 45 institution 311 institution surveyed rehabilitated patient cardiac complicationsmanifestations COVID19 disease mainly acute coronary syndrome 296 pulmonary artery embolism 259 40 facility required close partially completely 14 feared partial complete closure end 2020 cost testing SARSCoV2 infection suspected 721 mainly borne rehabilitation facility CONCLUSIONS Despite limitation shortterm data collection response rate approx 45 present study give indication challenging situation COVID19 pandemic cardiological rehabilitation facility Germany,covid-19;cardiac rehabilitation;kardiologische rehabilitation
Decreased Mortality Time First Wave Patients COVID19 Geriatric Care Data Stockholm GeroCovid Study,34216553,OBJECTIVE describe temporal change treatment care shortterm mortality outcome geriatric patient first wave COVID19 pandemic DESIGN Observational study SETTING PARTICIPANTS Altogether 1785 patient diagnosed COVID19 6744 hospitalized nonCOVID19 cause 7 geriatric clinic Stockholm March 6 July 31 2020 included METHODS Across admission month patient vital sign pharmacological treatment relationship risk inhospital death analyzed using Poisson regression model Incidence rate IRs incidence rate ratio IRRs death presented RESULTS patient COVID19 IR mortality 27 17 10 8 2 March July respectively standardization demographic vital sign Compared patient admitted March risk inhospital death decreased 29 IRR 071 95 confidence interval CI 051099 April 61 039 026058 May 68 032 019055 June 86 014 003058 July proportion patient admitted geriatric care oxygen saturation 90 decreased 13 1 partly explains improvement COVID19 patient survival nonCOVID19 patient pandemic mortality rate remained relatively stable IR 13 23 Compared nonCOVID19 geriatric patient IRR death declined 11 time higher IRR 117 95 CI 611223 16 time 261 050137 March July patient COVID19 CONCLUSIONS IMPLICATIONS Mortality risk geriatric patient Stockholm region declined time throughout first pandemic wave COVID19 improved survival rate time partly related improvement saturation status admission patient hospitalized later throughout pandemic Lower incidence later month could led le severe hospitalized case driving mortality,covid-19;geriatric;mortality
Predicting mortality individual patient COVID19 multicentre Dutch cohort,34281922,OBJECTIVE Develop validate model predict mortality patient diagnosed COVID19 admitted hospital DESIGN Retrospective cohort study SETTING multicentre cohort across 10 Dutch hospital including patient 27 February 8 June 2020 PARTICIPANTS SARSCoV2 positive patient age =18 admitted hospital MAIN OUTCOME MEASURES 21day allcause mortality evaluated area receiver operator curve AUC sensitivity specificity positive predictive value negative predictive value predictive value age explored comparison agebased rule used practice excluding age analysis RESULTS 2273 patient included 516 died discharged palliative care within 21 day admission Five feature set including premorbid clinical presentation laboratory radiology value derived 80 feature Additionally Analysis Variance ANOVA based datadriven feature selection selected 10 feature highest F value age number home medication urea nitrogen lactate dehydrogenase albumin oxygen saturation oxygen saturation measured room air oxygen saturation measured oxygen therapy blood gas pH history chronic cardiac disease linear logistic regression nonlinear treebased gradient boosting algorithm fitted data AUC 081 95 CI 077 085 082 079 085 respectively using 10 selected feature model outperformed agebased decision rule used practice AUC 069 065 074 age 70 Furthermore performance remained stable excluding age predictor AUC 078 075 081 CONCLUSION model showed good performance better test characteristic agebased decision rule using 10 admission feature readily available Dutch hospital model hold promise aid decisionmaking hospital bed shortage,covid-19;public health;risk management
Trend Health Service Utilization Challenges Faced COVID19 Pandemic Primary Units Addis Ababa MixedMethods Study,34291123,Introduction COVID19 pandemic imposed extraordinary challenge health socioeconomic facet nation globally Health facility encountered tremendous challenge contain service delivery level study aim ass trend health service utilization challenge faced COVID19 pandemic primary unit Addis Ababa Ethiopia Method multifacilitybased crosssectional study conducted Addis Ababa 1 30 August 2020 mixedmethods design employed quantitative qualitative data collected 5 health center Facilities selected randomly 5 subcities interviewee recruited purposively structured questionnaire used collect quantitative data HMIS unit facility Qualitative data collected using semistructured keyinformant interview guide Quantitative data analyzed using Microsoft Excel 10month timeseries trend generated qualitative data qualitative data analysis QDAminor software used Results Timeseries comparison preCOVID19 era load COVID19 period showed extensive disparity service delivery capacity health facility huge drop inpatient flow unit PICT VCT FP service subunits OPDs recorded following COVID19 outbreak keyinformant interview also revealed challenge fear infection stigma poor infrastructure challenge related human resource challenge related supply prevention treatment input prominently encountered health center Conclusion COVID19 wave negatively impacted many service delivery point study setting presence weak infrastructure lack PPEs fear infection stigma staff workload mentioned predominant challenge faced outbreak Health authority arrange multifaceted support ensure uninterrupted service delivery primary healthcare unit,covid-19;ethiopia;challenges;health service utilization;primary healthcare unit
Alternative Strategies Estimation Disease s Basic Reproduction Number ModelAgnostic Study,34216281,work present modelagnostic evaluation four different model estimate disease s basic reproduction number evaluation presented twofold first theory behind model reviewed compared model tested eight impartial simulation scenario constructed experimental framework allows model fulfill assumption hence obtain unbiased result case Among model one proposed Thompson et al Epidemics 29100356 2019 ie Bayesian estimation method well established epidemiological practice three model include novel statespace method two simulationbased approach based Poisson infection process advantage flaw model discussed theoretical practical standpoint Finally present evolution Covid19 outbreak Colombia case study computing basic reproduction number one reviewed method,basic reproduction number;bayesian statistics;kalman filter;poisson process;simulations
SARSCoV2 Pandemic Changed Traumatology Hospital Setting Analysis 498 Fractured Patients,34208115,BACKGROUND SARSCoV2 pandemic one biggest challenge many health system world making lot overwhelmed enormous pressure manage patient reported Institutional Experience specific aim describe distribution type treated injury organizational setup hospital METHODS Data fractured patient admitted surgical treatment time frame 9 March 20204 May 2020 1 March 201931 May 2019 collected compared Furthermore surgery duration parameter effectiveness health management compared RESULTS total 498 patient included Mean age significantly lower age 2019 femoral fracture significantly frequent 2020 Mean surgery time significantly longer 2020 Mortality rate difference two year found statistically significant Time interval diagnosis surgery diagnosis dischargedecease significantly lower 2020 2020 patient admitted negative swab turned positive following test SARSCoV2 CONCLUSIONS COVID19 pandemic modified epidemiology hospitalized patient traumatic reason leading increased admission older patient femoral fracture Nevertheless institutional experience showed efficient change hospital organization improvement several parameter effectiveness health management led null infection rate patient,sars-cov-2;fractures;health care management;hospital setting;traumatology
Case Report Saga PostCOVID19 Complications,34373809,Coronavirus disease 2019 COVID 19 caused severe acute respiratory syndrome coronavirus 2 characterized symptom fever sore throat cough fatigue myalgia headache diarrhea dysgeusia majority case cause mild illness However severe case virus activates immune system causing systemic inflammation immune dysregulation prothrombotic state leading various complication Among hospitalized patient COVID19 pneumonia sepsis respiratory failure frequent complication However even second year COVID19 pandemic knowledge myriad clinical feature complication still incomplete continues evolve present case patient developed several complication postCOVID19 one admitted severe COVID19 received standard COVID19 treatment mechanical ventilation postCOVID19 state extending six month serially developed deep vein thrombosis endogenous endophthalmitis empyema postinflammatory arthritis hip joint knowledge case reported earlier literature,arthritis;covid-19;empyema;endophthalmitis;thrombosis
Immunogenicity Protective Efficacy Intranasal Liveattenuated Vaccine SARSCoV2,34368648,Global deployment effective safe vaccine necessary curtail coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 evaluated Newcastle disease virus NDV based vectoredvaccine mouse hamster immunogenicity safety protective efficacy SARSCoV2 Intranasal administration recombinant r NDVS vaccine expressing spike protein SARSCoV2 mouse induced high level SARSCoV2specific neutralizing immunoglobulin IgA IgG2a antibody cellmediated immunity Hamsters immunised two dos vaccine showed complete protection lung infection inflammation pathological lesion following SARSCoV2 challenge Importantly administration two dos intranasal rNDVS vaccine significantly reduced SARSCoV2 shedding nasal turbinate lung hamster Collectively intranasal vaccination potential control infection site inoculation prevent clinical disease virus transmission halt spread COVID19 pandemic,covid-19;immunity;pandemic;sars-cov-2;vaccines;viral infection
survey patient disease perception impact COVID19 pandemic person living amyotrophic lateral sclerosis Malaysia,34284643,Aim investigate patient perception disease management impact COVID19 pandemic person living amyotrophic lateral sclerosis ALS Malaysia Patients method online survey comprising 42 question conducted ALS patient peak COVID19 pandemic Results Responses received 3760 62 participant ALS directly caregiver COVID19 pandemic twothirds patient negatively impacted sudden disruption hospital appointment rehabilitation session reduced social interaction Conclusion study provided insight patient perception care management ALS Malaysia facilitate implementing change improve care person living devastating illness,als;covid-19;malaysia;disease management;motor neurone disease;survey
Quantifying Viral Particle Aerosolization Risk Tracheostomy Surgery Tracheostomy Care,34292321,Importance respiratory disease outbreak COVID19 pandemic aerosolgenerating procedure including tracheostomy associated risk viral transmission health care worker Objective quantify particle aerosolization tracheostomy surgery tracheostomy care evaluate intervention minimize risk viral particle exposure Design Setting Participants comparative effectiveness study conducted August 2020 January 2021 tertiary care academic institution Aerosol generation measured real time optical particle counter simulated manikin tracheostomy surgical clinical condition including cough airway nebulization open suctioning electrocautery Aerosol sampling also performed vivo swine tracheostomy procedure n = 4 without electrocautery Fluorescent dye used visualize cough spread onto surgical field swine tracheostomy Finally 6 tracheostomy covering compared tracheostomy covering quantify reduction particle aerosolization Main Outcomes Measures Respirable aerosolized particle concentration Results Cough airway humidification open suctioning electrocautery produced aerosol particle substantially baseline Compared uncovered tracheostomy decreased aerosolization found use tracheostomy covering including cotton mask 738 95 CI 630 845 = 38 polyester gaiter 795 95 CI 687 903 = 72 humidification mask 828 95 CI 720 937 = 86 heat moisture exchanger HME 910 95 CI 802 1017 = 190 surgical mask 899 95 CI 793 1006 = 128 Simultaneous use surgical mask HME decreased particle concentration compared either HME 95 CI 16 123 Cohen = 12 surgical mask 95 CI 27 132 = 19 used independently Procedures performed electrocautery increased total aerosolized particle 1500 particlesm3 per 5second interval 95 CI 13801610 particlesm3 per 5second interval = 18 Conclusions Relevance finding laboratory animal comparative effectiveness study indicate tracheostomy surgery tracheostomy care associated significant aerosol generation putting health care worker risk viral transmission airborne disease Combined HME surgical mask coverage tracheostomy associated decreased aerosolization thereby reducing risk viral transmission health care worker,
Hemoadsorption management patient venovenous ECMO support severe COVID19 acute respiratory distress syndrome,34219277,BACKGROUND AIM Patients severe coronavirus disease 2019 COVID19 develop profound cytokinemediated proinflammatory response study report outcome 10 patient COVID19 supported venovenous extracorporeal membrane oxygenation VVECMO selected emergency use hemoadsorption column integrated ECMO circuit MATERIALS METHODS Pre posttreatment clinical data inflammatory marker assessed determine safety feasibility using system evaluate clinical effect RESULTS hemoadsorption median level interleukin IL 2R IL6 IL10 decreased 54 86 64 respectively Reductions marker observed lactate dehydrogenase 49 ferritin 46 ddimer 7 Creactive protein 55 procalcitonin 76 lactate 44 Vasoactiveinotrope score decreased significantly treatment interval 80 median hospital length stay 53 day 3685 90days post cannulation survival 90 similar group patient without use hemoadsorption CONCLUSIONS Addition hemoadsorption VVECMO patient severe COVID19 feasible reduces measured cytokine level However small series precise impact overall clinical course survival benefit still remains unknown,cardiovascular pathology;cardiovascular research;perfusion
Deleterious Effects COVID19 Peripartum Period Case Report,34208425,Coronavirus Disease 2019 COVID19 pandemic continues wreak havoc across nation globe one significant global health crisis time recent attention turned effect COVID19 pregnancy puerperium Although case asymptomatic patient disease may accompanied serious complication pneumonia acute respiratory distress multi organ failure death Several case study noted patient comorbidities significant risk complication recent systematic review metaanalysis author conclude cardiovascular disease associated increased composite poor outcome patient COVID19 following case report highlight multisystem complication severity symptom take place childbirth patient comorbid obstetric prenatal condition initially asymptomatic COVID19 infection,covid-19;co-morbidities;complications;pregnancy;puerperium
COVID19 Gaping Wounds South Africa s Suboptimal Immunisation Coverage Implementation Research Imperative Assessing Addressing Missed Opportunities Vaccination,34201684,Despite South Africa s substantial investment effort ensuring universal access immunisation service progress stalled remains suboptimal across province district additional challenge posed ongoing coronavirus disease 2019 COVID19 pandemic disrupted immunisation service globally including South Africa growing evidence missed opportunity vaccination MOV major contributor suboptimal immunisation progress globally much known burden determinant MOV South African context Herein make case assessing MOV strategy address current immunisation coverage gap mitigating adverse impact COVID19 pandemic immunisation service illustrate practical implementation research approach assessing burden MOV among child primary care setting understanding factor associated MOV designing implementing evaluating contextappropriate quality improvement intervention addressing missed opportunity effort vital building health system resilience maintaining immunisation programme capacity optimally deliver essential health service routine childhood immunisation even pandemic,covid-19;south africa;immunisation coverage;implementation research;missed opportunities for vaccination;quality improvement
Modeling withinHost SARSCoV2 Infection Dynamics Potential Treatments,34198530,goal study develop mathematical model simulate action drug target SARSCoV2 virus infection accomplish goal developed mathematical model describes control SARSCoV2 infection innate adaptive immune component Invasion virus trigger innate immunity whereby interferon render target cell resistant infection infected cell removed effector cell adaptive immune response represented plasma cell virusspecific antibody model parameterized validated viral load measurement collected COVID19 patient apply model simulate three potential antiSARSCoV2 therapy 1 Remdesivir repurposed drug shown inhibit transcription SARSCoV2 2 alternative hypothetical therapy inhibits virus entry host cell 3 convalescent plasma transfusion therapy Simulation result point importance early intervention ie three therapy effective must administered sufficiently early day two onset symptom model serve key component integrative platform rapid silico testing potential COVID19 therapy vaccine,covid-19;remdesivir;convalescent plasma transfusion;immune response;mathematical modeling
early detection immunoglobulin via opticalbased lateral flow immunoassay platform COVID19 pandemic,34283860,coronavirus disease COVID19 global public health challenge currently persisting grand scale method meet rapid quantitative detection antibody ass body s immune response natural COVID19 illness vaccine effect urgently needed present study attempt made integrate newly designed spectrometer COVID19 test strip procedure augmentation provides quantitative capacity lateral flow immunoassay LFIA Optical interpretation result quantitative alpha index rather visual qualification done quickly 510 minute developed product compared several serological IgMIgG antibody reagent market recruiting 111 participant suspected COVID19 infection March May 2020 hospital Taking RTPCR diagnostic gold standard quantitative spectral LIFA platform could correctly detect 12 COVID19 patient Concerning RTPCR negative patient three antibody testing method found positive case opticalbased platform exhibited ability early detection immunoglobulin RTPCR negative patient apparent trend elevation IgM level acute phase infection IgG level rose later exhibited risk falsenegative diagnosis RTPCR COVID19 testing significant detection ability new opticalbased platform demonstrated clinical potential,
Efficacy Safety Hydroxychloroquine Hospitalized COVID19 Patients Systematic Review MetaAnalysis,34198792,systematically reviewed efficacy safety hydroxychloroquine treatment hospitalized COVID19 Randomized controlled trial RCTs evaluating hydroxychloroquine treatment hospitalized COVID19 patient searched 2nd December 2020 Primary outcome allcause mortality need mechanical ventilation need noninvasive ventilation ICU admission oxygen support 14 30 day Secondary outcome clinical recovery worsening discharge radiological progression pneumonia virologic clearance serious adverse event SAE adverse event Inverse variance random effect metaanalyses performed Thirteen RCTs n=18540 included Hydroxychloroquine total dos ranged 2000 12400 mg treatment duration 5 16 day follow time 5 30 day Compared control hydroxychloroquine nonsignificantly increased mortality 14 day RR 107 95 CI 092125 30 day RR 108 95 CI 100116 Hydroxychloroquine affect primary secondary outcome except SAEs significantly higher control RR 124 95 CI 105146 Eleven RCTs high concern bias Subgroup analysis consistent main analysis Hydroxychloroquine efficacious treating hospitalized COVID19 patient caused severe adverse event Hydroxychloroquine recommended treatment hospitalized COVID19 patient,covid-19;hospitalization;hydroxychloroquine;mechanical ventilation;mortality
Introduction BNT162b2 vaccine COVID19 nursing home outbreak,34363871,BACKGROUND Coronavirus disease 2019 COVID19 outbreak often occur nursing home prompt frequent surveillance testing SARSCoV2 single dose BNT162b2 vaccine reduces viral load transmission study describe realworld efficacy BNT162b2 singledose vaccination COVID19 outbreak Veterans Affairs Community Living Center CLC METHODS 1222051421 twice weekly antigen testing used detect COVID19 among 146 resident CLC Residents without prior history COVID19 agreed immunization vaccinated BNT162b2 vaccine 121620 1621 Singledose vaccine efficacy determined day 121 day 1421 first vaccine dose RESULTS outbreak occurred 122201721 attack rate 308 45146 467 2145 case due asymptomatic COVID19 One unit accounted 778 3545 case vaccine analysis 116 resident median age 745 year 931 108116 = 1 comorbid condition first second dose 155 1597 vaccinated resident 212 419 unvaccinated resident developed COVID19 p=081 One week second dose case COVID19 occurred CONCLUSIONS Albeit limited small number single dose BNT162b2 vaccine efficacious preventing COVID19 nursing home outbreak,active surveillance;bnt162b2 vaccine;covid-19;infection prevention;nursing home;sars-cov-2;mrna vaccine
Age Acute Ischemic Stroke Outcome North American Patients COVID19,34219466,Background Acute ischemic stroke AIS context COVID19 received considerable attention propensity affect patient age aimed evaluate effect age functional outcome mortality following acute ischemic event Methods Results prospectively maintained database comprehensive stroke center Canada United States analyzed patient AIS March 14 September 30 2020 tested positive SARSCoV2 primary outcome Modified Rankin Scale score discharge secondary outcome mortality Baseline characteristic laboratory value imaging thrombectomy workflow process time assessed Among 126 patient COVID19 diagnosed AIS median age 63 year range 2794 35 278 patient AIS aged =55 year group 47 373 aged 56 70 group 44 349 aged 70 group Intravenous tissue plasminogen activator thrombectomy rate comparable across group P=0331 0212 respectively significantly lower rate mortality group favoring younger age 219 versus 450 versus 488 P=0047 multivariable adjustment possible confounders 1year increase age significantly associated fewer instance favorable outcome Modified Rankin Scale 0 2 odds ratio 095 95 CI 090099 P=0048 higher mortality 106 95 CI 102110 P=0007 Conclusions AIS context COVID19 affect young patient much greater rate prepandemic control Nevertheless instance poor functional outcome mortality closely tied increasing age,covid-19 pandemic;sars-cov-2;acute ischemic stroke;age outcomes
New safer management breast cancer patient need neoadjuvant therapy SARSCOVID pandemic,34219707,first hit SARSCOVID pandemic important reorganization Healthcare Services done new protocol pathway protect frail patient oncological patient designed second hit pandemic stressed new pathway suggest healthworkers improvement safer management patentsWe reported experience organizing clinical pathway neoadjuvant therapy candidate patient based execution sentinel lymphonode biopsy placement implantable venous access port access operating room neoadjuvant chemotherapy suggesting possible organizational model period OctoberDecember 2020 included new type path twelve patient registered case COVID among patient included think new path adopted amid second hit useful Breast Units facing challenge guaranteeing highest standard care historical moment health emergency occupies effort health worker economic resource health system,breast cancer;covid-19;neoadjuvant therapy;patient's pathway
Comparing Infection Profiles Expectant Mothers COVID19 Impacts Maternal Perinatal Outcomes First Two Waves Pandemic,34201923,2020 Coronavirus Disease19 COVID19 incidence fluctuated two clear wave across spring autumn period study designed compare maternal perinatal clinical outcome obstetrics patient COVID19 two wave infection Spain conducted observational analytical ambispective cohort study longitudinal followup mother confirmed SARVCoV2 infection different hospital country MarchNovember 2020 recruited 1295 pregnant woman SARSCoV2 infection 78 hospital 846 653 diagnosed first wave 449 347 second wave result show patient developing COVID19 first wave symptom triage early pregnancy greater rate COVID19related maternal morbidity caesarean section preterm birth first wave register two case maternal mortality first wave Maternal morbidity event showed strong link perinatal mortality event first wave compared second wave maternal morbidity associated pneumonia Likewise maternal morbidity showed strong correlation perinatal morbidity event wave describe difference patient profile management two wave related maternal perinatal outcome Differences also observed management pregnant woman COVID19 Thus fewer caesarean section maternal perinatal morbidity event reduced second wave impact respiratory symptom severity including greater need maternal treatment greater last period Identifying impact change profile well treatment maternalperinatal morbidity mortality help improve wellbeing patient newborn,covid-19;maternal and perinatal medicine;morbidity;pregnancy
COVID19 Pandemic impact Brazil s Public Dental System,34287465,present study aimed estimate impact COVID19 pandemic dental care procedure Public Health System Brazil retrospective ecological study carried comprising 5564 Brazilian municipality number dental procedure per 100000 inhabitant performed Brazilian Public Health System SUS outcome impact pandemic estimated comparing rate procedure month 2020 rate observed equivalent month 2019 considering period March August Regulatory legislation regarding restriction dental care issued state government 27 Brazilian federative unit used mediation analysis 55 reduction observed March procedure IRR = 045 95 CI 039051 month rate reduction remained = 88 biggest decrease observed collective preventive procedure reduction =99 April August Procedures le likely generate aerosol tooth extraction prosthetic emergency showed smallest reduction reduction mediated restriction imposed state government p 005 impact COVID19 pandemic noteworthy term decrease number dental procedure carried Brazilian Public Dental Service lack access delay elective procedure lack preventive collective procedure could result overburdened system postPandemic,
Epidemiological Clinical Biomarker Profile Pediatric Patients Infected COVID19,34293142,BACKGROUND Given limited diverse nature published literature related COVID19 pediatrics imperative provide evidencebased summary disease characteristic guiding policy decision aim provide comprehensive overview epidemiological clinical biomarker profile COVID19 infection pediatric population METHODS umbrella review published systematic review PubMed preprint database screened Literature search conducted December 2019 April 2021 Details clinical radiological laboratory feature collected review Qualitative observation synthesized pooled prevalence mortality asymptomatic case assessed using metaanalysis RESULTS Evidence synthesis 38 systematic review included total 1145 study 334398 child adolescent Review revealed COVID19 relatively milder better prognosis pediatrics However patient comorbidity higher risk Metaanalysis review showed 2117 95 CI 17818 24729 patient asymptomatic mortality rate 012 95 CI003560246 Though publication bias significant heterogeneity observed Fever 4864 cough 35559 common symptom affecting almost every alternate patient Ground glass opacity prevalence range274615 frequent radiographic observation Rise Creactive protein lactate dehydrogenase Ddimer ranged 1454 12250 0367 respectively included review 447 AMSTAR 132 GRADE lower quality CONCLUSION Current umbrella review provides updated information regarding characteristic COVID19 infection pediatrics used guide policy decision regarding vaccination prioritization early screening identification atrisk population,asymptomatic;biomarkers;covid-19;mortality;pediatrics;radiology
SARSCoV2 pathological matrix remodeling mediator,34286362,BACKGROUND Recognizing sharp elevation short period time COVID19 SARSCoV2 propagation marked whole world Induced inflammation afterwards infection engenders high infiltration immune cell cytokine trigger matrix metalloproteinases MMPs activation endopeptidases mediator lung extracellular matrix ECM basic element alveolus structure gas exchange METHODS immune cell MMPs secreted cytokine several mediator gathered pathological matrix remodeling occurs phenomenon tends tissue destruction first place pulmonary hypertrophy fibrosis second place FINDINGS pathological matrix remodeling establishment pathological disease take place even infection state Since post COVID19 pulmonary fibrosis emerging complication disease urge better understand characterize implication ECM remodeling SARSCoV2 infection CONCLUSION Targeting MMPs inhibitor could probable solution occurred event since many cured patient remain severe sequel even end infection,cytokine;immune cells;mmps;matrix remodeling;sars-cov-2;therapeutic target
Diagnostic Clinical PostSARSCoV2 Scenarios Cancer Patients SARSCoV2 Retrospective Analysis Three German Cancer Centers,34208007,Oncologists face challenge management SARSCoV2 infection postSARSCoV2 cancer treatment analyzed diagnostic clinical postSARSCoV2 scenario patient three German cancer center RTPCR confirmed SARSCoV2 infection Sixtythree patient SARSCoV2 hematologic solid neoplasm included Thirty patient initially asymptomatic 10 developed COVID19 symptom subsequently Altogether 20 32 patient asymptomatic 18 29 mild 12 19 severe 13 20 critical course Lymphocytopenia increased risk severecritical COVID19 threefold p = 0015 Asymptomatic course associated age remission status therapy comorbidities Secondary bacterial infection accompanied one third critical COVID19 case Treatment delayed postSARSCoV2 46 patient 9 developed progressive disease PD Cancer therapy modified 8 SARSCoV2 survivor deteriorating performance PD last followup 17 patient died COVID19 n = 8 PD n = 9 giving estimated 73 fourmonth overall survival rate SARSCoV2 infection heterogenous course cancer patient Lymphocytopenia carry significant risk severecritical COVID19 SARSCoV2 disruption therapy serious SARSCoV2 infection Careful surveillance allow early restart anticancer treatment,covid-19;sars-cov-2;sars-cov-2 scenarios;cancer patients
Impact COVID19 Pandemic Alzheimer s Disease Dementias,34335338,Introduction Numerous country went lockdown contain COVID19 outbreak impeded followup chronic disease cognitive impairment CI Cognitive neuropsychiatric change COVID19 pandemic neglected China world s whistleblower investigate cognitive neuropsychologic change CI well proportion rapid cognitive decline RCD COVID19 pandemic provide clinical evidence CI intervention public health emergency Methods performed descriptive retrospective study based medical record memory clinic Tianjin Dementia Institute collected facetoface evaluation Information 205 patient CI including patient mild cognitive impairment dementia 131 Alzheimer s disease AD analyzed compared control group COVID19 pandemic Results Among 205 CI patient score Chinese Mini Mental State Examination CMMSE Montreal Cognitive Assessment MoCA activity daily living ADLs global Neuropsychiatric Inventory NPI significantly different baseline followup evaluation p 005 1407 +287 month finding recorded among AD patient exhibited sleep disturbance followup baseline 328 vs 206 p = 0035 compared control group slightly worse performance cognitive 100 400 100 CMMSE 100 200 000 MoCA 100 000 900 ADLs neuropsychological 000 100 350 global NPI profile followup presented particularly delusion agitation irritability appetite disturbance p 005 Twentyfive 191 AD patient 48 366 control suffered RCD COVID19 pandemic Moreover AD patient COVID19 pandemic 0408 time 95 confidence interval 02320716 le likely suffer RCD control Conclusion Confinement might ease cognitive neuropsychiatric deterioration AD patient compared crisis help prevent RCD AD patient,alzheimer's disease;covid-19;cognitive;dementia;neuropsychiatric symptom
Molecular Mechanisms Palmitic Acid Augmentation COVID19 Pathologies,34281182,coronavirus disease 2019 COVID19 pandemic claimed 27 million life globally Obesity associated increased severity mortality COVID19 However molecular mechanism obesity exacerbates COVID19 pathology welldefined level free fatty acid FFAs elevated obese subject study therefore designed examine excess level different FFAs may affect progression COVID19 Biological molecule associated palmitic acid PA COVID19 retrieved QIAGEN Knowledge Base Ingenuity Pathway Analysis tool used analyze datasets explore potential pathway affected different FFAs study found one top 10 canonical pathway affected PA coronavirus pathogenesis pathway mediated key inflammatory mediator including PTGS2 cytokine including IL1beta IL6 chemokines including CCL2 CCL5 transcription factor including NFkappaB translation regulator including EEF1A1 apoptotic mediator including BAX contrast n3 fatty acid may attenuate PA s activation coronavirus pathogenesis pathway inhibiting activity mediator IL1beta CCL2 PTGS2 BAX Furthermore PA may modulate expression ACE2 main cell surface receptor SARSCoV2 spike protein,covid-19;chemokines;cytokines;n-3 fatty acid;obesity;palmitic acid
Transmission dynamic forecast COVID19 pandemic Mexico MarchDecember 2020,34288969,Mexico experienced one highest COVID19 mortality rate world delayed implementation social distancing intervention late March 2020 phased reopening country June 2020 facilitated sustained disease transmission region study systematically generate compare 30day ahead forecast using previously validated growth model based mortality trend Institute Health Metrics Evaluation Mexico Mexico City near realtime Moreover estimate reproduction number SARSCoV2 based method rely genomic data well case incidence data Subsequently functional data analysis technique utilized analyze shape COVID19 growth rate curve state level characterize spatiotemporal transmission pattern SARSCoV2 early estimate reproduction number Mexico estimated Rt 1113 genomic case incidence data Moreover mean estimate Rt fluctuated around 10 late July till end September 2020 spatial analysis characterizes statelevel dynamic COVID19 four group distinct epidemic trajectory based epidemic growth rate result show sequential mortality forecast GLM Richards model predict downward trend number death thirteen forecast period Mexico Mexico City However subepidemic IHME model perform better predicting realistic stable trajectory COVID19 mortality trend last three forecast period 09211021 09281027 09281027 Mexico Mexico City finding indicate phenomenological model useful tool shortterm epidemic forecasting albeit forecast need interpreted caution given dynamic implementation lifting social distancing measure,
COVID19 vaccination intention first year pandemic systematic review,34227179,AIMS OBJECTIVES synthesise evidence regarding vaccination intention identify factor contributing vaccine hesitancy among healthcare professional general population globally BACKGROUND COVID19 vaccine becomes available worldwide attention directed community vaccine uptake achieve populationwide immunity number factor reported influence vaccine intention METHODS Following Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guideline systematic search COVID19 vaccination intention related literature published 31 December 2020 seven database undertaken RESULTS Thirty article included systematic review Overall COVID19 vaccination intention first year pandemic ranged 277 933 Findings highlighted sociodemographic difference perception risk susceptibility COVID19 vaccine attribute influenced vaccination intention Healthcare professional particularly nurse higher vaccine hesitancy reportedly due concern regarding vaccine safety efficacy mistrust health authority Negative information COVID19 vaccine social medium low confidence health system associated lower acceptability among community Interestingly cumulative increase COVID19 caseloads country time associated vaccination intention CONCLUSIONS significant variability vaccine intention rate worldwide would hamper effort achieve immunity COVID19 Nurses concern vaccine safety efficacy need addressed increase vaccine acceptance maximise influence vaccination decision community misinformation social medium negatively impact vaccination uptake authoritative reliable information vaccine attribute disease risk vaccination benefit needed RELEVANCE CLINICAL PRACTICE Concerns vaccine safety efficacy including misinformation important contributor vaccine hesitancy Addressing factor particularly among nurse considered trusted influencers vaccination decision community important strategy pandemic preparedness,covid-19;coronavirus;vaccination;vaccine acceptance;vaccine hesitancy;vaccine uptake
Impact SARSCoV2 Pandemic New Cases T1DM Children SingleCentre Cohort Study,34199272,Type 1 diabetes mellitus T1DM represents one frequent chronic illness affecting child early diagnosis disease crucial play key role preventing development lifethreatening acute complication diabetic ketoacidosis etiopathogenetic role viral infection long suggested emerging data pointing towards complex bidirectional relationship diabetes COVID19 aim study ass impact COVID19 pandemic incidence severity new T1DM case child Romania analyzed difference group 312 patient diagnosed T1DM period 20032019 group 147 child diagnosed pandemic data investigated using statistical analysis series relevant variable total number newly diagnosed T1DM increased 3008 period March 2020February 2021 compared previous year patient pandemic group higher mean age onset T1DM le frequently living urban area presented higher mean value HbA1c Diabetic ketoacidosis onset T1DM 6740 frequent higher percentage patient presented severe form duration T1DM symptom differ significantly two group number 8 patient associated SARSCoV2 infection time T1DM diagnosis,covid-19;children;diabetic ketoacidosis;early diagnosis;epidemics;type 1 diabetes mellitus
COVIDTrach prospective cohort study mechanically ventilated patient COVID19 undergoing tracheostomy UK,34282409,Objectives COVIDTrach UK multicentre prospective cohort study project aim evaluate outcome tracheostomy patient COVID19 receiving mechanical ventilation record incidence SARSCoV2 infection among healthcare worker involved procedure Design Data patient demographic clinical history outcome entered prospectively updated time via online database REDCap Clinical variable compared outcome logistic regression used develop model mortality Participants recorded whether operator tested positive SARSCoV2 within 2 week procedure Setting UK National Health Service department involved treating patient COVID19 receiving mechanical ventilation Participants cohort comprised 1605 tracheostomy case 126 UK hospital collected 6 April 26 August 2020 Main outcome measure Mortality following tracheostomy successful wean mechanical ventilation length time tracheostomy wean discharge hospital complication tracheostomy reported SARSCoV2 infection among operator Results median time intubation tracheostomy 15 day IQR 11 21 285 18 patient died following procedure 1229 93 survivor successfully weaned mechanical ventilation censoring 1049 81 discharged hospital Age inspired oxygen concentration positive endexpiratory pressure setting fever number day ventilation tracheostomy C reactive protein use anticoagulation inotropic support independently predicted mortality Six report received operator testing positive SARSCoV2 within 2 week procedure Conclusions Tracheostomy appears safe mechanically ventilated patient COVID19 operator performing procedure identified clinical parameter predictive mortality Trial registration number study registered ClinicalTrialsGov NCT04572438,anaesthesiology devices;covid-19;cohort study;ear-nose-throat devices
Empirical Assessment US Coronavirus Disease 2019 Crisis Standards Care Guidelines,34286282,establish feasibility empirically testing crisis standard care guideline DESIGN Retrospective singlecenter study SETTING ICUs large academic medical center United States SUBJECTS Adult critically ill patient admitted ICU 27 patient admitted acute respiratory failure due coronavirus disease 2019 37 patient admitted diagnosis coronavirus disease 2019 INTERVENTIONS Review electronic health record MEASUREMENTS MAIN RESULTS Many US state released crisis standard care guideline algorithm allocate scarce healthcare resource coronavirus disease 2019 pandemic compared state guideline represent different approach incorporating disease severity comorbidities New York Maryland Pennsylvania Colorado Following algorithm calculated priority score time ICU admission cohort patient primary diagnosis coronavirus disease 2019 disease coronavirus disease 2019 n = 64 assessed discrimination 28day mortality area receiver operating characteristic curve simulated realtime decisionmaking applying triage algorithm group two five 10 patient prediction 28day mortality priority score area receiver operating characteristic curve 056 049 053 066 069 New York Maryland Pennsylvania Colorado raw Sequential Organ Failure Assessment score algorithm respectively group five patient percentage decision made without deferring lottery 1 57 80 88 95 New York Maryland Pennsylvania Colorado raw Sequential Organ Failure Assessment score algorithm respectively percentage decision made without lottery higher subcohort without coronavirus disease 2019 compared subcohort coronavirus disease 2019 CONCLUSIONS Inclusion comorbidities consistently improve algorithm s performance predicting 28day mortality Crisis standard care algorithm result substantial percentage tied priority score Crisis standard care algorithm operate differently cohort without coronavirus disease 2019 proofofprinciple study demonstrates feasibility importance empirical testing crisis standard care guideline understand whether meet goal,crisis triage;ethical triage;intensive care;intensive care unit;medical ethics
Patient Experience Hospital Oncology Service Implementation NoVisitor Policy COVID19,34377777,Hospital visitor restriction policy prompted Coronavirus Disease 2019 COVID19 may lead le comfortable informed inpatient experience oncology patient admitted nonCOVID19 condition surveyed oncology inpatient n = 47 n = 65 implementation novisitor policy using validated questionnaire measure patient experience Results revealed significant difference percentage patient reporting `` problem P 05 question Patient experience adversely impacted visitor restriction enacted response COVID19 oncology service measured questionnaire capturing common concern among inpatient,covid-19;hospital communication;inpatient oncology;patient experience;physician-patient communication;quality improvement
Prognostic Factors COVID19 Patients New Neurological Manifestations Retrospective Cohort Study Romanian Neurology Department,34220483,Introduction emerging Coronavirus Disease COVID19 pandemic caused Severe acute respiratory syndrome coronavirus 2 SARSCoV2 serious public health issue due rapid spreading high mortality rate lack specific treatment Given unpredictable clinical course risk assessment stratification severity COVID19 required Apart serving admission criterion prognostic factor might guide future therapeutic strategy Aim aimed compare clinical feature biological parameter elderly age = 65 year nonelderly age 65 year patient COVID19 new neurological symptomsconditions also aimed determine factor independently associated allcause inhospital mortality Methods consecutive patient COVID19 new neurological symptomsconditions admitted Neurology Department April 1 August 23 2020 enrolled observational retrospective cohort study Patient characteristic demographic data comorbidities biological parameter imaging finding clinical course recorded Allcause inhospital mortality main outcome whereas COVID19 severity hospitalization duration level supplemental oxygen secondary outcome Results One hundred fortyeight patient included 541 woman average age 5984 + 1906 year 473 elderly majority cardiovascular metabolic comorbidities elderly group frequent neurological symptomsmanifestations responsible hospitalization stroke symptom followed confusion whereas nonelderly headache prevailed final neurological diagnosis significantly varied two group acute cerebrovascular event acute confusional state dementia commonly encountered elderly 6571 1428 respectively secondary headache attributed SARSCoV2 infection often experienced nonelderly 3846 elderly statistically significant higher median value white blood cell 8060 vs 6090muL neutrophil count 6060 vs 4125muL Creactive protein 292 vs 572 mgL ferritin 482 vs 187 mgdL fibrinogen 477 vs 374 mgdL Ddimer 116 vs 042 prothrombin time 15115 vs 138s aspartate transaminase 268 vs 208 Ul creatinine 096 vs 077 mgdL blood urea nitrogen level 511 vs 2765 mgdL well lower median value hemoglobin 1305 vs 139 gdL lymphocyte count 1245 vs 1670muL Moreover advanced age significantly associated extensive lung involvement 25 vs 10 higher fatality rate 40 vs 9 Overall mortality rate 236 Age well neutrophil count Creactive protein fibrinogen activated partial thromboplastin time level independently associated mortality Conclusions Older age higher neutrophil count Creactive protein fibrinogen activated partial thromboplastin time level independent predictor mortality COVID19 patient new neurological manifestationsconditions admission,covid-19;confusion;elderly;headache;mortality;neurological symptoms;risk factors;stroke
SARSCoV2 pancreas potential pathological interaction,34373155,widespread extrapulmonary complication coronavirus disease 2019 COVID19 gained momentum pancreas another major target severe acute respiratory syndrome coronavirus 2 SARSCoV2 take closer look potential pathological interaction provide overview current knowledge understanding SARSCoV2 infection pancreas special focus pancreatic islet propose direct indirect systemic mechanism pancreas injury result COVID19diabetes fatal bidirectional relationship,ace2;covid-19;sars-cov-2;diabetes;inflammation;insulin;islets;pancreas;beta-cell
Modeling populationwide testing SARSCoV2 containing COVID19 pandemic Okinawa Japan,34221791,break chain SARSCoV2 transmission contain coronavirus disease 2019 COVID19 pandemic populationwide testing practiced various country However scant research addressed topic Japan modeling exercise extracted number daily reported case COVID19 Okinawa October 1 November 30 2020 explored possible scenario decreasing COVID19 incidence combining populationwide screening andor social distancing policy reveal permanent lockdown theoretically replaced mass testing sufficient target population adequate frequency must mobilized addition solely imposing circuit breaker bring favorable outcome long run mass testing present implication minimizing period lockdown result highlight importance incentivizing citizen join frequent testing ensure appropriate isolation study also suggests early containment COVID19 feasible prefecture mobility low andor easily controlled geographic characteristic Rigorous investment public health manifestly vital contain COVID19,covid-19;asymptomatic: health security;containment;mass testing;public policy
Unique SARSCoV2 Spike Protein P681H Variant Detected Israel,34201088,routine detection surveillance reporting novel SARSCoV2 variant crucial threaten hinder global vaccination effort Herein report novel local variant nonsynonymous mutation spike protein P681H local Israeli variant associated higher infection rate higher prevalence Furthermore local variant successfully neutralized serum fully vaccinated individual comparable level B117 variant Israel wildtype strain variant concern routine monitoring sequencing still required,covid-19;sars-cov-2;sequencing;variant of concern;virus neutralization
SARSCoV2 antibody response dynamic heterogeneous diagnostic performance four serological test neutralization test symptomatic healthcare worker nonsevere COVID19,34229209,BACKGROUND COVID19 patient experience nonsevere illness presence SARSCoV2 antibody suggest possible protection reinfections prior SARSCoV2 infected individual OBJECTIVES aim prospective observational study longitudinally ass antibody response first 46 month polymerase chain reaction PCR confirmed SARSCoV2 infection study diagnostic performance four different enzymelinked immunosorbent assay ELISAs surrogate virus neutralization test sVNT symptomatic healthcare worker HCWs nonsevere COVID19 STUDY DESIGN HCWs teaching hospital included March 8 June 15 2020 PCRconfirmed SARSCoV2 infection past 3 month performance four ELISAs Wantai BioRad Platelia BioTrading Immy clarus Euroimmun evaluated serum sample obtained moment study inclusion subsequently 1 2 3 month thereafter Furthermore last available serum sample sVNT GenScript performed RESULTS 309 sample 80 positive HCWs included 70 88 SARSCoV2 seropositive detection rate SARSCoV2 antibody different ELISAs heterogenous ranging 64 Euroimmun ELISA 88 Wantai ELISA Wantai ELISA highest almost perfect agreement sVNT 96 Cohen s kappa 083 CONCLUSION SARSCoV2 neutralizing antibody detectable symptomatic individual nonsevere COVID19 presence antibody remained stable six month initial infection large variability diagnostic test performance ELISA test,antibody;covid-19;elisa;healthcare workers;neutralization;sars-cov-2;serology
multicenter study investigating SARSCoV2 tertiarycare hospital wastewater viral burden correlate increasing hospitalized case well hospitalassociated transmission outbreak,34229222,SARSCoV2 detected wastewater abundance correlated community COVID19 case hospitalization death sought use wastewaterbased detection SARSCoV2 ass epidemiology SARSCoV2 hospital August December 2020 twiceweekly wastewater sample three tertiarycare hospital totaling 2100 dedicated inpatient bed collected Hospital1 Hospital2 could captured single sampling point whereas Hospital3 required three separate monitoring site Wastewater sample concentrated cleaned using 4Ssilica column method assessed SARSCoV2 genetargets N1 N2 E control using RTqPCR Wastewater SARSCoV2 measured quantification cycle Cq genome copy genome normalized fecal biomarker PMMoV compared total daily number patient hospitalized active COVID19 confirmed case hospitalacquired infection occurrence unitspecific outbreak 165 wastewater sample collected 159 96 assayable N1gene SARSCoV2 detected 641 sample N2 497 E 10 N1 N2 wastewater increased time term amount detectable virus proportion sample positive consistent increasing hospitalization site single monitoring point Pearson s r = 0679 P 00001 Pearson s r = 0799 P 00001 respectively Despite increasing hospitalization study period nosocomialacquired case COVID19 Pearson s r = 0389 P 0001 unitspecific outbreak discernable significant increase detectable SARSCoV2 N1RNA median 112 copiesml versus outbreakfree period 0 copiesml P 00001 Wastewaterbased monitoring SARSCoV2 represents promising tool SARSCoV2 passive surveillance case identification containment mitigation acute care medical facility,covid-19;hospital-acquired;sewage;wastewater;wastewater-based epidemiology
Promoting physical activity participation nutrition education telehealth intervention child autism spectrum caregiver,34216816,growing empirical support suggests child autism spectrum well caregiver experience significant health disparity global COVID19 pandemic magnified need address health among vulnerable population growing trend delivery telehealth intervention delivery method child autism spectrum caregiver remains relatively examined primary goal PLANE Physical Literacy Nutrition Education promote positive trajectory health child autism spectrum primary caregiver delivery telehealth physical activity nutrition education program study preexperimental analysis PLANE across 12 month activity delivered virtually weekly synchronous asynchronous programming total 180 participant enrolled intervention including child autism spectrum caregiver week new physical activity skill along opportunity recipe assembly delivered remotely Supplemental material disseminated online including step step direction outlining behavioral skill methodology opportunity additional skill practice reading material support weekly topic Study outcome examined parentchild dyad include rate overweightobesity physical activity nutrition quality life Finally feasibility telehealth intervention also measured Justification conceptualization delivery PLANE well warranted PLANE represents promising intervention scalable sustainable replicable,autism spectrum disorders;health;nutrition;physical activity;telehealth
COVID19 incidence district Madrid relationship socioeconomic demographic indicator,34212940,OBJECTIVE preventive measure taken face new epidemic require knowledge number infected group vulnerable know cumulative incidence COVID19 city Madrid 21 district first 4 month epidemic relationship socioeconomic demographic variable METHODS Crosssectional ecological study 39270 case 39270 case diagnosed beginning pandemic June 26 2020 published Comunidad de Madrid studied district distribution gross fair incidence related one independent variable Municipal Statistics Estudio de Salud 2018 Madrid Salud Incidence r r 2 coefficient obtained factor Multiple Linear Regression MLR model studied RESULTS city Madrid present cumulative incidence COVID19 double national one 100 Standardized Cumulative Incidence Ratio RIAE 20459 per 100 district RIAE southeast 240 per 100 district per caput household rate per caput income mortality rate infectious disease men reached high inverse correlation RIAE r 03 RLM model 3 indicator predicts 30 RIAES CONCLUSIONS relationship material wealth risk COVID19 infection inverse knowledge district per caput income household rate mortality rate due infectious disease men reduces uncertainty accumulated incidence 30,covid-19;coronavirus;epidemiology;incidence;spain;standardization
Nanobiotechnology enabled approach wastewater based epidemiology,34334850,impact ongoing coronavirus pandemic highlight importance environmental monitoring inform public health safety Wastewater based epidemiology WBE drawn interest tool analysis biomarkers wastewater network Wide scale implementation WBE requires variety field deployable analytical tool realtime monitoring Nanobiotechnology enabled sensing platform offer potential biosensors capable highly efficient sensitive detection target analytes review provides overview design working principle nanobiotechnology enabled biosensors recent progress use biosensors detection biomarkers addition application biosensors analysis severe acute respiratory syndrome coronavirus 2 SARSCoV2 virus highlighted relate potential expanded use biosensors WBEbased monitoring Finally discus opportunity challenge future application biosensors WBE effective monitoring investigation public health threat,biomarkers;biosensors;covid-19;electrochemical sensing;nanobiotechnology;nucleic acid based diagnostic tools;sars-cov-2;sers;wastewater-based epidemiology
call caution regarding infectionacquired COVID19 immunity potentially unintended effect `` immunity passport mitigate,34219801,Research suggests emerging information infectionacquired COVID19 immunity interpreted caution introduction `` immunity passport would enable people recovered COVID19 travel freely return work may therefore detrimental consequence managed carefully two study examined perceived suspected imagined recovery COVID19 concept immunity passport influence people s intention engage behavior aimed reduce spread COVID19 also consider way lessen potential negative effect Study 1 N = 1604 participant asked imagine recovered COVID19 reported lower social distancing intention compared control condition Participants suspected versus imagined recovered past infection report lower preventative intention compared control condition even high level certainty past infection Study 2 N = 1732 introducing idea immunity passport also reduced social distancing intention compared control condition latter effect however attenuated cautious information equivocal science COVID19 also presented participant Participants suspected COVID19 past compared control condition revealed similar pattern result higher level certainty past infection Caution regarding infectionacquired COVID19 immunity immunity passport crucial COVID19 response Implications premature pandemic announcement well potential remedy discussed,
Counting Pandemic Statistics Remotely Using Webcams,34289923,OBJECTIVE Lack mask use large public event might spread COVID19 possible measure similar public health information using publicly available webcam demonstrate rapid assessment approach measuring mask usage public event METHOD monitored crowd public area Sturgis SD using live highdefinition townsponsored video stream analyze prevalence mask wearing developed rapid coding procedure mask wearing analyzed brief 5 25 min video segment ass maskwearing compliance outdoor public area calculated compliance estimate compared reliability among human coder RESULTS able observe quantify public behavior public street approach rapidly estimated public health information eg 512 people observed 25 minute 23 mask usage available day Coders produced reliable estimate across sample video counting masked user maskwearing proportion video data stored Databraryorg CONCLUSIONS approach implication disaster response public health approach easy use provide day result provide public health stakeholder key information public behavior,
Mechanisms socioeconomic difference COVID19 screening hospitalization,34351971,BACKGROUND Social ecological difference early SARSCoV2 pandemic screening outcome documented mean difference arisen well understood OBJECTIVE characterize socioeconomic chronic diseaserelated mechanism underlying difference DESIGN Observational cohort study SETTING Outpatient emergency care PATIENTS 12900 Cleveland Clinic Health System patient referred SARSCoV2 testing March 17 April 15 2020 INTERVENTIONS Nasopharyngeal PCR test SARSCoV2 infection MEASUREMENTS Test location emergency department ED vs outpatient care COVID19 symptom test positivity hospitalization among positive case RESULTS identified six class symptom ranging test positivity 34 23 NonHispanic Black raceethnicity disproportionately represented group highest positivity rate NonHispanic Black patient ranged 181 95 confidence interval 091359 time age 20 237 154365 time age 80 likely test positive SARSCoV2 virus nonHispanic White patient test positivity significantly different across neighborhood income spectrum Testing emergency department 54 39 75 cardiovascular disease 25 17 38 related increased risk hospitalization among 1247 patient tested positive LIMITATIONS Constraints availability test kit forced provider selectively test SARSCov2 CONCLUSION NonHispanic Black patient patient lowincome neighborhood tended toward severe prolonged symptom profile increased comorbidity burden factor associated higher rate testing ED NonHispanic Black patient also higher test positivity rate,
Heparanase potential player SARSCoV2 infection induced coagulopathy,34132790,current formidable COVID19 pandemic appealing address idea may invoke therapeutic intervention Clotting disorder well recognized patient infected severe acute respiratory syndrome SARS caused novel coronavirus SARSCoV2 lead severe complication worsen prognosis subject Increasing evidence implicate Heparan sulfate proteoglycans HSPGs Heparanase various disease pathology including hypercoagulability state Moreover HSPGs Heparanase involved several viral infection enhance cell entry release virus Herein discus molecular involvement HSPGs heparanase SARSCoV2 infection namely cell entry release accompanied coagulopathy complication assumedly could blocked heparanase inhibitor Heparin Pixatimod,covid-19;coagulopathy;heparanase;sars-cov-2
Acute arterial ischemia COVID19,34211545,Since coronavirus pandemic set Spain March 2020 noteworthy increase incidence acute limb ischemia ALI observed recently discovered SARSCoV 2 may lead ALI secondary arterial thrombosis Elevation Ddimer DD patient coronavirus infection COVID19 indicates hypercoagulable state cause acute arterial thrombosis remarkably high DD elevation reported poor prognosis factor COVID19 way SARSCoV 2 result arterial thrombosis may multiple hand surgical revascularization ALI associated poor outcome COVID19 patient probably relation hypercoagulability describe two ALI case patient required urgent surgical treatment limb salvage positive novel coronavirus infection COVID 19,covid-19;ischemia;thrombosis
Potential therapeutic approach early entry SARSCoV2 interrupting interaction spike protein SARSCoV2 angiotensinconverting enzyme 2 ACE2,34371003,COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 quickly spread around globe present precise effective treatment patient COVID19 rapid development drug urgently needed order contain highly infectious disease virus spike protein protein recognize angiotensinconverting enzyme 2 ACE2 receptor host cell membrane undergo series conformational change protease cleavage membrane fusion complete virus entry protein important target vaccine drug development provide brief overview molecular mechanism virus entry well potential antiviral agent act SACE2 proteinprotein interaction Specifically focused experimentally validated andor computational prediction identified inhibitor target SARSCoV2 protein ACE2 enzyme associated viral infection review offer valuable information discovery development potential antiviral agent combating SARSCoV2 addition deepening understanding mechanism SARSCoV2 infection targeted prevention treatment drug explored aid advanced technology future,covid-19;sars-cov-2;angiotensin-converting enzyme 2;cell entry;protein-protein interaction (ppi) inhibitors;spike protein
Vaccineinduced immune thrombotic thrombocytopenia extremely rare adverse event major potential consequence,34346643,Vaccineinduced immune thrombotic thrombocytopenia VITT diagnosed venous arterial thrombosis thrombocytopenia caused antibody platelet factor 4 PF4 activate thrombocyte confirmed heparininduced platelet activation HIPA test occurring 4 28 day vaccination COVID19 extremely rare syndrome recognized Astra Zeneca reporting incidence 091 per 100000 Janssen vaccins 022 per 100000 Causality vaccine difficult ascertain HIPA test negative severe thrombosis cerebral sinus splanchnic thrombosis without thrombocytopenia Symptoms compatible thrombosis bleeding occurring specific time window vaccination prompt urgent assessment thrombocyte count appropriate diagnostic test Heparinlike anticoagulant avoided central laboratory assessment essential Early recognition likely improves prognosis extremely rare severe complication vaccination COVID19,
Obesity implication cerebral circulation intracranial compliance severe COVID19,34226849,Objective Multiple factor identified cause intracranial compliance impairment ICCI among patient obesity hand obesity linked worst outcome COVID19 Thus hypothesis severe acute respiratory syndrome SARS conducing cerebral hemodynamic disorder CHD able worsen ICCI play additional role prognosis determination COVID19 among obese patient becomes suitable Methods 50 case SARS COVID19 evaluated presence ICCI cerebrovascular circulatory disturbance correspondence whether unfavorable outcome death impossibility mechanical ventilation weaning MVW within 7 day evaluation objective observe whether obese patient BMI = 30 disclosed worse outcome test result compared lean subject clinical background Results 23 46 patient among 50 obesity ICCI verified 18 78 obese whereas 13 48 27 nonobese p = 0029 CHD significantly different group despite high prevalent 69 unfavorable outcome observed among obese 44 lean subject p = 0075 Conclusion present study intracranial compliance impairment significantly observed among obese subject may contributed SARS COVID19 worsen prognosis,covid-19;cerebral hemodynamics;intracranial compliance;obesity;severe acute respiratory syndrome
Improving performance deep learning model using statistical feature case study COVID19 forecasting,34226777,COVID19 pandemic affected aspect people s life disrupted economy Forecasting number case infected virus help authority make accurate decision intervention must implemented control pandemic Investigation study COVID19 forecasting indicates various technique statistical mathematical machine deep learning utilized Although deep learning model shown promising result context performance improved using auxiliary feature Therefore study propose two hybrid deep learning method utilize statistical feature auxiliary input associate main input Specifically design hybrid method multihead attention mechanism statistical feature ATTFE combined method convolutional neural network statistical feature CNNFE apply COVID19 data 10 country highest number confirmed case result experiment indicate hybrid model outperform conventional counterpart term performance measure experiment also demonstrate superiority hybrid ATTFE method long shortterm memory model,covid-19 pandemic;deep learning;hybrid methods;statistical features
Uncovering Signals Coronavirus Genome,34202172,signal analysis complete genome sequenced coronavirus variant concernB117 Alpha B1135 Beta P1 Gamma and coronavirus variant interestB1429B1427 Epsilon B1525 Eta is presented using open GISAID data deal certain new type finite alternating sum series independently distributed term associated binary 01 indicator nucleotide base method provides additional information conventional similarity comparison via alignment method Fourier Power Spectrum approach lead uncover distinctive pattern regarding intrinsic data organization complete genomics sequence according progression along nucleotide base position present new method could useful bioinformatics surveillance dynamic coronavirus genome variant,sars-cov-2;alternating series;comparative genomics variants;sequence analysis
Social Distancing Lockdown Wide Use Mask Magic Solution DoubleEdged Sword Respiratory Viruses Epidemiology,34205119,use nonpharmaceutical intervention NPIs social distancing lockdown massive use mask largely prevented spread SARSCoV2 also respiratory virus influenza respiratory syncytial virus RSV decrease high country influenza RSV epidemic occurred Far beneficial fact problematic since absence circulation certain pathogen lead decrease herd immunity promote rise serious longerlasting epidemic start sooner alleviate collateral effect may occur due decrease circulation virus influenza necessary increase production influenza vaccine carry mass vaccination campaign focus vaccinating main driver virus child,covid-19;epidemic;influenza;pandemic;respiratory syncytial virus;respiratory virus
Radiologically Suspected Organizing Pneumonia Patient Recovering COVID19 Case Report,34227752,report case coronavirus disease 2019 COVID19 associated radiologically suspected organizing pneumonia repeated negative Severe acute respiratory syndrome coronavirus 2 SARSCoV2 polymerase chain reaction PCR result nasopharyngeal swab sputum sample positive result bronchoalveolar lavage fluid Performing SARSCoV2 RTPCR upper respiratory tract sample could fail detect COVID19associated pneumonia SARSCoV2 could etiology radiologically suspected organizing pneumonia,bronchoalveolar lavage;covid-19;organizing pneumonia;polymerase chain reaction;sars-cov-2
Neue Krankheiten mit Bluttranskriptomik entschlusseln,34219982,COVID19 pandemic leading increasing number patient world Reports dysregulated immune system severe case call better characterization ongoing change dissect COVID19driven immune host response profiled whole blood transcriptomes enabling datadriven stratification based molecular phenotype analysis allowed prediction patient subgroupspecific drug candidate targeting dysregulated systemic immune response host,
Emergent Pneumonia Children,34222146,recent decade multiple pathogen virus bacteria emerged causal agent pneumonia affecting adult albeit le frequently child purpose article classified emerging pathogen follows True emerging pathogen identified first time affecting human population SARSCoV1 SARSCoV2 MERSCoV avian influenza hantavirus Reemerging known pathogen circulation controlled reappeared measles tuberculosis antimicrobial resistant bacteria CAMRSA Mycoplasma pneumoniae Acinetobacter baumannii Pseudomonas aeruginosa Stenotrophomonas maltophilia new serotypes postvaccine pneumococcal finally called old known new presentation including common pathogen particular condition changed form presentation rhinovirus nonSARS coronavirus review epidemiology form presentation therapy prognosis child compared adult aim able recognize establish appropriate therapy prognostic effective control measure,covid - 19;children;emerging respiratory pathogens;pneumonia - clinical features and management;re-emerging respiratory pathogens
Noninvasive respiratory support patient selfinflicted lung injury COVID19 narrative review,34217468,COVID19 pneumonia associated hypoxaemic respiratory failure ranging mild severe worldwide shortage ICU bed relatively high number patient respiratory failure receiving prolonged noninvasive respiratory support even clinical status would required invasive mechanical ventilation experimental clinical data reporting vigorous breathing effort spontaneous ventilation worsen lung injury cause phenomenon termed patient selfinflicted lung injury PSILI aim narrative review provide overview PSILI pathophysiology role noninvasive respiratory support COVID19 pneumonia Respiratory mechanic vascular compromise viscoelastic property lung inhomogeneity work breathing oesophageal pressure swing discussed concept PSILI widely investigated recent year controversy persist regarding mechanism minimise risk PSILI intensivists better understand underlying pathophysiology optimise type noninvasive respiratory support provided patient COVID19 pneumonia decide optimal timing intubation patient,ards;covid-19;p-sili;sars-cov-2;high-flow nasal oxygen therapy;lung injury;noninvasive ventialtion;spontaneous breathing
SARSCoV2 Cytomegalovirus CoInfectionsA Case Series Critically Ill Patients,34201947,SARSCoV2 pandemic placed great strain developed health care system especially context critical care Although coinfections cytomegalovirus CMV frequent critically ill due underlying immune suppression multiple cause impact COVID19 patient remains unclear Furthermore severe COVID19 recently associated significant immune suppression may turn impact CMV reactivation possibly contributing clinical course Nevertheless multiple confounding factor patient certainly challenge upcoming research author present case series five patient admitted intensive care unit ICU context respiratory failure due severe COVID19 patient evolved CMV reactivation ICU stay,covid-19;cytomegalovirus;sars-cov-2;co-infections;critical care
Benefits Tocilizumab patient severe form SARSCoV2 infection Experience intensive care unit Mohammed VI university hospital Oujda,34221397,Background COVID19 new disease appeared December 2019 Millions people infected died infection today pathophysiology treatment infection remain unknown lot study trying solve mystery trail inflammation remains convincing especially Interleukin 6 IL6 could play important role reaction cascade leading cytokine storm According study although number Tociluzimab TCZ antiIL6 could prevent even suppress storm leading le severe clinical state disease faster recovery could decrease use oxygen avoid risk intubation mortality Patients method singlecenter retrospective observational case review brought together 557 COVID19 seriously ill patient pulmonary involvement 25 + SatO2AA 90 admitted intensive care unit university hospital March 1 st 2020 February 28 th 2021 divided 2 group Tociluzimab group TCZ group Non Tociluzimab group NON TCZ facilitate comparison aim study compare length hospital stay use mechanical ventilation mortality TCZ group versus NON TCZ group Results average age patient 6205 year +1351 6261 year +1633 respectively TCZ versus NON TCZ group 76 76 men 24 woman 24 TCZ group 313 6849 men 144 3151 woman NON TCZ group average BMI 28 kgm2 +452 TCZ group versus 2789 kgm2 +473 NON TCZ group Among TCZ group included 38 38 diabetic patient 38 hypertensive 38 12 heart disease 12 2 chronic renal failure 2 NON TCZ group regrouped 35 765 diabetic 33 722 hypertensive 12 heart disease 267 5 chronic renal failure 109 patient mean time consultation patient almost similar two group 886 +728 day TCZ 883 +703 day NON TCZ group mean length ICU hospital stay 9 day 494 TCZ group 875 day 473 one saturation admission 7492 1045 TCZ group ranging 40 92 7356 NON TCZ group Lung damage COVID19 extensive 12 severe 32 critical 56 TCZ group enrolled case Meanwhile extensive 2363 severe 4135 critical 3501 NON TCZ group biological finding found average white blood cell 1225612082 emm 3 lymphocyte 761842 emm 3 CRP 181199 mgL ferritin 1747528 mugL fibrinogen 692627 gL TCZ group versus NON TCZ group Medical care based isolation oxygenotherapy azithromycin vitamin C zinc vitamin salicylic acid dexamethasone followed methylprednisolone anticoagulation hospitalized patient TCZ group received least 1 course Tociluzimab dosed 400 mg 2 patient received 2 dos 1 patient received 3 dos indication Tociluzimab course department based set argument increase oxygen requirement progression lesion chestcomputed tomography increase inflammation marker including IL6 CRP ferritin fibrinogen decrease percentage lymphocyte invasive mechanical ventilation indicated 4 4 patient TCZ group versus 192 4201 NON TCZ Among 100 patient included cohort TCZ group 40 died intensive care unit 60 favorable evolution decrease biological marker inflammation However NON TCZ group 197 4310 passed away Conclusion use Tociluzimab ICU patient severe COVID19 pneumonia contribute significant difference reduction hospital stay However invasive mechanical ventilation le needed patient receiving Tociluzimab others Moreover mortality benefit associated use Tociluzimab 10 day hospitalization,covid-19;case series;cytokine storm;interleukin-6;morocco;tocilizumab
Association Early Favipiravir Use Reduced COVID19 Fatality among Hospitalized Patients,34216123,BACKGROUND antiviral agent favipiravir RNAdependent RNA polymerase RdRp inhibitor MATERIALS METHODS examined patient clinical laboratory radiological diagnosis severe coronavirus disease 2019 COVID19 pneumonia investigated effect administering enteral favipiravir 2 x 1600 mg loading dose 2 x 600 mg maintenance dose 5 day addition standard COVID19 treatment RESULTS total 180 patient hospitalized Istanbul Tuzla State Hospital received favipiravir treatment March 20 2020 May 30 2020 examined 47 patient died Thirtythree patient died aged 65 year 70 indicating fatality higher elderly patient died least one comorbidity 101 patient initiated favipiravir within =3 day hospitalization 17 died 17 79 patient initiated favipiravir 3 day hospitalization 30 died 38 P = 0002 CONCLUSION found initiation favipiravir within first 72 h onset disease symptom reduced fatality patient COVID19,covid-19;favipiravir;hospitalization;time-to-treatment
Population Mobility Trends Deprivation Index SpatioTemporal Spread Coronavirus Disease 2019 Ireland,34200681,Like country worldwide coronavirus disease COVID19 adversely affected Ireland aim study investigate spatiotemporal trend COVID19 incidence ii describe mobility trend measured aggregated mobile phone record iii investigate association deprivation index population density COVID19 case accounting spatial temporal correlation Standardised incidence ratio case calculated mapped high spatial resolution electoral division level time Trends percentage change mobility compared preCOVID19 period plotted investigate impact lockdown restriction implemented hierarchical Bayesian spatiotemporal model Besag York Mollie BYM commonly used disease mapping investigate association covariates number case three distinct `` wave COVID19 case Ireland date Lockdown restriction led substantial reduction human movement particularly 1st 3rd wave Despite adjustment population density incidence ratio IR = 1985 19152058 average number person per room IR = 10411 526422533 found association deprivation index COVID19 incidence IR = 1210 CI 10771357 deprived quintile compared least deprived large range spatial heterogeneity COVID19 case Ireland method presented used explore locally intensive surveillance possibility localised lockdown measure curb transmission infection keeping lowincidence area open result suggest prioritising densely populated deprived area increased risk comorbidities vaccination rollout may capture people risk infection potentially also increased risk hospitalisation,covid-19;disease mapping;spatial statistics;spatio-temporal;standardised incidence ratio
Antiinflammatory effect GLP1 patient COVID19,34348067,INTRODUCTION Understanding pathogenesis risk factor control coronavirus disease 2019 COVID19 necessary Due importance inflammatory pathway pathogenesis COVID19 patient evaluating effect antiinflammatory medication important Glucagonlike peptide 1 receptor agonist GLP1 RA awellknown glucoselowering agent antiinflammatory effect AREAS COVERED Resources extracted PubMed database using keywords glucagonlike peptide1 GLP1 RA SARSCoV2 COVID19 inflammation April2021 review effect GLP1RA reducing inflammation modifying risk factor COVID19 severe complication discussed However GLP1 degraded DPP4 aplasma halflife 25 minute make difficult measure GLP1 plasma level clinical setting EXPERT OPINION Since definitive treatment available COVID19 far determining promising target design andor repurpose effective medication necessary,glucagon-like peptide 1 receptor agonists;anti-inflammatory;covid-19;glp-1;pro-inflammatory
Surgery COVID observational study,34215550,AIM evaluate surgery program strategy adopted adult otorhinolaryngology head neck surgery department area badly affected Covid19 epidemic peak main objective analyze reason cancelling surgery postoperative course operated patient secondary objective ass situation postponed patient MATERIAL METHODS singlecenter observational study carried COVID19 period France included 124 patient scheduled surgery period March 21May 20 2020 number nature operation performed postponed reviewed RESULTS total 540 patient operated COVID period 460 postponed Operations maintained urgent semiurgent case operated patient show sign infection hospital stay total 298 postponed patient lost followup 491 rescheduled CONCLUSION application national international recommendation minimized risk loss chance operated patient without increasing risk contamination postponement canceled operation resulted considerable loss followup Intensified followup necessary patient,covid-19;ent;head and neck cancer;surgery
Enhance Portable Radiograph Fast High Accurate COVID19 Monitoring,34204846,work aimed assist physician improving speed diagnostic accuracy interpreting portable CXRs well monitoring treatment process see whether patient improving deteriorating treatment objective especially high demand setting ongoing COVID19 pandemic recent progress development artificial intelligence AI introduce new deep learning framework align enhance quality portable CXRs consistent closely match higher quality conventional CXRs enhanced portable CXRs help doctor provide faster accurate diagnosis treatment planning contribution work fourfold Firstly new database collection subjectpair radiograph introduced subject collected pair sample portable conventional machine Secondly new deep learning approach presented align subjectpairs dataset obtain pixelpairs dataset Thirdly new PairFlow approach presented endtoend invertible transfer deep learning method enhance degraded quality portable CXRs Finally performance proposed system evaluated UAMS doctor term image quality topological property work undertaken collaboration Department Radiology University Arkansas Medical Sciences UAMS enhance portablemobile COVID19 CXRs improve speed accuracy portable CXR image aid urgent COVID19 diagnosis monitoring treatment,covid-19;cxr;alignment;artificial intelligence;chest x-ray;conventional cxr;deep learning;enhancement;portable cxr
Small molecule therapeutic destabilize ACE2RBD complex molecular dynamic study,34214539,ongoing coronavirus disease 19 COVID19 pandemic infected million people claimed hundred thousand life made worldwide health emergency Understanding severe acute respiratory syndrome coronavirus 2 SARSCoV2 mechanism infection crucial development potential therapeutic vaccine infection process triggered direct binding SARSCoV2 receptorbinding domain RBD hostcell receptor angiotensinconverting enzyme 2 ACE2 Many effort made design repurpose therapeutic deactivate RBD ACE2 prevent initial binding addition direct inhibition strategy small chemical compound might able interfere destabilize metastable prefusion complex ACE2RBD approach employed prevent progress virus infection early stage study molecular docking employed analyze binding two chemical compound SSAA09E2 Nilotinib druggable pocket ACE2RBD complex structural change result interference ACE2RBD complex analyzed molecular dynamic simulation Results show Nilotinib SSAA09E2 induce significant conformational change ACE2RBD complex intervene hydrogen bond influence flexibility protein Moreover essential dynamic analysis suggests presence small molecule trigger largescale conformational change may destabilize ACE2RBD complex,
Mobility COVID19 Related Dynamic Analysis Portuguese Districts,34205561,research work propose ass dynamic correlation different mobility index measured daily basis new case COVID19 different Portuguese district analysis based global correlation measure capture linear nonlinear relationship time series robust dynamic way period without significant change nonpharmacological measure result show mobility retail recreation grocery pharmacy public transport show higher correlation new COVID19 case mobility park workplace residence also noted relationship lower district lower population density lead need differentiated confinement policy order minimize impact terrible economic social crisis,covid-19;correlation coefficient;detrended cross-correlation analysis;mobility indices
Airway management adult patient COVID19 High flow nasal oxygen summary evidence local expert opinion,34344162,use high flow nasal oxygen care COVID19positive adult patient remains area contention Early guideline discouraged use high flow nasal oxygen therapy setting due risk viral spread healthcare worker However need balance relative risk increased aerosol generation virus transmission healthcare worker role high flow nasal oxygen reducing hypoxaemia managing airway highrisk patient intubation sedation procedure author article undertook narrative review present result several recent paper Surrogate outcome study suggest risk high flow nasal oxygen dispersing aerosolsized particle probably great first perceived Smoke laservisualisation experiment particle counter study suggest generation dispersion bioaerosols via high flow nasal oxygen flow rate 60 lmin similar standard oxygen therapy risk appears similar oxygen supplementation via Hudson mask 15 lmin significantly le low flow nasal prong oxygen 15 lmin nasal continuous positive airway pressure illfitting mask bilevel positive airway pressure coughing patient However given limited safety data recommend cautious approach intubation COVIDpositive suspected COVIDpositive patient support use high flow nasal oxygen extend time desaturation atrisk group include morbidly obese predicted difficult airway patient significant hypoxaemia ensuring wellfitted high flow nasal oxygen prong staff wearing full personal protective equipment sedation case support use high flow nasal oxygen elevated risk hypoxaemia eg bariatric endoscopy pronepositioned procedure recommend securing airway cuffed endotracheal tube longer duration procedure theatre staff remain close proximity upper airway considering use surgical mask reduce risk exhaled particle dispersion,aerosols;sars-cov-2;anaesthesia;healthcare workers;high flow nasal oxygen;hypoxia;non-invasive ventilation;oxygen
COVID19 pandemic threat antimicrobial resistance containment,34290883,23 April 2021 outbreak COVID19 claimed around 150 million confirmed case 3 million death worldwide Yet even serious silent pandemic antimicrobial resistance AMR likely complicating outcome COVID19 patient study discus current knowledge emergence SARSCoV2 highlight likely contribution COVID19 pandemic escalation AMR COVID19 engenders extensive antibiotic overuse misuse undoubtedly substantially increase AMR rate worldwide Amid expanding COVID19 pandemic policymakers consider hidden threat AMR much may well enhanced improper use antibiotic treat patient severe COVID19 infection,covid-19 pandemic;covid-19 vaccines;sars-cov-2;antimicrobial resistance;antimicrobial stewardship
C9orf72 Intermediate Repeats Confer Genetic Risk Severe COVID19 Pneumonia Independently Age,34209673,cytokine storm autoimmune feature dysfunction myeloid cell significantly contribute severe coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection Genetic background host seems partly responsible severe phenotype gene related innate immune response seem critical host determinant C9orf72 gene role vesicular trafficking autophagy regulation lysosome function highly expressed myeloid cell involved immune function regulating lysosomal degradation mediator innate immunity large noncoding hexanucleotide repeat expansion HRE gene main genetic cause frontotemporal dementia FTD amyotrophic lateral sclerosis ALS characterized neuroinflammation high systemic level proinflammatory cytokine HREs intermediate length although rare frequent autoimmune disorder C9orf72 full mutation result haploinsufficiency intermediate HREs seem modulate gene expression well impair autophagy Herein sought explore whether intermediate HREs C9orf72 may risk factor severe COVID19 Although found intermediate HREs small portion 240 patient severe COVID19 pneumonia magnitude risk requiring noninvasive mechanical ventilation conferred harboring intermediate repeat 10 unit least one C9orf72 allele twice respect shorter expansion adjusted age odds ratio 236 95 confidence interval CI 104537 p = 0040 association intermediate repeat 10 unit severe clinical outcome p = 0025 also validated independent cohort 201 SARSCoV2 infected patient data suggest C9orf72 HREs 10 unit may influence pathogenic process driving severe COVID19 phenotype,c9orf72;covid-19;sars-cov-2;autophagy;genetic risk;innate immunity;intermediate alleles
Potential Prophylactic Treatments COVID19,34372498,World Health Organization declared SARSCoV2 outbreak Public Health Emergency International Concern end January 2020 pandemic two month later virus primarily spread human via respiratory droplet causative agent Coronavirus Disease 2019 COVID19 vary severity asymptomatic mild disease vast majority case respiratory failure multiorgan failure death Recently several vaccine approved emergency use SARSCoV2 However worldwide availability acutely limited therefore SARSCoV2 still expected cause significant morbidity mortality upcoming year Hence additional countermeasure needed particularly pharmaceutical drug widely accessible safe scalable affordable comprehensive review target prophylactic arena focusing smallmolecule candidate order consolidate potential list medication categorized either antiviral repurposed drug miscellaneous thorough screening relevant clinical trial conducted brief molecular andor clinical background provided potential drug rationalizing prophylactic use antiviral inflammatory modulator Drug safety profile discussed current medical indication research status regarding relevance COVID19 shortly reviewed near future significant body information regarding effectiveness drug clinically studied COVID19 expected accumulate addition information regarding efficacy prophylactic treatment,covid-19;sars-cov-2;post-exposure;pre-exposure;prophylaxis;repurposed drugs;treatment
Analysis COVID19 comorbidity coinfection model optimal control,34226774,work develop analyze mathematical model dynamic COVID19 reinfection order ass impact prior comorbidity specifically diabetes mellitus COVID19 complication model simulated using data relevant dynamic disease Lagos Nigeria making prediction attainment peak period presence absence comorbidity model shown undergo phenomenon backward bifurcation caused parameter accounting increased susceptibility COVID19 infection comorbid susceptibles well rate reinfection recovered previous COVID19 infection Simulations cumulative number active case including comorbidity different reinfection rate show infection peak reducing decreasing reinfection recovered previous COVID19 infection addition optimal control costeffectiveness analysis model reveal strategy prevents COVID19 infection comorbid susceptibles costeffective control strategy prevention COVID19,covid-19;comorbidity;data-fitting;optimal control;reinfection
Quantitative assessment effectiveness joint measure led Fangcang shelter hospital response COVID19 epidemic Wuhan China,34210269,OBJECTIVE quantitatively evaluate effectiveness Fangcang shelter hospital designated hospital time interval illness onset diagnosis toward prevention control COVID19 epidemic METHODS used SEIAR SEIACQFH warehouse model simulate twoperiod epidemic Wuhan calculate time dependent basic reproduction number BRNs symptomatic infected individual asymptomatic infected individual exposed individual communityisolated infected individual Scenarios varied term maximum number open bed Fangcang shelter hospital designated hospital time interval illness onset hospital visit diagnosis considered quantitatively ass optimal measure RESULTS BRN decreased 450 Jan 22 2020 018 March 18 2020 Without Fangcang shelter hospital cumulative number case death would increase 1858 5173 respectively number bed designated hospital decreased 12 14 number cumulative case would increase 17804 921 respectively time interval illness onset hospital visit 4 day number cumulative case death would increase 279 619 respectively Fangcang shelter hospital established number bed designated hospital reduced 14 time interval visiting hospital diagnosis became 4 day cumulative number case would increase 26897 CONCLUSION declining BRNs indicate high effectiveness joint measure joint measure led Fangcang shelter hospital crucial need rolled globally especially medical resource limited,covid-19;effectiveness;fangcang shelter hospital;quantitative assessment
Connected diagnostics improve accurate diagnosis treatment conditional payment malaria service Kenya,34348696,BACKGROUND subSaharan Africa material human capacity diagnose patient reporting fever healthcare provider largely insufficient Febrile patient typically treated presumptively antimalarial andor antibiotic overprescription lead drug resistance involves unnecessary cost health system International funding malaria currently sufficient control malaria Transition domestic funding challenged UHC effort recent COVID19 outbreak Herewith present digital approach improve efficiency diagnosis treatment malaria endemic Kisumu Kenya Connected Diagnostics objective study evaluate feasibility user experience clinical performance approach Kisumu METHODS intervention performed Oct 2017Dec 2018 across five private provider Kisumu Patients enrolled MTIBA platform diagnostic test result digitized positive patient digitally entitled malaria treatment Data sociodemographics healthcare transaction medical outcome analysed using standard descriptive quantitative statistic Provider perspective gathered 19 semistructured interview RESULTS total 11689 febrile patient digitally tested five private provider Malaria positivity ranged 74 302 provider significantly amongst poor p 005 Prescription antimalarial substantially aberrant National Guidelines 28 overprescription 46633 per provider prescription branded versus generic antimalarial differing amongst facility correlating socioeconomic status client Challenges encountered transitioning microscopy RDT CONCLUSION provide full proofofconcept innovative Connected Diagnostics use digitized malaria diagnostics earmark digital entitlement correct malaria treatment patient approach large costsaving quality improvement potential,conditional payments;connected diagnostics;diagnosis;kenya;malaria;treatment
Mild anemia single independent predictor mortality patient COVID19,34226904,coronavirus disease 2019 COVID19 caused Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 led unprecedented international health crisis COVID19 clinical presentation cover wide range asymptomatic severe illness death Given limited therapeutic resource unexpected clinical feature disease readily accessible predictive biomarkers urgently needed improve patient care management asked degree anemia may influence outcome patient COVID19 end identified 3777 patient positively diagnosed COVID19 March 1 April 1 2020 New York City evaluated 2562 patient available red blood cell hemoglobin related laboratory value Multivariable cox proportional hazard regression showed anemia significant independent predictor mortality hazard ratio HR 126 95 Confidence Interval CI 106151 independent age sex comorbidities direct correlation degree anemia risk mortality hemoglobin treated continuous variable HRadj 105 CI 101109 hemoglobin level maximally predictive mortality 115 gdL male 118 gdL female finding identify routinely measured biomarker predictive disease outcome aid refining clinical care algorithm optimize resource allocation Mechanisms impact anemia COVID19 outcome likely multiple nature require investigation,covid-19;rbc;anemia;haemoglobin;mortality;prognosis
COVID19 Kidney Nephrologists Care COVID19 rather Maintaining Focus Renal Patients,34344017,Clinical Background novel severe acute respiratory syndrome coronavirus 2 SARSCoV2 rapidly spread globally late 2019 reaching pandemic proportion Epidemiology related disease COVID19 exacerbates progress due patient abnormal inflammatoryimmune response widespread endothelial damage complementinduced blood clotting microangiopathy COVID19 manifest mainly respiratory illness case severe viral pneumonia may lead acute respiratory distress syndrome respiratory failure death Challenges Many extrapulmonary manifestation commonly occur substantial proportion patient severe COVID19 exhibit sign kidney damage Clinically kidney involvement range mildmoderate proteinuria hematuria acute kidney injury AKI requiring renal replacement therapy RRT pathophysiologic mechanism kidney damage AKI patient COVID19 remain unclear known multifactorial Current knowledge implies direct SARSCoV2dependent effect kidney cell tubular epithelial cell podocytes indirect mechanism systemic effect viral infection secondary critical pulmonary illness management Prevention Treatment Standardofcare strategy apply specific evidence suggest COVID19 AKI managed differently type severely ill patient conservative management fails RRT considered choice RRT approach sequential extracorporeal therapy depends local availability resource expertise focus longterm followup COVID19 patient especially developed kidney injury dysfunction represents opportunity integrated multidisciplinary research clarify natural history COVID19 renal sequela best therapeutic intervention mitigate,
COVID19 lung pathology,34333882,COVID19 global emergency 10 million case 500 000 death worldwide SARS CoV2 RNA virus belonging family coronaviridae high infectivity manifestation disease range asymptomatic mild symptom severe pneumonia ARDS CT scan lung show consolidation `` Ground Glass Opacities person comorbidities considered higher rate acquiring infection Asthma allergy identified major risk factor COVID19 number asthmatic patient COVID19 high enough considered occurrence COVID19 COPD patient related smoking ACE2 expression patient considerably high relation COVID19 Tuberculosis also reflected term stigma associated diagnosis treatment disease community eventually increasing chance people s reluctance seek medical help Cancer patient usually susceptible infection Lung cancer different Additionally lung cancer also strong association smoking increasing risk risk getting infection severity high autoimmune disorder well fungal infection Currently definite treatment COVID19 However currently used modality hydroxychloroquine antiviral drug,covid-19;sars-cov-2;cytokine storm;lung;pulmonary
Toxicological insight Spike fragment SARSCoV2 exposure environment threat aquatic health,34216962,Spike protein protein critical component infection new coronavirus SARSCoV2 objective work evaluate whether peptide protein could cause negative impact aquatic animal aquatic toxicity SARSCoV2 Spike protein peptide derivative evaluated tadpole n = 50 tadpoles5 replicates 10 animal specie Physalaemus cuvieri Leptodactylidae synthesis purification characterization peptide PSDP2001 PSDP2002 PSDP2003 aquatic contamination simulated peptide 24 h exposure two concentration 100 500 ngmL control group `` C composed tadpole kept polyethylene container containing dechlorinated water Oxidative stress antioxidant biomarkers AChE activity assessed concentration PSPD2002 PSPD2003 increased catalase superoxide dismutase antioxidant enzyme activity well oxidative stress nitrite level hydrogen peroxide reactive oxygen specie three peptide also increased acetylcholinesterase activity highest concentration peptide showed molecular interaction silico acetylcholinesterase antioxidant enzyme Aquatic particle contamination SARSCoV2 cholinesterasic effect P cuvieri tadpole finding indicate COVID19 constitute environmental impact biological damage potential,acetylcholinesterase;amphibians;coronavirus;oxidative stress;sars-cov-2
Early Outcomes Bivalirudin Therapy Thrombotic Thrombocytopenia Cerebral Venous Sinus Thrombosis Ad26COV2S Vaccination,34226070,Vaccineinduced thrombotic thrombocytopenia newly described disease process setting expanding access COVID19 vaccination United States Centers Disease Control Prevention recommends treatment alternative heparin patient suspected vaccineinduced thrombotic thrombocytopenia time reported outcome treatment vaccineinduced thrombotic thrombocytopenia bivalirudin heparin alternative describe early outcome treatment vaccineinduced thrombotic thrombocytopenia bivalirudin heparin alternative 40yearold Caucasian woman found thrombocytopenia cerebral venous sinus thrombosis pulmonary embolism following vaccination COVID19 Ad26COV2S exhibited steady rise platelet count 20x10 9 L hospital day 0 115x10 9 L discharge hospital day 6 182x10 9 L outpatient followup day 9 patient exhibited transient drop hemoglobin clinical evidence bleeding patient demonstrate clinical sequela thrombosis reported resolution headache Vaccination Ad26COV2S appears associated small significant risk thrombotic thrombocytopenia within 13 day receipt Centers Disease Control Prevention guidance consider alternative heparin accompanied specifically recommended alternative single patient treated bivalirudin suspected vaccineinduced thrombotic thrombocytopenia subsequently experienced symptom improvement rise platelet count demonstrate immediate negative outcome provider may consider bivalirudin alternative heparin patient suspected vaccineinduced thrombotic thrombocytopenia following Ad26COV2S vaccination pending definitive research,
Patient safety time federally mandated registered nurse patient ratio,34227123,COVID19 highlighted role registered nurse RNs healthcare system shortage equipment plus overwhelming demand nursing care placed significant stress nurse physical emotional toll caring COVID patient adequate number nurse many case placed many nurse harm s way Despite healthcare system reporting significant profit COVID nurse benefited financially ICU nurse found assigned three patient defined RN patient ratio urgent need Pass effort mandate via Federal legislation ratio failed largely due hospital opposition California mandated RN patient ratio since 2011 experience proven patient outcome improve well nurse retention Hospitals decrease largely offset impact hospital net revenue decreasing acquired infection reducing 30readmission rate improving patient satisfaction score documented recent Harris poll consumer appears ready support nurse nurse enjoying significant public support political climate change favorable compared past YoderWise Planned Policy Change illustrates Federal legislation mandate RN patient ratio achievable,improved outcomes;patient ratio;quality of care;registered nurses
Immunonutrition effect coping COVID19,34286803,COVID19 implication still threat global health face pandemic food nutrition key issue boost immune system bioactivity functional food nutrient probiotic prebiotics water fatsoluble vitamin mineral flavonoid glutamine arginine nucleotide PUFAs contributes immune system modulation establishes status nutrient factor immune competence food contribute especially pandemic minimization complication SARSCoV2 infection Therefore important support nutritional strategy strengthening immune status associated good eating habit way confront COVID19,
Potential drug lead SARSCoV2 phytochemical Aerva lanata Machine Learning approach,34368407,COVID19 outbreak recently reported worldwide pandemic threat part intervention machine learning molecular simulation approach report inhibitory effect thirty compound reported sacred plant Aerva lanata predicted activity screened ligand comparable one present medication hydroxy chloroquine HCQ main protease PDB6YB7 SARSCoV2 study pointed effectiveness plant twenty seven compound potential activity main protease compared reference HCQ robustness phytochemical ervoside present Aerva lanata computed high anticoronavirus activity result indicative potential natural antivirus source subsidizes thwarting invasion coronavirus human body Many phytochemical computed effective towards SARSCoV2 study used drug various disease Perhaps compound could attractive management COVID19 clinical trial must performed order validate observation,aerva lanata;docking;machine learning;sars-cov-2
Knowledge health care worker regarding COVID19 pandemic response plan study university affiliated hospital Jordan,34222706,Background education training healthcare worker HCWs pandemic response plan infection control protocol ICP precaution critical breaking virus transmission chain study aimed ass knowledge HCWs regarding COVID19 pandemic response plan ICP Concomitantly evaluating effectiveness impact institutional measure policy training program Methods crosssectional study using electronic questionnaire used collect data 267 HCWs Universityaffiliatedhospital April 2020 Results study 907 participant nurse 66 female 603 participant received specific training caring COVID19 patient least 943 reviewed pandemic response plan ICP COVID19 475 292 participant provided direct care suspected confirmed COVID19 patient respectively 857 100 participant answered item correctly regarding COVID19 pandemic response plan measure precaution Furthermore correct answer 95 item Conclusion HCWs high level knowledge COVID19 pandemic response plan ICP Training disseminating updated plan protocol different method intranet onsite training addition regular method effective,covid-19 pandemic;health care workers;infection control;jordan;knowledge;precautions
Dynamically adjusted strategy response development COVID19 pandemic new normal,34372862,Presently development COVID19 situation different country region clearly differentiated Due difference resource infrastructure awareness epidemic prevention control capability COVID19 prevention control various region also shown significant imbalance COVID19 epidemic entering new normal objective study provide dynamically adjusted strategy response development COVID19 pandemic new normal face new normal one key normalizing epidemic prevention control part implement precise policy based dynamic COVID19 epidemic particular response need ongoing COVID19 prevention control must pay attention new vulnerability new feature dynamic epidemic study health government official benefit insight preparing longterm challenge certainty uncertainty future facing COVID19,covid-19;pandemic;public health;response;strategy
Outcomes risk factor death patient coronavirus disease2019 COVID19 pneumonia admitted intensive care unit Egyptian University Hospital retrospective cohort study,34215561,BACKGROUND characteristic outcome risk factor inhospital death critically ill intensive care unit ICU patient coronavirus disease2019 COVID19 described patient Europe North America China data COVID19 patient Middle Eastern country aim study investigate characteristic outcome risk factor inhospital death critically ill patient COVID19 pneumonia admitted ICUs University Hospital Egypt METHODS Retrospective analysis patient COVID19 pneumonia admitted April 28 July 29 2020 two ICUs dedicated isolation treatment patient severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection Cairo University Hospitals Diagnosis confirmed patient using realtime reverse transcription polymerase chain reaction respiratory sample radiologic evidence pneumonia RESULTS 177 patient admitted ICUs study period 160 patient COVID19 pneumonia included analysis mean age 60 + 14 year 675 male 23 patient known comorbidities overall ICU hospital mortality rate 244 ICU hospital length stay 7 2575 interquartile range 410 10 2575 interquartile range 714 day respectively multivariable analysis inhospital death dependent variable ischemic heart disease history smoking secondary bacterial pneumonia independently associated higher risk inhospital death whereas greater PaO2FiO2 ratio admission ICU associated lower risk CONCLUSION cohort critically ill patient COVID19 pneumonia ischemic heart disease history smoking secondary bacterial pneumonia independently associated higher risk inhospital death,covid-19;hospital mortality;intensive care unit;ischemic heart disease;sars-cov-2
Low symptomatic COVID19 elderly patient follicular lymphoma treated rituximabbased immunotherapy case report,34222459,BACKGROUND Follicular lymphoma indolent lymphoma may progress highly aggressive form requiring immunochemotherapy regimen utilize rituximab antiCD20 monoclonal antibody may affect clinical course novel coronavirus severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection coronavirus disease 2019 COVID19 describe first case mild COVID19 ongoing oncological treatment without significant deterioration rituximab administration CASE SUMMARY 74yearold female enlargement right palatine tonsil diagnosed follicular lymphoma following tonsillectomy started immunochemotherapy according rituximab cyclophosphamide vincristine prednisone regimen home fourth cycle developed nonspecific symptom excessive fatigue loss appetite nausea misdiagnosed adverse effect chemotherapy Unexpectedly interim positron emission tomographycomputed tomography scan performed shortly rituximab administration revealed previously nonexistent pulmonary change potentially infectious etiology SARSCoV2 infection confirmed nasopharyngeal swab reverse transcriptase polymerase chain reaction test performed following day Despite rituximab infusion patient remained oligosymptomatic discharged home selfisolation reached negative SARSCoV2 status subsequently scheduled regimen patient successfully received six cycle rituximab cyclophosphamide vincristine prednisone obtained complete remission positron emission tomographycomputed tomography CONCLUSION case show rituximabbased immunotherapy due follicular lymphoma may evident negative effect COVID19 clinical course,covid-19;case report;follicular lymphoma;rituximab;sars-cov-2
Intranasal plus subcutaneous prime vaccination dual antigen COVID19 vaccine elicits Tcell antibody response mouse,34290317,developed COVID19 vaccine hAd5 SFusion + NETSD express SARSCoV2 spike nucleocapsid N protein modification increase immune response delivered using human adenovirus serotype 5 hAd5 platform demonstrate subcutaneous SC prime SC boost vaccination CD1 mouse dualantigen vaccine elicits Thelper cell 1 Th1 biased Tcell humoral response N greater seen hAd5 wild type delivering unmodified S compared SC intranasal prime vaccination SC boost show prime boost effective generating Th1 biased humoral response combination tested SC prime SC boost elicits greater cell response Finally used combined SC plus SC + prime without boost found SC + prime alone effective generating humoral Tcell response SC + prime boost finding SC + primeonly delivery potential provide broad immunityincluding mucosal immunityagainst SARSCoV2 support testing vaccine delivery approach animal model viral challenge,
SARSCoV2 nosocomial infection acquired French university hospital 1st wave Covid19 pandemic prospective study,34353356,BACKGROUND healthcare facility nosocomial transmission respiratory virus major issue SARSCoV2 exempt nosocomial transmission goal describe COVID19 nosocomial case first pandemic wave among patient French university hospital compliance hygiene measure METHODS conducted prospective observational study Grenoble Alpes University Hospital 01032020 11052020 included hospitalised patient documented SARSCoV2 diagnosis Nosocomial case defined delay 5 day hospitalisation first symptom Hygiene measure evaluated 11052020 22052020 Lockdown measure effective France 17032020 ended 11052020 Systematic wearing mask mandatory healthcare worker HCW visit prohibited institution 13032021 duration lockdown period RESULTS Among 259 patient included 14 54 considered nosocomial COVID19 Median time symptom onset 25 day interquartile range 1242 Eleven patient 79 risk factor severe COVID19 Five died 36 including 4 death attributable COVID19 Two cluster identified first cluster 5 case including 3 nosocomial acquisition tested HCWs positive second cluster 3 case including 2 nosocomial case 4 HCWs positive Surgical mask wearing hand hygiene compliance adequate 95 61 HCWs respectively CONCLUSIONS number nosocomial COVID19 case hospital low Compliance regarding mask wearing hand hygiene lockdown measure drastically reduced transmission virus Monitoring nosocomial COVID19 case first wave enabled u determine extent hygiene measure taken effective patient protected Trial registration Study ethic approval obtained retrospectively 30 September 2020 CECIC RhoneAlpesAuvergne ClermontFerrand IRB 5891,covid-19;hand hygiene;healthcare-associated infection;mask;outbreak;sars-cov-2
Predicting critical state COVID19 diagnosis model development using large US electronic health record dataset,34285316,COVID19 pandemic challenging healthcare system worldwide early identification patient high risk complication crucial present prognostic model predicting critical state within 28 day following COVID19 diagnosis trained data US electronic health record IBM Explorys including demographic comorbidities symptom hospitalization 15753 COVID19 patient 2050 went critical state deceased Nonrandom traintest split time repeated 100 time led ROC AUC 0861 0838 0883 precisionrecall AUC 0434 0414 0485 median interquartile range interpretability analysis confirmed evidence major risk factor eg older age higher BMI male gender diabetes cardiovascular disease efficient way compared clinical study demonstrating model validity personalized prediction could enable finegraded risk stratification optimized care management,
alphaV beta6 Integrin Intriguing Target COVID19 Related Diseases,34132013,outbreak SARSCoV2 extraordinary event constituted global health emergency novel coronavirus continuing spread world need therapeutic agent control pandemic increasing alphaV beta6 Integrin may intriguing target inhibition SARSCoV2 entry also diagnosistreatment COVID19 related fibrosis emerging type fibrotic disease probably affect significant part recovered patient short article possible role integrin fighting COVID19 discussed basis recently published evidence showing underestimated involvement may interesting development novel pharmacological tool,covid-19;rgd;sars-cov-2;fibrosis;alphavbeta6
Association COVID19 Exposure Selfreported Compliance Public Health Guidelines Among Essential Employees Institution Higher Education US,34287634,Importance Detailed analysis infection rate paired behavioral employeereported risk factor vital understanding transmission SARSCoV2 infection may exacerbated mitigated workplace Institutions higher education heterogeneous work unit supported continued inperson employment COVID19 pandemic providing test site occupational health evaluation Objective evaluate association selfreported protective behavior prevalence SARSCoV2 infection among essential inperson employee first 6 month COVID19 pandemic US Design Setting Participants crosssectional study conducted July 13 September 2 2020 institution higher education Fort Collins Colorado Employees 18 year older without symptom COVID19 identified essential inperson worker first 6 month pandemic included Participants completed survey blood nasal swab sample collected ass active SARSCoV2 infection via quantitative reverse transcriptasepolymerase chain reaction qRTPCR past infection serologic testing Exposure Selfreported practice protective behavior COVID19 according public health guideline provided employee Main Outcomes Measures Prevalence current SARSCoV2 infection detected qRTPCR previous SARSCoV2 infection detected IgG SARSCoV2 testing platform frequency protective behavior practice essential worker concern regarding contracting COVID19 exposing others measured based survey response Results Among 508 participant 305 600 woman 451 888 nonHispanic White individual mean SD age 411 125 year qRTPCR positive test result 2 participant 04 seroreactive IgG antibody Handwashing mask wearing reported frequently work 480 947 496 978 participant respectively outside work 465 915 481 947 participant respectively Social distancing reported le frequently work 403 795 outside work 465 915 P 001 Participants highly motivated avoid exposure concern spreading infection others 419 830 personal protection 319 632 P 001 Conclusions Relevance crosssectional study essential worker institution higher education employee reported compliance public health practice outside work able operate safely work environment COVID19 pandemic,
Modelling impact COVID19 pandemic quality populationbased colorectal cancer screening,34217416,COVID19 pandemic severely affected regular public health intervention including populationbased cancer screening Impacts screening delay change structure screening process resultant longterm outcome unknown therefore necessary develop systematic framework ass thesis impact related component quality Using populationbased cancer screening fecal immunochemical test FIT illustration main analysis ass various scenario screening delay associated capacity primary screening full time equivalent FTE colonoscopy impact longterm outcome based Markov decision tree model population level second analysis quantify extent COVID19 epidemic measured social distancing index affected capacity FTE translated delay exponential relationship COVID19 epidemic led 25 29 34 39 statistically significantly incremental risk late cancer delay 05year 1year15year 2year respectively compared regular biennial FIT screening corresponding statistically finding four delayed schedule death colorectal cancer CRC 26 28 29 30 respectively higher social distancing index led lower capacity uptake screening larger reduction FTE resulting longer screening delay longer waiting time impacted longterm outcome summary systematic modelling approach developed demonstrating strong impact screening delay caused COVID19 epidemic longterm outcome illustrated Taiwan populationbased FIT screening CRC,covid-19;colorectal cancer;fecal immunochemical test;screening;social distancing
Acute kidney injury Update 2021,34344035,One five hospitalized patient suffers acute kidney injury AKI Depending severity AKI associated 15fold increased risk mortality constitutes major risk factor subsequent cardiovascular event development chronic kidney disease concise review summarizes recently published study focusing 1 automated AKI detection using electronic health recordsbased AKI alert system 2 renal replacement therapy optimal timing anticoagulation regimen 3 coronavirus disease2019 COVID19 associated AKI,
Association Hyperglycemia Hospital Presentation Hospital Outcomes COVID19 Patients without Type 2 Diabetes Retrospective Cohort Study Hospitalized InnerCity COVID19 Patients,34206813,study aimed determine relationship among hyperglycemia HG presence type 2 diabetes T2D outcome COVID19 Demographic data blood glucose level BG measured admission hospital outcome COVID19 patient hospitalized Boston University Medical Center 1 March 4 August 2020 extracted hospital database HG defined BG 200 mgdL Patients type 1 diabetes BG 70 mgdL excluded total 458 patient T2D 976 patient without T2D included study mean + SD age 56 + 17 year 642 45 female HG occurred 193 42 42 4 patient without T2D respectively Overall inhospital mortality rate 9 Among patient without T2D HG statistically significantly associated mortality ICU admission intubation acute kidney injury severe sepsisseptic shock adjusting potential confounders p 005 However ICU admission acute kidney injury associated HG among patient T2D p 005 Among 235 patient HG presence T2D associated decreased odds mortality ICU admission intubation severe sepsisseptic shock adjusting potential confounders including BG p 005 conclusion HG subset patient without T2D could strong indicator high inflammatory burden leading higher risk severe COVID19,covid-19;sars-cov-2;blood glucose;coronavirus;hyperglycemia;mortality;type 2 diabetes mellitus
Three epitopedistinct human antibody RenMab mouse neutralize SARSCoV2 cooperatively minimize escape mutant,34285195,Coronavirus disease 2019 COVID19 pandemic disease caused newly emerging severe acute respiratory syndrome coronavirus 2 SARSCoV2 caused 38 million death date Neutralizing antibody effective therapeutic measure However many naturally occurring mutation receptorbinding domain RBD emerged evade existing neutralizing antibody utilized RenMab novel mouse carrying entire human antibody variable region neutralizing antibody discovery obtained several potent RBDblocking antibody categorized four distinct group epitope mapping determined involved residue epitope three representative antibody cryoelectron microscopy CryoEM study Moreover performed neutralizing experiment 50 variant strain single combined mutation found mixing three epitopedistinct antibody almost eliminated mutant escape study provides sound basis rational design fully human antibody cocktail SARSCoV2 preemergent coronaviral threat,
Clinician staff perspective potential disparity introduced rapid implementation telehealth service COVID19 mixedmethods analysis,34132810,COVID19 pandemic rapidly altered ambulatory health care delivery may worsened disparity health care access ass telehealth implementation experience ambulatory personnel different discipline perspective potential telehealth disparity make recommendation equitable telehealth delivery used convergent parallel mixedmethods design Clinic manager geriatric medicine internal medicine psychiatry emailed survey clinician staff regarding experience telehealth care delivery Quantitative survey response analyzed Fisher s Exact test Qualitative response coded thematically Recommendations categorized type implementation strategy Quantitative qualitative finding telehealth disparity merged joint data display Respondents n = 147 57 response rate distributed across three specialty 66 internal medicine 19 psychiatry 14 geriatric medicine Prior 2020 77 clinician never delivered telehealth service Spring 2020 78 reported conducting half clinic visit telehealth Among clinician 52 agreedstrongly agreed rapid telehealth implementation exacerbated access care disparity older adult patient limited internet access needing interpretation service Staff expressed similar difficulty telehealth setup especially patient improve telehealth equity clinician recommended change infrastructure ii train educate stakeholder iii support clinician Clinicians staff reported specific subpopulation challenge accessing telehealth visit avoid perpetuating telehealth access disparity codiscovery equitable implementation strategy patient clinic urgently needed,covid-19;health disparities;implementation strategies;telehealth
SARSCoV2 infection patient betathalassemia French experience,34217815,INTRODUCTION iron overload complication thrombosis infectious predisposition patient severe form thalassemia likely increased risk COVID19 complication RESULTS national survey conducted year 2020 across French reference center hemoglobinopathy identified 16 case COVID19 confirmed RTPCR betathalassemia patient age ranged 11 month 60 year 15 patient transfusiondependent 6 splenectomized Concerning iron overload related complication none diabetes cirrhosis one experienced heart failure 4 pediatric patient paucisymptomatic viral episode Three patient 41 49 57 year old developed COVID19 pneumonia requiring oxygen therapy without need mechanical ventilation Neutropenia absolute neutrophil count 05 10 9 L observed 2 patient receiving longterm treatment hydroxycarbamide deferiprone thrombosis event organ failure death occurred patient recovered CONCLUSION Severity COVID19 population young middleaged patient appeared increased compared general population remained mild moderate already described series reported literature Occurrence adverse event related chronic treatment administered thalassemia disease may favored infectious episode,covid-19;sars-cov-2;thalassemia
SARSCoV2 percent positivity risk factor among people HIV urban academic medical center,34288954,Since onset COVID19 pandemic unclear vulnerable people HIV PwH SARSCoV2 infection sought determine PwH likely test positive SARSCoV2 people without HIV identify risk factor associated SARSCoV2 positivity among PwH conducted crosssectional study collected electronic medical record data patient underwent SARSCoV2 PCR testing academic medical center Presence HIV chronic disease based presence ICD10 diagnosis code calculated percent positivity SARSCoV2 among PwH among people without HIV Among PwH compared demographic factor comorbidities HIV viral load CD4 Tcell count antiretroviral therapy ART regimen tested positive SARSCoV2 tested negative Comparisons made using chi squared test Wilcoxon rank sum test Multivariate model created using logistic regression Among 69763 people tested SARSCoV2 06 431 PwH PwH significantly likely test positive SARSCoV2 people without HIV 72 31431 v 84 582069763 p = 035 likely younger Black male pvalues 0001 significant difference HIV clinical factor chronic disease ART regimen among PwH testing positive SARSCoV2 versus testing negative sample PwH likely contract SARSCoV2 despite likely member demographic group known higher risk infection Differences PwH tested positive SARSCoV2 tested negative seen HispanicLatino ethnicity nonHispanic Latino v unknown Hispanic Latino ethnicity 02 95 CI 06 09 site testing inpatient v outpatient 31 95 CI 13 74,
Improvements clinical sign Parkinson s disease using photobiomodulation prospective proofofconcept study,34215216,BACKGROUND Parkinson s disease PD progressive neurodegenerative disease cure treatment option incidence increasing due aging population longer disease duration potentially COVID19 sequela Photobiomodulation PBM successfully used animal model reduce sign PD protect dopaminergic neuron OBJECTIVE ass effectiveness PBM mitigate clinical sign PD prospective proofofconcept study using combination transcranial remote treatment order inform best practice larger randomized placebocontrolled trial RCT METHODS Twelve participant idiopathic PD recruited Six randomly chosen begin 12 week transcranial intranasal neck abdominal PBM remaining 6 waitlisted 14 week commencing treatment 12week treatment period participant supplied PBM device continue home treatment Participants assessed mobility fine motor skill balance cognition treatment began 4 week treatment 12 week treatment end home treatment period Wilcoxon Signed Ranks test used ass treatment effectiveness significance level 5 RESULTS Measures mobility cognition dynamic balance fine motor skill significantly improved p 005 PBM treatment 12 week one year Many individual improvement minimal clinically important difference threshold judged meaningful participant Individual improvement varied many continued one year sustained home treatment demonstrable Hawthorne Effect treatment effect side effect treatment observed CONCLUSIONS PBM shown safe potentially effective treatment range clinical sign symptom PD Improvements maintained long treatment continued one year neurodegenerative disease decline typically expected Home treatment PD person help carer might effective therapy option result study indicate large RCT warranted TRIAL REGISTRATION Australian New Zealand Clinical Trials Registry registration number ACTRN12618000038291p registered 12012018,cognition;mobility;motor symptoms;parkinson's disease;photobiomodulation
critical review environmental presence pharmaceutical drug tested covid19 treatment,34226801,March 11 2020 World Health Organization declared COVID19 pandemic outbreak caused worldwide impact becoming health threat general population professional date specific antiviral treatment vaccine COVID19 infection however drug clinically tested use drug large scale raise great concern imminent environmental risk since elimination compound feces urine associated inefficiency sewage treatment plant removal result persistence environment putting risk health human specie Thus goal work conduct review study evaluated presence drug chloroquine hydroxychloroquine azithromycin ivermectin dexamethasone remdesivir favipiravir HIV antiviral environment research indicated presence drug environment different region concentration data could serve basis comparative study following pandemic,emerging micropollutants;environmental pollution;medicaments;pandemic;sars-cov-2
Low vitamin level prognosis COVID19 paediatric population systematic review,34293161,AIM aim study relationship vitamin level risk severity COVID19 infection pediatric population systematic review METHODS searched PubMed CINAHL EMBASE Cochrane Library Google Scholar December 2019 June 2021 retrieving article studying association vitamin deficiency COVID19 Qualitative detail synthesized evidence table quantitative data used deriving pooled estimate metaanalysis RESULTS initial search 2261 article eight eligible study two review included systematic review Metaanalysis quantitative data six study showed pooled prevalence vitamin deficiency 4591 95 CI 2514867450 infected pediatric patient low level vitamin increased risk severe disease odds ratio 55 95 CI 1560 19515 p = 0008 also found child adolescent vitamin deficiency greater risk COVID infection compared patient normal vitamin level Improvement disease severity vitamin supplementation also noted CONCLUSION systematic review showed almost half pediatric COVID patient suffer vitamin deficiency also clear low level vitamin associated greater risk infection poorer outcome pediatrics,
SARSCoV2 Nsp1 Ein kleines Protein blockiert die Immunantwort,34219981,Coronavirus disease 2019 COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 facilitate replication avoid immune control SARSCoV2 manipulates target cell result revealed SARSCoV2 nonstructural protein 1 Nsp1 play key role viral immune evasion block mRNA tunnel cellular ribosome resulting shutdown translation strong attenuation host s antiviral immune response,
COVID19 pandemic reason prioritize need health care system ensure sustainability scoping review January October 2020 Review,34373725,worldwide spread severe acute respiratory syndrome coronavirus 2 SARSCoV2 led World Health Organization characterize pandemic public health emergency international concern National health care system country initial surge pandemic unable handle sanitarian crisis emerged Thus prevention control future global health emergency must priority present scoping review aimed retrieve article summarize current experience issue related historical knowledge epidemiology clinical feature overall burden SARSCoV2 health care service summary comprehensive overview information learnt period presented current review Furthermore taking account global experience need planning cohesive functional health service similar pandemic event occur future highlighted next public health issue prevented rather treated spite vaccination benefit number sporadic case SARSCoV2infections persist Information collected remains relevant appraising similar threat faced future Overall collaborative health care plan need rethought increase preparedness,coronavirus disease 2019;human coronavirus;multidisciplinary health planning
Impact COVID19 Pandemic Disease Severity Quality Life Parkinson s Disease,34220066,Background challenge faced lockdown period may worsen motor nonmotor symptom Parkinson s disease PD Objective study undertaken investigate impact lockdown disease activity caregiver perception quality life patient PD Materials Methods crosssectional study conducted June till September 2020 Sixtyfour patient PD caregiver interviewed telephonically obtaining consent response recorded mean structured questionnaire Nonmotor symptom scale NMSS Parkinson Disease Questinnaire8 PDQ8 applied PDQ8 severity index PDQ8 SI score expressed percentage raw PDQ8 score total score Data analsyed using SPSS version 200 Results 64 patient 39 609 men 25 391 woman overall median age patient 65 55256975 year median duration 48 3084 month Twentysix 406 patient reported symptomatic worsening lockdown period Slowness activity daily living walking worsened 15 577 14 538 patient respectively tremor increased 12 462 patient Mood sleep disturbance common nonmotor symptom worsen Increase nonmotor symptom NMSS total score independent predictor PDQ8 score Increase nonmotor symptom lockdown independent predictor highest quartile PDQ8 SI score Conclusions Motor nonmotor symptom worsened patient PD lockdown increase nonmotor symptom independently associated poorer quality life among patient PD lockdown,covid-19;parkinson's disease;lockdown;non-motor symptoms;quality of life
COVID19 postmortem finding departed teach u,34341671,present asthmatic 39 year old female frontline healthcare worker contact COVID19 patient suffered respiratory problem day found dead spouse Postmortem PM examination showed lung consolidation histological evidence diffuse alveolar damage DAD form hyaline membrane disease well atypical cell thrombus fibrin plug inside pulmonary capillary Swab sample testing SARSCoV2 confirmed infection status SARSCoV2 novel coronavirus first emerged Wuhan China PM contributing immensely uncovering pathophysiological mechanism disease SARSCoV2 enters host cell via angiotensinconverting enzyme 2 ACE2 lead fatal pneumonia characterised histologically DAD consistent PM finding due invasion virus type II pneumocytes lead death type II pneumocytes increased capillary permeability compromise gas exchange lead eventually cardiorespiratory failure death,ace2;dad;sars-cov-2;hyaline membrane;post-mortem
Abnormal MRI finding orbital visual pathway patient severe COVID19 Observations French multicenter COVID19 cohort,34284038,OBJECTIVES COVID19 multisystemic disease Ophthalmological abnormality relatively rare among COVID19infected patient aim study report orbital visual pathway MRI finding nationwide multicenter cohort patient severe COVID19 METHODS IRBapproved retrospective multicenter study included participant presenting severe COVID19 underwent brain MRI March 4th May 1st 2020 Two neuroradiologists `` blinded blinded data individually analyzed morphological MRIs focusing orbit visual pathway second consensus reading session performed case disagreement reader Clinical ophthalmological data compared MRI finding Descriptive statistical analysis interobserver agreement MRI reading using nonweighted Cohen kappa statistic performed RESULTS 129 participant 43 33 woman 86 67 men mean age 63 + 14 year included study 17129 13 patient abnormal MRI finding orbit visual pathway 1117 65 patient FLAIRWI hyperintense optic disc 617 35 patient abnormal signal least one visual pathway structure 66 100 optic nerve 16 17 optic chiasm 26 33 optic tract 16 17 optic radiation CONCLUSIONS study showed substantial number patient severe COVID19 presented abnormal MRI finding orbit visual pathway might lead potentially severe visual impairment,covid-19;mri;orbit;sars-cov-2
Coronavirus DiseaseAssociated Mucormycosis Tertiary Care Hospital India Case Series,34354889,BACKGROUND Coronavirus disease COVID19 remains health concern new challenge emerging pandemic progress recent rise opportunistic infection especially mucormycosis COVID19 patient complicating outcome Mucormycosis well known infect patient diabetes mellitus malignancy chemotherapy immunocompromised condition treatment COVID19 largely remains systemic steroid immunomodulators add risk invasive fungal infection METHODOLOGY present retrospective case series 13 patient individual clinical characteristic along demography treatment detail data collected retrospectively single center caters large population COVID19 patient varying severity RESULTS Thirteen patient presented COVID19 associated mucormycosis CAM median age higher nonsurvivors 495 year higher odds death 238 severe COVID overall mortality 643 Moreover diabetes mellitus present 615 patient mortality 75 11 846 patient received prior steroid COVID19 incidence hyperglycemia admission equal among survivor nonsurvivors CONCLUSION prevalence mucormycosis seems increasing among COVID19 patient may associated increased use steroid possible immunocompromised state imposed SARSCoV2 coexisting condition diabetes mellitus mortality CAM remarkably high apart preventive practice rational use immunomodulators high index suspicion early diagnosis would key survival,cam;covid-19;diabetes mellitus;mucormycosis;steroids
Immunological mechanism vaccineinduced protection COVID19 human,34211186,COVID19 vaccine designed elicit immune response ideally neutralizing antibody NAbs SARSCoV2 spike protein Several vaccine including mRNA adenoviralvectored protein subunit wholecell inactivated virus vaccine reported efficacy phase III trial received emergency approval many country two mRNA vaccine approved date show efficacy even one dose nonNAbs moderate helper 1 cell response detectable almost NAbs single dose adenovirus vaccine elicit polyfunctional antibody capable mediating virus neutralization driving antibodydependent effector function well potent cell response data suggest protection may require low level NAbs might involve immune effector mechanism including nonNAbs cell innate immune mechanism Identifying mechanism protection well correlate protection crucially important inform vaccine development guide use licensed COVID19 vaccine worldwide,
isolated sudden sensorineural hearing loss SSNHL idiopathic acute facial paralysis Bell s palsy symptom COVID19,34214773,OBJECTIVES symptom COVID19 time presentation mainly include fever cough respiratory distress myalgia hand neurological symptom disruption taste smell cerebrovascular pathology wellknown whereas neurological symptom sign newly recognized Suddenonset sensorineural hearing loss SSNHL idiopathic acute facial paralysis Bell s palsy otologic emergency frequently encountered otorhinolaryngology specialist Although many article describing SSNHL Bell s palsy literature literature describing relationship COVID19 limited study aimed present neurootologic relationship SSNHL Bell s palsy COVID19 MATERIAL METHODS pretreatment realtime oronasopharyngeal PCR test COVID19 symptomatology COVID19 infection status patient presented clinic isolated SSNHL Bell s palsy April 2020 April 2021 questioned data patient collected Throughout treatment patient followedup term COVID19 infection prospective study Moreover observe change incidence data patient visiting January 2019 January 2020 also collected data patient statistically analyzed using SPSS RESULTS study included total 177 patient SSNHL group consisted 91 patient Bell s palsy group consisted 86 patient Neither group showed statistically significant difference comparison year without pandemic term patient number incidence sex age morbidity response treatment social habit statistically significant difference age Bell s palsy group difference medically significant CONCLUSION result study observe relationship COVID19 case SSNHL Bell s palsy recommended apply standard otologic treatment isolated SSNHL Bell s palsy patient whose association COVID19 determined,covid-19;idiopathic acute facial paralysis (bell's palsy);otorhinolaryngological symptoms;sudden sensorineural hearing loss (ssnhl)
Airway Alveoli Organoids Valuable Research Tools COVID19,34288642,coronavirus disease 2019 COVID19 caused novel coronavirus SARSCoV2 affect tissue different body system mostly respiratory system damage evoked lung may occasionally result severe respiratory complication eventually lead death Studies human respiratory infection limited scarcity functional model mimic vivo physiology pathophysiology last decade organoid model emerged potential research tool due possibility reproducing vivo tissue culture Despite studied one year still effective treatment COVID19 investigation using pulmonary tissue possible therapeutic still limited Thus human lung organoids provide robust support simulate SARSCoV2 infection replication aid better understanding effect human tissue present review describes methodological aspect different protocol develop airway alveolus organoids promising perspective investigate COVID19,3d cell models;sars-cov-2;coculture;lung;respiratory disorders;virions
Esophagectomy Esophageal Cancer Performed Early Phase COVID19 Pandemic,34217786,Delay time esophagectomy esophageal cancer shown worse perioperative longterm outcome hypothesized COVID19 would cause delay surgery worse perioperative outcome compared standard operation esophagectomies esophageal cancer single institution MarchJune 2020 COVID19 group 2019 reviewed perioperative detail compared group Ninetysix esophagectomies performed 2019 v 37 MarchJune 2020 COVID19 group difference group found preoperative comorbidities Waittime surgery final neoadjuvant treatment similar median 50 day 2019 v 53 day COVID19 p = 0601 increased upstaging clinical stage pathologic stage 94 2019 v 75 COVID19 p = 0841 Fewer overall complication occurred COVID19 v 2019 432 v 646 p = 0031 complication similar specific grade Readmission rate statistically different COVID19 2019 162 v 104 p = 038 perioperative mortality COVID19 infection seen COVID19 group Esophagectomy esophageal cancer associated worse outcome COVID19 pandemic minimal risk infection careful COVID19 guideline followed Prioritization recommended ensure delay surgery,covid-19;delays of surgery;esophageal cancer;esophagectomy
Ozone eliminates Novel Coronavirus SarsCoV2 mucosal sample,34336226,Recent investigation shown severe acute respiratory syndrome coronavirus 2 SARSCoV2 able resist surface diffusion occurs droplet remain suspended air aerosol ozone generated situ oxygen active ingredient `` biocidal action little known capacity inactivate specifically SARSCoV2 show first time efficiency ozone treatment neutralize SARSCoV2 present nasopharynx secretion sample high viral load data show ozone effectiveness SARSCoV2 elimination,covid-19;ozone;sars-cov-2;disinfection
Best Practices Administering Monoclonal Antibody Therapy Coronavirus COVID19,34283506,COVID19 clinical syndrome due infection SARSCoV2 discovered Wuhan China December 2019 spread pandemic level 2020 Globally affected 168 million people death toll 35 million patient United States number case 32 million number people died COVID19 exceeded 586000 patient Coronavirus dashboard 05282021 Severe Acute Respiratory Syndrome Coronavirus2 one coronaviruses singlestranded RNA virus close resemblance SARS outbreak 2003 1 SARSCoV2 differs MERS middle east respiratory syndrome SARS Severe Acute Respiratory Syndrome coronaviruses easier spread lower fatality rate 2 SARSCoV2 transmitted inhalation air carrying droplet person person droplet spread coughing sneezing singing shouting even talking addition SARSCoV2 detected multiple service touching mucous membrane hand contaminated SARSCoV2 virus may also another transmission source COVID 19 start incubation period around 5 day exposure could range 2 14 day patient identify recent contact COVID 19 patient clinical presentation varies asymptomatic case severe symptom fatigue headache anosmia loss smell sensation ageusia loss taste sensation dyspnea dry cough persistent may stimulate gag reflex induce vomiting Hypoxia may worsen require assisted ventilation whether invasive noninvasive physical sign include fever tachycardia hypoxia resulting acute respiratory failure acute respiratory distress syndrome Extrapulmonary manifestation described many COVID patient multiple organ system including limited cutaneous acral lesion cardiovascular myocardial injury myocarditis neurologic headache stroke gastrointestinal nausea vomiting diarrhea elevated liver enzyme 3 national institute Health classifies manifestation SARSCoV2 follows Asymptomatic Presymptomatic Infection positive testing SARSCoV2 symptom consistent COVID19 Mild Illness Individuals various sign symptom COVID19 shortness breath dyspnea abnormal chest imaging Moderate Illness presence lower respiratory disease hypoxia oxygen saturation SpO =94 room air Severe Illness Hypoxia Spo 94 room air ratio arterial partial pressure oxygen fraction inspired oxygen PaOFiO 300 mm Hg respiratory frequency 30 breathsmin lung infiltrates 50 Critical Illness Individuals respiratory failure septic shock andor multiple organ dysfunction Mild moderate case COVID19 usually managed outpatient basis Patients requiring oxygen therapy maintain oxygenation usually hospitalized may require intensive care management assisted ventilation organ support treatment secondary infection Management non hospitalized patient COVID19 outpatient setting involves triaging severity symptom oxygen requirement Identifying patient risk factor deterioration close monitoring Patients without risk factor deterioration usually managed supportive care selfmonitoring Meanwhile patient risk factor deterioration offered AntiSARSCoV2 monoclonal antibody,
Broad spectrum anticoronavirus activity series antimalaria quinoline analogue,34217752,study series 10 quinoline analogue evaluated vitro antiviral activity panel alpha betacoronaviruses including severe acute respiratory syndrome coronaviruses 1 2 SARSCoV1 SARSCoV2 well human coronaviruses HCoV 229E OC43 Chloroquine hydroxychloroquine potent antiviral EC50 value range 01212 muM Chloroquine displayed favorable selectivity index ie ratio cytotoxic versus antiviral concentration 165 HCoVOC43 HEL cell Potent anticoronavirus activity also observed amodiaquine ferroquine mefloquine although associated substantial cytotoxicity mefloquine Primaquine quinidine quinine tafenoquine blocked coronavirus replication higher concentration piperaquine completely lacked antiviral cytotoxic effect timeofaddition experiment HCoV229Einfected HEL cell revealed chloroquine interferes viral entry postattachment stage Using confocal microscopy viral RNA synthesis could detected upon treatment SARSCoV2infected cell chloroquine inhibition SARSCoV2 replication chloroquine hydroxychloroquine coincided inhibitory effect autophagy pathway visualized dosedependent increase LC3positive puncta latter effect le pronounced even absent quinolines summary showed several quinoline analogue including chloroquine hydroxychloroquine amodiaquine ferroquine mefloquine exhibit broad anticoronavirus activity vitro,antiviral;covid-19;chloroquine;coronavirus;quinoline
Green tea intake effect laboratory parameter disease symptom hospitalised patient Covid 19 structured protocol randomized controlled trial,34344427,OBJECTIVES current randomized controlled trial RCT conducted ass effect green tea intake disease symptom laboratory parameter including Creactive protein CRP erythrocyte sedimentation rate ESR complete blood count CBC patient mildtomoderate Covid19 infection TRIAL DESIGN Randomized doubleblinded parallel 11 ratio clinical trial exploratory study PARTICIPANTS recruit patient COVID19 infection admitted Yasuj Shahid Jalil Hospital Yasuj City Kohgiluyeh BoyerAhmad Province Iran Participants inclusion criterion follows Inclusion Criteria Patients aged =18 year COVID19 diagnosis according realtime polymerase chain reaction RTPCR Exclusion Criteria Pregnancy lactation Disseminated intravascular coagulation type coagulopathy Severe congestive kidney failure history participating clinical trial last 30 day INTERVENTION COMPARATOR Intervention Two capsule containing 450 mg green tea extract along routine treatment COVID19 patient intervention group Two capsule containing placebo plus routine treatment patient COVID19 infection Capsules taken twice day lunch dinner 14 day MAIN OUTCOMES Changes disease symptom laboratory parameter including CRP ESR CBC 14 day intervention compared control group RANDOMISATION Eligible patient randomly assigned intervention control group 11 ratio Randomization performed based 8 permuted block block size 10 patient intervention control group matched according sex age category Randomization done using computergenerated random number Randomizationcom BLINDING MASKING appearance placebo green tea capsule similar term shape color packed bag prepared company Also researcher participant aware division end study NUMBERS RANDOMISED SAMPLE SIZE total sample determined based CRP MCID high CRP level considered 26 mgL Accordingly total sample size 37 patient intervention group required TRIAL STATUS protocol Version 10 June 5 2021 Recruitment start July 11 2021 anticipated completed September 21 2021 TRIAL REGISTRATION IRCT20150711023153N3 http wwwirctirtrial55948 retrospectively registered June 4 2021 FULL PROTOCOL full protocol attached additional file accessible Trials website Additional file 1 interest expediting dissemination material familiar formatting eliminated Letter serf summary key element full protocol,cbc;covid-19;crp;esr;randomised controlled trial;green tea supplement;protocol
simple prognostic score COVID19 hospitalized patient developing deep vein thrombosis,34212790,OBJECTIVE aim study analyze specificity accuracy sensitivity simple easy calculate prognostic score hospitalized COVID19 patient developing deep vein thrombosis METHODS March 1st April 28th 942 COVID19 patient severe symptom admitted hospital San Matteo PaviaItaly Thirty two patient 34 developed deep vein thrombosis hospitalization patient hemostatic inflammatory parameter abnormal simple prognostic score developed based presence specific co morbidity Ddimers level quick San Matthew Scorequick SMS RESULTS Nine patient died condition multiple organ failure 23 patient 719 survived left hospital good general condition developed score based simply two parameter 1 presence four specific co morbidity 2 systemic level DDimers quick San Matthew Score resulted sensitivity specificity overall accuracy 90 94 92 93 respectively compared favorably score score prospectively validated 100 COVID19 patient developed deep vein thrombosis collected literature prospectively confirmed hospital CONCLUSIONS finding study underline importance immediate aggressive therapeutic approach moderate highrisk patient COVID19 infection quick SMS score may help identify patient high risk mortality follow clinical outcome patient simple easy calculate prognostic score may also facilitate communication among health worker,"deep vein thrombosis, covid-19, prognostic score, sars-cov-2, prognosis"
Screening SARSCoV2 via PCR serological testing asymptomatic healthcare worker,34219921,prevalence seroconversion rate SARSCoV2 infection among asymptomatic health care worker US unclear study utilized realtime polymerase chain reaction RTPCR SARSCoV2 testing serological evaluation detect IgG antibody specific SARSCoV2 antigen asymptomatic health care worker total 197 subject mean age 35 year recruited study 67 reported prolonged contact known COVID19 patient 8 42 tested positive RTPCR 23 117 detectable level IgG antibody SARSCoV2 19 subject detectable IgG antibody week 1 11 579 lost antibody response week 3 statistically significant difference found baseline characteristic exposure status subject positive negative result RTPCR antibody positivity conclusion found low incidence PCR positivity SARSCoV2 highrisk group likely demonstrates effectiveness proper personal protective equipment use low transmission risk health care setting detectable IgG antibody titer low significant portion subject lost antibody response repeat testing may mean antibody response asymptomatic patient categorically different symptomatic hospitalized patient COVID19,antibody;covid-19;pcr testing;sars-cov-2;healthcare workers;serology
Diabetes MellitusA Risk Factor Unfavourable Outcome COVID19 PatientsThe Experience Infectious Diseases Regional Hospital,34201473,Early research implication concerning evolution infection caused new coronavirus people glucose metabolism dysfunction case diabetic show severe form disease predominate risk category Moreover seems even patient normal glycaemic status COVID19 may predispose development hyperglycaemia modulates immune mechanism inflammatory response direct effect morbidity mortality Thus taking account scientific data well increased frequency diabetes general population aimed ass risk unfavourable outcome diabetic patient strong connection presence severity pulmonary disease interstitial pneumoniabronchopneumonia well effectiveness Tocilizumab administration result study indicate threefold higher risk death patient diabetes COVID19 RR = 303 IC95 237386 p = 0001 compared nondiabetic patient risk developing severe form acute respiratory failure 15 time higher first studied category conclusion say diabetic diagnosed SARSCoV2 infection predisposed immunological organic dysfunction may ultimately result death treatment monoclonal antiIL6 antibody effective diabetic patient nondiabetics p 005 effectiveness Tocilizumab significant studied group diabetic patient responded better therapy compared nondiabetesmellitus DM one 767 vs 35 p = 0001,covid-19;cytokine storm;diabetes mellitus
Post COVID syndrome new challenge medicine,34227079,huge concern raised SARSCoV2 pandemic public health management social impact still debate particularly COVID19 may affect infected people much longer expected typical airborne viral disease scientific community actually wondering etiopathogenesis clinical development `` postCOVID complex symptomatology close symptom typically observed chronic fatigue syndrome recently named `` postacute sequela COVID19 PASC commentary try focus recent news issue,
Low morbidity Danish patient common variable immunodeficiency disorder infected severe acute respiratory syndrome coronavirus 2,34375571,BACKGROUND Manifestations outcome severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection well documented patient common variable immunodeficiency disorder CVID METHODS Danish nationwide retrospective clinicianreported survey RESULTS Eleven patient CVID SARSCoV2 infection identified median age 50 year range 2272 immunoglobulin replacement therapy Eight patient preexisting comorbidities Three patient asymptomatic SARSCoV2 infection seven developed mild coronavirus disease 2019 COVID19 One patient severe disease hypoxia required oxygen therapy patient multiple comorbidities including well known risk factor severe COVID19 patient recovered CONCLUSIONS result suggest CVID may risk factor severe COVID19 However monitoring immunodeficient population needed confirm observation,covid-19;sars-cov-2;common variable immunodeficiency;inborn errors of immunity;primary immunodeficiency
Characterization antibody response asymptomatic symptomatic SARSCoV2 infection,34214116,SARSCoV2 pandemic causing high morbidity mortality burden worldwide unprecedented strain health care system investigate time course antibody response relation outcome performed study hospitalized COVID19 patient comparison also investigated time course antibody response SARSCoV2 asymptomatic subject Study result show patient produce strong antibody response SARSCoV2 high correlation different viral antigen spike protein nucleoprotein among antibody class IgA IgG IgM neutralizing antibody antibody peak reached 3 week hospital admission followed sharp decrease difference observed parameter antibody class including neutralizing antibody subject recovered fatal outcome asymptomatic subject developed antibody detectable level,
Cell Death Coronavirus Infections Uncovering Role COVID19,34201847,Cell death mechanism crucial maintain appropriate environment functionality healthy cell However viral infection dysregulation process present participate pathogenetic mechanism disease review describe feature severe acute respiratory syndrome coronavirus 2 SARSCoV2 immunopathogenic mechanism characterizing present coronavirus disease COVID19 Lymphopenia monocytopenia important contributor COVID19 immunopathogenesis fine mechanism underlying phenomenon still unknown several hypothesis raised assign role cell death far reduction specific type immune cell concerned Thus discus three major pathway apoptosis necroptosis pyroptosis suggest likely occur simultaneously COVID19 patient describe SARSCoV2 direct indirect role inducing cell death Indeed one hand cell death caused virus entry cell excessive concentration cytokine chemokines process known COVID19related cytokine storm exerts deleterious effect circulating immune cell However overall knowledge mechanism still scarce study needed delineate new therapeutic strategy,covid-19;apoptosis;cell death
Decline neutralising antibody response sustained Tcell immunity COVID19 patient 7 month postinfection,34336207,Objectives study aimed explore severe acute respiratory syndrome coronavirus 2 SARSCoV2 specific humoral response Tcell response patient recovered coronavirus disease 2019 COVID19 understand natural protective immune response facilitate development vaccine Methods conducted combined assessment change neutralising antibody level SARSCoV2specific Tcell response time 27 patient 7 month infection Results neutralising antibody remained detectable 963 patient second visit 7 month postonset symptom However humoral response including titre spike receptorbinding domain IgG neutralising antibody decreased significantly compared first clinic visit contrast proportion spikespecific CD4 + cell CD8 + cell COVID19 patient recovery persistently higher healthy control significant change observed proportion spikespecific CD4 + cell patient recovered COVID19 within 7 month Conclusion SARSCoV2specific Tcell immune response persisted neutralising antibody decayed study needed extend longevity neutralising antibody evaluate whether cell sufficient protect patient reinfection,covid-19;sars-cov-2;t cells;neutralising antibody
SARSCoV2 Spike protein enhances ACE2 expression via facilitating Interferon effect bronchial epithelium,34228987,OBJECTIVE study focused interaction SARSCoV2 host Type Interferon IFN response identify whether IFN effect could influenced product SARSCoV2 METHODS structural nonstructural protein SARSCoV2 transfected overexpressed bronchial epithelial cell line BEAS2B respectively typical antiviral IFNstimulated gene ISG ISG15 expression detected qRTPCR RNAseq based transcriptome analysis performed control Spike proteinoverexpressed BEAS2B cell expression ACE2 IFN effector JAKSTAT signaling activation detected control proteinoverexpressed BEAS2B cell qRTPCR orand Western blot respectively interaction protein STAT1 STAT2 association JAK1 downstream STAT1 STAT2 measured BEAS2B cell coimmunoprecipitation coIP RESULTS protein could activate IFN effect downstream ISGs expression transcriptome analysis overexpression protein induced set gene expression including series ISGs SARSCoV2 receptor ACE2 Mechanistically protein enhanced association upstream JAK1 downstream STAT1 STAT2 promote STAT1 STAT2 phosphorylation ACE2 expression CONCLUSION SARSCoV2 protein enhances ACE2 expression via facilitating IFN effect may help infection,ace2;interferon;sars-cov-2;spike
Bloodstream Infection Risk Incidence Deaths Hospitalized Patients Coronavirus Disease Pandemic,34352195,Hospitalacquired infection emerging major concurrent condition coronavirus disease COVID19 pandemic conducted retrospective review hospitalization MarchOctober 2020 adult tested reverse transcription PCR severe acute respiratory syndrome coronavirus 2 evaluated association COVID19 diagnosis risk laboratoryconfirmed bloodstream infection LCBIs primary outcome time LCBI risk death using logistic competing risk regression adjustment relevant covariates total 10848 patient included analysis 918 85 given diagnosis COVID19 232 21 LCBIs hospitalization patient 58 25 classified central lineassociated bloodstream infection adjusting covariates COVID19positive status associated higher risk LCBI death Reinforcement infection control practice implemented COVID19 ward review superiority inferiority ranking method National Healthcare Safety Network criterion might needed,covid-19;sars-cov-2;bloodstream infection risk;coronavirus disease;coronaviruses;deaths;hospitalized patients;incidence;infection control;pandemic;prone positioning;respiratory infections;severe acute respiratory coronavirus 2;viruses;zoonoses
Patient satisfaction acceptability telehealth specialist medical outpatient clinic COVID19 pandemic Australia,34213046,BACKGROUND Outpatient clinic shifted rapidly telehealth Australia Coronavirus disease 19 COVID19 pandemic drastically altering patient care experience AIMS investigate patient satisfaction acceptability telehealth consultation COVID19 pandemic METHODS Prospective observation study conducted two hospital rheumatology outpatient department OPD undertaking telehealth consultation COVID19 modified version validated telehealth evaluation survey posted patient attending telehealth OPD rheumatology clinic including balanced 5point Likert scale freetext response Cluster analysis applied Likertscale question alongside thematic analysis freetext response RESULTS 128 respondent 29 response rate 695 woman majority 875 aged 50 year older telehealth consultation conducted telephone Nearly onefifth patient indicated consistent dissatisfaction telehealth across range question patient older reported lower educational qualification lower health literacy score lacked access Internet many patient found mode consultation convenient patient expressed concern regarding absence physical examination recurrent theme desire mixedmodel clinic future flexibility telehealth facetoface consultation CONCLUSIONS study offer unique insight patient experience telehealth current global pandemic uncommon mode consultation delivery urban area study suggests defining place telehealth future healthcare delivery patient perspective careful patient selection key Disease progression language cognitive ability health literacy technology access patient clinician preference important consideration deciding effectively embed integrate telehealth consultation,health system improvement;outpatient care;telemedicine
Impact First 2020 COVID19 Lockdown Metabolic Control Patients Phenylketonuria,34204602,present study assessed patient metabolic control phenylketonuria PKU first 2020 COVID19 lockdown Poland Blood phenylalanine Phe result test 535 patient performed 2019 first month 2020 analysed sixweek lockdown period compared preceding sixweek period well two corresponding period 2019 three nonlockdown period patient failed perform Phe test lockdown period 327 nonlockdown period 156 151 172 p 0001 median Phe level patient performed testing four period differ period However patient tended perform one test lockdown ORs 143 160 95 CI 101204 111230 pvalue 002 0005 Patients take blood lockdown 467 performed significantly fewer blood test remaining period median IQR 1 01 vs 2 14 p 0001 conclusion direct assessment patient compliance based upon Phe level pandemic lockdown possible Prepandemic noncompliant patient frequently failed perform test lockdown whereas previously compliant one likely perform one test strongly suggests metabolic control might worsened,covid-19 pandemic;pku;compliance;phenylketonuria
Clinical Efficacy Corticosteroids Early Stages Deterioration COVID19 Pneumonia,34285519,Background World Health Organization strongly suggests using corticosteroid patient severe coronavirus disease 2019 COVID19 Similarly large randomized controlled clinical trial RCT UK found dexamethasone effectively reduced mortality rate severe COVID19 patient However safety profile corticosteroid controversial area study Case Description case COVID19 patient described clinical characteristic observed mildly symptomatic patient progress critically ill patient dramatic improvement corticosteroid therapy early stage deterioration process COVID19 pneumonia Conclusion suitable timing dosage use corticosteroid maximize effect worsening COVID19 pneumonia discussed One main pathophysiological hypothesis severe COVID19 patient related cytokine storm virus load effectively treated corticosteroid therapy,covid-19 pneumonia;clinical characteristics;corticosteroids;cytokine storm
Primary haemophagocytic lymphohistiocytosis ChediakHigashi Syndrome triggered acute SARSCoV2 infection sixweekold infant,34132389,,chediak-higashi;sars-cov-2;infant;primary hlh
Towards Goals Refine Prophylactic Therapeutic Strategies COVID19 Linked Aging Metabolic Syndrome,34204163,severe acute respiratory syndrome coronavirus 2 SARSCoV2 gave rise coronavirus disease 2019 COVID19 pandemic strong correlation demonstrated worse COVID19 outcome aging metabolic syndrome MetS primarily derived obesityinduced systemic chronic lowgrade inflammation numerous complication including type 2 diabetes mellitus T2DM majority COVID19 death occurs people age 65 Individuals MetS inclined manifest adverse disease consequence mortality COVID19 review examine prevalence molecular mechanism underlying enhanced risk COVID19 elderly people individual MetS Subsequently discus current progress treating COVID19 including development new COVID19 vaccine antiviral towards goal elaborate prophylactic therapeutic treatment option vulnerable population,covid-19;sars-cov-2;aging;diabetes;metabolic syndrome;obesity;therapeutic drugs;vaccines
Projecting effect easing societal restriction nonCOVID19 emergency demand UK Statistical inference using public mobility data,34212400,well established societal restriction effective reducing COVID19 emergency demand evidence also suggests impact upon emergency demand directly related COVID19 infection Hospital planning may benefit greater understanding association ability reliably forecast future level nonCOVID19 demand Activity data Accident Emergency E attendance emergency admission sourced hospital within Bristol North Somerset South Gloucestershire healthcare system regressed upon publicly available mobility data obtained Google s Community Mobility Reports local area Seasonal trend controlled using time series decomposition model used predict nonCOVID19 emergency demand UK Government s plan sequentially lift restriction 21 June 2021 addition three alternative hypothetical relaxation strategy Rates public mobility within local area shown account 77 65 variance nonCOVID19 related E attendance emergency admission respectively Modelling support increase emergency demand line level timing societal restriction significant increase expected upon ending legal limit study find nonCOVID19 emergency demand associate level societal restriction rate public mobility representing key determinant predictive modelling healthcare system improve demand forecasting effectively managing hospital capacity,covid-19;coronavirus;demand forecasting;emergency demand;public mobility
Exploring effect PM25 temperature COVID19 transmission Seoul South Korea,34343550,recent surge new severe acute respiratory syndromecoronavirus 2 SARSCov2 COVID19 South Korea study attempt investigate effect environmental condition air pollutant PM25 meteorological covariate Temperature COVID19 transmission Seoul account unobserved heterogeneity daily confirmed case COVID19 across 25 contiguous district within Seoul adopt full Bayesian hierarchical approach generalized linear mixed model formal statistical analysis suggests exists positive correlation 7day lagged effect PM25 concentration number confirmed COVID19 case implies elevated risk infectious disease Conversely temperature shown negative correlation number COVID19 case leading reduction relative risk addition clarify random fluctuation relative risk COVID19 mainly originates temporal aspect whereas significant evidence variability relative risk observed term spatial alignment 25 district Nevertheless study provides empirical evidence using modelbased formal assessment regarding COVID19 infection risk 25 district Seoul different perspective,covid-19 transmission;hierarchical bayesian;local municipality;particulate matter 2.5;relative risks;temperature
review ECMO cardiac arrest,34223349,Cardiac arrest important public health concern affecting estimated 356500 people outofhospital setting 209000 people inhospital setting year cause cardiac arrest include acute coronary syndrome pulmonary embolism dyskalemia respiratory failure hypovolemia sepsis poisoning among many others order tackle enormous issue high mortality among sufferer cardiac arrest ongoing research seeking improved treatment protocol novel therapy One mechanical device increasingly utilized cardiac arrest venoarterial extracorporeal membrane oxygenation VAECMO Presently one published randomized controlled trial examining use VAECMO part cardiopulmonary resuscitation CPR process referred extracorporeal cardiopulmonary resuscitation ECPR Recently significant progress providing ECPR refractory cardiac arrest patient narrative review seek outline use ECPR inhospital outofhospital cardiac arrest well provide information expected outcome associated use,covid-19;cardiac arrest;ecmo;ecpr;extracorporeal cardiopulmonary resuscitation;extracorporeal membrane oxygenation
Prevalence correlate COVID19 vaccine hesitancy general public Iraqi Kurdistan crosssectional study,34347294,Low vaccine acceptance major barrier vaccination coverage every health system study aimed explore prevalence associated factor COVID19 vaccine hesitancy sample general population Iraqi Kurdistan general population gender different educational level sociodemographic characteristic Duhok governorate eligible participate crosssectional study 2021 Therefore online Google form sent main page social group two main social medium platform obtain representative sample individual different educational level author visited main shopping center Duhok city collect information illiterate lowlevel education individual study found 835 n = 773 participant received 514 n = 476 intend receive COVID19 vaccine small percentage decided receive COVID19 vaccine yet n = 17 18 intention receive COVID19 vaccine increased increasing level education 259 267 398 536 illiterate high school high school college higher respectively p 00001 Healthcare worker likely intend receive COVID19 575 v 401 p 00001 Individuals concern side effect COVID19 vaccine likely receive intend receive COVID19 vaccine Prevalence COVID19 vaccine hesitancy high region correlated lower education concern side effect,covid-19;acceptance rate;vaccine hesitancy
Health Care Professionals Experiences Use Video Consultation Qualitative Study,34287207,BACKGROUND number remote video consultation doctor patient increased last year especially COVID19 pandemic health care service faced rising rate chronic illness many patient confident selfmanagement illness addition improved longterm outlook serious condition cancer might require flexibility everyday life OBJECTIVE study aimed investigate medical doctor outpatient clinic use experience use video consultation hematological patient focus relational organizational aspect METHODS study designed explorative qualitative study Data collected via participant observation focus group interview medical doctor RESULTS study identified possibility barrier relation adapting alternative way meeting patient clinical setting One main finding study medical doctor afraid missed important observation able perform physical examination needed also emphasized handshake eye contact important order get overall impression patient s situation also became clear medical doctor used body language lot video consultation compared consultation physical setting medical doctor found contact patient via screen good fact technology working well made feel comfortable video consultation CONCLUSIONS study found medical doctor able maintain good contact patient despite screen able ass patient satisfying manner However still uncertainty among doctor fact could examine patient physically New knowledge use gesture body language video consultation obtained,doctor's perspective;hematology;outpatient clinic;telehealth;video consultation
Serological Response Lung Transplant Recipients Two Doses SARSCoV2 mRNA Vaccines,34208884,BACKGROUND Lungtransplant LT recipient high risk COVID19 due immunosuppression respiratory tropism SARSCoV2 information effect COVID19 mRNA vaccine elicit immunogenic response twodose 2D regimen LT recipient sparse Thus assessed effect PfizerBioNTech Moderna mRNA vaccine 2D regimen antispike response immunocompromised LT recipient METHODS utilized serum sample LT recipient vaccinated SARSCoV2 2D either PfizerBioNTech Moderna vaccine 2Dvaccinated naive nontransplanted nonexposed COVID19 group Antibody response assessed using FDAapproved SARSCoV2 antinucleocapsid protein IgG assay IgGNC SARSCoV2 antispike protein IgM assay IgMSP SARSCoV2 antispike protein IgG II assay IgGSP CD4+ Tcell activity assessed marker immune competence using ImmuKnow R assay RESULTS 25 1873 SARSCoV2 uninfectedLT patient generated positive spikeIgG response following 2D vaccine 36 925 Moderna cohort 19 948 Pfizer cohort 2D LT patient elicited significantly lesser median IgGSP response 17 AUmL 95 CI 0675 AUmL compared nontransplanted uninfected naive subject 14209 AUmL 95 CI 1126118836 AUmL p 00001 LT patient Modernaevoked seropositivity trend higher Pfizer CONCLUSION 2D COVID19 vaccination elicits dampened serological response LT patient Whether assessing arm host immunity combined higher vaccine dose better capture elicit improved immunogenicity immunocompromised population warrant investigation,covid-19 mrna vaccines;igg;igm;sars-cov-2;spike;lung transplantation;nucleocapsid;serological response;two doses
Targeted metabolomics identifies high performing diagnostic prognostic biomarkers COVID19,34282210,Research exploring development outcome COVID19 infection led need find better diagnostic prognostic biomarkers crosssectional study used targeted metabolomics identify potential COVID19 biomarkers predicted course illness assessing 110 endogenous plasma metabolite individual admitted local hospital diagnosistreatment Patients classified four group approximately 40 according standard polymerase chain reaction PCR COVID19 testing disease course PCRcontrols ie nonCOVID control PCR+nothospitalized PCR+hospitalized PCR+intubated Blood sample collected within 2 day admissionPCR testing Metabolite concentration data demographic data clinical data used propose biomarkers develop optimal regression model diagnosis prognosis COVID19 area receiver operating characteristic curve AUC 95 CI used ass model predictive value panel included kynurenine tryptophan ratio lysoPC C260 pyruvic acid discriminated nonCOVID control PCR+nothospitalized AUC = 0947 95 CI 09310962 second panel consisting C102 butyric acid pyruvic acid distinguished PCR+nothospitalized PCR+hospitalized PCR+intubated AUC = 0975 95 CI 09680983 lysoPC C280 differentiated PCR+hospitalized PCR+intubated patient AUC = 0770 95 CI 07360803 additional study targeted metabolomics confirm diagnostic value plasma biomarkers panel could eventually clinical use medical practice,
COVID19 international border surveillance Toronto s Pearson Airport cohort study,34210736,OBJECTIVES primary objective estimate positivity rate air traveller coming Toronto Canada September October 2020 arrival day 7 day 14 secondary objective estimate degree risk based country origin ass knowledge attitude towards COVID19 control measure subjective wellbeing quarantine period DESIGN Prospective cohort arriving international traveller SETTING Toronto Pearson Airport Terminal 1 Toronto Canada PARTICIPANTS Participants study passenger arriving international flight Inclusion criterion aged 18 older final destination within 100 km airport spoke English French provided consent Excluded taking connecting flight internet access exhibited symptom COVID19 arrival exempted quarantine MAIN OUTCOME MEASURES Positive SARSCoV2 virus reverse transcription PCR selfadministered oralnasal swab general wellbeing using WHO5 Wellbeing Index RESULTS 16 361 passenger enrolled 248 15 95 CI 13 17 tested positive 167 67 identified arrival 67 27 day 7 14 6 day 14 positivity rate increased 1 September 2 October Average wellbeing score declined 198 maximum 25 155 arrival day 7 p 0001 CONCLUSIONS single arrival test pick twothirds individual become positive day 14 rest detected second test day 7 result support strategy identified mathematical model reduced quarantine combined testing effective 14day quarantine,covid-19;diagnostic microbiology;epidemiology;public health
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandemrepeat spike protein RBD protects mouse COVID19,34289779,AbstractA safe effective vaccine urgently needed control unprecedented COVID19 pandemic Four adenovirus vectored vaccine expressing spike protein approved use generated several recombinant chimpanzee adenovirus AdC7 vaccine expressing receptorbinding domain RBD tandemrepeat dimeric RBD RBDtr2 found vaccination via either intramuscular intranasal route highly immunogenic mouse elicit humoral cellular immune response AdC7RBDtr2 showed higher antibody response compared either AdC7S AdC7RBD Intranasal administration AdC7RBDtr2 additionally induced mucosal immunity neutralizing activity bronchoalveolar lavage fluid Either singledose twodose mucosal administration AdC7RBDtr2 protected mouse SARSCoV2 challenge undetectable subgenomic RNA lung relieved lung injury AdC7RBDtr2elicted serum preserved neutralizing activity circulating variant especially Delta variant result support AdC7RBDtr2 promising COVID19 vaccine candidate,covid-19;sars-cov-2;adenovirus;antibody;immune response;vaccine
Effect COVID19 Thoracic Oncology Surgery Spain Spanish Thoracic Surgery Society SECT Survey,34207878,first wave COVID19 Spanish Society Thoracic Surgeons SECT surveyed member ass impact pandemic thoracic oncology surgery Spain May 2020 SECT member invited complete online 40item multiple choice questionnaire questionnaire developed SECT Scientific Committee sent via email overall response rate 192 respondent answered least 915 item one exception question resident respondent 893 worked public hospital reported impact pandemic routine clinical activity considered extreme severe 755 respondent 255 50 respectively Multidisciplinary tumour board held either fewer member attending electronic platform 446 359 respectively Surgical activity decreased 957 415 center performing surgery oncological patient 117 emergency Nearly 60 respondent reported modifying standard protocol earlystage cancer preoperative workup center approximately 80 reported using full personal protective equipment operating COVID19 positive patient COVID19 pandemic severely affected thoracic oncology surgery Spain lack common protocol led variable care delivery lung cancer patient,covid-19;lung cancer;surgical treatment
Mucormycosis Deadly New Worry COVID19 Pandemic,34226483,Recently mucormycosis extremely rare fungal infection emerging matter concern COVID19 saprophytic fungi Mucorales specie cause disease Mucormycosis immunocompromised host Clinical presentation mucormycosis related underlying condition rhinocerebral disease common form especially patient diabetes mellitus pulmonary cutaneous gastrointestinal infection also occur Severe COVID19 lifethreatening disease various factor including diabetes especially complicated ketoacidosis previous respiratory pathology immunosuppressive therapy nosocomial infection source systemic immune alteration COVID19 predispose mucormycosis specific biomarkers available diagnose mucormycosis imaging involved area histopathological examination biopsied tissue important diagnosis underlying medical condition must corrected include good glycemic control tapering steroid reducing stopping immunosuppressive medication Systemic antifungal therapy liposomal Amphotericin B medical treatment choice though drug resistance uncommon Surgical debridement devitalized tissue often required Severe COVID19 patient secondary coinfections require longer hospitalization higher risk death mortality rate almost 50 despite timely adequate treatment judicious use systemic glucocorticoid immunosuppressive agent treating severe disease hyperglycemia control seems vital preventing managing mucormycosis,
COVID19 Vaccines Effective People Obesity Position Statement Obesity Society,34212511,position statement issued Obesity Society response published literature well inquiry made Society patient provider society member policy maker others regarding efficacy vaccine person obesity severe acute respiratory syndrome coronavirus 2 SARSCoV2 virus cause Coronavirus Disease19 COVID19 Obesity Society critically evaluated data published peerreviewed literature briefing document Emergency Use Authorization application submitted PfizerBioNTech Moderna Johnson Johnson conclude vaccine highly efficacious efficacy significantly different people without obesity based scientific evidence available time publication Obesity Society belief definitive way determine three COVID19 vaccine `` best weight subpopulation due difference trial design outcome measure phase 3 trial elapsed time dos regional difference presence SARSCoV2 variant eg South Africa B1351 Johnson Johnson trial three trial demonstrated high efficacy COVID19associated hospitalization death Therefore Obesity Society encourages adult obesity =18 year =16 year PfizerBioNTech undergo vaccination one currently available vaccine authorized emergency use US Food Drug Administration soon able,
Virtual mask fitting pediatric patient COVID19 case series,34345656,Introduction COVID19 pandemic unprecedented threat health care system Clinicians pivot develop creative timely `` virtual solution provide clinical care aim develop standardized approach virtual `` mask fitting child either initiated already existing longterm ventilation LTV pediatric hospital Case outcome present three case involving care child required mask fitting noninvasive ventilation NIV LTV team consultation delivered via videoconference phone guidance respiratory therapist RT family caregiver FC took measurement child using standardized clinical approach developed LTV RTs Based measurement appropriate mask selected Successful mask fit based patientFC report well objective leak data obtained NIV download data Discussion Virtual clinic used managing patient LTV program feasible efficient resulting improved workflow RTs convenience patient FCs Patients FCs significantly le pressure attend inperson clinic expressed high satisfaction term experience importantly meeting respiratory care need Within context COVID19 remote patient education intervention delivered effectively reducing risk exposure inperson visit hospital Conclusion virtualtelemedicine program manage pediatric patient requiring mask fitting LTV feasible option COVID19,niv;facial;full face;long-term ventilation;measurement;nasal;respiratory therapist;template
Opinion uptake chloroquine treatment COVID19 mandatory lockdown subSaharan African region,34212739,BACKGROUND search effective treatment coronavirus disease 2019 COVID19 infection continues public opinion around potential use chloroquine CQ treating COVID19 remains mixed AIM examine opinion uptake CQ treating COVID19 subSaharan African SSA region SETTING study conducted online survey software titled SurveyMonkey METHODS Anonymous online survey 1829 SSA country conducted lockdown period using Facebook WhatsApp author network Opinion uptake CQ COVID19 treatment assessed using multivariate analysis RESULTS 14 respondent believed CQ could treat COVID19 32 took CQ COVID19 treatment Multivariate analysis revealed respondent Central adjusted odds ratio aOR 254 95 confidence interval CI 143 443 West Africa aOR 179 95 CI 115 288 higher odds believing CQ could treat COVID19 Respondents East Africa reported higher odds uptake CQ COVID19 Central Western Southern Africans Knowledge disease compliance public health advice associated belief uptake CQ COVID19 treatment CONCLUSION Central West African respondent likely believe CQ treatment COVID19 whilst uptake medication pandemic higher amongst East Africans Future intervention discouraging unsupervised use CQ target respondent Central West East African region,africa;chloroquine hydrochloride;coronavirus;poisoning;sub-saharan africa
Low Phase angle associated 60day mortality COVID19 Critically illpatients,34291834,BACKGROUND Malnutrition status body composition indicator bioimpedance BIA parameter associated increased risk death several pathology aim study describe association phase angle PhA indicator obtained BIA length hospital stay day mechanical ventilation 60day mortality critically ill patient infected SARSCOV2 METHODS prospective cohort mechanically ventilated patient COVID19 assessed nutritional risk body composition BIA within 48 hour ICU admission Logistic linear regression model used analyze association variable clinical outcome Survival analysis PhA value performed using KaplanMeier curve RESULTS Sixtyseven patient included PhA 036 p = 0002 SPA 045 p = 0001 extracellular watertotal body water ratio 325 p = 0002 significant predictor 60day mortality PhA 385 degree female 525 degree male showed good AUC 083 p = 003 fair AUC 074 p = 0003 discrimination respectively mortality prediction Using cutoff value low PhA associated significantly increased risk 60day mortality HR 308 95 CI 112841 p = 002 association detected SPA CONCLUSION Low PhA value could predictor 60day mortality COVID19 critically ill patient biological marker could incorporated part nutritional mortality risk assessment population article protected copyright right reserved,covid-19;bioelectrical impedance;mechanical ventilation;mortality;nutritional risk;nutritional status;phase angle
Evaluation PCR cycle threshold value patient population quidel lyra SARSCoV2 assay,34218165,Lyra SARSCoV2 assay primary method molecular testing performed BarnesJewish Healthcare System St Louis Missouri initial COVID19 surge midMarch lateApril 2020 performed retrospective analysis 1043 positive Lyra SARSCoV2 result 36 day investigate association cycle threshold CT value patient characteristic Total RNA extracted NP OP swab using either EasyMag KingFisher automated extraction system quantified RotorGene Q Qiagen Applied Biosystems 7500 Fast Dx thermocyclers respectively Notably found lower significant median lower CT sample tested KingFisherABI 7500 fastDX KFABI system compared EasyMagRotorGene EMRGQ platform Since 775 test ran EMRGQ pipeline perform additional analysis value found C value outpatient care setting compared sample obtained emergency department inpatient significantly lower C value collective finding suggests difference viral load amongst various patient population,clinical virology;molecular assays;sars-cov-2
Analytical Performance COVID19 Detection Methods RTPCR Scientific Societal Concerns,34357032,Background Health social management SARSCoV2 epidemic responsible COVID19 disease requires screening tool diagnostic procedure Reliable screening test aim identifying truely infectious individual spread viral infection therefore essential tracing harnessing epidemic diffusion Instead diagnostic test supplement clinical radiological finding thus helping establishing diagnosis Several analytical assay mostly using RTPCRbased technology become commercially available healthcare worker clinical laboratory However test showed critical limitation given relevant number falsepositive falsenegative case far reported Moreover analytical technique demonstrated significantly influenced preanalytical bias sensitivity showed dramatic time dependency Aim Herein critically investigate limit perspective currently available RTPCR technique especially referring required performance providing reliable epidemiological clinical information Key Concepts Current data cast doubt use RTPCR swab screening procedure tracing evolution current SARSCOV2 pandemic Indeed huge number falsepositive falsenegative result deprives trustworthiness decision making based data Therefore refine current available analytical test quickly identify individual able really transmit virus aim control prevent large outbreak,covid-19;rt-pcr;sars-cov-2;clinical pathology;false negative;false positive;pandemic
Immunosuppression minimization kidney transplant recipient hospitalized COVID19,34282376,Background Immunosuppressed patient kidney transplant recipient KTs increased mortality risk setting coronavirus disease 2019 COVID19 role management chronic immunosuppressive therapy COVID19 must characterized Methods Herein report followup cohort 47 KTs admitted two Spanish Kidney Transplant Units survived COVID19 impact management immunosuppression COVID19 graft function immunologic event evaluated Results least one immunosuppressive agent withdrawn 83 patient antimetabolite frequent Steroids generally stopped dose even increased 15 patient part treatment COVID19 Although immunosuppressive drug suspended median time 17 day rejection episode de novo donorspecific antibody observed 3 month discharge significant change occurred calculated panel reactive antibody Acute graft dysfunction common 55 severity related tacrolimus trough level higher patient receiving antiviral end followup patient recovered baseline kidney function Conclusions observational study suggests immunosuppression KTs hospitalized due COVID19 could safely minimized,acute kidney injury;allograft rejection;coronavirus disease 2019;donor-specific antibodies;immunosuppression;kidney transplantation
New Onset Hepatic Steatosis PostSevere Multisystem Inflammatory Syndrome Children MISC Case Report,34209719,emergence Multisystem Inflammatory Syndrome MISC following SARSCoV2 infection child adolescent provided new diagnostic management challenge limited knowledge condition natural history existing literature MISC currently data longterm outcome report case 14yearold boy significant past medical history presented condition multiorgan dysfunction due MISC SARS CoV2 infection subsequent clinicallaboratory sign hepatic steatosis shortterm followup case suggests hepatic steatosis may possible sequela following SARSCoV2 infection MISC medical treatment Therefore close longterm followup needed establish pathophysiology evolution condition patient following MISC,mis-c;sars-cov-2;hepatic steatosis;transaminases;ultrasonography
SARSCov2 Natural Infection Symptomatic Cat Diagnostic Clinical Medical Management One Health Vision,34205893,Despite reported increase SARSCoV2infected pet description clinical feature natural infection medical follow symptomatic pet still sufficiently documented study report case indoor cat displayed respiratory sign gastrointestinal syndrome following COVID19 diagnosis owner Thoracic radiography suggestive bronchial pneumonia blood test indicative mild inflammatory process Nasal oropharyngeal swab tested positive RTqPCR assay targeting SARSCoV2 gene 14 day owner tested positive virus Nasal swab persisted RTqPCR positive 31 day Serology confirmed presence antibody ELISA electrochemiluminescence analysis plaque reduction neutralization test recording high antibody titre 31 day cat improved medical treatment clinically recovered study suggests exposure SARSCoV2 could lead natural infection bronchial pneumonia cat along possible prolonged persistence SARSCoV2 RNA upper airway albeit low level cat developed neutralizing antibody reaching high titre 31 day description SARSCoV2 naturally infected pet medical management diagnostic finding would useful enhance knowledge COVID19 susceptible animal,rt-qpcr molecular detection;sars-cov-2;cat;medical features and management;serology;viral genome sequencing
epidemiology etiology respiratory tract infection Northern Taiwan early phase coronavirus disease 2019 COVID19 outbreak,34217634,BACKGROUND Coronavirus disease 2019 COVID19 manifest symptom common etiology respiratory tract infection RTIs pandemic COVID19 identifying etiology correctly patient RTI symptom crucial disease control preventing healthcare system collapsing applying sensitive PCRbased molecular assay detected etiologic agent delineated epidemiologic picture RTIs early phase COVID19 pandemic METHODS December 2019 February 2020 screened patient presented RTIs using multiplex PCRbased diagnostic assay Data pediatric adult patient compared different month unit hospital RESULTS 1631 patient including 1445 adult 186 pediatric patient screened 8 virus 4 bacteria identified Positive rate 25 December 37 January 20 February pediatric patient higher positive rate adult Ps 0001 pediatric patient RhVEnV commonly detected followed parainfluenza virus Mycoplasma pneumoniae infection occurred pediatric patient RhVEnV commonly detected agent pediatric patient admitted intensive care unit ICUs influenza accounted majority adult case critical illness Noticeably seasonal coronavirus ranked second adult pediatric patient ICU admission CONCLUSION focused pandemic COVID19 common etiology still accounted majority RTIs lead severe disease including seasonal coronaviruses,coronavirus disease 2019;epidemiology;etiologies;respiratory tract infections;seasonal coronavirus
Vitamin Plasma Levels COVID19 Patients Prospective Multicenter Study Hypothesis,34202697,COVID19 pandemic disease cause severe pulmonary damage hyperinflammation Vitamin crucial factor development immune function known reduced case acute inflammation prospective multicenter observational crosssectional study analyzed vitamin plasma level SARSCoV2 infected individual 40 hospitalized patient included 22 developed critical disease Acute Respiratory Distress Syndrome ARDS Extracorporeal membrane oxygenation ECMO 9 developed severe disease oxygen supplementation 9 developed moderate disease oxygen supplementation total 47 agematched convalescent person earlier infected SARSCoV2 included control group Vitamin plasma level determined highperformance liquid chromatography Reduced vitamin plasma level correlated significantly increased level inflammatory marker CRP ferritin marker acute SARSCoV2 infection reduced lymphocyte count LDH Vitamin level significantly lower hospitalized patient convalescent person p 001 hospitalized patient critically ill showed significantly lower vitamin level moderately ill p 005 Vitamin plasma level 02 mgL significantly associated development ARDS = 554 1013026 p = 0048 mortality 521 106255 p = 0042 Taken together conclude vitamin plasma level COVID19 patient reduced acute inflammation severely reduced plasma level vitamin significantly associated ARDS mortality,ards;covid-19;sars-cov-2;inflammation;pandemic;pneumonia;retinoic acid;retinol;vitamin a
Evidence antibody protective correlate COVID19 vaccine,34210573,correlate protection CoP urgently needed expedite development additional COVID19 vaccine meet unprecedented global demand ass whether antibody titer may reasonably predict efficacy serve basis CoP evaluated relationship efficacy vitro neutralizing binding antibody 7 vaccine sufficient data generated calibrated titer human convalescent serum reported study robust correlation seen neutralizing titer efficacy rho = 079 binding antibody titer efficacy rho = 093 despite geographically diverse study population subject different force infection circulating variant use different endpoint assay convalescent serum panel manufacturing platform Together evidence natural history study animal model result support use postimmunization antibody titer basis establishing correlate protection COVID19 vaccine,covid-19;correlate of protection;sars-cov-2;vaccine
Social medium management COVID19 developing country case Cameroon,34367423,Since first reported case coronavirus disease 2019 COVID19 Wuhan China virus spread every continent including subSaharan Africa exist cure vaccine COVID19 Classic public health approach hygiene sanitation social distancing recommended measure contain spread causative virus possible combine strict lockdown measure western country practical almost every country subSaharan Africa Cameroon without symptom encouraged respect measure hygiene sanitation physical distancing wear mask public place develop symptom isolated accredited COVID19 management centre recover However latter strategy ineffective containing local spread virus testing robust Intuitively control virus Cameroon depends largely engaged public fighting virus Social medium complement use community health worker community public engagement viewpoint discus optimize public engagement combat misinformation develop culture preparedness amidst COVID19 pandemic time resource essence,covid-19;cameroon;social media
Dietary Intake Supplement Use Among Saudi Residents COVID19 Lockdown,34198578,Healthy diet supplement use may prove sustainable strategy lower COVID19 infection study investigated dietary change lockdown observed dietary supplement DS use among resident Saudi Arabia crosssectional study collected data via online electronic survey questionnaire among male N = 921 female N = 1044 residing Saudi Arabia 15 year age significant decrease prevalence male vs lockdown improved change dietary habit 686 vs 658 p = 0004 similar female participant 69 vs 734 vs 69 p 0001 frequency multivitamin user among COVID19 participant significantly lower nonusers 444 vs 556 p 0003 Male respondent within 2635 year age likely use multivitamin supplement female 301 vs 226 p 005 age group Predictors DS use increased age group income education level COVID19 status conclusion increase unhealthy diet behavior observed among Saudi male female pandemic lockdown predictor DS use included increased age income education level COVID19 status,covid-19;saudi arabia;diet behavior;dietary supplements;education;income;multivitamin
Role Chest Imaging Viral Lung Diseases,34198575,infection caused novel betacoronavirus SARSCoV2 officially declared pandemic World Health Organization March 2020 However last 20 year viral infection cause respiratory tract infection leading hundred thousand death worldwide referring particular severe acute respiratory syndrome SARS influenza H1N1 Middle East respiratory syndrome MERS Although pandemic period SARSCoV2 infection first diagnosis exclude many virus cause pulmonary manifestation recognized description main radiological pattern radiologist suggest diagnosis viral pneumonia also combining information clinical laboratory data,covid-19;computed tomography;coronavirus;differential diagnosis;viral pneumonia
Concurrent mutation RNAdependent RNA polymerase spike protein emerged epidemiologically successful SARSCoV2 variant,34210996,D614G mutation Spike protein SARSCoV2 effectively replaced early pandemiccausing variant Using pseudotyped lentivectors confirmed aspartate replacement glycine position 614 markedly infectious Molecular modelling suggests G614 mutation facilitates transition towards open state Spike protein explain epidemiological success D614G analysed evolution 27086 highquality SARSCoV2 genome sequence GISAID observed striking coevolution D614G P323L mutation viral polymerase Importantly exclusive presence G614 L323 become epidemiologically relevant contrast combination two mutation gave rise viral GL variant replaced initial DP variant result suggest P323L mutation located interface domain RNAdependent RNA polymerase necessary alteration led epidemiological success present variant SARSCoV2 However observe significant correlation reported COVID19 mortality different country prevalence Wuhan versus GL variant Nevertheless comparing speed emergence ultimate predominance individual country clear GL variant display major epidemiological supremacy original variant,
Targeting Neuroinvasion SARSCoV2 Emerging Trends Drug Antibody Delivery Combat COVID19,34228437,SARSCoV2 us nasal cavity major route entry human body nasal administration drug antibody directed virus prove effective pulmonary COVID19 also prevention potential early neuroinvasion caused virus recent report potential application antibodyladen nasal spray treatment COVID19 proposed use drug recently proven effective SARSCoV2 administered via inhalation route using modified transcribrial device reported previously use Naegleria fowleri target SARSCoV2 fight COVID1,covid-19;sars-cov-2;inhalation drug delivery;neuroinvasion;transcribial device
Stopping COVID19 pandemic dental office review SARSCoV2 transmission crossinfection prevention,34342550,Due essential role dentist stopping COVID19 pandemic purpose review help dentist detect weakness disinfection crosscontamination prevention protocol triage dental treatment meet need patient pandemic used PRISMA identify peerreviewed publication supplemented guidance center disease control infection control guideline dentist Dentists must triage dental treatment meet need patient pandemic ongoing pandemic changed practice dentistry forever change make cumbersome timeconsuming costly due possible pathway transmission mitigation step needed prevent spread COVID19 Dental chairside rapid test SARSCoV2 urgently needed dentist need screen patient COVID19 even though 75 people COVID19 symptom Despite widespread anxiety fear devastating health effect COVID19 61 dentist implemented change treatment protocol urgent matter public health dentist must identify additional step take prevent spread COVID19 effective step stop pandemic dental office vaccinate dentist staff patient triage dental treatment patient separate vulnerable patient separate COVID19 patient prevent crosscontamination disinfect area touched patient maintain social distancing change personal protective equipment patient,covid-19 testing;covid-19 vaccination;dentists;sars-cov-2;triage dental treatments
Cutaneous Manifestations SARSCoV2 InfectionA Series Cases Largest Infectious Diseases Hospital Western Romania,34202233,1 Background SARSCoV2 infection appeared isolated epidemic outbreak December 2019 proved contagious within 3 month declared COVID19 pandemic one year prevaccination period virus acted unhindered highly contagious predominantly respiratoryoriented aggression Although lung damage responsible 3090025 death provided sufficient data facilitate understanding pathogenic mechanism observation data meet quality emerging clinical aspect rash remain without welldefined etiopathogenic support wellcontoured clinical framework 2 Methods Results followed occurrence cutaneous manifestation patient hospitalized second third outbreak SARSCoV2 main clinic infectious disease county Timis recorded laboratory investigation clinical evolution five suggestive case 3 Conclusions presented case added many present future clinical observation allow better knowledge understanding SARSCoV2 infection requirement become global priority entire medical scientific community,sars-cov-2;cutaneous manifestations;erythematous-macular rash;immune response
Novel coronavirus mitigation measure implemented radiotherapy centre low middleincome country systematic review,34211781,Background aim study identify strategy adopted radiotherapy centre low middleincome country LMICs mitigate effect COVID19 Studies summarising COVID19 mitigation strategy designed implemented radiotherapy centre LMICs avoid delay deferrments interruption radiotherapy service lacking Materials method systematic review conducted reported accordance preferred reporting item systematic review metaanalysis guideline Ovid Embase Ovid MEDLINE CINAHL searched peerreviewed article reported measure adopted radiotherapy centre LMICs reduce risk COVID19 Information different strategy extracted included study textual narrative synthesis conducted Results 60 article retrieved eleven included Majority study conducted China Ten included study employed qualitative design Four theme identified preparing equipping staff reinforcing infection prevention control policy strengthening coordination communication maintaining physical distancing Studies reported radiotherapy centre formed COVID19 response multidisciplinary team maximised use telehealth adjusted layout waiting area divided staff team dedicated room isolating suspected case adopted triage system Conclusions Local adaptation established global strategy coupled timely development guideline flexibility innovation allowed radiotherapy leader continue deliver radiotherapy service cancer patient LMICs COVID19 crisis Robust data collection must encouraged LMICs provide evidencebased knowledge use event another pandemic,covid-19;cancer;implementation;low and middle-income countries;radiotherapy
Social Media Monitoring COVID19 Pandemic Influenza Epidemic Adapting Informal Language Arabic Twitter,34346892,BACKGROUND Twitter real time messaging platform widely used people organisation share information many topic could potentially useful analyse tweet infectious disease monitoring purpose order reduce reporting lag time provide independent complementary source data compared traditional approach However analysis currently possible Arabic speaking world due lack basic building block research dialectal variation OBJECTIVE collect around 4000 Arabic tweet related COVID19 Influenza clean label tweet relative Arabic Infectious Diseases Ontology includes nonstandard terminology 11 core concept 21 relation aim study analyse Arabic tweet estimate usefulness health surveillance understand impact informal term analysis show effect deep learning method classification process identify location infection spreading METHODS apply multilabel classification technique Binary Relevance Classifier Chains Label Powerset Adapted Algorithm MLKNN NBSVM BERT AraBERT identify tweet appearing infected individual also use Named Entity Recognition predict place name mentioned tweet RESULTS achieve F1score 88 Influenza case study 94 COVID19 one Adapting nonstandard terminology informal language help improve accuracy much 15 average improvement 8 Deep learning method achieve 94 F1score classifying process geolocation detection algorithm predict average 54 accuracy location user using tweet content CONCLUSIONS study identifies two Arabic social medium datasets monitoring tweet related Influenza COVID19 demonstrates importance including informal term regularly used social medium user analysis also prof BERT achieves good result used new term COVID19 tweet Finally tweet content may contain useful information determine location disease spread CLINICALTRIAL,
Graphene nanoplatelet graphene oxide functionalization face mask material inhibits infectivity trapped SARSCoV2,34222841,Recent advancement bidimensional nanoparticles production graphene G graphene oxide GO potential meet need highly functional personal protective equipment PPE SARSCoV2 infection ability G GO interact microorganism provides opportunity develop engineered textile use PPE limit spread COVID19 PPE current use highrisk setting COVID transmission provides physical barrier decrease infection likelihood inactivate virus show virus preincubation soluble GO inhibits SARSCoV2 infection VERO cell Furthermore GGOfunctionalized polyurethane cotton contact SARSCoV2 infectivity fabric nearly completely inhibited finding presented constitute important innovative nanomaterialbased strategy significantly increase PPE efficacy protection SARSCoV2 virus may implement water filtration air purification diagnostics method,disease;health sciences;materials science;nanostructure;public health
Growth assessment child COVID19 pandemicCan rely parental measurement,34289178,AIM COVID19 pandemic prompted rapid development remote medical service lockdown period child s growth data obtained parent home assessment study aimed ass accuracy home height weight measurement analyse utility clinical decisionmaking METHODS retrospective singlecentre observational study Children aged 318 year measured weight height home using guidance provided parent proper measurement technique subsequent professional reevaluation endocrine institution clinic two set measurement compared analysed according various clinical parameter RESULTS Height measurement home clinic comparable diff = 01 + 13cm p = 042 amongst 107 child mean age 102 + 37 561 male participating study except overweight obese child significantly higher clinic diff = 086 + 148cm p = 0018 Weight BMI significantly higher clinic diff = 045 + 08kg diff = 03 + 06kgm 2 p 0001 p 0001 respectively CONCLUSIONS Height measurement child parent accurate except obese overweight child whereas weight measurement tended lower clinic proper guidance parent home measurement height weight accurate suitable clinical decisionmaking,covid-19;growth assessment;home measurements;parents reported measurements
Deep convolution neural network differentiate COVID19 pulmonary abnormality chest radiograph Evaluation using internal external datasets,34219953,aimed evaluate performance convolutional neural network CNNs classification coronavirus disease 2019 COVID19 disease using normal pneumonia COVID19 chest radiograph CXRs First collected 9194 CXRs open datasets 58 Korea University Anam Hospital KUAH number normal pneumonia COVID19 CXRs 4580 3884 730 respectively CXRs obtained open dataset randomly assigned training tuning test set 701020 ratio external validation KUAH 20 normal 20 pneumonia 18 COVID19 dataset verified radiologist using computed tomography used Subsequently transfer learning conducted using DenseNet169 InceptionResNetV2 Xception identify COVID19 using open datasets internal KUAH dataset external histogram matching Gradientweighted class activation mapping used visualization abnormal pattern CXRs average AUC accuracy multiscale mixedCOVID19Net using three CNNs five fold 099 + 001 9294 + 045 099 + 001 9312 + 023 099 + 001 9357 + 029 respectively using open datasets internal Furthermore value 075 7414 072 6897 077 6897 respectively best model among fivefold crossvalidation KUAH dataset external using domain adaptation various stateoftheart model trained open datasets show satisfactory performance clinical interpretation Furthermore domain adaptation external datasets found important detecting COVID19 well disease,covid-19;chest radiography;computer-aided diagnosis (cad);deep learning;lung diseases
Risk factor transfer Respiratory Intermediate Care Unit Intensive Care Unit COVID19,34130948,BACKGROUND Patients hospitalized COVID19related pneumonia often need several degree ventilatory support performed Respiratory Intermediate Care Units RICUs Intensive Care Units ICUs depend severity acute respiratory distress syndrome firm consensus transfer predictor RICU ICU METHODS retrospective observational single center study evaluated 96 COVID19 patient referred RICU acute respiratory failure ARF according transferal ICU stay RICU compared demographic data baseline laboratory profile final clinical outcome identify early risk factor transfer RESULTS best predictor transfer ICU elevated Creactive protein lymphopenia mortality rate lower RICU ICU transferred patient died mostly younger men le comorbidities RICU CONCLUSIONS inflammatory marker predict need transfer RICU ICU Due ongoing COVID19 pandemic urge better clinical stratification early meaningful profile patient admitted RICU risk transferal ICU,covid-19;covid-19 icu transfer risk factors;covid-19 management italy;respiratory intermediate care unit
Cytokine Storm Syndrome SARSCoV2 Infections Functional Role Mast Cells,34359931,Cytokine storm syndrome cascade escalated immune response disposing immune system exhaustion might ultimately result organ failure fatal respiratory distress Infection severe acute respiratory syndromecoronavirus2 result uncontrolled production cytokine eventually development cytokine storm syndrome Mast cell may react virus collaboration cell lung autopsy finding patient died coronavirus disease emerged 2019 COVID19 showed accumulation mast cell lung thought cause pulmonary edema inflammation thrombosis review present evidence cytokine response mast cell may initiate inappropriate antiviral immune response cause development cytokine storm syndrome also explore potential mast cell activator adjuvant COVID19 vaccine discus medication target function mast cell could value treatment COVID19 Recognition cytokine storm crucial proper treatment patient preventing release mast cell mediator impeding impact imposed mediator could reduce severity COVID19,covid-19;sars-cov-2;cytokine storm;mast cells;vaccine
Prognostic immunological value ATP6AP1 breast cancer implication SARSCoV2,34228637,Abnormal ATPase H+ Transporting Accessory Protein 1 ATP6AP1 expression may promote carcinogenesis investigated association ATP6AP1 breast cancer BC COVID19 Oncomine Gene Expression Profiling Interactive Analysis Human Protein Atlas KaplanMeier plotter database used evaluate expression prognostic value ATP6AP1 BC ATP6AP1 upregulated BC tissue higher ATP6AP1 expression associated poorer outcome Data Tumor Immune Estimation Resource TumorImmune System Interaction Database KaplanMeier plotter indicated ATP6AP1 expression correlated immune infiltration prognostic effect BC depended tumorinfiltrating immune cell subtype level Multiple database used evaluate association ATP6AP1 clinicopathological factor ass mutation methylation ATP6AP1 analyze gene coexpression enrichment ATP6AP1 promoter hypomethylated BC tissue differentially methylated different disease stage subtypes Data Gene Expression Omnibus indicated ATP6AP1 level certain cell type reduced SARSCoV2 infection Ultimately higher ATP6AP1 expression associated poorer prognosis higher lower infiltration particular immune cell BC BC patient may particularly susceptible SARSCoV2 infection may alter prognosis,atp6ap1;covid-19;sars-cov-2;bioinformatics;breast cancer;immune infiltration;prognosis
Prescription Filling Patterns EvidenceBased Medical Therapies Heart Failure COVID19 Pandemic United States,34214650,BACKGROUND Maintaining steady medication supply public health crisis major health priority leveraged large US pharmacyclaims database understand use evidencebased therapy heart failure HF care coronavirus disease2019 COVID19 pandemic METHODS analyzed 27027650 individual claim allpayer pharmacyclaims database across 56155 chain independent mailorder pharmacy 14164 zip code 50 state Prescriptions dispensed 2week interval evidencebased HF therapy 2020 indexed comparable timeframes 2019 normalized yeartoyear change HF medical therapy relative observed stable basket drug RESULTS Fills losartan lisinopril carvedilol metoprolol peaked week March 2020 demonstrated trajectory thereafter relatively consistent reference set drug Fills spironolactone +4 eplerenone +18 showed modest trend toward increased relative use 2020 Fills empagliflozin +75 dapagliflozin +65 sacubitrilvalsartan +61 showed striking longitudinal increase throughout 2020 deviated substantially yeartoyear trend overall basket drug 3 therapy fill quantity size increased relatively throughout 2020 generic brandname therapy prescription fill pattern mailorder pharmacy increased substantially expected trend beginning March 2020 CONCLUSION Prescription fill established generic therapy used HF care maintained whereas sacubitrilvalsartan sodiumglucose cotransporter2 inhibitor steeply increased COVID19 pandemic nationwide pharmacy claim data provide reassurance therapeutic access public health crisis evidencebased medication used HF care,covid-19;generic;guideline-directed medical therapy;heart failure;prescription fills
Development rapid costeffective toploading device detection antiSARSCoV2 IgGIgM antibody,34290350,Infection SARSCoV2 Betacoronavirus caused pandemic affected globe negatively gold method RTPCR detect SARSCoV2 timeconsuming need sophisticated equipment professional personnel hand rapid test offer fast result detect antiSARSCoV2 antibody Abs aim study develop new rapid costeffective method detection antiSARSCoV2 IgGIgM Abs new toploading detection device developed composed small piece plastic 25 x 25 x 05 mm opening center piece nitrocellulose NC membrane enough block opening one side adhesive tape affix NC plastic piece NC blotted antihuman IgGIgM rabbit serum device evaluated commercially available IgGIgM ELISA detection kit using normal Covid19positive HCV HBV Cytomegaloviruspositive serum Outcomes demonstrated simplicity reproducibility accuracy new device result obtained le 5 min anticipate developed assay method used widely point care deciding use expensive nucleic acid assay,
Current New Drugs COVID19 Treatment Effects Liver,34221930,Corona virus disease COVID 19 caused novel severe acute respiratory syndrome coronavirus2 commonly referred SARSCoV2 March 2020 World Health Organization declared COVID19 outbreak pandemic Though target organ virus primarily lung recent understanding pathobiology disease immune dysregulation associated clear COVID19 affect multiple organ system Several drug therapy tried repurposed combat wrath posed disease October 22 2020 USA Food Drug Administration approved remdesivir use adult pediatric patient 12 year age older Several drug tried COVID19 hepatotoxicity potential side effect review aim provide latest insight various drug used treatment COVID19 effect liver,covid-19;drug-induced liver injury;drugs;liver
Severe acute respiratory syndrome coronavirus2 SARSCoV2 infection thyroid disease update,34224435,PURPOSE REVIEW Severe acute respiratory syndrome coronavirus2 SARSCoV2 infection associated excess morbidity mortality patient hypertension diabetes little known thyroid disease Thus goal review literature respect patient underlying hypo hyperthyroidism increased risk contracting SARSCoV2 infection ii underlying hypo hyperthyroidism impact prognosis SARSCoV2 infection iii SARSCoV2 infection cause de novo thyroid dysfunction RECENT FINDINGS Patients hypo hyperthyroidism increased risk contracting SARSCoV2 diagnosis hypo hyperthyroidism associated worsened prognosis SARSCoV2 infection SARSCoV2 infection associated subsequent thyrotoxicosis euthyroid sick syndrome subacute thyroiditis autoimmune thyroid disease SUMMARY finding suggest receiving treatment thyroid dysfunction per se impact patient risk acquiring SARSCoV2 infection management already contracted Additional study larger number patient longterm followup required order clarify whether patient SARSCoV2 infection le prone develop thyroid dysfunction andor thyroid autoimmunity patient recovering virus infection,
Durable Antibody Responses Staff Two LongTerm Care Facilities Post SARSCoV2 Outbreaks,34287058,SARSCoV2 disproportionate impact nonhospital health care setting longtermcare facility LTCFs communal nature facility paired highrisk profile resident resulted thousand infection death high case fatality rate detect presymptomatic infection identify infected worker performed weekly surveillance testing staff two LTCFs revealed large outbreak one site collected serum staff member throughout study evaluated binding neutralization measure seroprevalence seroconversion type functionality antibody site incident infection detected 40 staff preexisting SARSCoV2 neutralizing antibody suggesting prior exposure outbreak site saw rapid seroconversion following infection Neutralizing antibody level stable many week following infection suggesting durable longlived response Receptorbinding domain antibody neutralizing antibody strongly correlated site high seroprevalence among staff two unique introduction SARSCoV2 facility seronegative infected staff period study result workplace spread outbreak Together result suggest high seroprevalence rate among staff contribute immunity within workplace protect subsequent infection spread within facility IMPORTANCE Longterm care facility LTCFs disproportionately impacted COVID19 due communal nature highrisk profile resident LTCF staff ability introduce SARSCoV2 facility spread causing outbreak tested staff weekly two LTCFs collected blood throughout study measure SARSCoV2 antibody One site large outbreak infected individual rapidly generated antibody infection site almost half staff already antibody suggesting prior infection majority antibody bind receptorbinding domain SARSCoV2 spike protein potently neutralizing stable many month nonoutbreak site two unique introduction SARSCoV2 facility result workplace spread outbreak result reveal high seroprevalence among staff contribute immunity protect subsequent infection spread within facility,adaptive immunity;coronavirus;neutralizing antibodies;surveillance studies
Aspergillus Critically Ill COVID19 Patients Scoping Review,34199528,Several report published Aspergillus finding COVID19 patient leading proposition new disease entity COVID19associated pulmonary aspergillosis scoping review designed clarifying concept finding Aspergillus spp COVID19 patient interpreted searched Medline identify study Aspergillus spp finding COVID19 patient Included observational study containing following information explicit mention total number study population study period reason obtaining respiratory sample case definition clinical outcome Excluded case series case report review Identified 123 publication 8 observational study included included study following issue identified proportion immunocompromised patient considered host factor varied 0 17 study mention radiographic finding explicitly Respiratory sample mostly obtained investigate clinical deterioration Aspergillus culture antigen PCR testing bronchoalveolar lavage BAL fluid performed 233 663 study population Two study performed periodic sample BAL Galactomannan index GI positivity BAL 10 28 GI blood found 09 67 available sample prevalence COVID19associated pulmonary aspergillosis ranged 27 277 Studies compared mortality defined case noncases showed increased mortality case study showed antifungal treatment reduced mortality Concluding review showed study defined clinical entity COVID19associated pulmonary aspergillosis positive Aspergillus test respiratory sample main driver diagnosis many difference study term test algorithm Aspergillus test used largely determined prevalence Whether antifungal therapy either prophylaxis preemptive targeted therapy lead better outcome COVID19associated pulmonary aspergillosis patient still need answered,aspergillus;covid-19;mortality;scoping review
DimachkieSpectrum Acute Neuropathy Associated Covid19 Clinical electrophysiological study 13 patient single center,34333121,OBJECTIVES analyze clinical nerve conduction pattern patient acute neuropathy preceded concomitantly Covid19 disease Acute Neuropathy Associated Covid19 ANAC 19 METHODS Retrospective analysis clinical detail laboratory evaluation electrophysiological parameter patient ANAC 19was done data compared non Covid GBS described literature also patient acute neuropathy without Covid 19 presented center period study RESULTS Records thirteen patient ANAC 19were reviewed patient clinically paraparesis electrophysiologically showed demyelinating neuropathy Peroneal Sural nerve frequently abnormal motor sensory nerve respectively proportion patient showed peroneal velocity sparing pattern Higher incidence paraparesis encephalopathy differentiated ANAC 19from non Covid GBS CONCLUSIONS ANAC 19has comparable electrophysiological profile non Covid GBS However distinct clinical presentation,covid-19 disease;guillain-barre syndrome;para infectious neuropathy;peripheral neuropathy
Changes influenza vaccination coverage associated COVID19 pandemic Japan,34226857,Changes influenza vaccination coverage COVID19 pandemic Japan limited change individual behavior threat disease also vaccine dissemination policy based systembased intervention including behavioral economic approach desirable,covid-19;barriers to the vaccination;influenza vaccine
Investigation Long COVID Prevalence Relationship EpsteinBarr Virus Reactivation,34204243,Coronavirus disease 2019 COVID19 patient sometimes experience longterm symptom following resolution acute disease including fatigue brain fog rash Collectively become known long COVID aim first determine long COVID prevalence 185 randomly surveyed COVID19 patient subsequently determine association occurrence long COVID symptom reactivation EpsteinBarr virus EBV 68 COVID19 patient recruited surveyed found prevalence long COVID symptom 303 56185 included 4 initially asymptomatic COVID19 patient later developed long COVID symptom Next found 667 2030 long COVID subject versus 10 220 control subject primary study group positive EBV reactivation based positive titer EBV early antigendiffuse EAD IgG EBV viral capsid antigen VCA IgM difference significant p 0001 Fisher s exact test similar ratio observed secondary group 18 subject 2190 day testing positive COVID19 indicating reactivation may occur soon concurrently COVID19 infection finding suggest many long COVID symptom may direct result SARSCoV2 virus may result COVID19 inflammationinduced EBV reactivation,covid-19;ebv;epstein-barr virus;epstein-barr virus reactivation;pacs;sars-cov-2;chronic covid syndrome;coronavirus;long covid;post-acute covid-19 syndrome
Transient Changes Preexposure Prophylaxis Use Daily Sexual Behavior Implementation COVID19 Restrictions Among Men Sex Men,34229327,BACKGROUND assessed Dutch restriction imposed March 15 2020 affected sexual behavior preexposure prophylaxis PrEP condom use among PrEP user Amsterdam METHODS used data 1 PrEP use 2 anal sex act 3 condom use per partner type steady partner SPs known casual partner KCPs unknown casual partner UCPs collected daily mobile application used December 1 2019 June 30 2020 compared period versus March 15 2020 regarding average proportion day per week end point reported average proportion anal sex act covered PrEP andor condom RESULTS included data 136 men sex men March 15 2020 proportion day anal sex increased SPs odds ratio = 126 95 confidence interval CI = 110 144 decreased KCPs = 073 95 CI = 064 082 UCPs = 054 95 CI = 048 061 Shifts partner type profound immediately March 15 2020 whereas returning prerestriction level midMay 2020 proportion day PrEP use decreased 74 58 March 15 2020 P 0001 March 15 2020 PrEP use sex decreased UCPs beta = 036 95 CI = 072 000 SPs KCPs Condom use sex decreased KCPs beta = 036 95 CI = 067 004 UCPs beta = 024 95 CI = 046 003 SPs CONCLUSIONS MSM decreased sex casual partner increased sex SP change transient Decreases sex act casual partner paralleled decrease PrEP use However condom use sex casual partner decreased indicating importance continued sexual health service including sexually transmitted infection screening PrEP care COVID19 restriction,
Factors associated intention Syrian adult population accept COVID19 vaccination crosssectional study,34218807,BACKGROUND OBJECTIVES global effort develop deliver COVID19 vaccine rapidly vaccine hesitancy stand barrier effort aimed estimate proportion Syrian adult population intending vaccinated COVID19 principally ass demographic attitudinal factor associated order approach suitable solution METHODS anonymous online questionnaire conducted 23rd December 2020 5th January 2021 various province Syria total 3402 adult sampled reflect population demographic factor Attitudinal factor included Covid19 fear risk belief origin Vaccination hesitancy knowledge also measured intention get vaccinated COVID19 primary endpoint RESULTS According statement 1222 participant 3592 consent get vaccinated COVID19 finding indicate male gender younger age rural residence child smoking fear COVID19 individual perceived severity believing natural origin coronavirus high vaccination knowledge positive predictor embracing COVID19 vaccine available CONCLUSION COVID19 vaccine acceptance rate considerably poor across Syrian population compared population developed country Vaccine hesitancy closely bound fear side effect doubt vaccine efficacy Factors conspiracy belief myth vaccine lower vaccine uptake Thus interventional educational campaign increasingly required overcome misinformation avert low vaccination acceptance rate,covid-19;pandemic;syria;vaccine hesitancy
systematic review metaanalysis COVID19 kidney transplant recipient Lessons learned,34212499,Kidney transplant recipient KTR may increased risk adverse COVID19 outcome due prevalent comorbidities immunosuppressed status Given global difference COVID19 policy treatment robust assessment evidence necessary evaluate clinical course COVID19 KTR Studies mortality acute kidney injury AKI KTR World Health Organization COVID19 database systematically reviewed selected study published March 2020 January 18th 2021 including least five KTR COVID19 Randomeffects metaanalyses performed calculate overall proportion including 95 confidence interval 95 CI Subgroup analysis performed time submission geographical region sex age time transplantation comorbidities treatment included 74 study 5559 KTR COVID19 640 male mean age 582 year mean 73 month transplantation total risk mortality 23 95 CI 21 27 AKI 50 95 CI 44 56 high among KTR COVID19 regardless sex age comorbidities underlining call accelerate vaccination program KTR Given suboptimal reporting across identified study urge researcher consistently report anthropometrics kidney function baseline discharge change immunosuppressive therapy AKI renal outcome among KTR,clinical research/practice;complication: infectious;immunosuppressive regimens;infection and infectious agents - viral;infectious disease;kidney transplantation/nephrology;meta-analysis;translational research/science
comprehensive review therapeutic potential curcumin nanoformulations,34131980,Today due prevalence various disease novel coronavirus SARSCoV2 diabetes central nervous system disease cancer cardiovascular disorder extensive study conducted therapeutic property natural synthetic agent literature review herbal medicine commercial product global market showed curcumin Cur many therapeutic benefit compared natural ingredient Despite unique property Cur use clinical trial limited poor biopharmaceutical property Cur short halflife plasma low bioavailability poor absorption rapid metabolism low solubility acidic physiological pH chemical instability body fluid major concern associated clinical application Cur Recently nanoformulations emerging approach develop improve therapeutic efficacy various drug Many study shown Cur nanoformulations tremendous therapeutic potential various disease SARSCoV2 cancer inflammatory osteoporosis nanoformulations inhibit many disease several cellular molecular mechanism However successful longterm clinical result required confirm safety clinical efficacy present review aim update explain therapeutic potential Cur nanoformulations,curcumin;bioavailability;biological applications;commercial nanoproducts;nanoformulations;therapeutic mechanisms
Characterization Immune Responses SARSCoV2 Human Pathogenic Coronaviruses Using Multiplex BeadBased Immunoassay,34200301,Serological assay simultaneously detect antibody multiple target SARSCoV2 structurally related coronaviruses provide holistic picture antibody response pattern Wellvalidated multiplex immunoassay scarce evaluated performance 11plex serological assay capable detecting antibody directed four antigenic target SARSCoV2 S1 protein human pathogenic coronaviruses used 620 wellcharacterized serum n = 458 seropositive n = 110 seronegative SARSCoV2 preSARSCoV2 era n = 52 seronegative SARSCoV2 era SARSCoV2 positive negative standard calculated sensitivity specificity well positive negative predictive value including 95 confidence interval difference mean fluorescence intensity 95 CI used ass potential crossreaction antibody SARSCoV2 coronaviruses sensitivity 95 CI detecting antiSARSCoV2 antibody four antigenic target ranged 834 767867 937 910957 specificity 982 936998 100 967100 observed obvious crossreaction antiSARSCoV2 antibody antibody coronaviruses except SARSCoV1 high sensitivity specificity warrant reliable utilization assay populationbased seroprevalence survey vaccine efficacy study,bead-based immunoassay;cross-reaction;human coronaviruses;multiplex immunoassay
Protection K18hACE2 mouse ferret SARSCoV2 challenge singledose mucosal immunization parainfluenza virus 5based COVID19 vaccine,34215591,Transmissionblocking vaccine urgently needed reduce transmission SARSCoV 2 cause COVID19 pandemic upper respiratory tract initial site SARSCoV2 infection many individual remains primary site virus replication ideal COVID19 vaccine reduce upper respiratory tract virus replication block transmission well protect severe disease optimized vaccine candidate parainfluenza virus 5 PIV5 expressing SARSCoV2 protein CVXGA1 demonstrated singledose intranasal immunization CVXGA1 protects lethal infection K18hACE2 mouse severe disease model CVXGA1 immunization also prevented virus infection ferret blocked contact transmission mucosal vaccine strategy inhibited SARSCoV2 replication upper respiratory tract thus preventing disease progression lower respiratory tract PIV5based mucosal vaccine provides strategy induce protective innate cellular immune response reduce SARSCoV2 infection transmission population,
Role Laboratory Medicine SARSCoV2 Diagnostics Lessons Learned Pandemic,34356292,Since 2019 novel coronavirus outbreak began Wuhan China diagnostic method field molecular biology developing faster ever vigilant eye world s research community Unfortunately medical community prepared testing large volume range biological material whether blood sample antibody immunological testing salivaryswab sample realtime PCR reason many medical diagnostic laboratory made switch working field molecular biology research undertaken speed flow sample laboratory aim narrative review evaluate current literature laboratory technique diagnosis SARSCoV2 infection available pubmedgov Google Scholar according writer knowledge experience laboratory medicine ass available information field molecular biology comparing realtime PCR LAMP technique RNA sequencing immunological diagnostics examines newest technique along limitation use SARSCoV2 diagnostics,covid-19;lamp assay;sars-cov-2;real-time polymerase chain reaction
Changes ACE2 Expression Affect SARSCoV2 Virulence Related Complications Closer Look MembraneBound Soluble Forms,34201415,SARSCoV2 virus utilizes angiotensin converting enzyme ACE2 cell entry infection enzyme important function reninangiotensin aldosterone system preserve cardiovascular function addition heart expressed many tissue including lung intestine brain kidney however function organ mostly unknown ACE2 membranebound soluble form expression level altered disease state variety medication Currently clear altered ACE2 level influence ACE2 virulence relevant complication addition membranebound soluble form thought different effect work topic literature SARSCoV virus high genetic resemblance SARSCoV2 also us ACE2 enzyme enter cell much lower affinity recent study SARSCoV2 mainly clinical study aiming relating effect medication thought influence ACE2 level COVID19 outcome patient medication review paper aim summarize known relationship ACE2 level SARSCoVSARSCoV2 virulence altered ACE2 expression state,ace inhibitors;ace-2;ards;covid-19;raas;sars-cov;angiotensin receptor blockers;shedding
Overcoming COVID19 China despite shortcoming public health system learn,34228254,BACKGROUND OBJECTIVE COVID19 pandemic started Wuhan China December 2019 Although doubt reporting case death China seems country able control epidemic effectively many country paper would like analyze measure taken China compare country order find learn China METHODS develop system dynamic model COVID19 pandemic Wuhan Based number simulation analyze impact changing parameter contact rate development second wave RESULTS Although China s health care system seems poorly financed inefficient epidemic brought control comparably short period time second wave experienced Wuhan today measure contain epidemic differ implemented country China applied early rigorously instance consequent implementation health code contacttracking technology contributed contain disease effectively prevented second third wave CONCLUSIONS China s success fighting COVID19 based strict implementation set measure including digital management country discus relaxing lockdown rate 50 per 100000 inhabitant China started local lockdowns rate 3 per 100000 call public debate whether policy would feasible liberal country well,covid-19;contact-tracking technology;health care system;health codes;system dynamics model
betalink motif protein architecture,34342277,betalink composite protein motif consisting G1beta betabulge type II betaturn generally found end two adjacent strand antiparallel betasheet 12positions betabulge also 34positions betaturn result Nterminal portion polypeptide chain orientated right angle betasheet reported betalink frequently found certain protein fold SCOPe structural classification specific location connects betasheet another area protein found location connects one betasheet another betasandwich related structure small four five sixstranded betabarrels connects two betastrands polypeptide chain cross open end barrel found larger eightstranded betabarrels straightforward betameanders case initiate connection single betasheet alphahelix betalink also provides framework catalysis serine protease catalytic serine part conserved betalink cysteine protease including pro human SARSCoV2 two residue active site located conserved betalink,sars-cov-2 protease;serine proteases;beta-barrel;beta-bulge;beta-link;beta-sandwich;beta-turn
Fatal COVID19 Child Persistence SARSCoV2 Despite Extensive Multidisciplinary Treatment Case Report,34208887,Critical Coronavirus disease 2019 COVID19 developed 7yearold girl history dystrophy microcephaly central hypothyroidism Starting gastrointestinal symptom patient developed severe myocarditis followed progressive multiple organ failure complicated Pseudomonas aeruginosa bloodstream infection Intensive care treatment consisting invasive ventilation drainage pleural effusion high catecholamine therapy could prevent progression heart failure leading implantation venoarterial extracorporeal life support VAECLS additional left ventricle support catheter Impella R pump Continuous venovenous hemofiltration CVVH extracorporeal hemadsorption therapy CytoSorb R initiated Whole exome sequencing revealed mutation unknown significance DExHBOX helicase 30 DHX30 gene encoding RNA helicase COVID19 specific antiviral immunomodulatory treatment lead viral clearance control hyperinflammation resulting patient s death extracorporeal life support ECLS day 20 fatal case illustrates potential severity pediatric COVID19 suggests evaluation antiviral treatment strategy vaccination program child,dexh-box helicase 30 (dhx30);impella;children;coronavirus disease 2019 (covid-19);extracorporeal life support (ecls)
Mechanical Ventilation Extracorporeal Membrane Oxygenation Considerations COVID19,34283476,Coronavirus disease 2019 COVID19 led global pandemic nearly 158 million case worldwide 33 million death Due easy transmissibility high virulence caused overwhelming number infection leading nearcollapse healthcare infrastructure country review focus case Severe COVID19 requiring mechanical ventilation well advanced rescue therapy form extracorporeal membrane oxygenation ECMO,
Changepoint analysis INAR process application COVID19 data,34226773,article consider problem changepoint analysis count time series data integervalued autoregressive process order 1 INAR 1 timevarying covariates type feature observe many reallife scenario especially COVID19 data set number active case time start falling increase order capture feature use Poisson INAR 1 process timevarying smoothing covariate using model model component active case timepoint namely number nonrecovery case previous timepoint ii number new case timepoint t study theoretical property proposed model along forecasting simulation study performed study effectiveness proposed method Finally analyze two COVID19 data set compare proposed model another PINAR 1 process timevarying covariate changepoint demonstrate overall performance proposed model,active cases;covid-19;change-point;inar(1) process;poisson distribution;smoothing function;time-varying covariates
Significant Decrease Annual Cancer Diagnoses Spain COVID19 Pandemic RealData Study,34203185,COVID19 pandemic caused profound change health organization primary hospital care level crosssectional study aim investigate impact COVID19 pandemic annual rate new cancer diagnosis two universityaffiliated hospital study includes patient pathological diagnosis cancer attended two hospital Malaga Spain first year pandemic study population compared patient diagnosed previous year 2019 analyze whether possible difference annual rate diagnosis due pandemic cause patient diagnosed 2018 2017 also compared 2340 new cancer diagnosis compared 2825 patient 2019 represented decrease 172 p = 00001 Differences number cancer patient diagnosed 2018 2019 2840 new case 05 increase 2017 2019 2909 new case 3 increase statistically significant highest number patient lost diagnosis 2020 breast cancer 261 colorectal neoplasm 169 head neck tumor 198 study incidence rate throughout first year COVID19 pandemic show diagnosis new cancer patient significantly impaired Health system must take necessary measure restore prepandemic diagnostic procedure recover lost patient diagnosed,covid-19 pandemic;cancer diagnoses;real data
Assessment knowledge attitude practice towards COVID19 among paramedical staff Central India crosssectional online survey,34222534,BACKGROUND Knowledge disease influence paramedic s attitude practice incorrect attitude practice directly increase risk infection Understanding paramedic s knowledge attitude practice KAPs possible risk factor help predict outcome planned behavior ass KAP regarding COVID19 Google form among paramedical staff tertiary care teaching institute central India MATERIALS METHODS crosssectional multicentric questionnairebased study conducted May 2020 August 2020 among 230 paramedical staff two tertiary care teaching institute Google form Data analyzed Chisquare test parametric test using GraphPad prism software version 50 RESULTS participant knowledge symptomatology COVID19 However significantly participant nursing cadre know definition close contact mean knowledge score 484 + 06 mean score attitude 448 + 083 Overall 5478 paramedical staff follow correct prevention strategy significantly nursing staff correctly practice infection control measure upon arrival COVID19 patient P = 0033 significant difference among group regarding wearing appropriate personal protective equipment transportingaccompanying patient confirmed COVID 19 P = 0009 overall score practice 397 + 103 practice score significantly better nursing cadre compared nonnursing cadre P = 0038 CONCLUSION Majority participant good knowledge positive attitude Nursing cadre follows better preventive practice compared nonnursing cadre performing COVIDrelated duty Considering fact dodge responsible poor practice identified resolved India able conquest battle disease,covid-19;and practice;attitudes;knowledge;nursing staff;personal protective equipment
Associations Indoor Environmental Quality Infectious Diseases Knowledge Beliefs Practices Hotel Workers Wuhan China,34208312,Knowledge belief practice regarding infectious disease key element ensure practitioner health safety important carry survey hotel study aim determine level knowledge belief practice regarding infectious disease among practitioner association environmental quality hotel Wuhan China surveyed infectious disease knowledge belief practice practitioner 18 hotel detected hotel environment including physical factor temperature humidity noise indoor air quality benzene toluene xylene formaldehyde CO CO2 total count fungi aerobic plate count PM10 PM25 128 practitioner included 289 male questionnaire included knowledge belief practice regarding infectious disease study found moderate level knowledge belief good health practice People s belief toward COVID19 correlated significantly knowledge p 005 Beliefs health practice correlated significantly environmental quality p 005 However environmental quality correlated negatively classification hotel Conclusively despite good health practice practitioner knowledge belief toward infectious disease need strengthen Hotels emphasize health education practitioner improvement environmental hygiene Integrating three component comprehensive environmental promotion program warranted,beliefs;environmental quality;infectious diseases;knowledge;practices
COVID19 Causing Hypotension Frail Geriatric Hypertensive Patients,34207161,BACKGROUND association coronavirus disease 2019 COVID19 hypertension one frequently discussed topic current study since hypertension identified risk factor coronavirus disease However study seem focused BP blood pressure patient hypertension COVID19 REPORT report present case five frail geriatric patient avg age 783 +64 year sarcopenia controlled hypertension office BP 140 mmHg diagnosed SARSCoV2 FINDINGS Control ABPM performed COVID19 showed hypertensive patient hypotensive previously wellestablished therapy suddenly intensive CONCLUSIONS finding suggest BP control COVID19 needed ABPM particularly frail geriatric patient mean luxury necessity,covid-19;blood pressure;geriatric;hypertension;hypotension
Atlas der SARSCoV2RNAProteinInteraktionen infizierten Zellen,34219983,Using RNA antisense purification mass spectrometry identified 100 human protein directly specifically bind SARSCoV2 RNA infected cell gain insight function selected RNA interactors applied genetic perturbation pharmacological inhibition experiment mapped contact site viral RNA led identification host dependency factor defense strategy guide design novel therapeutic SARSCoV2,
COVID19 6 month hospital discharge pulmonary function impairment heterogeneity,34285908,6 month half COVID19 discharged subject present impaired respiratory function exertional dyspnoea mainly due reduced CO diffusion 34 followed pulmonary restriction 19 http bitly3vcnbdR,
Promising traditional Indian medicinal plant management novel Coronavirus disease systematic review,34132429,Traditional Indian medical practice Ayurveda Siddha Unani homeopathy vast reservoir knowledge medicinal plant promising pharmacological property plant paved way developing therapy novel Coronavirus CoV infection current review summarize published work literature effect traditional Indian medicinal plant acute respiratory infection COVID19 SARS Influenza Respiratory syncytial virus infection registered clinical trial traditional Indian herbal medicine COVID19 current study aim comprehensively evaluate data traditional Indian medicinal plant warrant use COVID19 management PubMed Embase Cochrane database searched along different clinical trial database total 22 relevant traditional Indian medicinal plant 35 relevant study included current study potential antiviral property virusinduced respiratory illness along promising immunomodulatory thrombolytic property 36 randomized nonrandomized registered clinical trial also included aimed evaluating efficacy herbal plant formulation COVID19 management antiviral immunomodulatory thrombolytic activity traditional Indian medicinal plant laid strong rationale use developing therapy SARSCoV2 infection study identified important potential traditional Indian medicinal herb Ocimum tenuiflorum Tinospora cordifolia Achyranthes bidentata Cinnamomum cassia Cydonia oblonga Embelin ribes Justicia adhatoda Momordica charantia Withania somnifera Zingiber officinale Camphor Kabusura kudineer could used therapeutic strategy SARSCoV2 infection,ayurvedic medicine;covid-19;sars virus;unani medicine;homeopathy;medicinal plants;respiratory syncytial virus infections
Kinetic characterisation inhibitor sensitivity Candida albicans Candida auris recombinant AOX expressed selfassembled proteoliposome system,34285303,Candidemia caused Candida spp serious threat hospital setting major cause acquired infection death possible contributor Covid19 mortality Candidemia incidence rising worldwide following increase fungicideresistant pathogen highlighting need effective antifungal agent novel mode action membranebound enzyme alternative oxidase AOX promotes fungicide resistance absent human making desirable therapeutic target However lipophilic nature AOX substrate ubiquinol10 hindered kinetic characterisation physiologicallyrelevant condition present purification expression recombinant AOXs C albicans C auris selfassembled proteoliposome PL system Kinetic parameter Km Vmax respect ubiquinol10 determined PL system also employed doseresponse assay novel AOX inhibitor information critical future development novel treatment Candidemia,
Targeting SARSCoV2 nonstructural protein 15 endoribonuclease silico perspective,34290822,newly emerged human coronavirus SARSCoV2 begun spread last year sparked worldwide study molecular docking utilized test previously approved drug SARSCoV2 nonstructural protein 15 Nsp15 screened 23 drug three saquinavir valrubicin aprepitant show paramount predicted binding affinity 91 96 92 kcalmol respectively SARSCoV2 Nsp15 Moreover saquinavir aprepitant make nonbonded interaction Leu201 active site cavity Nsp15 drug valrubicin interacts Arg199 Leu201 binding pattern may effective targeted protein leading Nsp15 blockage virus abolition Additionally pharmacological property screened drug known since approved different virus,covid-19;nsp15;sars-cov-2;endoribonuclease;molecular docking
Clinical Significance Micronutrient Supplementation Critically Ill COVID19 Patients Severe ARDS,34203015,interplay inflammation oxidative stress vicious circle potentially resulting organ damage Essential micronutrient selenium Se zinc Zn support antioxidative defense system commonly depleted severe disease singlecenter retrospective study investigated micronutrient level Se Zn supplementation critically ill patient COVID19 induced acute respiratory distress syndrome ARDS explored potential relationship immunological clinical parameter According intensive care unit ICU standard operating procedure patient received 10 mg intravenous Se daily top artificial nutrition contained various amount Se Zn Micronutrients inflammatory cytokine lymphocyte subset clinical data extracted patient data management system admission 10 14 day treatment Fortysix patient screened eligibility 22 patient included study Twentyone patient 95 suffered severe ARDS 14 patient 64 survived ICU discharge admission majority patient low Se status biomarkers Zn level along elevated inflammatory parameter Se supplementation significantly elevated Se p = 0027 selenoprotein P level SELENOP p = 0016 normal range Accordingly glutathione peroxidase 3 GPx3 activity increased time p = 0021 Se biomarkers notably SELENOP inversely correlated CRP r = 0495 PCT r = 0413 IL6 r = 0429 IL1beta r = 0440 IL10 r = 0461 Positive association found CD8 + cell r = 0636 NK cell r = 0772 total IgG r = 0493 PaO2FiO2 ratio r = 0504 addition survivor tended higher Se level 10 14 day compared nonsurvivors p = 0075 Sufficient Se Zn level may potentially clinical significance adequate immune response critically ill patient severe COVID19 ARDS,acute respiratory distress syndrome;critical care;nutrient supplementation;oxidative stress;selen;zinc
Interferongamma release assay testing ass COVID19 vaccination response SARSCoV2 seronegative patient rituximab case report,34216738,describe case 44yearold female Rituximab treatment multiple sclerosis undetectable SARSCoV2 IgG specific antibody eighteen day second dose SARSCoV2 vaccine Interferongamma release assay testing SARSCoV2 positive day nineteen demonstrating robust Tcell mediated response despite lack antibodymediated response,
Hemorrhagic stroke associated COVID19 infection Mexico General Hospital,34352870,INTRODUCCION en la actual pandemia de COVID19 existe evidencia creciente que ha identificado el neurotropismo del virus SARSCoV2 sus complicaciones neurologicas incluida la enfermedad cerebrovascular isquemica escasamente hemorragia cerebral HC OBJETIVO describir la caracteristicas clinicas radiologicas de laboratorio pronosticas de los pacientes con HC asociada al SARSCoV2 METODOS se incluyeron pacientes consecutivos con prueba de PCR confirmatoria para infeccion por SARSCoV2 HC RESULTADOS en un periodo de 90 dia en un centro de referencia COVID19 en Mexico de 1108 pacientes con infeccion por SARSCoV2 se encontraron 4 pacientes 036 con HC Tenian una edad de 71 +122 ano 2 eran mujeres Se encontro que do tenian factores de riesgo cardiovascular previos En do casos se encontro el origen en el nucleo dentado mientras que los otros do correspondieron al talamo Tres de los cuatro pacientes murieron Postulamos que el descontrol hipertensivo coagulopatia trombocitopenia la respuesta inmune inducida por el virus SARSCoV2 podrian desencadenar HC en un paciente con riesgo previo CONCLUSIONES la HC se asocia la infeccion por SARSCoV2 con mal pronostico cuando se presenta Los equipos de neurocirugia deben estar preparados para el tratamiento oportuno de estos pacientes INTRODUCTION current COVID19 pandemic growing body evidence identified neurotropism SARSCoV2 virus neurological complication including cerebrovascular disease focusing mainly ischemic scarcely hemorrhagic stroke HS OBJECTIVE objective study describe clinical radiological laboratory test prognostic characteristic patient SARSCoV2 associated HS METHODS Consecutive patient confirmatory PCR test SARSCoV2 infection HS demonstrated head CT included study RESULTS period 90 day COVID19 reference center Mexico total 1108 patient SARSCoV2 infection found 4 patient 036 meet criterion age 71 +122 year 2 woman found two prior cardiovascular risk factor Two HS originated dentate nucleus two corresponded thalamus Three four patient died suggest catastrophic uncontrolled blood pressure coagulopathy thrombocytopenia immune response induced SARSCoV2 could specific patient trigger HS CONCLUSIONS HS associated SARSCoV2 infection poor prognosis presented Neurosurgery team prepare timely appropriate treatment patient,covid-19;cerebrovascular disease;coagulopathy;coagulopatia;enfermedad cerebrovascular;hemorragia cerebral;hemorrhagic stroke;sars-cov-2;sars-cov-2 infection
Efficiency pooled surveillance testing academic lab detect inhibit COVID19 outbreak,34355577,Robust surveillance testing key strategic plan prevent COVID19 outbreak slow spread SARSCoV2 pandemic however limited resource facility time often impair implementation widespread surveillance effort mitigate resource limitation employed strategy pooling sample reducing reagent cost processing time utilizing academic faculty lab successful pooled surveillance testing conducted throughout Fall 2020 semester detect positive SARSCoV2 infection population 4400 student semester 25000 individual COVID status evaluation made pooling eight individual sample one quantitative reverse transcription polymerase chain reaction pooled surveillance strategy highly effective detecting infection significantly reduced financial burden cost 36 million,covid-19;pandemic policy;pooled surveillance;qrt-pcr diagnostics
COVID19 Diabetes,34379444,prevalence diabetes people coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus2 SARSCoV2 varied worldwide available evidence suggests significant increase severity mortality COVID19 people either type 1 T1DM type 2 diabetes mellitus T2DM especially association poor glycemic control newonset hyperglycemia newonset diabetes T1DM T2DM increasingly recognized context COVID19 associated worse outcome conclusive evidence yet suggests direct tropism SARSCoV2 beta cell pancreatic islet approved oral antidiabetic agent appear safe people T2DM COVID19 conclusive data yet available indicate mortality benefit class drug absence large randomized controlled trial Expected final online publication date Annual Review Medicine Volume 73 January 2022 Please see http wwwannualreviewsorgpagejournalpubdates revised estimate,
Identification Human SARSCoV2 Monoclonal Antibodies Convalescent Patients Using EBV Immortalization,34287229,report isolation two human IgG1k monoclonal antibody mAbs directed SARSCoV2 spike protein mAbs isolated two donor recovered COVID19 infection first pandemic peak Lombardy region Italy first European initially affected region March 2020 used method EBV immortalization purified memory B cell supernatant screening spike S12 assay mAb isolation method allowed rapid isolation clone one donor showing 7 clone positive spike protein whereas donor produce positive clone 91 tested RNA extracted positive clone 3947 day postEBV infection allowing VH VL sequencing clone sequenced 100 day culture showing mutation taken place vitro expansion B cell clone could expanded culture 4 month EBV immortalization secreted antibody stably time allowing purify mg quantity mAb functional assay without generating recombinant protein Unfortunately neither mAb significant neutralizing activity virus infection assay several different SARSCoV2 isolates antibody sequence made freely available,ebv;sars-cov-2;monoclonal antibody
Outbreak SARSCoV2 Lineage 20I501YV1 Nursing Home Underlines Crucial Role Vaccination Residents Staff,34199663,Elderly resident nursing home high risk lifethreatening COVID19related outcome report epidemiological serological investigation SARSCoV2 outbreak Italian nursing home described Among resident one 1920 regularly vaccinated SARSCoV2 midFebruary 2021 nonvaccinated staff member nursing home diagnosed SARSCoV2 infection Following outbreak investigation total 70 1420 resident aged 77100 year found positive phylogenetic analysis showed outbreak caused SARSCoV2 variant concern 20201201 socalled `` UK variant However one positive subject 1314 fully asymptomatic symptomatic patient vaccinated 86yearold female highly compromised health background deceased approximately two week later subsequent serological investigation showed deceased patient vaccinated subject develop antispike protein antibody response therefore likely vaccine nonresponder Although available mRNA SARSCoV2 vaccine able prevent several asymptomatic infection able avert symptomatic disease case caused SARSCoV2 variant concern 20201201 nursing home resident,covid-19;italy;sars-cov-2;elderly;nursing home;vaccination
Usability Telemedicine Physical Therapy Rehabilitation Systematic review,34287208,BACKGROUND term Telemedicine coined 1970s imply healing distance Physical therapy rehabilitation PTR focus reinstitution function bodily strength movement Covid19 created challenge oneonone PTR session due social distancing requires minimization nonessential physical contact outpatient service PTR staggered minimized increase adherence social distancing requirement flatten pandemic s curve Telemedicine applicable PTR several way including guided therapy session remote monitoring patient progress videoconferencing Telemedicine allows patient access PTR comfort home minimizes travel cost general strain body Although encumbered various challenge telemedicine could revolutionize delivery PTR also increasing access essential healthcare service OBJECTIVE Purpose Covering main aspect telemedicine usability physical therapy rehabilitation encourage using telemedicine physical therapy world region covered especially Middle East METHODS Method systematic search libgenis jmirorg wileycom sagepubcom scholargooglecom performed using search term Telemedicine asynchronous telemedicine synchronous telemedicine Covid19 rehabilitation medicine physical therapy rehabilitation videoconferencing Medicaid program telehealth HIPAA Papers published Oct 22nd 2020 English included RESULTS Telemedicine costeffective physical therapy Rehabilitation particularly pandemic like COVID19 also s time human resource saving especially handsoff skill rehabilitation CONCLUSIONS Telemedicine revolutionary aspect medicine seen unexpected uptake following Covid19 pandemic people formerly preferred live session PTR convenience telemedicine increasingly emerging various advantage including reduced cost implication reduced waiting time reduction nonessential travel obtain therapy increased preference telemedicine 9 recognizes importance Telemedicine conducted regional global survey analyze viability onset global lockdown due Covid19 APTA expressed need physiotherapist utilize telemedicine alternative efficient PTR delivery within bound social recommendation curveflattening Telemedicine PTR various advantage including cost reduction convenience access reduction long waiting list among others patient 10 PTR also availed area remote fullfledged PTR center utilization nurse aide social support system therapist effectively conduct therapy session videoconferencing Laws governing adoption use telemedicine PTR include HIPAA DPL regulate extent therapist collect use store data collected online therapy session Therapists need obtain verifiable consent patient commencement CLINICALTRIAL,
Overview Canada s Answer COVID19 Pandemic s First Wave JanuaryApril 2020,34281075,Canada federal state almost 38 million inhabitant distributed ten province three territory power regarding health case study describes health infrastructure situation COVID19 outbreak adaptation face expected case available epidemiologic data beginning first wave JanuaryApril 2020 public health economic measure taken control pandemic federal level breaking province territory Canadian health infrastructure offered average 129 intensive care unit bed per 100000 occupancy rate 90 outbreak unevenly distributed across province territory Canada implemented public health measure social distancing hospitalization death rate due pandemic still lower country province territory adapted implemented specific measure Cumulated case death substantially increased midMarch 2020 reaching 65 case 2 death per 100000 April 12 strong difference across province territory Canada affected COVID19 pandemic s first wave generally slower dynamic USA European Union period suggests implementation public health measure health indicator still low may efficient Canada yet longterm care sector faced many challenge province drove large part pandemic indicator,covid-19;canada;capacity building;health system;impact;interventions
Antibody response SARSCoV2 vaccine 45965 adult general population United Kingdom,34290390,report cohort 45965 adult receiving either ChAdOx1 BNT162b2 SARSCoV2 vaccine prior infection SARSCoV2 seroconversion rate quantitative antibody level single dose lower older individual especially aged 60 year Two vaccine dos achieved high response across age Antibody level increased slowly lower level single dose ChAdOx1 compared single dose BNT162b2 waned following single dose BNT162b2 older individual descriptive latent class model identified four responder subgroup including low responder group commonly consisted people aged 75 year male individual longterm health condition Given finding propose available vaccine prioritized previously infected second dos prioritized individual aged 60 year data needed better understand extent quantitative antibody response associated vaccinemediated protection,
Abnormal Liver Biochemistry Tests Acute Liver Injury COVID19 Patients Current Evidence Potential Pathogenesis,34287285,Globally million person contracted coronavirus disease 2019 COVID19 past several month resulting significant mortality Health care system negatively impacted including care individual cancer chronic disease chronic active hepatitis cirrhosis hepatocellular carcinoma various probable pathogenic mechanism presented account liver injury COVID19 patient hepatotoxicity cause therapeutic drug severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection bile duct cell hepatocytes hypoxia systemic inflammatory response Liver biochemistry test aspartate aminotransferase AST alanine aminotransferase ALT gammaglutamyl transferase GGT alkaline phosphatase ALP deranged COVID19 patient liver injury Hepatocellular damage result elevation serum AST ALT level early onset disease cholestatic pattern develops disease progress cause higher level ALP GGT direct total bilirubin liver biochemistry test prognostic marker disease severity carefully monitored COVID19 patient conducted systematic review abnormal liver biochemistry test COVID19 possible pathogenesis involved Significant finding regarding severity hepatocellular pattern incidence related clinical outcome COVID19 patient highlighted,acute;biochemistry;coronavirus;disease;function;infection;injury;liver;mortality;severity;tests
Mutations SARSCoV2 ORF8 Altered Bonding Network Interferon Regulatory Factor 3 Evade Host Immune System,34335535,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 continuously mutating since first emergence early 2020 alteration led virus gain significant difference infectivity pathogenicity host immune evasion previously found openreading frame 8 ORF8 SARSCoV2 inhibit interferon production decreasing nuclear translocation interferon regulatory factor 3 IRF3 Since several mutation ORF8 observed therefore present study adapted structural biophysical analysis approach explore impact various mutation ORF8 S24L L84S V62L W45L recently circulating mutant Pakistan ability bind IRF3 evade host immune system found mutation ORF8 could affect binding efficiency IRF3 based molecular docking analysis supported molecular dynamic simulation Among reported mutation W45L found bind stringently IRF3 analysis revealed mutation ORF8 may help virus evade immune system changing binding affinity IRF3,irf3;md simulation;orf8 mutants;sars-cov-2;protein-protein docking
Foodtradeassociated COVID19 outbreak contaminated wholesale food supermarket Beijing,34222840,reemerging outbreak COVID19 Beijing China summer 2020 originated SARSCoV2infested wholesale food supermarket postulated Xinfadi market outbreak link foodtrade activity Susceptible disease Infectious Recovered coupled Agent Based Modelling SIRABM analysis studying diffusion SARSCoV2 particle suggested tradedistancing strategy effectively reduces reproduction number R0 retail shop closure strategy reduced number visitor market nearly half addition buylocal policy option reduced infection 70 total Therefore retail closure buylocal policy could serve significantly effective strategy potential reduce size outbreak prevent probable outbreak future,agent based modelling;covid-19 outbreak;control measures;food distribution network;transmission mechanism
Evolving ribonucleocapsid assemblypackaging signal genome human animal coronaviruses targeting transmission evolution,34338591,worldwide COVID19 pandemic intensified strongly study molecular mechanism related coronaviruses origin coronaviruses risk humantohuman animaltohuman humantoanimal transmission coronaviral infection understood broader evolutionary level detailed comparative study paper studied ribonucleocapsid assemblypackaging signal RNAPS genome seven known pathogenic human coronaviruses SARSCoV SARSCoV2 MERSCoV HCoVOC43 HCoVHKU1 HCoV229E HCoVNL63 compared RNAPS genome related animal coronaviruses including SARSBatCoV MERSCamelCoV MHV BatCoV MOP1 TGEV one camel alphacoronaviruses RNAPS genome coronaviruses evolved due weakly specific interaction genomic RNA N protein helical nucleocapsids Combining transitional genome mapping Jaccard correlation coefficient allows u perform analysis directly term underlying motif distributed genome coronaviruses RNAPS distributed quasiperiodically genome period 54 nt biased 57 nt 51 nt genome longer shorter SARSCoV respectively comparison experimentally verified packaging signal MERSCoV MHV TGEV proved distribution particular motif strongly correlated packaging signal also found many motif highly conserved character positioning genome throughout lineage make promising therapeutic target mechanism encapsidation affect recombination coinfection wellCommunicated Ramaswamy H Sarma,covid-19;genome packaging;helical nucleocapsid;human and animal coronaviruses;packaging signals
COVID19 Vaccine Delivery System Drug Repurposing Application Molecular Modeling Approach,34366663,acute respiratory syndrome coronavirus SARSCoV2 spread across world resulting pandemic COVID19 human zoonotic disease caused novel coronavirus CoV strain thought originated wild captive bat initial COVID outbreak region global COVID19 outbreak started Guangdong Province China s southernmost province global response COVID19 pandemic hampered sheer number infected people many need intensive care succumbing disease epidemic handled combination disease control public health intervention compassionate treatment impacted clear antiCOVID19 medication available time However need find medication turn tide led development number investigational drug potential candidate improving outcome especially severely critically ill Although many adjunctive medication still studied clinical trial professional organization attempted define circumstance use deemed offlabel compassionate important remind reader new information COVID19 s clinical feature treatment option outcome released regular basis mainstay treatment remains optimized supportive care therapeutic effectiveness subsequent agent still studied,covid-19;drug repurposing;molecular modeling;nanoparticles;vaccine
Immunological predictor disease severity patient COVID19,34216735,BACKGROUND Identifying immune cell involved coronavirus disease 2019 COVID19 disease progression predictor poor outcome important manage patient adequately METHODS prospective observational cohort study enrolled 48 patient COVID19 hospitalized tertiary hospital Oman 53 nonhospitalized patient confirmed mild COVID19 RESULTS Hospitalized patient older 58 year v 36 year P 0001 comorbid condition diabetes 65 v 21 P 0001 Hospitalized patient significantly higher inflammatory marker P 0001 Creactive protein 114 v 4 mgl interleukin 6 IL6 33 v 371 pgml lactate dehydrogenase 417 v 214 Ul ferritin 760 v 196 ngml fibrinogen 6 v 3 gl Ddimer 10 v 03 mugml disseminated intravascular coagulopathy score 2 v 0 neutrophillymphocyte ratio 4 v 11 P 0001 multivariate regression analysis statistically significant independent early predictor intensive care unit admission death higher level IL6 odds ratio 103 P = 003 frequency large inflammatory monocyte CD14+CD16+ odds ratio 1117 P = 0010 frequency circulating naive CD4+ cell CD27+CD28+CD45RA+CCR7+ odds ratio 0476 P = 003 CONCLUSION IL6 frequency large inflammatory monocyte frequency circulating naive CD4 cell used independent immunological predictor poor outcome COVID19 patient prioritize critical care resource,covid-19;immunological predictors;inflammatory markers;lymphocyte subsets;mortality predictors
Antiphospholipid Antibodies Infection Non Nova Sed Nove,34220842,clinical significance antiphospholipid antibody aPL context infection attracted attention since first discovery patient syphilis fact recognition aPL patient infection described parallel understating syndrome Since first description aPLpositive test three patient COVID19 diagnosed January 2020 Wuhan China large number study took part ongoing debate SARS2Cov 2 induced coagulopathy many following report speculated potential role aPL order get insight effective role detectable aPL prothrombotic status observed COVID19 patient performed observational agesex controlled study compare aPL profile hospitalized patient COVID observed patient thrombotic APS b patient culturalserologicallyproved infection data showed positive aPL testing half patient 53 COVID19 patient viralbacterial infection 49 However aPL profile different comparing patient overt APS patient aPL detected contest infection Caution therefore required interpretation generalization role aPL management patient COVID19 introducing aPL testing part routine testing patient COVID19 larger welldesigned clinical study required prothrombotic status patient COVID19 unquestionable different mechanism aPL investigated,covid-19;antiphospholipid antibodies;antiphospholipid antibody syndrome;infection;thrombosis
Investigation plasma exchange hemoperfusion effect complication treatment patient severe COVID19 SARSCoV2 disease systematic scoping review,34228355,previous study suggested plasma exchange PE hemoperfusion HP played cardinal role treatment severe coronavirus disease 2019 COVID19 case diminishing cytokine storm study aimed ass effect PE HP cytokine storm patient severe COVID19 systematic scoping review Four Electronic database Medline accessed PubMed Scopus Science Direct Cochrane library searched systematically February 2 2021 using MESH term related keywords English language Considering title abstract unrelated study excluded full text remained study evaluated author independently finding assessed reported total 755 article obtained within first step searching 518 remained removing duplication title abstract screening 438 removed rest 59 paper excluded Finally reading full text remained article 21 included data extraction previously reported evidence case report case series Findings summarized two category first category encompassed nine study regarding HP continuous renal replacement therapy second category included twelve study PE result revealed HP PE within cytokine storm phase would beneficial high probability treatment severely ill COVID19 patient Highlights study showed plasma exchange PE hemoperfusion HP played important role treatment patient severe COVID19 disease result systematic scoping review revealed HP PE within cytokine storm phase would beneficial high probability treatment severely ill COVID19 patient,covid-19;coronavirus;hemoperfusion;plasma exchange;plasmapheresis;renal replacement therapy
ADME Pharmacokinetic Properties Remdesivir Drug Interaction Potential,34358081,11 March 2020 World Health Organization classified Coronavirus Disease 2019 COVID19 global pandemic tested healthcare system administration treatment ingenuity across world COVID19 caused novel beta coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 Since inception pandemic treatment option either limited ineffective Remdesivir drug originally designed used Ebola virus antiviral activity SARSCoV2 included COVID19 treatment regimen Remdesivir adenosine nucleotide analog prodrug metabolically activated nucleoside triphosphate metabolite GS443902 active nucleoside triphosphate metabolite incorporated SARSCoV2 RNA viral chain preventing replication lack reported drug development characterization study remdesivir public domain created void information absorption distribution metabolism elimination ADME property pharmacokinetics PK drugdrug interaction DDI limited understanding property clinician prevent subtherapeutic supratherapeutic level remdesivir thus avoid complication COVID19 patient Remdesivir metabolized cytochrome P450 CYP nonCYP enzyme carboxylesterases narrative review evaluated currently available ADME PK DDI information remdesivir discussed potential DDIs remdesivir different COVID19 drug regimen agent used comorbidities Considering nascent status remdesivir therapeutic domain extensive future work needed formulate safer COVID19 treatment guideline involving medication,adme;covid-19;cytochrome p450;drug interaction;pharmacokinetics;remdesivir;transporter
Isolated Acute Cerebrovascular Involvement COVID19 without Fever Respiratory Symptoms Indian Perspective,34227776,Background Stroke COVID19 reported critically ill patient globally Stroke singular manifestation COVID19 absence typical symptom fever cough dyspnea under recognized Objective Comparative study clinical laboratory parameter COVID19 stroke patient without typical symptom onset stroke case without COVID19 infection Methods 28consecutive stroke patient eight coronavirus infection twenty without COVID19 admitted neurology department tertiary care centre North West India 20 June2020 19 July2020 enrolled retrospective study Results COVID19 patient higher frequency seizure 4 50 v 2 10 p= 003 altered mental status 6 75 v 6 30 p= 004 Severity ischemic stroke NIHSS 20 3 75 v 2 18 mortality p=004 despite comparable vascular risk factor stroke two group higher COVID19 patient Three four COVID19 young stroke died Two female COVID19 develop typical symptom six male 75 developed fever dyspnea mean delay 27 day Standard deviation 17 stroke onset six patient developed fever subsequently expired Inflammatory marker neutrophil lymphocyte ratio p 0001and ESR p 0001 transaminase p=0038 creatinine p=0009 significantly elevated COVID19 patient Conclusion Isolated cerebrovascular involvement presentation COVID19Stroke severity mortality higher COVID19 young stroke exemption Development fever associated clinical worsening COVID19 pandemic far India atypical presentation need recognized early warrant stringent diagnostic protocol,
Feasibility Social Distancing Practices US Schools Reduce Influenza Transmission Pandemic,32437117,BACKGROUND Schools socially dense environment schoolbased outbreak often predate fuel communitywide transmission seasonal pandemic influenza preemptive school closure effectively reduce influenza transmission disruptive currently recommended pandemic assessed feasibility implementing social distancing practice K12 school first step seeking alternative preemptive school closure METHODS conducted 36 focus group education public health official across United States identified characterized theme compared feasibility practice primary versus secondary school region United States RESULTS Participants discussed 29 school practice 25 withinschool practice implemented part school day 4 reducedschedule practice impact school hour Participants reported elementary school commonly implement several withinschool practice part routine operation homeroom stay restriction hall movement staggering recess time routine implementation limited use individualized schedule within elementary school withinschool practice generally felt feasible elementary school secondary school reducedschedule practice shortening school week school day considered feasible however reducedschedule practice generally perceived le feasible withinschool practice grade level CONCLUSIONS finding suggest school many option increase social distance closing Future research evaluate seemingly feasible practice effective reducing influenza transmission school surrounding community,
3 Tth Endonuclease Cleavage Polymerase Chain Reaction 3TECPCR Technology SingleBaseSpecific Multiplex Pathogen Detection using TwoOligonucleotide System,34199760,Polymerase chain reaction PCR standard nucleic acid amplification technology infectious disease pathogen detection primary diagnostic tool employed global COVID19 pandemic Various PCR technology adaptation typically using twooligonucleotide dyebinding method threeoligonucleotide hydrolysis probe system enable realtime multiplex target detection singlebase specificity identification singlenucleotide polymorphism SNPs small number twooligonucleotide PCR system facilitating multiplex detection SNP identification reported however method often limitation term target specificity production variable falsepositive result requirement extensive optimisation postamplification analysis study introduces 3 Tth endonuclease cleavage PCR 3TECPCR twooligonucleotide PCR system incorporating modified primerprobe thermostable cleavage enzyme Tth endonuclease IV realtime multiplex detection SNP identification Complete analytical specificity low limit detection singlebase specificity simultaneous multiple target detection demonstrated study using 3TECPCR identify bacterial meningitis associated pathogen first report twooligonucleotide realtime multiplex PCR technology singlebase specificity using Tth endonuclease IV,bacterial meningitis;multiplex detection;nucleic acid diagnostics;polymerase chain reaction;single-nucleotide polymorphism
Could New COVID19 Mutant Strain Undermine Vaccination Efforts Mathematical Modelling Approach Estimating Spread B117 Using Ontario Canada Case Study,34204918,Infections represent highly dynamic process characterized evolutionary change event involve pathogen host Among infectious agent virus Severe Acute Respiratory Syndromerelated Coronavirus type 2 SARSCoV2 infectious agent responsible currently ongoing Coronavirus disease 2019 COVID2019 pandemic particularly high mutation rate Taking account mutational landscape infectious agent important shed light evolution capability time new infectious strain COVID19 emerge around world imperative estimate new strain may overtake wildtype strain different population Therefore developed generalpurpose framework estimate time mutant variant able take wildtype strain emerging infectious disease outbreak study used COVID19 casestudy however model adaptable emerging pathogen devised twostrain mathematical framework model wild mutanttype viral population fit cumulative case data parameterize model using Ontario case study found context underreporting current case level variant strain unlikely dominate MarchApril 2021 current nonpharmaceutical intervention Ontario need kept place longer even vaccination order prevent another outbreak spread variant strain Ontario likely observed widened peak daily reported case vaccine efficacy maintained across strain still possible achieve high level immunity population end 2021 finding important practical implication term public health policy decisionmakers equipped mathematical tool enable estimation takeover mutant strain emerging infectious disease,covid-19 pandemic;emerging infectious diseases;mathematical model;mutant strains
COVID19 Vaccine Priority Strategy Using Heterogenous Transmission Model Based Maximum Likelihood Estimation Republic Korea,34203821,1 Background vaccine supply likely limited 2021 due constraint manufacturing maximize benefit rollout phase optimal strategy vaccine allocation necessary based country s epidemic status 2 Methods first developed heterogeneous population model considering transmission matrix using maximum likelihood estimation based epidemiological record individual COVID19 case Republic Korea Using model vaccine priority minimizing mortality incidence investigated 3 Results simulation result showed optimal vaccine allocation strategy minimize mortality incidence prioritize elderly healthcare worker adult long reproductive number 12 09 4 Conclusion simulation result support current Korean government vaccination priority strategy prioritizes healthcare worker senior group minimize mortality condition reproductive number remains 12 study revealed order maintain current vaccine priority policy important ensure reproductive number exceed threshold concurrently implementing nonpharmaceutical intervention,covid-19;healthcare worker;mathematical modeling;maximum likelihood estimation;reproductive number;vaccine priority
Eprescribing access prescription medicine lockdown experience patient AotearoaNew Zealand,34210271,BACKGROUND Health service internationally compelled change method service delivery response global COVID19 pandemic mitigate spread infection amongst health professional patient AotearoaNew Zealand widespread electronic delivery prescription eprescribing enabled aim research explore patient experience lockdown change prescribing interface general practice community pharmacy affected access prescription medication METHOD research employed mixedmethod approach included online survey n = 1010 indepth interview subset survey respondent n = 38 first COVID19 lockdown MarchMay 2020 Respondents recruited snowballing approach starting social medium email list contact research team keeping approach descriptive statistic survey data thematic analysis qualitative interview openended question survey data combined RESULTS respondent received prescription lockdown sent directly pharmacy people picked medication pharmacy home delivery medication rare 4 Survey interview respondent wanted eprescribing continue postlockdown described thing worked well encountered delay process acquiring prescription medication CONCLUSIONS Eprescribing potential improve access prescription medication convenient patient increase eprescribing lockdown highlighted system could improved better feedback error consistency across practice pharmacy proactive communication patient equitable prescribing cost,community pharmacies;coronavirus;general practice;lockdown;pandemics;prescriptions;primary health care
Intranasal Vaccination Strategy Control COVID19 Pandemic Veterinary Medicine Perspective,34202429,world currently facing ongoing coronavirus disease 2019 COVID19 pandemic disease highly contagious respiratory disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 Current control measure used many country include social distancing wearing face mask frequent hand washing selfisolation vaccination current commercially available vaccine injectable vaccine although intranasal vaccine trial stage reported side effect COVID19 vaccine perception towards safety vaccine frequent mutation virus may lead poor herd immunity veterinary medicine attaining herd immunity one main consideration disease control herd immunity depends use efficacious vaccine vaccination coverage population Hence many aerosol intranasal vaccine developed control veterinary respiratory disease Newcastle disease rinderpest infectious bronchitis haemorrhagic septicaemia Different vaccine technology could employed improve vaccination coverage including usage intranasal live recombinant vaccine live mutant vaccine paper discus potential use intranasal vaccination strategy human COVID19 based veterinary intranasal vaccine strategy,covid-19;coronavirus;intranasal;pandemic;vaccine
Laryngotracheal aspiration test reduce false negative rate patient suspected SARSCOV2 pneumonia despite negative nasopharyngeal swab,34210553,BACKGROUND emergency department ED definitive diagnosis SARSCOV2 pneumonia challenging nasopharyngeal swab NPS give false negative result Strategies reduce false negative rate NPS limitation Serial NPSs 2448 h one another timeconsuming sputum collected majority patient bronchoalveolar lavage BAL sensitive test requires specific expertise Laryngotracheal aspiration LTA easy perform showed similar accuracy BAL diagnosis pulmonary disease however studied diagnose SARSCOV2 pneumonia OBJECTIVE observational crosssectional study performed evaluate negative predictive value LTA patient suspected SARSCOV2 pneumonia despite negative NPS METHODS EDs two university hospital consecutive patient suspected SARSCOV2 pneumonia despite negative NPS underwent LTA performed nasotracheal tube connected vacuum system Final diagnosis based respiratory specimen test NPS LTA BAL hospital data established two reviewer case discordance third reviewer RESULTS 117 patient enrolled LTA feasible patient patient experienced adverse event Fifteen 127 patient diagnosed communityacquired SARSCOV2 pneumonia 13 LTA positive 2 17 LTA negative negative predictive value NPS LTA 873 799 927 981 933 998 respectively CONCLUSIONS LTA resulted feasible safe reduced false negative rate patient suspected SARSCOV2 pneumonia despite negative NPS,bronchoalveolar lavage;covid-19;diagnosis;emergency department;laryngotracheal aspiration;pharyngeal swab;sars-cov-2
Antibiotic prescribing pattern patient hospitalized COVID19 lesson first wave,34223144,Background high proportion hospitalized patient COVID19 receive antibiotic despite evidence show low level true bacterial coinfection Methods retrospective cohort study examining antibiotic prescribing pattern 300 patient sequentially diagnosed COVID19 Patients grouped 3 subcohorts Group 1 received antibiotic Group 2 received antibiotic microbiologically confirmed infection Group 3 empirically treated antibiotic pneumonia primary aim identify factor influenced prescription continuation antibiotic Group 3 Secondary aim examine difference outcome group Results total 292 patient included 63 Group 1 35 Group 2 194 Group 3 median age 60 year IQR 4476 majority ethnically Irish 62 median duration antibiotic 7 day IQR 510 Group 3 factor associated prescription IV antibiotic admission raised Creactive protein CRP P = 0024 increased age P = 0023 higher quick SOFA P = 0016 score fever 375 degree C P = 0011 Factors associated duration antibiotic course duration hypoxia P 0001 maximum respiratory support requirement P = 0013 Twentyone patient Group 3 one antibiotic escalation event n = 139 escalation deescalation therapy Conclusions Duration hypoxia need respiratory support may acted surrogate measure improvement usual response measure CRP neutrophilia culture clearance absent Continuous review antibiotic prescription forefront clinical management hospitalized patient COVID19,
Evaluation SARSCoV2 Spike Protein Antibody Titers Cord Blood COVID19 Vaccination Pregnancy Polish Healthcare Workers Preliminary Results,34205434,BACKGROUND coronavirus disease 2019 COVID19 pandemic given rise need develop vaccine quickly possible pregnant woman increased risk contracting severe COVID19 higher mortality essential ass safety vaccine administered pregnancy METHODS aim study determine titer specific maternal cord antibody severe acute respiratory syndrome coronavirus 2 protein antenatal vaccination secondary objective evaluate ratio umbilical cord maternal antibody titer Patients included study enrolled undergoing voluntary vaccination COVID19 pregnancy different week gestation patient analyzed initial study vaccinated BNT162b2 mRNA COVID19 vaccine RESULTS result current study document high antiS total IgG antibody titer cord serum birth motherinfant pair analyzed mean umbilical cord blood sample IgG antibody titer antiS protein 102651 UmL +SD 76925 mean cordtomaternal antiS IgG antibody ratio 128 +SD 0798 significant positive correlation observed week gestation first dose administered week gestation second dose administered respective cordtomaternal ratio r = 048 p = 00029 first dose r = 039 p = 00102 second dose CONCLUSIONS date despite prevalence COVID19 vaccination lack conclusive evidence supporting safety efficacy vaccination pregnant woman Therefore result present complementary study suggests maternal immunization may provide neonatal protection transplacental transfer antibody particular importance demonstration antibody transfer correlated time vaccination delivery may allow future determination optimal timing COVID19 vaccination pregnant woman,covid-19;pregnancy;vaccine
Understanding principle noninvasive positive pressure ventilation,34219428,Noninvasive positive pressure ventilation NPPV provides respiratory support patient without need invasive intubation Although used several year critical care NPPV come prominence management option certain patient respiratory complication coronavirus disease 2019 COVID19 led increased care provision nurse little experience expertise critical care NPPV article provides overview principle NPPV use type 1 type 2 respiratory failure explains pathophysiology several condition often lead respiratory failure NPPV mitigate respiratory failure improve gas exchange individualised assessment patient s suitability NPPV evaluation effectiveness therapy crucial ensure safe effective use Nurses also important role providing explanation support patient,covid-19;cardiorespiratory;coronavirus;critical care;high dependency care;intensive care;mechanical ventilation;non-invasive ventilation;respiratory;ventilation
Maternal mortality COVID19 pandemic Mexico preliminary analysis first year,34215243,BACKGROUND Mexico COVID19 pandemic led preventative measure confinement social interaction limitation paradoxically may aggravated healthcare access disparity pregnant woman accentuated health system weakness addressing highrisk patient pregnancy objective estimate maternal mortality ratio 1 year analyze clinical course pregnant woman hospitalized due acute respiratory distress syndrome COVID19 METHODS retrospective surveillance study national maternal mortality performed February 2020February 2021 Mexico related COVID19 case pregnant woman including outcome Comparisons made patient died survived identify prognostic factor underlying health condition distribution RESULTS Maternal Mortality Ratio increased 568 studied period confirmed COVID19 cause 2293 case Additionally unconfirmed case represented 45 maternal death Among hospitalized pregnant woman Acute Respiratory Distress Syndrome consistent COVID19 smoking cardiovascular disease common among patient faced fatal outcome also common age group 19 38 addition pneumonia associated asthma immune impairment diabetes increased BMI increased odds death Odds Ratio 230 170 respectively CONCLUSIONS Maternal Mortality Ratio Mexico increased 60 1 year pandemic COVID19 linked 254 maternal death studied period Lethality among pregnant woman diagnosis COVID19 28 asthma immune impairment increased propensity developing pneumonia obesity diabetes increased odds inhospital death Measures needed improve access coordinated wellorganized healthcare reduce maternal death related COVID19 pandemic collateral effect,covid-19;maternal mortality;mexico;pandemics
Limited neutralization authentic SARSCoV2 variant carrying E484K vitro,34223909,Whether monoclonal antibody able neutralise SARSCoV2 variant concern investigated using pseudoviruses study show bamlanivimab casirivimab imdevimab efficiently neutralise authentic SARSCoV2 including variant B117 Alpha variant B1351 Beta P2 Zeta resistant bamlanivimab partially casirivimab,sars-cov-2;bamlanivimab;casirivimab;corona virus;imdevinab;monoclonal antibodies
virological impact SARSCoV2 D614G mutation,34289053,coronavirus disease 2019 COVID19 caused infection severe acute respiratory syndrome coronavirus 2 SARSCoV2 emerged December 2019 caused 140 million infection worldwide end April 2021 enveloped singlestranded positivesense RNA virus SARSCoV2 underwent constant evolution produced novel variant carrying mutation conferring fitness advantage current prevalent D614G variant glycine substituted aspartic acid position 614 spike glycoprotein protein one variant became main circulating strain worldwide short period time past year intensive study world defined epidemiological characteristic highly contagious variant revealed underlying mechanism review aim presenting overall picture impact D614G mutation virus transmission elucidating underlying mechanism D614G virus pathogenicity providing insight development effective therapeutic,covid-19;d614g;sars-cov-2;infectivity;virus mutation
Investigation Efficiency Mask Wearing Contact Tracing Case Isolation COVID19 Outbreak,34201860,Case isolation contact tracing two essential part control measure prevent spread COVID19 however additional intervention mask wearing required Taiwan successfully contained local COVID19 transmission initial imported case country early 2020 applying abovementioned intervention order explain containment disease spread Taiwan understand efficiency different nonpharmaceutical intervention mathematical model developed stochastic model implemented order estimate effectiveness mask wearing together case isolation contact tracing investigated different approach towards mask usage estimated effect intervention basic reproduction number R0 simulated possibility controlling outbreak assumption nonmedical medical mask 20 50 efficiency respectively case isolation work 100 70 people wear medical mask R0 = 25 almost 80 probability outbreak control 60 contact tracing whereas nonmedical mask highest probability 20 large proportion infectiousness onset symptom 40 presence asymptomatic case investigated intervention isolation case contact tracing mask wearing people implemented high level help control disease spread Superspreading event also included model order estimate impact outbreak understand restriction gathering social distancing help control outbreak obtained quantitative result agreement empirical COVID19 data Taiwan,covid-19;case isolation;contact tracing;mask wearing;non-pharmaceutical interventions;outbreak control
SwabExpress endtoend protocol extractionfree covid19 testing,34286830,BACKGROUND urgent need massively scaled clinical testing SARSCoV2 along global shortage critical reagent supply necessitated development streamlined laboratory testing protocol Conventional nucleic acid testing SARSCoV2 involves collection clinical specimen nasopharyngeal swab transport medium nucleic acid extraction quantitative reverse transcription PCR RTqPCR 1 testing scaled across world global supply chain buckled rendering testing reagent material scarce 2 address shortage developed SwabExpress endtoend protocol developed employ mass produced anterior naris swab bypass requirement transport medium nucleic acid extraction METHODS evaluated anterior naris swab transported dry eluted lowTE buffer directtoRTqPCR alternative extractiondependent viral transport medium validated protocol using heat treatment viral inactivation added proteinase K digestion step reduce amplification interference tested protocol across archived prospectively collected swab specimen finetune test performance RESULTS optimization SwabExpress low limit detection 24 moleculesuL 100 sensitivity 994 specificity compared sidebyside traditional RTqPCR protocol employing extraction realworld specimen SwabExpress outperforms automated extraction system simultaneously reducing cost handson time CONCLUSION SwabExpress simplified workflow facilitates scaled testing COVID19 without sacrificing test performance may serve template simplification PCRbased clinical laboratory test particularly time critical shortage pandemic,
Evaluation Hand Hygiene Behaviour Compliance General Public Using Public Restrooms Northern Ireland NI Initial Weeks Novel Coronavirus COVID19 Pandemic,34204779,BACKGROUND ongoing novel coronavirus COVID19 global pandemic resulted significant level morbidity mortality worldwide particularly among elderly immunosuppressed group Although adequate hand hygiene HH behaviour compliance widely accepted effective selfprotective measure preventing spread disease like COVID19 previous research suggests normal hand hygiene compliance poor generally improves disease pandemic research aimed evaluate hand hygiene behaviour compliance general public initial week COVID19 pandemic Northern Ireland NI METHODS crosssectional study involved use infraredimaging camera observe hand hygiene behaviour compliance general public using one set male female public restroom RESULTS finding study indicated level hand hygiene compliance general public poor initial week 8293 overall washing hand adequately CONCLUSIONS Inadequate HH behaviour compliance may added significantly rapid rate spread COVID19 initial week pandemic NI Current public health campaign appear based study desired impact may need reviewed reenforced order achieve level hand hygiene compliance required slow spread COVID19 communicable disease future,covid-19;behaviour;compliance;general public;hand hygiene;observation
Physical recovery COVID19 pneumosepsis ICU survivor compared nonCOVID pneumosepsis ICU survivor postICU hospitalization RECOVID retrospective cohort study,34343362,BACKGROUND Coronavirus Disease 2019 COVID19 pneumosepsis survivor high risk developing ICU acquired weakness ICUAW due high incidence acute respiratory distress syndrome common need prolonged invasive ventilation remains unknown regular postpneumosepsis physical rehabilitation strategy suitable extraordinary patient category METHODS retrospectively compared physical recovery COVID19 nonCOVID pneumosepsis ICU survivor ICU hospital discharge defined difference performance Medical Research Council SumScore MRCSS Chelsea Critical Care Physical Assessment tool CPAx percentage predicted handgrip strength POPHGS ANCOVA model built using age sex Barthelindex BMI admission APACHEII score adequacy protein delivery ICU stay ward length stay covariates RESULTS 35 COVID19 ICU patient could compared 21 nonCOVID pneumosepsis ICU survivor patient scored =48 MRCSS ICU discharge indicating ICUAW ICUAW resolved COVID19 nonCOVID patient upon hospital discharge although significantly 52 vs 22 p = 081 controlling covariates COVID19 patient performed worse physical functioning assessment upon ICU discharge improved hospital discharge MRCSS n 2 = 0214 p = 002 CPAx n 2 = 0153 p = 011 POPHGS remained lower COVID19 patient throughout hospital stay CONCLUSION COVID19 ICUsurvivors vulnerable group concerning ICUAW show better tendency towards physical rehabilitation nonCOVID pneumosepsis ICUsurvivors postICU hospitalization period regarding MRCSS CPAx COVID19 ICU patient might benefit early intensive physical therapy CLINICAL RELEVANCY STATEMENT COVID19 ICU survivor high risk ICUacquired weakness well known immense personal societal consequence group COVID19 ICU survivor quickly growing worldwide insight requirement optimal physical rehabilitation method assessing paramount importance article protected copyright right reserved,
Calcium channel blocker improve prognosis patient coronavirus disease 2019 hypertension,34133354,BACKGROUND Hypertension considered important risk factor coronavirus disease 2019 COVID19 commonly antihypertensive drug reninangiotensinaldosterone system RAAS inhibitor calcium channel blocker CCBs betablockers association commonly used antihypertensive medication clinical outcome COVID19 patient hypertension well studied METHODS conducted retrospective cohort study included patient admitted COVID19 Huo Shen Hospital Guanggu District Maternal Child Health Hospital Hubei Province Wuhan China Clinical laboratory characteristic extracted electronic medical record Hypertension antihypertensive treatment confirmed medical history clinical record primary clinical endpoint allcause mortality Secondary endpoint included rate patient common ward transferred intensive care unit hospital stay duration Logistic regression used explore risk factor associated mortality prognosis Propensity score matching used balance confounders different antihypertensive treatment KaplanMeier curve used compare cumulative recovery rate Logrank test performed test difference KaplanMeier curve different group RESULTS Among 4569 hospitalized patient COVID19 317 14494569 history hypertension significant difference mortality rate hypertensive patient CCBs 7359 without 21359 195 vs 585 risk ratio RR 032 95 confidence interval CI 013076 chi2 = 761 P = 00058 matching confounders mortality rate similar RAAS inhibitor 4236 nonRAAS inhibitor 9236 cohort 169 vs 381 RR 043 95 CI 013143 chi2 = 198 P = 01596 Hypertensive patient betablockers 13340 showed statistical difference mortality compared without 11340 382 vs 324 RR 119 95 CI 053269 chi2 = 017 P = 06777 CONCLUSIONS study find positive negative effect RAAS inhibitor betablockers COVID19 patient hypertension CCBs could improve prognosis,
Evaluation 2 commercial antiSARSCoV2 antibody assay immunocompetent immunocompromised inpatient population COVID19,34224944,INTRODUCTION COVID19 pandemic widespread introduction SARSCoV2 antibody testing introduced without full understanding assay performance antibody kinetics following infection SARSCoV2 METHODS performed evaluation 2 antiSARSCoV2 antibody assay detailed look effect immune status antibody sensitivity RESULTS assay demonstrated 100 specificity overall sensitivity Roche 921 =14 day 948 =21 day overall sensitivity Abbott 944 =14 day 982 =21 day 741 17 patient included cohort immunocompromised Seroconversion seen le commonly immunocompromised 47 571 seroconverted excluding patient 100 sensitivity seen assay =21 day DISCUSSION Performance assay immunocompetent appeared excellent 21 day postsymptom onset assay highly specific,anti-sarscov-2 antibody;antibody waning;covid-19;immunocompromised;immunosuppressed;sars-cov-2
SiteSpecific Steric Control SARSCoV2 Spike Glycosylation,34213308,central tenet design vaccine display nativelike antigen elicitation protective immunity abundance Nlinked glycans across SARSCoV2 spike protein potential source heterogeneity among many different vaccine candidate investigation investigate glycosylation recombinant SARSCoV2 spike protein five different laboratory compare protein infectious virus cultured Vero cell find pattern conserved across sample associated sitespecific stalling glycan maturation act highly sensitive reporter protein structure Molecular dynamic simulation fully glycosylated spike support model steric restriction shape enzymatic processing glycans result suggest recombinant spikebased SARSCoV2 immunogen glycosylation reproducibly recapitulates signature viral glycosylation,
Developing Scale Measuring Patient Expectations Service Quality Hospitals India COVID19,34132627,paper develops scale measure perceived service quality hospital pandemic develop scale data 206 respondent India subjected exploratory confirmatory factor analysis newly developed scale named PANDSERVQUAL includes factor namely assistance facility layout trust empathy promptness knowledge resulting scale likely useful researcher exploring service quality research health care quality well Findings facilitate understanding patient s expectation regarding service quality hospital pandemicSupplemental data article available online http doiorg1010800018586820211939827,covid-19;pand-servqual;hospital employees;patients' expectations;service quality
Changes Health Behaviors Mental Physical Health among Older Adults Severe Lockdown Restrictions COVID19 Pandemic Spain,34281004,used data 3041 participant four cohort communitydwelling individual aged =65 year Spain collected prepandemic facetoface interview telephone interview conducted week 7 15 beginning COVID19 lockdown average confinement associated deterioration lifestyle risk factor smoking alcohol intake diet weight except decreased physical activity increased sedentary time reversed end confinement However chronic pain worsened moderate decline mental health seem reverse restriction lifted observed Males older adult greater social isolation greater feeling loneliness poorer housing condition well higher prevalence chronic morbidity increased risk developing unhealthier lifestyle mental health decline confinement hand previously greater adherence Mediterranean diet physical activity protected older adult developing unhealthier lifestyle confinement another lockdown imposed future pandemic public health program specially address need older individual male sex greater social isolation suboptimal housing condition chronic morbidity greater vulnerability enacted movement restriction,covid-19;chronic pain;confinement;elderly;lifestyle behaviors;lockdown;mental health
Evaluation index cardiac electrophysiological balance COVID19 patient,34282628,AIM aim current study evaluate index Cardiac Electrophysiological Balance iCEB hospitalized COVID19 patient receiving Hydroxychloroquine azithromycin HCQ AZ combination therapy determine susceptibility ventricular arrhythmia among patient METHOD Sixtyseven COVID19 patient admitted ward included study Electrocardiograms ECGs obtained patient initiation treatment treatment day 5 QTQRS iCEB QTcQRS iCEBc ratio calculated RESULTS QRS QT QTc interval significantly prolonged day 5 measurement compared pretreatment period p 005 Overall mean iCEB 36+04 treatment 38+04 day 5 study population p 0001 Considering iCEBc value significant increase observed patient receiving HCQAZ treatment compared pretreatment period 41+05 v 44+06 p 0001 CONCLUSIONS best knowledge first study investigate iCEB iCEBc parameter patient COVID19 HCQAZ therapy study demonstrated significantly increased iCEB iCEBc value following HCQAZ treatment COVID19 patient iCEB iCEBc may serve noninvasive simple novel biomarker detecting increased proarrhythmia risk COVID19 patient Tab 3 Fig 3 Ref 36,covid-19;hydroxychloroquine;azithromycin ventricular arrhythmia.;index of cardiac electrophysiological balance (iceb)
Ivermectin prevent hospitalization patient COVID19 IVERCORCOVID19 randomized doubleblind placebocontrolled trial,34215210,BACKGROUND Severe acute respiratory syndrome coronavirus 2 SARSCoV2 changed life scientific community investigating repurposed treatment prevent disease progression coronavirus disease COVID19 patient OBJECTIVE determine whether ivermectin treatment prevent hospitalization individual early COVID19 DESIGN SETTING PARTICIPANTS randomized doubleblind placebocontrolled study conducted nonhospitalized individual COVID19 Corrientes Argentina Patients SARSCoV2 positive nasal swab contacted within 48 h telephone invite participate trial randomized 501 patient August 19th 2020 February 22nd 2021 INTERVENTION Patients randomized ivermectin N = 250 placebo N = 251 arm staggered dose according patient s weight 2 day MAIN OUTCOMES MEASURES efficacy ivermectin prevent hospitalization evaluated primary outcome evaluated secondary outcome relationship safety efficacy end point RESULTS mean age 42 year SD + 155 median time since symptom onset inclusion 4 day interquartile range 36 primary outcome hospitalization met 14250 56 individual ivermectin group 21251 84 placebo group odds ratio 065 95 confidence interval 032131 p = 0227 Time hospitalization statistically different group mean time study enrollment invasive mechanical ventilatory support MVS 525 day SD + 171 ivermectin group 10 day SD + 2 placebo group p = 0019 statistically significant difference secondary outcome including polymerase chain reaction test negativity safety outcome LIMITATIONS Low percentage hospitalization event dose ivermectin including highrisk population CONCLUSION Ivermectin significant effect preventing hospitalization patient COVID19 Patients received ivermectin required invasive MVS earlier treatment significant difference observed secondary outcome TRIAL REGISTRATION ClinicalTrialsgov NCT04529525,
Modifications intravitreal injection response COVID19 pandemic,34292208,Coronavirus disease 2019 COVID19 pandemic caused unprecedented disruption normal operation healthcare system worldwide scale hospital suspended nonurgent surgery outpatient visit downsized clinical loading redistribute manpower counteract pandemic s impact far evidencebased guideline defining clear line urgent nonurgent indication intravitreal injection IVI Herein aimed summarize IVI algorithm modification discus patient prioritization according medical need hostile environment COVID crisis Assessing current literature found neovascular agerelated macular degeneration considered utmost priority among condition require IVI condition assigned high priority include monocular quasimonocular patient one eye 2040 neovascular glaucoma new patient significant vision loss Although patient central retinal vein occlusion proliferative diabetic retinopathy advised delay treatment found consistent evidence correlated worse outcome Diabetic macular edema branched retinal vein occlusion patient undertaking treatment delay regularly followed every 23 month Serving principle management behind algorithm modification reduction patient visit IVI therapy count reckoned together risk permanent visual loss COVID infection,
Cerebrovascular Accident SARSCoV19 COVID19 Systematic Review,34352787,BACKGROUND common neurologic symptom reported patient affected SARSCoV2 headache dizziness myalgia mental fog anosmia growing basis published peerreviewed case reporting stroke setting SARSCoV2 infection peerreviewed literature suggests increased risk cerebrovascular accident CVA setting COVID19 infection METHODS searched 3 database PubMed MEDLINE CINAHL search term COVID19 novel coronavirus stroke cerebrovascular accident Case series case study presenting patient positive COVID19 CVA published January 1 September 1 2020 included Data collection analysis completed risk bias assessed RESULTS search identified 28 study across 7 county comprising 73 patient Amongst patient hospitalized COVID19 infection CVA average age 60 common preexisting condition hypertension diabetes mellitus without preexisting condition significantly younger average age 47 Amongst hospitalized patient COVID19 CVA bimodal association COVID19 infection severity majority patient classified mild critical COVID19 infection DISCUSSION data suggest SARSCoV2 risk factor developing stroke particularly patient hypertension diabetes Furthermore younger average age stroke patient SARSCoV2 particularly patient zero identifiable preexisting condition creates high suspicion SARSCoV2 independent risk factor development stroke however yet proven without comparable control population data suggest risk developing CVA setting COVID19 infection dependent upon severity illness Continued study must done understand epidemiologic factor COVID19 infection stroke pathophysiology COVIDassociated hypercoagulable state,covid-19;cerebrovascular attack;coronavirus;stroke
Low neutralizing antibody response WM CLL NHL patient first dose BNT162b2 AZD1222 vaccine,34283338,Vaccination SARSCoV2 considered important preventive strategy COVID19 efficacy patient hematological malignancy largely unknown investigated development neutralizing antibody NAbs SARSCoV2 patient Waldenstrom Macroglobulinemia WM Chronic Lymphocytic Leukemia CLL NonHodgkin Lymphoma NHL first dose vaccine D22 WMCLLNHL patient lower NAb titer compared control median NAb inhibition titer 17 range 091 IQR 827 WMCLLNHL patient versus 32 range 298 IQR 1948 control P 0001 8 14 patient versus 114 54 control developed NAb titer = 30 D22 p 0001 data indicate first dose BNT162b2 AZD1222 lead lower production NAbs SARSCoV2 patient WMCLLNHL compared control similar age gender without malignant disease Even though response rate optimal vaccination still considered essential possible performed treatment initiation patient suboptimal response considered prioritized booster dos,azd1222;antibodies;bnt162b2;covid-19;chronic lymphocytic leukemia;non-hodgkin lymphoma;sars-cov-2;vaccine;waldenstrom macroglobulinemia
Wisdom crowd detects COVID19 severity ahead officially available data,34211001,unfolding crisis crucial forecast severity early stage yet access reliable data often challenging early wisdom crowd effective forecasting similar scenario investigated whether initial regional social medium reaction emerging COVID19 pandemic three critically affected country significant relation observed mortality month later obtained COVID19 related regionally geolocated tweet Italian Spanish United States region quantified predictive power wisdom crowd using correlation regression geolocated Tweet Intensity TI initial social medium attention peak versus cumulative number death month ahead found intensity initial COVID19 related tweet attention beginning pandemic across Italian Spanish United States region significantly related p 0001 extent region affected pandemic month later association striking Italy peak TI late February 2020 two region reported mortality collective wisdom crowd early stage pandemic information number infection broadly available strikingly predicted extent mortality reflecting regional severity pandemic almost month later finding could underpin creation realtime novelty detection system aimed early reporting severity crisis impacting territory leading early activation control measure stage available data extremely limited,
Fully automated fastflow synthesis antisense phosphorodiamidate morpholino oligomers,34285203,Rapid development antisense therapy enable ondemand response new viral pathogen make personalized medicine genetic disease practical Antisense phosphorodiamidate morpholino oligomers PMOs promising candidate fill role challenging synthesis limit widespread application rapidly prototype potential PMO drug candidate report fully automated flowbased oligonucleotide synthesizer optimized synthesis platform reduces coupling time 22fold compared previously reported method demonstrate power automated technology synthesis milligram quantity three candidate therapeutic PMO sequence unserved class Duchenne muscular dystrophy DMD test platform synthesize PMO target genomic mRNA SARSCoV2 demonstrate antiviral effect platform could find broad application designing new SARSCoV2 DMD antisense therapeutic also rapid development PMO candidate treat new emerging disease,
Multidisciplinary Approach Evaluate Presence Hepatic Cardiac Abnormalities Patients PostAcute COVID19 SyndromeA Pilot Study,34204032,1 Background Patients suffering novel coronavirus 2019 COVID19 disease could experience several extrapulmonary involvement including cardiovascular complication liver injury study aim evaluate presence cardiac liver alteration patient postacute COVID19 syndrome using transthoracic echocardiography TTE liver elastography LE 2 Methods total 97 subject recovering COVID19 attending hospital s specialized outpatient clinic persisting symptom 3 11 week acute illness included study basal COVID19 assessment subsequently clinical evaluation laboratory test TTE LE 3 Results considering presence pulmonary injury COVID19 patient divided two group Although none altered systolic function evidenced pulmonary hypertension diastolic dysfunction increased liver stiffness viscosity steatosis around onethird patient significantly higher value subject pulmonary injury compared without 4 Conclusion persisting symptom characterizing postacute COVID19 syndrome could explained residual cardiac hepatic lesion worse severe COVID19 form patient may risk developing liver fibrosis cardiac alteration investigated first 12 week onset infection,covid-19;cardiovascular alterations;cytokine storm;inflammation;liver elastography;liver injury;transthoracic echocardiography
Depinar drug potentially inhibits binding entry COVID19 host cell based computeraided study,34221065,Background purpose new coronavirus Covid19 resulted great global concern Due mortality virus scientist world trying employ different strategy tackle concern virus enters cell via phagocytosis binding angiotensinconverting enzyme II receptor invading body stay hidden period 24 day incubation period Experimental approach report use silico study selected several FDAapproved compound posse antiviral property chose viral Spike protein target drug compound carried screening process FDA databank order find effective ligand FindingsResults result dock MD revealed 10 compound high affinity receptorbinding domain motif protein best inhibitor ingredient Depinar managed effectively block interaction cell virus Conclusion implication result study approved silico study due lack time test efficiency compound vitro vivo study However selected compound FDA approved supplement like vitamin B12 nt cause side effect patient,corona;covid-19;depinar;docking-based virtual screening;molecular dynamics.
Alprostadil associated low molecular weight heparin treat limb ischemia caused SARSCoV2,34211521,current coronavirus pandemic already taken great toll globally causing massive morbidity mortality One severe form thrombophilic state damage several system article report case 60yearold female patient presented mild flu symptom turned SARSCoV2 infection ended developing arterial thrombosis limb ischemia private care hospital Sorocaba Sao Paulo Brazil Considering progression decided intervene low molecular weight heparin Alprostadil achieving good clinical outcome description aim identify key point clinical sign offer evidence therapeutic window treatment option coagulatory presentation COVID19,covid-19;arterial thrombosis;heparin;limb ischemia;thromboembolism
quasiexperimental study effect health food safety training intervention restaurant food handler COVID19 pandemic,34221365,restaurant business turned dynamic evergrowing industry food safety must priority establishment especially COVID19 pandemic aim study determine effect training intervention health food safety knowledge attitude selfreported practice KAP restaurant food handler COVID19 pandemic quasiexperimental study conducted 159 restaurant food handler Tehran Iran training intervention developed based latest global guideline KAP subject measured training Fisher s exact test paired test repeated measure ANOVA used statistical analysis Data analysis done using IBMSPSS software total knowledge score participant low 176 moderate 352 good 472 training changed 5 low 239 moderate 711 good training total pretraining attitude score 06 774 182 38 changed 0 strongly negative 491 negative 333 positive 176 strongly positive respectively Also selfreported practice score participant training 13 56 427 changed 0 weak 264 acceptable 736 desirable intervention respectively Paired test result showed statistically significant increase score interaction training age education statistically significant increasing knowledge attitude score participant repeated measure ANOVA Improving KAP food handler health food safety training improve status restaurant minimize outbreak pandemic disease including COVID19 effective step community health Thus urgent need policymakers design online system continuous food safety training food handler,covid-19 prevention;food handlers;public health;training intervention
Mortality risk factor Spanish cohort oldestold patient hospitalized COVID19 acute geriatric unit OCTACOVID study,34287813,PURPOSE determine predictor inhospital mortality related COVID19 oldestold patient DESIGN Singlecenter observational study SETTING PARTICIPANTS Patients = 75 year admitted Acute Geriatric Unit COVID19 METHODS Data hospital admission retrieved electronic medical record demographic geriatric syndrome delirium fall polypharmacy functional cognitive status comorbidities previous treatment clinical laboratory radiographic characteristic Cox proportional hazard model used evaluate inhospital mortality RESULTS Three hundred patient consecutively included 627 female mean age 863 + 66 year Barthel Index BI 60 127 patient 428 126 420 Charlson Index CI = 3 patient 216 727 frail Clinical Frailty Scale = 5 134 patient 451 dementia degree overall inhospital mortality rate 37 following factor associated higher inhospital mortality multivariant analysis CURB65 score = 35 HR 799 95 CI 3551996 p 0001 incident delirium HR 172 110270 p = 0017 dementia HR 301 95 CI 1376705 p = 0017 Protective factor concurrent use angiotensinconverting enzyme inhibitor HR 042 95 CI 025072 p = 0002 prescription hydroxychloroquine HC 037 95 CI 022062 p 0001 treatment admission CONCLUSIONS IMPLICATIONS finding suggest recognition geriatric syndrome together CURB65 score may useful tool help clinician establish prognosis oldestold patient admitted hospital COVID19,covid-19;mortality;older adults;risk factors;sars-cov-2
ECMMISHAM recommendation clinical management COVID19 associated mucormycosis low middleincome country,34133816,Reports increasing emergence COVID19associated mucormycosis CAM globally driven particularly low middleincome country recent unprecedented surge CAM India drawn worldwide attention 28252 mucormycosis case counted India first country mucormycosis declared notifiable disease However misconception management diagnosing treating infection continue occur Thus European Confederation Medical Mycology ECMM International Society Human Animal Mycology ISHAM felt need address clinical management CAM low middleincome country article provides comprehensive document help clinician managing infection Uncontrolled diabetes mellitus inappropriate high dose indicated corticosteroid use major predisposing factor surge High count Mucorales spore indoor outdoor environment immunosuppressive impact COVID19 patient well immunotherapy possible additional factor Furthermore hyperglycaemic state lead increased expression glucose regulated protein GRP 78 endothelial cell may help entry Mucorales tissue Rhinoorbital mucormycosis common presentation followed pulmonary mucormycosis Recommendations focused early suspicion disease confirmation diagnosis Regarding management glycaemic control elimination corticosteroid therapy extensive surgical debridement antifungal therapy standard proper care Due limited availability amphotericin B formulation present epidemic alternative antifungal therapy also discussed,mucorales;covid-19;sars-cov-2;corticosteroids;diabetes;infection;mucormycosis
Two Cases PostModerna COVID19 Vaccine Encephalopathy Associated Nonconvulsive Status Epilepticus,34367780,Coronavirus disease 2019 COVID19 infection cause many complication including central nervous system CNS complication One common COVID19 CNS complication COVID19 encephalopathy disorder characterized cognitive impairment altered consciousness even seizure Moderna COVID19 vaccine recently approved mRNAbased vaccine aimed preventing COVID19 infection complication describe two patient known neurological psychiatric history presented encephalopathy seizure began part one Moderna COVID19 vaccine series knowledge report postModerna COVID19 vaccine encephalopathy literature suggest mechanism complication thoroughly discus Moderna vaccine possibly responsible addressing confounders patient,covid-19;covid-19 vaccine complication;covid-19-related encephalopathy;moderna vaccine encephalopathy;non-convulsive status epilepticus;vaccine seizures
Early assessment first wave COVID19 pandemic cancer screening service International Cancer Screening Network COVID19 survey,34217420,Screening decrease burden breast cervical colorectal cancer COVID19 pandemic led many country suspend cancer screening service part response pandemic International Cancer Screening Network ICSN carried online survey ass effect first wave COVID19 pandemic cancer screening 33item survey distributed 834 email address gather information setting ass decisionmaking process led cancer screening suspension Information communication impact resource patient followup collected Quantitative data analyzed frequency overall setting comment section survey item captured nuanced detail Responses recategorized 66 setting representing 35 country setting suspended cancer screening service n = 60 909 March 2020 n = 45 682 guided government decision n = 51 773 setting made decision whether suspend service based preparedness plan n = 17 258 setting professional reassigned n = 41 621 infrastructure repurposed n = 35 530 first wave COVID19 pandemic profound effect cancer screening worldwide including suspension service almost setting setting unprepared deal scale pandemic demonstrated flexibility response result contribute inform experience lesson learned next step global cancer screening community evaluate impact COVID19 prepare future disruption,covid-19;cancer screening;disruption;health care services
Coronary artery calcification lowdose chest CT early predictor severe progression COVID19A multicenter multivendor study,34288966,PURPOSE Cardiovascular comorbidity anticipates severe progression COVID19 becomes evident coronary artery calcification CAC lowdose chest computed tomography LDCT purpose study predict patient s obligation intensive care treatment evaluating coronary calcium burden initial diagnostic LDCT METHODS Eightynine consecutive patient parallel LDCT positive RTPCR SARSCoV2 included three center primary endpoint admission ICU tracheal intubation death 22day followup period CAC burden represented Agatston score Multivariate logistic regression modeled prediction primary endpoint independent variable `` Agatston score 0 well CT lung involvement score patient sex age clinical predictor severe COVID19 progression history hypertension diabetes prior cardiovascular event active smoking hyperlipidemia laboratory parameter creatinine Creactive protein leucocyte well thrombocyte count relative lymphocyte count ddimer lactate dehydrogenase level RESULTS excluding multicollinearity `` Agatston score 0 independent regressor within multivariate analysis prediction primary endpoint p 001 independent regressors creatinine p = 002 leucocyte count p = 004 Agatston score significantly higher COVID19 case completed primary endpoint 642 interquartile range 174094 vs 0 interquartile range 00 CONCLUSION CAC scoring LDCT might help predict future obligation intensive care treatment day patient admission hospital,
Agricultural Stakeholders Perceptions Occupational Health Safety Southeastern US Coastal States,34205311,Agriculture remains highly dangerous industry occupational health safety study sought understand perspective agricultural professional respect current state industry challenge opportunity relevant occupational health safety Additional question related COVID19 pandemic emerged finding well Eleven industry professional interviewed transcript qualitatively analyzed emergent theme following constant comparative method Three theme emerged finding description current state occupational health safety agricultural industry barrier improving occupational health safety enablers occupational health safety theme contained subthemes description industry encompassed regulation inherent danger attitude education Barriers included education health care access logistics discrimination cultural competency economic consideration labor contracting system Enablers included education regulation health care prevention finding consistent existing literature revealing interconnected overlapping challenge opportunity research recommended broader sample participant especially farmworkers,covid-19;agriculture;barriers;enablers;farmworkers;occupational health and safety
Understanding protection SARSCoV2 using metabolomics,34226622,COVID19 pandemic still raging country Although recent mass vaccination campaign opened new chapter battle SARSCoV2 world still far herd immunity urgent need identify healthy people high risk contracting COVID19 well supplement nutraceuticals reduce risk infection mitigate symptom present study metabolic phenotype could protect individual SARSCoV2 infection predispose developing COVID19 investigated Untargeted metabolomics performed serum sample collected 51 healthcare worker good health beginning COVID19 outbreak Italy later exposed risk developing COVID19 Half developed COVID19 within three week blood collection result demonstrate presence specific signature associated protection SARSCoV2 Circulating monolaurin wellknown antiviral antibacterial property higher protected subject suggesting potential defensive role SARSCoV2 infection thus dietary supplement could boost immune system infection addition data demonstrate people higher level cholesterol higher risk developing COVID19 present study demonstrates metabolomics great help developing personalized medicine supporting public healthcare strategy Studies larger cohort subject necessary confirm finding,
Safety Immunogenicity BNT162b2 mRNA COVID19 Vaccine Patients Allogeneic HCT CD19based CART therapyA SingleCenter Prospective Cohort Study,34214738,Data scarce regarding safety immunogenicity BNT162b2 mRNA COVID19 vaccine patient undergoing immune cell therapy thus prospectively evaluated two domain patient receiving vaccine allogeneic hematopoietic cell transplantation HCT n = 66 CD19based chimeric antigen receptor cell CART therapy n = 14 Overall vaccine well tolerated mild nonhematologic vaccinereported adverse event minority patient Twelve percent patient first dose 10 patient second dose developed cytopenia three case graftversushost disease exacerbation dose single case impending graft rejection summarized possibly related Evaluation immunogenicity showed 57 patient CART infusion 75 patient allogeneic HCT evidence humoral andor cellular response vaccine Cox regression model indicated longer time infusion cell female sex higher CD19 + cell associated positive humoral response whereas higher CD4 + CD8 + ratio correlated positive cellular response confirmed ELISpot test conclude BNT162b2 mRNA COVID19 vaccine impressive immunogenicity patient allogeneic HCT CART Adverse event mostly mild transient significant hematologic event observed hence patient closely monitored,cart;covid-19;hct;vaccination
Resume Elective Orthopaedic Surgical Procedures COVID19 Pandemic,34214423,document prepared College Orthopedics Portuguese Medical Association aim developing guideline resumption elective surgical activity Orthopedics COVID19 pandemic set criterion allow prioritization surgery according severity clinical situation based existing published classification Moreover provides organizational model patient preparation describes patient pathway preoperative intraoperative postoperative period also describes safety rule elective surgery model monitoring patient discharge according scientific evidence,covid-19;elective surgical procedures;orthopedic procedures;pandemics
Impact Coronavirus Disease 2019 COVID19 Pandemic Medical Use Military Hospitals Korea,34282607,BACKGROUND coronavirus disease 2019 COVID19 pandemic began December 2019 yet ended COVID19 already created transition health care one decrease medical use healthrelated issue COVID19 infection Korean soldier relatively homogeneous term age physical condition show similar disease distribution pattern every year directly affected change government attempt control COVID19 nonpharmaceutical intervention study aimed identify change pattern outpatient visit admission military hospital range disease type pandemic METHODS Outpatient attendance admission data military hospital South Korea January 2016 December 2020 analyzed active enlisted soldier aged 1832 year included Outpatient visit diagnosis pneumonia acute upper respiratory tract infection infectious conjunctivitis infectious enteritis asthma allergic rhinitis allergic conjunctivitis atopic dermatitis urticaria fracture analyzed Admissions pneumonia acute enteritis fracture also analyzed outpatient visit admission 2020 disease counted weekly basis compared average number visit period year 2016 2019 corrected value calculated dividing ratio total weekly number outpatient visit admission corresponding medical department 2020 average 20162019 RESULTS total 5813304 case outpatient care 143022 case admission analyzed pneumonia observed corrected number outpatient visit admission 2020 decreased significantly compared average year P 0001 result similar outpatient visit acute upper respiratory tract infection infectious conjunctivitis P 0001 corrected number outpatient visit infectious enteritis showed significant increase 2020 P = 0005 corrected number outpatient visit asthma 2020 differ average previous 4 year number visit allergic disease increased significantly P 0001 fracture observed corrected number outpatient visit admission 2020 decreased significantly compared average year P 0001 CONCLUSION COVID19 pandemic outpatient visit military hospital respiratory conjunctival infection fracture decreased whereas visit allergic disease change increased slightly Admissions pneumonia decreased significantly 2020 acute enteritis fracture also decreased showed increased proportion compared previous year result important illustrate changing pattern lifestyle result public encouragement adopt nonpharmaceutical intervention pandemic effect medical need infectious noninfectious disease select group,covid-19;military personnel;nonpharmaceutical intervention;south korea
High Effectiveness SARSCoV2 Vaccines Reducing COVID19Related Deaths 75YearOlds Ceara State Brazil,34287384,Brazil SARSCoV2 vaccination program far prioritized people 75 year age end March 2021 Ceara State total 313328 elderly people received least one dose vaccine 45 OxfordAstraZenecaFiocruz 55 CoronaVacSinovacButantan 159970 received two dos 83 CoronaVacSinovacButantan 17 OxfordAstraZenecaFiocruz single dose already significant reduction COVID 19related death protection ratio 1931 95 CI 18202048 attributable protection ratio 948 higher protection ratio observed application two dos vaccine 13267 95 CI 1098816018 attributable protection ratio 992 SARSCoV2 vaccine highly effective reducing number COVID19related death 75yearolds Brazil one hardest hit country current pandemic,covid-19;covid-19 vaccines;sars-cov-2;epidemiology;mortality;public health
Toward better understanding persistent headache mild COVID19 Three migrainelike yet distinct scenario,34363619,One year outbreak coronavirus disease 2019 COVID19 referral persistent headache often defined `` postCOVID headache become increasingly common outpatient headache clinic However important take consideration term may include spectrum clinically different headache type describe three case migrainelike headache individual history mild COVID19 infection demonstrate different phenotype persistent headache seen case highlight importance careful evaluation assessing complexity `` postCOVID headache well need investigate different underlying pathophysiological mechanism,sars-cov-2;headache;migraine;post-covid-19
Coronavirus Disease 2019Induced Thyroiditis,34332823,BACKGROUND Coronavirus Disease 2019 COVID19 disease present acute respiratory symptom well documented sequela yet fully understood CASE REPORT present case 51year old woman recently diagnosed COVID19 presented symptom including chest pain palpitation difficulty swallowing anterior neck discomfort ultimately diagnosed COVID19induced thyroiditis discharged propranolol nonsteroidal antiinflammatory medication EMERGENCY PHYSICIAN AWARE Thyroiditis present symptom similar etiology like pulmonary embolism discus process evaluating treating thyroiditis discus risk administering iodinated contrast medium could exacerbate thyroid dysfunction,covid-19;sars-cov-2;coronavirus disease 2019;viral thyroiditis
Longitudinal evaluation COVID19 chest CT disease progression based Tchebichef moment,34219952,Blur key property perception COVID19 computed tomography CT image manifestation Typically blur cause edge extension brings shape change infection region Tchebichef moment TM verified efficiently shape representation Intuitively disease progression patient time treatment represented different blur degree infection region since different blur degree cause magnitude change TM infection region image blur infection region captured TM observation longitudinal objective quantitative evaluation method COVID19 disease progression based TM proposed COVID19 disease progression CT image database COVID19 DPID built employ radiologist subjective rating manual contouring test compare disease progression CT image acquired patient time image preprocessed including lung automatic segmentation longitudinal registration slice fusion fused slice image region interest ROI obtained Next gradient fused ROI image calculated represent shape gradient image fused ROI separated size block block energy calculated quadratic sum nondirect current moment value Finally objective assessment score obtained TM energynormalized applying block variance conducted experiment COVID19 DPID experiment result indicate proposed metric supply satisfactory correlation subjective evaluation score demonstrating effectiveness quantitative evaluation COVID19 disease progression,covid-19 ct image;tchebichef moments;blur;disease progression;objective evaluation
Outcomes extracorporeal membrane oxygenation influenza versus COVID19 first wave COVID19,34369601,PURPOSE Extracorporeal membrane oxygenation ECMO refractory treatment acute respiratory distress syndrome ARDS due influenza severe acute respiratory syndrome coronavirus 2 SARSCoV2 also referred coronavirus disease 2019 COVID19 conducted study compare outcome influenza patient treated venovenousECMO VVECMO COVID19 patient treated VVECMO first wave COVID19 METHODS Patients institution ARDS due COVID19 influenza placed ECMO August 1 2010 September 15 2020 included comparative retrospective study improve homogeneity VVECMO patient analyzed clinical characteristic outcome extracted analyzed RESULTS total 28 COVID19 patient 17 influenza patient identified included ECMO survival rate 68 1928 COVID19 patient 94 1617 influenza patient p = 04 Thirty day survival rate ECMO decannulation 54 1528 COVID19 patient 76 1317 influenza patient p = 13 COVID19 patient spent longer time ECMO compared flu patient 21 vs 12 day p = 025 COVID19 patient 2628 vs 217 immunomodulatory therapy ECMO initiation p 001 COVID19 patient higher rate new infection ECMO 50 vs 18 p = 03 bacterial pneumonia 36 vs 6 p = 024 CONCLUSIONS COVID19 patient treated institution VVECMO statistically lower ECMO survival rate influenza patient possible COVID19 immunomodulation therapy may increase risk superimposed infection,ards;covid-19;ecmo;influenza;outcomes
Family Medicine Residents Experience Early Phases COVID19 Pandemic,34286221,Background Objectives Residents thrust onto front line US medical response COVID19 study aimed quantify describe experience family medicine resident nationally early phase pandemic Specific area interest included training received resident personal sense safety purpose study look difference among resident based geographic location Method May 2020 survey conducted Council Academic Family Medicine Educational Research Alliance CERA random sample 5000 resident member American Academy Family Physicians AAFP Results overall response rate survey 566 2835000 40 resident reported felt moderate significant personal danger COVID19 pandemic Fewer 20 tested COVID19 Among respondent 176 657 resident provided direct patient care COVID19positive patient trained personal protective equipment medical aspect COVID19 162 reported training care COVID19 patient Minority resident resident larger urban area le likely receive timely training Conclusions COVID19 pandemic major impact family medicine resident medical education sense safety Regional variation resident educational experience pandemic exist Training prior COVID19 exposure universal sample minority resident le likely receive timely training White resident,
COVID19 pandemic year sample Polish myasthenia gravis patient observational study,34346049,AIM STUDY Coronavirus disease 2019 COVID19 incidence mortality recovery hospitalisation rate vary different country study aimed present clinical characteristic sample unvaccinated Polish myasthenia gravis MG patient first year COVID19 pandemic taking account number MG exacerbation detailed description severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection course need modify immunosuppressive therapy Clinical rationale study ass impact first COVID19 pandemic year MG course sample unvaccinated patient MATERIALS METHODS retrospective observational study involving 30 unvaccinated Polish MG patient consulted neurological outpatient clinic 1131 March 2020 baseline 1131 March 2021 endpoint RESULTS period evaluation exacerbation MG requiring hospitalisation reported 11 patient Among four treated intravenous immunoglobulin another six required plasma exchange study group COVID19 identified 10 patient seven experienced mild course SARSCoV2 infection spontaneous recovery remaining three patient MG exacerbation SARSCoV2 infection reported patient experienced MG exacerbation preceding month concurrently COVID19 aged 50 year Due SARSCoV2 infection required antibiotic oxygen therapy hospitalisation necessary case two obese patient None patient died due COVID19 require discontinuation immunosuppressive therapy study period total 12 patient study group experienced neither MG exacerbation SARSCoV2 infection CONCLUSIONS presented sample Polish MG patient favourable outcome COVID19 observed study needed evaluate reliable course COVID19 taking account international difference type treatment applied ratio vaccinated unvaccinated MG patient,covid-19;sars-cov-2;immunosuppression;myasthenia gravis;pandemic
innovative protocol artificial speechdirected contactless administration laboratorybased comprehensive cognitive assessment PAAD2 trial management COVID19 pandemic,34217888,COVID19 pandemic resulted suspending inperson human subject research across institution US extensive cognitive assessment phase2 clinical trial Physical Activity Alzheimer s Disease2 PAAD2 also paused March 2020 important identify strategy mitigate risk COVID19 transmission testing initially required substantial human speech close persontoperson contact test direction instant feedback paperpencil test Given current understanding COVID19 transmission dramatically adjusted testing protocol minimize production speech droplet allow social distancing maintaining integrity testing adopted stateoftheart speech synthesis computerization technique create avatar speak behalf experimenter verbal instructionsfeedback used document camera observe paperpencil test required distance automated testing sequence timing paper aim 1 describe innovative laboratorybased cognitive testing protocol completely contactfree computerspeaking semiautomated administration 2 evaluate integrity modified protocol n = 37 compared original protocol n = 32 successfully operated modified protocol since July 2020 evidence COVID19 transmission testing data support modified protocol robust capture data identical original protocol transition data collection method critical pandemic useful future study mitigate risk contagious disease transmission standardize laboratorybased psychological test Trial registration ClinicalTrialsgov NCT03876314 Registered March 15 2019,alzheimer's disease;artificial intelligence;executive function;neuropsychological tests;physical activity;speech synthesis;text-to-speech;working memory
Quantitative BenefitRisk Analysis ChAdOx1 nCoV19 Vaccine among People 60 Italy,34201330,OxfordAstraZeneca ChAdOx1 nCoV19 vaccine COVID19 infection granted conditional marketing authorization European Commission January 2021 However following report Pharmacovigilance Risk Assessment Committee PRAC European Medicines Agency reported association thromboembolic event TEE particular disseminated intravascular coagulation DIC cerebral venous sinus thrombosis CVST many European country either limited individual older 5560 year suspended use used publicly available data carry quantitative benefitrisk analysis vaccine among people 60 Italy Specifically used data PRAC Eudravigilance ECDC estimate excess number death TEE DIC CVST expected vaccine user stratified age group used data National Institute Health calculate agespecific COVID19 mortality rate Italy Preventable death calculated assuming 72 vaccine efficacy eightmonth period Finally benefitrisk ratio ChAdOx1 nCoV19 vaccination calculated ratio preventable COVID19 death vaccinerelated death using MonteCarlo simulation found among subject aged 2029 year benefitrisk BR ratio clearly favorable 070 95 Uncertainty Interval UI 027211 However age group benefit vaccination largely exceeded risk age 3049 BR ratio 229 95 UI 1011864 age 5059 BR ratio 15771 95 UI 1176921215 Although many country limited use ChAdOx1 nCoV19 vaccine benefit using vaccine clearly outweigh risk people older 30 year Study limitation included risk underreporting provide agespecific estimate use vaccine strategic fundamental part immunization campaign considering safety efficacy preventing COVID19 complication,covid-19;chadox1 ncov-19;benefit-risk analysis;thrombo-embolic events;vaccine
Association obesity venous thromboembolism myocardial injury COVID19,34281793,INTRODUCTION Although obesity coronavirus disease 2019 COVID19 independently induce inflammation thrombosis association obesity class risk thrombosis patient COVID19 remains unclear METHODS retrospective cohort study included consecutive patient hospitalized COVID19 single institution Patients categorized based obesity class main outcome venous thromboembolism VTE myocardial injury marker microvascular thrombosis COVID19 Adjustments made sociodemographic variable cardiovascular disease risk factor comorbidities RESULTS 609 patient COVID19 included 351 58 patient without obesity 110 18 patient class obesity 76 12 patient class II obesity 72 12 patient class III obesity Patients class III obesity significantly higher riskadjusted odds VTE compared patient without obesity = 254 95 CI 105614 class obesity = 395 95 CI 1401114 class III obesity Patients class III obesity significantly higher riskadjusted odds myocardial injury compared patient without obesity = 215 95 CI 112412 VTE myocardial injury significantly associated greater riskadjusted odds mortality CONCLUSION study demonstrates macrovascular microvascular thromboses may contribute elevated morbidity mortality patient obesity COVID19,obesity;thrombosis
Mathematical model COVID19 Nigeria optimal control,34345579,novel Coronavirus Disease 2019 COVID19 highly infectious disease caused new strain severe acute respiratory syndrome coronavirus 2 SARSCoV2 work proposed mathematical model COVID19 carried qualitative analysis along epidemic indicator basic reproduction number R 0 model stability analysis COVID19 free equilibrium CFE Endemic equilibrium EE using Lyaponuv function considered extended basic model optimal control system incorporating three control strategy use facemask hand sanitizer along social distancing treatment COVID19 patient active screening testing third control prevention recurrence reinfection human recovered COVID19 Daily data given Nigeria Center Disease Control NCDC Nigeria used simulation proposed COVID19 model see effect control measure biological interpretation finding COVID19 effectively managed eliminated Nigeria control measure implemented capable taking sustaining basic reproductive number R 0 value unity three control strategy well managed government namely NCDC Presidential Task Force PTF Federal Ministry Health FMOH policymakers COVID19 Nigeria eradicated,basic reproduction number;covid-19;global stability;model-fitting;optimal control
evidence plasmablast transdifferentiate developing neutrophil severe COVID19 disease,34221402,Objectives recent singlecell RNA sequencing study Wilk et al suggested plasmablast transdifferentiate developing neutrophil patient severe COVID19 disease explore evidence Methods downloaded original data code used author study replicate finding explore possibility regressing variable may led author overfit data Results lineage relationship plasmablast developing neutrophil break key feature regressed data overfitted analysis Conclusion Plasmablasts transdifferentiate developing neutrophil singlecell RNA sequencing powerful technique biological discovery hypothesis generation However caution exercised bioinformatic analysis interpretation data finding crossvalidated orthogonal technique,b cells;covid-19;sars-cov-2;emergency granulopoiesis;low-density neutrophils;neutrophils;plasma cells;single-cell rna sequencing
Covera19 know when hold em when fold em translational thought experiment,34226878,function protein depends structure structural integrity protein dynamic depends interacting nearby neighboring moiety influence property induce folding structural change conformational change induced nearby neighbor microenvironmental milieu moment guided chemical electrical bonding attraction literature reference describe potential environmental milieu change disfavor SARSCoV2 attachment receptor survival outside host many study effect pH acid base balance supporting importance protein structure function focus pH role extracellular intracellular protein actionable requirement Covera19 Fold em Hold em seen various function effect furin seek acidic milieu action compatible amino acid sequence currently aided histidine component structural change protein enter exit host Questions throughout text posed focus current thought reviewing applicable COVID19 translational research science order understand complexity Covid19 pH need COVID19 player journey human host environment well efficacious readily available repurposed drug outofthe box easily available treatment reviewed,
CariesCare International adapted pandemic child Caries multicentre singlegroup interventional study protocol,34210281,BACKGROUND Comprehensive caries care shown effectiveness controlling caries progression improving health outcome controlling caries risk preventing initialcaries lesion progression patient satisfaction date cariesprogression control effectiveness patientcentred riskbased CariesCare International CCI system derived ICCMS practice 2019 remains unproven onset COVID19 pandemic previously planned multicentre RCT shifted `` Caries study aiming ass singleintervention group child cariescontrol effectiveness CCI adapted pandemic nonaerosols generating procedure nonAGP reducing inoffice time METHODS 1year multicentre singlegroup interventional trial adaptedCCI effectiveness assessed one single group term toothsurface level caries progression control secondarily individuallevel caries progression control child s oralhealth behaviour change parent dentist process acceptability cost exploration sample size 258 35 68 year old patient calculated removing half previous RCT allowing 25 dropout including generally health child 27 per centre singlegroup intervention adaptedCCI 4Dcycle caries care nonAGP reduced inoffice appointment time trained examiner per centre conduct examination baseline 555 month 3 month basic management 85 12 month assessing child s CCI caries risk oralhealth behaviour visually staging assessing carieslesions severity activity without airdrying ICDASmerged Epi fillingssealants missingdentalsepsis teeth tooth symptom synthetizing together parent externaltrained dental practitioner DP patient toothsurface level diagnosis personalised care plan DP deliver adaptedCCI caries care Parents dentist process acceptability assessed via TreatmentEvaluationInventory questionnaire cost term number appointment activity Twentyone centre 13 country participate DISCUSSION result Caries adapted pandemic provide clinical data could help support shifting caries care child towards individualised oralhealth behaviour improvement toothpreserving care improving health outcome explore caries progression controlled pandemic conducting nonAGP reducing inoffice time TRIAL REGISTRATION RetrospectivelyregisteredClinicalTrialsgovNCT0466659707122020 http registerclinicaltrialsgovprsappactionSelectProtocol sid=S000AGM4 se lectaction=Edit uid=U00019IE ts=2 cx=uwje3h Protocolversion 2 27012021,aerosols;covid-19;children;conservative care;dental care;dental caries;multicenter study;outcome assessment;remote consultation
Similarities Differences COVID19Related Multisystem Inflammatory Syndrome Children Kawasaki Disease,34222140,December 2019 first case coronavirus disease COVID19 first reported Wuhan China March 2021 120 million confirmed case COVID19 27 million death COVID19 mortality rate adult around 15 small proportion child requires hospitalization intensive care Recently increasing number COVID19 case child associated new multisystem inflammatory syndrome clinical feature laboratory characteristic similar Kawasaki disease KD KD shock syndrome toxic shock syndrome However new disorder distinct clinical feature laboratory characteristic condition also known multisystem inflammatory syndrome child MISC associated COVID19 observed mostly Europe United States emerging phenomenon raised question whether disorder KD triggered SARSCoV2 syndrome characterized multisystem inflammation mimic KD narrative review discus difference MISC KD aim increasing pediatrician awareness new condition guide process differential diagnosis,kawasaki disease;coronavirus disease 2019;difference;multisystem inflammatory syndrome in children;pediatric multisystem inflammatory syndrome temporally associated with sars-cov-2
Dietary food containing nitric oxide donor early curator SARSCoV2 infection possible role immune system,34374096,Severe acute respiratory syndrome coronavirus 2 SARS CoV2 lethal virus cause COVID19 Coronavirus disease 2019 respiratory illness caused COVID19 pandemic Even though multiple pharmacological trial ongoing proof treatment effectively cure prevent COVID19 Currently COVID19infected patient managed nonspecific medication suppress symptom associated comorbidities Nitric oxide biosignaling molecule shown effective treating several viral infection human Household Natural food rich nitrite nitrate donor scientifically proven therapeutic benefit immunerelated respiratory tract infection understood could inhibit early stage SARS CoV2 invasion human cell Fruits vegetable containing nitrite nitrate revised thought potential antiCoV agent effective control associated systemic disorder purpose review highlight key fact treatment prevention COVID19 infection food rich nitric oxide donor PRACTICAL APPLICATIONS Improving body s immune system early step considered preventive measure stop spreading COVID19 infection Emerging research continues mount dietary nitratesnitrites plant food healthy well keep u away infectious disease incorporated lowrisk adjuvant therapy various infection systemic disorder concept portrays regular consuming food fruit vegetable rich nitric oxide potential promote health improve general wellbeing reduce risk associated highly contagious disease Hence recommend adding nitrate nitritescontaining food regular diet improve selfimmunity well fight COVID19 disease,covid-19;dietary nitric oxide;fruits and vegetables;immune function
Evidence Biological Age Acceleration Telomere Shortening COVID19 Survivors,34200325,SARSCoV2 infection determines COVID19 syndrome characterized worst case severe respiratory distress pulmonary cardiac fibrosis inflammatory cytokine release immunosuppression condition led death 215 total infected world population far Among survivor presence socalled persistent postCOVID19 syndrome PPCS common finding COVID19 survivor PPCS present one symptom fatigue dyspnea memory loss sleep disorder difficulty concentrating study cohort 117 COVID19 survivor postCOVID19 144 noninfected volunteer COVID19free analyzed using pyrosequencing defined CpG island previously identified suitable biological age determination result show consistent biological age increase postCOVID19 population determining DeltaAge acceleration 1045 + 729 year +525 year range normality compared 368 + 817 year COVID19free population p 00001 significant telomere shortening parallel finding postCOVID19 cohort compared COVID19free subject p 00001 Additionally ACE2 expression decreased postCOVID19 patient compared COVID19free population DPP4 change light observation hypothesize epigenetic alteration associated postCOVID19 condition particularly younger patient 60 year,ace2;covid-19;dna methylation;dpp-4;deltaage;biological age;epigenetics;post-covid-19;telomeres
New HeparanaseInhibiting TriazoloThiadiazoles Attenuate Primary Tumor Growth Metastasis,34199150,Compelling evidence tie heparanase endoglycosidase cleaves heparan sulfate side HS chain proteoglycans step tumor development including tumor initiation angiogenesis growth metastasis chemoresistance Moreover heparanase level correlate shorter postoperative survival cancer patient encouraging development heparanase inhibitor anticancer drug Heparanaseinhibiting heparinheparan sulfatemimicking compound neutralizing antibody highly effective animal model cancer progression yet none compound reached stage approval clinical use present study focused newly synthesized triazolothiadiazoles compound 4iodo2 3 ptolyl 124 triazolo 34b 134 thiadiazol6yl phenol 4MMI identified potent inhibitor heparanase enzymatic activity cell invasion experimental metastasis tumor growth mouse model best knowledge first report showing marked decrease primary tumor growth mouse treated small molecule inhibit heparanase enzymatic activity result encourages optimization 4MMI preclinical clinical study primarily cancer also indication ie colitis pancreatitis diabetic nephropathy tissue fibrosis involving heparanase including viral infection COVID19,cell invasion;heparanase-inhibiting compounds;metastasis;primary tumor growth;small molecules;triazolo-thiadiazoles
Multisystem inflammatory syndrome child singlecenter experience,34227711,BACKGROUND case series aim evaluate presenting symptom laboratory data systemic finding response early treatment patient followed diagnosis multisystemic inflammatory syndrome associated novel coronavirus disease 2019 COVID19 METHODS presentation laboratory finding response treatment patient hospitalized diagnosed multisystemic inflammatory syndrome evaluated retrospectively RESULTS total 32 patient included study median age 90 15204 month 625 patient male 594 case nonspecific disease 312 typical complete Kawasaki 94 phenotypic characteristic atypical incomplete Kawasaki patient found low albumin elevated Creactive protein sedimentation rate ddimer patient elevated Nterminal proBtype natriuretic peptide procalcitonin Lymphopenia detected 25 patient 781 serum ferritin level elevated 25 patient 781 Eleven 344 patient responded well intravenous immunoglobulin treatment Twenty patient 625 received intravenous immunoglobulin steroid therapy secondline therapy one patient 31 received thirdline therapy intravenous immunoglobulin + steroid +anakinra + plasmapheresis None patient died CONCLUSIONS patient mild clinical symptom responded well intravenous immunoglobulin steroid therapy first secondline therapy one patient clinically stabilized thirdline treatment respond intravenous immunoglobulin steroid therapy think patient diagnosed multisystem inflammatory syndrome child recovered recommended quickly medical intervention Treatment therefore started immediately patient diagnosed multisystem inflammatory syndrome child response 24 h initial treatment next treatment protocol started,covid 19;multisystem inflammatory syndrome;pediatrics
Risk Hospitalization COVID19 Patients Predicted Lung Ultrasound Primary Care,34200028,BACKGROUND usefulness Lung Ultrasound LUS diagnosis interstitial syndrome caused COVID19 broadly described aim study evaluate LUS may predict complication hospital admission COVID19 pneumonia primary care patient METHODS observational study collect data cohort 279 patient clinical symptom COVID19 pneumonia attended Balaguer Primary Health Care Area 16 March 2020 30 September 2020 collected result LUS scan reported one general practitioner created database analysed absolute relative frequency LUS finding association hospital admission found different LUS pattern diffuse attenuated diffuse predominantly unilateral risk factor hospital admission p 005 Additionally evolutionary pattern acute phase represented risk factor p = 00019 contrary normal ultrasound pattern protective factor p = 00037 Finally presence focal interstitial pattern associated hospital admission p = 04918 CONCLUSION lung ultrasound useful predict complication COVID19 pneumonia diagnose lung disease cancer tuberculosis pulmonary embolism chronic interstitial pneumopathy pleuropericarditis pneumonia heart failure,covid-19;assessment risk;hospitalization;lung interstitial disease;primary health-care;ultrasound
Developing First Telenursing Service COVID19 Patients Experience South Korea,34206977,study aimed examine process establishing telenursing service COVID19 patient mild symptom admitted community treatment center CTC process establishing service reviewed degree satisfaction provided service investigated based medical record patient submitted discharge CTC total 113 patient admitted patient entered selfmeasured vital sign symptom COVID19 infection electronic questionnaire mobile application nurse implemented remote nursing based patient input data educational material including video selfmeasuring vital sign living guideline prepared arranged advance telenursing protocol regarding whole process patient admission discharge used applied five CTCs noncontact counseling service s satisfaction convenience score 465 point 462 point respectively 5 point noncontact nursing counseling service played important role monitoring patient medical condition spread COVID19 experience establishing telenursing service CTC provides clear direction innovate healthcare service future disaster,covid-19;republic of korea;community treatment center;non-contact nursing counseling service;telehealth;telenursing
bivalent recombinant vaccine targeting S1 protein induces neutralizing antibody SARSCoV2 variant wildtype virus,34226895,emerging variant severe acute respiratory syndrome coronavirus2 SARSCoV2 pandemic call urgent development universal corona virus disease 2019 COVID19 vaccine could effective wildtype SARSCoV2 mutant strain current study formulated protein subunit vaccine AS03 adjuvant recombinant protein S1 subunit SARSCoV2 S1WT S1 variant K417N E484K N501Y D614G subunit S1Mut immunized transgenic mouse express human angiotensinconverting enzyme 2 hACE2 S1 proteinspecific antibody production neutralization capability SARSCoV2 B1351 variant measured immunization mouse result revealed S1Mut antigen effective inhibiting receptorbinding domain ACE2 binding B1351 variant wildtype SARSCoV2 Furthermore development bivalent vaccine exhibited ideal neutralization property wildtype B1351 variant well variant finding may provide rationale development bivalent recombinant vaccine targeting S1 protein induce neutralizing antibody SARSCoV2 variant wildtype virus may importance explore potential clinical use bivalent recombinant vaccine future,sars-cov-2;bivalent vaccine;recombinant protein;variant
Lockdown effect Parkinson s disease COVID19 pandemic pilot study,34212285,coronavirusdisease 2019 COVID19 outbreak precipitated prolonged lockdown measure subsequent social distancing isolation reduction mobility increased psychological stress may worsen Parkinson s disease PD Therefore telemedicine proposed provide care PD patient evaluate effect lockdown motor nonmotor symptom PD patient COVID19 pandemic feasibility telemedicine Motor nonmotor aspect longitudinally assessed using structured questionnaire baseline inperson February 2020 followup remote webbased video lockdown evaluation seventeen PD patient evaluated baseline fourteen agreed participate completed followup evaluation impairment nonmotor aspect measured MDSUPDRS part p 0001 lockdown Nine patient participated independently telemedicine evaluation five needed help relative preliminary finding suggest impairment nonmotor symptom PD patient support feasibility need telemedicine monitoring PD patient COVID19 pandemic guarantee optimal assistance reducing burden infection finding also suggest movement disorder clinic carefully considering sociodemographics clinical feature developing telemedicine program,covid-19;motor symptoms;non-motor symptoms;parkinson's disease;psychological performance;telemedicine
Ischemic Lesions Brain Neonate SARSCoV2 Infection,34288632,Aim describe term newborn acquired severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection multisystem involvement including seizure associated ischemic lesion brain Background Coronavirus disease 2019 COVID19 predominantly respiratory infection may affect many system pediatric COVID19 case range asymptomatic mildmoderate disease specific clinical sign described neonatal COVID19 infection child severe central nervous system compromise rarely reported Case Description describe 17dayold newborn acquired SARSCoV2 infection family meeting admitted fever seizure lethargy consumption coagulopathy ischemic lesion brain cardiac involvement documented Conclusions SARSCoV2 neonatal infection associated multiorganic involvement patient significant central nervous system compromise associated ischemic lesion laboratory finding consumption coagulopathy found Clinical Significance Although neonatal SARSCoV2 infection infrequent associated multiorganic involvement Neonatologists pediatrician aware unusual way presentation COVID19 newborn infant,
Danish citizen preference athome oropharyngealnasal SARSCoV2 specimen collection,34216732,INTRODUCTION Diagnostic confirmation SARSCoV2 selfcollection specimen reliable method compared healthcare worker collected sample Citizens preference collection method unknown athome collection could several advantage METHODS study investigated preference guided athome selfcollection versus athospital specimen collection healthcare worker RESULTS Among 3709 participant athome swab collection preferred setting 2362 637 compared 1347 363 reporting preference athospital swabbing procedure CONCLUSION high preference guided athome selfcollection oropharyngealnasal SARSCoV2 specimen exists could future norm beyond COVID19,covid-19;diagnostics;oropharyngeal/nasal swab;patient-reported;sars-cov-2;self-collection
Pathophysiology Clinical Manifestations COVID19Related Acute Kidney InjuryThe Current State Knowledge Future Perspectives,34209289,continually evolving severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic resulted vast number either acute chronic medical impairment pathophysiology yet fully understood SARSCoV2 tropism organ associated bilateral organ crosstalks well targeted dysfunction among acute kidney injury AKI seems highly prevalent infected patient need efficient management COVIDrelated AKI patient aspect still investigated nephrologists however another reason concern disturbingly high proportion various type kidney dysfunction patient recovered COVID19 Even though clinical picture AKI COVIDrelated AKI seems quite similar must considered regarding latter little known optimal management longterm consequence discrepancy raise urgent need research aimed evaluating molecular mechanism associated SARSCoV2induced kidney damage well standardized management COVIDrelated AKI patient following review present comprehensive mostrecent insight pathophysiology clinical manifestation recommended patient management treatment strategy postmortem finding patient COVIDrelated AKI,aki;covid-19;sars-cov-2;sars-cov-2 tropism;acute kidney injury;coronavirus;glomerulopathy;survival rate
Genome Editing Technologies Cellular Defense Viral Pathogens,34336867,Viral infectious disease significant threat welfare world population Besides widespread acute viral infection eg dengue fever chronic infection eg human immunodeficiency virus HIV hepatitis B virus HBV emerging virus severe acute respiratory syndrome coronavirus 2 SARSCoV2 pose great challenge world Genome editing technology including clustered regularly interspaced short palindromic repeat CRISPR CRISPRassociated Cas protein zincfinger nuclease ZFNs transcription activatorlike effector nuclease TALENs played essential role study new treatment viral infectious disease cell line animal model clinical trial Genome editing tool used eliminate latent infection provide resistance new infection Increasing evidence shown genome editingbased antiviral strategy simple design quickly adapted combat infection wide spectrum viral pathogen including emerging coronaviruses review development application genome editing technology preventing eliminating infection caused HIV HBV HPV HSV SARSCoV2 discus latest advance could enlighten development genome editing novel therapy viral infectious disease,crispr/cas;hiv;sars-cov-2;emerging pathogen;genome editing;hepatitis b;viral infectious disease
Impact novel coronavirus infection patient uveitis associated autoimmune disease Result COVID19GEAS patient survey,34217471,INTRODUCTION objective study know characteristic COVID19 patient uveitis associated Systemic Autoimmune Disease SAD telematic survey MATERIAL METHODS Internal Medicine Society Group Systemic Autoimmune disease conducted telematic survey patient SAD learn characteristic COVID19 population RESULTS total 2789 patient answered survey 28 diagnosis uveitis associated SAE majority 82 female caucasian 82 mean age 48 year frequent SAEs Behcet s disease followed sarcoidosis systemic lupus erythematosus 46 patient receiving corticosteroid treatment mean prednisone dose 11 mgday Regarding infection 14 50 patient reported symptom compatible SARSCoV2 infection RTPCR performed nasopharyngeal smear two patient one 4 positive CONCLUSIONS asymptomatic symptomatic COVID19 patient ASDassociated UNI received similar immunosuppressive treatment,anti-tnf-alpha therapy;covid-19;corticoides;corticosteroids;immunosuppression;inmunosupresion;tratamiento anti-tnf alfa;uveitis;uveitis
Pilot study evaluate safety culture perception operating theatre acute NHS Trust using National Air Traffic Services NATS App,34281735,area critical safety organisation perceived actual culture National Air Traffic Services NATS work closely large safetycritical industry including various aviation company enable identify strength vulnerability aim improving safe practice NATS developed simple free downloadable selfassessment App individual use ass culture perception organisation App 16 question arranged four domain knowledge used date healthcare part initiative improve staff culture evaluated operating theatre colleague safety perception large acute NHS Trust pilot study using NATS safety App Staff downloaded App smart device completing Responses sent anonymously App collated NATS total 146 colleague downloaded completed questionnaire One hundred seventeen staff 80 felt encouraged report safety concern 86 n=126 confirmed lack available support healthcare manager 43 respondent n=63 would find easy challenge colleague observed unsafe behaviour pilot study identified positive indicator evolving NHS safety culture concern speaking support challenging colleague without fear issue known occur across healthcare work needed NHS provide supportive environment improve patient safety lower hierarchy surgical team,covid-19;culture;human factors;medical error;risk;safety
Coronavirus Disease 2019 COVID19 Diagnostic Tools Focus Detection Technologies Limitations,34287238,ongoing coronavirus disease COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 pose severe threat human health global economy resulted overwhelming stress health care system worldwide Despite global health catastrophe especially number infection fatality COVID19 pandemic also revolutionized research discovery remarkable success diagnostics treatment vaccine development use many diagnostic method helped establish public health guideline mitigate spread COVID19 However limited information shared method need scientific community learn technology addition sensitivity specificity limitation review article focused providing insight major method used SARSCoV2 detection describe detail core principle method including molecular serological approach along reported claim rate false negative false positive type specimen needed level technology time required perform test Although study rank prioritize method information help development guideline diagnostic protocol clinical setting reference laboratory,covid-19;fica;lamp;pcr;sars-cov-2;diagnostic tools;mngs;pandemics
Accurate longrange forecasting COVID19 mortality USA,34226584,need improved model accurately predict COVID19 dynamic vital managing pandemic consequence use machine learning technique design adaptive learner based epidemiological data available given time produce model accurately forecast number reported COVID19 death case United States 10 week future mean absolute percentage error 9 addition accurate longrange COVID predictor far developed capture observed periodicity daily reported number effectiveness based three design feature 1 producing different model parameter predict number COVID death case time given number week future 2 systematically searching available covariates historical value find effective combination 3 training model using `` lastfold partitioning proposed model validated last instance training dataset rather crossvalidated Assessments many published COVID predictor show predictor 1948 accurate,
Mesenchymal stem cell derived exosomes combat Covid19,34363275,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 causing ongoing pandemic coronavirus disease 2019 Covid19 Effective therapy required treatment patient severe stage disease Mesenchymal stem cell MSCs evaluated numerous clinical trial present challenge carcinogenic risk special storage condition coupled insufficient data mechanism action majority unique property MSCs related paracrine activity especially exosomes impact MSCsderived exosomes MSCEs complication Covid19 investigated several study MSCEs may improve complication Covid19 cytokine storm acute respiratory distress syndrome ARDS acute lung injury ALI Additionally exosomes evaluated applicable nanosize carrier antiviral therapeutic agent Herein consider several potential application MSCs derived exosomes treatment Covid19,ali;ards;covid-19;sars-cov-2;exosomes;mesenchymal stem cell
Pharmacists involvement COVID19 vaccination across Europe situational analysis current practice policy,34218402,One year since emergence COVID19 pandemic rapid response measure implemented internationally mitigate spread virus Following rapid successful preclinical human trial several vaccine authorised use across Europe European Medicines Agency national regulatory authority Clinical trial shown promising result including important reduction disease severity hospitalisation mortality order maximise public health benefit available vaccine pressing need vaccinate large proportion population Internationally prompted coordination existing service enormous scale development implementation novel vaccination strategy ensure maximum inoculation shortest possible timeframe Pharmacists promoted healthcare professional enhance rollout COVID19 vaccination programme paper aim summarise current policy practice relation pharmacist involvement COVID19 vaccination 13 country across Europe,covid-19;coronavirus;pharmacist;pharmacy;public health;vaccine
Love time COVID19 scoping review male sexual health,34211656,coronavirus disease 2019 COVID19 outbreak constitutes unparalleled socioeconomic burden global scale critically ill COVID19 patient disease manifest state hyper inflammation causing cytokine storm lead various pulmonary cardiovascular spurious manifestation One reported sequela COVID19 sexual dysfunction male even recovery disease Various mechanism proposed regarding erectile dysfunction patient suffers COVID19 important hypothesis endothelial dysregulation subclinical hypogonadism psychosocial misery pulmonary impairment contributing erectile dysfunction Assessment testicular function hormonal axis needed ass novel association COVID19 sexual reproductive health issue male,covid-19;erectile dysfunction;male hypogonadism;sexual health
Enveloped Viruses Exploit Secretory Proprotein Convertases Regulate Infectivity Spread,34202098,Inhibition binding enveloped virus surface glycoprotein host cell receptor major target vaccine constitutes efficient strategy block viral entry infection various host cell tissue Cellular entry usually requires fusion viral envelope host plasma membrane entry mechanism often preceded `` priming andor `` activation step requiring limited proteolysis viral surface glycoprotein expose fusogenic domain efficient membrane juxtaposition 9membered family Proprotein Convertases related SubtilisinKexin PCSK serine protease PC1 PC2 Furin PC4 PC5 PACE4 PC7 SKI1S1P PCSK9 participate posttranslational cleavage andor regulation multiple secretory protein typeI membranebound Furin SKI1S1P major convertases responsible processing surface glycoprotein enveloped virus Stefan Kunz considerably contributed define role SKI1S1P activation arenavirus causing hemorrhagic fever Furin recently implicated activation spike Sprotein SARSCoV2 Furininhibitors tested antiviral COVID19 member PCSKfamily also implicated viral infection PCSK9 Dengue Herein summarize various function PCSKs present argument whereby inhibition could represent powerful arsenal limit viral infection causing present future pandemic,covid-19;furin;pcsk9;sars-cov-2;ski-1/s1p;enveloped virus;pandemic;proprotein convertases
COVID19Associated Cardiovascular Complications,34209705,Coronavirus disease 2019 COVID19 reported cause cardiovascular complication myocardial injury thromboembolic event arrhythmia heart failure Multiple mechanismssome overlapping notably role inflammation IL6potentially underlie complication reported cardiac injury may result direct viral invasion cardiomyocytes consequent unopposed effect angiotensin II increased metabolic demand immune activation microvascular dysfunction Thromboembolic event widely reported venous arterial system attracted intense interest underlying mechanism could potentially due endothelial dysfunction secondary direct viral invasion inflammation Additionally thromboembolic event may also consequence attempt immune system contain infection immunothrombosis neutrophil extracellular trap Cardiac arrhythmia also reported wide range implicated contributory factor ranging direct viral myocardial injury well factor including atrisk individual underlying inherited arrhythmia syndrome Heart failure may also occur progression cardiac injury precipitation secondary initiation withdrawal certain drug accumulation desArg 9 bradykinin DABK excessive induction proinflammatory G protein coupled receptor B1 BK1 presenting cardiovascular symptom include chest pain dyspnoea palpitation currently intense interest vaccineinduced thrombosis treatment Long COVID since many patient survived COVID19 describe persisting health problem review summarise proposed physiological mechanism COVID19associated cardiovascular complication,covid-19;long covid;sars-cov-2;cardiovascular system
FullLength Computational Model SARSCoV2 Spike Protein Implications Viral Membrane Fusion Mechanism,34208191,SARSCoV2 virus become one greatest cause infectious death morbidity since 1918 flu pandemic Substantial unprecedented progress made elucidation viral infection process short time however understanding structurefunction dynamic spike protein membrane fusion process viral uptake remains incomplete Employing computational approach use fulllength structural model SARSCoV2 spike protein integrating CryoEM image biophysical property fill gap understanding propose membrane fusion model incorporating structural transition associated proteolytic processing spike protein initiate regulates series event facilitate membrane fusion viral genome uptake membrane fusion mechanism highlight notable role S1 subunit eventual mature spike protein uptake host membrane comprehensive view account distinct neutralizing antibody binding effect targeting spike protein enhanced infectivity SARSCoV2 variant,covid-19;s protein;sars-cov-2;coronavirus;fusion mechanism;membrane fusion;spike protein;viral entry
Stochastic modelling dynamic infection caused SARSCoV2 COVID19 various condition lockdown quarantine testing,34336562,develop mathematical model transmission spread infection caused severe acute respiratory syndrome coronavirus 2 SARCoV2 cause coronavirus disease 2019 COVID19 disease since classified World Health Organization global pandemic focus attention virus transmission closed population hence use compartmental epidemic model study inherent dynamic infection various subgroup population assume random interaction member different subgroup hence employ stochastic modelling technique absence vaccine novel coronavirus government worldwide put place various intervention strategy including travel ban lockdown screening testing quarantine etc order reduce hopefully eliminate transmission spread COVID19 virus intervention built model investigate effect effectiveness particular observe two subgroup containing infectious individual namely subgroup comprising unidentified asymptomatic individual well subgroup comprising unquarantined symptomatic individual pose greatest risk transmission spread infection therefore also observe result rapid realtime mass testing well effective mandatory quarantine infected individual fundamentally critical necessary step reducing internal transmission spread COVID19 virus particular result indicate lockdown important extent implemented effectively help reducing rate transmission ie help flatten transmission curve hence allow policy maker healthcare practitioner put place important process realtime mass testing mandatory quarantine including hospitalization treatment result presented single wave part single wave COVID19 infection given population condition repeated result would correspondingly extend multiple wave infection,covid-19;lockdown;quarantine;sars-cov-2;stochastic modelling;testing
Dynamic profile SARSCoV2 infection among hospitalized patient Kuwait descriptive study,34353284,BACKGROUND coronavirus induced disease 2019 COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 Wuhan China December 2019 currently spreading rapidly worldwide study aimed analyze dynamic profile SARSCoV2 infection among hospitalized patient would characterize period viral shedding detection among patient METHODS Retrospectively 103 confirmed SARSCoV2 patient hospitalized Jaber hospital Kuwait included Demographic clinical characteristic patient collected Nasopharyngeal swab obtained different time interval analyzed RealTime RTPCR SARSCoV2 infection RESULTS 103 hospitalized patient SARSCoV2 infection median age 41 year 64 male median period admission positive SARSCoV2 RTPCR test 19 day IQR 1322 median period admission active negative SARSCoV2 RTPCR test result 22 day IQR 1626 Older patient patient comorbidities patient symptom likely extended viral shedding CONCLUSION first time descriptive study conducted Kuwait SARSCoV2 RTPCR test result 103 patient positive SARSprovided solid proof good understanding dynamic profile SARSCoV2 infection among patient Kuwait information enrich global knowledge emerging SARSCoV2,covid-19;kuwait;rt-pcr;sars-cov-2
Rapid antigen test detection SARSCoV2 narrative review,34217106,rapid identificationand isolation COVID19 patient become cornerstone control recent outbreak Realtime quantitative polymerase chain reaction routinely used confirm COVID19 diagnosis considered gold standard due high sensitivity specificity Nevertheless usually take several day relatively higher cost Antigen test based emerged cope disadvantage offering rapid result easytouse procedure low cost objective narrative review provide uptodate data CEmarked rapid antigen test RATs COVID19 Given large number study focused representative widely used Spain Standard Q Nadal Panbio CerTest Wondfo RATs become useful validated tool controlling spread COVID19 allowing rapid identification active infection isolation positive patient present revision literature demonstrated sensitivity specificity available RATs Spain high accomplish European regulation recommendation,antigen test;covid-19;centro de atencion medica;diagnosis;diagnostico;point-of-care;rapid;rapido;sars-cov-2;test de antigenos
AntiSARSCoV2 Vaccines Monoclonal Antibodies Facing Viral Variants,34207378,severe acute respiratory syndrome coronavirus 2 SARSCoV2 genetically variable allowing adapt various host including human Indeed SARSCoV2 accumulated around two mutation per genome month first relevant event context occurrence mutant D614G Spike gene Moreover several variant emerged including wellcharacterized 20I501YV1 20H501YV2 20J501YV3 strain addition detected within cluster 19B501Y 20C655Y France Mutants also emerged animal including variant transmitted human namely Mink variant detected Denmark emergence variant affected transmissibility virus example 20I501YV1 82 transmissible preexisting variant severity ability escape natural adaptive vaccine therapeutic immunity respect review literature variant currently emerged effect vaccine therapy particular monoclonal antibody mAbs emergence SARSCoV2 variant must examined allow effective preventive curative control strategy developed,sars-cov-2;antibody;emergence;immunity;mutations;vaccine;variant
COVID19 related mortality kidney transplant hemodialysis patient comparative prospective registry based study,34132811,BACKGROUND COVID19 exposed hemodialysis patient kidney transplant recipient unprecedented lifethreatening infectious disease raising concern kidney replacement therapy KRT strategy pandemic present study investigated association type KRT COVID19 severity adjusting difference individual characteristic METHODS Data kidney transplant recipient hemodialysis patient diagnosed COVID19 February 1st December 1st 2020 retrieved ERACODA Cox regression model adjusted age sex frailty comorbidities used estimate hazard ratio HR 28day mortality risk patient subset tested symptom RESULTS total 1670 patient 496 functional kidney transplant 1174 hemodialysis included 169 kidney transplant 239 hemodialysis patient died within 28 day presentation unadjusted 28day mortality risk 33 lower kidney transplant recipient compared hemodialysis patient HR 067 95 CI 052085 fully adjusted model risk 78 higher kidney transplant recipient HR 178 95 CI 122261 compared hemodialysis patient association similar patient tested symptom fully adjusted model HR 200 95 CI 131306 risk dramatically increased first posttransplant year Results similar endpoint eg hospitalization ICU admission mortality beyond 28 day across subgroup CONCLUSIONS Kidney transplant recipient greater risk severe course COVID19 compared hemodialysis patient therefore require specific infection mitigation strategy,covid-19;dialysis;kidney;mortality;transplantation
Surgery pancreatic tumor midst COVID19 pandemic,34222414,spread new coronavirus COVID19 infection 2020 significant impact treatment cancer worldwide COVID19 pandemic biggest challenge pancreatic surgeon difficulty providing oncological care review article standpoint surgeon explain concept triaging patient pancreatic tumor COVID19 pandemic actual impact COVID19 treatment patient pancreatic tumor vital point selecting best therapeutic approach patient pancreatic tumor pandemic 1 Oncologists need tailor treatment plan based COVID19 phase tumor malignant potential patient comorbidities 2 Optimal treatment pancreatic cancer planned according condition patient tumor resectability based national comprehensive cancer network resectability criterion choose best therapeutic approach patient pancreatic tumor pandemic need tailor treatment plan based elective surgery acuity scale ESAS Newly established ESAS pancreatic tumor flowchart indicating treatment strategy pancreatic cancer feasible overcome situation,covid-19;national comprehensive cancer network resectability criteria;pancreatic ductal adenocarcinoma;pancreatic tumor;pandemic;surgical treatment
Characteristics coronavirus disease 2019 review emerging literature,34214071,Background 2019 coronavirus disease outbreak COVID19 spread rapidly around world extent ultimate effect still unclear ongoing constantly evolving pandemic Aims compile literature synthesize SpanishLatin American language available international information describing etiological pathophysiological epidemiological management aspect COVID19 Methods Narrative review using specific section created database criterion selecting study depended specific area addressed etiological pathophysiological epidemiological aspect treatment alternative etc References Spanish English included Results World Health Organization report COVID19 disease zoonotic origin transmitted human host first case identified late 2019 January 2020 Wuhan city China categorized highly contagious transmissible human attributed structural feature novel coronavirus clinical presentation variable nonspecific well severity clear tropism respiratory system severe case may develop pneumonia respiratory failure multiorgan failure thus death occurs age group lower percentage child 19 year age 24 Mortality varies country region 15 93 total reported case Associated risk factor presence comorbidities advanced age immunosuppression Conclusions date thousand scientific article attempt explain onset progression possible treatment option global impact disease still certainty level quality evidence essential generate document synthesized translated Spanish language bring information place country impacted disease,sars-cov-2;diagnosis;physiopathology;treatment;covid-19
Structural insight distinctive RNA recognition therapeutic potential RIGIlike receptor,34287999,RNA virus including coronavirus develop unique strategy evade host immune response interrupting normal function cytosolic retinoic acidinducible geneI RIGI like receptor RLRs RLRs rapidly detect atypical nucleic acid thereby triggering antiviral innate immune signaling cascade subsequently activates interferon transcription induction proinflammatory cytokine chemokines Nonetheless receptor manipulated viral protein subvert host immune system sustain infectivity replication potential virus RIGI sens singlestranded doublestranded short doublestranded RNAs recognizes key signature 5triphosphate moiety blunt end viral RNA Meanwhile melanoma differentiationassociated gene 5 MDA5 triggered longer double stranded RNAs messenger RNAs lacking 2Omethylation 5cap RNA aggregate Therefore structural insight nucleicacidsensing downstream signaling mechanism receptor hold great promise developing effective antiviral therapeutic intervention review highlight critical role played RLRs viral infection well ligand recognition mechanism addition highlight crosstalk tolllike receptor RLRs provide comprehensive overview RLRassociated disease well therapeutic potential RLRs development antiviraldrugs Moreover believe RLRbased antiviral serve step toward countering recent coronavirus disease 2019 pandemic,covid-19;mda5;rig-i;rig-i-like receptor;antivirals;coronavirus
SARSCoV2 Isolates Show Impaired Replication Human Immune Cells Differential Ability Replicate Induce Innate Immunity Lung Epithelial Cells,34378952,primary target organ coronavirus disease 2019 COVID19 infection respiratory tract Currently limited information ability severe acute respiratory syndrome coronavirus 2 SARSCoV2 infect regulate innate immunity human immune cell lung epithelial cell compared ability four Finnish isolates SARSCoV2 COVID19 patient replicate induce interferon IFNs cytokine different human cell isolates failed replicate dendritic cell macrophage monocyte lymphocyte induction cytokine gene expression seen However isolates replicated Calu3 cell readily induced type type III IFN gene expression hCoV19FinlandFIN252020 isolate originating traveler Milan March 2020 showed better ability replicate induce IFN inflammatory response Calu3 cell isolates SARSCoV2 data increase knowledge pathogenesis antiviral mechanism SARSCoV2 infection human cell system IMPORTANCE rapid spread coronavirus disease 2019 COVID19 pandemic information replication severe acute respiratory syndrome coronavirus 2 SARSCoV2 regulation innate immunity human immune cell lung epithelial cell needed present study show SARSCoV2 failed productively infect human immune cell different isolates SARSCoV2 showed differential ability replicate regulate innate interferon response human lung epithelial Calu3 cell finding open way study mechanism pathogenesis SARSCoV2 human cell,covid-19;calu-3 cell;sars-cov-2;tpck-treated trypsin;vero e6 cell;human dc;human macrophage;interferon (ifn) response;viral replication
Preoperative chest computed tomography emergency surgery COVID19 pandemic,34351807,BACKGROUND COVID19 pandemic challenge recommendation patient preoperative assessment preventing severe acute respiratory syndrome coronavirus type 2 transmission COVID19associated postoperative complication morbidity PURPOSE evaluate contribution chest computed tomography preoperatively assessing patient suspected infected COVID19 time referral METHODS Candidates emergency surgery screened via chest computed tomography 8 27 April 2020 retrospectively evaluated Computed tomography image analysed presence COVID19associated intrapulmonary change applicable laboratory recorded clinical symptom extracted RESULTS Eightyeight patient underwent preoperative chest computed tomography 24 rated moderately suspicious 11 highly suspicious computed tomography Subsequent reverse transcription polymerase chain reaction RTPCR performed seven patient tested negative COVID19 Seven patient showed COVID19associated clinical symptom classified mildly moderately severe per clinical classification grading system one case severe Four case underwent RTPCR negative result CONCLUSION cohort without clinical suspicion COVID19 infection upon referral preoperative computed tomography COVID19 pandemic yield high suspicion infection even patient lack clinical symptom RTPCRnegative recommendation made based result contribute debate,imaging and x-ray / infection control / equipment / patient safety/outcomes / pre-assessment
Reactivation Varicella Zoster Virus Vaccination SARSCoV2,34205861,Seven immunocompetent patient aged 50 year old presented herpes zoster HZ infection median 9 day range 720 vaccination SARSCoV2 occurrence HZ within time window 121 day vaccination defined increased risk reported cellmediated immunity involvement suggest COVID19 vaccination probable cause HZ case support importance continuing assessment vaccine safety ongoing massive vaccination COVID19 pandemic encourage reporting communication vaccinationassociated adverse event,sars-cov-2;herpes zoster;mrna vaccines
COVID19 South Korea Proper timing Easing Mask mandate COVID19 Vaccination,34346306,25 July 2021 Korea Disease Control Prevention Agency reported 1422 new COVID19 case 188848 total case 2073 total death 110 fatality rate Since first SARSCoV2 case reported effort find treatment vaccine COVID19 widespread Four vaccine s emergency use listing approved usage BNT162b2 mRNA1273 AZD1222 Ad26COV2S Vaccines SARSCoV2 need least 14 day achieve effectiveness Thus people abide prevention control measure including wearing mask washing hand social distancing However lot new case reported vaccination many people follow prevention control measure end 14 day period doubt need break free mask mandate let u decide timing haste Even mask mandate eased changed depending number reported case vaccination well prevention control measure circumstance changing influence mutant coronavirus,breakthrough infection;covid-19;mask;sars-cov-2;vaccination
Assessment Knowledge Practice Attitude Biomedical Waste Management among Healthcare Professionals COVID19 Crises AlAhsa,34207056,Biomedical waste BMW management essential practice healthcare professional HCPs preventing health also environmental hazard Coronavirus disease COVID19 become global pandemic posing significant challenge healthcare sector crosssectional study performed ass knowledge practice attitude BMW management among HCPs taking care patient COVID19 associated demographic variable AlAhsa healthcare sector 256 HCPs selected randomly 105 41 excellent knowledge 87 34 good knowledge 64 25 poor knowledge mean score 131 + 36 higher mean score 144 + 32 obtained physician 136 + 38 nurse HCPs Regarding practice 72 281 HCPs used discarded PPE handling biomedical waste Additionally 88 344 followed proper hand hygiene procedure whenever needed Physicians nurse respiratory therapist favorable attitude HCPs statistically significant association found among knowledge level educational qualification p 00001 gender p 0001 work experience p 005 Emphasis needed train HCPs regarding proper BMW management pandemic prevent infection transmission,covid-19;kpa;biomedical waste;healthcare;healthcare professionals
Communicable Illness Mitigation Strategies Traveling Elite Sporting Organizations,34292110,CONTEXT Transmission communicable disease observed sporting organization often preventable Early detection isolation treatment significantly diminish time lost recently paucity standardized guideline outlining feasible preventable measure protect athlete staff contagious illness Therefore purpose narrative highlight optimal prevention practice transmission mitigation particular focus hygiene activity travel consideration professional sporting organization EVIDENCE ACQUISITION Current recommendation Centers Disease Control Prevention peerreviewed journal STUDY DESIGN Clinical review LEVEL EVIDENCE Level 5 RESULTS Communicable illness prevention strategy begin level sufficient personal hygiene practice Common area surface cleaning recommendation including shared equipment sanitization usage well designated equipment use specific athlete considered minimize crosscontamination particular likedposition player Intelligent design shared area include redistributing layout communal space feasibly spreading locker designation minimum distance 6 ft one another Travel consideration include placing susceptible passenger closest window seating boarding last exiting first Team physician knowledge essential personnel medical history effort risk stratify staff member player setting communicable disease CONCLUSION Providing framework illness management prevention important considering effect player health missed time performance overall cost Containment commonly observed communicable illness optimized sufficient personal hygiene practice common area surface cleaning recommendation intelligent design shared area travel hotel consideration well appropriate screening tool isolation technique STRENGTH RECOMMENDATION TAXONOMY SORT B,covid-19;hygiene;prevention-strategy;sporting organization;transmission;travel
Effect Canakinumab v Placebo Survival Without Invasive Mechanical Ventilation Patients Hospitalized Severe COVID19 Randomized Clinical Trial,34283183,Importance Effective treatment patient severe COVID19 needed Objective evaluate efficacy canakinumab antiinterleukin1beta antibody patient hospitalized severe COVID19 Design Setting Participants randomized doubleblind placebocontrolled phase 3 trial conducted 39 hospital Europe United States total 454 hospitalized patient COVID19 pneumonia hypoxia requiring invasive mechanical ventilation IMV systemic hyperinflammation defined increased blood concentration Creactive protein ferritin enrolled April 30 August 17 2020 last assessment primary end point September 22 2020 Intervention Patients randomly assigned 11 receive single intravenous infusion canakinumab 450 mg body weight 40 60 kg 600 mg 6080 kg 750 mg 80 kg n = 227 placebo n = 227 Main Outcomes Measures primary outcome survival without IMV day 3 day 29 Secondary outcome COVID19related mortality measurement biomarkers systemic hyperinflammation safety evaluation Results Among 454 patient randomized median age 59 year 187 woman 412 417 919 completed day 29 trial day 3 29 198 223 patient 888 survived without requiring IMV canakinumab group 191 223 857 placebo group rate difference 31 95 CI 31 93 odds ratio 139 95 CI 076 254 P = 29 COVID19related mortality occurred 11 223 patient 49 canakinumab group v 16 222 72 placebo group rate difference 23 95 CI 67 22 odds ratio 067 95 CI 030 150 Serious adverse event observed 36 225 patient 16 treated canakinumab v 46 223 206 received placebo Conclusions Relevance Among patient hospitalized severe COVID19 treatment canakinumab compared placebo significantly increase likelihood survival without IMV day 29 Trial Registration ClinicalTrialsgov Identifier NCT04362813,
Macro level factor influencing strategic response emergent pandemic scoping review,34221359,Background Strategic planning critical successful pandemic management study aimed identify review scope analytic depth situation analysis conducted understand utility capture documented macrolevel factor impacting pandemic management Methods synthesise disparate body literature adopted twostep search review process systematic search literature conducted identify study since 2000 1 employed situation analysis 2 examined contextual factor influencing pandemic management included study analysed using sevendomain system approach discipline strategic management Results Nineteen study included final review ranging single country 6 regional multicountry study 13 Fourteen study single disease focus 5 study evaluating response one COVID19 Severe Acute Respiratory Syndrome SARS Middle East Respiratory Syndrome MERS Influenza H1N1 Ebola virus disease Zika virus disease pandemic Six study examined single domain political economic sociological technological ecological wider industry PESTELI 5 study examined two four domain 8 study examined five domain Methods employed predominantly literature review recommendation focus predominantly addressing inhibitor sociological technological domain recommendation articulated political domain Overall legislative domain least represented Conclusions Expost analysis using sevendomain strategic management framework provides opportunity planned systematic response pandemic remains critical current COVID19 pandemic evolves,
Type2 Diabetes Risk Factor Severe COVID19 Infection,34205044,current outbreak caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 termed coronavirus disease 2019 COVID19 generated notable challenge diabetic patient Overall people diabetes higher risk developing different infectious disease demonstrate increased mortality Type 2 diabetes mellitus T2DM significant risk factor COVID19 progression severity poor prognosis increased mortality diabetes contributes COVID19 severity unclear however may correlated effect hyperglycemia systemic inflammatory response immune system dysfunction Using envelope spike glycoprotein SARSCoV2 COVID19 bind angiotensinconverting enzyme 2 ACE2 receptor key protein expressed metabolic organ tissue pancreatic islet Therefore suggested diabetic patient susceptible severe SARSCoV2 infection glucose metabolism impairment complicate pathophysiology COVID19 disease patient review provide insight COVID19 disease complication relevant diabetes try focus present data growing concept surrounding SARSCoV2 infection T2DM patient,sars-cov-2;adipose tissue;diabetes;glucose metabolism;immune response;vaccines
progress chemokines chemokine receptor autism spectrum disorder,34077795,Autism spectrum disorder ASD group neurodevelopmental disorder main symptom ASD impairment social communication abnormal behavioral pattern Studies shown immune dysfunction neuroinflammation play key role ASD patient experimental model Chemokines group small protein regulate cell migration mediate inflammation response via binding chemokine receptor Thus chemokineschemokine receptor may involved neurodevelopmental disorder associated ASD review summarize research progress chemokine aberration ASD also review recent progress clinical treatment ASD pharmacological research related chemokineschemokine receptor review highlight possible connection chemokineschemokine receptor ASD provides novel potential target drug discovery ASD,autism spectrum disorders;covid-19;chemokine receptors;chemokines
Identification 13 Guanidinobenzoyl AminidinobenzoylContaining Drugs Potentially Inhibit TMPRSS2 COVID19 Treatment,34209110,Positively charged group mimic arginine lysine natural substrate trypsin necessary drug inhibit trypsinlike serine protease TMPRSS2 involved viral entry spread coronaviruses including SARSCoV2 Based assumption identified set 13 approved clinically investigational drug positively charged guanidinobenzoyl andor aminidinobenzoyl group including experimentally verified TMPRSS2 inhibitor Camostat Nafamostat Molecular docking using CITASSERpredicted TMPRSS2 catalytic domain model suggested guanidinobenzoyl aminidinobenzoyl group drug could form putative salt bridge interaction sidechain carboxyl group Asp435 located S1 pocket TMPRSS2 Molecular dynamic simulation revealed high stability putative salt bridge interaction longtime 100 n simulation molecular mechanicsgeneralized Born surface areabinding free energy assessment perresidue energy decomposition analysis also supported strong binding interaction TMPRSS2 proposed drug result suggest proposed compound addition Camostat Nafamostat could effective TMPRSS2 inhibitor COVID19 treatment occupying S1 pocket hallmark positively charged group,covid-19;sars-cov-2;tmprss2;docking;drug;molecular dynamics
Effect Social Distancing Early Spread Novel Coronavirus,34226769,article quantifies effect individual social distancing spread novel coronavirus use data time spent individual activity would potentially expose crowd American Time Use Survey linked statelevel data positive test COVID Tracking Project estimate count data specification observed COVID19 infection state level function control demographic variable measure social distance capture amount time individual across state spend activity potentially expose crowd Parameter estimate reveal number statelevel novel coronavirus infection decrease respect measure individual social distance practical perspective parameter estimate suggest typical individual US state spend eight hour away crowd completely would translate approximately 240000 fewer COVID19 infection across state result suggest least United States social distancing policy effective slowing spread novel coronavirus,
Clinical coding long COVID English primary care federated analysis 58 million patient record situ using OpenSAFELY,34340970,BACKGROUND Long COVID describes new persistent symptom least 4 week onset acute COVID19 Clinical code describe phenomenon recently created AIM describe use longCOVID code variation use general practice demographic variable time DESIGN SETTING Populationbased cohort study English primary care METHOD Working behalf NHS England OpenSAFELY data used encompassing 96 English population 1 February 2020 25 May 2021 proportion people recorded code long COVID measured overall demographic factor electronic health record software system EMIS TPP week RESULTS Long COVID recorded 23 273 people Coding unevenly distributed among practice 267 practice never used code Regional variation ranged 203 per 100 000 people East England 95 confidence interval CI = 193 214 556 per 100 000 people London 95 CI = 541 571 Coding higher among female 521 95 CI = 513 529 male 281 95 CI = 275 287 higher among practice using EMIS 537 95 CI = 529 544 using TPP 209 95 CI = 203 214 CONCLUSION Current recording long COVID primary care low variable practice may reflect patient presenting clinician patient holding different diagnostic threshold challenge design communication diagnostic code Increased awareness diagnostic code recommended facilitate research planning service also survey qualitative work better evaluate clinician understanding diagnosis,covid-19;electronic health records;general practice;long covid;primary health care
Thyroid surgery COVID19 pandemic result systematic review,34282552,PURPOSE COVID19 pandemic elective thyroid surgery experiencing delay problem COVID19 pandemic ongoing research purpose systematically collect literature data characteristic thyroid operation performed ass safetyrisks associated thyroid surgery COVID19 pandemic METHODS used procedure consistent PRISMA guideline comprehensive literature MEDLINE PubMed Scopus made using Thyroid `` coronavirus search term RESULTS total 293 article identified 9 study met inclusion criterion total number patient undergoing thyroid surgery 2217 indication surgery malignancy 1347 case 608 Screening protocol varied depending hospital protocol maximum level personal protection equipment adopted hospital length stay 23 day Total thyroidectomy chosen 1557 patient 15571868 834 596 procedure 5961558 383 combined lymph node dissection Crossinfections registered 14 case 14721 19 three 3721 04 severe pulmonary complication COVID19 377 patient 3771868 202 complication surgery 285 285377 756 hypoparathyroidism 71 71377 188 recurrent laryngeal nerve injury CONCLUSION risk SARSCoV2 transmission thyroid surgery relatively low study could promote restart planned thyroid surgery due COVID19 Future study warranted obtain solid data risk complication thyroid surgery COVID19 era,covid-19;surgery;thyroid
Environmental Contamination SARSCoV2 COVID19 hospital Wuhan China 2020,34347340,Coronavirus disease 2019 COVID19 pandemic caused high number infection death healthcare worker globally Distribution possible transmission route SARSCoV2 hospital environment clarified herein collected 431 environmental 391 surface 40 air sample intensive care unit ICU general ward GWs three hospital Wuhan China February 21 March 4 2020 detected SARSCoV2 RNA realtime quantitative PCR viral positive rate contaminated area 178 28157 whereas virus detected clean area Higher positive rate 2259 373 found ICU GWs 363 48 surface computer keyboard mouse ICU contaminated 810 800 followed ground 69 667 outer glove 25 400 17 air sample contaminated area one sample collected distance around 30 cm patient positive Enhanced surface disinfection hand hygiene effectively decontaminated virus environment finding might help understand transmission route contamination risk SARSCoV2 evaluate effectiveness infection prevention control measure healthcare facility article protected copyright right reserved,
Investigating effect air conditioning distribution transmission COVID19 virus particle,34219992,effect indoor airflow confirmed diffusion transmission droplet generated talking sneezing person viral respiratory infection COVID19 present study investigate effect airflow indoor environment classroom distribution transmission droplet emitted speaking cough infected person numerical analysis investigate persistence deposition particle surface desk face resident teacher student various scenario including opening window study put forward two type condition teacher speaking cough student distribution pathogenic particle Computational Fluid Dynamics used conduct study using EulerLagrange approach capture transport particle RANS equation compute airflow field classroom result indicate significant effect air conditioning open window close infected person reducing environmental pathogen Moreover concentration virus particle increase greatly near output hence presence people area increase risk contracting disease Furthermore window closed due low output capacity particle spread area domain increase risk infection Therefore recommended window open indoors environment especially window next speaker,cfd;classroom;deposition;eulerian-lagrangian model;sars-cov-2
War COVID19 National Identification Linked Adoption DiseasePreventive Behaviors China United States,34226776,Fighting COVID19 pandemic requires large number citizen adopt diseasepreventive practice contend national identification mobilize motivate people engage preventive behavior protect collective return would heighten national identification test reciprocal link conducted study two country diverse national tactic toward curbing pandemic 1 twowave longitudinal survey China Study 1 N = 1200 national goal fight COVID19 clearly set 2 fivewave longitudinal survey United States Study 2 N = 1001 national leader President Trump rejected severity COVID19 early stage Results revealed national identification associated increase diseasepreventive behavior country general However higher national identification associated greater trust Trump s administration among politically conservative American participant associated slower adoption preventive behavior reciprocal effect diseasepreventive behavior national identification observed China Overall finding suggest although national identification may serve protective factor curbing pandemic beneficial effect reduced political context,covid-19;disease prevention;disease-preventive behavior;national discourse;national identification;pandemic;social identity approach
Decline Motor Function COVID19 Pandemic Restrictions Recovery Child Cerebral Palsy Case Report,34204239,Children cerebral palsy CP experience various restriction owing underdeveloped mobility Home confinement due coronavirus disease 2019 pandemic may increase restriction report case 7yearold boy CP Gross Motor Function Classification System level IV whose motor function declined period physical therapy discontinued due lockdown approximately four month end home confinement patient s ability maintain sitting posture weightbearing capacity lower extremity decreased Gross Motor Function Measure total score also decreased 345 319 resuming physical therapy patient recovered function status seen discontinuation physical therapy took almost twice long confinement period reaffirm frequent physical therapy crucial maintaining motor function nonambulatory child CP countermeasure future urgent effort needed development telerehabilitation,covid-19;cerebral palsy;home confinement;motor function;recovery
Multibiomarker earlystage predictor progression Coronavirus disease 2019 COVID19 infection,34220307,Coronavirus disease 2019 COVID19 spread widely community many country Although mild patient could cured body s ability selfheal many patient quickly progressed severe disease undergo treatment intensive care unit ICU Thus important effectively predict patient mild disease likely progress severe disease total 72 patient hospitalized COVID19 Shandong Provincial Public Health Clinical Center 1141 patient included published paper enrolled study determined combination interleukin6 IL6 Neutrophil NEUT Natural Killer NK cell highest prediction accuracy 75 sensitivity 95 specificity progression COVID19 infection binomial regression equation accounted multiple risk score combination IL6 NEUT NK also established multiple risk score good indicator early stratification mild patient risk category important adjusting treatment plan preventing death,covid-19;il-6;multi-biomarker;predictors;progression
Hospitalisation Drug Infusion Increase Levels Anxiety Risk Disease Relapse Patients Inflammatory Bowel Disease COVID19 Outbreak,34362053,coronavirus disease 2019 COVID19 pandemic immunomodulatory therapy hospital admission suspected increase risk infection Nevertheless patient inflammatory bowel disease IBD treated intravenous iv biologics move hospital drug infusion investigated impact hospitalisation patient IBD conducted survey including consecutive IBD patient initially clinical biochemical remission treated biologics end first lockdown period Patients underwent normally scheduled clinical visit performed hospital ivtreated patient home patient treated sc drug administered patient Hospital Anxiety Depression Scale HADS questionnaire 12 question specifically related COVID19 implication total 189 IBD patient recruited 112 593 treated iv drug 77 407 sc one relapse recorded either group hospitalized vs nonhospitalized p = n well COVID19 infection demonstrated patient contact people suspected symptom directly experiencing total HADS score obtained sum item also almost identical group 371 + 28 vs 372 + 28 p = 098 patient treated iv drug receiving televisit n = 17 rate satisfaction telemedicine 588 significantly lower compared treated sc drug 948 p 00005 result suggest hospitalisation COVID19 outbreak increase risk COVID19 infection well risk IBD relapse moreover similar level anxiety group could confirm need convert patient iv sc therapy,covid-19;crohn's disease;biologics;clinical;ulcerative colitis
Clinical Outcome COVID19 Patients Presenting Gastrointestinal Symptoms,34290914,Background Patients coronavirus disease 2019 COVID19 usually fever respiratory tract complaint however many report gastrointestinal GI symptom frequency GI symptom range 16 61 Although COVID19 morbidity mortality related pulmonary disease poor outcome linked GI symptom Therefore study aimed determine outcome COVID19 patient presented GI symptom Methods conducted retrospective cohort study Isra University Hospital Hyderabad Pakistan April 2020 October 2020 Results total 395 polymerase chain reactionpositive individual included difference age comorbidities found 84 patient needed intensive care unit admission 17 GI symptom P= 0357 Moreover GI symptom reported 942 patient required mechanical ventilation P = 0674 35184 patient required noninvasive ventilation P = 0029 GI symptom reported 47206 patient discharged room air without supplemental oxygen P= 0549 1177 died P = 0025 211 referred elsewhere due financial issue P = 0999 732 left medical advice P = 0764 2869 discharged requiring oxygen home P = 0001 Conclusions Patients GI symptom reduced odds mortality increased odds discharge requiring supplemental oxygen,covid-19;gastrointestinal symptoms;intensive care unit;mechanical ventilation;non-invasive ventilation
COVID19 Consequences Anchoring Bias,34287136,Suspicion coronavirus disease febrile patient might lead anchoring bias causing misdiagnosis infection epidemiologic risk present bias potentially severe consequence illustrated case human granulocytic anaplasmosis Lyme disease pregnant woman human granulocytic anaplasmosis another person,covid-19;lyme disease;sars-cov-2;anchoring bias;coronavirus disease;human granulocytic anaplasmosis;respiratory infections;severe acute respiratory syndrome coronavirus 2;vector-borne infections;viruses;zoonoses
Disproportionate COVID19 vaccine acceptance rate among healthcare professional eve nationwide vaccine distribution Bangladesh,34224292,BACKGROUND Acceptance COVID19 vaccine target group would play crucial role stemming pandemic Healthcare professional HCPs priority group vaccination due highest risk exposure infection survey aimed ass acceptance COVID19 vaccine Bangladesh RESEARCH DESIGN METHODS crosssectional survey using online questionnaire conducted January 3 25 2021 among HCPs n=834 Bangladesh main outcome measure vaccine acceptance HCPs one available RESULTS Less 50 HCPs would receive vaccine COVID19 available 54 willing take vaccine stage future Female participant OR164 95 CI11722297 respondent 1834 year old OR242 95 CI13144463 HCPs public sector OR209 95 CI15212878 receive flu vaccine previous year OR31 95 CI15526001 likely delay vaccination CONCLUSIONS study revealed available le half HCPs would accept COVID19 vaccine Bangladesh ensure broader success vaccination drive tailored strategy vaccine promotion campaign targeting HCPs general population needed,bangladesh;covid-19;healthcare professionals;vaccine acceptance;vaccine hesitancy;vaccine literacy
Time review injectable medicine prepared administered European hospital,34218767,known decade use injectable medicine European hospital associated frequent medication error cause preventable severe harm death national European inquiry report concerning improving patient safety recommending greater use pharmacy aseptic preparation service provision readyto administer injectables widely implementedIn England experience treating patient COVID19 infection brought focus benefit significantly extending pharmacy aseptic preparation service benefit include saving nursing time system place resilience capacity reducing variation practice improving clinical staff patient experience enabling injectable medicine administered patient home also recognised action required standardise policy procedure injectable medicine mplement use smart infusion device dose error reduction software help minimise drug administration errorsHospital pharmacist key role developing service bring European hospital line provided hospital pharmacy North America,
fractionalorder model CoViD19 dynamic reinfection importance quarantine,34334968,Coronavirus disease 2019 CoViD19 infectious disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 Among many symptom cough fever tiredness common People 60 year old associated comorbidities likely develop worsening health condition paper proposes noninteger order model describe dynamic CoViD19 standard population model incorporates reinfection rate individual recovered disease Numerical simulation performed different value order fractional derivative reinfection rate result discussed biological point view,covid-19;epidemic model;fractional calculus;mathematical model;reinfection
COVID19 response New Zealand general surgical department tertiary metropolitan hospital,34224196,BACKGROUND Worldwide coronavirus disease 2019 COVID19 significantly challenged delivery healthcare New Zealand NZ faced similar potential challenge despite geographically isolated Given rapid change COVID19 pandemic hospital NZ tasked formulating COVID19 response based Ministry Health s MoH recommendation METHODS paper evaluates six metropolitan general surgical department NZ responded COVID19 term change made roster theatre clinic acute admission well additional measure taken reduce risk staff exposure also explores NZ fared comparison international guideline recommendation Data centre provided appointed clinician RESULTS centre adapted new roster restructuring team Handovers multidisciplinary team meeting educational session held virtually Different strategy implemented ration hospital resource reduce risk staff exposure Nonurgent operation endoscopy clinic deferred allocation dedicated COVID19 operating theatre Potential COVID19 suspect screened prior admission treated separately Various admission imaging pathway utilised increase efficiency CONCLUSION General surgical department NZ implemented comprehensive COVID19 response room work towards unified national response analysis show centre across NZ taken similar approach aligned international practice,covid-19;new zealand;delivery of health care;patient care team;resource allocation
Computational prediction protein sequence COVID19 virus via machine learning algorithm,34291385,rapid spread coronavirus disease COVID19 become worldwide pandemic affected 15 million patient reported 27 country Therefore computational biology carrying virus correlate human population urgently need understood paper classification human protein sequence COVID19 according country presented based machine learning algorithm proposed model based distinguishing 9238 sequence using three stage including data preprocessing data labeling classification first stage data preprocessing s function convert amino acid COVID19 protein sequence eight group number based amino acid volume dipole based conjoint triad CT method second stage two method labeling data 27 country 0 26 first method based selecting one number country according code number country second method based binary element country According country machine learning algorithm used discover different COVID19 protein sequence last stage obtained result demonstrate 100 accuracy 100 sensitivity 90 specificity via countrybased binary labeling method linear support vector machine SVM classifier Furthermore significant infection data USA prone correct classification compared country fewer data unbalanced data COVID19 protein sequence considered major issue especially US s available data represents 76 total 9238 sequence proposed model act prediction tool COVID19 protein sequence different country,covid-19 protein sequences;conjoint triad (ct);machine learning algorithms;support vector machine (svm)
Developmental dysplasia hip screening lockdown COVID19 experience Northern Italy,34211601,Purpose Developmental dysplasia hip DDH ultrasound screening USS usually performed Italy outpatient halted indefinite period centre lockdown aim study analyze effect COVID19 DDHUSS two paediatric orthopaedic centre one critical area western World Methods academic teaching hospital paediatric trauma centre University hospital DDH referral centre H classified national COVID19 hub involved Graf s method applied centre paediatrician directly referred patient delayed DDHUSS suspicious unstable hip H paediatrician parent could directly refer screening service Results mean age 95 patient 190 hip referred DDHUSS 385 month 01 74 175 type nine type IIa + five type one type IV H screened patient 2020 78 period 2019 total 28 patient 32 hip 8 IIb 5 IIc 8 11 III late diagnosis mean age 114 day 96 146 period 2019 eight patient 11 hip 8 IIb 1 1 III 1 IV mean age 142 day 92 305 late diagnosis Conclusion DDHUSS screening newborn halted lockdown centre still performed diagnosis treatment overloaded causing delay DDH management Level evidence IV,covid-19;developmental dysplasia of the hip;late diagnosis;screening;ultrasound
Derangements biochemical marker thyroid function analysis among COVID19positive patient developing country singlecenter experience,34213779,,
Mesenteric ischemia COVID19 patient review current literature,34222436,BACKGROUND Coronavirus disease 2019 COVID19 virus affected system body defying impression respiratory virus AIM see association mesenteric ischemia COVID19 METHODS initial screening filtering title PubMed Google Scholar 124 article selected Articles read full reference skimmed relevance Twentysix article case report case series found eligible inclusion References 26 article checked additional case Two publication found total 28 article 22 case report 6 case series included review manuscript RESULTS total 41 case acute mesenteric ischemia COVID19 patient reported literature since outbreak pandemic include patient comorbidities CONCLUSION conclusion based literature review precise published knowledge regarding acute mesenteric ischemia patient COVID19 essential understand relevance patient gastrointestinal symptom threshold diagnostic investigation also kept low timely diagnosis management disorder,acute abdomen;covid-19;influenza;mesenteric ischemia;sars-cov-2;severe acute respiratory syndrome
Deep learning empowered COVID19 diagnosis using chest CT scan image collaborative edgecloud computing platform,34220289,novel coronavirus outbreak spread worldwide causing respiratory infection human leading huge global pandemic COVID19 According World Health Organization way curb spread increasing testing isolating infected Meanwhile clinical testing currently followed easily accessible requires much time give result scenario remote diagnostic system could become handy solution existing study leverage deep learning approach provide effective alternative clinical diagnostic technique However difficult use complex network resource constraint environment address problem developed finetuned deep learning model inspired architecture MobileNet V2 model Moreover developed model optimized term size complexity make compatible mobile edge device result extensive experimentation performed realworld dataset consisting 2482 chest Computerized Tomography scan image strongly suggest superiority developed finetuned deep learning model term high accuracy faster diagnosis time proposed model achieved classification accuracy 9640 approximately ten time shorter response time prevailing deep learning model McNemar s statistical test result also prove efficacy proposed model,covid-19;chest ct scan;deep learning;diagnosis;edge computing;mobilenet v2
COVID19 global pandemic planning Presence SARSCoV2 fomite university hospital setting,34219476,severe acute respiratory syndrome coronavirus 2 SARSCoV2 surged across globe great effort expended understand mechanism transmission spread hospital perspective topic critical limit prevent SARSCoV2 iatrogenic transmission within healthcare environment Currently virus believed transmitted primarily respiratory droplet growing body evidence suggests spread also possible aerosolized particle fomite Amidst growing volume patient coronavirus disease 2019 COVID19 purpose study evaluate potential SARSCoV2 transmission fomite Samples collected exposed skin clinician n = 42 hightouch surface n = 40 collected encounter COVID19 patient Samples analyzed using two assay CDC 2019nCoV RealTime Reverse Transcription polymerase chain reaction RTqPCR assay SYBR Green assay targeted 121 bp region within Sgene SARSCoV2 None sample tested positive CDC assay two hightouch surface area tested positive SARSCoV2 using Spike assay However viral culture reveal viable SARSCoV2 positive sample Overall result study suggest SARSCoV2 RNA widely present either exposed skin flora hightouch surface area hospital location tested inability recover viable virus sample tested positive molecular assay however rule possibility SARSCoV2 transmission fomite,coronavirus;sars-cov-2;fomites
Evaluation Side Effects Associated COVID19 Vaccines Saudi Arabia,34207394,BACKGROUND PfizerBioNTech OxfordAstraZeneca recently introduced vaccine combat COVID19 pandemic clinical trial mild moderate side effect associated vaccine Thus aimed evaluate shortterm postvaccination side effect METHODS Crosssectional retrospective study using online questionnaire conducted among COVID19 vaccine recipient Saudi Arabia General demographic data collected vaccineassociated side effect receiving least one dose vaccine evaluated RESULTS final sample consisted 515 participant median age 26 year study participant female 57 Nearly 13 study subject reported previous infection SARSCoV2 OxfordAstraZeneca PfizerBioNTech vaccine received 75 25 study participant respectively Side effect associated COVID19 vaccine reported 60 study subject reported fatigue 90 pain site injection 85 CONCLUSION Side effect reported post OxfordAstraZeneca PfizerBioNTech vaccine among study participant different reported clinical trial indicating safe profile vaccine study needed evaluate effectiveness current vaccine protection SARSCoV2 reinfections,covid-19;sars-cov-2;side effects;vaccine
MAVS Immune Recognition Pathway Viral Infection Sepsis,34348482,SIGNIFICANCE estimated close 50 million case sepsis result 11 million annual fatality worldwide pathognomonic feature sepsis dysregulated inflammatory response arising viral bacterial fungal infection Immune recognition pathogenassociated molecular pattern PAMPs hallmark host immune defense combat microbe prevent progression sepsis MAVS ubiquitous adaptor protein located outer mitochondrial membrane activated cytosolic pattern recognition receptor PRRs RIGI MDA5 following binding viral RNA agonist Recent Advances Substantial progress made deciphering activation MAVS pathway interacting protein downstream signaling event IRFs NFkappaB context dependent type IIII interferon response CRITICAL ISSUES evolutionary race pathogen host virus developed immune evasion strategy cleavage degradation blockade protein MAVS pathway example SARSCoV2 protein ORF9b protein antagonize MAVS signaling protective type interferon response FUTURE DIRECTIONS role MAVS sensor nonviral pathogen host cell injury metabolic perturbation awaits better characterization future New technical advance multidimensional singlecell analysis singlemolecule method accelerate rate new discovery ultimate goal manipulate MAVS activity form immunemodulatory therapy combat infection sepsis,
Dysregulated liver function SARSCoV2 infection Current understanding perspective,34366609,Since first reported December 2019 severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection spread rapidly around world cause ongoing pandemic Although clinical manifestation SARSCoV2 infection predominantly respiratory system liver enzyme abnormality exist around half case indicate liver injury raise clinical concern present consensus whether liver injury directly caused viral replication liver tissue indirectly systemic inflammatory response review aim summarize clinical manifestation explore underlying mechanism liver dysfunction patient SARSCoV2 infection,covid-19;cytokine storm;dysregulated liver function;sars-cov-2
Role lung hemostasis system review literature,34292683,lung tissue contains various hemostatic system element released lung physiological pathological condition COVID19 pandemic led increase number patient acute respiratory distress syndrome ARDS intensive care unit worldwide lung damaged coagulation disorder mediated tissue factor TF factor VIIa F VIIa inhibition pathway completely eliminates intrapulmonary fibrin deposition tissue factor pathway inhibitor TFPI also contributes pulmonary coagulationdisturbance ARDS Pulmonary coagulationdisturbance caused pneumonia worsen damage lung thus contribute progression disease Cytokines main linking factor inflammation change blood clotting fibrinolysis source proinflammatory cytokine lung probably alveolar macrophage activation alveolar macrophage occurs nuclear factor kappabi NFkappaB control thetranscription expression immune response gene cell apoptosis lead development inflammation autoimmune disease result direct stimulation TF activation Conversely coagulation affect bronchoalveolar inflammation Coagulation lead formation protease interact specific cellular receptor activating intracellular signaling pathway use anticoagulant therapy also antiinflammatory effect perhaps one therapeutic target coronavirus infectionThe difficulty seems appropriate study anticoagulant intervention influence clinically significant cardiorespiratory parameter,covid-19;hemostatic;lungtissue;review literature
Supporting Protecting People Dementia COVID19 Pandemic,34219720,aimed explore awareness preparedness dementia caregiver people mild cognitive deficit prevent COVID19 infection cope indirect consequence pandemic total 139 patientcaregiver dyad received telephone survey 109 completed survey majority respondent reported moderatetogood knowledge typical manifestation COVID19 Conversely informed atypical presentation recognize emergency warning sign Filling knowledge gap COVID19 vulnerable people may represent significant resource tackle pandemic,atypical manifestations;covid-19;caregiving;cognitive disorders;dementia;education
systematic review efficacy safety treatmentdurability lowdose rituximab treatment Pemphigus special focus COVID19 pandemic concern,34287098,BACKGROUND Rituximab FDAapproved monoclonal antibody adult moderate severe potentially lifethreatening pemphigus vulgaris Recent study focused assessment efficacy safety lowdose rituximab 2 gram cycle METHOD Databases searched 2010 2020 last update 1 June 2020 RESULT Nine study entered including180 case 92 woman 88 men age range 983 year dosage Rituximab cycle varied ultralowdose =500 mg cycle either multiple infusion single infusion lowdose 2 x 375 mgm 2 2 x 500 mg modifieddose 3 x 375 mgm 2 3 x 500 mg efficacy safety Rituximab study known recovery time relapse time side event According study 2 x 500 lead complete remission broad range 35 82 difference might explained different endpoints variable cumulative corticosteroid dosage RTX administration Although study showed low dose RTX efficient controversy regarding choosing lowdose severe patient CONCLUSION Considering effectiveness lowdose intermediate dose ultralowdose protocol Rituximab inducing remission pemphigus disease considering factor cost therapy need induce minimum immunosuppression minimum duration COVID19 pandemic suggested use lowdose Rituximab protocol 2 infusion 500 mg Rituximab interval 2 week induce remission mildtomoderate pemphigus patient,covid-19;pemphigus;autoimmune bullous skin disorder;low-dose;rituximab;systematic review;ultra-low-dose;under-standard dose
Limb ischemia patient COVID19,34211543,narrative review cover lifethreatening thromboembolic event associated SARSCoV2 infectionCOVID19 address physical change cause vascular arterial damage limb laboratory management coagulation management anticoagulation COVID19 s relationship deep venous thrombosis arterial thrombosis also emphasized main thromboembolic event described literature illustrated example experience COVID19 patient,covid-19;sars-cov-2;anticoagulants;embolisms and thrombosis;endovascular techniques;vascular diseases
SARSCoV2 antispike antibody titre vaccination BNT162b2 naive previously infected individual,34293641,Great expectation placed vaccine COVID19 control pandemic reviewed antibody titre cohort healthcare worker HCWs vaccinated BNT162b2 ass influence previous infection stratified result according individual history nasopharyngeal swab NPS symptom Among 3475 HCWs highest titre recorded among infected 6 month vaccination independently symptom followed infected le 6 month vaccination especially symptom uninfected HCWs Vaccination BNT162b2 boost immunity acquired infection particularly infected 6 month vaccination,bnt162b2;covid-19;healthcare workers;vaccination
Support policy foster healthy food environment incentivize healthy food purchase mitigate cancer inequity,34223908,COVID19 pandemic highlighted inequitable access resource leading disproportionate burden disease vulnerable community USA However inequity health outcome limited COVID19 Approximately 18 cancer related dietary behavior excess body weight Underserved community minority racialethnic group living neighborhood low socioeconomic status experience barrier healthy eating including lack access highquality healthy food higher availability unhealthy food beverage local retail food outlet Strikingly population likely die cancer related dietary intake obesity like colorectal liver pancreatic cancer reduce cancer inequity policy maker act supporting program incentivize healthy food purchase improve local food environment underserved community,cancer;farm bill;health equity;health policy;healthy food financing initiative;supplemental nutrition assistance program
Titers Prevalence Duration SARSCoV2 Antibodies Local COVID19 Outbreak Following Vaccination,34199357,Information concerning development neutralizing antibody duration critical establishing herd immunity COVID19 sought evaluate SARSCoV2 spike protein receptorbinding domain RBD specific antibody duration capacity SARSCoV2 neutralization volunteer pandemic spread within community starting March 2020 participant highest starting titer longestlasting response 12 month postdiagnosis SARSCoV2 neutralization capacity correlated antiRBD antibody level majority participant confirmed COVID19 diagnosis mild asymptomatic infection also detected low largely nonneutralizing antiRBD IgG titer participant known COVID19 diagnosis Finally found antibody response induced vaccination significantly higher induced natural infection Thus study suggests vaccination still critical even naturally infected diagnosed COVID19,covid-19;sars-cov-2;anti-rbd igg;antibodies;asymptomatic;duration;neutralization;vaccine
PostSARSCoV2vaccination cerebral venous sinus thrombosis analysis case notified European Medicines Agency,34293217,BACKGROUND PURPOSE Cerebral venous sinus thrombosis CVST described vaccination SARSCoV2 clinical characteristic 213 postvaccination CVST case notified European Medicines Agency reported METHODS Data adverse drug reaction SARSCoV2 vaccination notified 8 April 2021 Medical Dictionary Regulatory Activities Term Central nervous system vascular disorder obtained EudraVigilance database Postvaccination CVST compared 100 European patient CVST COVID19 pandemic derived International CVST Consortium RESULTS 213 CVST case identified 187 AstraZenecaOxford ChAdOx1 nCov19 vaccination 26 messenger RNA mRNA vaccination 25 PfizerBioNTech BNT162b2 one Moderna mRNA1273 Thrombocytopenia reported 107187 CVST case 57 95 confidence interval CI 50 64 ChAdOx1 nCov19 group none mRNA vaccine group 0 95 CI 0 13 7100 7 95 CI 3 14 preCOVID19 group ChAdOx1 nCov19 group 39 21 reported COVID19 polymerase chain reaction test performed within 30 day CVST symptom onset negative 117 patient reported outcome ChAdOx1 nCov19 group 44 38 95 CI 29 47 died compared 210 20 95 CI 6 51 mRNA vaccine group 3100 3 95 CI 1 8 preCOVID19 group Mortality amongst patient thrombocytopenia ChAdOx1 nCov19 group 49 95 CI 39 60 CONCLUSIONS Cerebral venous sinus thrombosis occurring ChAdOx1 nCov19 vaccination clinical profile distinct CVST unrelated vaccination CVST ChAdOx1 nCov19 vaccination associated thrombocytopenia,covid-19 vaccine;cvst;ema;thrombocytopenia
Correlation Level Social Distancing Activity Influenza Epidemic COVID19 Pandemic Subway UseBased Assessment,34362150,Social distancing effective measure mitigate spread novel viral infection absence antiviral agent insufficient vaccine supply Subway utilization density may reflect social activity degree social distancing general population study aimed evaluate correlation subway use density activity influenza epidemic coronavirus disease 2019 COVID19 pandemic using timeseries regression method subway usebased social distancing score SSDS calculated using weekly ridership 11 major subway station temporal association SSDS influenzalike illness ILI rate COVID19 pandemic activity analyzed using structural vector autoregressive modeling Granger causality GC test three influenza season 20172020 timeseries regression presented significant causality SSDS ILI p = 00484 COVID19 pandemic January 2020 SSDS suppressed level similar average previous four year contrast ILI rate negative correlation COVID19 activity SSDS GC analysis revealed negative causal relationship COVID19 SSDS p = 00098 SSDS showed significant timeseries association ILI rate COVID19 activity public transportation use sufficiently suppressed additional social mobility restriction unlikely significantly affect COVID19 pandemic activity would important strengthen universal maskwearing detailed public health measure focused risk activity particularly enclosed space,covid-19;public health;severe acute respiratory syndrome coronavirus 2;social distancing;subway
COVID19 Unmasking Emerging SARSCoV2 Variants Vaccines Therapeutic Strategies,34356617,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 etiological agent coronavirus disease 2019 COVID19 pandemic topic major concern global human health challenge restrain COVID19 pandemic compounded emergence several SARSCoV2 variant viz B117 Alpha B1351 Beta P1 Gamma B16172 Delta show increased transmissibility resistance towards vaccine therapy Importantly convincing evidence increased susceptibility SARSCoV2 infection among individual dysregulated immune response comorbidities Herein provide comprehensive perspective regarding vulnerability SARSCoV2 infection patient underlying medical comorbidities discus ongoing vaccine mRNA proteinbased viral vectorbased etc therapeutic monoclonal antibody small molecule plasma therapy etc modality designed curb COVID19 pandemic also discus detail challenge posed different SARSCoV2 variant concern VOC identified across globe effect therapeutic prophylactic intervention,covid-19;sars-cov-2;antibody;biomolecules;comorbidities;coronavirus;immune dysregulated;spike protein;vaccines;variants;variants of concern (voc)
Implementation dematerialization patient file context COVID ONCORAD radiotherapy unit Transition `` paperless,34215522,Paper patient file sharing clearly identified risk behavior COVID19 virus transmission radiotherapy unit order overcome ONCORAD radiotherapy unit worked total dematerialization paper patient file within 3 week methodology based quality approch work led convincing improvement management risk priori smoother patient care workflow,aura(r) report;covid-19 virus;dematerialization;dossiers patients;demarche qualite;dematerialisation;patient files;quality approach;rapport aura(r);virus covid-19
Transmission Coronavirus via Aerosols Influence Environmental Conditions Transmission,34212634,COVID19 pandemic endangered human health production since 2019 emerging disease caused SARSCoV2 potential transmissibility via aerosol caused heated debate work summarizes current research finding virus aerosol generation aerodynamic property environmental influencing factor survivability order elucidate coronavirus transmission via aerosol occurrence distinction SARSCoV2 SARSCoV1 MERSCoV real atmospheric environment summarized deficiency existing research direction necessary future research confirming airborne transmission mechanism coronavirus well need multidisciplinary research discussed,aerosols;coronavirus;environmental influencing conditions;survivability;transmission
PostMortem Detection SARSCoV2 RNA LongBuried Lung Samples,34202678,Coronavirus Disease 19 COVID19 pandemic caused unexpected death toll worldwide Even though several guideline management infectious corps proposed limited number postmortem analysis pandemic led inaccuracy counting COVID19 death contributed lack important information pathophysiology SARSCoV2 infection Due impossibility carrying autopsy corps scientific community raised question whether confirmatory analysis could performed exhumed body long period burial ass presence SARSCoV2 RNA Postmortem lung sample collected 16 patient died COVID19 infection buried long period time custom RNA extraction protocol developed enhance extraction viral RNA degraded sample highly sensitive molecular method including RTqPCR droplet digital PCR ddPCR used detect presence SARSCoV2 RNA custom extraction protocol developed allowed u extract total RNA effectively lung sample collected SARSCoV2 viral RNA effectively detected sample RTqPCR ddPCR regardless length burial ddPCR result confirmed persistence virus anatomical niche revealed high viral load lung sample suggesting active infection time death best knowledge first study demonstrate persistence SARSCoV2 viral RNA lung even long postmortem interval 78 day extraction protocol herein described highly sensitive molecular analysis performed could represent standard procedure SARSCoV2 detection degraded lung specimen Finally innovative result obtained encourage postmortem confirmatory analysis even long postmortem interval,covid-19;sars-cov-2;autopsy;post-mortem swab;viral rna
Pleomorphic liposarcoma male breast lesson rare malignancy COVID19 pandemic,34285035,52yearold man presented recurrent right side breast lump undergone excision lump right breast followed adjuvant chemoradiotherapy 1 year ago diagnosis pleomorphic liposarcoma Imaging revealed 47x36 mm lesion right side chest wall involving pectoralis muscle patient underwent right radical mastectomy Histology specimen showed undifferentiated pleomorphic sarcoma infiltrating underlying skeletal muscle Therefore planned chemoradiotherapy due lockdown COVID19 pandemic lost followup later presented malignant pleural effusion case emphasis impact COVID19 pandemic rare malignancy,breast cancer;breast surgery
Safety immunogenicity Recombinant Stabilized Prefusion SARSCoV2 Spike Protein Vaccine MVCCOV1901 Adjuvanted CpG 1018 Aluminum Hydroxide healthy adult Phase 1 doseescalation study,34222848,Background phase 1 doseescalation openlabel trial evaluate safety immunogenicity MVCCOV1901 SARSCoV2 S2P protein vaccine adjuvanted aluminum hydroxide CpG 1018 Methods September 28 November 13 2020 77 participant screened 45 healthy adult 20 49 year age administered two dos MVCCOV1901 dos 5 mug 15 mug 25 mug spike protein 28 day apart 15 participant dose group followed 28 day second dose time interim analysis Adverse event laboratory data recorded safety evaluation Blood sample collected humoral cellular immune response various time point Trial Registration ClinicalTrialsgov NCT04487210 Findings Solicited adverse event mostly mild similar subject experienced fever second dose geometric mean titer GMTs SARSCoV2 spikespecific immunoglobulin G 71782 77461 112206 5 mug 15 mug 25 mug dose group respectively neutralizing activity detected method Day 43 GMTs 5385 9931 19058 pseudovirus 333 763 1674 wildtype virus cellular immune response induced MVCCOV1901 demonstrated substantially higher number IFNgamma producing cell suggesting Th1skewed immune response Interpretation MVCCOV1901 vaccine well tolerated elicited robust immune response suitable development Funding Medigen Vaccine Biologics Corporation,
Learning Leveraging MultiLevel Changes Responses COVID 19 Pandemic Facilitate Breast Cancer Prevention Efforts,34208878,coronavirus pandemic COVID19 multilevel effect nonCOVID19 health health care including deferral routine cancer prevention screening delay surgical procedure Health health care use also affected pandemicrelated loss employerbased health insurance food housing disruption heightened stress sleep disruption social isolation disruption projected contribute excess nonCOVID19 death coming decade time municipality health system individual making change response pandemic including modification environmental promote health implementation telehealth platform shift towards greater selfcare using remote platform maintain social connection used multilevel biopsychosocial model examine available literature relationship COVID19related change breast cancer prevention identify current gap knowledge identify potential opportunity future research found COVID19 impacted several aspect social economic life variety mechanism including unemployment change health care delivery change eating activity change mental health change reduced others explored enhanced,covid-19;breast cancer;cancer prevention;review paper
Antiviral Activity Influenza Virus Defective Interfering Particles SARSCoV2 Replication Vitro Stimulation Innate Immunity,34359926,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 causing coronavirus disease 2019 COVID19 emerged late 2019 resulted devastating pandemic Although first approved vaccine already administered end 2020 worldwide vaccine availability still limited Moreover immune escape variant virus emerging current vaccine may confer limited protection existing antiviral treatment option COVID19 show limited efficacy Influenza virus IAV defective interfering particle DIPs previously proposed antiviral treatment influenza disease also panspecific treatment interferon IFN sensitive respiratory virus infection investigate applicability IAV DIPs antiviral treatment COVID19 conducted vitro coinfection experiment cell culturederived DIPs IFNsensitive SARSCoV2 human lung cell show treatment IAV DIPs lead complete abrogation SARSCoV2 replication Moreover inhibitory effect dependent janus kinasesignal transducer activator transcription JAKSTAT signaling result suggest boosting IFNinduced antiviral activity IAV DIPs major contributor suppressing SARSCoV2 replication Thus propose IAV DIPs effective antiviral agent treatment COVID19 potentially also suppressing replication new variant SARSCoV2,covid-19;di244;op7;sars-cov-2;antiviral;defective interfering particles;influenza a virus;innate immunity
Establishment novel triage system SARSCoV2 among trauma victim trauma center limited facility,34222675,Objectives triage trauma patient potential COVID19 remains major challenge given significant number patient may asymptomatic presymptomatic study aimed compare specificity sensitivity available triage system COVID19 among trauma patient Furthermore aimed develop novel triage system SARSCoV2 detection among trauma patient center limited resource Methods patient referred center February May 2020 enrolled prospective study evaluated SARSCoV2 triage protocol Iranian Ministry Health Medical Education MOHME European Centre Disease Control Prevention ECDC effectiveness finding COVID19 infected individual among trauma patient used data design stepwise triage protocol detect COVID19 positive patient among trauma patient Results According finding protocol showed 100 specificity 133 sensitivity MOHME protocol 99 specificity 233 sensitivity ECDC protocol showed 933 sensitivity 895 specificity prioritize patient based traumatic injury unstable condition stepwise triage protocol prioritizes traumatic injury 933 sensitivity 903 specificity Conclusion study show triage protocol MOHME ECDC best equipped diagnose SARSCoV2 infected individual among trauma patient proposed stepwise triage system patient triaged according hemodynamic condition COVID19 related clinical state COVID19 related laboratory finding triage model lead accurate resourceeffective management trauma patient potential COVID19 infection Level evidence Level,covid-19;diagnosis;multiple trauma;triage
silico analysis identification antiviral coumarin derivative 3chymotrypsinlike main protease novel coronavirus SARSCoV2,34213728,Coronavirus disease 2019 COVID19 pandemic viral disease caused SARSCoV2 generated serious damage human population global economy Therefore currently considered one important global health problem human society urgent need potent drug vaccine effectively combat virus chymotrypsinlike protease 3CLpro SARSCoV2 play key role viral replication inside host thus promising drug target design develop effective antiviral drug SARS coronaviruses study evaluated antiviral coumarin phytochemical potential inhibitor coronaviruses 3CLpro silico approach molecular docking ADMET prediction molecular dynamic simulation MMPBSA binding energy calculation Natural coumarin derivative docked 3CLpro SARSCoV2 investigation docked 3CLpro SARSCoV MERSCoV docking score natural compound compared 3CLpro referenced inhibitor ritonavir lopinavir cocrystal inhibitor N3 Molecular docking study suggested half coumarin phytochemical favorable interaction binding pocket coronaviruses 3CLpro exhibited better binding affinity toward 3CLpro ritonavir lopinavir antiviral phytochemical interact strongly one catalytic dyad residue His41 Cys145 key residue SARSCoV2 main protease MD simulation binding free energy calculation using MMPBSA carried three 3CLprocoumarin complex 3CLproN3lopinavir result confirmed 3CLproglycycoumarin 3CLprooxypeucedanin hydrate 3CLproinophyllum P complex highly stable experience fewer conformation fluctuation share similar degree compactness Also pharmacokinetics druglikeness study showed good result selected coumarin phytochemicalsTherefore coumarin phytochemical could used antiviral agent treatment COVID19 study,covid-19;coumarin phytochemicals;molecular docking;molecular dynamics;sars-cov-2
Coronaviruses Bats Review Americas,34201926,SARSCoV2 coronavirus focus attention caused three million human death globally coronaviruses MERSCoV suggested related coronaviruses hosted bat work show bibliographic review frequency detection coronavirus bat specie Americas presence coronavirus bat examined 25 investigation 11 country Americas 2007 2020 Coronaviruses explored 9371 individual 160 specie bat 187 coronavirus sequence deposited GenBank distributed 43 specie bat 91 coronaviruses sequence identified infect single specie bat remainder show change host dominating intragenera change far MexCoV6 related MERSCoV coronavirus pathogenic human coronavirus research effort yet unexplored bat specie warranted,alphacoronavirus;betacoronavirus;covid-19;chiropterans;mers;sars;host
Rationale American Society Retina Specialists Best Practice Recommendations Conducting Vitreoretinal Surgery COVID19 Era,34222758,Purpose detail rationale behind recommendation recently published American Society Retina Specialists ASRS outlining best practice safety vitreoretinal surgeon staff performing vitreoretinal surgery coronavirus disease COVID 19 pandemic Methods committee ASRS Best Practices Retinal Surgery COVID19 Pandemic reviewed existing evidence information SARSCoV2 transmission risk factor vitreoretinal surgery Recommendations based best available published data cumulative clinical experience recommendation policy organization Grading Recommendations Assessment Development Evaluation GRADE approach used ass strength recommendation confidence evidence serve interim recommendation routinely updated given gap knowledge lack highquality data evolving subject Results Relevant existing literature related method transmission ocular manifestation SARSCoV2 summarized data clinical experience driving recommendation preoperative intraoperative postoperative surgical consideration anesthesia choice well consideration intravitreal injection provided Conclusion Recommendations provided goal protecting vitreoretinal surgeon associated personnel exposure SARSCoV2 interventional vitreoretinal procedure rapidly evolving topic numerous remaining gap current knowledge recommendation evolve current manuscript intended serve foundation continued dialogue best practice,asrs;covid-19;grade;ppe;sars-cov-2;evidence;guidelines;recommendations;vitreoretinal surgery
Relationship preexisting allergy anaphylactic reaction post mRNA COVID19 vaccine administration,34215453,Two mRNA vaccine COVID19 PfizerBioNTech Moderna approved emergency use United States approval dosing million recipient report anaphylaxis began appear Vaccine Adverse Reporting System VAERS provide analysis relationship prior history allergy andor anaphylaxis anaphylaxis rate following administration mRNA COVID19 vaccine Overall reported incidence anaphylaxis estimated rare 42 case per million dos appeared relative incidence anaphylaxis following administration COVID19 vaccine two seven time higher recipient prior history allergy andor anaphylaxis respectively report provides valuable metric make evidencebased decision subject preexisting allergic condition receiving COVID19 mRNA vaccine,anaphylaxis following covid-19 vaccine;covid-19;mrna vaccine
Major cardiac concern therapy vaccination COVID19,34222851,necessity impact SARSCoV2 world s health led development production practical useful vaccine deadly respiratory virus Since April 2020 vaccine virus developed Given comorbidities diabetes hypertension cardiovascular disease prone virus risk infection vaccine designed protect highrisk respiratory illness review discussed cardiovascular alteration SARSCoV2 treatment also reviewed vaccination information study done primary consideration cardiac patient,covid-19;cardiac patients;sars-cov-2;vaccine
Detection significant antiviral drug effect COVID19 reasonable sample size randomized controlled trial modeling study,34228712,BACKGROUND Development effective antiviral drug Coronavirus Disease 2019 COVID19 global health priority Although several candidate drug identified vitro vivo model consistent compelling evidence clinical study limited lack evidence clinical trial may stem part imperfect design trial investigated clinical trial antiviral need designed especially focusing sample size randomized controlled trial METHODS FINDINGS modeling study conducted help understand reason behind inconsistent clinical trial finding design better clinical trial first analyzed longitudinal viral load data Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 without antiviral treatment use withinhost virus dynamic model fitted viral load categorized 3 different group clustering approach Comparison estimated parameter showed 3 distinct group characterized different virus decay rate pvalue 0001 mean decay rate 117 d1 95 CI 106 127 d1 0777 d1 0716 0838 d1 0450 d1 0378 0522 d1 3 group respectively heterogeneity virus dynamic could confounding variable associated treatment allocation compassionate use program ie observational study Subsequently mimicked randomized controlled trial antiviral simulation antiviral effect causing 95 99 reduction viral replication added model realistic assumed randomization treatment initiated time lag symptom onset Using duration virus shedding outcome sample size detect statistically significant mean difference treatment placebo group 11 allocation 13603 11670 antiviral effect 95 99 respectively per group patient enrolled regardless timing randomization sample size reduced 584 458 antiviral effect 95 99 respectively patient treated within 1 day symptom onset enrolled confirmed sample size similarly reduced using cumulative viral load log scale outcome used conventional virus dynamic model may fully reflect detailed mechanism viral dynamic SARSCoV2 model need calibrated term parameter setting model structure would yield reliable sample size calculation CONCLUSIONS study found estimated association observational study biased due large heterogeneity viral dynamic among infected individual statistically significant effect randomized controlled trial may difficult detected due small sample size sample size dramatically reduced recruiting patient immediately developing symptom believe first study investigated study design clinical trial antiviral treatment using viral dynamic model,
Weight Status Body Composition Dynamics Children Adolescents COVID19 Pandemic,34291022,Introduction preventive measure taken attempt prevent COVID19 spread lead closure school leisure time activity impact pandemic pediatric weight status unclear report around world predict grave consequence increasing obesity aimed examine change body composition parameter child adolescent pandemic Materials Methods observational study 220 pediatric subject 109 boy mean current age 118 + 33 year 37 underweight 123 normal weight 60 overweightobesity underwent height body composition measurement bioelectrical impedance analysis Tanita MC780MA GMON Professional Software pandemic Height body mass index BMI muscletofat ratio MFR zscores calculated Data collected participant medical file included home address socioeconomic position calculation pubertal stage selfreported sleep duration physical activity performance Results vast majority cohort 818 stable improved MFR zscores pandemic MFR zscores significantly increased subject underweight p = 005 normal weight p = 0008 subject overweightobesity p = 0169 significant association BMI zscores r = 0961 p 0001 MFR zscores r = 0854 p 0001 pandemic multivariate linear regression model identified socioeconomic position prepandemic BMI zscores prepandemic MFR zscores physical activity level pandemic predictor delta MFR zscores F = 12267 p 0001 Age sex prepandemic physical activity time elapsed initiation first nationwide lockdown BIA assessment pandemic emerge predictor delta MFR zscore Conclusions encouraging finding demonstrate improvement body composition parameter subject underweight normal weight stability subject overweightobesity Engagement physical activity pandemic predicted improvement lower socioeconomic position predicted deterioration,bmi;covid-19;bioimpedance;body composition;children and adolescents;muscle-to-fat ratio;overweight and obesity;weight status
Green Tea Polyphenol Catechins Inhibit Coronavirus Replication Potentiate Adaptive Immunity AutophagyDependent Protective Mechanism Improve Acute Lung Injury Mice,34200327,Effective antiviral therapeutic urgently required fight severe acute respiratory syndrome SARS caused SARS coronavirus SARSCoV polyphenol catechin could confer antioxidative antiinflammatory antiviral antimicrobial activity assessed therapeutic effect catechin SARSCoV replication Vero E6 cell preventive effect catechin CD25CD69CD94CD8 + cytotoxic lymphocytesmediated adaptive immunity protective effect lipopolysaccharideinduced acute lung injury ALI mouse found catechin containing 328 epigallocatechin gallate 152 epicatechin gallate 132 epicatechin 108 epigallocatechin 104 gallocatechin 44 catechin directly inhibited SARSCoV replication submicromolecular concentration Fourweek catechin ingestion increased CD8 + cell percentage upregulated CD69 + CD25 + CD94NKG2ACD8 + lymphocytesmediated adaptive immunity increased type cytokine release responding ovalbuminalum Catechins significantly reduced lipopolysaccharideinduced cytokine storm oxidative stress ALI inhibiting PI3KAKTmTOR signaling upregulate Beclin1Atg5Atg12LC3IImediated autophagy mechanism Pretreatment autophagy inhibitor 3Methyladenine reversed inhibiting effect catechin cytokine oxidative stress level ALI conclusion data indicated catechin directly inhibited SARSCoV replication potentiated CD25CD69CD94CD8 + lymphocytesmediated adaptive immunity attenuated lipopolysaccharideinduced ALI cytokine storm PI3KAKTmTORsignalingmediated autophagy may applied prevent andor treat SARSCoV infection,sars-cov replication;acute lung injury;adaptive immunity;autophagy;catechins;cytokine storm
Myopericarditis previously healthy adolescent male following COVID19 vaccination case report,34133825,report case previously healthy 16yearold male developed myopericarditis following second dose PfizerBioNTech COVID19 vaccine identified trigger Adolescents young adult experiencing chest pain COVD19 vaccination seek emergent medical care emergency provider low threshold consider evaluate myopericarditis data needed better understand potential association COVID19 vaccine myopericarditis true causal link identified risk must also viewed context million patient safely vaccinated known morbidity mortality COVID19 infection see widespread vaccine rollout important potential adverse reaction reported continue monitor rare potentially serious side effect identified vaccination trial,covid-19;myocarditis
Challenges pregnant woman seeking institutional care COVID19 lockdown India content analysis online news report,34287202,India s nationwide lockdown curtail transmission Covid19 given rise concern health system s response maternal child health MCH service paper aim understand challenge faced pregnant woman seeking institutional care lockdown conducted qualitative content analysis 54 online news report published English Hindi 25 March 2020 31 May 2020 covered case across 17 state India 16 maternal death Three broad thematic category challenge pregnant woman emerged analysis 1 physical access health facility 2 admission health facility 3 lack respectful maternity care lockdown conclusion strengthening health system incorporating MCH Covid19 response imperative Failure provide quality MCH service lockdown implication continuum woman s care maternal mortality human right,
Comparability six different immunoassay measuring SARSCoV2 antibody neutralising antibody level convalescent plasma utility prediction,34342366,BACKGROUND Convalescent plasma CP therapy COVID19 provides virus neutralising antibody may ameliorate outcome SARSCoV2 infection effectiveness CP likely depends antiviral neutralising potency determined using vitro neutralising antibody assay STUDY DESIGN METHODS evaluated ability three immunoassay antispike antibody EUROimmun Ortho Roche pseudotypebased neutralisation assay two assay quantify ACE2 binding spike protein GenScript haemagglutinationbased HAT assay predict neutralising antibody titre 113 convalescent plasma donation Assay output analysed linear regression calculation sensitivity specificity ROC analysis RESULTS Median value plasma sample containing neutralising antibody produced conversion factor assay unitage x65 pseudotype x19 GenScript x34 HAT assay x008 EUROimmun x164 Roche x010 Ortho selected assay sufficient identifying high titre donation based ROC analysis area curve ranged 917 HAT GenScript assay 956 pseudotype assay However ability predict actual neutralising antibody level varied substantially shown linear regression correlation value 027 Ortho 061 pseudotype assay DISCUSSION Combined study data demonstrates selected assay effective identifying donation high neutralising antibody level potentially suitable surrogate assay donation selection convalescent plasma therapy,
Acute upper limb arterial ischemia patient diagnosed COVID19 case series,34211540,Infection coronavirus 2 cause severe acute respiratory syndrome SARSCoV2 human detected first time Wuhan China 2019 spread globally course 2020 different clinical manifestation challenging wide spectrum presentation ranging asymptomatic infection severe form result death objective study describe series four case acute arterial ischemia involving upper limb patient diagnosed COVID19 managed clinically anticoagulation platelet antiaggregation prostanoids Two patient discharged hospital regression delimitation ischemic zone without needing surgical intervention two patient died pulmonary complication Adequate understanding pathophysiology disease could support better clinical management complication,covid-19;anticoagulants;emboli and thrombosis;ischemia;prostaglandins
Emergency Department Patient Experiences COVID19 Pandemic,34368429,Emergency department ED utilization changed notably coronavirus disease 2019 COVID19 pandemic United States purpose study gain thorough understanding ED patient experience early stage COVID19 pandemic study used consensual qualitative approach analyze openended response postED patient experience survey February July 2020 Comments included analysis pertained care pandemic eg mentioned `` virus `` mask `` PPE total 242 COVIDspecific comment 192 unique patient analyzed median age 49 year 69 female Six theme identified visually observed change experience process change expression understanding appreciation sense security COVID19 diseasespecific comment `` classic satisfaction comment align previous literature patient experience COVID19 pandemic challenged health care system across world unique unprecedented way study identified six theme better elucidate ED patient experience unprecedented public health crisis,covid;coronavirus;emergency department;experience;patient;satisfaction
Epidemiological spatiotemporal characteristic COVID19 Rwanda,34368752,Background coronavirus disease 2019 COVID19 taken million life disrupted living standard individual societal worldwide level causing serious consequence globally Understanding epidemic curve spatiotemporal dynamic crucial development effective public health plan response allocation resource Thus conducted study ass epidemiological dynamic spatiotemporal pattern COVID19 pandemic Rwanda Methods Using surveillance package R software version 402 implemented endemicepidemic multivariate time series model infectious disease analyze COVID19 data reported Rwanda Biomedical Center Ministry Health March 15 2020 January 15 2021 Results COVID19 pandemic occurred two wave Rwanda showed heterogenous spatial distribution across district Rwandan government responded effectively efficiently implementation various health measure intervention policy drastically reduce transmission disease Analysis three component model showed affected district displayed epidemic component within area whereas effect epidemic component spatial neighbor experienced district surround affected district infection followed disease endemic trend district Conclusion epidemiological spatiotemporal dynamic COVID19 Rwanda show implementation measure intervention contributed significantly decrease COVID19 transmission within district accentuates critical call continued intra inter organization community engagement nationwide ensure effective efficient response pandemic,covid-19;rwanda;spatio-temporal model;surveillance
COVID19 drug pathophysiology therapeutic approach,34213847,review provides update different therapeutic approach used treat SARSCoV2 infection well resulting paradoxical inflammation disorder,anti-inflammatory drugs;anticoagulant drugs;antiviral drugs;cytokinic storm;sars-cov-2 viral cycle
Review paediatric inflammatory bowel disease service pandemic impact CNS role,34288747,BACKGROUND Inflammatory bowel disease IBD chronic relapsing remitting condition COVID19 pandemic severely disrupted provision medical care across world IBD clinical nurse specialist CNSs played pivotal role care child IBD pandemic national lockdown recovery phase article aim look impact COVID19 paediatric IBD service one child s hospital effect IBD CNSs workload METHOD retrospective review clinical note service s IBD database January 2019 September 2020 RESULTS significant increase number email telephone contact IBD CNS team lockdown increase virtual clinic increase new IBD patient coming service reduction number facetoface consultant clinic CONCLUSION COVID19 disrupted medical service child IBD led reduction facetoface activity also led significant increase virtual activity CNSs taken wider role cover patient care time medical nursing redeployment,covid-19;ibd;ibd clinical nurse specialists;inflammatory bowel disease;virtual clinics
Preterm birth stillbirth rate COVID19 pandemic populationbased cohort study,34344771,BACKGROUND Conflicting report emerged rate preterm birth stillbirth COVID19 pandemic report account natural variation rate aimed evaluate variation preterm birth stillbirth rate COVID19 pandemic Ontario Canada METHODS conducted retrospective cohort study using linked population health administrative database pregnant people giving birth hospital Ontario July 2002 December 2020 calculated preterm birth stillbirth rate assessed preterm birth 2228 2932 3336 week gestation stillbirth term preterm gestation used Laney control P chart 18year study period 6mo observation period interrupted timeseries analysis monthly rate recent 4 year RESULTS evaluated 2 465 387 pregnancy including 13 781 resulted stillbirth mean preterm birth rate cohort 796 range 732 859 January December 2020 determined preterm birth rate Ontario 787 special cause variation mean stillbirth rate cohort 056 range 048 070 January December 2020 stillbirth rate 053 special cause variation find special cause variation preterm birth stillbirth subgroup found change slope gap prepandemic pandemic period using interrupted timeseries analysis INTERPRETATION Ontario Canada found special cause variation unusual change preterm birth stillbirth rate overall subgroup first 12 month COVID19 pandemic compared previous 175 year,
Detection COVID19 Virus Surfaces Using Photonics Challenges Perspectives,34205401,propagation virus become global threat proven coronavirus disease COVID19 pandemic Therefore quick detection viral disease infection could necessary study aim develop framework virus diagnosis based integrating photonics technology artificial intelligence enhance healthcare public area marketplace hospital airfield due distinct spectral signature laser effectiveness classification monitoring virus However providing insight technical aspect also help researcher identify possibility difficulty field content study collected six authoritative database Web Science IEEE Xplore Science Direct Scopus PubMed Central Google Scholar review includes analysis summary laser technique diagnose COVID19 fluorescence method surfaceenhanced Raman scattering surface plasmon resonance integration Raman scattering SPR technique Finally select best strategy could potentially effective method reducing epidemic spreading improving healthcare environment,covid-19;coronavirus;laser diagnosis techniques;light-matter interaction;optical biosensor;photonics
Review COVID19 Myocarditis Competitive Athletes Legitimate Concern Fake News,34336948,Since first reported case COVID19 December 2019 global landscape shifted toward unrecognizable paradigm sport world immune ramification major sport league abbreviated season fan attendance eradicated athlete opted entire season athlete cardiovascular complication COVID19 particularly concerning myocarditis implicated significant portion sudden cardiac death SCD athlete 22 Multiple study attempted evaluate postCOVID myocarditis develop consensus returntoplay RTP guideline led conflicting information internist primary care doctor advising athlete aim review pathophysiology diagnosis viral myocarditis discus heterogeneity regarding incidence COVID myocarditis among athlete summarize current expert recommendation RTP goal provide guidance practitioner managing advising athlete COVID era,covid athletes;covid myocarditis;covid-19;cardiac complications of covid;pre-participation physicals;return to play;sports after covid;sudden cardiac death athletes
Safety practice inoffice laryngology procedure clinical reintroduction amidst COVID19,34226876,Objective Describe safety practice performing inoffice laryngology procedure clinical reintroduction amidst coronavirus disease 2019 COVID19 pandemic Methods anonymous survey Qualtrics created evaluate demographic preprocedure testing practice setting anesthesia personal protective equipment PPE use five procedure category nonmucosaltraversing injection mucosaltraversing injection endoscopy without suction endoscopy suctionmucosal intervention via working channel laser via working channel survey emailed Fall Voice Community Doc Matter member American BronchoEsophagological Association ABEA May June 2020 Results Eightytwo respondent analyzed response rate 10 Respondents represented diverse location including international reported academic 71 private practice 16 laryngology fellowship training 76 significant practice devotion laryngology bronchoesophagology early reintroduction continued perform procedure category office preferred setting though 36 preferred laser procedure preference preprocedural SARSCov2 testing procedure involving working channel 67 procedure highest proportion respondent discontinuing procedure due COVID19 Various type topical anesthesia reported including nebulizer treatment common form personal protective equipment utilized glove 95 N95 mask 67 Poweredair purifying respirator general surgical mask used infrequently Conclusions early reintroduction respondent reported generally continuing perform office laryngology procedure greater mucosal manipulation affected decision stop procedure due COVID19 perform preprocedural SARSCov2 testing alter topical anesthesia Gloves N95 mask predominate PPE Level Evidence NA,covid-19;coronavirus;laryngoscopy;otolaryngology;personal protective equipment
Diagnosis Anosmia Hyposmia Systematic Review,34285823,Background Anosmia hyposmia many etiology including trauma chronic sinusitis neoplasm respiratory viral infection rhinovirus SARSCoV2 aimed systematically review literature diagnostic evaluation anosmiahyposmia Methods PubMed EMBASE Cochrane database searched article published since January 1990 using term combined Medical Subject Headings MeSH included article evaluating diagnostic modality anosmia written English language used original data two patient Results total 2065 unique title returned upon initial search 226 abstract examined yielding 27 fulltext article meeting inclusion criterion Level evidence ranging 1 4 level 2 study included total 13577 patient utilized diagnostic tool orthonasal smell test Sniffin Sticks UPSIT along validated abridged smell test Though various imaging modality including MRI CT frequently mentioned workup olfactory dysfunction routine imaging used primarily diagnose smell loss Conclusion literature includes several study validity reliability various smell test diagnosing anosmia Along thorough history physical validated orthonasal smell test part workup patient suspected olfactory dysfunction widely studied modality MRI criterion timing sequence imaging modality heterogenous,covid-19;mri;oerp;sars-cov-2;spect;anosmia;diagnosis;fmri;hyposmia;infection;smell loss;smell test;trauma;viral
Hypotheses fact genetic factor related severe COVID19,34367930,Genomewide association analysis allows identification potential candidate gene involved development severe coronavirus disease 2019 COVID19 Hence seems genetics matter well Nevertheless virus s nature including RNA structure determines rate mutation leading new viral strain epidemiological clinical consequence Given observation herein comment current hypothesis possible role gene association COVID19 severity discus major candidate gene identified potential genetic factor associated COVID19 severity infection susceptibility HLA ABO ACE2 TLR7 ApoE TYK2 OAS DPP9 IFNAR2 CCR2 etc study gene genetic variant great benefit prevention assessment individual risk disease severity different population scientific data serve basis development clinically applicable diagnostic prognostic test patient high risk COVID19,ace2;apoe;ccr2;dpp9;genome-wide association studies;ifnar2;oas;sars-cov-2;severe covid-19;tlr7;tyk2
Comparison electrocardiogram ECG waveform centralized ECG measurement simple 6lead mobile ECG device standard 12lead ECG,34288227,BACKGROUND Interval duration measurement IDMs compared standard 12lead electrocardiogram ECGs 6lead ECGs recorded AliveCor s KardiaMobile 6L handheld mobile device designed use patient home METHODS Electrocardiograms recorded within average 15 min 705 patient Mayo Clinic s Windland Smith Rice Genetic Heart Rhythm Clinic Interpretable 12lead 6lead recording available 685 705 97 eligible patient common diagnosis congenital long QT syndrome LQTS 343685 50 followed unaffected relative patient 146685 21 patient genetic heart disease including hypertrophic cardiomyopathy 36 52 arrhythmogenic cardiomyopathy 23 34 idiopathic ventricular fibrillation 14 20 IDMs performed central ECG laboratory using lead II semiautomated technique RESULTS Despite difference patient position supine 12lead ECGs sitting 6lead ECGs mean IDMs comparable mean value 12lead 6lead ECGs QTcF heart rate PR QRS differing 26 m 55 beat per minute 10 12 m respectively Despite modest difference heart rate interval close enough allow detection clinically meaningful abnormality CONCLUSIONS 6lead handheld device potentially useful clinical followup remote patient safety followup patient participating clinical trial visit investigational site technology may extend use 12lead ECG recording current COVID19 pandemic remote patient monitoring becomes common virtual hybriddesign clinical study,bland-altman;qtc;clinical trials;electrocardiogram;interval duration measurements;remote monitoring;virtual trials
Immunoassay SARSCoV2 nucleocapsid protein using novel red emissionenhanced carbon dotbased silica sphere,34282816,imminent develop new type rapid COVID19 detection method high sensitivity used novel red emissionenhanced carbon dot CD based silica RCS sphere signal lateral flow immunochromatography LFI ultrasensitively detect novel severe acute respiratory syndrome coronavirus 2 nucleocapsid protein SARSCoV2 NPs red emission CDs enhanced enriched silica sphere simple way amino end Nbeta aminoethyl gammaaminopropyltrimethoxy anchor carboxylrich CDs enhance red emission end embedded silica carrier composite silica sphere werecoated 3 triethylsilyl propylamine protect CDs promote bioconjugation obtain RCS sphere optimal emission peak aqueous solution solid state RCS sphere 634 nm 638 nm respectively quantum yield QYs 485 357 respectively red emission wide excitation range ultraviolet region red region best excitation wavelength 580 nm Two fluorescence detection mode RCSLFI technology SARSCoV2 NP assay available simple mode observation ultraviolet light sensitivity 100 pg mL1 advanced mode detection fluorescence microscope sensitivity 10 pg mL1 assay also exhibit advantage fast detection speed high specificity simple operation addition feasibility method actual sample detection verified human serum standardaddition method result show method excellent practicability believe method valuable supplement diagnosis COVID19,
Efficacy safety convalescent plasma therapy SARSCoV2 patient hemodialysis,34133062,BACKGROUND passive immunization patient SARSCoV2 convalescent plasma CP theoretically beneficial patient endstage renal disease immunosuppressed unable mount adequate immune response Hence study conducted evaluate safety efficacy CP patient chronic kidney disease hemodialysis moderatetosevere SARSCoV2 infection METHODS prospective observational cohort study conducted consecutive 68 moderatetosevere SARSCoV2 infected patient maintenance hemodialysis acute worsening chronic kidney disease required initiation hemodialysis Patients received CP compared primary outcome death hospitalization Clinical characteristic duration hospitalization inflammatory parameter compared two group subgroup analysis done find whether early initiation plasma associated better outcome RESULTS Sixteen patient 44 plasma group 14 45 patient control group died hospitalization p = 095 median duration hospitalization 9 614 day plasma group 9 616 control group p = 060 difference mortality duration hospitalization respect early initiation CP p = 029 Fistula thrombosis occurred two patient 111 plasma group CONCLUSION Therapy CP appear confer clinical benefit moderatetosevere SARSCoV2 infected patient chronic kidney disease hemodialysis,covid 19;chronic kidney disease;hemodialysis;plasma therapy
Natural product phytochemical potential antiSARSCoV2 drug,34132421,current pandemic responsible crippling health care system caused novel SARSCoV2 2019 leading coronavirus disease 2019 COVID19 virus enters human attachment Spike protein ACE receptor present lung epithelial cell surface followed cleavage protein cellular transmembrane serine protease TMPRSS2 entry SARSCoV2 RNA genome released cytosol highjack host replication machinery viral replication assemblage well release new viral particle major drug target identified SARSCoV2 hostvirus interaction study include 3CLpro PLpro RNAdependent RNA polymerase protein Several report natural compound along synthetic product displayed promising result Tripterygium wilfordii Pudilan Xiaoyan Oral Liquid Saponin derivates Artemisia annua Glycyrrhiza glabra L Jinhua Qinggan granule Xuebijing Propolis review attempt disclose natural product identified antiSARSCoV2 based silico prediction effect variety phytochemical either alone andor combination conventional treatment along possible molecular mechanism involved prevention treatment SARSCoV2 disease,covid-19;mers-cov;rna-virus;sars-cov;sars-cov-2;coronaviruses;natural compounds;phytochemicals;prevention;therapy
Rolling CircleAmplified GQuadruplexHemin DNAzyme Chemiluminescence Immunoassay SARSCoV2 Protein,34227801,Sensitive detection SARSCoV2 protein remains great research interest clinical screening diagnosis owing coronavirus epidemic ultrasensitive chemiluminescence CL imaging strategy developed proximity hybridization trigger formation rolling circleamplified Gquadruplexhemin DNAzyme detection SARSCoV2 protein target protein first recognized pair DNAantibody conjugate Ab1 Ab2 form proximityligated complex Ab1SARSCoV2Ab2 contained DNA sequence complemental block DNA thus induced strand displacement reaction release primer blockprimer complex released primer triggered rolling circle amplification form abundant DNAzyme unit presence hemin produced strong chemiluminescent signal detection target protein catalyzing oxidation luminol hydrogen peroxide proposed assay showed detectable concentration range 5 order magnitude detection limit 646 fgmL excellent selectivity simple procedure acceptable accuracy intrinsic high throughput imaging technique analysis serum sample demonstrated potential applicability proposed detection method clinical screening diagnosis,
StructureBased Virtual Screening Reveals Ibrutinib Zanubrutinib Potential Repurposed Drugs COVID19,34209188,Coronavirus disease COVID 19 leading global health threat date caused severe acute respiratory syndrome coronavirus SARSCoV2 Recent clinical trial reported use Bruton s tyrosine kinase BTK inhibitor treat COVID19 patient could reduce dyspnea hypoxia thromboinflammation hypercoagulability improve oxygenation However mechanism action remains unclear Thus study employ structurebased virtual screening SBVS repurpose BTK inhibitor acalabrutinib dasatinib evobrutinib fostamatinib ibrutinib inositol 1345tetrakisphosphate spebrutinib XL418 zanubrutinib SARSCoV2 Molecular docking conducted BTK inhibitor structural nonstructural protein SARSCoV2 host target ACE2 TMPRSS2 BTK Molecular mechanicsgeneralized Born surface area MMGBSA calculation molecular dynamic MD simulation carried selected complex high binding energy Ibrutinib zanubrutinib found potent drug screened based result computational study Results show ibrutinib zanubrutinib could exploit different mechanism viral entry replication stage could repurposed potential inhibitor SARSCoV2 pathogenesis,btk inhibitors;covid-19;md simulations;sars-cov-2;ibrutinib;protein-ligand binding free energy;zanubrutinib
Postviral effect COVID19 olfactory system implication,34339626,BACKGROUND mechanism upper respiratory virus including SARSCoV2 impairs chemosensory function known COVID19 frequently associated olfactory dysfunction viral infection provides research opportunity evaluate natural course neurological finding Clinical trial prospective histological study newonset postviral olfactory dysfunction limited small sample size paucity advanced neuroimaging data neuropathological sample Although data neuropathological specimen available neuroimaging olfactory system acute phase infection still rare due infection control concern critical illness represents substantial gap knowledge RECENT DEVELOPMENTS active replication SARSCoV2 within brain parenchyma ie neuron glia proven Nevertheless postviral olfactory dysfunction viewed focal neurological deficit patient COVID19 Evidence also sparse direct causal relation SARSCoV2 infection abnormal brain finding autopsy transsynaptic spread virus olfactory epithelium olfactory bulb Taken together clinical radiological histological ultrastructural molecular data implicate inflammation without infection either olfactory epithelium olfactory bulb inflammation lead persistent olfactory deficit subset people recovered COVID19 Neuroimaging revealed localised inflammation intracranial olfactory structure date histopathological ultrastructural molecular evidence suggest SARSCoV2 obligate neuropathogen NEXT prevalence CNS olfactory bulb pathosis patient COVID19 known postulate people recovered COVID19 chronic recrudescent permanent olfactory deficit could prognostic increased likelihood neurological sequela neurodegenerative disorder long term inflammatory stimulus nasal olfactory epithelium olfactory bulb connected brain region might accelerate pathological process symptomatic progression neurodegenerative disease Persistent olfactory impairment without perceptual distortion ie parosmias phantosmias SARSCoV2 infection could therefore serve marker identify people increased longterm risk neurological disease,
Pneumocystis pneumonia COVID19 pandemic era similarity challenge,34364804,clinical picture fungal disease Pneumocystis pneumonia resembles course coronavirus disease 2019 COVID19 presenting diagnostic challenge pandemic era discus concern Pneumocystis jirovecii severe acute respiratory syndrome coronavirus 2 SARSCoV2 coinfection similarity impact immunosuppression suggested diagnostic pathway suspected coinfection,covid-19;pneumocystis jirovecii;sars-cov-2;pneumonia
Absence SARSCoV2 Antibodies Natural Environment Exposure Sheep Close Contact Humans,34359111,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 zoonotic causative agent coronavirus disease 2019 COVID19 caused pandemic situation million infected human worldwide Among domestic animal limited study regarding transmissibility exposure infection natural condition animal exposed andor susceptible SARSCoV2 infection cat ferret dog contrast information susceptibility ruminant SARSCoV2 study tested antibody response 90 ovine prepandemic serum sample 336 sheep serum sample pandemic period June 2020 March 2021 case animal close contact veterinary student community composed 700 member None serum sample analyzed seroreactive based enzymelinked immunosorbent assay ELISA using receptorbinding domain RBD spike antigen sense statistical difference observed compared prepandemic sheep result suggest seems unlikely sheep could play relevant role epidemiology SARSCoV2 infection first study report absence evidence sheep exposure SARSCoV2 natural condition,elisa;sars-cov-2;coronavirus disease 2019 (covid-19);ruminants;serology;sheep
Changes presentation newly diagnosed type 1 diabetes child COVID19 pandemic tertiary center Southern Turkey,34291625,OBJECTIVES COVID19 pandemic global health problem high morbidity mortality study aimed investigate patient diagnosed type 1 diabetes pandemic evaluate effect pandemic clinical finding patient comparing finding year prior METHODS Patients diagnosed type 1 diabetes mellitus 2019 2021 separated two group Patients diagnosed prepandemic diagnosed pandemic RESULTS number newly diagnosed diabetes case increased 46 prepandemic period 74 pandemic period number case diagnosed diabetic ketoacidosis DKA clinic increased 587 919 found moderate severe DKA rate 185 148 235 221 respectively Besides average HbA1c higher average bicarbonate lower case diagnosed pandemic period compared prepandemic period p=0048 p 0001 respectively found celiac autoantibody positivity antibody glutamic acid decarboxylase anti GAD positivity islet cell antibody ICA ICA anti GAD positivity coexistence higher p=0045 p=0008 p=0007 respectively among patient diagnosed pandemic CONCLUSIONS observed increase number patient newly diagnosed type 1 diabetes mellitus increase autoantibody positivity higher rate severity DKA COVID19 pandemic period compared prepandemic period,covid-19 pandemic;diabetic ketoacidosis;type 1 diabetes mellitus
COVID19 vaccine hesitancy patient systemic autoimmune rheumatic disease interviewbased survey,34213580,Patients systemic autoimmune rheumatic disease AIRD vulnerable SARS Cov2 infection Vaccination infection prevent patient developing severe disease vaccine hesitancy group emerge hurdle need understand perception regarding vaccination AIRD patient study interviewbased survey done AIRD patient control group general population questionnaire included subject s demographic detail duration diagnosis activity AIRD question regarding perception vaccination survey included 280 patient AIRD 102 control subject 54 152280 patient 67 68102 control willing get vaccinated p = 003 Patients 45years age willing vaccinate age = 45years 619 vs 448 p = 0001 Patients lower education vaccine hesitancy graduation 38 vs 69 p 0001 common reason vaccine hesitancy notyetdecided fear related vaccine sideeffects disease worsening 29 82280 patient already vaccinated 35 3582 mild event fevermyalgiaheadache AIRD patient fewer side effect control disease flare seen one patient Thus educating AIRD patient regarding pro con vaccination particularly concerning immunological disease help u overcome vaccine hesitancy message clearly penetrate negligible risk AIRDflares COVID19 immunization side effect mild manageable,covid-19 vaccination;rheumatic disease;vaccine hesitancy
Spontaneous Pneumomediastinum COVID19 Pneumonia,34367760,Spontaneous pneumomediastinum SPM collection air within mediastinal cavity commonly described literature mechanical ventilation perforation hollow viscera Coronavirus disease 2019 COVID19 rare salient etiology complication current pandemic narrating case 46yearold male COVID19 pneumonia complicated SPM complication identified chest computed tomography CT managed conservatively leading favorable outcome SPM undemanding management timely identification appropriate treatment institution crucial milieu literature search revealed similar case SPM COVID19 different outcome important one included report,covid-19;ct scan;mechanical ventilation;pneumonia;spontaneous pneumomediastinum
Social control nursing performance defense life COVID19 pandemic,34287572,OBJECTIVE reflect social control health contribution nursing make cope COVID19 pandemic METHODS theoretical reflection elaborated discussion based literature experience author performance social control Primary Care divided two topic first related aspect institutionalized social control second related perspective nursing space RESULTS limit relevant aspect nurse role social control presented contributing perspective praxis health based ethicalpolitical commitment technical competence coordination management care face pandemic FINAL CONSIDERATIONS nurse role social control favor strengthening struggle right life profit especially popular participation community context Primary Care,
Inactivation SARSCoV2 Simulated Sunlight Contaminated Surfaces,34287031,studied stability severe acute respiratory syndrome coronavirus 2 SARSCoV2 different simulated outdoor condition changing temperature 20 degree C 35 degree C illuminance darkness 10 klx 56 klx andor cleanness surface 50 relative humidity RH darkness loss viability virus stainless steel temperature dependent hidden effect sunlight first minute exposure virus show sensitivity sunlight proportional illuminance intensity sunlight presence interfering substance moderate effect virus viability even elevated illuminance Thus SARSCoV2 rapidly inactivated simulated sunlight presence absence high level interfering substance 20 degree C 35 degree C 50 relative humidity IMPORTANCE Clinical matrix contains high level interfering substance study first reveal presence high level interfering substance little impact persistence SARSCoV2 stainless steel following exposure simulated sunlight Thus SARSCoV2 rapidly inactivated outdoor environment presence absence interfering substance result indicate transmission SARSCoV2 unlikely occur outdoor surface dependent illuminance intensity Moreover study interested lineage SARSCoV2 experiment studied stability Ltype strain comprise majority strain isolated worldwide patient Nevertheless effect sunlight seems similar regardless strain studied suggesting greater spread certain variant correlated better survival outdoor condition,sars-cov-2;emerging disease;environmental survival;inactivation;interfering substances;stainless steel;sunlight;viruses
COVID19 Cardiometabolic Disease,34224449,Cardiometabolic disease describes combination metabolic abnormality increase risk type 2 diabetes mellitus T2DM cardiovascular disease CVD including pathological change insulin resistance hyperglycemia dyslipidemia abdominal obesity hypertension HTN environmental risk factor smoking sedentary lifestyle poor diet poverty number coronavirus disease 2019 COVID19 patient continues rise T2DM CVD HTN obesity component sequela cardiometabolic disease identified among others key risk factor associated increased mortality patient Numerous study done elucidate relationship COVID19 cardiometabolic disease Cardiometabolic disease associated increased susceptibility COVID19 worse outcome COVID19 including intensive care mechanical ventilation death proinflammatory state cardiometabolic disease specifically obesity associated worse prognosis COVID19 patient evidence suggest antihypertensive antidiabetic medication discontinued COVID19 patient patient closely monitored ensure blood pressure blood glucose level stable Assessment vaccination efficacy cardiometabolic disease patient also discussed,
COVID19 pandemic reproductive genetic counseling Changes access service delivery academic medical center United States,34224635,COVID19 pandemic widely disrupted delivery healthcare service including genetic counseling ensure continuity care reproductive genetic counselor large academic medical center United States rapidly transitioned practice 90 inperson patient consultation predominantly telehealth model present study describes transition regard patient access genetic counseling genetic screening chart review patient seen reproductive genetic counselor January 2020 August 2020 completed time frame included three month prior COVID19 pandemic first five month COVID19 Patient demographic clinical appointment data compared preCOVID19 duringCOVID19 timeframes Overall 886 patient seen via telehealth COVID19 significant difference based upon patient age p = 20 indication appointment p = 06 gestational age p = 06 However nonEnglish speaking patient often seen inperson telehealth p 001 patient residing farther clinic seen via telehealth p = 004 DuringCOVID19 result prenatal cellfree DNA screening expanded carrier screening delayed p 001 Additionally consenting screening patient seen COVID19 likely complete sample collection intended screening compared seen preCOVID19 = 615 95 CI = 1432670 p = 015 Overall study support access genetic counseling service genetic screening maintained global pandemic like COVID19 Genetic counselor wellequipped pivot swiftly challenging time however must continue work address barrier accessing genetic service especially nonEnglish speaking population Future study needed pose solution obstacle confronted service delivery model global pandemic,covid-19;genetic counseling;genetic counselors;genetic services;prenatal genetic counseling;service delivery models;telemedicine
Hyperactivated RAGE Comorbidities Risk Factor Severe COVID19The Role RAGERAS Crosstalk,34204735,receptor advanced glycationend product RAGE multiligand receptor role inflammatory pulmonary pathology Hyperactivation RAGE ligand reported sustain inflammation oxidative stress common comorbidities severe COVID19 RAGE essential deleterious effect reninangiotensin system RAS participates infection multiorgan injury COVID19 patient Thus RAGE might major player severe COVID19 appears useful therapeutic molecular target infection SARSCoV2 role RAGE gene polymorphism predisposing patient severe COVID19 discussed nbsp,ager polymorphisms;covid-19 comorbidities;rage
Effectiveness lowdose radiation therapy improve mortality COVID19,34219180,INTRODUCTION Performing lowdose radiation therapy LDRT new approach treat pneumonia resulting COVID19 disease paper aim evaluate effectiveness LDRT treating COVID19 patient METHODS Medline searched `` lowdose `` radiation therapy `` COVID19 `` pneumonia `` inflammation retrieve paper published lowdose radiation therapy improve mortality COVID19 patient clinical investigation included original case report paper selected paper RESULTS completed clinical trial performed LDRT treat COVID19 showed effectiveness LDRT treating COVID19 90 CONCLUSION vast majority primary secondary outcome clinical trial investigation regarding LDRT treating COVID19 found LDRT considered feasible treatment improve mortality COVID19 patient,covid-19;low-dose radiation therapy;pneumonia
Profiles epidemiologicalnutritional transition burden morbimortality COVID19 Argentina ecological study,34287589,study aimed identify epidemiologicalnutritional profile Argentina compare burden morbimortality COVID19 multigroup ecological study conducted 24 geographic unit Argentina estimated percent change 2005 2018 indicator epidemiologicalnutritional transition sociodemographic indicator according geographic unit performed principal component analysis hierarchical cluster analysis identify geographic grouping define profile epidemiologicalnutritional transition group calculated summary measure COVID19 cumulative incidence CI mortality case fatality epidemiological week 50 establishing comparison via Student s test Three profile identified 1 reemergence infectious disease 2 persistence cardiovascular disease despite social health lifestyle improvement 3 consolidation triad obesitysedentarismcardiometabolic disease Mean COVID19 cumulative incidence mortality higher province profile 1 compared profile 2 CI p = 00159 mortality p = 00187 profile 3 CI p = 00205 Casefatality higher profile 3 includes province unfavorable socioeconomic condition showing significant difference profile 2 p=00307 conclusion distinct epidemiologicalnutritional profile Argentina tend differ term COVID19 epidemiological situation Strategies fight COVID19 consider underlying epidemiological nutritional sociodemographic characteristic,
Repurposing Psychotropic Agents Viral Disorders Beyond Covid,34375133,Recent report highlighted possible role antipsychotic chlorpromazine antidepressant fluvoxamine anticoronavirus disease 2019 COVID19 agent objective narrative review explore known activity psychotropic medication virus addition severe acute respiratory syndrome coronavirus 2 SARSCoV2 PubMed queried `` drug repurposing antiviral activity `` antiviral activity `` psychotropic drug individual agent November 2020 100 psychotropic agent 37 drug including 27 history pediatric use identified studied preclinical setting found activity virus human pathogen Effects evaluated type virus category psychotropic agent Activity identified virus known cause epidemic SARSCoV2 Ebola cause rare disorder Human Papillomatosis Virusrelated respiratory papillomatosis Individual drug class psychotropics often activity multiple virus promiscuity explained shared viral cellular target Safety profile psychotropics may tolerable context used longterm setting psychiatric illness Nonetheless translation vitro result clinical arena slow Psychotropic medication class deserve study including clinical trial repurposing antiviral drug child adult,covid-19;drug repurposing;psychotropic drugs;respiratory papillomatosis;viral infections
Multisystem inflammatory syndrome associated COVID19 pediatric disease,34346604,BACKGROUND Since start COVID19 pandemic hyperinflammatory syndrome appeared develops week SARSCoV2 infection multisystem inflammatory syndrome described mainly child MISC lately also found adult MISA CASE DESCRIPTION present case woman MISA fever diarrhoea hypotension laboratory abnormality high inflammatory marker coagulation parameter troponinT Nterminal probrain natriuretic peptide NTproBNP electrocardiogram marked diffuse STdepressions diagnosed early stage MISA treated successfully immune suppression antiaggregants anticoagulant CONCLUSION MISA MISC similar potentially lifethreatening inflammatory syndrome lead severe cardiac dysfunction cardiovascular failure effective treatment prevention complication timely recognition essential Clinicians therefore mindful multisystem inflammatory syndrome child also adult,
Evaluation SelfCollected MidTurbinate Nasal Swabs Saliva Detection SARSCoV2 RNA,34132579,Rapid accurate diagnostic testing essential bring ongoing COVID19 pandemic end demand SARSCoV2 testing continues increase amid supply shortage many laboratory investigated use source nasopharyngeal NP swab Saliva midturbinate nasal swab attractive alternative allow selfcollection wellaccepted patient Saliva also requires limited consumables compared performance health care providercollected NP swab patientcollected midturbinate MT swab patientcollected saliva specimen SARSCoV2 detection using laboratory developed PCR assay received Emergency Use Authorization FDA 281 total evaluable sample 33 117 NP swab 33 117 MT swab 32 114 saliva specimen positive SARSCoV2 following resolution discordant result compared NP swab saliva exhibited sensitivity 909 3033 specificity 992 246248 patientcollected MT swab exhibited sensitivity 939 3133 specificity 992 246248 comparing consensus standard sensitivity 100 3131 NP MT swab 968 3031 saliva specimen specificity NP swab saliva specimen 988 247250 992 248250 MT swab Pretreatment saliva proteinase K heating 15 minute prior extraction reduced invalid rate 267 52195 0 0195 data show patientcollected midturbinate nasal swab saliva suitable source selfcollection individual require routine monitoring SARSCoV2 infection,
SARSCoV2 Portrayed HIV Contrary Viral Strategies Similar Disguise,34198973,SARSCoV2 HIV zoonotic virus rapidly reached pandemic scale causing global loss fear COVID19 AIDS pandemic ignited massive effort worldwide develop antiviral strategy characterize viral architecture biological immunological property clinical outcome Although virus comparable appearance enveloped virus positivestranded RNA envelope spike mediating cellular entry entry process downstream biological immunological pathway clinical outcome disease course strikingly different review provides systemic comparison virus structural functional characteristic delineating distinct strategy efficient spread,covid-19 and aids pandemics;hiv;sars-cov-2;viral entry;zoonotic viruses
Novel malaria vaccine,34347570,Malaria vaccine hold significant promise lifesaving benefit especially child bear major burden malaria mortality RTS SAS01 malaria vaccine provides moderate efficacy tested implementation study parallel multiple strategy advanced test nextgeneration malaria vaccine including novel approach build principle learned RTS development vaccination radiationattenuated sporozoite development monoclonal antibody targeting immunogenic peptide Novel vaccine delivery approach also advanced including selfamplifying RNA vaccine delivery selfassembling protein nanoparticle method circumsporozoite proteinbased approach whole organism vaccination Techniques employed COVID19 vaccine development also considered malaria vaccination including sustained release polymer nanoparticle hydrogel vaccination chargealtering releasable transporter vaccine science advance new approach optimize knowledge gained highly effective malaria vaccine provide sustained protection within reach,plasmodium falciparum;malaria elimination;malaria vaccine
COVID19 Mortality Rate Incidence Latin America Dependence Demographic Economic Variables,34199070,pandemic caused COVID19 left million infected dead around world Latin America one affected area work sought determine mean multiple regression analysis study correlation influence population density life expectancy proportion population vulnerable employment together GDP per caput mortality rate due COVID19 Latin American country result indicated country higher population density lower number death Population vulnerable employment GDP showed positive influence life expectancy appear significantly affect number COVID19 death addition influence variable number confirmed case COVID19 analyzed concluded lack resource major burden vulnerable population combating COVID19 population density ensure better designed institution quality infrastructure achieve social distancing together effective measure lower death rate,covid-19;death rate;life expectancy;population density;vulnerable employment
Genetic emergence B16172 COVID19,34336227,Many proactive step taken worldwide fight SARSCoV2 pandemic prevent COVID19 spread realistic approach Recently novel variant B16172 identified India rapidly transmitting country challenging current therapeutic wide vaccination future research COIVD19,"covid-19 pandemic;indian sars-cov-2 consortium on genomics (insacog), sars-cov-2;delta variant;global initiative on sharing all influenza data (gisaid)"
National Early Warning Score 2 laboratory predictor correlate clinical deterioration hospitalized patient COVID19,34284639,Aim aimed determine prognostic value National Early Warning Score 2 NEWS2 laboratory parameter first week COVID19 Materials method adult patient hospitalized confirmed COVID19 11 March 11 May 2020 retrospectively included Results Overall 611 patient included result showed NEWS2 procalcitonin neutrophillymphocyte ratio albumin D0 D3 D5 D7 best predictor clinical deterioration defined composite ICU admission hospitalization inhospital death Procalcitonin highest odds ratio clinical deterioration day Conclusion study provides list several laboratory parameter correlated NEWS2 potential predictor clinical deterioration patient COVID19,covid-19;news2;albumin;in-hospital mortality;neutrophil/lymphocyte ratio;procalcitonin
COVID19 cause pregnancy loss pandemic systematic review,34379700,INTRODUCTION association Coronavirus Disease 2019 COVID19 abortion debated since beginning COVID19 pandemic aimed conduct systematic review understand better potential effect Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 fetal loss infected mother presented abortion following infection METHODS included article published PubMedMedline Web Science clinicaltrialsgov Embase database 2019 2020 comprehensive search via appropriate keywords including COVID19 abortion synonym study abortion data COVID19 confirmed pregnant female collected RESULTS 208 potentially relevant article 11 article eligible include systematic review included report published following reason 1 Firsttrimester miscarriage 2 Late miscarriage 3 complication COVID19 infection pregnancy 4 COVID19 disease artificial pregnancy Firsttrimester abortion found 5 study secondtrimester abortion 7 study Two patient acquired infection hospital stay referred abortion Reports related abortion pregnant female COVID19 show miscarriage due COVID19 first trimester due placental insufficiency CONCLUSIONS increased risk abortion mother positive test result SARSCoV2 several case report case series identified pandemic Placental inflammation viral infection may result fetal growth retardation induce abortion consistent evidence vertical transmission virus mother fetus requires investigation,
Risk acute myocardial infarction ischaemic stroke following COVID19 Sweden selfcontrolled case series matched cohort study,34332652,BACKGROUND COVID19 complex disease targeting many organ Previous study highlight COVID19 probable risk factor acute cardiovascular complication aimed quantify risk acute myocardial infarction ischaemic stroke associated COVID19 analysing COVID19 case Sweden METHODS selfcontrolled case series SCCS matched cohort study done Sweden personal identification number patient COVID19 Sweden Feb 1 Sept 14 2020 identified crosslinked national inpatient outpatient cancer cause death register control matched age sex county residence Sweden International Classification Diseases code acute myocardial infarction ischaemic stroke identified cause hospital admission patient COVID19 SCCS patient COVID19 matched control individual matched cohort study SCCS method used calculate incidence rate ratio IRR first acute myocardial infarction ischaemic stroke following COVID19 compared control period matched cohort study used determine increased risk COVID19 confers compared background population increased acute myocardial infarction ischaemic stroke first 2 week following COVID19 FINDINGS 86 742 patient COVID19 included SCCS study 348 481 matched control individual also included matched cohort study day exposure excluded risk period SCCS IRR acute myocardial infarction 289 95 CI 151555 first week 253 129494 second week 160 084304 week 3 4 following COVID19 day exposure included risk period IRR 844 5451308 first week 256 131501 second week 162 085309 week 3 4 following COVID19 corresponding IRRs ischaemic stroke day exposure excluded risk period 297 171515 first week 280 160488 second week 210 133332 week 3 4 following COVID19 day exposure included risk period IRRs 618 406942 first week 285 164497 second week 214 136338 week 3 4 following COVID19 matched cohort analysis excluding day 0 odds ratio acute myocardial infarction 341 158736 stroke 363 169780 2 week following COVID19 day 0 included matched cohort study acute myocardial infarction 661 3561220 ischaemic stroke 674 3711220 2 week following COVID19 INTERPRETATION finding suggest COVID19 risk factor acute myocardial infarction ischaemic stroke indicates acute myocardial infarction ischaemic stroke represent part clinical picture COVID19 highlight need vaccination COVID19 FUNDING Central ALFfunding Base Unit ALFFunding Region Vasterbotten Sweden Strategic funding 2020 Department Clinical Microbiology Umea University Sweden Stroke Research Northern Sweden Laboratory Molecular Infection Medicine Sweden,
Physician Satisfaction Telemedicine COVID19 Pandemic Mayo Clinic Florida Experience,34226884,Objective evaluate physician perception attitude toward telemedicine use tertiary care academic institution northeast Florida coronavirus disease 2019 pandemic Patients Methods anonymous 38question crosssectional survey developed using Qualtrics survey software Qualtrics emailed staff physician specialty discipline Mayo Clinic Florida survey open August 17 2020 September 1 2020 Collected data included general demographic characteristic employment information attitude experience telemedicine use coronavirus disease 2019 pandemic perception patient experience effect telemedicine burnout Results survey distributed 529 eligible physician institution 103 physician responding 20 distribution specialty 22 primary care specialty 41 internal medicine subspecialties 18 surgical specialty Collectively 63 found comparable quality care provided virtually v inperson whereas 80 perceived telemedicine costeffective total 76 physician felt telemedicine increased flexibility control patient care activity 36 reporting improved worklife balance 30 reporting improved burnout symptom Overall 42 preferred using telemedicine inperson visit possible Conclusion Physicians generally positive attitude regarding adoption telemedicine perceived quality health care delivery generally comparable inperson care Future study needed explore attitude regarding telemedicine pandemic virtual technology may used improve physician professional personal wellbeing,"covid-19, coronavirus disease 2019"
Knowledge awareness COVID19 among Indonesian migrant worker Greater China Region,34284218,OBJECTIVES Migrant worker one vulnerable population group coronavirus disease 2019 COVID19 pandemic study investigated knowledge awareness COVID19 among Indonesian migrant worker IMWs Macao SAR Hong Kong SAR Taiwan STUDY DESIGN crosssectional study METHODS Data collected online survey February March 2020 gain information 1 participant sociodemographic characteristic 2 experience awareness regarding COVID19 information 3 knowledge understanding COVID19 series Chisquared ttest logistic regression analysis conducted RESULTS survey completed 491 participant 921 female Knowledge COVID19 obtained multiple source including large proportion online social medium However participant obtained information employer local social network migrant organisation answered greater number question correctly Onethird participant reported receiving hoax fake news incorrect information obtained information unverified source Participants interested information cure COVID19 578 knew specific drug vaccine currently available Almost participant correctly identified fever wearing facemask main COVID19 symptom prevention strategy respectively Participants senior high school higher education worked domestic care worker greater knowledge COVID19 counterpart CONCLUSIONS Public health communication strategy using multiple channel including employer community organisation would help minimise COVID19 knowledge gap addition recommended digital literacy content added public health campaign,health communication;health education;infodemic;labour worker;migrant health
Risk Factors Fungal CoInfections Critically Ill COVID19 Patients Focus Immunosuppressants,34356924,Severe case coronavirus disease 2019 COVID19 managed intensive care unit prone complication including secondary infection opportunistic fungal pathogen Systemic fungal coinfections hospitalized COVID19 patient may exacerbate COVID19 disease severity hamper treatment effectiveness increase mortality reiterate role fungal coinfections exacerbating COVID19 disease severity well highlight emerging trend related fungal disease burden COVID19 patient Furthermore provide perspective risk factor fungal coinfections hospitalized COVID19 patient highlight potential role prolonged immunomodulatory treatment driving fungal coinfections including COVID19associated pulmonary aspergillosis CAPA COVID19associated candidiasis CAC mucormycosis reiterate need early diagnosis suspected COVID19associated systemic mycoses hospital setting,covid-19;covid-19-associated candidiasis;covid-19-associated pulmonary aspergillosis;corticosteroid treatment;fungal co-infections;mucormycosis
Questioning sexspecific difference association smoking survival rate hospitalized COVID19 patient,34351990,INTRODUCTION absence universally accepted association smoking COVID19 health outcome investigated relationship representative cohort one world s highest tobacco consuming region first report Middle East North Africa tackle specifically association smoking COVID19 mortality demonstrating novel sexdiscrepancy survival rate among patient METHODS Clinical data 743 hospitalized COVID19 patient retrospectively collected leading centre COVID19 testing treatment Lebanon Logistic regression KaplanMeier survival curve Cox proportional hazard model adjusted age stratified sex used ass association current cigarette smoking status patient COVID19 outcome RESULTS addition high smoking prevalence among hospitalized COVID19 patient 423 enrolled smoker tended higher reported ICU admission 283 v 166 p 0001 longer length stay hospital 120 + 78 v 108 day p 0001 higher death incidence compared nonsmokers 605 v 395 p 0001 Smokers elevated odds ratio death = 23 p 0001 ICU admission = 20 p 0001 remained significant multivariate regression model adjusted age stratified sex data revealed current smoking status reduces survival rate male patient HR = 19 95 CI 10293616 p = 0041 affect survival outcome among hospitalized female patient HR = 079 95 CI = 03741689 p = 0551 CONCLUSION high smoking prevalence detected hospitalized COVID19 cohort combined worse prognosis higher mortality rate smoking patient study first highlight potential sexspecific consequence smoking COVID19 outcome might explain higher vulnerability death disease among men,
Safety immunogenicity evaluation inactivated wholevirusSARSCOV2 emerging vaccine development Egypt,34286215,Background Current worldwide pandemic coronavirus disease 2019 COVID19 high number mortality rate huge economic problem require urgent demand safe effective vaccine development Inactivated SARSCoV2 vaccine alum Hydroxide play important role reducing impact COVID19 pandemic study vaccine efficacy evaluated detection neutralizing antibody protect mouse challenge SARSCoV 2 3 week second dose conclude vaccine described safety desirable property data support development plan clinical trial Methods Characterized SARSCOV2 strain severe acute respiratory syndrome coronavirus 2 isolates SARSCoV2humanEGYEgySERVAC2020 accession number MT981440 MT981439 MT981441 MT974071 MT974069 MW250352 GenBank isolated Egyptian patient SARSCoV2positive Development inactivated vaccine carried BSL3 facility immunogenicity determined mouse two dos 55 100 mug per dose Results distinct cytopathic effect induced SARSCOV2 propagation Vero cell monolayers viral particle identified Coronaviridae transmission electron microscopy RTPCR infected cell culture Immunogenicity developed vaccine indicated high antigenbinding neutralizing antibody titer regardless dose concentration excellent safety profile death clinical symptom mouse group efficacy inactivated vaccine formulation tested wild virus challenge vaccinated mouse viral replication detection lung tissue Conclusions Vaccinated mouse recorded complete protection challenge infection via inhibition SARSCOV2 replication lung tissue mouse following virus challenge regardless level serum neutralizing antibody finding support future trial evaluation applicable SARSCoV2 vaccine candidate,sars-cov-2;emerging vaccine;inactivation;isolation
Outcome Hospitalized Parkinson s Disease Patients without COVID19,34226870,Background Parkinson s disease PD patient population already reduced life expectancy rendered particularly vulnerable Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 Objectives determined risk factor increase risk death patient Parkinson s disease infected SARSCoV2 Methods Patients diagnosis PD admitted Montefiore Hospital Bronx New York tested SARSCoV2 identified Retrospective review electronic medical record confirmed diagnosis patient classified severity PD PD severity demographic socioeconomic factor comorbidities correlated mortality rate patient SARSCoV2 Results identified 162 patient meeting criterion chart review confirmed diagnosis PD 70 patient 70 patient 53 positive SARSCoV2 17 negative PD patient SARSCoV2 infection higher mortality rate 358 compared PD patient without infection 59 P = 0028 PD patient older 70 year age advanced Parkinson s disease reduction medication nonHispanics largely comprised BlackAfrican Americans statistically significant higher mortality rate infected Conclusions PD increase mortality rate SARSCoV2 infection age controlled However certain unalterable factor advanced disease age greater 70 year alterable one reduction PD medication placed PD patient increased risk mortality Also several socioeconomic factor contributed mortality example nonHispanic patient SARSCoV2 infection fared worse likely driven poorer outcome BlackAfricanAmerican cohort,parkinson's disease;sars-cov-2;ethnicity;mortality;socioeconomic
Clinical Performance Paraoxonase1Related Variables Novel Markers Inflammation Coronavirus Disease19 Machine Learning Approach,34205807,SARSCoV2 infection produce response innate immune system causing oxidative stress strong inflammatory reaction termed cytokine storm one leading cause death Paraoxonase1 PON1 protects oxidative stress hydrolyzing lipoperoxides Alterations PON1 activity associated proinflammatory mediator chemokine CC motif ligand 2 CCL2 glycoprotein galectin3 aimed investigate alteration circulating level PON1 CCL2 galectin3 126 patient COVID19 interaction clinical variable analytical parameter machine learning approach used identify predictive marker disease comparison recruited 45 COVID19 negative patient 50 healthy individual approach identified synergy oxidative stress inflammation fibrogenesis positive patient observed negative patient PON1 activity parameter greatest power discriminate patient either positive negative COVID19 level CCL2 galectin3 similar suggest measurement serum PON1 activity may useful marker diagnosis COVID19,covid-19;sars-cov-2;biomarkers;chemokines;galectin-3;machine learning;paraoxonase-1
SARSCoV2 immune evasion B1427B1429 variant concern,34210893,novel variant concern VOC named CAL20C B1427B1429 originally detected California carry spike glycoprotein mutation S13I signal peptide W152C Nterminal domain NTD L452R receptorbinding domain RBD Plasma individual vaccinated Wuhan1 isolatebased messenger RNA vaccine convalescent individual exhibited neutralizing titer reduced 2 35fold B1427B1429 variant relative wildtype pseudoviruses L452R mutation reduced neutralizing activity 14 34 RBDspecific monoclonal antibody mAbs S13I W152C mutation resulted total loss neutralization 10 10 NTDspecific mAbs NTD antigenic supersite remodeled shift signal peptide cleavage site formation new disulfide bond revealed mass spectrometry structural study,
Hormonal intervention treatment veteran COVID19 requiring hospitalization HITCH multicenter phase 2 randomized controlled trial best supportive care v best supportive care plus degarelix study protocol randomized controlled trial,34225789,BACKGROUND Therapeutic targeting hostcell factor required SARSCoV2 entry alternative strategy ameliorate COVID19 severity SARSCoV2 entry lung epithelium requires TMPRSS2 cell surface protease Preclinical correlative data human suggest antiandrogenic therapy reduce expression TMPRSS2 lung epithelium Accordingly hypothesize therapeutic targeting androgen receptor signaling via degarelix luteinizing hormonereleasing hormone LHRH antagonist suppress COVID19 infection ameliorate symptom severity METHODS randomized phase 2 placebocontrolled doubleblind clinical trial 198 patient compare efficacy degarelix plus best supportive care versus placebo plus best supportive care improving clinical outcome male Veterans hospitalized due COVID19 Enrolled patient must documented infection SARSCoV2 based positive reverse transcriptase polymerase chain reaction result performed nasopharyngeal swab severity illness level 35 hospitalized requiring invasive mechanical ventilation Patients stratified age history hypertension severity centrally randomized 21 degarelix placebo composite primary endpoint mortality ongoing need hospitalization requirement mechanical ventilation 15 randomization Important secondary endpoint include time clinical improvement inpatient mortality length hospitalization duration mechanical ventilation time achieve normal temperature maximum severity COVID19 illness Exploratory analysis aim ass association cytokine viral load various comorbidities outcome addition TMPRSS2 expression target tissue development antiviral antibody also investigated DISCUSSION trial repurpose FDA approved LHRH antagonist degarelix commonly used prostate cancer suppress TMPRSS2 host cell surface protease required SARSCoV2 cell entry objective determine temporary androgen suppression single dose degarelix improves clinical outcome patient hospitalized due COVID19 TRIAL REGISTRATION ClinicalTrialsgov NCT04397718 Registered May 21 2020,androgen receptor;androgen suppression;anti-androgen;covid-19;coronavirus;hormone therapy;sars-cov-2;tmprss2
Exploring Reproductive Health Impact COVID 19 pandemic Depth Interviews key stakeholder Pakistan,34290785,Objective explore effect COVID 19 reproductive child health service gender relation Methods Qualitative Exploratory Research Due lockdown setting online interview Zoom Sampling purposive Five indepth interview conducted June 2020 followed compilation result manuscript writing July August 2020 Results Maternal Neonatal morbidity mortality rise part collateral damage C19 routine service maternity care family planning post abortion care vaccination also lockdown Baby boom unwanted pregnancy unsafe abortion violence woman secondary consequence C19 Conclusion critical service never stop include maternal neonatal essential service MNCH service continuity maintained optimize maternal neonatal health prevent unwanted pregnancy abortion appropriate standard operating procedure protective equipment health facility need open LHWs community mobilisers PPEs continue service,covid 19;fp;lock down;pandemic;qualitative study;rh
Investigation management pulmonary embolism 1 probabilitybased approach,34338014,Pulmonary embolism remains common potentially deadly disease despite advance diagnostic imaging treatment prevention Managing pulmonary embolism requires multifactorial approach involving risk stratification determining appropriate diagnostics selecting individualised therapy article review pathophysiology risk factor clinical presentation diagnostic evaluation therapeutic management early outpatient management pulmonary embolism second part summarises pulmonary embolism setting pregnancy COVID19 recurrent disease chronic thromboembolic pulmonary hypertension,computed tomography pulmonary angiogram;d-dimer;pulmonary embolism;thrombolysis;ventilation/perfusion scan
LSIGN receptor liver sinusoidal endothelial cell SARSCoV2 virus,34291736,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 remains pandemic Severe disease associated dysfunction multiple organ infected cell express ACE2 canonical entry receptor SARSCoV2 report Ctype lectin receptor LSIGN interacted Ca2+dependent manner highmannosetype Nglycans SARSCoV2 spike protein found LSIGN highly expressed human liver sinusoidal endothelial cell LSECs lymph node lymphatic endothelial cell blood endothelial cell Using highresolution confocal microscopy imaging detected SARSCoV2 viral protein within LSECs liver autopsy sample patient COVID19 found pseudotyped virus enveloped SARSCoV2 spike protein authentic SARSCoV2 virus infected LSIGNexpressing cell relative control cell Moreover blocking LSIGN function reduced CoV2type infection result indicate LSIGN receptor SARSCoV2 infection LSECs major source clotting factor vWF factor VIII FVIII LSECs liver autopsy sample patient COVID19 expressed substantially higher level vWF FVIII LSECs uninfected liver sample data demonstrate LSIGN endothelial cell receptor SARSCoV2 may contribute COVID19associated coagulopathy,cell biology;coagulation;endothelial cells;vascular biology
Transplantation program facing lack empirical evidence SARSCoV2 vaccination society recommendation consensus update,34288294,BACKGROUND Since phase III trial prominent vaccine excluded immunocompromised immunosuppressed patient data safety efficacy SARSCoV2 vaccine recipient solid organ transplantation scarce AIMS study offer synthesis expert opinion aligned available data addressing key question clinical management SARSCoV2 vaccination transplant patient METHOD online research performed retrieving available recommendation national international transplantation organization state institution SARSCoV2 vaccination management transplant recipient RESULTS Eleven key statement identified recommendation 18 national international society consensus individual statement evaluated mean Society Recommendation Consensus score highest consensus level SRC found prioritized access vaccination transplant patient despite anticipation weakened immune response currently authorized vaccine considered safe transplant patient SRC handling immunosuppressive medication timely management vaccine aspect aligned available expert opinion CONCLUSION Expert consensus determined crucial aspect implementation SARSCoV2 vaccination program hereby offer tool immediate decisionmaking empirical data becomes available,covid-19;sars-cov-2 vaccination;solid organ transplantation
Comparative Analysis Coronavirus Nucleocapsid N Proteins Reveals SADSCoV N Protein Antagonizes IFNbeta Production Inducing Ubiquitination RIGI,34220846,Coronaviruses CoVs known global threat recently ongoing COVID19 pandemic claimed 2 million human life Delays interference IFN response closely associated severity disease caused CoV infection abundant viral protein infected cell entry step CoV nucleocapsid N protein likely play key role IFN interruption conducted comprehensive comparative analysis report herein N protein representative human animal CoVs four different genus swine acute diarrhea syndrome CoV SADSCoV porcine epidemic diarrhea virus PEDV severe acute respiratory syndrome CoV SARSCoV SARSCoV2 Middle East respiratory syndrome CoV MERSCoV infectious bronchitis virus IBV porcine deltacoronavirus PDCoV suppress IFN response multiple strategy particular found N protein SADSCoV interacted RIGI independent RNA binding activity mediating K27 K48 K63linked ubiquitination RIGI subsequent proteasomedependent degradation thus inhibiting host IFN response data provide insight interaction CoVs host offer new clue development therapy important virus,coronavirus;interferon;nucleocapsid protein;retinoic acid-inducible gene i (rig-i);swine acute diarrhea syndrome coronavirus (sads-cov);ubiquitination
QTc interval prolongation inflammation mortality patient COVID19,34291390,PURPOSE Systemic inflammation associated corrected QT QTc interval prolongation role inflammation QTc prolongation COVID19 patient investigated METHODS Patients laboratoryconfirmed SARSCoV2 infection admitted IRCCS San Raffaele Scientific Institute Milan Italy March 14 2020 March 30 2020 included QTcI defined QTc interval Bazett formula first ECG performed hospitalization new drug treatment QTcII QTc ECG performed initiation hydroxychloroquine drug treatment RESULTS QTcI long 45 patient 45 normal 55 patient 55 Patients long QTcI older frequently male CReactive protein CRP white blood cell WBC count hospitalization higher patient long QTcI long QTcII QTcI significantly correlated CRP level hospitalization median followup 83 day 14 patient 14 died death attributed ventricular arrhythmia Patients long QTcI long QTcII shorter survival compared normal QTcI QTcII patient respectively Cox multivariate analysis independent predictor mortality age HR = 11 CI 95 104118 p = 0002 CRP ECG II HR 11 CI 95 1011 p = 002 CONCLUSIONS QTc hospitalization simple risk marker mortality risk COVID19 patient reflects myocardial inflammatory status,covid-19;inflammation;qt interval;qtc;sars-cov-2
COVID19 Liver Lessons Learnt EAST WEST Year Later,34352133,Globally severe acute respiratory syndrome coronavirus 2 SARSCoV2 virus major cause significant morbidity mortality Since start pandemic several hepatobiliary manifestation coronavirus disease 2019 COVID19 described unique consideration raised review aim summarize pathogenesis hepatobiliary manifestation COVID19 discus similarity contrasting feature diseasespecific management across range hepatobiliary disease EAST WEST Published study regional society guideline EAST WEST comprehensively reviewed summarized wide range hepatobiliary manifestation including infrequent chronic manifestation cholangiopathy observed COVID19 pathogenesis liver injury multifactorial scant evidence direct SARSCoV2 infection liver Patients nonalcoholic fatty liver disease cirrhosis liver cancer potentially increased risk severe COVID19 unique consideration chronic hepatitis B C hepatocellular carcinoma immunosuppressed autoimmune hepatitis liver transplant recipient surge SARSCoV2 infection liver transplant activity variably impacted Preliminarily SARSCoV2 vaccine appear safe chronic liver disease transplant recipient emerging data suggest need third dose immunosuppressed patient conclusion patient chronic liver disease particularly cirrhosis liver transplant recipient vulnerable severe COVID19 past year several unique consideration highlighted across spectrum hepatobiliary disease Vaccination strongly recommended chronic liver disease liver transplant recipient,covid-19;cirrhosis;hepatitis;liver transplant;vaccination
Chemotherapy resumption breast cancer patient COVID19,34287742,BACKGROUND many study verified effect recent anticancer treatment patient COVID19 data optimal time cancer treatment resumption well safety chemotherapy COVID19 patient many cancer patient recovering COVID19 urgent need reliable clinical information Herein report case invasive ductal carcinoma able successfully resume chemotherapy infection SARCoV2 CASE PRESENTATION patient 38yearold nonsmoking Japanese woman significant medical history fever day 5 6 second course adjuvant FEC therapy day 7 tested positive SARSCoV2 RTPCR hospitalized 11 day resumed therapy day 25 discharge remaining clinical symptom patient completed four course initial chemotherapy without major adverse event recurrence COVID19 subsequently completed four course docetaxel second regimen therapy CONCLUSIONS Evaluating risk patient essential resuming anticancer therapy cancer patient s postCOVID19,breast cancer;covid-19;case report;chemotherapy;resumption;severe acute respiratory syndrome coronavirus 2
Association serum amyloid level predicting disase severity COVID19 patient systematic review metaanalysis,34286504,OBJECTIVE Global health resource faced huge challenge pandemic coronavirus disease 2019 COVID19 since December 2019 Numerous clinical report focused association serum amyloid SAA level severe COVID19 However systematic analysis synthesizing finding performed metaanalysis aim systematically review role SAA level distinguishing among patient mild severe critical COVID19 MATERIALS METHODS comprehensive literature search conducted PubMed Embase Web Science database beginning COVID19 outbreak February 1 2021 Two investigator independently reviewed suitable study Pooled standardized mean difference SMDs 95 confidence interval CIs correlation coefficient r computed using randomeffects model RESULTS included 19 317 title identified search involving total 1806 mild case 1529 severe case Compared mild group severe group markedly higher SAA level SMD=1155 95 CI 089 142 Subgroup analysis revealed SAA level difference severe group mild group associated age sample size detection method Sensitivity analysis showed credibility robustness result addition six study involving 1144 patient severe COVID19 433 patient critical COVID19 SAA significantly higher patient critical COVID19 SMD=0476 95 CI 013 082 CONCLUSIONS High circulating SAA level markedly associated COVID19 severity especially subject aged le 50 year compared patient mild COVID19 SAA concentration also significantly higher patient critical COVID19 compared severe COVID19 study large cohort needed confirm whether SAA useful tool discriminating among patient stable COVID19 acute exacerbation subject without disease,
Seroprevalence Risk Factors Associated SARSCoV2 Infection Health Care Workers Early COVID19 Pandemic Italy,34228126,Importance Identifying health care setting professional increased risk SARSCoV2 infection crucial defining appropriate strategy resource allocation protocol protect health care worker HCWs patient Moreover information crucial decrease risk HCWs health care facility become amplifier SARSCoV2 transmission community Objective ass association different health care professional category operational unit including inhospital ward outpatient facility territorial care department seroprevalence odds SARSCoV2 infection Design Setting Participants crosssectional study conducted using IgG serological test collected April 1 May 26 2020 Lombardy region Italy Voluntary serological screening offered clinical nonclinical staff providing health care service support health care service region Data analyzed June 2020 April 2021 Exposures Employment health care sector Main Outcomes Measures Seroprevalence positive IgG antibody test SARSCoV2 collected odds ratio experiencing infection calculated Results total 140782 professional employed health sector invited participate IgG serological screening among 82961 individual 590 response rate tested SARSCoV2 antibody median interquartile range IQR range age 50 4056 1983 year 59839 721 woman Among individual 10115 HCWs 122 95 CI 120 124 positive result median IQR range age 50 3955 2080 year 7298 722 woman Statistically significantly higher odds infection found among health assistant adjusted odds ratio aOR 148 95 CI 133165 nurse aOR 128 95 CI 117141 compared administrative staff among worker employed internal medicine aOR 224 95 CI 187268 palliative care aOR 184 95 CI 138244 rehabilitation aOR 159 95 CI 133191 emergency department aOR 156 95 CI 129189 compared working telephone operator Statistically significantly lower odds infection found among individual working forensic medicine aOR 040 95 CI 019088 histology anatomical pathology aOR 071 95 CI 052097 medical device sterilization aOR 054 95 CI 035084 compared working telephone operator odds infection physician laboratory personnel statistically significantly different found among administrative staff odds infection worker employed intensive care unit infectious disease ward statistically significantly different telephone operator Conclusions Relevance finding suggest professional partially accustomed managing infectious disease higher odds SARSCoV2 infection finding suggest adequate organization clinical ward personnel appropriate personal protective equipment supply training worker directly repeatedly exposed patient clinical subclinical COVID19 prioritized decrease risk infection health care setting,
AIEmpowered Computational Examination Chest Imaging COVID19 Treatment Review,34368756,Since first case coronavirus disease 2019 COVID19 discovered December 2019 COVID19 swiftly spread world end March 2021 136 million patient infected Since second third wave COVID19 outbreak full swing investigating effective timely solution patient checkups treatment important Although SARSCoV2 virusspecific reverse transcription polymerase chain reaction test recommended diagnosis COVID19 test result prone false negative early course COVID19 infection enhance screening efficiency accessibility chest image captured via Xray computed tomography CT provide valuable information evaluating patient suspected COVID19 infection advanced artificial intelligence AI technique AIdriven model training lung scan emerge quick diagnostic screening tool detecting COVID19 infection patient article provide comprehensive review stateoftheart AIempowered method computational examination COVID19 patient lung scan regard searched paper preprints bioRxiv medRxiv arXiv published period January 1 2020 March 31 2021 using keywords COVID lung scan AI quality screening 96 study included review reviewed study grouped three category based target application scenario automatic detection coronavirus disease infection segmentation severity assessment prognosis prediction latest AI solution process analyze chest image COVID19 treatment advantage limitation presented addition reviewing rapidly developing technique also summarize publicly accessible lung scan image set article end discussion challenge current research potential direction designing effective computational solution fight COVID19 pandemic future,covid-19;roi segmentation;chest imaging;diagnostic model;image analysis;machine learning;prognosis prediction;severity assessment
Immune Response Viral Shedding Time Clinical Characterization COVID19 Patients Gastrointestinal Symptoms,34222268,Background Aims Gastrointestinal GI symptom frequently observed coronavirus disease COVID19 symptom Previous study mainly focused epidemiology characteristic patient GI symptom little known role immune response susceptibility severity infection analyzed COVID19 case determine immune response clinical characteristic COVID19 patient GI symptom Methods Based presence GI symptom 79 patient Xuzhou divided GI nonGI group retrospective study investigating clinical characteristic selected laboratory abnormality immune response treatment clinical outcome performed compare patient without GI symptom Results Approximately 25 patient reported least one GI symptom result showed significantly higher rate fatigue increased LDH increased CK higher percentage increase neutrophiltolymphocyte ratio NLR lymphopenia bilateral pneumonia patient GI symptom significant change serum amylase SAA immunoglobulin Ig G IgM Creactive protein CRP procalcitonin PCT interleukin6 IL6 viral shedding time liver injury kidney injury two group observed clinical type admission patient GI symptom reported significantly higher rate critical disease type 20 vs 33 p = 0033 However survival rate differ two group Conclusions Increase total lymphocyte NLR well elevation CRP SAA PCT IL6 CK LDH closely associated COVID19 GI symptom implying reliable indicator COVID19 patient GI symptom likely develop severe disease,covid-19;clinical characterization;epidemiology;gastrointestinal symptoms;immune response
Expression ACE2 Virus Entry Protein Nervus Terminalis Reveals Potential Alternative Route Brain Infection COVID19,34290590,Previous study suggested SARSCoV2 virus may gain access brain using route along olfactory nerve However general consensus obligatory virus entry receptor angiotensin converting enzyme 2 ACE2 expressed olfactory receptor neuron timing arrival virus brain target inconsistent neuronal transfer along olfactory projection determined whether nervus terminalis neuron peripheral central projection considered potential alternative route nose brain Nervus terminalis neuron postnatal mouse doublelabeled antibody ACE2 two nervus terminalis marker gonadotropinreleasing hormone GnRH choline acetyltransferase CHAT show small fraction CHATlabeled nervus terminalis neuron large majority GnRHlabeled nervus terminalis neuron cell body region olfactory epithelium olfactory bulb express ACE2 cathepsins B L Nervus terminalis neuron therefore may provide direct route virus nasal epithelium possibly via innervation Bowman s gland brain target including telencephalon diencephalon possibility need examined suitable animal model human tissue,ace2;covid-19;sars-cov-2;brain infection;cathepsin;nervus terminalis;olfactory system
COVID19 testing result really say real statistic concealed behind accessible data,34224155,Accurate comprehensive testing crucial practitioner portray pandemic Without testing data yet exact number infected people determined due lack comprehensive testing number seropositive SARSCoV2 infection obviously relative extent testing However true number infection might still far higher reported value compare country based number seropositive SARSCoV2 infection misleading may enough test carried properly monitor outbreak paper closely look COVID19 testing result Herein try draw conclusion based reported data first presence possible relationship COVID19 transition patient age assessed COVID19 case fatality rate CFR compared agedemographic data different country Based result method estimating lower bound minimum number actual positive case developed validated Results study shown CFR metric reflecting spread virus factor extent testing necessarily show real size outbreak Moreover large difference susceptibility age found result suggest similarity age distribution COVID19 population agedemographic improving course pandemic addition country lower CFRs similar COVID19 age distribution result comprehensive testing Finally method estimation real number infected people based age distribution reported CFRs extent testing developed validated,cfr;covid-19;age-demographic;estimation;pandemic;spread
High Rates Hidden HCV Infections among Hospitalized Patients Aged 5585,34205096,BACKGROUND AIMS solicited country eliminate HCV 2030 Italian government started routine screening HCV infection January 2021 initially targeting subject born 1969 1989 aim achieving microelimination designed hospitalwide project focusing inpatient born 1935 1985 conducted institution METHOD inpatient aged 35 85 admitted 10 February 2020 9 February 2021 many different disease condition underwent HCV antibody HCVAb testing thirdgeneration ELISA positive reflex HCV RNA testing genotyping performed Clinical history fibrosis diagnosis laboratory data concomitant medication available RESULTS HCV screening rate inpatient 100 total 11748 participant enrolled 5350 male HCVAb positivity rate 303 HCVAb rate increased age higher patient born 1935 1944 481 rate HCV RNA positivity 097 vast majority 8070 HCV RNApositive participant 55 older 40 case HCV RNApositive patient unaware infection Although 16 patient died HCV chronic infection diagnosis two due COVID19 HCV treatment prescription one due COVID19 7456 patient HCV diagnosis linked HCV treatment despite comorbidities patient older 65 died active HCV infection CONCLUSION present study revealed rate active HCV infection among inpatient lower reported past general population appears result widespread use pangenotypic directacting antiviral agent DAAs overall rate active infection lower rate observed 19351954 cohort high rate inpatient unaware HCV infection high number death among subject active HCV infection born 1935 1954 suggest least southern Italy targeted screening birth cohort may required reduce number undiagnosed case hidden infection,hcv;birth cohort;linkage-to-care;micro-elimination;screening;sofosbuvir/velpatasvir
Understanding Post Entry Sorting Adenovirus Capsids Chance Change Vaccine Vector Properties,34202573,Adenovirus vectorbased genetic vaccine emerged powerful strategy SARSCoV2 health crisis success unexpected adenovirus combine many desirable feature genetic vaccine highly immunogenic low well characterized pathogenic profile paired technological approachability Ongoing effort improve adenovirusvaccine vector include use rare serotypes nonhuman adenovirus review focus viral capsid choice genotype influence uptake subsequent subcellular sorting describe understanding capsid property stability entry process change fate entering particle translates difference immunity outcome discus detail mutating membrane lytic capsid protein VI affect specie C virus postentry sorting briefly discus approach could wider implication vaccine andor vector development,sars-cov-2;adaptive immunity;adenovirus;autophagy;innate immunity;intracellular trafficking;vaccine vector;virus entry
Persisting Antibody Response SARSCoV2 Local Austrian Population,34222275,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 caused global pandemic recently prevalence persistence antibody following peak SARSCoV2 infection provides insight potential level population immunity June 2020 succeeded testing almost half population Austrian town higher incidence COVID19 infection performed followup study reassess prevalence SARSCoV2specific IgA IgG antibody 68 participant previous study found prevalence IgG IgA antibody remained remarkably stable 84 cohort prevailing SARSCoV2specific antibody slight decrease 93 4 month patient confirmed COVID19 seroconversion potentially provides immunity reinfection result suggest stable antibody response observed least 6 month postinfection implication developing strategy testing protecting population,covid-19;sars-cov-2;antibody;population;serotype
Emergence SARSCoV2 Variant Impact Prevalence COVID19 Cases Nabatieh Region Lebanon,34199617,Background outbreak unknown respiratory illness caused novel coronavirus SARSCoV2 emerged city Wuhan Hubei Province China December 2019 referred coronavirus disease2019 COVID19 Soon declared global pandemic World Health Organization March 2020 SARSCoV2 mainly infects respiratory tract different outcome ranging asymptomatic infection severe critical illness leading death Different SARSCoV2 variant emerging three raised concern worldwide due high transmissibility among population Objective study prevalence COVID19 region NabatiehSouth Lebanon past year ass presence SARSCoV2 variant effect spread infection time lockdown Methods study 37474 nasopharyngeal swab sample collected analyzed detection SARSCoV2 virus suspected patient attending tertiary health care center South Lebanon period 16 March 2020 21 February 2021 Results result demonstrated variation prevalence rate ranging le 1 full lockdown country 84 upon easing lockdown restriction reaching 275 holiday 2021 New Year celebration Interestingly new variant appeared starting January 2021 significant positive association prevalence positive test percentage variant Conclusions result indicate lockdown implemented Lebanese official effective intervention contain COVID19 spread study also showed lifting lockdown measure holiday allowed indoor crowded gathering occur caused surge COVID19 case rise mortality rate nationwide importantly confirmed presence highly transmissible SARSCoV2 variant circulating Lebanese community least January 2021 onwards,covid-19;lebanon;sars-cov-2;lockdown;variant
Optimization Vero Cells Grown Polymer Fiber Carrier Disposable Bioreactor Inactivated Coxsackievirus A16 Vaccine Development,34200441,present vaccine available hand foot mouth disease caused Coxsackie virus A16 CVA16 infection present study isolated epidemic strain CVA16 optimized production virus Vero cell system comprised growing infected cell polymer fiber paper carrier serumfree medium containing 05 wv lactalbumin hydrolysate mini bioreactor Disposable Bioflo310 AmProtein Current perfusion bioreactors used monitor virus infection Vero cell culture total number cell increased 15 x 10 9 30 x 10 10 optimized culture process virus titer reached 78 x 10 7 TCID50mL three day infection inactivated CVA16 prepared optimized culture procedure elicited slightly higher neutralizing antibody titer compared derived routine culture procedure result promote largescale production inactivated CVA16 vaccine using nonwoven polymer fiber paper cell culture,coxsackie virus a16;disposable mini bioreactor;polymer fiber paper carriers;vaccine
COVID19 preparedness Clinical pharmacy service remote staffing quaternary level trauma comprehensive stroke center,34286818,PURPOSE rapid spread novel severe acute respiratory syndrome coronavirus 2 SARSCoV2 cause coronavirus disease 2019 COVID19 strained resource healthcare system around world accordance recommendation World Health Organization Centers Disease Control Prevention US Department Defense Intermountain Medical Center IMED Murray UT developed plan provide remote clinical pharmacy service protect health pharmacy caregiver maintaining appropriate clinical pharmacy coverage optimally care patient SUMMARY utilization telemedicine technology permit clinical pharmacist readily communicate nurse physician caregiver patient identified strategy allow clinical pharmacist continue participate daily round provide consultation collaborative practice agreement verify medication order collect medication history provide antimicrobial stewardship deliver medication education patient offsite location pharmacy department IMED proactively tested telemedicine technology defined role clinical pharmacist identified communication strategy prior rapid rise COVID19 case state Utah CONCLUSION proactive measure described help ensure pharmacy caregiver appropriate remote access capable confidently using resource step allow optimal care hospitalized patient promote social distancing may added benefit decreasing spread SARSCoV2 among patient caregiver,covid-19;sars-cov-2;clinical pharmacy;novel coronavirus;remote work;telepharmacy
Peridomestic Mammal Susceptibility Severe Acute Respiratory Syndrome Coronavirus 2 Infection,34286685,Wild animal implicated origin severe acute respiratory syndrome coronavirus 2 SARSCoV2 largely unknown virus affect wildlife specie wildlife could ultimately serve reservoir maintaining virus outside human population show several common peridomestic specie including deer mouse bushytailed woodrats striped skunk susceptible infection shed virus respiratory secretion contrast demonstrate cottontail rabbit fox squirrel Wyoming ground squirrel blacktailed prairie dog house mouse racoon susceptible SARSCoV2 infection result expand knowledge base susceptible specie provide evidence humanwildlife interaction could result continued transmission SARSCoV2,covid-19;sars-cov-2;united states;coronavirus;coronavirus disease;cottontail rabbit;deer mouse;experimental infection;house mouse;infections;mesocarnivore;peridomestic;raccoon;respiratory infections;rodent;severe acute respiratory syndrome coronavirus 2;squirrel;striped skunk;viruses;wildlife;woodrat;zoonoses
Genetic counseling virtual visit equity era COVID19 beyond,34291525,Overnight result COVID19 pandemic telehealth rapidly transitioned limited application widespread implementation field genetic counseling well positioned make transition virtual care since generally le need patient seen inperson physical exam urgent care Going forward virtual visit presumably become mainstay provision genetic service anticipated clinic adopt `` hybrid model inperson virtual visit option commentary highlight success challenge rapid implementation virtual visit focusing benefited versus challenged left behind also discus genetic testing consideration including additional step required patient clinician testing ordered outside clinical setting result delay lack testing altogether Future research consideration presented address need among vulnerable help ensure equitable access benefit,covid-19;disparities;genetic counseling;genetic testing;telegenetics;telehealth;virtual visits
Dental Education COVID19 Pandemic German Dental Hospital,34199085,Due SARSCoV2 pandemic dental treatment performed undergraduate student University MarburgGermany immediately stopped spring 2020 stepwise reinstalled new hygiene concept full recovery winter 202021 Patient treatment student course evaluated based three aspect 1 Testing patient SARSCoV2 Rapid Antigen SCRA Test applied student assistant SA 2 Improved hygiene regimen separated treatment unit crossventilation preoperative mouth rinse rubber dam application wherever possible 3 Recruitment patient 735 patient preregistered two course 384 patient treated total 699 test SCRA test performed SAs half patient treated course healthy 40 patient preregistered treated course revealed disease relevant COVID p 0001 46 patient concern visit dental hospital due increase COVID incidence level 14 person refused tested presented concept suitable enable patient treatment student course SARSCoV2 pandemic,covid-19;sars-cov-2 rapid antigen test;dental education;online learning;patient treatment by students
Conventional microfluidic method airborne virus isolation detection,34352699,COVID19 pandemic threat infectious disease public health safety become much apparent Viral bacterial fungal disease led loss million life especially developing world Diseases caused airborne virus like SARSCoV2 difficult control virus easily transmissible circulate air hour contain outbreak virus SARSCoV2 institute targeted precaution important detect air understand infect target Pointofcare PoC diagnostics pointofneed PoN detection method necessary rapidly test patient environmental sample precaution immediately applied Traditional benchtop detection method ELISA PCR culture suitable PoC PoN monitoring take hour day require specialized equipment Microfluidic device made low cost perform assay rapidly PoN also integrated air liquidbased sampling technology capture analyze virus air body fluid conventional microfluidic virus detection method reviewed compared use air sampling device capture concentrate virus discussed first followed review analysis method immunoassay RTPCR isothermal amplification conventional microfluidic platform review provides overview capability microfluidics virus handling detection useful infectious disease researcher biomedical engineer public health agency,airborne transmission;microfluidics;point-of-need;virus;virus collection;virus detection
Impact COVID19 Pandemic HealthcareSeeking Behaviors among Frequent Emergency Department Users Cohort Study,34208194,2020 Taiwan s healthcare system faced notable burden imposed coronavirus disease COVID19 pandemic Emergency department ED highrisk area severe acute respiratory syndrome coronavirus 2 transmission effect COVID19 utilization ED service among frequent ED user remains unknown cohort study determined impact COVID19 pandemic healthcareseeking behavior among frequent ED user Taipei City Hospital Taiwan included ED user aged = 18 year admitted Taipei City Hospital February 2019January 2020 pandemic February 2020January 2021 pandemic Frequent ED user patient four ED visit per year Stepwise logistic regression performed identify predictor frequent ED use COVID19 pandemic Frequent ED user shorter hospital stay ED pandemic adjusting sociodemographic factor covariates patient triage status level 45 pneumonia diagnosis giddiness dyspnea likely frequent ED visitor COVID19 pandemic reduce risk acquiring COVID19 important utilize territorial healthcare telehealth avoid inappropriate ED visit patient low level risk chronic disease,covid-19 pandemic;emergency department;frequent users
Pharmacist dispensing abortion pill Canada Diffusion Innovation meet integrated knowledge translation,34344393,BACKGROUND Since Canadian drug regulatory approval mifepristone medical abortion 2015 market availability January 2017 role pharmacist abortion provision changed rapidly sought identify factor influenced initiation provision medical abortion perspective Canadian pharmacist bridging two framework Diffusion Innovation Health Service Organizations integrated knowledge translation METHODS conducted oneonone semistructured interview pharmacist residing Canada intended stock dispense mifepristone within first year availability data collection analysis interpretation guided reflexive thematic analysis supported integrated knowledge translation partnership pharmacy stakeholder RESULTS completed interview 24 participant across Canada 33 stocked 21 dispensed mifepristone found pharmacist willing able integrate medical abortion care practice initiated practice satisfied dispensing experience analysis indicated several key Diffusion Innovation construct impacted uptake mifepristone including innovation relative advantage complexity compatibility technical support system readiness innovationsystem fit dedicated time resource diffusion dissemination expert opinion boundary spanner champion social network peer opinion implementation external collaboration linkage Participants experience suggest integrated knowledge translation facilitated evidencebased change mifepristone dispensing restriction communication change front line pharmacist CONCLUSIONS illustrate Diffusion Innovation integrated knowledge translation may work together complimentary framework implementation science research Unlike USA UK highly regulated setting globally pharmacist Canada permitted dispense mifepristone medical abortion contribute literature show mifepristone dispensed outside hospital clinic medical office safe acceptable patient prescribers finding particular importance current COVID19 pandemic response call continued equitable access abortion care primary practice,"abortion, induced;canada;diffusion of innovation;mifepristone;pharmacists;primary health care"
COVID 19 disease independently predicted endothelial dysfunction measured flowmediated dilatation,34286447,systemic effect COVID19 disease still largely uncertain need scrutinized trial Endothelial dysfunction ED responsible majority adverse cardiovascular event Flowmediated dilation FMD easily obtainable method ass ED accurately aimed evaluate ED measuring FMD following COVID19 disease Patients diagnosed COVID19 disease recruited hospital two month discharge Sex agematched healthy subject determined control group Blood sample FMD measurement obtained participant subject divided two group according presence ED determined FMD measurement two group compared term demographic feature presence recovered COVID19 disease total 92 subject consisting 59 without ED 33 ED included study ED + group older p = 0015 likely hypertension p = 0044 COVID19 rate higher ED + group p = 0009 neutrophil count p = 0047 CRP p = 0036 higher eGFR p = 0044 lower ED + group backward multivariable regression analysis COVID19 disease = 3611 95 CI 106912198 p = 0039 BMI = 1122 95 CI 10231231 p = 0015 independent predictor ED COVID19 disease may cause ED major underlying factor cardiovascular disease Furthermore COVID19 disease may deteriorate existing cardiovascular disease course Detecting ED early phase preventing new treatment modality may improve short longterm outcome,covid-19 disease;endothelial dysfunction;flow-mediated dilatation
CrossSectional Study SARSCoV2 Seroprevalence Fall 2020 February 2021 Allegheny County Western Pennsylvania USA,34204122,Seroprevalence study important understanding dynamic local virus transmission evaluating community immunity ass seroprevalence SARSCoV2 Allegheny County urbansuburban county Western PA 393 human blood sample collected Fall 2020 February 2021 examined spike protein receptorbinding domain RBD nucleocapsid protein N antibody RBDpositive sample evaluated virusspecific neutralization activity result showed seroprevalence 55 RBD ELISA 45 N ELISA 25 Fall 2020 increased 247 RBD ELISA 149 N ELISA 129 February 2021 Neutralization titer significantly correlated RBD titer N titer Using two assay able distinguish infected vaccinated individual February cohort higher median income white race associated serological finding consistent vaccination study demonstrates 45fold increase SARSCoV2 seroprevalence Fall 2020 February 2021 Allegheny County PA due increased incidence natural disease vaccination Future seroprevalence study need include effect vaccination assay result incorporate nonvaccine antigen serological assessment,elisa;sars-cov-2;neutralization assay;seroprevalence
COVID19 Impact Musculoskeletal Regenerative Medicine Research Maintaining Lab Continuity,34198945,BACKGROUND Research field musculoskeletal tissue engineering regenerative medicine may suffer slowdown ongoing COVID19 pandemic emergency likely harm development new therapeutic strategy translation clinic long term Recently need maintain continuity research activity field assumed even greater importance due accumulation data concerning effect SARSCoV2 musculoskeletal system study aimed identification series safe handling practice COVID19 diffusion apply research environment thus allowing maintenance research lab activity METHODS control measure apply mitigate COVID19 risk identified categorized utilizing Hierarchy Controls also compared analysis assessed pandemic consider additional risk COVID19 RESULTS Results highlighted relevant implemented measure control SARSCoV2 based protecting people engineering eg ventilation social distancing administrative eg hand sanitization work shift measure Personnel Protective Equipment rather eliminating hazard source eg smart working CONCLUSIONS Work continuity research lab COVID19 emergency guaranteed ensuring protection researcher workplace considering physical environment type operator work activity proven ability worker face biological risk increased knowledge awareness lab risk useful prevent mitigate future viral outbreak,covid-19;control measures;regenerative medicine;risk assessment
Suitability Google Trends digital surveillance ongoing COVID19 epidemic case study India,34343467,OBJECTIVE Digital surveillance shown mixed result supplement traditional surveillance Google Trends GT used digital surveillance H1N1 Ebola MERS used GT correlate information seeking COVID19 number test case India METHODS obtained data daily test case ECDC covid19indiaorg used comprehensive search strategy retrieve GT data COVID19 related informationseeking behaviour India 1st January 31st May 2020 form relative search volume RSV used timelag correlation analysis ass temporal relationship RSV daily new COVID19 case test RESULTS GT RSV showed high timelag correlation daily reported test case term `` COVID 19 `` COVID `` social distancing `` soap `` lockdown national level five highburden state high correlation observed five term along `` Corona Peaks RSV national level highburden state corresponded medium coverage government declaration ongoing pandemic CONCLUSION correlation observed GT data COVID19 testscases India may either due mediacoverage induced curiosity healthseeking,ict in healthcare;disease surveillance;infodemiology;pandemic;time lag correlation
Glyconanomaterials Human Virus Detection Inhibition,34206886,Viruses among infectious pathogen responsible highest death toll around world Lack effective clinical drug viral disease emphasizes need speedy accurate diagnosis early stage infection prevent rapid spread pathogen Glycans important molecule involved different biological recognition process especially spread infection mediating virus interaction endothelial cell Thus novel strategy based nanotechnology developed identifying inhibiting virus fast selective precise way nanosized nature nanomaterials exclusive optical electronic magnetic mechanical feature improve patient care using sensor minimal invasiveness extreme sensitivity review provides overview latest advance functionalized glyconanomaterials rapid selective biosensing detection molecule biomarkers specific glycoprotein novel promising antiviral agent different kind serious virus Dengue virus Ebola virus influenza virus human immunodeficiency virus HIV influenza virus Zika virus coronavirus SARSCoV2 COVID19,sars-cov-2;antiviral drug;biosensor;coronavirus;glycan;glycoconjugates;nanomaterial;nanoparticles;virus
Prevention spread SARS COV2 Rapid Antigenic Tests passenger entering Italian seaport,34223865,Abstract 38282 passenger entering Italy major seaport submitted SARSCoV2 rapid antigenic test 272 06 resulted positive 212 934 confirmed positive qRTPCR leaving 06 false positive resident area control Local Health Authority seaport immediately submitted isolation investigated contact tracing others notified Local Health Authority following day procedure made possible fulltime dedication local healthcare worker managed passenger disembarking around clock along month emergency,covid-19 mortality;italy;usa
Metabolomic analysis reveals new stagespecific feature COVID19,34289974,current pandemic coronavirus disease 19 COVID19 affected 160 million individual caused million death worldwide least part due unclarified pathophysiology disease Therefore identifying underlying molecular mechanism COVID19 critical overcome pandemic Metabolites mirror disease progression individual acquiring extensive insight pathophysiological significance disease progression provide comprehensive view metabolic characterization serum COVID19 patient stage using untargeted targeted metabolomic analysis compared healthy control observed different alteration pattern circulating metabolite mild severe recovery stage discovery cohort validation cohort suggest metabolic reprogramming glucose metabolism urea cycle potential pathological mechanism COVID19 progression finding suggest targeting glucose metabolism urea cycle may viable approach fight COVID19 various stage along disease course,
Oxidative Stress Inflammation SARSCoV2 Chlamydia pneumoniaeAssociated Cardiovascular Diseases,34202515,Throughout year growing number study provided evidence oxidative stress inflammation may involved pathogenesis infectious agentrelated cardiovascular disease Amongst numerous respiratory pathogen severe acute respiratory syndrome coronavirus 2 SARSCoV2 novel coronavirus responsible global ongoing pandemic Chlamydia pneumoniae widely known intracellular obligate bacteria seem essential role promoting reactive oxygen specie cytokine production present review highlight common oxidative inflammatory molecular pathway underlying cardiovascular disease associated SARSCoV2 C pneumoniae infection main therapeutic preventive approach using natural antioxidant compound also discussed,chlamydia pneumoniae;sars-cov-2;antioxidants;cardiovascular diseases;inflammation;oxidative stress
Estimates Determinants SARSCov2 Seroprevalence Infection Fatality Ratio Using Latent Class Analysis PopulationBased Tirschenreuth Study HardestHit German County Spring 2020,34200766,SARSCoV2 infection fatality ratio IFR remain controversially discussed implication political measure German county Tirschenreuth suffered severe SARSCoV2 outbreak spring 2020 particularly high case fatality ratio CFR estimate seroprevalence underreported infection IFR Tirschenreuth population aged =14 year JuneJuly 2020 conducted populationbased study including home visit elderly analyzed 4203 participant SARSCoV2 antibody via three antibody test Latent class analysis yielded 86 standardized countywide seroprevalence factor underreported infection 50 25 overall IFR Seroprevalence twofold higher among medical worker one third among current smoker similar proportion registered infection seroprevalence show agetrend factor underreported infection 122 young versus 17 =85yearold Agespecific IFRs 05 60 year age 10 age 6069 132 age 70+ Senior care home accounted 45 COVID19related death reflected IFR 75 among individual aged 70+ overall IFR 14 excluding senior care home resident computation data underscore senior care home infection key determinant IFR additionally age insufficient targeted testing young need investigation behavioral molecular cause fewer infection among current smoker,clia;elisa;sars-cov-2;antibodies;infection fatality ratio;latent class analysis;senior care homes;seroprevalence;smoking;underreported infections
Breathlessness COVID19 Call Research,34333497,Breathlessness also known dyspnoea debilitating frequent symptom Several report highlighted lack dyspnoea subgroup patient suffering COVID19 sometimes referred `` silent `` happy hypoxaemia Reports also mentioned absence clear relationship clinical severity disease level breathlessness reported patient cerebral complication COVID19 largely demonstrated high prevalence acute encephalopathy could possibly affect processing afferent signal topdown modulation breathlessness signal review aim highlight mechanism involved breathlessness summarize pathophysiology COVID19 known effect brainlung interaction offer hypothesis alteration breathlessness perception COVID19 patient suggest way researching phenomenon,breathlessness;coronavirus disease 19;dyspnoea;neuroinvasion;severe acute respiratory syndrome coronavirus 2
Potency BNT162b2 mRNA1273 vaccineinduced neutralizing antibody severe acute respiratory syndromeCoV2 variant concern systematic review vitro study,34286893,BNT162b2 mRNA1273 two type mRNAbased vaccine platform received emergency use authorization emergence novel severe acute respiratory syndrome SARSCoV2 variant raised concern reduced sensitivity neutralization elicited antibody aimed systematically review recent vitro study evaluating effectiveness BNT162b2 mRNA1273 induced neutralizing antibody SARSCoV2 variant concern searched PubMed Scopus Web Science addition bioRxiv medRxiv term including SARSCoV2 BNT162b2 mRNA1273 neutralizing antibody June 29 2021 modified version Consolidated Standards Reporting Trials CONSORT checklist used assessing included study quality total 36 vitro study meeting eligibility criterion included systematic review B117 Alpha B1351 Beta P1 Gamma B16172 Delta four SARSCoV2 variant recently identified variant concern Included study implemented different method regarding pseudovirus live virus neutralization assay measuring neutralization titre utilized virus two dose vaccination BNT162b2 mRNA1273 B1351 variant least sensitivity neutralizing antibody B117 variant sensitivity better neutralized relative comparator strain P1 B16172 variant intermediate level impaired naturalization activity antibody elicited prior vaccination review suggests immune serum derived vaccinated individual might show reduced protection individual immunized mRNA vaccine recent SARSCoV2 variant concern,bnt162b2;sars-cov-2;mrna-1273;neutralizing antibody;variants of concern
Right Ventricle COVID19,34200990,Infection novel severe acute respiratory coronavirus2 SARSCoV2 result COVID19 disease primarily affecting respiratory system provoke spectrum clinical manifestation severe acute respiratory distress syndrome ARDS significant proportion COVID19 patient also develop various cardiac complication among dysfunction right ventricle RV appears particularly common especially severe form disease associated dismal prognosis Echocardiographic study indeed reveal right ventricular dysfunction 40 patient proportion even greater RV explored strain imaging echocardiography pathophysiological mechanism RV dysfunction COVID19 include process increasing pulmonary vascular hydraulic load others reducing RV contractility precipitate acute uncoupling RV pulmonary circulation Understanding mechanism provides fundamental basis adequate therapeutic management RV dysfunction incorporates protective mechanical ventilation prevention treatment pulmonary vasoconstriction thrombotic complication well appropriate management RV preload contractility comprehensive review provides detailed update evidence RV dysfunction COVID19 pathophysiological mechanism therapy,ards;covid-19;pulmonary circulation;right ventricle
Prevalence Characteristics RheumatoidAssociated Autoantibodies Patients COVID19,34285538,Objective Patients rheumatic immune disease likely develop severe critical COVID19 aimed determine whether rheumatoid factor antibody present COVID patient level type rheumatoid factor antibody produced COVID19 patient related degree patient s condition study also aimed determine prevalence characteristic rheumatoid factor antibody patient COVID19 Methods Sera collected 129 patient COVID19 tested rheumatoid factor antibody ELISA Five patient tracked several month monitor dynamic change antibody Results Rheumatoidassociated autoantibody detected 2016 patient 26129 following infection severe acute respiratory syndrome coronavirus 2 SARSCoV2 addition IgMRF primarily present critically ill patient IgARF mainly present mild patient Five patient able track several month monitor dynamic change antibody Rheumatoid factor antibody peak later phase disease last longer time AntiJo1 antibody found one five patient Conclusion case series report rheumatoidassociated autoantibody present patient COVID19 clinical significance antibody fully understood needed characterization autoantibody related severity patient s disease exist long time patient s body impact patient s health unknown,covid-19;iga-rf;igg-rf;igm-rf;sars-cov-2;anti-jo-1;rheumatoid factor
Viral Load Difference Symptomatic Asymptomatic COVID19 Patients Systematic Review MetaAnalysis,34287354,conducted systematic review metaanalysis investigate possible difference SARSCoV2 viral load asymptomatic symptomatic COVID19 patient Preferred Reporting Items Systematic Reviews MetaAnalyses guideline followed abstracting data assessing validity searched MEDLINE Scopus Web Science Google Scholar investigation English language reporting data threshold cycle Ct realtime RTPCR assay RNAdependent RNA polymerase RdRp envelope E nucleocapsid N SARSCoV2 gene asymptomatic symptomatic COVID19 patient Results Overall 703 COVID19 patient 553 symptomatic 150 asymptomatic analyzed Five investigation reported mean age patient evidencing asymptomatic patient younger symptomatic patient 340 vs 403 year respectively Pooled data regarding level expression RdRp gene revealed significant difference symptomatic asymptomatic subject Similarly difference observed comparing mean Ct value E N gene Based realtime RTPCR data difference exist viral load symptomatic asymptomatic COVID19 subject considering Ct value RdRp E N gene expression Asymptomatic subject may represent reservoir infection significantly contribute maintenance pandemic,covid-19;sars-cov-2;real-time rt-pcr;viral load
SARSCoV2 Viruses Build Invasion Route Hijack Host Nucleocytoplasmic Trafficking System,34200500,host nucleocytoplasmic trafficking system often hijacked virus accomplish replication suppress host immune response Viruses encode many factor interact host nuclear transport receptor NTRs nucleoporins nuclear pore complex NPC access host nucleus review discus viral factor host factor involved nuclear import export viral component nucleocytoplasmic shuttling vital replication many virus also review several drug target host nuclear transport machinery discus feasibility use antiviral treatment,dengue virus;ebola virus;epstein-barr virus;hs-afm;hepatitis b virus;human immunodeficiency virus;human papillomavirus;influenza a;sars-cov-2;antiviral drug;clinical trial;exportin;importins;nuclear transport inhibitor;nucleoporins;viral nuclear export;viral nuclear import
Electrocardiographic Findings InHospital Mortality COVID19 Patients Retrospective Cohort Study,34223190,Background Although current evidence point possible prognostic value electrocardiographic ECG finding inhospital mortality COVID19 patient study performed small sample size study aim investigate ECG change prognostic indicator inhospital mortality Methods retrospective cohort study finding first second ECGs COVID19 patient extracted change ECGs examined abnormal finding second ECG nt present initial ECG time admission defined ECG change ECGs interpreted cardiologist prognostic value abnormal ECG finding inhospital mortality COVID19 patient evaluated using multivariate analysis report relative risk RR Results Data ECGs recorded time admission extracted file 893 patient likewise second ECGs could extracted record 328 patient initial ECG presence sinus tachycardia RR = 2342 p 0001 supraventricular arrhythmia RR = 1688 p = 0001 ventricular arrhythmia RR = 1854 p = 0011 interventricular conduction delay RR = 1608 p = 0009 abnormal R wave progression RR = 1766 p = 0001 time admission independent prognostic factor inhospital mortality second ECG sinus tachycardia RR = 2222 p 0001 supraventricular arrhythmia RR = 1632 p 0001 abnormal R wave progression RR = 2151 p = 0009 abnormal wave RR = 1590 p = 0001 also independent prognostic factor inhospital mortality Moreover comparing first second ECGs found incidence supraventricular arrhythmia RR = 1973 p = 0005 ST segment elevationdepression RR = 2296 p 0001 hospitalization ECG novel change two independent prognostic factor inhospital mortality COVID19 patient Conclusion Due fact using electrocardiographic data easy accessible easy continuously monitor patient tool ECGs useful identifying highrisk COVID19 patient mortality,covid-19;electrocardiography;hospital mortality;prognosis
Plant derived active compound potential anti SARSCoV2 agent insilico study,34225565,Plants valued potential source drug variety disease often considered le toxic human investigated antiviral compound may potentially target SARSCoV2 antigenic spike host protein angiotensinconverting enzyme2 ACE2 transmembrane serine protease2 TMPRSS2 scrutinized 36 phytochemical 15 Indian medicinal plant known effective RNA virus via molecular docking Besides TMPRSS2 structure modeled validated using SWISSMODEL Docking performed using Autodock Vina 42 followed visualization docking pose Pymol version 240 Discovery Studio Visualizer Molecular docking showed 12 36 active compound interacted efficiently ACE2 TMPRSS2 protein ADMET profile generated using swissADME pkCSM server revealed compound possessed druggable property Amber 12 simulation package used carry energy minimization molecular dynamic MD simulation total simulation time protein WFA protein WND complex 300 n 100 n per replica total 120 structure extracted last 60 n MD simulation analysis MMPBSA MMGBSA employed ass binding energy ligand receptorbinding domain viral Sprotein method suggested WND WFA showed thermodynamically favorable binding energy protein higher affinity WND Interestingly Leu455 hotspot residue protein also predicted participate binding ACE2 engaged WND WFA HighlightsPlants natural active compound may aid development COVID19 therapeuticsMD simulation study revealed stable binding withanolide withaferin spike proteinWithanolide withaferin could effective SARSCoV2 spike proteinDiscovery druggable agent le lack binding affinity ACE2 avoid organ associated comorbiditiesAccording ADMET selected phytochemical may used druggable compoundsCommunicated Ramaswamy H Sarma,ace2;covid-19;md simulation;sars-cov-2;tmprss2;homology modelling;molecular docking;natural products;spike protein
Fractional Model Numerical Algorithms Predicting COVID19 Isolation Quarantine Strategies,34226872,December 2019 new outbreak Wuhan China attracted worldwide attention virus spread rapidly country world objective paper investigate mathematical modelling dynamic novel coronavirus COVID19 CaputoFabrizio fractional derivative presence quarantine isolation strategy existence uniqueness solution fractional model proved using fixed point iteration fractional model shown diseasefree endemic equilibrium pointWe construct fractional version foursteps AdamsBashforth method well error estimate method used method determine numerical scheme model Matlab program illustrate evolution virus country Morocco Qatar Brazil Mexico well support theoretical result Least square fitting way find best fit curve line set point apply method paper construct algorithm estimate parameter fractional model well fractional order model give estimate better classical model,covid-19;caputo-fabrizio derivative;fractional adams-bashforth method;fractional differential equations;seir epidemic model
Quantifying Importance COVID19 Vaccination Future Outlook,34218862,Predictive model played critical role local national international response COVID19 pandemic United States health care system governmental agency relied several model Institute Health Metrics Evaluation Youyang Gu YYG Massachusetts Institute Technology Centers Disease Control Prevention ensemble predict short longterm trend disease activity Mayo Clinic Bayesian SIR model recently made publicly available informed Mayo Clinic practice leadership site across United States shared Minnesota governmental leadership help inform critical decision past year One key accuracy Mayo Clinic model ability adapt constantly changing dynamic pandemic uncertainty human behavior change rate contact among population time geographic location new virus variant Mayo Clinic model also used forecast COVID19 trend different hypothetical world vaccine available vaccination longer accepted point forward 75 population already vaccinated Surveys indicate half American adult hesitant receive COVID19 vaccine lack understanding benefit vaccination important barrier use focus paper illustrate stark contrast 3 scenario demonstrate mathematically benefit high vaccine uptake future course pandemic,
Clinical histopathological spectrum delayed adverse cutaneous reaction following COVID19 vaccination,34292611,BACKGROUND people become vaccinated SARSCoV2 virus report delayed cutaneous hypersensitivity reaction beginning emerge METHODS IRBapproved retrospective case series biopsy specimen potential cutaneous adverse reaction PfizerBioNTech Moderna mRNA vaccine identified reviewed Clinical information obtained requisition form referring clinician medical chart review RESULTS Twelve case included Histopathological feature two injectionsite reaction showed mixedcell infiltrate eosinophil spongiotic dermatitis eosinophil Three biopsy specimen came generalized eruption showed interface change consistent exanthematous drug reaction Three biopsy specimen revealed predominantly spongiotic pattern consistent eczematous dermatitis Smallvessel vascular injury seen two specimen diagnosed urticarial vasculitis leukocytoclastic vasculitis respectively two case newonset bullous pemphigoid supported histopathological examination direct immunofluorescence study Eosinophils seen 10 case CONCLUSIONS Dermatopathologists aware potential cutaneous adverse reaction mRNAbased COVID19 vaccine Histopathological pattern include mixedcell infiltrates epidermal spongiosis interface change Eosinophils common finding always present Direct immunofluorescence study may helpful immunemediated cutaneous presentation vasculitis bullous pemphigoid,covid-19;cutaneous adverse reaction;vaccine
Effects Na + H + Ion Exchanger Susceptibility COVID19 Course Disease,34285709,Na + H + ion exchanger NHE pump Na + inward cell H + ion outside cell NHE activity increase response decrease intracellular pH maintains intracellular pH narrow range Patients obesity diabetes hypertension elderly prone severe acute respiratory syndrome coronavirus2 SARSCoV2 infection angiotensin II Ang II level high chronic disease diabetes hypertension obesity Ang II main stimulator NHE increased Ang II level cause prolonged NHE activation patient longterm increase NHE activity cause H + ion leave cell patient diabetes hypertension obesity Increasing H + ion outside cell lead increase oxidative stress reactive oxygen specie H + ion flow cell due increased oxidative stress vicious circle cause intracellular pH drop Although NHE activated intracellular pH decrease prolonged NHE activation chronic disease aforementioned Novel coronavirus disease 2019 COVID19 progression may severe mortal patient SARSCoV2 readily invades cell low intracellular pH cause infection reninangiotensin system NHE play vital role regulating intracellular pH reduction NHE activity prolonged activation may cause susceptibility SARSCoV2 infection lowering intracellular pH patient diabetes hypertension obesity Prolonged NHE activation patient COVID19 may worsen course disease Scientists continue investigate mechanism disease factor affect clinical progression,
Antibodies Targeting Two Epitopes SARSCoV2 Neutralize Pseudoviruses Spike Proteins Different Variants,34358019,COVID19 pandemic caused SARSCoV2 infection prevent spread SARSCoV2 effective vaccine required Two linear peptide potential Bcell epitope spike protein SARSCoV2 aa 440460 aa 494506 synthesized used immunize rabbit Hightiter antibody IgG produced purified verified Western blot analysis Antibodies two epitope could effectively neutralize SARSCoV2 pseudoviral particle spike protein original strain basal wildtype also strain single point mutation D614G two emerging variant Alpha Beta variant prevalent around world SARSCoV conclusion antibody two epitope protective information important development vaccine SARSCoV2,alpha variant;beta variant;covid-19;d614g;sars-cov-2;epitope;neutralization;pseudovirus;spike protein
hospital cluster COVID19 associated SARSCoV2 superspreading event,34334353,BACKGROUNDPURPOSE Superspreading event SSEs pivotal spread SARSCoV2 study aimed investigate SSE COVID19 hospital explore transmission dynamic heterogeneity SSE METHODS performed contact tracing close contact cluster nasopharyngeal throat swabbing SARSCoV2 realtime RTPCR Environmental survey performed epidemiological clinical characteristic SSE studied RESULTS Patient 1 congestive heart failure cellulitis onset COVID19 two week hospitalization index case Patient 1 led 8 confirmed case including four health care worker HCW Persons tested positive SARSCoV2 HCW n = 4 patient 1 s family n = 2 accompanying person uninfected inpatient n = 1 inpatient admitted SSE n = 1 attack rate among HCW 32 4127 Environmental survey confirmed contamination bed rail mattress sink room patient 1 stayed suggesting fomite transmission index case s sputum remained positive illness day 35 Except one asymptomatic patient least three patient acquired infection index case presymptomatic period effective reproduction number Rt 09 89 CONCLUSION host factor heart failure longer viral shedding transmissibility SARSCoV2 Rt presymptomatic transmission possible multiple mode transmission altogether contributed SSE Rapid response advance deployment multilevel protection hospital could mitigate COVID19 transmission one generation thereby reducing impact healthcare system,covid-19;hospital;outbreak;sars-cov-2;superspreading event
Factors Affecting COVID19 Preventive Behaviors among University Students Beijing China Empirical Study Based Extended Theory Planned Behavior,34209072,Higher education institution HEIs among social system irreplaceable role combating COVID19 However know little institutional individual factor might facilitate university student belief behavior toward preventive behavior COVID19 within higher education context study applies extended theory planned behavior TPB model investigate structural relationship among institutional climate attitude subjective norm perceived behavioral control preventive behavior university student detect moderating impact perceived risk structural model Data collected 3693 university student 18 university Beijing China online survey Structural equation modeling SEM multigroup analysis performed examine empirical model result reveal 1 institutional climate significant direct effect preventive behavior COVID19 among university student 2 TPB component namely attitude subjective norm perceived behavioral control partially mediate relationship institutional climate preventive behavior COVID19 3 perceived risk moderate several path model Theoretical practical implication offered recommendation future research outlined,covid-19 preventive behaviors;extended theory of planned behavior;institutional climate;university students
Isothermal amplificationbased assay rapid sensitive detection severe acute respiratory syndrome coronavirus 2 Opportunities recent development,34216498,coronavirus disease 2019 COVID19 global pandemic caused novel coronavirus called severe acute respiratory syndrome coronavirus 2 SARSCoV2 date virus detected 219 country world Therefore managing disease becomes priority detecting presence virus crucial step Presently realtime RT polymerase chain reaction RTqPCR considered gold standard nucleic acid amplification test NAAT test protocol RTqPCR complicated place high demand equipment testing reagent research personnel skill expensive Therefore simpler pointofcare POC test needed accelerate clinical decisionmaking take workload centralized test laboratory Various isothermal amplificationbased assay developed sensitive detection different microorganism recently applied detection SARSCoV2 require programable thermocycler produce result single temperature therefore considered simple Unlike RTqPCR method highly sensitive specific le timeconsuming simple affordable used POC diagnostic kit COVID19 review discussed potential isothermal amplificationbased assay alternative RTqPCR detection SARSCoV2,sars-cov-2;isothermal amplification-based assays;molecular diagnostics;novel coronavirus;rapid detection
Cardiac Involvement COVID19 Patients Contemporary Review,34206074,Background widely variable clinical manifestation SARSCoV2 disease COVID19 range asymptomatic infection multiple organ failure death Among organ affected heart affect people already previous cardiovascular problem also healthy people reason overlook symptom perform targeted examination even apparently unrelated heart quick recognition timely therapy Aim study review recapitulates current state knowledge potential mechanism manifestation myocarditis patient COVID19 infection Methods webbased search published data performed relevant study patient diagnosed COVID19induced acute myocarditis total 50 report included analysis study evaluated highlight male predominance average age patient 55 year common presenting symptom included fever shortness breath cough chest pain Among ECG change nonspecific STsegment Twave amplitude alteration ventricular tachycardia episode reported Finally wanted use general evaluation without distinguishing various country taking consideration peer reviewer regardless declared value journal published Results critical finding common presenting symptom included fever shortness breath cough chest pain Among ECG change nonspecific STsegment Twave amplitude alteration ventricular tachycardia episode reported patient elevated level cardiac inflammatory biomarkers measured Left ventricular dysfunction hypokinesis commonly exhibited symptom Cardiac Magnetic Resonance Imaging CMRI confirmed diagnosis myocarditis feature cardiac edema cardiac injury Nine patient underwent histopathological examination Treatment corticosteroid immunoglobulin applied strategy following administration antiviral Discussion Despite exponentially growing knowledge management COVID19 infection current available data SARSCoV2correlated myocarditis still limited several difficulty may encountered differential diagnosis acute myocarditis context COVID19 disease Conclusions diagnostic criterion evaluation strategy myocarditis well described guideline diagnosis treatment myocarditis COVID19 patient yet established Therefore research needed advance understanding disease process define appropriate strategic approach patient,sars-cov-2;cardiac magnetic resonance;cardiomyopathy;cardiovascular therapy;endomyocardial biopsy;viral myocarditis
Korean Society Infectious DiseasesNational Evidencebased Healthcare Collaborating Agency Recommendations AntiSARSCoV2 Monoclonal Antibody Treatment Patients COVID19,34216134,Neutralizing antibody targeted receptorbinding domain severe acute respiratory syndrome coronavirus 2 SARSCoV2 spike protein developed evaluation clinical trial US Food Drug Administration currently issued emergency use authorization neutralizing monoclonal antibody nonhospitalized patient mild moderate coronavirus disease 2019 COVID19 high risk progressing severe disease andor hospitalization term situation urgent need investigate clinical aspect develop strategy deploy effectively clinical practice provide guidance use antiSARSCoV2 monoclonal antibody treatment COVID19 based latest evidence,anti-sars-cov-2 monoclonal antibody;covid-19;korea
DoseRelated Aberrant Inhibition Intracellular Perforin Expression S1 Subunit Spike Glycoprotein Contains ReceptorBinding Domain SARSCoV2,34203929,Studies shown severe case COVID19 tend high viral load correlate functional impairment cytotoxic lymphocyte feature cytokine storm syndrome similar manifestation severe influenza partially explained suppressed perforin expression test hypothesis spike glycoprotein SARSCoV2 may inhibit perforin expression determined kinetics immune response CD8+ cell low dose LD high dose HD S1 stimulation vitro dendritic cell DC T cell model seven day incubation cytotoxic activity intracellular perforin expression CD8+ cell induced HDS1presenting DCs aberrantly lower induced LDS1presenting DCs day three incubation Discrepantly level lymphoproliferation cytokine interferongamma tumor necrosis factoralpha production induced HDS1presenting DCs significantly higher induced LDS1presenting DCs day four doserelated response dos S1 intracellular perforin expression showed significant linear correlation negative slope conclusion S1 subunit may suppress perforin expression CD8+ cell decrease cytotoxic capacity kill spikepresenting cell dosedependent manner persistence antigen presentation may result overproduction interferongamma subsequent proinflammatory cytokine may help explain insufficient cytotoxicity high quantity virus highly replicated strain SARSCoV2 severe case COVID19,covid-19;sars-cov-2;cytokine storm syndrome;cytotoxicity;lymphoproliferation;perforin
Outofhospital cardiac arrest mortality Swiss Cantons high low COVID19 incidence nationwide analysis,34223367,Aims Many country reported increase outofhospital cardiac arrest OHCAs mortality COVID19 pandemic However data refer regional setting national data still missing aimed ass OHCA incidence population mortality COVID19 pandemic whole Switzerland different region Cantons according infection rate Methods considered OHCAs death occurred Switzerland first diagnosed case COVID19 February 25th subsequent 65 day period 2019 also compared Cantons high versus low COVID19 incidence Results 24 reduction OHCA case observed Switzerland reduction particularly high 214 highincidence COVID19 canton whilst OHCAs increased 77 lowincidence COVID19 canton Mortality increased 86 entire nation 278 increase highincidence canton slight decrease 07 lowincidence canton observed OHCA occurred frequently home CPR AED use bystander le frequent pandemic Conversely OHCAs percentage first responder present initiated CPR used AED increased outcome patient COVID19 highincidence canton worse compared lowincidence canton Conclusions COVID19 pandemic Switzerland mortality increased Cantons highincidence infection whilst lowincidence one OHCA occurrence followed opposite trend showing variable related healthsystem EMS organization deeply influence OHCA occurrence pandemic,covid-19;mortality;out-of-hospital cardiac arrest;switzerland
Social contact epidemic spreading health system Mathematical modeling application COVID19 infection,34198391,Lockdown social distancing well testing contact tracing main measure assumed government control limit spread COVID19 infection reason special attention recently paid scientific community mathematical modeling infection spreading including classical model effect distribution contact individual Among approach coupling classical SIR model statistical study distribution social contact among population led present author build Social SIR model able accurately follow effect decrease contact resulting lockdown measure adopted various European country first phase epidemic Social SIR recently tested improved fruitful collaboration Health Protection Agency ATS province Pavia Italy made possible disposal relevant data relative spreading COVID19 infection province half million people starting February 2020 statistical analysis data relevant fit best parameter mathematical model make shortterm prediction spreading evolution order optimize response local health system, disease control; epidemic models; healthcare system; nonlinear incidence rate; social contacts
COVID19 Severity Obesity Leptin Inflammatory Cytokine Interplay Link High Morbidity Mortality,34220807,Obesity one foremost risk factor coronavirus infection resulting severe illness mortality pandemic progress Obesity wellknown predisposed chronic inflammatory condition dynamic obesity impact immunity may change disease severity pneumonia especially acute respiratory distress syndrome primary cause death SARSCoV2 infection adipocytes adipose tissue secret leptin proportion individual body fat mass increase circulating plasma leptin typical characteristic obesity correlate leptinresistant state Leptin considered pleiotropic molecule regulating appetite immunity immunity leptin function cytokine coordinate host s innate adaptive response promoting Th1 type immune response Leptin induced proliferation function antigenpresenting cell monocyte helper cell subsequently influencing proinflammatory cytokine secretion cell TNFalpha IL2 IL6 Leptin scarcity resistance linked dysregulation cytokine secretion leading autoimmune disorder inflammatory response increased susceptibility towards infectious disease Therefore leptin activity leptin longlasting super active antagonist s dysregulation patient obesity might contribute high mortality rate patient SARSCoV2 infection review systematically discus interplay mechanism leptin inflammatory cytokine contribution fatal outcome COVID19 patient obesity,covid-19;cytokine;inflammation;leptin;mortality;obesity
Clinical Differences COVID19 COVIDLike Syndrome,34200168,COVID19 infection due SARSCoV2 virus identified cause present pandemic Several typical characteristic present infection particular pneumonia possible lung failure atypical clinical presentation described daily physician around world Groundglass opacity pneumonia common dangerous presentation COVID19 disease usually associated positive nasopharyngeal swab NPS test detectable SARSCoV2 viral RNA Compared general population hospital worker greater risk infection ever since first patient hospitalized However hospital worker also reported COVIDlike symptom despite repeated negative swab test tested positive SARSCoV2 antibody serological test postulate COVIDlike syndrome possible particular hospital worker characterized symptom similar COVID19 repeated negative nasopharyngeal swab repeated negative NSPs make difference daily clinical management people experienced single false negative nasopharyngeal swab furthermore clear clinical differentiation situation still lacking literature reason report main finding cohort patient COVIDlike syndrome compared similar group affected typical COVID19,covid-19;covid-like syndrome;sars-cov-2;atypical covid-19 clinical presentation;nasopharyngeal swab
Adverse reaction PfizerBioNTech vaccination healthcare worker Malta s state hospital,34228863,BACKGROUND longterm control COVID19 depends effective global vaccination strategy Protecting healthcare worker HCWs serious infection critical Malta European country initiated vaccination rollout using PfizerBioNTech COVID19 vaccine targeting HCWs study determined vaccination adverse effect AEs cohort METHOD online survey disseminated HCWs via work email 29321 9421 gather AEs regarding pain redness swelling injection site fever chill fatigue musclejoint pain headache vomiting diarrhoea severity following dose Likert scale Descriptive comparative multiple binary regression analysis performed RESULTS response 3030 n = 1480 achieved commonest AEs pain injection site 8892 CI 95 87219042 mostly mild 51 moderate 43 Fatigue reported 7297 CI 95 70657517 42 mild 41 moderate Females reported significantly P = 05 respectively pain 190 redness 249 swelling injection site 133 fever 174 chill 232 fatigue 243 muscle 154 joint pain 201 headache 207 vomiting 343 adjusted age HCW role Localised AEs reported following vaccine dos unlike systemic AEs mostly reported second dos CONCLUSION Vaccination benefit outweigh minor AEs experienced female exhibiting higher susceptibility general low vaccination AEs observed within HCW cohort encouraging help allaying vaccine hesitancy among population,
Trap Pathogen Neutrophil Extracellular Traps Role Mucosal Epithelial Skin Diseases,34208037,Neutrophils abundant circulating innate immune cell comprise first immune defense line rapidly recruited cell site infection inflammation main microbicidal mechanism degranulation phagocytosis cytokine secretion formation extracellular trap Neutrophil extracellular trap NETs microbicidal mechanism involves neutrophil death Since discovery vitro vivo neutrophil challenged range stimulus capable inducing inhibiting NET formation objective understand function regulation health disease network composed DNA granular component capable immobilizing killing pathogen comprise enzyme myeloperoxidase elastase cathepsin G acid hydrolases cationic peptide antimicrobial antifungal activity Therefore excessive formation NETs also lead tissue damage promote local systemic inflammation Based concept review focus role NETs different infectious inflammatory disease mucosal epithelium skin,covid-19;gonorrhea;infection;inflammation;inflammatory bowel disease;mucosal epithelium;neutrophil extracellular traps;neutrophils;skin disease;systemic lupus erythematosus
Mucormycosis COVID19 epidemic pandemic,34290893,Mucormycosis aspergillosis rare invasive lifethreatening infection primarily caused Rhizopus arrhizus Aspergillus fumigatus higher case fatality rate 50 respectively Invasive Aspergillosis Mucormycosis established recognized complication SARSCoV2 infection case intimately linked related prior corticosteroid therapy new highly infectious Delta strain B16172 B161721 AY1 coronavirus running rampant throughout India causing unprecedented death toll new crisis evolving Invasive `` black fungus Mucormycosis creating epidemic within global pandemic unique socioeconomic genetic health status Indian population culminates melting pot sustains viable triad `` black fungus infection gain stronghold Diabetes mellitus immunosuppression current COVID19 global pandemic massive surge country produced `` perfect storm Ophthalmologist across India reported surge invasive Mucormycosis case rise orbital compartment syndrome often calling radical procedure enucleation surgery `` black fungus pandemic invasive Mucormycosis resulted sinister secondary infection complication closely linked COVID19 infection India therefore upmost importance neighbouring country particularly Nepal Asiatic nation take great cognizance indolent `` black fungus killer ensure new screening testing protocol early identification ensure effective management,covid-19;india;mycoses;sars-cov-2;sars-cov-2 delta variant;sars-cov-2 variants;zygomycosis
Viral stimulation modulates endotyperelated ACE2 expression eosinophilic chronic rhinosinusitis,34282808,BACKGROUND Angiotensinconverting enzyme 2 ACE2 receptor targeted severe acute respiratory syndrome coronavirus 2 SARSCoV2 highly expressed nasal mucosa Chronic rhinosinusitis CRS show diverse endotypes aggravated viral infection Whether viral stimulation CRS endotype influence ACE2 expression remains unclear investigated expression ACE2 transmembrane protease serine 2 TMPRSS2 mediate entry SARSCoV2 cell assessed polyinosinic polycytidylic acid poly C induced change based CRS endotype METHODOLOGY ACE2 TMPRSS2 expression evaluated based CRS phenotype endotype tissue type Correlations ACE2TMPRSS2 expression inflammatory mediator nasal polyp NP examined Airliquid interface culture experiment performed ass effect major cytokine poly C stimulation ACE2TMPRSS2 expression primary epithelial cell healthy nasal mucosa eosinophilic NP ENP noneosinophilic NP NENP RESULTS primary nasal epithelial cell interleukin IL 13 decreased ACE2 expression increased TMPRSS2 Eosinophilic CRS showed lower ACE2 expression noneosinophilic CRS regardless CRS phenotype CRS endotype independent factor associated ACE2TMPRSS2 expression NP Serum tissue eosinophilic marker level inversely correlated ACE2 expression whereas tissue neutrophilic marker level ACE2 expression positively correlated NP ACE2 expression suppressed ENP tissue however combination poly C IL13 induced ACE2TMPRSS2 upregulation ENP CONCLUSIONS ENP tissue lower ACE2 expression NENP however viral stimulation promotes ACE2TMPRSS2 upregulation ENP,
Imbalance von Willebrand factor ADAMTS13 axis rather biomarker strong inflammation endothelial damage cause thrombotic process critically ill COVID19 patient,34219357,BACKGROUND Critically ill patient coronavirus disease 2019 COVID19 prone developing macrothrombosis microthrombosis COVID19 reported rarely associated thrombotic microangiopathies disintegrin metalloprotease thrombospondin type repeat member 13 ADAMTS13 severe deficiency hallmark thrombotic thrombocytopenic purpura TTP induces formation platelet unusually large von Willebrand factor VWF multimer microthrombi immunemediated TTP ADAMTS13 adopts specifically open conformation VWFADAMTS13 couple may contribute microthrombi formation pulmonary alveolar capillary COVID19 OBJECTIVE investigate clinical feature hemostatic laboratory parameter VWFADAMTS13 axis ADAMTS13 conformation critically ill COVID19 patient admission METHODS Fifty three critically ill COVID19 patient enrolled March 18 May 9 2020 monocentric hospital RESULTS median age 59 year maletofemale ratio 281 reported seven pulmonary embolism 15 death Biological investigation showed increased fibrinogen factor V level strongly increased Ddimers correlated mortality patient presented severe thrombocytopenia microangiopathic hemolytic anemia imbalance high VWF antigen level normal slightly decreased ADAMTS13 activity level strongly elevated VWFADAMTS13 ratio correlated mortality Three patient partial quantitative deficiency ADAMTS13 also reported closed conformation ADAMTS13 patient reinforcing specificity open conformation ADAMTS13 hallmark TTP CONCLUSION suggest slightly decreased normal ADAMTS13 activity highly elevated VWF rather biomarkers reflecting strong inflammation endothelial damage rather driver thrombotic process COVID19,adamts13;adamts13 conformation;covid-19;thrombotic microangiopathy;von willebrand factor
colloidal goldbased immunochromatographic strip rapid detection SARSCoV2 antibody vaccination,34222853,Vaccination intervention consideredan important preventive measure block transmission severe acute respiratory syndrome coronavirus 2 SARSCoV2 protect organism pathogen infection effectively However quick accurate technique evaluate immune efficacy SARSCoV2 inactivated vaccine remains scarce paper IgMIgG antibody combined detection colloidal gold immunochromatography assay kit optimized developed ass efficacy inactivated SARSCoV2 vaccine collected fingertip blood sample 3 vaccinee 1 unvaccinated sample result showed proportion antibody high second shot immunization colloidal goldbased immunochromatographic strip rapid convenient easy operate used auxiliary method preliminary evaluation antibody effect vaccine recipient provide reference index potential clinical application value vaccine,colloidal gold immunization;igm-igg antibody;inactivated sars-cov-2 vaccine
COVID19 Dental Settings Novel Risk Assessment Approach,34198770,novel coronavirus COVID19 outbreak public health emergency international concern emergency led postponing elective dental care procedure postponing aimed protect public unknown risk caused COVID19 beginning outbreak public health authority aerosolgenerating procedure close proximity dental care worker patient dentistry represented sufficient justification delay dental visit Dental care priority many year study proven lack delay dental care cause severe consequence oral health general population cause high global burden oral disease Safety necessary resuming dental activity risk assessment efficient method understanding preventing COVID19 infectious threat facing dental industry affecting dental care worker patient study safe dental care delivery adapted risk assessment criterion approach occupational classification system Based tool also recommend measure help minimize infectious risk dental setting,covid-19;sars-cov-2;dental care;dentistry;hygiene;infection control;occupational safety;oral health;public health;risk assessment
Modifications Made Minimally Invasive Gynecologic Oncology Surgery COVID19 Pandemic Period,34220047,COVID19 pandemic threatening world country today Minimally invasive surgery initially thought higher risk spreading disease aerosolisation viral particle pneumoperitoneum article outline various protective measure taken minimally invasive surgery decrease aerosol spread Gynecologic Oncology unit COVID pandemic period Precautions taken anesthesia trocar insertion surgery special precaution smoke evacuation viral filter outlined,aerosol;covid-19;gynecological oncology;minimally invasive surgery;ultra-low particulate air filtration systems;viral filter
HeJieShenShi Decoction Adjuvant Therapy Severe Coronavirus Disease 2019 Retrospective Cohort Potential Mechanistic Study,34220524,Combination therapy using Western traditional Chinese medicine shown notable effect coronavirus disease 2019 COVID19 HeJieShenShi decoction HJSS composed Bupleurum chinense DC Scutellaria baicalensis Georgi Pinellia ternata Thunb Makino Glycyrrhiza uralensis Fisch ex DC nine herb used treat severe COVID19 clinical practice aim study compare clinical efficacy HJSS combination therapy Western monotherapy severe COVID19 study potential action mechanism HJSS February 2020 March 2020 81 patient severe COVID19 Wuhan Tongji Hospital selected retrospective cohort study Network pharmacology conducted predict possible mechanism HJSS COVID19related acute respiratory distress syndrome ARDS Targets active component HJSS screened using Traditional Chinese Medicine Systems Pharmacology TCMSP PharmMapper database target COVID19 ARDS obtained GeneCards Online Mendelian Inheritance Man database key target HJSS COVID19 ARDS obtained based proteinprotein interaction network PPI Kyoto Encyclopedia Genes Genomes analysis KEGG conducted predict pathway related target HJSS COVID19 ARDS `` herbingredienttargetpathway network established using Cytoscape 327 Results showed duration negative conversion time nucleic acid shorter patient received HJSS combination therapy HJSS combination therapy also relieved fever patient severe COVID19 Network pharmacology analysis identified interleukin IL 6 tumor necrosis factor TNF vascular endothelial growth factor VEGFA catalase CAT mitogenactivated protein kinase MAPK 1 tumor protein p53 TP53 CCchemokine ligand CCL2 MAPK3 prostaglandinendoperoxide synthase 2 PTGS2 IL1B key target HJSS COVID19related ARDS KEGG analysis suggested HJSS improved COVID19related ARDS regulating hypoxiainducible factor HIF 1 NODlike receptor TNF cell receptor sphingolipid PI3KAkt tolllike receptor VEGF FoxO MAPK signaling pathway conclusion HJSS used adjuvant therapy severe COVID19 therapeutic mechanism may involved inhibiting viral replication inflammatory response oxidative stress alleviating lung injury study required confirm clinical efficacy action mechanism,acute respiratory distress syndrome;coronavirus disease 2019;he-jie-shen-shi decoction;network pharmacology;retrospective cohort study
Possible Role Remdesivir Plasma Therapy Selective Sweep Emergence New SARSCoV2 Variants,34362060,Since summer 2020 SARSCoV2 strain origin COVID19 pandemic suddenly replaced new SARSCoV2 variant highly transmissible spread high rate variant include Marseille4 lineage Nextclade 20AEU2 Europe 20I501YV1 variant first detected UK 20H501YV2 variant first detected South Africa 20J501YV3 variant first detected Brazil variant characterized multiple mutation viral spike protein targeted neutralizing antibody elicited response infection vaccine immunization usual coronavirus mutation rate genetic drift alone account rapid change Recent report occurrence mutation immunocompromised patient received remdesivir andor convalescent plasma monoclonal antibody treat prolonged SARSCoV2 infection led u hypothesize experimental therapy fail cure patient COVID19 could favor emergence immune escape SARSCoV2 variant review data support hypothesis urge physician clinical trial promoter systematically monitor viral mutation wholegenome sequencing patient administered treatment,covid-19;sars-cov-2;anti-spike antibodies;mutants;plasma therapy;remdesivir;variant
COVID19 gastrointestinal system brief review,34130944,COVID19 recent pandemic still major health problem modern time already 175 lakh people succumbed deadly disease disease caused novel coronavirus named SARSCOV2 International Committee Taxonomy Viruses virus originated Wuhan city Hubei province China December 2019 within short period spread across many country globe lot basic well clinical research going study mode transmission mechanism action SARSCOV2 infection therapeutic SARSCOV2 known infect lung also infects organ human body including gastrointestinal GI tract liver pancreas via angiotensinconverting enzyme ACE 2 important component reninangiotensin system short review mainly discussing mode SARSCOV2 transmission physiological counterbalancing role ACE2 ACE tissue pattern ACE2 expression overall effect COVID19 human gastrointestinal System Therefore review shed light possible mechanism SARSCOV2 infection GI system pathological symptom raising potential possibility GI tract acting secondary site SARSCoV2 tropism infection Finally future study understand fecaloral transmission virus correlation viral load severity GI symptom proposed gain knowledge GI symptom COVID19 aid early diagnosis prognosis,ace2;covid-19;gastrointestinal system;sars-cov-2;virus
Race Ethnicity Neighborhood Characteristics InHospital Coronavirus Disease2019 Mortality,34334737,BACKGROUND Despite many study reporting disparity coronavirus disease2019 COVID19 incidence outcome Black HispanicLatino population mechanism fully understood inform mitigation strategy OBJECTIVE aim test whether neighborhood factor beyond individual patientlevel factor associated inhospital mortality COVID19 hypothesized Area Deprivation Index ADI neighborhood censusblocklevel composite measure associated COVID19 mortality independently race ethnicity patient factor RESEARCH DESIGN Multicenter retrospective cohort study examining COVID19 inhospital mortality SUBJECTS Inclusion required hospitalization positive SARSCoV2 test COVID19 diagnosis three large Midwestern academic center MEASURES primary study outcome COVID19 inhospital mortality Patientlevel predictor included age sex race insurance body mass index comorbidities ventilation Neighborhoods examined national ADI neighborhood deprivation rank comparing inhospital mortality across ADI quintiles Analyses used multivariable logistic regression fixed site effect RESULTS Among 5999 COVID19 patient median age 61 interquartile range 4473 48 male 30 Black 108 died Among patient died 32 lived disadvantaged quintile 11 lived least disadvantaged quintile 52 Black 24 HispanicLatino 85 White patient lived disadvantaged neighborhoodsLiving disadvantaged neighborhood quintile predicted higher mortality adjusted odds ratio 174 95 confidence interval 113267 independent race Age male sex Medicare coverage ventilation also predicted mortality CONCLUSIONS Neighborhood disadvantage independently predicted inhospital COVID19 mortality Findings support call consider neighborhood measure vaccine distribution policy mitigate disparity,
Paradoxical low severity COVID19 PraderWilli syndrome data French survey 647 patient,34289876,BACKGROUND Patients PraderWilli syndrome PWS often comorbidities especially obesity may constitute risk factor severe form COVID19 aimed ass prevalence medical course SARSCoV2 infection child adult PWS November 2020 January 2021 performed detailed medical survey 342 adult 305 child PWS followed French reference center RESULTS obtained response 288 adult 84 239 child 78 March 2020 January 2021 38 adult 132 13 child 54 PWS SARSCoV2 infection Mean age adult 341 + 119 year mean body mass index 406 + 127 kgm 2 82 obesity 37 diabetes 3 child 23 obesity none diabetes Similar general population frequent symptom COVID19 asthenia fever cough headache shortness breath patient favorable outcome CONCLUSION PWS risk factor severe COVID19 child adult contrary evolution SARSCoV2 infection adult PWS seems favorable expected given comorbidities,covid-19;obesity;oxytocin;prader-willi syndrome;sars-cov-2
Temporal association SARSCoV2 newonset myasthenia gravis causal coincidental,34290032,Several case report COVID19 patient myasthenia gravis MG documented However newonset autoimmune MG following COVID19 reported rarely report one case 65yearold man presented u dysphagia 6 week following mild COVID19 evaluated diagnosed antiacetylcholine receptor antibody AchR positive nonthymomatous generalised MG subsequently developed myasthenic crisis improved treatment intravenous immunoglobulin prednisolone pyridostigmine Systematic literature review showed eight similar case Analysis case including one reported showed feature mean age 558 year male gender 5 time interval COVID19 MG 556 day generalised 5 bulbar andor ocular symptom 4 antiAchR antibody 7 antimusclespecific kinase antibody 2 improved immunotherapy Although many hypothesis proposed explain causal relationship two could well sheer coincidence,covid-19;immunology;infectious diseases;neurology;neuromuscular disease
COVID19 inpatient gastrointestinal onset sex care need difference district Ferrara Italy,34344331,BACKGROUND COVID19 characterized interstitial pneumonia presentation disease digestive symptom may occur work aimed evaluating 1 prevalence presentation digestive symptom cohort COVID19 inpatient 2 difference patient without gastrointestinal onset 3 difference among male female gastrointestinal presentation 4 outcome group subject without gastrointestinal onset METHOD retrospectively divided patient hospitalized COVID19 two group 1 one digestive symptom DSG 2 without digestive symptom NDSG compared subject DSG NDSG male female DSG group term demographic age sex inflammation organ damage index length stay inhospital 100day mortality RESULTS prevalence gastrointestinal symptom presentation 125 DSG group showed prevalence female tended shorter hospital stay DSG patient younger higher load comorbidities difference concerning inflammation organ damage index need intensification care inhospital 100day mortality detected Among DSG patient male younger female comorbid higher serum CRP showed longer length hospital stay Survival function DSG patient general favourable NDSG adjusted sex age comorbidities CONCLUSIONS 1 prevalence gastrointestinal presentation among hospitalized COVID19 patient 125 2 DSG patient average younger comorbid prevalence female shorter hospital stay 3 DSG group male higher Charlson Comorbidity Score needed longer hospital stay 4 DSG subject seem survive longer NDSG group,covid-19;coronavirus infection;digestive symptoms;gastrointestinal onset;sars-cov-2
EpitopeFunctionalized Gold Nanoparticles Rapid Selective Detection SARSCoV2 IgG Antibodies,34133128,Rapid inexpensive immunodiagnostic assay monitor severe acute respiratory syndrome coronavirus 2 SARSCoV2 seroconversion essential conducting largescale COVID19 epidemiological surveillance profiling humoral response SARSCoV2 infection immunization Herein colorimetic serological assay detect SARSCoV2 IgGs patient plasma developed using short antigenic epitope conjugated gold nanoparticles AuNPs Four immunodominant linear Bcell epitope located spike nucleocapsid N protein SARSCoV2 characterized IgG binding affinity used highly specific biological motif nanoparticle recognize target antibody Specific bivalent binding SARSCoV2 antibody epitopefunctionalized AuNPs trigger nanoparticle aggregation manifest distinct optical transition AuNPs plasmon characteristic within 30 min antibody introduction Coimmobilization two epitope improved assay sensitivity relative singleepitope AuNPs limit detection 32 nM commensurate IgG level convalescent COVID19infected patient passivation strategy pursued preserve sensing response human plasma medium tested 35 clinical plasma sample varying illness severity optimized nanosensor assay successfully identify SARSCoV2 infection 100 specificity 83 sensitivity epitope conserved within circulating COVID19 variant proposed platform hold great potential serve costeffective highly specific alternative classical immunoassay employing recombinant viral protein epitopeenabled nanosensors expand serodiagnostic toolbox COVID19 epidemiological study humoral response monitoring vaccine efficiency assessment,covid-19;sars-cov-2;antibody;epitope;gold nanoparticle;serology
Methods Respiratory Virus Detection Advances towards PointofCare Early Intervention,34203612,Respiratory viral infection threaten human life inflict enormous healthcare burden worldwide Frequent monitoring viral antibody viral load effectively help control spread virus make timely intervention However current method detecting viral load require dedicated personnel timeconsuming Additionally COVID19 detection generally relied automated PCR analyzer highly instrumentdependent expensive emerging technology development respiratory viral load assay pointofcare POC testing urgently needed viral screening Recent advance loopmediated isothermal amplification LAMP biosensors nanotechnologybased paper strip microfluidics offer new strategy develop rapid lowcost userfriendly respiratory viral monitoring platform review summarized traditional method respiratory virus detection present stateofart technology monitoring respiratory virus POC,covid-19;detection;point-of-care;respiratory virus
Patient Satisfaction Telephone Versus Video Televisits CrossSectional Survey Urban Multiethnic Population,34333039,OBJECTIVE examine difference telephone videotelevisits identify whether visit modality associated satisfaction urban academic general urology practice METHODS crosssectional analysis patient completed televisit urology practice summer 2020 performed Likertbased satisfaction telephone survey offered patient within 7 day televisit Patient demographic televisit modality telephone v video outcome visit eg followup visit scheduled order placed retrospectively abstracted chart compared telephone video cohort Multivariate regression analysis used evaluate variable associated satisfaction controlling potential confounders RESULTS 269 patient analyzed 73 196269 completed telephone televisit Compared video cohort telephone cohort slightly older mean 588 year vs 542 year p=003 significant difference frequency order placed medication change lab imaging inperson followup visit within 30days cohort Survey result showed overall 847 patient satisfied significant difference telephone video cohort Visit type associated satisfaction multivariable analysis use interpreter OR813 1006594 p=005 lab ordered OR274 112670 p=003 female patient gender OR228 103503 p=004 significantly associated satisfaction CONCLUSIONS Overall patient satisfied televisit Additionally telephone videotelevisits similar regarding patient opinion patient characteristic visit outcome Efforts increase access coverage telehealth particularly telephonetelevisits continue past COVID19 pandemic,hispanic;multiethnic;non-hispanic black;non-hispanic white;out-patient;telehealth;telemedicine;telephone;urology;video
Association cardiometabolic risk factor COVID19 susceptibility severity mortality review,34222055,novel coronavirus began spreading China Wuhan gradually spreaded country led announcement World Health Organization March 11 2020 new pandemic important point presented World Health Organization disease better understand risk factor exacerbate course disease worsen prognosis Due high majority cardio metabolic risk factor like obesity hypertension diabetes dyslipidemia among population 60 year old higher cardio metabolic risk factor along age people could worsen prognosis coronavirus disease 2019 COVID19 mortality study aimed review article beginning pandemic impression cardio metabolic risk factor COVID19 effectiveness COVID19 manage disease factor studied article including hypertension diabetes mellitus dyslipidemia obesity exacerbate course Covid19 disease different mechanism inflammatory process caused coronavirus also create vicious cycle controlling disease patient,covid-19;cardio metabolic risk factors;diabetes mellitus;dyslipidemia;hypertension;obesity
COVID19 Pandemic Situation Malaysia Lessons Learned Perspective Population Density,34207205,paper attempt ascertain impact population density spread severity COVID19 Malaysia Besides describing spatiotemporal contagion risk virus ultimately seek test hypothesis higher population density result exacerbated COVID19 virulence community population density 143 district Malaysia per data Malaysia s 2010 population census plotted cumulative COVID19 case infection rate COVID19 case obtained Malaysia s Ministry Health official website data three variable collected 19 January 2020 31 December 2020 Based observation district high population density highly interconnected neighbouring district whether geographically socioeconomically infrastructurally tend experience spike COVID19 case within week Using parametric approach Pearson correlation population density found moderately strong relationship cumulative COVID19 case pvalue 0000 R 2 0415 weak relationship COVID19 infection rate pvalue 0005 R 2 0047 Consequently provide several nonpharmaceutical lesson including urban planning strategy passive containment measure may better support disease intervention future contagious disease,covid-19;malaysia;pearson correlations;coronavirus;non-pharmaceutical measures;population density;spatio-temporal
Maternity care COVID19 protocol qualitative evidence synthesis woman s maternity care provider view experience,34345765,Background Considerable change maternity care provision internationally implemented response COVID19 change often occurring suddenly little advance warning potential affect woman s maternity care provider experience maternity care positively negatively reason gain insight understanding personal professional experience perform synthesis available qualitative evidence woman maternity care provider view experience maternity care COVID19 Methods analysis qualitative evidence synthesis conducted Studies eligible include pregnant postpartum woman six month maternity care provider received provided care COVID19 retrieve relevant literature electronic database CINAHL EMBASE MEDLINE PsycINFO Cochrane COVID study register http covid19cochraneorg searched 01Jan2020 date search combination search term based COVID19 pregnancy childbirth maternity care study design used guide search methodological quality included study assessed least two reviewer using Evidence Policy Practice Information EPPI Centre 12criteria quality assessment tool Thomas Harden approach thematic synthesis used data synthesis involve line line coding extracted data establishing descriptive theme determining analytical theme Confidence finding review assessed two reviewer independently using Grading Recommendations Assessment Development EvaluationConfidence Evidence Reviews Qualitative research GRADECERQual Conclusion proposed synthesis evidence help identify maternity care need global pandemic perspective receiving providing care evidence inform help enhance care provision future,covid-19;maternity care;pregnancy and childbirth;qualitative evidence synthesis;systematic review;thematic synthesis
SARSCoV2 Reinfection Patients Negative Immunoglobulin G Following Recovery COVID19,34367645,many patient infected severe acute respiratory syndrome coronavirus 2 SARSCoV2 eventually produce neutralising antibody degree susceptibility previously infected individual reinfection SARSCoV2 currently unknown better understand impact immunoglobulin IgG level reinfection recovered coronavirus disease 2019 COVID19 patient antinucleocapsid IgG level SARSCoV2 measured 829 patient previously confirmed infection recovery Notably 87 patient detectable IgG concentration one case asymptomatic reinfection 45 month initial recovery amongst patient detectable antinucleocapsid IgG level 25 87 patient negative antinucleocapsid IgG reinfected within one three month first infection Therefore patient recover COVID19 detectable antinucleocapsid IgG concentration appear remain susceptible reinfection SARSCoV2 apparent immunity Also although result suggest chance lower possibility recovered patient positive antinucleocapsid IgG finding reinfected similarly exists,covid-19;sars-cov-2;immunoglobulin g;reinfection
Herbal plant immunity modulators COVID19 primary preventive measure home quarantine,34377631,novel coronavirus severe acute respiratory syndrome coronavirus 2 SARSCoV2 deadly virus spread globally claimed million life novel virus transmits mainly droplet close human contact s impact different country varies depending geographical location climatic condition food habit cultural activity Several precautionary measure well many medicine applied different combination limit spread infection result preliminary relief people infected first stage infection alternative approach introduced proposes natural herb minimal side effect improve overall immunity essential herb immunomodulatory effect mentioned article along suggestion improved immunity protection,covid-19;sars;herbals;immunity;medicine;traditional application
Acceptability Healthcare Professionals Get Vaccinated COVID19 Two Weeks Initiation National Vaccination,34204614,Background Objectives greatest challenge vaccine face acceptance general population Healthcare professional HCPs recommendation significant influence general public vaccination behavior aim study ass willingness HCPs get vaccinated COVID19 two week initiation vaccination Materials Methods conducted anonymous online survey 1115 December 2020 among HCPs email delivered local medical nursing stuff association Results 711 656 HCPs intended accept vaccination 59 23 still undecided acceptance rate higher physician 765 significantly lower nurse 483 responder intended accept vaccination male p = 001 physician p = 0001 older p = 002 married p = 0054 child p = 0001 treated patient COVID19 p 0001 multivariate logistic regression predictor HCPs willingness get vaccinated parenthood = 419 p = 0003 physician = 279 p = 004 treating confirmedsuspected COVID19 patient = 287 p = 0036 Conclusions Low vaccination acceptance rate found especially nurse may negative impact vaccination compliance general public interventional educational program enhance vaccination crucial,covid-19;greece;sars-cov-2;acceptance;healthcare professional;nurses;physicians;vaccination
Walking memory lane SARSCoV2 B cell,34355822,Bcell response COVID19 vaccine convalescent individual,
COVID19 Lockdown Effects Acute Stroke Care Latin America,34284323,OBJECTIVES COVID19 pandemic forced important change health care worldwide Stroke care network affected especially peak period assessed impact pandemic lockdown stroke admission care Latin America MATERIALS METHODS multinational study 7 country 18 center patient admitted pandemic outbreak MarchJune 2020 Comparisons made period 2019 Numbers case stroke etiology severity acute care hospitalization outcome assessed RESULTS country reported mild decrease stroke admission compared period 2019 1187 vs 1166 p = 003 Among stroke subtypes reduction ischemic stroke admission 783 vs 739 p = 001 compared 2019 especially NIHSS 05 501 vs 449 p = 003 substantial increase proportion stroke admission beyond 48 h symptom onset observed 138 vs 205 p 0001 Nevertheless difference total reperfusion treatment rate observed similar doortoneedle doortoCT doortogroin time period stroke outcome alltype mortality hospitalization 49 vs 97 p 0001 length stay IQR 15 day vs 09 day p 0001 likelihood discharged home 916 vs 830 p 0001 compromised COVID19 lockdown period CONCLUSIONS Latin America survey mild decrease admission COVID19 lockdown period significant delay time consultation worse hospitalization outcome,acute stroke therapy;covid-19;developing countries;latin america;lockdown;stroke
Characteristics outcome familypractice patient coronavirus disease 2019 case series,34284815,BACKGROUND clinical history outcome coronavirus disease 2019 among people hospitalized yet well characterized better inform clinical evaluation set characterize natural history coronavirus disease 2019 primary health care METHODS Case series patient rostered physician universityaffiliated Family Medicine clinic Cases met Centers Disease Control Prevention definition coronavirus disease 2019 March 1 May 21 2020 RESULTS total 89 patient meeting Centers Disease Control Prevention criterion coronavirus disease 2019 documented average age 556 year range 695 year one symptomatic Fiftyseven case 64 polymerase chain reaction test coronavirus disease 2019 772 tested positive Thirty case 337 reported contact confirmed probable case coronavirus disease 2019 Based Charlson Comorbidity Index 28 case 315 comorbid condition median number day symptom onset first polymerase chain reaction test 6 day interquartile range 2311 day median duration fever 35 day interquartile range 17 day Twentyfour case 27 visited Emergency Department 10 admitted hospital median number day symptom onset first Emergency Department visit 8 day interquartile range 3527 day CONCLUSIONS start pandemic implementation basic measure diagnostic testing delayed improve control spread coronavirus disease 2019 need substantially reduce time symptom onset diagnostic testing subsequent contact tracing minimize unnecessary Emergency Department visit propose testable strategy Family Medicine engage coronavirus disease 2019 patient acute phase illness,community medicine;epidemiology;family medicine;general practice;primary care;sars-cov-2
Heterogeneity matter Contact structure individual variation shape epidemic dynamic,34283842,recent COVID19 pandemic mathematical modeling constitutes important tool evaluate prospective effectiveness nonpharmaceutical intervention NPIs guide policymaking research however centered around characterizing epidemic based point estimate like average infectiousness average number contact work use stochastic simulation investigate consequence population s heterogeneity regarding connectivity individual viral load level Therefore translate COVID19 ODE model stochastic multiagent system use contact network model complex interaction structure probabilistic infection rate model individual viral load variation observe large dependency dispersion dynamical evolution population s heterogeneity adequately captured point estimate instance used ODE model particular model assume clinical transmission parameter may lead different conclusion depending different type heterogeneity population instance existence hub contact network lead initial increase dispersion effective reproduction number lower herd immunity threshold HIT compared homogeneous population population heterogeneity stem solely individual infectivity variation,
COVID19 California State Prison System Observational Study Decarceration Ongoing Risks Risk Factors,34291377,BACKGROUND Correctional institution nationwide seeking mitigate COVID19related risk OBJECTIVE quantify change California s prison population since pandemic began identify risk factor COVID19 infection DESIGN California state prison March 1October 10 2020 described resident demographic characteristic health status COVID19 risk score room occupancy labor participation used Cox proportional hazard model estimate association rate COVID19 infection room occupancy outofroom labor respectively PARTICIPANTS Residents California state prison MAIN MEASURES Changes incarcerated population s size composition housing activity risk factor analysis exposure variable room type cell vs dormitory labor participation room occupant participating prior 2 week outcome variable incident COVID19 case rate KEY RESULTS incarcerated population decreased 191 119401 96623 study period October 10 2020 115 resident aged =60 183 high COVID19 risk score 310 participated outofroom labor 148 lived room =10 occupant Nearly 40 resident high COVID19 risk score lived dormitory 9 prison major outbreak 6928 room 21750 resident dormitory resident higher infection rate cell resident adjusted hazard ratio AHR 251 95 CI 225280 resident room labor participation higher rate resident room AHR 156 95 CI 139174 CONCLUSION Despite reduction room occupancy mixing California prison still house many medically vulnerable resident risky setting Reducing risk requires combination strategy including rehousing decarceration vaccination,covid-19;sars-cov-2;exposures;incarcerated populations;infections;prisons
Retinal vascular finding patient COVID19,34345766,Purpose purpose study compare retinal vascular caliber COVID19 patient healthy subject Methods prospective casecontrol study Fortysix patient COVID19 successfully treated 38 age gendermatched healthy subject enrolled study Fundus photography taken using fundus fluorescein angiography FA Visucam 500 Carl Zeiss Meditec Jena Germany Retinal vascular caliber analyzed IVAN semiautomated retinal vascular analyzer Nicole J Ferrier College Engineering Fundus Photography Reading Center University Wisconsin Madison WI USA Central retinal artery equivalent CRAE central retinal vein equivalent CRVE arteryvein ratio AVR compared group Results mean age 378 + 95 year COVID19 group n = 46 40 + 8 year control group n = 38 p = 045 mean CRAE 18156 + 640 COVID19 group 17129 + 1506 control group p = 0006 mean CRVE 22634 + 2383 COVID19 group 21094 + 2222 control group p = 0044 AVR 081 + 009 COVID19 group 082 + 013 control group p = 0712 Conclusion Patients COVID19 vasodilation retinal vascular structure recovery may risk retinal vascular disease COVID19 patient must followed recovery,covid-19;retinal vascular caliber;retinal vasodilation
Perspective Immunopathogenesis Immunotherapies Kawasaki Disease,34350146,Kawasaki Disease KD acute inflammatory illness mostly occurs child 5 year age intractable fever mucocutaneous lesion lymphadenopathy lesion coronary artery CAL KD sharing clinical symptom systemic inflammatory syndrome child MISC related COVID19 Certain gene identified associated KD finding usually differ country race Human Leukocyte Antigen HLA allele type tolllike receptor TLR expression also correlated KD acute hyperinflammation KD mediated imbalance augmented helper 17 Th17 Th1 response high level interleukin IL 6 IL10 IL17A IFNgamma IP10 contrast reduced Th2Treg response lower IL4 IL5 FoxP3 TGFbeta expression KD varying phenotypic variation regarding age gender intravenous immunoglobulin IVIG resistance macrophage activation shock syndrome sign macrophage activation syndrome MAS interpreted hyperferritinemia thrombocytopenia contradictory thrombocytosis typical KD sign KD shock syndrome KDSS interpreted overproduction nitric oxide coagulopathy five decade IVIG aspirin standard treatment KD However KD patient refractory IVIG required additional medication inflammation study proposed delineate immunopathogenesis IVIGresistance KDSS identify high risk patient genetic susceptibility develop ideal treatment regimen providing idiotypic immunoglobulin curb cytokine storm overproduction epigenetic induction Treg function,kawasaki disease;kawasaki disease shock syndrome;th17/treg imbalance;coronary artery aneurysm;coronavirus disease 2019;immunotherapy;intravenous immunoglobulin resistance;multisystem inflammatory syndrome in children
Epidemiological modelling health economic effect COVID19 control Australia s second wave,34221849,Background investigated public health economy outcome different level social distancing control second wave outbreak Australia identify implication public health management COVID19 Methods Individualbased compartment model used simulate effect different social distancing detection strategy Australian COVID19 infection economy March July 2020 model used evaluate effect different social distancing level early relaxation suppression measure term public health economy outcome Results model fitted observation July 2020 yielded projection consistent subsequent case showed better public health outcome lower economy cost occur social distancing measure stringent implemented earlier implemented sufficiently long duration Early relaxation suppression result worse public health outcome higher economy cost Conclusions Better public health outcome reduced COVID19 fatality positively associated lower economy cost higher level social distancing achieving zero community transmission lower public health economy cost compared allowing community transmission continue early relaxation social distancing increase public health economy cost,compartment models;individual based models;pandemic;sars-cov-2;social distancing
Prioritizing breast imaging service COVID pandemic survey breast imaging facility within Breast Cancer Surveillance Consortium,34217424,COVID19 pandemic disrupted breast cancer screening diagnostic imaging United States sought evaluate medical facility prioritized breast imaging service period reduced capacity upon reopening closure fall 2020 surveyed 77 breast imaging facility within Breast Cancer Surveillance Consortium United States survey ascertained pandemic s impact clinical practice MarchSeptember 2020 Nearly facility 97 reported closing operating reduced capacity point period facility open August 2020 though 14 still operating reduced capacity September 2020 period reopening reduced capacity 93 facility reported prioritizing diagnostic breast imaging breast cancer screening diagnostic imaging facility prioritized based rescheduling canceled appointment 89 specific indication diagnostic imaging 89 patient demand 84 individual characteristic risk factor 77 time since last imaging examination 72 screening mammography facility prioritized based rescheduled cancelations 96 patient demand 83 individual characteristic risk factor 73 time since last mammogram 71 biopsy service 90 facility reported prioritization based rescheduling canceled exam patient demand patient characteristic risk factor level suspicion imaging observed pattern large geographically diverse sample facility United States indicate multiple factor commonly used prioritize breast imaging service period reduced capacity,breast cancer;breast imaging;covid-19;diagnostic imaging;health services research;healthcare delivery;mammography;preventive services;radiology;screening
deep learning framework using CNN stacked BiGRU COVID19 prediction India,34335985,novel coronavirus infection COVID19 first appeared Wuhan China December 2019 COVID19 declared global pandemic rapidly spreading disease across world India second populated nation world still fighting coronavirus reached stage community transmission take place exponential rate Therefore crucial examine future trend COVID19 India anticipate affect economic social growth short run paper new deep learning framework using CNN stacked BiGRU developed predicting analyzing COVID19 case India proposed model predict next 30 day new positive case new death case recovery rate containment health index value high accuracy proposed method compared Gaussian process regression GPR model COVID19 datasets experimental result show proposed framework highly reliable COVID19 prediction GPR model,bi-gru;cnn;covid-19;containment and health index;rnn;sequence learning
Examination COVID19 Mitigation Efficiency among 23 Countries,34207404,purpose paper compare relative efficiency COVID19 transmission mitigation among 23 selected country including 19 country G20 two heavily infected country Iran Spain two highly populous country Pakistan Nigeria mitigation efficiency country evaluated stage using data envelopment analysis DEA tool change mitigation efficiency analyzed across stage Pearson correlation test conducted change examine impact efficiency rank previous stage subsequent stage indicator developed judge epidemic stability applied practical case involving lifting travel restriction restarting economy country result showed Korea Australia performed highest efficiency preventing diffusion COVID19 whole period covering 105 day since first confirmed case USA ranked bottom China Japan Korea Australia judged recovered attack COVID19 due higher epidemic stability,covid-19;epidemic stability;mitigation efficiency;stay-at-home order
Molecular detection coronavirus current emerging methodology,34225540,Introduction Seven coronavirus specie identified infect human human coronavirus infection historically associated mild respiratory symptom similar common cold three coronaviruses identified since 2003 Severe Acute Respiratory Syndrome Coronavirus SARSCoV Middle East Respiratory Syndrome Coronavirus MERSCoV SARSCoV2 cause lifethreatening severe respiratory syndrome coronavirus disease 2019 COVID19 caused highly transmissible SARSCoV2 triggered worldwide health emergency Due lack effective drug vaccination rapid reliable detection vital importance control coronavirus epidemicspandemicsArea covered literature search performed Pubmed covering detection diagnostics SARS MERS SARSCoV2 review summarized current knowledge established emerging method coronavirus detection characteristic different diagnostic approach described strength weakness method analyzed compared addition future trend field coronavirus detection also discussedExpert opinion Nucleic acidbased RTPCR current goldenstandard coronavirus detection immunoassay provide history coronavirus infection besides diagnostic information Integrated highthroughput system hold great potential trend future detection diagnosis virus infection,covid-19;crispr;coronavirus;elisa;lamp;lfa;rt-pcr;sars-cov-2;diagnosis;molecular detection
Performing nasopharyngeal swabsGuidelines based anatomical study,34216513,Nasopharyngeal swab performed collect material diagnosing disease affecting respiratory system Covid19 Yet systematic anatomical study defines concrete prerequisite successfully targeting nasopharyngeal mucosa therefore aim simulating nasopharyngeal swab human body donor characterize parameter allowing supporting enter nasopharynx swab avoiding endangering cribriform plate aid metal probe commercial swab total 314 nasopharyngeal swab anatomical headneck specimen stemming 157 body donor simulated Important anatomical parameter photodocumented measured provide information angle distance prominent anatomical landmark particularly important position probe occupies advancement naris upper lower part nasopharynx cribriform plate Based data suggest simple safe threestep procedure conducting nasopharyngeal swab addition define easily recognizable signal correct performance Evaluations prove procedure specimen without deformation nasal cavity allows swab enter nasopharynx whereas widespread used alternative succeeds le 50 data key successful collection nasopharyngeal material detecting characterizing pathogen SARSCoV2 high affinity pharyngeal mucosa demonstrate danger damaging cribriform plate olfactory mucosa swab unlikely potentially higher performing nasal swab,covid-19;sars-cov-2;anatomy;nasopharynx;respiratory
COVID19 Prevention Practices Associated Factors Among Farmers PeriUrban Areas Northeastern Ethiopia,34285502,Background COVID19 global health threat due rapid spread ability kill million people majority pandemicfighting approach rely prevention activity influenced variety factor Farmers vulnerable COVID19 evaluating existing prevention practice associated factor critical prevent COVID19 pandemic Objective ass COVID19 prevention practice associated factor among farmer periurban area Northeastern Ethiopia Methods communitybased crosssectional study design conducted among 409 selected farmer Data collected using facetoface interview onthespotobservational checklist Data analyzed using bivariable logistic regression model 95 CI confidence interval bivariable analysis crude odds ratio COR varibales pvalue le 0250 included multivariable analysis adjsuted odds ratio AOR Factors associated COVID19 preventive practice determined using multivariable analysis pvalue 0050 Results 409 participant 206 636 157 384 117 286 satisfactory knowledge positive attitude good prevention practice COVID19 respectively Age farmer greater equal 45 year AOR 32 95 CI 1761 educational status secondary school AOR 31 95 CI 1466 income level greater equal 200100 Ethiopian birr ETB AOR 19 95 CI 1134 found significantly associated COVID19 prevention practice Conclusion Even though majority farmer satisfactory knowledge considerable proportion negative attitude poor COVID19 prevention practice Age educational status income level factor associated COVID19 prevention practice Hence health education given improve farmer knowledge attitude prevention practice minimize risk COVID19 among farmer semiurban area northestern Ethiopia,covid-19;dawa chefa district;farmers;northeast ethiopia;peri-urban areas
Retracted Safety COVID19 VaccinationsWe Rethink Policy,34202529,Background COVID19 vaccine expedited review without sufficient safety data wanted compare risk benefit Method calculated number needed vaccinate NNTV large Israeli field study prevent one death accessed Adverse Drug Reactions ADR database European Medicines Agency Dutch National Register larebnl extract number case reporting severe side effect number case fatal side effect Result NNTV 200700 prevent one case COVID19 mRNA vaccine marketed Pfizer NNTV prevent one death 9000 50000 95 confidence interval 16000 point estimate number case experiencing adverse reaction reported 700 per 100000 vaccination Currently see 16 serious side effect per 100000 vaccination number fatal side effect 411100000 vaccination three death prevented vaccination accept two inflicted vaccination Conclusions lack clear benefit cause government rethink vaccination policy,covid-19;ema;sars-cov2;adverse drug reaction;fatal side effects;mrna-vaccine;number needed to vaccinate;safety;side effects;vaccination
Equity Cuban National Health System s response COVID19,34220992,Cuba s National Health System managed guarantee effective equitable response COVID19 Universal free health coverage based primary care follows principle equity greatest resource allocated area lowest socioeconomic stratum higher risk concentrated followed medium high stratum order allowed similar mortality rate three stratum Cuban national mortality rate one lowest Region Americas first case identified Cuba Plan Coronavirus Prevention Control elaborated multisectoral participation first case confirmed Temporary National Working Group Fight COVID19 created advisory body government action face pandemic began preventive measure community continued isolation center ended community action surveillance follow recovered patient Following principle territoriality molecular diagnosis laboratory created province one Free medical care treatment preparation single national intersectoral government plan use particular strategy research diagnosis case tracing implementation universal protocol disease prevention treatment confirmed case made possible control disease health equity perspective,coronavirus infections;cuba;health equity;primary health care;universal health coverage
Confusion abdominal pain COVID19 vaccination,34346657,BACKGROUND Vaccineinduced immune thrombotic trombocytopenia VITT rare phenomenon may present diffuse atypical symptom CASE DESCRIPTION present case 63 year old female patient abdominal pain confusion tromboctytopenia CT scan show sinustrombosis trombosis vena renalis diagnosis VITT confirmed positive HIT test initiating treatment immunoglobulines nonheparinoid anticoagulans symptom improved platelet count increased CONCLUSION case illustrates awareness case atypical symptom history vaccination important recognize phenomenon,
Evolution trace SARSCoV2 January 19 March 12 2020 United States,34292617,kind human betacoronavirus SARSCoV2 endangered globally public health January 2021 virus resulted 2209195 death studying evolution trend characteristic 265 SARSCoV2 strain United States January March found strain divided six clade USA clade1 USA clade2 USA clade3 USA clade4 USA clade5 USA clade6 US clade1 may ancestral clade USA clade2 interim clade USA clade1 USA clade3 three clade similar codon usage pattern USA clade6 newest adaptable clade Mismatch analysis protein alignment showed evolution clade arises special mutation viral protein may help strain invade replicate transcribe Compared previous research classification suggest clade GISAID independent clade WuhanHu1 EPIISL402125 ancestral reference sequence study decoded evolutionary dynamic SARSCoV2 early stage United States give clue infer current evolution trend SARSCoV2 study function viral mutational protein,sars-cov-2;clade;coronavirus;evolution
Polysubstance use trend variability among individual opioid use disorder rural versus urban setting,34293380,Rural area United States disproportionately impacted opioid epidemic exacerbated COVID19related economic upheaval polysubstance use important determinant overdose risk variability polysubstance use result numerous factor eg access preference yet described particularly among rural person opioid use disorder PWOUD Survey data pastmonth use prescription illicit opioids 12 nonopioid psychoactive drug class analyzed national sample rural n=3872 urban n=8153 resident entering treatment OUD 2012 2019 Trend analysis opioid stimulant use compared rural urban PWOUD Latent class analysis assessed substance use trend identified typology ruralurban PWOUD underwent comparative analysis 2019 prescription opioid use remained greater rural versus urban PWOUD methamphetamine use showed greater growth rural compared urban area Latent class analysis identified variability polysubstance use five identical subgroup ruralurban PWOD high polysubstance polyprescription prescription opioidfocused prescription opioidfocused polysubstance use illicit opioidfocused Polyprescription highest rural area illicit opioidfocused use highest urban area Demographic characteristic comorbid condition healthcare coverage associated betweengroup difference significant variability polysubstance use may identify specific prevention treatment need subpopulation OUD patient intervention focused reducing opioid prescription early engagement mental health resource wider distribution naloxone screeningtreatment plan take account use multiple substance,opioid use disorder;polysubstance use;rural
COVID19 Antibody Detecting Rapid Diagnostic Tests Show High CrossReactivity Challenged PrePandemic Malaria Schistosomiasis Dengue Samples,34202195,COVID19 Antibody Detecting Rapid Diagnostic Tests COVID19 Ab RDTs preferred tool SARSCoV2 seroprevalence study particularly low middleincome country present study challenged COVID19 Ab RDTs prepandemic sample patient exposed tropical pathogen retrospective study performed archived serum n = 94 EDTA whole blood n = 126 sample obtained 20102018 196 traveler malaria n = 170 schistosomiasis n = 25 dengue n = 25 COVID19 Ab RDTs selected based regulatory approval status independent evaluation result detecting antigen Among 13 COVID19 Ab RDT product overall crossreactivity 185 crossreactivity malaria schistosomiasis dengue 203 181 75 respectively Crossreactivity current recent malaria malaria antibody Plasmodium specie parasite density similar Crossreactivity among different RDT product ranged 27 489 median value 145 IgM represented 679 crossreactive test line Crossreactivity associated detecting antigen patient category disease sub group except schistosomiasis two product =60 crossreactivity high crossreactivity malaria schistosomiasis andto lesser extentdengue call risk mitigation using COVID19 Ab RDTs coendemic region,covid-19;sars-cov-2;cross-reactivity
Evaluation Social Media Campaign Saskatchewan Promote Healthy Eating COVID19 Pandemic Social Media Analysis Qualitative Interview Study,34133314,BACKGROUND beginning COVID19 pandemic presented many sudden challenge regarding food including grocery shopping change eg reduced store hour capacity restriction empty store shelf due food hoarding restaurant closure need cook home closure food access program Eat Well Saskatchewan EWS implemented 16week social medium campaign eatwellcovid19 led dietitian nutrition student focused sharing story submitted Saskatchewan public eating healthy COVID19 pandemic OBJECTIVE goal study describe implementation eatwellcovid19 social medium campaign result evaluation campaign included campaign performance using social medium metric experience perspective campaign follower METHODS Residents Saskatchewan Canada invited submit personal story experience EWS eating healthy COVID19 pandemic April August 2020 week one three story featured EWS social medium platformsFacebook Instagram Twitteralong evidencebased nutrition information help resident become resilient challenge related food nutrition experienced COVID19 pandemic Individuals submitted story entered weekly draw 100 grocery gift card Social medium metric semistructured qualitative interview campaign follower used evaluate eatwellcovid19 campaign RESULTS total 75 story submitted 74 individual variety topic eg grocery shopping traditional skill gardening 42 story featured social medium EWS shared 194 eatwellcovid19 post across social medium platform Facebook n=100 Instagram n=55 Twitter n=39 Facebook eatawellcovid19 reached 100571 follower left 128818 impression resulting 9575 engagement Instagram campaign reached 11310 follower made 14145 impression received 823 like 15 comment Twitter eatwellcovid19 made 15199 impression received 424 engagement Featured story submission post best engagement Facebook like comment Instagram EWS social medium page reported increase following campaign Instagram +30 Facebook +14 Twitter +12 Results interview revealed two type campaign follower appreciated hearing story submitted follower helped feel connected community social isolation appreciated evidencebased information CONCLUSIONS Numerous story submitted eatwellcovid19 social medium campaign various topic Instagram Facebook post featured story highest engagement campaign EWS s social medium following increased 10 platform approach used eatwellcovid19 campaign could considered others looking develop health promotion campaign,"covid-19;saskatchewan;diet, healthy;dietitian;health promotion;nutrition;social media"
comprehensive review various category face mask resistant Covid19,34368502,science usage face mask common public avert COVID19 transmission proceeding swiftly primary route transmission COVID19 probably small respiratory droplet transmissible asymptomatic presymptomatic individual According World Health Organization wearing mask public help reduce transmission COVID19 virus Different category type mask usage reviewed work nutshell review work elucidates aspect utilizing various face mask along possibility fight ongoing pandemic COVID19,covid-19;mask;pandemic;who
Development validation early warning score system COVID19 patient,34221413,COVID19 major urgent ongoing threat global health Globally 24 million infected disease claimed million life November 2020 Predicting patient need respiratory support important guiding individual patient treatment also ensuring sufficient resource available ability six common Early Warning Scores EWS identify respiratory deterioration defined need advanced respiratory support highflow nasal oxygen continuous positive airway pressure noninvasive ventilation intubation within prediction window 24 h evaluated shown score perform suboptimally specific task Therefore alternative EWS based Gradient Boosting Trees GBT algorithm developed able predict deterioration within next 24 h high AUROC 94 accuracy sensitivity specificity 70 96 70 respectively GBT model outperformed best EWS LDTEWS NEWS increasing AUROC 14 GBT model make prediction based current baseline measure routinely available vital sign blood test,
Dexamethasone may improve severe COVID19 via ameliorating endothelial injury inflammation preliminary pilot study,34214123,Dexamethasone provides benefit patient coronavirus disease 2019 COVID19 although data regarding immunological profile viral clearance limited study aimed evaluate difference biomarkers among patient severe COVID19 receive dexamethasone measured plasma biomarkers lung epithelialendothelial injury inflammation 31 patient severe COVID19 13 control Changes biomarkers clinical parameter compared 7day period among COVID19 patient also according dexamethasone use Thirtytwo patient severe COVID19 received mechanical ventilation n = 6 highflow nasal cannula n = 11 supplemental oxygen n = 15 analyzed Relative control patient severe COVID19 significantly higher concentration biomarkers related glycocalyx shedding endocan syndecan1 endothelial injury von Willebrand factor inflammation soluble receptor advanced glycation endproducts sRAGE interleukin6 7day decrease biomarkers endothelial injury angiopoietin2 Ang2 intercellular adhesion molecule1 ICAM1 sRAGE biomarker lung epithelial injury surfactant protein correlated decrease Creactive protein radiologic score day 7 Twenty patient 63 received dexamethasone dexamethasone nondexamethasone group differed term disease severity However dexamethasone associated marginally increased SpO2FiO2 significantly decrease Creactive protein radiologic score adjusting baseline imbalance Furthermore dexamethasone group exhibited significant decrease concentration Ang2 ICAM1 soluble form Tie2 receptor biomarker glycocalyx shedding sRAGE group exhibited clinically insignificant increase cycle threshold value Severe COVID19 may characterized severe endothelial injury inflammation le severe lung epithelial injury possibility dexamethasone improved severe COVID19 related endothelial injury without delaying viral clearance,
Evolving biothreat variant SARSCoV2 molecular property virulence epidemiology,34227076,SARSCoV2 enveloped RNA virus belong family Coronaviridae genus Beta coronavirus responsible COVID19 pandemic mutation rate high among RNA virus particular coronavirus replication error prone estimated mutation rate 4x104 nucleotide substitution per site per year Variants SARSCoV2 reported various country like United Kingdom South Africa Denmark Brazil India variant evolved due mutation spike gene SARSCoV2 concerning variant Variant Concern VOC 20201201 United Kingdom B1617 variant India variant include B1351 lineage cluster 5SARSCoV2 variant Denmark 501V2 variantSARSCoV2 variant South Africa lineage B11248lineage P1 Brazil Mutations protein may result change transmissibility virulence SARSCoV2 date alteration virulence pathogenicity reported among variant many part globe opinion since protein significantly altered suitability existing vaccine specifically targeting protein SARSCoV2 variant major concern mutation SARSCoV2 continuous evolving process may result transformation naive SARSCoV2 totally new subset antigenically different SARSCoV2 virus period time,
Clinical condition echocardiographic parameter associated mortality COVID19,34287861,BACKGROUND Coronavirus disease 2019 COVID19 recently recognized viral infective disease complicated acute respiratory stress syndrome ARDS cardiovascular complication including severe arrhythmia acute coronary syndrome myocarditis pulmonary embolism aim present study identify clinical condition echocardiographic parameter associated inhospital mortality COVID19 METHODS multicentre retrospective observational study including seven Italian centre Patients hospitalized COVID19 1 March 22 April 2020 included study population association baseline variable risk inhospital mortality assessed multivariable logistic regression competing risk analysis RESULTS 1401 patient admitted participating centre confirmed diagnosis COVID19 226 161 underwent transthoracic echocardiography TTE included present analysis Inhospital death occurred 68 patient 301 multivariable analysis left ventricular ejection fraction LVEF P 001 tricuspid annular plane systolic excursion TAPSE P 001 ARDS P 001 independently associated inhospital mortality competing risk analysis found significantly higher risk mortality patient ARDS v without ARDS HR 766 CI 395148 patient TAPSE =17 mm v TAPSE 17 mm HR 508 CI 315819 patient LVEF =50 v LVEF 50 HR 406 CI 250659 CONCLUSIONS TTE might useful tool risk stratification patient COVID19 particular reduced LVEF reduced TAPSE may help identify patient higher risk death hospitalization,covid-19;sars-cov-2;echocardiography;left ventricular ejection fraction;outcome;tricuspid annular plane systolic excursion
Hypothesis Designation Liposomal Scavenger System Fighting 2019nCoV,34132188,2019 novel coronavirus 2019nCoV also known severe acute respiratory syndrome coronavirus 2 SARSCoV2 COVID19 virus member family Coronaviridae responsible current pandemic disease COVID19 seventh member family Coronaviridae infects human 229E OC43 NL63 HKU1 SARSCoV Middle East respiratory syndrome coronavirus MERSCoV Fever dry cough severe pneumonia seen common symptom early stage COVID19 case progress acute respiratory stress syndrome septic shock organ failure death development effective treatment vaccination treating preventing lethal condition urgent need order fight crisis effective vaccine different efficacy profile introduced Herein theoretically designed scavenger system gathering 2019nCoVs breaking reintroducing immune system,2019-ncov;covid-19;coronaviridae;sars-cov-2;liposomal scavenger system;treatment
Extracorporeal membrane oxygenation ECMO critically ill patient coronavirus disease 2019 COVID19 retrospective cohort study,34292632,PURPOSE role extracorporeal membrane oxygenatio ECMO rescue therapy respiratory failure critically ill coronavirus disease 2019 COVID19 patient remains controversial aimed evaluate clinical outcome ECMO treatment COVID19 compared conventional ventilation support METHODS retrospective cohort study data collected extremely critical patient COVID19 January 2020 March 2020 intensive care unit hospital charge national rescue team Wuhan China epicenter pandemic Patients classified ECMO group conventional ventilation nonECMO group Clinical characteristic technical characteristic laboratory result mortality complication two group analyzed RESULTS 88 patient extremely critical COVID19 screened 34 received ECMO support 31 received conventional ventilation support group comparable characteristic baseline term age gender comorbidities ECMO conventional therapy patient two group sever acute respiratory distress syndrome mean partial pressure arterial oxygen fraction inspired oxygen PaO2 FiO2 ratio 696 754 respectively time reporting patient ECMO significantly lower inhospital mortality compared control group 588 vs 935 p = 001 CONCLUSION ECMO shown decrease mortality extremely critical ill COVID19 patient compared conventional treatment Although complication occurred frequently ECMO could still rescue therapy treatment COVID19 pandemic,covid-19;ecmo;sars-cov-2
SARSCoV2DENV coinfection series case Federal District Midwestern Brazil,34332542,BACKGROUND Since novel coronavirus disease outbreak 1797 million people infected SARSCoV2 worldwide including population living dengueendemic region particularly Latin America Southeast Asia raising concern impact possible coinfections METHODS Thirteen SARSCoV2DENV coinfection case reported Midwestern Brazil April September 2020 described Information gathered hospital medical record regarding relevant clinical laboratory finding diagnostic process therapeutic intervention together clinicianassessed outcome followup RESULTS 13 case seven patient presented Acute Undifferentiated Febrile Syndrome six preexisting comorbidities diabetes hypertension hypopituitarism Two patient pregnant common symptom clinical sign reported first evaluation myalgia fever dyspnea six case initial diagnosis dengue fever delayed diagnosis concomitant infection frequently applied therapeutic intervention antibiotic analgesic total four patient hospitalized None transferred intensive care unit died Clinical improvement verified patient maximum 21 day CONCLUSIONS case reported highlight challenge differential diagnosis importance considering concomitant infection especially improve clinical management possible prevention measure Failure consider SARSCoV2DENV coinfection may impact individual community level especially endemic area,covid-19;case series;co-infection;denv;dengue;sars-cov-2
Seasonal Regional Influences Alcohol Consumption Analysis NearRealTime Urine Drug Test Results Seeking Health Care,34352493,AIMS examine probability detecting alcohol via urine drug testing UDT influenced age gender seasonality geography COVID19 time seeking health care METHODS crosssectional study UDT result January 1 2013 December 31 2020 conducted using adult patient specimen submitted testing health care professional part routine care UDT analysis used LCMSMS detect two alcohol metabolite ethyl glucuronide ethyl sulfate Seasonal adjustment positivity rate accomplished using STL method trend analysis performed seasonally adjusted rate Logistic regression used associate demographic feature interaction term collection year US census division included help understand changing nature alcohol use time across division RESULTS Alcohol positivity rate show strong seasonal change oscillating profile peak summer low point winter highest predicted positivity rate alcohol male patient 4564 year age primary care setting Alcohol positivity peaked 2016 declined following year remaining relatively steady since 2017 small significant increase noted COVID19 emergency declaration March 13 2020 probability alcoholpositive varies significantly geographic region region changing rate CONCLUSIONS Alcohol positivity UDT patient seeking health care influenced multiple factor increased COVID19 pandemic,alcohol use;covid-19;influences on alcohol positivity;patients seeking health care;urine drug testing
Datadriven method present future pandemic Monitoring modelling managing,34220287,survey analysis role datadriven methodology pandemic modelling control provide roadmap access epidemiological data source control epidemic phenomenon review available methodology discus challenge development datadriven strategy combat spreading infectious disease aim bring together several different discipline required provide holistic approach epidemic analysis data science epidemiology systemsandcontrol theory 3Manalysis presented whose three pillar Monitoring Modelling Managing focus potential datadriven scheme address three different challenge raised pandemic monitoring epidemic evolution assessing effectiveness adopted countermeasure ii modelling forecasting spread epidemic iii making timely decision manage mitigate suppress contagion step roadmap review consolidated theoretical approach including datadriven methodology shown successful context discus application past present epidemic Covid19 well potential application future epidemic,epidemic control;epidemiological models;forecasting;machine learning;model predictive control;optimal control;pandemic control;surveillance systems
Impact COVID19 Smoking Behaviours Support SmokeFree Zones Saudi Arabia,34203424,article focus impact COVID19 smoking smoking cessation behaviour support smokefree zone Jeddah Saudi Arabia pretested structured survey distributed email OctoberNovember 2020 student staff University Jeddah Responses analysed using descriptive statistic summative content analysis open text Participants providing open text comment n = 374666 564 nonsmokers n = 293 783 former smoker n = 26 70 current smoker n = 55 147 household member n = 220 588 friend smoke n = 198 529 plus daily exposure secondhand smoke home n = 125 334 awareness COVID19 smoking inside cafesrestaurants indoor outdoor public place exposure warning medium promoting smoking widespread support smokefree zone Smokers plan accessing smoking cessation support inconsistent retrospective report Many express positivity highlighting reduction smoking also negative report increased smoking COVID19 pandemic affected every aspect society worldwide People home restricted freedom movement limitation social liberty individual account help focus evidencebased smoking prevention cessation programme postCOVID19,covid-19;saudi arabia;barriers for quitting;quitting tobacco products;secondhand smoking;smoke free zones;smoking cessation
Global Pandemic Substance Use Disorder Healthcare Professionals Viewpoints Merging Two Crises,34130597,INTRODUCTION COVID19 resulted extraordinary adversity Mandates distancing variation treatment service implemented slow transmission virus created new challenge person Substance Use Disorder SUD better understand phenomenon surveyed healthcare professional believe COVID19 impacted person SUD need occur effectively treat vulnerable population Methods Attending physician resident nurse medical nursing student healthcare professional asked respond three openended question related impact COVID19 person SUD Two independent coder reviewed comment utilizing constant comparative analysis develop theme Results Common theme concern found respective participant n = 205 including lack access treatment feeling isolation negative impact mental health possibility relapse Healthcare strategy effectively treat help person SUD included increasing access treatment including telehealth development peer support group availability mental health resource development enhanced communication channel provider patient systematic change Conclusion COVID19 pandemic overdose death dramatically increased shortterm longterm effect pandemic become apparent swift comprehensive response policy must enacted study provides insight healthcare provider effect pandemic person SUD Many preexisting issue remain unresolved eg stigma healthcare disparity pandemic presented new obstacle noted provider finding study provide implication important discussion regarding development strategy substance use treatment harm reduction,covid-19;substance use disorder
Prediction two novel overlapping ORFs genome SARSCoV2,34339929,Six candidate overlapping gene detected SARSCoV2 yet current method struggle detect overlapping gene recently originated However gene might encode protein beneficial virus provide model system understand gene birth complement existing detection method first demonstrated selection pressure avoid stop codon alternative reading frame driving force origin retention overlapping gene built detection method CodScr based selection pressure Finally combined CodScr method detect property overlapping gene biased nucleotide amino acid composition detected two novel ORFs ORFSh ORFMh overlapping spike membrane gene respectively selection pressure may beneficial SARSCoV2 ORFSh ORFMh present ORF uninterrupted stop codon 100 95 SARSCoV2 genome respectively,codon usage;membrane protein;multivariate statistics;overlapping reading frame;selection pressure;spike protein;virus evolution
Pharmacological Treatment Patients Mild Moderate COVID19 Comprehensive Review,34281149,Mild moderate COVID19 found 80 patient Although mortality low mild moderate COVID19 may progress severe even critical stage one week pose substantial burden health care system ultimately culminates death incapacitation hospitalization Therefore pharmacological treatment paramount patient condition especially recognized risk factor disease progression conducted comprehensive review medical literature searching randomized study carried patient mild moderate COVID19 total 14 randomized study identified enrolling total 6848 patient Nine study 64 randomized placebocontrolled trial whereas five openlabel randomized trial 35 observed Bamlanivimab nitazoxanide reduced viral load whereas ivermectin may shortened time viral clearance Interferon Beta1 reduced time viral clearance vitamin reduced viral load Favirapir peginterferon levamisole improved clinical symptom whereas fluvoxamine halted disease progression inhaled budesonide reduced number hospitalization visit emergency department colchicine reduced number death hospitalization Collectively therefore finding show treatment early COVID19 may associated reduced viral load thus potentially decreasing disease spread community Moreover treatment patient mild moderate COVID19 may also associated improved clinical symptom hospitalization disease progression suggest colchicine inhaled budesonide nitazoxanide along nonpharmacological measure based efficacy cost may used mitigate effect COVID19 pandemic middleincome country,covid-19;sars-cov-2;mild disease;moderate disease
TMPRSS2 RNADependent RNA Polymerase Effective Targets Therapeutic Intervention Treatment COVID19 Caused SARSCoV2 Variants B117 B1351,34378968,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent coronavirus disease 2019 COVID19 pandemic development therapeutic intervention urgently needed far monoclonal antibody drug repositioning main method drug development effort partially successful Since beginning COVID19 pandemic emergence SARSCoV2 variant reported many part world main concern whether current vaccine therapeutic still effective variant virus Viral entry viral RNAdependent RNA polymerase RdRp main target current drug development therefore inhibitory effect transmembrane serine protease 2 TMPRSS2 RdRp inhibitor compared among early SARSCoV2 isolate lineage two recent variant lineage B117 lineage B1351 identified United Kingdom South Africa respectively vitro analysis viral replication showed drug targeting TMPRSS2 RdRp equally effective two variant concern IMPORTANCE COVID19 pandemic causing unprecedented global problem public health human society vaccine monoclonal antibody successfully developed quickly currently used numerous variant causative SARSCoV2 emerging threatening efficacy vaccine monoclonal antibody order respond challenge assessed antiviral efficacy smallmolecule inhibitor developed treatment COVID19 found still effective SARSCoV2 variant Since smallmolecule inhibitor target viral host factor mutated sequence viral spike protein expected potent control measure COVID19 pandemic,covid-19;rna-dependent rna polymerase;sars-cov-2;tmprss2;variant
Relation ORF8a mitochondrial protein TOM70 SARSCoV2 infection,34228876,,
HIV Risk Among Urban Suburban People Inject Drugs Elevated Risk Among Fentanyl Cocaine Injectors Maryland,34287755,Drug overdose remains leading cause death US growing rate attributable illicit fentanyl use Recent HIV outbreak among people inject drug PWID service disruption COVID19 renewed concern HIV resurgence examined relationship fentanyl use three injectionrelated HIV risk behavior among PWID Baltimore City BC Anne Arundel Country AAC Maryland PWID N = 283 recruited study targeted sampling streetbased location BC AAC July 2018 March 2020 Receptive syringe sharing RSS adjusted odds ratio AOR 28 95 confidence interval CI 1263 daily injecting AOR 19 95 CI 1036 associated injecting fentanyl cocaine together Fentanyl availability COVID19 bring new HIV prevention challenge particularly among inject fentanyl cocaine highlighting importance expand sustain harm reduction prevention treatment service PWID reduce HIV overdose burden,epidemiology;hiv/aids;injection drug use
Targetbased drug discovery ADMET profiling bioactivity study antibiotic potential inhibitor SARSCoV2 main protease pro,34226871,recent outbreak new strain Coronavirus SARSCoV2 become global health burden resulted death proven drug found effectively cure fastspreading infection hence need explore old drug known profile tackling pandemic computeraided drug design approach involving virtual screening used obtain binding score inhibiting efficiency previously known antibiotic SARSCoV2 main protease pro druglikeness analysis repurposed drug done using Molinspiration chemoinformatics tool Absorption Distribution Metabolism Excretion Toxicity ADMET analysis carried using ADMET SAR2 webserver analysis performed include bioactivities repurposed drug probable antiSARSCoV2 agent oral bioavailability analysis among others result compared drug currently involved clinical trial ongoing pandemic Although antibiotic speculated use treatment viral infection literature emerged lately reveal antiviral potential immuneboosting ability antibiotic study identified Tarivid Ciprofloxacin binding affinity 83 kcalmol 81 kcalmol respectively significant inhibitor SARSCoV2 pro better pharmacokinetics druglikeness oral bioavailability bioactivity property ADMET property inhibitory strength compared Remdesivir 76 kcalmol Azithromycin 63 kcalmol observation provide insight research clinical trial cure management COVID19,admet profiling;antibiotics;covid-19;molecular docking;sars-cov-2 main protease (mpro)
Contingency planning healthcare worker mask case medical supply chain failure Lessons learned novel mask manufacturing COVID19 Pandemic,34363872,INTRODUCTION COVID19 pandemic placed unprecedented strain medical supply chain Early pandemic uncertainty regarding personal protective equipment PPE high Protecting healthcare worker contracting illness critical preserve trust workforce capacity METHODS describe initiative design manufacture novel reusable halfface respirator case conventional medical supply chain failed meet demand required new collaboration hospital physician medical school school engineering describe organizational priority constraint process design testing approval health system engaged first time directly design manufacturing process PPE RESULTS original mask design developed University Hospital initial batch novel mask manufactured first wave SARSCOV2 pandemic mask die necessary produce reserve case depletion store conventionally sourced PPE CONCLUSIONS COVID19 pandemic demonstrated fragility medical supply chain Organizations considering similar effort anticipate constraint raw material supply chain flexible adaptive fast incident command structure vital identifying priority area needing alternative approach creating connection providing rapid approval found organizational value demonstrating commitment assuring PPE supply healthcare worker safety,covid-19;incident command;masks;pandemic;personal protective equipment
Performance Evaluation MatMaCorp COVID19 2SF Assay Detection SARSCoV2 Nasopharyngeal Swabs,34378961,coronavirus disease 2019 COVID19 pandemic taken unprecedented toll clinical diagnostic testing need PCRbased testing remains met Nucleic acid amplification testing NAAT recommended method diagnosis severe acute respiratory syndrome coronavirus 2 SARSCoV2 due inherent advantage sensitivity specificity study evaluated performance MatMaCorp COVID19 2SF test reverse transcriptionPCR RTPCR assay qualitative detection SARSCoV2 nasopharyngeal NP swab run Solas 8 instrument MatMaCorp Lincoln NE Solas 8 device portable kit labinabox design provides reagent shelfstable lyophilized powder format total 78 remnant clinical specimen used evaluate COVID19 2SF test Sixtytwo clinical specimen originally tested Xpert Xpress SARSCoV2 assay Cepheid Inc Sunnyvale CA used evaluate clinical accuracy COVID19 2SF test negative percent agreement NPA 100 95 confidence interval CI 839 100 positive percent agreement PPA 854 95 CI 708 944 Sixteen remnant specimen positive common respiratory pathogen FilmArray respiratory panel 20 BioFire Salt Lake City UT assayed Solas 8 device evaluate specificity crossreactivity respiratory pathogen identified unique labinabox design shelfstable reagent MatMaCorp COVID19 2SF test offer laboratory rapid option diagnostic NAAT SARSCoV2 help meet diagnostic need IMPORTANCE demand molecular testing COVID19 remains met study MatMaCorp Solas 8 device COVID19 test provides first evaluation platform,covid-19;matmacorp;rt-pcr;sars-cov-2;solas 8;point of care
Management minor burn COVID19 pandemic patientcentred approach,34211739,Introduction UK government introduced lockdown measure 23 March 2020 due first wave COVID19 pandemic restructuring clinical service necessary accommodate mandatory change also maintaining best possible standard patient care present study explored initial management followup patientreported outcome burn injury 15 total body surface area TBSA height COVID19 lockdown tertiary burn centre Methods retrospective review adult patient burn 15 TBSA national lockdown 23 March 2020 10 May 2020 undertaken Queen Elizabeth Hospital Birmingham QEHB UK referral nonQEHB telemedicine external QEHB emergency internal department reviewed management length hospital stay pattern followup ward attender selfcare community outreach nurse telephone survey based structured questionnaire conducted establish patient satisfaction Results total 84 burn patient included study mean age 39 year age range = 1991 year male female ratio 41 Patients managed nonoperatively n = 69 82 operatively n = 15 18 Patients attended ward attender acute burn clinic n = 36 61 telephone survey captured 70 n = 59 study population 57 patient 97 respondent pleased ongoing care burn healing Conclusion integration patient led selfcare reduction admission minimal clinic attendance telemedicine followup effective model small burn management COVID19 pandemic high degree patient satisfaction achieved continuous approachable communication channel burn multidisciplinary team continue implement effective model burn management throughout COVID19 pandemic subsequent period Lay Summary lockdown measure due first wave COVID19 pandemic affected way manage medical emergency including burn initial management followup patient satisfaction small burn injury lockdown reported previously aim study examine outcome term small burn management hospital stay number clinic review healing patient satisfaction lockdown period burn centre UK would look need operation whether patient stayed longer required intervention reviewed adult patient small burn national lockdown 23 March 2020 10 May 2020 Queen Elizabeth Hospital Birmingham QEHB referral telemedicine referral system external QEHB internal reviewed management length hospital stay pattern followup Patients reviewed acute burn clinic given advice burn management dressing selfcare Followup mostly via email telemedicine telephone survey based structured questionnaire conducted find patient satisfaction Four time men woman small burn lockdown period average age 39 year majority managed conservatively dressing 82 small proportion required operation 18 patient attended acute burn clinic 61 initial assessment management telephone survey captured 70 patient 97 respondent pleased care burn healing integration patientled selfcare reduction admission minimal clinic attendance telemedicine followup effective model burn management COVID19 pandemic high degree patient satisfaction achieved continuous approachable communication channel burn multidisciplinary team continue implement effective model burn management throughout COVID19 pandemic subsequent period,covid-19;telemedicine;burn management;lockdown;patient satisfaction;self-care
Models care chronic myeloid leukemia patient COVID19 pandemic United Kingdom Changes patient attitude remote consultation future implication,34226902,ongoing COVID19 pandemic presented numerous challenge provision patient care within hematology undertook questionnairebased study investigating experience opinion patient chronic myeloid leukemia CML UK relation different model followup care received pandemic One hundred fiftyfour patient completed online questionnaire 19 patient experienced remote clinic prior pandemic compared 91 afterward experience remote clinic proportion patient positive remote clinic concept increased 34 52 P 05 However asked compare experience face face versus remote clinic 48 preferred facetoface clinic compared 17 preferring remote clinic 35 expressed preference pandemic frequency blood test unchanged 71 patient although performed number different location majority patient 57 medication delivered home small number 8 difficulty obtaining medication term future model care 72 patient favor building remote appointment clinic model 61 expressing preference mixture remote facetoface appointment also interest greater utilization primary care blood testing finding help optimize future model care CML patient,
Prevalence Impact Atrial Fibrillation Hospitalized Patients COVID19 Systematic Review MetaAnalysis,34199857,BACKGROUND patient COVID19 cardiovascular complication common associated poor prognosis Among association atrial fibrillation AF COVID19 described however extent relationship unclear aim study investigate epidemiology AF COVID19 patient impact allcause mortality METHODS systematic review metaanalysis performed reported according PRISMA guideline protocol study registered PROSPERO CRD42021227950 PubMed EMBASE systematically searched relevant study randomeffects model used estimate pooled odds ratio 95 confidence interval CI RESULTS Overall 31 study included analysis total number 187716 COVID19 patient prevalence AF found high 8 patient COVID19 95 CI 63102 95 prediction interval PI 20271 high degree heterogeneity study multiple metaregression model including geographical location age hypertension diabetes showed factor accounted third heterogeneity AF COVID19 patient le likely female likely older hypertensive critical status without AF Patients AF showed significant increase risk allcause mortality 397 95 CI 276571 high degree heterogeneity sensitivity analysis focusing newonset AF showed consistency result CONCLUSIONS Among COVID19 patient AF found 8 patient AF COVID19 patient older hypertensive likely critical status COVID19 patient AF associated 4fold higher risk death study needed define best treatment strategy improve prognosis AF COVID19 patient,covid-19;atrial fibrillation;outcomes;prognosis
COVID19 agedependent immunology clinical outcome implication vaccine,34284839,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 leading acute respiratory distress syndrome ARDS Understanding evolution virus immunepathogenic process critical designing future therapeutic intervention review collate information structure genome viral life cycle adult pediatric host immune response response SARSCoV2 immunological response prototype developmental origin health disease DOHaD hypothesis explain sociogeographic difference impacting severity mortality rate SARSCoV2 infection DOHaD hypothesis identifies relevance trained innate immunity age group geography effective vaccination COVID19 vaccine rolled may pertinent ass populationbased immunological response understand effectiveness safety across different population age group,coronavirus;adaptive immunity;cytokine storm syndrome;innate immunity;multisystem inflammatory syndrome
Cytomegalovirus Uninvited Guest Response Vaccines People Living HIV,34209711,stark contrast rapid development vaccine severe acute respiratory syndrome coronavirus 2 SARSCoV2 effective human immunodeficiency virus HIV vaccine still lacking Furthermore despite virologic suppression CD4 Tcell count normalization antiretroviral therapy ART people living HIV PLWH still exhibit increased morbidity mortality compared general population difference health outcome related higher risk behavior also HIVrelated immune activation viral coinfections Among coinfections cytomegalovirus CMV latent infection wellknown inducer longterm immune dysregulation Cytomegalovirus contributes persistent immune activation PLWH receiving ART directly skewing immune response toward increasing immune activation modification gut microbiota microbial translocation addition induction immunosenescence CMV associated decreased response infection vaccine review provides comprehensive overview influence CMV immune system mechanism underlying reduced response vaccine discus new therapeutic advance targeting CMV could used improve vaccine response PLWH,cmv;hiv;cytomegalovirus;gut inflammation;immune activation;immunosenescence;vaccine
Using Proper Mean Generation Intervals Modeling COVID19,34291032,susceptibleexposedinfectiousrecovered SEIR epidemic model exponentially distributed duration exposedinfectious status mean generation interval GI time lag infection primary case secondary case equal mean latent period LP plus mean infectious period IP widely reported GI COVID19 short 5 day However many work top journal used longer LP IP sum ie GI eg 7 day discrepancy lead overestimated basic reproductive number exaggerated expectation infection attack rate AR control efficacy argue important use suitable epidemiological parameter value proper estimationprediction Furthermore propose epidemic model ass transmission dynamic COVID19 Belgium Israel United Arab Emirates UAE estimated timevarying reproductive number R 0 based COVID19 death data found Belgium highest AR followed Israel UAE,covid-19;generation interval;infectious period;latent period;reproduction number
Patient Experiences Transition Telephone Counseling COVID19 Pandemic,34199582,Background identify document treatment experience among patient opioid use disorder OUD context rapid move inperson telephone counseling due COVID19 pandemic Methods Participants n = 237 completed survey openended question included following domain 1 satisfaction telephone counseling 2 perceived convenience 3 change therapeutic relationship 4 perceived impact substance use recovery 5 general feedback Responses coded using thematic analysis Codes subsequently organized theme subthemes covering 98 response Interrater reliability coding participant response ranged 089 095 Results Overall patient reported telephone counseling improved therapeutic experience Specifically 74 respondent coded providing response consistently indicating `` positive valency `` Positive valency response include 1 feeling supported 2 greater comfort privacy 3 increased access counselor 4 resolved transportation barrier Conversely `` negative valency response include 1 impersonal experience 2 reduced privacy Conclusions Telephone counseling present set challenge investigated improve quality care longterm patient outcome,needs assessment;opioid use disorder treatment;qualitative;telehealth services
Capnocytophaga canimorsus meningitis bacteraemia without dog bite immunocompetent individual,34290010,describe case immunocompetent 75yearold man Capnocytophaga canimorsus bacteraemia meningitis C canimorsus commonly found oral flora dog human infection typically occurring following bite Unusually patient dog owner history bite scratch mark Admission blood culture flagged positive Gramnegative bacillus prolonged molecular analysis required C canimorsus isolated blood cerebrospinal fluid high mortality rate invasive infection patient s case antibiotic therapy commenced prior laboratory confirmation patient making complete recovery case highlight importance including C canimorsus differential diagnosis unwell patient keep dog even without bite case occurred amid heightened awareness COVID19 may represent predisposition zoonosis social isolation increased humanpet contact,immunology;infection (neurology);infectious diseases;meningitis
Early spontaneous pneumothorax pneumomediastinum pneumorrhachis adolescent SARSCoV2 infection,34227077,report case spontaneous pneumomediastinum pneumothorax emphysema subcutaneous pneumorrhachis occurring adolescent resulting positive SARSCoV2 nasopharyngeal swab admission Emergency Department child presented left cervical sternal pain without respiratory symptom Radiological study showed sizeable pneumomediastinum bilateral apical pneumothorax massive emphysema subcutaneous pneumorrhachis Patients clinical condition stood stable monitoring needed conservative management knowledge first description spontaneous pneumomediastinum pneumothorax emphysema subcutaneous pneumorrhachis COVID19 adolescent without concomitant pneumonia,
Immunogenicity safety CoronaVac vaccine patient cancer receiving active systemic therapy,34342517,Aim evaluate immunogenicity safety CoronaVac vaccine patient cancer receiving active systemic therapy Methods multicenter prospective observational study conducted 47 patient receiving active systemic therapy cancer CoronaVac administered two dos 3 mugday day 0 28 Antibody level higher 1 IUml defined immunogenicity Results immunogenicity rate 638 3047 entire patient group 595 2542 receiving least one cytotoxic drug 100 five five receiving monoclonal antibody immunotherapy alone Age independent predictive factor immunogenicity odds ratio 0830 p = 0043 Conclusion half cancer patient receiving active systemic therapy developed immunogenicity,covid-19;cancer;chemotherapy;immunogenicity;immunotherapy;monoclonal antibody;safety;tumors;vaccine
Acute Myocardial Infarction Due Microvascular Obstruction Young Woman Recently Recovered COVID19 Infection,34198838,Although cardiovascular complication common hospitalized COVID19 patient milder case recovered home le studied report case young woman recently recovered COVID19 home week recovery admitted institution acute chest pain sign ischemia electrocardiogram elevated cardiac troponins Coronary angiography showed normal epicardial coronary artery cardiac magnetic resonance showed transmural late gadolinium enhancement LGE midventricular level lateral wall finding strongly suggestive minor transmural myocardial infarction case report highlight role multimodality imaging detecting cardiac injury COVID19 patient well fact mild COVID19 case recovered home also exposed thromboembolic event convalescent period,covid-19;cardiac magnetic resonance imaging;case-report;echocardiography;myocardial infarction;strain
U shape association hemoglobin level inhospital mortality COVID19 patient,34213716,hypothesis high hemoglobin Hb level might associated hypercoagulable state death due COVID19 9467 hospitalized COVID19 patient patient subdivided 5 group based level Hb Hb 10 gdL 10 gdL = Hb 12 gdL 12 gdL = Hb 14 gdL 14 gdL = Hb 16 gdL Hb = 16 gdL Compared patient 12 gdL = Hb 14 gdL patient Hb = 16 gdL significantly higher adjusted inhospital mortality 95 CI 162 115227 P = 0005,covid-19;hemoglobin;mortality
Utilization telehealth outpatient diabetes management COVID19 pandemic patient fare,34227718,BACKGROUND coronavirus disease 2019 COVID19 pandemic many outpatient service public hospital including diabetes service adopted telehealth appointment clinic patient concern patient glycaemic control may worsen pandemic METHODS conducted retrospective review patient diabetes managed telehealth consultation 5 month two metropolitan hospital Sydney attendance rate glycaemic control unplanned admission hospital assessed compared period 12 month prior patient reviewed via facetoface appointment RESULTS April September 2020 attendance rate telehealth consultation diabetes service two hospital 889 884 994 2020 higher 2019 852 818 959 p = 0016 patient attended via facetoface appointment 629 patient reviewed via telehealth 2020 service 12 month glycaemic control better 2020 HbA1c 78 + 14 62 + 15 mmolmol compared 12 month ago 82 + 17 66 + 19 mmolmol p 0001 difference number unplanned admission cohort 2020 n = 58 92 compared 2019 n = 75 119 p = 0100 CONCLUSION study showed patient diabetes received care via telehealth consultation COVID19 lockdown glycaemic control slightly better unplanned admission rate higher compared preCOVID19 period Telehealth consultation offer important care delivery option management patient diabetes circumstance article protected copyright right reserved,covid-19;diabetes mellitus;glycaemic control;outpatient service;telehealth
Sudden Sensorineural Hearing Loss Mild COVID19 Case Series Analysis Literature,34287226,BACKGROUND growing evidence otoneurological involvement SARSCoV2 tinnitus balance disorder smell taste disorder HL COVID19 patient still marginally studied Investigating role SARSCoV2 aetiological factor Sudden Sensorineural Hearing Loss SSNHL may offer opportunity address treatment strategy maximize clinical recovery avoid side effect METHODS RESULTS purpose present case study five patient experienced SSNHL COVID19 Patients selected COVID19 positive adult subject mild clinical presentation admitted outpatient Ear Nose Throat Department Cardarelli Hospital due onset SSNHL infection underwent complete audiovestibular investigation SSNHL treatment protocol patient described detailed analysis CONCLUSIONS SSNHL could occasional symptom COVID19 even mild manifestation disease experience lead u underline value promptly recognizing addressing uncommon symptom giving patient opportunity receive early treatment,covid-19;sars-cov-2;ssnhl;coronavirus;hearing loss;sudden sensorineural hearing loss;tinnitus;treatment;vertigo
Application Traditional Chinese Medicine Systems Pharmacology Drug Prevention Treatment COVID19,34225580,novel coronavirus named SARSCoV2 causing severe acute pneumonia COVID19 rapid spread nationally internationally resulting major global health emergency Chinese government scientist implemented series rigorous measure scientific research prevent control SARSCoV2 infection However still specific antiviral drug vaccine SARSCoV2 proven traditional Chinese medicine TCM exerts important role prevention treatment COVID19 caused SARSCoV2 outbreak Although therapeutic effect TCM formula attractive molecular mechanism action fully elucidated emerging strategy system pharmacology proposed promising method interpret drug action complex biological system quickly screen bioactive compound TCM treat treatment COVID19 caused SARSCoV2 Therefore study epidemiology TCM therapy system pharmacologybased method TCM reviewed COVID19 provide perspective prevention treatment SARSCoV2 infection effort made reduce disease burden improve ability design antiviral drug vaccine benefit health care system economic development even social stability,covid-19;drug discovery;review;sars-cov-2;systems pharmacology;traditional chinese medicine
COVID19 impact rural black church Congregants Results CMC project,34227136,COVID19 pandemic devastating effect Black rural population mortality rate among Blacks three time Whites rural Black population experiencing limited access COVID19 resource primary purpose study explore health financial psychological impact COVID19 among rural White Appalachian Black nonrural central Kentucky church congregant Secondarily sought examine association sociodemographics behavior attitude belief regarding COVID19 intent vaccinate used cross sectional survey design developed construct Health Belief Theory Planned Behavior model majority 942 respondent =36 year total 54 central Kentucky 475 Appalachia Among participant pandemic worsened anxiety depression delayed access medical care association sociodemographics practicing COVID19 prevention behavior Appalachian region associated financial burden delay medical care p = 003 Appalachian respondent lower perceived benefit attitude COVID19 prevention behavior p = 0004 0001 respectively Among respondent perceived risk contracting COVID high 54 yet 332 indicated unlikeliness receive COVID19 vaccine offered COVID19 pandemic differential impact White rural Black nonrural population Nurses public health official ass knowledge explore patient s attitude regarding COVID19 prevention behavior well advocate public health resource reduce differential impact COVID19 atrisk population,covid-19;health belief model;theory of planned behavior;health equity
Physical Therapy Sedation Extracorporeal Membrane Oxygenation COVID19Associated Acute Respiratory Distress Syndrome,34284915,OBJECTIVES study aimed determine whether patient extracorporeal membrane oxygenation ECMO coronavirus disease 2019 COVID19 achieved lower rate physical therapy participation required sedation ECMO without COVID19 DESIGN Retrospective observational matchedcohort study SETTING Bicenter academic quaternary medical center PARTICIPANTS adult ECMO severe COVID19associated acute respiratory distress syndrome ARDS 2020 matched matched 11 based age + 15 year medical center adult ECMO ARDS associated COVID19 INTERVENTIONS Observational MEASUREMENTS MAIN RESULTS Measurements collected retrospectively first 20 day ECMO support included daily level physical therapy activity number daily sedation infusion dos level sedation agitation Richmond Agitation Sedation Score first 20 day ECMO support 22 patient ECMO COVID19associated ARDS achieved similar proportion day active physical therapy participation ECMO compared matched patient ECMO nonCOVID19 ARDS 225 v 75 respectively p value 043 similar proportion day Richmond Agitation Sedation Score =2 ECMO 475 v 275 respectively p value 0065 similar proportion day chemical paralysis ECMO 84 v 180 respectively p value 035 CONCLUSIONS result matched cohort study supported sedation requirement dramatically greater significantly limit early physical therapy patient COVID19associated ARDS venovenous extracorporeal membrane oxygenation VVECMO versus without COVID19associated ARDS VVECMO,covid-19;ecmo;adult;extracorporeal membrane oxygenation;physical therapy;sedation
Targeting SARSCoV2 Polymerase New Nucleoside Analogues,34200204,Despite fact COVID19 vaccine already available market effective FDAapproved drug treat disease several already known drug drug repositioning shown inhibitory activity SARSCoV2 RNAdependent RNA polymerase drug included family nucleoside analogue effort synthesized group new nucleoside analogue modified sugar moiety replaced quinazoline entity Different nucleobase derivative used order increase inhibition Five new nucleoside analogue evaluated vitro assay targeting polymerase SARSCoV2,covid-19;nucleoside derivatives;quinazoline moiety
Elongated PEObased nanoparticles bind highdensity lipoprotein HDL receptor scavenger receptor class B SRBI,34352314,Targeting cellsurface receptor nanoparticles NPs crucial aspect nanomedicine show soft flexible elongated NPs polyethyleneoxide PEO exterior polybutadiene PBD interior PEOPBD filomicelles interact directly major highdensity lipoprotein HDL receptor SARSCoV2 uptake factor SRBI Filomicelles 6fold stronger interaction reconstituted SRBI PEOPBD sphere HDL lipid transport inhibitor BLT1 block uptake filomicelles macrophage Idla7 cell latter constitutively expressing SRBI Idla7SRBI Coinjections HDL filomicelles wildtype mouse reduced filomicelle signal liver increased filomicelle plasma level true SCARB1 mouse SRBI binding followed phagocytosis filomicelle macrophage entry SRBI needed entry Idla7SRBI cell PEOPBD sphere interact strongly SRBI experiment result show elongated PEObased NPs bind cell via cooperativity among SRBI receptor cell surface,filomicelle;hdl;nanoparticle;peg;sars-cov-2;sr-bi
Evaluation surrogate virus neutralization test highthroughput serosurveillance SARSCoV2,34224754,Highthroughput serological test detect neutralizing antibody SARSCoV2 desirable serosurveillance vaccine efficacy evaluation Although conventional neutralization test cVNT remains gold standard confirm presence neutralizing antibody serum test labourintensive massive screening program le reproducible live virus cell culture involved performed independent evaluation commercially available surrogate virus neutralization test sVNT GenScript cPass done without biosafety level 3 containment le 2 hour using cVNT Luminex multiplex immunoassay MIA reference sVNT obtained sensitivity 94 CI 9096 panel 317 immune serum obtained hospitalized mild COVID19 case Belgium sensitivity 89 CI 8193 panel 184 healthcare worker Democratic Republic Congo also found strong antibody titer correlation r 08 among different technique used conclusion evaluation suggests sVNT could powerful tool monitordetect neutralising antibody cohort population study technique could especially useful vaccine evaluation study subSaharan Africa basic infrastructure perform cVNTs lacking,luminex;sars-cov-2;cpass;neutralizing antibody test;serosurveillance
Abnormality NK cell population prolonged severe COVID19 patient,34339730,BACKGROUND understanding adaptive immune response COVID19 patient rapidly evolving information innate immune response natural killer NK cell still insufficient OBJECTIVE aimed examine phenotypic functional status NK cell change course mild severe COVID19 METHODS performed RNA sequencing RNAseq flow cytometric analysis NK cell patient mild severe COVID19 multiple time point course disease using cryopreserved peripheral blood mononuclear cell PBMCs RESULTS RNAseq analysis NK cell exhibited distinctive feature compared healthy donor significant enrichment proinflammatory cytokinemediated signaling pathway Intriguingly found unconventional CD56 dim CD16 neg uCD56 dim NK cell population expanded cryopreserved PBMCs COVID19 patient regardless disease severity accompanied decreased NK cell cytotoxicity NK cell population rapidly normalized alongside disappearance uCD56 dim NK cell recovery NK cell cytotoxicity mild COVID19 patient occurred slowly severe COVID19 patient CONCLUSION current longitudinal study provides deep understanding NK cell biology COVID19,covid-19;nk cells;sars-cov-2;cytotoxicity;innate immunity;unconventional cd56(dim)cd16(neg) nk cells
18 FFDGPETCT SARSCoV2 infection sequela,34340958,recent month much scientific effort focused research SARSCoV2 infection consequence human Still many aspect remain unknown known damage caused SARSCoV2 multifactorial extension go beyond lung inflammation acute phase appearance numerous complication sequela date knowledge usefulness 18 FFDGPETCT acute phase limited incidental detection SARSCoV2 unsuspected pneumonia Recent study appearing collecting finding 18 FFDGPETCT long COVID19 persistent COVID19 state well alteration caused mass vaccination population metabolic study work aim review existing literature focusing three issue briefly present preliminary experience,(18)f-fdg-pet/ct;(18)f-fdg-pet/tc;covid-19 persistente;inflamacion;inflammation;long covid-19;sars-cov-2;vaccine;vacuna
Disease Flare Reactogenicity Patients Rheumatic Musculoskeletal Diseases Following TwoDose SARSCoV2 Messenger RNA Vaccination,34346185,OBJECTIVE evaluate disease flare postvaccination reaction reactogenicity patient rheumatic musculoskeletal disease RMD following twodose SARSCoV2 mRNA vaccination METHODS 1377 patient RMD received twodose SARSCoV2mRNA vaccination 16 December 2020 April 15 2021 completed questionnaire detailing local systemic reaction experienced within 7 day vaccine dose D1 D2 one month D2 detailing flare RMD Associations demographicclinical characteristic flare requiring treatment evaluated using modified Poisson regression RESULTS 11 percent reported flare requiring treatment report severe flare Flare associated prior SARSCoV2 infection IRR 209 p=002 flare six month preceding vaccination IRR 236 p 0001 use combination immunomodulatory therapy IRR 195 p 0001 frequently reported local systemic reaction included injection site pain D1 87 D2 86 fatigue D1 60 D2 80 reactogenicity increased D2 particularly systemic reaction allergic reaction SARSCoV2 diagnosis reported CONCLUSION Flare underlying RMD following SARSCoV2 vaccination uncommon report severe flare Local systemic reaction typically interfere daily activity early safety data help address vaccine hesitancy patient RMD,covid-19;sars-cov-2;flare;mrna vaccine;rheumatic disease
Metabolomics Diagnosis Prognosis COVID19,34367265,Coronavirus disease 2019 COVID19 pandemic triggered unprecedented global effort developing rapid inexpensive diagnostic prognostic tool Since genome SARSCoV2 uncovered detection viral RNA RTqPCR played significant role preventing spread virus early detection tracing suspected COVID19 case screening atrisk population However large number alternative test method based SARSCoV2 RNA protein host factor associated SARSCoV2 infection developed evaluated application metabolomics infectious disease diagnostics evolving area science boosted urgency COVID19 pandemic Metabolomics approach rely analysis volatile organic compound exhaled COVID19 patient hold promise application largescale screening population pointofcare POC setting hand successful application massspectrometry detect specific spectral signature associated COVID19 nasopharyngeal swab specimen may significantly save cost turnaround time COVID19 testing diagnostic microbiology virology laboratory Active research also ongoing discovery potential metabolomicsbased prognostic marker disease applied serum plasma specimen Several metabolic pathway related amino acid lipid energy metabolism found affected severe disease COVID19 particular tryptophan metabolism via kynurenine pathway persistently dysregulated several independent study suggesting role several metabolite pathway tryptophan kynurenine 3hydroxykynurenine potential prognostic marker disease However standardization test method largescale clinical validation necessary test applied clinical setting rapidly expanding data metabolic profile COVID19 patient varying degree severity likely metabolomics play important role near future predicting outcome disease greater degree certainty,covid-19;sars-cov-2;diagnosis;mass-spectrometry;metabolomics;nuclear magnetic resonance;prognosis;volatile organic compounds
Dinitrosyl iron complex DNICs inhibitor SARSCoV2 main protease,34337637,repurposing DNICs designed medicinal purpose possibility protease inhibition investigated silico using AutoDock 426 AD4 vitro via FRET protease assay AD4 validated predictive computational tool coordinatively unsaturated DNIC binding using known crystal structure proteinbound DNIC PDB1ZGN calculation RMSD = 177 silico data dimeric DNICs TGTARRE muSTGTA Fe 2 2 TGTA = 1thiobetadglucose tetraacetate TGRRE muSTG Fe 2 2 TG = 1thiobetadglucose identified promising lead inhibition via coordinative inhibition Cys145 SARSCoV2 Main Protease SC2Mpro vitro study indicate inhibition protease activity upon DNIC treatment IC50 38 + 2 muM TGTARRE 33 + 2 muM TGRRE study present simple computational method predicting DNICprotein interaction vitro study consistent silico lead,
Symptom Age Homophilies SARSCoV2 Transmission Networks Early Phase Pandemic Japan,34205133,Kanagawa Hokkaido affected COVID19 early stage pandemic Japan s initial response included contact tracing PCR analysis anyone suspected exposed SARSCoV2 retrospective study analyzed publicly available COVID19 registry data Kanagawa Hokkaido n = 4392 Exponential random graph model ERGM network analysis performed examine demographic symptomological homophilies Age symptomatic asymptomatic status homophilies seen prefecture Symptom homophilies suggest nuanced genetic difference virus may affect epithelial cell type range result diversity symptom seen individual infected SARSCoV2 Environmental variable temperature humidity may also play role overall pathogenesis virus higher level asymptomatic transmission observed Kanagawa Moreover patient contracted virus secondary tertiary contact shown asymptomatic frequently contracted primary case Additionally transmission stopped primary secondary level expected significant viral transmission seen healthcare setting,covid-19;sar-cov-2;asymptomatic patients;demographic homogeneities and heterogeneities;exponential random graph model (ergm) network analysis;symptomological homogeneities and heterogeneities;viral transmission networks
Eyes Health Care Worker Compliance Personal Protective Equipment COVID19 Pandemic,34282072,BACKGROUND Personal protective equipment PPE play critical role protecting health care worker HCWs coronavirus disease2019 COVID19 pandemic shortage PPE supply drastically changed way PPE obtained used HCWs PURPOSE objective investigate impact COVID19 pandemic patient isolation type PPE compliance METHODS investigation survey HCWs level 1 trauma teaching hospital regarding PPE compliance pattern prior COVID19 pandemic RESULTS HCWs reported increase PPE compliance COVID19 pandemic Nearly half 486 respondent reported isolation type impacted decision wear PPE likely forgo PPE contact precaution CONCLUSIONS HCWs identified multiple barrier compliance underutilization PPE contact precaution suggests risk exposure interpreted low could future target education,
Effect BCG vaccination proinflammatory response elderly individual,34348897,investigated influence Bacillus CalmetteGuerin BCG vaccination unstimulated plasma level wide panel cytokine chemokines acutephase protein APPs matrix metalloproteinases MMPs growth factor group healthy elderly individual age 60 80 year baseline vaccination 1 month vaccination part clinical study examine effect BCG COVID19 result demonstrated BCG vaccination resulted diminished plasma level type 1 2 17 proinflammatory cytokine type 1 interferon BCG vaccination also resulted decreased plasma level CC CXC chemokines APPs MMPs growth factor Plasma level aforementioned parameter significantly lower vaccinated individual compared unvaccinated control individual Thus study demonstrates immunomodulatory property BCG vaccination suggests potential utility nonspecific vaccination COVID19 downmodulating pathogenic inflammatory response,
remdesivir parent nucleoside GS441524 potential oral drug vitro vivo DMPK assessment,34221871,Remdesivir RDV US Food Drug Administration FDA approved drug treating COVID19 However RDV given intravenous route pressing medical need oral antiviral Significant evidence suggests role parent nucleoside GS441524 clinical outcome RDV could largely underestimated performed vitro vivo drug metabolism pharmacokinetics DMPK assessment examine potential RDV particularly GS441524 oral drug vitro assessment RDV exhibited prohibitively low stability human liver microsome HLMs 12 = approximately 1 min primary CYPmediated metabolism monooxidation likely phosphoramidate moiety observation poorly aligned potential oral use RDV though presence cobicistat microsomal stability drastically boosted level observed without enzyme cofactor NADPH Conversely GS441524 showed excellent metabolic stability human plasma HLMs vivo study CD1 mouse GS441524 displayed favorable oral bioavailability 57 Importantly GS441524 produced adequate drug exposure mouse plasma lung effectively converted active triphosphate suggesting could promising oral antiviral drug treating COVID19,"adk, adenosine kinase;antiviral;covid-19;cyp, cytochrome p450;cobi, cobicistat;dmpk, drug metabolism and pharmacokinetics;drug metabolism;ems, enhanced mass scan;epi, enhanced product ion;fipv, feline infectious peritonitis coronavirus;gs-441524;hints, histidine triad nucleotide binding proteins;hlms, human liver microsomes;ida, information dependent acquisition;mlms, mouse liver microsomes;mrm, multiple reaction monitoring;nucleoside;oral bioavailability;rdv, remdesivir;rdrp, rna-dependent rna-polymerases;remdesivir;sars-cov-2;sof, sofosbuvir;taf, tenofovir alafenamide"
Modelling Voluntary General Population Vaccination Strategies COVID19 Outbreak Influence Disease Prevalence,34201285,novel statistical model based twolayer contact information graph suggested order study influence disease prevalence voluntary general population vaccination COVID19 outbreak Details structure number susceptible infectious recoveredvaccinated individual contact layer simultaneously transferred information layer evergrowing wealth information becoming available COVID virus modelled individual level simplified proxy predictor amount disease spread informed individual node heterogeneous graph make decision vaccination `` motivated benefit obtained result showed disease information type global local significant impact individual vaccination decision number different scenario investigated scenario showed case stronger impact globally broadcasted disease information individual tend vaccinate larger number time infection already spread within population individual make vaccination decision based locally available information vaccination rate uniformly spread infection outbreak duration Prioritising elderly population vaccination lead increased number infected case higher reduction mortality developed model accuracy allows precise targeting vaccination order depending individual number social contact Precisely targeted vaccination combined preexisting immunity public health measure limit infection isolated hotspot inside population well significantly delay lower infection peak,covid-19;digital twinning;graph theory;infectious diseases;information spread;modelling;vaccination
Liver Impairment Hematological Changes Patients Chronic Hepatitis C COVID19 Retrospective Study One Year Pandemic,34200570,Background Objectives COVID19 pandemic ongoing public health emergency Patients chronic disease greater risk complication poor outcome objective study investigate liver function abnormality clinical outcome patient COVID19 chronic hepatitis C Materials Methods retrospective singlecenter study conducted cohort 126 patient history hepatitis C confirmed COVID19 01 April 2020 30 December 2020 Several clinical outcome compared patient active nonactive HCV infection risk liver impairment allcause mortality active HCV patient analyzed using multivariate logistic regression model Results Among 1057 patient followup chronic HCV infection 126 119 confirmed COVID19 95 754 treatment achieved SVR 31 246 found active HCV replication significantly higher proportion severe COVID19 case active HCV group compared nonactive HCV group 322 vs 73 p 0001 Multivariate analysis showed age sex alanine aminotransferase Creactive protein procalcitonin HCV viral load significant independent risk factor liver impairment allcause mortality length stay hospital intensive care unit COVID19 significantly higher patient active HCV infection pvalue 0001 higher proportion patient required mechanical ventilation Conclusions Active HCV infection independent risk factor allcause mortality COVID19 patient,covid-19;sars-cov-2 infection;hepatitis c virus;liver impairment;mortality risk
Abnormal Coagulation Function Patients COVID19 Significantly Related Hypocalcemia Severe Inflammation,34222271,study aimed detect analyze correlate clinical characteristic blood coagulation function blood calcium level inflammatory factor patient mild severe COVID19 infection enrolled COVID19 infected patient Wuhan Jin Yintan Hospital 17 case Wuhan China Suzhou Infectious Disease Hospital 87 case Suzhou China Xuzhou Infectious Disease Hospital 14 case Xuzhou China admission basic information collected Xray chest CT image obtained data routine blood test liver kidney function myocardial enzyme electrolyte blood coagulation function erythrocyte sedimentation rate ESR Creactive protein CRP IL6 procalcitonin PCT calcitonin laboratory test obtained patient grouped according clinical classification method based pneumonia diagnosis treatment plan new coronavirus infection trial version 7 China measurement mild 56 case severe case 51 case compared analyzed COVID19 patient presented fever Chest Xray CT image showed multiple patchy ground glass opacity lung COVID 19 infected patient especially patient severe case Compared patient mild infection patient severe infection older p = 0023 significant increase AST BUN level CK LDH CKMB proBNP Myo patient severe COVID19 infection also increased significantly compared patient mild case Patients severe COVID19 infection presented coagulation dysfunction increased Ddimer fibrin degradation product FDP level Severe COVID19 patient low serum calcium ion Ca 2+ concentration high calcitonin PCT level exhibited serious systemic inflammation Ca 2+ COVID19 patient significantly negatively correlated PCT calcitonin Ddimer PFDP ESR CRP IL6 Ddimer COVID19 patient significantly positively correlated CRP IL6 conclusion patient severe COVID19 infection presented significant metabolic dysfunction abnormal blood coagulation sharp increase inflammatory factor calcitonin procalcitonin level significant decrease Ca 2+ Decreased Ca 2+ coagulation dysfunction COVID19 patient significantly correlated inflammatory factor,covid-19;coagulation function;hypocalcemia;inflammation;metabolic disorder
Role Mechanism Histone Deacetylases Acute Kidney Injury,34220520,Acute kidney injury AKI common clinical complication incidence 818 hospitalized patient AKI also complication COVID19 patient associated increased risk death recent year numerous study suggested epigenetic regulation critically involved pathophysiological process prognosis AKI Histone acetylation one epigenetic regulation negatively regulated histone deacetylases HDACs Increasing evidence indicates HDACs play important role pathophysiological development AKI regulation apoptosis inflammation oxidative stress fibrosis cell survival autophagy ATP production mitochondrial biogenesis MB review summarize discus role mechanism HDACs pathogenesis AKI,acute kidney injury;epigenetic modification;histone deacetylase;mitochondrial biogenesis;oxidative stress
SixMonth Pulmonary Function Venovenous Extracorporeal Membrane Oxygenation Coronavirus Disease 2019 Patients,34291224,OBJECTIVES Venovenous extracorporeal membrane oxygenation largely used patient refractory acute respiratory distress syndrome due coronavirus disease 2019 data longterm pulmonary function among venovenous extracorporeal membrane oxygenation survivor available DESIGN Retrospective observational cohort SETTING Two mixed medicalsurgical tertiary 30 bed secondary 22 bed ICUs PATIENTS critically ill adult coronavirus disease 2019 survivor treated venovenous extracorporeal membrane oxygenation March 10 April 30 2020 MEASUREMENTS MAIN RESULTS last available lung function 6minute walking test performed median 178 day range 72232 ICU admission analyzed Among 32 coronavirus disease 2019 patient treated venovenous extracorporeal membrane oxygenation study period 11 34 median age 56 yr median duration mechanical ventilation extracorporeal membrane oxygenation therapy 26 15 respectively successfully weaned discharged home Spirometry performed nine patient volumetric lung function preserved median forced vital capacity 83 predicted value 5199 predicted value median forced expiratory volume 1 second 82 predicted value 6099 predicted value Also median residual volume lung capacity 100 predicted value 50140 predicted value 90 predicted value 50100 predicted value diffusion capacity lung carbon monoxide 6minute walking test decreased 58 predicted value 3795 predicted value 468 meter 365625 meter corresponding 6390 predicted value respectively CONCLUSIONS Among survivor severe coronavirus disease 2019 pneumonia treated venovenous extracorporeal membrane oxygenation preserved longterm volumetric lung function decreased diffusion capacity lung carbon monoxide observed,acute respiratory distress syndrome;coronavirus disease 2019;extracorporeal membrane oxygenation;pulmonary function test
relationship time high COVID19 response level timing peak daily incidence analysis government Stringency Index 148 country,34225774,BACKGROUND transmission dynamic severity coronavirus disease 2019 COVID19 pandemic different across country region Differences government policy response may explain difference aimed compare worldwide government response spread COVID19 examine relationship response level response timing epidemic trajectory METHODS Free publiclyaccessible data collected Coronavirus Government Response Tracker OxCGRT used Nine subindicators reflecting government response 148 country collected systematically January 1 May 1 2020 subindicators scored aggregated common Stringency Index SI value 0 100 reflects overall stringency government s response daily basis Groupbased trajectory modelling method used identify trajectory SI Multivariable linear regression model used analyse association time reach highlevel SI time peak number daily new case RESULTS result identified four trajectory response spread COVID19 based response initiated January 13 January 13 February 12 February 12 March 11 last stagefrom March 11 day declared pandemic COVID19 going Governments response upgraded spread COVID19 varied substantially across country adjustment SI level geographical region initiation stage day earlier high SI level SI 80 start response associated 044 standard error 008 P 0001 R 2 = 065 day earlier peak number daily new case Also day earlier high SI level date first reported case associated 065 standard error 008 P 0001 R 2 = 042 day earlier peak number daily new case CONCLUSIONS Early start highlevel response COVID19 associated early arrival peak number daily new case may help reduce delay flattening epidemic curve low spread level,covid-19;multivariable linear regression models;response;stringency index
Pairing fact imagined consequence improves pandemicrelated risk perception,34341120,COVID19 pandemic reached staggering new peak global resurgence year crisis began Although public health guideline initially helped slow spread disease widespread pandemic fatigue prolonged harm financial stability mental wellbeing contributed resurgence late stage pandemic became clear new intervention needed support longterm behavior change examined subjective perceived risk COVID19 relationship perceived risk engagement risky behavior study 1 n = 303 found subjective perceived risk likely inaccurate predicted compliance public health guideline study 2 n = 735 developed multifaceted intervention designed realign perceived risk actual risk Participants completed episodic simulation task expected imagining COVIDrelated scenario would increase salience risk information enhance behavior change Immediately following episodic simulation participant completed risk estimation task individualized feedback local viral prevalence found information prediction error measure surprise drove beneficial change perceived risk willingness engage risky activity Imagining COVIDrelated scenario beforehand enhanced effect prediction error learning Importantly intervention produced lasting effect persisted 1 3wk delay Overall describe fast feasible online intervention effectively changed belief intention risky behavior,covid-19;cognition;intervention;psychology;risk
Case COVID19 Pregnancy Complicated Hydrops Fetalis Intrauterine Death,34203545,Coronavirus disease 2019 COVID19 rapidly evolved worldwide pandemic causing serious global public health problem risk vertical transmission SARSCoV2 still debated consequence virus pregnant woman fetus remain unknown report case pregnancy complicated hydrops fetalis developed 7 week recovery mild SARSCoV2 infection leading intrauterine death foetus Evidence SARSCoV2 placentitis demonstrated presence viral particle placenta identified immunohistochemistry excluded possible etiological factor nonimmunologic hydrops fetalis believe fetal consequence case related vertical transmission SARSCoV2 virus best knowledge second reported case literature COVID19 infection complicated hydrops fetalis intrauterine fetal demise,covid-19;sars-cov-2;coronavirus;fetal death;hydrops fetalis;placenta;pregnancy;vertical transmission
Antiviral Effect Chemical Compounds Targeting DEDEDh Motifs Viral Proteins Lymphocytic Choriomeningitis Virus SARSCoV2,34202565,Arenaviruses coronaviruses include several human pathogenic virus Lassa virus Lymphocytic choriomeningitis virus LCMV SARSCoV MERSCoV SARSCoV2 Although virus belong different virus family posse common motif DEDEDh motif known exonuclease ExoN motif study proofofconcept study DEDEDh motif viral protein NP arenavirus nsp14 coronaviruses could drug target performed Docking simulation study two structurally different chemical compound ATA PV6R DEDEDh motif viral protein indicated compound target DEDEDh motif concentration exhibited modest cell toxicity used compound treat LCMV SARSCoV2 infection two different cell line A549 Vero 76 cell ATA PV6R inhibited postentry step LCMV SARSCoV2 infection study strongly suggest DEDEDh motif viral protein could drug target combat two distinct viral family arenavirus coronaviruses,ded/edh motif;lymphocytic choriomeningitis virus (lcmv);sars-cov-2;antivirals;exonuclease (exon) motif
COVID19 Becoming 911 Moment Borders Health,34228523,COVID19 pandemic dramatic impact crossborder movement people government begin reopen border cautiously restart travel attention shifting border procedure could facilitate travel protecting homeland traveler may infected first time recent memory border management rethought pressure large external force article examines parallel current situation early 2000s September 11 2001 attack US target caused seismic shift managing border find echo today s response initial fragmentation chaos two decade ago eventually gave way coordinated international system also analyze implication emerging border health infrastructure migration challengesparticularly addressing irregular crossing border `` crisis create aftershock pandemic aspect people move could felt decade immigration mobility management public health priority must considered alongside one another,
Evidencing Influence COVID19 Pandemic Imposed Lockdown Measures Fitness Status Adolescents Preliminary Report,34198858,established COVID19 pandemic resulted decreased physical activity level potentially leading reduced physical fitness aim research investigate impact COVID19 lockdown fitness index adolescent observed high school adolescent 33 girl aged 1517 year divided two cohort first cohort control n = 48 included adolescent school 20182019 year second cohort lockdown n = 66 observed school year 20192020 COVID19 lockdown measure imposed Variables included body height body mass BMI situp 600 dash cohort tested beginning end observed school year factorial analysis variance repeated measurement evidenced improvement situp 600 dash control decrease capacity lockdown cohort lockdown cohort decrease muscular fitness evident boy girl differential change cohort evidenced anthropometrics Results suggest COVID19 lockdown negatively influenced muscular fitness status adolescent especially boy,education;exercise;health fitness;pandemic;physical capacities;youth
Antiviral Activity Two Marine Carotenoids SARSCoV2 Virus Entry Silico Vitro,34204256,marine carotenoid fucoxanthin siphonaxanthin powerful antioxidant attracting focused attention identify variety health benefit industry application study binding energy carotenoid SARSCoV2 Spikeglycoprotein predicted molecular docking simulation inhibitory activity confirmed SARSCoV2 pseudovirus HEK293 cell overexpressing angiotensinconverting enzyme 2 ACE2 Siphonaxanthin Codium fragile showed significant antiviral activity IC50 874 muM SARSCoV2 pseudovirus entry fucoxanthin Undaria pinnatifida sporophyll acute toxicity predicted relatively low pharmacokinetic prediction indicate GI absorption Although study needed elucidate inhibition viral infection siphonaxanthin result provide useful information application marine carotenoid treatment prevention COVID19,covid-19;antiviral activity;carotenoid;fucoxanthin;molecular docking;seaweed;siphonaxanthin
Factors influencing willingness primary care physician provide care coronavirus disease pandemic nationwide survey Taiwan,34210735,OBJECTIVES COVID19 pandemic continues advance worldwide tremendous impact public health economy society Primary healthcare crucial every country pandemic integrated coordinated healthcare delivery system hence paramount importance maintain sufficient frontline workforce study aimed identify factor influencing willingness primary care physician provide care COVID19 pandemic DESIGN Cross sectional study SETTING Nationwide survey PARTICIPANTS Primary care physician working community Taiwan selected using cluster sampling method based practice region May June 2020 OUTCOME MEASURES willingness primary care physician provide care COVID19 pandemic RESULTS study surveyed 1000 primary care physician nationwide 625 valid questionnaire received included final analysis effective response rate 625 Factors significantly associated physician willingness provide care COVID19 joining Community Healthcare Group CHCG p 0001 perceived overall benefit providing care p 0001 perceived le overall barrier providing care p 0001 higher knowledge score COVID19 p=0049 physician s major specialty p=0009 multivariate logistic regression model CONCLUSIONS Building comprehensive primary care system Taiwan s CHCG training family physician general practitioner protecting supporting primary care physician important response infectious disease pandemic finding study inform development guideline support maintain primary healthcare workforce COVID19 pandemic future event,covid-19;primary care;public health
Targeting SARSCoV2Platelet Interactions COVID19 VaccineRelated Thrombosis,34290613,clear COVID19 pneumonia associated coagulopathy multiorgan failure use anticoagulants reduce incidence pulmonary embolus help survival suggests coagulopathy likely plateletdriven rather thrombindriven significant evidence suggest SARSCoV2 virion directly interact platelet trigger activation leading thrombocytopenia thrombosis propose model multiple interaction SARSCoV2 platelet many similarity Staphylococcus aureus Dengue virus platelet activation thrombosis major factor poor prognosis therapeutic target plateletSARSCoV2 interaction potential treating COVID19 virus infection,fcgamma receptor iia;sars-cov-2;bacteria;immunothrombosis;platelets;sepsis;vaccine thrombosis;virus
Evidence Respiratory Infection Transmission Within Physician Offices Could Inform Outpatient Infection Control,34339241,Early COVID19 pandemic outpatient clinic throughout US shifted toward virtual care limit viral transmission office However health care facility reopened evidence risk acquiring respiratory viral infection medical office setting remains limited inform policy reopening outpatient care setting analyzed rate potential airborne disease transmission medical office setting focusing influenzalike illness quantified whether exposed patient seen medical office patient influenzalike illness likely return similar illness next two week compared nonexposed patient seen earlier day Patients exposed influenzalike illness medical office setting likely nonexposed patient revisit similar illness within two week adjusted absolute difference 07 per 1000 patient Similar pattern observed exposure urinary tract infection back pain noncontagious control condition result highlight potential threat reopening outpatient clinic pandemic value virtual visit patient suspected respiratory infection,
Progress pitfall year drug repurposing screen COVID19,34218010,Near end 2019 new betacoronavirus started efficiently transmit human resulting current COVID19 pandemic Unprecedented worldwide effort made identify repurpose antiviral therapeutic collection approved drug known bioactive compound Typical pitfall approach promiscuouscytotoxic compound leading false positive combined bypassing antiviral drug development parameter due urgency resulted often disappointing outcome flood publication pressreleases medium post created confusion general public sometime mobilized precious resource clinical trial minimal prospect success Breakthroughs made laboratory clinic resulting empiric identification mitigators clinical sign discovery improved disease management immunomodulators opinion piece aim capture lesson believe COVID19 pandemic taught drug repurposing screen,
Evolutionary Tracking SARSCoV2 Genetic Variants Highlights Intricate Balance Stabilizing Destabilizing Mutations,34281387,currently ongoing COVID19 pandemic caused SARSCoV2 accounted million infection death across globe Genome sequence SARSCoV2 published daily public database availability genome data set allowed unprecedented access mutational pattern SARSCoV2 evolution made use genomic information conducting phylogenetic analysis identifying lineagespecific mutation catalogued lineagedefining mutation analyzed stabilizing destabilizing impact viral protein recorded persistence D614G S477N A222V V1176F variant global expansion PANGOLIN variant B1 addition retention Q57H B1X R203KG204R B11X T85I B12B13 G15S+T428I CX I120F DX variation observed Overall recorded striking balance stabilizing destabilizing mutation therefore leading wellmaintained protein structure selection pressure form newly developed vaccine therapeutic mount coming month task mapping viral mutation recording impact key viral protein crucial preemptively catch escape mechanism SARSCoV2 may evolve IMPORTANCE Since initial isolation Wuhan China large number SARSCoV2 genome sequence shared publicly accessible repository thus enabling scientist detailed evolutionary analysis investigated evolutionarily associated mutational diversity overlaid major phylogenetic lineage circulating globally using 513 representative genome detailed phylogenetic persistence key variant facilitating global expansion PANGOLIN variant B1 including recent fastexpanding B117 lineage stabilizing destabilizing impact catalogued lineagedefining mutation viral protein indicates possible involvement balancing protein function structure clear understanding mutational profile high clinical significance catch vaccine escape mechanism protein make crucial component vaccine recently approved development vein study provides imperative framework baseline data upon analysis could built newer variant SARSCoV2 continue appear,sars-cov-2;evolution;mutation;stability;vaccine
COVID19 oncological disease,34362259,BACKGROUND Coronavirus disease 2019 COVID19 respiratory tract infection caused severe acute respiratory syndrome coronavirus named SARSCoV2 initially emerged China late 2019 rapid global spread novel virus led World Health Organization declare pandemic gt 30000000 confirmed case 946000 death gt 21000000 recovery reported 18 September 2020 according Johns Hopkins Coronavirus Resource Center Initial report Asia suggested elderly patient multiple comorbidities specifically diabetes hypertension obesity increased risk developing severe COVID19 following SARSCoV2 infection data risk evolved evidence increasingly shown patient cancer indeed particularly vulnerable group However effect various confounding factor including older average patient population often underlying comorbidities including suppressed immune system and 8202 hypercoagulable state difficult separate effect cancer Common presenting symptom SARSCoV2 including dyspnoea cough fever fatigue dysgeusia le commonly diarrhoea and 8202 hyperinflammatory syndrome equally confusing clinician common symptom cancer toxicity anticancer therapy Furthermore radiographic dilemma distinguishing immunecheckpoint inhibitorinduced pneumonitis caused SARSCoV2 infection conflicting data effect certain therapy patient outcome left clinician considerable angst help patient acute worsening symptom optimal way Predicted increase mortality follows delay discovery progress resulting temporary closing research laboratory cancer center also diversion resource patient care temporary suspension clinical trial enrolment company local institution possibility travelling specialized medical center whose activity essential delivery improvement patient care reduced Viral mutation might also occur transmission spread lead statement SARSCoV2 forever remain looming threat oncological community crucial remember cancer pandemic gt 18000000 people diagnosed worldwide every year Many society including European Society Medical Oncology American Society Clinical Oncology providing clinical recommendation management patient cancer challenging time recognizing continuation precise treatment patient critical role physician PURPOSE aim presentation point contact overlapping area mentioned disease entity purpose possible simplification diagnostic therapeutic management cancer patient suspected already proven COVID19 disease,covid-19;crp;white blood cells;cancer;coagulation;fever;recommendation
Liver injury COVID19 patient metabolic syndromea narrative review,34353107,OBJECTIVE comprehensively analyze liver injury patient metabolic syndrome affected coronavirus disease 2019 COVID19 provide clinical reference prevention treatment BACKGROUND current COVID19 pandemic pose major threat human life health Metabolic syndrome also major global health problem evidence suggests patient metabolic syndrome increased risk COVID19 complication Liver injury one main manifestation extrapulmonary organ injury patient COVID19 Currently effect metabolic syndrome liver injury patient COVID19 unclear METHODS study searched PubMed Embase China National Knowledge Infrastructure CNKI database article latest development liver injury COVID19 patient metabolic syndrome 2019 comprehensively analyze current knowledge liver injury patient metabolic syndrome affected COVID19 used free key word `` metabolic syndrome `` hypertension `` obesity `` diabetes `` dyslipidemia `` liver injury `` SARSCoV2 `` COVID19 field imposed language restriction CONCLUSIONS COVID19 metabolic syndrome component closely related liver injury may induce liver injury direct indirect mechanism Therefore COVID19 combined metabolic syndrome may increase risk liver injury ruled two disease superimposed effect liver injury,metabolic syndrome;coronavirus disease 2019 (covid-19);liver injury
Infectious Respiratory Diseases Decreased COVID19 Pandemic South Korea,34205018,Infectious respiratory disease highly contagious common thus considered one leading cause morbidity mortality worldwide followed incidence rate IRs eight infectious respiratory disease including chickenpox measles pertussis mumps invasive pneumococcal disease scarlet fever rubella meningococcal disease COVID19 mitigation measure implemented South Korea compared IRs corresponding period previous 3 year Overall IRs disease age sexstandardization significantly decreased intervention period compared preintervention period p 005 eight disease However difference IRs eight disease IRs agestandardization significant p 005 period significant regard sexstandardization incidence rate ratio eight disease preintervention period compared intervention period ranged 31 41 result showed positive effect mitigation measure preventing development respiratory infectious disease regardless age sex need consider agestructure population calculate effect size future measure could applied nationwide prevent occurrence reduce transmission outbreak infection study provides evidence strengthening infectious disease management policy South Korea,covid-19;incidence rate;incidence rate ratio;infectious respiratory disease;mitigation measures
Gut Dysbiosis IL21 Response Patients Severe COVID19,34199203,BACKGROUND disease severity ranging asymptomatic acute illness associated inflammatory response suggested alteration gut microbiota may play crucial role development chronic disorder due COVID19 infection study describes gut microbiota dysbiosis COVID19 patient implication relating disease DESIGN cross sectional prospective study performed thirty RTPCRconfirmed COVID19 patient admitted India Institute Medical Sciences Bhopal India September 10 20 2020 Ten healthy volunteer recruited control group IFN TNF IL21 profiling conducted using plasma sample gut bacterial analysis performed obtaining metagenomics data stool sample RESULTS Patients variable COVID19 severity showed distinct gut microflora peripheral interleukin21 level low FirmicuteBacteroidetes ratio caused depletion fibreutilizing bacteria F prausnitzii B Plebius Prevotella increase Bacteroidetes associated gut microbiota dysbiosis COVID19 disease severity CONCLUSIONS loss functional attribute signature commensal gut due dysbiosis predisposing factor COVID19 pathophysiology,covid-19;il-21;brain-gut interaction;dietary fibre;gut microbiome;mucosal immunity
Viral infection urology,34228144,INTRODUCTION COVID coronavirus disease 2019 pandemic shown impressively infectious disease enormous impact healthcare system beyond specialty urology patient present daily practice viral infection associated numerous disease METHODOLOGY aim review describe viral infection relevant urology particular emphasize vaccination prevention selective literature search carried subject `` COVID urology `` urogenital viral infection `` viral urological infection transplant medicine `` vaccination prevention viral disease RESULTS Coronaviruses already caused two local epidemic SARS severe acute respiratory syndrome epidemic MERS Middle East respiratory syndrome epidemic fact SARSCoV2 SARS coronavirus 2 disease contagious even without symptom essentially led rapid spread global pandemic large number virus also induce viremia detected ejaculate thus associated possible urogenital infection include mumps virus Coxsackie virus enterovirus among others also shown Zika virus infection also sexually transmitted via sperm carrier Viruses therefore also play important role reproduction performing kidney transplant urologist often confronted viral infection effective weapon virus prevention vaccination CONCLUSION term ethiopathogenesis genitourinary tract often affected virus context viremia reactivation due immunosuppression Immunomodulation vaccination prophylaxis play leading role therapy,covid-19;sars-cov2;transplantation;urogenital infections;vaccination
Targeting TLR4 Signaling Blunt ViralMediated Acute Lung Injury,34282358,Respiratory viral infection longstanding global burden ranging seasonal recurrence unexpected pandemic yearly hospitalization seasonal virus influenza fluctuate greatly depending circulating strain congruency predicted strain used yearly vaccine formulation often predicted accurately antiviral agent available influenza efficacy limited due temporal disconnect time infection symptom development viral resistance Uncontrolled influenza infection lead severe inflammatory response initiated pathogenassociated molecular pattern PAMPs hostderived dangerassociated molecular pattern DAMPs ultimately signal pattern recognition receptor PRRs Overall pathogenhost interaction result local cytokine storm leading acute lung injury ALI severe acute respiratory distress syndrome ARDS concomitant systemic involvement severe life threatening consequence addition traditional antiviral treatment blocking host s innate immune response may provide viable approach combat infectious pathogen SARSCoV2 pandemic illustrates critical need novel treatment counteract ALI ARDS caused death million worldwide review examine antagonizing TLR4 signaling effective experimentally ameliorating ALI lethal infection challenge model triggered influenza also ALIinducing virus,ali;hmgb1;tlr4;influenza;viruses
First Report Fusarium asiaticum Causing Stem Rot Ligusticum chuanxiong China,34213965,Ligusticum chuanxiong known Chuanxiong China traditional ediblemedicinal herb playing important role fighting COVID19 et al 2020 March 2021 investigated stem rot Chuanxiong six adjacent field 100 ha Chengdu Sichuan Province China disease incidence 5 field Symptomatic plant showed stem rot watersoaked lesion blackening white hypha present stem Twelve symptomatic Chuanxiong plant 2 plantsfield sampled Diseased tissue margin necrotic lesion surface sterilized 75 ethanol 45 2 NaClO 5 min Samples rinsed three time sterile distilled water cultured potato dextrose agar PDA 25 masculineC 72 h Fourteen fungal culture isolated 18 diseased tissue eight monosporic isolates showed uniform characteristic eight fungal isolates showed fluffy white aerial mycelium produced yellow pigment age Mung bean broth used induce sporulation Macroconidia sickleshaped slender 3 5septate averaged 50 70 mum length Based morphological feature colony conidium isolates tentatively identified Fusarium spp Leslie Summerell 2006 identify specie partial translation elongation factor 1 alpha TEF1alpha gene amplified sequenced ODonnell et al 1998 TEF1alpha sequence LCSR01 LCSR02 LCSR05 isolates GenBank no MZ169386 MZ169388 MZ169387 100 9972 9986 identical F asiaticum strain NRRL 26156 respectively phylogenetic tree based TEF1alpha sequence showed isolates clustered F asiaticum using NeighborJoining algorithm Furthermore isolates identified using specific primer pair Fg16 FR Nicholson et al 1998 result showed isolates GenBank no MZ164938 MZ164939 MZ164940 100 identical F asiaticum NRRL 26156 Pathogenicity test isolate LCSR01 conducted Chuanxiong wounding Chuanxiong stalk rhizome sterile needle wound inoculated mycelium PDA plug total 30 Chuanxiong rhizome stalk inoculated mycelium PDA plug five mockinoculated Chuanxiong rhizome stalk served control inoculation stalk rhizome kept moist chamber 25 degree C dark 8 day post inoculation dpi inoculated stalk rhizome exhibited watersoaked blackened lesion 10 dpi stalk turned soft decayed abundant hypha grew exterior infected plant similar observed field disease symptom observed control plant pathogen reisolated inoculated tissue identity confirmed described Ten fungal culture reisolated 10 inoculated tissue nine fungal culture F asiaticum fulfilling Koch s postulate knowledge first report F asiaticum causing stem rot Chuanxiong China Chuanxiong cultivated rotation rice multiple year rotation may played role increase inoculum density soil stem rot epidemic Chuanxiong Diseased Chuanxiong may contaminated mycotoxin produced F asciaticum 3acetyldeoxynivalenol nivalenol may deleteriously affect human health Therefore crop rotation considered carefully reduce disease impact,<italic>fusarium asiaticum</italic>;<italic>ligusticum chuanxiong</italic>;stem rot
Artificial intelligence prediction COVID19 progression using CT imaging clinical data,34223954,OBJECTIVES Early recognition coronavirus disease 2019 COVID19 severity guide patient management However challenging predict COVID19 patient progress critical illness study aimed develop artificial intelligence system predict future deterioration critical illness COVID19 patient METHODS artificial intelligence AI system timetoevent analysis framework developed integrate chest CT clinical data risk prediction future deterioration critical illness patient COVID19 RESULTS multiinstitutional international cohort 1051 patient RTPCR confirmed COVID19 chest CT included study 282 patient developed critical illness defined requiring ICU admission andor mechanical ventilation andor reaching death hospital stay AI system achieved Cindex 080 predicting individual COVID19 patient critical illness AI system successfully stratified patient highrisk lowrisk group distinct progression risk p 00001 CONCLUSIONS Using CT imaging clinical data AI system successfully predicted time critical illness individual patient identified patient high risk AI potential accurately triage patient facilitate personalized treatment KEY POINT AI system predict time critical illness patient COVID19 using CT imaging clinical data,coronavirus infections;deep learning;disease progression;helical ct
Neurological manifestation patient symptomatic COVID19 admitted Bafoussam Regional Hospital Cameroon,34285749,Introduction although main manifestation COVID19 respiratory several neurological symptom complication also reported pandemic seems epidemiological specificity subSaharan Africa may reflected type frequency neurological symptom study aimed report neurological manifestation associated symptomatic COVID19 subSaharan African setting Methods conducted retrospective review symptomatic PCRconfirmed COVID19 case admitted Bafoussam Regional Hospital March September 2020 Patients file reviewed discharge consultant neurologist Sociodemographic characteristic comorbidities symptom admission neurological symptom hospitalization management inhospital outcome recorded Comparisons patient without neurological symptom performed using Fisher s exact MannWhitney U test Results enrolled 177 symptomatic patient 68 men Mean age 546 + 178 year range 299 year Comorbidities present 576 patient including hypertension 271 diabetes mellitus 254 Neurological symptom found 113 638 patient frequent headache 390 myalgia 356 anosmia 119 impaired consciousness 107 delirium 56 Regarding presenting symptom fever frequent patient neurological symptom without 814 versus 500 p 0001 digestive symptom le frequent patient neurological symptom 09 versus 94 p= 0004 Conclusion neurological manifestation frequent heterogeneous patient symptomatic COVID19 study needed clarify pathophysiology neurological symptom COVID19 impact patient longterm outcome,africa;covid-19;coronavirus;anosmia;headache
Inhospital mortality SARSCoV2 stratified hemoglobin level retrospective study,34226901,study estimate inhospital mortality severe acute respiratory syndrome coronavirus 2 SARSCoV2 patient stratified hemoglobin Hb level Patients stratified according hemoglobin level two group Hb 100 gL Hb 100 gL total 6931 patient included 6377 92 patient hemoglobin level 100 gL mean age 44 + 17 year 66 patient male median length overall hospital stay 13 day 2 31 remaining 554 8 patient hemoglobin level 100 gL Overall mortality 176 patient 254 significantly higher group hemoglobin level 100 gL 124 224 group hemoglobin level 100 gL 52 082 Risk factor associated increased mortality determined multivariate analysis KaplanMeier survival analysis showed hemoglobin predictor mortality Cox proportional hazard regression coefficient hemoglobin HB = 100 category hemoglobin significant B = 279 SE = 017 HR = 1634 p 0001 Multivariate logistic regression showed Hb 100 gL higher cumulative allcause inhospital mortality 224 vs 08 adjusted odds ratio aOR 033 95 CI 020055 p 0001 study hemoglobin level 100 gL found independent predictor inhospital mortality,covid-19;sars-cov-2;anemia;hemoglobin;in-hospital mortality
Effects Abeta142 Binding SARSCoV2 Spike Protein S1 Subunit AngiotensinConverting Enzyme 2,34360989,Increasing evidence suggests elderly people dementia vulnerable development severe coronavirus disease 2019 COVID19 Alzheimer s disease AD major form dementia betaamyloid Abeta level blood increased however impact elevated Abeta level progression COVID19 remains largely unknown finding demonstrate Abeta142 Abeta140 bound various viral protein preferentially high affinity spike protein S1 subunit S1 severe acute respiratory syndrome coronavirus 2 SARSCoV2 viral receptor angiotensinconverting enzyme 2 ACE2 binding mainly Cterminal residue Abeta142 Furthermore Abeta142 strengthened binding S1 SARSCoV2 ACE2 increased viral entry production IL6 SARSCoV2 pseudovirus infection model Intriguingly data surrogate mouse model intravenous inoculation Abeta142 show clearance Abeta142 blood dampened presence extracellular domain spike protein trimer SARSCoV2 whose effect prevented novel antiAbeta antibody conclusion finding suggest binding Abeta142 S1 SARSCoV2 ACE2 may negative impact course severity SARSCoV2 infection investigation warranted elucidate underlying mechanism examine whether reducing level Abeta142 blood beneficial fight COVID19 AD,ace2;alzheimer's disease;abeta;covid-19;sars-cov-2 spike protein
Search NonProtein Protease Inhibitors Constituted Indole Acetylene Core,34201422,possible inhibitor protease contains indole core aromatic polar acetylene designed synthesized indole derivative molecular architecture kindred biologically relevant specie obtained five synthetic step overall yield 37 22 phenylazanediyl di ethan1ol indole derivative evaluated docking assay using main protease SARSCoV2M pro molecular target play key role replication process virus Additionally indole derivative evaluated inhibitor enzyme kallikrein 5 KLK5 serine protease considered anticancer drug target,klk5 protease;sars-cov-2-mpro;docking studies;indole derivatives;inhibitor of proteases;studies in silico;synthesis
Current issue treatment rehabilitation patient neurological disorder consequence COVID19 Resolution Advisory Board,34283545,Last year global medical community faced pandemic new coronavirus infection caused SARSCoV2 date considerable expert experience indicates brain along corresponding respiratory system target organ new coronavirus infection Moreover number symptom central peripheral nervous system persist several week month even ten month designate protracted clinical condition new definition introduced PostCOVID19 Condition Advisory Board Neurologists Rehabilitation Therapists met discus practical experience taking account scientific information COVID19 available time meeting develop unified approach management patient neurological complication consequence new coronavirus infection Advisory Board worked resolution formulated tactic managing patient neurological manifestation COVID19 substantiation importance expediency development implementation special program clinical examination patient undergone COVID19 would include clinical examination detailed assessment cognitive function early identification diagnosis neurodegeneration subsequent therapy given,covid-19;covid-19 associated stroke;long covid;post covid-19 cognitive disorders;post- covid-19 condition;medical rehabilitation;neurodegenerative diseases;neurometabolic
Multidrug Resistence Prevalence COVID Area,34201519,Coronavirus disease 2019 COVID19 caused SARSCoV2 often complicated severe acute respiratory syndrome new coronavirus outbreak started China December 2019 rapidly spread around world high diffusibility virus reason outbreak pandemic viral disease reaching 100 million infected people globally first three month 2021 various treatment used use antimicrobial drug management especially bacterial coinfections frequent patient admitted intensive care addition critically ill patient SARSCoV2 infection subjected prolonged mechanical ventilation therapeutic procedure often responsible developing hospital coinfections due multidrugresistant bacteria Coinfections contribute increase morbiditymortality viral respiratory infection performed study review recent article published antibiotic bacterial resistance virus predict risk factor coronavirus disease 2019 ass multidrug resistance patient hospitalized COVID19 area,covid-19;clinical characteristics;multidrug-resistant;risk factors
Compliance child removable functional appliance microchip integrated covid19 pandemic systematic review,34281334,Treatments removable appliance widely used Europe correct dentoskeletal dysgnatia growth phase period poor cooperation patient Adherence weartime prescription often achieved represent main argument use removable device Suspected noncompliant behavior wear time prescription often subject medicolegal dispute deteriorate doctorpatient relationship use microchip allows document objectively clarify patient s behavior conduct systematic review orthodontic literature identify factor associated compliance orthodontic treatment conduct systematic review aimed identity factor associate compliance orthodontic treatment main purpose ass objective level time use removable appliance selfreported level literature search conducted electronic database PubMed Cochrane Library following search term used compliance functional removable orthodontic appliance Randomized nonrandomized controlled trial prospective cohort study case series qualitative mixedmethods study objectively assessing compliance level included study total 94 article identified PubMed 14 article Cochrane paper selected included qualitative analysis categorized according subject age clinical appliance compliance factor wear time monitoring Removable appliance important part orthodontic treatment used growth phase patient Collaboration removable functional device determines success failure treatment,covid-19;sars-cov-2;theramon(r) system;compliance;functional removable appliances
Relative synonymous codon usage ORF1ab SARSCoV2 SARSCoV,34228320,BACKGROUND COVID19 novel coronavirus disease caused new coronavirus SARSCoV2 spread world brings harm human many country Humans suffered lot SARSCoV2 SARSCoV year 2003 important understand difference relationship two type virus OBJECTIVE compare relative synonymous codon usage ORF1ab gene SARSCoV2 SARSCoV relative synonymous codon usage genome studied paper bioinformatics perspective METHODS ORF1ab gene important nonstructural polyprotein coding gene used nucleic acid detection marker many measurement method SARSCoV2 30 strain SARSCoV 20 strain considered research object present paper relative synonymous codon usage value ORF1ab gene calculated characterize difference evolutionary characteristic among 50 strain RESULTS significant difference SARSCoV SARSCoV2 relative synonymous codon usage value ORF1ab gene concerned result suggest codon usage pattern SARSCoV similar human SARSCoV2 inner difference SARSCoV2 strain larger SARSCoV denote larger diversity exit SARSCoV2 virus CONCLUSION result show relative synonymous codon usage value coronavirus could used research evolutionary phenomenon,covid-19;codon usage pattern;coronavirus;gene evolution;relative synonymous codon usage;sars-cov;sars-cov-2
Antiviral Activity Metabolites Peruvian Plants SARSCoV2 Silico Approach,34202092,1 Background COVID19 pandemic lack treatment reason search potential compound therapeutic target still necessary Bioinformatics tool allowed rapid silico screening possible new metabolite candidate natural resource repurposing known one Thus work aimed select phytochemical candidate Peruvian plant antiviral potential three therapeutical target SARSCoV2 2 Methods applied silico technics virtual screening molecular docking molecular dynamic simulation MMGBSA estimation 3 Results Rutin compound present Peruvian native plant showed affinity three target SARSCoV2 molecular dynamic simulation demonstrated high stability receptorligand system time simulation result showed MproRutin system exhibited higher binding free energy PLproRutin NRutin system MMGBSA analysis 4 Conclusions study provides insight natural metabolite Peruvian plant therapeutical potential found Rutin potential candidate multiple pharmacological property SARSCoV2,bioinformatics;peru;rutin;sars-cov-2;drug discovery;in silico;natural products
Integration human factorsergonomics healthcare system giant leap safety key strategy Covid19,34220185,article present model integrating Human FactorsErgonomics HFE healthcare system make robust resilient believe increase impact HFE Covid19 pandemic integration carried simultaneously level micro meso macro healthcare system new model recognizes interrelationship HFE system characteristic capacity coverage robustness integrity resilience hope model serve reference giant leap design improve safety effectiveness healthcare service holistic system perspective,healthcare;human factors integration;patient safety;resilience;systems ergonomics
Implementation warfarin direct oral anticoagulant conversion initiative pharmacistrun anticoagulation clinic COVID19 pandemic,34226885,Due community transmission coronavirus disease 2019 COVID19 social distancing stayathome order implemented statewide effort limit spread disease posed unique challenge patient medication requiring close continued monitoring clinic staff anticoagulation clinic Thus innovative measure implemented Cleveland Clinic Health System CCHS maintain health care ambulatory patient initiative evaluate patient warfarin direct oral anticoagulant DOAC conversion used pharmacistrun anticoagulation clinic article describes patient screened eligibility education pharmacist utilization student learner process workflow provider notification conversion Follow monitoring challenge encountered future direction also described,covid-19;doac;ambulatory care;anticoagulation;pharmacy services;warfarin
Analysis Ear Nose Throat Manifestations COVID19 Patients,34377166,Introduction Coronavirus disease 2019 COVID19 dramatically spread world crossing border country presented mainly lower respiratory tract symptom fever cough dyspnea chest tightness However COVID19 cause different upper respiratory tractrelated symptom including nasal congestion sore throat olfactory dysfunction Objective discus different ear nose throat ENT manifestation COVID19positive patient relation manifestation severity COVID19 Methods detected ENT manifestation polymerase chain reaction PCR confirmed positive COVID19 patient Zagazig Isolation Hospitals Zagazig University hospital Zagazig Chest hospital AlAhrar hospital Zagazig Fever hospital proportional allocation period April 15 June 15 2020 patient subjected full history taking COVID19 categorized 4 class severity patient underwent computed tomography CT chest Afterwards collected data analyzed compared Results Among included 120 COVID19 patient frequent reported ENT manifestation sore throat 30 nasal congestion 283 nasal obstruction 267 sneezing 266 headache 25 smell taste dysfunction 25 rhinorrhea 20 upper respiratory tract infection URTI 15 tonsil enlargement 10 common nonENT manifestation fever 883 cough 633 dyspnea 45 Conclusion Fever cough dominant symptom COVID19 ENT manifestation COVID19 common part suspected clinical criterion COVID19 particularly nasal examination nonsignificant common symptom sore throat followed nasal congestion obstruction headache lastly olfactory dysfunction,covid-19;ent;coronavirus;hyposmia;nose;otorhinolaryngology
Impact COVID19 pandemic restriction cardiorespiratory health New Zealanders,34365699,BACKGROUND OBJECTIVE COVID19 pandemic caused disruption health social interaction travel economy worldwide New Zealand government closed border nonresidents required arrival quarantine 14 day also implemented strict contactrestriction system eliminate COVID19 community measure also reduced circulation respiratory virus influenza respiratory syncytial virus assessed impact measure hospital admission respiratory cardiac disease METHODS National data hospital admission week 2020 compared admission previous 5 year Analyses curtailed week 33 COVID19 outbreak Auckland led different level pandemic restriction making national data difficult interpret RESULTS number acute infectious respiratory admission similar previous year introduction COVID19 restriction fell lower remained low pandemic restriction eased usual winter peak respiratory admission seen 2020 small reduction period strictest contact restriction noninfectious respiratory cardiac admission similar previous year usual winter peak heart failure admission observed CONCLUSION observed pattern hospital admission 2020 compatible hypothesis circulating respiratory virus drive normal seasonal trend respiratory admission contrast finding suggest respiratory virus drive winter peak heart failure,covid-19;sars cov-2;congestive heart failure;coronavirus disease;myocardial infarction;pandemic restrictions;respiratory admission;respiratory virus;winter peak
Integrated humanSARSCoV2 metabolic model present novel treatment strategy COVID19,34353886,coronavirus disease 2019 COVID19 pandemic caused new coronavirus SARSCoV2 currently responsible 3 million death 219 country across world 140 million case absence FDAapproved drug SARSCoV2 highlighted urgent need design new drug developed integrated model human cell SARSCoV2 provide insight virus pathogenic mechanism support current therapeutic strategy show biochemical reaction required growth general maintenance human cell first healthy state demonstrate entry SARSCoV2 human cell cause biochemical structural change leading change cell function cell death new computational method predicts 20 unique reaction drug target model provides platform future study viral entry inhibition immune regulation drug optimisation strategy model available BioModels http wwwebiacukbiomodelsMODEL2007210001 software tool findCPcli implement computational method available http githubcomfindCPfindCPcli,
Nutritional Impact Potential Consequences COVID19 Severity,34291074,Background late 2019 viral disease due novel coronavirus reported Wuhan China rapidly developed exploding pandemic pose severe threat human health world May 2021 insufficient treatment option management global disease shortage vaccine Important aspect help defeat coronavirus infection seems healthy strong resilient immune system Nutrition metabolic disorder obesity diabetes play crucial role community health situation general especially new pandemic seems enormous impact lifestyle metabolic disorder immune status coronavirus disease 2019 COVID19 severity recovery reason important consider impact lifestyle consumption welldefined healthy diet pandemic Aims review summarise recent finding effect nutrition COVID19 susceptibility disease severity treatment Understanding specific dietary feature might help improve public health strategy reduce rate severity COVID19,covid-19;sars-cov-2;nutrition;probiotics;proteins
Vitamin supplementation potential adjunctive therapeutic approach COVID19 biological clinical plausibility,34380185,recent pandemic severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent Coronavirus Disease 2019 COVID19 introduced human population 21st century coronavirus disease SARSCoV Middle East respiratory syndrome MERSCoV Major investigation underway worldwide search pharmaceutical intervention COVID19 many agent administered offlabel route Several case study check restrict clinical manifestation COVID19 According fact efficacy micronutrients like vitamin proven treat prevent infectious disease antimicrobial immunomodulatory activity potential role vitamin COVID19 treatment prevention must considered,covid-19;immunomodulatory functions;prophylaxis;treatment;vitamins
Molecular benchmark SARSCoV2 epidemic,34131116,pressing concern SARSCoV2 epidemic viral outbreak extent containment measure halting viral spread straightforward way ass tally active case recovered one throughout epidemic show epidemic control assessed molecular information well characterized epidemic Iceland demonstrate viral concentration decreased newly diagnosed epidemic transitioned exponential growth phase containment phase viral concentration case identified population screening decreased faster symptomatic considered high risk targeted healthcare system viral concentration persists recovering individual found half case still positive two week demonstrate accumulation mutation SARSCoV2 genome exploited track rate new viral generation throughout different phase epidemic accumulation mutation decrease transmission rate decrease containment phase Overall molecular signature SARSCoV2 infection contain valuable epidemiological information used ass effectiveness containment measure,
Hepatitis B VirusDerived Peptide Inhibit Infection Human Lung Cells SARSCoV2 Type1 InterferonDependent Manner,34202029,current COVID19 pandemic highlighted urgent need develop effective therapeutic strategy evaluated vitro antiviral effect SARSCoV2 hepatitis B virus HBV hexamer peptide Poly6 capable eliciting antiviral effect human immunodeficiency virus 1 HIV1 novel HIV1 integrase inhibitor strong anticancer immune response IFNIdependent manner novel potential adjuvant anticancer immunotherapy report Poly6 exerts antiSARSCoV2 effect estimated 50 inhibitory concentration 2617 microM human bronchial epithelial cell line Calu3 VeroE6 cell deficient type 1 interferon IFNI signaling proved via assay based mRNA profile inhibitor blocking antibody Poly6 exert antiSARSCoV2 effect IFNIdependent manner also found Poly6 inhibits IL6 production enhanced SARSCoV2 infected Calu3 cell transcription translation level mediated via IL10 induction IFNIdependent manner result indicate feasibility Poly6 IFNIinducing COVID19 drug potent antiviral antiinflammatory activity,il-6;poly6;sars-cov-2;a hepatitis b virus (hbv)-derived peptide;type i ifn (ifn-i)
impact COVID19 pregnancy Part Clinical presentation untoward outcome pregnant woman COVID19,34369462,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 coronavirus disease 2019 COVID19 pandemic disease rapidly widely disseminating world Based experience H1N1 Severe Acute Respiratory Syndrome SARS Middle East Respiratory Syndrome MERS coronavirus pandemic pregnant woman infected disproportionately likely develop severe illness need hospitalization intensive care finally die disease compared nonpregnant counterpart pregnant woman without infection Although one half pregnant woman COVID19 asymptomatic well symptom frequently mild observation present challenge regarding service provision prevention management may result overlooking risk COVID19 pregnancy predictable despite much advance critical care recent decade 2020 COVID19 pandemic pregnant woman COVID19 really higher risk progress severe illness require hospitalization need intensive care use mechanical ventilation well extracorporeal membrane oxygenation ECMO important die nonpregnant counterpart pregnant woman without COVID19 magnitude risk pregnant woman extend newborn COVID19 resultant significantly increasing perinatal neonatal morbidity mortality rate heightened risk untoward outcome pregnant woman emphasizes urgent need national international recommendation guideline optimize prevention management strategy COVID19 pregnancy Active passive prevention COVID19 approved effective strategy woman attempt pregnant pregnancy Understanding pregnant woman vulnerable population essential improve care novel urgent COVID19 pandemic current review part summarize uptodate information impact laboratoryconfirmed SARSCoV2 infection pregnant woman focus clinical presentation untoward pregnancy outcome pregnant woman infected SARSCoV2,
SARSCoV2 Infection Significance Oral Health Management Era `` New Normal COVID19,34207046,year ago coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 declared pandemic World Health Organization world approaching fourth wave period vaccine developed much shorter period thought possible initiation pertinent vaccination However oral cavity come renewed scrutiny worldwide saliva mixture salivary secretion pharyngeal secretion gingival crevicular fluid shown contain infective viral load mediating route SARSCoV2 transmission via droplet aerosol contagion also used sample viral RNA testing usefulness comparable nasopharyngeal swab oral cavity important portal ingres SARSCoV2 entryway bronchus alveolus rest lower respiratory tract causing inflammation viral infection Moreover angiotensinconverting enzyme 2 host receptor SARSCoV2 coupled protease responsible viral entry found expressed tongue oral mucosa suggesting oral cavity site virus replication propagation Furthermore possibility aspiration oral bacteria periodontal pathogen along saliva lower respiratory tract may complicating factor COVID19 chronic obstructive pulmonary disease diabetes known COVID19 comorbidities greater risk disease aggravation higher death rate comorbidities strong connection chronic periodontitis periodontal pathogen oral health management effective measure prevent comorbidities addition oral bacteria particularly periodontal pathogen could proinflammatory stimulant respiratory epithelium upon exposure aspirated bacteria Therefore may expected oral health management prevents comorbidities involved aggravating COVID19 also effect COVID19 progression review discus significance oral health management SARSCoV2 infection era `` new normal COVID19 COVID19 prevention reference hypothetical mechanism author researcher proposed,covid-19;sars-cov-2;oral bacteria;oral health;saliva
Obesity Strongly Predicts COVID19Related Major Clinical Adverse Events Coptic Clergy,34206658,BACKGROUND AIMS Coptic clergy due specific work involving interaction many people could subjected increased risk infection COVID19 aim study substudy COVID19CVD international study impact pandemic cardiovascular system ass prevalence COVID19 among Coptic priest identify predictor clinical adverse event METHODS Participants geographically divided three group GroupI Europe USA Group II Northern Egypt Group III Southern Egypt Participants demographic index cardiovascular risk factor possible source infection number liturgy infection management major adverse event MAEs comprising death mechanical ventilation assessed RESULTS 1570 clergy serving 25 diocese 255 162 infected mean age 495 + 12 year mean weekly number liturgy 344 + 10 overall prevalence rate 162 differ Egypt whole overseas p = 023 Disease prevalence higher Northern Egypt clergy compared Europe USA combined 184 vs 121 p = 003 tended higher Southern Egypt 184 vs 136 p = 009 Ten priest 392 died COVID19related complication 26 102 suffered MAE clergy Southern Egypt obese remaining risk factor le prevalent compared Europe USA p = 001 multivariate analysis obesity = 4180 2479 1215 p = 001 age = 1055 0024 1141 p = 002 systemic hypertension = 1931 1169 2004 p = 0007 predicted MAEs Obesity powerful independent predictor MAE Southern Egypt systemic hypertension Northern Egypt p 005 CONCLUSION Obesity prevalent among Coptic clergy seems powerful independent predictor major COVID19related adverse event Coptic clergy encouraged follow recommendation cardiovascular disease COVID19 prevention,covid-19;coptic clergy;major adverse events;obesity;prevalence
COVID19 Vaccine Acceptance Azuay Province Ecuador CrossSectional Online Survey,34205483,investigated COVID19 vaccination acceptance level Azuay province Ecuador online survey 12th 26th February start COVID19 vaccination campaign Ecuador Overall 1219 respondent participated survey mean age 32 + 13 year 693 participant 57 female total 1109 91 participant indicated willing vaccinated COVID19 vaccine vaccine least 95 effective 835 685 90 effective 493 405 70 effective 676 555 participant indicated feared side effect 237 194 thought vaccine effective Older age postgraduate education history negative COVID19 test high level worry contracting COVID19 believing COVID19 infection prevented vaccine understanding currently effective vaccine COVID19 associated higher vaccination acceptance vaccination education campaign needed increase knowledge Ecuadorians COVID19 vaccine increase trust vaccine People lower education level living rural area may need targeted campaign,covid-9;ecuador;hesitancy;vaccine acceptance
modelbased estimation COVID19 period prevalence undiagnosed population Canadian province,34228626,BACKGROUND development successful coronavirus disease 2019 COVID19 control strategy requires thorough understanding trend geographic demographic distribution disease burden term estimation population prevalence includes crucial process unravelling number patient remain undiagnosed OBJECTIVE study estimate period prevalence COVID19 March 1 2020 November 30 2020 proportion infected population remained undiagnosed province Quebec Ontario Alberta British Columbia Canada METHODS modelbased mathematical framework based disease progression transmission model developed estimate historical prevalence COVID19 using provinciallevel statistic reporting seroprevalence diagnosis death resulting COVID19 framework applied three different age cohort 30 3069 70+ province studied RESULTS estimate COVID19 period prevalence March 1 2020 November 30 2020 473 442 499 288 275 302 327 272 370 295 277 315 Quebec Ontario Alberta British Columbia respectively Among cohort considered study estimated total number infection ranged 2fold number diagnosis among Quebecers aged 70+ 26476 diagnosed total 53549 6fold number diagnosis among British Columbians aged 70+ 3108 diagnosed total 18147 CONCLUSIONS estimate indicated high proportion population infected March 1 November 30 2020 remained undiagnosed Knowledge COVID19 period prevalence undiagnosed population provide vital evidence policy maker consider planning COVID19 control intervention vaccination program CLINICALTRIAL,
Human immunoglobulin transchromosomic bovine hyperimmunized SARSCoV2 spike antigen efficiently neutralizes viral variant,34228597,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 variant aminoacid substitution deletion spike protein reduce effectiveness monoclonal antibody mAbs may compromise immunity induced vaccine report polyclonal fully human antiSARSCoV2 immunoglobulin produced transchromosomic bovine TchIgGSARSCoV2 hyperimmunized two dos plasmid DNA encoding SARSCoV2 Wuhan strain gene followed repeated immunization protein purified insect cell resulting TchIgGSARSCoV2 termed SAB185 efficiently neutralizes SARSCoV2 vesicular stomatitis virus VSV SARSCoV2 chimera vitro Neutralization potency retained variant including S477N E484K N501Y substitution present recent variant concern contrast ease selection escape variant mAbs convalescent human plasma unable isolate VSVSARSCoV2 mutant resistant TchIgGSARSCoV2 neutralization fully human immunoglobulin potently inhibits SARSCoV2 infection may provide effective therapeutic combat COVID19,sars-cov-2;polyclonal antibodies;transchromosomic bovines;variants
Early detection COVID19 outbreak using human mobility data,34283839,BACKGROUND Contact mixing play key role spread COVID19 Thus mobility restriction varying degree including nationwide lockdown implemented 200 country appropriately target timing location severity measure intended encourage social distancing country level essential predict outbreak occur widespread METHODS analyze aggregated anonymized health data cell phone mobility data Israel develop predictive model daily new case test positivity rate next 7 day different geographic region Israel evaluate model goodness fit using root mean squared error RMSE use prediction fivetier categorization scheme predict severity COVID19 region next week measure magnitude accuracy extent correct severity tier predicted RESULTS Models using mobility data outperformed model use mobility data reducing RMSE 173 predicting new case 102 predicting test positivity rate best set predictor new case consisted 1day lag past 7day average new case along measure internal movement within region best set predictor test positivity rate consisted 3days lag past 7day average test positivity rate along measure internal movement Using predictor RMSE 4812 case per 100000 people predicting new case 079 predicting test positivity rate predicting new case 0775 accuracy prediction within one tier 10 predicting test positivity rate 0820 accuracy within one tier 0998 CONCLUSIONS Using anonymized macrolevel data human mobility data along health data aid prediction COVID19 outbreak likely occur method provides useful tool government decision maker particularly postvaccination era focused intervention needed contain COVID19 outbreak mitigating collateral damage global restriction,
Management Mycotic Aneurysm Patient COVID19 Case Report,34198541,aim paper share experience managing patient Klebsiella pneumoniae mycotic abdominal aortic aneurysm also infected COVID19 69yearold male transferred hospital management infrarenal mycotic abdominal aortic aneurysm hospital course patient contracted severe acute respiratory syndrome coronavirus 2 SARSCoV2 intubated due respiratory distress short period mycotic aneurysm increased size 25 cm 39 cm emergency repair expanding aneurysm achieved using previously described protocol coating endovascular stent rifampin patient managed rifampincoated endovascular stent graft without major complication Postoperatively patient demonstrate neurological deficit vascular compromise remained afebrile postoperative course extubated sometime thereafter transferred ward additional monitoring prior discharge rehab hospital longterm antibiotic hospital stay monitored serial ultrasound ensure absence abscess formation aortic aneurysm growth graft endoleak 6 week stent graft placement underwent CT scan showed patent stent graft residual sac size 25 cm without evidence abscess endoleak followup period 180 day patient remained asymptomatic remaining longterm antibiotic Thus patient whose surgical risk prohibitive endovascular stent graft used bridge definitive surgical management,covid-19;klebsiella pneumoniae;sars-cov-2;endoleak;endovascular stents;follow-up studies;mycotic aneurysm;rifampin
Elucidating cause COVID19 infection related death vaccination,34284226,BACKGROUND AIMS Symptomatic asymptomatic COVID19 infection reported vaccination current article try elucidate various cause behind COVID19 infection mortality following COVID19 vaccination suggest possible strategy counteract threat METHODS carried comprehensive review literature using suitable keywords COVID19 Pandemics Vaccines Mortality deaths infections India search engine PubMed SCOPUS Google Scholar ResearchGate January May 2021 Epidemiology risk factor Adverse Events Following Immunization AEFI mortality COVID19 vaccination assessed RESULTS number factor associated symptomatic asymptomatic COVID19 infection reported vaccination high viral load comorbidities mutant strain Variants Concern VOC leading Vaccine escape casual attitude towards COVID Appropriate Behaviors appear important factor infection death COVID19 vaccination CONCLUSIONS COVID19 Infection mortality COVID19 vaccination great concern Application COVID Appropriate Behaviour CAB vaccination essential population Effective Vaccines mutant strain enhanced vaccination drive key strategy avoid quintessential threat Early medical intervention highrisk group prevent overall mortality,covid-19;mortality;pandemics;sars-cov-2;vaccine
Comprehensive Laboratory Data Analysis Predict Clinical Severity Coronavirus Disease 2019 1952 Patients Daegu Korea,34374346,Background Laboratory parameter abnormality commonly observed COVID19 patient however clinical significance remains controversial assessed prevalence characteristic clinical impact laboratory parameter COVID19 patient hospitalized Daegu Korea Methods investigated clinical laboratory parameter 1952 COVID19 patient admission nine hospital Daegu Korea average patient age 581 year 700 359 patient men patient classified mild N=1612 moderate N=294 severe N=46 disease group based clinical severity score used chisquare test multiple comparison analysis multinomial logistic regression evaluate correlation laboratory parameter disease severity Results Laboratory parameter admission three disease group significantly different term hematologic Hb Hct white blood cell count lymphocyte platelet count coagulation prothrombin time activated partial thromboplastin time biochemical albumin aspartate aminotransferase alanine aminotransferase lactate blood urea nitrogen creatinine electrolyte inflammatory Creactive protein procalcitonin cardiac creatinine kinase MB isoenzyme troponin molecular virologic Ct value SARSCoV2 RdRP gene parameter Relative lymphopenia prothrombin time prolongation hypoalbuminemia significant indicator COVID19 severity Patients hypoalbuminemia lymphopenia higher risk severe COVID19 Conclusions Laboratory parameter abnormality admission common significantly associated clinical severity serve independent predictor COVID19 severity Monitoring laboratory parameter including albumin lymphocyte count crucial timely treatment COVID19,coronavirus disease 2019;hypoalbuminemia;laboratory parameters;lymphopenia;prothrombin time;severity
Tracking interaction singlewall carbon nanotube SARSCov2 spike glycoprotein molecular dynamic simulation study,34333227,COVID19 newly discovered type coronavirus cause pandemic infection first reported Wuhan China December 2019 One critical problem regard identify innovative drug may reduce manage global health concern Nanoparticles shown pivotal role drug delivery system recent decade surface nanoparticles could covered layer composed different biomolecules eg protein macromolecule following incubation biological fluid proteinrich layer called `` Protein Corona study allatom molecular dynamic simulation used investigating monomeric B domain spike glycoprotein due role accessibility spike glycoprotein singlewall carbon nanotube SWCNTs interaction energy value carbon nanotube B domain viral spike glycoprotein evaluated obtained result based LennardJones potential demonstrated SWCNTs affinity B domain S1 subunit spike glycoprotein adsorption SWCNTs B domain surface led significant change solventaccessible surface internal hydrogen bond finally tertiary structure could provide reasonable method impede interaction angiotensinconverting enzyme II SARSCoV2 spike glycoprotein decrease mean square displacement B domain shown adsorption SWCNTs result increasing hydrophobichydrophilic property B domain arrangement SWCNTs B domain surface interaction using 2acetamido2deoxybetadglucopyranose group 988 991 992 demonstrated change affinity S1 subunit could used barrier viral replication analysis SWCNTB domain complex indicated presence SWCNTs able cause alteration S1 subunit spike protein nanotube could employed invitro invivo antiviral study Also SWCNTs able utilized drug delivery system,drug delivery;molecular dynamics simulation;single-wall carbon nanotube;spike glycoprotein
Isolated anxious qualitative exploration impact COVID19 pandemic individual living spinal cord injury UK,34292136,Objective People living spinal cord injury SCI often immunocompromised increased risk respiratory infection Given restriction response COVID19 pandemic SCI may increased risk health deterioration though experienced poorly understood study explored experience people living SCI COVID19 pandemicDesign Participants completed online survey consisting demographic question openended qualitative question pertaining experience pandemic Thematic analysis utilized analytical approachSetting Communitybased sample UKParticipants Participants recruited via social medium outlet UKbased SCIspecific support charity snowball sampling N = 42 F = 34 = 8 Results Key theme included 1 lost access health service support capturing concern surrounding barrier healthcare rehabilitation intensified secondary consequence SCI spasm pain 2 health anxiety perpetuated perceived heightened vulnerability respiratory complication 3 social isolation significantly reduced social contact even care provider compounding health experiencesConclusion People living SCI COVID19 pandemic experienced variety personal physical psychological social challenge could disrupt daily functioning quality life Increased utilization telehealth recommended support continued engagement rehabilitation foster connection community amongst others SCI health professional,covid-19;infection;isolation;pandemic;sci;thematic analysis
silico analysis RNAdependent RNA polymerase SARSCoV2 therapeutic potential existing antiviral drug,34216889,continued sustained threat SARSCoV2 virus worldwide urgently call farreaching effective therapeutic strategy treating emerging infection Accordingly study explores mode action therapeutic potential existing antiviral drug Multiple sequence alignment phylogenetic analysis indicate RNAdependent RNA polymerase RdRp SARSCoV2 mutable similar bat coronavirus RaTG13 Successive interaction RdRp nsp12 alone complex cofactor nsp78 viral RNA demonstrated binding affinity value remained site interaction RdRp highly conserved homologous sequence different organism altered presence selected antiviral drug Remdesivir Sofosbuvir antiviral drug Sofosbuvir reduced number hydrogen bond formed RdRp RNA Remdesivir bound tightly viral RNA viral RdRp alone nsp1278 hexadecameric complex resulting significant number hydrogen bond formed uracilrich region interaction nsp1278 complex RNA mediated specific interaction site nsp78 Therefore conserved nature RdRp interaction site alteration due drug intervention indicate therapeutic potential selected drug article provide additional focus interacting amino acid nsp78 complex highlight crucial region could targeted precluding correct recognition subunit involved hexadecameric assembly rationally design molecule endowed significant antiviral profile,computational biology;molecular modelling;rdrp;remdesivir;sars-cov-2;sofosbuvir
Something Personal Seeing Someone s Face Provider Perceptions Video Visits HomeBased Primary Care COVID19,34210200,rapid deployment video visit COVID19 may posed unique challenge homebased primary care HBPC practice due handson model care older adult population qualitative study examined provider perception video visit first wave COVID19 crisis New York City NYC interview HBPC clinicalmedical director program manager nurse practitionersnurse manager social work manager n = 13 six NYCarea practice Providers reported combination commercial health systemsupported consumer eg FaceTime technological platform essential Video visit benefit included triaging patient need collecting patient information increasing scheduling capacity Barriers included cognitive sensory ability technology access reliance caregiver aide addressing sensitive topic incomplete exam Effectively integrating video visit requires considering technology proactively integrated practice policy promotes platform flexibility crucial fostering video integration,covid-19;home health;homebound;primary care;telehealth;telemedicine
High excess death Sweden first wave COVID19 Policy deficiency dry tinder,34213362,AIMS first wave COVID19 pandemic Sweden registered high level excess death Nonpharmaceutical intervention adopted Sweden milder compared implemented Denmark Moreover Sweden might started pandemic large proportion vulnerable elderly high mortality risk study aimed clarify whether excess mortality Sweden explained large stock dry tinder instead attributed faulty lockdown policy METHODS analysed weekly death count Sweden Denmark July 2007 June 2020 used novel method shortterm mortality forecasting estimate expected excess death first COVID19 wave Sweden Denmark RESULTS first part epiyear 20192020 death low Sweden Denmark absence COVID19 relatively low level death would expected later part epiyear registered death however way upper bound prediction interval Sweden within range Denmark CONCLUSIONS Dry tinder account modest fraction excess Swedish mortality risk death first COVID19 wave rose significantly Swedish woman aged 85 slightly Danish woman aged 85 risk discrepancy seems likely result difference Sweden Denmark care housing elderly organised coupled le successful Swedish strategy shielding elderly,covid-19;denmark;mortality displacement;sweden;excess deaths;frail elderly;non-pharmaceutical intervention policies
Understanding physician preference telemedicine COVID19 pandemic,34227993,BACKGROUND contrast current broad dissemination telemedicine across medical specialty previous research focused effectiveness telemedicine special population behavioral health encounter demonstrating physician patient factor impact efficacious use telemedicine OBJECTIVE evaluated physician perception appropriateness telemedicine patient attending primary care practice federally qualified health center New York City METHODS Anonymous crosssectional survey including closed openended question used chisquare test whether provider certain specialty likely state would use telemedicine future used ttest compare age would vs would use telemedicine used logistic regression test whether age specialty correlated desire use telemedicine future used thematic content analysis describe reason provider felt would want use telemedicine future describe situation felt telemedicine would appropriate RESULTS 272 FHC provider sent electronic survey 159 58 responded within 2week survey time frame Mean age provider 45 year range 2875 Overall 81 stated would use telemedicine future Compared Family Medicine Internal Medicine Behavioral Health Dental OBGYN specialty provider Pediatrics MedPeds Subspecialties Surgery Protelemedicine specialty likely believe telemedicine would useful post pandemic 94 vs 72 p 005 Providers reported would use telemedicine future younger mean age 44 4246 vs 50 4655 p 001 regression analysis protelemedicine specialty age significantly associated odds reporting would use telemedicine future prospecialties 52 17162 younger age 105 101108 Providers want use telemedicine future cited concern inadequate patient care lack physical patient interaction technology issue lack necessity Providers felt telemedicine would useful cited following situation follow visit medication refill urgent care patient convenience specific condition behavioral health dermatology visit chronic care management CONCLUSIONS majority health provider resource poor setting federally qualified health center believed telemedicine would useful providing care pandemic CLINICALTRIAL,
Effectiveness ChAdOx1 nCOV19 Vaccine Experience tertiary care institute,34334893,Background first dose ChAdOx1 nCoV 19 Corona Virus Vaccine Covishield administered eligible beneficiary tertiary care institute Western Maharashtra 16 Jan 21 past three month almost 97 staff vaccinated present study analysis incidence COVID case unvaccinated vaccinated population institute Methods Covid 19 infection RTPCR positive 01 February 21 25 April 21 included study analyzed per vaccination status ass COVID 19 transmission contact Secondary Attack Rates SAR prevaccination period JunOct 20 compared present SAR Results total 113 case occurred study period 01 Feb 25 Apr 21 Lower number infection observed among fully vaccinated compared partially vaccinated nonvaccinated overall vaccine effectiveness found 886 81559237 441 455673 completely partially vaccinated individual respectively Hazard Ratios getting infected dropped significantly 28 day second dose SAR high risk contact HRCs found 425 lower SAR 206 prevaccination period Conclusion one earliest study India report impact COVID19 vaccination result indicate vaccine provides effective protection COVID19 infection However given complex dynamic vaccination role NPIs implementation COVID appropriate behavior undermined,covid-19 vaccination;immunity;secondary attack rate;vaccine effectiveness
Lean approach management patient undergoing intravitreal injection COVID19 pandemic,34212127,Background introduce Lean approach principle management patient undergoing intravitreal injection IVIs wet agerelated macular degeneration Methods Retrospective singlecentre cohort study Services location IVIs scheduling utilization staff data recording method ophthalmic examination surgical procedure analysed new Intravitreal Injection Centre IVIC developed according Lean principle Mean number daily IVIs performed mean time registration discharge mean turnover time patient percentage performed IVIs monthly scheduled IVIs patient rating experience 810 via standardized feedback questionnaire retrospectively analysed Results mean IVIs number per day increased 20 + 408 50 + 707 mean time registration discharge patient decreased 240 + 1414 60 + 816 min p = 000057 p 000001 respectively Mean turnover time patient decreased 10 + 141 8 + 2 min p = 0055 percentage monthly IVIs performed total scheduled IVIs increased 60 100 percentage satisfied patient rated IVIC 810 increased 45 95 p = 00177 p 000105 respectively Conclusion IVIC improved quality efficiency speed overall procedure clinical capacity IVI service fast oneway route patient limiting time wasted total distance travelled model facilitates creation onestop clinic justintime management principle may relevant ophthalmology service,intravitreal injection centre;lean methodology;age-related macular degeneration;anti-vegf;intravitreal injection;patient care management
Elevated Mortality Among People Experiencing Homelessness COVID19,34291120,reviewed publicly available data major US health jurisdiction compare severe acute respiratory syndrome coronavirus 2 case fatality rate people experiencing homelessness general population case fatality rate among people experiencing homelessness 13 time 95 CI 1115 general population suggesting people experiencing homelessness prioritized vaccination,covid-19;case fatality rate;homelessness;public health surveillance
Computer Game Assisted Task Specific Exercises Treatment Motor Cognitive Function Quality Life Stroke Randomized Control Study,34293643,OBJECTIVES Computer game assisted task specific exercise CGATSE rehabilitation gaming system RGS used stroke rehabilitation facilitate patient performance high intensity task based repetitive exercise aiming enhance neuroplasticity CGATSE maybe appealing option home based rehabilitation stroke patient especially COVID19 pandemic study aimed determine effect CGATSE hemiplegic armhand function cognitive function quality life stroke MATERIALS METHODS Thirty stroke patient randomized two group participant received twenty session physical therapy addition therapy group undertook thirty minute CGATSE using Rejoyce gaming system control group undertook thirty minute occupational therapy OT Motor function evaluated treatment using Fugl Meyer upper extremity FMUE Brunnstrom stage stroke recovery BSSR arm hand CGATSE group also completed Rejoyce arm hand function test RAHFT Cognitive function evaluated using mini mental state examination Montreal Cognitive Assessment MoCA Stroke Specific Quality Life SSQOL scale RESULTS FMUE BSSR arm SSQOL improved group p 005 BSSR hand improved CGATSE group p = 0024 RAHFT score improved CGATSE group p = 0008 MoCA score significantly improved control group p = 0008 CONCLUSIONS CGATSE may beneficial providing continuation care stroke especially Covid19 pandemic home based rehabilitation option becoming increasingly important Benefits CGATSE improving cognitive function le clear RGS aimed improving motor function may compared gaming system designed target cognitive development detailed higher cortical function deficit test used outcome measure,cognitive function;exercise;occupational therapy;physical therapy;stroke;stroke rehabilitation;telerehabilitation
Multisystem thromboembolism COVID19 patient case report,34211655,Hypercoagulability found patient diagnosed novel coronavirus 19 COVID19 identified major cause morbidity mortality Herein report challenge managing patient presenting 5 day history COVID19 diagnosis complicated deep venous thrombosis pulmonary embolism ischemic stroke setting atrial septal aneurysm presumed patent foramen ovale paradoxical embolism identified clot transit echocardiogram application anticoagulation felt high risk patient transferred tertiary facility patient underwent thrombus aspiration eventually complicated hemorrhagic conversion stroke,covid-19;dvt;anticoagulation;hypercoagulability;ischemic stroke;pulmonary embolism;thromboembolism
Many Faces Innate Immunity SARSCoV2 Infection,34199761,innate immune system important initial antiviral response SARSCoV2 result overactivity suppression innate immune system dysregulated immune response associated poor outcome patient significant NeutrophiltoLymphocyte ratio NLR due neutrophilia alongside lymphopenia Elevated interleukin IL 6 IL8 lead overactivity prominent feature severe COVID19 patient IL6 result lymphopenia COVID19 patient typically significantly altered lymphocyte subset IL8 attracts neutrophil may play significant role lung tissue damage formation neutrophil extracellular trap leading cytokine storm acute respiratory distress syndrome Several factor like preexisting comorbidities genetic risk viral pathogenicity therapeutic efficacy act important modifier SARSCoV2 risk disease interplay innate host inflammatory response review discus role innate immune system play important modifier SARSCoV2 infection,covid-19;sars-cov-2;cytokines;innate immunity
Lectin Pathway Mediates Complement Activation SARSCoV2 Proteins,34290717,Early persistent activation complement considered play key role pathogenesis COVID19 Complement activation product orchestrate proinflammatory environment might critical induction maintenance severe inflammatory response SARSCoV2 recruiting cell cellular immune system site infection shifting state activation towards inflammatory phenotype precedes pathophysiological milestone event like cytokine storm progressive endothelial injury triggering microangiopathy complement activation cause acute respiratory distress syndrome ARDS date application antiviral drug corticosteroid shown efficacy early stage SARSCoV2 infection failed ameliorate disease severity patient progressed severe COVID19 pathology report demonstrates lectin pathway LP recognition molecule complement system MBL FCN2 CL11 bind SARSCoV2 S Nproteins subsequent activation LPmediated C3b C4b deposition addition result confirm underline Nprotein SARSCoV2 bind directly LP effector enzyme MASP2 activates complement Inhibition LP using inhibitory monoclonal antibody MASP2 effectively block LPmediated complement activation FACS analysis using transfected HEK293 cell expressing SARSCoV2 protein confirm robust LPdependent C3b deposition cell surface inhibited MASP2 inhibitory antibody light present result encouraging performance clinical candidate MASP2 inhibitor Narsoplimab recently published clinical trial suggest targeting MASP2 provides unsurpassed window therapeutic efficacy treatment severe COVID19,covid-19;sars-cov-2;complement system;innate immunity;lectin pathway
Determinants willingness general population get vaccinated COVID19 developing country,34222130,Purpose Vaccination costefficient intervention slow spread coronavirus disease 2019 COVID19 pandemic study aim ass population s willingness take COVID19 vaccine Jordan investigate potential determinant acceptance Materials Methods study used online survey distributed November 2020 introducing vaccine item investigating sociodemographic characteristic seasonal flu vaccination history COVID19 vaccine acceptance available factor affecting decisionmaking Also `` COVID19 risk perception belief toward COVID19 vaccine benefit barrier assessed Results total 2208 participant completed survey participation rate 131 mean+standard deviation age 332+135 557 female Study participant almost equally distributed willingness unwillingness indecision take COVID19 vaccine 304 364 315 respectively Younger adult male married child bachelor higher education employee student healthcare worker reported receiving flu vaccine higher rate COVID19 vaccine acceptance compared counterpart p 0001 category COVID19 risk perception perceived vaccine benefit barrier significant predictor intention Among undecided unwilling take COVID19 vaccine safety side effect common concern Conclusion low rate COVID19 vaccine acceptance developing country alarming significant proportion indecisive Interventions elevate vaccine acceptance addressing safety efficacy targeting vulnerable group recommended,acceptance;barriers;benefits;covid-19;coronavirus;developing country;jordan;risk perception;vaccine
Barriers facilitator clinical trial participation underrepresented nonunderrepresented fibromyalgia patient crosssectional internet survey,34286136,Background need wellpowered randomized clinical trial fibromyalgia However challenge recruitment presented study aim describe ass perception barrier facilitator associated factor participation underrepresented nonunderrepresented fibromyalgia patient Methods performed online survey REDCap Research Electronic Data Capture targeting fibromyalgia patient April 7 July 3 2020 COVID19 stay home mandate restricted United States America described compared survey characteristic underrepresented nonunderrepresented participant performed logistic regression model ass associated factor clinical trial participation Results total 481 completed survey including 168 underrepresented fibromyalgia patient 1 1109 reported previous participation clinical trial significant perceived barrier investigatorrelated lack friendliness research staff opportunity receive result centerrelated privacy confidentiality policy institution s reputation 2 participation rate perceived barrier facilitator similar underrepresented nonunderrepresented patient positively associated low income higher age clinical trial awareness physician negatively associated perception investigatorrelated barrier 4 underrepresented population presence emotional support Conclusion finding suggest low rate participation regardless underrepresented population status Strategies involving physician liaison increase awareness clinical trial well improving patientresearcher communication considered population,clinical trials participation;fibromyalgia;recruitment;underrepresented population
Telehealth Australian cardiology Insight factor predicting use telephone versus video COVID19 pandemic,34227713,BACKGROUND use telehealth increased dramatically Australia 2020 pragmatic response COVID19 pandemic however difference telehealth modality established AIM identify characteristic contributing choosing telephone TP versus videoconsultation VC ass patient outcome telehealth modality METHODS conducted observational study cardiology outpatient tertiary hospital appointment 17 March 2020 12 August 2020 Demographic variable appointment modality compared group Outcomes assessed mortality emergency ED presentation cross appointment modality RESULTS 1754 telemedicine encounter 1188 patient seen TP 327 patient VC Consulting volume increased previous year Cardiac mortality low 03 difference mortality ED presentation telehealth modality Patients choosing TP VC older p 0001 likely female p = 0005 nonEnglishspeaking p = 0041 living metropolitan Melbourne p 00001 undertaking first appointment p = 0002 seeing particular cardiologist p 0001 VC patient likely early review p = 0015 likely TP p 00001 TP patient likely follow person p 00001 CONCLUSION COVID19 increased consultation volume without adverse patient outcome identified factor influencing choice telemedicine modality translate difference mortality ED presentation Telemedicine growing platform important role facilitating access healthcare diverse patient group article protected copyright right reserved,covid-19;telemedicine;ambulatory care;cardiology;telehealth
SARSCoV2 seroprevalence survey among health care provider Belgian public multiplesite hospital,34372955,Although severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic lasting 1 year exposition risk healthcare provider still unclear Available evidence conflicting investigated prevalence antibody SARSCoV2 staff large public hospital multiple site Antwerp region Belgium Risk factor infection identified mean questionnaire human resource data performed hospitalwide serology test week following first epidemic wave 16 March end May 2020 combined result answer individual questionnaire Overall seroprevalence 76 found higher seroprevalences nurse 100 95 confidence interval CI 89112 physician 64 95 CI 4687 paramedical 60 95 CI 4380 administrative staff 29 95 CI 1845 Staff indicated contact confirmed coronavirus disease 2019 COVID19 colleague higher seroprevalence 120 95 CI 107134 staff 42 95 CI 3550 finding present contact private setting Working general COVID19 ward emergency department intensive care unit also significant risk factor Since analysis point direction active SARSCoV2 transmission within hospital argue implementing stringent hospitalwide testing contacttracing policy special attention health care worker employed general COVID19 department Additional study needed establish transmission dynamic,sars-cov-2;health care worker;professional category;risk factor;seroprevalence
Therapeutic Effectiveness Safety Repurposing Drugs Treatment COVID19 Position Standing 2021,34220503,COVID19 transmitted SARSCoV2 one serious pandemic situation history mankind already infected huge population across globe horrendously contagious viral outbreak first identified China within short time affected world s health transport economic academic sector Despite recent approval antiCOVID19 vaccine unavailability insufficiency along lack potential therapeutic option continuing worsen situation valuable life continuing lost situation researcher across globe focusing repurposing prospective drug prophylaxis favipiravir remdesivir chloroquine hydroxychloroquine ivermectin lopinavirritonavir azithromycin doxycycline ACEIsARBs rivaroxaban protease inhibitor preliminarily based vitro vivo pharmacological toxicological study report followed clinical application Based available preliminary data derived limited clinical trial US National Institute Health NIH USFDA also recommended drug repurposed ie hydroxychloroquine remdesivir favipiravir However World Health Organization later recommended use chloroquine hydroxychloroquine remdesivir lopinavirritonavir treatment COVID19 infection Combining basic knowledge viral pathogenesis pharmacodynamics drug molecule well silico approach many drug candidate investigated clinical trial proven partially effective COVID19 many drug currently extensive screening repurposing prospective drug candidate different stage evaluation handy wellspring COVID19 management treatment along approved antiCOVID19 vaccine review article combined information completed clinical trial case series cohort study metaanalyses retrospective study focus current status repurposing drug 2021,covid-19;doxycycline;favipiravir;hydroxychloroquine;ivermectin;remdesivir;repurposing drugs;rivaroxaban
Detection immunoglobulin response COVID19 vaccination using novel rapid fingerstick assay,34214649,Coronavirus Disease 2019 COVID19 emerged global pandemic resulting significant mortality morbidity COVID19 vaccine shown highly effective preventing COVID19 infection significantly reducing disease severity mortality report novel COVID19 antibody test assay using unique platform rapidly detect SARSCoV2 antibody drop fingerstick blood subject following COVID19 vaccination show early detection SARSCoV2 antibody post vaccination persistence detectable antibody least 6 month Rapid point care COVID19 antibody test might role assessing appearance durability immune response following COVID19 vaccination,antibody;covid-19;fingerstick;immunity;sars-cov-2;serology;test;vaccination
Pulmonary rehabilitation COVID19 living systematic review protocol,34292923,Objective living systematic review aim provide timely rigorous continuously updated summary evidence available role pulmonary rehabilitation treatment patient COVID19 Design protocol living systematic review Data source conduct search LOVE Living OVerview Evidence platform COVID19 system map PICO question repository maintained regular search electronic database preprint server trial registry resource relevant COVID19 date language restriction applied Eligibility criterion selecting study method adapted already published common protocol multiple parallel systematic review specificity question include randomized trial evaluating effect pulmonary rehabilitation monotherapy combination interventionsversus sham treatment patient COVID19 Two reviewer independently screen study eligibility extract data ass risk bias pool result using metaanalysis apply Grading Recommendations Assessment Development Evaluation GRADE system ass certainty evidence outcome Ethics dissemination ethic approval considered necessary result review widely disseminated via peerreviewed publication social network traditional medium,breathing exercises;pulmonary rehabilitation;respiratory muscle training;systematic review;covid-19
Contributions international plant science community fight infectious disease humanspart 2 Affordable drug edible plant endemic reemerging disease,34181810,fight infectious disease often focus epidemic pandemic demand urgent resource command attention health authority medium However vast majority death caused infectious disease occur endemic zone particularly developing country placing disproportionate burden underfunded health system often requiring international intervention provision vaccine biologics hampered high cost limited scalability traditional manufacturing platform based microbial animal cell also challenge caused distribution storage particularly region without complete cold chain review article consider potential molecular farming address challenge endemic reemerging disease focusing edible plant development oral drug Key recent development field include successful clinical trial based orally delivered dried leaf Artemisia annua malarial parasite strain resistant artemisinin combination therapy ability produce clinicalgrade protein drug leaf treat infectious disease longterm storage protein drug dried leaf ambient temperature Recent FDA approval first orally delivered protein drug encapsulated plant cell treat peanut allergy opened door development affordable oral drug manufactured distributed remote area without cold storage infrastructure eliminate need expensive purification step sterile delivery injection,endemic disease;molecular farming;oral delivery;plant-made pharmaceuticals;re-emerging disease
Adapting coordinated specialty care postCOVID19 era study protocol integrative mixedmethods study,34225817,BACKGROUND Coordinated Specialty Care CSC program provide evidencebased service young people recent onset psychotic disorder OnTrackNY nationally recognized model CSC treatment New York state 2019 OnTrackNY awarded hub within Early Psychosis Intervention Network EPINET advance learning health care system LHS OnTrackNY network comprised 23 CSC team across New York state OnTrack Central intermediary organization provides training implementation support OnTrackNY team OnTrack Central coordinate centralized data collection protocol quality improvement evaluation program fidelity mechanism support practice basedresearch OnTrackNY site breadth coupled OnTrack Central oversight provides opportunity examine impact COVID19 crisis New York State supplementary funding awarded OnTrackNY EPINET hub 2021 purpose METHODS project examine implication modification service delivery within OnTrackNY LHS COVID19 crisis use Framework Reporting Adaptations ModificationEnhanced FRAME classify systematically code analyze modification CSC service ascertain impact utilize integrative mixed method Qualitative interview multilevel stakeholder program participant family provider team leader agency leader trainer OnTrack Central decisionmakers state local level used understand process making decision information modification CSC service impact Analysis OnTrackNY program data facilitate examining trend team staffing functioning participant service utilization outcome Study finding summarized CSC Model Adaptation Guide identify modification fidelity consistent impact service utilization care outcome DISCUSSION CSC Model Adaptation Guide inform CSC program state local mental health authority accountable regarding modification CSC service impact change care process participant service utilization outcome guide also inform development tailored technical assistance CSC program may need within OnTrackNY EPINET network CSC program nationally TRIAL REGISTRATION NCT04021719 July 16th 2019,covid-19;coordinated specialty care;early psychosis;fidelity;first episode psychosis;framework for reporting adaptations and modification-enhanced;learning healthcare system;specialized treatment;telehealth;youth and young adults
COVID19 impact screening test volume National Breast Cervical Cancer early detection program JanuaryJune 2020 United States,34217410,Women racial ethnic minority group face disproportionate burden cervical breast cancer United States Coronavirus Disease 2019 COVID19 pandemic might exacerbate disparity supply demand screening service reduced National Breast Cervical Cancer Early Detection Program NBCCEDP provides cancer screening service woman low income inadequate health insurance examined COVID19 s impact NBCCEDP screening service JanuaryJune 2020 found total number NBCCEDPfunded breast cervical cancer screening test declined 87 84 respectively April 2020 compared previous 5year average month extent decline varied geography raceethnicity rurality April 2020 screening test volume declined severely Health Human Services Region 2 New York 96 breast 95 cervical cancer screening compared previous 5year average greatest decline among American IndianAlaskan Native woman breast cancer screening 98 Asian Pacific Islander woman cervical cancer screening 92 Test volume began recover May June 2020 NBCCEDP breast cervical cancer screening test volume 39 40 5year average month respectively However breast cancer screening remained 50 5year average among woman rural area NBCCEDP program reported assisting health care provider resume screening,breast cancer screening;covid-19;cervical cancer screening;medically underserved;public health
Modeling Impact COVID19 Vaccination Lebanon Call SpeedUp Vaccine Roll,34202107,Four month SARSCoV2 vaccination campaign 107 Lebanese population received least one dose raising serious concern speed vaccine rollout impact event future surge Using mathematical modeling assessed shortterm impact various vaccine rollout scenario SARSCoV2 epidemic course Lebanon current population immunity level estimated model 40 15 April 2021 large epidemic wave predicted social distancing restriction gradually eased variant concern introduced Reaching 80 vaccine coverage end 2021 flatten epidemic curve result 37 34 decrease peak daily number severecritical disease case death respectively reaching intermediate coverage 40 result 1011 decrease Reaching 80 vaccine coverage August would prevent twice many severecritical disease case death reached December Easing restriction longer duration resulted favorable vaccination impact conclusion vaccination impact shortterm scaleup rapid reach high coverage least 70 sustaining social distancing measure rollout current vaccination pace unlikely achieved Concerted effort need made overcome local challenge substantially scale vaccination avoid surge country multiple crisis limited healthcare capacity largely unprepared,covid-19;lebanon;sars-cov-2;coronavirus;epidemiology;mathematical model;vaccine
Challenges Maternal Child Health Services Delivery Access Pandemics Public Health Disasters Lowand MiddleIncome Countries Systematic Review,34209238,Maternal child health MCH global priority many decade essential public health service Ensuring seamless delivery vital desirable MCH outcome systematic review outlined challenge accessing continuing MCH service public health emergenciespandemics disaster comprehensive search approach built based keywords MeSH term relevant MCH service pandemicsdisasters online repository Medline CINAHL Psyc INFO Epistemonikos searched study included twenty studiesseven Ebola outbreak two Zika virus five related COVID19 five disaster one related conflict situation finding indicate potential impact emergency MCH service Low utilization access service described common challenge unavailability personal safety equipment fear infection primary factor affected service delivery available evidence though limited indicates significant effect disaster pandemic MCH However primary indepth study needed understand better overall impact emergency especially COVID19 pandemic MCH synthesis offer valuable insight policymakers ensuring uninterrupted provision MCH service emergency,covid-19;disasters;maternal and child health;pandemics;reproductive health
Application Clinical Decision Support System Assist Breast Cancer Patients Lifestyle Modifications COVID19 Pandemic Randomised Controlled Trial,34203025,Clinical decision support system CDSS data aggregation tool based computer technology assist clinician promote healthy weight management prevention cardiovascular disease carried randomised controlled 3month trial implement lifestyle modification breast cancer BC patient mean CDSS COVID19 pandemic total 55 BC woman stage IIIIA enrolled randomly assigned either Control group receiving general lifestyle advice n = 28 CDSS group n = 27 CDSS provided personalised dietary plan based Mediterranean diet MD together physical activity guideline Food data anthropometry blood marker quality life evaluated 3 month higher adherence MD recorded CDSS group accompanied lower body weight kg body fat mass percentage compared control p 0001 CDSS arm global healthquality life significantly improved trial endpoint p 005 Fasting blood glucose lipid level ie cholesterol LDL triacylglycerols CDSS arm remained unchanged p 005 elevated control arm 3 month p 005 conclusion CDSS could promising tool assist BC patient lifestyle modification COVID19 pandemic,mediterranean diet;breast cancer;cardiovascular risk factors;clinical decision support systems;obesity;oxidative stress;quality of life
Narrative Analysis Impact COVID19 Patients Chronic Obstructive Pulmonary Disease Caregivers Healthcare Professionals Italy,34335023,Purpose COVID19 pandemic disrupted many life including people suffering chronic obstructive pulmonary disease COPD caregiver main aim study use narrative medicine validated approach promoting quality care explore COVID19 pandemic impacted quality care quality life psychological factor social factor people affected COPD caregiver healthcare professional HCPs secondary aim explore role telemedicine combating isolation providing access care Methods crosssectional observational narrative medicine study conducted July November 2020 across Italy online semistructured questionnaire narrative plot completed 146 participant 79 COPD patient 24 caregiver 43 HCPs Narrations analyzed descriptive statistic evaluated using NVivo 11 software break text identify recurring theme major semantic cluster Results first lockdown 5822 response COPD patient indicated terror fear andor apprehension reopening figure 3544 Among caregiver figure 100 first lockdown 4583 reopening metaphor commonly used patient describe COPD COVID19 monster murderer respectively Patients described home often clean lonely offering shelter narrative 42 COPD patient 452 described coping 126 COPD patient reported regular access medical visit lockdown 591 general practitioner pulmonologists reported using telemedicine perceived satisfactory patient caregiver Conclusion relevant aim multidisciplinary multilevel system care empowers telemedicine integrates specific psychological support program COPD patient caregiver,copd;covid-19;chronic obstructive pulmonary disease;narrative medicine;quality of life
Obesity May Associated 28Day Mortality Duration Invasive Mechanical Ventilation Length Intensive Care Unit Hospital Stay Critically Ill Patients Severe Acute Respiratory Syndrome Coronavirus2 Retrospective Cohort Study,34210077,Background Objectives aim study investigate association obesity 28day mortality duration invasive mechanical ventilation length stay Intensive Care Unit ICU hospital patient admitted ICU SARSCoV2 pneumonia Materials Methods retrospective observational cohort study patient admitted ICU SARSCoV2 pneumonia single Dutch center association obesity body mass index 30 kgm 2 28day mortality duration invasive mechanical ventilation length ICU hospital stay investigated Results 121 critically ill patient pneumonia due SARSCoV2 confirmed RTPCR Fortyeight patient obesity 335 28day allcause mortality 281 Patients obesity significant difference 28day survival KaplanMeier curve log rank p 0545 compared patient without obesity Obesity made significant contribution multivariate Cox regression model prediction 28day mortality p = 0124 age Sequential Organ Failure Assessment SOFA score significant independent factor p 0001 0002 respectively statistically significant correlation observed obesity duration invasive mechanical ventilation length ICU hospital stay Conclusion Onethird patient admitted ICU SARSCoV2 pneumonia obesity present study showed relationship obesity 28day mortality duration invasive mechanical ventilation ICU hospital length stay study needed substantiate finding,sars-cov-2;intensive care unit;invasive mechanical ventilation;length of stay;obesity;severe acute respiratory syndrome coronavirus-2
Perceptions Telehealth Among Commercial Members Responded PatientExperience Survey Onset Coronavirus19 Pandemic,34348054,Introduction body literature telehealth perception among commercial member limited Therefore administered patientexperienced survey Clinician Group Consumer Assessment Healthcare Providers Systems CGCAHPS determine member perception telehealth including willingness pay likelihood access Methods study used crosssectional design member assigned two group telehealth visit primary care provider PCP provider practice telehealth visit provider outside PCP s practice Logistic regression model used observe group difference telehealth perception Results total 444 member replied CGCAHPS survey virtual visit 211 telehealth visit provider outside PCP s practice 788 telehealth visit PCP provider practice Compared member saw provider outside PCP s practice member saw PCP provider practice 376 higher odds confidence interval 95 CI 149944 rating inperson care different virtual care 229 higher odds 95 CI 130404 reporting would likely use telehealth future 170 higher odds 95 CI 099291 responding would willing pay inoffice visit copay telehealth visit Conclusion result suggest familiarity member s PCP extends provider s practice impact member outlook telehealth,covid;commercial telemedicine;policy;telehealth;telemedicine
Recommendations use personal protective equipment PPE surgical procedure SARSCov pandemic,34211534,Since Coronavirus Disease 2019 classified pandemic World Health Organization 2019 many measure proposed reduce risk chance contamination new coronavirus context wearing personal protective equipment important especially hospital environment situation involving healthcare since degree exposure notably higher among subgroup healthcare professional aim article propose roadmap sequence personal protective equipment use surgical procedure coronavirus pandemic recommendation based Brazil s public health policy World Health Organization guideline Five roadmaps PPE sequence presented commonly performed procedure fitting central venous catheter fitting catheter requiring radioscopy open surgery diagnostic therapeutic angiography dressing,covid;sars-cov;coronavirus;personal protective equipment;surgical procedures
Want Program Looks Whole Life Focus Group Study Ideal Components mHealth Weight Management Program African American Women,34351276,BACKGROUND high rate obesity ownership smartphones online search nutrition dieting information among African American woman AAW provide unique opportunity develop costeffective accessible acceptable mHealth weight management program Furthermore participate development evaluation program OBJECTIVE explore ideal component culturally relevant mHealth weight management program AAW examine component may vary age group DESIGN Twelve focus group triad conducted AAW north central Florida framework method used manage organize synthesize analyze data theme age group 18 29 young 30 50 middle age 51+ older PARTICIPANTSSETTING Thirtysix smartphone owner expressed desire lose weight recruited several community partnership RESULTS Based body mass index BMI young woman classified overweight BMI 2623 + 67 middleaged woman obese BMI3072 + 831 older woman obese BMI 3103 + 567 searched online dieting information within past 12 month Five overarching theme designing mHealth weight management program identified 1 holistic program go beyond dieting 2 social medium integration support sense community 3 selfmonitoring app 4 twoway text messaging 5 program varying length meaningful incentive CONCLUSION AAW receptive mHealth weight management program may appealing COVID19 pandemic Holistic program 4 6 week addressed stress eating social medium component included educational text per week may appealing AAW,african american women;black women;digital health;obesity;mhealth
Digital health primary care Past pandemic prospect,34221352,article reflects breadth digital development seen primary care time well rapid significant change prompted COVID19 crisis Recent research experience shone light factor influencing implementation usefulness approach well unresolved challenge unintended consequence considered relation digital technology infrastructure also wider aspect health system nature primary care work culture patient characteristic inequality ethical issue around data privacy inclusion empowerment empathy trust Implications future direction sustainability approach discussed taking account novel paradigm artificial intelligence growing capture primary care data secondary us Decision maker encouraged think holistically value likely added risk taken away judging innovation carry forward concludes responding public health emergency created something digital big bang primary care incremental adaptive patientcentered strategy focused augmenting rather replacing existing service likely prove fruitful longer term,
Boswellic acidsBoswellia serrata extract potential COVID19 therapeutic agent elderly,34224069,severe case COVID19 highest rate death among elderly urgent need search agent treat disease control progression Boswellia serrata traditionally used treat chronic inflammatory disease lung review aim highlight currently published research shown evidence potential therapeutic effect boswellic acid BA B serrata extract COVID19 associated condition reviewed published information March 2021 Studies collected search online electronic database academic library PubMed Scopus Web Science Egyptian Knowledge Bank Several recent study reported BAs B serrata extract safe agent multiple beneficial activity treating similar symptom experienced patient COVID19 low oral bioavailability improvement buccaloral cavity hygiene traditional use chewing B serrata gum may beneficial oral use cheapest option lot poorer people promising effect B serrata BA attributed antioxidant antiinflammatory immunomodulatory cardioprotective antiplatelet aggregation antibacterial antifungal broad antiviral activity B serrata BA act multiple mechanism common mechanism may direct interaction IkappaB kinase inhibiting nuclear factorkappaBregulated gene expression However recent mechanism proposed BA inhibited formation classical 5lipoxygenase product also produced antiinflammatory LOXisoformselective modulators conclusion small moderate dose B serrata extract may useful enhancing adaptive immune response mild moderate symptom COVID19 However large dos BA may beneficial suppressing uncontrolled activation innate immune response clinical result required determine certainty whether sufficient evidence benefit COVID19,antioxidant;antiviral immunomodulator;boswellic acids/boswellia serrata;covid-19;anti-inflammatory
impact coronavirus disease 2019 quality life treatment disruption patient breast cancer multiethnic cohort,34292583,BACKGROUND coronavirus disease 2019 COVID19 pandemic continues spread remains unclear vulnerable population preexisting health condition like cancer affected METHODS July September 2020 author conducted crosssectional study surveyed 2661 patient breast cancer registered Chicago Multiethnic Epidemiologic Breast Cancer Cohort received 1300 response 715 White patient 224 Black patient survey measured psychosocial wellbeing participant COVID19 pandemic examined whether experienced type financial challenge treatment disruption RESULTS result indicated feeling isolation increased significantly pandemic Meanwhile overall median isolationstress score 12 scale 0 never 4 always significantly different White patient Black patient Onethird patient experienced type financial challenge time Medicaid recipient almost 80 Black likely experience financial challenge addition approximately onefourth patient experienced difficulty getting treatment CONCLUSIONS study indicates quality life patient breast cancer scheduled treatment adversely affected COVID19 pandemic finding suggest support provided hospital center medical research community patient cancer challenging pandemic LAY SUMMARY author surveyed patient breast cancer Chicago using questionnaire examine life affected coronavirus disease 2019 COVID19 pandemic result indicate life patient breast cancer scheduled treatment adversely affected pandemic addition patient covered Medicaid Black likely experience financial challenge finding suggest hospital center medical research community reach provide information support patient cancer challenging pandemic,breast cancer;coronavirus disease 2019 (covid-19);epidemiology;quality of life;racial disparities
Rhamnolipids NanoMicelles Potential Hand Sanitizer,34206211,COVID19 pandemic disease caused SARSCoV2 continues cause global health economic problem since emerging China late 2019 standard antiviral treatment Thus several strategy adopted minimize virus transmission social distancing face covering protection hand hygiene Rhamnolipids glycolipids produced formally Pseudomonas aeruginosa biosurfactants shown broad antimicrobial activity study investigated antimicrobial activity rhamnolipids selected multidrug resistant bacteria SARSCoV2 Rhamnolipids produced growing Pseudomonas aeruginosa strain LeS3 new medium formulated chicken carcass soup isolated rhamnolipids characterized molecular composition formulated nanomicelles antibacterial activity nanomicelles demonstrated vitro Gramnegative Grampositive drug resistant bacteria silico study docking rhamnolipids structural nonstructural protein SARSCoV2 also performed demonstrated efficient specific interaction rhamnolipids active site protein Additionally computational study suggested rhamnolipids membrane permeability activity Thus obtained result indicate SARSCoV2 could another target rhamnolipids could find utility fight COVID19 future perspective considered,covid-19;pseudomonas aeruginosa;sars-cov-2;antibacterial agent;antiviral agent;docking studies;nano-micelles;rhamnolipids
Coinfections Respiratory Pathogens among Patients COVID19,34287033,Emerging evidence indicates severe acute respiratory syndrome coronavirus 2 SARSCoV2 infected individual increased risk coinfections therefore physician need cognizant excluding treatable respiratory pathogen report coinfection SARSCoV2 respiratory pathogen patient admitted coronavirus disease COVID care facility Indian tertiary care hospital June 2020 January 2021 tested 191 patient SARSCoV2 33 respiratory pathogen using fast track diagnostics respiratory pathogen 33 FTD33 assay Additionally information regarding relevant respiratory pathogen collected reviewing laboratory data Overall 13 pathogen identified among patient infected SARSCoV2 466 89191 patient coinfection one additional pathogen Bacterial coinfections 414 79191 frequent Staphylococcus aureus common followed Klebsiella pneumoniae Coinfections SARSCoV2 Pneumocystis jirovecii Legionella pneumophila also identified viral coinfection rate 73 human adenovirus human rhinovirus common Five patient cohort positive culture Acinetobacter baumannii K pneumoniae two patient active Mycobacterium tuberculosis infection total 471 90191 patient coinfections identified higher proportion patient coinfections cohort support systemic use antibiotic patient severe SARSCoV2 pneumonia rapid deescalation based respiratory PCRculture result timely simultaneous identification coinfections contribute improved health COVID19 patient enhanced antibiotic stewardship pandemic IMPORTANCE Coinfections COVID19 patient may worsen disease outcome need investigation found higher proportion patient COVID19 coinfected one additional pathogen better understanding prevalence coinfection respiratory pathogen COVID19 patient profile pathogen contribute effective patient management antibiotic stewardship current pandemic,covid-19;sars-cov-2;coinfections;multiple-pathogen testing;respiratory pcr
Characteristics Developments Mesenchymal Stem Cell Therapy COVID19 Update,34211556,outbreak coronavirus disease 2019 COVID19 far resulted hundred million people infected COVID19 pose threat human health around world Severe acute respiratory syndrome coronavirus 2 SARSCoV2 confirmed pathogenic virus COVID19 SARSCoV2 belongs betacoronavirus family virus mainly transmitted respiratory tract proven SARSCoV2 mainly target angiotensinconverting enzyme II ACE2 receptor surface various cell human main clinical symptom COVID19 include fever cough severe acute respiratory distress syndrome ARDS Current evidence suggests damage caused virus may closely related induction cytokine storm COVID19 specific drug measure yet shown cure COVID19 completely Cellbased approach primarily mesenchymal stem cell MSCs identified antiinflammatory immune function COVID19 Clinical study using MSCs derivativesexosomes COVID19 treatmentare investigation review current progress biological characteristic clinical manifestation cellbased treatment development COVID19 Providing uptodate information COVID19 potential MSC therapy help highlight route prevent treat disease,
Defining Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 Placentitis Report 7 Cases Confirmatory Situ Hybridization Distinct Histomorphologic Features Evidence Complement Deposition,34338723,CONTEXT Case report rare case series demonstrated variable placental pathology setting maternal severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection rare small study demonstrating infection placental parenchyma histologic manifestation included variable degree histiocytic intervillositis perivillous fibrin deposition syncytiotrophoblast necrosis OBJECTIVE To characterize placental pathological feature SARSCoV2 infected placenta irrespective fetalmaternal transmission examine frequency C4d activation case DESIGN Retrospective study seven placenta mother active SARSCoV2 infection placental infection demonstrated RNA situ hybridization RESULTS Six placenta liveborn neonate 5 singleton 1 nonfused diamnioticdichorionic twin placenta one stillbirth Five eight neonate including stillbirth tested negative SARSCoV2 negative neonatal infection remaining three neonate well time discharge placenta positive SARSCoV2 infection RNA situ hybridization demonstrated variable degree histiocytic intervillositis perivillous fibrin deposition trophoblast necrosis Three case demonstrated feature fetal vascular malperfusion CD68 highlighted intervillous histiocyte C4d expression present along villous border 6 7 case CONCLUSIONS SARSCoV2 placentitis defined triad histiocytic intervillositis perivillous fibrin deposition trophoblast necrosis feature may occur case without confirmed transplacental transmission damage caused SARSCoV2 placentitis likely mediated complement activation,
Neutralizing Antibodies Titers Side Effects Response BNT162b2 Vaccine Healthcare Workers without Prior SARSCoV2 Infection,34358158,main expected result vaccine virus ability produce neutralizing antibody Currently several vaccine SARSCoV2 applied prevent mortal complication PfizerBioNTech BNT162b2 one first authorized USA Mexico 11 December 2020 study evaluated efficacy vaccine antibody production neutralizing capacity side effect healthcare worker without prior SARSCoV2 infection group unvaccinated individual prior COVID19 main finding production 100 neutralizing antibody group second dose welltolerated adverse effect possible presence immunosenescence finally support single dose vaccine individual prior COVID19 would sufficient achieve immunization comparable people without prior COVID19 complete vaccination program 2 dos,bnt162b2;covid-19;neutralizing antibodies;vaccine side effects
Economic social impact COVID19 public health measure result anonymous online survey Thailand Malaysia UK Italy Slovenia,34285007,OBJECTIVES understand impact COVID19 public health measure different social group conducted mixedmethods study five country SEBCOVsocial ethical behavioural aspect COVID19 report result online survey STUDY DESIGN STATISTICAL ANALYSIS Overall 5058 respondent Thailand Malaysia UK Italy Slovenia completed selfadministered survey May June 2020 Poststratification weighting applied association categorical variable assessed Frequency count percentage used summarise categorical data Associations categorical variable assessed using Pearson s chi 2 test Data analysed Stata 150 RESULTS Among five country Thai respondent reported Slovenian respondent least affected economically following factor associated greater negative economic impact 1824 year 65 year older lower education level larger household child 18 household flexibleno income Regarding social impact respondent expressed concern social life physical health mental health wellbeingThere large difference country term voluntary behavioural change compliance agreement COVID19 restriction Overall selfreported compliance higher among respondent selfreported high understanding COVID19 UK respondent felt able cope longest Thai respondent shortest going essential need work Many respondent reported seeing news perceived fake proportion varying country education level selfreported level understanding COVID19 CONCLUSIONS data showed COVID19 public health measure uneven economic social impact people different country social group Understanding factor associated impact help inform future public health intervention mitigate negative consequence TRIAL REGISTRATION NUMBER TCTR20200401002,epidemiology;public health
Masitinib broad coronavirus 3CL inhibitor block replication SARSCoV2,34285133,urgent need antiviral agent treat SARSCoV2 infection screened library 1900 clinically safe drug OC43 human betacoronavirus cause common cold evaluated top hit SARSCoV2 Twenty drug significantly inhibited replication virus vitro Eight drug inhibited activity SARSCoV2 main protease 3CLpro potent masitinib orally bioavailable tyrosine kinase inhibitor Xray crystallography biochemistry show masitinib act competitive inhibitor 3CLpro Mice infected SARSCoV2 treated masitinib showed 200fold reduction viral titer lung nose well reduced lung inflammation Masitinib also effective vitro tested variant concern B117 B1351 P1,
Epidemiology tickborne encephalitis Poland 20102019 impact COVID19 pandemic notified incidence disease,34338473,INTRODUCTION Tickborne encephalitis TBE endemic many part Eurasia including country previously considered free disease incidence TBE changing owing various ecological climatic factor factor influencing variability number TBE case still investigation 2020 new coronavirus SARSCoV2 emerged causing COVID19 pandemic Governments reorganized health care system contain surge COVID19 case avoid hospital overload Moreover new measure modified several aspect social habit leading change incidence numerous disease aimed evaluate epidemiology TBE last decade 20102019 demonstrate impact surge SARSCoV2 infection TBE incidence reported national surveillance database MATERIAL METHODS performed analysis TBE notification epidemiologic report year 20102019 pandemic year 2020 national regional level Poland included data two infectious disease department located TBEprevalent province Poland RESULTS case TBE occur two province Northeastern Poland May December increasing temporal trend occurred Poland 20162017 increased number case COVID19 coincided reduction number reported TBE case 2020 CONCLUSIONS Tickborne encephalitis virus activity Poland invariably concentrated endemic region Northeastern Poland fluctuating considerably year year decrease TBE incidence surge COVID19 patient conceivably resulted underreporting due limited access specialized diagnostics endemic area TBE included differential diagnostics case central nervous system infection suspected,covid-19;incidence;tick-borne encephalitis
RF Sensing Based Breathing Patterns Detection Leveraging USRP Devices,34199681,Noncontact detection breathing pattern remote unobtrusive manner significant value healthcare application disease diagnosis COVID19 infection prediction epidemic prevention control period COVID19 noncontact approach great significance minimize physical burden patient least requirement active cooperation infected individual pandemic noncontact approach also reduce environmental constraint remove need extra preparation According latest medical research breathing pattern person infected COVID19 unlike breathing associated flu common cold One noteworthy symptom occurs COVID19 abnormal breathing rate individual infected COVID19 rapid breathing requires continuous realtime detection breathing pattern helpful prediction diagnosis screening people infected COVID19 research work softwaredefined radio SDR based radio frequency RF sensing technique machine learning ML algorithm exploited develop platform detection classification different abnormal breathing pattern ML algorithm used classification purpose performance evaluated basis accuracy prediction speed training time result show platform detect classify breathing pattern maximum accuracy 994 complex tree algorithm research significant clinical impact platform also deployed practical use pandemic nonpandemic situation,covid-19;csi;ofdm;sdr;usrp;breathing pattern
Challenges Adaptation Otorhinolaryngology Practice Pandemic Lockdown Experience Malaysian COVID19 Hospital,34285652,COVID19 taken world storm since first case appeared Wuhan China December 2019 June 2020 10 million case COVID19 case worldwide Malaysia first case January 2020 acted promptly implementing several drastic measure contain disease Subsequently Ministry Health Malaysia implemented guideline recommendation management COVID19 Department OtorhinolaryngologyHead Neck Surgery ORLHNS provides service patient ear nose throat head neck disease provides audiology speech language therapy well undergraduate postgraduate training department s staff heavily involved examination intervention upper aerodigestive tract problem challenge distinctly different specialty article discus COVID19 affected ORLHNS service measure taken Hospital Melaka Malaysia,covid-19;malaysia;health services;otorhinolaryngology;pandemic
Attitudes towards COVID19 Vaccine Willingness Get Vaccinated among Healthcare Workers French Guiana Influence Geographical Origin,34205613,Background context global COVID19 pandemic expansion transmissible 20J501YV3 Gamma variant concern VOC mRNA vaccine made available French Guiana overseas French territory South America midJanuary 2021 study aimed estimate willingness vaccinated sociodemographic motivational correlate among Health Care Workers HCWs French Guiana Methods crosssectional survey conducted January 22 March 26 2021 among sample HCWs French Guiana asked willingness get vaccinated COVID19 vaccine hesitancy vaccine uptake vaccine attitude Factors associated willingness get vaccinated analyzed ordinal logistic regression using Stata software Results total 579 HCWs interviewed including 220 physician 200 nurse often working hospital 54 liberal sector 22 Overall 656 respondent reported willing already vaccinated COVID19 243 respondent reported want get vaccinated COVID19 112 unsure HCWs willing get vaccine older worried COVID19 confident management epidemic Conversely participant le likely vaccinated willing nurse another nonmedical profession born French Guiana feared adverse effect trust pharmaceutical company management epidemic authority Conclusion Negative attitude towards vaccine major public health concern among HCWs French Guiana considering current active epidemic Gamma VOC General vaccine hesitancy concern future side effect particular represent important barrier Low confidence government science significant COVID19 vaccine refusal among nonmedical staff Public health messaging information vaccine safety tailored address concern specific challenge HCWs French Guiana must taken account,covid-19 vaccines;french guiana;south america;health personnel;vaccine hesitancy;willingness to get vaccinated
Combining Probabilistic Forecasts COVID19 Mortality United States,34219901,COVID19 pandemic placed forecasting model forefront health policy making Predictions mortality case hospitalisation help government meet planning resource allocation challenge paper consider weekly forecasting cumulative mortality due COVID19 national state level US Optimal decisionmaking requires forecast probability distribution rather single point forecast Interval forecast also important support decision making provide situational awareness consider case probabilistic forecast provided multiple forecasting team combine forecast extract wisdom crowd use dataset made publicly available COVID19 Forecast Hub notable feature dataset availability forecast participating team varies greatly across 40 week study evaluate accuracy combining method previously proposed interval forecast prediction probability distribution include use simple average median trimming method addition propose several new weighted combining method result show although median useful early week pandemic simple average preferable thereafter history forecast accuracy accumulates best result produced weighted combining method us weight inversely proportional historical accuracy individual forecasting team,covid-19;distributional forecasts;forecast combining;interval forecasts;or in health services
Cardiovascular cerebrovascular renal comorbidities COVID19 patient systematicreview metaanalysis,34221254,Background COVID19 infected 35 million people worldwide led 1 million death Several risk factor increase COVID19 severity emerged including age history cardiovascular disease hypertension kidney disease However number outstanding question persist including whether comorbidities correlate increased mortality COVID19 whether age significant confounding variable account observed relationship COVID19 severity comorbidities Methods Findings conducted systematic review metaanalysis study documenting COVID19 patient hypertension cardiovascular disease cerebrovascular disease chronic kidney disease classified COVID19 case severenonsevere deceasedsurviving calculated odds ratio four comorbidities cohort 36 study comprising 22573 patient included metaanalysis found hypertension prevalent comorbidity deceased COVID19 patient 554 CI 494613 followed cardiovascular disease 307 CI 226388 cerebrovascular disease 134 CI 912192 chronic kidney disease 905 CI 557150 risk death also significantly higher patient comorbidities greatest risk factor chronic kidney disease 886 CI 5271489 followed cardiovascular disease 687 CI 556850 hypertension 487 CI 419566 cerebrovascular disease 428 CI 286641 risk significantly higher previously reported correlation comorbidities COVID19 severity similar previously reported figure Using metaregression analysis age moderating variable observed age contributes observed risk explain fully Conclusions metaanalysis observed cardiovascular cerebrovascular kidneyrelated comorbidities COVID19 significantly contributes greater risk mortality increased disease severity also demonstrated age may confounder association,covid-19;comorbidity;meta-analysis
Twelve Months COVID19 Gastroenterologists Need Know,34333726,Corona virus disease19 COVID19 latest global pandemic COVID19 mainly transmitted respiratory droplet apart respiratory symptom patient often present gastrointestinal symptom liver involvement Given high percentage COVID19 patient present gastrointestinal symptom GIS review report practical uptodate reference physician clinical practice patient affected chronic gastrointestinal GI disease inflammatory bowel disease coeliac disease chronic liver disease time COVID19 First summarised data origin pathogenetic mechanism SARSCoV2 performed literature search December 2020 examining clinical manifestation GI involvement Next illustrated summarised recent guideline adhere GI procedure endoscopy liver biopsy faecal transplantation maintaining social distance deal immunosuppressive treatment Finally focussed special condition faecaloral transmission gut microbiota rapid accumulation information relating condition make particularly essential revise literature take account recent publication medical consultation patient care,covid-19;coeliac disease;gastrointestinal symptoms;inflammatory bowel disease;liver diseases;sars-cov-2
Impact COVID19 Liver Disease Progression,34222744,Severe acute respiratory syndrome coronavirus2 SARSCoV2 novel coronavirus cause coronavirus disease 19 COVID19 infected million people worldwide month minority significant number infected individual require hospitalization intensive care start new virus pandemic apparent obese andor diabetic individual bad prognosis COVID19 progression strongly suggesting association liver disease severe COVID19 chronic liver disease CLD associated immune dysregulation inflammation unsurprising patient CLD may carry greater risk adverse outcome following SARSCoV2 infection Initial COVID19 data also indicated healthy infected individual display abnormal liver function test suggesting possible direct implication SARSCoV2 liver damage show COVID19 affect liver metabolism increase morbidity mortality individual underlying CLD,
Challenges detect SARSCoV2 environmental medium need strategy implement detection methodology wastewater,34221893,Understanding risk putting place preventative method seamlessly continue daily activity essential tool fight pandemic social commercial leisure activity impact environmental medium Therefore accurately predict fate behavior virus environment necessary understand analyze available detection method possible transmission pathway preventative technique aim review critically analyze summarize research done regarding SARSCOV2 virus detection focusing sampling laboratory detection method environmental medium Special attention given wastewater sewage sludge review summarized survival virus surface estimate risk carried different environmental medium water wastewater air soil order explain community higher risk critical analysis concludes detection SARSCoV2 current technology sampling strategy would reveal presence virus information could used design systematic sampling point throughout sewage system available taking account peak flow importantly economic factor sample approach provide clue potential future viral outbreak saving financial resource reducing testing necessity viral detection hence contributing appropriate confinement policy government could used define precisely postpandemic additional wave measure if needed,covid-19;cost-effective outbreak monitoring;environmental media;post-pandemic decision making tool;sars-cov-2;sewage line sampling
COVID19 New Challenge Pulmonary Rehabilitation,34362142,Coronavirus disease 2019 COVID19 currently one immense burden global healthcare often characterized rapid progression occurrence symptom particularly affecting respiratory system Continuous refinement treatment protocol improves prognosis however COVID19 survivor often left symptomatic burden dyspnea fatigue Therefore necessary continue comprehensive treatment including pulmonary rehabilitation study aimed review available literature pulmonary rehabilitation patient diagnosed COVID19 pulmonary rehabilitation program implemented various form ie aerobic exercise breathing exercise effective cough exercise diaphragmatic breathing respiratory muscle training Based literature review found pulmonary rehabilitation program result improvement respiratory function reduction fatigue dyspnea improvement exercise endurance quality life completing shortterm longterm program depression anxiety problem improve Pulmonary rehabilitation combined psychological therapy crucial COVID19 survivor play substantial role patient recovery,sars-cov-2;coronavirus;depression;pulmonary rehabilitation;quality of life;respiratory function
adult child ED COVID19 symptom confirmed contact rapid POC antigen test =72 sensitivity =99 specificity vs RTPCR,34224272,SOURCE CITATION Mockel Corman VM Stegemann MS et al SARSCoV2 antigen rapid immunoassay diagnosis COVID19 emergency department Biomarkers 2021 2621320 33455451,
Successful Treatment 39YearOld COVID19 Patient Respiratory Failure Selective CReactive Protein Apheresis,34351878,BACKGROUND High Creactive protein CRP plasma level severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection associated poor prognosis CRP activating classical complement pathway interacting macrophage via Fc gamma receptor cause pulmonary inflammation subsequent fibrosis Recently reported firstinman CRP apheresis `` highrisk COVID19 patient Treatment unfortunately clinically unsuccessful report successful CRP apheresis treatment `` lowerrisk COVID19 patient respiratory failure CASE REPORT 39yearold male patient suffering fatigue dyspnea fever 4 day referred u patient intubated Polymerase chain reaction PCR analysis throat smear revealed SARSCoV2 infection Mutation analysis revealed VOC B 117 variant CRP level 792 mgL increased 16163 mgL Procalcitonin PCT level continuously normal 05 ngml Antibiotic therapy started avoid bacterial superinfection CRP apheresis performed via central venous access CRP level declined maximum 16163 mgL 3258 mgL apheresisassociated adverse effect observed Subsequently CRP plasma level declined day day normalized day 5 patient extubated day 5 discharged Intensive Care Unit ICU day 6 second low CRP peak maximum 2241 mgL day 7 remained clinically inapparent patient discharged good clinical condition CRP level 694 mgL day 8 CONCLUSIONS SARSCoV2 infection induce uncontrolled CRPmediated autoimmune response ancient immunity patient autoimmune response potently successfully suppressed early selective CRP apheresis,
effect nonpharmaceutical intervention demand health care mortality evidence COVID19 Scandinavia,34334957,study effectiveness nonpharmaceutical intervention NPIs COVID19 allocation scarce resource hospital sector Scandinavia Denmark Norway imposed strict NPIs Sweden followed extraordinarily lenient approach use event study compare COVID19 hospitalization intensivecare ICU patient death Sweden Denmark Norway outcome variable initially follow common trend diverge 23 week lockdown timing effect similarity trend Denmark Norway highly consistent causal effect lockdown use event study build counterfactual model predicts outcome variable Denmark Norway followed Sweden s approach absence strict NPIs peak number hospitalization would 25 35 time large Denmark Norway Overall Denmark Norway would 334 671 percent hospitalpatient day 277 379 percent ICUpatient day 402 1015 percent death benefit lockdown term healthcare mortality cost amount 1 4 09 35 percent GDP Denmark Norway,covid-19;health economics;healthcare costs;mortality;non-pharmaceutical interventions
HighThroughput Fluorescent Assay Inhibitor Screening Proteases RNA Viruses,34206406,Spanish flu polio epidemic ongoing COVID19 pandemic profound example severe widespread disease caused RNA virus coronavirus pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 demand affordable reliable assay testing antiviral test inhibitor viral protease developed inexpensive highthroughput assay based fluorescent energy transfer FRET assayed array inhibitor papainlike protease SARSCoV2 validated protease tickborne encephalitis virus emphasize versatility reaction progress monitored loss FRET signal substrate robust reproducible assay used testing inhibitor 96 384well plate,sars-cov-2;tbev;discovery;drug;flavivirus;high-throughput screening;papain-like;protease;virus
necessity early antiinflammatory therapy initiation case mildtomoderate COVID19 personal experience attending pharmacist resident,34212899,professor attending pharmacist field pharmaceutical science writer coauthor least 5 manuscript different aspect COVID19 15 month first report COVID19 120 million people world infected virus 25 million died Although different treatment approach proposed management COVID19 patient steal remained controversial regard want share personal experience exposure coronavirus consequence infection health status 51 year old male known case hypertension dyslipidemia chronic kidney disease working hour colleague Faculty Pharmacy visited one colleague office leaving Faculty colleague declares RTPCR test COVID19 positive took 3 day experience first sign COVID19 fever Many complication occurred different stage COVID19 infection shared explained detail suggested pharmacotherapies According pathophysiology COVID19 infection personal experience COVID19 infection want emphasize necessity early initiation antiinflammatory agent including corticosteroid colchicine highrisk patient mildtomoderate COVID19 pneumonia show respiratory system involvement order prevent progression severe critical stage disease,
Continue Lose Battle Cancers Stop Triggers Environmental Pollution,34198930,Besides current health concern due COVID19 cancer longerlasting even dramatic pandemic affect almost third human population worldwide emphasis cause posed genetic predisposition chance wrong lifestyle mainly obesity smoking Moreover medical weapon cancer improved much last century although research progress diagnosed malignant tumour still rely surgery radiotherapy chemotherapy main problem focused fighting difficult battle instead preventing controlling trigger Quite opposite knowledge link environmental pollution cancer surged 1980s Carcinogens water air soil continued accumulate disproportionally grow number dose bringing u today s carnage synthesis critical review state knowledge link cancer environmental pollution three environmental compartment provided research gap briefly discussed future direction indicated New evidence suggests relevant take account dose also time exposed carcinogen review end stressing dedication put studying environmental cause cancer prevent avoid curing precautionary approach towards environmental pollutant must much reactionary urgent need leave behind outdated petrochemicalbased industry good production,air;cancer;carcinogens;environment;pollution;soil;water
Newonset restless leg syndrome COVID19 patient case report literature review,34285741,Restless leg syndrome RLS sleep disorder characterized sudden urge move lower limb period rest accompanied unpleasant sensation like tingling burning leg Often urge partially relieved movement leg However cause disturbance sleep leading daytime fatigue Herein present unusual case newonset restless leg syndrome COVID19 infected patient presented three week uncomplicated delivery via caesarean section patient managed sleep hygiene measure oral iron vitamin C tablet apart general COVID19 management medication subsequently leading significant improvement discussed possible associated factor pathophysiological mechanism management RLS case COVID infected individual,covid-19;restless leg syndrome;case report;sleep
Myricetin Inhibits SARSCoV2 Viral Replication Targeting pro Ameliorates Pulmonary Inflammation,34220507,coronavirus disease 2019 COVID19 spread widely around world seriously affected human health ten million people view lacking antivirus drug target SARSCoV2 urgent need develop effective new drug study reported discovery SARSCoV2 pro inhibitor selected 15 natural compound including 7 flavonoid 3 coumarins 2 terpenoids one henolic one aldehyde one steroid compound molecular docking enzymatic screening Myricetin identified potent inhibit activity IC50 3684 + 0076 muM enzyme assay binding pose Myricetin SARSCoV2 pro identified using molecular docking method binding pocket SARSCoV2 pro chromone ring Myricetin interacts His41 pipi stacking 3 4 7hydroxyl Myricetin interact Phe140 Glu166and Asp187 hydrogen bond Significantly result showed Myricetin potent effect bleomycininduced pulmonary inflammation inhibiting infiltration inflammatory cell secretion inflammatory cytokine IL6 IL1alpha TNFalpha IFNgamma Overall Myricetin may potential drug antivirus symptomatic treatment COVID19,3clpro (mpro);covid-19;sars-cov-2;myricetin;pulmonary inflammation
Corilagin 136TriOgalloybetaDglucose potential inhibitor SARSCoV2 variant,34223589,COVID19 disease caused virus SARSCoV2 first detected December 2019 still emerging virus mutation Although almost control country due effective vaccine mitigating worldwide pandemic urgency develop additional vaccine therapeutic treatment imperative work natural polyphenols corilagin 136triOgalloybetadglucose TGG investigated determine structural basis inhibitor interaction potential candidate inhibit SARSCoV2 viral entry target cell First therapeutic potential ligand assessed ACE2wildtype RBD first use molecular docking followed molecular dynamic take account conformational flexibility play significant role ligand binding captured using docking analyze precisely affinity ligand using MMPBSA binding free energy show ligand bind ACE2wildtype RBD interface good affinity might prevent ACE2RBD association Second confirm potency ligand block ACE2RBD association using combination surface plasmon resonance biochemical inhibition assay experiment confirm TGG lesser extent corilagin inhibit binding RBD ACE2 experiment simulation show ligand interact preferentially RBD weak binding observed ACE2 hence avoiding potential physiological sideeffects induced inhibition ACE2 addition wildtype RBD also study numerically three RBD mutation E484K N501Y E484KN501Y found main SARSCoV2 variant concern find corilagin could effective RBDE484K le effective RBDN501Y RBDE484KN501Y mutant TGG strongly bind relevant location three mutant demonstrating significant interest molecule potential inhibitor variant SARSCoV2,
Development ultrasensitive fluorescent immunochromatographic assay based multilayer quantum dot nanobead simultaneous detection SARSCoV2 antigen influenza virus,34219970,Rapid accurate diagnosis severe acute respiratory syndrome coronavirus 2 SARSCoV2 fl uenza virus FluA antigen early stage virus infection key control epidemic spread developed twochannel fluorescent immunochromatographic assay ICA ultrasensitive simultaneous qualification two virus biological sample highperformance quantum dot nanobead QB fabricated adsorption multilayers dense quantum dot QDs onto SiO2 surface used highly luminescent label ICA system ensure highsensitivity stability assay combination monodispersed SiO2 core approximately 180 nm numerous carboxylated QDs formed hierarchical shell ensured QBs possessed excellent stability superior fluorescence signal convenient surface functionalization developed ICA biosensor achieved simultaneous detection SARSCoV2 FluA one test within 15 min detection limit reaching 5 pgmL SARSCoV2 antigen 50 pfumL FluA H1N1 Moreover method showed high accuracy specificity throat swab sample two order magnitude improvement sensitivity compared traditional AuNPbased ICA method Hence proposed method promising convenient tool detection respiratory virus,flua;immunochromatographic assay;multilayer quantum dot;sars-cov-2;simultaneous detection
reliability saliva detection SARSCoV2 symptomatic asymptomatic patient Insights diagnostic performance utility COVID19 screening,34284319,Current literature focused testing saliva symptomatic patient little information available regarding saliva performance asymptomatic severe acute respiratory syndromecoronavirus2 SARSCoV2 infection compared paired saliva nasopharyngeal swab NPS collected 33 symptomatic 12 asymptomatic known SARSCoV2positive patient Saliva overall sensitivity 59 specificity 95 negative predictive value 98 Saliva demonstrated higher sensitivity symptomatic 80 vs asymptomatic individual 36 P = 0006 highrisk symptomatic febrile andor comorbidities 82 vs lowrisk asymptomatic afebrile comorbidities 22 patient P = 00002 Cycle threshold Ct value NPS specimen higher salivanegative vs salivapositive case P = 002 0001 Overall finding show despite saliva s low sensitivity asymptomatic SARSCoV2 infection detect infection lower Ct value potentially higher chance viral transmission Additional study warranted fully evaluate saliva screening test coronavirus disease2019,asymptomatic;covid-19;nasopharyngeal swab;sars-cov-2;saliva;screening
Misalignment COVID19 hotspot clinical trial site,34352105,Hundreds interventional clinical trial launched United States identify effective treatment strategy combating COVID19 pandemic However date small fraction trial completed enrollment delaying scientific investigation COVID19 treatment option study present novel metric examine geographic alignment COVID19 hotspot interventional clinical trial site evaluate trial access time evolving pandemic Using temporal COVID19 case data USAFactsorg trial data ClinicalTrialsgov US county categorized based number case trial analysis suggests alignment access worsened pandemic shifted time recommend strategy metric evaluate alignment case trial Future study warranted investigate impact misalignment case clinical trial site clinical trial recruitment,
Association anemia COVID19 hospitalized patient,34290821,Aim COVID19 major threat public health worldwide large proportion COVID19 patient proved develop anemia Herein investigate association anemia severe pneumonia Materials method 137 COVID19confirmed patient admitted Wuhan Union Hospital Wuhan China 13 February 17 March 2020 included clinical characteristic laboratory data studied multivariable logistic regression analysis performed Results anemic patient le likely develop fever early stage COVID19 Elevated IL6 level found anemic COVID19 patient compared without anemia COVID19 patient anemia 82 time greater possibility developing severe pneumonia compared counterpart without anemia Conclusion study comprehensively describes clinical characteristic anemic patient ordinary severe critical COVID19 demonstrates close relationship anemia severe COVID19,covid-19 and blood oxygen levels;anemia;hemoglobin
Second wave COVID19 Italy Preliminary estimation reproduction number cumulative case projection,34336564,second wave novel coronavirus Italy caused 247369 new case 1782 death October 2020 significantly alarming infectious disease controlling board impose mitigation measure controlling epidemic growth paper estimate latest COVID19 reproduction number R0 project epidemic size future 45 day R0 value calculated 283 95 CI 1542 cumulative incidence 100015 95 CI 73201100352 daily incidence might reached 15012 95 CI 823416197 respectively,epidemic size;italian population;projections;second wave covid-19
Olfactory Dysfunction Patients Infected 2019 Novel Coronavirus,34222108,Introduction current study aimed investigating occurrence feature olfactory dysfunction patient confirmed coronavirus disease 2019 COVID19 infection Materials Methods Patients laboratory clinically confirmed COVID19 infection enrolled longitudinal study managed either inpatient outpatient setting demographic clinical outcome data retrieved patient medical record Olfactory dysfunction feature including onset pattern duration recovery time investigated visual analog scale VAS utilized selfrating subjective measurement olfactory function Results According result mean age patient n=502 obtained 468+185 year moreover 524 476 case female male respectively also revealed 354 645 subject outpatient hospitalized respectively Based finding 178 384 subject olfactory dysfunction mean value VAS hyposmic patient estimated 25+25 83 +21 94+16 first evaluation 2 week 1 month followup P 0001 onset olfactory dysfunction suddenly 587 majority case experienced olfactory dysfunction time symptom 72 511 Based result 04 subject infected COVID19 olfactory dysfunction isolated symptom olfactory dysfunction recovered 2 week 18 253 anosmic 37 468 hyposmic patient Conclusion Olfactory dysfunction seemed important symptom COVID19 infection occurrence disturbance transient selflimited condition significantly higher among female subject,covid-19;olfactory dysfunction;smell disorder
Reviewing Antiviral Research Viruses Causing Human Diseases Structure Guided Approach,34348638,littlest pathogen virus continuously foremost strange microorganism consider Viral Infections cause extreme sickness archived HIVAIDS widespread later Ebola Zika episode Apprehensive framework distortion regularly watched result numerous viral contamination Besides numerous infection oncoviruses trigger different sort cancer Nearly every year modern infection specie rise debilitating world populace annihilating episode Subsequently need creating antiviral combat rising infection case innovation begin antiviral medicate Idoxuridine 1962 revelation Baloxavir marboxil Xofluza FDAapproved 2018 hone creating antiviral changed significantly article different auxiliary science strategy described referral therapeutic innovation,antivirals;covid-19;cancer;cryo-em;drug design;structural biology;virus;x-ray crystallography
antiandrogen enzalutamide downregulates TMPRSS2 reduces cellular entry SARSCoV2 human lung cell,34210968,SARSCoV2 attack various organ destructively lung cellular entry requires two host cell surface protein ACE2 TMPRSS2 Downregulation one thus potential therapeutic approach COVID19 TMPRSS2 known target androgen receptor ligandactivated transcription factor androgen receptor activation increase TMPRSS2 level various tissue notably prostate show treatment antiandrogen enzalutamidea welltolerated drug widely used advanced prostate cancerreduces TMPRSS2 level human lung cell mouse lung Importantly antiandrogens significantly reduced SARSCoV2 entry infection lung cell support experimental data analysis existing datasets show striking coexpression AR TMPRSS2 including specific lung cell type targeted SARSCoV2 Together data presented provides strong evidence support clinical trial ass efficacy antiandrogens treatment option COVID19,
Evaluation vertical transmission SARSCoV2 utero Nine pregnant woman newborn,34217121,INTRODUCTION Severe acute respiratory syndrome coronavirus 2 SARSCoV2 mainly transmitted droplet close contact caused pandemic worldwide March 2020 According current case report cohort study symptom pregnant woman infected SARSCoV2 similar normal adult may cause series adverse consequence pregnancy placental abruption fetal distress epilepsy pregnancy etc However whether SARSCoV2 transmitted fetus placental barrier still focus debate METHODS study order find whether SARSCoV2 infect fetus placental barrier performed qualitative detection virus structural protein spike protein nucleoprotein targeted receptor protein Angiotensin Converting Enzyme 2 ACE2 Basigin CD147 molecular chaperone GRP78 expression placental tissue seven pregnant woman diagnosed COVID19 immunohistochemistry Amniotic fluid neonatal throat anal swab breastmilk sample collected immediately operating room delivery room verification delivery tested SARSCoV2 reverse transcriptionpolymerase chain reaction RTPCR RESULTSDISCUSSION result showed CD147 expressed basal side chorionic trophoblast cell membrane ACE2 expressed maternal side GRP78 strongly expressed cell membrane cytoplasm RTPCR result Amniotic fluid neonatal throat anal swab breastmilk sample negative basis finding speculated may due placental barrier mother baby example villous matrix interstitial blood vessel low expression virusrelated receptor ACE2 CD147 GRP78 probability vertical transmission SARSCoV2 placenta low,covid-19;placenta infection;sars-cov-2;targeted receptor protein expression;vertical transmission
review antiviral activity Chitosan including patented application potential use COVID19,34218488,Chitosan abundant organic polysaccharide relatively easily obtained chemical modification animal fungal source material Chitosan derivative shown exhibit direct antiviral activity useful vaccine adjuvant potential antiSARSCoV2 activity thorough timely review look recent history investigation role chitosan derivative antiviral agent proposes future application treatment endemic SARSCoV2,covid;adjuvant;antimicrobial;antiviral;chitosan;coronavirus;nanoparticles;vaccine
TimeVariant Positive Air Pressure Drainage Stacks Pathogen Transmission Pathway COVID19,34199937,Timevariant positive air pressure drainage stack pose risk pathogenic virus transmission habitable space however excessive risk significance yet sufficiently addressed drainage system design study proposes novel measure probable pathogenic virus transmission risk highrise drainage stack occurrence positive air pressure proposed approach based timevariant positive air pressure measured 38 high drainage stack fullscale experimental tower steady flow condition flow rate 14 Ls 1 discharging height 15 33 stack base maximum pressure probabilistic positive air pressure discharging stack ventilation section water Zone discharging drainage stack determined demonstrated positive air pressure lower frequency compared stack zone could propagate along upper 13 portion ventilation pipe H = 063 towards ventilation opening rooftop probabilistic positive pressure stack height found related water discharging height flow rate risk model positive air pressure proposed Taking 119th 124th 140th 11547th COVID19 case epidemiological investigation Hong Kong baseline concern excessive risk system overuse evaluated result showed 2080 increase frequency discharge flow rate number floor identified risk increased 1 9 1 6 34 25storey residential building respectively outcome apply facility planning selfquarantine arrangement highrise building pathogenic virus transmission associated drainage system overuse concern,covid-19;drainage stack;experiment;high-rise;pathogen transmission;positive air pressure
Frequency Thrombocytopenia Platelet Factor 4Heparin Antibodies Patients Cerebral Venous Sinus Thrombosis Prior COVID19 Pandemic,34213527,Importance Cases cerebral venous sinus thrombosis combination thrombocytopenia recently reported within 4 28 day vaccination ChAdOx1 nCov19 AstraZenecaOxford Ad26COV2S JanssenJohnson Johnson COVID19 vaccine immunemediated response associated platelet factor 4heparin antibody proposed underlying pathomechanism Objective determine frequency admission thrombocytopenia heparininduced thrombocytopenia presence platelet factor 4heparin antibody patient diagnosed cerebral venous sinus thrombosis prior COVID19 pandemic Design Setting Participants descriptive analysis retrospective sample consecutive patient diagnosed cerebral venous sinus thrombosis January 1987 March 2018 7 hospital participating International Cerebral Venous Sinus Thrombosis Consortium Finland Netherlands Switzerland Sweden Mexico Iran Costa Rica 952 patient 865 available baseline platelet count included subset 93 patient frozen plasma sample collected previous study September 2009 February 2016 analyzed presence platelet factor 4heparin antibody Exposures Diagnosis cerebral venous sinus thrombosis Main Outcomes Measures Frequencies admission thrombocytopenia platelet count 150 x103muL heparininduced thrombocytopenia diagnosed treating physician platelet factor 4heparin IgG antibody optical density 04 subset patient previously collected plasma sample Results 865 patient median age 40 year interquartile range 2953 year 70 woman 73 84 95 CI 68 105 thrombocytopenia mild 100149 x103muL 52 60 moderate 5099 x103muL 17 20 severe 50 x103muL 4 05 Heparininduced thrombocytopenia platelet factor 4heparin antibody diagnosed single patient 01 95 CI 01 07 convenience sample 93 patient cerebral venous sinus thrombosis included laboratory analysis 8 9 thrombocytopenia none 95 CI 0 4 platelet factor 4heparin antibody Conclusions Relevance patient cerebral venous sinus thrombosis prior COVID19 pandemic baseline thrombocytopenia uncommon heparininduced thrombocytopenia platelet factor 4heparin antibody rare finding may inform investigation possible association ChAdOx1 nCoV19 Ad26COV2S COVID19 vaccine cerebral venous sinus thrombosis thrombocytopenia,
impact COVID19 pandemic waiting time elective surgery patient multicenter study,34228727,BACKGROUND concern health care reorganization first COVID19 wave led delay elective surgery resulting increased complication even mortality multicenter study examined change waiting time elective surgery COVID19 pandemic Finland METHODS Data elective surgery gathered three Finnish public hospital year 20172020 Surgery incidence waiting time examined year 2020 compared reference year 20172019 mean annual monthly weekly waiting time calculated 95 confidence interval CI common diagnosis group examined separately FINDINGS total 88 693 surgery included study period mean waiting time 2020 926 CI 915938 day whereas mean waiting time reference year 858 CI 851865 day resulting average 8 increase waiting time 2020 Elective procedure incidence decreased rapidly onset first COVID19 wave March 2020 recovered May June surgery incidence 22 higher reference year remained level end year May 2020 thereafter November waiting time longer monthly increase varying 7 34 gastrointestinal genitourinary disease neoplasm waiting time longer 2020 cardiovascular musculoskeletal disease waiting time shorter 2020 CONCLUSION health care reorganization due pandemic increased elective surgery waiting time much onethird even though elective surgery rate increased onefifth lockdown,
Targeted Minimal StafftoPatient Ratios Unachievable Nationwide Survey German ICUs COVID19 Pandemic,34290932,Introduction Adequate staffing intensive care unit ICUs important factor provide optimal care ensure favorable outcome critically ill patient Recently need ICU bed reached unprecedented level management treatment critically ill patient focus aim study ass targeted actual nursetopatient NPR physiciantopatient ratio PPR regarding patient without COVID19 Methods conducted nationwide online survey assessing standard care German ICUs treating patient COVID19 asked question regarding targeted PPR NPR implementation daily clinical practice head German ICU department Results received 244 response 171 eligible final analysis Targeted median PPR ratio 8 interquartile range IQR = 4 targeted NPR 2 IQR = 1 COVID19 patient median targeted PPR 6 IQR = 2 median targeted NPR 2 IQR = 0 Targeted PPRs rarely met 152 never met 35 responding institution Targeted NPRs rarely met 322 never 53 responding institution Conclusion contrast PPR targeted NPRs largely unattainable German ICUs result raise concern view study linking worse outcome critically ill patient suboptimal NPRs warrant health policy effort regarding optimal staffing ICU,covid-19;icu;nurse-to-patient-ratio;nursing shortage;physician-to-patient-ratio;staffing
Chest Computed Tomography Severity Score Predict Adverse Outcomes Patients COVID19,34216124,BACKGROUND novel coronavirus disease 2019 COVID19 continues wreak havoc worldwide study assessed ability chest computed tomography CT severity score CSS predict intensive care unit ICU admission mortality patient COVID19 pneumonia MATERIALS METHODS total 192 consecutive patient COVID19 pneumonia aged 20 year typical CT finding reversetranscription polymerase chain reaction positive admitted tertiary hospital included Clinical symptom admission shortterm outcome obtained semiquantitative scoring system used evaluate parenchymal involvement association CSS disease severity outcome evaluated Prediction CSS assessed area receiveroperating characteristic ROC curve RESULTS incidence admission ICU 228 men 141 woman CSS related ICU admission mortality Areas ROC curve 0764 total CSS Using stepwise binary logistic regression model gender age oxygen saturation CSS significant independent relationship ICU admission death Patients CSS =125 fourtime risk ICU admission death odds ratio 166 95 confidence interval 166 925 multivariate regression analysis showed superiority CSS clinical information comorbidities CONCLUSION CSS strong predictor progression ICU admission death substantial role noncontrast chest CT imaging presence typical feature COVID19 pneumonia reliable predictor clinical severity patient s outcome,covid-19;ct severity score;chest ct;prognosis;sars-cov-2
Prevalence SARSCoV2 Infection University Barcelona Third COVID19 Pandemic Wave Spain,34204383,severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic started December 2019 still major global health challenge Lockdown measure social distancing sparked global shift towards online learning deeply impacted university daily life University Barcelona UB exception Accordingly aimed determine impact SARSCoV2 pandemic UB end performed crosssectional study sample 2784 UB member n = 52529 Participants answered brief ad hoc online epidemiological questionnaire provided nasal swab reverse transcription polymerase chain reaction RTPCR SARSCoV2 analysis venous blood sample SARSCoV2 IgG antibody assay Total prevalence SARSCoV2 infection positive RTPCR positive IgG 149 95 CI 133 170 Fortyfour participant 16 95 CI 1221 positive SARSCoV2 RTPCR IgG SARSCoV2 observed 128 95 CI 116141 participant Overall waiting population vaccination andor increased herd immunity concentrate identifying isolating new case contact,covid-19 prevalence;sars-cov-2;spain;administrative and service staff;coronavirus;faculty members;infection status;seroprevalence;students;university community
CardioCerebral Infarction FreeFloating Thrombosis Hyperperfusion COVID19,34208052,Cardiocerebral infarction refers acute ischemic stroke AIS acute myocardial infarction AMI occur concurrently uncommon phenomenon grave prognosis Intraluminal carotid thrombus ICT infrequently encountered cause ischemic stroke associated underlying hypercoagulable state One severe yet prevalent complication infection Coronavirus Disease 2019 COVID19 thrombosis multipathway inflammatory response present unique case cardiocerebral infarction freefloating intraluminal thrombus left internal carotid artery setting recent COVID19 infection etiology event attributed COVID19 hypercoagulable state CT perfusion imaging also showed interesting imaging finding hyperperfusion believed form dysfunctional cerebral autoregulation,covid-19;neuroimaging;perfusion;stroke;thrombus
Antimicrobial resistance low middleincome country current status future direction,34225545,Introduction Rising rate antimicrobial resistance AMR globally continue pose agrave threat human health Low middleincome country LMICs disproportionately affected partly due high burden communicable diseasesAreas covered reviewed current trend AMR LMICs examined force driving AMR region state intervention undertaken curb AMR across developing world discussed impact current COVID19 pandemic effort exploredExpert opinion dynamic drive AMR LMICs inseparable political economic sociocultural environmental force shape nation COVID19 pandemic exacerbated underlying factor increase AMR progress made implementing surveillance measure LMICs implementation concrete measure meaningfully impact AMR rate must address underlying structural issue generate promote AMR turn require large infrastructural investment significant political,antibiotic use;antimicrobial resistance (amr);antimicrobial stewardship;low- and middle-income countries (lmics);review
GenomeWide Analysis Codon Usage Patterns SARSCoV2 Virus Reveals Global Heterogeneity COVID19,34207362,ongoing outbreak coronavirus disease COVID19 significantly implicated global heterogeneity genome organization severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent global heterogeneity whole genome SARSCoV2 well characterized due lack comparative study large enough sample size around globe reduce standard deviation acceptable margin error better understand SARSCoV2 genome architecture performed comprehensive analysis codon usage bias sixty 60 strain get snapshot global heterogeneity study show relatively low codon usage bias SARSCoV2 viral genome globally nearly overpreferred codon AU ended concluded SARSCoV2 genome primarily shaped mutation pressure however marginal selection pressure overlooked Within AU rich virus genome SARSCoV2 standard deviation GC 4291 + 584 GC3 value 3014 + 693 point towards global heterogeneity virus Several SARSCoV2 viral strain originated different viral lineage exact geographic location also support fact Taking together finding suggest general root ancestry global genome different different genome s level adaptation host research may provide new insight codon pattern host adaptation global heterogeneity SARSCoV2,covid-19;codon usage bias;coronavirus;sars-cov-2;heterogeneity of covid-19;mutational bias;natural selection
SelenoFunctionalization Quercetin Improves NonCovalent Inhibition pro Antiviral Activity Cells SARSCoV2,34208928,development new antiviral drug SARSCoV2 valuable longterm strategy protect global population COVID19 pandemic complementary vaccination Considering viral main protease pro among promising molecular target light importance viral replication cycle natural flavonoid quercetin 1 recently reported potent pro inhibitor vitro explored effect produced introduction organoselenium functionality scaffold particular report new synthetic method prepare previously inaccessible C8 selenoquercetin derivative screening small library flavonols flavone derivative observed compound inhibit protease activity vitro first time demonstrate quercetin 1 8 ptolylselenyl quercetin 2d block SARSCoV2 replication infected cell nontoxic concentration IC50 192 muM 8 muM respectively Based docking experiment driven experimental evidence propose noncovalent mechanism pro inhibition hydrogen bond selenium atom Gln189 residue catalytic pocket could explain higher pro activity 2d result better antiviral profile,sars-cov-2;flavanols;main protease;selenium
Diabetes increase risk COVID19 altitude dependent manner analysis 1280806 Mexican patient,34343179,AIMS objective study analyze impact Diabetes Mellitus DM patient COVID19 varies according altitudinal gradient METHODS obtained 1280806 record adult patient COVID19 DM analyze probability COVID19 development COVID19 pneumonia hospitalization intubation admission Intensive Care Unit ICU casefatality rate CFR Variables controlled age sex altitude residence calculate adjusted prevalence prevalence ratio RESULTS Patients DM 218 higher prevalence COVID19 additional 1202 higher prevalence COVID19 pneumonia adjusted prevalence also higher outcome well hospitalization intubation ICU admission COVID19 pneumonia patient DM 970 194 higher CFR respectively increasing altitude probability confirmed COVID19 case development pneumonia decreased along CFR patient without DM However COVID19 patient DM likely require intubation residing high altitude CONCLUSIONS study suggests patient DM higher probability confirmed COVID19 case developing pneumonia Higher altitude protective relationship SARSCoV2 infection however may associated severe case patient without DM High altitude decrease CFR COVID19 patient work also show woman le affected men regardless altitude,
Quantifying COVID19 importation risk dynamic network domestic city international country,34285082,Since outbreak December 2019 novel coronavirus 2019 COVID19 spread 191 country caused million death Many country experienced multiple epidemic wave faced containment pressure domestic international transmission study conduct multiscale geographic analysis spread COVID19 policyinfluenced dynamic network quantify COVID19 importation risk different policy scenario using evidence China spatial dynamic panel data SDPD model explicitly distinguishes effect travel flow effect transmissibility within city across city across national border find withincity transmission dominant transmission mechanism China beginning outbreak domestic transmission mechanism muted significantly weakened importation posed threat identify effective containment policy matching change point domestic importation transmissibility parameter timing various intervention simulation suggest importation risk limited domestic transmission control cumulative case would almost 13 time higher domestic transmissibility resurged precontainment level importation 32 time higher domestic transmissibility remained precontainment level since outbreak finding provide practical insight infectious disease containment call collaborative coordinated global suppression effort,covid-19;importation risk;mobility networks;spatial dynamic panel data model;spatiotemporal analysis
critical overview computational approach employed COVID19 drug discovery,34212944,COVID19 resulted huge number infection death worldwide brought severe disruption society economy since Great Depression Massive experimental computational research effort understand characterize disease rapidly develop diagnostics vaccine drug emerged response devastating pandemic 130 000 COVID19related research paper published peerreviewed journal deposited preprint server Much research effort focused discovery novel drug candidate repurposing existing drug COVID19 many project either exclusively computational computeraided experimental study Herein provide expert overview key computational method application discovery COVID19 smallmolecule therapeutic reported research literature outline first year COVID19 pandemic appears drug repurposing produced rapid global solution However several known drug used clinic cure COVID19 patient repurposed drug continue considered clinical trial along several novel clinical candidate posit truly impactful computational tool must deliver actionable experimentally testable hypothesis enabling discovery novel drug drug combination open science rapid sharing research result critical accelerate development novel much needed therapeutic COVID19,
SARSCoV2 Acute Cerebrovascular Events Overview,34362133,Since coronavirus disease 2019 COVID19 pandemic due severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection accumulating evidence indicates SARSCoV2 infection may associated various neurological manifestation including acute cerebrovascular event ie stroke cerebral venous thrombosis event occur prior even onset COVID19 s general symptom Although mechanism underlying cerebrovascular complication patient COVID19 yet fully elucidated hypercoagulability state inflammation altered angiotensinconverting enzyme 2 ACE2 signaling association SARSCoV2 may play key role ACE2 play critical role preserving heart brain homeostasis review discus current state knowledge possible mechanism underlying acute cerebrovascular event patient COVID19 review current epidemiological study case report neurovascular complication association SARSCoV2 well relevant therapeutic approach considered worldwide number published COVID19 case cerebrovascular event growing prospective study would help gather valuable insight pathophysiology cerebrovascular event effective therapy factor predicting poor functional outcome related event COVID19 patient,angiotensin-converting enzyme 2 (ace-2);cerebral venous thrombosis;coronavirus disease 2019 (covid-19);hypercoagulability;severe acute respiratory syndrome coronavirus 2 (sars-cov-2);stroke
Vaccination status COVID19 related mortality hospital based cross sectional study,34334894,Background Efficacy vaccine studied clinical trial setting likely different effectiveness realworld scenario Indian Armed Forces launched vaccine drive COVID19 16 Jan 2021 study evaluated effect vaccination mortality amongst hospitalized COVID patient Methods cross sectional study done admitted moderate severe COVID19 patient designated COVID hospital New Delhi primary outcome assessed association fully vaccinated mortality Unadjusted odds ratio 95 CI performed predictor Logistic regression used multivariable analysis adjusted odds ratio obtained Results 1168 patient included study male preponderance mean age 546 + 1751 year total 266 23 patient partially vaccinated COVISHIELD R 184 16 fully vaccinated Overall 518 443 patient comorbidities 332 284 died Among fully vaccinated 125 23184 mortality 3145 309984 among unvaccinated 03 95 CI 02 05 p 00001 logistic regression model complete vaccination status younger age found associated survival Conclusions Vaccination two dos COVISHIELD R associated lower odds mortality among hospitalized patient moderate severe COVID,covishield;covid-19;cross sectional study;predictors of mortality;vaccination
Lifestylemediated nitric oxide boost prevent SARSCoV2 infection perspective,34364972,severe acute respiratory syndrome coronavirus 2 SARSCoV2 spread worldwide seriously threatened public health causing significant morbidity mortality Patients coronavirus disease COVID19 preexisting endothelial dysfunction caused aging diabetes hypertension obesity high risk lifethreatening thromboembolic complication suggests possibility reduced endothelial nitric oxide production bioavailability could common underlying pathology progression COVID19 Increasingly evidence experimental clinical study SARSCoV2 infection show inhibits pathogenesis COVID19 including virus entry host cell viral replication host immune response subsequent thromboembolic complication Restoring bioavailability may potential preventive earlytreatment option COVID19 review aim provide indepth discussion bioavailability prevent SARSCoV2 infection particularly focusing lifestyle factor nitraterich diet physical exercise nasal breathing could easily performed daily basis boost bioavailability,ards;covid-19;endothelial dysfunction;lifestyle;nitric oxide;sars-cov-2
Effect Aprotinin Avifavir R Combination Therapy Moderate COVID19 Patients,34199134,COVID19 contagious multisystem inflammatory disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 studied efficacy Aprotinin nonspecific serine protease inhibitor combination Avifavir R Hydroxychloroquine HCQ drug recommended Russian Ministry Health treatment therapy moderate COVID19 patient prospective singlecenter study included participant moderate COVID19related pneumonia laboratoryconfirmed SARSCoV2 admitted hospital Patients received combination intravenous IV Aprotinin 1000000 KIU daily 3 day HCQ cohort 1 inhalation inh treatment Aprotinin 625 KIU four time per day 5 day HCQ cohort 2 IV Aprotinin 1000000 KIU daily 5 day Avifavir cohort 3 cohort 13 combination therapy showed 100 efficacy preventing transfer patient n = 30 intensive care unit ICU effect combination therapy cohort 3 prominent median time SARSCoV2 elimination 35 day IQR 3040 normalization CRP concentration 35 day IQR 35 Ddimer concentration 5 day IQR 4 5 body temperature 1 day IQR 13 improvement clinical status discharge hospital 5 day IQR 55 improvement lung lesion patient 14 day 100,covid-19;sars-cov-2;aprotinin;favipiravir
Hypokalaemic Paralysis Associated COVID19 Infection,34227783,Introduction COVID19 pandemic affecting mainly respiratory gastrointestinal system Severe acute respiratory syndrome coronavirus2 SARSCOV2 bind angiotensin converting enzyme 2 ACE2 reninangiotensin system RAS resulting hypokalaemia hereby report hypokalaemic paralysis induced COVID19 Case 56 year old male comorbidities presented fever 2days weakness bilateral lower limb 1 day severe hypokalaemia serum potassium 205 mEqL RTPCR nasopharyngeal swab SARSCoV 19 positive diagnosed case hypokalaemic paralysis induced COVID19 infection Conclusion suggest pandemic era COVID19 patient present paralysis hypokalaemia induced paralysis kept differential diagnosis known COVID19 infection lead hypokalemia new Hypokalaemic paralysis manifestation COVID19,
Near realtime observation reveals increased prevalence young patient ICU emerging third SARSCoV2 wave Switzerland,34291810,AIMS STUDY ongoing COVID19 pandemic launch largescale vaccination campaign virus mutation hinted possible change transmissibility virulence affecting disease progression critical illness carry potential future vaccination failure monitor disease development time respect critically ill COVID19 patient report near realtime prospective observational data RISC19ICU registry indicate changed characteristic critically ill patient admitted Swiss intensive care unit ICUs onset third pandemic wave METHODS 1829 3344 critically ill COVID19 patient enrolled international RISC19ICU registry 31 May 2021 treated Switzerland included present study 1690 patient admitted ICU 1 February 2021 compared 139 patient admitted emerging third pandemic wave RESULTS Third wave patient mean 52 year 95 confidence interval CI 32 ndash 71 younger median 660 year interquartile range IQR 570 ndash 730 v 620 year IQR 545 ndash 680 p lt 00001 higher body mass index patient admitted previous pandemic period presented lower SAPS II APACHE II score le need circulatory support lower white blood cell count ICU admission PF ratio similar 14 increase ventilatory ratio observed time p = 003 CONCLUSION Near realtime registry data show latest COVID19 patient admitted ICUs Switzerland onset third wave average 5 year younger higher body mass index presented lower physiological risk score trend towards severe lung failure difference may primarily related ongoing nationwide vaccination campaign possibility change virushost interaction may cofactor age shift change disease characteristic cause concern taken account public health vaccination strategy ongoing pandemic ClinicalTrialsgov Identifier NCT04357275,
Care Leukemic Patients Times SARSCoV2,34342734,PURPOSE REVIEW spread novel coronavirus SARSCoV2 associated disease coronavirus disease 2019 COVID19 significantly derailed cancer care Patients leukemia likely severe infection increased rate mortality paucity information modify care leukemia patient view COVID19 risk imposed restriction review available literature impact COVID19 different type leukemia patient suggest general well diseasespecific recommendation care based available evidence RECENT FINDINGS COVID19 infection impact leukemia subtypes variable way standard treatment leukemia similarly varying effect course COVID19 infection Useful treatment strategy include deferring treatment possible use le intensive regimen outpatient targeted oral agent requiring minimal monitoring prioritization curative lifeprolonging strategy Reducing health care encounter rational transfusion standard resource allocation preemptive advance care planning serve interest leukemia patient Ad hoc modification based expert opinion extrapolation previous welldesigned study way forward navigate crisis supplanted rigorous prospective evidence,covid-19;coronavirus;leukemia;pandemic
Screening Olfactory Dysfunction COVID19 Patients Using Quick Smell Identification Test,34226867,OBJECTIVE determine prevalence OD confirmed case COVID19 among population using quick smell identification test QSIT screening tool METHODS Cross sectional study carried Qatif areaSaudi Arabia among adult hospitalized patient confirm COVID19 period May July 2020 adult confirmed COVID19 patient interviewed history current disease associated symptom well performing QSIT Participants history olfactory dysfunction critical case required ICU admission excluded RESULTS prevalence OD among COVID19 case 163 population using QSIT compared 274 selfreported symptom Females higher prevalence compare male 305 111 respectively statistically significant P 0001 patient reported higher prevalence ageusia 319 significant association OD P 0001 QSIT showed high positive negative predictive value detecting OD among patient COVID19 84 93 respectively CONCLUSION QSIT useful validated easy apply tool screening OD among patient COVID19 patient presented solely symptom occurs unnoticed COVID19 patient required objective test detection,covid-19;odor;olfaction disorders;prevalence;smell test
National Trends Cycling Light Norwegian Bike Traffic Index,34201144,National international strategy recommendation intended increase physical activity general population Active transportation included interdisciplinary strategy meet recommendation Cycling seems health enhancing walking transportation since cycling seems reduce risk cardiovascular disease associated risk factor Furthermore health benefit cycling proven outrun risk injury mortality Politicians seem approve costly infrastructure strategy increase amount cycling population improve public health shift sustainable travel habit linear relationship cyclefriendly infrastructure amount commuter cycling demonstrated However Norway global level lack robust evaluation action sensitive monitoring system observe possible change Therefore aimed develop Norwegian bike traffic index describe national regional local trend counted cycle trip used transparent methodology index used developed adapted country included 89 stationary counter whole country Counters monitored cycling 2018 onward index organized local regional national level Furthermore index adjusted population density counter level presented ratio counted cycle trip comparing 2018 subsequent year index presented percentage change 95 confidence interval Norway counted cycle trip increased 11 2018 100 100100 2020 1110 10621151 large geographical difference Southern Norway significant increase 23 Northern Norway nonsignificant decrease 8 2018 2020 index may indicate possible related effect local national cycling strategy COVID19 pandemic affected Norwegian travel habit urban area,active travel;bicycle transport;employee commuting;monitoring bicycle employee ride;the norwegian bike traffic index
Detection Alpha Betacoronaviruses Miniopterus fuliginosus Rousettus leschenaultii two specie Sri Lankan Bats,34203592,Bats known potential reservoir numerous humanpathogenic virus identified natural host coronaviruses causing Severe Acute Respiratory Syndrome SARS human Since emergence SARSCoV2 2019 interest prevalence coronaviruses bat newly raised study investigated different bat specie living sympatric colony Wavul Galge cave Koslanda Sri Lanka three field session 2018 2019 395 bat captured Miniopterus Rousettus Hipposideros Rhinolophus spp either rectal swab fecal sample collected overall 396 rectal swab fecal sample screening coronaviruses nested PCR resulted 33 positive sample 31 originated Miniopterus fuliginosus two Rousettus leschenaultii Sanger sequencing phylogenetic analysis obtained 384nt fragment RNAdependent RNA polymerase revealed examined M fuliginosus bat excrete alphacoronaviruses examined R leschenaultii bat excrete betacoronaviruses Despite sympatric roosting habitat coronaviruses showed host specificity seemed limited one specie result represent important basis better understand prevalence coronaviruses Sri Lankan bat may provide basis pursuing study particular bat specie interest,miniopterus fuliginosus;rousettus leschenaultii;sri lanka;alphacoronavirus;bat coronavirus;betacoronavirus;cave-dwelling;sympatric colony
Antibodies Responses SARSCoV2 Large Cohort Vaccinated Subjects Seropositive Patients,34358130,COVID19 current global threat characterization antibody response vitally important update vaccine development strategy study assessed SARSCoV2 antibody concentration SARSCoV2 positive patient N = 272 subject vaccinated BNT162b2 mRNA COVID19 vaccine N = 1256 participant sociodemographic data COVID19 vaccination record serological analysis SARSCoV2 infection status collected IgG antibody S1S2 antigen SARSCoV2 detected Almost vaccinated subject 998 showed seropositivity antiSARSCOV2 IgG 80 vaccinated subject IgG concentration 200 AUmL Tobit multivariable regression analysis SARSCoV2 vaccination statistically significantly associated increased IgG concentration beta coef = 2664 p 0001 statistically significant reduction SARSCoV2 IgG concentration found older age beta coef = 196 per year increase p 0001 male sex beta coef = 223 p 0001 day immunization beta coef = 167 per day increase p 0001 finding could support vaccination campaign confirming high immunogenicity SARSCoV2 vaccine investigation respect natural infection study required evaluating role age day immunization persistence vaccine antibody protection disease,covid-19 vaccine;sars-cov-2 infection;antibody concentrations
Risk Assessment Infection Airborne Droplets Aerosols Different Levels Cardiovascular Activity,34226815,Since end 2019 COVID19 pandemic caused SARSCoV2 virus threatening humanity Despite fact various scientist across globe try shed light new respiratory disease yet fully understood Unlike many study geographical spread pandemic including study external transmission route work focus droplet aerosol transport deposition inside human airway purpose digital replica human airway used particle transport various level cardiovascular activity enclosed space studied mean computational fluid dynamic influence room size activity take place aerosol concentration studied contribution aim ass risk various level exercising inhaling infectious pathogen gain insight deposition behavior aerosol human airway size distribution expiratory droplet aerosol play crucial role disease onset progression size expiratory droplet aerosol differs various exhaling scenario reported experimental particle size distribution taken account setting environmental condition model aerosol deposition employ OpenFOAM using EulerLagrangian frame including ReynoldsAveraged NavierStokes resolved turbulent flow Within study effect different exercise level thus breathing rate well particle size distribution room size investigated enable new insight local particle deposition human airway virus load general observation made exercising higher level activity increasing risk develop severe cause COVID19 disease due increased aerosolized volume reach lower airway thus knowledge inhaled particle dynamic human airway various exercising level provides valuable information infection control strategy,
codesign clinical virtual care pathway engage support family requiring neonatal intensive care response COVID19 pandemic COVES study,34220279,Background response COVID19 pandemic family presence restriction neonatal intensive care unit NICU enacted limit disease transmission resulted communication challenge negatively impacting family integrated care Aim develop clinical care pathway ensure optimal neonatal care support family response parental presence restriction imposed COVID19 pandemic Methods agile codesign process utilizing expert consensus large interdisciplinary team focus group semistructured interview family HCPs used codesign clinical virtual care pathway Results Three clinical virtual care pathway codesigned 1 building maintaining relationship family healthcare provider 2 awareness resource 3 standardized COVID19 messaging Modifications made optimize uptake utilization clinical area Conclusion Clinical care virtual pathway successfully codesigned meet need ensure equitable family centered care,covid-19;co-design;neonatal intensive care;virtual pathways
Impact pandemic surgical activity colorectal cancer Spain Results national survey,34210653,INTRODUCTION pandemic impact colorectal cancer surgery hospital 2020 75 colorectal cancer patient estimated require surgery objective data impact pandemic management surgical waiting list available conducted survey colorectal surgery unit ass impact colorectal cancer surgery waiting list METHOD personnel charge colorectal surgery unit nationwide received survey February April 2020 eight question divided three sectionscessation date colorectal cancer surgery number patient waiting treatment use neoadjuvant therapy postpone surgery RESULTS Sixtyseven unit participated study 791 unit ceasing type activity 328 total 463 partial cessation 209 continuing surgical activity addition 65 unit used prolonged neoadjuvant therapy rectal cancer patient 40 unit performed least five emergency colorectal cancer surgery estimated least one month intense surgical activity required catch CONCLUSIONS Currently patient unit long waiting list must redistributed least within country future event second wave pandemic effective program manage unit s resource developed prevent total collapse,covid-19;colorectal cancer;coronavirus;cancer colorrectal;pandemia;pandemic;sars-cov-2
SARSCoV2 surveillance Norway rat Rattus norvegicus Antwerp sewer system Belgium,34224205,SARSCoV2 humantoanimal transmission lead establishment novel reservoir evolution new variant potential start new outbreak human tested Norway rat inhabiting sewer system Antwerp Belgium presence SARSCoV2 following local COVID19 epidemic peak addition discus use interpretation SARSCoV2 serological test nonhuman sample November December 2020 Norway rat oral swab faeces tissue sewer system Antwerp collected tested RTqPCR presence SARSCoV2 Serum sample screened presence antiSARSCoV2 IgG antibody using Luminex microsphere immunoassay MIA Samples considered positive checked neutralizing antibody using conventional viral neutralization test cVNT serum 35 rat tested MIA showing three potentially positive serum later negative cVNT tissue sample 39 rat analysed tested negative SARSCoV2 RNA first study evaluates SARSCoV2 infection urban rat conclude sample rat analysed never infected SARSCoV2 However monitoring activity continue due emergence new variant prone infect Muridae rodent,belgium;muridae;sars-cov-2;disease outbreaks;rats
Renal Resistive Index Kidney Clinics,34213804,Renal Resistive Index RRI measurement resistance renal blood flow value higher 070 marker increased resistance correlated kidney injury severity Additionally may associated mortality rate postsurgery population COVID19 subject found high RRI associated high level serum Creactive protein marker systemic inflammatory reaction syndrome Finally propose RRI marker kidney injury also tool evaluate course critical illness,c-reactive protein;covid-19;acute kidney injury;hemodynamics;systemic inflammatory response syndrome;ultrasounds
Human Models COVID19 Research,34287894,Coronavirus disease 2019 COVID19 infectious disease caused newly emerged severe acute respiratory syndrome SARS coronavirus2 SARSCoV2 COVID19 present diverse clinical spectrum ranging asymptomatic carrier state patient lifethreatening multiorgan failure death Huang et al 48a greatest risk factor severe disease age higher morbidity mortality rate elderly population despite younger people shedding similar level virus Yanez et al 104 overall case fatality rate COVID19 23 rising 148 patient age 80 49 among critically ill Kang Jung 55 Currently therapeutic COVID19 limited overcome important use physiologically relevant model reproduce pathology infection evaluate efficacy antiviral drug Models airway infection including use human infection challenge model welldefined disease relevant vitro system help determine key component perpetuate severity disease briefly review human model currently used COVID19 research drug development article protected copyright right reserved,
Loculated Empyema SARSCoV2 Infection Report Two Cases Review Literature,34377699,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 Clinical manifestation diverse vary mild respiratory symptom severe hypoxic respiratory failure severe case infection cause gastrointestinal renal cardiac neurological haematological complication result multiorgan failure report parapneumonic effusion patient COVID19 describe two patient COVID19 loculated empyema discus clinical course therapeutic option LEARNING POINTS clinical manifestation COVID19 vary mild severe disease result multiorgan failurePleural empyema usually treated combination antibiotic surgical drainage pleural cavity,covid-19;empyema;sars-cov-2;loculated pleural effusion
Candidate AntiCOVID19 Medicinal Plants Ethiopia Review Plants Traditionally Used Treat Viral Diseases,34221083,Background Emerging viral infection among major global public health concern pandemic COVID19 contagious respiratory vascular disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 medicine treat SARSCoV2 except vaccine Therefore searching plantoriginated therapeutic treatment COVID19 required Consequently reviewing medicinal plant used treat different viral infection mandatory review article aim review ethnobotanical knowledge medicinal plant traditionally used treat different viral disease Ethiopian people suggests plant candidate fight COVID19 Methods Articles written English searched online public database using searching term like `` Traditional Medicine `` Ethnobotanical study `` Active component `` Antiviral activity `` Ethiopia Ethnobotanical data analyzed using Excel statistical software program Result 46 article reviewed total 111 plant specie claimed treat viral infection Fiftysix 504 plant specie reported antiviral active component promising treat COVID19 Lycorine gingerol shogaol resveratrol rhoifolin oleanolic acid kaempferol rosmarinic acid almond oil ursolic acid hederagenin nigellidine alphahederin apigenin nobiletin tangeretin chalcone hesperidin epigallocatechin gallate allicin diallyl trisulfide ajoene aloenin artemisinin glucobrassicin curcumin piperine flavonoid anthraquinone hydroxychloroquine jensenone Conclusion Ethiopian traditional knowledge applies lot medicinal plant treat different viral infection Reports chemical component many confirm promising fight COVID19,
COVID Toes Three Siblings,34292264,Dermatologists reported outbreak pernio red purple swollen painful toe COVID19 pandemic subject lacked positive CoV19 polymerase chain reaction PCR antibody preceding illness dermatologist termed illness `` COVID toe Pernio usually affect adult versus `` COVID toe usually child Pernio preceded clear history exposure wet cold Patients `` COVID toe lack history Also unusual multiple family member `` COVID toe case report describes `` COVID toe 18yearold preceding illness negative SARSCoV19 PCR initially negative SARSCoV19 antibody also 2 sibling also developed `` COVID toe index case repeat SARSCoV19 antibody positive Seroconversion rarely reported patient `` COVID toe `` COVID toe patient lack clinical history COVID19 SARSCoV19 PCR antibody negative mystery,
Dexamethasone Treatment COVID19 Primus Inter Pares,34203880,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 rapidly spread globally becoming huge public health challenge Even though vast majority patient asymptomatic patient present pneumonia acute respiratory distress syndrome ARDS septic shock death shown several study severity clinical outcome related dysregulated antiviral immunity enhanced persistent systemic inflammation Corticosteroids used treatment COVID19 patient reported elicit benefit reducing lung inflammation inflammationinduced lung injury Dexamethasone gained major role therapeutic algorithm patient COVID19 pneumonia requiring supplemental oxygen mechanical ventilation wide antiinflammatory action seems form basis beneficial action taming overwhelming `` cytokine storm Amid plethora scientific research therapeutic option COVID19 still unanswered question right timing right dosing right duration corticosteroid treatment aim review article summarize data dexamethasone treatment COVID19 outline clinical consideration corticosteroid therapy patient,covid-19;corticosteroids;dexamethasone
Clinical feature outcome COVID19 positive child tertiary healthcare hospital Karachi,34228363,coronavirus disease 2019 COVID19 pandemic continues evolve difference epidemiological clinical feature among pediatrics noticed across different country describe spectrum COVID19 pediatric patient treated tertiary health care conducted retrospective chart review pediatric patient admitted Indus Hospital Health care network Korangi campus Karachi April 1st 2020 July 31st 2020 total 141 COVID19 case reported male 81 57 median age 8 0317 year Moderate severe infection noted 36 26 17 12 child respectively Fever 50 common clinical feature SF ratio le 264 significantly associated severe disease p 05 Lab investigation differed significantly across disease severity group included IL6 level p 01 Prothrombin time p 05 Majority child advised home isolation 89 63 29 205 admitted mortality observed 10 7 child significant difference observed child without malignancy Preexisting comorbidities significantly associated COVID19 infection among child Reduced SF ratio elevated Prothrombin time interleukin6 level associated greater disease severity,covid-19;infections;interleukin-6;multisystem inflammatory syndrome (mis-c);pandemics;pediatrics;tertiary healthcare
Adversity early life pregnancy immunologically distinct total life adversity macrophageassociated phenotype woman exposed interpersonal violence,34282132,Early childhood pregnancy two sensitive period heightened immune plasticity exposure adversity may disproportionately increase health risk However need deeper phenotyping disentangle impact adversity sensitive period across total lifespan study examined whether retrospective report adversity childhood pregnancy associated inflammatory imbalance ethnically diverse cohort 53 lowincome woman seeking familybased trauma treatment following exposure interpersonal violence Structured interview assessed early life adversity trauma exposure = age 5 pregnancy adversity total lifetime adversity Blood serum assayed proinflammatory TNFa IL1ss IL6 CRP antiinflammatory IL1RA IL4 IL10 cytokine CD14+ monocyte isolated subsample n = 42 gene expression assayed RNA sequencing Illumina HiSeq 4000 TruSeq cDNA library primary outcome macrophageassociated M1M2 gene expression phenotype evaluate sensitivity specificity contrasted M1M2 gene expression second clinicallyvalidated macrophageassociated immunosuppressive phenotype endotoxin tolerance proinflammatory antiinflammatory cytokine level Adjusting demographic socioeconomic status psychopathology higher adversity early life s = 337 p = 0029 pregnancy s = 332 p = 0032 associated higher M1M2 gene expression whereas higher lifetime adversity s = 341 p = 0031 associated lower immunosuppressive gene expression Adversity sensitive period uniquely associated M1M2 imbalance among lowincome woman interpersonal violence exposure Given M1M2 imbalance found sepsis severe COVID19 myriad chronic disease finding implicate novel immune mechanism underlying impact adversity health,
Identification Severe Acute Respiratory Syndrome Coronavirus2 inhibitor silico structurebased virtual screening molecular interaction study,34132436,novel coronavirus Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 COVID19 caused worldwide pandemic fatal virus affected health human being well socioeconomic situation world date concrete medicinal solution proposed combat viral infection calling urgent strategic costeffective drug development approach may achievable applying targeted computational virtual screening protocol Immunity body s natural defense diseasecausing pathogen boosted consuming plantbased natural food product Active constituent derived natural source also scavenge free radical antiinflammatory activity Herbs spice used various medicinal purpose study 296 365 natural synthetic derivative ligand belonging 102 class compound obtained PubChem assessed Lipinski s parameter potential bioavailability derivative 3254 obeyed Lipinski s rule virtually screened 115 top derivative docked SARSCoV2 SARSCoV MERSCoV HCoVHKV1 main protease pro receptor using AutoDock Vina AutoDock iGEMDOCK 21 lowest binding energy exhibited ligand 2 6 four pro s molecular dynamic simulation also performed ligand 6 using GROMACS package Good bioactivity score absorption distribution metabolism excretion toxicity profile druglike pharmacokinetic parameter also obtained Hydroxychloroquine used control drug,lipinski;sars-cov-2;docking;protease;simulation;virtual screening
framework support integration priority setting preparedness alert control evaluation stage disease pandemic,34293263,COVID19 pandemic needresource gap necessitated decision maker context ration access lifesaving intervention demonstrated critical need systematic fair priority setting resource allocation mechanism Disease outbreak becoming increasingly common priority setting lesson previous disease outbreak could better harnessed inform decision making planning future disease outbreak purpose paper discus priority setting resource allocation could ideally integrated pandemic planning preparedness framework used inform COVID19 pandemic recovery plan plan future outbreak Priority setting resource allocation disease outbreak tend evoke process similar rule rescue result inefficient unfair resource allocation negative effect health nonhealth program increased health inequity Integrating priority setting resource allocation activity throughout four phase emergency preparedness framework could ensure priority setting health emergency systematic evidence informed fair,covid-19;ebola;priority setting;pandemic planning;resource allocation
Triangle cytokine storm central nervous system involvement viral infection COVID19 role sFasL neuropilin1,34225390,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 identified cause coronavirus disease 2019 COVID19 often linked extreme inflammatory response activation neutrophil extracellular trap NETs cytokine storm sepsis robust cause multiorgan damage particular potential route SARSCoV2 entry angiotensinconverting enzyme 2 ACE2 linked central nervous system CNS involvement CNS recognized one susceptible compartment cytokine storm affected neuropilin1 NRP1 ACE2 widelyrecognized SARSCoV2 entry pathway However NRP1 recently introduced novel path viral entry Apoptosis cell invaded virus involves Fas receptorFas ligand FasL signaling moreover Fas receptor may function controller inflammation Furthermore NRP1 may influence FasL modulate cytokine profile neuroimmunological insult SARSCoV2 infection may inhibited therapeutic approach targeting soluble Fas ligand sFasL cytokine storm element related viral entry pathway current review explain pivotal player behind activation cytokine storm associated vast CNS injury also hypothesize sFasL may affect neuroinflammatory process trigger cytokine storm COVID19,covid-19;central nervous system;coronavirus;cytokine storm;hyperinflammation;neuropilin-1
Lassa fever amidst COVID19 pandemic Africa rising concern effort challenge future recommendation,34289134,Lassa fever caused Lassa virus Arenaviruses family reemerging public health concern led 300000 infection 5000 death annually Africa Highly prevalent Sierra Leone Liberia Guinea Nigeria Cote dlvoire Ghana Togo Benin patient infected virus manifest cough sore throat headache nausea vomiting among symptom Coexisting coronavirus disease 2019 COVID19 pandemic impact case Lassa fever African population reported decrease due hesitancy visiting clinic lead unreported casesall contributing silent outbreak West Africa Thus overcome current burden gap challenge caused Lassa fever amidst COVID19 Africa various recommendation efficient control transmission measure disease containment strategy correct misperceptions made,africa;covid-19;lassa fever;lassa virus;endemic;infectious disease;pandemic;public health
COVID19 skin lesion rarely positive RTPCR test macrophage activation vascular impact SARSCoV2induced cytokine storm,34213786,BACKGROUND Several skin manifestation reported since start COVID19 pandemic chilblainslike livedoid lesion urticarialike pseudoKawasaki disease others Histopathologic image lesion often show aspect endothelitis image similar autoimmune vasculitis Cutaneous lesion often negative RTPCR SARSCoV2 virus METHOD RESULTS reviewed recent article mechanism COVID19 synthesized main pathway inflammatory cascade penetration cell respiratory epithelium SARSCoV2 virus initiate `` cytokine storm well described previous publication expression interferon type IFNI one key element antiviral response COVID19 patient IFNI expression seems play important role induction interleukin 6 IL6 chemotactic factor GranulocyteMacrophage ColonyStimulating Factor GMCSF consequent activation monocytemacrophage system followed expression TNFalpha finally induction coagulation factor extrinsic intrinsic pathway CONCLUSIONS simplified synthesis main pathophysiological mechanism COVID19 could help u understand least partially importance macrophage activation vascular involvement many skin lesion remain often negative situ test SARSCoV2,
Complete heart block associated Remdesivir COVID19 case report,34222786,Background Since pandemic began 2020 Remdesivir widely used treatment coronavirus disease2019 COVID19 describe case patient COVID19 developed transient complete atrioventricular AV block bradycardia initiating treatment Remdesivir Case summary 72yearold male history atrial fibrillation lung cancer hospitalized COVID19 Electrocardiogram ECG admission demonstrated atrial fibrillation right bundle branch block started course Dexamethasone Remdesivir Within 24 h starting Remdesivir noted atrial fibrillation ventricular rate 30 40 bpm Day 5 Remdesivir therapy ECG demonstrated complete AV block completed Remdesivir regimen next 48 h closely monitored AV block resolved spontaneously remained asymptomatic adequate chronotropic response activity pacemaker implantation recommended Discussion Despite widespread use Remdesivir little known information cardiac toxicity Daily ECGs close cardiac surveillance patient develop severe bradycardia AV block essential Discontinuation medication usually result resolution cardiac disturbance,av block;bradycardia;covid-19;case report;heart block;remdesivir;sars-cov2
Comparative AntiInflammatory Effects Salix Cortex Extracts Acetylsalicylic Acid SARSCoV2 Peptide LPSActivated Human Vitro Systems,34201817,usefulness antiinflammatory drug adjunct therapy improve outcome COVID19 patient intensely discussed paper Willow bark Salix cortex used century relieve pain inflammation fever main active ingredient salicin metabolized human body salicylic acid precursor commonly used pain drug acetylsalicylic acid ASA report vitro antiinflammatory efficacy two methanolic Salix extract standardized phenolic compound comparison ASA context SARSCoV2 peptide challenge Using SARSCoV2 peptideIL1beta LPSactivated human PBMCs inflammatory intestinal Caco2HT29MTX coculture Salix extract ASA concentrationdependently suppressed prostaglandin E2 PGE2 principal mediator inflammation inhibition COX2 enzyme activity protein expression observed ASA one Salix extract activated PBMCs suppression relevant cytokine ie IL6 IL1beta IL10 seen Salix extract antiinflammatory capacity Salix extract still retained transepithelial passage liver cell metabolism advanced coculture model system consisting intestinal Caco2HT29MTX cell differentiated hepatocytelike HepaRG cell Taken together vitro data suggest Salix extract might present additional antiinflammatory treatment option context SARSCoV2 peptide challenge however confirmatory data needed,pge2;sars-cov-2 peptides;salix species;acetylsalicylic acid (asa);anti-inflammatory effects;cytokine;in vitro;willow bark
Comorbidities sequela blood biomarkers associated clinical outcome Mount Sinai Health System COVID19 patient,34228746,continuing rise SARSCoV2 infection globally emergence various wave different country understanding characteristic susceptibility infection clinical severity outcome remain vital retrospective study data extracted 39539 patient deidentified Mount Sinai Health System COVID19 database assessed risk mortality based presence comorbidities organspecific sequela 7032 CoV2 positive + patient Prevalence cardiovascular metabolic comorbidities high among SARSCoV2+ individual Diabetes obesity coronary artery disease hypertension atrial fibrillation heart failure increased overall mortality risk asthma Ethnicity modified risk mortality associated comorbidities regard secondary complication setting infection individual acute kidney injury acute myocardial injury showed increase mortality risk Cerebral infarct acute venous thromboembolic event associated increased risk mortality Biomarkers cardiovascular injury coagulation inflammation compared deceased survived individual found cardiac coagulation biomarkers elevated fell beyond normal range often deceased patient Several inflammatory marker evaluated increased deceased patient summary identified comorbidities sequela along peripheral blood biomarkers associated elevated clinical severity poor outcome COVID19 patient Overall finding detail granularity previously reported factor may impact susceptibility clinical severity mortality course COVID19 disease,
Evolution Use Extracorporeal Membrane Oxygenation Respiratory Failure,34208906,Extracorporeal membrane oxygenation ECMO used increasing frequency support patient acute respiratory failure commonly severe form acute respiratory distress syndrome ARDS marked increase global use ECMO followed publication large randomized trial 2009 experience garnered 2009 influenza H1N1 pandemic supported release large randomized clinical trial 2018 confirming benefit using ECMO patient severe ARDS Despite rapid expansion ECMOrelated publication optimal management patient receiving ECMO term patient selection ventilator management anticoagulation transfusion strategy evolving recently ECMO utilized expanding variety condition including case severe pulmonary cardiac failure coronavirus disease 2019 COVID19 review evaluates modern evidence ECMO respiratory failure current challenge field,h1n1 influenza a;acute respiratory distress syndrome;coronavirus disease 2019;extracorporeal membrane oxygenation
Thoracic Surgery COVID19 Pandemic Novel Approach Reach Guideline Consensus,34202563,COVID19 pandemic challenge international national healthcare system field thoracic surgery procedure may deferred due mandatory constraint access diagnostics staff followup facility lack prospective data management benign malignant thoracic condition pandemic Therefore derived recommendation 14 thoracic society address key question topic COVID19 field thoracic surgery Respective recommendation extracted degree consensus among different organization calculated high degree consensus found temporarily suspend noncritical elective procedure procedure benign condition prioritize patient symptomatic advanced cancer Prior hospitalization patient screened respiratory symptom indicating possible COVID19 infection society recommended screen patient COVID19 prior admission weak consensus usage serology test CT scan COVID19 diagnostics Nearly society suggested postpone elective procedure patient suspected confirmed COVID19 recommended constant reevaluation patient Additionally summarized recommendation focusing precaution theater management chest drain study provides novel approach informed guidance thoracic surgeon COVID19 pandemic absence scientific evidencebased data,covid-19;sars-cov-2;guidelines;recommendations;thoracic surgery
Deep geometric representation modeling effect mutation proteinprotein binding affinity,34347784,Modeling impact amino acid mutation proteinprotein interaction play crucial role protein engineering drug design study develop GeoPPI novel structurebased deeplearning framework predict change binding affinity upon mutation Based threedimensional structure protein GeoPPI first learns geometric representation encodes topology feature protein structure via selfsupervised learning scheme representation used feature training gradientboosting tree predict change proteinprotein binding affinity upon mutation find GeoPPI able learn meaningful feature characterize interaction atom protein structure addition extensive experiment show GeoPPI achieves new stateoftheart performance predicting binding affinity change upon single multipoint mutation six benchmark datasets Moreover show GeoPPI accurately estimate difference binding affinity recently identified SARSCoV2 antibody receptorbinding domain RBD protein result demonstrate potential GeoPPI powerful useful computational tool protein design engineering code datasets available http githubcomLiuxg16GeoPPI,
SARSCoV2 discovery genome structure transcription replication,34281608,SARSCoV2 extremely contagious respiratory virus causing adult atypical pneumonia COVID19 severe acute respiratory syndrome SARS SARSCoV2 singlestranded positivesense RNA +RNA genome 299 kb exhibit significant genetic shift different isolates entering susceptible cell expressing ACE2 TMPRSS2 SARSCoV2 genome directly function mRNA translate two polyproteins ORF1a ORF1b region cleaved two viral protease sixteen nonstructural protein nsp116 initiate viral genome replication transcription SARSCoV2 genome also encodes four structural E N six accessory 3a 6 7a 7b 8 9b protein translation requires newly synthesized individual subgenomic RNAs sgRNA infected cell Synthesis fulllength viral genomic RNA gRNA sgRNAs conducted inside doublemembrane vesicle DMVs viral replication transcription complex RTC comprises nsp7 nsp8 nsp9 nsp12 nsp13 short RNA primer produce sgRNAs RTC start RNA synthesis highly structured gRNA 3 end switch template various transcription regulatory sequence TRSB site along gRNA body probably mediated longdistance RNARNA interaction TRS motif gRNA 5 leader TRSL responsible RNARNA interaction TRSB upstream ORF skipping viral genome produce individual sgRNAs Abundance individual sgRNAs viral gRNA synthesized infected cell depend location readthrough efficiency TRSB Although study needed unprecedented COVID19 pandemic taught world painful lesson invest proactively prepare future emergence type coronaviruses possible biological horror,
Evaluation Two Rapid Antigenic Tests Detection SARSCoV2 Nasopharyngeal Swabs,34202731,1 Background current context COVID19 crisis need fast easytouse sensitive diagnostic tool addition molecular method therefore decided evaluate performance newly available antigen detection kit `` reallife laboratory condition 2 Methods sensitivity specificity two rapid diagnostic test RDT the COVID19 Ag RespiStrip Coris Bioconcept Belgium CoRDT coronavirus antigen rapid test cassette Healgen Scientific LLC USA HeRDT were evaluated 193 nasopharyngeal sample using RTPCR gold standard 3 Results sensitivity obtained HeRDT 88 collected sample 911 sample Ct = 31 CoRDT test sensitivity obtained 62 collected sample 689 sample Ct = 31 4 Conclusions Despite excellent specificity obtained kit poor sensitivity CoRDT allow use rapid diagnosis COVID19 HeRDT satisfied World Health Organization s performance criterion rapid antigen detection test high sensitivity quick response ease use allowed implementation HeRDT laboratory University Hospital Liege,covid-19;sars-cov-2;antigen detection;rapid diagnostic test
Exploring Behavioral Typologies Inform COVID19 Health Campaigns PersonCentered Approach,34292858,United States continues ravaged COVID19 becomes increasingly important implement effective public health campaign improve personal behavior help control spread virus design effective campaign research needed understand current mitigation intention general public diversity intention theoretical predictor COVID19 campaign particularly challenging mitigation involves myriad diverse behavior study take personcentered approach investigate data survey N = 976 Pennsylvania adult Latent class analysis revealed five class mitigation one marked complete adherence health recommendation 34 sample one complete refusal 9 sample three mixture adherence refusal Statistically significant covariates class membership included relatively positive injunctive norm risk due essential worker household personal knowledge someone became infected COVID19 belief COVID19 leaked biological weapon Additionally trait reactance associated nonadherence health mavenism associated adherence finding may used good effect local healthcare provider institution also inform broader policymaking decision regarding public health campaign mitigate COVID19,
Curfew Effective Limiting SARSCoV2 Progression Evaluation France Based Epidemiokinetic Analyses,34131877,BACKGROUND Since late summer 2020 French authority implemented curfewlightened lockdownalternating strategy instead strict lockdown improve acceptability limit socioeconomic consequence However data curfewrelated efficacy control epidemic scarce OBJECTIVE investigate effect COVID19 spread France curfew combined local andor nationwide restriction late summer 2020 midFebruary 2021 DESIGN conducted comparative evaluation using susceptibleinfectedrecovered SIR based model completed epidemiokinetic tool MAIN MEASURES analyzed timecourse epidemic progression rate curfew French Guyana five metropolitan region additional restriction implemented different time Using linear regression decayincrease rate daily contamination calculated epidemic regression halflives t12beta identified period KEY RESULTS French Guyana two decay period rapid regression t12beta 10 day observed curfew slowing t12beta 43 day curfew lightened 2week prelockdown curfew 2020101720201102 ProvenceAlpesCotedAzur AuvergneRhoneAlpes IledeFrance epidemic progression unchanged postlockdown curfew 2020121520200214 epidemic slowly regressed GrandEst t12beta 37 day whereas progression rate plateaued AuvergneRhoneAlpes increased immediately ProvenceAlpesCotedAzur IledeFrance NouvelleAquitaine whatever curfew starting time 0600 0800 pm Interestingly delayed slow decay 17 day t12beta 64 day occurred curfew region except IledeFrance CONCLUSIONS Curfew allowed temporary control SARSCoV2 epidemic however variably French region without preventing lockdown necessity accelerate epidemic regression observed French Guyana curfew implemented timely additional restriction,covid-19;sars-cov-2;curfew;epidemic;lockdown;modeling
Omphalopagus conjoined twin separation coronavirus disease19 pandemic era case report,34221850,Introduction importance Conjoined twin rare congenital anomaly characterized fusion certain anatomical structure Coronavirus19 COVID19 new emerging infectious respiratory disease affecting worldwide potentially lead acute respiratory distress ARDS child COVID19 reconstructed healthcare system including surgical care decisionmaking Case presentation Herein describe surgical separation 25 month old omphalopagus conjoined twin one Baby presenting COVID19associated respiratory distress well challenge faced preparation execution complex surgical procedure Clinical discussion Baby underwent antiviral therapy oxygen supplementation ventilation ICU baby B remained stable confirmed negative SARSCoV2 separation surgery conducted baby become clinically stable Defect closure reconstruction accomplished one week followup Baby died lung infection baby B remained well one year Conclusion complexity surgical separation requires careful planning multidisciplinary team Surgical separation conjoined twin pandemic era reported much literature report required provide insight,"ards, acute respiratory distress syndrome;cdc, centers for disease control and prevention;covid-19;covid-19, coronavirus disease-19;cpap, continuous positive airway pressure;ct-scan, computed tomography-scan;cusa, cavitron ultrasonic surgical aspirator;case report;children;conjoined twins separation;ecmo, extracorporeal membrane oxygenation;hcp, healthcare providers;hfn, high flow nasal;hfov, high-frequency oscillation ventilation;icu, intensive care unit;ivc, inferior vena cava;mri, magnetic resonance imaging;mrsa, methicillin-resistant staphylococcus aureus;npwt, negative pressure wound therapy;orc, oxidized regenerated cellulose;omphalopagus conjoined twins;pcr, polymerase chain reaction;pda, patent ductus arteriosus;pds, polydioxanone suture;picu, pediatric intensive care unit;pod, post-operative day;ppe, personal protective equipment;scare, surgical case report;who, world health organization;cm, centimeter;lpm, litres per minute"
LongTerm Outcomes Patients Coronavirus Disease 2019 One Year Hospital Discharge,34209085,BACKGROUND longterm effect COVID19 remain largely unclear study aim investigate postacute health consequence mortality one year hospital discharge METHODS surviving adult patient discharged hospital admission due acute COVID19 first wave pandemic underwent comprehensive interview Functional assessment performed patient aged 65 Clinical hospital record reviewed mortality cause assessed RESULTS total 587 patient COVID19 discharged hospital including 266 hospital admission 321 emergency room Mortality within following year occurred 34266 128 10321 31 respectively due cause directly possibly related COVID19 205 25 patient PostCOVID19 syndrome assessed 543 patient one year discharge clinical complaint reported 901 patient needed hospitalization 804 discharged emergency room p = 0002 breathlessness 416 tiredness 354 ageusia 302 anosmia 263 common complaint Ongoing symptom attributed COVID19 reported 668 495 patient respectively p 0001 Newly developed COPD asthma diabetes heart failure arthritisas well worsening preexisting comorbiditieswere found CONCLUSIONS Oneyear mortality among survivor acute COVID19 75 significant proportion COVID19 patient experienced ongoing symptom 1 year onset disease,covid-19;spain;mortality;post-acute covid-19 syndrome;predictors;risk factors
Adding saliva testing oropharyngeal deep nasal swab testing increase PCR detection SARSCoV2 primary care child,34287935,OBJECTIVE compare concordance acceptability saliva testing standardofcare oropharyngeal bilateral deep nasal swab testing severe acute respiratory syndrome coronavirus2 SARSCoV2 child general practice DESIGN Prospective multicentre diagnostic validation study SETTING Royal Children s Hospital two general practice cohealth West Melbourne Cirqit Health Altona North Melbourne JulyOctober 2020 PARTICIPANTS 1050 people provided paired saliva oropharyngealnasal swab SARSCoV2 testing MAIN OUTCOME MEASURES Numbers case SARSCoV2 detected either specimen type realtime polymerase chain reaction concordance result paired specimen positive percent agreement PPA virus detection specimen type RESULTS SARSCoV2 detected 54 1050 people assessable specimen 5 including 19 case 35 specimen positive overall PPA 72 95 CI 5884 saliva 63 95 CI 4976 oropharyngealnasal swab 35 positive specimen people aged 10 year PPA 86 95 CI 7095 saliva 63 95 CI 4579 oropharyngealnasal swab Adding saliva testing standardofcare oropharyngealnasal swab testing increased overall case detection 59 95 CI 2995 Providing saliva preferred oropharyngealnasal swab participant 75 including 141 153 child 10 year age 92 CONCLUSION child 10 year age adult saliva testing alone may suitable SARSCoV2 detection child 10 saliva testing may suitable adjunct oropharyngealnasal swab testing increasing case detection,covid-19;child health;diagnosis;general practice;infectious diseases;public health;respiratory tract infections
Antimicrobial Stewardship Patients Confirmed COVID19,34338173,173 hospitalized COVID19 patient receiving antibiotic retrospectively assigned early late discontinuation group Length therapy shorter early discontinuation group 3 v 7 day p 00001 Mortality 143 v 207 p=0316 length stay 7 vs 9 day p=0063 similar,covid-19;antimicrobial stewardship
Deaf Community s Experiences Navigating COVID19 Pandemic Information,34213997,BACKGROUND Users American Sign Language ASL deaf often face barrier receiving health information contributing significant gap health knowledge health literacy reduce spread coronavirus disease 2019 COVID19 risk public government health care provider encouraged social distancing use face mask hand hygiene quarantine Unfortunately COVID19 information rarely available ASL put deaf community disadvantage accessing reliable COVID19 information OBJECTIVE study s primary objective compare COVID19related information access participant deaf participant hearing METHODS study included 104 adult deaf 74 adult hearing participated prior health literacy study Surveys conducted April July 2020 via video conference smartphone apps phone call COVID19 data linked preexisting data demographic health literacy data measured Newest Vital Sign NVS ASLNVS KEY RESULTS Neither group participant differed ability identify COVID19 symptom Adults deaf 47 time likely report difficulty accessing COVID19 information p = 011 yet reported using preventive strategy overall Simultaneously adult deaf 60 lower odds staying home calling doctor versus seeking health care immediately something else compared participant hearing suspected COVID19 p = 020 CONCLUSIONS Additional education recommended COVID19 management guidance accessible health care navigation strategy needed deaf community health care provider Public health official ensure public service announcement accessible audience connect trusted agent within deaf community help disseminate health information online ASL social medium channel HLRP Health Literacy Research Practice 2021 5 2 e162e170 Plain Language Summary Compared participant hearing higher portion participant deaf reported challenge accessing understanding trusting COVID19 information Although respondent deaf similar knowledge symptom compared participant hearing used prevention strategy likely plan immediate care suspected symptom Improved guidance COVID19 management health care navigation accessible deaf community needed,
Complications nasal SARSCoV2 testing review,34348963,Transnasal swab testing detection SARSCoV2 well established Centers Disease Control Prevention advocate swabbing either anterior naris middle turbinate nasopharynx specimen collection depending available local resource purpose review investigate complication related transnasal SARSCoV2 testing specific attention specimen collection site swab approach literature demonstrates nasopharyngeal swabbing associated increased risk complication remain goldstandard test due greater diagnostic accuracy relative anterior nasal middle turbinate swab,covid-19;education;medical;nasal cavity
Air Pollution COVID19 Possible Dangerous Synergy Male Fertility,34202243,Several study indicate semen quality strongly declined last decade worldwide Air pollution represents significant cofactor COVID19 impact negative effect male reproductive system prooxidant inflammatory immunedysregulating mechanism recently reported chronic exposure PM25 cause overexpression alveolar ACE2 receptor entry route SARSCoV2 organism shared lung testis expression highest body testis ACE2Ang 17 MasR pathway play important role regulation spermatogenesis indirect mechanism testicular damage could due blockade ACE2 receptor SARSCoV2 prevents conversion specific angiotensin excess cause inflammation overproduction cytokine PM25induced overexpression alveolar ACE2 receptor turn could increase local viral load patient exposed pollutant producing ACE2 receptor depletion compromising host defense presenting overall view epidemiological data molecular mechanism manuscript aim interpret possible synergistic effect air pollution COVID19 male reproductive function warning spread SARSCoV2 fertile year may represent significant threat global reproductive health great concern especially men age maximum reproductive capacity important topic debate policy maker Altered environmental condition together direct indirect short longterm effect viral infection could cause worsening semen quality important consequence male fertility especially area higher environmental impact,ace2;covid-19;sars-cov-2;air pollution;male fertility;semen quality
Carpal cubital tarsal tunnel syndrome SARSCoV2 infection causal link,34217126,COVID19 complex disease many clinicopathological issue including respiratory gastrointestinal neurological renal cutaneous coagulative one addition reactive arthritis reported different author hypothesize peripheral microangiopathy involving nerve supply viral demyelination immunemediated irritating antigenic stimulus synovial sheath SARSCoV2 infection may induce carpal cubital tarsal tunnel syndrome variable entity genetically predisposed subject associated myxoid nerve degeneration,carpal tunnel syndrome;coronavirus disease 2019 (covid-19);cubital tunnel syndrome;histopathology;severe acute respiratory syndrome coronavirus 2 (sars-cov-2);tarsal tunnel syndrome
Impact COVID19 outbreak severe trauma trend healthcare system reassessment Lombardia Italy analysis regional trauma registry,34281575,BACKGROUNDS COVID19 pandemic drastically strained health system worldwide obligating reassessment healthcare delivered Lombardia Italy Regional Emergency Committee REC established regional health system reorganized three hospital designated hub trauma care aim study evaluate effect reorganization regional care comparing distribution patient COVID19 outbreak describe change epidemiology severe trauma among two period METHODS cohort study conducted using retrospectively collected data Regional Trauma Registry Lombardia LTR compared data trauma patient admitted three hub hospital COVID19 outbreak September 1 November 19 2019 recorded pandemic February 21 May 10 2020 hospital Demographic data level prehospital care Advanced Life SupportALS Basic Life SupportBLS type transportation mechanism injury MOI abbreviated injury score AIS 1998 version injury severity score ISS revised trauma score RTS ICU admission survival outcome patient admitted three trauma center designed hub reviewed Screening COVID19 performed nasopharyngeal swab chest ultrasound andor computed tomography RESULTS COVID19 pandemic trauma patient admitted hub increased 464 v 283 p 0001 increase prehospital time 718 v 613 min p 001 observed hospital mortality unaffected TRISS ISS AIS ICU admission similar period COVID19 outbreak observed substantial change MOI severe trauma patient admitted three hub increase unintentional 319 v 185 p 005 intentional fall 84 v 12 p 005 whereas pandemic restriction reduced road related injury 356 v 60 p 005 Deaths scene significantly increased 177 v 68 p 0001 CONCLUSIONS COVID19 outbreak affected epidemiology severe trauma patient increase trauma patient admission designated facility high level care obtained satisfactory result COVID19 patient overwhelmed resource hospital,covid-19;emergency;trauma;trauma care
NeutrophiltoLymphocyte Ratio Early Variation NLR Predict InHospital Mortality Severity ED Patients SARSCoV2 Infection,34207918,1 Introduction neutrophilto lymphocyte ratio valued predictive marker several inflammatory disease example increasing NLR risk factor mortality sepsis also appears helpful setting cancer aim work study prognostic value NLR disease severity mortality patient infected SARSCoV2 upon admission Emergency Department ED early variation DeltaNLR first 24 h management H24 2 Methods 1 March 30 April 2020 conducted multicenter retrospective cohort study patient moderate severe coronavirus disease 19 COVID19 hospitalized presenting ED 3 Results total 1035 patient included study Factors associated infection severity Creactive protein level 1007 CI 95 10051010 p 0001 NLR H24 1117 CI 95 10601176 p 0001 DeltaNLR 1877 CI 95 11603036 p 001 best threshold DeltaNLR predict severity infection 0222 sensitivity 561 specificity 683 multivariate analysis biochemical factor significantly associated mortality DeltaNLR 2142 CI 95 11324056 p 0019 best threshold DeltaNLR predict mortality 0411 sensitivity 533 specificity 673 4 Conclusion NLR early variation DeltaNLR could help physician predict severity mortality associated SARSCoV2 infection hence contributing optimized patient management accurate triage treatment,covid-19;nlr;mortality;severity
Macrolactin Novel Inhibitory Agent SARSCoV2 pro Bioinformatics Approach,34212286,COVID19 disease put world lockdown search therapeutic drug still ongoing Therefore study used silico screening identify natural bioactive compound fruit herbaceous plant marine invertebrate able inhibit protease activity SARSCoV2 PDB 6LU7 used extensive screening strategy drug likeliness antiviral activity value prediction molecular docking ADME molecular dynamic MD simulation MMGBSA total 17 compound shortlisted using Lipinski s rule 5 compound showed significant predicted antiviral activity value Among 5 2 compound Macrolactin Stachyflin showed good binding energy 922 800 kcalmol respectively within binding pocket pro catalytic residue 41 CYS 145 two compound analyzed determine ADME property ADME evaluation 2 compound suggested could effective developing therapeutic drug used clinical trial MD simulation showed proteinligand complex Macrolactin Stachyflin target receptor 6LU7 stable 100 nanosecond MMGBSA calculation pro Macrolactin complex indicated higher binding free energy 4258 + 635 kcalmol Dynamic crosscorrelation matrix DCCM principal component analysis PCA residual movement MD trajectory confirmed stability Macrolactin bound state 6LU7 conclusion study showed marine natural compound Macrolactin could effective therapeutic inhibitor SARSCoV2 protease 6LU7 Additional vitro vivo validation strongly needed determine efficacy therapeutic dose Macrolactin biological system,admet;coronavirus;md simulation;mm/gbsa;molecular docking;treatment
Asymptomatic mild symptomatic SARSCoV2 infection elicits durable neutralizing antibody response child adolescent,34228642,SARSCoV2 continues spread globally question emerged regarding strength durability immune response specific population study evaluated humoral immune response 69 child adolescent asymptomatic mild symptomatic SARSCoV2 infection detected robust IgM IgG IgA antibody response broad array SARSCoV2 antigen time acute infection 2 4 month acute infection participant Notably antibody response associated virus neutralizing activity still detectable 4 month acute infection 94 child Moreover antibody response neutralizing activity serum child adolescent comparable superior observed serum 24 adult mild symptomatic infection Taken together finding indicate child adolescent mild asymptomatic SARSCoV2 infection generate robust durable humoral immune response likely contribute protection reinfection,adaptive immunity;immunology;infectious disease
Acute myocarditis associated antiCOVID19 vaccination,34222133,Novel anticoronavirus disease 2019 mRNA vaccine rapidly implemented worldwide Therefore attention given potentially lifethreatening adverse reaction report three young male patient developed acute myocarditis 2 day receiving second dose BNT162b2 vaccine Primary acute myocarditis previously reported association vaccine include adjuvant high index suspicion maintained order diagnose treat patient develop autoinflammatory vaccinerelated complication timely manner research required order explore significance phenomenon underlying molecular mechanism,adverse effects;inflammation;messenger;rna
Isothermal recombinase polymerase amplificationlateral flow detection SARSCoV2 etiological agent COVID19,34224752,rapid detection novel pathogen including SARSCoV2 necessitates development easytouse diagnostic test readily adapted utilized clinical laboratory field setting Delay diagnosis facilitated rapid spread novel virus throughout world resulting global mortality surpass 25 million people Development pointofcare diagnostic assay performed rural decentralized health care center expand testing capacity needed developed qualitative test based recombinasepolymeraseamplification coupled lateral flow reading RPALF rapid detection SARSCoV2 RPALF detected SARSCoV2 limit detection 354 viral cDNA nucleocapsid N gene copiesmuL Additionally RPALF able detect 02525 copiesmuL SARSCoV2 N gene containing plasmid evaluated 37 nasopharyngeal sample using CDC s N3 N1 N2 RTrealtime PCR assay SARSCoV2 reference test found 100 concordance RPALF RTqPCR reference test determined 1818 positive 1919 negative sample positive sample Ct value 1937 RTqPCR RPALF primer probe cross react relevant betacoronaviruses SARS MERS first isothermal amplification test paired lateral flow developed qualitative detection COVID19 allowing rapid viral detection prospective applicability resource limited decentralized laboratory,coronavirus;diagnostics;lateral flow;point-of-care;rpa;sars-cov-2
Machine Learning Predict InHospital Mortality COVID19 Patients Using Computed TomographyDerived Pulmonary Vascular Features,34204911,Pulmonary parenchymal vascular damage frequently reported COVID19 patient assessed unenhanced chest computed tomography CT widely used triaging exam Integrating clinical data chest CT feature CTderived vascular metric aimed build predictive model inhospital mortality using univariate analysis MannWhitney U test machine learning model support vector machine SVM multilayer perceptrons MLP Patients RTPCRconfirmed SARSCoV2 infection unenhanced chest CT performed emergency department admission included retrieving outcome discharge death 8515 trainingtest dataset split 897 patient 229 26 patient died hospitalization higher median pulmonary artery diameter 290 mm patient survived 270 mm p 0001 higher median ascending aortic diameter 366 mm versus 340 mm p 0001 SVM MLP best model considered ten input feature yielding 0747 precision 0522 recall 0800 0844 precision 0680 recall 0567 area curve respectively model integrating clinical radiological data pulmonary artery diameter third important predictor age parenchymal involvement extent contributing reliable inhospital mortality prediction highlighting value vascular metric improving patient stratification,covid-19;x-ray computed;computer;lung;machine learning;neural networks;prognosis;pulmonary artery;support vector machine;tomography
Assessment Ventilation Perfusion Patients COVID19 Discloses Unique Information Pulmonary Function Clinician Case Reports VP SPECT,34349582,VP SPECT 4 consecutive patient COVID19 suggests ventilation perfusion image may applied diagnose exclude pulmonary embolism verify nonsegmental diversion perfusion ventilated area dead space ventilation may represent inflammation pulmonary vasculature detect reversed mismatch poor ventilation better preserved perfusion shunt perfusion bilateral pulmonary inflammation indicate redistribution lung perfusion antigravitational hyperperfusion due cardiac congestion VP mismatch reversed mismatch may extensive enough diminish dramatically preserved matching ventilationperfusion induce severe hypoxemia COVID19,covid-19;sars-cov-2;spect;ventilation;perfusion;pulmonary embolism
SARSCoV2 transit characterization SARSCoV2 genome Venezuelan migrant Colombia,34333122,OBJECTIVES evaluate genomic epidemiology SARSCoV2 Venezuelan migrant living Colombia METHODS SARSCoV2 30 clinical specimen collected Venezuelan migrant sequenced Genomes compared Wuhanreferencegenome identify polymorphism reconstruct phylogenetic relationship perform comparative genomic analysis Geographic sociodemographic clinical data also studied across genotype RESULTS demonstrate presence six distinct SARSCoV2 lineage circulating among Venezuelan migrant well close relationship SARSCoV2 genomic sequence obtained individual living VenezuelanColombian border region La Guajira Colombia Zulia Venezuela Three cluster C1 C2 C3 wellsupported phylogenomic inference supporting hypothesis three potential transmission route across ColombianVenezuelan border genome included point mutation previously associated increased infectivity mutation L18F Nterminal domain spike protein associated compromised binding neutralizing antibody found 230 6 genome identified statistically significant association symptomatology cluster C2 CONCLUSION close phylogenetic relationship SARSCoV2 genome Venezuelan migrant person living VenezuelaColombian border support importance human movement spread COVID19 emerging virus variant,l18f;lineages;sars-cov-2;venezuelan-colombian border;mutations
safety COVID19 convalescent plasma donation multiinstitutional donor hemovigilance study,34227689,BACKGROUND Although safety therapeutic efficacy COVID19 convalescent plasma CCP extensively evaluated safety CCP donation explored multiinstitutional context STUDY DESIGN METHODS Nine blood collection organization BCOs participated multiinstitutional donor hemovigilance effort ass safety CCP donation Donor adverse event DAEs defined according Standard Surveillance Complications Related Blood Donation severity assessed using severity grading tool Multivariate analysis performed determine attribute associated DAE severity RESULTS overall DAE rate 377 per 1000 donation Repeat apheresis apheresisnaive donor experienced adverse event rate 199 498 per 1000 donation respectively Female donor contributed 519 CCP donation DAE rate 494 per 1000 donation DAE rate male donor 274 per 1000 donation Vasovagal reaction accounted half reported DAEs 511 adjustment volume CCP donated associated vasovagal reaction severity odds ratio 65 95 confidence interval CI 25171 Donor age donation history also associated DAE severity Considerable difference DAE type rate observed across participating BCOs despite use standardized hemovigilance definition CONCLUSION safety CCP donation appears comparable conventional apheresis plasma donation similar associated risk factor DAE type severity,ccp;covid-19;adverse events;convalescent plasma;donor hemovigilance
StructureGuided Design Conformationally Constrained Cyclohexane Inhibitors Severe Acute Respiratory Syndrome Coronavirus2 3CL Protease,34213885,series nondeuterated deuterated dipeptidyl aldehyde masked aldehyde inhibitor incorporate structure conformationally constrained cyclohexane moiety synthesized found potently inhibit severe acute respiratory syndrome coronavirus2 3CL protease biochemical cellbased assay Several inhibitor also found nanomolar inhibitor Middle East respiratory syndrome coronavirus 3CL protease corresponding latent aldehyde bisulfite adduct found equipotent precursor aldehyde Highresolution cocrystal structure confirmed mechanism action illuminated structural determinant involved binding spatial disposition compound disclosed herein provides effective mean accessing new chemical space optimizing pharmacological activity cellular permeability identified inhibitor lack cytotoxicity warrant advancement potential therapeutic COVID19,
Assessment maternofoetal transmission SARSCoV2 prospective pilot study,34334910,Background issue vertical transmission SARSCoV2 infection foetus yet resolved main reason lack bigger study analyse question evidence affection foetus antenatal intrapartum period limited anecdotal report look possibility vertical transmission Severe Acute Respiratory Syndrome Corona Virus2 SARSCoV2 infection foetus prospective pilot study conducted tertiary health care COVID19 designated centre Armed Forces Methods study conducted 01 June 2020 15 October 2020 included 54 covidpositive pregnant mother delivery amniotic fluid cord blood sample collected sterile manner Amniotic fluid sample collected vaginal delivery chance contamination high sample tested presence SARSCoV2 gene Reverse Transcriptasee Polymerase Chain Reaction RTPCR test result analysed Newborns allowed room mother underwent throat nasal swab RTPCR testing covid within 2448 h delivery Results total 1520 pregnant mother underwent RTPCR test study period Total positivity rate among pregnant woman 28 54 covidpositive woman study period amniotic fluid RTPCR test carried 43 woman cord blood tested 45 woman Conclusion RTPCR test amniotic fluid cord blood nasal throat swab newborn delivered SARSCoV2positive pregnant woman negative Based study possibility intrauterine vertical transmission SARSCoV2 infection appears unlikely,amniotic fluid;cord blood;nasal and throat swab;pregnancy;rt-pcr;sars-cov-2;vertical transmission
Role spatial patterning Nprotein interaction SARSCoV2 genome packaging,34214535,Viruses must efficiently specifically package genome excluding cellular nucleic acid viral subgenomic fragment virus use specific packaging signal conserved sequence structure motif present fulllength genome Recent work shown viral protein important packaging undergo liquidliquid phase separation LLPS one two viral nucleic acid binding protein condense genome compositional simplicity viral component lends well theoretical modeling compared complex cellular organelle Viral LLPS limited one two viral protein single genome enriched LLPSpromoting feature previous study observed LLPSpromoting sequence severe acute respiratory syndrome coronavirus 2 located 5 3 end genome whereas middle genome predicted consist mostly solubilizing element arrangement sufficient drive single genome packaging genome compaction genome cyclization addressed question using coarsegrained polymer model LASSI study LLPS nucleocapsid protein RNA sequence either promote LLPS solubilization respect genome cyclization find optimal arrangement restricts LLPSpromoting element 5 3 end genome consistent native spatial patterning Genome compaction enhanced clustered LLPSpromoting binding site whereas single genome packaging efficient binding site distributed throughout genome result suggest many variably positioned LLPSpromoting signal support packaging absence singular packaging signal argues necessity feature hypothesize model generalizable multiple virus well cellular organelle paraspeckles enrich specific long RNA sequence defined arrangement,
Rapid Inactivation Vitro SARSCoV2 Saliva Black Tea Green Tea,34201131,Saliva play major role humantohuman transmission SARSCoV2 virus saliva SARSCoV2infected individual rapidly efficiently inactivated beverage ingestion beverage may attenuate spread virus infection within population Recently reported SARSCoV2 significantly inactivated treatment black tea green tea roasted green tea oolong tea well constituent epigallocatechin gallate EGCG theasinensin TSA galloylated theaflavins However remains unclear extent tea inactivates virus present saliva saliva contains various protein nitrogenous product electrolyte could influence antivirus effect tea assessed whether tea inactivated SARSCoV2 added human saliva virus added healthy human saliva vitro treatment black tea green tea infectivity virus evaluated TCID50 assay virus titer fell detectable level le 1100 treatment black tea green tea 10 s black teatreated virus le remarkably replicated cell compared untreated virus finding suggest possibility ingestion tea may inactivate SARSCoV2 saliva infected individual although clinical study required determine intensity duration antiviral effect tea saliva human,covid-19;catechin;novel coronavirus;saliva;tea;theaflavin
Critically ill infant multisystem inflammatory syndrome related COVID19,34351888,INTRODUCCION La COVID19 se ha convertido en una amenaza para la salud publica mundial Sin embargo la formas graf en ninos son poco frecuentes Se presenta el caso de un lactante con sindrome inflamatorio multisistemico relacionado con COVID19 CASO CLINICO Lactante de 8 me que estuvo en contacto con adultos positivos para COVID19 El lactante inicio con una forma leve de la enfermedad que progreso con rapidez una forma critica de presentacion inicialmente con estado epileptico su ingreso con evidencia de inflamacion en laboratorios afeccion sistemica grave con falla multiorganica prueba de reaccion en cadena de la polimerasa para SARSCoV2 nasofaringea positiva El lactante fallecio 7 dia despues de su ingreso CONCLUSIONES El espectro de presentacion de la COVID19 en ninos menores de 1 ano e variable aun se cuentan con criterios consensuados para el diagnostico el tratamiento Todo lactante con enfermedad grave con compromiso multiorganico al ingreso en tiempos de pandemia obliga realizar una meticulosa historia clinica considerar la infeccion por SARSCoV2 hasta su confirmacion BACKGROUND COVID19 become threat global public health However severe form COVID19 presentation child rare present case infant COVID 19related multisystem inflammatory syndrome CASE REPORT describe case 8monthold infant contact COVID19 positive adult infant began mild symptom disease rapidly progressed critical form presentation initially epileptic status upon admission laboratory evidence inflammation severe systemic condition multiple organ failure positive nasopharyngeal SARSCoV2 PCR test infant died 7 day admission CONCLUSIONS spectrum COVID19 presentation child one year age variable still established criterion diagnosis treatment infant presenting severe disease multiple organ involvement admission time pandemic require thorough medical history consider SARSCoV2 infection proven otherwise,covid-19;infant;lactante;multisystem inflammatory syndrome;sindrome inflamatorio multisistemico
Teledermatology COVID19 pandemic systematic review,34368789,Background Teledermatology TD emerged critical way delivering care remotely COVID19 pandemic Objective conducted systematic review ass TD implemented worldwide Methods searched PubMed SCOPUS EMBASE Web Science Google Scholar article use TD patient care written English published December 1 st 2019 October 15 th 2020 Results 27 study included involving 16981 patient significant uptake TD pandemic Synchronous TD appeared commonly implemented asynchronous TD Common ambulatory dermatosis acne eczema reported amenable TD assessment management TD also appeared useful diagnosis cutaneous involvement COVID19 infection followup stable oncodermatology case Limitations Pooled analysis relevant outcome always possible due heterogeneity methodology included study Conclusions TD useful convenient tool management common ambulatory dermatosis COVID19 pandemic,covid-19;coronavirus;sars-2-cov;systematic review;teledermatology;telehealth;telemedicine
Thrombotic risk child COVID19 infection systematic review literature,34293539,OBJECTIVE Coagulation inflammatory parameter mildly altered child SARSCoV2 COVID19 infection laboratory evidence proinflammatory procoagulant state noted multisystem inflammatory syndrome child MISC clear whether pediatric condition related thrombotic event study reviewed literature thrombotic complication child COVID19 infection MISC DATA SOURCES searched Medline PubMed Advanced Search Builder Scopus Web Science Google Scholar electronic database 1 January 2021 using medical subject heading MeSH term text word combination truncated synonym THROMBOSIS THROMBOPHILIA CHILD CHILDREN INFANT COVID19 SARSCoV2 STUDY ELIGIBILITY CRITERIA Inclusion criterion child COVID19 SARSCOV2 infection search limited article published English Exclusion criterion review published study study published abstract letter conference proceeding discussion paper animal study editorial RESULTS screening duplicate initial search yielded 86 record 12 case report involving 19 child comorbidities absent mild 737 common site thrombosis lung 21 often used drug heparin 42 Two study international survey n = 337 patient large multicenter study n = 186 patient MISC risk ischemic stroke SARSCoV2 infection 082 deep venous thrombosis MISC 43 lower child adult CONCLUSIONS Thrombodic thromboembolic event rare pediatric patient COVID19 infection MISC Nonetheless adult high index suspicion maintained child COVID19 infection MISC particularly comorbidities predisposing thrombotic event,covid-19;childhood;children;sars-cov-2;thrombophilia;thrombosis
Contagion Management Mediterranee Infection University Hospital Institute,34203657,Mediterranee Infection University Hospital Institute IHU located recent building includes expert wide range infectious disease IHU strategy develop innovative tool including epidemiological monitoring pointofcare laboratory ability mass screen population study review strategy guideline proposed IHU application COVID19 pandemic summarise various challenge raise Early diagnosis enables contagious patient isolated treatment initiated early stage reduce microbial load contagiousness context COVID19 pandemic deal shortage personal protective equipment reagent massive influx patient 27 January 2020 5 January 2021 434925 nasopharyngeal sample tested presence SARSCoV2 12055 patient COVID19 followed outpatient clinic 1888 patient hospitalised Institute constantly adapting strategy ongoing situation IHU succeeded expanding upgrading equipment improving circuit flow better manage infected patient,covid-19;sars-cov-2;contagion;diagnosis;institut hospitalo-universitaire mediterranee infection;point-of-care;rapid diagnostic test
Analysis transmission dynamic COVID19 via closedform solution susceptibleinfectiousquarantineddiseased model quarantineadjusted incidence function,34226778,analyze disease control prevention strategy susceptibleinfectiousquarantineddiseased SIQD model quarantineadjusted incidence function established closedform solution variable SIQD model quarantineadjusted incidence function provided beta equal gamma + alpha utilizing classical technique solving ordinary differential equation ODEs epidemic peak time required attain peak provided closed form provided closedform expression force infection rate susceptible becomes infected management epidemic perceptive using control prevention strategy explained well epidemic start rho 0 1 peak epidemic appears number infected attains peak value rho 0 = 1 disease dy rho 0 1 provided comparison estimated actual epidemic peak COVID19 Pakistan forecast epidemic peak United state Brazil India Syrian Arab Republic given well,dynamical systems in biology;exact solutions
SARSCoV2 Infectivity Severity COVID19 According SARSCoV2 Variants Current Evidence,34203844,BACKGROUND conducted review summarize relation viral mutation infectivity SARSCoV2 also severity COVID19 vivo vitro METHOD Articles identified literature search 31 May 2021 PubMed Web Science Google Scholar RESULTS Sixtythree study included date study showed viral mutation especially D614G variant correlate higher infectivity wildtype virus However evidence association viral mutation severity disease scant SARSCoV2 variant 382nucleotide deletion associated le severe infection patient 11083G U mutation significantly associated asymptomatic patient contrast ORF1ab 4715L protein 614G variant significantly frequent patient country high fatality rate also reported current evidence showed variant concern led increased infectivity deteriorating epidemiological situation However relation variant severity COVID19 infection contradictory CONCLUSION COVID19 pandemic continues spread worldwide necessary anticipate large clinical cohort evaluate virulence transmissibility SARSCoV2 mutant,covid-19;sars-cov-2;infectivity;mutants;severity;variants
Introducing onequeue model paediatric emergency department,34290040,Introduction One Queue paediatric emergency department PED changing singlestream triage destination PED improve patient flow clinician experience team cohesion,covid-19;data collection;health services research;qualitative research
COVID19 Lockdown CPAP Adherence Vulnerable Ones Less Likely Improve Adherence,34290535,Purpose Due possible interplay factor predisposing severe COVID19 outcome negative health consequence poorly controlled OSA adherence continuous positive airway pressure CPAP therapy among OSA patient might crucial COVID19 pandemic Lockdownrelated change CPAP adherence investigated CPAP user willing participate study Prelockdown adherence age gender comorbidities anxiety analyzed predictor COVID19 lockdown adherence Patients Methods crosssectional study performed Split Sleep Medicine Center included 101 severe OSA patient 782 male CPAP memory card assessed 6 month prelockdown 40 day lockdown MarchApril 2020 period total 81 patient prelockdown met good CPAP adherence criterion =4 hoursnight 70 night Results CPAP adherence improved COVID19 lockdown total sample severe OSA patient percentage adherent night CPAP usage hour per night increased lockdown good prelockdown CPAP adherers p=0011 p=0001 respectively woman p=0003 p=0001 respectively respondent younger 58 year p=0007 p 0001 respectively 20101 poor prelockdown CPAP adherers 9 shifted good lockdown adherence comorbidities BMI anxiety taken account older male respondent recognized le likely improve CPAP usage hour lockdown R 2 =94 p=0032 Conclusion lockdownrelated CPAP adherence improved severe OSA patient shift almost half poor prelockdown adherers towards good lockdown CPAP adherence Women younger good prelockdown CPAP adherers adherent lockdown Despite vulnerable group OSA COVID19 expected adherence improvement observed men older patient,covid-19;cpap;cpap adherence;osa;lockdown
Photobiomodulation Therapy Possible New Approach COVID19 Systematic Review,34207199,COVID19 viral disease characterized pandemic World Health Organization March 2020 Since researcher world looking way fight disease Many case complication arise insufficient immune response due low immunity intense release proinflammatory cytokine damage structure organ lung Thus hypothesis arises photobiomodulation therapy PBMT use lowlevel laser LLLT may ally approach patient COVID19 since effective increasing immunity helping tissue repair reducing proinflammatory cytokine systematic review performed use PubMedMEDLINE Web Science Scopus Google Scholar database following keywords `` lowlevel laser therapy photobiomodulation therapy COVID19 inclusion criterion complete article published January 2020 January 2021 English exclusion criterion language editorial review brief communication letter editor comment conference abstract article provide full text bibliographic search found 18 article PubmedMEDLINE database 118 article Web Science 23 article Scopus 853 article Google Scholar Ten article included qualitative synthesis four commentary article discussed pathogenesis effect PBMT COVID19 Two vitro lab experiment showed effect PBMT prevention thrombosis positive result wound healing viral infection using intravascular irradiation ILIB associated Phthalomethyl D Two case report showed PBMT improved respiratory index radiological finding inflammatory marker severe COVID19 patient One case series reported clinical improvement PBMT 14 acute COVID19 patient rehabilitation 24 patient preventive treatment 70 people One clinical trial 30 patient severe COVID19 require invasive mechanical ventilation showed PBMTstatic magnetic field statistically different placebo length stay Intensive Care Unit improved diaphragm muscle function ventilation decreased inflammatory marker review suggests PBMT may positive role treatment COVID19 Still necessity clinical trial remains field sufficient research evidence regarding effect PBMT COVID19 disease large gap,covid-19;sars-cov-2 infection;immunity;inflammation;low-level laser therapy;photobiomodulation therapy;systematic review
HRas gene take part host immune response COVID19,34226505,Ras gene family member play relevant role cancer especially mutated However may play additional role condition beside cancer performed gene expression analysis using NanoString PanCancer IO 360 panel peripheral blood mononuclear cell PBMC six COVID19 patient found HRas gene significantly upregulated KRas NRas gene downregulated particular HRas gene upregulation evident COVID19 patient severe disease compared result obtained analyzing two different independent datasets including total 53 COVID19 patient gene expression analysis performed using ImmunologyV2 panel Comparative analysis HRas gene expression patient confirmed preliminary result fact able confirm upregulation expression HRas gene exact role specific upregulation HRas gene response SARSCoV2 infection possible role cancer still remains elucidated conclusion HRas gene participates host immune response SARSCoV2 virus infection especially patient affected severe form COVID19,
Time course exercise capacity patient recovering COVID19associated pneumonia,34287504,OBJECTIVE High prevalence muscle weakness impaired physical performance hospitalized patient recovering COVID19associated pneumonia reported objective determine whether level exercise capacity discharge would affect longterm functional outcome patient METHODS three five week discharge acute care hospital T0 patient underwent sixminute walk test 6MWT divided two group according distance walked percentage predicted value 75 group =75 group T0 three month later T1 patient completed Short Physical Performance Battery Euro Quality Life Visual Analogue Scale pulmonary function respiratory muscle function assessed addition repeat 6MWT also performed T1 RESULTS T0 6MWD value Short Physical Performance Battery score lower 75 group =75 group difference found Euro Quality Life Visual Analogue Scale score pulmonary function variable respiratory muscle function variable length hospital stay previous treatment T1 group improved exercise capacity subject 75 group showed significant improvement dyspnea lower extremity function Exercise capacity functional status value returned predicted value patient group CONCLUSIONS Four week discharge COVID19 survivor exercise limitation showed significant difference physiological clinical characteristic perceived health status compared patient without exercise limitation Three month later patient recovered exercise capacity,
Characteristics COVID19 case contact reported area Madrid beginning deescalation,34219127,OBJECTIVE Deescalation began May 2020 increase social interaction influence COVID19 epidemiological surveillance aim study characterization COVID19 case detected period METHODS analyzed certain variable interest coming epidemiological survey carried area Madrid May 2020 stratified result depending temporal relation deescalation Prevalence category response average duration minute telephonic call calculated Confidence interval estimated 95 RESULTS included 167 case 305 incident 491 prevalent main source infection home 380 CI 95 314462 Regarding healthcare social care worker main source infection workplace 930 854100 Average number close contact per case 20 1822 15 1020 among predeescalation incident case 24 1830 among postdeescalation Average duration survey 359 minute 322389 321 244398 among predeescalation incident case 370 296444 among postdeescalation contact household beginning deescalation CONCLUSIONS Home prevalent place acquisition infection among general population workplace prevalent among healthcare social care worker initial phase deescalation represents change regarding source infection may increase number close contact,covid-19;close contacts;deescalation;epidemiological surveillance;healthcare workers;spain
Nosocomial mucormycosis thigh,34290961,describe case nosocomial mucormycosis thigh immunocompromised patient admitted COVID19 acute respiratory distress syndrome,covid-19;cutaneous;fungi;immunocompromised;mucormycosis;musculoskeletal
Estimation Admission Ddimer Cutoff Value Predict Venous Thrombotic Events Hospitalized COVID19 Patients Analysis SEMICOVID19 Registry,34287774,BACKGROUND Venous thrombotic event VTE frequent COVID19 elevated plasma Ddimer pDd dyspnea common entity OBJECTIVE determine admission pDd cutoff value associated inhospital VTE patient COVID19 METHODS Multicenter retrospective study analyzing atadmission pDd cutoff value predict VTE anticoagulation intensity along hospitalization due COVID19 RESULTS Among 9386 patient 22 VTE 16 pulmonary embolism PE 04 deep vein thrombosis DVT 02 VTE higher prevalence tachypnea 429 vs 311 p = 00005 basal O2 saturation 93 454 vs 331 p = 00003 higher admission pDd median IQR 14 0655 vs 06 0412 mugml p 00001 platelet count median IQR 208 158289 vs 189 148245 platelet x 10 9 L p = 00013 pDd cutoff 11 mugml showed specificity 72 sensitivity 49 positive predictive value PPV 4 negative predictive value NPV 99 inhospital VTE cutoff value 47 mugml showed specificity 95 sensitivity 27 PPV 9 NPV 98 Overall mortality proportional pDd value lowest incidence pDd category depending anticoagulation intensity 263 pDd 10 mugml treated prophylactic dose p 00001 288 pDd patient pDd 20 mugml treated intermediate dose p = 00001 313 pDd 30 mugml full anticoagulation p = 00183 CONCLUSIONS hospitalized patient COVID19 pDd value greater 30 mugml considered screen VTE consider fulldose anticoagulation,covid-19;d-dimer;sars-cov-2;deep vein thrombosis;pulmonary embolism;venous thrombotic event
Elevated Rates Indeterminate Results QuantiFERON R TB Gold Plus COVID19 Patients,34346720,Interferongamma release assay used screen various patient population latent tuberculosis infection issue Journal Clinical Microbiology Ward et al J Clin Microbiol 59 e0081121 2021 http doiorg101128JCM0081121 investigated increased indeterminate rate QuantiFERONTB Gold Plus assay among COVID19 patient independent immunosuppressive agent lymphopenia study COVID19 patient indeterminate QuantiFERONTB Gold Plus result trended toward decreased survival well increased serum IL6 IL10 level though difference statistically significant suggest pattern cytokine expression support impairment Th1 specifically interferongamma production critically ill COVID19 patient indicated indeterminate QuantiFERONTB Gold Plus result Clinicians aware increased rate indeterminate QuantiFERONTB Gold Plus result critically ill COVID19 patient,
Association Hypertension Severity Mortality Hospitalized Patients COVID19 Wuhan China Singlecentered Retrospective Study,34287571,BACKGROUND Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 spread worldwide OBJECTIVE investigate association hypertension severitymortality hospitalized patient COVID19 Wuhan China METHODS total 337 patient diagnosed COVID19 Seventh Hospital Wuhan City January 20 February 25 2020 enrolled analyzed retrospective singlecenter case study significance level adopted statistical analysis 005 RESULTS 337 patient confirmed diagnosis COVID19 297 878 discharged hospital 40 patient 229 died median age 58 year range 1891 year 112 332 patient diagnosed hypertension admission median age 650 year range 3891 year 67 598 95 CI 506 690 men p=00209 Patients hypertension presented significantly higher portion severe case 69 616 95 CI525 708 vs 117 520 95 CI 454 586 severe patient 23 193 95 CI129 281 vs 27 120 95 CI 77 163 critical patient p=00014 higher mortality rate 20 179 95 CI 107 251 vs 20 89 95 CI 51 126 p=00202 Moreover hypertensive patient presented abnormal level multiple indicator lymphopenia inflammation heart liver kidney lung function admission hypertension group still displayed higher level TnT creatinine approaching discharge CONCLUSION Hypertension strongly associated severity mortality COVID19 Aggressive treatment may considered COVID19 patient hypertension especially regarding cardiac kidney injury,
adult child rapid POC antigen test COVID19 LumiraDx =97 sensitivity specificity vs RTPCR,34224255,SOURCE CITATION Drain PK Ampajwala Chappel C et al rapid highsensitivity SARSCoV2 nucleocapsid immunoassay aid diagnosis acute COVID19 point care clinical performance study Infect Dis Ther 2021 1075361 33629225,
Theory Planned Behavior Analysis Social Distancing COVID19 Pandemic Focusing IntentionBehavior Gap,34228112,BACKGROUND COVID19 continues spread globally important understand psychological factor may influence compliance social distancing PURPOSE present study examined whether Theory Planned Behavior TPB construct associated social distancing focus exploring moderator intentionbehavior relationship METHODS Using longitudinal design US adult N = 507 selfreported TPB construct social distancing behavior baseline 3 month later Participants 48 US States District Columbia average 5039 year old SD = 1532 range = 1880 majority NonHispanic White 716 bachelor s degree higher 553 resided suburban area 558 RESULTS positive attitude toward social distancing increased time p = 002 subjective norm weakened p 001 perceived behavioral control PBC remained stable p = 22 Interestingly despite increase intention baseline followup p 001 significant decrease social distancing behavior time p 001 Consistent TPB baseline attitude p 001 subjective norm p 001 PBC p 001 social distancing associated baseline intention social distance turn baseline intention significantly associated social distancing behavior followup p 001 Younger adult p 001 nonWhite participant p = 002 displayed greater intentionbehavior gap relative older White participant contrast participant stable intention time displayed stronger intentionbehavior relationship p 001 CONCLUSIONS Targeting individual attitude norm PBC may effectively promote protective behavior intended mitigate spread COVID19 similar viral outbreak Future research examine effective strategy translating social distancing intention action,covid-19;intention-behavior;prevention;social distancing;theory of planned behavior
Novel JustInTimeOnlineTraining Nasopharyngeal Swab Specimen Collection COVID19 Pandemic,34336443,INTRODUCTION spread coronavirus disease 2019 COVID19 controlled timely detection infected patient using nasopharyngeal NP swab test followed isolation treatment One challenge encountered NP swab collection train healthcare provider HCPs different training background experience collecting NP swab specimen across Nebraska including sizeable rural area Inperson training NP swab collection skill challenging due social distancing developed JustInTimeOnline Training JITOT delivered using Facebook Live TM meet HCPs training need METHODS Online training held April 21 2020 attended 453 HCPs quasiexperimental study based survey multiple choice questionnaire MCQ conducted evaluate effectiveness improving participant knowledge attitude RESULTS Group mean knowledge score increased pretest score 57 95 posttest showing large effect size Hedges g = 0976877 fivepoint Likert scale majority 8621 survey respondent agreedstrongly agreed training increased overall comfort nasal swab specimen collection compared pretraining comfort 3793 procedure majority respondent 9655 posttraining evaluation agreedstrongly agreed `` delivery method appropriate CONCLUSION JITOT session helpful teach demonstrate clarify doubt improve knowledge comfort participant quickly delivered using free social medium platform broader outreach public health emergency,covid-19;jit;just-in-time-online-training;nasal swab;nasopharyngeal swabbing;online training;procedural skills;public health education;public health emergency of international concern;rural
COVID19 cumulative incidence asymptomatic infection fatality Long Island NY JanuaryAugust 2020 cohort World Trade Center responder,34283876,BACKGROUND New York City Long Island NY early focus COVID19 epidemic US effect COVID19 different subpopulations key epidemiologic parameter remain unknown highly uncertain investigated epidemiology COVID19 January August 2020 established academic monitoring cohort N = 9697 middleaged World Trade Center responder residing Long Island NY METHODS seroprevalence survey series crosssectional survey nested prospective cohort study Measures included IgG antibody testing SARSCoV2 polymerase chain reaction PCR testing review electronic medical record survey symptom Correlates infection analyzed multivariable logistic regression RESULTS cohort predominantly men midfifties 6597 cohort member successfully contacted 68 1042 11 individual participated seroprevalence survey 369 individual 56 6597 study participant underwent PCR testing estimated standardized cumulative incidence 219 95 CI 201239 asymptomatic proportion 164 36219 95 CI 118220 case hospitalization ratio 94 36385 95 CI 66127 case fatality ratio 18 7385 95 CI 0737 hospitalization fatality ratio 83 336 95 CI 18225 Confirmed SARSCoV2 infection associated younger age raceethnicity currently employed CONCLUSIONS result present study suggest high cumulative incidence SARSCoV2 among WTC responder spring summer 2020 contribute narrowing plausible range proportion infection exhibit symptom increased risk infection among younger employed individual likely reflect higher probability exposure virus racial disparity infection risk warrant investigation,
Progress COVID19 vaccine effort virus vaccine variant versus efficacy effectiveness escape,34373623,2020 saw development testing vaccine severe acute respiratory syndrome coronavirus 2 SARSCoV2 unprecedented pace first half 2021 seen vaccine rollout many country Progress article provide snapshot ongoing vaccine efficacy study well realworld data vaccine effectiveness impact virus variant concern deployed high proportion adult population currently approved vaccine extremely effective preventing COVID19 particularly severe disease Nonetheless still significant challenge ensuring equitable vaccine access around globe lesson learned controlling pandemic next pandemic,
NanoMicroparticle Platforms Developing NextGeneration Vaccines,34198865,first vaccine ever made based liveattenuated inactivated pathogen either whole cell fragment Although vaccine required coadministration antigen adjuvant induce strong humoral response could elicit poor CD8 + Tcell response contrast nextgeneration nanomicroparticlebased vaccine offer several advantage traditional one induce potent CD8 + Tcell response time ideal carrier protein adjuvant nucleic acid fact nanocarriers loaded molecule able modulate immune response inducing different effector function regulatory activity make ideal tool inverse vaccination whose goal shut immune response autoimmune disease Poly lacticcoglycolic acid PLGA liposome biocompatible material approved Food Drug Administration FDA clinical use therefore suitable nanoparticlebased vaccine Recently another candidate platform innovative vaccine based extracellular vesicle EVs shown efficiently codeliver antigen adjuvant review discus potential use PLGANPs liposome EVs carrier peptide adjuvant mRNA DNA development nextgeneration vaccine endemic emerging virus light recent COVID19 pandemic,plga;advanced vaccines;extracellular vesicles;liposome;virus infection
Sequential contralateral facial nerve palsy following COVID19 vaccination first second dos,34281950,61yearold man presented ENT emergency clinic history unilateral facial nerve palsy occurring shortly dose PfizerBioNTech COVID19 vaccine first episode developed 5 hour administration first dose second 2 day administration second dose Investigations initial presentation emergency department unremarkable patient diagnosed Bell s palsy occasion describe first case Bell s palsy occurring dose UKapproved COVID19 vaccine Single episode unilateral facial nerve palsy reported clinical trial subsequent case report evidence however episode dose also describe earliest onset symptom timing administration vaccine suggesting Bell s palsy associated vaccine,covid-19;cranial nerves;otolaryngology / ent;safety;vaccination/immunisation
2020 Year Review Shared Ventilation COVID19,34210744,COVID19 resulting severe acute respiratory syndrome coronavirus 2 SARSCoV2 resulted pandemic respiratory failure previously unencountered Early pandemic concentrated infection highdensity population city threatened overwhelm health system ventilator shortage predicted early proposed solution use shared ventilation use single ventilator support = 2 patient Spurred illconceived social medium post idea spread lay press Prior 2020 7 publication topic year later 40 publication addressed technical detail shared ventilation clinical experience shared ventilation well numerous limitation ethic technique review literature regarding shared ventilation peerreviewed article published 2020,ards;covid-19;peep/cpap;gas exchange;mechanical ventilation
Occupational COVID19 Exposures Secondary Cases among Healthcare Personnel,34375702,Throughout COVID19 pandemic healthcare personnel HCP high risk exposure SARSCoV2 patient coworker paper summarizes occupational exposure SARSCoV2 secondary case among HCP large health system Key finding indicate transmission COVID19 HCP low especially close adherence PPE guideline lapse infection prevention practice including dining together omitting eye protection patient care especially time COVID19 circulating widely community increase risk exposure subsequent transmission HCP,coronavirus disease 2019 (covid-19);exposure;healthcare epidemiology;infection control;occupational health;pandemic
Urgent surgery COVID19positive pediatric patient,34292420,BACKGROUND present case COVID19positive pediatric patient urgent urological surgery spinal anesthesia avoid aerosolizing procedure CASE PRESENTATION 12yearold COVID19positive boy presented urgent wound incision drainage circumcision site anesthetic plan consisted spinal anesthesia sedation transported COVID19 isolation floor negative pressure operating room placed lateral decubitus position oxygen delivered facemask sedation spinal anesthesia achieved first attempt patient maintained spontaneous ventilation without airway intervention Patient recovered operation room transported back floor CONCLUSION Spinal anesthesia safe alternative general endotracheal anesthesia many pediatric urology procedure Effective team communication preparation key caring COVID19positive patient perioperative setting avoid minimize risk healthcare provider,airway management;covid-19;pediatric anesthesia;perioperative management;spinal anesthesia
SeroPrevalence SARSCoV2 Antibodies HighRisk Populations Vietnam,34208212,response coronavirus disease 2019 COVID19 pandemic Vietnam enforced strict quarantine contact tracing physical distancing policy resulting one lowest number individual infected severe acute respiratory syndromecoronavirus2 SARSCoV2 globally study aimed determine prevalence SARSCoV2 antibody positivity among highrisk population Vietnam prevalence survey undertaken within four community Vietnam least two COVID19 case confirmed Participants classified according location exposure household contact close contact community member healthcare worker HCWs responsible treating COVID19 case Participants completed baseline questionnaire SARSCoV2 IgG antibody quantified using commercial assay total 3049 community member 149 health care worker consented study Among 13 individual seropositive 04 five household contact 527 185 one close contact 153 19 seven community member 72954 02 detectable SARSCoV2 antibody HCWs negative SARSCoV2 antibody Participants tested median 151 interquartile range 149 152 week exposure study found low prevalence SARSCoV2 antibody highrisk community healthcare worker community Vietnam known COVID19 case,covid-19;sars-cov-2;vietnam;seroprevalence
Predicting COVID19 health behaviour initiation consistency interruption discontinuation among social medium user Nigeria,34223610,Literature predictor health behaviour initiation interruption consistency discontinuation scarce study sought fill gap suggesting model take account variable Using structural equation modelling surveyed 470 social medium user Nigeria found perceived vulnerability perceived seriousness benefit action selfefficacy cue action significantly predict health behaviour initiation Also predictor health interruption found perceived vulnerability perceived seriousness benefit action challenge action perceived realness predictor health behaviour consistency found perceived vulnerability perceived seriousness benefit action perceived realness selfefficacy cue action Finally predictor health behaviour discontinuation found perceived vulnerability perceived seriousness perception realness behaviour fatigue behaviour discomfort explored implication result health promotion made suggestion study,covid-19;health behaviour;health belief model;modelling;social media nigeria
Impact Government Planning Responses Pandemics People Disability Rapid Review,34208739,ObjectiveTo collate evidence 1 risk infection people disability infectious disease outbreak andor pandemic 2 government response pandemic plan people disability MethodsThrough two rapid review relevant peerreviewed study grey literature published 2002 onwards English language identified Data synthesised narratively ResultsAim 1 680 study two study included review grey literature eligible inclusion evidence regarding risk inconclusive Aim 2 50 study three peerreview study along four government report included literature largely reported measure taken maximise prevention transmission COVID19 general population program including people disability ConclusionOverall inconclusive evidence risk infection people disability infectious disease outbreak andor pandemic government preparedness planning disease outbreak andor pandemic largely exclude people disability population health perspective disease outbreak pandemic including COVID19 pandemic along general population important government include people disability pandemic planning response,disability;emergency preparedness;outbreak;pandemic;response;risk of infection
successful case extracorporeal membrane oxygenation COVID19 walking home without oxygen supplementation,34211653,Introduction Severe acute respiratory syndrome coronavirus 2 SARSCoV2 emerged Wuhan China December 2019 strain coronavirus cause coronavirus disease 2019 COVID19 Approximately onethird patient COVID19 require intensive care unit ICU admission almost 30 patient develop acute respiratory distress syndrome ARDS Extracorporeal membrane oxygenation ECMO used salvage therapy severe ARDS role ECMO treatment COVID19 remains unclear although emerging evidence approach may effective salvage therapy severe ARDS Case Presentation present case previously healthy 39yearold Hispanic male presented hospital flulike symptom including headache fatigue myalgia 8 day late April 2020 denied dyspnea exertion patient s symptom progressed resulting pneumonia acute respiratory distress syndrome ARDS patient managed prone positioning convalescent plasma venovenous extracorporeal membrane oxygenation VVECMO 35 day patient successfully recovered able ambulate independently discharged home acute care hospital without oxygen supplementation hospital day 63 Conclusion present one first documented case ECMO severe ARDS due COVID19 prolonged hospital course requiring VVECMO patient discharged home acute care hospital without oxygen requirement ambulated independently likely result daily aggressive mobilityfocused rehabilitation,covid-19;sars-cov-2;acute respiratory distress syndrome;ambulation;discharge home;extracorporeal membrane oxygenation;respiratory failure
Methylprednisolone 60 Days Hospital Survival Coronavirus Disease 2019 Pneumonia,34291223,OBJECTIVES determine methylprednisolone s dose duration administration onset symptom association 60 day hospital survival coronavirus disease 2019 pneumonia DESIGN Cohort study SETTING Thirteen hospital New Jersey United States March June 2020 PATIENTS Sevenhundred fiftynine hospitalized coronavirus disease 2019 patient INTERVENTIONS performed propensity matched cohort study patient received methylprednisolone methylprednisolone Patients methylprednisolone group differentiated dose high dose low dose duration administration onset symptom MEASUREMENTS MAIN RESULTS propensity matched sample 99 380 26 methylprednisolone 69 215 319 lowdose methylprednisolone 74 164 552 highdose methylprednisolone expired Overall median survival methylprednisolone 250 lowdose methylprednisolone 390 highdose methylprednisolone 200 le equal 7 day duration 190 714 day duration 300 greater 14 day duration 440 onset symptom le equal 7 day 200 onset symptom 714 day 270 statistically significant logrank p = 0001 Multivariate Cox regression showed nursing home resident coronary artery disease invasive mechanical ventilation independently associated mortality Methylprednisolone associated reduced mortality compared methylprednisolone hazard ratio 040 95 CI 027059 p 0001 added benefit high dose Lowdose methylprednisolone 714 day associated reduced mortality compared le equal 7 day hazard ratio 045 95 CI 022091 p = 00273 additional benefit greater 14 day hazard ratio 127 95 CI 060269 p = 05434 Combination therapy tocilizumab associated reduced mortality monotherapy p 00116 CONCLUSIONS Lowdose methylprednisolone associated reduced mortality given greater 7 day onset symptom additional benefit greater 14 day High dose associated higher mortality,acute respiratory distress syndrome;coronavirus disease 2019;methylprednisolone;pneumonia
Chimeric spike mRNA vaccine protect Sarbecovirus challenge mouse,34214046,emergence SARSCoV 2003 SARSCoV2 2019 highlight need develop universal vaccination strategy broader Sarbecovirus subgenus Using chimeric spike design demonstrate protection challenge SARSCoV SARSCoV2 SARSCoV2 B1351 bat CoV BtCoV RsSHC014 heterologous BtCoV WIV1 vulnerable aged mouse Chimeric spike mRNAs induced high level broadly protective neutralizing antibody highrisk Sarbecoviruses contrast SARSCoV2 mRNA vaccination showed marked reduction neutralizing titer heterologous Sarbecoviruses SARSCoV WIV1 challenge mouse resulted breakthrough infection Chimeric spike mRNA vaccine efficiently neutralized D614G mink cluster five UK B117 South African B1351 variant concern Thus multiplexedchimeric spike prevent SARSlike zoonotic coronavirus infection pandemic potential,
Lipopeptides Vaccine Development,34228433,development lipopeptides lipidated peptide vaccine discussed including role antigen andor adjuvant Distinct class lipopeptide architecture covered including simple linear ligated construct lipid core peptide design synthesis immunological response important class glycerolbased Tolllike receptor agonist lipopeptides Pam3CSK4 contains three palmitoyl chain CSK4 hexapeptide sequence many derivative model immunogenic compound also reviewed Selfassembled lipopeptide structure including spherical wormlike micelle shown act vaccine agent also described work discussed includes example lipopeptides developed model antigen well immunotherapy treat many infectious disease including malaria influenza hepatitis COVID19 many others well cancer immunotherapy proceeded clinical development research discussed highlight huge potential diversity role lipopeptides contemporary future vaccine development,
Beauty Simplicity DelayedType Hypersensitivity Reaction Measure Cellular Immune Responses RNASARSCov2 Vaccinated Individuals,34205888,BACKGROUND Monitoring cellular immune response elicited vaccinated individual highly complicated METHODS 28 individual participated vaccination process 12 BNT162b2 mRNA Pfizer vaccine Specific antiRBD IgG using classic ELISA performed day 10 20 one dose vaccine day 35 two vaccine dos serum sample participant parallel DTH delayedtype hypersensitivity Skin Test using protein performed 1128 two dos 2828 vaccine RESULTS 628 individual considered positive specific antiRBD IgG positive day 10 whereas 28 individual positive day 20 Moreover 2828 individual increased OD ratio day 36 2 dos DTH cutaneous test performed 1128 participant day 20 1 dose showing 811 positive reaction 12 h DTH participant performed day 36 2 dos showing 2828 positive reaction 12 h CONCLUSION report describes first publication result obtained using vivo method classical DTH response Spike protein ass Tcell immune response vaccinated individual affordable simple test would help answer basic immunogenicity question largescale population vaccine study,covid-19;dth;sars-cov-2;t-cell response;cell response;delayed-type hypersensitivity;humoral response;skin test
AntiSARSCoV2 anticytokine storm neutralizing antibody therapy COVID19 Update challenge perspective,34371330,Coronavirus disease 2019 COVID19 declared World Health Organization pandemic since March 2020 disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 available tool avoid contamination transmission virus physical distancing use N95 surgical mask hand hygiene Vaccines another essential tool reduce impact pandemic though present challenge term production logistics particularly underdeveloped developing country One critical early research finding interaction spike virus protein angiotensinconverting enzyme 2 ACE2 human receptor Developing strategy block interaction therefore identified way treat infection Neutralizing antibody nAbs emerged therapeutic approach since pandemic started Infected patient may asymptomatic present mild symptom others may evolve moderate severe disease leading death immunological phenomenon known cytokine storm observed patient severe disease characterized proinflammatory cytokine cascade response lead lung injury Thus treatment strategy focus anticytokine storm nAbs review summarizes latest advance research clinical trial challenge perspective antibodybased treatment ABT therapy COVID19,antibody-based treatments;covid-19;cytokine storm;neutralizing;passive immunotherapy;sars-cov-2;spike
Critical fluctuation epidemic model explain COVID19 postlockdown dynamic,34226646,COVID19 pandemic progressed research mathematical modeling became imperative influential understand epidemiological dynamic disease spreading momentary reproduction ratio r epidemic used public health guiding tool evaluate course epidemic evolution r reasoning behind tightening relaxing control measure time investigate critical fluctuation around epidemiological threshold resembling new wave even community disease transmission rate Formula see text significantly changing Without loss generality use simple model treated analytically result applied complex model describing COVID19 epidemic analysis show rather supercritical regime infectivity larger critical value Formula see text leading new exponential growth infection subcritical regime infectivity smaller critical value Formula see text small import able explain dynamic behaviour COVID19 spreading lockdown lifting Formula see text hovering around threshold value,
Bioluminescent Biosensor Quantifying Interaction SARSCoV2 Receptor ACE2 Cells Vitro,34199601,severe acute respiratory syndrome coronavirus2 SARSCoV2 currently spreading mutating increasing speed worldwide Therefore urgent need simple sensitive highthroughput HTP assay quantify virushost interaction order quickly evaluate infectious ability mutant virus develop validate virusinhibiting drug developed ultrasensitive bioluminescent biosensor evaluate viruscell interaction quantifying interaction SARSCoV2 receptor binding domain RBD cellular receptor angiotensinconverting enzyme 2 ACE2 living cell vitro successfully used novel biosensor analyze SARSCoV2 RBD mutant evaluated candidate small molecule SMs antibody peptide may block RBD ACE2 interaction simple rapid HTP biosensor tool significantly expedite detection viral mutant antiCOVID19 drug discovery process,ace2;covid-19;nanobit;rbd;sars-cov-2;bioluminescent biosensor;therapeutic drugs
Obesity severe coronavirus disease 2019 molecular mechanism path forward therapeutic opportunity,34373739,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 appears higher pathogenicity among patient obesity Obesity termed body mass index greater 30 kgm 2 demonstrated important comorbidity disease severity coronavirus disease 2019 COVID19 pandemic associated adverse event Unraveling mechanism behind phenomenon assist scientist clinician policymakers responding appropriately COVID19 pandemic review systemically delineated potential mechanistic link obesity worsening COVID19 altered physiology underlying disease metabolism immunity cytokine storm thrombosis Problematic ventilation caused obesity preexisting medical disorder exacerbate organ dysfunction patient obesity Chronic metabolic disorder including dyslipidemia hyperglycemia vitamin deficiency polymorphism metabolismrelated gene obesity probably aid SARSCoV2 intrusion impair antiviral response Obesityinduced inadequate antiviral immunity interferon natural killer cell invariant natural killer cell dendritic cell cell B cell early stage SARSCoV2 infection lead delayed viral elimination increased viral load expedited viral mutation Cytokine storm defective antiviral immunity probably contributes tissue damage pathological progression resulting severe symptom poor prognosis prothrombotic state driven large part endothelial dysfunction platelet hyperactivation hypercoagulability impaired fibrinolysis obesity also increase risk severe COVID19 mechanism susceptibility severe condition also open possibility hostdirected therapy population obesity bridging work done field researcher gain holistic view path forward therapeutic opportunity break vicious cycle obesity devastating complication next emerging pandemic,coronavirus disease 2019;immunity;inflammation;metabolism;obesity;thrombosis
Diagnostic Challenges Pneumocystis Pneumonia COVID19 Pandemic Case Young Patient Ground Glass Opacities Pulmonary Embolism Chest CT,34373796,coronavirus disease 2019 COVID19 pandemic wreaking havoc across globe pandemic given rise mindset physician tend neglect cause pneumonia especially patient present sign symptom commonly associated COVID19 Herein report case young man presenting emergency department common clinical radiological laboratory feature COVID19 pneumonia shortness breath hypoxia pulmonary embolism elevated Ddimer bilateral ground glass opacity computed tomography chest later diagnosed Pneumocystis pneumonia treated appropriate antibiotic corticosteroid case highlight importance performing thorough clinical history differentiating clinical radiological feature COVID19 pneumonia pneumonia etiology,
Repurposing protease insilico analysis binding potential extracellular fungal protease selected viral protein,34226889,Proteases long target many drug potential therapeutic agent wellknown underexplored area Due heightened threat new emerging infectious agent worthwhile tap vast microbial protease resource identify potential therapeutic docking protease fungus Penicillium janthinellum NCIM 1366 protein encoded SARSCoV2 virus enzyme potential bind thereby degrade viral protein identified Insilico docking analysis revealed fungal commercially available protease belonging A1A M20A S10 S8A T1A family able bind viral spike envelope ORF7a Nsp2 protein binding energy 50 kJmol thereby opening possibility developing additional therapeutic application enzyme,antiviral;covid;fungal;penicillium;protease;therapeutic
FollowUp Analysis Pulmonary Function Exercise Capacity Radiological Changes Quality Life Two Months Recovery SARSCoV2 Pneumonia,34204878,Background objective According World Health Organization 100 million people already recovered SARSCoV2 infection Therefore imperative understand possible outcome COVID19 aim study evaluate pulmonary function exercise capacity residual radiological change healthrelated quality life HRQoL followup cohort SARSCoV2 pneumonia survivor Materials Methods Patients SARSCoV2 infection radiologically confirmed lung injury chronic lung disease prior infection included study Patients evaluation 2 month discharge hospital included spirometry FVC FEV1 FEV1FVC determination lung volume TLC VC RV diffusing capacity lung carbon monoxide DLCO adjusted hemoglobin 6Minute Walk Test 6MWT chest CT scan 36Item Short Form General Health Survey SF36 Results Fiftyone patient 25 men 26 woman included mean age 56 year SD1172 Eighteen patient 353 experienced moderate COVID19 21 412 severe COVID19 12 235 critically ill mean followup visit time discharge hospital 60 day SD17 Pulmonary function followup impaired 24 472 patient Reduced lung volume observed 15 294 patient DLCO reduction 15 294 patient one patient displayed obstruction Twelve patient 51 1251 273 showed reduced physical capacity 6 MWT 351 91 showed desaturation SO2 90 Different level abnormality found 4951 961 patient followup chest CT median radiological score 109 SD + 887 possible maximal score 25 Groundglass opacity common radiological feature found 45 882 patient SF36 score demonstrated reduction health status across domain lowest score limitation social activity physical problem vitality general health Conclusion group COVID19 pneumonia survivor 2 month hospital discharge residual change lung chest CT lung function reduced physical HRQoL status found significant number patient evaluate COVID19 longterm consequence longer followup period needed,covid-19;consequences;follow-up;pneumonia
Convalescent Plasma Pregnant Women COVID19 Systematic Literature Review,34206468,treatment COVID19 particularly critical pregnant woman considering potential teratogenic effect antiviral agent immunedepression related pregnancy aim review systematically examine current evidence clinical use convalescent plasma pregnancy electronic database Medline PubMed Advanced Search Builder Scopus Web Science Google Scholar searched 1 January 2021 Inclusion criterion pregnant woman COVID19 SARSCoV2 infection convalescent plasma hyperimmune plasma used treatment searched clinical trial registry censored 5 January 2021 eligible study way elimination duplication initial search yielded 79 potentially relevant record 67 subsequently excluded 12 remaining record case report involving 12 pregnancy Six mother reported well two reported preeclampsia one case maternal outcome described survival clinical improvement discharged oxygen rehabilitation regard neonate two declared well four transient morbidity two critically ill one died normal ongoing pregnancy postdelivery information reported remaining three case Clinical trial way planned investigate use convalescent plasma COVID19 pregnancy lacking first systematic review literature regarding treatment COVID19 pregnancy published literature data seem indicate convalescent plasma administered pregnant woman severe COVID19 provides benefit mother fetus quality available study however limited since case report thus suffer relevant reporting bias,covid-19;sars-cov-2;convalescent plasma;fetus;hyperimmune plasma;newborn;pregnancy
Corneal Donation Current Guidelines Future Direction,34285462,Purpose review aim outline current practice guideline corneal donation eye banking describes implication COVID19 emerging disease corneal donor pool discus future trend improve increase efficiency process involved corneal donation eye banking Summary Corneal screening preservation corneal storage prevention systemic disease transmission donor recipient crucial shaping policy FDA eye bank across world Eye bank globally developed varying guideline criterion evaluating viability donor cornea Variables age donor medical history potential disease transmission important screening parameter known infectious disease may transmissible cornea emerging infectious disease well studied may transmissible infection particular coronavirus impacted corneal transplantation SARSCoV2 expression detected corneal tissue conjunctiva recent year partialthickness corneal transplantation introduced Lamellar graft corneal layer utilized transplantation specific area damaged,covid-19;cornea transplant;donor cornea;donor recipient;eye bank;keratoplasty
COVID19 pandemic opioid use disorder Expanding treatment buprenorphine combining safety precaution telehealth,34210567,BACKGROUND study investigated efficacy safety providing medication opioid use disorder MOUD individualized telehealth Kentucky state severely impacted simultaneously opioid epidemic COVID19 pandemic METHODS investigation analyzed pre postCOVID19 characteristic 191 opioid use disorder OUD buprenorphine outpatient completed 18question survey late 2020 related COVID testing OUD relapse obstacle maintaining abstinence treatment resource RESULTS study revealed statistically significant change drug use onset COVID19 pandemic despite monthly volume increase Results demonstrated statistically significant barrier treatment including loss housing transportation food insecurity onset depression patient required hospitalization succumbed OUD COVID19 Potentially effective resource utilization finding included clinic transportation 247 crisis intervention Respondents rated telehealth helpful used individualized hybrid model matching patient s need available resource based COVID19 safety guideline CONCLUSION report yield key clinical insight providing outpatient MOUD care COVID19 pandemic validating inperson care safe effective Patients experience proved helpful identifying quantifying obstacle abstinence conjunction facilitating continued patient access essential clinical resource Notably telehealth supplement rather replace inperson treatment,addiction;buprenorphine;covid-19;medication for opioid use disorder (moud);opioid use disorder (oud);telehealth;treatment
COVID19 vaccine know far,34288409,novel coronavirus described late 2019 could imagined within year 100 vaccine candidate would preclinical development several would clinical trial even approved use scale COVID19 outbreak pushed scientific community working collaboration pharmaceutical company public health body policymakers funders government develop vaccine SARSCoV2 recordbreaking speed well driving major amendment usual timeframe bringing vaccine fruition pandemic accelerated development nextgeneration technology vaccinology giving rise two frontrunner RNA vaccine Although none critical safety efficacy step skipped within compressed schedule technology underpinning novel vaccine refined scientist many year significant proportion global population sceptical benefit COVID19 vaccine wary potential risk interviewbased article give overview vaccine developed work generate robust immune response COVID19 well addressing common question relating safety efficacy,
COVID19 LevelLoading Transferring Emergency Department Patients Partner Academic Medical Center Within Healthcare System,34225276,COVID19 continues challenge bed capacity ability hospital provide quality care patient around country However COVID19 pandemic given point time impact hospital equallyeven within single healthcare system one hospital may caring patient hallway another available inpatient bed demonstrate program levelload COVID19 patient 2 academic medical center healthcare system transferring patient time admission emergency department one institution directly inpatient bed institution 42 day 50 patient transferred saved 432 beddays home academic medical center without adverse event transfer upgrade ICU within first 24 hour admission Programs like expand healthcare system s ability allocate personnel resource efficiently patient maximize quality care delivered even pandemic,
COVID19 liver transplant candidate pretransplant posttransplant outcome ELITAELTR multicentre cohort study,34281984,OBJECTIVE Explore impact COVID19 patient waiting list liver transplantation LT postLT course DESIGN Data consecutive adult LT candidate COVID19 collected across Europe dedicated registry analysed RESULTS 21 February 20 November 2020 136 adult case laboratoryconfirmed SARSCoV2 infection 33 centre 11 European country collected 113 COVID19 Thirtyseven 37113 327 patient died median 18 1030 day respiratory failure major cause 3337 892 60day mortality risk significantly change first 353 95 CI 239 500 second 260 95 CI 162 402 wave Multivariable Cox regression analysis showed Laboratory Model Endstage Liver Disease LabMELD score =15 Model Endstage Liver Disease MELD score 1519 HR 546 95 CI 181 1650 MELD score =20 HR 524 95 CI 177 1555 dyspnoea presentation HR 389 95 CI 202 751 two negative independent factor mortality Twentysix patient underwent LT median time 785 IQR 44102 day 25 96 alive median followup 118 day IQR 31170 CONCLUSIONS Increased mortality LT candidate COVID19 327 reaching 45 decompensated cirrhosis DC LabMELD score =15 observed significant difference first second wave pandemic Respiratory failure major cause death dismal prognosis patient DC support adoption strict preventative measure urgent testing vaccination efficacy population Prior SARSCoV2 symptomatic infection affect early posttransplant survival 96,covid-19;liver cirrhosis;liver transplantation
SARSCoV2 Genetic Variability NonSpecific Immunity Associated Use Different BCG StrainsA Molecular Clinical Approach,34200951,effect BCG vaccination tuberculosis reduction COVID19 infection related effect BCG vaccine immunomodulation nonspecific immunity early stage pandemic country universal BCG vaccination program registered low number new case COVID19 situation reversed exemplified India high genetic variability SARSCoV2 known characteristic RNA virus causing occurrence SARSCoV2 variant may led virus adapting overcome initial immune protection strain United Kingdom B117 Brazil B1128 B1133 South Africa B1351 India B1617 characterized greater ability spread environment comparison original infectious agent SARSCoV2 remembered large variation genetic makeup SARSCoV2 may result future change pathogenicity immunogenicity antigenicity therefore necessary carefully study mutation occurring within virus determine whether current vaccine remain effective However study show monoclonal antibody produced vaccination COVID19 effective newly developed variant,bcg vaccinations;covid-19;sars-cov-2;who recommendation;genetic variability;tuberculosis;variants
Reopening Italy s school September 2020 Bayesian estimation change growth rate new SARSCoV2 case,34210737,OBJECTIVES COVID19 s second wave started debate potential role school primary factor contagion resurgence Two opposite position appeared convinced school played major role spreading SARSCoV2 infection studied growth rate total number SARSCoV2 infection Italian region school reopening SeptemberOctober 2020 investigating hypothesis association school resurgence virus METHODS Using Bayesian piecewise linear regression scrutinise number daily SARSCoV2 infection region looked estimate changepoint growth rate confirmed case compared changepoints school opening date Italian region regression allows discus change steepness infection curve changepoint RESULTS 15 21 Italian region 71 estimated change rate growth total number daily SARSCoV2 infection case occurred average 1666 day 95 CI 1447 1873 since school reopening number day required SARSCoV2 daily case double went average 4750 day 95 CI 3718 5761 changepoint average 772 day 95 CI 700 848 CONCLUSION Studying rate growth daily SARSCoV2 case region provides evidence favour link school reopening resurgence virus number factor could played role many give definitive answer Still temporal correspondence warrant systematic experiment investigate potential confounders could clarify much reopening school mattered,epidemiology;infectious diseases;public health
effect COVID19 newly established burn center,34222736,Objective study aim investigate effect COVID19 epidemiological feature burn agent burn percentage hospitalization time burn center Methods singlecenter retrospective study included total 401 patient admitted study center October 2019 July 2020 patient admitted March 1 2020 considered preMarch group admitted March 1 2020 considered postMarch group According age patient divided group aged = 18 year aged 18 year Demographic clinical characteristic patient burn agent burn surface area COVID19 status treatment followup data recorded Results study result showed significant difference number patient admission age sex patient burn agent length hospital stay COVID19 outbreak Conclusions Burn center work safely COVID19 outbreak paying special attention precaution mandated national global health authority However increase pandemic burden may force burn center converted alternate COVID19 facility case care burn patient may pose great problem,burn;burn center;covid-19
Prioritizing cervical cancer screening service COVID19 pandemic Response academic medical center public safety net hospital California,34217411,expeditious diagnosis treatment highgrade cervical precancers fundamental cervical cancer prevention However COVID19 pandemic healthcare system time restricted inperson visit deemed urgent Professional society provided guidance clinician regarding way traditional cervical cancer screening might modified many gap remained address gap leader screening program academic medical center urban safety net hospital California formed rapidaction committee provide guidance practitioner Patients divided 6 category corresponding various stage screening process ranked risk underlying highgrade cervical precancer cancer Tiers corresponding intensity local pandemic constructed clinical delay lengthened lowestrisk patient tier escalated final product management grid designed escalate deescalate change local epidemiology COVID19 pandemic effort resulted substantial delay clinical screening service mandated healthcare system population effect delaying cervical cancer outcome well beneficial effect related decreasing transmission severe acute respiratory coronavirus 2 yet elucidated,covid-19;cervical cancer screening;consensus guidelines
Evaluation Strategies Fight COVID19 French Paradigm,34209087,1 Background collected COVID19 mortality data age distribution deceased France European country well specifically city Paris Marseille compared 2 Methods Data mortality related COVID19 associated age distribution collected government institution various European country France data obtained INSEE Sante Publique France Allcause mortality also examined order study potential excess mortality using EuroMOMO Marseille data came epidemiological surveillance system 3 Results France one European country impacted COVID19 proportion death people 60 year age higher 65 Italy 46 Spain 47 Excess mortality 5 death also observed IledeFrance GrandEst two French region highest mortality proportion death under60 age group considerable IledeFrance 99 vs 45 Southern region significantly higher number patient hospitalized intensive care deceased Paris Marseille 4 Conclusions patient management ie screening diagnosis including biological assessment clinical examination likely explains high mortality associated COVID19,covid-19;france;marseille;paris;sars-cov-2;deaths
unifying nonlinear probabilistic epidemic model space time,34226649,Covid19 epidemic dramatically relaunched importance mathematical modelling supporting government decision slow disease propagation hand remains challenging task mathematical modelling interplay different model could key element modelling strategy propose continuous spacetime nonlinear probabilistic model derive many existing model deterministic stochastic example SI SIR SIR stochastic continuoustime stochastic model discrete stochastic model FisherKolmogorov model partial analogy statistical interpretation quantum mechanic provides interpretation model Epidemic forecasting one possible application principle model used order locate region space infection probability going increase connection nonlinear probabilistic nonlinear deterministic model analyzed particular shown FisherKolmogorov equation connected linear probabilistic model hand generalized version FisherKolmogorov equation derived nonlinear probabilistic model shown characterized nonhomogeneous timedependent diffusion coefficient anomalous diffusion encodes information nonlinearity probabilistic model,
Intelligent antiepidemic mask based KF ECF fusion algorithm,34219793,response environmental pollution spread Coronavirus Disease 2019 COVID19 paper proposes new type smart mask design specifically proposes optimized double closedloop control method especially improved filtering fusion algorithm Using filtering fusion algorithm proposed paper Kalman filter KF filter raw data attitude sensor explicit complementary filtering data fusion used obtain attitude angle body time obtained attitude angle combined acceleration blood oxygen concentration obtain behaviour characteristic value basis speed oxygen supply fan captured photoelectric sensor used form closed loop characteristic value behaviour Finally structure mask upgraded optimized fluid mechanic simulation experiment verified combination replaceable filter cloth intelligent control system ultraviolet disinfection device effectively protect people s health,
Case Chilblainslike Lesions Post SARSCoV2 Vaccine,34210829,SARSCoV2 described cause `` COVID coronavirus disease toe chilblainslike syndrome 123 33yearold White woman evaluated hospital painful newonset blue purple nodule tip 3 finger 2 toe 7 day receiving Moderna SARSCoV2 vaccine Figure 1,
Phyllanthin hypophyllanthin isolated compound Phyllanthus niruri inhibit protein receptor corona virus COVID19 silico approach,34214339,OBJECTIVES Phyllanthus niruri known immunomodulator also reported posse antiviral activity several RNA virus hepatitis B virus hepatitis C virus inhibiting viral entry replication Since current situation Coronavirus Disease 2019 COVID19 infected among world caused severe disease high morbidity urgently needed find new agent COVID19 Therefore silico screening COVID19 receptor carried initial stage drug discovery evaluating activity phyllanthin hypophyllanthin isolated Phyllanthus niruri inhibiting spike glycoprotein 6LZG main protease 5R7Y play target receptor COVID19 METHODS Molegro Virtual Docker 60 used determine best binding energy rerank score show total energy bond calculation RESULTS Phyllanthin hypophyllanthin demonstrated posse greater binding affinity toward COVID19 inhibition site native ligand rerank score phyllanthin hypophyllanthin lower native ligand 6LZG 5R7Y result indicated phyllanthin hypophyllanthin stronger interaction native ligand spike glycoprotein entry inhibitor main protease translation replication inhibitor CONCLUSIONS conclusion phyllanthin hypophyllanthin predicted strong activity COVID19 inhibiting spike glycoprotein main protease silico study research needed support development P niruri inhibitor agent COVID19 bioassay study,covid-19;phyllanthus niruri;hypophyllanthin;in silico;phyllanthin
Effects 2Week 5000 IU versus 1000 IU Vitamin D3 Supplementation Recovery Symptoms Patients Mild Moderate Covid19 Randomized Clinical Trial,34202578,OBJECTIVE Vitamin deficiency associated increased risk COVID19 severity multicenter randomized clinical trial aim determine effect 5000 IU versus 1000 IU daily oral vitamin D3 supplementation recovery symptom clinical parameter among mild moderate COVID19 patient suboptimal vitamin status STUDY DESIGN SETTING total 69 reverse transcriptase polymerase chain reaction RTPCR SARSCoV2 positive adult hospitalized mild moderate COVID19 disease allocated receive daily 2 week either 5000 IU oral vitamin D3 n = 36 21 male 15 female 1000 IU oral vitamin D3 standard control n = 33 13 male 20 female Anthropometrics measured blood sample taken pre postsupplementation Fasting blood glucose lipid serum 25 OH inflammatory marker measured COVID19 symptom noted admission monitored full recovery RESULTS Vitamin supplementation 2 week caused significant increase serum 25 OH level 5000 IU group adjusted p = 0003 Withingroup comparison also showed significant decrease BMI IL6 level overtime group pvalues 005 clinically significant betweengroup comparison KaplanMeier survival analysis revealed 5000 IU group significantly shorter time recovery day 1000 IU group resolving cough even adjusting age sex baseline BMI Ddimer 62 + 08 versus 91 + 08 p = 0039 ageusia loss taste 114 + 10 versus 169 + 17 p = 0035 CONCLUSION 5000 IU daily oral vitamin D3 supplementation 2 week reduces time recovery cough gustatory sensory loss among patient suboptimal vitamin status mild moderate COVID19 symptom use 5000 IU vitamin D3 adjuvant therapy COVID19 patient suboptimal vitamin status even short duration recommended,covid-19;clinical trial;saudi;vitamin d;vitamin d insufficiency
Erythema nodosumlike eruption coronavirus disease 2019 case report literature review Asian country,34289146,worldwide coronavirus disease 2019 COVID19 outbreak skin manifestation seen COVID19 patient report case COVID19 patient developed cutaneous lesion diagnosed erythema nodosumlike lesion associated COVID19 Nasopharyngeal swab polymerase chain reaction PCR confirmed severe acute respiratory syndrome coronavirus 2 SARSCoV2 Histopathologically extensive inflammation seen epidermis fat tissue organized thrombus disrupted inner elastic lamina seen intradermal vessel finding suggest septal panniculitis cutaneous polyarteritis nodosa result PCR using specimen skin lesion negative patient took nonsteroidal antiinflammatory drug skin lesion improved 3 week characterize skin eruption reviewed previous report COVID19 confirmed detection SARSCoV2 infection Asian country type eruption timing appearance case seemed rare Differences skin manifestation Western Asian country noted,coronavirus disease 2019;erythema nodosum;race;severe acute respiratory syndrome coronavirus 2;thrombosis
Rare Case Herpes Zoster Adult Patient Recovered Symptomatic Reinfection COVID19,34377609,coronavirus disease 2019 COVID19 patient various dermatological condition observed Varicella zoster virus VZV herpes simplex virus must ruled considering vesicular exanthem linked COVID19 immunological status host impact natural history herpes zoster HZ Age major risk factor case HZ Reactivation VZV triggered iatrogenic immunosuppression diseaserelated immunocompromised state agerelated immunosenescence Rarely dermatological symptom reported recovered COVID19 patient hereby present rare case HZ recovered patient symptomatic reinfection COVID19,adult;covid-19;herpes zoster;sars-cov-2;varicella zoster
Development framework intervention strategy point care quality improvement different level healthcare delivery system India initial lesson,34344739,BACKGROUND Inadequate quality care identified one significant challenge achieving universal health coverage lowincome middleincome country address WHOSEARO point care quality improvement POCQI method developed paper describes developing dynamic framework implementation POCQI across India 2015 2020 METHODS total 10 intervention strategy designed per need local health setting strategy implemented across 10 state India using modification translating research practice framework Healthcare professional administrator trained POCQI using combination onsite online training method followed coaching mentoring support implementation strategy changed fully digital community practice platform active phase COVID19 pandemic Dashboard process outcome indicator crude cost implementation collected analysed across implementation site RESULTS Three implementation framework evolved study period combined population benefitting intervention 103 million pool QI team 131 facility successfully undertook 165 QI project supported pool 240 mentor study period total 21 QI resource 6 publication peerreviewed journal also developed average cost implementing POCQI initiative target population one million US 3219 total 100 online activity conducted 6 month digital community practice framework recently extended digitally across SouthEast Asian region CONCLUSION development implementation framework POCQI essential requirement initiative s successful countrywide scale implementation plan flexible healthcare system s need target population implementing agency s capacity amenable multiple iterative change,health services research;healthcare quality improvement;implementation science
SelfIsolation Quarantine UK s First Wave COVID19 MixedMethods Study NonAdherence,34209105,Selfisolation quarantine measure introduced UK Government 12 March 2020 part delay phase control spread SARSCoV2 Nonadherence selfisolation 7 day development symptom considered suboptimal little known adherence quarantine 14 day cohabitant developed symptom study aim analyse nonadherence behaviour selfisolation quarantine measure identifying potential psychosocial demographic predictor exploring people s account experience measure mixedmethods convergent design used comprising online survey n = 681 completed resident six North London borough qualitative interview subsample participant n = 16 Findings identified accessing community support lack control leaving house lack perceived benefit need follow rule behaviour associated nonadherence quarantine 427 Nonadherence selfisolating measure 244 associated individual perceived lack control responsibility lack control leaving house uncertainty symptom experienced lack access test distrust Government Adherence selfisolation quarantine could improved strengthening perceived benefit selfisolate message emphasising effectiveness implementing twoway information system support symptom identification Governmentfunded locally supported package different level financial food practical need,covid-19;uk;adherence behaviours;mixed-methods;quarantine;self-isolation
COVID19 infection severe rhabdomyolysis,34219929,Although patient COVID19 mild nonspecific myalgia mild elevation creatinine kinase level severe myalgia along elevation creatinine kinase level 10 time upper normal limit darkcolored urine indicate underlying severe rhabdomyolysis report describes 60yearold morbidly obese man found severe rhabdomyolysis along acute kidney injury darkcolored urine positive COVID19 test prolonged hospital course requiring continuous renal replacement therapy mechanical ventilation multiple vasopressor eventually died multiorgan failure management severe rhabdomyolysis COVID19 challenging fluid resuscitation done cautiously monitoring early sign fluid overload,covid-19;sars-cov-2;respiratory failure;rhabdomyolysis
COVID19 UK water sector Exploring organizational response resilience framework,34226833,unprecedented scale impact COVID19 pandemic required organization adapt facet operation impact UK water sector extends beyond engineering treatment process social economic environmental consequence Semistructured interview conducted executive 10 UK water company investigate organizational response pandemic response impacted operational delivery Safe SuRe framework used structure interview question analysis Emergent theme change customer behaviour change operational practice industry collaboration mapped onto framework ripple effect map developed Lessons learnt highlight failure adequately prepare scale threat success sectorlevel collaboration need embrace new way working,covid-19;safe and sure;organisational response;resilience;water sector
Lethal ageism shadow pandemic response tactic,34292599,AIM paper examines aspect pandemic policy response COVID19 SARSCoV2 variant present integrated view consequence response tactic national health service level older adult BACKGROUND Nurses positioned intersection health service policy implementation therefore influence clinical protocol health policy direction post pandemic crucial preventing premature death 65+ year age group others SOURCES EVIDENCE Perspectives presented based critical evaluation many published report comment research insight concerning pandemic evidence combined experience various field study professional service enables envisage decision policy may mean older people nurse society worldwide DISCUSSION Established information world population pattern location health national group made le reliable population shift caused year geopolitical conflict impact pandemic Added already chaotic context pandemic disrupted society health service economy Ageist response system disadvantaged older people generated trust deficit need resolved CONCLUSION pandemic recedes policy management decision taken government hospital administrator telling indicator whether established systematic ageism exposed pandemic continue compromise health longevity older adult IMPLICATIONS NURSING HEALTH SOCIAL POLICY ascendency nursing influence within health social policy environment must strengthened enable nurse champion equity fairness pandemic recovery effort,covid-19;sars-cov-2 variants;ageism;caremongering;nursing;nursing policy and health policy;pandemic;senicide;service rationing
Impact cancelled General Anaesthetic dental extraction appointment child due COVID19 pandemic,34218535,BACKGROUND COVID19 resulted cancellation general anaesthetic procedure including dental extraction GAX child UK exacerbating existing inequality robust evidence child deprived ethnic background greater risk caries therefore likely affected cancellation AIM identify impact possible mitigation cancelled general anaesthetic procedure child South East England DESIGN Data collected service provider number child appointment cancelled first lockdown Paediatric dentist clinical lead contributed view likely impact cancellation affected child RESULTS 1456 child appointment cancelled six week 20th March 30th June 2020 key theme identified provider included lengthening waiting list challenge swab testing selfisolation need reorientate dental service increase prevention CONCLUSION COVID19 exacerbated existing health inequality within community Different part NHS must work together ensure child access service treat improve oral health,dental public health;oral health inequalities;paediatric extractions;prevention
COVID19 Workplaces Secondary Transmission,34374745,OBJECTIVES Coronavirus disease COVID19 contagion work well studied healthcare worker however enough assessed working setting little known indeed risk COVID19 transmission occupational exposure nonhealth working place study aim describe COVID19 cluster among worker office Italy METHODS retrospective observational study cluster COVID19 occurred 20 November 3 December 2020 group six colleague AF working office full time 5 day week 8 h day worker used following prevention measure social distancing desk 1 176501 range plexiglas panel hand disinfection use face mask However wear face mask static position sitting desk aerate place frequently RESULTS disease spread one worker subject four 80 five colleague subject BF subject negative COVID19 14 day last contact subject 20 November 2020 confirmed nasopharyngeal swab testing Subject particular contact subject 48 h symptom onset COVID19 positivity subject promptly communicated colleague started selfisolation relative none household infected COVID19 transmission observed household subject CONCLUSIONS rapid communication COVID19 positivity colleague prompt isolation index case s close contact allowed eliminate secondary transmission household contagion index case s colleague occurred second day symptom onset Distancing 1 use plexiglas panel sanitizing hand gel inconstant use face mask may enough infection prevention closed place poor ventilation high occupancy,covid-19;sars-cov-2;pandemic;preventive measures;secondary contagion;working place
Association Severe Tongue Edema Prone Positioning Patients Intubated COVID19,34287907,OBJECTIVESHYPOTHESIS Prone positioning frequently used patient intubated COVID19related lung injury improve oxygenation institution observed severe tongue edema develop patient Hence sought determine incidence tongue edema cohort whether prone positioning risk factor associated complication STUDY DESIGN Retrospective cohort study METHODS singlesystem retrospective cohort study patient intubated respiratory failure secondary COVID19 subsequently developed clinically notable tongue edema March 13 July 5 2020 RESULTS 260 patient intubated COVID19related respiratory failure study period 158 patient 608 underwent least one episode proning Twelve patient total 46 developed clinically significant tongue edema Eleven twelve patient 917 developed tongue edema underwent proning prior development edema Prone positioning associated increased incidence tongue edema odds ratio 756 95 confidence interval CI 0965946 P = 027 proned patient developed edema complication noted proning shortly supination range 04 day Tongue edema primarily managed conservative measure one patient required tracheostomy definitive management CONCLUSIONS Tongue edema appears develop subset patient COVID19 intubated appears associated prone positioning likely multifactorial nature investigation incidence pathophysiology warranted LEVEL EVIDENCE 4 Laryngoscope 2021,covid-19;intubation;prone positioning;proning;tongue edema
Optimization man power deployment Covid19 screening tertiary care hospital study utility queuing analysis,34284837,OBJECTIVES recent Covid19 pandemic burdened healthcare facility especially presence limited infrastructure aimed applying queuing model Covid19 screening area optimize screening service ensuring patient refused service METHODS mean arrival time patient number physician mean screening time queue characteristic observed entered MMcK queuing model using R programming optimize number physician required screening area RESULTS Considering mean arrival seven patient 10 minute screening three patient 10 minute one physician two physician assigned capacity probability saturation system 15 patient loss rate 105 per 10 minute Queuing simulation three physician reduced patient loss rate 0013 per 10 minute saturation probability 02 However increase arrival rate 10 20 led early saturation system CONCLUSION Queuing model offer opportunity healthcare provider hospital administrator optimize patient care service especially critical area everchanging situation current pandemic,health system;patient loss;queuing model;saturation;waiting time
Early Effects Passive LegRaising Test Fluid Challenge Norepinephrine Cerebral Autoregulation Oxygenation COVID19 Critically Ill Patients,34220684,Background Coronavirus disease 2019 COVID19 patient high risk neurological complication consequent several factor including persistent hypotension paucity data effect therapeutic intervention designed optimize systemic hemodynamics cerebral autoregulation CA group patient Methods Singlecenter observational prospective study conducted San Martino Policlinico Hospital Genoa Italy October 1 December 15 2020 Mechanically ventilated COVID19 patient least one episode hypotension received passive leg raising PLR test included treated fluid challenge FC andor norepinephrine NE according patient clinical condition different moment primary outcome ass early effect PLR test FC NE clinically indicated maintain adequate mean arterial pressure MAP CA CA index measured transcranial Doppler TCD Secondary outcome evaluate effect PLR test FC NE systemic hemodynamic variable cerebral oxygenation rSo2 noninvasive intracranial pressure nICP Results Twentythree patient included underwent PLR test 22 patient received FC 14 treated NE median age 62 year interquartile range = 57685 year 78 male PLR test led low CA index 58 44763 FC NE administration resulted CA index 908 742100 100 100100 respectively PLR test nICP based pulsatility index nICP based flow velocity diastolic formula increased 186 177196 vs 193 182198 mm Hg p = 0009 129 8518 vs 15 105197 mm Hg p = 0001 respectively PLR test FC NE resulted significant increase MAP rSo2 Conclusions mechanically ventilated severe COVID19 patient PLR test adversely affect CA individualized strategy aimed assessing hemodynamic cerebral need warranted patient high risk neurological complication,cerebral autoregulation;cerebral oxygenation;fluid challenge;norepinephrine;passive leg raising test
Electrostatic Interactions Explain Higher Binding Affinity CR3022 Antibody SARSCoV2 4A8 Antibody,34228472,structural understanding mechanism antibody bind SARSCoV2 atomic level highly desirable tell development effective antibody treat Covid19 use steered molecular dynamic SMD coarsegrained simulation estimate binding affinity monoclonal antibody CR3022 4A8 SARSCoV2 receptorbinding domain RBD SARSCoV2 Nterminal domain NTD Consistent experiment SMD coarsegrained simulation indicate CR3022 higher affinity SARSCoV2 RBD 4A8 NTD coarsegrained simulation indicate former bind three time stronger respective epitope finding show CR3022 candidate Covid19 therapy likely better choice 4A8 Energetic decomposition interaction energy two complex reveals electrostatic interaction explain difference observed binding affinity two complex result could lead new approach developing antiCovid19 antibody good candidate must contain charged amino acid area contact virus,
Systematic review host genetic association Covid19 prognosis susceptibility learned 2020,34338380,Biomarker identification may provide strategic opportunity understand disease pathophysiology predict outcome improve human health reduce healthcare cost highly heterogeneous Covid19 clinical manifestation suggests complex interaction several different human viral environmental factor systematically reviewed genetic association study evaluating Covid19 severity susceptibility SARSCoV2 infection following PRISMA recommendation research comprised paper published December 31 st 2020 PubMed BioRXiv database focusing genetic association study Covid19 prognosis susceptibility found 20 eligible genetic association study 11 assessed Covid19 outcome 14 evaluated infection susceptibility five analyzed effect Qgenie assessment indicated moderate quality Five largescale association study GWAS wholegenome exome sequencing reported consistent replication date Promising hit found 3p2131 region ABO locus Candidate gene study examined ACE1 ACE2 TMPRSS2 IFITM3 APOE Furin IFNL3 IFNL4 HLA TNFa gene ABO system evaluated single locus ABO sampled region HLA three five candidate gene study respectively Metaanalysis could performed Available data showed need report replicate claimed association,covid-19;sars-cov-2;candidate genetic variants;genetic association;polymorphisms;susceptibility
DIABased Proteome Profiling Nasopharyngeal Swabs COVID19 Patients,34292740,Since recent outbreak COVID19 intense effort understand viral pathogenesis host immune response combat SARSCoV2 become evident different host alteration identified SARSCoV2 infection based whether infected cell animal model clinical sample studied Although nasopharyngeal swab routinely collected SARSCoV2 detection RTPCR testing host alteration nasopharynx proteomic level systematically investigated Thus sought characterize host response global proteome profiling nasopharyngeal swab specimen mass spectrometer combining trapped ion mobility spectrometry TIMS highresolution QTOF mass spectrometer parallel accumulationserial fragmentation PASEF deployed unbiased proteome profiling First deep proteome profiling pooled nasopharyngeal swab sample performed PASEF enabled DDA mode identified 7723 protein used generate spectral library approach provided peptide level evidence five missing protein MSMS spectrum mobilograms validated synthetic peptide Subsequently quantitative proteomic profiling carried 90 individual nasopharyngeal swab sample 45 positive 45 negative DIA combined PASEF termed diaPASEF mode resulted total 5023 protein identification 577 protein found upregulated SARSCoV2 positive sample Functional analysis upregulated protein revealed alteration several biological process including innate immune response viral protein assembly exocytosis best knowledge study first deploy diaPASEF quantitative proteomic profiling clinical sample show feasibility adopting approach understand mechanism pathway altered disease,covid-19;diapasef;host response
C1Inhibitor Structure Functional Diversity Therapeutic Development,34348603,Human C1Inhibitor C1INH also known C1esterase inhibitor important multifunctional plasma glycoprotein uniquely involved regulatory network complement contact coagulation fibrinolytic system C1INH belongs superfamily serine proteinase inhibitor serpins exhibit inhibitory activity towards several target protease plasmatic cascade operating major antiinflammatory protein circulation addition inhibitory activity C1INH also involved noninhibitory interaction endogenous protein polyanions cell infectious agent C1INH essential multiple physiological process better known deficiency regard Hereditary Angioedema HAE rare autosomal dominant disease clinically manifested recurrent acute attack increased vascular permeability edema Since link first established functional C1INH deficiency plasma HAE 1960s tremendous progress made biochemical characterization C1INH therapeutic development replacement therapy patient C1INHdependent HAE Various C1INH biological activity recent advance HAEtargeted therapy availability C1INH commercial product prompted intensive investigation C1INH potential treatment clinical condition HAE article provides updated overview structure biological activity C1INH role HAE pathogenesis recent advance research therapeutic development C1INH also considers trend using C1INH therapeutic preparation application angioedema sepsis endotoxin shock severe thrombotic complication COVID19 patient,c1-inhibitor;c1-inhibitor products;complement;contact system;hereditary angioedema;therapeutic development
Changes Care Provision COVID19 Impact Patient WellBeing,34350341,fast onset extensive impact COVID19 necessitated strict public health measure temporary diversion personnel resource type medical care study examined prevalence disruption impact patientperceived wellbeing using untargeted survey majority surveyed patient experienced change routine medical care whose appointment postponed canceled patient indicated overall negative impact emotional physical wellbeing highlighted impact disruption nonurgent medical care largescale public health emergency,covid-19;expectations;health care planning or policy;patient;patient satisfaction
Lactoferrin SARSCoV2 Vitro Silico Evidences,34220505,Lactoferrin Lf cationic glycoprotein synthetized exocrine gland present human secretion also secreted neutrophil infection inflammation site glycoprotein posse antimicrobial activity due capability chelate two ferric ion per molecule well interact bacterial viral anionic surface component cationic feature Lf bind cell protecting host bacterial viral injury antiinflammatory activity mediated ability enter inside nucleus host cell thus inhibiting synthesis proinflammatory cytokine gene particular Lf downregulates synthesis IL6 involved iron homeostasis disorder lead intracellular iron overload favoring viral replication infection wellknown antiviral activity Lf demonstrated DNA RNA enveloped naked virus therefore Lf could efficient counteracting also SARSCoV2 infection purpose performed vitro assay proving Lf exerts antiviral activity SARSCOV2 direct attachment SARSCoV2 cell surface component activity varied according concentration 100500 mugml multiplicity infection 01001 cell type Vero E6Caco2 cell Interestingly silico result strongly supported hypothesis direct recognition Lf spike glycoprotein thus hinder viral entry cell vitro observation led u speculate potential supplementary role Lf management COVID19 patient,covid-19;sars-cov-2;bovine lactoferrin;lactoferrin;spike
Inflammatory Mechanisms COVID19 Atherosclerosis Current Pharmaceutical Perspectives,34205487,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 associated excess mortality worldwide cardiovascular system second common target SARSCoV2 lead severe complication including acute myocardial injury myocarditis arrhythmia venous thromboembolism well major thrombotic event direct endothelial injury excessive systemic inflammatory response review focus similarity difference inflammatory pathway involved COVID19 atherosclerosis Antiinflammatory agent immunomodulators recently assessed may constitute rational treatment reduction cardiovascular event COVID19 atherosclerotic heart disease,covid-19;sars-cov-2;anti-inflammatory treatment;atherosclerosis;inflammation
Key summary German national treatment guidance hospitalized COVID19 patient Key pharmacologic recommendation national German living guideline using Evidence Decision Framework last updated 17052021,34228347,PURPOSE executive summary national living guideline aim provide rapid evidence based recommendation role drug intervention treatment hospitalized patient COVID19 METHODS guideline make use systematic assessment decision process using evidence decision framework GRADE recommended standard 2021 Recommendations consented interdisciplinary panel Evidence analysis interpretation supported CEOsys project providing extensive literature search living meta analysis executive summary selected key recommendation drug therapy presented including quality evidence rationale level recommendation RESULTS guideline contains 11 key recommendation COVID19 drug therapy eight based systematic review andor metaanalysis three recommendation represent consensus expert opinion Based current evidence panel make strong recommendation corticosteroid scale 59 prophylactic anticoagulation hospitalized patient COVID19 standard care Intensified anticoagulation may considered patient additional risk factor venous thromboembolism VTE low bleeding risk IL6 antagonist tocilizumab may added case high supplemental oxygen requirement progressive disease scale 56 Treatment nMABs may considered selected inpatient early SARSCoV2 infection hospitalized COVID19 Convalescent plasma azithromycin ivermectin vitamin D3 used COVID19 routine care CONCLUSION COVID19 drug therapy several option sufficiently supported evidence living guidance updated new evidence emerges,covid-19;living guideline;living meta-analysis;sars-cov-2
Aerosol Dynamics Model Estimating Risk ShortRange Airborne Transmission Inhalation Expiratory Droplets SARSCoV2,34132519,highly infectious SARSCoV2 novel coronavirus resulted global pandemic hundred million people already impacted infected number expected go Coughing sneezing even talking emit respiratory droplet carry infectious virus important understand exhaled particle move air exposed person better predict airborne transmission impact SARSCoV2 many study conducted airborne spread virus causing disease SARS measles however limited study couple transport characteristic aerosol dynamic droplet study comprehensive model simultaneous droplet evaporation transport due diffusion convection gravitational settling developed determine near spatial temporal concentration viable virus exhaled infected individual exposure viable virus estimated calculating respiratory deposition risk infection determined using doseresponse model developed model used quantify risk shortrange airborne transmission SARSCoV2 inhalation virusladen droplet infected individual directly front person exposed surrounding air stagnant effect different parameter viral load infectivity factor emission source physical separation exposure time ambient air velocity dilution mask usage determined risk exposure,covid-19;sars-cov-2;aerosol transmission;airborne;coronavirus
Perioperative Obstetric Care Coronavirus Infectious Disease 2019 Anesthetic Perspective,34349324,Background novel coronavirus infectious disease2019 COVID19 global pandemic involving many country affected seventynine million people worldwide greater million death current scenario Aims aim study improvise perioperative obstetric healthcare tertiary healthcare center Settings Design retrospective case series parturients infected COVID19 Materials Methods present case series COVID19infected parturients evidence pregnant woman likely become seriously affected coronavirus yet group patient vulnerable infection Hence objective management patient includes caring range asymptomatic critically ill woman peripartum period protection healthcare provider exposure disease treating treating paramount importance Results limited literature available effect disease risk complication pregnancy variable affect respiratory system exacerbate susceptibility infection complicates delay diagnosis COVID19infected parturients affect clinical outcome Thus need focused optimal management tertiary healthcare center total 109 lower segment cesarean section patient hospital two maternal neonatal death among 12 emergency case performed Conclusions Collaborative effort imperative among expert anesthesiologist obstetrician tackle impact disease must surveillance system place reporting maternal fetal data pandemic,global pandemic;healthcare providers;operation theatre;surgical scenario
Healthcare Professionals Promotion Physical Activity Older Adults Survey Knowledge Routine Practice,34199893,Healthcare professional key role promoting physical activity particularly among population greatest risk poor health due physical inactivity research aimed develop understanding healthcare professional knowledge decision making routine practice physical activity promotion older adult crosssectional survey conducted practicing healthcare professional general practice physiotherapy occupational therapy nursing Ireland Northern Ireland received 347 eligible response 703 respondent agreeing discussing physical activity job 300 agreeing received suitable training initiate conversation patient physical activity Awareness content objective national guideline physical activity varied considerably across health profession surveyed Less third respondent clear plan initiate discussion physical activity routine practice older adult Assessment physical activity routine neither signposting physical activity support Considering COVID19 pandemic implication 816 respondent agreed healthcare professional play increased role promoting physical activity older adult part routine practice Appropriate education training access resource essential supporting healthcare professional promotion physical activity routine practice Effective physical activity promotion healthcare setting potential health benefit population level particularly older adult population,behaviour change;healthcare professionals;older adults;physical activity;policy;theoretical domains framework
Adherence Immunosuppression Medications among Heart Transplant Recipients Challenges Opportunities Potential Role Digital Approaches COVID19 Era,34200823,Society medical practice restructured dramatically avoid spread COVID19 virus telehealthtelemedicine mask wearing nationwide social distancing practice become widespread However still face unprecedented challenge field patient require frequent active followup visit monitoring including solidorgan transplant particular heart transplant Adherence immunosuppression remains unique challenge heart transplantation especially COVID19 pandemic Failure adhere immunosuppression disastrous consequence including graft rejection death article discus challenge related adherence immunosuppression medication among heart transplant recipient well opportunity leverage digital approach intervention monitor optimize adherence behavior health outcome population,covid;covid-19;adherence;compliance;digital;ehealth;heart transplant;immunosuppression;mhealth;pandemic
Insights modulation interferon response NAD + context COVID19,34378474,COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 resulted dramatic worldwide mortality Along developing vaccine medical profession exploring new strategy curb pandemic better understanding molecular consequence SARSCoV2 cellular infection could lead effective safer treatment review discus potential underlying impact SARSCoV2 modulating interferon IFN secretion causing mitochondrial NAD + depletion could directly linked COVID19 s deadly manifestation known surmised imbalanced innate immune response mitochondrial dysfunction postSARSCoV2 infection potential benefit welltimed IFN treatment NAD + boosting therapy context COVID19 pandemic discussed,innate immune system;sars-cov-2;mitochondrial dysfunction;nicotinamide adenine dinucleotide
Host factor facilitating SARSCoV2 virus infection replication lung,34223911,SARSCoV2 virus causing major pandemic facing world today Although SARSCoV2 primarily cause lung infection variety symptom proven systemic impact body SARSCoV2 spread community quickly infecting human age ethnicity gender However fatal outcome linked specific host factor comorbidities age hypertension immunodeficiencies chronic lung disease metabolic disorder major shift microbiome patient suffering coronavirus disease 2019 COVID19 also observed linked worst outcome disease many comorbidities already known associated dysbiosis microbiome hypertension diabetes metabolic disorder Host factor microbiome change believed involved network acquisition infection development disease review detail manuscript immune response toward SARSCoV2 infection well host factor involved facilitation worsening infection also address impact COVID19 host s microbiome secondary infection also worsen disease,covid-19;co-morbidities;host factor;innate immune response;microbiome;sars-cov-2
MyeloidDerived Suppressor Cells Potential Biomarker Therapeutic Target COVID19,34220859,Clinical presentation COVID19 highly variable yet precise mechanism govern pathophysiology different disease course remain poorly defined Across spectrum disease severity COVID19 impairs innate adaptive host immune response activating innate immune cell recruitment resulting low lymphocyte count Recently several report shown patient severe COVID19 exhibit dysregulated myeloid cell compartment increased myeloidderived suppressor cell MDSCs correlating disease severity MDSCs turn promote virus survival suppressing Tcell response driving highly proinflammatory state secretion various mediator immune activation summarize evidence MDSCs myeloid cell dysregulation COVID19 infection discus potential MDSCs biomarkers therapeutic target COVID19 pneumonia associated disease,covid-19;mdsc;biomarkers;immunity;immunology
Relative sensitivity anterior naris nasopharyngeal swab initial detection SARSCoV2 ambulatory patient Rapid review metaanalysis,34283845,Nasopharyngeal NP swab considered `` gold standard diagnosing SARSCoV2 infection anterior naris midturbinate swab nasal swab often used performed metaanalysis comparing sensitivity nasal nasopharyngeal swab composite reference standard initial diagnosis SARSCoV2 infection ambulatory patient study registered PROSPERO CRD42020221827 Data source included study appearing January 1 2020 March 20 2021 identified search PubMed medRxiv bioRxiv Studies included least 20 subject simultaneously provided nasal nasopharyngeal specimen reverse transcriptionpolymerase chain reaction testing confusion matrix could constructed Authors individually assessed study inclusion compared assessment author independently extracted data element difference reconciled review initial data source Extracted data included specimen site patient characteristic collection site confusion matrix comparing result nasal nasopharyngeal swab Assessed composite reference standard anterior naris swab le sensitive 82 88 nasopharyngeal swab 98 population 10 specimen positivity negative predictive value swab type greater 98 Midturbinate anterior naris swab seem perform similarly lower sensitivity associated nasal swab SARSCoV2 diagnosis justified ability screen patient reduced personal protective equipment requirement conclusion limited small number study significant heterogeneity study design study outcome,
Strengthening Country Readiness PandemicRelated Mass Movement Policy Lessons Learned,34204689,COVID19 pandemic thus far restricted large movement people nonetheless exclude disruptive power virus similar characteristic COVID19 affecting high lowincome country factor future mass migration Indeed top 15 country affected COVID19 host 9 million refugee therefore important investigate strengthen readiness country health policy ensure well equipped deal potential large influx epidemicrelated refugee migrant Using Bardach Policy Framework tool analysis article investigates readiness country potential public health event mass migration generated future pandemic therefore aiming health response forecasting exercise article review policy put place country faced large influx migrant 2011 2015 policyprolific year Arab Spring migration introduction stringent measure Europe new evidence generated response COVID19 pandemic including ECDC Guidance infection prevention control COVID19 migrant refugee reception detention centre EUEEA UK WHO Lancet priority dealing migration COVID19 formulate policy option able strengthen national system capacity responding influx epidemicrelated migrant management highly infectious disease,covid-19;health policy;health system strengthening;migration;readiness;refugees
Severe acute respiratory syndrome SARS coronavirus2 infection COVID19 pregnancy overview,34225131,novel severe acute respiratory syndrome SARS coronavirus2 cause COVID19 disease result severe morbidity mortality especially vulnerable group Pregnancy virtue physiological anatomical adaptation increase risk severe infection especially respiratory tract single stranded RNA virus transmitted droplet well soiled fomite various degree disease severity asymptomatic mild moderate severe critical infection pregnancy asymptomatic mildly symptomatic woman consequence mother pregnancy minimal unless additional risk factor diabetes hypertension cardiorespiratory disease obesity ethnic minority background woman symptom present fever unproductive cough sore throat myalgia nasal congestion loss smell taste associated leukocytosis lymphopenia Diagnosis RTPCR nasopharyngeal flocked swab saliva pathognomonic feature groundglass appearance pulmonary infiltrates chest Xray CT scan Management pregnancy nonpregnant woman COVID19 indication elective delivery assisted delivery second stage moderate severe critical disease may required shorten stage COVID19 indication interrupting pregnancy caesarean section latter may performed facilitate ventilation support resuscitation severe disease Pain relief labour different regional analgesia preferred operative delivery Postpartum thromboprophylaxis considered breast feeding encouraged appropriate precaution minimize vertical transmission Pregnant lactating woman encouraged receive mRNA based vaccine evidence adverse outcome,covid-190;coronavirus;pregnancy;sars-2;vaccination;vertical transmission
Compliance hand sanitizer quality SARSCoV2 pandemic Assessing impurity ethanol plant,34333308,Using alcoholbased disinfectant effective method preventing spread COVID19 However nontraditional manufacturer alcoholbased disinfectant ethanol plant need undergo additional treatment curb impurity limit set Food Drug Association FDA produce alcoholbased disinfectant transform disinfectantgrade alcohol 17 process stream drymill ethanol plant analyzed determine quality parameter acetaldehyde acetal propanol methanol water including chemical oxygen demand total suspended solid nutrient Results suggest process stream generated distillation column requires treatment acetaldehyde acetal concentration significantly higher impurity limit set FDA addition second distillation column could potential method addressing impurity minimal influence hazardous air pollutant generation water use,hand sanitizer production;hazardous air pollutants;impurities;process streams;sars-cov-2
Experiences Parents Preterm Children Hospitalized Regarding Restrictions Interact Children Imposed COVID19 Pandemic,34214287,OBJECTIVES describe experience parent hospitalized preterm child regarding restriction implemented neonatal intensive care unit NICU COVID19 pandemic METHODS Qualitative study Semistructured interview conducted April October 2020 12 parent preterm child whose child hospitalized discharged NICU pandemic analysis performed tool grounded theory open axial coding RESULTS study identified four category regarding experience 1 needing information refers need clear close information compensate physical distance 2 limiting interaction child expressed painful situation minimizes opportunity learning care home preterm child 3 pandemic adding fear virus appears new threat child vulnerable given premature condition 4 limiting social support discharge identifies parent le family professional support care discharge time pandemic CONCLUSIONS Parents preterm child lived difficult experience became complex within context pandemic experience parent preterm child time COVID19 indicate restriction enter neonatal unit prevent virus transmission limited interaction preterm child health staff increased need information,"coronavirus infections;family nursing;infant, premature;intensive care units, neonatal;neonatal nursing;pandemics;parents"
Lung ultrasound correlate radiographic severity pattern COVID19 pneumonia preliminary study,34353099,BACKGROUND Coronavirus Disease 2019 COVID19 outbreaking late 2019 proportion patient developed pneumonia Although chest CT pivotal diagnostic tool COVID19 pneumonia CT expensive also radiological burden patient urgent investigate role lung ultrasound LUS diagnosing monitoring COVID19 pneumonia METHODS total 8 patient confirmed case COVID19 pneumonia Shantou Central Hospital January 2020 February 2020 retrospectively studied participant underwent chest HRCT LUS examination independently performed within 1 day radiological pattern reviewed 2 radiologist blind clinical information senior ultrasound physician blind HRCT result clinical data performed bedside LUS isolation ward CT score used semiquantitative scoring system ass radiographic severity extent Blines score denoting extent severity sonographic lesion calculated summing number Blines 18 scanning site RESULTS Blines 100 pleural irregularity 25 consolidation 25 pleural effusion 25 main finding LUS examination Interstitial abnormality groundglass opacity GGO consolidation local bilateral patchy shadowing main finding HRCT examination finding LUS HRCT compared point point high consistency found 2 measurement significant correlation also found Blines score CT score r=096 95 confidence interval CI 081 099 P=00001 CONCLUSIONS LUS pattern Blines score significantly correlated HRCT finding score respectively supporting role assessing COVID19 pneumonia severity screening following dynamic change pneumonia,b-lines;covid-19 pneumonia;lung ultrasound (lus);high resolution computed tomography (hrct);severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
Bone Marrow Sanctuary Plasma Cells Memory TCells Implications Adaptive Immunity Vaccinology,34203839,bone marrow BM key protective immunological memory harbor major fraction body s plasma cell memory CD4+ memory CD8+ Tcells Despite paramount significance human immune system many aspect BM enables decadelong immunity pathogen still poorly understood review discus relationship BM survival niche longlasting humoral immunity intrinsic extrinsic factor define memory cell longevity show BM also capable adopting many responsibility secondary lymphoid organ Additionally data differentiation maintenance memory Tcells plasma cell upon vaccination human reported discus factor determine establishment longlasting immunological memory BM learn vaccination technology antigen design Finally using insight touch holistic understanding BM necessary development modern efficient vaccine pandemic SARSCoV2,b-cells;covid-19;sars-cov-2;t-cells;bone marrow;infection;memory;plasma cells;residency;vaccination
Role hepatosteatosis prognosis COVID 19 disease,34214871,PURPOSE measure degree fatty liver using noncontrast enhanced chest computed tomography CT investigate relationship severity prognosis coronavirus disease 2019 COVID19 adult patient METHODS retrospective study included consecutive patient diagnosed COVID19 using realtime reversetranscription polymerase chain reaction RTPCR subsequently underwent noncontrast enhanced chest CT October 10 December 10 2020 Hepatic attenuation value measured Couinaud segment 2 4 8 based CT image relationship value Pneumonia Severity Score PSS requirement hospitalization length hospital intensive care unit ICU stay analyzed RESULTS study included 414 patient 182 female 4396 among 106 256 diagnosed hepatosteatosis HS patient HS PSS score higher 108 + 496 vs 807 + 512 p 0001 69 65 received inpatient care Moreover number HS patient received inpatient care 199 95 confidence interval CI 126315 p 0003 time higher nonHS patient significant difference found HS nonHS patient regard length hospital ICU stay CONCLUSION HS easily evaluated using noncontrast enhanced chest CT COVID19 patient used prognostic marker determine requirement hospitalization,covid-19;computed tomography;hepatosteatosis;hounsfield unit
Detection SARSCoV2 Surfaces Households Persons COVID19,34360477,SARSCoV2 transmission contaminated surface fomite concern COVID19 pandemic Households important site transmission throughout COVID19 pandemic limited information SARSCoV2 contamination surface setting describe environmental detection SARSCoV2 household person COVID19 better characterize potential risk fomite transmission Ten household =1 person laboratoryconfirmed COVID19 =2 member total enrolled Utah USA Nasopharyngeal anterior nasal swab collected member tested presence SARSCoV2 RTPCR Fifteen surface sampled household tested presence viability SARSCoV2 SARSCoV2 RNA detected 23 15 150 environmental swab sample frequently nightstands 46 67 pillow 423 17 light switch 321 14 Viable SARSCoV2 cultured one sample household SARSCoV2positive surface =1 person first tested positive SARSCoV2 = 6 day prior environmental sampling SARSCoV2 surface contamination occurred early course infection respiratory transmission likely notably surface close prolonged contact person COVID19 fomite transmission might possible risk low,sars-cov-2;fomite transmission;household transmission;prevention
Umbilical Cordderived Mesenchymal Stem Cells modulate TNF soluble TNF Receptor 2 sTNFR2 COVID19 ARDS patient,34227081,OBJECTIVE aimed explaining mechanism therapeutic effect Umbilical Cord Mesenchymal Stem Cells UCMSC subject COVID19 Acute Respiratory Distress Syndrome ARDS Patients COVID19 ARDS present hyperinflammatory response characterized high level circulating proinflammatory mediator including tumor necrosis factor alpha beta TNFalpha TNFbeta Inflammatory function TNFs inhibited soluble TNF Receptor 2 sTNFR2 patient COVID19 ARDS UCMSC appear impart robust antiinflammatory effect treatment associated remarkable clinical improvement investigated level TNFalpha TNFbeta sTNFR2 blood plasma sample collected subject COVID19 ARDS enrolled trial UCMSC treatment PATIENTS METHODS analyzed plasma sample subject COVID19 ARDS n=24 enrolled Phase 12a randomized controlled trial UCMSC treatment Plasma sample obtained Day 0 baseline UCMSC control infusion Day 6 post infusion Plasma concentration sTNFR2 TNFalpha TNFbeta evaluated using quantitative multiplex protein array RESULTS data indicate Day 6 infusion UCMSC recipient develop significantly increased level plasma sTNFR2 significantly decreased level TNFalpha TNFbeta compared control CONCLUSIONS observation suggest sTNFR2 play mechanistic role mediating UCMSC effect TNFalpha TNFbeta plasma level determining decrease inflammation COVID19 ARDS,
Incidence Outcomes Acute Kidney Injury Patients Admitted Hospital COVID19 Retrospective Cohort Study,34290876,Background incidence acute kidney injury AKI patient COVID19 association mortality disease severity understudied Canadian population Objective determine incidence AKI cohort patient COVID19 admitted medicine intensive care unit ICU ward association inhospital mortality disease severity aim stratify outcome outofhospital AKI inhospital AKI Design Retrospective cohort study registry patient COVID19 Setting Three community 3 academic hospital Patients total 815 patient admitted hospital COVID19 March 4 2020 April 23 2021 Measurements Stage AKI ICU admission mechanical ventilation inhospital mortality Methods classified AKI comparing highest lowest recorded serum creatinine hospital staged AKI based Kidney Disease Improving Global Outcomes KDIGO system calculated unadjusted adjusted odds ratio stage AKI outcome ICU admission mechanical ventilation inhospital mortality Results 815 patient registered 439 539 developed AKI 253 576 presented AKI 186 424 developed AKI inhospital odds ICU admission mechanical ventilation death increased AKI stage worsened Stage 3 AKI occurred hospitalization increased odds death odds ratio = 787 435 1423 Stage 3 AKI occurred prior hospitalization carried increased odds death = 528 260 1073 Limitations Observational study small sample size limit precision estimate Lack nonhospitalized patient COVID19 hospitalized patient without COVID19 control limit causal inference Conclusions Acute kidney injury whether occurs prior hospitalization associated high risk poor outcome patient COVID19 Routine assessment kidney function patient COVID19 may improve risk stratification Trial registration study registered publicly accessible registry involve health care intervention human participant,covid-19;canada;kdigo;acute kidney injury;severity
QT Interval Monitoring Handheld Heart Rhythm ECG Device COVID19 Patients,34211828,Background QTc prolongation adverse effect COVID19 therapy use handheld device scenario addressed Objectives evaluate feasibility QTc monitoring smart device COVID19 patient receiving QTcinterfering therapy Methods Prospective study consecutive COVID19 patient treated hydroxychloroquine + azithromycin + lopinavirritonavir ECG monitoring performed 12lead ECG KardiaMobile6L registry also sequentially obtained cohort healthy patient evaluated difference QTc COVID19 patient three different monitoring strategy 12lead ECG baseline followup 12lead ECG baseline followup smart device B fully monitored handheld 6lead ECG group C Time needed obtain ECG registry also documented Results One hundred eightytwo COVID19 patient included 119 654 B 50 275 C 13 71 QTc peak hospitalization significantly increase group difference observed three monitoring strategy QTc prolongation p = 0864 control group one ECG registry smart device allowed QTc measurement mean QTc differ technique p = 0612 displaying moderate reliability ICC 056 019076 Time ECG registry significantly longer 12lead ECG handheld device cohort p 0001 Conclusion QTc monitoring KardiaMobile6L COVID19 patient feasible Time ECG registration significantly lower smart device may offer important advantage prevention virus dissemination among healthcare provider,covid-19;kardiamobile-6l;qtc;handheld ecg;ventricular arrhythmia
Highprecision costefficient sequencing realtime COVID19 surveillance,34211026,COVID19 global case climbed 33 million million total death September 2020 Realtime massive SARSCoV2 whole genome sequencing key tracking chain transmission estimating origin disease outbreak Yet method simultaneously achieved high precision simple workflow low cost developed highprecision costefficient SARSCoV2 whole genome sequencing platform COVID19 genomic surveillance CorvGenSurv Coronavirus Genomic Surveillance CorvGenSurv directly amplified viral RNA COVID19 patient NasopharyngealOropharyngeal NPOP swab specimen sequenced SARSCoV2 whole genome three segment longread highthroughput sequencing Sequencing whole genome three segment significantly reduced sequencing data waste thereby preventing dropout genome coverage validated precision pipeline control genomic RNA sequencing Sanger sequencing produced near fulllength whole genome sequence individual COVID19 test positive April June 2020 Los Angeles County California USA sequence highly diverse G clade nine novel amino acid mutation including NSP12M755I ORF8V117F readily adaptable design CorvGenSurv grant wide access genomic surveillance permitting immediate public health response sudden threat,
National PrePandemic Survey PatientReported Health Confidence Implications PostPandemic Practice,32826425,Patientreported health confidence valuable indicator effective patientclinician communication improves outcome reduces costly care use national survey examines health confidence attainment United States COVID pandemic strained health care resource Health confidence low percentage respondent financially secure 36 financially insecure 18 Persons enrolled employer unionsponsored plan highest household income report higher level health confidence Health policy support measurement monitoring health confidence clinical practice improve population health maximize resource efficiency,
Dynamics host immune response SARSCoV2,34222416,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 recent global health threat spreading throughout world worrisome speed current wave coronavirus disease 2019 COVID19 seems mercy mysterious virus challenge ability control viral infection opportunity control COVID19 pandemic gradually fading Currently pandemic management relies preventive intervention Although prevention good strategy mitigate SARSCoV2 transmission still considered absolute solution eliminate pandemic Currently developing potent immunity viral infection seems promising strategy drive ongoing global tragedy However emergence new challenge context immune response COVID19 road control devastating pandemic seems bumpier thus pivotal characterize dynamic host immune response COVID19 order develop efficient prophylactic therapeutic tool begs question whether effector mechanism immune system indeed potent possible contributing factor developing severe lethal form COVID19 review possible role immunopathologic phenomenon including antibodydependent enhancement cytokine storm original antigenic sin severity mortality COVID19 discussed,antibody-dependent enhancement;covid-19;cytokine storm;immune response;original antigenic sin;sars-cov-2
Immunoinformatics Approach SARSCoV2 Latam Populations MultiEpitope Vaccine Candidate Directed towards World s Population,34205992,coronavirus pandemic major public health crisis affecting global health system dire socioeconomic consequence especially vulnerable region Latin America LATAM urgent need vaccine help control contagion reduce mortality alleviate social cost study propose rational multiepitope candidate vaccine SARSCoV2 Using bioinformatics constructed library potential vaccine peptide based affinity common major human histocompatibility complex HLA II molecule LATAM population predict immunological complex among antigenic nontoxic nonallergenic peptide extracted conserved region 92 proteome Although HLAC greatest antigenic peptide capacity SARSCoV2 HLAB HLAA could relevant based COVID19 risk infection LATAM country also used threedimensional structure SARSCoV2 protein identify potential region antibody production best HLAI II prediction increased coverage common allele region evoking B lymphocyte response grouped optimized final multiepitope construct containing adjuvant Beta defensin3 TpD PADRE recognized invoking safe specific immune response Finally used Molecular Dynamics identify multiepitope construct may stable target TLR4MD2 would prove safe provide physicochemical requirement conducting experimental test around world,latam;sars-cov-2;in silico;vaccine
Clinical Features Covid19 Infection Study SARSCoV2 Positive Patients Mymensingh Region Bangladesh,34226453,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 spread almost every country globe considered World Health Organization pandemic SARSCoV2 cause Coronavirus disease 2019 COVID19 Many country reporting symptomatic characteristic case give better observation various clinical presentation SARSCoV2 infection However symptomatic literature limited Bangladesh aim study analyze symptomatic characteristic patient SARSCoV2 positive real time reverse transcription polymerase chain reaction rRT PCR test data 146 patient positive SARSCoV2 virus resident different district Mymensingh region analyzed Patients demographic symptom history comorbidities condition like DM HTN Hypothyroid etc travel contact collected MMC Daily Reported data April 1 2020 April 30 2020 Among total 3184 patient nasopharyngeal sample got 146 458 positive SARSCoV2 146 positive patient patient male 95 65 majority 80 548 21 40year age group patient 61 4178 resident Mymensingh include Mymensingh Sadar Valuka Trishal Ishhorganj Among patient 94 644 symptomatic 52 356 asymptomatic symptomatic patient presented mostly fever 45 3082 cough 33 226 breathlessness 9 616 majority patient 54 369 history contact SARSCoV2 patient 16 11 travel history within 14 day rRTPCR test positive 3 2 patient history comorbidities condition like DM HTN Hypothyroid etc number SARSCoV2 case rapidly increasing country education population common symptom virus infection needed mostly therefore individual may able recognize symptom people might get tested,
Review Cardiac Cardiovascular Effects COVID19 Adults Children,34340244,Symptomatic coronavirus disease 2019 COVID19 typically affect respiratory system involve cardiovascular system Cardiac complication COVID19 result directly myocarditis indirectly numerous mechanism Differentiating primary secondary cardiovascular involvementour focus reviewmay help identify longterm effect COVID19 heart adult child,angiotensin-converting enzyme 2;covid-19/complications;sars-cov-2;biomarkers;cardiovascular diseases/epidemiology/etiology/physiopathology/virology;comorbidity;coronavirus infections/complications;cytokines/blood;disease progression;myocarditis/etiology
Quality Recommendations Relevant Clinical Practice Guidelines COVID19 Management Systematic Review Critical Appraisal,34222270,Background morbidity mortality coronavirus disease 2019 COVID19 still increasing study aimed ass quality relevant COVID19 clinical practice guideline CPGs compare similarity difference recommendation Methods comprehensive search conducted using electronic database PubMed Embase Web Science representative guideline repository December 1 2019 August 11 2020 updated April 5 2021 obtain eligible CPGs Appraisal Guidelines Research Evaluation AGREE II tool used evaluate quality CPGs Four author extracted relevant information completed data extraction form data analyzed using R version 360 software Results total 39 CPGs identified quality encouragingly high median score interquartile range IQR every domain AGREE II evidencebased CPGs EBCPGs versus vs consensusbased CPG CBCPGs 8194 75008472 vs 5833 52786806 scope purpose 5972 38897500 vs 3611 33333611 stakeholder involvement 6458 32297188 vs 2292 16672656 rigor development 7500 52788681 vs 5278 50006389 clarity presentation 4063 22406250 vs 2083 13542500 applicability 5833 500010000 vs 5000 50007708 editorial independence respectively methodological quality EBCPGs significantly superior CBCPGs majority domain P 005 agreement diagnosis criterion COVID19 guideline show Remdesivir may beneficial patient hydroxychloroquine + azithromycin may consistent suggestion regarding discharge management instance discharge isolation management health status monitoring may continued Conclusions general methodological quality EBCPGs greater CBCPGs However still required improved Besides consistency COVID19 recommendation topic diagnosis criterion different hydroxychloroquine + azithromycin may beneficial treat patient COVID19 remdesivir may favorable riskbenefit severe COVID19 infection isolation management health status monitoring discharge may still necessary Chemoprophylaxis including SARSCoV 2 vaccine antiviral drug COVID19 still require trial confirm,agree ii;covid-19;sars-cov-2;diagnosis;discharge management;guideline;prophylaxis;treatments
Preconception Care Men Women Pandemic Intervention Proposal,34203317,COVID19 pandemic measure resulted limited outdoor activity reduced group meeting etc leading unhealthy habit Several study showed certain unhealthy habit lead serious consequence men woman well affect future offspring 1 Background Therefore present community intervention preconception stage avoid future risk purpose intervention change lifestyle belief health men woman preconception period 2 Methods design intervention bibliographic search performed English Spanish main database health science nursing Cochrane PubMed Web Science CINAHL LILACS Dialnet using descriptor MeSH health science 3 Results proposed variety lifestyle analyzed including aspect physical activity nutrition etc addition stress management emphasized relaxation workshop three different technique proposed reduce anxiety level stressful situation 4 Conclusions Due limited scientific result intervention carried preconception period simultaneously men woman community intervention address topic needed ass impact action health population,community intervention;lifestyle;pandemic;preconception
ShortTerm Efficacy Safety Oral Nasal Corticosteroids COVID19 Patients Olfactory Dysfunction European Multicenter Study,34199734,Background objective study investigate efficacy safety early administration oral corticosteroid OC nasal corticosteroid NC addon olfactory training OT versus OT alone patient olfactory dysfunction OD related coronavirus disease 2019 COVID19 Methods Patients positive diagnosis COVID19 OD prospectively recruited March 22 December 15 2020 4 European hospital Patients confirmed OD psychophysical testing patient undertook OT addon 10 day OC group 1 OC + OT 1 month NC group 2 NC + OT olfactory training alone group 3 OT Olfactory evaluation SniffinSticks test carried time inclusion 1 2 month start therapeutic course Results total 152 hyposmic anosmic patient completed study Group 1 2 3 included 59 22 71 patient respectively patient group comparable regarding baseline SniffinSticks test median SniffinSticks test value significantly improved pre postintervention group increase SniffinSticks test value higher group 1 OC + OT compared group 2 3 p 0001 one month treatment remain 2 month Groups 1 2 3 respectively presented parosmia 2071 282 922 409 4271 592 patient difference statistically significant group 1 3 p 0001 patient worsening disease increase severity COVID19 symptom Conclusions use OCs patient OD related mild COVID19 generally welltolerated without case deterioration symptom OC associated greater improvement psychophysical olfactory evaluation 1month posttreatment difference 2 month Parosmia may reduced following treatment OC NC basis preliminary result possible state considering 2 month efficacy OC NC respect OT alone riskbenefit ratio benefit start specific treatment COVID19 related OD demonstrated need randomised controlled trial ass,covid-19;sars-cov-2;anosmia;olfactory;smell;treatment
Association Frailty Adverse Outcomes Patients Suspected COVID19 Infection,34199572,Older age frailty predictor adverse outcome patient COVID19 emergency medicine patient present diagnosis suspicion COVID19 aim study ass association frailty age death admission intensive care patient suspected COVID19 singlecentre prospective cohort study performed Emergency Department tertiary care hospital Patients 65 year older suspected COVID19 presenting Emergency Department first wave pandemic consecutively enrolled patient underwent nasopharyngeal SARSCoV2 PCR swab test Patients Clinical Frailty Scale CFS 4 considered frail Associations age gender frailty COVID19 status composite adverse outcome 30dayintensivecareadmission andor 30daymortality tested 372 patient analysed median age 77 year 154 414 woman 44 118 COVID19positive 125 336 frail worst outcome seen frail COVID19patients six 667 adverse outcome Frailty CFS 4 COVID19positivity associated adverse outcome adjustment age gender frailty 501 CI 2561017 p 0001 COVID19 347 CI 148789 p = 0003 Frailty strongly associated adverse outcome outperformed age predictor emergency patient suspected COVID19,covid-19;sars-cov-2;age;emergency department;frailty;intensive care;mortality
Lymphocyte subset alteration disease severity imaging manifestation delayed hospitalization COVID19 patient,34210280,BACKGROUND COVID19 continuously threated public health heavily Present study aimed investigate lymphocyte subset alteration disease severity imaging manifestation delayed hospitalization COVID19 patient METHODS Lymphocyte subset classified using flow cytometry peripheral blood collected 106 patient RESULTS Multivariate logistic regression showed chest tightness lymphocyte count gammaglutamyl transpeptidase independent predictor severe COVID19 cell CD4 + cell B cell count severe patient significantly lower mild patient p = 0004 0003 0046 respectively cell count gradually decreased increase infiltrated quadrant lesion computed tomography CT p = 0043 cell CD4 + cell CD8 + cell count gradually decreased increase infiltrated area maximum lesion CT p = 0002 0003 0028 respectively severe patient count cell CD4 + cell CD8 + cell gradually decreased increased delayed hospitalization p = 0001 003 0001 respectively proportion cell CD8 + cell gradually decreased increased delayed hospitalization p 0001 proportion NK cell B cell gradually increased increased delayed hospitalization p = 0007 0002 respectively mild patient NK cell count gradually decreased increased delayed hospitalization p = 0012 CONCLUSION lymphocyte subset negatively correlated disease severity CT manifestation delayed hospitalization count lymphocyte subset changed profound proportion,covid-19;computed tomography;delayed hospitalization;flow cytometry;lymphocyte subsets
Prevalence Risk Factors CoronaVac Side Effects Independent CrossSectional Study among Healthcare Workers Turkey,34203769,BACKGROUND COVID19 vaccine hesitancy serious threat mass vaccination strategy need accelerated currently order achieve substantial level community immunity Independent nonsponsored study great potential enhance public confidence vaccine accelerate uptake process METHODS nationwide crosssectional study side effect SE CoronaVac carried February 2021 among Turkish healthcare worker recently vaccinated questionnaire inquired local systemic SEs occurred shortterm within four week following vaccination RESULTS total 780 healthcare worker included study 625 experienced least one SE Injection site pain 415 common local SE fatigue 236 headache 187 muscle pain 112 joint pain 59 common systemic SEs Female healthcare worker 679 significantly affected local systemic SEs male colleague 514 Younger age previous infection compromised health status chronic illness regular medicine uptake associated increased risk CoronaVac SEs Conclusions independent research show higher prevalence CoronaVac SEs reported phase IIII clinical trial general result study confirm overall safety CoronaVac suggest potential risk factor SEs Genderbased difference SEs distribution among age group worth investigation,covid-19;coronavac;turkey;drug-related side effects and adverse reactions;health personnel;mass vaccination;prevalence
Responding COVID19 second wave Thailand diversifying adapting lesson first wave,34285042,Thailand s first wave COVID19 March 2020 triggered boxing event nightclub Bangkok spread 68 province nation responded rapidly strong public health social measure 26 March 2020 Contact tracing performed 1000 surveillance rapid response team support 11 million village health volunteer identify isolate quarantine casesThailand implemented social measure April 2020 including fullscale national lockdown curfew 14day mandatory quarantine international traveller strong health system infrastructure people s adherence social measure wholeofgovernment approach first wave recorded 3042 case 57 death 146 case fatality rate Economic activity resumed 1 May 2020 end year 17 December 2020 second wave carried undocumented migrant captured quarantine system total lockdown earlier led serious negative economic impact government employed targeted strategy locking specific area employing active case finding Essential resource including case finding team clinician medicine mobilisedWith synergistic multisectoral effort involving health nonhealth private sector outbreak contained February 2021 Total case seven time higher first wave however early admission treatment resulted 011 case fatality rate conclusion experience responding first wave informed second wave response targeted locking affected locality active case finding affected site,covid-19;health policy;public health
Anterior uveitis onset bnt162b2 vaccination coincidence,34289406,BACKGROUND Uveitis visionthreatening inflammation considered ophthalmic emergency generally arises result autoimmune condition infection ocular trauma may also occur isolated disorder past decade several case vaccineassociated uveitis described hepatitis B virus vaccine leading cause CLINICAL CASE case anterior uveitis 23yearold male onset 14 day second dose BNT162b2 COVID19 vaccine reported Initial symptom pain photophobia red eye Ocular examination showed pericheratic conjunctival hyperaemia posterior synechiae anterior chamber cell + keratic precipitate lower quadrant posterior segment show alteration optical coherence tomography ruled presence cystoid macular oedema 10day treatment course topical steroid cycloplegic eye drop ocular inflammatory sign disappeared visual acuity completely restored Even causality remains presumed warning given physician possibility eye inflammation following SARSCoV2 vaccination,adverse event;bnt162b2 vaccine;sars-cov-2;uveitis
Exploiting epidemiological data understand epidemiology factor influence COVID19 pandemic Libya,34367931,75 confirmed case coronavirus disease 2019 COVID19 reported Libya National Center Disease Control first two month following first confirmed case 24 March 2020 However dramatic increase positive case June 19 November 2020 approximately 357940 sample tested reverse transcription polymerase chain reaction result revealed total number 76808 confirmed case 47587 recovered case 1068 death case fatality ratio estimated 140 mortality rate estimated 1590 100000 people epidemiological situation markedly changed midJuly beginning August country proceeded cluster phase COVID19 spread almost Libyan city reflects high transmission rate virus regional level highest positivity rate average 1454 Apparently underestimation actual number COVID19 case due low testing capacity Consequently Libyan health authority need initiate largescale casescreening process enforce testing capacity contact testing within time frame easy task Advisably Libyan health authority improve public health capacity conduct strict hygienic measure among society vaccinate many people COVID19 minimize case fatality ratio socioeconomic impact pandemic Libya,covid-19;epidemiological patterns;libya;pandemic;potential factors;prevalence
Remote Patient Monitoring Identifies Need Triage Patients Acute COVID19 Infection,34292768,Background Telehealth frequently used provision care remote patient monitoring RPM COVID19 pandemic Precision Recovery Program PRP remotely monitored supported patient COVID19 home environment Methods singlecenter retrospective cohort study reviewing data acquired PRP clinical initiative Results 679 patient enrolled PRP 156 patient screened clinician following deterioration symptom vital sign total 240 occasion included analysis 240 occasion 162 67 escalated PRP physician Thirtysix patient referred emergency department 12 7 admitted hospital common risk factor coinciding hospital admission cardiac 67 age 65 42 obesity 25 pulmonary 17 common symptom reported triggered screening event dyspneatachypnea 27 chest pain 14 gastrointestinal issue 8 Vital sign commonly triggered screening event pulse oximetry 15 heart rate 11 temperature 9 Discussion Common factor risk factor vital sign symptom among patient requiring screening triage hospitalization identified providing clinician information support decision making utilizing RPM cohort Conclusion clinicianled RPM program patient acute COVID19 infection provided supportive care screening deterioration Similar model considered implementation COVID19 cohort condition risk rapid clinical deterioration home setting,covid-19;sars-cov-2;hospitalization;remote monitoring;telehealth;telemedicine;triage
Development nano affinity column study ligand including SARSCoV2 related protein binding heparan sulfate proteoglycans,34132262,interaction heparan sulfate proteoglycans HSPGs present cell surface target protein lead cell signaling considered viral receptor analysis recognition mechanism HSPG potential ligand highthroughput screening drug discovery thus remain important challenge Glycidyl methacrylatebased monolith thus prepared situ miniaturized capillary column internal diameter 75 mum HSPG grafted onto use Schiff base method quantity grafted HSPG nanogram range 11 nanogram per cm capillary length significant importance working le available expensive biological material advantage miniaturized capillary column follows immobilization process HSPG onto organic monolithic support reliable reproducible ii resultant affinity capillary column showed strong resistance change temperature pH negligible nonspecific interaction confirm proper functioning miniaturized capillary column molecular recognition HSPG five selected compound including three ligand interest related SARSCoV2 studied,
Elite athlete COVID19 Predictors course disease,34334321,OBJECTIVES aim study identify predictor determining course COVID19 antibody response elite athlete DESIGN Observational study METHODS Routine medical screening physical examination resting ECG laboratory test including antibody response performed 1268days diagnosis COVID19 111 athlete different sport RESULTS Clinical symptom observed 84 subject severity COVID19 mild 82 athlete moderate 2 case Athletes aged 26 male likely develop symptomatic COVID19 Asymptomatic subject younger predominantly female 18 subject symptom still present 20 1268 day median range since positive diagnosis Antibody response observed 88 athlete magnitude correlated time since diagnosis COVID19 RTPCR fatigue fever conjunctivitis difference antibody response group distinguished sport discipline p=050 sex p=059 antibody response correlate BMI p=012 age p=013 number symptom p=043 duration p=019 CONCLUSIONS severity COVID19 elite athlete predominantly mild without complication Athletes return sport two symptomfree week additional heart screening usually required Determination antibody shown useful indicator previous COVID19 disease symptom used predictor antibody response,antibody response;coi;exercise;return to sport;sars-cov-2;sport
Imdevimab,34283431,Imdevimab one severe acute respiratory syndrome coronavirus 2 SARSCoV2 neutralizing antibody proposed use clinical management coronavirus disease 2019 COVID19 used combination casirivimab reduces viral load improves clinical outcome activity review indication contraindication activity adverse event key element imdevimab therapy clinical setting also highlight essential point needed member interprofessional team managing COVID19 patient,
Multisystem Inflammatory Syndrome Adult MISA Successfully Treated Anakinra Glucocorticoids,34203277,current SARSCoV2 pandemic novel syndrome termed `` multisystem inflammatory syndrome child MISC emerged MISC linked COVID19 shared feature Kawasaki disease Toxic Shock Syndrome common pathogenetic substrate hyperinflammation cytokine storm Lately MIS also described adult =21 year age named `` MISA consensus treatment MISA successful use glucocorticoid immunoglobulin reported case series solid evidence lacking Furthermore role biologic agent proven benefit COVID19 MISC Kawasaki disease still unexplored report detail clinical picture diagnostic process led diagnosis MISA 27yearold man focusing treatment anakinra glucocorticoid resulted full recovery knowledge first report successful use anakinra MISA drug already proven useful treatment refractive case MISC Anakinra may also play pivotal role treatment MISA,covid-19;mis-a;sars-cov-2;anakinra;multisystem inflammatory syndrome
Modulation ACE2 mRNA inflammatory cytokine human thyroid cell pilot study,34224085,INTRODUCTION Angiotensinconvertingenzyme2 ACE2 demonstrated receptor cellular entry SARSCoV2 ACE2 mRNA identified several human tissue recently also thyroid cell vitro PURPOSE Aim present study investigate effect proinflammatory cytokine ACE2 mRNA level human thyroid cell primary culture METHODS Primary thyroid cell culture treated IFNgamma TNFalpha alone combination 24 h ACE2 mRNA level measured RTPCR control level IFNgamma inducible chemokine CXCL10 measured respective cell culture supernatant RESULTS mean level ACE2 mRNA increased treatment IFNgamma TNFalpha thyroid cell preparation combination treatment consistently synergically increase ACE2mRNA difference CXCL10 consistently increased IFNgamma synergically increased combination treatment IFNgamma + TNFalpha respect IFNgamma alone CONCLUSIONS result present study show IFNgamma lesser extent TNFalpha consistently increase ACE2 mRNA level NHT primary culture interestingly combined stimulation proven effective according synergic effect registered CXCL10 produce different response term ACE2 mRNA modulation result would suggest elevated level proinflammatory cytokine could facilitate entering virus cell increasing ACE2 expression andor account different degree severity SARSCOV2 infection hypothesis deserves confirmed specific study,ace-2;covid-19;sars-cov-2;thyrocytes;thyroid
Ocular Systemic Manifestations Paediatric Multisystem Inflammatory Syndrome Associated COVID19,34209269,study aimed achieve better understanding epidemiological clinical characteristic multisystem inflammatory syndrome child MISC following coronavirus disease 2019 COVID19 searched PubMed Embase December 2019 March 2021 included peerreviewed clinical study case series proportion patient conjunctivitis systemic symptomssigns ss Kawasaki disease KD exposure history suspectedconfirmed COVID19 case obtained Moreover positive rate nasopharyngeal realtime reverse transcriptase polymerase chain reaction RTPCR serum antibody severe acute respiratory syndrome coronavirus 2 SARSCoV2 recorded Overall 32 study 1458 patient included pooled analysis Around half patient conjunctivitis five common systemic manifestation fever 964 gastrointestinal ss 767 shock 615 rash 571 neurological ss 368 Almost onethird presented complete KD half exposure history COVID19 case positivity serology 822 higher nasopharyngeal RTPCR 370 MISC associated COVID19 lead several feature similar KD Epidemiological laboratory finding suggest postinfective immune dysregulation may play predominant role study crucial elucidate underlying pathogenesis,covid-19;sars-cov-2;conjunctivitis;meta-analysis;multisystem inflammatory syndrome
Natural killer cell unconventional cell COVID19,34217135,NK cell diverse population unconventional cell MAIT cell gammadelta cell invariant NKT cell DNTabeta cell important early effector lymphocyte cell NK cell MAIT cell wellestablished role antiviral defense function population remains elusive summarize discus current knowledge NK cell unconventional cell response SARSCoV2 infection Also covered role cell pathogenesis severe COVID19 Understanding early systemic local lung effector lymphocyte response novel disease likely aid ongoing effort combat pandemic,
Prediction identification cell epitope COVID19 balanced cytokine response development peptide based vaccine,34221846,Recent outbreak 2019 novel Corona virus pose serious challenge global health system lieu paucity experimental data tool basic understanding host immune response SARSCoV2 well thought effective measure needed control COVID19 pandemic identified specific overlapping antigenic peptide epitope OAPE within 4 structural protein SARSCoV2 predictive triggering robust CD4 CD8 cell response host using bioinformatics tool NetMHC40 IEDB Vaxijen20 speculate early release proinflammatory cytokine protection later release antiinflammatory cytokine prevention immunopathology designing vaccine Covid19 Therefore selected immunogenic OAPE subjected silico tool IL6Pred IFNepitope PIPEL analyzing proinflammatory response OAPEs found proinflammatory nature subjected prediction server IL4Pred IL10Pred PreAIP characterize inducer antiinflammatory response well finally filtered 12 OAPE affinity CD4 CD8 cell well inducer proinflammatory antiinflammatory cytokine confirmation OAPE binding affinity respective cell specific MHC allele using docking study pepATTRACT Hex80 Discovery studio found immunogenic potential 3 negative control peptide NCPs included study Additionally constructed CTxBadjuvanated multiepitopic vaccine inclusive 12 OAPEs nontoxic nonallergenic capable inducing proinflammatory antiinflammatory cytokine successful silico cloning docking modeled subunit vaccine construct toll like receptor2 TLR2 confirmed high efficacy multiepitopic vaccine balanced interplay cytokine help creating steadystate immune equilibrium silico immune simulation study vaccine using CImmSim server also showed higher percentage cell along production proinflammatory well antiinflammatory cytokine Experimental validation prediction based study Peripheral Blood Mononuclear Cells PBMCs uninfected individual patient recovered individual facilitate production high priority effective SARS CoV2 vaccine candidate Supplementary Information online version contains supplementary material available 101007s40203021000987,anti-inflammatory t cell epitopes;covid-19;in silico cloning;peptide-based vaccine candidates;sars-cov-2
Urticarial vasculitis,34222586,Urticarial vasculitis rare clinicopathologic entity characterized chronic recurrent episode urticarial lesion Skin finding disease difficult distinguish visually chronic idiopathic urticaria unique individual lesion persist =24 hour leave behind dusky hyperpigmentation disease often idiopathic linked certain drug infection autoimmune connective disease myelodysplastic disorder malignancy recently author reported association urticarial vasculitis COVID19 well influenza AH1N1 infection Urticarial vasculitis extend systemically well often affecting musculoskeletal renal pulmonary gastrointestinal ocular system Features leukocytoclastic vasculitis seen histopathologic examination diagnostic disease always seen practice antibiotic dapsone colchicine hydroxychloroquine popular firstline therapy especially mild cutaneous disease severe case immunosuppressive including methotrexate mycophenolate mofetil azathioprine cyclosporine well corticosteroid may necessary control recently select biologic therapy including rituximab omalizumab interleukin1 inhibitor shown promise treatment recalcitrant refractory case,hypocomplementemic;hypocomplementemic urticarial vasculitis;leukocytoclastic vasculitis;urticarial vasculitis;urticarial vasculitis syndrome
investigation beneficial effect highdose interferon beta 1a compared lowdose interferon beta 1a severe COVID19 COVIFERON II randomized controlled trial,34224994,INTRODUCTION Coronavirus disease 2019 COVID19 serious obstacle front public health Interferonbeta 1a IFNbeta 1a used treat patient COVID19 aimed compare effectiveness highdose IFNbeta 1a compared low dose IFNbeta 1a severe COVID19 case METHODS randomized controlled clinical trial eligible patient confirmed SARSCoV2 infection randomly assigned receive one two following therapeutic regimen intervention group treated highdose IFNbeta 1a Recigen Subcutaneous injection 88 mug 24 million IU day 1 3 6 + lopinavir ritonavir Kaletra 400 mg100 mg twice day 10 day orally control group treated lowdose IFNbeta 1a Recigen Subcutaneous injection 44 mug 12 million IU day 1 3 6 + lopinavir ritonavir Kaletra 400 mg100 mg twice day 10 day orally RESULT total 168 COVID 19 confirmed patient underwent randomization 83 assigned intervention group 85 assigned control group Median Time Clinical Improvement TTIC case treated lowdose IFNbeta1a shorter case treated highdose IFNbeta1a 6 v 10 day P = 0018 mortality rate intervention control group 41 365 respectively CONCLUSION use highdose IFNbeta 1a improve TTCI hospitalized patient moderate severe COVID19 Also significant effect mortality reduction compared treating lowdose IFNbeta 1a TRIAL REGISTRATION trial registered ClinicalTrialsgov NCT04521400,covid-19;interferon-beta 1a;lopinavir/ritonavir;randomized controlled trial;sars-cov-2
Training woman s pelvic floor muscle pregnancy postpartum primary health center best practice implementation project,34224524,INTRODUCTION AIMS Pelvic floor muscle training PFMT enhances muscle strength coordination prevents urinary incontinence associated giving birth goal improve woman s PFMT pregnancy postpartum La Rioja Spain METHODS evidence implementation project used JBI evidence implementation framework First conducted PFMT baseline audit ass criterion midwife training sent questionnaire midwife measure criterion PFMT urinary incontinence risk assessment reviewed medical record 60 woman selected consecutive sampling 15 woman risk urinary tract infection UTIs inclusion criterion PFMT program Second used Getting Research Practice guideline identify barrier fulfillment criterion design implement strategy improve compliance Finally repeated audit measure compliance verify change RESULTS midwife received updated PFMT optimizing compliance first criterion 67 100 remaining criterion providing PFMT pregnant woman identifying woman high risk incontinence facilitating supervised PFMT program woman high risk UTIs went 0 compliance 17 96 67 respectively CONCLUSION project effective building consensus improving midwife practice facilitating mother PFMT project continued novel coronavirus coronavirus disease 2019 COVID19 epidemic Spain midwife woman manager involved change well designed registration system use online tool communication midwife woman,
Theophylline Treatment COVID19 Induced Sinus Bradycardia,34205865,retrospective case series two patient laboratoryconfirmed coronavirus 2 SARSCoV2 infection presented University Arkansas Medical Sciences January 2021 Medical record patient reviewed using EPIC electronic health record system Clinical laboratory treatment data reviewed period bradycardia patient patient presented dizziness presyncope related sinus bradycardia received treatment 1 mg IV atropine theophylline 200 mg orally share two case theophylline treatment COVID19 induced sinus bradycardia first patient 39yearold female past medical history polycystic ovarian syndrome presented emergency department lightheadedness dizziness Two week prior presentation tested positive COVID19 infection treated azithromycin dexamethasone aspirin Upon presentation ECG showed sinus bradycardia rate 48 bpm second patient 21yearold female significant past medical history presented presyncope Three week prior presentation tested positive COVID19 infection treated symptomatically home Upon presentation ECG showed junctional rhythm heart rate 51 bpm,covid-19;bradyarrhythmias;bradycardia;junctional rhythm;theophylline
COVID19 effect endothelium HIVpositive patient subSaharan Africa Cardiometabolic risk thrombosis vascular function ENDOCOVID STUDY,34332551,BACKGROUND COVID19 affected almost every country world especially term health system capacity economic burden People subSaharan Africa SSA often face interaction human immunodeficiency virus HIV infection noncommunicable disease cardiovascular disease Role HIV infection antiretroviral treatment ART altered cardiovascular risk questionable still need carry research field However thus far unclear impact COVID19 coinfection people living HIV PLHIV without therapy ENDOCOVID project aim investigate whether HIVinfection COVID19 patient modulates time course disease alters cardiovascular risk change vascular endothelial function coagulation parameters thrombosis risk METHODS total 1026 patient included study Cardiovascular research PLHIV n = 114 three recruiting center without ART n = 114 three recruiting center COVID19 HIVnegative COVID19 n = 114 three recruiting center carried via clinical biochemical measurement cardiovascular risk factor biomarkers cardiovascular disease CVD Vascular endothelial function measured brachial artery flowmediated dilatation FMD carotid intimamedia thickness IMT assessment retinal blood vessel analysis along vascular endothelial biomarkers cogualation marker correlation HIVinfection COVID19 PLHIV without ART role enhancement cardiovascular risk endothelial dysfunction assessed admission weekly discharge 4 week postdischarge possible IMPACT PROJECT ENDOCOVID project aim evaluate longterm cardiovascular risk vascular endothelial function PLHIV thus revealing important transitional cardiovascular phenotype COVID19 study registered clinicaltrialsgov NCT04709302,antiretroviral therapy;covid-19;cardiovascular risk factors;hiv;thrombosis;vascular endothelial function
Prevalence Predictors Prolonged Cognitive Psychological Symptoms Following COVID19 United States,34349633,BackgroundObjectives Little known regarding prevalence predictor prolonged cognitive psychological symptom COVID19 among communitydwellers aimed quantitatively measure selfreported metric fatigue cognitive dysfunction anxiety depression sleep identify factor associated metric among United States resident without COVID19 Methods solicited 1000 adult United States resident online survey conducted February 35 2021 utilizing commercial crowdsourcing community research platform platform curate eligible participant approximate United States demographic age sex race proportion COVID19 diagnosed laboratory testing andor exposure known positive contact subsequent typical symptom Prolonged COVID19 selfreported coded symptom = 1 month following initial diagnosis primary outcome NIH PROMISNeuroQoL shortform Tscores fatigue cognitive dysfunction anxiety depression sleep compared among prolonged COVID19 symptom COVID19 without prolonged symptom COVID19 negative subject Multivariable backwards stepwise logistic regression model constructed predict abnormal NeuroQoL metric Results Among 999 respondent average age 45 year range 1884 49 male 76 76 history COVID19 1976 25 COVID19 positive participant reported prolonged symptom lasting median 4 month range 113 Prolonged COVID19 participant often younger female Hispanic history depressionmoodthought disorder P 005 experienced significantly higher rate unemployment financial insecurity symptom created greater interference work household activity compared COVID19 status group P 005 adjusting demographic past medical history stressor covariates multivariable logistic regression analysis COVID19 status independently predictive worse NeuroQoL cognitive dysfunction score adjusted 1152 95 CI 101228 P = 0047 significant difference quantitative measure anxiety depression fatigue sleep Conclusion Prolonged symptom occurred 25 COVID19 positive participant NeuroQoL cognitive dysfunction score significantly worse among COVID19 positive subject even accounting demographic stressor covariates Fatigue anxiety depression sleep score differ COVID19 positive negative respondent,covid-19;community dwellers;cognitive;long-hauler;post-acute sequelae of sars-cov-2 infection;stressors
Interim Estimates COVID19 Vaccine Effectiveness Mass Vaccination Setting Data Italian Province,34200538,retrospective cohort study compared rate virologicallyconfirmed SARSCoV2 infection symptomatic lethal COVID19 among resident Italian province Pescara received one two dos COVID19 vaccine versus unvaccinated official data National Health System used total 69539 vaccinated adult compared 175687 unvaccinated Among subject received least one vaccine dose 85 infection 012 18 severe 3 lethal COVID19 case recorded average followup 38 day Among unvaccinated number 6948 400 933 053 241 014 respectively serious adverse event reportsyet unconfirmedwere 24 102394 administered dos Cox model adjusting age gender selected comorbidities effectiveness either BNT162b2 ChAdOx1 nCoV19 mRNA1273 vaccine higher 95 preventing infection mostly due B117 variant symptomatic lethal COVID19 difference observed across gender among 691 subject received second dose vaccine later recommended date Although preliminary finding support current immunization policy may help reducing vaccine hesitancy,covid-19;italy;sars-cov-2;cohort study;vaccine effectiveness;vaccine hesitancy
Aging COVID19 susceptibility disease severity clinical outcome role entangled risk factor,34352287,emergence Severe Acute Respiratory Syndrome Corona Virus 2 SARSCoV2 late 2019 associated high rate mortality morbidity determined old population increased risk affliction COVID19 infection also atypical presentation severe form disease mortality common population plethora mechanism risk factor contribute higher risk infection old population instance aging associated increment expression AngiotensinConverting Enzyme2 ACE2 receptor SARSCoV2 spike protein precipitate replication virus old population hand immune dysregulation change gut microbiota result aging contribute cytokine storm one main indicator disease severity Decrement sex steroid especially woman well growth hormone crucial role immune regulation key contributor disease severity old age Senescenceassociated oxidative stress mitochondrial dysfunction pneumocytes immune cell contribute severity infection exacerbative manner addition lifestyleassociated factor nutrition physical activity compromised old age known important factor COVID19 infection Agingassociated comorbidities especially cardiovascular disease diabetes mellitus also put older adult increased risk complication disease severity,ards;mortality;older adults;sars-cov-2
SARSCoV2 B117 Infection Syrian Hamster Cause Severe Disease Naturally Acquired Immunity Confers Protection,34133199,Epidemiological study revealed emergence multiple severe acute respiratory syndrome coronavirus 2 SARSCoV2 variant concern VOC including lineage B117 rapidly replacing old variant B117 variant linked increased morbidity rate transmissibility potentially mortality ass viral fitness vivo address whether B117 variant capable immune escape conducted infection reinfection study naive convalescent Syrian hamster 10 month old Nasal wash sample hamster infected B117 variant exhibited slightly higher viral RNA level lower infectious titer B1 G614 variantinfected hamster two variant induced comparable lung pathology hamster Despite sporadic transient lowlevel infection nasal cavity convalescent hamster recovered previous USAWA1 isolate D614 infection displayed observable clinical sign lung pathology following B117 rechallenge Altogether study find B117 variant significantly differs B1 variant pathogenicity Syrian hamster heterologous natural infectioninduced immunity confers protection secondary challenge B117 variant IMPORTANCE rapid emergence several variant concern SARSCoV2 call evaluation viral fitness pathogenicity animal model order understand mechanism enhanced transmission possible increase morbidity mortality rate demonstrated immunity naturally acquired prior infection firstwave variant confer nearly complete protection B117 variant Syrian hamster upon reexposure Strikingly although B117 variant appears replicate higher level nose ancestral B1 variant induce severe lung pathology hamster,b.1.1.7;covid-19;sars-cov-2 variants;syrian hamster;spike protein
Computational Insights Potential NSAIDs Treating COVID19 Priority Set Lead Optimization,34205704,discovery drug capable inhibiting SARSCoV2 priority human being due severity global health pandemic caused COVID19 end repurposing FDAapproved drug NSAIDs COVID19 provide therapeutic alternative could utilized effective safe treatment COVID19 antiinflammatory activity NSAIDs also advantageous treatment COVID19 found SARSCoV2 responsible provoking inflammatory cytokine storm resulting lung damage study 40 FDAapproved NSAIDs evaluated molecular docking main protease SARSCoV2 Among tested compound sulfinpyrazone 2 indomethacin 3 auranofin 4 proposed potential antagonist COVID19 main protease Molecular dynamic simulation also carried promising member screened NSAID candidate 2 3 4 unravel dynamic property NSAIDs target receptor conducted quantum mechanical study revealed hybrid functional B3PW91 provides good description spatial parameter auranofin 4 Interestingly promising structureactivity relationship SAR concluded study could help future design potential SARSCoV2 main protease inhibitor expected antiinflammatory effect well NSAIDs may used medicinal chemist lead compound development potent SARSCoV2 pro inhibitor addition NSAIDs selectively designated treatment inflammation resulting COVID19,dft calculations;sars-cov-2 main protease;docking;drug repurposing;molecular dynamics
detection SARSCoV2 RNA indoor air dental clinic COVID19 pandemic,34341930,indoor environment dental clinic dental personnel patient exposed risk infection transmission SARSCoV2 via particle droplet study investigated presence SARSCoV2 RNA indoor air dental clinic Tehran Iran Air sampling done n = 36 collecting particulate sample PTFE filter flow rate 30 58 Lmin sample analyzed novel coronavirus nucleic acid diagnostic realtime PCR kit 13 36 sample positive SARSCoV2 RNA Logistic regression showed sampling site s volume PM25 concentration number people number active patient treatment unit significantly positively related presence SARSCoV2 RNA Thus strategy control spread COVID19 include reducing number infected people dental clinic adding filtration system andor improving ventilation condition,airborne transmission;covid-19;dental clinics;indoor air;pm2.5;sars-cov-2
Neurological mental health consequence COVID19 potential implication wellbeing labour force,34222864,Recent case study show SARSCoV2 infectious disease COVID19 associated accelerated decline mental health particular cognition elderly individual also neurological neuropsychiatric illness young people Recent study also show bidirectional link COVID19 mental health people previous history psychiatric illness higher risk contracting COVID19 COVID19 patient display variety psychiatric illness Risk factor response central nervous system virus show large overlap pathophysiological process associated Alzheimer s disease delirium postoperative cognitive dysfunction acute disseminated encephalomyelitis characterized cognitive impairment similarity lead hypothesis neurological symptom could arise neuroinflammation immune cell dysfunction periphery well central nervous system assumption longterm consequence COVID19 may lead cognitive impairment wellbeing patient thus today s workforce resulting large loss productivity Therefore particular attention paid neurological protection treatment recovery COVID19 cognitive consequence may require monitoring,alzheimer's disease;covid-19;cognitive decline;post-operative cognitive dysfunction;production loss
NurseCoordinated Blood Pressure Telemonitoring Urban Hypertensive Patients Systematic Review MetaAnalysis,34199019,Coronavirus disease 2019 COVID19 put hypertensive patient densely populated city increased risk Nursecoordinated home blood pressure telemonitoring NCHBPT may help address screened study published English three database inception 30 November 2020 effect NCHBPT compared inperson treatment Outcomes included change blood pressure BP following intervention rate BP target achievement COVID19 1916 article identified 27 comparison included review intervention group reduction 5731 mmHg 95 confidence interval 41207341 p 0001 systolic blood pressure SBP 2342 mmHg 14823202 p 0001 diastolic blood pressure DBP identified rate target BP achievement significant intervention group risk ratio RR = 1261 11541378 p 0001 effect intervention time showed SBP reduction 3000 mmHg 599911999 2000 8755 mmHg 517712334 2020 DBP reduced 2000 mmHg 27246724 2000 3529 mmHg 12215838 2020 Analysis target BP ratio 2010 RR = 1101 10131198 2020 RR = 1906 14622487 suggested improved BP control pandemic NCHBPT significantly improves office blood pressure UC among urban hypertensive patient,covid-19;blood pressure;coordination;hypertension;nurse;telemonitoring;urban
Nonarteritic anterior ischaemic optic neuropathy sequential SARSCoV2 virus pneumonia preventable endothelial protection,34281937,present case nonarteritic anterior ischaemic optic neuropathy NAION ocular systemic risk factor patient recovered recent SARSCoV2 pneumonia NAION common acute optic neuropathy among individual 50 year age result transient hypoperfusion optic nerve head circulation especially patient low vascular compliance due ocular systemic risk factor attribute ophthalmological condition SARSCoV2 virusassociated endotheliopathy prevented timely protection endothelial function vitamin K2,covid-19;capillary;cranial nerves;eye
Evaluation anticancer anticovid19 property cationic pentapeptide GluGlnArgProArg rice bran protein disomer analog molecular docking simulation,34352727,Bioactive peptide derived food protein becoming increasingly popular due growing awareness healthpromoting property structure mechanism anticancer action pentapeptide GluGlnArgProArg EQRPR derived rice bran protein known Theoretical experimental method employed fill gap conformation analysis EQRPR pentapeptide performed first obtained lowest energy conformer optimized experimental structural data obtained FTIR CD spectroscopy agree well theoretical result disomer introduced onebyone position Disomers peptide also examined possible antiproteolytic activity enhancement property molecular docking revealed avid binding pentapeptide integrins alpha5beta1 alphaIIbbeta3 Kd value 90 nM 180 nM respectively Moreover EQRPR Disomers showed strong binding affinity apo holoforms pro spike glycoprotein ACE2 dACE2 predicted result indicate pentapeptide may significantly inhibit SARSCoV2 infection Thus peptide potential leading molecule drug discovery process multifunctional diverse biological activity,anti-cancer peptides;cationic peptides;circular dichroism;ftir;molecular docking;molecular modeling
Seroprevalence SARSCoV2 Binding Neutralizing Antibodies Healthcare Workers Epidemic Peak Referral Hospitals Quarantine Sites Saudi Arabia,34372618,Healthcare worker HCWs high risk SARSCoV2 infection compared general population aimed evaluate characterize SARSCoV2 seropositivity rate randomly collected sample among HCWs largest referral hospital quarantine site peak COVID19 epidemic city Jeddah second largest city Saudi Arabia using crosssectional analytic study design 693 participant recruited 29 June 10 August 2020 223 322 95 CI 288358 found confirmed seropositive SARSCoV2 antibody among 197 883 never diagnosed COVID19 Seropositivity significantly associated participant reporting COVID19 compatible symptom seropositive HCW participant 140 628 asymptomatic large proportion asymptomatic SARSCoV2 case detected study demand periodic testing general hospital policy,covid-19 pandemic;hcws;jeddah;sars-cov-2;anti-s abs;seroprevalence
Lipid bilayer degradation induced SARSCoV2 spike protein revealed neutron reflectometry,34290262,SARSCoV2 spike protein responsible membrane fusion event allows virus enter host cell cause infection process start binding spike extramembrane domain angiotensinconverting enzyme 2 ACE2 membrane receptor highly abundant lung study extramembrane domain SARSCoV2 Spike sSpike injected model membrane formed supported lipid bilayers presence absence soluble part receptor ACE2 sACE2 structural feature studied subnanometer level neutron reflection case presence protein produced remarkable degradation lipid bilayer Indeed membrane synthetic natural lipid significant reduction surface coverage observed Quartz crystal microbalance measurement showed lipid extraction start immediately sSpike protein injection measurement indicate presence protein induces removal membrane lipid presence absence ACE2 suggesting sSpike molecule strongly associate lipid strip away bilayer via nonspecific interaction cooperative effect sACE2 sSpike lipid extraction also observed,
COVID19 Encephalitis SARSCoV2 Detected Cerebrospinal Fluid Presenting Stroke Mimic,34217071,report case 35yearold male COVID19 encephalitis presenting stroke mimic suddenonset expressive receptive dysphasia mild confusion right arm incoordination patient received thrombolysis suspected ischaemic stroke later became febrile SARSCoV2 detected cerebrospinal fluid Electroencephalography demonstrated excess slow wave neuroimaging reported normal Respiratory symptom absent throughout nasopharyngeal swab negative SARSCoV2 recent followup patient made full neurological recovery Clinicians therefore consider testing SARSCoV2 CSF patient present acute focal neurology confusion fever pandemic even evidence respiratory infection,covid-19;encephalitis;sars-cov-2;stroke mimic
COVID19 mucormycosis superinfection Exploring missing pathophysiological link,34377450,coronavirus disease 2019 continues unearth new facet portend grave clinical implication recent time mounting fervor regarding coronavirus disease 2019 mucormycosis superinfection correlation two conspicuous underlying pathophysiological mechanism render patient coronavirus disease 2019 susceptible mucormycosis vice versa still elusive,covid-19;immunosupression;morbidity;mortality;mucormycosis
new highcontent screening assay entire hepatitis B virus life cycle identifies novel antiviral,34222850,Background Aims Chronic hepatitis B incurable disease Addressing unmet medical need therapy hampered lack suitable cell culture model investigate HBV life cycle single experimental setup sought develop platform suitable investigate aspect entire HBV life cycle Methods HepG2NTCPsec+ cell inoculated HBV Supernatants infected cell transferred naive cell Inhibition infection determined primary secondary infected cell highcontent imaging viral cellular factor Novel antiviral triaged cell infected cell culture patientderived HBV stably virus replicating cell HBV internalisation targetbased receptor binding assay conducted Results developed HBV platform screened 2102 drug bioactives identified 3 early 38 late novel HBV life cycle inhibitor using infectious HBV genotype D Two early inhibitor pranlukast EC50 43 muM 50 cytotoxic concentration CC50 50 muM cytochalasin EC50 007 muM CC50 50 muM 2 late inhibitor fludarabine EC50 01 muM CC50 134 muM dexmedetomidine EC50 62 muM CC50 50 muM investigated Pranlukast inhibited HBV preS1 binding whereas cytochalasin prevented internalisation HBV Fludarabine inhibited secretion HBV progeny DNA whereas dexmedetomidine interfered infectivity HBV progeny Patientderived HBV genotype C efficiently inhibited fludarabine EC50 008 muM dexmedetomidine EC50 87 muM Conclusions newly developed highcontent assay suitable screen largescale drug library enables monitoring entire HBV life cycle discriminates inhibition early late viral life cycle event Lay summary HBV infection incurable chronic disease available treatment Addressing unmet medical need hampered lack suitable cell culture model study entire viral life cycle single experimental setup developed imagebased approach suitable screen large number drug using cell line infected HBV produce large amount virus particle transferring viral supernatant infected cell uninfected target cell could monitor entire viral life cycle used system screen drug library identified novel antiHBV inhibitor potently inhibit HBV various phase life cycle assay important new tool study HBV life cycle accelerate development novel therapeutic strategy,"%cv, percent coefficient of variation;%imax, percent maximum inhibition;cc50, 50% cytotoxic concentration;chb, chronic hepatitis b;cpam, core protein allosteric modifiers;drc, dose-response curve;entry;fda, food and drug administration;fda-approved drugs;geq, genome equivalents;hbv;hbvpt, patient-derived hbv;hcc, hepatocellular carcinoma;hcs, high content screening;hid, n-hydroxyisoquinolinedione;hlcs, hepatocyte-like cells;hts, high-throughput screening;hepg2-ntcp;high-throughput screening;ifa, immunofluorescence analysis;ifnalpha, interferon alpha;ifnlambda, interferon lambda;lhb, hbv large surface protein;lmv, lamivudine;moa, mechanism of action;myrb, myrcludex b;ntcp, sodium taurocholate cotransporting polypeptide;peg, polyethylene glycol;pf-rcdna, protein-free relaxed circular dna;patient-derived hbv;replication;sars-cov-2, severe acute respiratory syndrome coronavirus 2;sop, standard operation procedure;small-molecule inhibitors;supernatant transfer;tdf, tenofovir disoproxil fumarate;ti, therapeutic index;virion secretion;cccdna, covalently closed circular dna;dpi, days post-infection;ipscs, induced pluripotent stem cells;p1, passage 1;p2, passage 2;pgrna, pregenomic rna"
2020 Pandemic observational study exploring public knowledge attitude plan preference towards death end life care Wales,34284754,BACKGROUND Understanding public attitude towards death dying important inform public policy around End Life Care EoLC studied public attitude towards death dying Wales METHODS online survey conducted 2018 Social medium HealthWiseWales platform used recruit participant Data analysed using descriptive statistic thematic analysis RESULTS 2210 people participated Loss independence 84 manner death leaving beloved behind biggest fear around death dying term EoLC participant sought timely access care 84 surrounded loved one 62 home le priority 24 50 familiar Advance Care Planning ACP lack standard procedure well support execution plan ability revisit plan hindered uptake taboo around death conversation lack opportunity skill initiate discussion personal fear discomfort inhibited talking death dying 72 felt talk enough death dying advocated normalising talking demystifying death positive approach Health professional could initiate support conversation depended communication skill manageable workload pressure Participants encouraged public health approach endorsed use social medium public platform b formal education c formal legal action signposting access information CONCLUSIONS People ready talk death dying COVID19 increased awareness combination topdown bottomup initiative across level setting increase awareness knowledge serviceutilisationdrivers support health professional people towards shared decision align people s end life wish preference,communication;cultural issues;death and dying;end of life care;public attitudes;public health;quality of life;supportive care;terminal care
Frequency risk factor outcome hospital readmission COVID19 patient,34215803,determine proportion patient COVID19 readmitted hospital common cause factor associated readmission Multicenter nationwide cohort study Spain Patients included study admitted 147 hospital March 1 April 30 2020 Readmission defined new hospital admission 30 day discharge Emergency department visit discharge considered readmission study period 8392 patient admitted hospital participating SEMICOVID19 network 298 patient 42 7137 patient readmitted discharged 1541 177 died index admission 35 died hospital readmission 117 p = 0007 median time discharge readmission 7 day IQR 315 day frequent cause hospital readmission worsening previous pneumonia 54 bacterial infection 13 venous thromboembolism 5 heart failure 5 Age odds ratio 102 95 confident interval 95 CI 101103 ageadjusted Charlson comorbidity index score 113 95 CI 106121 chronic obstructive pulmonary disease 184 95 CI 126269 asthma 152 95 CI 104222 hemoglobin level admission 092 95 CI 086099 groundglass opacification admission 086 95 CI076098 glucocorticoid treatment 129 95 CI 100166 independently associated hospital readmission rate readmission hospital discharge COVID19 low Advanced age comorbidity associated increased risk readmission,
Mortality associated risk factor COVID19 infection dialysis patient Qatar nationwide cohort study,34293004,CONTEXT Patients maintenance dialysis susceptible COVID19 severe form studied mortality associated risk COVID19 infection dialysis patient state Qatar METHODS observational analytical retrospective nationwide study included adult patient maintenance dialysis therapy tested positive COVID19 PCR assay nasopharyngeal swab period February 1 2020 July 19 2020 primary outcome study mortality COVID19 dialysis patient Qatar risk factor associated secondary objective study incidence severity COVID19 dialysis patient comparing outcome hemodialysis peritoneal dialysis patient Patient demographic clinical feature collected national electronic medical record Univariate Cox regression analysis performed evaluate potential risk factor mortality cohort RESULTS 76 1064 dialysis patient diagnosed COVID19 age 56+136 56 hemodialysis 20 peritoneal dialysis 56 male study period 71 dialysis patient contracted COVID19 Male dialysis patient double incidence COVID19 female 9 versus 45 respectively p 001 common symptom presentation fever 579 cough 566 shortness breath 25 Pneumonia diagnosed 72 dialysis patient COVID19 High severity manifested 25 patient requiring admission intensive care unit 184 ARDS 171 required mechanical ventilation 145 required inotropes mean length hospital stay 192 + 12 day Mortality due COVID19 among dialysis cohort 15 Univariate Cox regression analysis risk factor associated COVID19related death dialysis patient showed significant increase risk age 1077 CI 95 10181139 p = 001 CHF COPD 8974 CI 95 1039775 p = 0046 history DVT 5762 CI 95 122727057 p = 0026 Atrial fibrillation 7285 CI 95 202926150 p = 0002 hypoxia 166 CI 95 357477715 p = 0001 ICU admission HR308 CI 95 392412 p = 0001 Mechanical ventilation HR 5007 CI 95 643912 p 0001 using inotropes HR 1917 CI 95 11577185 p 0001 multivariate analysis ICU admission found significantly associated death = 328 353054 p = 0002 CONCLUSION first study conducted national level Qatar exploring COVID19 dialysis population Dialysis patient high incidence COVID19 infection related mortality compared previous report general population state Qatar 71 versus 4 15 versus 015 respectively also observed strong association death related COVID19 infection dialysis patient admission ICU,
Newgraduate physiotherapist training need readiness telehealth,34282699,INTRODUCTION COVID19 pandemic necessitated rapid transition telehealth delivery many Australian physiotherapy service Little known newgraduate training need method service deliveryAim explore readiness specific training need newgraduate physiotherapist telehealth service delivery Australia METHODS Qualitative individual telephone interview newgraduate physiotherapist n = 16 two videoconference focus group supervisor newgraduate physiotherapist n = 7 undertaken Thematic analysis used RESULTS Two global theme three organizing theme generated two global theme `` support need novice practitioner `` best prepare telehealth DISCUSSION CONCLUSION Newgraduate physiotherapist supervisor perceive preprofessional exposure practical skill training telehealth essential Elements undertaking physical assessment via telehealth verbal communication effective clinical reasoning telehealth assessment treatment highlighted area need stakeholder group perceived rapid transition telehealth challenged selfefficacy newgraduates clinical experience rely preparation ongoing support newgraduates adopt telehealth workplace considered critical given shift Australian healthcare online platform,telehealth;curriculum;interviews;physiotherapy;qualitative
Clinical manifestation sociodemographic status COVID19 patient secondwave pandemic Bangladeshi experience,34215560,BACKGROUND Bangladesh densely populated country substandard healthcare system mediocre economic framework Due enormous number people unaware development COVID19 s secondwave infection become severe threat present investigation aimed characterize clinical sociodemographic characteristic COVID19 Bangladesh METHODS crosssectional analysis carried COVID19 patient confirmed RTPCR undergoing specialized COVID19 hospital March 1 April 15 2021 total 1326 sample collected Samples obtained noncritical COVID19 patient critically ill patient required emergency intensive care medication April 17 May 03 2021 SARSCoV2 infection clinical assessment performed based interim guideline diagnosis conducted RTPCR Later identifying symptomatic asymptomatic patient based checking Clinical Observation Form COF patient filled COF form Finally statistical analysis done using SPSS 20 statistical program RESULTS investigation total 326 patient diagnosed COVID19 positive Among approximately 1902 n = 62 asymptomatic 8098 n = 264 symptomatic finding show occurrence infection varied depending age sex residence occupation smoking habit comorbidities etc However Males 6012 affected female 3988 surprisingly pandemic infected urban rural resident almost equally urban = 5092 rural = 4908 Approximately 19 asymptomatic 62 symptomatic case least one comorbid disorder Interestingly unexpected result exhibited case smoker nonsmokers affected smoker study indicates community transmission COVID 19 people highly infected occupation 3558 house 2393 traveling 1288 Noteworthy according report large number 1933 individual know exactly contaminated SARSCoV2 Patients commonly treated antibiotic 9509 followed second corticosteroid 4601 Antiviral drug remdesivir oxygenation also needed patient Among treated approximately 6933 isolated home 2791 treated dedicated COVID19 hospital Finally 9663 discharged without complication 003 died CONCLUSION investigation concludes male became infected female Interestingly urban rural people became nearly equally infected noticed community transmission SARSCoV2 people highly infected workplace higher rate silent transmission indicates caution needed identify asymptomatic patient infected people isolated home whereas nearly onefourth treated hospital Clinically antibiotic widely used treatment However majority patient discharged without complication current investigation would helpful understand clinical manifestation sociodemographic situation second wave COVID19 pandemic Bangladesh,asymptomatic-symptomatic;bangladesh;covid-19;clinical manifestations;second-wave
Characteristics predictor silent hypoxemia cohort hospitalized COVID19 patient,34293703,BACKGROUND intriguing feature recently unveiled COVID19 patient `` silent hypoxemia phenomenon refers discrepancy subjective wellbeing sensation suffering hypoxia manifested absence dyspnea OBJECTIVE describe clinical characteristic predictor silent hypoxemia hospitalized COVID19 patient METHODS conducted prospective cohort study including consecutive hospitalized adult = 18 year patient confirmed COVID19 presenting emergency department oxygen saturation SpO2 = 80 room air March 15 June 30 2020 analyzed characteristic disease severity inhospital outcome patient presenting dyspnea without dyspnea silent hypoxemia RESULTS studied 470 case 644 men median age 55 year interquartile range 4664 447 951 patient dyspnea 23 49 silent hypoxemia demographic clinical characteristic comorbidities laboratory imaging finding disease severity outcome similar group Higher breathing heart rate correlated significantly lower SpO2 patient dyspnea silent hypoxemia Independent predictor silent hypoxemia presence newonset headache 2919 95 CI 11017742 P = 0031 presenting emergency department within first eight day symptom onset 3183 95 CI 1024989 P = 0045 CONCLUSIONS Patients silent hypoxemia sought medical attention earlier newonset headache often also likely display lower hemodynamic compensatory response hypoxemia may underestimate disease severity,covid-19;happy hypoxemia;sars-cov-2;silent hypoxemia
Persistierende Beschwerden nach akuter COVID19Erkrankung `` LongCOVID,34344032,patient complain persisting symptom acute COVID19 universal definition yet postacute sequela also termed Long COVID Although prevalence remains established delayed recovery seems common acute infectious disease Common complaint include fatigue exercise intolerance dyspnea exertion chest pain neuropsychiatric symptom Female sex comorbidities severity acute disease identified risk factor persisting symptom however important highlight limited patient severe COVID19 Whilst pathogenesis prognosis largely unknown diagnostic evaluation focus exclusion objective organ dysfunction Due variable presentation management interdisciplinary may include physiotherapy rehabilitation programme psychological support article aim summarize current limited evidence persisting symptom COVID19,
Discrete simulation analysis COVID19 prediction isolation bed number,34221726,Background outbreak COVID19 defined World Health Organization pandemic containment depends traditional public health measure However explosive growth number infected case short period time caused tremendous pressure medical system Adequate isolation facility essential control outbreak study aim quickly estimate demand number isolation bed Methods established discrete simulation model epidemiology adjusting fitting necessary epidemic parameter effect following indicator development epidemic occupation medical resource explained 1 incubation period 2 response speed detection capacity hospital 3 disease healing time 4 population mobility Finally method predicting number isolation bed summarized multiple linear regression city level model simulates epidemic situation perspective population mobility Results simulation show incubation period response speed detection capacity hospital disease healing time degree population mobility infectivity cured patient different effect infectivity scale duration epidemic Among 1 incubation period 2 response speed detection capacity hospital 3 disease healing time 4 population mobility significant impact demand number isolation bed P 005 agrees following regression equation N = P x 0273 + 0009I + 0234M + 0012T1 + 0015T2 x 1 + V,covid-19;computer simulation;modeling and analysis;number of isolation beds
Diagnostic performance chest radiography high COVID19 prevalence setting experience European reference hospital,34218365,PURPOSE study s aim analyse diagnostic performance chest radiography CXR patient suspected coronavirus disease 19 COVID19 METHODS retrospectively considered 826 consecutive patient suspected COVID19 presenting emergency department ED February 21 March 31 2020 high disease prevalence setting enrolled patient underwent CXR rhinooropharyngeal swab realtime reverse transcriptionpolymerase chain reaction rRTPCR CXRs evaluated expert radiologist second independent analysis performed two resident consensus reader blinded rRTPCR result classified CXRs positivenegative depending presenceabsence typical finding COVID19 using rRTPCR reference standard RESULTS finally analysed 680 patient median age 58 547 80 tested positive COVID19 diagnostic performance CXR interpreted expert reader follows sensitivity 790 95 CI 753823 specificity 812 95 CI 735875 PPV 945 95 CI 920964 NPV 484 95 CI 417552 accuracy 793 95 CI 760822 resident sensitivity 751 95 CI 712787 specificity 579 95 CI 499664 PPV 880 95 CI 847908 NPV 362 95 CI 297430 accuracy 716 95 CI 681750 found significant difference reporting sensitivity p = 0013 specificity p 00001 expert radiologist v resident CXR sensitivity higher patient symptom onset 5 day ED presentation compared = 5 day 844 v 707 CONCLUSIONS CXR showed sensitivity 79 specificity 81 diagnosing viral pneumonia symptomatic patient clinical suspicion COVID19 study lower prevalence setting needed,pneumonia;radiology/radiography
Reactivation VogtKoyanagiHarada disease control 6 year following antiSARSCoV2 vaccination,34224024,BACKGROUNDPURPOSE VogtKoyanagiHarada VKH disease primary stromal choroiditis bilateral granulomatous panuveitis initialonset VKH treated early relentlessly disease controlled even `` cured substantial number case reporting patient treated early sustained fashion inflammation free seven year presented reactivation 6 week second dose antiSARSCoV2 vaccination CASE REPORT 43yearold woman presented severe initialonset VKH disease brought control using steroidal nonsteroidal Immunosuppression mycophenolic acid cyclosporine additional infliximab infusion persistence subclinical choroiditis identified ICGA infliximab alone disease inflammation free subclinical disease absence sunset glow fundus 6 year However following antiSARSCoV2 vaccination severe resurgence disease occurred exudative retinal detachment Disease rapidly brought control oral prednisone 1 mgkg therapy new loading scheme infliximab therapy CONCLUSION VKH disease result autoimmune process directed melanocyte associated antigen controlled early sustained immunosuppressive treatment introduced seems antiSARSCoV2 vaccination origin reactivation longtime controlled disease,anti-sars-cov-2 vaccination;autoimmune stromal choroiditis;vogt-koyanagi-harada disease: indocyanine green angiography
Characteristics outcome COVID19 infection 45 patient breast cancer multicenter retrospective study Hubei China,34225090,BACKGROUND COVID19 pandemic significant worldwide health crisis Breast cancer patient COVID19 fragile require particular clinical care study aimed identify clinical characteristic breast cancer patient COVID19 risk associated anticancer treatment METHODS medical record breast cancer patient laboratoryconfirmed COVID19 collected among 9559 COVID19 patient seven designated hospital 13th January 18th March 2020 Hubei China Univariate multivariate analysis performed ass risk factor COVID19 severity RESULTS 45 breast cancer patient COVID19 33 733 developed nonsevere COVID19 12 267 developed severe COVID19 3 67 patient died median age 62 year 3 67 patient stage IV breast cancer Univariate analysis showed age 75 Eastern Cooperative Oncology Group ECOG score associated COVID19 disease severity P 005 Multivariate analysis showed patient received chemotherapy within 7 day significantly higher risk severe COVID19 logistic regression model RR = 13886 95 CI 1014190243 P = 0049 Cox proportional hazard model HR = 13909 95 CI 1086178150 P = 0043 pronounced neutropenia higher LDH CRP procalcitonin level patient P 005 CONCLUSIONS breast cancer cohort severity COVID19 could associated baseline factor age 75 ECOG score Chemotherapy within 7 day symptom onset could risk factor severe COVID19 reflected neutropenia elevated LDH CRP procalcitonin level,anti-cancer treatment;breast cancer;covid-19;chemotherapy;retrospective study
Acute medical unit first wave COVID19 pandemic crossnational exploratory study impact response,34376474,BACKGROUND COVID19 pandemic represents one greatest ever challenge healthcare UK beyond acute medical unit AMUs first point assessment care majority medical inpatient design system inevitably played important role COVID19 response date little published COVID19 pandemic affected AMUs reorganised resource process structure METHODS retrospective study August 2020 10 AMUs across Europe Australasia used standardised questionnaire investigate existing practice structure AMUs national context local hospital experience change practice COVID19 pandemic view regarding future practice RESULTS Changes AMU structure process organisation described two context preventing controlling spread COVID19 adding value patient s acute care journey local context describe novel practice arisen highlight area concern CONCLUSIONS AMUs able adapt meet demand acute care delivery first wave COVID19 pandemic Operational planning prioritisation resource must optimised ensure sustainability service future wave,amu;covid-19;processes;response;structures
casecontrol study association periodontitis coronavirus disease COVID19,34347879,BACKGROUND Coronavirus disease COVID19 periodontitis share common characteristic exaggerated inflammatory response periodontal disease shown associated respiratory disease pneumonia quite possible relationship may exist periodontitis COVID19 Hence aim present study determine whether periodontitis poor oral hygiene associated COVID19 METHODS case control study conducted Patients positive realtime reverse transcription polymerase chain reaction result severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection included case group n = 79 patient negative result included control group n = 71 periodontal examination involved recording plaque score calculus score tooth mobility gingival bleeding probing depth recession clinical attachment level CAL RESULTS Logistic regression analysis showed significant association mean plaque score = 1 odds ratio 701 95 confidence interval CI 1832694 gingivitis 1765 95 CI 5955237 mean CAL = 2 mm 846 95 CI 3472063 severe periodontitis 1175 95 CI 3893549 COVID19 finding prevalent case group CONCLUSION Based abovementioned observation concluded association periodontitis severity COVID19 Gingival bleeding dental plaque accumulation also frequent among COVID19 patient Hence essential maintain periodontal health good oral hygiene important measure COVID19 prevention management article protected copyright right reserved,covid-19;sars-cov-2;clinical attachment level;coronavirus;oral health;oral hygiene;periodontitis
COVID19 Myths Reality,34284707,COVID19 new human respiratory disease killed nearly 3 million people year since start pandemic global public health challenge infectious agent SARSCoV2 differs coronaviruses number structural feature make virus pathogenic transmissible review discus important characteristic main SARSCoV2 surface antigen spike protein ability receptorbinding domain RBD switch `` standingup position open prefusion conformation receptor binding `` lyingdown position closed prefusion conformation immune system evasion ii advantage high binding affinity RBD open conformation human angiotensinconverting enzyme 2 ACE2 receptor efficient cell entry iii protein preliminary activation intracellular furinlike protease facilitation virus spreading across different cell type describe interaction protein cellular receptor coreceptors antagonist well hypothetical mechanism homotrimeric spike structure destabilization trigger fusion viral envelope cell membrane physiological pH mediates viral nucleocapsid entry cytoplasm transition protein prefusion conformation postfusion one surface virion treatment reagent betapropiolactone essential especially relation vaccine production also compare COVID19 pathogenesis severe outbreak `` avian influenza caused AH5 AH7 highly pathogenic virus discus structural similarity SARSCoV2 protein hemagglutinins highly pathogenic strain Finally touch prospective currently used COVID19 antiviral antipathogenetic therapeutic well recently approved conventional innovative COVID19 vaccine molecular immunological feature,covid-19;s protein;sars-cov-2;hemagglutinin;influenza virus;structure;vaccines
Multiinstitution consensus paper acquisition portable chest radiograph glass barrier,34216091,BACKGROUND conserve personal protective equipment PPE reduce exposure potentially infected COVID19 patient several Californian facility independently implemented method acquiring portable chest radiograph glass barrier originally developed University Washington METHODS work quantifies transmission radiation glass barrier using six radiographic system five facility Patient entrance air kerma EAK effective dose estimated without glass barrier Beam penetrability resulting exposure index EI deviation index DI measured used adjust tube currenttime product mAs glass barrier beam hardening contrasttonoise ratio CNR measured image quality phantom ensure diagnostic integrity Finally scatter survey performed ass staff radiation exposure inside outside exam room RESULTS glass barrier attenuated mean 61 normal Xray beam mAs increased match EI value discernible degradation image quality determined CNR corroborated subjective assessment image quality chest radiologist glasshardened beam acted filter low energy Xrays facility observed slight change patient effective dos scattering phantom glass barrier within room CONCLUSIONS Glass barrier require approximate 25 time increase beam intensity technique factor held constant refinement necessary increased sourcetoimage distance beam quality order adequately match EI value result significant increase radiation dose delivered patient use lead apron mobile shield increased distance scattering source employed practicable order keep staff radiation dos low reasonably achievable,covid-19;chest x-ray;infection prevention;radiation safety
CoVrimer tool aligning SARSCoV2 primer sequence selection conserveddegenerate primer,34293476,mutation SARSCoV2 virus accumulate rapidly novel primer amplify virus sensitively specifically demand developed webserver named CoVrimer user search align existing newly designed conserveddegenerate primer pair sequence viral genome ass mutation load primer amplicons CoVrimer us mutation data obtained online platform established NGDCCNCB 12 May 2021 identify genomic region either conserved low level mutation potential primer pair designed provided user filtering based generalized SARSCoV2 specific parameter Alignments primer probe visualized respect reference genome indicating variant detail level conservation Consequently CoVrimer likely help researcher challenge posed viral evolution freely available http konulabappsbilkentedutr3838CoVrimer,covid-19;conserved primers;genome alignment;mutation;primer design;sars-cov-2
Seroprevalence SARSCoV2 Antibodies Factors Associated Seropositivity University Salamanca DIANCUSAL Study,34361998,BACKGROUND Systematic screening antibody SARSCoV2 crucial tool surveillance COVID19 pandemic University Salamanca USAL Spain designed project called `` DIANCUSAL Diagnosis New Coronavirus COVID19 University Salamanca measure antibody SARSCoV2 among 34000 student academic staff influence university community spread SARSCoV2 pandemic city Salamanca neighboring town hosting USAL campus could substantial OBJECTIVE aim study estimate prevalence SARSCoV2 antibody among USAL student professor staff evaluate demographic academic clinical lifestyle behavioral factor related seropositivity METHODOLOGY DIANCUSAL study ongoing university populationbased crosssectional study work described herein conducted JulyOctober 2020 USAL student professor staff invited complete anonymized questionnaire Seroprevalence antiSARSCoV2 antibody detected quantified using chemiluminescent assay IgG IgM PRINCIPAL FINDINGS total 8197 2471 participant included mean age 314 145 SD year 660 participant female seroprevalence 825 overall highest student education campus 125 professor biomedical campus 126 significant difference among faculty p = 0006 Based questionnaire loss smell fever symptom strongly associated seropositivity 226 seropositive participant asymptomatic Social distancing effective hygiene measure p = 00007 significant difference seroprevalence participant without household exposure SARSCoV2 p = 00000 student lived private home lived dormitory IgG antibody decreased time participant confirmed selfreported COVID19 diagnosis CONCLUSIONS analysis revealed overall 825 seroprevalence end October 2020 higher seroprevalence student staff Thus need tailored measure USAL community official average seroprevalence area similar 78 22 June 124 15 November 2020 Instead USAL member comply public health measure,covid-19;sars-cov-2;salamanca;spain;antibodies;screening;seroprevalence;university
Neuropathological finding COVID19 patient neurological symptom argue direct brain invasion SARSCoV2 critical systematic review,34339563,BACKGROUND Neuropathological study elucidate mechanism nervous system damage associated SARSCoV2 infection Despite literature topic rapidly expanding correlation neurological symptom brain pathology finding COVID19 patient remain largely unknown METHODS performed systematic literature review neuropathological study COVID19 including 438 patient 45 paper published April 22 2021 retrieved quantitative data regarding demographic clinical neuropathological finding carried Wilcoxon ranksum test chisquare test compare patient subgroup based different clinical brain pathology feature RESULTS Neuropathological finding COVID19 patient microgliosis 525 astrogliosis 456 inflammatory infiltrates 440 hypoxicischemic lesion 408 edema 253 hemorrhagic lesion 205 SARSCoV2 RNA protein identified brain specimen 419 283 subject respectively Detailed clinical information available 245 patient 559 among 96 subject 392 presented neurological symptom association typical COVID19 manifestation found detection rate SARSCoV2 RNA protein brain specimen differ patient vs without neurological symptom ii brain edema hypoxicischemic lesion inflammatory infiltrates frequent subject neurological impairment iii neurological symptom common among older individual CONCLUSIONS systematic revision clinical correlate COVID19 highlight pathogenic relevance brain inflammatory reaction hypoxicischemic damage rather neuronal viral load analysis indicates focused study design needed especially perspective potential therapeutic trial,covid-19;sars-cov-2;brain;neurological symptoms;neuropathology
Heparan Sulfate Proteoglycans Viral Infection Treatment Special Focus SARSCoV2,34207476,Heparan sulfate proteoglycans HSPGs encompass group glycoprotein composed unbranched negatively charged heparan sulfate HS chain covalently attached core protein complex HSPG biosynthetic machinery generates extraordinary structural variety HS chain enable bind plethora ligand including growth factor morphogens cytokine chemokines enzyme matrix protein bacterial viral pathogen interaction translate key regulatory activity HSPGs wide range cellular process receptor activation signaling cytoskeleton assembly extracellular matrix remodeling endocytosis cellcell crosstalk others Due ubiquitous expression within tissue large functional repertoire HSPGs involved many physiopathological process thus emerged valuable target therapy many human disease Among function HSPGs assist many virus invading host cell various step life cycle Viruses utilize HSPGs attachment host cell internalization intracellular trafficking egress spread Recently HSPG involvement pathogenesis SARSCoV2 infection established summarize current knowledge molecular mechanism underlying HSPGSARSCoV2 interaction downstream effect provide overview HSPGbased therapeutic strategy could used combat fearsome virus,sars-cov-2;heparan sulfate proteoglycans;pathogenesis;therapy;virus
Improved glycaemia Covid19 pandemic lockdown sustained postlockdown `` Eat Help Government Scheme adult Type 1 diabetes United Kingdom,34283880,AIMS majority study report Covid19 pandemic lockdown detrimental effect glycaemia sought explore impact lockdown glycaemia whether sustained following easing restriction METHODS Retrospective observational analysis adult child type 1 diabetes attending UK specialist centre using realtime intermittently scanned continuous glucose monitoring Data following 28day time period collected prelockdown ii lockdown iii immediately lockdown iv month following relaxation restriction coinciding Governmentsubsidised restaurant food Data analysed time glycaemic range expressed median IQR RESULTS 145 adult aged 355 258513 year diabetes duration 190 70290 year multiple daily injection insulin 60 continuous insulin infusion 40 included adult time range 70180mgdL increased lockdown 602 452693 compared prelockdown 567 435653 p 0001 maintained postlockdown time period Similarly time range 180mgdL reduced lockdown compared prelockdown p = 001 sustained thereafter child significant change glycaemia observed lockdown multivariable analysis greater increase TIR 3910mmolL 70180mgdL lockdown associated higher level deprivation coefficient 4208 95 CI 0588 7828 p = 002 CONCLUSIONS Glycaemia adult improved lockdown people deprived area likely benefit effect sustained easing restriction governmentsubsidised restaurant eating adverse impact glycaemia,
Combination rRTPCR AntiNucleocapsidAntiSpike Antibodies Characterize Specimens Low Viral SARsCoV2 Load RealLife Experience,34200837,objective present study evaluate true positivity among people whose result initial testing nasopharyngeal swab NPS showed low viral load severe acute respiratory syndrome coronavirus 2 SARSCoV2 Seventyseven people detected low viral load SARsCoV2 nasopharyngeal sample Ct = 35 enrolled study purpose second NPS collected rRTPCR realtime reverse transcription polymerase chain reaction combined pair serum sample detection antinucleocapsid antiN antispike antiS antibody 8 people subsequent examination indicated increase viral load thereafter followed increase antiN antiS antibody finding compatible early stage COVID19 infection 9 people already increased antiN antibody subsequent examination showed decrease absence viral load increase antibody indicative late stage COVID19 infection 60 people subsequent examination showed absence infection indicated absence viral load antibody propose combination second NPS one serumspecimen taken three day first NPS help significantly avoid falsepositive result,covid-19;greece;n gene;anti-nucleocapsid antibodies;anti-spike antibodies;diagnosis;false positive;low viral load
Lung ultrasound finding hospitalized COVID19 patient relation venous thromboembolic event ECHOVID19 study,34213740,PURPOSE Several study reported thromboembolic event common severe COVID19 case sought investigate relationship lung ultrasound LUS finding hospitalized COVID19 patient development venous thromboembolic event VTE METHODS total 203 adult included COVID19 ward prospective multicenter study mean age 686 year 567 men patient underwent 8zone LUS ultrasound image analyzed offline blinded Several LUS finding investigated total number Blines Bline score LUSscores RESULTS Median time admission LUS examination 4 day IQR 2 8 median number Blines 12 IQR 8 18 44 217 positive Bline score hospitalization 17 patient developed VTE 4 deepvein thrombosis 15 pulmonary embolism 12 following 5 prior LUS fully adjusted multivariable Cox model excluding participant VTE prior LUS LUS parameter significantly associated VTE total number Blines HR = 114 95 CI 103 126 per 1 Bline increase positive Bline score HR = 979 95 CI 187 5135 LUSscore HR = 151 95 CI 110 207 per 1point increase Bline score LUSscore remained significantly associated VTE sensitivity analysis CONCLUSION hospitalized COVID19 patient pathological LUS finding common total number Blines Bline score LUSscore associated VTE finding indicate LUS examination may useful risk stratification clinical management COVID19 finding considered hypothesis generating CLINICALTRIALS GOV ID NCT04377035,b-lines;covid-19;lung ultrasound;venous thromboembolic events
Influence COVID19 Pandemic Lifestyles Health Sciences University Students Spain Longitudinal Study,34200390,COVID19 pandemic significantly impacted daily activity worldwide University student may experienced substantial change daily living result restriction university attendance return normalcy may take long time understanding influence shift daily routine lifestyle university student may inform approach support overall wellbeing analyzed change lifestyle student enrolled health science university COVID19 pandemic longitudinal study took place Faculty Medicine Nursing University Basque Country Spain final sample consisted 113 nursing student 109 medical student 45 physiotherapy student result demonstrate change lifestyle university student pandemic MedDiet adherence score percentage student high adherence increased pandemic increase due increased consumption vegetable nut term physical activity practice moderate intense physical activity maintained result provide important information public health authority educational institution guide strategy maintain wellbeing student enhance opportunity young adult lead healthy lifestyle,covid-19;mediterranean diet;health science university students;physical activity
Family Presence Restrictions Telemedicine Use Neonatal Intensive Care Units Coronavirus Disease Pandemic,34356569,aimed describe parental presence policy telemedicine use Japanese neonatal intensive care unit NICUs coronavirus disease COVID19 pandemic crosssectional study performed online survey 110 level III unit 19 November 2020 18 December 2020 Nurses evaluation current situation COVID19 compared retrospective preCOVID19 December 2019 evaluation Responses received 52 NICUs distributed across region Japan median allowed parental presence time decreased 12 h 1 h 29 NICUs allowed entry parent simultaneously COVID19 increase number unit providing telemedicine telephone online visit COVID19 compared COVID19 2 19 hybrid design NICUs 1189 bed singlepatient room allowed longer parental presence time NICUs =90 bed multibed room number unit implementing kangaroo care decreased COVID19 compared COVID19 need telemedicine increased among Japanese NICUs mitigate adverse effect parental restriction limited physical contact due COVID19 pandemic,nicu design;hospital restriction policy;neonatal intensive care unit;parent;telemedicine
Intersubject variation ACE2 protein expression human airway epithelium relationship SARSCoV2 infection,34289058,SARSCoV2 initiate entry airway epithelium binding receptor ACE2 explore whether interindividual variation ACE2 abundance contributes variability COVID19 outcome measured ACE2 protein abundance primary airway epithelial culture derived 58 human donor lung found evidence sex agedependent difference ACE2 protein expression found variation ACE2 abundance minimal effect viral replication induction interferon response airway epithelium infected SARSCoV2 result highlight relative importance additional host factor beyond viral receptor expression determining COVID19 lung disease outcome,ace2;covid-19;sars-cov-2;airway epithelia;risk factors;viral receptor abundance
Clinical Efficacy Remdesivir Favipiravir Treatment Covid19 Patients Scenario Far,34365935,novel SARSCoV2 new disease caused severe destruction human life across globe including infection mortality financial crisis scientific researcher directed towards development treatment controlling measure coronavirus Currently approved drug treatment disease several antiviral drug shown therapeutic effect remdesivir favipiravir two drug drug shown therapeutic potential treatment COVID19 inhibiting viral enzyme RNAdependent RNA polymerase purpose systematic review provide overview effectiveness two drug based clinical trial reported current published data,covid-19;coronavirus;sars-cov-2;antiviral;favipiravir;remdesivir
Identification pyrogallol warhead design covalent inhibitor SARSCoV2 3CL protease,34131140,ongoing pandemic coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 urgently need effective cure 3CL protease 3CL pro highly conserved cysteine proteinase indispensable coronavirus replication providing attractive target developing broadspectrum antiviral drug describe discovery myricetin flavonoid found many food source nonpeptidomimetic covalent inhibitor SARSCoV2 3CL pro Crystal structure protease bound myricetin derivative unexpectedly revealed pyrogallol group worked electrophile covalently modify catalytic cysteine Kinetic selectivity characterization together theoretical calculation comprehensively illustrated covalent binding mechanism myricetin protease demonstrated pyrogallol serve electrophile warhead Structurebased optimization myricetin led discovery derivative good antiviral activity potential oral administration result provide detailed mechanistic insight covalent mode action pyrogallolcontaining natural product template design nonpeptidomimetic covalent inhibitor 3CL pro highlighting potential pyrogallol alternative warhead design targeted covalent ligand,
100 year Bacillus CalmetteGuerin immunotherapy cattle COVID19,34131332,Bacillus CalmetteGuerin BCG widely used vaccine worldwide used prevent tuberculosis century BCG also stimulates antitumour immune response urologist harnessed treatment nonmuscleinvasive bladder cancer growing body evidence indicates BCG offer protection various nonmycobacterial viral infection nonspecific effect BCG occur via induction trained immunity form basis hypothesis BCG vaccination could used protect severity coronavirus disease 2019 COVID19 Perspective article highlight key milestone 100year history BCG project potential role COVID19 pandemic,
Effects Mediterranean Lifestyle COVID19 Lockdown Spain Preliminary Study,34222306,aim ass beneficial effect Mediterranean stylediet period confinement due COVID19 sample 51 older patient part clinical trial Instituto de Investigacion sanitarium Biomedica de Alicante ISABIAL CEIM Participants randomly assigned two condition experimental vs control group pretest survey assessment conducted confinement posttest survey conducted confinement period Adherence Mediterranean Diet nutritional status evaluated selfreported questionnaire Individuals initiated Mediterranean Diet intervention program confinement increased 35 level adherence Mediterranean Diet maintained nutritional status confinement case BMI statistically significant difference group confinement result suggest adherence Mediterranean Diet may play important role establishment appropriate dietary guideline confinement situation COVID19,covid-19;confinement;mediterranean diet;nutritional status;older
COVSegNET deep convolution neural network COVID19 lung CT image segmentation,34226795,COVID19 new type respiratory infectious disease pose serious threat survival human being world Using artificial intelligence technology analyze lung image COVID19 patient achieve rapid effective detection study proposes COVSegNET model accurately segment ground glass opaque lesion COVID19 lung CT image COVSegNET model based fully convolutional neural network model structure mainly includes convolutional layer nonlinear unit activation function maximum pooling layer batch normalization layer merge layer flattening layer sigmoid layer forth experiment evaluation result seen dice coefficient sensitivity specificity COVSegNET model 0561 0447 0996 respectively advanced deep learning method COVSegNET model use smaller training set shorter test time obtain better segmentation result,covid-19;convolution neural network;image segmentation;lung ct image
Continued nucleic acid test SARSCoV2 following discharge patient COVID19 Luan China,34221722,Background Studies shown discharged Coronavirus disease 2019 COVID19 patient retested positive SARSCoV2 followup RTPCR test sought ass result continued nucleic acid testing SARSCoV2 patient COVID19 patient discharged Luan China Methods conducted RTPCR test sputum throat swab fecal anal swab urine sample collected 67 COVID19 patient following discharge Samples collected 7th 14th day following discharge Patients testing positive 7th 14th day retested 24 hour tested negative twice Results Seventeen 1767 254 discharged COVID19 patient positive RTPCR retest SARSCoV2 Among 14 824 sputum positive five 294 throat swab positive seven 412 fecal anal swab positive one 59 urine sample positive five 294 sputum throat swab positive four 235 sputum fecal test positive one 59 positive four specimen shortest period time discharge last positive test 7 day longest 48 day median 16 day proportion positive fecal anal swab test increased third week median Cq cutoff value onset 267 first week 377 second sixth week 40 sixth week significant difference RTPCR retest positive group unrecovered positive group Conclusions high proportion patient retested positive COVID19 Discharge criterion remained fairly consistent encourage region affected COVID19 appropriately amend current criterion,covid-19;discharge criteria;rt-pcr;sars-cov-2
ProInflammatory Chemokines CXCL9 CXCL10 CXCL11 Upregulated Following SARSCoV2 Infection AKTDependent Manner,34205098,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 highly transmissible RNA virus causative agent Coronavirus disease 2019 COVID19 pandemic Patients severe COVID19 may develop acute lung injury ALI acute respiratory distress syndrome ARDS require mechanical ventilation Key feature SARSCoV2 induced pulmonary complication include overexpression proinflammatory chemokines cytokine contribute cytokine storm current study inflammatory state Calu3 human lung epithelial cell characterized significantly elevated transcript immunostimulatory chemokines CXCL9 CXCL10 CXCL11 present Additionally increase gene expression cytokine IL6 TNFalpha IFNgamma observed transcription CXCL9 CXCL10 IL6 IFNgamma also induced lung human transgenic angiotensin converting enzyme 2 ACE2 mouse infected SARSCoV2 elucidate cell signaling pathway responsible chemokine upregulation SARSCoV2 infected cell small molecule inhibitor targeting key signaling kinase used induction CXCL9 CXCL10 CXCL11 gene expression response SARSCoV2 infection markedly reduced treatment AKT inhibitor GSK690693 Samples COVID19 positive individual also displayed marked increase CXCL9 CXCL10 CXCL11 transcript well transcript AKT pathway current study elucidates potential pathway specific target reducing induction chemokines may contributing SARSCoV2 pathogenesis via hyperinflammation,ali;ards;cxcl10;calu-3;sars-cov-2;betacoronavirus;cytokine storm;hace2 mice
Mechanistic Aspects Medicinal Plants Secondary Metabolites Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2,34225607,BACKGROUND OBJECTIVE Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 highly pathogenic virus responsible respiratory disease termed coronavirus disease 2019 COVID19 SARSCoV2 genome encodes various structural nonstructural protein necessary viral entry replication Among protein papainlike protease PLpro 3Clike protease 3CLpro RNAdependent RNA polymerase RdRp helicase serine protease spike protein potential target herbal remedy phytocompounds inhibition viral infection replication present confirmed cure COVID19 Various plant component introduced SARSCo2 number review article also published article focusing mechanistic aspect plant derivative SARSCV2 METHOD material review article prepared significant scientific database including Web Science PubMed Science Direct Scopus Google Scholar RESULTS Different medicinal plant phytocompounds interact important structural nonstructural SARSCoV2 protein Natural compound form strong bond active site SARSCoV2 protease make large conformational change phytochemical potential inhibitor structural nonstructural SARSCoV2 protein Spike protein PLpro 3CLpro important antiSARSCoV2 action medicinal plant metabolite inhibition virus replication entry blocking angiotensinconverting enzyme 2 ACE2 receptor `` Transmembrane protease serine 2 TMPRSS2 regulation inflammatory mediator inhibition endothelial activation tolllike receptor TLRs activation nuclear factor erythroidderived 2related factor 2 Nrf2 important natural immune booster helpful prevention curing various symptom related COVID19 include Allium sativum Nigella sativa Glycyrrhiza glabra Zingiber officinalis Ocimum sanctum Withania somnifera Tinospora cordifolia Scutellaria baicalensis Also Kaempferol Quercetin Baicalin Scutellarin Glycyrrhizin Curcumin Apigenin Ursolic acid Chloroquine best candidate treating symptom associated SARSCoV2 infection CONCLUSION Medicinal plant andor bioactive compound inhibitory effect SARSCoV2 support human immune system help fighting COVID19 rejuvenating immune system,biological compounds;covid-19;medicinal plants;novel coronavirus;phytochemicals;sars-cov-2;secondary metabolites;severe acute respiratory syndrome-2
COVID19 vaccine safety efficacy patient ImmuneMediated Inflammatory Disease Review available evidence,34363909,Dermatologists diagnose treat many immunemediated inflammatory disease IMID Understanding inherent immune dysregulation disease well additional disruption come result IMID treatment important COVID19 pandemic vaccine becoming widely available dermatologist need familiar risk benefit vaccination patient particularly taking biologics order informed discussion patient review present current evidence related COVID19 vaccine safety efficacy patient IMID review existing recommendation vaccination SARSCoV2 Given current evidence minimal concern patient greater risk harm COVID19 vaccination compared healthy control benefit avoiding severe COVID19 vaccination outweigh theoretical risk vaccine outstanding question whether patient biologics generate sufficient immune response vaccine may dependent specific biologic therapy indication treated underscore importance following patient IMID vaccination determine vaccine safety efficacy duration population,covid-19;imid;mctd;sars-cov-2;sle;atopic dermatitis;autoimmune disease;autoimmunity;biologics;dermatomyositis;hidradenitis suppurativa;myositis;pemphigoid;pemphigus;psoriasis;sarcoid;sclerosis;vaccines;vasculitis
Physical Activity May Mitigate COVID19 Infections People Obesity Call Action,34355868,start COVID19 pandemic US 425 adult 185 child obesity 12 le 50 population met physical activity recommendation 3 Emerging evidence indicates physical activity declined pandemic likely due part school closure restricted access common indoor outdoor place people active Public health intervention urgently needed promote active lifestyle engagement physical activity mitigate physical mental adverse impact COVID19 4 association obesity increased risk COVID19 infection hospitalization intensive care unit admission death unequivocal 56 Furthermore obesity increase risk intubation death patient le 65 year old infected COVID19 independent diabetes hypertension,bmi;covid-19;exercise;immunity;pandemic
Respiratory Distress Hospitalized NonMechanically Ventilated COVID19 Adults Retrospective Multicenter Cohort Study,34344174,BACKGROUND COVID19 typically present respiratory symptom may progress severe disease standard guideline managing respiratory distress eg opioids anxiolytic palliative care team well versed managing symptom AIM Determine extent hospitalized COVID19 patient moderate respiratory distress received medication palliative consultation symptom management intervention association outcome DESIGN Retrospective chart review hospitalized COVID19+ patient March 2April 30 2020 SETTING Large integrated health system New York Metropolitan area PATIENTS 312 adult patient hospitalized COVID19 order nonrebreather mask meeting criterion moderate respiratory distress Respiratory Distress Observation Scale concurrent respiratory rate =30 heart rate =110 point hospitalization Patients receiving mechanical ventilation intensive care excluded RESULTS COVID19 patient experiencing moderate respiratory distress receive medication palliative consultation symptom management Patients received medication predominantly white older DoNotResuscitate order Patients received palliative consultation likely older female white DoNotResuscitate order Mortality similar receiving medication CONCLUSION Medications palliative expertise symptom management underused patient moderate respiratory distress due COVID19 Education trigger may help provider identify moderate respiratory distress consider symptomatic treatment palliative consultation appropriate,covid-19;coronavirus;dyspnea;palliative care;symptom management
Eight month followup study pulmonary function lung radiographic related physiological characteristic COVID19 survivor,34226597,describe longterm health outcome patient COVID19 investigate potential risk factor Clinical data hospitalization mean SD day 249 15 day discharge 40 survivor confirmed COVID19 including 25 severe case collected analyzed retrospectively followup severe case higher incidence persistent symptom DLCO impairment higher abnormal CT score compared mild case CT score followup positively correlated age LDH level cumulative day oxygen treatment total dosage glucocorticoid used CT peak score hospitalization DLCO followup negatively correlated cumulative day oxygen treatment hospitalization DLCOVA followup positively correlated BMI TNFalpha level Among three group categorized survivor normal DLCO abnormal DLCO normal DLCOVA abnormal DLCO DLCOVA survivor abnormal DLCO DLCOVA lowest serum IL2R IL8 TNFalpha level survivor abnormal DLCO normal DLCOVA highest level inflammatory cytokine hospitalization Altogether COVID19 greater longterm impact lung physiology severe case longterm radiological abnormality maybe relate old age severity COVID19 Either absent excess inflammation COVID19 course would lead impairment pulmonary diffusion function,
Successful Clearance 300 Day SARSCoV2 Infection Subject BCell Depletion Associated Prolonged BDEAP COVID REGENCOV AntiSpike Monoclonal Antibody Cocktail,34201591,59yearold male follicular lymphoma treated antiCD20mediated Bcell depletion ablative chemotherapy hospitalized COVID19 infection Although patient develop specific humoral immunity mild clinical course overall failure therapeutic option allowed infection persist nearly 300 day active accumulation SARSCoV2 virus mutation rescue therapy infusion REGENCOV 10933 10987 antispike monoclonal antibody performed 270 day initial diagnosis Due partial clearance first dose 24 g consolidation dose 8 g infused six week later Complete virus clearance could observed following month vaccinated PfizerBioNTech antiCOVID19 vaccination successful management patient required prolonged enhanced quarantine monitoring virus mutation pioneering clinical decision based upon close consultation coordination multidisciplinary expert virology immunology pharmacology input REGN FDA IRB health care team patient patient s family Current decision take revolve around patient s follicular lymphoma management monitoring virus clearance persistence beyond disappearance REGENCOV monoclonal antibody antiSARSCoV2 vaccination Overall specific guideline similar case established,b-deap covid-19;b-cell depletion associated prolonged covid-19;covid-19;regen-cov;regn10933 and regn10987;sars-cov-2 persistence;anti-cd20-mediated b-cell depletion;anti-covid-19 vaccine;obinutuzumab;spike mutation;virus mutations
Combination therapy onasemnogene risdiplam spinal muscular atrophy type 1,34287987,INTRODUCTIONAIMS currently three medication approved spinal muscular atrophy SMA use medication combination well described METHODS retrospective report four case SMA treated dual onasemnogene risdiplam therapy institution RESULTS Following onasemnogene therapy four patient experienced perceived plateau therapeutic benefit time daily risdiplam started Transient fatigue weakness seen two patient following risdiplam initiation resolved within 1 mo One patient hospitalized severe acute respiratory syndrome coronavirus2 SARSCoV2 postviral pneumonia week following risdiplam initiation adverse effect related onasemnogene risdiplam combination therapy identified patient experienced objective subjective improvement DISCUSSION Combination therapy onasemnogene risdiplam patient SMA appears welltolerated large prospective trial needed determine whether dual therapy efficacious monotherapy identify rare adverse event may occur use combination therapy,sma;adverse events;gene therapy;onasemnogene;risdiplam
Wildlife rehabilitation center potential source transmission SARSCoV2 native wildlife Latin America,34219749,COVID19 pandemic impacted entire world causing great number mortality human affecting economy conservation effort finally recognized prevent pandemic wildlife rehabilitation center WRCs play relevant role animal welfare nevertheless also represent imminent risk pathogen transmission humanstoanimals animal Moreover WRCs could spread pathogen natural habitat reintroduction infectious individual biosafety concern WRCs may increase economic social impact COVID19 extends explored current situation Latin American WRCs COVID19 pandemic determine feasibility SARSCoV2 introduction amplification spread within institution surveyed WRCs eight Latin American country found pandemic affecting institution many aspect worker symptom compatible COVID19 reduced economic resource lack information support governmental authority forced WRCs reduce workforce veterinary visit animal food ration increase number animal released scenario generates risky environment transmission SARSCoV2 especially felid mustelid nonhuman primate Therefore imperative respect quarantine period monitor incoming patient increase biosecurity measure develop apply guideline recommendation protection personnel biosafety enclosure instrument utmost importance proper safer reintroduction recovered wildlife,covid-19;latin america;sars-cov-2;conservation;health risks;wildlife rehabilitation centers
Frequency phenotype headache covid19 study 2194 patient,34282206,estimate frequency headache patient confirmed COVID19 characterize phenotype headache attributed COVID19 comparing patient depending need hospitalization sex observational study done systematically screened eligible patient reference population 261431 March 8 first case April 11 2020 physician administered survey assessing demographic clinical data phenotype headache study period 2194 patient population risk diagnosed COVID19 Headache described 5142194 patient 234 95 CI 217253 including 3831614 237 outpatient 131580 226 inpatient headache phenotype studied detail 458 patient mean age 51 year 72 female prior history headache 49 Headache frequent first symptom COVID19 Median headache onset within 24 h median duration 7 day persisted 1 month 13 patient Pain bilateral 80 predominantly frontal 71 pressing quality 75 severe intensity Systemic symptom present 98 patient Headache frequency phenotype similar patient without need hospitalization comparing male female patient intense femalesTrial registration study supported Institute Health Carlos III ISCIII code 070446780474011 Regional Health Administration Gerencia Regional de Salud Castilla Leon GRS 2289A2020,
Universal health coverage tuberculosis care India time Covid19 Aligning Ayushman Bharat National Health Assurance Scheme improve case detection reduce death catastrophic health expenditure,34213460,India largest global burden new case tuberculosis TB death due TB occur predominantly poor suffer catastrophic cost diagnosis treatment National Tuberculosis Elimination Programme ambitious goal 80 reduction incidence TB 90 reduction mortality due TB 2025 0 occurrence catastrophic cost household affected TB 2020 Covid19 pandemic resulting disruption TB service expected worsen situation gap case finding peripheral level access care higher level patient TB estimated 32 patient active TB access diagnostic service catastrophic cost associated hospitalization barrier access seriously ill patient Deaths due TB India occur largely home medical facility preventable appropriate inpatient care Ayushman Bharat scheme Health Wellness Centres HWCs coverage inpatient care Pradhan Mantri Jan Arogya Yojana PMJAY facilitate achievement goal TB elimination HWCs provide opportunity close casefinding gap first point contact enabling sputum transport service designated microscopy centre facilitate case detection reduce diagnostic delay decrease community transmission incidence TB benefit package PMJAY cover patient pulmonary TB inpatient evaluation form TB enhance allocation treatment cover management comorbid condition severe undernutrition anaemia HIV diabetes,
Health sociodemographic implication Covid19 second pandemic wave Israel compared first wave,34215274,BACKGROUND Israel s containment first wave Covid19 relatively successful Soon afterwards however summer month harsher pandemic wave developed resulting many seriously ill dead Israelis Israel world s first country impose second general lockdown present study outline early month Israel s second pandemic wave imposition second general lockdown impact various community investigation conducted conjunction five sociodemographic variable population density socioeconomic status rate elderly population minority status Jewish Arab identity religiosity UltraOrthodox vs Jewish community METHODS analysis based cross sectional study morbidity rate investigated residential community basis Following descriptive statistic move present multivariate analysis explore association five aforementioned sociodemographic variable Covid19 morbidity Israel early second pandemic wave vs first Covid19 outbreak RESULTS descriptive statistic regression show morbidity rate significantly positively associated community population density significantly negatively associated socioeconomic status SES size elderly population result differ Wave morbidity significantly associated SES Another difference visavis Wave rise morbidity Arab community led disappearance previously observed significant negative association morbidity minority Arab status Exceptional morbidity found UltraOrthodox Jewish community CONCLUSION second wave Covid19 Israel profoundly affected marginalized community characterized high residential density low SES minority status marginalized disempowered community also badly hit acknowledging potential contribution various possible cause highlight policy response Israel s government early week second Covid19 outbreak suggesting severe second wave might possibly associated belated undecided government response period,arab;covid-19;elderly population;israel;jewish;minority;morbidity rate;population density;socioeconomic status;vulnerable populations
Pharmacist intervention prescribing error Use standardized approach inpatient setting,34283219,DISCLAIMER effort expedite publication article related COVID19 pandemic AJHP posting manuscript online soon possible acceptance Accepted manuscript peerreviewed copyedited posted online technical formatting author proofing manuscript final version record replaced final article formatted per AJHP style proofed author later time PURPOSE objective study implement standardized process across health system determine prevalence clinical relevance prescribing error intercepted pharmacist METHODS prospective multicenter observational study conducted across 11 hospital Pharmacistintercepted prescribing error collected inpatient order verification 6 consecutive week utilizing standardized documentation process potential harm error evaluated using modified National Coordinating Council Medication Error Reporting Prevention NCCMERP index physician validation error stratified potentially low serious lifethreatening harm Endpoints included median error rate per 1000 patient day error type potential harm correlating cost avoidance RESULTS Pharmacists intervened 7187 error resulting mean error rate 39 error per 1000 patient day Among error 466 n = 3349 determined potentially serious consequence 24 n = 175 could lifethreatening intercepted equates 874000 avoided cost top 3 error type occurring highest frequency `` wrong doseratefrequency n = 2298 320 `` duplicate therapy n = 1431 199 `` wrong timing n = 960 134 `` Wrong doseratefrequency n = 49 28 `` duplicate therapy n = 26 149 `` drugdisease interaction n = 24 137 error occurred highest frequency among error potential lifethreatening harm `` Wrong doseratefrequency n = 1028 307 `` wrong timing n = 573 171 `` duplicate therapy n = 482 144 error occurred highest frequency among error potentially serious harm CONCLUSION Documentation pharmacist intervention prescribing error via standardized process creates platform multicenter analysis prescribing error trend opportunity development systemwide solution reduce potential harm prescribing error,health-system pharmacy;medication safety;prescribing errors
SARSCoV2 seroprevalence healthcare worker Swiss tertiary care centre end first wave crosssectional study,34226231,OBJECTIVE ass SARSCoV2 transmission healthcare worker HCWs using seroprevalence surrogate marker infection tertiary care centre according exposure DESIGN Seroprevalence crosssectional study SETTING Single centre end first COVID19 wave Lausanne Switzerland PARTICIPANTS 1874 4074 responder randomly selected 46 response rate stratified work category among 13 474 139 HCWs MAIN OUTCOME MEASURES Evaluation SARSCoV2 serostatus paired questionnaire SARSCoV2 acquisition risk factor internal external workplace RESULTS overall SARSCoV2 seroprevalence rate among HCWs 100 95 CI 87 115 HCWs daily patient contact experience increased rate seropositivity relative without 103 v 96 respectively p=064 HCWs direct contact patient COVID19 working COVID19 unit experience increased seropositivity rate relative counterpart 104 v 98 p=069 106 v 99 p=069 respectively However specific location contact patient irrespective COVID19 statusin patient room reception areasdid correlate increased rate seropositivity 119 v 75 p=0019 143 v 92 p=0025 respectively contrast HCWs suspected proven SARSCoV2infected household contact significantly higher seropositivity rate without contact 190 v 87 p 0001 421 v 94 p 0001 respectively Finally consistent use mask public transportation correlated decreased seroprevalence 53 mask user v 112 intermittent mask use p=0030 CONCLUSIONS overall seroprevalence 10 without significant difference seroprevalence HCWs exposed patient COVID19 HCWs exposed suggests fully place protective measure limited SARSCoV2 occupational acquisition within hospital environment SARSCoV2 seroconversion among HCWs associated primarily community risk factor particularly household transmission,covid-19;epidemiology;infection control;occupational & industrial medicine;preventive medicine;virology
Compassionate mesenchymal stem cell treatment severe COVID19 patient case report,34212566,COVID19 presentation range coldlike symptom severe symptom development acute respiratory distress syndrome ARDS report severe COVID19 patient mechanically ventilated developed ARDS bacterial infection rapid clinical deterioration exhaustion treatment option family attending physician requested compassionate use adult allogeneic bone marrowderived mesenchymal stem cell MSC addition commonly used immunosuppressive antiviral supportive therapy clinical course discussed thoroughly special emphasis safety effect MSC therapy Compassionate MSC treatment given three round affected ARDS regression patient discharged intensive care unit 31 day hospital 49 day good general condition MSC treatment associated side effect well tolerated threeweek period therefore studied larger trial considered compassionate use,
Assessment Referrals Hospitalizations Hospital Transformed COVID19 Facility Poland `` Spring Wave Epidemic 2020A CrossSectional Study,34281079,study aimed evaluate hospitalization COVIDdedicated facility `` spring wave epidemic 2020 Poland analyze change access hospital treatment country early phase pandemic investigated referral admission Ministry Interior Administration hospital Bialystok 14 April 14 August 2020 total 238 patient referred hospital median age 645 year IQR 4478 commonly fever n = 151 635 135 567 admitted 55 number hospitalized period 2019 SARSCoV2 confirmed 42 177 case Older people concomitant disease disability dominated Seventeen patient 126 required ICU treatment 19 14 died Based National Health Fund data also examined change rate hospitalization Poland selected Polish COVID nonCOVID hospital February August 2019 2020 number hospitalization Poland decreased dramatically comparison 2019 low hospitalization rate significantly lower structurally similar nonCOVID hospital observed transformed hospital Better use hospital resource observed hospital semitransformed flexibility adapt epidemiological need study seems confirm system transformed COVID hospital resulted unused healthcare resource limited patient access medical service early period epidemic consequence systemic modification allowing maximization adequate use Polish healthcare system s limited resource implemented,covid-19 hospital;covid-19 patients characteristics;covid-19 treatment;healthcare system
Fundamental evolution Orthocoronavirinae including three deadly lineage descendent Chiropterahosted coronaviruses SARSCoV MERSCoV SARSCoV2,34219906,severe acute respiratory syndrome coronavirus SARSCoV emerged human 2002 Despite report showing Chiroptera original animal reservoir SARSCoV many argue Carnivorahosted virus likely origin emergence Middle East respiratory syndrome coronavirus MERSCoV 2012 also involves Chiropterahosted lineage However factor lack comprehensive phylogeny hamper understanding host shift MERSCoV emerged human Artiodactyla Since 2019 origin SARSCoV2 causative agent coronavirus disease 2019 COVID19 added episodic history zoonotic transmission event introduce phylogenetic analysis 2006 unique complete genome different lineage Orthocoronavirinae used gene annotation align orthologous sequence total evidence analysis parsimony optimality criterion Deltacoronavirus Gammacoronavirus set outgroups understand spillover Alphacoronavirus Betacoronavirus among ten order animal corroborated Chiropterahosted virus sister group SARSCoV SARSCoV2 MERSrelated virus zoonotic event qualified quantified provide comprehensive picture risk coronavirus emergence among human Finally used 250 SARSCoV2 genome dataset elucidate phylogenetic relationship SARSCoV2 Chiropterahosted coronaviruses,
increase cellular oxygen availability COVID19,34351690,,
Hyperacute reversible encephalopathy related cytokine storm following COVID19 vaccine,34284342,describe first case hyperacute reversible encephalopathy following COVID19 vaccination patient presented acute onset encephalopathy mainly characterized agitation confusion rapidly responsive high dosage steroid therapy complete remission within 3 day onset clinical manifestation related systemic CSF cytokine hyperproduction responsive steroid therapy Although occurrence encephalopathy vaccination may casual temporal association speculate cytokinestorm could result excessive innate immune response vaccine predisposed patient susceptible autoimmunity,covid-19;cytokines;encephalopathy;neuroinflammation;vaccination
Fitness strength severity COVID19 prospective register study 1 559 187 Swedish conscript,34226237,OBJECTIVE investigate possible connection cardiorespiratory fitness CRF muscle strength early adulthood severity COVID19 later life DESIGN Prospective registrybased cohort study PARTICIPANTS 1 559 187 Swedish men undergoing military conscription 1968 2005 mean age 183 SD 073 year MAIN OUTCOME MEASURES Hospitalisation intensive care death due COVID19 March September 2020 relation CRF muscle strength RESULTS High CRF late adolescence early adulthood protective association severe COVID19 later life 95 CI 076 067 085 hospitalisation n=2 006 061 048 078 intensive care n=445 056 037 085 mortality n=149 compared lowest category CRF association remains unchanged controlled body mass index BMI blood pressure chronic disease parental education level baseline incident cardiovascular disease 2020 Moreover lower muscle strength late adolescence showed linear association higher risk three outcome controlled BMI height CONCLUSIONS Physical fitness young age associated severity COVID19 many year later underscore necessity increase general physical fitness population offer protection future viral pandemic,covid-19;epidemiology;public health
Deferoxamine B Natural Excellent Versatile Metal Chelator,34071479,Deferoxamine B outstanding molecule widely studied past decade ability bind iron many metal ion versatility metal chelator make suitable number medicinal analytical application wellknown iron chelation therapy recent use sensor device three bidentate hydroxamic functional group deferoxamine B centerpiece metal binding ability allows formation stable complex many transition lanthanoid actinoid metal ion addition ferric ion fact 20 different metal complex deferoxamine b characterized term chemical speciation solution addition availability terminal amino group often involved complexation open way deferoxamine B modification functionalization review aim collect summarize available data concerning complexformation equilibrium solution deferoxamine B different metal ion general overview progress application past decade also discussed including treatment iron overloadassociated disease clinical use cancer neurodegenerative disorder role diagnostic tool,chelation therapy;deferoxamine b (dfob);metal complexes;solution equilibria
Lessons Learned Naturalistic Study Online Treatment Pediatric Rehabilitation,34205724,COVID19 pandemic forced many health care provider modify service model adopting telehealth telerehabilitation minimal time plan execution ALYNPediatric Rehabilitation Hospital Jerusalem Israel responded alacrity providing broad range rehabilitation service young people via online therapy first 5 month pandemic objective naturalistic study 1 monitor usage user experience online rehabilitation provided young people receiving outpatient session physical therapy occupational therapy speech language therapy psychology 2 consider advantage disadvantage retaining model online treatment full part postCOVID19 online rehabilitation treatment program provided 147 young people aged 3 month 20 year mean 85 SD 53 monitored evaluated via data medical record well interview questionnaire focus group result use descriptive inferential statistic analyze data type frequency therapy provided 147 young people five monthperiod 2392 therapy session provided 61 therapist four discipline involved 564 young people received two type therapy via online rehabilitation repeated measure ANOVA showed significant difference time per therapy Feedback recommendation process therapist parent young people collected two focus group professional staff n = 12 parent young people parent n = 5 young people n = 3 Telerehabilitation service perceived beneficial effective great majority young people parent healthcare professional result discussed within context conventional therapy well comparison report online service similar population conclude hybrid approach inperson therapy session coordinated synchronous online session provide bestcase fit young people chronic disability,covid-19;focus group;online therapy;pediatric rehabilitation;remote therapy;tele-rehabilitation;telehealth
Potential predictor outcome among hospitalized COVID19 patient treated convalescent plasma singlecenter study,34211649,Background coronavirus disease 2019 pandemic major international public health crisis led 3 million death April 2021 Several therapeutic tried deadly illness including antiviral immunosuppressive agent convalescent plasma CP study present innercity safety net hospital experience CP therapy Methods retrospective chart review hospitalized patient confirmed COVID19 treated CP Results total 60 patient received CP study period mean age patient study 5895 year common presenting symptom shortness breath 85 cough 73 Hypertension 65 diabetes mellitus 55 common comorbidities patient multivariate regression analysis male sex nausea loss appetite presentation associated improvement oxygenation CP Total survival time history obstructive airway disease home use angiotensinconverting enzyme inhibitor angiotensinreceptor blocker associated decreased survival whereas Hispanic ethnicity showed trend towards lower survival CP therapy Conclusions study highlight several important characteristic innercity safety net hospital patient population might benefit CP therapy,covid-19;convalescent plasma;ethnicity
COVID19 personal protective equipment protocol compliance audit,34226166,BACKGROUND Personal protective equipment PPE compliance important reduce rate transmission virulent pathogen health care worker Medical officer compliance PPE protocol COVID19 audited regional hospital Australia early pandemic response METHODS Compliance assessed based order technique donning doffing PPE medical officer multiple department level seniority audited RESULTS Average compliance participant 5861 donning 6884 doffing CONCLUSION Medical Officer compliance PPE donning doffing poor additional training required,covid-19;hospital;medical officer;pandemic;personal protective equipment
Assessing spatial distribution COVID19 prevalence Brazil using decentralised sewage monitoring,34229195,Brazil become one epicentre COVID19 pandemic case heavily concentrated large city Testing data extremely limited unreliable restricts health authority ability deal pandemic Given stark demographic social economic heterogeneity within Brazilian city important identify hotspot limited resource available greatest impact study show decentralised monitoring SARSCoV2 RNA sewage used ass distribution COVID19 prevalence city methodology developed study allowed identification hotspot comprehensively monitoring sewer distributed Belo Horizonte Brazil s third largest city result show vulnerable neighbourhood city hardest hit pandemic indicating many Brazilians situation much worse reported official figure,covid-19;decentralised sewage monitoring;health vulnerability;hotspots;wastewater-based epidemiology;prevalence
COVID19 Vaccination Patients Classic Kaposi s Sarcoma,34200648,novel coronavirus disease 2019 COVID19 represented overwhelming challenge worldwide health system Patients cancer considered higher risk severe COVID19 increased mortality case infection Although data novel severe acute respiratory syndrome coronavirus 2 SARSCoV2 vaccination patient cancer limited enough evidence supporting antiinfective vaccination general patient active cancer history previous malignancy Subjects classic Kaposi s sarcoma KS represent small subset cancer patient considered heightened risk infection due several factor including age impaired immune function status Several case human herpesviruses reactivation among critically ill COVID19 patient described Moreover case severe infection treatment immunomodulating agent patient CKS exposed significant risk viral reactivation disease progression Considering baseline clinical risk factor patient CKS complex interplay two viral agent SARSCoV2 vaccination strongly recommended among patient KS KS represents interesting field study interaction among chronic viral infection SARSCoV2 host s immune system Prospective observational study needed provide insight vaccine activity safety among patient cancer optimal vaccine schedule potential interaction antineoplastic therapy comorbidities including chronic viral infection,covid-19;hhv-8 dna;kaposi's sarcoma;sars-cov-2;cancer;vaccination
Clinical Presentation Cases SARSCoV2 Reinfection Reactivation,34227769,Background Reinfectionreactivation SARSCoV2 matter great interest immunological vaccine perspective However little known clinical presentation reinfectionreactivation report case series 9 COVID19 patient experienced two clinically andor virologicallyconfirmed episode COVID19 Methods Epidemiological clinical characteristic 9 healthcare worker HCWs two episode SARSCoV2 described Results incidence reinfectionreactivation amongst HCWs 2 9 491 average remission period 66 day range 4378 day Amongst case reinfection 49 asymptomatic first episode symptomatic second episode negative correlation number day patient took become SARSCoV2 negative RTCPR andor clinically recover first episode second episode irrespective time spent remission Conclusion Shorter duration SARSCOV2 infection first episode associated longer time recovery second episode patient reinfectionreactivation,
Impact Mass Workplace COVID19 Rapid Testing Health Healthcare Resource Savings,34281065,Background epidemiological situation generated COVID19 cast sharp relief delicate balance public health priority economy business obliged toe line employee health continued production effort detect many case possible isolate contact cut transmission chain limit spread virus workplace mass testing strategy implemented public health industrial context minimize risk disruption activity Objective evaluate economic impact mass workplace testing strategy carried large automotive company Catalonia term health healthcare resource saving Methodology Analysis health cost impact based estimation mortality morbidity avoided screening resulting saving healthcare cost Results economic impact mass workplace testing strategy using PCR RAT test approximately euro1044 per test performed euro557549 per positive detected 38 figure corresponds saving derived better use health resource hospital bed ICU bed followup infected case remaining 62 corresponds improved health rate due avoided morbidity mortality scenario higher positivity rate greater impact infection health use health resource result could ten time higher euro13024 per test performed euro6956559 per positive detected Conclusion context COVID19 preventive action carried private sector safeguard industrial production also concomitant public benefit form saving healthcare cost Thus governmental body need recognize value implementing strategy private setting facilitate example subsidy,covid-19;sars-cov-2;asymptomatic screening;economic analysis;employee population health;mass testing;return to work practices;surveillance;workplace mitigation;workplace testing
HERC5 ISGylation Pathway Critical Modulators Antiviral Immune Response,34207696,Mammalian cell developed elaborate network immunoproteins serve identify combat viral pathogen Interferonstimulated gene 15 ISG15 152 kDa tandem ubiquitinlike protein UBL used specific E1E2E3 ubiquitin cascade enzyme interfere activity viral protein Recent biochemical study demonstrated E3 ligase HECT RCC1containing protein 5 HERC5 regulates ISG15 signaling response hepatitis C HCV influenzaA IAV human immunodeficiency virus HIV SARSCoV2 viral infection Taken together potent antiviral activity displayed HERC5 ISG15 make promising drug target development novel antiviral therapeutic augment host antiviral response review examine emerging role ISG15 antiviral immunity particular focus HERC5 orchestrates specific timely ISGylation viral protein response infection,hect e3 ubiquitin ligase;herc5;isg15;isgylation;antiviral immune response;interferon
Collaborative Structured Network Maintenance Mechanical Ventilators SARSCoV2 Pandemic,34207413,SARSCoV2 pandemic Brazil grown rapidly since first case reported 26 February 2020 pandemic spread low availability medical equipment increased especially mechanical ventilator Brazilian Unified Health System SUS claimed 40508 mechanical ventilator would insufficient support Brazilian population pandemic peak lack ventilator especially public hospital required quick assertive effective action minimize health crisis work provides overview rapid deployment network maintaining disused mechanical ventilator public private healthcare unit region Brazil SARSCoV2 pandemic Data referring process maintaining equipment acquiring part conducting national international training collected analyzed total 4047 ventilator received maintenance site 2516 ventilator successfully repaired returned healthcare unit represents success rate 6217 result show maintenance initiative directly impacted availability reliability equipment allowing access ventilator public private health system increasing capacity bed pandemic,sars-cov-2;collaborative network;maintenance;mechanical pulmonary ventilators;pandemic
Healthcare Professionals Role Social Media Public Health Campaigns Analysis Spanish Pro Vaccination Campaign Twitter,34199495,COVID19 pandemic generated great impact worldwide population health also economic social level health emergency key element still need information become daily concern many people Social medium represent powerful tool searching gathering healthrelated information thus becoming new place health authority need present disseminate information preventive measure like vaccine COVID19 well try block information public health measure main goal study analyze role healthcare professional Twitter support campaign public institution vaccination COVID19 address study analysis message sent Twitter containing hashtag yomevacuno 12 December 2020 developed using NodeXL software Social Media Research Foundation Redwood CA USA focusing content analysis tweet user account identify healthcare professional result show healthcare professional represent 1138 user responsible 635 impression generated network yomevacuno observe traffic information generated healthcare professional significant comparison institution p = 0633 compared common user p = 00014 active healthcare professional pharmacist 4017 nurse 2717 physician 1214 activity 9043 message mainly focused sharing message generated user account original content generated healthcare professional 7895 favorable storytelling vaccine without sharing information vaccine vaccination conclusion study participation healthcare professional dissemination generation information within yomevacuno communication strategy led Spanish Ministry Health scarce emphasize need enhance communication skill social network support public health campaign increasingly important social medium,covid-19;healthcare professionals;public health;social media;vaccines
Relevance PlantDerived Se Compounds Human Health SARSCoV2 COVID19 Pandemic Era,34202330,Dietary selenium Se compounds accumulated plant essential human metabolism normal physiological process Inorganic organic Se specie readily absorbed human body metabolized differently thus exhibit distinct mechanism action act antioxidant serve source Se synthesis selenoproteins Selenocysteine particular incorporated catalytic center protein specific insertion mechanism due electronic feature enhances catalytic activity biological oxidant Selenite Seorganic compound may also act direct antioxidant cell due strong nucleophilic property addition Seamino acid easily subjected oxidation corresponding thiolsthioethers bind redoxactive metal ion Adequate Se intake aid preventing several metabolic disorder affords protection viral infection present epidemic caused novel coronavirus SARSCoV2 threatens human health across several country impact global economy Therefore Sesupplementation could complementary treatment vaccine pharmacological drug reduce viral load mutation frequency enhance immune system population low Se intake diet,covid-19;organic se;plant-selenium compounds;selenite;selenoproteins
Case report late dual coronary stent thrombosis patient coronavirus disease 2019,34222777,Background Coronavirus disease 2019 COVID19 associated hypercoagulability high rate thrombosis case coronary stent thrombosis associated COVID19 reported Case summary report describe case 65yearold man history coronary artery disease CAD admitted following outofhospital cardiac arrest related STsegment elevation myocardial infarction revealing late dual coronary stent thrombosis left anterior descending posterior descending artery Ten day prior admission diagnosed COVID19 pneumonia treated dexamethasone led rapid clinical improvement resuscitation coronary angiography revealed acute thrombotic occlusion two previous drugeluting stent implanted 2010 2018 high thrombus burden successfully treated percutaneous coronary intervention patient present complication hospital stay transferred cardiac rehabilitation centre Discussion Dual stent thrombosis exceptional event highlighting high procoagulant state promoted coronavirus 19 case suggests strengthening antithrombotic therapy CAD patient presenting COVID19 discussed,covid-19;case report;st-segment elevation myocardial infarction;stent thrombosis
Imaging Cardiovascular Inflammation COVID19 Era,34207266,Cardiac complication among frequent extrapulmonary manifestation COVID19 associated high mortality rate Moreover positive SARSCoV2 patient underlying cardiovascular disease likely require intensive care higher risk death underlying mechanism myocardial injury multifaceted severe inflammatory response cause myocardial inflammation coronary plaque destabilization acute thrombotic event ischemia Cardiac magnetic resonance CMR imaging noninvasive method choice identifying myocardial injury able differentiate underlying cause various often challenging clinical scenario Multimodal imaging protocol incorporate CMR computed tomography provide complex evaluation respiratory cardiovascular complication SARSCoV2 infection relation biological evaluation systemic inflammation guide appropriate therapeutic management every stage disease use artificial intelligence improve diagnostic accuracy imaging technique thus enabling risk stratification evaluation prognosis present manuscript aim review current knowledge possible modality imaging COVIDrelated myocardial inflammation postCOVID coronary inflammation atherosclerosis,covid-19;artificial intelligence;cardiac magnetic resonance;inflammation;multimodal imaging;myocardial injury
Determining frequency serious adverse reaction inactive SARSCOV2 vaccine,34219684,BACKGROUND Vaccines new combat strategy COVID19 success large number vaccine continued development vaccine change course current pandemic OBJECTIVE aim study determine frequency serious adverse reaction caused administration inactive vaccine administration healthcare worker COVID19 pandemic METHODS prospective study conducted among healthcare professional working city Training Research Hospital applied second dose CoronaVac vaccine number personnel included study 329 data recorded SPSS 23 program chisquare test used statistical analysis RESULTS average age participant study 3577+907 participant 281 physician frequency ratio stated serious adverse reaction vaccination 332 Three common systemic serious adverse reaction headache state sleepfatigue nausea vomiting respectively Serious adverse reaction occurred within 114+04 day vaccine administration average duration serious adverse reaction determined 168+077 day 622 participant serious side effect woman p 0001 participant serious adverse reaction 775 health care professional p 001 CONCLUSION lifethreatening serious adverse reaction determined regarding CoronaVac vaccine administered study However local serious adverse reaction nauseavomiting fever sleepinessfatigue occurred frequently study required newly introduced vaccine,covid-19;pandemic;fever;healthcare professionals;hospital;injection site
landscape SARSCoV2 fresh fruit vegetable fake hidden transmission risk,34219847,first notification reporting cluster coronavirus Wuhan City China 114 million case SARSCoV2 confirmed 2530000 death 400000 new case 10000 death daily Numerous virus susceptible contaminate crop growth harvesting handling marketing minimally processing step share one common factor human Different study showed virus might persist different crop period 2 14 day different condition refrigeration household freezing Little known SARSCoV2 preliminary study showed virus might survive 24 hr cardboard 72 hr plastic material used fruit vegetable packaging Based preliminary data evidence food food packaging associated transmission SARSCoV2 Certainly date scientific evidence SARSCoV2 might transmitted contact ingestion contaminated fresh minimally processed fruit vegetable However risk even though considered improbable `` completely definitely discarded ignored particularly virus spreading word agency indicated case commodity handler contaminated among multiple people involved farm table crosscontamination may occur risk contamination food food contact material packaging infected asymptomatic worker discarded even though considered `` Low = meaning rare excluded,
closer look spreader COVID19 Wisconsin US,34198410,study design use mathematical model primarily address question main driver COVID19 symptomatic infectious presymptomatic asymptomatic infectious state Wisconsin entire United States set stage first briefly simulate illustrate benefit lockdown lockdown scenario general dominant influence presymptomatic asymptomatic infectious symptomatic infectious shown various way Numerical simulation US show increase testing isolating presymptomatic asymptomatic infectious group 4 time impact increase testing symptomatic infectious term cumulative death increase testing presymptomatic asymptomatic infectious group also significantly impact order twice much reducing control reproduction number testing symptomatic infectious Lastly use model simulate implementation natural herd immunity strategy entire US state Wisconsin epicenter COVID19 simulation provide specific example confirming strategy requires significant number death immunity achieved strategy certainly questionable term success, covid-19; asymptomatic infectious; natural herd immunity; pre-symptomatic infectious; symptomatic infectious
Case Study Two Post Vaccination SARSCoV2 Infections P1 Variants CoronaVac Vaccinees Brazil,34206727,rapid development efficacious safe vaccine coronavirus disease 2019 COVID19 instrumental mitigating transmission severe acute respiratory syndrome coronavirus 2 SARSCoV2 Moreover emergence SARSCoV2 variant raised concern efficacy vaccine Herein report two case breakthrough infection P1 variant patient vaccinated CoronaVac one two vaccine authorized emergency use Brazilian immunization program observation suggest vaccine reduced severity disease highlight potential risk illness following vaccination subsequent infection P1 variant well continued effort prevent diagnose infection vaccinated person,covid-19;sars-cov-2;vaccine
COVID19 vaccine hesitancy Zambia glimpse possible challenge ahead COVID19 vaccination rollout subSaharan Africa,34227914,unprecedented speed multiple vaccine SARSCoV2 available 1 year COVID19 pandemic first identified push achieve global control new vaccine old challenge present including coldchain storage logistics mass vaccination vaccine hesitancy Understanding much hesitancy toward COVID19 vaccine might occur factor may driving concern improve ability public health worker communicator maximize vaccine uptake nested survey within measlesrubella mass vaccination campaign Zambia November 2020 asked sentiment belief toward COVID19 COVID19 vaccine Among parent bringing child receive measlesrubella vaccine found high acceptability COVID19 vaccination child substantial uncertainty hesitancy receiving vaccine COVID19 vaccination hesitancy correlated belief around COVID19 severity risk well vaccine safety effectiveness,covid-19;zambia;vaccine;vaccine acceptance;vaccine hesitancy;vaccine safety
Association Dementia Clinical Outcome COVID19 Nationwide Cohort Study Propensity Score Matched Control South Korea,34218641,OBJECTIVE Despite high prevalence dementia older adult hospitalized severe acute respiratory syndrome coronavirus 2 infection SARSCoV2 called COVID19 research investigating association preexisting diagnosis dementia prognosis COVID19 scarce aimed investigate treatment outcome patient dementia COVID19 METHODS explored nationwide cohort total 2800 subject older 50 year diagnosed COVID19 January April 2020 Among 223 patient underlying dementia dementia group matched 11 dementia nondementia group pair yielding 223 patient without dementia dementia group using propensity score matching RESULTS Mortality rate COVID19 higher dementia group dementia group 336 vs 202 p=0002 Dementia group higher proportion patient requiring invasive ventilatory support dementia group 341 vs 220 p=0006 Multivariable analysis showed dementia group higher risk mortality dementia group odds ratio=305 p 0001 also found patient dementia group higher risk needing invasive ventilatory support dementia group CONCLUSION result suggest system including strengthen quarantine required patient dementia COVID 19 pandemic,covid-19;dementia;mortality.;sars-cov-2
Longterm SARSCoV2specific immune inflammatory response individual recovering COVID19 without postacute symptom,34358460,describe severe acute respiratory syndrome coronavirus 2 SARSCoV2 specific cell response soluble marker inflammation antibody level neutralization capacity longitudinally 70 individual PCRconfirmed SARSCoV2 infection Participants represent spectrum illness recovery including persistent viral shedding saliva many experiencing postacute sequela SARSCoV2 infection PASC cell response remain stable 9 month Whereas magnitude early CD4 + cell immune response correlate severity initial infection preexisting lung disease independently associated higher longterm SARSCoV2specific CD8 + cell response Among participant PASC 4 month following coronavirus disease 2019 COVID19 symptom onset observe lower frequency CD8 + cell expressing CD107a marker degranulation response Nucleocapsid N peptide pool stimulation rapid decline frequency Nspecific interferongammaproducing CD8 + cell Neutralizing antibody level strongly correlate SARSCoV2specific CD4 + cell response,covid-19;pasc;sars-cov-2;t cell;immunity;long covid;post-acute sequelae of sars-cov-2 infection
Peripheral Artery Disease Abdominal Aortic Aneurysm Forgotten Diseases COVID19 Pandemic Results Observational Study RealWorld Management,34209552,Background Objectives well established patient peripheral artery disease PAD well abdominal aortic aneurysm AAA increased cardiovascular CV mortality Despite higher risk PAD AAA patient often suboptimality treated study assessed CV profile PAD AAA patient quantifying survival benefit targetbased riskfactors modification even light COVID19 pandemic Materials Methods PAD AAA patient admitted reason Vascular Unit January 2019 February 2020 retrospectively analyzed Biochemical CV profile well ongoing medical therapy recorded Benefits CV riskfactors control estimated using SMARTREACH model followup visit year 2020 scheduled Results total 669 patient included 190 showed AAA 479 PAD stage 54 PAD 41 AAA patient lipidlowering drug nonoptimal lowdensity lipoprotein LDL level better control modifiable CV riskfactors based current guideline would offer absolute risk reduction mean 10year CV risk 9 PAD 14 AAA Unfortunately followup visit lost COVID19 limitation Conclusions Lipid profile PAD AAA patient far guidelinebased target medical management suboptimal center COVID19 pandemic impacted strict surveillance required highrisk patient achievement guidelinebased therapeutic target would definitively confer additional significant benefit reducing CV risk patient,covid-19;abdominal aortic aneurysm;cardiovascular risk;lipid profile;peripheral artery disease
manage COVID19 infodemics case study targeted health worker Italy,34132208,INTRODUCTION Istituto Superiore di Sanita ISS asked rapid technical scientific advice State Regions SarsCoV2 pandemic preparedness METHODS ad hoc Working Group Scientific Literature update WG SL set ISS MarchMay 2020 screen preprints peer reviewed paper arXiv medRxiv bioRxiv Pubmed provide real time knowledge empirical evidence addressed healthworkers RESULTS WG SL screened total 4568 preprints 15590 peer reviewed paper delivered daily summary report preprint selection ISS President activity National Scientific Technical Committee framework weekly open access publication COVID Contents peerreviewed paper interest health professional monitored satisfaction questionnaire CONCLUSIONS Promoting heath literacy crosscutting approach powerful heritage Public Health Institutes proven effective non pharmacological intervention,
Successful treatment COVID19 infection convalescent plasma B celldepleted patient may promote cellular immunity,34350584,Treatment convalescent plasma shown safe COVID19 infection although efficacy reported immunocompetent patient varies Nevertheless neutralizing antibody key requisite fight viral infection Patients depleted antibodyproducing B cell treated rituximab antiCD20 haematological malignancy lack fundamental part adaptive immunity Treatment convalescent plasma appears general benefit particularly vulnerable cohort analysed clinical course inflammation marker three Bcell depleted patient suffering COVID19 treated convalescent plasma addition measured serum antibody level well peripheral blood CD38HLADR positive Tcells ex vivo CD137 positive Tcells vitro stimulation SARSCoV2 derived peptide patient observed therapy convalescent plasma effective three patient analysis CD137 positive Tcells stimulation SARSCoV2 peptide showed increase peptidespecific Tcells application convalescent plasma conclusion demonstrate efficacy convalescent plasma therapy three B celldepleted patient present data suggests application convalescent plasma elevates systemic antibody level transiently may also boost specific cell response article protected copyright right reserved,b-cell deficiency;covid-19;convalescent plasma;sars-cov-2;t cell immunity
Mucormycosis inevitable complication Covid19 India,34289382,Mucormycosis black fungus infection le common disease highly fatal infection infecting immunocompromised individual site predilection fungus found lung brain addition sequestration sinusoidal space Presently ongoing COVID 19 pandemic prevalence infection found high Indian population fungus establishes affecting compromised immune system individual thereby making individual susceptible diseasesinfection reason attributed sudden upsurge steroidal therapeutic abuse tocilizumab therapy diabetes mellitusTo avert cytokine storm medical health worker necessitated include steroid drug COVID 19 treatment protocol however inclusion drug patient essentially require steroid immune system debilitated permit invasion fungus According International Diabetes Federation IDF 77 million Indians known diabetic cautioning physician vigilante impending black fungus infection event COVID19 affliction individual causal relationship antihyperglycemic drug weakened immune system opportunity fungus invasion review attempt explain interrelatedness COVID19 infection treatment eventual black fungus infection risk,covid-19;diabetes mellitus;immunity;mucormycosis;steroidal drugs
Knowledge Attitude Practice Toward Corona virus Infection Among Pregnant Women Attending Antenatal Care Public Hospitals Three Wollega Zones Ethiopia,34290526,Background Pregnancy immunesuppressed state make pregnant woman generally susceptible COVID19 infection severe illness Extensive precaution recommended avoid exposure virus Knowledge attitude toward disease play integral role readiness accept public health measure study aimed ass knowledge attitude practice towards COVID19 among pregnant woman attending antenatal clinic three Wollega zone Ethiopia Methods Institutionbased crosssectional study employed among 415 pregnant woman attending antenatal care public hospital three Wollega zone Ethiopia July August 2020 data collected using intervieweradministered structured questionnaire level knowledge assessed using 12 multiple choice question score equal mean considered adequate knowledge Binary logistic regression performed adjusted odds ratio Pvalue =005 95 CI taken statistically significant Results study indicates twothirds 754 95 CI 711793 436 pregnant woman adequate knowledge good practice coronavirus pandemic respectively pregnant woman attended secondary school urban resident likely good knowledge AOR = 299 1750 16 1227 respectively Maternal age = 25 yearsand urban resident two predictor good practice preventive measure AOR = 17 1226 23 1340 respectively Conclusions Recommendations target population demonstrated acceptable knowledge poor practice toward COVID19 Healthcare provider give attention educating pregnant woman point contact legal enforcement implemented improve practice preventive measure Special consideration given rural area lesseducated pregnant woman,ethiopia;attitude;corona virus infection;knowledge;pregnant women
Impact poor disease surveillance system COVID19 response africa Time rethink rebuilt,34368503,Infectious disease outbreak long posed public health threat especially Africa incidence infectious outbreak risen exponentially Although Africa witnessed several outbreak emerging reemerging infectious disease Ebola virus disease epidemicprone disease little attention given towards strengthening health surveillance system However recent COVID19 pandemic uncovered region s already due inefficient ineffective health surveillance system However impact posed COVID19 pandemic health system region catastrophic also stressed importance rethinking focusing lesson learned COVID19 pandemic paper examine Africa s poor disease surveillance system affected response strategy aimed COVID19 containment ensure early disease outbreak identification prompt public health intervention Africa current disease surveillance response mechanism must strengthened,africa;covid-19;disease surveillance;health system
Clinical characteristic inhospital outcome COVID19 patient history heart failure propensity scorematched study,34218753,BACKGROUND Data clinical course outcome COVID19 disease among patient history heart failure HF scarce Therefore aim study ass clinical characteristic prognostic biomarkers inhospital outcome patient history HF hospitalised confirmed COVID19 METHODS total 8321 consecutive patient hospitalised suspected COVID19 disease screened Furthermore 3849 patient laboratoryconfirmed SARSCoV2 infection included study Two hundred forty COVID19 patient history HF 240 without HF paired PSM evaluated RESULTS Mean age 727 + 990 year 646 men Oxygen saturation systolic diastolic blood pressure admission significantly lower heart rate significantly higher patient history HF compared without Patients HF compared without significantly higher leukocyte count Ddimer CRP procalcitonin hsTnI lactate lower albumin lymphocyte Compared patient without HF previous HF longer length stay ICU 622 vs 371 p 0001 increased risk mechanical ventilation 421 vs 154 p 0001 inhospital death 392 vs 154 p 0001 composite outcome 529 vs 171 p 0001 CONCLUSION History HF associated higher risk mechanical ventilation cardiogenic shock mortality longer ICU stay patient hospitalised COVID19 therefore diagnosis HF alone important predicting clinical outcome,covid-19;heart failure;coronavirus;hospitalization;mortality;outcome
Immune thrombocytopenia option new perspective,34224465,Immune thrombocytopenia haematological autoimmune disorder characterized elevated platelet demolition due presence antiplatelet autoantibody derived B cell irregular deficient process platelet production bone marrow review brief presentation old strategy used nowadays yet focused new drug used treatment immune thrombocytopenia mechanism action posology basing last scientific literature observation CoViD19 associated immune thrombocytopenia also put evidence Particular attention dedicated concept ideal treatment represent solution failure normal process production survival platelet also improve quality life patient minimum adverse event Anyway despite enormous advance last year investigation necessary order define scrupulously longterm efficacy new molecule proposed,
Tomographic score RADCovid Score ass clinical severity novel coronavirus infection,34332917,OBJECTIVES severity pulmonary Covid19 infection assessed pattern extent parenchymal involvement observed computed tomography CT important standardize analysis objective practical reproducible system propose method stratifying radiological severity pulmonary disease Radiological Severity Score RADCovid Score Covid19 patient quantifying infiltrate chest CT including assessment accuracy predicting disease severity METHODS retrospective singlecenter study analyzed patient confirmed diagnosis Covid19 infection realtime reversetranscriptase polymerase chain reaction underwent chest CT hospital admission March 6 April 6 2020 CT scan classified positive negative equivocal radiological severity score RADCovid Score assigned Clinical severity also assessed upon hospital admission RESULTS 658 patient included Agreement beyond chance kappa statistic RADCovid Score almost perfect among observer 0833 overall agreement 895 RADCovid Score positively correlated clinical severity death ie higher RADCovid Score greater clinical severity mortality association proved independent age comorbidities Accuracy score 669 CONCLUSIONS RADCovid Score showed good accuracy predicting clinical severity hospital admission mortality patient confirmed Covid19 infection independent predictor severity,chest ct;covid-19;hospitalization;infection;severity
Scalp Leiomyosarcoma Diagnosis Treatment Global Pandemic COVID19,34349859,Leiomyosarcoma aggressive uncommon sarcoma effecting smooth muscle tissue Prompt tissue diagnosis staging workup key preventing distant metastasis Identification rare sarcoma become increasingly difficult decreased ability seek noncoronavirus disease 2019 COVID19 medical care pandemic caused widespread healthcare demand provider reaching full capacity causing care resource shifted pandemic experienced 83yearold male significantly delayed seek medical attention scalp lesion several month due combination fear decreased available appointment Since patient presented delayed scalp leiomyosarcoma required extensive excision flap reconstruction lesion case shed light importance weighing risk benefit associated cancer management pandemic patient healthcare provider healthcare system s response pandemic also played role case well shorter appointment time decreased frequency followup result pandemic catastrophic impact diagnostic pathway cancer case report discus difficulty diagnosing treating rare cancer scalp leiomyosarcoma amidst global pandemic importance telemedicine improving future outcome,covid-19;pandemic;scalp leiomyosarcoma;telemedicine
microRNA Heterogeneity InnateImmune Defense Efficacy SARSCoV2 InfectionA Commentary,34207055,Severe acute respiratory syndrome coronavirus2 SARSCoV2 member genus Betacoronavirus family Coronaviridae posse unusually large singlestranded viral RNA ssvRNA genome 29811 nucleotide nt cause severe acute respiratory distress highly lethal viral pneumonia known COVID19 COVID19 also present multiple ancillary systemic disease often involves cardiovascular inflammatory andor neurological complication Pathological viral genome consisting ssvRNA like cellular messenger RNA mRNA susceptible attack destruction neutralization andor modulation naturally occurring small noncoding RNAs sncRNAs within host cell known microRNAs miRNAs paper proposes action 2650 known human miRNAs sncRNAs form basis underrecognized unappreciated innateimmune regulator ssvRNA viral genome activity implication efficiency SARSCoV2 invasion infection replication Recent research indicates miRNA mRNA abundance speciation complexity varies widely amongst human individual may part explain variability innateimmune immunological pathophysiological response different human individual initiation progression SARSCoV2 infection multiple tissue type ii support understanding human biochemical genetic individuality variable resistance individual ssvRNAmediated viral infection disease commentary briefly address current finding concept fascinating research area noncoding RNA innateimmunity special reference natural host miRNAs SARSCoV2 current COVID19 pandemic,covid-19;homo sapien (hsa);messenger rna (mrna);microrna (mirna);severe acute respiratory syndrome coronavirus-2 (sars-cov-2)
Evaluation Rocuronium Continuous Infusion Critically Ill Patients COVID19 Pandemic Drug Shortages,34281428,Background Limited data exist support use rocuronium continuous infusion intensive care unit ICU Objective evaluate dosing monitoring adult patient received rocuronium hypoxemic respiratory failure Coronavirus Disease 2019 COVID19 pandemic Methods retrospective singlecenter study March 1 2020 May 31 2020 identified adult patient admitted ICU received rocuronium via continuous infusion Patients excluded received rocuronium 6 hour main outcome study determine median rocuronium maintenance continuous infusion rate ICU Secondary outcome study included initial continuous infusion rate duration therapy cumulative dose frequency median rocuronium bolus time resolution neuromuscular blockade relationship hourly administration rate rocuronium trainoffour TOF assessment Results Seventyone patient 97 paralytic infusion included Fiftynine patient 83 positive SARS CoV2 97 rocuronium infusion median dose initiation 3 35 mcgkgmin duration infusion 45 236925 hour median continuous infusion maintenance rate 43 2872 mcgkgmin negligible correlation dose rocuronium TOF result r = 04 total 1775 TOFs assessed 462 overparalyzed 357 wellparalyzed 181 underparalyzed Conclusions initial maintenance infusion dos analysis lower previously referenced,acute respiratory distress syndrome;neuromuscular blocking agent;rocuronium
COVID19 discrimination framework Xray image considering radiomics selective information feature ranking novel hybrid classifier,34219966,medical imaging procedure detection coronavirus apart medical test approval diagnosis special significance Imaging procedure also useful detecting damage caused COVID19 Chest Xray imaging frequently used diagnose COVID19 different pneumonia paper present taskspecific framework detect coronavirus Xray image Binary classification three different label healthy bacterial pneumonia COVID19 performed two differentiated data set corona stated positive Firstorder statistic gray level cooccurrence matrix gray level run length matrix gray level size zone matrix analyzed form fifteen subdata set ascertain necessary radiomics Two normalization method compared make data meaningful Furthermore five feature ranking approach Bhattacharyya entropy Roc ttest Wilcoxon mentioned provide necessary information stateoftheart classifier based Gaussmapbased chaotic particle swarm optimization neural network proposed framework designed according analysis radiomics normalization approach filterbased feature ranking method experiment seven metric evaluated objectively determine result accuracy area receiver operating characteristic ROC curve sensitivity specificity gmean precision fmeasure proposed framework showed promising score two Xraybased data set especially accuracy area ROC curve rate exceeding 99 classification coronavirus vs others,binary categorization;chaotic;coronavirus;framework design;hybrid classifier;optimization
Impact COVID19 pandemic incidence otitis medium effusion adult child multicenter study,34218309,PURPOSE compare analyze incidence otitis medium effusion OME COVID19related pandemic period evaluate effect social change lockdown continuous use facial mask social distancing reduction social activity OME incidence child adult METHODS number diagnosed OME e five referral center 1 March 2018 1 March 2021 reviewed collected estimate reduction OME incidence child adult COVID19 pandemic period OME incidence three period time evaluated compared group 1patients OME diagnosis achieved 1032018 01032019 pandemic period Group 2patients OME diagnosis achieved 1032019 1032020 pandemic period Group 3patients OME diagnosis achieved 1032020 1032021 COVID19 pandemic period RESULTS nonpandemic period group 1 2 incidence OME five referral center considered similar 482 555 diagnosed case respectively contrast OME incidence center pandemic period group 3 clearly reduced lower total number 177 case OME estimated Percentage variation OME incidence first nonpandemic year considered group 1 pandemic period group 3 was63 3 absolute value decrease value of305 case Similarly comparing second nonpandemic year group 2 pandemic year group 3 percentage variation OME incidence was68 1 absolute value of305 case decreased CONCLUSIONS finding showed lower incidence OME pandemic period compared 2 previous non pandemic year drastic restrictive anticontagion measure taken Italian government contain spread COVID19 could positive impact lower OME incidence last pandemic year,covid-19;eustachian tube dysfunction;ome;otitis media effusion;upper airways respiratory infections
effect COVID19 pandemic healthrelated quality life homebased patient spinal cord injury Japan,34292122,CONTEXT COVID19 pandemic forced people maintain social distance refrain going result homebased patient spinal cord injury SCI le able go may difficulty easily receiving longterm care service concern healthrelated quality life HRQOL may deteriorated aimed clarify effect COVID19 pandemic HRQOL homebased patient SCIIn June 2020 COVID19 pandemic finally settling Japan conducted mail survey 266 patient SCI regarding change frequency going longterm care service HRQOL due COVID19 pandemic discharged hospital Rehabilitation medical center 2019 expected living home received answer 135 patient HRQOL FINDINGS Respondent characteristic indicated many elderly 741 60 year age many cervical SCI 705 Worsened HRQOL since impact COVID19 pandemic reported 40 respondent commonly reported dimension paindiscomfort Significantly many injured comparatively recently reduced frequency going receiving homevisit nursing rehabilitation service patient whose HRQOL unchanged CONCLUSION CLINICAL RELEVANCE study clarifies negative effect COVID19 pandemic HRQOL homebased patient SCI Many respondent worsened HRQOL particular paindiscomfort suggested decrease frequency going may one factor affected deterioration HRQOL,covid-19;health-related quality of life;home-based patients;pandemic;spinal cord injury
Preanalytical sample handling effect blood cytokine level quality control COVID19 biobank,34289718,Aim investigated effect preanalytical sample handling variation coronavirus disease 2019relevant circulating cytokine level IFNgamma IL10 IL12p70 IL17A IL6 TNFalpha Materials method collected blood different collection tube ethylenediaminetetraacetic acid sodium citrate lithium heparin serum subjected ethylenediaminetetraacetic acid plasma among others increasing delay centrifugation 80 degree C storage Six subject included experimental condition Cytokine level measured sample using Simoa Cytokine 6plex kit Results Different tube type resulted different blood cytokine level IL17A IL6 level declined 3 h centrifugation delay IFNgamma level declined 24 h postcentrifugation storage delay IL17A level declined 2week storage delay Conclusion recommended centrifuge tube quickly following collection accurate cytokine measurement,biobank;interferon;interleukin;pre-analytics;stability;tumor necrosis factor
SARSCoV2 RBDTetanus Toxoid Conjugate Vaccine Induces Strong Neutralizing Immunity Preclinical Studies,34219448,Controlling global COVID19 pandemic depends among measure developing preventive vaccine unprecedented pace Vaccines approved use development intend elicit neutralizing antibody block viral site binding host s cellular receptor Virus infection mediated spike glycoprotein trimer virion surface via receptor binding domain RBD Antibody response domain important outcome immunization correlate well viral neutralization show macromolecular construct recombinant RBD conjugated tetanus toxoid TT induce potent immune response laboratory animal advantage immunization RBDTT conjugate include predominant IgG immune response due affinity maturation longterm specific Bmemory cell result demonstrate potential conjugate COVID19 vaccine candidate enable advance clinical evaluation name SOBERANA02 paving way antiviral conjugate vaccine,
ManSpecific Lectins Plants Fungi Algae Cyanobacteria Potential Blockers SARSCoV MERSCoV SARSCoV2 COVID19 Coronaviruses Biomedical Perspectives,34203435,Betacoronaviruses responsible `` Severe Acute Respiratory Syndrome SARS `` Middle East Respiratory Syndrome MERS use spike protruding virion envelope attach subsequently infect host cell coronavirus spike protein contain receptor binding domain RBD allowing specific recognition either dipeptidyl peptidase CD23 MERSCoV angiotensinconverting enzyme ACE2 SARSCov SARSCoV2 host cell receptor heavily glycosylated protein includes complex highmannose type Nglycans well exposed surface spike detailed analysis carbohydratebinding specificity mannosebinding lectin plant algae fungi bacteria revealed depending origin preferentially recognize either complex type Nglycans highmannose type Nglycans Since complex highmannose glycans substantially decorate protein mannosespecific lectin potentially useful glycan probe targeting SARSCoV MERSCoV SARSCoV2 virion Mannosebinding legume lectin like pea lectin monocot mannosebinding lectin like snowdrop lectin algal lectin griffithsin specifically recognize complex Nglycans highmannose glycans respectively particularly adapted targeting coronaviruses biomedical prospect targeting coronaviruses mannosespecific lectin wideranging including detection immobilization prevention control coronavirus infection,covid-19;mers-cov;sars-cov;sars-cov-2;algae lectins;artocarpin;biomedical applications;coronaviruses;cyanobacteria lectins;fungi lectins;mannose-specific lectins;pea lectin;plant lectins;snowdrop lectin
Using Machine Learning Algorithms Develop Clinical DecisionMaking Tool COVID19 Inpatients,34207560,BACKGROUND Within UK COVID19 contributed towards 103000 death Although multiple risk factor COVID19 identified using data improve clinical care proven challenging main aim study develop reliable multivariable predictive model COVID19 inpatient outcome thus enabling riskstratification earlier clinical decisionmaking METHODS Anonymised data consisting 44 independent predictor variable 355 adult diagnosed COVID19 UK hospital manually extracted electronic patient record retrospective casecontrol analysis Primary outcome included inpatient mortality required ventilatory support duration inpatient treatment Pulmonary embolism sequala secondary outcome balancing data key variable feature selected outcome using random forest Predictive model learned constructed using Bayesian network RESULTS proposed probabilistic model able predict using feature selected risk factor probability mentioned outcome Overall finding demonstrate reliable multivariable quantitative predictive model four outcome utilise readily available clinical information COVID19 adult inpatient research required externally validate model demonstrate utility risk stratification clinical decisionmaking tool,bayesian network;covid-19;sars cov;random forest;risk stratification;synthetic minority oversampling technique (smote)
Amplicon Metagenomic Analysis Middle East Respiratory Syndrome MERS Coronavirus Microbiome Patients Severe MERS,34287009,Middle East respiratory syndrome coronavirus MERSCoV zoonotic infection emerged Middle East 2012 Symptoms range mild severe include respiratory gastrointestinal illness virus mainly present camel population occasional zoonotic spill human severity infection human influenced numerous factor similar severe acute respiratory syndrome coronavirus 2 SARSCoV2 underlying health complication play major role Currently MERSCoV SARSCoV2 coincident Middle East thus rapid way sequencing MERSCoV derive genotype information molecular epidemiology needed Additionally complicating factor MERSCoV infection coinfections require clinical management ability rapidly characterize infection would advantageous rapidly sequence MERSCoV ampliconbased approach developed coupled Oxford Nanopore long read length sequencing metagenomic approach evaluated clinical sample patient MERS data illustrated wholegenome nearwholegenome information MERSCoV could rapidly obtained approach provided data consensus genome presence minor variant including deletion mutant metagenomic analysis provided information background microbiome advantage approach insertion deletion identified major driver genotype change coronaviruses IMPORTANCE Middle East respiratory syndrome coronavirus MERSCoV emerged late 2012 Saudi Arabia virus serious threat people Middle East also world detected 27 country MERSCoV spreading Middle East neighboring country approximately 35 reported patient virus died severe coronavirus infection far described Saudi Arabia destination many million people world visit religious purpose Umrah Hajj vulnerable area imposes unique challenge effective control epidemic significance study clinical sample patient MERS used rapid indepth sequencing metagenomic analysis using long read length sequencing,mers-cov;minion;metagenomics;sequencing
WholeGenome Sequencing SARSCoV2 Quarantine Hotel Outbreak,34287141,Hotel quarantine international traveler used prevent coronavirus disease spread Australia quarantine hotelassociated community outbreak detected South Australia Realtime genomic sequencing enabled rapid confirmation tracking outbreak recently returned traveler linked 2 case infection traveler facility,australia;covid-19;sars-cov-2;coronavirus disease;genome sequencing;hotel quarantine;respiratory infections;severe acute respiratory syndrome coronavirus 2;vaccines;viruses;zoonoses
Primary cutaneous anaplastic large cell lymphoma marked spontaneous regression organ manifestation SARSCoV2 vaccination,34228815,Primary cutaneous anaplastic large cell lymphoma pcALCL belongs primary cutaneous CD30+ cell lymphoproliferative disorder 1 Systemic involvement relatively rare rather confined regional lymph node 1 describe patient recurrent pcALCL diffuse lung manifestation spontaneously regressed one SARSCoV2 vaccination report 57yearold male patient 10year history biopsyproven CD30+ CD3+ CD4+ ALK clonal cell receptor gamma chain rearrangement pcALCL frequent local relapse predominantly affecting scalp neck,
Disinfection Neonatal Resuscitation Equipment LowResource Settings Importance Reality Considerations Future,34281001,Preventable neonatal death due prematurity perinatal event infection leading cause underfive mortality vast majority death resourcelimited area Deaths due infection associated lack access clean water overcrowded nursery improper disinfection reprocessing equipment including vital resuscitation equipment Reprocessing recently come heightened attention COVID19 pandemic bringing issue forefront across economic level however particularly challenging lowresource setting 2015 Eslami et al published letter editor Resuscitation highlighting concern disinfection equipment used resuscitate newborn Kenya address issue improper disinfection global health nongovernment organization PATH gathered group expert due lack bestpractice evidence published guideline recommendation reprocessing neonatal resuscitation equipment lowresource area guideline follow goldstandard principle highlevel disinfection however ongoing concern complexity guideline would make feasibility sustainability difficult setting designed Observations hospital Kenya Malawi reinforce concern purpose review discus proper disinfection equipment important challenging lowresource setting suggestion solution move forward,disinfection;global child health;neonatal infection;neonatal mortality;reprocessing
Epidemiological Significance SARSCoV2 RNA Dynamic NasoPharyngeal Swabs,34200850,16 March 15 December 2020 132357 nasopharyngealoropharyngeal swab collected province Teramo Abruzzo Region Italy tested presence SARSCoV2 genomic RNA commercially available molecular assay total 12880 swab resulted positive 8212 positive patient 4150 woman 4062 men median age statistically different woman median 4955 + 239 SD men median 4835 + 235 SD difference found comparison cycle threshold N proteinencoding gene CT N median value gender Differences observed CT N gene median value swab collected March September well pairwise comparison September October November December CT N gene median value observed specific period characterizing SARSCoV2 epidemic 2020 also compared incidence COVID19 case strong inverse correlation highlighted Pearson correlation coefficient = 0978 finding confirm usefulness CT N value indirect detection parameter monitor viral load population,abruzzo;covid-19;sars-cov-2;cycle threshold;naso-pharyngeal swab;viral circulation
Postinfection treatment protease inhibitor increase survival mouse fatal SARSCoV2 infection,34210738,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection continues serious global public health threat 3Clike protease 3CLpro virus protease encoded SARSCoV2 essential virus replication previously reported series smallmolecule 3CLpro inhibitor effective inhibiting replication human coronaviruses including SARSCoV2 cell culture animal model generated series deuterated variant 3CLpro inhibitor GC376 evaluated antiviral effect SARSCoV2 deuterated GC376 displayed potent inhibitory activity SARSCoV2 enzyme cellbased assay K18hACE2 mouse develop mild lethal infection commensurate SARSCoV2 challenge dos proposed model efficacy testing antiviral agent treated lethally infected mouse deuterated derivative GC376 Treatment K18hACE2 mouse 24 h postinfection derivative compound 2 resulted increased survival mouse compared vehicletreated mouse Lung virus titer decreased histopathological change ameliorated compound 2treated mouse compared vehicletreated mouse Structural investigation using highresolution crystallography illuminated binding interaction 3CLpro SARSCoV2 SARSCoV deuterated variant GC376 Taken together deuterated GC376 variant excellent potential antiviral agent SARSCoV2,k18-ace2 mice;sars-cov-2;antiviral;protease inhibitors
COVID19 celiac disease multicentric retrospective cohort study,34227075,OBJECTIVE Celiac disease CD autoimmune disorder characterized increased susceptibility bacterial viral infection Therefore CD patient could exposed increased risk contracting SARSCoV2 virus declared pandemic status March 2020 study aim investigate incidence SARSCoV2 infection CD patient ass impact CD risk contracting virus PATIENTS METHODS retrospective multicentric cohort study evaluated 542 celiac patient answered questionnaire concerning underlying disease adherence glutenfree diet residual symptom possible SARSCoV2 infection swab outcome presence characteristic symptom type treatment received referring period 20th January 2020 27th October 2020 RESULTS Five patient 092 tested positive 2 asymptomatic 3 developed symptom COVID19 incidence SARSCoV2 infection CD patient significantly different general population ratio positivediagnostic swab tends higher CD patient general population IR 015 006 p=006 whereas number subject performed swab group significantly lower IR 006 015 p 0001 CONCLUSIONS Although CD patient susceptible infection incidence SARSCoV2 infection sample significantly different general population However positivediagnostic swab ratio seems higher probably also due lower number patient tested,
Anaesthesia Critical Care Department Major Academic Centre s Adaptation Face COVID19 Pandemic,34290525,new novel coronavirus major impact healthcare system internationally Hospitals struggling manage sudden influx critical patient Anaesthesiologists critical care physician front liner fight COVID19 carry highest risk getting infected Due rapid response Saudi government s early warning fortunate hospital see slower rise COVID19 case allowing u time prepare make room expected rise highly infectious critical patient time protecting nonCOVID19 patient staff trainee Additionally team continued provide essential specialized care patient hospital maintain academic nonclinical service within university review present different protocol challenge lesson learned development COVID19 anaesthesia critical care department plan major teaching hospital Jeddah Saudi Arabia ultimate aim share experience similar institution,sars-cov-2;airway team;crisis planning;hospital resource;infection prevention;management;medical education
STElevation Myocardial Infarction 23YearOld Female Mystery Thrombus Formation,34211808,Acute STelevation myocardial infarction STEMI rarely seen young adult however encountered underlying cause either genetic condition leading earlyonset coronary artery disease CAD acquired prothrombotic condition idiopathic condition like spontaneous coronary artery dissection SCAD case describes healthy 23yearold female presented sudden onset severe angina found laminated thrombus left anterior descending coronary artery LAD evidence intraluminal dissection plaque rupture Although underlying etiology thrombus formation remains unknown coronavirus disease 2019 COVID19 related thrombotic event prime suspect addition another culprit excluded phentermineinduced coronary vasospasm commercially available medication weight loss report address current literature acute coronary syndrome young adult review potential etiology coronary artery thrombosis led nearfatal acute coronary syndrome patient,asymptomatic covid-19;coronary artery thrombus;coronary artery vasospasm;covid and heart;covid-19 outbreak;hyper coagulable state;phentermine;sar-cov 2 infection;spontaneous coronary artery thrombosis;st-segment elevation myocardial infarction (stemi)
COVID19 Transmission Transportation 1st 12th Grade Students Experience Independent School Virginia,34287893,BACKGROUND Inschool transmission COVID19 among K12 student low mitigation layer used risk acquiring COVID19 school bus transportation well defined Given operational limitation many school district data needed determine mitigation required keep COVID19 transmission low bus transport METHODS independent school Virginia monitored 1154 student grade 1 12 asymptomatic PCR testing every 2 week August 24 2020 March 19 2021 highest community transmission Fifteen bus served 462 student operating near capacity 2 student every seat using physical distancing minimum 25 ft universal masking simple ventilation technique RESULTS total 39 individual present bus COVID19 infectious period resulted quarantine 52 student Universal testing contact tracing revealed transmission linked bus transportation CONCLUSIONS study demonstrates model safe operation school bus near capacity COVID19 transmission low student transport employing mitigation including simple ventilation universal masking minimal physical distance highest community transmission,covid-19;disease mitigation;disease transmission;school bus;school transport
Working Pandemic Risk Infected andor Risks Related Social Distancing First Validation SAPH W Questionnaire,34199612,BACKGROUND COVID19 pandemic led worldwide healthcare system severe crisis personnel paid major cost Many study promptly dedicated physical psychological consequence COVID19 exposure among healthcare employee whereas research working population substantially ignored bridge current lack knowledge safe behavior related risk COVID19 contagion work aim study validate new tool SAPH W Safety Work ass worker perception safety METHODS total 1085 participant employed several organization sited across area different level risk contagion completed online questionnaire test SAPH W validity measurement invariance research sample randomly divided two RESULTS first subsample Confirmatory Factor Analysis demonstrated adequacy SAPH W factorial structure second subsample multigroup Confirmatory Factor Analysis revealed SAPH W invariant across gender ecological risk level type occupation inperson vs remote working CONCLUSIONS study evidenced psychometric property SAPH W brief tool monitor worker experience safety perception regarding COVID19 risk organisational setting,covid-19;occupational health;perceived safety assessment
Provider Perspectives Impact COVID19 Pandemic Newborn Screening,34287223,onset COVID19 pandemic caused significant change healthcare delivery Telemedicine rapidly unexpectedly became primary vehicle ambulatory management newborn screen NBS referral require varying level acuity whether telemedicine could used safe effective medium return result unknown sent online survey metabolism provider internationally investigate triage difference abnormal NBS result COVID19 pandemic survey compared personal practice period MarchJune 2019 MarchJune 2020 Responses received 44 provider practicing 8 country Nearly 93 practiced area widespread SARSCOV2 community transmission spring 2020 significant expansion telemedicine use NBS referral onset COVID19 pandemic 12 95 CI 366393 p 00001 Telehealth primarily replaced inperson ambulatory metabolism visit increased frequency virtual care similar across NBS analytes Providers found telehealth NBS referral equally efficacious inperson care Institutional patient survey showed difference satisfaction provider communication provider empathy appointment logistics survey limited unprecedented disruption healthcare delivery necessitating validation telegenetics NBS postpandemic era Nevertheless finding demonstrate telemedicine potentially viable practical tool triaging abnormal NBS result,covid-19 pandemic;newborn screening;telegenetics;telemedicine
Feasibility utility facemask sampling detection SARSCoV2 ongoing pandemic,34224033,Easy access screening timely identification isolation infectious COVID19 patient remains crucial sustaining international effort control COVID19 spread major barrier limiting broadbased screening lack simple rapid costeffective COVID19 testing method evaluated feasibility utility facemask sampling cohort 42 COVID19positive 36 COVID19negative patient used prototype SteriStrips 3 applied inner surface looped surgical facemasks Assure worn patient minimum wear time 3 h removed sent SARSCoV2 PCR testing Baseline demographic symptomatology also collected Facemask sampling positivity highest within first 5 day symptomatic presentation Patients nasopharyngeal andor oropharyngeal swab SARSCoV2 PCR Ct value 2509 SARSCoV2 detected facemask sampling patient Ct value = 252 SARSCoV2 detected facemask sampling Facemask sampling identify patient COVID19 early symptomatic phase high viral load hence allowing timely identification isolation highest transmission risk Given widespread use facemasks method potentially easily applied achieve broadbased even continuous population screening,covid-19;epidemiology;rapid diagnostics;sars-cov-2
Conformational Variability Correlation Prediction Transmissibility Neutralization Escape Ability Multiple Mutation SARSCoV2 Strains using SSSCPreds,34337269,Identifying fundamental cause transmissibility multiple mutation strain vaccine nullification difficult general source significant concern conformational variability mutation site B16172 Delta B16171 kappa B1427429 epsilon P1 gamma B1351 beta B117 alpha S477N wildtype strain assessed using deep neuralnetworkbased prediction program conformational flexibility rigidity protein SSSCPreds find although conformation G614 rigid assigned lefthanded LH alphahelixtype one D614 flexible without hydrogen bonding latch T859 rigidity glycine stabilizes local conformation effectively aspartic acid latch thereby contributes reduction S1 shedding high expression increase infectivity finding sequence flexibilityrigidity map pattern B117 similar wildtype strain largely different B1351 P1 correlate minor escape ability B117 increased rigidity amino acid sequence YRYRLFR SSSCPreds data B1427429 near L452R mutation site contributes 2fold increased B1427B1429 viral shedding vivo increase transmissibility relative wildtype circulating strain similar manner D614G concordance rigidity ratio multiple mutation strain B16172 wildtype one receptorbinding domain RBD receptorbinding motif RBM region provide good indication transmissibility neutralization escape ability except binding affinity mutation site N501Y,
Serum neurofilament light protein correlate unfavorable clinical outcome hospitalized patient COVID19,34131052,Brain imaging study patient COVID19 show evidence macro microhemorrhagic lesion multifocal white matter hyperintensities lesion consistent posterior reversible leukoencephalopathy Imaging study however subject selection bias prospective study challenging scale evaluated whether serum neurofilament light chain NFL neuroaxonal injury marker could predict extent neuronal damage cohort 142 hospitalized patient COVID19 NFL elevated serum patient COVID19 compared healthy control including without overt neurological manifestation Higher NFL serum concentration associated worse clinical outcome 100 hospitalized patient COVID19 treated remdesivir trend toward lower NFL serum concentration observed data suggest patient COVID19 may experience neuroaxonal injury may risk longterm neurological sequela Neuroaxonal injury considered outcome acute pharmacotherapeutic trial COVID19,
Corona Contact Tracing Apps Empirical Study SelfFocused OtherFocused Health Concerns Predictors AppUptake,34227995,BACKGROUND Corona contact tracing apps novel promising measure reduce spread COVID19 help balance need maintain normal life economic activity much possible still avoiding exponentially growing case number However majority citizen need willing install app effective Hence knowledge driver appuptake crucial OBJECTIVE present study aim add understanding underlying psychological factor motivating appuptake specifically investigated role concern one s health concern unknowingly infect others METHODS twowave survey N = 346 Germanspeaking participant Switzerland Germany conducted measured uptake two decentralized contact tracing apps officially launched government `` CoronaWarnApp Germany `` SwissCovid Switzerland well concern regarding COVID19 control variable RESULTS controlling demographic variable well general attitude towards government pandemic logistic regression analysis showed significant effect selffocused concern Odds Ratio = 164 P 01 Meanwhile concern unknowingly infect others contribute significantly prediction appuptake concern one s health Odds Ratio = 101 P = 92 Longitudinal analysis replicated pattern showed support possibility appuptake provokes change level concern Testing curvilinear relationship evidence found `` much concern lead defensive reaction reduces appuptake CONCLUSIONS one first study ass installation already launched corona tracing apps study extends knowledge motivational landscape appuptake Based practical implication communication strategy app design discussed CLINICALTRIAL,
Elective Cesarean Section Obstetric COVID19 Patients Spinal Anesthesia Prospective Study,34349329,Background Managing obstetric emergency COVID19 pandemic real challenge patient need timely intervention save life mother baby Hence avoid lifethreatening challenge pregnant patient electively admitted tested COVID19 near term anticipate difficulty prevent complication Aim aim ass impact COVID19 infection maternal morbidity mortality well effect neonate spinal anesthesia Settings Design prospective observational study Materials Methods One hundred fifteen COVID19positive pregnant patient age group 2040 year July 2020 December 2020 electively taken cesarean section spinal anesthesia Patients needed emergency cesarean delivery excluded study Emergency cesarean delivery avoided reduce risk aerosol generation general anesthesia endotracheal intubation COVID19 patient pose significant risk viral exposure doctor staff Written informed consent obtained patient Spinal anesthesia given L4L5 intervertebral space Demographic parameter anesthetic surgical parameter neonatal parameter observed inadvertent event noted Statistical Analysis Data expressed mean median percentage number Results pregnancy singleton None patient converted general anesthesia One hundred ten either mildly symptomatic asymptomatic Five patient severe symptom needed intensive care unit care preoperatively postoperatively Seven patient developed spinal hypotension managed vasopressor significant thrombocytopenia noted patient None patient developed symptomatic thromboembolism Vertical transmission reported case baby born weight 2500 g good APGAR score Conclusion Spinal anesthesia LSCS safe effective obstetric anesthesia COVID19 parturient newborn,covid-19;elective caesarean;spinal anesthesia
Opinions belief knowledge people multiple sclerosis COVID19 pandemic vaccine,34216996,BACKGROUND Considering potential COVID19 impact pwMS health importance vaccination population decided ass pwMS belief knowledge COVID19 pandemic b acceptance towards COVID19 vaccination c pwMS opinion general vaccination METHODS Observational study based crosssectional 1020 th September 2020 online survey conducted cohort pwMS followed two Portuguese hospital survey included measure characterize sample questionnaire designed ass topic defined study RESULTS 270 respondent completed full survey response rate 582 pwMS greatest concern pandemic aggravation MS especially patient older 50 year old Almost 40 patient older 50 felt pandemic negatively affected MS related medical assistance patient believed would recover COVID19 infection half responder feared MS aggravation got COVID19 pronounced patient progressive MS 12 participant want vaccinated almost 40 unsure Regarding vaccine general almost third participant feared side effect MS related complication CONCLUSION knowledge pwMS opinion COVID19 pandemic impact vaccination useful better address issue Fears expectation towards vaccination must discussed pwMS,covid-19 pandemic;multiple sclerosis;opinions;questionnaire;vaccines
selective sweep Spike gene driven SARSCoV2 human adaptation,34289344,coronavirus disease 2019 COVID19 pandemic underscore need better understand animaltohuman transmission coronaviruses adaptive evolution within new host scanned 182000 severe acute respiratory syndrome coronavirus 2 SARSCoV2 genome selective sweep signature found distinct footprint positive selection located around nonsynonymous change A1114G T372A within spike protein receptorbinding domain RBD predicted remove glycosylation increase binding human ACE2 hACE2 cellular receptor change present human SARSCoV2 sequence closely related virus bat pangolin predicted T372A RBD bound hACE2 higher affinity experimental binding assay engineered reversion mutant A372T found A372 wildtype WT SARSCoV2 enhanced replication human lung cell relative putative ancestral variant T372 effect 20 time greater wellknown D614G mutation finding suggest mutation likely contributed SARSCoV2 emergence animal reservoir enabled sustained humantohuman transmission,covid-19;sars-cov-2;emergence;molecular virology;selective sweep;spillover;viral adaptation
Ruthenium Complexes Fight Pathogenic Microorganisms Extensive Review,34199283,widespread use antibiotic resulted emergence drugresistant population microorganism Clearly one see need develop new effective antimicrobial agent go beyond explored chemical space regard unique mode action eg reactive oxygen specie ROS generation redox activation ligand exchange depletion substrate involved vital cellular process render metal complex promising drug candidate Several Ru IIIII complex included currently undergoing clinical trial anticancer agent Based indepth knowledge chemical property biological behavior interest developing new ruthenium compound antibiotic antifungal antiparasitic antiviral drug risen review discus advantage disadvantage Ru IIIII framework antimicrobial agent aspect regarding relationship chemical structure mechanism action cellular localization andor metabolism ruthenium complex bacterial eukaryotic cell discussed well Regarding antiviral activity light current event related Covid19 pandemic Ru IIIII compound used SARSCoV2 eg BOLD100 also reviewed herein,covid-19;antibacterial;antimicrobial;antiparasitic;antiviral;ruthenium
Learning deregulation asymmetric impact lockdown reopening risky behavior COVID19,34226759,coronavirus disease 2019 COVID19 pandemic state issued rescinded stayathome order restricted mobility develop model learning deregulation predicts lifting stayathome order signal going become safer Using restaurant activity data find implementation stayathome order initially limited impact activity rose quickly state reopenings result suggest consumer inferred reopening safer eat rational mistaken inference occurs model may explain sharp rise COVID19 case followed reopening state,covid-19;coronavirus;mobility;public health measures
COVID19 Experiences PPE Health Concerns Toronto Canada Bicycle Delivery Workers Crosssectional Pilot Survey,34212190,OBJECTIVES pilot recruitment method bicycle delivery worker Toronto Canada ass worker experience COVID19 personal protective equipment PPE METHODS crosssectional study online survey deployed advertised via social medium paid free posting July August 2020 incentive draw used motivate participation analysis summarized descriptive statistic sample variable relevant COVID19 RESULTS Complete response received 35 participant participant reported diagnosis COVID19 however four participant indicated experiencing symptom participant reported used PPE especially mask andor respirator 971 714 participant indicated employer provided PPE mask glove Participants expressed concern precarious work uncertainty COVID19 exposure risk CONCLUSIONS Bicycle delivery worker precarious working population may difficult reach research recruitment purpose Given essential role delivery COVID19 pandemic work needed characterize exposure risk population,covid-19;ppe;bicycle delivery;courier;gig economy;precarious work
Acute transverse myelitis inactivated COVID19 vaccine,34370410,Vaccines severe acute respiratory syndrome coronavirus 2 SARSCoV2 rapidly developed prevent coronavirus disease 2019 COVID19 pandemic increasing safety concern regarding COVID19 vaccine report 78year old woman presented tetraparesis paresthesia bilateral upper extremity urinary retention oneday duration Three week symptom vaccinated CoronaVAC vaccine Sinovac Life Sciences China Spine magnetic resonance imaging showed longitudinally extensive transverse myelitis TM C1 T3 spinal cord segment extensive diagnostic workup performed exclude possible cause TM suggest longitudinally extensive TM may associated COVID19 vaccination case best knowledge first report longitudinally extensive TM developing CoronaVac vaccination Clinicians aware neurological symptom vaccination COVID19,covid-19;adverse effect;transverse myelitis;vaccination
Nosocomial Outbreak COVID19 Hematologic Ward,34216126,BACKGROUND Coronavirus disease 2019 COVID19 outbreak occur hospital many part world hospital setting possibility airborne transmission need investigated thoroughly MATERIALS METHODS nosocomial outbreak COVID19 hematologic ward tertiary hospital Seoul Korea found 11 patient guardian COVID19 vigorous contact tracing closedcircuit television monitoring found one patient probably acquired COVID19 airbornetransmission performed airflow investigation simulation software wholegenome sequencing severe acute respiratory syndrome coronavirus 2 SARSCoV2 RESULTS nine individual COVID19 hematologic ward six stayed one multipatient room Room 36 three stayed different room Room 1 34 35 Guardian room 35 close contact case room 36 patient room 34 used shared bathroom teeth brushing 40 minute index used Airflow simulation revealed air spread bathroom adjacent room 1 patient room 1 used shared bathroom Airflow associated poor ventilation shared bathroom due dysfunctioning airexhaust grill door shared bathroom unintended negative pressure adjacent room CONCLUSION Transmission SARSCoV2 hematologic ward occurred rapidly multipatient room shared bathroom setting addition case possible airborne transmission due unexpected airflow,airborne transmission;covid-19;hematologic malignancy;multi-patient room;sars-cov-2
Longitudinal analysis utility liver biochemistry hospitalised COVID19 patient prognostic marker,34222741,Background Aims association liver biochemistry clinical outcome SARSCoV2 infection currently unclear utility longitudinallymeasured liver biochemistry prognostic marker mortality unknown aimed determine whether abnormal liver biochemistry assessed baseline repeat measure time associated death hospitalised patient COVID19 compared without COVID19 UK population Approach Results extracted routinely collected clinical data large teaching hospital UK matching 585 hospitalised SARSCoV2 RTPCRpositive patient 1165 hospitalised RTPCRnegative patient age gender ethnicity preexisting comorbidities 268 157585 COVID19 patient died compared 119 1391165 nonCOVID19 group p 0001 presentation significantly higher proportion COVID19 group elevated alanine aminotransferase 207 vs 146 p=0004 hypoalbuminaemia 587 vs 350 p 0001 compared nonCOVID19 group Within COVID19 group hypoalbuminaemia presentation 183fold increased hazard death compared normal albumin adjusted HR 183 95 CI 125267 whilst hazard death 4fold higher aged =75 year adjusted HR 396 95 CI 259604 3fold higher preexisting liver disease adjusted HR 337 95 CI 158716 COVID19 group alkaline phosphatase ALP increased R=0192 p 00001 albumin declined R=0123 p=00004 time patient died Conclusion UK population liver biochemistry commonly deranged patient COVID19 Baseline hypoalbuminaemia rising ALP time could prognostic marker death investigation larger cohort required develop better understanding relationship liver biochemistry disease outcome,sars-cov-2;coronavirus;electronic health records;liver biochemistry;liver function tests
Pulmonary function computerized tomography feature sixminute walk test three month severe COVID19 patient treated intravenous pulsed methylprednisolone preliminary report,34284567,COVID19 ARDS high mortality therapeutic option present preliminary report experience using highdose pulsed methylprednisolone COVID19 ARDS threemonth outcome performed retrospective analysis patient treated highdose methylprednisolone COVID19 ARDS threemonth lung function 6MWT CT finding 15 patient treated 10 survived discharge Reduced DLCO commonest abnormality lung function test lowest mean value Parenchymal band commonest CT finding 50 patient fibrosis threemonths Mean 6MWD 654 predicted abnormal 625 patient cohort patient COVID19 ARDS treated highdose methylprednisolone pulse CT lung function 6MWT abnormality unsurprisingly common three month although 10 patient treated early disease course survived possible therapeutic effect randomised controlled trial needed ass benefit treatment,
Eclampsia posterior reversible encephalopathy syndrome parturient complicated SARS COVID19 pneumonia,34214521,primigravida 32 week gestation presented u eclampsia Posterior Reversible Encephalopathy Syndrome PRES along SARS COVID19 pneumonia Immediate termination pregnancy done general anesthesia patient electively ventilated view increased oxygen requirement therapy using magnesium sulphate antihypertensive steroid convalescent plasma carried condition patient steadily improved leading extubation 4th postoperative day subsequent discharge 8th day admission,covid-19;eclampsia;posterior reversible encephalopathy syndrome
Pathophysiology COVID19associated acute kidney injury,34226718,Although respiratory failure hypoxaemia main manifestation COVID19 kidney involvement also common Available evidence support number potential pathophysiological pathway acute kidney injury AKI develop context SARSCoV2 infection Histopathological finding highlighted similarity difference AKI patient COVID19 AKI nonCOVIDrelated sepsis Acute tubular injury common although often mild despite markedly reduced kidney function Systemic haemodynamic instability likely contributes tubular injury Despite description COVID19 cytokine storm syndrome level circulating cytokine often lower patient COVID19 patient acute respiratory distress syndrome cause COVID19 Tissue inflammation local immune cell infiltration repeatedly observed might critical role kidney injury might endothelial injury microvascular thrombus Findings high viral load patient died AKI suggest contribution viral invasion kidney although issue renal tropism remains controversial impaired type interferon response also reported patient severe COVID19 light observation potential pathophysiological mechanism COVID19associated AKI may provide insight therapeutic strategy,
Acute longitudinal extensive transverse myelitis secondary asymptomatic SARSCoV2 infection,34226258,35yearold woman 6 month post partum presented acute onset back pain T8 level progressing bilateral lower limb weakness sensory loss urinary retention constipation patient preexisting inflammatory disease recently developed ulcerative colitis antenatally Five day prior admission tested positive asymptomatically SARSCoV2 reversetranscriptase PCR nasopharyngeal swab positive swab result confirmed admission Clinical examination revealed bilaterally exaggerated knee reflex lower limb weakness positive Babinski s sign Sensation impaired L4 L5 dermatome absent S1 S2 MRI finding suggested longitudinal extensive transverse myelitis multiple region patchy hyperintensity seen thoracic region spinal cord centrally peripherally started course intravenous corticosteroid improvement seen clinically repeat imaging case demonstrates rare complication asymptomatic COVID19 infection explores potential neurotropic property COVID19,covid-19;neurology (drugs and medicines);obstetrics and gynaecology;spinal cord;ulcerative colitis
Elevated Procalcitonin Positively Associated Severity COVID19 MetaAnalysis Based 10 Cohort Studies,34207689,Background Objectives Procalcitonin PCT positively associated severity COVID19 including severe critical fatal outcome confounding factor considered aim metaanalysis estimate adjusted relationship elevated procalcitonin admission severity COVID19 Materials Methods searched 1805 article PubMed Web Science Embase database 2 April 2021 article selected reported adjusted relationship applying multivariate analysis PCT severity COVID19 pooled effect estimate calculated randomeffects model Results metaanalysis included 10 cohort study total 7716 patient Patients elevated procalcitonin admission higher risk severe critical COVID19 pooled effect estimate 177 95 confidence interval CI 138229 2 = 856 p 0001 Similar result also observed dead patient pooled effect estimate 177 95 CI 136230 adjusting diabetes positive association PCT severity COVID19 decreased Subgroup analysis revealed heterogeneity study sensitivity analysis showed result robust evidence publication bias Egger s test p = 0106 Conclusions Higher procalcitonin positively associated severity COVID19 potential biomarker evaluate severity COVID19 predict prognosis,covid-19;sars-cov-2;meta-analysis;procalcitonin;severity
Assessing risk SARSCoV2 transmission international professional golf,34221443,Objectives published data incidence risk SARSCoV2 transmission playing golf sport played outdoors social distancing possible purpose prospective study report incidence transmission regarding SARSCoV2 professional golfer competing PGA European Tour across 23 event 11 country Methods Daily symptom temperature check weekly reverse transcriptase PCR RTPCR screening performed determine potential carriage SARSCoV2 Onset type symptomology analysed Gene expression cycle threshold Cts reviewed positive case Repeat PCR testing performed positive player RTPCR analysis included human housekeeping gene various RNA gene specific SARSCoV2 Results study period 2900 RTPCR test performed 195 professional golfer competing European Tour Four player tested positive onsite study period 014 test positive result declared Ct 40 Two positive test returned part routine protocol two reported history close contact individual tested positive SARSCoV2 isolated target tested asymptomatic time testing three developing symptom subsequently None required hospital admission transmission player player Conclusion Golf outdoor sport social distancing possible meaning risk low guidance followed participant Risk transmission SARSCoV2 mitigated highly accurate RTPCR testing participant setting safe bubble includes testing player support staff well person coming contact course tournament example driver hotel staff report also provide reassurance participant policy maker regarding community golf encouraged health benefit provides relatively lowrisk environment minimal risk transmission observing sensible viral hygiene protocol,covid-19;golf;immune system;infection;viral
Unfurl Corona Virus Thwack Human Environment Review,34222734,new Covid SARSCoV2 Severe Acute Respiratory Syndrome Coronavirus2 first recognized Wuhan China December 2019 address similar family Severe Acute Respiratory Syndrome Coronavirus1 SARSCoV1 January 30 2020 World Health Organization pronounced flareup Public Health Emergency International Concern Diagnosis disease carried using special molecular test mandatory associate individual COVID 19 symptom isolation necessary prevent transmission virus review highlight formation prodrome transmission survival mechanism COVID 19 show pandemic circumstance fundamentally improves air quality various urban area across globe decrease water contamination commotion diminishes tension traveller objection may help reclamation natural framework worldwide effect new outbreak yet dubious,corona virus;global pandemic;pollution;sars-cov2
Nitazoxanide superiority placebo treat moderate COVID19 Pilot prove concept randomized doubleblind clinical trial,34222847,Background absence specific antiviral treat COVID19 lead repositioning candidate drug Nitazoxanide NTZ broad antiviral effect Methods randomized doubleblind pilot clinical trial comparing NTZ 600 mg BID versus Placebo seven day among 50 individual 25 arm SARSCOV2 RTPCR+ PCR hospitalized mild respiratory insufficiency May 20 th 2020 September 21 st 2020 ClinicalTrialsgov NCT04348409 Clinical virologic endpoint inflammatory biomarkers evaluated fivepoint scale disease severity SSD used Findings Two patient died NTZ arm compared 6 placebo arm p = 0564 NTZ superior placebo considering SSD p 0001 mean time hospital discharge 66 vs 14 day p = 0021 negative PCR day 21 p = 0035 whereas placebo group presented adverse event p = 004 Among adverse event likely related study drug 14 detected NTZ group 22 placebo p = 024 Among 30 adverse event unlikely related 21 occurred placebo group p = 004 decrease baseline higher NTZ group dDimer p = 0001 USRCP p 0002 TNF p 0038 IL6 p 0001 IL8 p = 0014 HLA DR CD4 + lymphocyte p 005 CD38 CD4 + CD8 + p 005 CD38 HLADR CD4+ p 001 Interpretation Compared placebo clinical virologic outcome improvement inflammatory outcome superiority NTZ warrant investigation drug moderate COVID19 larger clinical trial higher incidence adverse event placebo arm might attributed COVID19 related symptom,covid-19;interleukins;lymphocytes cell activation markers;nitazoxanide;randomized controlled clinical trial
Factors associated clinical severity emergency department patient presenting symptomatic SARSCoV2 infection,34223443,Objective measure association race ethnicity comorbidities insurance status need hospitalization symptomatic emergency department patient severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection Methods study cohort study symptomatic patient presenting single emergency department ED laboratoryconfirmed SARSCoV2 infection March 7August 9 2020 collected patientlevel information regarding demographic insurance status comorbidities level care mortality using structured chart review compared characteristic patient categorized 1 home discharge 2 general hospital ward admission 3 intensive care unit ICU admission death within 30 day index visit Univariate multivariable logistic regression analysis performed report odds ratio 95 confidence interval 95 CI hospital admission versus ED discharge home ICU care versus general hospital ward admission Results total 994 patient presented ED symptom included analysis 551 554 patient discharged home 314 316 patient admitted general hospital ward 129 130 admitted ICU dying Patients requiring admission likely Black public insurance Medicaid andor Medicare Patients admitted ICU dying likely aged = 65 year male multivariable logistic regression old age public insurance diabetes hypertension obesity heart failure hyperlipidemia independent predictor hospital admission comparing needed ICU care versus general hospital ward admission univariate logistic regression patient Medicaid 24 95 CI 1246 Medicare 42 95 CI 2184 Medicaid Medicare 43 95 CI 2477 history chronic obstructive pulmonary disease 22 95 CI 1242 hypertension 17 95 CI 1127 heart failure 26 95 CI 1447 likely admitted ICU die Black 11 95 CI 0429 HispanicLatino 10 95 CI 0618 patient le likely admitted ICU however association statistically significant multivariable logistic regression old age male sex public insurance heart failure independent predictor ICU caredeath Conclusion Comorbidities public insurance predictor severe illness patient SARSCoV2 study suggests disparity severity seen COVID19 among Black patient may attributable part low socioeconomic status chronic health condition,covid-19 disease;sars-cov-2 infection;emergency medicine;infectious diseases;socioeconomic factors
COVID19 impact emergency urological admission Australian tertiary hospital,34288346,BACKGROUNDS COVID19 pandemic unprecedented threat health healthcare system published data impact urological presentation Australia METHODS retrospective analysis admission urology service Liverpool Hospital Australia February 1st April 30th 2020 previous 5 year RESULTS total 397 admission 2020 438 2019 mean age proportion male mean length stay similar 2020 229 emergency admission period previous 5 year 195 218 emergency admission 2019 220 planned admission 168 2020 2019 2020 significant difference proportion patient admission longer 10 day P = 0602 requiring intensive care unit admission P = 0708 inpatient operative management P = 0171 Among emergency admission mean Charlson Comorbidity Index significantly lower 2020 compared 2019 P = 0009 CONCLUSIONS Despite pervasive fear COVID19 pandemic multiple substantial alteration hospital system structure elective operating restriction significant difference number acuity emergency admission observed Due limitation elective operating expected reduction planned admission finding contrast multiple recent study may result patient demographic healthseeking behaviour appear significantly influenced pandemic,covid-19;pandemics;urologic surgical procedures
Diagnostic test accuracy telehealth assessment dementia mild cognitive impairment,34282852,BACKGROUND Many million people living dementia around world diagnosed negative impact access care treatment rational service planning Telehealth use information communication technology ICT provide health service distance may way increase access specialist assessment people suspected dementia especially living remote rural area also much used COVID19 pandemic important know whether diagnosis made using telehealth assessment accurate made conventional facetoface clinical setting OBJECTIVES Primary objective ass diagnostic accuracy telehealth assessment dementia mild cognitive impairment Secondary objective identify quality quantity relevant research evidence identify source heterogeneity test accuracy data identify synthesise data patient clinician satisfaction resource use cost feasibility telehealth assessment model included study SEARCH METHODS searched multiple database clinical trial register 4 November 2020 published grey literature registered trial applied search filter language restriction screened retrieved citation duplicate assessed duplicate full text paper considered potentially relevant SELECTION CRITERIA included review crosssectional study 10 participant referred specialist service assessment suspected cognitive disorder Within period one month le participant undergo two clinical assessment designed diagnose dementia mild cognitive impairment MCI telehealth assessment index test conventional facetoface assessment reference standard telehealth assessment could informed data collected facetoface eg nurse working primary care contact patient specialist clinician responsible synthesising information making diagnosis take place remotely using ICT DATA COLLECTION ANALYSIS Two review author independently extracted data included study Data extracted covered study design setting participant detail index test reference standard result form number participant given diagnosis dementia MCI Data also sought dementia subtype diagnosis quantitative measure patient clinician satisfaction resource use cost feasibility assessed risk bias applicability included study using QUADAS2 entered result 2x2 table order calculate sensitivity specificity telehealth assessment diagnosis allcause dementia MCI cognitive syndrome combining dementia MCI presented result included study narratively study derive summary estimate sensitivity specificity MAIN RESULTS Three study 136 participant eligible inclusion Two study 20 100 participant took place community setting Australia one study 16 participant conducted veteran home USA Participants referred primary care undiagnosed cognitive symptom identified high risk dementia screening test care home Dementia MCI target condition larger study study targeted dementia diagnosis one small study used pure telehealth model ie involving element facetoface assessment study generally wellconducted considered two study high risk incorporation bias substantial amount information collected facetoface nurse used inform index test reference standard assessment One study unclear risk selection bias diagnosis allcause dementia sensitivity telehealth assessment ranged 080 100 specificity 080 100 considered lowcertainty evidence due imprecision inconsistency study risk bias diagnosis MCI data available one study 100 participant giving sensitivity 071 95 CI 054 084 specificity 073 95 CI 060 084 considered lowcertainty evidence due imprecision risk bias diagnosis cognitive syndrome dementia MCI data study gave sensitivity 097 95 CI 091 099 specificity 022 95 CI 003 060 majority diagnostic disagreement concerned distinction MCI dementia occurring approximately equally either direction also tendency patient identified cognitively healthy facetoface assessment diagnosed MCI telehealth assessment number small insufficient data make assessment accuracy dementia subtype diagnosis One study provided small amount data indicating good level clinician especially patient satisfaction telehealth model data resource use cost feasibility AUTHORS CONCLUSIONS found eligible study small number participant important difference study providing data analysis whether target condition dementia two study dementia MCI one study data suggest telehealth assessment may highly sensitive specific diagnosis allcause dementia assessed reference standard conventional facetoface assessment estimate imprecise due small sample size betweenstudy heterogeneity may apply mainly telehealth model incorporate considerable amount facetoface contact healthcare professional doctor responsible making diagnosis diagnosis MCI telehealth assessment best estimate sensitivity specificity somewhat lower based single study Errors occurred cognitively healthyMCI MCIdementia boundary However evidence diagnostic disagreement frequent would expected due known variation clinician opinion assigning dementia diagnosis,
CrossReactive SARSCoV2 Neutralizing Antibodies Deep Mining Early Patient Responses,34211469,Passive immunization using monoclonal antibody play vital role fight COVID19 recent emergence viral variant reduced sensitivity current antibody vaccine highlight importance broad crossreactivity study describes deepmining antibody repertoire hospitalized COVID19 patient using phage display technology B cell receptor BCR repertoire sequencing isolate neutralizing antibody gain insight early antibody response comprehensive discovery approach yielded panel potent neutralizing antibody bind distinct viral epitope including epitope conserved SARSCoV1 Structural determination nonACE2 receptor blocking antibody reveals previously undescribed binding epitope unlikely affected mutation recently reported major viral variant including B117 UK B1351 South Africa B1128 Brazil Finally combining sequence RBD binding neutralizing antibody B cell receptor repertoire sequencing also describe highly convergent early antibody response Similar IgMderived sequence occur within study group also within patient response described multiple independent study published previously,covid-19;sars-cov-2 variants;antibodies;convergence;phage display
Optimizing testing COVID19 India,34292931,COVID19 testing across India us mix two type test Rapid Antigen Tests RATs relatively inexpensive pointofcare lateralflowassay test also le sensitive reversetranscriptase polymerasechainreaction RTPCR test close 100 sensitivity specificity laboratory setting delay returning result well increased cost relative RATs may vitiate advantage Indiawide 49 COVID19 test RATs Indian state including large state Uttar Pradesh pop 2279 million Bihar pop 1213 million use much higher proportion test show using simulation based epidemiological network model judicious use RATs yield epidemiological outcome comparable obtained RTPCRbased testing isolation positive provided condition met RAT test sensitivity low b reasonably large fraction population order 05 per day tested c testing positive isolated sufficient duration testing accompanied nonpharmaceutical intervention increased effectiveness ass optimal testing regime taking account test sensitivity specificity background seroprevalence current test pricing find surprisingly even 100 RAT test regime acceptable epidemiological well economic standpoint provided condition outlined met,
commercial automated immunoassay utilized predict neutralizing antibody SARSCoV2 infection comparative study three different assay,34340267,Background Highthroughput assay infer neutralizing activity SARSCoV2 great importance assessing immunity induced natural infection COVID19 vaccine aimed evaluate performance degree correlation three fully automated antiSARSCoV2 immunoassay neutralization activity using surrogate virusneutralizing test sVNT GenScript targeting receptorbinding domain Methods 110 serum collected PCRconfirmed asymptomatic COVID19 individual tested neutralizing antibody nAbs using sVNT Positive sample tested three automated immunoassay targeting different viral antigen Mindray CL900i R Abbott Architect Ortho VITROS R diagnostic sensitivity specificity agreement correlation sVNT assessed Receiver operating characteristic ROC curve analysis performed determine optimal threshold predicting presence neutralizing activity assay Results three assay showed 100 specificity highest sensitivity 990 demonstrated VITROS R followed 943 CL900i R 810 Architect VITROS R CL900i R strongest correlation sVNT rho = 0718 rho = 0712 respectively Architect showed moderate correlation rho = 0618 ROC curve analysis indicated manufacturer s recommended cutoff value adequate predicting presence nAbs providing strong correlation sVNT Conclusion VITROS R CL900i R serological assay detect antibody SARSCoV2 spike protein could serve reliable assay predict neutralization activity infection vaccination,automated immunoassay;clia;covid-19;neutralizing antibodies;sars-cov-2;serology;surrogate virus neutralization test (svnt)
Precautionary Behavior Practices Psychological Characteristics COVID19 Patients Quarantined Persons,34199908,BACKGROUND since coronavirus disease COVID19 first reported 2019 South Korea enforced isolation patient confirmed case COVID19 well quarantine close contact individual diagnosed COVID19 person traveling abroad order contain spread Precautionary behavior practice psychological characteristic confirmed quarantined person investigated planning pandemic recovery preparedness METHODS study conducted 1716 confirmed patient quarantined person Daegu Busan region high number case confirmed early stage COVID19 outbreak South Korea collected online survey data 23 April 20 May 2020 Daegu 28 April 27 May 2020 Busan cooperation Daegu Busan Infectious Disease Control Centers public health center region COVID19 symptom precautionary behavior practice psychological state need improvement isolationquarantine environment examined using online survey RESULTS compared patient infected coronavirus quarantined person engaged hygienerelated behavior eg hand washing cough etiquette proper maskwearing social distancing COVID19 patient strong fear stigma quarantined person strong fear contracting COVID19 Study participant responded necessary provide financial support adequate information isolationquarantine CONCLUSIONS study highlight importance precautionary behavior prevent COVID19 infection need provide support psychological financial patient quarantined person reinforce effective communication social solidarity public health emergency preparedness PHEP pandemic situation,covid-19 pandemic;isolation;online survey of patients and contacts;public health emergency preparedness;quarantine
Ultrasensitive highthroughput rapid simultaneous detection SARSCoV2 antigen IgGIgM antibody within 10 min immunoassay biochip,34282508,COVID19 severe threat global health Facing pandemic developed spaceencoding microfluidic biochip highthroughput rapid sensitive simultaneous quantitative detection SARSCoV2 antigen protein IgGIgM antibody serum proposed immunoassay biochip integrates advantage graphene oxide quantum dot GOQDs microfluidic chip capable conducting multiple SARSCoV2 antigen IgGIgM antibody 60 serum sample simultaneously 2 muL sample volume patient Fluorescence intensity antigen IgG antibody detection emission wavelength 680 nm used quantify target concentration excitation wavelength 632 nm emission wavelength 519 nm used detection IgM antibody excitation wavelength 488 nm method developed large linear quantification detection regime 5 order magnitude ultralow detection limit 03 pgmL optimized condition le 10min qualitative detection time proposed biosensing platform greatly facilitate rapid diagnosis COVID19 patient also provide valuable screening approach infected patient medical therapy vaccine recipient,covid-19;fluorescence detection;immunoassay biochip;sars-cov-2 igg/igm antibodies;sars-cov-2 antigens
Close proximity risk assessment SARSCoV2 infection,34225157,Although interpersonal distance represents important parameter affecting risk infection due respiratory virus mechanism exposure exhaled droplet remains insufficiently characterized study integrated risk assessment presented SARSCoV2 close proximity exposure speaking infectious subject susceptible subject based threedimensional transient numerical model description exhaled droplet spread emitted speaking person coupled recently proposed SARSCoV2 emission approach Particle image velocimetry measurement conducted validate numerical model contribution large droplet risk barely noticeable distance well 06 whereas drop zero greater distance depends airborne droplet particular short exposure 10 minimum safety distance 075 maintained lower risk 01 exposure 1 15 min distance increase 11 15 respectively Based interpersonal distance across country reported function interacting individual cultural difference environmental sociopsychological factor approach presented revealed addition intimate personal distance particular attention must paid exposure longer 1 min within social distance 1,cfd analysis;close proximity;droplets;piv;sars-cov-2;virus transmission
Covid19 Face Mask Protection Pediatric Setting,34221172,report experience regarding pediatric patientcase covid19 infection initially considered common viral infection managed accordingly first 36 hour hospitalized Wearing simple surgical face mask protective measure personnel adopted staff member tested covid19 infection swab specimen nasopharynx pharynx found negative 710 day coming contact patient Thirtyone day contact covid19 patient one staff member respiratory symptom therefore returned work case show importance facemask wearing prevent transmission various respiratory infection including caused novel SARSCoV2 microorganism,
Priorities action risk COVID19 pandemic flash survey among surgical oncologist,34222646,Objectives Corona virusinduced disease 19 COVID19 pandemic globally affected surgical treatment cancer patient challenged ethical principle surgical oncologist around world treatment also diagnosis followup disrupted Methods online survey sent Twitter surgical society worldwide survey consisted 29 closedended question conducted period 24 day beginning March 26 2020 Results Overall 394 surgical oncologist 41 different country answered questionnaire predominant guiding principle `` saving life 240 62 different aspect lockdown found hence large support mean 7193 10 Shutdown elective surgery modification cancer care found mean support 70 + 30 58 + 31 respectively Modification cancer care longer two week considered unacceptable 114 29 responder Hundred fifty six 40 138 36 expect `` return normal beyond six month surgical practice cancer care respectively Conclusions Surgical oncologist show strong longlasting support lockdown measure aiming save life impact pandemic surgical oncology perceived controversially majority forced already accept inacceptable many colleague,covid-19;priorities;surgical oncology
Seroprevalence antiSARSCoV2 total antibody higher younger Austrian blood donor,34132990,PURPOSE Frequently infection coronavirus 2 SARSCoV2 asymptomatic provoke mild symptom case often remain unnoticed difficult estimate actual number infection Aim study determine seroprevalence antiSARSCoV2 total antibody Austrian blood donor METHODS 20228 blood donor aged 18 72 year resident four Austrian federal state screened antiSARSCoV2 total antibody 5th June 4th December 2020 evaluate impact sex age AB0blood group donation period antiSARSCoV2 seroprevalence multiple logistic regression done RESULTS data reveal antiSARSCoV2 seroprevalence 25 overall significantly depending time point blood donation first Austrian lockdown seroprevalence lower compared following month rate constantly rising younger blood donor showed significantly higher seroprevalence difference found concerning sex AB0 blood group CONCLUSION Broad testing strategy required better determine number SARSCoV2 infection Screening blood donor representative group adult population could valid tool determine number recorded unrecorded case SARSCoV2 infection,blood donation;covid-19;sars-cov-2;seroprevalence
Potentials communitybased early detection cardiovascular disease risk COVID19 pandemic,34217235,BACKGROUND Coronavirus Disease 2019 COVID19 pandemic led significant decline Non Communicable Diseases NCD screening early detection activity especially Cardiovascular Disease CVD study aim ass potential communitybased selfscreening CVD risk mhealth application METHODS operational research actively involving community carry selfscreening mHealth application Community health worker recruited facilitator encourage community carry selfscreening evaluate potential communitybased selfscreening CVD risk use several indicator response rate level CVD risk community acceptance RESULTS 846 individual reached cadre 53 442 individual carried selfscreening Based result selfscreening CVD risk known around 213 high risk developing CVD next 10 year result evaluation semistructured question showed 48 people positive impression 22 assessed selfscreening could increase awareness informative 3 suggested improvement selfscreening tool CONCLUSION Cadres play important role reaching facilitating community environment remain aware health condition conducting selfscreening CVD risk availability mHealth application public easily access simplify CVD risk prediction expand screening coverage especially COVID19 pandemic social restriction policy community activity,covid-19;cardiovascular disease;community-based;early detection;mhealth
Traumatic Brain Injury SARSCoV2 Pandemic,34223525,Emergency department EDs eerily quiet illness apart COVID19 short communication assessed effect COVID19 ED attendance rate traumatic brain injury TBI Data collected consecutive patient TBI attending hospital Haaglanden Medical Center Hague Netherlands first 3 week Dutch lockdown March 18 April 6 period last year observed 36 decrease ED attendance TBI since beginning SARSCoV2 pandemic 91 vs 143 Patients presented lockdown significantly older compared patient visited ED previous year 72 vs 57 p = 001 significant difference found,covid-19;sars-cov-2;coronavirus;head trauma;traumatic brain injury
Surveillance Antibacterial Usage COVID19 Pandemic England 2020,34356762,Changes antibacterial prescribing COVID19 pandemic anticipated given clinical feature severe respiratory infection syndrome caused SARSCoV2 mirror bacterial respiratory tract infection Antibacterial consumption measured items1000 population primary care Defined Daily Doses DDDs 1000 admission secondary care England 2015 October 2020 Interrupted timeseries analysis conducted evaluate effect pandemic antibacterial consumption community rate antibacterial item prescribed decreased 2020 extra 14 per month 95 CI 23 05 compared COVID19 hospital volume antibacterial use decreased COVID19 overall 121 compared preCOVID 95 CI 191 44 although rate usage hospital increased steeply April 2020 Use antibacterial prescribed respiratory infection broadspectrum antibacterial predominately Watch antibacterial hospital increased setting Overall volume antibacterial use beginning COVID19 pandemic decreased primary secondary setting although increase rate usage hospital April 2020 specific antibacterial highlight importance antimicrobial stewardship pandemic ensure appropriate prescribing avoid negative consequence patient outcome antimicrobial resistance,covid-19;antibacterials;antibiotics;antimicrobial stewardship
Analysis Available Nutrition Recommendations Combat COVID19 Scoping Review,34285642,current COVID19 pandemic remains severe doubt COVID19 pandemic affecting every aspect life Currently spread inaccurate information fake news internet public causing community panic Thus study aim obtain available information food nutrition related prevention treatment COVID19 various source scoping review framework used chart evidence nutritional recommendation prevent COVID19 based preferred method reporting systematic review metaanalysis extension scoping review PRISMAScR article categorised three main group general dietary recommendation ii supplementation specific micronutrient iii mixture supplementation traditional herb miscellaneous food total 60 article met inclusion criterion used review scoping review demonstrates miracle cure food supplement cure prevent COVID19 Currently confirmed treatment vaccine disease Practicing healthy eating habit best nutritional recommendation pandemic Hence review hopefully provide evidencebased nutrition recommendation available current COVID19 treatment hope authority inform public medium stop spread nutrition pseudoscience wake COVID19 pandemic,covid-19;nutrition intervention;nutrition prevention;nutrition recommendation;pandemic
Mortality Predictors Patients Diagnosed COVID19 Emergency Department ECG Laboratory CT,34204209,Background Objectives aim study investigate parameter used predict mortality patient diagnosed COVID19 emergency department ED Materials Methods Patients diagnosed COVID19 ED included prospective study patient divided two group surviving patient included Group 1 survivor patient died included Group 2 nonsurvivors electrocardiogram ECG laboratory result chest computerized tomography CCT finding two group compared CCT image classified according finding normal mild moderate severe Results 419 patient included study 347 83 survived survivor 72 17 died nonsurvivor heart rate respiratory rate found higher peripheral oxygen saturation SpO2 diastolic blood pressure DBP found lower nonsurvivor patient QRS corrected QT interval QTc measured longer nonsurvivor patient CCT image 792 nonsurvivor patient severe finding 115 survivor patient severe finding WBC neutrophil NLR lactate Ddimer fibrinogen C Reactive Protein CRP urea creatinine creatine kinaseMB CKMB hsTroponin level found higher partial pressure carbon dioxide PCO2 base excess bicarbonate HCO3 lymphocyte eosinophil level found lower nonsurvivor patient highest AUC calculated SpO2 level eosinophil level Conclusions COVID19 fatal disease whose mortality risk estimated clinical laboratory imaging study patient evaluated together ED SpO2 measured starting oxygen therapy eosinophil level CT finding important predictor mortality risk,covid-19;computerized tomography;emergency medicine;laboratory;mortality
Influence lockdown due COVID19 weightloss result first year sleeve gastrectomy,34130814,INTRODUCTION COVID19 pandemic lead lockdown population many country Spain state alarm established March 15 June 20 2020 Usually fact decreased people s mobility physical activity addition producing exacerbating psychological disorder aim determine influence condition shortterm ponderal result patient undergoing laparoscopic vertical gastrectomy May 2019 May 2020 METHODS Casecontrol study comparing percentage excess weight lost EWL percentage total weight lost TWL patient underwent VG last year affected lockdown April part March 2020 group 1 EWL TWL control group group 2 obtained previous series RESULTS mean EWL group 1 4737+1859 group 2 5113+1759 P=438 Meanwhile mean TWL group 1 2114+817 group 2 2467+801 P=115 CONCLUSIONS Population lockdown COVID19 get worse shortterm result vertical gastrectomy study larger number patient necessary draw firm conclusion,bariatric surgery;covid-19;cirugia bariatrica;confinamiento;gastrectomia vertical;lockdown;manga gastrica;resultados;results;sleeve gastrectomy;vertical gastrectomy
Identification CrossReactive CD8 + Cell Receptors High Functional Avidity SARSCoV2 Immunodominant Epitope Natural Mutant Variants,34222571,Despite growing knowledge cell response COVID19 patient lack detailed characterization cellantigen interaction cell function predicted peptide library SARSCoV2 N protein restricted three prominent HLAA allele Asian population found specific CD8 + cell response identified 75 COVID19 convalescent patient 1520 total 15 SARSCoV2 epitope N protein identified among 3 dominant epitope characterized found epitope N protein N 361369 KTFPPTEPK dominant epitope selected peptide library Importantly discovered 2 N 361369 specific cell receptor TCRs high functional avidity independent CD8 coreceptor TCRs exhibited complementary crossreactivity several presently reported N 361369 mutant variant wildtype epitope natural function TCRs cytotoxic immunity SARSCoV2 determined dendritic cell DCs lung organoid model found N 361369 epitope could normally processed endogenously presented different type antigen presenting cell elicit successful activation effective cytotoxicity CD8 + cell ex vivo study evidenced potential mechanism cellular immunity SARSCoV2 illuminated potential way viral clearance COVID19 patient result indicate utilizing CD8independent TCRs SARSCoV2associated antigen may provide functional superiority beneficial adoptive cell immunotherapy based natural genetically engineered cell Additionally information highly relevant development nextgeneration vaccine protection continuously emerged SARSCoV2 mutant strain,cd8+ t cell;hla class i;lung organoid;sars-cov-2;t cell epitope;tcr
Modeling cardiac response hemodynamic change associated COVID19 computational study,34198390,Emerging study address COVID19 infection impact human cardiovascular system relates particularly development myocardial injury acute coronary syndrome myocarditis arrhythmia heart failure Prospective treatment approach advised patient study interplay local change reduced contractility global variable peripheral resistance heart rate cardiac function considered lumped parameter computational model cardiovascular system threedimensional multiphysics model cardiac electromechanics mathematical model allows simulate systemic pulmonary circulation four cardiac valve four heart chamber equation describing underlying physical process assessment conventionally relevant parameter cardiac function obtained numerical simulation propose computational model effectively reveal interaction cardiac pulmonary function virtual subject normal impaired cardiac function baseline affected mild severe COVID19, covid-19; cardiac function; cardiovascular system; computational models; numerical simulations
Performance Crisis Standards Care Guidelines Cohort Critically Ill COVID19 Patients United States,34337554,Many US state published crisis standard care CSC guideline allocating scarce critical care resource COVID19 pandemic However performance guideline maximizing population benefit well tested 2272 adult COVID19 requiring ICU admission drawn STOPCOVID multicenter cohort tested three approach CSC algorithm SOFA score grouped range SOFA score range plus comorbidities hypothetical approach using raw SOFA score grouped range found area receiver operating characteristic AUROC curve three algorithm demonstrate modest discrimination 28day mortality Adding comorbidity scoring modestly improves algorithm performance SOFA score alone algorithm incorporating comorbidities modestly worse predictive performance Black compared White patient CSC algorithm empirically examined refine approach allocation scarce resource pandemic avoid potential exacerbation racial inequity,crisis standards of care;critical care;intensive care;medical ethics;triage
Validated Mathematical Model Cytokine Release Syndrome Severe COVID19,34355020,June 2021 new contagious disease Coronavirus disease 2019 COVID19 infected 172 million people worldwide causing 37 million death Many aspect related interaction disease s causative agent SAR2CoV2 immune response well understood multiscale interaction among various component human immune system pathogen complex Mathematical computational tool help researcher answer open question disease work present system fifteen ordinary differential equation model immune response SARSCoV2 model used investigate hypothesis SARSCoV2 infects immune cell reason induces highlevel production inflammatory cytokine Simulation result support hypothesis explain survivor lower level cytokine level nonsurvivors,covid-19;sars-cov-2;citokine storm;computational immunology;mathematical modelling;sensitivity analysis
Perfect Storm COVID19 Associated Cardiac Injury Implications Neurological Disorders,34223524,Coronavirus disease 2019 COVID19 lead considerable lung damage even death Less known effect COVID19 cardiovascular system recent JAMA Cardiology article Shi colleague reported association cardiac injury higher risk inhospital mortality patient COVID19 Approximately 20 82 patient study cohort presented cardiac injury investigator identified cardiac injury independent risk factor mortality hospitalization 52 cardiac injury vs 5 without cardiac injury p 0001 Consequently finding highly relevant patient preexisting cardiovascular cerebrovascular disease Among patient neurological disorder considerable prevalence myocardial injury patient acute neurological illness appears adversely affect prognosis Individuals underlying neurological disorder particularly vulnerable increased cardiocerebrovascular disease risk due physical limitation pathophysiology condition Thus would like specifically highlight attention health care professional treating patient pervasive neurological disorder potentially elevated risk poorer COVID19 related outcome,covid-19;sars-cov-2;cardiac injury;injury-associated comorbidities;neurological disorders;risk factors
rapid review medication taking adherence among patient rheumatic disease COVID19 pandemic,34219400,OBJECTIVES aimed identify appraise synthesize contextualize rapidly emerging report medication taking adherence among patient rheumatic disease COVID19 pandemic METHODS searched MEDLINE EMBASE CINAHL peerreviewed communication letter manuscript published COVID19 pandemic evaluating medication taking among individual rheumatic disease appraised assessment reporting medication adherence according established definition three distinct problem medication taking ie noninitiation poor implementation discontinuation pooled finding using random effect model RESULTS included 31 peerreviewed study synthesis various jurisdiction 25 described medication taking among rheumatology patient 6 described medication prescribing among rheumatology provider pooled prevalence overall medication nonadherence 148 confidence interval CI 123 172 medication discontinuation ie stopping prescription poor implementation ie taking medication dosefrequency prescribed 95 CI 51 140 96 CI 62 130 respectively Noninitiation ie startingnot filling new prescription addressed CONCLUSIONS Medication taking among individual rheumatic disease COVID19 pandemic varies globally Unclear reporting extensive variation research method study creates barrier research replication comparison generalization specific patient population Future research area use consistent transparent approach defining measuring medication taking problem order ensure finding appropriately describe epidemiology medication adherence potential identify modifiable target improving patient care,covid-19;arthritis;medication adherence;rapid review;rheumatic disease
Potential Role Aberrant Mucosal Immune Response SARSCoV2 Pathogenesis IgA Nephropathy,34358031,outbreak severe acute respiratory syndrome coronavirus 2 SARSCoV2 become global concern Immunoglobin IgA contributes virus neutralization early stage infection Longitudinal study needed ass whether SARSCoV2specific IgA production persists longer time patient recovered severe COVID19 lasting symptom disabling consequence also alerted susceptible host tracked antiSARSCoV2 spike protein receptorbinding domain RBD antibody level cohort 88 COVID19 patient found 523 patient produced antiSARSCoV2 RBD IgA IgG IgM level IgA remained stable 441 day infection One IgAdominant COVID19 patient concurrently IgA nephropathy IgAN presented elevated serum creatinine worse proteinuria infection continued seven month postinfection serum level antiSARSCoV2 RBD total IgA higher patient healthy control Changes composition intestinal microbiota increased IgA highly coated bacteria elevated concentration proinflammatory cytokine IL18 indicative potential involvement intestinal dysbiosis inflammation systemic IgA level consequently disease progression Collectively work highlighted potential adverse effect mucosal immune response SARSCoV2 infection additional care taken COVID19 patient presenting chronic disease IgAN,covid-19;iga nephropathy;sars-cov-2;humoral immune response;intestinal dysbiosis and inflammation
Using mixedeffects modeling estimate decay kinetics response SARSCoV2 infection,34286216,duration natural immunity response severe acute respiratory syndrome coronavirus 2 SARSCoV2 matter debate literature present example recent publication characterizing SARSCoV2 immunity time author fit pooled longitudinal data using fitted slope infer duration SARSCoV2 immunity fact approach lead misleading conclusion result statistical modelfitting artifact exemplify phenomenon reanalyzed one marker pseudovirus neutralizing titer publication using mixedeffects modeling methodology better suited longitudinal datasets like finding showed halflife longer variable reported author example selected u illustrates utility mixedeffects modeling provide accurate estimate duration heterogeneity halflives molecular cellular biomarkers SARSCoV2 immunity,covid-19;durability of immune response;immunology;mixed-effects modeling;population pk/pd
Safety protocol exercise facility result detectable sarsCoV2 spread case study,34288594,Coronavirus 2019 COVID19 disease public health emergency international concern million confirmed case globally Closed environment reduced ventilation contribute spread COVID19 including superspreading event Exercising closed place increase risk transmission Therefore many fitness facility closed part mandated shutdown early pandemic Evidencebased safety protocol emerged substantially reduce risk transmission report three positive case SARSCoV2 identified Dojo exercise facility Manlius NY three distinct time point case present Dojo 2 day prior symptom time period considered highly infectious safety protocol included universal mask wearing valve multiple highefficiency particulate air HEPA filter reduced capacity resulted known spread COVID19,covid-19;exercise;safety protocols
Narrative Review Clinical Practicalities Bamlanivimab Etesevimab Antibody Therapies SARSCoV2,34374951,severity coronavirus disease 2019 COVID19 range mild death high morbidity mortality rate reported amongst vulnerable subset patient termed high risk vaccine remain primary option COVID19 prevention neutralizing monoclonal antibody mAbs bamlanivimab etesevimab shown benefit certain subpopulation exposure severe acute respiratory syndrome coronavirus 2 SARSCoV2 Unlike vaccinederived immunity develops time administration neutralizing mAbs immediate passive immunotherapy potential reduce disease progression emergency room visit hospitalization death Bamlanivimab alone together etesevimab hold emergency use authorization several country globally country increasingly transitioning use bamlanivimab etesevimab together authorized mAbs basis evolving variant landscape regulatory authorization access drug current guideline administration bamlanivimab alone together etesevimab informed iterative process testing development Herein rationale guideline provided sharing learning gathered throughout development process mAbs addition review address common clinical question received health care professional HCPs patient regarding indicated population dose use medication vaccine duration protection variant clinical practice prevalence SARSCoV2 variant differ country state prescribing HCPs consider prevalence bamlanivimab etesevimab resistant variant area data available regarding potential efficacy impact considering treatment optionsTrial Registration ClinicalTrialsgov identifier NCT04427501 NCT04411628 NCT04497987 NCT04634409,bamlanivimab;covid-19;clinical;etesevimab;health care practitioners;monoclonal antibodies;sars-cov-2;treatment
single centered study reveals association liver injury COVID19 infection,34220212,Despite fact year pandemic COVID19 infection ongoing research analysis reveal many complication comorbidities associated COVID19 study aimed investigating clinical laboratory assessment COVID19 patient without liver injury Methods Symptomatic 541 COVID19 positive patient admitted Al Kuwait Hospital Dubai United Arab Emirates UAE recruited study data collected retrospectively including demographic data blood test symptom radiographical assessment clinical outcome COVID19 Results Around 19 recruited COVID19 patient displayed sign acute liver injury Also increase percentage critical ICUadmitted mortality rate COVID19 case liver injury well higher percentage septic shock acute respiratory distress syndrome ARDS COVID19 patient liver injury pronounced bilateral consolidation lymphopenia neutrophilia Additionally patient higher level CRP LDH procalcitonin ferritin dimer level Finally higher percentage patient taking various COVID19 therapy COVID19 patient liver injury group Conclusion COVID19 patient acute liver injury higher risk serious outcome including death,covid-19;liver injury;uae;drugs;organ dysfunction
COVID19 Trigger Brain Autoimmunity,34213312,Entry SARSCoV2 central nervous system CNS activates microglia triggering chronic neuroinflammation possibly neurodegeneration complex transcriptome SARSCoV2 share molecular similarity diverse human CNS protein epitope leading cytokine storm various autoantibody potentially culminating autoimmune state COVID19 initiated CNS autoimmune cascade may occur via multiple pathway including molecular mimicry bystander activation epitope spreading production autoantibody immortalization effector Bcells,alzheimer's disease;covid-19;sars-cov-2;autoimmunity;blood-brain barrier;cytokine storm;dementia;neurodegenerative disease;neuroinflammation
SARSCoV2 Receptor Binding Domain StablePotential Target SARSCoV2 Detection SurfaceEnhanced Raman Spectroscopy,34283162,work report new approach detecting SARSCoV2 RBD protein RBD using surfaceenhanced Raman spectroscopy SERS technique optical enhancement obtained thanks preparation nanostructured AgAu substrate Fabricated AuAg nanostructures used SERS experiment RBD protein detection SERS substrate show higher capability sensitivity detect RBD protein short time 3 low power able push detection limit protein single protein detection level 1 pM latter equivalent 1 fM detection limit virus Additionally shown SERS technique useful figure presence RBD protein antibody functionalized substrate case SERS detection based proteinantibody recognition led shift Raman peak allowed signal discrimination RBD target Bovine serum albumin BSA protein perfect agreement 3D simulated model based finite element method experiment reported confirming SERS frequency shift potential trace protein detection result could open way develop new prototype based SERS sensitivity selectivity rapid detection low concentration virus even single protein level,bsa;sars-cov-2 receptor binding domain;sers;silver/gold nanostructures
Impact suspension restart Dutch breast cancer screening program breast cancer incidence stage COVID19 pandemic,34217417,COVID19 pandemic forced Dutch national breast screening program halt week 12 2020 week 26 breast program resumed 40 capacity increased 60 week 34 examined impact suspension restart screening program incidence screendetected nonscreendetected breast cancer selected woman aged 5074 diagnosed week 235 2018 n = 7250 2019 n = 7302 2020 n = 5306 Netherlands Cancer Registry Weeks 235 divided seven period based event occurring start COVID19 pandemic Incidence screendetected nonscreendetected tumor calculated overall age group cTstage cTNMstage period 2020 compared incidence period 20182019 averaged incidence screendetected tumor decreased week 1213 reached almost zero week 1425 increased week 2635 Incidence nonscreendetected tumor decreased lesser extent week 1216 decrease incidence seen age group mainly occurred cTis cT1 DCIS stage tumor Due suspension breast cancer screening program restart reduced capacity incidence screendetected breast tumor decreased 67 week 935 2020 equates 2000 potentially delayed breast cancer diagnosis August 2020 indication shift towards higher stage breast cancer restart screening,breast cancer incidence;breast cancer screening;covid-19;clinical tumor stage;ct-stage
Quantifying SARSCoV2 viral load current status future prospect,34369836,Introduction severe acute respiratory syndrome coronavirus2 SARSCoV2 emerged novel viral agent quickly spread worldwide SARSCoV2 responsible human coronavirus disease 2019 COVID19 claimed hundred thousand life immeasurable toll economy Currently clinical case identified qualitative molecular testing However need quantitative assessment gaining tractionAreas covered review current state future perspective SARSCoV2 viral load quantification presentedExpert opinion Viral load quantification critical measure informs clinician treatment response actionable viral load level guidance patient management Additionally pathogen epidemiological consequence viral load provide information guide infection control measure policy qualitative detection sufficient identify case initiate containment mitigation measure vast majority COVID19 case certain situation SARSCoV2 quantification needed ass viral load trending However obstacle quantification including variability respiratory specimen collection lack commutable reference material time need quantification clinical epidemiological management growing especially concerning individual prolonged RNA shedding,covid-19;molecular diagnostics;sars-cov-2;quantitative assay;viral load
RNA World SARSCoV2 Edited Story RNA Viral Evolution,34202997,current SARSCoV2 pandemic underscore importance understanding evolution RNA genome RNA subject formation similar lesion DNA evolutionary physiological impact RNA lesion viral genome yet characterized Lesions may drive evolution RNA genome induce break repaired recombination cause base substitution mutagenesis also known base editing past decade base editing mutagenesis DNA genome subject many study revealing exposure ssDNA subject hypermutation involved etiology cancer However base editing RNA genome studied extent Recently hypermutation singlestranded RNA viral genome also documented though role evolution population dynamic summarize current knowledge key mechanism cause RNA genome instability covering area RNA world theory SARSCoV2 pandemic today also highlight key question remain pertains RNA genome instability mutation accumulation experimental strategy addressing question,adar;apobec;rna editing;rna world theory;genome stability;hypermutation;messenger rna;viral rna;viral evolution
Punctate inner choroidopathy reactivation following COVID19 case report,34219492,PURPOSE purpose study report experience case punctate inner choroidopathy PIC reactivation following COVID19 CASE REPORT 29yearold caucasian woman past ophthalmological history bilateral PIC reported sudden visual acuity decrease right eye 3 week SARSCoV2 infection bestcorrected visual acuity BCVA 2032 fundus examination multimodal imaging including indocyaninegreen angiography fundus autofluorescence optical coherence tomography consistent unilateral PIC reactivation active choroidal lesion responded highdose corticosteroid functional improvement CONCLUSION SarsCoV2 infection could induce autoimmune autoinflammatory dysregulation genetically predisposed subject report case PIC reactivation following COVID19,retinal pathology;choroidal/retinal inflammation;immunology;retina
Risk factor long covid previously hospitalised child using ISARIC Global followup protocol prospective cohort study,34210789,BACKGROUND longterm sequela coronavirus disease 2019 Covid19 child remain poorly characterised study aimed ass longterm outcome child previously hospitalised Covid19 associated risk factor METHODS prospective cohort study child =18 year old admitted confirmed Covid19 Children admitted hospital April 2 2020 August 26 2020 included Telephone interview using International Severe Acute Respiratory emerging Infection Consortium ISARIC Covid19 Health Wellbeing paediatric followup survey Persistent symptom 5 month categorised system involved FINDINGS 518 853 61 eligible child available followup assessment included study Median age 104 year IQR 3152 270 521 girl median followup since hospital discharge 256 223271 day time followup interview 126 243 participant reported persistent symptom among fatigue 53 107 sleep disturbance 36 69 sensory problem 29 56 common Multiple symptom experienced 44 84 participant Risk factor persistent symptom older age `` 611 year odds ratio 274 95 confidence interval 137 575 `` 1218 year 268 141 54 history allergic disease 167 104 267 INTERPRETATION quarter child experienced persistent symptom month hospitalization acute covid19 infection almost one ten experiencing multisystem involvement Older age allergic disease associated higher risk persistent symptom followup,
Characteristics facial skin problem microbiome variation wearing mask fighting COVID19,34363249,COVID19 pandemic caused 168 million people infected 3 million people die 1 Although COVID19 vaccination work general population started herd immunity achieved short term term 2 Wearing mask still effective mean public prevent control spread COVID19 However occurrence facial skin problem caused wearing mask may condition influence maintenance mask wearing among public,
SARSCoV2 Vaccine Willingness among Pregnant Breastfeeding Women First Pandemic Wave CrossSectional Study Switzerland,34206645,pregnant woman high risk severe SARSCoV2 infection COVID19 vaccine available Switzerland study aimed ass willingness Swiss pregnant breastfeeding woman become vaccinated crosssectional online study conducted first pandemic wave vaccination practice willingness become vaccinated SARSCoV2 vaccine available evaluated binary multichoice openended question Factors associated vaccine willingness evaluated univariable multivariable analysis total 1551 woman responded question related primary outcome 297 153515 pregnant 386 4001036 breastfeeding woman willing get vaccinated SARSCoV2 vaccine available first wave Positive predictor associated SARSCoV2 vaccine acceptance age older 40 year higher educational level history influenza vaccination within previous year obstetrician primary healthcare practitioner third trimester pregnancy first pandemic wave Switzerland low SARSCoV2 vaccination acceptance rate emphasizing need identify reduce barrier immunization pregnant breastfeeding woman particularly among youngest lower educational level,covid-19;sars-cov-2;breastfeeding;coronavirus;pregnancy;vaccine willingness
COVID19 patient incubation period 27 case report,34368314,BACKGROUND highly contagious disease coronavirus disease 2019 COVID19 wreaking havoc around world due continuous spread among close contact mainly via droplet aerosol contaminated hand surface Therefore centralized isolation close contact suspected patient important measure prevent transmission COVID19 present quarantine duration country 14 due fact incubation period severe acute respiratory syndrome coronavirus type 2 SARSCoV2 usually identified 114 median estimate 475 d Since COVID19 patient incubation period also contagious case incubation period 14 need evaluated CASE SUMMARY 70yearold male patient admitted Department Respiratory Medicine First Affiliated Hospital Harbin Medical University April 5 due cough sputum shortness breath April 10 patient transferred Fever Clinic treatment due close contact one confirmed COVID19 patient room period April 10 May 6 nucleic acid antibody SARSCoV2 tested 7 4 time respectively negative May 7 patient developed fever maximum temperature 39 respiratory difficulty deteriorated result nucleic acid antibody detection SARSCoV2 positive May 8 nucleic acid antibody detection SARSCoV2 Heilongjiang Provincial Center Disease Control also positive patient diagnosed COVID19 reported Chinese Center Disease Control Prevention CONCLUSION case highlight importance SARSCoV2 incubation period epidemiological investigation clinical observation urgently needed identify optimal incubation period SARSCoV2 formulate rational evidencebased quarantine policy COVID19 accordingly,covid-19;case report;incubation period;quarantine duration;sars-cov-2
Scoring System Evaluate Performance ICU Ventilators Pandemic COVID19 Lung Model Study,34336879,Ventilators intensive care unit ICU lifesupport device help physician gain additional time cure patient aim study establish scoring system evaluate ventilator performance context COVID19 scoring system established weighting ventilator performance five different aspect stability pressurization response leak alteration performance reaction volume delivery accuracy oxygen delivery weighting factor determined analytic hierarchy process AHP Survey sent 66 clinical mechanical expert scoring system built based 54 valid reply total 12 commercially available ICU ventilator providing noninvasive ventilation evaluated using novel scoring system total eight ICU ventilator noninvasive ventilation mode four dedicated noninvasive ventilator tested according scoring system Four COVID19 phenotype simulated using ASL5000 lung simulator namely 1 increased airway resistance IR 10 cm H2OLs 2 low compliance LC compliance 20 mlcmH2O 3 low compliance plus increased respiratory effort LCIE respiratory rate 40 inspiratory effort 10 cmH2O 4 high compliance HC compliance 50 mlcmH2O ventilator set three combination pressure support positive endexpiratory pressure level data collected baseline three customized leak level Significant inaccuracy variation performance different noninvasive ventilator observed especially aspect leak alteration oxygen volume delivery ventilator stable performance different simulated phenotype whereas others 10 scoring difference feasible use proposed scoring system evaluate ventilator performance COVID19 pandemic clinician aware possible strength weakness ventilator,accuracy in volume delivery;analytic hierarchy process;leakage correction;performance of triggering;scoring system;stability of pressurization;ventilator performance
Cardiovascular adverse effect lopinavirritonavir hydroxychloroquine COVID19 patient Cases single pharmacovigilance centre,34285902,article summarize cardiovascular adverse event observed three patient treatment COVID19 discus association lopinavir ritonavir LPVr hydroxychloroquine HCQ case reported regional pharmacovigilance centre April 2020 three patient 75 year age male multimorbid hospitalized treatment COVID19 part treatment received strictly monitored offlabel therapy LPVr HCQ given prior written informed consent one patient erythromycin also administered three patient developed significant QTc time prolongation shortly therapy drug account treatment discontinued early case QTc time recovered three patient,
Human Stem Cell Models SARSCoV2 Infection Cardiovascular System,34365591,virus responsible coronavirus disease 2019 COVID19 severe acute respiratory syndrome coronavirus 2 SARSCoV2 infected 190 million people date causing global pandemic SARSCoV2 relies binding spike glycoprotein angiotensinconverting enzyme 2 ACE2 infection addition fever cough shortness breath severe case SARSCoV2 infection may result rapid overproduction proinflammatory cytokine overactive immune response known cytokine storm lead several serious clinical manifestation acute respiratory distress syndrome myocardial injury Cardiovascular disorder acute coronary syndrome ACS heart failure enhance disease progression onset infection also arise hospitalized patient COVID19 Tissuespecific differentiated cell organoids derived human pluripotent stem cell hPSCs serve excellent model address SARSCoV2 damage lung heart review summarize molecular basis SARSCoV2 infection current clinical perspective bidirectional relationship cardiovascular system viral progression Furthermore also address utility hPSCs dynamic model SARSCoV2 research clinical translation,covid-19;cytokine storm;heart failure;human pluripotent stem cells;sars-cov-2
SARSCoV2 detection wastewater early warning indicator COVID19 pandemic Madrid region case study,34364862,COVID19 pandemic ongoing year changed priority boosted WBE study aim work contributed knowledge sharing methodology developed SARSCoV2 detection wastewater Madrid region six million half inhabitant sewer system combined system first pilot test small metropolitan area carried order define criterion selection sampling point applied entire region Methodologys laboratory analysis statistical analysis interpretation data also presented work relies highly fieldwork sewer network safe accessibility paramount total 289 sampling point weekly characterised sampling point represents sewershed cascade distribution Samples tested SARSCoV2 concentration gcL genome copy per litre physicochemical parameter also analysed validate discard first could unusual virus presence Field result correlated health indicator incidence rate hospitalisation data information daily shared regional health authority disaggregated municipality aggregated entire Madrid region Results proved anticipate health indicator tool used early warning indicator COVID19 pandemic work planned apply current scheme permanent epidemiological surveillance system 87 sampling point pinpoint infection hotspot activate linked sewersheds event outbreak,covid-19;public health methodology;sars-cov-2;wbe;wastewater-based epidemiology (wbe)
Clinicopathologic Findings COVID19Associated Ischemic Enterocolitis,34292620,AIMS Coronavirus disease 2019 COVID19 recognized predominantly respiratory tract infection patient manifest severe systemic symptomscoagulation abnormality evaluated impact severe COVID19 infection gastrointestinal tract METHODS RESULTS examined clinicopathologic finding 28 resected ischemic bowel 22 patient severe COVID19 patient required intubation preoperatively presented acute decompensation shortly surgery Ddimer level markedly elevated measured case mean 5394 ngmL Histologically 25 case 19 patient showed evidence acute ischemia necrosis group characteristic finding presence small vessel fibrin thrombus 2425 case 96 numerous 64 case Compared control cohort 35 nonCOVID19related acute ischemic bowel patient COVID19 significantly likely show isolated small intestine involvement 32 vs 6 p 0001 small vessel fibrin thrombus 100 vs 43 p 0001 submucosal vessel fibrinous degeneration perivascular neutrophil 90 vs 54 p 0001 fibrin strand within submucosal vessel 58 vs 20 p=0007 histologic evidence pneumatosis 74 vs 34 p=0010 Three case cohort histopathologic finding normally seen setting chronic ischemia notably prominent fibroblastic proliferation affecting outer layer muscularis propria CONCLUSIONS Herein describe histopathologic finding COVID19associated ischemic bowel postulate relationship hypercoagulable state seen patient severe COVID19 infection Additional experience case may elucidate specific feature mechanism COVID19associated ischemic enterocolitis,covid-19;fibrin thrombi;gastrointestinal;ischemic enterocolitis;microthrombi
reproductive number Delta variant SARSCoV2 far higher compared ancestral SARSCoV2 virus,34369565,Delta variant replacing SARSCoV2 variant found mean R0 508 much higher R0 ancestral strain 279 Rapidly ramping vaccine coverage rate enhancing public health social measure even urgent important,alpha variant;b1.617.2;covid-19;delta variant;r0;sars-cov-2;variants of concerns;wuhan;basic reproductive number;epidemic potential;pandemic;transmissibility
Clinical Characteristics Outcomes Patients Hospitalized COVID19 Pneumonia Developed Bradycardia,34215897,OBJECTIVE ass clinical characteristic clinical outcome bradycardic patient coronavirus disease 2019 COVID19 pneumonia METHODS electronic medical record 221 consecutive patient hospitalized COVID19 pneumonia June September 2020 retrospectively reviewed Patient characteristic electrocardiographic data clinical laboratory information retrospectively collected Patients treated drug blunt chronotropic response nodal analyzed separately RESULTS patient whose heart rate 60 beat per minute bpm 136221 615 included Serial electrocardiography revealed patient 130137 977 remained sinus rhythm heart rate 50 59 bpm 75 patient 184 40 49 bpm range 66 40 bpm Medians development bradycardia swab polymerase chain reaction positivity duration bradycardia 41 hour 5 day respectively Bradycardia resolved 81 patient 596 statistically significant difference outcome according degree bradycardia 50 v 5059 P = 0073 significant difference noted overall cohort comparing COVID19 treatment according resolution bradycardia however considering patient receiving nodal agent antiarrhythmic treatment lenzilumab common patient resolution bradycardia patient without resolution bradycardia 122 v 00 P = 0030 CONCLUSIONS Sinus bradycardia occurs frequently patient severe COVID19 degree bradycardia correlate clinical outcome Lenzilumab may associated resolution bradycardia,
Dog Walking COVID19 Pandemic Lockdown Experiences UK Dog Owners,34200926,BACKGROUND study investigated impact first COVID19 UK lockdown dog walking ownership METHODS online survey circulated via social medium MayJune 2020 Completed response n = 584 analysed using within betweengroup comparison multivariable linear logistic regression model created Openended data coded key theme RESULTS lockdown dog walked le frequently yet similar duration per week closer home Dogs whose owner lived alone whose owner household member heightened vulnerability COVID19 walked le highenergy dog minority owner continued dog walking despite exhibiting symptom needing selfisolate justifying lack help dog behavioural problem living le populated area importance outdoor exercise mental health Dog ownership multiple benefit companionship purpose motivation break bad positive focus well challenge change dog behaviour balancing dog need public health guidance accessing pet foodsupplies service sharing crowded outdoor space others emergency care plan pet pandemic handful developed one CONCLUSIONS Findings used inform public health dog welfare strategy future lockdown situation disaster emergency likely impact daily routine,covid-19;dog ownership;dog walking;lockdown;pandemic;public health
Risk factor mortality adult patient COVID19 hospitalised emerging country cohort study,34281931,OBJECTIVE describe mortality inhospital patient COVID19 compare risk factor survivor nonsurvivors DESIGN Prospective cohort adult inpatient SETTING Tertiary healthcare teaching hospital Guadalajara Mexico PARTICIPANTS patient confirmed COVID19 hospitalised 25 March 7 September 2020 included End study 7 November 2020 PRIMARY OUTCOME MEASURES Patient survival analysed KaplanMeier method comparison factor logrank test Mortality risk factor analysed multivariate Cox s proportionalhazard model RESULTS One thousand ten patient included 386 38 died 618 61 alive discharge six 06 remained hospitalised predominance men 63 high frequency overweightobesity 71 hypertension 54 diabetes 40 lung 9 cardiovascular 8 kidney disease 11 significantly frequent nonsurvivors Overweightobesity different group severity disease Manchester Triage System quick Sequential Organ Failure Assessment significantly worse nonsurvivors also significantly older 65 v 45 year respectively haematological biochemical coagulation inflammatory biomarkers altered survivor Mortality predictor invasive mechanical ventilation IMV 331 p 00001 admission intensive care unit ICU 218 p 00001 age 102 p 00001 Manchester Triage System urgent 144 p=002 immediatevery urgent 202 p=0004 baseline C reactive protein CRP 1002 p=0009 antecedent kidney disease 158 p=004 CONCLUSIONS Mortality hospitalised patient COVID19 emerging country centre seemed higher developed country Patients displayed high frequency risk factor poor outcome need IMV ICU admission older age severe disease admission antecedent kidney disease higher CRP level significantly predicted mortality,covid-19;infectious diseases;internal medicine;public health
Emerging Advances Nanotechnology Drug Vaccine Delivery Viral Associated Respiratory Infectious Diseases VARID,34203268,Viralassociated respiratory infectious disease one prominent subset respiratory failure known viral respiratory infection VRI VRIs proceeded infection caused virus infecting respiratory system past 100 year viral associated respiratory epidemic common cause infectious disease worldwide Due several drawback current antiviral treatment drug resistance generation nontargeting viral protein development novel nanotherapeutic nanovaccine strategy considered essential Due specific physical biological property nanoparticles hold promising opportunity antiviral treatment vaccine viral infection Besides specific physiological property respiratory system significant demand utilizing nanodesigns production vaccine antiviral agent airwaylocalized administration SARSCoV2 immediate example respiratory virus enveloped positivesense singlestranded RNA virus belonging coronaviridae family COVID19 lead acute respiratory distress syndrome similarly member coronaviridae Hence reviewing current past emerging nanotechnologybased medication similar respiratory viral disease identify pathway towards generating novel SARSCoV2 nanotherapeutics andor nanovaccines,covid-19;sars-cov-2;nano-vaccine;nanomedicine;respiratory disease;viral infection
Impact Telehealth Intervention Activity Profiles Older Adults COVID19 Pandemic Pilot Study,34209416,BACKGROUND Physical inactivity COVID19 pandemic public health concern older adult Telehealth present safe platform conducting healthrelated intervention may additional benefit widespread reach pilot study sought examine telehealth intervention changed activity profile older adult COVID19 pandemic METHODS n =13 adult aged 706 + 45 year participated 6 week telehealth intervention COVID19 pandemic didactic intervention content shared online participant worked trained interviewer telephone discus physical activity baseline postintervention Multimedia Activity Recall Children Adults examined activity profile accelerometry estimated time spent sedentary physical activity RESULTS Relative baseline measure 88 minday 95 confidence interval CI 39 137 increase computer time 36 minday CI 10 62 reduction time spent active transport postintervention Moderatetovigorous physical activity participation also increased estimated 2 minday CI 21 26 12 minweek CI 154 180 trend statistically significant CONCLUSION recommend support provided older adult transitioning telehealth especially migration telehealth progress,aging;computers;exercise;geriatrics;internet;movement;telemedicine
Tofacitinib Patients Hospitalized Covid19 Pneumonia,34133856,BACKGROUND efficacy safety tofacitinib Janus kinase inhibitor patient hospitalized coronavirus disease 2019 Covid19 pneumonia unclear METHODS randomly assigned 11 ratio hospitalized adult Covid19 pneumonia receive either tofacitinib dose 10 mg placebo twice daily 14 day hospital discharge primary outcome occurrence death respiratory failure day 28 assessed use eightlevel ordinal scale score ranging 1 8 higher score indicating worse condition Allcause mortality safety also assessed RESULTS total 289 patient underwent randomization 15 site Brazil Overall 893 patient received glucocorticoid hospitalization cumulative incidence death respiratory failure day 28 181 tofacitinib group 290 placebo group risk ratio 063 95 confidence interval CI 041 097 P = 004 Death cause day 28 occurred 28 patient tofacitinib group 55 placebo group hazard ratio 049 95 CI 015 163 proportional odds worse score eightlevel ordinal scale tofacitinib compared placebo 060 95 CI 036 100 day 14 054 95 CI 027 106 day 28 Serious adverse event occurred 20 patient 141 tofacitinib group 17 120 placebo group CONCLUSIONS Among patient hospitalized Covid19 pneumonia tofacitinib led lower risk death respiratory failure day 28 placebo Funded Pfizer STOPCOVID ClinicalTrialsgov number NCT04469114,
Modelling Analysis COVID19 Transmission State Emergency Japan,34206732,ass effectiveness containment strategy proposed Japan SEIAQR susceptibleexposedinfectedasymptomaticquarantinedrecovered model established simulate transmission COVID19 divided spread COVID19 Japan different stage based policy effective reproduction number transmission parameter determined evaluate measure conducted Japanese Government period 7 April 2020 Japanese authority declared state emergency control rapid development pandemic Based simulation result spread COVID19 Japan inhibited containment action state emergency effective reproduction number reduced 199 state emergency 092 state emergency transmission parameter fitted characterized quantifiable variable including ratio untracked case PCR test index proportion COCOA app user official contact confirming application impact variable control COVID19 investigated modelling analysis 8 January 2021 Japanese Government declared another state emergency simulated result demonstrated spread could controlled May keeping strategy higher intensity PCR testing suggested larger proportion COCOA app user reduce final number infection time needed control spread COVID19,covid-19;containment policies;mathematical modelling;state of emergency
Dynamic Assay Profiling AntiSARSCoV2 Antibodies ACE2Spike RBD Neutralization Capacity,34372581,Serological assay widely employed coronavirus disease 2019 COVID19 pandemic measure antibody response severe acute respiratory syndrome coronavirus 2 SARSCoV2 track seroconversion population However currently available assay allow determination neutralization capacity within assay protocol Furthermore commercial serology assay high buyin cost inaccessible many research group replicated serological enzymelinked immunosorbent assay detection SARSCoV2 antibody isotypes developed Icahn School Medicine Mount Sinai New York Additionally modified protocol include neutralization assay minor modification protocol used assay screen local COVID19 patient serum n = 91 preCOVID19 control serum n = 103 obtained approximate parity approved commercial antinucleoproteinbased assay serum Furthermore data neutralization assay closely aligns generated using spikebased pseudovirus infection model subset patient serum analyzed,sars-cov-2;antibody;enzyme-linked immunosorbent assay;neutralization;pseudovirus infection model;serology
Time belief exercise importance predict increased activity initial COVID19 restriction Ireland,34293147,aim work investigate physical activity level associated barrier facilitator physical activity Irish adult initial COVID19 restriction Members general population completed online questionnaire Responses 1274 participant 12741568 81 completion rate indicated majority 461 n = 587 people active usual restriction however 286 n = 365 reported le active Fiftyfive percent 553 n = 702 participant meeting public health physical activity guideline half 533 n = 679 reported finding new way active Walking 86 n = 1101 physical activity home 47 n = 593 online resource 38 n = 483 frequently reported time physically active 2326 SD 19482794 greater belief importance physical activity 1192 SD 10011444 predictive exercising usual unable access usual mean exercise 1612 SD 13691902 advised go outside home 1402 SD 11651698 working usual 1201 SD 10131443 predictive exercising le usual positive trend physical activity engagement Irish adult initial COVID19 restriction likely influenced governmental decision permitting people leave home exercise increased use homebased online exercise resource However almost one three people reported le active usual highlighting need targeted support restriction period,covid-19;barriers;exercise;facilitators;physical activity
Knowledge Perceptions COVID19 among Health Care Workers Evidence COVID19 Hospitals Second Pandemic Wave,34287390,Health care worker HCWs face higher risk infection since work front line COVID19 patient management Misinterpretations current scientific evidence among HCWs may impact delivery appropriate care COVID19 patient increase risk SARSCoV2 transmission hospital setting Moreover knowledge may affect HCWs perception depending broad belief past experience aim study explore knowledge perception HCWs regarding COVID19 issue second wave pandemic crosssectional survey involving printed questionnaire conducted 21 October 2020 31 January 2021 four tertiary care hospital located four distant geographical region Greece total 294 HCWs participated study majority HCWs provided precise response regarding general knowledge perception practice concerning COVID19 pandemic However response hand hygiene antimicrobial use HCWs COVID19 mistaken study reveals certain degree misconception knowledge gap HCWs everyday practice especially regarding hand hygiene antimicrobial use COVID19 patient,covid-19;sars-cov-2;attitudes;healthcare workers;knowledge;perceptions
COVID19 outbreak investigation geriatric palliative hospital,34228187,BACKGROUND second COVID19 wave large COVID19 outbreak happened 90bed geriatric palliative care hospital December 2020 whereby 32 healthcare personnel HCP 29 patient became infected within 23 day 13 patient died bed occupancy rate dropped 20 Drastically enhanced hygiene measure directly outbreak detection could stop nosocomial infection among patient le effective among HCP OBJECTIVE Outbreak investigation detection risk factor infection HCP MATERIAL METHODS Anonymous online survey among HCP January February 2021 investigating potential risk factor PCR positive infection poorly fitting FFP2 mask close contact positive patient team meeting positive HCP RESULTS 184 HCP 96 completed survey 522 including 38 became infected HCP 8 remained asymptomaticoligosymptomatic 30 HCP became ill median 10 day 2 continuously Factors associated infection close contact positive patient timedependent manner despite wearing FFP2 mask 60 95 CI 1622 88 HCP 55 described poorly fitting FFP2 mask infection mostly attributed longer contact positive sometimes restless patient overall exhausting working situation repeatedly mentioned CONCLUSION COVID outbreak within careintense geriatric context challenging control especially among HCP Longer patient contact limited compliance patient counteracts strict hygiene measure Vulnerability HCP patient requires additional preventive intervention rapidly effective vaccination priority health policy,coronavirus;disease outbreak;geriatrics;health personnel;personal protective equipment
Ability willingness utilize telemedicine among rheumatology patientsa crosssectional survey,34219187,INTRODUCTIONOBJECTIVES study aim ass patient ability willingness utilize telemedicine TM along identifying barrier widespread adoption TM rheumatology METHODS observational crosssectional study patient visiting rheumatology clinic conducted 2018 used survey ass patient attitude perceived effectiveness comparing TM versus inperson visit well patient access technology distance traveled patient attend clinic visit demographic parameter RESULTS total 214 patient included Negative correlation found increase age access technology frontfacing camera mean age difference 128 telephone mean age difference 144 stable internet connection mean age difference 151 well believing need could met TM r 224 p 0001 thinking TM could appropriate alternative method healthcare r 298 p 0001 Younger patient reported conflict appointment work hour mean age difference 1173 Followup patient likely feel visit could possible phone mean difference 113 video conferencing mean difference 113 compared new patient Older patient le likely think purpose rheumatology visit could achieved phone r 207 p = 0003 video conferencing r 331 p = 0001 distance traveled patient willing utilize TM compared inperson visit r 0167 p = 0019 CONCLUSION necessity due COVID19 pandemic rheumatology clinic increasingly turning TM result study suggest access familiarity technology may still limited certain demographic particularly elderly Furthermore study help understand additional barrier widespread adoption patient perceived limitation TM Key Points study aimed ass rheumatology patient willingness utilize telemedicine TM determining factor barrier may exist widespread adoption TM using crosssectional survey setting rheumatologic clinic age patient significant contributing factor patient s perception TM older patient le likely think purpose rheumatology visit could achieved phone via videoconferencing social trend limited access technology among elderly population reinforced result study Patients greater commute clinic likely willing utilize TM consultation result study highlight elevated difficulty elderly patient population utilizing TM current outbreak COVID19 importance utilizing TM specifically among elderly population could prove vital Future study focus elderly population method helping patient become familiar TM would beneficial Studies help orchestrate future guideline TM field rheumatology Based study result newpatient encounter inperson facetoface encounter whenever possible followed TM visit established patient able open using depending diagnosis symptom individual patient,rheumatology;technology;telemedicine
Applications separation technology novel coronavirus research epidemic prevention detection,34227364,novel coronavirus disease 2019 COVID19 outbreak brought light unprecedented challenge global public health security Researchers devoted effort indepth research severe acute respiratory syndrome coronavirus 2 SARSCoV2 bring epidemic control rapidly possible Among many area burgeoning SARSCoV2 related research various analytical technology applied advancement virus detection development vaccine innovative therapy Separation technology merit simple operation high separation efficiency high selectivity become widely used key progress life science medicine pharmaceutical discovery development field Separation technology played irreplaceable role isolation detection diagnosis treatment prevention novel coronavirus review overview relevant literature presented ISI Web Science spanning Jan 1st 2020Dec 31 2020 using `` SARSCoV2 `` COVID19 keywords top 20 research direction summarized based paper published high impact international journal e g Nature Science Cell Incorporating impact published paper review summarizes primary separation technology applied coronavirus study discus contribution following six technology affinity chromatography size exclusion chromatography liquid chromatography magnetic bead separation technology centrifugal technology micronanoseparation technology electrophoresis First affinity chromatography size exclusion chromatography discussed frequently used protein purification technique Nature Science Cell SARSCoV2 related protein purified affinity chromatography size exclusion chromatography summarized application coronavirus transmission infection mechanism drug screening introduced Subsequently high performance liquid chromatography HPLC introduced mainly employed assessing purity candidate drug Liquid chromatographytandem mass spectrometry LCMSMS incorporates strength HPLC MS offering high separation efficiency structural analysis capability extended application LCMSMS applied characterization binding SARSCoV2 related protein potential inhibitor metabolic analysis candidate drug SARSCoV2 nucleic acid test magnetic bead separation technology play crucial role separation novel coronaviruses combination analytical technique magnetic bead separation technology applied cytological analysis immunological detection functionalization bead surface Centrifugal technology undoubtedly basic separation technology employed almost SARSCoV2 related research controlling centrifugation speed centrifugal technology rapidly isolate virus particle cultured cell complex sample Micronano separation technology microfluidics offer advantage including small size low sample consumption rapid diffusion large surface area general microfluidic technology often used combination technology realize highly sensitive detection SARSCoV2 related protein Finally application electrophoresis introduced commonly engages analysis polymerase chain reaction PCR product novel coronavirus study application electrophoresis relatively limited potential development contribute significantly future research conclusion review summarizes contribution six primary separation technology novel coronavirus study including epidemic detection prevention analyzes main problem facing coronavirus detection effort discus role separation technology addressing problem aim providing reference broader application separation technology,affinity chromatography (ac);centrifugation;electrophoresis;liquid chromatography (lc);magnetic bead separation;micro/nano-separation;separation technology;severe acute respiratory syndrome coronavirus 2 (sars-cov-2);size exclusion chromatography (sec)
SARSCoV2 infection global outbreak implication public health,34366657,Background novel corona virus formally named severe acute respiratory syndrome coronavirus 2 SARSCoV2 result causing coronavirus disease 2019 COVID19 latest prevalent pandemic worldwide compared infectious disease like Avian flu Middle East respiratory syndrome severe acute respiratory syndrome SARS Main body Coronavirus disease 2019 COVID19 currently occurring pandemic world emerged Wuhan China end December 2019 spreading across worldwide coronavirus spreading easily direct contact infected people droplet inhalation also air droplet hit huge amount population even reported death Still small amount asymptomatic transmission people spread throughout globe People need special care protect transmission disease However drug far show efficacy immediate need development vaccine order decrease COVID19 case organization rapidly involve preparation vaccine many vaccine developed various country government took safety measure control spread virus also minimize morbidity mortality rate least possible Conclusion purpose review article increase understanding COVID19 facilitate people take move facing challenge world,ace2 receptors;covid-19;pandemic;sars-cov-2019;structural proteins
Acute mesenteric ischemia small bowel imaging finding COVID19 comprehensive review literature,34354803,BACKGROUND Coronavirus disease 2019 COVID19 infectious condition caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 rapidly spread worldwide since first description Wuhan December 2019 Even though respiratory manifestation prevalent responsible disease morbidity mortality extrapulmonary involvement progressively gained relevance particular gastrointestinal GI sign symptom reported twothirds patient COVID19 might represent first case disease presentation presence associated study increased risk severe disease course Proposed pathogenic mechanism explaining GI tract involvement either direct viral access intestinal cell via angiotensinconverting enzyme 2 indirect damage intestinal wall mesenteric ischemia induced hypercoagulable state associated COVID19 infection Although typical SARSCoV2 infection several small bowel manifestation described infected patient underwent form abdominal imaging radiological finding mainly reported patient abdominal symptom among abdominal pain common AIM discus small bowel radiological manifestation SARSCoV2 infection abdominal imaging study METHODS Bibliographical search performed PubMed using following keywords `` COVID19 `` imaging `` gastrointestinal `` abdominal `` small bowel RESULTS 62 patient described radiologic small bowel alteration mesenteric ischemia diagnosed 31 case 50 small bowel wall thickening 10 case 16 pneumatosis nine case 15 intussusception eight case 13 pneumoperitoneum two case 3 paralytic ileus two case 3 also reported mesenteric adipose tissue hypertrophy lymph node enlargement young woman CONCLUSION far difficult establish whether manifestation direct consequence SARSCoV2 infection collateral finding infected patient recognition would pivotal set closer followup reduce missed diagnosis,abdomen;covid-19;radiology;sars-cov-2;small intestine
ComputerAidedDiagnosis Service Decentralized Medical Cloud Efficient Rapid Emergency Response Intelligence,34219860,COVID19 pandemic resulted significant increase workload emergency system healthcare provider around world emergency system dealing large number patient various stage deteriorating condition require significant medical expertise accurate rapid diagnosis treatment issue become prominent place lack medical expert stateoftheart clinical equipment especially developing country machine intelligence aided medical diagnosis system provide rapid dependable autonomous lowcost solution medical diagnosis emergency condition paper privacypreserving computeraided diagnosis CAD framework called Decentralized deep Emergency response Intelligence DEI provides secure machine learning based medical diagnosis cloud proposed proposed framework provides blockchain based decentralized machine learning solution aid health provider medical diagnosis emergency condition DEI us blockchain smart contract train CAD machine learning model using data medical cloud preserving privacy patient record Using proposed framework data patient help increase overall accuracy CAD model balancing diagnosis datasets minority class special case case study DEI demonstrated solution COVID19 diagnosis DEI framework help pandemic management providing rapid accurate diagnosis overwhelming medical workload condition,blockchain;covid-19 pandemic;computer aided diagnosis;emergency response;machine learning
COVID19 first pandemic postgenomic era,34352474,scale international effort sequence SARSCoV2 genome unprecedented Early availability genome allowed rapid characterisation virus thus kickstarting many highly successful vaccine development programme Worldwide genomic resource provided good understanding pandemic supported close monitoring emergence viral genomic diversity pinpointed site prioritise functional characterisation Continued genomic surveillance global viral population crucial inform timing vaccine update preempt spread immune escape lineage genome sequencing provided u exceptionally powerful tool monitor evolution SARSCoV2 room improvement particular form le heterogeneous global surveillance tool rapidly identify concerning viral lineage,
Current Infection Prevention Control Strategies COVID19 Hospitals,34289652,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus2 SARSCoV2 appeared first China since December 2019 Transmission SARSCoV2 occurs primarily droplet coughing sneezing also occurs inhalation aerosolized secretion travel remain suspended air longer Since early outbreak described COVID19 case healthcare worker HCWs early stage disease may asymptomatic may lead incorrect diagnosis delayed diagnosis may lead nosocomial spread virus One important cause transmission among HCWs aerosolized virus closed environment long time possible prevent control spread COVID19 hospital outpatient treatment triage Infection control measure including wearing surgical mask hand hygiene social distance considered essential preventing humantohuman transmission SARSCoV2 Immediate response practice infection control measure critical saving life epidemic inside outside hospital Analyzing current knowledge feature SARSCoV2 infection screening personal protection protocol triage psychological support practice healthcare professional promising term controlling infection,covid-19;healthcare workers;infection;prevention and control
Modeling spread COVID19 New York City,34226811,paper proposes ensemble predictor weekly increase number confirmed COVID19 case city New York zip code level Within Bayesian model averaging framework baseline Poisson regression count data set covariates includes autoregressive term spatial effect demographic socioeconomic variable result second wave coronavirus pandemic show regressors significant predict number new confirmed case pandemic unfolds pointwise interval forecast exhibit strong predictive ability insample outofsample,bayesian model averaging;covid-19;poisson regression;prediction models;spatial effects
COVID19 Changed Incidence Pattern Pediatric Traumas SingleCentre Study Pediatric Emergency Department,34207263,first wave COVID19 spread worldwide March May 2020 Italy one country world lockdown period prolonged restrictive date impact prolonged lockdown pediatric trauma fully investigated paper aimed analyze compare 2019 incidence fracture pattern patient admitted pediatric hospital total lockdown period singlecenter retrospective study performed data gathered Pediatric Emergency Department PED Bambino Gesu Children Hospital Rome Palidoro PED pediatric referral center Rome hub pediatric trauma region admission diagnosis fracture trauma sprain dislocation lockdown period 10 March4 May included demographic data diagnosis type treatment fracture segment bone involvement time interval trauma presentation PED recorded 2020 reduction total trauma fracture compared 2019 p 0001 occurred 81 Superior limb inferior limb fracture decreased 2020 compared 2019 p 005 identification pediatric trauma fracture trend could useful reorganize PED Epidemiological data previous lockdown could helpful prepare healthcare system new pandemic wave Moreover sharing national statistic correlating country protocol could helpful solve problem case worldwide emergency situation,covid 19;children;epidemiology;fracture;lockdown;pediatric;trauma
Otitis Media Disappeared COVID19 Pandemic Fortuitus Effect Domestic Confinement,34199138,BACKGROUND measure patient flow Pediatric Emergency Department PED Italian lockdown particular care term otolaryngological ENT related diagnosis METHODS retrospective evaluation electronic chart child admitted PED City Center Milan Italy disease outcome compare distribution diagnosis performed PED 21 February3 May 2019 period 1 21 February3 May 2020 period 2 RESULTS total 4538 child evaluated period 1 compared 1310 period 2 statistically significant overall effect diagnosis study period attested pvalue 0001 pseudo R2 = 0010 ENTrelated diagnosis frequently documented period 1 804 vs 195 pvalue 0001 well related middle ear infection 928 vs 72 pvalue 0001 Noncomplicated acute otitis medium frequently occurred period 1 920 vs 80 pvalue 0001 significant difference number complicated middle ear infection occurred 958 vs 42 CONCLUSIONS exceptional circumstance Italian lockdown resulted significant decrease patient attendance PED especially considering diagnosis related ENT disorder middle ear disease noncomplicated middle ear infection,covid-19;children;emergency;infection;otitis media
Roles existing drug drug target COVID19 management,34222852,December 2019 highly transmissible pneumonia epidemic caused novel coronavirus severe acute respiratory syndrome coronavirus 2 SARSCoV2 erupted China country resulting devastation health crisis worldwide currently search using existing drug support curb current highly contagious viral infection spirally increasing since pandemic began based drug related RNAviruses MERSCov SARSCov Moreover researcher scrambling identify novel drug target discover novel therapeutic option vanquish current pandemic Since definitive treatment control Covid19 vaccine remain lifeline Currently many vaccine candidate developed reported positive result Therapeutic target helicases transmembrane serine protease 2 cathepsin L cyclin Gassociated kinase adaptorassociated kinase 1 twopore channel viral virulence factor 3chymotrypsinlike protease suppression excessive inflammatory response inhibition viral membrane nucleocapsid envelope accessory protein inhibition endocytosis identified potential target COVID19 infection review also summarizes plantbased medicine treatment COVID19 saposhnikoviae divaricata lonicerae japonicae flos scutellaria baicalensis lonicera japonicae others Thus review aimed focus promising therapeutic target repurposed COVID19 viral element used COVID19 vaccine candidate,"3clpro, 3-chymotrypsin-like protease;aak1, adaptor-associated kinase 1;ace-2, angiotensin-converting enzyme-2;cef, cepharanthine;covid-19;covid-19, coronavirus disease-2019;existing drug;gak, cyclin g-associated kinase;mers-cov, middle east respiratory syndrome coronavirus;management;nsp, non-structure protein;orf, open reading frame;plpro, papain-like protease;rdrp, rna-dependence rna-polymerase;sars-cov-2, severe acute respiratory syndrome coronavirus-2;tmprss2, transmembrane serine protease 2;tpc2, two-pore channel 2;therapeutic target"
Operationalisation consensual One Health roadmaps country improved IHR capacity health security,34210688,COVID19 pandemic devastating reminder mitigating threat emerging zoonotic outbreak relies collective capacity work across human health animal health environment sector Despite critical need shared approach collaborative benchmark International Health Regulations IHR Monitoring Evaluation Framework specifically Joint External Evaluation JEE often reveal low level performance collaborative technical area TAs thus identifying real need work humananimalenvironment interface improve health security National Bridging Workshops NBWs proposed jointly World Organisation Animal Health World Health Organization provide opportunity national human health animal health environment relevant sector country explore efficiency gap coordination management zoonotic disease result gathered prioritised roadmap support operationalisation recommendation made JEE TAs multisectoral One Health approach beneficial collaborative TAs 12 19 JEE twothirds recommendation implemented one multiple activity jointly agreed NBW Interestingly associated Benchmark Tool IHR appears NBW activity often associated lower level performance anticipated JEE mission revealing country often overestimate capacity humananimalenvironment interface Deeper focused widely shared discussion professional highlight need concrete foundation multisectoral coordination meet goal One Health improved global health security IHR,covid-19;diseases;disorders;health policy;health systems;infections;injuries;public health
Immune thrombocytopenia severe hematological consequence patient COVID19 case report,34373729,Since first appearance coronavirus disease 2019 COVID19 multiple study focused novel coronavirus Within month clinical paraclinical manifestation mechanism change induced elaborated Clinically virus mainly cause common cold also result severe fatal pneumoniaacute respiratory syndrome Regarding biological change similar virus lead reduced lymphocyte count second common change represented reduced thrombocyte count Furthermore patient blood clotting abnormality inflammatory syndrome raised Ddimer lactate dehydrogenase level Detection immune thrombocytopenia asymptomatic patient tested positive COVID19 justifies need perform differential diagnosis testing COVID19 Typically patient severe form COVID19 develop mild thrombocytopenia severe thrombocytopenia rarely reported aim case report present situation one asymptomatic patient tested positive COVID19 developed severe immune thrombocytopenia,covid-19;bleeding;corticotherapy;immune thrombocytopenia;immunoglobulin;low platelet count;purpura;symptoms
multicentre survey reveals variation standard treatment treatment modification head neck cancer patient Covid19 pandemic,34226880,Background onset COVID19 pandemic necessitated rapid change practice head neck oncology UK delay onset pandemic release guideline cancer society network leading variable response individual centre survey conducted ass preCovid19 pandemic standard practice head neck oncology patient treatment modification introduced first wave pandemic UK Methodology UK National Cancer Research Institute NCRI Head Neck Clinical Studies Group initiated multicentre survey using questionnaire investigate effect feeding tube practice radiotherapy RT fractionation volume use chemotherapy neoadjuvant concurrent palliative setting use immunotherapy palliative setting access radiology histopathology service availability surgical procedure Results 30 centre approached across UK 23 767 centre responded included survey difference standard practice feeding tube policy RT dose fractionation well concurrent chemotherapy use 21 91 participating centre least one treatment modification 15 65 centre initiated change radical RT changing either hypofractionation acceleration schedule postoperative RT 10 centre 435 changed hypofractionation schedule 12 522 centre stopped neoadjuvant chemotherapy patient 13 565 centre followed selective omission chemotherapy concurrent chemoradiotherapy patient 17 739 centre changed firstline chemotherapy treatment pembrolizumab following NHS England s interim guidance 8 348 centre stopped treatment early offered delay patient already systemic treatment majority centre significant change associated surgery radiology histopathology dental screening Conclusion variation standard practice treatment modification head neck cancer patient Covid19 pandemic timely initiative required form consensus head neck cancer management UK country,covid-19 pandemic;chemotherapy;feeding tube;head and neck cancers;immunotherapy;radiotherapy;sars-cov-2;survey;treatment modifications
Tracking pipeline immunoinformatics COVID19 vaccine design,34219142,onset COVID19 pandemic amount data genomic proteomic sequence severe acute respiratory syndrome coronavirus 2 SARSCoV2 stored various database exponentially grown large volume data led production equally immense set immunological data require rigorous computational approach sort make sense Immunoinformatics emerged recent decade field capable offering approach bridging experimental theoretical immunology stateoftheart computational tool discus immunoinformatics assist development highperformance vaccine drug discovery needed curb spread SARSCoV2 Immunoinformatics provide set computational tool extract meaningful connection large set COVID19 patient data implemented design effective vaccine mind represent pipeline identify role immunoinformatics COVID19 treatment vaccine development process number free database protein sequence structure mutation introduced along docking web server assessing interaction antibody SARSCoV2 spike protein segment commonly considered antigen vaccine design,sars-cov-2;immunoinformatics;mutations;vaccine
Lacticaseibacillus paracasei DG enhances lactoferrin antiSARSCoV2 response Caco2 cell,34365895,novel severe acute respiratory syndrome coronavirus 2 SARSCoV2 causing ongoing global pandemic coronavirus disease 2019 COVID19 primarily manifest respiratory distress may also lead symptom associated gastrointestinal tract Probiotics living microorganism shown confer immune benefit study investigated immunomodulatory effect antiSARSCoV2 activity three different Lacticaseibacillus probiotic strain either alone combination lactoferrin using intestinal epithelial Caco2 cell line result revealed Lacticaseibacillus paracasei DG strain significantly induced expression gene involved protective antiviral immunity prevented expression proinflammatory gene triggered SARSCoV2 infection Moreover L paracasei DG significantly inhibited SARSCoV2 infection vitro L paracasei DG also positively affected antiviral immune activity lactoferrin significantly augmented antiSARSCoV2 activity Caco2 intestinal epithelial cell Overall work show probiotic strain L paracasei DG promising candidate exhibit prophylactic potential SARSCoV2 infection,probiotics;antiviral immunity;covid-19;lactobacilli;lactoferrin;sars-cov-2
Impact COVID19 pandemic patient health professional radiation oncology department Spanish tertiary hospital,34211774,Background sanitary emergency created COVID19 pandemic forced u take exceptional measure affect decisionmaking administration treatment radiotherapy aim study analyze impact COVID19 pandemic patient professional radiation oncology department Materials method implement plan objective maintaining radiotherapy treatment patient need time reducing risk spreading virus staff patient plan included measure aimed limiting patient s stay hospital selecting patient radiotherapy delayed protecting infection use physical protective measure Results March 16 May 31 2020 360 patient received radiotherapy department 14 patient 47 start treatment delayed average 28 day Four patient positive COVID19 polymerase chain reaction PCR 66 11 tested patient respectively Among professional two PCR positive 166 4 tested individual respectively serology analysis 4 50 department member IgG positive 8 Conclusions Despite fact department located region high incidence COVID19 infection impact pandemic patient staff moderate implementation measure infection adequate selection patient treatment allows radiation oncology department maintain clinical activity,covid-19;cancer;coronavirus;radiotherapy
Sphingolipids Modulators SARSCoV2 Infection,34222257,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 cause COVID19 pandemic severe consequence afflicted individual society whole biology infectivity virus intensively studied order gain better understanding molecular basis virushost cell interaction infection known SARSCoV2 bind angiotensinconverting enzyme 2 ACE2 via spike protein Priming virus specific protease lead viral entry via endocytosis subsequent step life cycle SARSCoV2 Sphingosine ceramide belong sphingolipid family abundantly present cell membrane lipid recently shown interfere uptake virus particle SARSCoV2 epithelial cell line primary human nasal cell culture mechanism action partly different sphingosine blocked whilst ceramide facilitated viral entry Acid sphingomyelinase ASM vital generation ceramide functional inhibition ASM drug like amitriptyline reduced SARSCoV2 entry epithelial cell Recent data indicates serum level sphingosine1phosphate S1P prognostic factor COVID2 severity stimulation sphingosine1phosphate receptor 1 S1PR1 might also constrain hyperinflammatory condition linked SARSCoV2 review recent exciting finding regarding sphingolipids uptake SARSCoV2 course COVID19 disease study required mechanism action potential use antidepressant drug sphingolipid modifier SARSCoV2 infection treatment serious fatal consequence disease,covid-19;sars-cov-2;biomarker;ceramide;drugs;sphingosine
COVID19 Aspiration Pneumonia Similar Pulmonary Findings Different Diagnosesa Pitfall 18F FDG PETCT,34345767,Since December 2019 severe acute respiratory syndrome coronavirus 2 SARSCoV2 become worldwide pandemic Especially center affected pandemic symptom fever cough myalgia fatigue andor radiological sign groundglass opacity typically related COVID19 often diverted clinician attention disease Despite urgency recognize cure SARSCoV2 infection plethora differential diagnosis must considered disease must equally promptly treated described case report,ab ingestis;aspiration pneumonia;covid-19;pneumonia;sars-cov-2;[18f]fdg pet/ct
NewOnset Bullous Pemphigoid COVID19 Patient,34211788,manuscript present report bullous pemphigoid rash associated COVID19 first time objective manuscript present unique dermatological case setting COVID19positive infection recognize virus symptomatology 37yearold female past medical history class III obesity type II diabetes mellitus hypertension presented emergency department September 2020 inpatient outpatient followup November 2020 patient denied personal family history skin disorder patient tested positive COVID19 prior hospitalization presented hospital severe persistent pruritic rash meeting dermatopathological serologic clinical criterion bullous pemphigoid diagnosis Histopathology H E punch biopsy left flexor wrist demonstrated epidermal keratinocyte necrosis subepidermal vesiculation eosinophil gossamer stranding papillary dermis subepidermal edema Direct immunofluorescence punch biopsy left flexor wrist demonstrated strong linear IgG staining dermoepidermal junction weaker focal linear C3 staining Antigenspecific serology consistent bullous pemphigoid previously reported cutaneous association COVID19 infection bullous pemphigoid making case important addition body evidence helping identify bullous pemphigoid setting viral infection,
Safety ChAdOx1 nCoV19 Vaccine Independent Evidence Two EU States,34207369,Recent report thrombosis following AstraZeneca COVID19 vaccine young female 55 yearsold led temporary suspension urgent investigation European Medicines Agency EMA concluded vaccine benefit still outweigh side effect SEs Therefore study aim provide early independent evidence vaccine SEs prevalence potential risk factor crosssectional surveybased study carried February March 2021 Germany Czech Republic among healthcare worker recently received AstraZeneca COVID19 vaccine study used validated selfadministered questionnaire composed twentyeight multiplechoice item covering demographic variable medical anamnesis local systemic oral skin related SEs vaccine ninetytwo included participant 772 female 793 Germany mean age 3537 + 1262 1964 yearsold 152 chronic illness 228 receiving medical treatment Overall 946 participant reported least one SE common local SE injection site pain 728 common systemic SEs fatigue 739 muscle pain 554 chill 489 feeling unwell 467 nausea 457 headache 293 vast majority 919 resolved within 13 day 35 yearsold group least affected age group SEs frequency insignificantly higher female previously infected participant vaccine safety elderly supported early finding study Chronic illness medical treatment associated increased risk SE incidence frequency blood disorder SEs reported sample independent study highly required evaluate safety AstraZeneca vaccine explore whether gender previous infection could associated vaccine SEs,azd1222;covid-19;chadox1 ncov-19;czech republic;germany;oxford-astrazeneca vaccine;drug-related side effects and adverse reactions;health personnel;mass vaccination
Forecasting impact environmental stress frequent wave COVID19,34376920,novel approach link environmental stress COVID19 case adopted research timedependent data extracted online repository freely available knowledge research Since time series data analysis desired COVID19 timedependent frequent wave manuscript developed time series model aid `` nonlinear autoregressive network exogenous input NARX approach distribution infectious agentcontaining droplet infected person uninfected person common form respiratory disease transmission SARSCoV2 mainly spread via shortrange respiratory droplet transmission Airborne transmission SARSCoV2 seems occurred long distance time unusual condition SARSCoV2 RNA found PM10 collected Italy research show SARSCoV2 particle adsorbed outdoor PM remained viable long time given epidemiology COVID19 outdoor air pollution unlikely significant route transmission research ANN time series used analyze data resulting COVID19 first second wave forecasted result show air pollution affect people different area Italy make people sick covid19 model developed based disease transmission data Italy,artificial neural network;environmental stress;epidemic forecasting;machine learning;sars-cov2
Perceived Benefits Matter COVID19 Preventive Behaviors Empirical Evidence Okara District Pakistan,34202471,2019 coronavirus disease COVID19 caused SARSCoV2 virus affected social determinant health worsening health inequity deteriorating healthcare capacity around globe objective study investigate COVID19 prevention behavior within framework Health Belief Model city Depalpur Okara District Pakistan May 2020 Using observational crosssectional quantitative study design facetoface field survey conducted epidemic COVID19 district Okara Pakistan sample 500 adult selected city Depalpur Okara district Pakistan using twostage sampling design cluster sampling stage one systematic random sampling stage two COVID19 prevention behavior scale computed based twelve dichotomous item Descriptive statistic analysis variance ANOVA negative binomial regression analysis performed common prevention behavior among study participant avoiding going walk park 810 followed leaving home lockdown 726 washing hand every day soap water 20 going home 640 Fewer people exhibited prevention behavior social distancing eg staying least six foot away people EU recommended minimum 152 444 following basic protective measure eg hand washing use face covering public social distancing order protect COVID19 330 result negative binomial regression analysis showed controlling HBM construct sociodemographic factor perceived benefit preventative action showed significant association prevention behavior scale IRR 116 CI 10611276 p 0001 study finding show public health intervention attempting control spread COVID19 Pakistan may want affect change people s perceived benefit preventative action mass awarenessraising campaign,"covid-19 preventative behaviors;okara, pakistan;cues to action;health belief model;health education;perceived susceptibility"
Sub3 CryoEM Structures Necrosis Virus Particles via Use Multipurpose TEM Electron Counting Camera,34202259,global pandemic cryoEM made great impact structure determination COVID19 protein However nearly highresolution result based data acquired stateoftheart microscope availability restricted number center across globe study infectious virus regulated forbidden One potential remedy employ multipurpose microscope investigated capability 200 kV multipurpose microscope equipped direct electron camera determining structure infectious particle used 30 nm particle grouper nerve necrosis virus test sample obtained cryoEM structure resolution high approximately 27 setting used electron counting comparison tested highend cryoEM Talos Arctica using similar virus Macrobrachium rosenbergii nodavirus obtain virtually resolution result revealed resolution ultimately limited depth field work update density map virus sub3A level allow building accurate atomic model de novo provide structural insight assembly capsid Importantly study demonstrated multipurpose TEMs capable highresolution cryoEM structure determination infectious particle thus germane research pandemic,cryo-em;direct electron camera;icosahedral particles;nodavirus;single particle
Telemedicine cystic fibrosis still need facetoface clinic,34215541,growing interest telemedicine cystic fibrosis recent year based largely convenience patient andor increasing frequency surveillance early detection assumed could improve treatment outcome 2020 covid19 pandemic catalysed pace development field CF patient presumed high risk infection clinic adapted digital platform provision lung function monitoring sample collection system present view multidisciplinary team member large paediatric CF centre worked well requires optimisation future response question posed Do still need face face clinic answer Yes every time everyone,cystic fibrosis;home monitoring;lung function;physiotherapy;psychology;remote care;spirometry;telehealth;telemedicine
Effect Tenofovir Disoproxil Fumarate Emtricitabine nasopharyngeal SARSCoV2 viral load burden amongst outpatient COVID19 pilot randomized openlabel phase 2 trial,34222849,Background Tenofovir emtricitabine interfere SARS CoV2 ribonucleic acid RNA dependent RNA polymerase RdRp Several cohort reported people treated tenofovir disoproxil fumarate emtricitabine le likely develop SARS CoV2 infection related severe COVID19 Methods conducted pilot randomized openlabel controlled phase 2 trial two hospital France Eligible patient consecutive outpatient aged =18 year RTPCRconfirmed SARSCoV2 infection interval symptom onset enrolment 7 day le Patients randomly assigned 11 ratio receive oral tenofovir disoproxil fumarate emtricitabine 2 pill day 1 followed 1 pill per day day 27 standard care primary secondary endpoint SARSCoV2 viral clearance baseline assessed cycle threshold Ct RTPCR nasopharyngeal swab collected day 4 day 7 respectively higher Ct corresponds lower SARS CoV2 viral burden endpoint time recovery number adverse event trial registered ClinicalTrialsgov NCT04685512 Findings November 20 th 2020 March 19 th 2021 60 patient enrolled randomly assigned treatment group 30 tenofovir disoproxil fumarate emtricitabine 30 standard care median number day symptom onset inclusion 4 day IQR 35 group Amongst patient received tenofovir disoproxil fumarate difference standard care increase Ct RTPCR baseline 23 95 confidence interval 06 52 p = 013 day 4 29 95 CI 01 52 p = 0044 day 7 day 7 630 tenofovir disoproxil fumarate emtricitabine group 330 standard care group reported COVIDrelated symptom Adverse event included 11 case gastrointestinal side effect grade = 2 three leaded drug discontinuation Three patient COVID19 related hospitalisation participant died Interpretation pilot study outpatient adult recent nonsevere COVID19 tenofovir disoproxil fumarate plus emtricitabine appeared accelerate natural clearance nasopharyngeal SARSCoV2 viral burden finding support conduct larger trial tenofovirbased therapy prevention early treatment COVID19 Funding external funding,
Impact Covid19 restriction carers person dementia UK qualitative study,34224555,BACKGROUND Informal carers provide majority support person dementia living home Restrictions imposed due COVID19 profound impact daily life entire population study provides insight impact restriction carers people dementia living home DESIGN Qualitative semistructured interview PARTICIPANTS Purposive sample carers provide least 10 hour care week person dementia living home SETTING United Kingdom RESULTS Twentythree carers interviewed thematic analysis identified three main themesChanges daily life impact carer health wellbeing reduced support health social support network result highlight impact restriction imposed daily life routine due pandemic wellbeing carers reduced social support lack access health care professional respite carers restriction negative consequence carers wellbeing experienced difficulty accessing formal care service respite care CONCLUSION Carers attempt continue provide physical emotional practical support person dementia community throughout COVID19 restriction prevent future carer crisis carers need better support system including formal carer service telecare solution work additional support respite restriction pandemic continue,covid-19;carer;dementia;older people;qualitative;thematic analysis
Consequences COVID19 Pandemic Governmental Containment Policies Detection Therapy Oral Malignant LesionsA Retrospective Multicenter Cohort Study Germany,34207863,1 Background response global COVID19 pandemic governmental measure undertaken impact crisis healthcare patient cancer largely unexplored multicenter cohort study aimed investigate potential screening delay consequence patient oral cancer OC pandemic 2 Material Methods Data patient first diagnosed OC different period collected especially term OC incidence tumor stageentity time intervention period lockdown LD 13 March16 June 2020 postlockdown PLD 17 June1 November 2020 corresponding equivalent 201819 differentiated compared 3 Results obvious trend towards higher incidence OC higher tumor stage whereas trend towards shorter time intervention LD2020 could observed Subgroup analysis revealed increased incidence OC within PLD2020 Mainz might explained partial closure dental practice federal state LD 4 Conclusions overall higher incidence OC found closure practice LD possibly delay cancer diagnosis Therefore measure must taken identify patient risk ensure basic healthcare especially context dental screening measure,covid-19;hnscc;sars-cov-2;head and neck cancer;lockdown;oral cancer;oral malignant lesions;pandemic;precursor lesions;screening
review neuroradiological abnormality patient coronavirus disease 2019 COVID19,34224248,BACKGROUND Severe acute respiratory syndrome coronavirus 2 SARSCoV2 led various neurological manifestation urgent need summary neuroimaging finding accelerate diagnosis treatment plan reviewed prospective retrospective study classify neurological abnormality observed patient SARSCoV2 infection METHODS relevant study published Scopus PubMed Clarivate Analytics database analysed search performed fulltext article published 23 January 2020 23 February 2021 RESULTS 23 study number patient SARSCoV2 infection 20850 number patient neurological manifestation 1996 95 total number patient neuroradiological abnormality 602 28 SARSCoV2 led various neuroimaging abnormality categorised neuroanatomical localisation lesion main probable underlying pathogenesis Cranial nerve spinal root abnormality cranial neuritis polyradiculitis Parenchymal abnormality fell four group thrombosis disorder namely ischaemic stroke sinus venous thrombosis b endothelial dysfunction damage disorder manifested various type intracranial haemorrhage posterior reversible encephalopathy syndrome c hypoxiahypoperfusion disorder leukoencephalopathy watershed infarction inflammatory disorder encompassing demyelinating disorder encephalitis vasculitislike disorder vasculopathy cytotoxic lesion corpus callosum Leptomeninges disorder included meningitis Ischaemic stroke frequent abnormality study CONCLUSION review study suggests anatomical approach classification heterogeneous neuroimaging finding patient SARSCoV2 neurological manifestation would lend well use practitioner diagnosis treatment planning,covid-19;neuroradiological;brain;computed tomography;magnetic resonance;spinal
Leucoefdin potential inhibitor SARS CoV2 pro,34281489,Leucoefdin important constituent various fruit banana raspberry etc explored target Pro protease SARS CoV 2 Ligand found bind active site Pro large negative binding energy molecular docking simulation study docking result showed Leucoefdin interacted Pro forming hydrogen bond Leu 141 His163 164 Glu 166 nonbonded interaction seen Met49 Pro52 Tyr54 Phe140 Leu141 Cys145 Met165 Results Leucoefdin coherence recently reported Pro proteaseinhibitor complex even displayed better binding energy kcalmol HTVS 628 SP 728 XP 929 MMGBSA 4471 compared reference ligand HTVS 487 SP 679 XP 575 MMGBSA 4776 LeucoefdinM Pro complex molecular dynamic simulation showed initial fluctuation RMSD plot certain period attained equilibrium remained stable entire simulation 150 n RMSF protein showed le secondary structure fluctuation greater number Hbond formation Leucoefdin 150 n simulation Post simulation MMGBSA analysis showed binding energy 4598 Kcalmol finding indicated potential Leucoefdin lead compound R drug discovery development SARS CoV2Communicated Ramaswamy H Sarma,leucoefdin;mpro;sars cov-2;docking;simulation
Patientled Remote IntraCapillary pharmacoKinetic Sampling fingerPRICKS therapeutic drug monitoring patient inflammatory bowel disease,34289028,BACKGROUND AIMS COVID19 public health restriction telemedicine replaced conventional outpatient follow patient chronic immunemediated inflammatory disorder treated biologic drug Innovative solution facilitate remote therapeutic drug monitoring therefore required Lowvolume intracapillary blood sampling undertaken patient home sample returned post central laboratory sought report effect COVID19 pandemic request therapeutic drug monitoring equivalence acceptability effectiveness low volume Patientled Remote IntraCapillary pharmacoKinetic Sampling fingerPRICKS compared conventional venepuncture METHODS undertook crosssectional blood sampling method comparison study compared sample type using linear regression model Drug antidrug antibody level measured using standard ELISAs Acceptability assessed using purposedesigned questionnaire RESULTS Therapeutic drug monitoring request adalimumab 965 705 106 per week 52 335 570 p 0001 infliximab 1845 1612 2142 161 135 1975 p = 034 reduced first UK stayathome lockdown compared preceding six monthsFingerprick sampling equivalent conventional venepuncture adalimumab infliximab vedolizumab ustekinumab drug antiadalimumab infliximab antibody level median IQR volume serum obtained using intracapillary sampling 195microL 130210 87 90103 patient agreed intracapillary testing easy 69 71103 preferred conventional venepunctureIn routine care 753 5877 patient returned two blood sample within 14 day permit remote assessment biologic therapeutic drug monitoring CONCLUSIONS Therapeutic drug monitoring undertaken using patientled remote intracapillary blood sampling potential key adjunct telemedicine patient immunemediated inflammatory disease,inflammatory bowel disease;biologics;capillary blood test;pharmacokinetics;therapeutic drug monitoring
Role Coronavirus RNAProcessing Enzymes Innate Immune Evasion,34204549,Viral RNA sensing trigger innate antiviral response human stimulating signaling pathway include crucial antiviral gene interferon RNA virus evolved strategy inhibit escape mechanism Coronaviruses use multiple enzyme synthesize modify process genomic RNA subgenomic RNAs include Nsp15 Nsp16 whose respective role RNA capping dsRNA degradation play crucial role coronavirus escape immune surveillance Evolutionary study coronaviruses demonstrate genome expansion Nidoviruses promoted emergence Nsp14ExoN activity led acquisition Nsp15 Nsp16RNAprocessing activity review discus main RNAsensing mechanism human well recent structural functional evolutionary insight coronavirus Nsp15 Nsp16 view potential antiviral strategy,sars-cov-2;coronavirus;immune evasion;innate immunity;viral rna sensing
SARSCoV2 vaccine effectiveness trump immunogenicity solid organ transplant recipient,34212494,,clinical research/practice;health services and outcomes research;infection and infectious agents - viral;infectious disease;kidney transplantation/nephrology;vaccine
Posterior Reversible Encephalopathy Syndrome brain haemorrhage COVID19 complication review available literature,34291313,BACKGROUND SARSCoV2 infection associated various neurological manifestation Since patient affected SARSCoV2 infection present coagulation immune system dysregulation ischemic haemorragic stroke uncommon irrespective respiratory distress However occurrence focal neurological deficit together symptom like headache cortical blindness seizure altered mental status prompt diagnosis Posterior Reversible Encephalopathy Syndrome PRES Antithrombotic treatment alteration endothelial function coagulopathy due COVID19 PRES leading breakdown bloodbrain barrier may contribute occurrence brain haemorrhage METHODS describe case COVID19 patient developed bilateral occipital lobe haemorrhage suggestive haemorrhagic PRES reviewed available literature haemorrhagic evolution PRES COVID19 RESULTS describe clinical radiological feature five COVID19 patient developed haemorrhagic PRES CONCLUSIONS Coagulopathy endothelial dysfunction resulting massive release cytokine host immune response may key factor pathogenesis COVID19related PRES Antithrombotic therapy leakage bloodbrain barrier subsequently increase risk haemorrhagic transformation lesioned brain tissue prompt diagnosis PRES mandatory since timely interruptionreversal antithrombotic therapy may key determinant good prognosis,covid-19;haemorrhage;pres;posterior reversible encephalopathy syndrome;sars-cov-2
Infection Prevention Performance among InFlight Cabin Crew South Korea,34203806,COVID19 declared worldwide pandemic 2020 thus preventing inflight infection transmission important stopping global spread via air travel Infection prevention IP performance among aircraft cabin crew crucial preventing inflight transmission aimed identify level IP performance factor affecting IP performance among aircraft cabin crew COVID19 pandemic South Korea online survey conducted 177 cabin crew member August September 2020 survey assessed IP performance IP awareness using fivepoint Likert scale also evaluated simulationbased personal protective equipment PPE training experience organizational culture average IP performance score 456 + 044 Although performance level maskwearing high 473 + 035 hand hygiene HH performance 447 + 056 low Multivariate analysis showed IP performance significantly associated IP awareness p 005 simulationbased PPE training experience p 005 Since HH performance relatively low cabin crew airline make effort improve HH performance Furthermore high level IP awareness PPE training experience improve IP performance among cabin crew member Therefore simulationbased PPE training strategy improve IP awareness essential preventing inflight infection transmission,covid-19;aircraft;infection control;inflight transmission;pandemic
Clinical characteristic risk factor mortality COVID19 inpatient Birjand Iran singlecenter retrospective study,34289910,BACKGROUND coronavirus disease 2019 COVID19 affected mortality worldwide Cox proportional hazard CPH model becoming popular timetoevent data analysis study aimed evaluate clinical characteristic COVID19 inpatient including survivor nonsurvivor thus helping clinician give right treatment ass prognosis guide treatment METHODS singlecenter study conducted Hospital COVID19 patient Birjand Inpatients confirmed COVID19 included Patients classified discharged survivor group death nonsurvivor group based outcome improvement death Clinical epidemiological characteristic well laboratory parameter extracted electronic medical record Independent sample test Chisquare test Fisher s exact test used evaluate association interested variable CPH model used survival analysis COVID19 death patient Significant level set 005 analysis RESULTS result showed mortality rate 174 62 17 patient died due COVID19 298 836 patient recovered discharged Clinical parameter comorbidities oxygen saturation lymphocyte platelet count hemoglobin level Creactive protein liver kidney function statistically significant studied group result CPH model showed comorbidities hypertension lymphocyte count platelet count Creactive protein level may increase risk death due COVID19 risk factor inpatient case CONCLUSIONS Patients lower lymphocyte count hemogram platelet count serum albumin high Creactive protein level also patient comorbidities may risk death given attention risk management progression COVID19 disease,covid-19;cox model;risk factors of death;survival model
Prevention COVID19 mRNAbased vaccine within general population California,34282839,BACKGROUND Estimates COVID19 vaccine effectiveness realworld condition understanding barrier uptake necessary inform vaccine rollout METHODS enrolled case testing positive control testing negative among population whose SARSCoV2 molecular diagnostic test result 24 February29 April 2021 reported California Department Public Health Participants matched age sex geographic region assessed participant selfreported history mRNAbased COVID19 vaccine receipt BNT162b2 mRNA1273 Participants considered fully vaccinated two week second dose receipt Among unvaccinated participant assessed willingness receive vaccination measured vaccine effectiveness via matched odds ratio prior vaccination comparing case control RESULTS enrolled 1023 eligible participant aged =18 year Among 525 case 71 135 received BNT162b2 mRNA1273 20 38 fully vaccinated either product Among 498 control 185 371 received BNT162b2 mRNA1273 86 163 fully vaccinated either product Two week second dose receipt 870 95 confidence interval 686946 862 684939 BNT162b2 mRNA1273 respectively Fully vaccinated participant receiving either product experienced 913 793963 683 279857 symptomatic asymptomatic infection respectively Among unvaccinated participant 424 159375 residing rural region 238 67281 residing urban region reported hesitancy receive COVID19 vaccination CONCLUSIONS Authorized mRNAbased vaccine effective reducing documented SARSCoV2 infection within general population California Vaccine hesitancy present barrier reaching coverage level needed herd immunity,covid-19;real-world evidence;test-negative design;vaccine effectiveness
home hemodialysis practical option older people,34133069,increasing demand incenter dialysis service largely driven rapid growth older population progressing endstage kidney disease Since onset COVID19 pandemic effort encourage homebased dialysis option increased due risk infective transmission patient receiving hemodialysis centerbased unit various practical clinical advantage patient receiving hemodialysis home However lack caregiver support cognitive physical impairment challenge vascular access preparation training home hemodialysis HHD initiation may present barrier successful implementation HHD older dialysis population Assessment older patient s frailty status may help clinician guide patient making decision HHD development assisted HHD care delivery model advancement telehealth technology provision HHD care may increase accessibility HHD service older patient review examines factor explores current unmet need barrier increasing access inclusion opportunity HHD older dialysis population,challenging patients;geriatrics;home hemodialysis
Translating SARSCoV2 wastewaterbased epidemiology prioritizing mass vaccination strategic overview,34212322,inception novel coronavirus forced world despair Rapid progress made addressing situation various clinical diagnostic method developed early detection transmission However rapidly increasing number infected population worldwide testing individual impractical wastewaterbased epidemiology WBE implemented evaluate disease outbreak early warning system pandemic preparedness Numerous study reported presence SARSCoV2 open drain STPs across globe via recovery efficiency surrogate virus existing virus concentration protocol However reported study justify use WBE identify pinpoint specific hotspot transmission could prioritized rapid effort contain accelerate active vaccination effort Identifying precise location hotspot could essential aspect controlling outbreak surge wave prioritizing region primary outbreak response article focus issue relating primary focus WBE adapted suitability utilization mass vaccination program discussed Effective use WBE information term source tracking might crucial move towards mass vaccination control outbreak COVID19 pandemic,epidemiology;policy making;sars-cov-2;vaccination;wastewater
Rare case gastrointestinal mucormycosis colonic perforation immunocompetent patient COVID19,34215642,Primary gastrointestinal mucormycosis rare disease associated increased mortality rarely reported immunocompetent host report first case mucormycosisassociated colonic perforation COVID19 patient favourable outcome 48yearold healthy male doctor home isolation due COVID19 admitted COVID19 intensive care unit symptom deteriorated patient put noninvasive ventilation NIV using Bilevel Positive Airway Pressure BiPAP treatment given per existing hospital protocol patient improved clinically discharged day 10 admission Two day later presented acute gastrointestinal symptom emergency department diagnosis perforation peritonitis made patient stabilised sigmoid colectomy descending colon colostomy done diagnosis gastrointestinal mucormycosis made injectable antifungal started patient discharged general condition improved,covid-19;adult intensive care;general surgery;infection (gastroenterology);infections
Acute Myocardial Injury Patient Attention Deficit Hyperactivity Disorder History Substance Abuse Multimodality Imaging Point View,34200122,cannabis amphetamine commonly used illegal substance worldwide associated number adverse cardiovascular effect including transient coronary vasospasm present case 39yearold male admitted institution 6h history severe chest pain STsegment elevation ECG Coronary angiography admission showed normal coronary artery patient 14year history substance abuse primarily amphetamine cannabis prescribed lisdexamfetamin Aduvanz R attention deficit hyperactivity disorder ADHD past 2 year cardiac magnetic resonance CMR following day showed widely distributed focal lesion late gadolinium enhancement mid subepicardial myocardium anterior lateral inferior wall suggestive chronic fibrotic lesion sign acute myocardial edema viral cause identified thorough investigation including negative SARSCOV2 endomyocardial biopsy Substanceabuseinduced coronary vasospasm leading STsegment elevation myocardial damage rise fall cardiac TnT well slightly reduced left ventricular ejection fraction 48 regional wall motion abnormality echocardiography likely diagnosis,st-segment elevation myocardial infarction;amphetamine;attention deficit hyperactivity disorder;cannabis;cardiac magnetic resonance;echocardiography;substance abuse
Recent Advances Discovery Antiviral Metabolites Fungi,34132180,world manages impact global pandemic caused COVID19 discovery new antiviral agent become way relevant urgent Viruses submicroscopic infectious agent replicate inside living cell different organism virus use nucleic acid DNA RNA replication maturity inside cell virus responsible various human plant disease belong class Picornaviridae Retroviridae Orthomyxoviridae Flaviviridae Pneumoviridae Virgaviridae Hepadnaviridae treatment option limited nonexistent consistent reemergence resistance development viral strain demand discovery development new antiviral drug possessing better efficacy Bioactive compound isolated fungi source new compound enhanced potency new mechanism action Fungi known produce diverse lot secondary metabolite due existence harsh climate often inhabitable many organism Due unique environment fungi produce variety secondary metabolite different chemical class like alkaloid quinone furanone pyrones benzopyranoids xanthones terpene steroid peptide many acyclic compound Fungal metabolite known display wide range bioactive attribute ie anticancer antibacterial antifungal antiAlzheimer s along antiviral property review article report 300 antiviral compound fungal source period 2009 2019 source compound marine endophytic fungi arranged based antiviral action different viral family compound promising use development future antiviral drug,h1n1;hiv;marine fungi;sars;antiviral metabolites;endophytic fungi;fungal secondary metabolites;mushrooms;viruses
Insufficient type IFN immunity underlies lifethreatening COVID19 pneumonia,34213846,established COVID Human Genetic Effort wwwcovidhgecom discover human genetic immunological base vast interindividual clinical variability human infected severe acute respiratory syndrome coronavirus 2 SARSCoV2 found 3 patient lifethreatening coronavirus disease 2019 COVID19 pneumonia ill inborn error gene controlling type interferon IFN dependent immunity control influenza virus least 10 patient lifethreatening COVID19 pneumonia neutralizing autoAbs 17 individual type IFNs finding indicate impaired type IFN immunity underlies lifethreatening COVID19 pneumonia least 13 patient discovery pave way research unexplained severe case provide rationale preventing treating disease individual risk recombinant type IFNs,autoantibodies;inborn errors of immunity;life-threatening covid-19;pneumonia;type i interferons
Update Functional Inhibitors Acid Sphingomyelinase FIASMAs SARSCoV2 Infection,34358117,SARSCoV2 outbreak characterized need search curative drug treatment paper present update knowledge interest functional inhibitor acid sphingomyelinase FIASMAs SARSCoV2 infection Fortynine FIASMAs suggested treatment SARSCoV2 infection using silico vitro vivo study study using largesized randomized doubleblinded controlled clinical trial needed evaluate FIASMAs SARSCoV2 infection offlabel therapy,covid-19;sars-cov-2;acid sphingomyelinase;functional inhibitors of acid sphingomyelinase (fiasmas);mortality
initial impact COVID19 Australasian Sonographers Part 1 Changes scan number sonographer work hour,34226862,Introduction COVID19 seen series lockdown suspension nonurgent elective surgery Subsequently drop number diagnostic imaging service billed April May 2020 survey undertaken March June 2020 determine initial impact COVID19 Australasian Sonographers article first 3part series present discus result survey pertaining change number scan performed change working hour sonographers remaining two article series address initial COVID19 impact Australasian Sonographers Methods online survey conducted containing question regarding change work hour examination number Results 444 participant answered survey Seventy eight percent sonographers reported decrease number examination performed department decrease work hour reported 68 sonographers almost quarter reporting lost hour higher percentage work hour change seenin private practice Many reduction work hour reported voluntary Conclusion Scan number ultrasound department affected COVID19 sonographers work hour,australasian;covid-19;impact;scan-numbers;sonographers;workhours
Catching SARSCoV2 Sequence Hybridization Comparative Analysis,34342536,Controlling monitoring still ongoing severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic regarding geographical distribution evolution emergence new mutation SARSCoV2 virus possible due continuous nextgeneration sequencing NGS sharing sequence data worldwide Efficient sequencing strategy enable retrieval increasing number highquality fulllength genome hence indispensable Two opposed enrichment method tiling multiplex PCR sequence hybridization bait capture established SARSCoV2 sequencing frequently used depending quality patient sample question hand focused evaluation sequence hybridization method studying five commercially available sequence capture bait panel regard sensitivity capture efficiency discovered SARSCoV2specific panel Twist Bioscience efficient panel followed two respiratory panel Twist Bioscience Illumina respectively result provide one hand decision basis sequencing community including computation using full capacity flow cell hand potential improvement manufacturer IMPORTANCE Sequencing genome circulating SARSCoV2 strain way monitor viral spread evolution virus Two different approach namely tiling multiplex PCR sequence hybridization bait capture commonly used fulfill task study describes first time combined approach droplet digital PCR ddPCR NGS evaluate five commercially available sequence capture panel targeting SARSCoV2 able determine sensitive efficient capture panel distinguish mode action various bait panel compute number read pair needed recover highquality fulllength genome calculating minimum number read pair needed providing optimized flow cell loading condition sequencing laboratory worldwide striving maximizing sequencing output simultaneously minimizing time cost sequencing resource,ngs;sars-cov-2;adaptive mutations;ddpcr;enrichment;mutations;next-generation sequencing;sequence capture
COVID19related death among woman reproductive age Brazil burden postpartum,34213771,OBJECTIVE compare risk death due COVID19 among pregnant postpartum nonpregnant woman reproductive age Brazil using severe acute respiratory syndrome surveillance system SARSSS METHODS secondary analysis performed Brazilian official SARSSS data retrieved August 17 2020 Cases stratified pregnancy status risk factor comorbidities outcome death recovery Multiple logistic regression employed examine association independent variable risk death RESULTS total 24 805 case included 3129 death 126 including 271 maternal death Postpartum associated increased risk death admission intensive care unit ICU mechanical ventilation Comorbidities higher impact case fatality rate among nonobstetric case cancer neurological kidney disease Among pregnant woman cancer diabetes mellitus obesity rheumatology disease associated risk death postpartum subgroup age 35 year diabetes mellitus independently associated higher chance death CONCLUSION Postpartum associated worse outcome among obstetric population despite lower risk dying without accessing ICU care Nonpregnant woman cancer neurological disease kidney disease higher risk death due COVID19,covid-19;cardiovascular disease;maternal death;obesity;postpartum;pregnancy;women of reproductive age
Leveraging National Nursing Home Huddles Rapid COVID19 Response,34204197,disproportionate number older adult resident US nursing home died COVID19 pandemic novelty virus spurred frequently changing guidance nursing facility navigated response effort May 2020 6month COVID19 Rapid Response Network Nursing Homes RRN launched leverage concept huddle across US nursing home reduce COVID19related morbidity mortality transmission identifying best practice rapidly implement fostering connection nursing home refocusing national narrative optimism nursing home care response effort Daily 20min huddle transitioned twice weekly program s final two month total 93 huddle featured 103 speaker 1960 participant engaging live huddle asynchronous learning 9033 participant said learned least two new idea participating 8917 strongly agreed agreed participating improved ability lead change organization Qualitative data echoed gratitude centralized source information best practice sense positivity community RRN provided Leveraging nursing home huddle national regional local system facility level may serve guidepost future pandemic work guidance new quickly evolving,covid-19;communication;community;huddles;learning;nursing facilities
Measuring oxygen access lesson health facility assessment Lagos Nigeria,34344666,COVID19 pandemic highlighted global oxygen system deficiency revealed gap understand measure oxygen access present case study oxygen access 58 health facility Lagos state Nigeria found large difference oxygen access facility primary v secondary government v private describe three key domain consider measuring oxygen access availability cost use 58 facility surveyed 8 14 facility functional pulse oximeter Oximeters N=27 typically located outpatient clinic 1227 44 paediatric ward 627 22 operating theatre 427 15 3458 59 facility functional source oxygen available day inspection 31 91 facility available single ward area typically operating theatre maternity ward Oxygen service free patient primary health centre available expensive hospital private facility median cost 2 day oxygen 13 000 US 36 27 500 US 77 Naira respectively obtained limited data cost oxygen service facility Pulse oximetry use low secondary care facility 32 2165 patient SpO2 documented negligible private facility 2 3177 primary health centre 1 2608 unable determine proportion hypoxaemic patient received oxygen therapy available data However triangulation existing data suggested facility equipped meet minimum oxygen demand highlight importance multifaceted approach measuring oxygen access ass access pointofcare ideally patientlevel propose standard metric report oxygen access describe integrated routine health information system existing health facility assessment tool,covid-19;cross-sectional survey;health services research;pneumonia;treatment
Multifaced Roles HDL Sepsis SARSCoV2 Infection Renal Implications,34205975,Highdensity lipoprotein HDLs class blood particle principally involved mediating reverse cholesterol transport peripheral tissue liver Omics approach identified crucial mediator HDL proteomic lipidomic profile involved distinct pleiotropic function Besides role cholesterol transporter HDLs display antiinflammatory antiapoptotic antithrombotic antiinfection property Experimental clinical study unveiled significant change HDL serum amount composition lead dysregulated host immune response endothelial dysfunction course sepsis SARSCoronavirus2infected patient admitted intensive care unit showed common feature sepsis disease overwhelmed systemic inflammatory response alteration serum lipid profile Despite relevant advance episode mild moderate acute kidney injury AKI occurring systemic inflammatory disease associated longterm complication high risk mortality multifaceted relationship kidney dysfunction dyslipidemia inflammation encourages deepen clarification mechanism connecting element review analyzes multifaced role HDL inflammatory disease renal involvement lipid metabolism novel potential HDLbased therapy,sars-cov-2 infection;acute kidney injury (aki);dysfunctional hdl;lipid profile changes;sepsis
COVID19 Future Clinical Epidemiology,34284101,Clinical epidemiology `` basic science clinical medicine 1 changed substantially last fifty year moving focus clinician driven research clinical setting large cohort trial NIH funding practice guideline COVID19 pandemic created major challenge clinician needed make urgent decision management new disease researcher needed understand clinical syndrome question greatest importance pandemic response Addressing challenge reunited clinician researcher collaborative effort inform decision disease risk prevention prognosis treatment least part shared sense need ration scarce resource rapid evolution understanding clinical syndrome recognition widespread uncertainty emphasis common good individual credit time tell whether experience COVID19 revive original practice clinical epidemiology `` application physician provides direct patient care epidemiologic biometric method study diagnostic therapeutic process order effect improvement health `` 2,
Antiviral Effects Green Tea EGCG Potential Application COVID19,34209485,Epigallocatechin3Ogallate EGCG abundant component catechin tea Camellia sinensis L O Kuntze play role virus inhibiting virus invasiveness restraining gene expression replication paper antiviral effect EGCG various virus including DNA virus RNA virus coronavirus enterovirus arbovirus reviewed Meanwhile antiviral effect EGCG epiisomer counterpart + gallocatechin3Ogallate GCG also discussed,covid-19;egcg;sars-cov;antiviral;tea polyphenol
Deep LearningBased Stroke Disease Prediction System Using RealTime Bio Signals,34206540,emergence aging society inevitable due continued increase life expectancy decrease birth rate social change require new smart healthcare service use daily life COVID19 also led contactless trend necessitating nonfacetoface health service Due improvement achieved healthcare technology increasing number study attempted predict analyze certain disease advance Research stroke disease actively underway particularly aging population Stroke fatal elderly disease requires continuous medical observation monitoring recurrence rate mortality rate high study examining stroke disease date used MRI CT image simple classification clinical approach imaging expensive timeconsuming requiring bulky equipment Recently increasing interest using noninvasive measurable EEGs compensate shortcoming However prediction algorithm processing procedure timeconsuming raw data need separated specific attribute obtained Therefore paper propose new methodology allows immediate application deep learning model raw EEG data without using frequency property EEG proposed deep learningbased stroke disease prediction model developed trained data collected realtime EEG sensor implemented compared different deeplearning model LSTM Bidirectional LSTM CNNLSTM CNNBidirectional LSTM specialized time series data classification prediction experimental result confirmed raw EEG data wielded CNNbidirectional LSTM model predict stroke 940 accuracy low FPR 60 FNR 57 thus showing high confidence system experimental result demonstrate feasibility noninvasive method easily measure brain wave alone predict monitor stroke disease real time daily life finding expected lead significant improvement early stroke detection reduced cost discomfort compared measuring technique,bidirectional;convolutional neural network (cnn);deep learning;electroencephalography (eeg);ensemble;long short-term memory (lstm);stroke disease analysis;stroke prediction
Hip Fractures Elderly COVID19 Pandemic LatinAmerican Perspective Minimum 90Day FollowUp,34290897,Introduction Hip fracture patient severely affected COVID19 pandemic however sub acute effect concomitant SARSCoV2 infection outcome highly exposed developing country still unknown objective describe morbidity mortality elderly patient admitted hip fracture COVID19 pandemic Chile minimum 90day followup Also elucidate predictor mortality compare mortality result prepandemic era Material Methods Multicentric retrospective review patient admitted fragility hip fracture 3 hospital COVID19 pandemic time 2019 clinical information image recorded patient followed minimum 90days Morbidity mortality primary outcome Unimultivariable model performed elucidate predictor mortality utilizing Weibull s regression Results Three hundred ninetyone case included 2020 cohort 162 patient 24 15 concomitant SARSCoV2 infection Fourteen patient 58 tested positive admission COVID19 + group higher risk inhospital 30day 90day mortality p 0001 also prolonged hospital stay presented complication readmission p 005 COVID19 + status older age independent predictor mortality HR = 65 p = 0001 109 p = 0001 respectively 2020 cohort twice risk mortality HR = 204 p = 0002 compared 2019 cohort However comparing COVID19 patient difference mortality risk HR = 130 p = 0343 Discussion COVID19 pandemic significantly affected healthcare system elderly patient Conclusions Hip fracture patient concomitant SARSCoV2 virus infection associated increased morbidity mortality throughout first 3 month COVID19 status older age significant predictor mortality Efforts directed nosocomial infection reduction prompt surgical management Level evidence Level III,covid-19;fragility fracture;hip fracture;survival analysis
Syncing sustainable urban mobility public transit policy trend based global data analysis,34285261,Unforeseeable development accompany progressive COVID19 recovery globally Similarly science inform change amidst progress Social isolation distancing imposed pandemic likely result changed habit behavior thinking paradigm Inevitably affect tremendous confusion inhibiting automated urban mobility s evolution mobility often seems magnanimously resistant change using international data analysis show road traffic largest net contributor global warming responsible even greater damage core claim justifies replacing private car PCs existing future public transit PT vehicle testing 17 major city globally 94 scenario proved PT superior equivalent PCs reducing travel time result foreseeable future scenario show potential reduction car traffic approximately twothirds compared current situation two arena proactive government promote sustainable urban mobility 1 developing autonomous vehicle PT 2 coordinating standardization seamless urban mobility global decision improving life future likely better received understood subsequent COVID19 focus concern change preoccupied u circumstance prior pandemic,
Coronavirus Pneumonia Outcomes Characteristics Patients InnerCity Area 3 Months Infection,34362155,BACKGROUND morbidity long term pulmonary consequence COVID19 infection continue unfold learn follow survivor disease report radiological evolution pulmonary function finding patient METHODS retrospective cohort study adult patient referred postacute COVID19 pulmonary clinic diagnosis COVID19 pneumonia study period initial peak pandemic New York City June December 2020 RESULTS 111 patient included average interval time COVID19 pneumonia initial clinic evaluation 12 week 482 patient moderate 223 severe infection Dyspnea cough common respiratory symptom post infection Radiographic abnormality improved majority patient ground glass opacity common residual abnormal finding Restrictive airway disease decreased diffusion capacity common finding pulmonary function test CONCLUSION study suggests need close serial monitoring functional radiological abnormality post COVID19 period Considering many clinicalradiological functional abnormality reversible suggest `` wait watch approach avoid unnecessary invasive work,covid-19;chest radiography;pneumonia;post covid;post coronavirus pneumonia
Side effect COVID19 vaccination among resident Poland,34227078,OBJECTIVE Side effect vaccine common people react differently different vaccine Manufacturers provide list side effect product Adverse reaction proof effectiveness vaccine immune system responding study compare side effect AstraZeneca Pfizer vaccine survey result show side effect first dose AstraZeneca vaccine common first second dos Pfizer vaccine respondent survey reported least one sideeffect AstraZeneca Pfizer vaccine reaction le common Pfizer preparation PATIENTS METHODS survey distributed via internet conducted among people vaccinated Pfizer AstraZeneca respondent asked side effect first second dos vaccine injection site pain arm pain muscle pain headache fever chill fatigue RESULTS questionnaire completed 705 people 196 vaccinated Pfizer 509 AstraZeneca Among vaccinated first dose AstraZeneca vaccine 965 reported least one postvaccination reaction 171 respondent reported side effect listed survey Among vaccinated first Pfizer dose vaccine reaction reported 939 respondent 2 respondent experienced side effect mentioned survey second dose Pfizer vaccine caused postvaccinal reaction subject 548 respondent adverse reaction 158 fewer adverse reaction first dose vaccine 294 experienced side effect first second dos Pfizer vaccine CONCLUSIONS Side effect result vaccination rare proof immune system responding However severe adverse reaction vaccine dangerous engender fear Concerns side effect complication COVID19 vaccine may eclipse opinion regarding benefit study show first dose AstraZeneca vaccine cause side effect often either dose Pfizer vaccine,
Antibody Cocktail Exhibits Broad Neutralization Activity SARSCoV2 SARSCoV2 Variants,34224110,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 precipitated multiple variant resistant therapeutic antibody study 12 highaffinity antibody generated convalescent donor early outbreak using immune antibody phage display library two RBDbinding antibody F61 H121 showed highaffinity neutralization SARSCoV2 whereas three S2target antibody failed neutralize SARSCoV2 Following structure analysis F61 identified linear epitope located residue G446S494 overlapped angiotensinconverting enzyme 2 ACE2 binding site H121 recognized conformational epitope located side face RBD outside ACE2 binding domain Hence cocktail two antibody achieved better performance neutralization SARSCoV2 Importantly two antibody also showed efficient neutralizing activity variant including B117 B1351 reacted mutation N501Y E484K L452R indicated may also neutralize recent India endemic strain B1617 unchanged binding activity F61 H121 RBD multiple mutation revealed broad neutralizing activity variant mitigated risk viral escape finding revealed therapeutic basis cocktail antibody constantly emerging SARSCoV2 variant provided promising candidate antibody clinical treatment COVID19 patient infected broad SARSCoV2 variant,angiotensin-converting enzyme 2 (ace2);antibody cocktail;broad neutralization;sars-cov-2 variants;severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
Identification Lung Blood Microbiota Implicated COVID19 Prognosis,34200572,implication microbiome Coronavirus disease 2019 COVID19 prognosis thoroughly studied study aimed characterize lung blood microbiome implication COVID19 prognosis analysis peripheral blood mononuclear cell PBMC sample lung biopsy sample bronchoalveolar lavage fluid BALF sample three tissue type found panel microbe differentially abundant COVID19 normal sample correlated immune dysregulation upregulation inflammatory pathway including key cytokine pathway interleukin IL 2 3 510 23 signaling pathway downregulation antiinflammatory pathway including IL4 signaling PBMC sample six microbe correlated worse COVID19 severity one microbe correlated improved COVID19 severity Collectively finding contribute understanding human microbiome suggest interplay identified microbe key inflammatory pathway may leveraged development immune therapy treating COVID19 patient,covid-19;sars-cov-2;blood microbiota;coronavirus;inflammation;lung microbiota;microbiome
United States Medicolegal Progress Innovation Telemedicine Age COVID19 Primer Neurosurgeons,34133724,Telemedicine received increased attention recent year potential solution expand clinical capability patient access care many field including neurosurgery Although patient physician attitude rapidly shifting toward greater telemedicine use light COVID19 pandemic remains uncertainty telemedicine s regulatory future Despite growing evidence telemedicine s utility remain number significant medicolegal barrier mass adoption wider implementation Herein examine recent progress state federal regulation United States governing telemedicine s implementation quality care finance billing privacy confidentiality risk liability geography interstate licensure special attention concern teleneurosurgical practice also review contemporary topic germane future teleneurosurgery including continued expansion reciprocity interstate licensure expanded coverage homecare service chronic condition expansion Center Medicare Medicaid Services reimbursement protection storeandforward technology Additionally discus recent success teleneurosurgery stroke care rehabilitation model teleneurosurgical best practice telemedicine technology continues mature expanse grows neurosurgeon familiarity benefit limitation controversy best allow successful adoption field maximize patient care outcome,covid-19;innovation;medicolegal;telemedicine;teleneurosurgery
Umbrella Review Work Health Impacts Working EpidemicPandemic Environment,34202087,umbrella review review examined evidence work health impact working epidemicpandemic environment factor associated impact risk mitigation intervention strategy address factor examined review article published MEDLINE PsycINFO Embase 2000 2020 Data extracted included review analyzed using narrative synthesis search yielded 1524 unique citation 31 included Included study focused health care worker risk infection COVID19 respiratory illness mental health outcome health care worker willingness respond public health event Reviews identified variety individual social organizational factor associated work health outcome well risk mitigation strategy addressed study outcome review examined intervention strategy workplace physical distancing quarantine none included longterm outcome exposure work epidemicpandemic Findings suggest number critical research evidence gap including need review occupational group potentially exposed impacted negative work health effect COVID19 addition health care worker longterm consequence transitioning postCOVID19 economy work health research equity social determinant health lens,covid-19;mental health and well-being;occupational health;pandemic;systematic review;work and health
Immune Response SARSCoV2 Asymptomatic Pediatric Allergic Cohort,34199430,Diseasespecific COVID19 pediatric comorbidity studied effectively date Atopy food anaphylaxis disease state require improved characterization SARSCoV2 infection risk provide first characterization assessed serum sample highly atopic food anaphylactic asymptomatic pediatric cohort across US height pandemic biobank 172 pediatric patient serum sample characterized specific atopic food anaphylactic immunologic marker US beginning pandemic 1 February 20 April 2020 Clinical demographic data analyzed addition sample analysis SARSCoV2 IgM IgG ELISA SARSCoV2 antibody result positive six patient 4 Nearly half pediatric patient history asthma 49 Total IgE total IgG IgG13 similar positive negative SARSCoV2 Median total IgG4 SARSCoV2 positive group nearly three time pvalue = 002 negative group Atopy controller medication confer additional benefit data suggest food anaphylaxis highly atopic child increased risk SARSCoV2 seropositivity specific population appears either equal potentially le risk general population Total specific IgG4 may novel predictor SARSCoV2 infection risk specific allergic pediatric population,antibody;atopy;infectious disease
Axonal Regeneration Glycosaminoglycan,34222264,Like biomolecules including nucleic acid protein glycan play pivotal role various cellular process instance modulates protein folding stability organizes extracellular matrix tissue elasticity regulates membrane trafficking addition cellsurface glycans often utilized entry receptor virus including SARSCoV2 Nevertheless role ligand specific surface receptor well understood exception selectins siglecs Recent report demonstrated chondroitin sulfate heparan sulfate glycosaminoglycans work physiological ligand shared receptor protein tyrosine phosphatase sigma PTPsigma two glycans differentially determine fate neuronal axon injury central nervous system heparan sulfate promotes axonal regeneration chondroitin sulfate inhibits inducing dystrophic endbulbs axon tip recent study demonstrated chondroitin sulfate CS PTPsigma axis disrupted autophagy flux axon tip dephosphorylating cortactin minireview introduce glycans work physiological ligand regulate intracellular signaling especially focusing chondroitin sulfate,ptpsigma;autophagy;axonal regeneration;chondroitin sulfate;dystrophic endbulb;heparan sulfate
Chronic Immune Activation CD4 + Cell Lymphopenia Healthy African Individuals Perspectives SARSCoV2 Vaccine Efficacy,34220854,Chronic immune activation considered driving force CD4 + cell depletion people infected HIV1 Interestingly normal immune profile adult HIVnegative individual living Africa also exhibit chronic immune activation reminiscent observed HIV1 infected individual characterized increased level soluble immune activation marker cytokine interleukin IL 4 IL10 TNFalpha cellular activation marker including HLADR CD38 CCR5 coupled reduced naive increased memory cell CD4 + CD8 + subset addition accompanied low CD4 + cell count compared Europeans also evidence mononuclear cell African infant secrete le innate cytokine South North Americans Europeans vitro Chronic immune activation Africans linked environmental factor parasitic infection could responsible previously observed immune hyporesponsiveness infection vaccine unclear whether immunogenicity effectiveness antiSARSCoV2 vaccine also reduced similar mechanism review study investigating phenomenon urgently required inform design delivery vaccine used African population,africa;covid-19;sars-cov-2;chronic immune activation;helminths;hyporesponsiveness;vaccine
MultiSubunit SARSCoV2 Vaccine Design Using Evolutionarily Conserved T B Cell Epitopes,34206865,SARSCoV2 pandemic created public health crisis worldwide Although vaccine virus efficiently rolled proving ineffective certain emerging SARSCoV2 variant high degree sequence similarity SARSCoV2 human coronaviruses HCoV present opportunity designing vaccine may offer protection SARSCoV2 emerging variant crossprotection HCoVs study performed bioinformatics analysis identify B cell epitope originating spike membrane nucleocapsid envelope protein sequence found evolutionarily conserved among seven major HCoVs Evolutionary conservation epitope indicates may critical role viral fitness therefore unlikely mutate viral replication thus making epitope attractive candidate vaccine designed vaccine construct comprises twelve six B cell epitope conserved among HCoVs vaccine predicted soluble water stable relatively long halflife exhibit low allergenicity toxicity docking result showed vaccine form stable complex tolllike receptor 4 immune simulation predicted vaccine may elicit strong IgG IgM cytotoxic cell response Therefore multiple perspective multisubunit vaccine design show potential elicit strong immuneprotective response SARSCoV2 emerging variant carrying minimal risk causing adverse effect,mers;sars-cov;sars-cov-2;epitope;human coronaviruses;vaccine
indirect impact COVID19 largescale containment measure incidence communityacquired pneumonia older people regionwide populationbased study Tuscany Italy,34216731,OBJECTIVE evaluate indirect effect COVID19 largescale containment measure incidence communityacquired pneumonia CAP older people first epidemic wave COVID19 Tuscany Italy METHODS populationbased study carried data Tuscany healthcare system outcome measure hospitalization rate CAP severity CAP hospitalization outpatient consumption antibacterial CAP people aged 65 older Outcomes compared corresponding period 2020 week 1 27 previous year RESULTS Compared average corresponding period previous 3 year significant reduction weekly hospitalization rate CAP observed week national containment measure imposed week 10 end first COVID19 wave July week 27 also significant decrease outpatient consumption antibacterial class CAP CONCLUSIONS implementation largescale COVID19 containment measure likely reduced incidence CAP older people first wave COVID19 pandemic Tuscany Italy Considering indirect impact pandemic containment measure respiratory tract infection may improve planning health service pandemic future,covid-19;community-acquired pneumonia;containment measures;indirect effects;older population;pandemic
Safety BNT162b2 COVID19 vaccine multiple sclerosis MS Early experience tertiary MS center Israel,34288285,BACKGROUND PURPOSE Although COVID19 vaccine currently recommended people multiple sclerosis MS fact specifically tested people MS raise uncertainty regarding safety population purpose study report reallife safety data BNT162b2 COVID19 vaccine cohort MS patient METHODS anonymous survey distributed 425 MS patient Participants asked general demographic diseaserelated question specific question regarding safety profile COVID19 vaccine RESULTS 425 MS patient 262 completed questionnaire median range participant age 42 2279 year 199 participant woman 759 66 participant 252 associated comorbidities total 198 participant 756 treated diseasemodifying therapy 239 participant 912 responder received BNT162b2 COVID19 vaccine 182 761 aged 55 year 57 239 aged 55 year Adverse event reported 136 participant 569 525 aged 55 year 403 aged 55 year p = 01517 36 participant 151 reported new worsening neurological symptom following vaccination frequent sensory disturbance 21 participant 583 symptom occurred within first 24 h vaccination resolved within 3 day total 28 participant 778 require medication treat symptom CONCLUSIONS survey indicates overall favorable safety profile BNT162b2 vaccine people MS data confirmed prospective largescale study,covid-19;adverse events;multiple sclerosis;safety;vaccine
AirwayOnAChip Designs Applications Lung Repair Disease,34206722,lung affected illness including asthma chronic obstructive pulmonary disease infection influenza SARSCoV2 Physiologically relevant model respiratory condition essential new drug development composition structure lung extracellular matrix ECM play major role function lung tissue cell Lungonchip model developed address limitation current twodimensional vitro model review describe various ECM substitute utilized modeling respiratory system explore application lungonchip model study cigarette smoke electronic cigarette vapor discus challenge opportunity related model characterization emphasis situ characterization method established emerging discus advancement field incorporation interstitial cell ECM potential provide effective tool interrogating lung biology disease especially mechanism involve interstitial element,airway-on-a-chip;analysis methods;bio-imaging;cigarette smoke;electronic cigarettes;endothelial cells;epithelial cells;exposures;extracellular matrix;fibroblasts;microfluidics;remodeling
Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent ULK1,34287052,Uncoordinated 51like kinase 1 ULK1 wellcharacterized initiator canonical autophagy basal pathological condition Porcine haemagglutinating encephalomyelitis virus PHEV neurotropic betacoronavirus betaCoV impairs ULK1 kinase hijack autophagy facilitate viral proliferation However machinery PHEVinduced autophagy initiation upon ULK1 kinase deficiency remains unclear time course PHEV infection showed significant accumulation autophagosomes APs nerve cell vivo vitro Utilizing ULK1knockout neuroblastoma cell identified ULK1 essential productive AP formation induced PHEV vitro phosphorylation study discovered mTORC1regulated ULK1 activation stall PHEV infection whereas AP biogenesis controlled AMPKdriven BECN1 phosphorylation lack BECN1 sufficient block LC3 lipidation disrupt recruitment LC3ATG14 complex Moreover BECN1 act bona fide substrate ULK1independent neural autophagy ectopic expression BECN1 somewhat enhances PHEV replication finding highlight novel machinery noncanonical autophagy independent ULK1 bypass conserved initiation circuit AMPKmTORC1ULK1 providing new insight interplay neurotropic betaCoV host IMPORTANCE ongoing COVID19 pandemic alongside outbreak SARS MERS pose betacoronavirus betaCoV global public health challenge Coronaviruses subvert haijack utilize autophagy promote proliferation thus exploring crosstalk betaCoV autophagy great significance confronting future betaCoV outbreak Porcine haemagglutinating encephalomyelitis virus PHEV highly neurotropic betaCoV invades central nervous system CNS pig understanding pathogenesis PHEVinduced neurological dysfunction yet limited discovered novel regulatory principle neural autophagy initiation PHEV infection productive autophagosome AP biogenesis bypassing multifaceted regulation ULK1 kinase PHEVtriggered noncanonical autophagy underscore complex interaction virushost help development therapeutic strategy targeting noncanonical autophagy treat betaCoV disease,
Abdominal wall block emergency ileostomy operation patient COVID19 pneumonia case report,34214519,anesthesia method administered emergency surgical procedure COVID19 Coronavirus Disease 2019 pneumonia patient carry great importance patient surgical team Regional block generally used ensure postoperative analgesia abdominal surgery general anesthesia case involving patient receiving anticoagulant treatment due COVID19 pneumonia planned emergency operation aim present anesthesia management rectus sheath transversus abdominis plane block combination ileostomy operation Due administered block patient given general anesthesia Hence transmission reduced minimizing aerosol formation term protecting health personnel worsening patient s pneumonia prevented case discussed term regional anesthesia technique offering good alternative appropriate case employee patient safety present day whole world affected COVID19 pandemic,anesthesia;covid-19;ileostomy;pneumonia
Prehospital characteristic COVID19 patient Helsinki experience first wave pandemic,34281612,BACKGROUND lack knowledge patient COVID19 disease differ patient similar sign symptom diagnosis COVID19 prehospital setting aim study compare characteristic two patient group met emergency medical service METHODS prehospital patient World Health Organisation pandemic declaration 1132020 3062020 recruited study patient screened using modified criterion suspected COVID19 Data electronic prehospital patient reporting system linked hospital laboratory result check laboratory confirmation COVID19 comparison divided patient two group screening laboratorypositive patient hospital diagnosis COVID19 screeningpositive laboratorynegative patient eventually received different diagnosis hospital RESULTS total 4157 prehospital patient fulfilled criterion suspected COVID19 infection study period Fivehundredthirtysix 129 suspected case received laboratory confirmation COVID19 proportion positive case relation suspected one peaked first 2 week declaration pandemic comparison laboratorypositive laboratorynegative case clinically insignificant difference group age tympanic temperature systolic blood pressure heart rate onscene time urgency category call mode transportation Foreignlanguagespeakers overrepresented amongst positive case native language speaker 266 vs 74 p 0001 number case sign symptom COVID19 disease reported patient turned positive test result 125 03 whole EMS patient population 119 verified COVID19 patient encountered EMS CONCLUSIONS sample suspected COVID19 patient laboratorypositive laboratorynegative patient clinically indistinguishable prehospital assessment Foreignlanguagespeakers high likelihood Covid19 modified criterion still form basis screening suspected COVID19 patient prehospital setting,ambulance;covid-19;emergency medical services;prehospital;sars-cov-2
Telemedicine Therapeutic Option Sports Medicine Results Nationwide CrossSectional Study among Physicians Patients Germany,34281045,BACKGROUND Worldwide number treatment field sport medicine increasing However COVID19 pandemic changed everyday life Many consultation cancelled postponed converted virtual format Telemedicine sport medicine could support physician study analyzes use perception telemedicine application among physician patient field sport medicine Germany METHODS prospective crosssectional study based survey sport medicine physician patient Germany COVID19 pandemic Descriptive statistic calculated RESULTS analyzed response 729 patient 702 sport medicine physician believed telemedicine useful physician patient rated knowledge telemedicine unsatisfactory majority respondent said currently use telemedicine would like Patients physician reported attitude changed positively towards telemedicine usage increased due COVID19 majority group agreed implementing virtual visit stable disease condition Telemedicine considered helpful followup monitoring prevention group CONCLUSION Telemedicine sport medicine seen limited use highly accepted among physician patient alike absence structured framework obstacle effective implementation Training course introduced improve limited knowledge regarding use telemedicine research telemedicine sport medicine needed includes largescale randomized controlled trial economic analysis exploration user preference,covid-19;digitalization;ehealth;health services research;sports medicine;telemedicine;telemedicine in sports medicine
Staff staff transmission driver healthcare worker infection COVID19,34344634,BACKGROUND High rate healthcare worker HCW infection due COVID19 attributed several factor including inadequate personal protective equipment PPE exposure high density patient COVID19 poor building ventilation investigated increase number staff COVID19 infection hospital determine factor contributing infection implement intervention required prevent subsequent infection METHODS conducted singlecentre retrospective cohort study staff working tertiary referral hospital tested positive SARSCoV2 25 January 2020 25 November 2020 primary outcome source COVID19 infection RESULTS 45 staff returned positive test result SARSCoV2 19 determined acquired hospital Fifteen 1519 79 95 CI 5494 identified contact tracing testing following exposure infected staff presumed stafftostaff transmission including outbreak 10 healthcare worker HCWs linked single ward cared COVID19 patient staff tearoom identified likely location transmission subsequent reduction HCW infection resolution outbreak following implementation enhanced control measure tearoom facility HCW contact 0204 0 95 CI 02 developed COVID19 infection following exposure unrecognised patient COVID19 CONCLUSION Unrecognised infection among staff may significant driver HCW infection healthcare setting Control measure implemented prevent acquisition staff well patientstaff transmission,healthcare worker infections;outbreak;sars-cov-2;staff break room;staff tearoom
Current State Knowledge Role Pets Zoonotic Transmission SARSCoV2,34208484,Pets play crucial role development human feeling social life care However era prevailing global pandemic COVID19 disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 many question addressing route virus spread transmission human dramatically emerging Although case SARSCoV2 infection found pet including dog cat ferret date strong evidence pettohuman transmission sustained pettopet transmission SARSCoV2 However increasing number study reporting detection SARSCoV2 farmed mink raise suspicion potential viral transmission animal human Furthermore due high susceptibility cat ferret mink hamster COVID19 infection natural andor experimental condition animal extensively explored animal model study SARSCoV2 pathogenesis transmission review present latest report focusing SARSCoV2 detection isolation characterization pet Moreover based current literature document study aiming broaden knowledge pathogenicity transmissibility SARSCoV2 development viral therapeutic drug vaccine Lastly considering high rate SARSCoV2 evolution replication also suggest route protection virus,covid-19;sars-cov-2;pets suitable animal models;zoonotic potential
Levels Produced Antibodies Vaccination mRNA Vaccine Effect Previous Infection SARSCoV2,34199029,aim study estimate immunogenic effect mRNA vaccine SARSCoV2 study included 510 participant received mRNA vaccine measurement antiCOVID19 antibody performed using Abbott SARSCoV2 IgG quantitative assay Abbott Overall mean titer antiSpike antibody 193192 + 17875 AUmL Vaccination induced robust immunogenic response previously infected SARSCoV2 compared noninfected subject Additionally individual asymptomatic vaccination produced lower level antibody compared feverish individual conclusion remarkably high level antiSpike COVID19 antibody observed vaccination,covid-19;sars-cov-2;anti-sars-cov-2 antibodies;vaccination
Studying SARSCoV2 Fluorescence Microscopy,34207305,COVID19 pandemic caused SARSCoV2 coronavirus deeply affected world community gave strong impetus development approach diagnostics therapy also fundamental research molecular biology virus Fluorescence microscopy powerful technology enabling detailed investigation viruscell interaction fixed live sample high specificity spatial resolution conventional fluorescence microscopy sufficient resolve virusrelated structure superresolution fluorescence microscopy solve problem paper review use fluorescence microscopy study SARSCoV2 related virus prospect application recently developed advanced method fluorescence labeling microscopywhich opinion provide important information molecular biology SARSCoV2are discussed,covid-19;rna labeling;sars-cov-2;coronavirus;genetically encoded probes;live cell fluorescence imaging;protein labeling;super-resolution fluorescence microscopy
Impact nonpharmaceutical intervention incidence vaccinepreventable disease COVID19 pandemic eastern China,34374635,BACKGROUND response coronavirus disease 2019 COVID19 pandemic many country implemented mitigating nonpharmaceutical intervention investigated impact intervention change public behavior incidence selected vaccinepreventable disease VPDs COVID19 pandemic eastern China METHODS routine monitoring data collected capital eastern China s Jiangsu Province extracted analyzed incidence influenza hand foot mouth disease HFMD varicella mumps pertussis hepatitis B also investigated change public behavior COVID19 pandemic telephone interview questionnaire survey RESULTS Compared baseline 20172019 incidence VPDs except influenza declined significantly 2020 HFMD decreased 7992 varicella decreased 771 mumps decreased 203 pertussis decreased 7891 hepatitis B decreased 031 reduction reported case child 014 year greater adult pertussis largest reduction approximately 80 child Influenza peak winter three year COVID19 pandemic Influenza rate took average 10 week recede lowest level Spring Festival 2020 took 1 week total 366 outbreak 20205 case reported COVID19 pandemic Among participant study 942 interviewee avoided going highrisk area 824 avoided going crowded place 929 wore mask going out884 washed hand frequently 679 maintained social distance CONCLUSIONS study showed significant reduction incidence VPDs implementation series nonpharmaceutical intervention COVID19 pandemic,covid-19;incidence;novel coronavirus;social distancing;wearing masks
review latest research pro targeting SARSCOV inhibitor,34355175,Since outbreak COVID19 pandemic caused SARSCoV2 infection still spreading alarming rate caused huge loss life economic damage worldwide Although one year passed effective treatment COVID19 pathogenic coronaviruses yet developed Therefore development SARSCoV2 inhibitor urgent priority Given pro sequence SARSCoV2 SARSCoV1 100 identical catalytic domain protein cleavage viral main protease pro one extensive drug target drug target investigated SARSCoV2 provide scientific researcher timely antiSARSCoV drug development information pro focus past current drug design development strategy Pro review believe review provide meaningful guidance design development innovative drug COVID19 pathogenic coronaviruses future,
Reach engagement effectiveness inperson online lifestyle change program prevent diabetes,34225674,BACKGROUND COVID19 accelerated interest need online delivery healthcare examined reach engagement effectiveness online delivery lifestyle change program LCP modelled Diabetes Prevention Program DPP multistate realworld setting METHODS Longitudinal nonrandomized study comparing online inperson LCP large multistate sample delivered 1 year Sample included atrisk adult n = 26743 referred online n = 9 inperson n = 11 CDCrecognized LCP multistate registry California Florida Colorado 2015 2018 main outcome effectiveness proportion achieving 5 weight loss oneyear secondary outcome included reach proportion enrolled among referred engagement proportion = 9 session week 26 used logistic regression modelling ass association participant setting level characteristic meaningful weight loss RESULTS Online LCP effectiveness lower 23 online participant achieving 5 weight loss compared 35 inperson participant p 0001 adult referred online program enrolled 56 v 51 p 0001 fewer engaged 6months attendance =9 session 46 v 66 p 0001 compared inperson participant CONCLUSIONS Compared adult referred inperson LCP referred online LCP likely enroll le likely engage Online participant achieved modest meaningful weight loss Online delivery LCP attractive strategy deliver scale DPP particularly social distancing measure currently place However unclear optimize delivery model maximal impact given tradeoff reach effectiveness,dpp;diabetes prevention programs;digital;lcp;lifestyle change programs;virtual
Validation Checklist Massive Vaccination Centers,34224553,Abstract Starting minimum requirement indicated Lombardy Region validation checklist developed expert design healthcare layout planning hygiene public health planning compliance order provide manager COVID19 massive vaccination center useful easytouse tool ensure quality safety efficiency different activity performed,covid-19;massive vaccination center;checklist;efficiency;layout;quality;safety;vaccination campaign
Correlations Olfactory Psychophysical Scores SARSCoV2 Viral Load COVID19 Patients,34287905,OBJECTIVESHYPOTHESIS aim study evaluate correlation severity duration olfactory dysfunction OD assessed psychophysical test viral load rhinopharyngeal swab determined direct method patient affected coronavirus disease 2019 COVID19 STUDY DESIGN Prospective cohort study METHODS Patients underwent psychophysical olfactory assessment Connecticut Chemosensory Clinical Research Center test determination normalized viral load nasopharyngeal swab within 10 day clinical onset COVID19 RESULTS Sixty COVID19 patient included study psychophysical testing 12 patient 20 cohort presented anosmia 11 183 severe hyposmia 13 183 moderate hyposmia 10 167 mild hyposmia overall prevalence OD 767 overall median olfactory score 50 interquartile range IQR 30725 significant difference clinical severity subgroup median normalized viral load detected series 256E+06 viral copies10 6 copy human beta2microglobulin mRNA present sample IQR 317E+04158E+07 without significant correlation COVID19 severity correlation viral load olfactory score baseline R 2 = 00007 P = 844 60day followup R 2 = 00077 P = 519 weak significant CONCLUSIONS presence OD seem useful identifying subject risk superspreaders risk developing longterm OD Similarly pathogenesis OD probably related individual factor rather viral load activity LEVEL EVIDENCE 4 Laryngoscope 2021,covid-19;sars-cov-2;anosmia;coronavirus;olfactory;viral load
Driveup INR testing phonebased consultation service COVID19 pandemic pharmacistlead anticoagulation clinic Qatar Monitoring clinical resource utilization patient oriented outcome,34226887,Background Coronavirus disease 2019 COVID19 pandemic resulted unprecedented pressure healthcare system led widespread utilization telemedicine telehealth service Combined teleclinics using driveup fingerstick International normalized ratio INR testing recommended decrease exposure risk anticoagulation patient Objective evaluate impact transitioning clinicbased anticoagulation management service driveup phonebased service COVID19 pandemic Qatar Methods study comprised two component retrospective cohort study eligible patient attended anticoagulation clinic 1year period 6 month 6 month service transition crosssectional survey eligible patient agreed provide data satisfaction new service Monitoring parameter clinical outcome resource utilization related warfarin therapy compared service transition Patients experience explored structured survey Results statistically significant difference clinicbased phonebased anticoagulation service mean time number visit within therapeutic range P = 67 P = 06 respectively mean number extreme subtherapeutic supratherapeutic INR value P = 32 P = 34 respectively incidence thromboembolic complication warfarin related hospitalization one reported bleeding one emergency visit 09 phonebased group v none clinicbased group Frequency INR testing compliance attending clinic appointment declined significantly P = 002 P = 001 respectively Overall patient highly satisfied new service majority patient found better 516 good traditional service 445 Patients preferred new service significantly younger counterpart P = 005 Conclusion service driveup INR testing phonebased consultation shown comparable traditional anticoagulation service finding support maintaining service part new normal pandemic,covid-19;anticoagulation;telehealth
Vaccine Effects Susceptibility Symptomatology Change Optimal Allocation COVID19 Vaccines South Korea Example,34202324,approved coronavirus disease COVID19 vaccine reduce risk disease 7095 however efficacy preventing COVID19 unclear Moreover limited vaccine supply raise question used effectively examine optimal allocation COVID19 vaccine South Korea constructed agestructured mathematical model calibrated using countryspecific demographic epidemiological data optimal control problem formulated aim finding timedependent agespecific optimal vaccination strategy minimize cost related COVID19 infection vaccination considering limited vaccine supply various vaccine effect susceptibility symptomatology result suggest `` susceptibilityreducing vaccine relatively evenly distributed among age group resulting 40 eligible age group vaccinated contrast `` symptomreducing vaccine administered mainly individual aged 2029 =60 year Thus study suggests vaccine profile determine optimal vaccination strategy finding highlight importance understanding vaccine s effect susceptibility symptomatology effective public health intervention,covid-19;mathematical model;optimal control theory;vaccination;vaccine efficacy
Prevalence factor associated longterm COVID19 sick leave workingage patient followed general practice Germany,34224870,OBJECTIVES investigate prevalence factor associated longterm sick leave workingage patient diagnosed COVID19 general practice Germany METHODS Patients aged 1865 year diagnosed COVID19 1255 general practice Germany March 2020 February 2021 included study Longterm sick leave defined sick leave least 4 week association predefined independent variable longterm sick leave studied using adjusted logistic regression model RESULTS study included 30 950 patient diagnosed COVID19 517 woman mean standard deviation age 415 +130 year prevalence longterm sick leave 58 Female sex older age several condition noninfective enteritis colitis reaction severe stress adjustment disorder atopic dermatitis mononeuropathy reflux disease diabetes mellitus hypertension positively significantly associated longterm sick leave CONCLUSION Longterm sick leave relatively rare COVID19 patient followed general practice Germany result confirmed invalidated setting country,covid-19;germany;coronavirus disease;general practices;long-term sick leave
CD8 + cell specific conserved coronavirus epitope correlate milder disease COVID19 patient,34210785,central feature SARSCoV2 pandemic individual become severely ill die whereas others mild disease course asymptomatic report development improved multimeric alphabeta cell staining reagent platform maxiferritin `` spheromer displaying 12 peptideMHC complex Spheromers stain specific cell efficiently peptideMHC tetramers capture broader portion sequence repertoire given peptideMHC Analyzing response unexposed individual find cell recognizing peptide conserved amongst coronaviruses abundant tend `` memory phenotype compared unique SARSCoV2 Significantly CD8 + cell conserved specificity much abundant COVID19 patient mild disease versus severe illness suggesting protective role,
impact social distancing contact tracing case isolation intervention suppress COVID19 epidemic modeling study,34284227,INTRODUCTION country dependent nonpharmaceutical public health intervention social distancing contact tracing case isolation mitigate COVID19 spread medicine vaccine widely available Minimal research performed independent combined impact intervention based empirical case data METHODS obtained data confirmed COVID19 case January 7th February 22nd 2020 Zhejiang Province China fit agestratified compartmental model using human contact information outbreak effectiveness social distancing contact tracing case isolation studied compared simulation also simulated twophase reopening scenario ass whether various strategy combining nonpharmaceutical intervention likely achieve populationlevel control secondwave epidemic RESULTS study sample included 1218 symptomatic case COVID19 664 interprovince travel history Results suggest 365 95 CI 128571 contact quarantined approximately five day 95 CI 22110 needed detect isolate case contact network would increase societal economic reopening avoiding second wave without strengthening nonpharmaceutical intervention compared first wave would exceedingly difficult CONCLUSIONS Continuous attention improvement nonpharmaceutical intervention needed secondwave prevention Specifically contact tracing merit attention,covid-19;case isolation;contact tracing;modeling;social distancing
Implementation documented written informed consent clinical trial communicable disease Lessons learned barrier solution future direction identified conduct COVID19 clinical trial,34222708,Background objective communicable nature many infectious disease including SARSCoV2 creates challenge implementing obtaining regulatorycompliant written informed consent goal project identify evaluate process address barrier maintaining clinical research staff safety Methods reviewed Federal Drug Administration FDA World Health Organization VA Office Research Development ORD guidance informed consent COVID19 pandemic identified pilottested several mechanism obtaining regulatorycompliant consent COVID19 therapeutic clinical trial Results Several process identified included standard facetoface consent plan maintaining paper copy signed consent form phone video chat consent process included taking picture signed consent form screen shot signed document video chat integration consent form software embedded within electronic health record secure software program electronic signature process FDAcompliant timeintensive often requiring four hour coordination clinical team research staff patient legally authorized representative Conclusions Future study could evaluate improve efficiency whether element consenting process requirement documented written signed consent rather witnessed oral consent acceptable standard research participant communicable disease,
CostEffectiveness Expanding Vaccination CellBased Influenza Vaccine Low Risk Adults Aged 50 64 Years United Kingdom,34199912,BACKGROUND response COVID19 UK National Health Service NHS extended influenza vaccination 50 64yearolds atrisk age group 202021 season objective research determine costeffectiveness continuing vaccinate quadrivalent cellbased vaccine QIVc compared returning atrisk policy pandemic resolve METHODS dynamic transmission model calibrated match infection data UK used estimate clinical economic impact vaccination across 10 influenza season base case effectiveness QIVc 639 list price GBP 994 RESULTS Vaccinating 50 50 64yearolds QIVc reduced average annual number clinical infection 682000 hospitalization 5800 death 740 UK base case incremental cost per qualityadjusted lifeyear gained ICER compared atrisk GBP6000 NHS perspective cost lost productivity considered vaccinating 50 64yearolds QIVc became costsaving CONCLUSION Vaccinating 50 64yearolds QIVc likely costeffective NHS consider continuing policy future season,cost-effectiveness;economic modeling;influenza vaccine
Nucleic Acid Testing SARSCoV2,34200331,coronavirus disease 2019 COVID19 caused large global outbreak accordingly important develop accurate rapid diagnostic method polymerase chain reaction PCR based method including reverse transcriptionpolymerase chain reaction RTPCR widely used assay detection SARSCoV2 RNA Along RTPCR method digital PCR emerged powerful tool quantify nucleic acid virus high accuracy sensitivity NonPCR based technique reverse transcription loopmediated isothermal amplification RTLAMP reverse transcription recombinase polymerase amplification RTRPA considered rapid simple nucleic acid detection method reviewed paper Nonconventional molecular diagnostic method including nextgeneration sequencing NGS CRISPRbased assay nanotechnology improving accuracy sensitivity COVID19 diagnosis review also focus standardization SARSCoV2 nucleic acid testing activity National Metrology Institutes NMIs highlight resource reference material RM provide value specified property Finally summarize useful resource convenient COVID19 molecular diagnostics,pcr;sars-cov-2;genome sequencing;isothermal amplification;nucleic acid testing;reference materials
SARSCoV2 testing disparity across geographical region large metropolitan area Brazil Results webbased survey among individual interested clinical trial COVID19 vaccine,34375647,year since novel coronavirus SARSCoV2 disease 2019 COVID19 reached status global pandemic number COVID19 case continues rise Brazil effective treatment approved yet mass vaccination stop spread SARSCoV2 end COVID19 pandemic Multiple COVID19 vaccine candidate development currently use study aim describe characteristic individual registered online platform participate clinical trial COVID19 vaccine Additionally participant characteristic according age presence comorbidities associated severe COVID19 difference SARSCoV2 testing across different geographical areasneighborhoods provided crosssectional webbased study conducted September December2020 aiming reach individual aged =18 year live Rio de Janeiro metropolitan area Brazil Among 21210 individual completed survey 20587 971 willing participate clinical trial COVID19 vaccine Among willing participate 578 individual aged 1859 year comorbidity 337 aged 1859 year least one comorbidity 86 aged =60 year regardless presence comorbidity Almost half 426 reported ever testing COVID19 proportion lower among aged =60 year p 0001 Prevalence positive PCR result 160 higher among aged 1859 year p 0009 Prevalence positive antibody result 100 difference across age comorbidity group Participants areasneighborhoods higher Human Development Index HDI reported ever testing SARSCoV2 frequently lower HDI area Interest participate clinical trial COVID19 vaccine candidate Rio de Janeiro significantly high online registry successfully reached large number individual diverse sociodemographic economic clinical background,brazil;covid-19;sars-cov-2;seroprevalence;survey;vaccine
Revisiting Effects HighSpeed Railway Transfers Early COVID19 CrossProvince Transmission Mainland China,34199158,Coronavirus disease 2019 COVID19 ongoing pandemic reported end 2019 Wuhan China rapidly disseminated province around one month study aim ass change intercity railway passenger transport early spatial transmission COVID19 mainland China Examining role railway transport property disease transmission could help quantify spatial spillover effect largescale travel restriction intervention study used daily highspeed railway schedule data compare difference citylevel network property destination arrival transfer service Wuhan city lockdown early stage spatial transmission COVID19 mainland China Bayesian multivariate regression used examine association structural change railway origindestination network incidence COVID19 case result show province rising transfer activity Wuhan city lockdown confirmed COVID19 case change destination arrival significant effect region increasing transfer activity located province neighboring Hubei widthwise longitudinal direction result indicate transfer activity enhance interpersonal transmission probability could crucial risk factor increasing epidemic severity Wuhan city lockdown destination railway passenger might affected Wuhan city lockdown itinerary route could changed due replacement important transfer hub Wuhan city Chinese railway transportation network result transfer service highspeed rail network could explain province surrounded Hubei higher number confirmed COVID19 case province,covid-19;wuhan city lockdown;high-speed rail network;intercity population flow;spatial transmission;transfer service
Transmission severe acute respiratory syndromecoronavirus2 SARSCoV2 infant feeding early care practice systematic review,34219674,BACKGROUND Perinatal practice breastfeeding kangaroo mother care roomingin delayed cord clamping varied institution COVID19 pandemic goal systematic review examine success different practice preventing viral transmission SARSCoV2 positive mother infant METHODS Electronic search performed Ovid MEDLINE Ovid Embase Cochrane Library EBSCOhost CINAHL Plus Web Science Scopus database Studies involving pregnant breastfeeding patient tested positive SARSCoV2 RTPCR included Infants tested within 48 hour birth two test hospital discharge included Infants older one week single test also included RESULTS Twenty eight study included aggregated data among 190 breastfeeding infant 22 tested positive SARSCoV2 115 4 152 263 among bottlefed Fisher s exact test p = 00006 positivity rate roomed infant 20103 194 significantly higher isolated 5300 167 P 00001 significant difference positivity rate among infant received kangaroo care 25 v 9 p = 02170 delayed cord clamping 362 v 09 p = 01116 CONCLUSIONS Lack robust study involving large patient population allow meaningful conclusion systematic review Aggregated data showed increased positivity rate SARSCoV2 among infant breast fed roomedin difference SARSCoV2 positivity rate infant received skin skin care delayed cord clamping,breast feeding;covid-19;delayed cord clamping;formula feeding;kangaroo;mother care;novel corona virus;rooming- in;skin to skin care
Peripheral neuropathy COVID19 due immunemechanisms preexisting risk factor antiviral drug bedding Intensive Care Unit,34287509,BACKGROUND minireview aim summarize discus previous recent advance clinical presentation pathophysiology diagnosis treatment outcome SARSCoV2associated peripheral neuropathy METHODS Literature review RESULTS Altogether 105 article SARSCoV2associated neuropathy describing 261 patient retrieved Peripheral neuropathy patient COVID19 frequent predominantly due immune mechanism neurotoxic side effect drug used treat symptom COVID19 lesser extent due compression peripheral nerve resulting prolonged bedding Intensive Care Unit ICU preexisting risk factor diabetes SARSCoV2 cause viral neuropathy Neurotoxic drug daptomycin linezolid lopinavir ritonavir hydrochloroquine cisatracurium clindamycin glucocorticoid administered caution patient appropriately bedded ICU prevent SARSCoV2associated neuropathy Patients GuillainBarre syndrome GBS benefit immunoglobulin plasma exchange steroid CONCLUSIONS Neuropathies peripheral nerve patient COVID19 frequent mostly result immune mechanism neurotoxic side effect drug used treat symptom COVID19 lesser extent compression peripheral nerve due prolonged bedding ICU SARSCoV2 cause infectious neuropathy,
Mechanics Insights AlphaLipoic Acid Cardiovascular Diseases COVID19 Infection,34360751,Coronavirus disease 2019 COVID19 first reported Wuhan China late December 2019 Since COVID19 spread rapidly worldwide declared global pandemic 20 March 2020 Cardiovascular complication rapidly emerging major peril COVID19 addition respiratory disease mechanism underlying excessive effect severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection patient cardiovascular comorbidities remain partly understood SARSCoV2 infection caused binding viral surface spike protein human angiotensinconverting enzyme 2 ACE2 followed activation protein transmembrane protease serine 2 TMPRSS2 ACE2 expressed lung mainly type II alveolar cell heart blood vessel small intestine etc appears predominant portal cellular entry virus Based current information people infected SARSCoV2 virus good prognosis patient reach critical condition especially elderly chronic underlying disease `` cytokine storm observed patient severe COVID19 contributes destruction endothelium leading `` acute respiratory distress syndrome ARDS multiorgan failure death origin general proinflammatory state may SARSCoV2mediated redox status endothelial cell via upregulation ACEAng IIAT1 receptor pathway increased mitochondrial reactive oxygen specie mtROS production Furthermore vicious circle oxidative stress OS inflammation induces endothelial dysfunction endothelial senescence high risk thrombosis coagulopathy microvascular dysfunction formation microthrombi way differentiate SARSCoV2 infection respiratory disease bring closer cardiovascular disease like myocardial infarction stroke Due role played OS evolution viral infection development COVID19 complication use antioxidant adjuvant therapy seems appropriate new pathology Alphalipoic acid ALA could promising candidate wide tissue distribution versatile antioxidant property interferes several signaling pathway Thus ALA improves endothelial function restoring endothelial nitric oxide synthase activity present antiinflammatory effect dependent independent antioxidant property improving mitochondrial function sustain tissue homeostasis critical situation enhancing reduced glutathione could indirectly strengthen immune system complex analysis could open new therapeutic perspective ALA COVID19 infection,covid-19;sars-cov-2;alpha-lipoic acid;cardiovascular disease;inflammation;oxidative stress
Safety SARSCoV2 vaccine systematic review metaanalysis randomized controlled trial,34225791,BACKGROUND Various modality vaccine coronavirus disease 2019 COVID19 based different platform immunization procedure successively approved marketing worldwide comprehensive review clinical trial assessing safety COVID19 vaccine urgently needed make accurate judgment mass vaccination MAIN TEXT systematic review metaanalysis conducted determine safety COVID19 vaccine candidate randomized controlled trial RCTs Data search performed PubMed Embase Cochrane library Scopus Web Science MedRxiv Included article limited RCTs COVID19 vaccine total 73633 subject 14 article included compare risk adverse event following immunization AEFI vaccinating different COVID19 vaccine Pooled risk ratio RR total AEFI inactivated vaccine viralvectored vaccine mRNA vaccine 134 95 confidence interval CI 111161 P 0001 165 95 CI 131207 P 0001 201 95 CI 178226 P 0001 respectively significant difference local systemic AEFI found first dose second dose addition people aged = 55 year significantly higher risk AEFI people aged = 56 year pooled RR 125 95 CI 115135 P 0001 CONCLUSIONS safety tolerance current COVID19 vaccine candidate acceptable mass vaccination inactivated COVID19 vaccine candidate lowest reported AEFI Longterm surveillance vaccine safety required especially among elderly people underlying medical condition,adverse events following immunization;covid-19 vaccine;meta-analysis;randomized controlled trial;safety
Penicillin Allergy Label Increases Risk Worse Clinical Outcomes COVID19,34293501,BACKGROUND Coronavirus disease2019 COVID19 range asymptomatic severe Several comorbidities associated worse clinical outcome Antibiotic use common COVID19 penicillin PCN allergy affect antibiotic choice may influence COVID19 outcome OBJECTIVE investigate impact PCN allergy label COVID19 outcome METHODS retrospective cohort study Webbased tool population cohort research TriNetX used identify adult COVID19 patient without PCN allergy label two cohort matched using 11 propensity score matching baseline demographic condition associated risk severe COVID19 30day risk hospitalization acute respiratory failure intensive care unit requirement mechanical ventilation requirement mortality compared group bacterial infection drive alternative antibiotic regimen additional analysis focused patient without bacterial infection RESULTS propensity score matching cohort consisted 13183 patient COVID19 patient PCN allergy higher risk hospitalization risk ratio RR = 146 95 confidence interval CI 141152 acute respiratory failure RR = 125 95 CI 119131 intensive care unit requirement RR = 120 95 CI 108134 mechanical ventilation RR = 117 95 CI 103132 compared patient without PCN allergy however mortality difference RR = 109 95 CI 096123 Although bacterial infection risk higher PCN allergic COVID19 patient exclusion patient bacterial infection yielded similar result CONCLUSIONS Penicillin allergic patient higher risk worse COVID19 outcome considered risk mitigation strategy,covid-19;drug allergy;hospitalization;mortality;penicillin;penicillin allergy;respiratory failure;severe acute respiratory syndrome coronavirus-2
Recent Progress Nanotechnology COVID19 Prevention Diagnostics Treatment,34361174,COVID19 pandemic currently unprecedented public health threat rapid spread infection led call alternative approach combat virus Nanotechnology taking root SARSCoV2 prevention diagnostics treatment infection light escalating demand managing pandemic comprehensive review highlight role nanomaterials response pandemic highly desirable review article comprehensively discus use nanotechnology COVID19 based three main category prevention diagnostics treatment first highlight use various nanomaterials including metal nanoparticles carbonbased nanoparticles magnetic nanoparticles COVID19 critically review benefit nanomaterials along application personal protective equipment vaccine development diagnostic device fabrication therapeutic approach remaining key challenge future direction nanomaterials COVID19 briefly discussed review informative helpful providing guidance developing nanomaterialbased product fight COVID19,covid-19;diagnostics;nanomaterials;prevention;treatment
rest break help acute fatigue among nursing staff 12h shift COVID19 pandemic crosssectional study,34227132,AIM study aimed explore whether 30min rest break effective lowering acute fatigue among 12h shift hospital nursing staff cared patient COVID19 among DESIGN study crosssectional design METHODS Data SAFECARE study collected online May June 2020 used subsample N = 338 comprised nursing staff reported working 12h shift providing direct patient care hospital used study Data sociodemographics work rest break subjective measure fatigue psychological distress sleep health used Hierarchical multiple linear regression followed stratified analysis conducted explore relationship rest break acute fatigue among nursing staff group without COVID19 patient care RESULTS sample average high acute fatigue Around 72 reported providing care patient COVID19 71 reported taking rest break sometimes often always group cared patient COVID19 significant relationship rest break acute fatigue p = 507 group cared patient hospitalized reason rest break associated lower acute fatigue p = 010 CONCLUSION finding showed importance inadequacy rest break reducing acute fatigue process withinwork recovery complex routine rest break facilitated nursing management hospital unit COVID19 pandemic IMPACT Rest break may present effective strategy lowering fatigue Although rest break associated le fatigue among staff caring patient COVID19 coworker experienced fatigue recovery frontline nursing staff routine rest break encouraged systematic evaluation pertaining sufficiency rest break high work demand future research needed,covid-19;breaks;fatigue;nurses;recovery;rest
onestep onepot CRISPR nucleic acid detection platform CRISPRtop Application diagnosis COVID19,34215080,existing CRISPRmediated diagnostic test require twostep procedure DNA RNA amplification followed CRISPRmediated sequencespecific detection nucleic acid detection increase complexity risk sample crosscontamination report new CRISPRmediated test called CRISPRtop CRISPRmediated testing onepot integrates simultaneous target preamplification CRISPRcas12bmediated detection onepot reaction mixture performed constant temperature novel CRISPRtop assay applied detect severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent COVID19 coronavirus disease 2019 COVID19 CRISPRtop target ORF1ab opening reading frame 1ab NP nucleoprotein gene SARSCoV2 operates 59 degree C 40 min minimal instrument COVID19 CRISPRtop assay return result within 60min easily interpreted visual fluorescence lateral flow readout analytical limit detection LoD COVID19 CRISPRtop 10 copy detection target per reaction crossreactivity observed nonSARSCoV2 template Among clinically collected nonCOVID19 sample assay s specificity 100 8080 oropharynx swab sample Among 52 COVID19 positive clinical sample collected COVID19 CRISPRtop assay yielded 38 731 positive result using fluorescence readout 35 673 positive result lateralflow readout diagnostic result similar obtained using RTPCR 34 positive 654 data indicate COVID19 CRISPRtop simple rapid accurate highly sensitive method SARSCoV2 detection used clinic field laboratory primary care facility resourcechallenged setting,covid-19;crispr;crispr-top;cas12b;nucleic acid detection;sars-cov-2
Use Ceftaroline Hospitalized Patients without COVID19 Descriptive CrossSectional Study,34201722,singlecenter crosssectional study conducted describe use ceftaroline large teaching hospital Northern Italy period also including first month coronavirus disease 2019 COVID19 pandemic primary objective describe use ceftaroline term indication characteristic patient secondary objective describe rate favorable clinical response patient bloodstream infection BSI due methicillinresistant Staphylococcus aureus MRSABSI receiving ceftaroline Overall 200 patient included study COVID19 83 165200 hospitalized medical ward 78 155200 Included patient COVID19 pneumonia given empirical ceftaroline suspicion bacterial coinfection superinfection Among patient MRSABSI ceftaroline used firstline therapy salvage therapy 25 312 75 912 case respectively monotherapy combination daptomycin 58 712 42 512 patient respectively favorable response registered 67 812 patient Improving etiological diagnosis bacterial infection essential optimize use ceftaroline COVID19 patient use ceftaroline MRSABSI either monotherapy combination antiMRSA agent showed promising rate favorable response,covid-19;mrsa;staphylococcus aureus;ceftaroline
COVID19 pandemic Italian obstetric department sharing experience,34212913,BACKGROUND AIM WORK outbreak novel coronavirus SARSCoV 2 significantly struck healthcare system worldwide course week hospital reorganized internal structure entirely level care Emergency room Departments including medical specialty METHODS order cope contingent state emergency Gynecology Obstetrics Unit University Hospital Udine introduced new protocol guidance usual standard care ensuring safe environment healthcare provider patient RESULTS continuous update scientific evidence department able increase capacity well maintain flexibility higher number admission required CONCLUSION aimed share experience provided relevant lesson expect prepare referral center highrisk pregnancy response pandemic COVID19,
presentationsphysician ratio predicts doortophysician time global length stay emergency department Italian multicenter study SARSCoV2 pandemic,34292458,investigate effect dramatic reduction presentation Italian Emergency Departments EDs main indicator ED performance SARSCoV2 pandemic February June 2020 retrospectively measured number daily presentation normalized number emergency physician duty presentationsphysician ratio doortophysician doortofinal disposition lengthofstay time seven EDs central area Tuscany Using multivariate regression analysis investigated relationship aforesaid variable patientlevel triage code age admission hospitallevel factor number physician duty working surface area academic vs community hospital analyzed data 105271 patient ten consecutive 14day period number presentation dropped 18239 6132 67 proportion patient visited le 60 min rose 56 86 proportion patient lengthofstay 4 h decreased 59 52 presentationsphysician ratio inversely related proportion patient doortophysician time 60 min slope 291 95 CI 423 159 R 2 = 039 proportion patient highpriority code presentationsphysician ratio inversely related proportion patient lengthofstay 4 h slope 040 95 CI 024 027 R 2 = 036 variability doortophysician time global lengthofstay predicted different factor appropriate benchmarking among EDs use performance indicator consider specific hospitallevel patientlevel factor,community hospital;door-to-physician;emergency department;length-of-stay;performance indicator
Antimicrobial Use COVID19 Patients First Phase SARSCoV2 Pandemic Scoping Review,34205440,scoping review provides new evidence prevalence pattern global antimicrobial use treatment COVID19 patient identifies commonly used antibiotic clinical scenario associated antibiotic prescribing first phase pandemic explores impact documented antibiotic prescribing treatment outcome COVID19 patient review complies PRISMA guideline Scoping Reviews protocol registered Open Science Framework first six month pandemic similar mean antibiotic prescribing rate patient severe critical illness 754 patient mild moderate illness 751 proportion patient prescribed antibiotic without clinical justification 515 vs 419 patient mild moderate illness severe critical illness Comparison patient provided antibiotic clinical justification given antibiotic without clinical justification showed lower mortality rate 95 vs 131 higher discharge rate 809 vs 693 shorter length hospital stay 93 day vs 122 day first 6 month pandemic antibiotic prescribed COVID19 patient regardless severity illness large proportion antibiotic prescribing mild moderate COVID19 patient clinical evidence bacterial coinfection Antibiotics may beneficial COVID19 patient without clinical evidence bacterial coinfection,covid-19 patients;antibiotic use;clinical justification;disease severity;secondary infections
Right Abortion Risk Times COVID19 Italian State Affairs within European Context,34204759,COVID19 health emergency thrown health system European country deep crisis forcing call postpone intervention deemed essential lifesaving order focus resource treatment COVID19 patient facilitate woman experiencing difficulty terminating pregnancy Italy Ministry Health adapted regulation force European country issued new guideline allow medical abortion 63 day ie 9 week gestational age without mandatory hospitalization decision met controversy based assumption abortion pill could `` incentivize woman resort abortion easily fact statistical data show country using medical abortion time number abortion increased author expect even Italy case European country use telemedicine likely gradually increase safe valuable option third phase health emergency author argue need favor pharmacological abortion setting adequately equipped counseling center case European country limiting hospitalization particularly complex case,covid-19;european backdrop;italian legislation;abortion;telemedicine
Regulation Viral Infection Diabetes,34199246,Though Diabetes Virus multiple agent mumps virus rubella virus influenza virus type hepatitis virus enterovirus rotavirus cytomegalovirus varicellazoster virus human herpesvirus 6 EpsteinBarr virus also SARSCoV2 reported associated diabetes,
Choquet fuzzy integralbased classifier ensemble technique COVID19 detection,34229144,COVID19 outbreak resulted global pandemic led million death date COVID19 early detection essential mitigation controlling spread infected patient community quarantine Although vaccination started take time reach everyone especially developing nation computer scientist striving come competent method using image analysis work classifier ensemble technique proposed utilizing Choquet fuzzy integral wherein convolutional neural network CNN based model used base classifier classifies chest Xray image patient common Pneumonia confirmed COVID19 healthy lung Since sample COVID19 case training standard CNN model scratch use transfer learning scheme train base classifier InceptionV3 DenseNet121 VGG19 utilize pretrained CNN model extract feature classify chest Xray image using two dense layer one softmax layer combine prediction score data individual model using Choquet fuzzy integral get final predicted label accurate prediction individual model determine fuzzymembership value classifier application Choquet fuzzy integral use validation accuracy classifier proposed method evaluated chest Xray image publicly available repository IEEE Kaggle datasets provides 9900 9900 9900 9902 average recall precision Fscore accuracy respectively also evaluated performance proposed model interdataset experimental setup chest Xray image another dataset CMSC678MLProject GitHub dataset fed trained model achieved 9905 test accuracy dataset result better commonly used classifier ensemble method well many stateoftheart method,covid-19;choquet integral;deep learning;ensemble method;machine learning;transfer learning;x-ray image
Interventions treatment persistent postCOVID19 olfactory dysfunction,34291813,BACKGROUND Olfactory dysfunction early sensitive marker COVID19 infection Although selflimiting majority case hyposmia anosmia persists profound effect quality life Little guidance exists treatment postCOVID19 olfactory dysfunction however several strategy proposed evidence relating treatment postviral anosmia medication olfactory training OBJECTIVES ass effect benefit harm intervention used proposed treat persisting olfactory dysfunction due COVID19 infection secondary objective keep evidence uptodate using living systematic review approach SEARCH METHODS Cochrane ENT Information Specialist searched Cochrane COVID19 Study Register Cochrane ENT Register CENTRAL Ovid MEDLINE Ovid Embase Web Science ClinicalTrialsgov ICTRP additional source published unpublished study date search 16 December 2020 SELECTION CRITERIA Randomised controlled trial including participant symptom olfactory disturbance following COVID19 infection individual symptom least four week included review Studies compared intervention treatment placebo DATA COLLECTION ANALYSIS used standard Cochrane methodological procedure Primary outcome recovery sense smell diseaserelated quality life serious adverse effect Secondary outcome change sense smell general quality life prevalence parosmia adverse effect including nosebleedsbloody discharge used GRADE ass certainty evidence outcome MAIN RESULTS included one study 18 participant compared use 15day course oral steroid combined nasal irrigation consisting intranasal steroidmucolyticdecongestant solution intervention Psychophysical testing used ass olfactory function baseline 20 40 day Systemic corticosteroid plus intranasal steroidmucolyticdecongestant compared intervention Recovery sense smell assessed 40 day 25 day cessation treatment using Connecticut Chemosensory Clinical Research Center CCCRC score tool range 0 100 score = 90 represents normal olfactory function evidence uncertain effect intervention recovery sense smell one three month 59 participant intervention group scored = 90 compared 09 control group risk ratio RR 1100 95 confidence interval CI 070 17366 1 study 18 participant lowcertainty evidence Change sense smell assessed using CCCRC score 40 day study reported improvement sense smell intervention group baseline median improvement CCCRC score 60 interquartile range IQR 40 compared control group median improvement CCCRC score 30 IQR 25 1 study 18 participant lowcertainty evidence Serious adverse event andother adverse event identified participant study however unclear outcome assessed recorded 1 study 18 participant lowcertainty evidence AUTHORS CONCLUSIONS limited evidence available efficacy harm treatment persistent olfactory dysfunction following COVID19 infection However identified ongoing trial area living systematic review update data regularly new result become available first version living review identified one study small sample size assessed systemic steroid nasal irrigation intranasal steroidmucolyticdecongestant However evidence regarding benefit harm intervention treat persistent postCOVID19 olfactory dysfunction uncertain,
Impact COVID19 Lockdown Patients Obesity Intensive Cognitive Behavioral TherapyA CaseControl Study,34208391,BACKGROUND COVID19 lockdown may negatively impacted treatment obesity study aimed ass effect COVID19 lockdown patient obesity treated intensive residential cognitive behavioral therapy CBTOB METHODS retrospective casecontrol study analyzed 129 patient severe obesity experienced COVID19 lockdown 6 month discharge intensive residential CBTOB comparing outcome weight loss bingeeating episode general health status sample patient matched gender age body mass index given treatment COVID19 outbreak control Patients assessed baseline phone interview 6month followup RESULTS group lost 9 baseline bodyweight reported significant decrease bingeeating episode similar general health status 6month followup However control patient achieved significantly greater weight loss experienced lockdown although half lockdown patient reported persisting CBTOB procedure discharge CONCLUSION Patients obesity treated CBTOB exposed COVID19 lockdown despite achieving lower weight loss nonexposed patient healthy weight loss 6month followup comparable reduction bingeeating behavior,covid-19;cognitive behavioral therapy;isolation;lockdown;treatment outcomes
tetrameric ACE2 protein broadly neutralizes SARSCoV2 spike variant concern elevated potency,34375715,SARSCoV2 receptor angiotensin converting enzyme 2 ACE2 previously engineered high affinity tetravalent format ACE2FcTD potential decoy protein SARSCoV2 infectionWe report protein show greatly enhanced binding SARSCoV2 spike protein SARSCoV2 variant concern B117 alpha variant originally isolated United Kingdom B1351 beta variant originally isolated South Africa picomolar compared nanomolar Kd value addition ACE2FcTD display greater neutralization SARSCoV2 pseudotype virus compared dimeric ACE2Fc enhanced activity variant B1351 tetrameric decoy protein would valuable addition SARSCoV2 therapeutic approach especially vaccination used also future coronavirus pandemic,ace2;covid-19;coronavirus;sar2-cov-2;spike protein;voc;variant spike
case secondary sclerosing cholangitis due COVID19,34364072,COVID19 first recognized World Health Organization December 2019 declared global pandemic March 2020 Although COVID19 primarily result pulmonary symptom becoming apparent lead multisystemic manifestation Liver damage elevated AST ALT seen patient COVID19 Although etiology liver damage still debated biliary damage rarely seen case demonstrates potential complication COVID19 previously healthy patient patient contracted COVID19 March 2020 endured complicated course including intubation multiple readmission chronic abdominal pain awaiting liver transplant case portrays biliary damage additional possible complication COVID19 importance imaging diagnosis,covid-19;cholangiopathy;hepatobiliary;secondary sclerosing cholangitis
Clinical Profile Pharmacological Treatment Predictors Death Among Hospitalized COVID19 Patients Acute Kidney Injury PopulationBased Registry Analysis,34211984,Introduction One worst clinical outcome coronavirus disease 2019 COVID19 pandemic acute kidney injury AKI Methods manuscript present result populationbased registry study assessing treatment comorbidities predictor hospital death among COVID19 patient AKI March 1st May 31th 2020 Death oxygen delivery ventilation acute dialysis need use medication various clinical outcome addition length stay hospital intensive care unit ICU evaluated Results Castile Leon largest region Spain 1087 patient admitted COVID19 n = 7307 developed AKI patient known hypertension 5793 cardiovascular disease 4899 diabetes 267 chronic kidney disease 1436 used antibiotic 9043 antimalarial 6045 steroid 4861 antiviral 3338 antisystemic inflammatory response syndrome SIRS drug 945 tocilizumab 831 Mortality among patient AKI doubled observed patient without AKI 461 vs 2179 Predictors hospital death COVID19 patient AKI ventilation need = 59 treatment steroid = 17 antiSIRS = 24 severe acute respiratory syndrome SARS occurrence = 28 SIRS occurrence = 25 Conclusions Acute kidney injury frequent serious complication among COVID19 patient high mortality requires attention treating physician prescribing medication looking manifestation particular disease SARS SIRS,covid-19;sars-cov-2;acute kidney injury;chronic kidney disease;mortality;treatment
Maintenance Electroconvulsive Therapy Essential Medical Treatment Patients Catatonia COVID19 Related Experience,34335326,Aim Describe naturalistic clinical course 14 week mixed adolescent youngadult patient group diagnosed developmental delay catatonia frequency maintenance electroconvulsive therapy MECT reduced secondary 2020 COVID19 pandemic restriction Methods Participants diagnosed catatonia receiving care specialized clinic n = 9 F = 5 = 4 ranged age 16 21 year ECT frequency reduced end March 2020 due institutional restriction Two parentscaregivers elected discontinue ECT due concern COVID19 transmission Majority n = 8 developmentally delayed degree intellectual disability ID Observable symptom rated three point scale virtual visit Results case experienced clinically significant decline Worsening motor symptom agitation aggression slowness repetitive selfinjury stereotypies speech deficit emerged within first 3 week persisted 14 week observation period frequent neurovegetative symptom appetite incontinence sleep Four participant deteriorated requiring rehospitalization 2 among 4 needed gastrostomy feeding tube Conclusion Moderate severe symptom became apparent 9 case observation period medication adjustment ineffective resuming MECT participant s baseline schedule usually week 7 resulted progressive improvement case improvement insufficient prevent rehospitalization 4 case summary rapid deterioration noted MECT acutely reduced setting COVID19 related restriction,catatonia;developmental delay;electroconvulsive therapy;maintenance ect;maintenance electroconvulsive therapy
Cultural Responsiveness Palliative Care COVID19 Pandemic,34223473,COVID19 pandemic much changed delivery palliative care PC However cultural responsiveness remains critical mission essential aim identifying individual goal care providing relief suffering patient Cultural responsiveness may also enhance trust could mitigating factor staggering health care disparity unmasked pandemic study author outline rationale renewed focus issue offer initial suggestion culturally responsive PC provided even extraordinary time,covid-19;cultural awareness;cultural competence;cultural humility;cultural responsiveness;palliative care
Evaluating impact COVID19 adoption virtual care general practice 20 country inSIGHT rationale study protocol,34292867,BACKGROUND recent decade virtual care emerged promising option support primary care delivery However despite potential adoption rate remained low outbreak COVID19 suddenly pushed forefront care delivery progress second year COVID19 pandemic need opportunity review impact remote care primary care setting reassess potential future role OBJECTIVE study aim explore perspective General Practitioners GPs Family Doctors use virtual care COVID19 pandemic b perceived impact quality safety care c essential factor highquality sustainable use virtual care future METHODS Online crosssectional questionnaire GPs distributed across 20 country survey hosted Qualtrics distributed using email social medium researcher personal contact network General Practitioners eligible survey working mainly primary care period COVID19 pandemic Descriptive statistical analysis performed quantitative variable relationship use virtual care perception impact quality safety care participant characteristic may explored Qualitative data freetext response analysed using framework analysis RESULTS Data collection took place June September 2020 manuscript s submission total 1605 GP respondent participated questionnaire data analysis currently ongoing CONCLUSIONS study provide comprehensive overview availability virtual care technology perceived impact quality safety care essential factor highquality future use addition description underlying factor influence adoption perception individual GPFD characteristic context work provided COVID19 pandemic may prove first great stress test capability capacity robustness digital system currently use remote care likely remain increasingly common approach future imperative identify main lesson unexpected transformation use inform policy decision health service design INTERNATIONAL REGISTERED REPORT DERR110219630099,
Evaluation automated molecular test detection SARSCoV2 pooled nasopharyngeal saliva specimen,34132419,BACKGROUND Pooling sample SARSCoV2 testing lowprevalence setting used effective strategy expand testing capacity mitigate challenge shortage supply evaluated two automated molecular test system detection SARSCoV2 RNA pooled specimen METHODS Pooled nasopharyngeal saliva specimen tested Qiagen QIAstatDx Respiratory SARSCoV2 Panel QIAstat Cepheid Xpert Xpress SARSCoV2 Xpert result compared standard RTqPCR test without pooling RESULTS nasopharyngeal specimen sensitivityspecificity pool testing approach 5 10 specimen per pool 77 100 n = 105 741 100 n = 260 QIAstat 971 100 n = 250 100 995 n = 200 Xpert respectively Pool testing saliva 10 specimen per pool n = 150 Xpert resulted 875 sensitivity 993 specificity compared individual test Pool size 5 10 specimen significantly affect difference RTqPCR cycle threshold CT standard testing RTqPCR CT value obtained pool testing QIAstat Xpert positively correlated individual testing Pearson s correlation coefficient r = 085 099 p 005 However CT value Xpert significantly stronger p 001 paired test QIAstat subset SARSCoV2 positive specimen mean difference 43 + 243 46 + 2 individual pooled test respectively CONCLUSION result suggest Xpert SARSCoV2 utilized pooled sample testing COVID19 screening lowprevalence setting providing significant cost saving improving throughput without affecting test quality,covid-19;qiastat-dx respiratory sars-cov-2 panel;sars-cov-2;xpert xpress sars-cov-2;sample pooling
Risk contracting SARSCoV2 COVID19 hospital admission impact protection effort acute stroke treatment,34225003,BACKGROUND unclear intervention designed restrict community inhospital exposure SARSCoV2 COVID19 virus influenced stroke care patient seeking acute treatment Therefore aimed determine COVID19 intervention impacted acute stroke treatment time ass risk contracting COVID19 due stay medical center METHODS Retrospective single center twophase study evaluating hospital community trend 122019 042020 compared previous year prepost n = 15693 intervention implementation Phase assessed stroke treatment time delay hospital arrival witnessed stroke volume Phase II postimplementation telephone survey assessed risk developing symptom testing positive COVID19 RESULTS Stroke volume declined 29 p 05 April March compared previous year However significant delay seeking medical care pre Mdn=112 post Mdn=95 p = 34 observed Witnessed stroke volume decreased 11 p 001 compared preimplementation group significant delay IV alteplase pre Mdn=22 min post Mdn=26 min p = 08 endovascular treatment pre Mdn=60 min post Mdn=80 min p = 45 observed Phase II 63 patient participated two tested 3 COVID19 positive admission four 6 within two week discharge COVID19 contraction risk hospitalization remained similar general population RR=175 95 CI 079363 Overall result indicated marked decrease stroke volume significant delay either seek provide acute stroke care evident COVID19 contraction risk low CONCLUSIONS Seeking acute stroke medical care outweighs risk COVID19 exposure,
Journals Review Recent Articles Editorial Team,34286359,review provide brief description recently published article addressing topic relevant pediatric cardiologist hope provide summary latest article published recently journal field article address 1 outcome COVID19 infection adult congenital heart disease showed increased mortality compared general population 2 hepatorenal dysfunction transplantation patient Fontan associated increased mortality 3 abnormal Von Willebrand factor metabolism angiopoietin signaling may contribute pulmonary AVM formation child Glenn circulation 4 low cardiac output Norwood procedure improves higher hemoglobin milrionone 5 comparison staged versus complete repair neonatal tetralogy Fallot reveiling pro con strategy 6 longterm outcome early repair complete atrioventricular canal show difference outcome patient repaired 3 month life,atrioventricular canal;atrioventricular septal defect;covid-19;collaterals;fontan;heart transplantation;norwood;tetralogy of fallot
Endothelial dysfunction COVID 19 cognitive impairment,34283537,Endothelial dysfunction important mechanism underlying multiple organ system failure COVID19 development endothelial dysfunction COVID19 disrupt organ perfusion cause procoagulant state leading macro microvascular thrombotic event Cognitive impairment common complication COVID19 develop acute delayed period directly related severity underlying disease Treatment endothelial dysfunction patient COVID19 take account leading pathogenetic factor development development neurological including cognitive disorder include neuroprotective drug One drug actovegin shown effective improving endothelial function microcirculation cognition,covid-19;sars-cov-2;actovegin;cognitive impairment;endothelial dysfunction;molecular mimicry
Use Lateral Flow Immunoassay Characterize SARSCoV2 RBDSpecific Antibodies Ability React UK SA BR P1 Variant RBDs,34208912,Identifying antispike antibody exhibit strong neutralizing activity current dominant circulating variant antibody escaped variant important implication development therapeutic diagnostic solution improving understanding humoral response severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection characterized seven antiSARSCoV2 receptor binding domain RBD antibody binding activity pairing capability neutralization activity SARSCoV2 three variant RBDs via lateral flow immunoassay result allowed u group antibody three distinct epitope bin study showed two antibody broadly potent neutralizing activity SARSCoV2 variant RBDs one antibody neutralize South African SA Brazilian P1 BR P1 RBDs antibody escaped SA BR P1 RBDs retained binding activity SA BR P1 RBDs unable induce neutralization demonstrated lateral flow immunoassay could rapid effective tool antibody characterization including epitope classification antibody neutralization kinetics potential contribution mutation N501Y E484K K417NT contained variant RBDs antibody pairing capability neutralization activity therapeutic antibody targeting strategy discussed,ace2;covid-19;sars-cov-2 variant;epitope binning;lateral flow immunoassay;neutralizing antibody;rapid neutralization test;receptor binding domain (rbd);spike protein;therapeutic antibody cocktail
Mechanisms underlying genetic susceptibility multisystem inflammatory syndrome child MISC,34224783,BACKGROUND Multisystem inflammatory syndrome child MISC pediatric complication severe acute respiratory syndrome coronavirus 2 infection characterized multiorgan inflammation frequently cardiovascular dysfunction occurs predominantly otherwise healthy child previously reported haploinsufficiency suppressor cytokine signaling 1 SOCS1 negative regulator type II interferon genetic risk factor MISC OBJECTIVES aimed identify additional genetic mechanism underlying susceptibility severe acute respiratory syndrome coronavirus 2associated MISC METHODS singlecenter prospective cohort study whole exome sequencing performed patient MISC impact candidate variant tested using patient PBMCs obtained least 7 month recovery RESULTS enrolled 18 patient MISC median age = 8 year interquartile range = 51225 year 89 condition obesity 2 boy significant infection history identified validated hemizygous deleterious defect XIAP encoding Xlinked inhibitor apoptosis CYBB encoding cytochrome b245 beta subunit Including previously reported SOCS1 haploinsufficiency genetic diagnosis identified 3 18 patient 17 contrast patient mild COVID19 patient defect SOCS1 XIAP CYBB exhibit inflammatory immune cell transcriptome enrichment differentially expressed gene pathway downstream IL18 oncostatin nuclear factor kappaB even recovery CONCLUSIONS Although inflammatory disorder rare general population cohort patient MISC enriched monogenic susceptibility inflammation result support use nextgeneration sequencing previously healthy child develop MISC,covid-19;mis-c;multisystem inflammatory syndrome in children;sars-cov-2;whole exome sequencing
Chloe COVID19 Evolution Intelligent Conversational Agent Address Infodemic Management Needs COVID19 Pandemic,34375299,UNSTRUCTURED unprecedented demand infodemic management due rapidly evolving information novel COVID19 pandemic viewpoint paper detail evolution Canadian digital information tool Chloe COVID19 based incremental leveraging artificial intelligence technique providing accessible summary Chloe s development show proactive cooperation health technology corporate sector lead rapidly scalable safe secure virtual chatbot assist public health effort keeping Canadians informed highlight Chloe s strength challenge faced development process future direction role chatbots infodemic management information presented may guide future collaborative effort health technology order enhance access accurate timely health information public,
Could urinary kidney injury molecule1 good marker subclinical acute kidney injury mild moderate COVID19 infection,34213713,PURPOSE evaluate urinary kidney injury molecule1 uKIM1 proximal tubule injury biomarker subclinical acute kidney injury AKI may occur COVID19 infection METHODS study included proteinuric n = 30 nonproteinuric n = 30 patient diagnosed mildmoderate COVID19 infection March September 2020 healthy individual control group n = 20 uKIM1 serum creatinine cystatin C spot urine protein creatinine albumin level patient evaluated average 21 day RESULTS median interquartile range uKIM1 level time presentation 246 141347 pgmL proteinuric group 83 29217 pgmL nonproteinuric group 55 21123 pgmL control group significantly high proteinuric group others p 0001 Creatinine cystatin C significantly higher proteinuric group group without proteinuria none patient met KDIGOAKI criterion uKIM1 positive correlation PCR nonalbumin proteinuria creatinine cystatin C CRP fibrinogen LDH ferritin negative correlation eGFR albumin p 005 multivariate regression analysis nonalbumin proteinuria p = 0048 BUN p = 0034 identified independent factor predicting high uKIM1 level 21 + 4 day proteinuria regressed normal level 20 67 patient proteinuric group addition uKIM1 level albuminuria nonalbumin proteinuria CRP significantly decreased CONCLUSIONS finding support kidney one target organ COVID19 may cause proximal tubule injury even patient present AKI criticalsevere COVID19 infection,acute kidney injury;covid-19;non-albuminuric proteinuria;sub-clinical;urinary kidney injury molecule-1
long must elective surgery delayed SARSCOV2 diagnosis Multiplecenter regional research,34363439,OBJECTIVE determine optimal postponement period elective surgery patient SARSCOV2 infection MATERIAL METHODS multiplecenter regional prospective cohort research included patient underwent elective surgery November 2020 compared outcome patient preoperative COVID19 without infection primary endpoint 30day mortality rate parameter stratified depending period COVID19 diagnosis using logistic regression RESULTS Preoperative COVID19 diagnosed 32 46 682 patient Thirtyday mortality rate patient without infection 15 Preoperative coronavirus infection increased mortality rate odds ratio 20 25 181 83 surgery within 02 34 56 78 week infection respectively Surgeries 78 week ensured result patient without infection odds ratio 15 78week postponement elective surgery patient COVID19 active symptom higher mortality rate compared without resolved symptom 50 vs 13 v 65 respectively CONCLUSION possible elective surgery delayed least 78 week COVID19 diagnosis patient active symptom 78 week diagnosis infection postponement surgery recommended,sars-cov-2;elective surgery;surgery
The Laryngectomee Guide Malaysian Language,34285656,The Laryngectomee Guide Panduan Pesakit Laringektomi available Malaysian language Guide provides information assist laryngectomees medical provider medical dental psychological issue contains information side effect radiation chemotherapy method speaking airway stoma voice prosthesis care eating swallowing medical dental psychological concern respiration anesthesia travelling cope COVID19 pandemic,chemotherapy;laryngectomee;radiation;rehabilitation;speech
InterHospital EscalationofCare Referrals Severe AlcoholRelated Liver Disease Recent Drinking COVID19 Pandemic,34219147,Alcohol sale consumption increased coronavirus disease 2019 pandemic downstream effect alcoholrelated liver disease ALD unclear analyzed interhospital escalationofcare referral tertiary care inpatient liver unit across 18 month December 2020 significant rise severe ALD recent unhealthy drinking regional community pandemic,
Widespread implementation lowcost telehealth service delivery antenatal care COVID19 pandemic interrupted timeseries analysis,34217399,BACKGROUND Little evidence available use telehealth antenatal care response COVID19 pandemic developed implemented new antenatal care schedule integrating telehealth across model pregnancy care inform clinical initiative aimed ass effectiveness safety telehealth antenatal care METHODS analysed routinely collected health data woman giving birth Monash Health large health service Victoria Australia using interrupted timeseries design assessed impact telehealth integration antenatal care March 23 2020 across lowrisk highrisk care model Allowing 1month implementation period March 23 2020 compared first 3 month telehealth integrated care delivered April 20 July 26 2020 conventional care delivered Jan 1 2018 March 22 2020 primary outcome detection outcome fetal growth restriction preeclampsia gestational diabetes Secondary outcome stillbirth neonatal intensive care unit admission preterm birth birth 37 week gestation FINDINGS Jan 1 2018 March 22 2020 20 031 woman gave birth Monash Health conventional care period 2292 woman gave birth telehealth integrated care period 20 154 antenatal consultation provided integrated care period 10 731 53 delivered via telehealth Overall compared conventional care period significant difference identified integrated care period regard number baby fetal growth restriction birthweight 3rd percentile 2 integrated care period v 2 conventional care period p=072 lowrisk care model 5 integrated care period v 5 conventional care period p=050 highrisk care model number stillbirth 1 v 1 p=079 2 v 2 p=070 pregnancy complicated preeclampsia 3 v 3 p=070 9 v 7 p=015 gestational diabetes 22 v 22 p=089 30 v 26 p=006 Interrupted timeseries analysis showed significant reduction preterm birth among woman highrisk model 068 change incidence per week 95 CI 137 0002 p=0049 significant difference identified outcome measure lowrisk highrisk care model telehealth integration compared conventional care INTERPRETATION Telehealth integrated antenatal care enabled reduction inperson consultation 50 without compromising pregnancy outcome care model help minimise inperson interaction COVID19 pandemic also considered postpandemic healthcare model FUNDING None,
case psoriasis successfully treated extracorporeal photopheresis COVID19 pandemic,34215520,Psoriasis chronic inflammatory skin disease characterized welldemarcated erythematous plaque silver scale Although many new emerging therapeutic agent often sufficient control disease still need alternative treatment option challenging case Extracorporeal photopheresis ECP applied many Tcellmediated disease restore immune homeostasis treat psoriasis effectively paper present psoriasis patient respond methotrexate narrowband ultraviolet B acitretin diagnosis nonHodgkin lymphoma patient contraindication cyclosporine fumaric acid ester biologics achieved remission total 12 session ECP two half month Although exacerbation recorded polymerase chain reaction PCR confirmed coronavirus 2019 COVID19 disease infection end first month score psoriasis area severity index PASI dermatological life quality index DLQI regressed significantly within two half month ECP seems provide effective rapid response psoriasis considered psoriasis patient fail respond contraindication existing treatment,comorbidity;extracorporeal photopheresis;management;psoriasis;treatment
Apneic Tracheostomy COVID19 Patients VenoVenous Extracorporeal Membrane Oxygenation,34209380,COVID19 creates impressive burden intensive care unit term need advanced respiratory care huge number acute respiratory distress syndrome ARDS requiring prolonged mechanical ventilation case prof insufficient refractory respiratory failure calling extracorporeal approach venovenous ECMO scenario patient need early tracheostomy procedure carried creates risk distribution aerosol particle possibly leading personnel infection use apneic tracheostomy proposed COVID19 patient case ECMO may produce lung derecruitment severe hypoxemia sudden worsening respiratory mechanic developed apneic tracheostomy technique applied 32 patient supported venovenous ECMO present data showing safety feasibility technique term patient care personnel protection Gas exchange pH show statistically significant change tracheostomy respiratory mechanic data need inspiratory pressure FiO2 use apneic tracheostomy safe option patient care ECMO reduced possibility virus spreading,ards;covid-19;sars-cov-2;infection control;respiratory faiulure;safety;tracheostomy;veno-venous ecmo
KI WU Polyomavirus Respiratory Samples SARSCoV2 Infected Patients,34207902,Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 declared global pandemic goal determine whether coinfections respiratory polyomaviruses Karolinska Institutet polyomavirus KIPyV Washington University polyomavirus WUPyV occur SARSCoV2 infected patient Oropharyngeal swab 150 individual 112 symptomatic COVID19 patient 38 healthcare worker infected SARSCoV2 collected March 2020 May 2020 tested KIPyV WUPyV DNA presence 112 SARSCoV2 positive patient 27 241 coinfected KIPyV 5 45 positive WUPyV 3 27 infected simultaneously KIPyV WUPyV Neither KIPyV WUPyV DNA detected sample healthcare worker Significant correlation found patient coinfected SARSCoV2 KIPyV p 005 SARSCoV2 cycle threshold value KIPyV WUPyV KIPyV WUPyV concurrently detected p 005 result suggest KIPyV WUPyV may behave opportunistic respiratory pathogen Additional investigation needed understand epidemiology prevalence respiratory polyomavirus COVID19 patient whether KIPyV WUPyV could potentially drive viral interference influence disease outcome upregulating SARSCoV2 replicative potential,karolinska institutet polyomavirus;nccr sequencing;sars-cov-2;washington university polyomavirus;co-infection;oropharyngeal swab
First envenomation report Cnidarian Physalia physalis Indonesia,34212350,Despite high number victim every year Physalia physalis s envenomations Indonesia scientifically unsounded annual event occurred mainly Java s southern beach Eastern Bali Islands tourist destination lack scientific report lead unaware uneducated beachgoers resulting high number victim turn may ruin economic sector Thus study aimed report P physalis s envenomation treatment southern beach Special Region Yogyakarta Province based 15 beach lifeguard primary health care unit report 20192020 envenomation case varied among beach year whereas highest number case reported popular beach Parangtritis beach partial beach closing due pandemic COVID19 caused number case 2020 slightly lower 2019 envenomations general symptom oedema local pain treated 5 food vinegar hot water available severe case dyspnoea nausea vomiting cephalgia reported twice 2019 hospitalised primary health care unit however many people still practise traditional nonscientific treatment particularly chaotic situation,indonesia;physalia physalis;envenomation;treatment
Pandemic Use Telehealth Oncology Rural Academic Medical Center,34287089,Introduction COVID19 pandemic resulted exponential increase telehealth response pandemic DartmouthHitchcock Health DHH Norris Cotton Cancer Center NCCC closed nonessential inperson service March 17 2020 began reopening April 27 2020 examined outpatient telehealth utilization DHH NCCC peripandemic period compared utilization Academic Medical Center AMC overall service line Methods Weekly outpatient volume percentage telehealth percentage video versus audioonly percentage new patient examined DHH AMC selected AMCbased service line January 1 October 31 2020 Results Compared AMC overall five primarily nonsurgical specialty oncology lower 1 proportion outpatient visit performed via telehealth example week 71220 oncology = 11 AMC = 21 mean 5 specialty = 38 2 percentage telehealth involving video versus audioonly 71220 oncology = 19 AMC = 58 mean 5 others = 60 Oncology closely resembled surgical specialty orthopedics 71220 2 telehealth 10 telehealth involved video Oncology also demonstrated 1 high proportion outpatient visit involving procedure oncology = 22 orthopedics = 12 2 difference telehealth inperson visit term percentage involving new patient Conclusions peripandemic period oncology service demonstrated lower average incorporation telehealth overall outpatient practice lower proportion telehealth performed video understanding result driver behind integral redesigning outpatient oncology care optimal integration telehealth,oncology;outpatient virtual visits;pandemic;rural;telehealth;telemedicine;teleoncology
COVID19 Sleep Circadian Rhythms Immunity Repurposing Drugs Chronotherapeutics SARSCoV2,34220430,severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic affected nearly 28 million people United States caused five hundred thousand death February 21 2021 novel coronavirus continues take toll United States across globe particularly among elderly 65 year clinician translational researcher taking closer look nexus sleep circadian rhythm immunity may contribute toward severe coronavirus disease19 COVID19 SARSCoV2induced multiorgan failure affect central peripheral organ causing increased mortality elderly However whether difference sleep circadian rhythm immunity older younger individual contribute agerelated difference systemic dysregulation target organ observed SARSCoV2 infection remain largely unknown Current literature demonstrates emerging role sleep circadian rhythm immunity development chronic pulmonary disease respiratory infection human mouse model exact mechanism underlying acute respiratory distress syndrome ARDS cardiopulmonary complication elderly patient combination associated comorbidities remain unclear Nevertheless understanding critical role sleep circadian clock dysfunction target organ immune status patient SARSCoV2 may provide novel insight possible therapy Chronotherapy emerging concept gaining attention sleep medicine Accumulating evidence suggests nearly half physiological function follow strict daily rhythm However healthcare professional rarely take implementing timedadministration drug consideration review summarize recent finding directly relating contributing role sleep circadian rhythm immune response modulating infectious disease process integrate chronotherapy discussion potential drug repurposed improve treatment management COVID19,covid-19;chronotherapy;sars-cov-2;circadian rhythms;immunity;sleep
Hologic Aptima SARSCoV2 assay enables high ratio pooling saving reagent improving turnaround time,34213803,BACKGROUND Hologic Aptima TMA SARSCoV2 assay employed test pooled nasopharyngeal NP sample evaluate performance pooled sample testing characterize variable influencing result METHODS Results 1033 previously tested NP sample retrieved characterize relative light unit RLU SARSCoV2positive sample tested population pooling strategy combining 10 SARSCoV2 sample one pool 101 used study result compared neat sample testing using Aptima TMA SARSCoV2 assay also CDC RTPCR Cepheid SARSCoV2 assay RESULTS Aptima assay compare favorably CDC RTPCR Cepheid SARSCoV2 assay sample pooled 10 1 experiment resulting signal strength assay suffers divide open pool assembled strongpositive versus weakpositive sample Pools former reliably detected positive percent agreement PPA 952 pool latter frequently misclassified negative PPA 40 weakpositive sample kRLU value lower 1012 constitute 34 total sample profile assay PPA approach 934 suggesting 101 pooled sample testing Aptima assay effective screening tool SARSCoV2 CONCLUSION Performing pooled testing one monitor weak positive kRLU lower 1012 quantification cycle Cq value higher 35 ongoing basis adjust pooling approach avoid reporting false negative,sars-cov-2;pooling samples;screening test;transcription-mediated amplification
Differing susceptibility C57BL6J DBA2J miceparents murine BXD family severe acute respiratory syndrome coronavirus infection,34281598,ongoing coronavirus disease2019 COVID19 pandemic caused novel coronavirus termed severe acute respiratory syndrome coronavirus2 SARSCoV2 closely related SARSCoV pose grave threat global health devastated society worldwide One puzzling aspect COVID19 impressive variation disease manifestation among infected individual majority asymptomatic exhibit mild symptom smaller largely agedependent fraction develop lifethreatening condition difference likely consequence host genetic factor Systems genetics using diverse replicable cohort isogenic mouse represents powerful way dissect host genetic difference modulate microbial infection report two founder large BXD family miceC57BL6J DBA2J differ substantially susceptibility mouseadapted SARSCoV MA15 Following intranasal viral challenge DBA2J develops severe disease C57BL6J evidenced pronounced sustained weight loss Disease accompanied high level pulmonary viral replication strain early infection substantially delayed viral clearance DBA2J data reveal parent BXD family segregated clear phenotypic difference MA15 infection support feasibility using family systemically dissect complex virushost interaction modulate disease progression outcome infection SARSCoV provisionally also SARSCoV2,bxd family;c57bl/6j;coronavirus disease-2019;dba/2j;sars-cov-2;severe acute respiratory syndrome coronavirus;susceptibility;systems genetics;viral replication;weight loss
crosssectional survey assessing influence theoretically informed behavioural factor hand hygiene across seven country COVID19 pandemic,34289816,BACKGROUND Human hygiene behaviour influence transmission infectious disease Changing maladaptive hygiene habit potential improve public health Parents teacher play important role disinfecting surface area helping child develop healthful handwashing habit current study aim inform future intervention help parent teacher take role using theoretically empirically informed behaviour change model called CapabilitiesOpportunitiesMotivationsBehaviour COMB model METHODS crosssectional online survey designed measure participant capability opportunity motivation 1 increase child s handwashing soap 2 increase cleaning surface area Additional item captured often participant believed child washed hand final survey administered early coronavirus pandemic May June 2020 3975 participant Australia China India Indonesia Saudi Arabia South Africa United Kingdom Participants selfidentified mum dad teacher child 5 10 year old ANOVAs analysis used compare participant capability opportunity motivation across country handwashing surface disinfecting Multiple regression analysis conducted country ass predictive relationship COMB component child s handwashing RESULTS ANOVA analysis revealed India lowest level capability opportunity motivation hand hygiene surface cleaning regression analysis revealed Australia Indonesia South Africa capability component significant predictor child s handwashing India capability opportunity significant United Kingdom capability motivation significant Lastly Saudi Arabia component significant CONCLUSIONS discussion explores Behaviour Change Wheel methodology could used guide intervention development community stakeholder country country assessed India offer greatest room improvement behaviour change technique influence people s capability opportunity prioritised,behaviour change;children;cross-sectional survey;hand hygiene
Severe COVID19 understanding role immunity endothelium coagulation clinical practice,34211530,SARSCoV2 responsible COVID19 pandemic immune system determinant factor defense viral infection Thus act balanced effective manner disease selflimited benign Nevertheless significant proportion population immune response exaggerated infected patient diabetes hypertension obesity cardiovascular disease likely progress severe form disease related chronic inflammation endothelial dysfunction Tolllike receptor expressed immune cell play important role physiopathology cardiovascular metabolic disease activated induce release inflammatory cytokine Hypercoagulability hyperinflammation platelet hyperresponsiveness endothelial dysfunction occur immune system hyperactivity caused viral activity thereby increasing risk arterial venous thrombosis discus interaction COVID19 immunity endothelium coagulation well cardiometabolic disease negative impact COVID19 prognosis,covid-19;atherosclerosis;endothelium;immunity;thrombosis
Respiratory Failure Extremely Premature Neonate COVID19,34200043,Coronavirus disease 2019 COVID19 condition associated SARSCoV2 typically result mild infection infant child However child risk factor chronic lung disease immunosuppression higher risk severe illness COVID19 report case 27weekgestation extremely premature infant born mother COVID19 infection infant initially treated surfactant deficiency developed worsening hypoxic respiratory failure fifth day life requiring escalating ventilatory support elevated level Creactive protein thrombocytopenia elevated level ddimer infant positive SARSCoV2 RTPCR Day 1 Day 42 life infant responded sevenday course dexamethasone gradually decreasing oxygen requirement could extubated noninvasive ventilation end fifth week birth infant currently home oxygen nasal cannula Prolonged shedding virus may unique feature disease premature infant Extreme prematurity immature lung immunocompromised status may predispose infant severe respiratory failure prolonged clinical course Instituting appropriate COVID19 protocol prevent spread disease neonatal intensive care unit NICU utmost importance Infection SARSCoV2 may implication management extremely premature infant NICU,covid-19;sars-cov-2;infant;prematurity;respiratory failure
Viruses Like Sugars Assess Glycan Involvement Viral Attachment,34200288,first step viral infection requires interaction host cell finding specific receptor trigger entry majority virus interact glycocalyx Identifying carbohydrate specifically recognized different virus important assessing cellular tropism identifying new antiviral target Advances tool available studying glycanprotein interaction made possible identify rapidly however important recognize limitation method order draw relevant conclusion review different technique genetic screening glycan array enzymatic pharmacological approach surface plasmon resonance detail glycan interaction enterovirus D68 severe acute respiratory syndrome coronavirus 2 SARSCoV2 highlighting aspect need clarification,ev-d68;hbga;sars-cov-2;attachment receptor;glycan;heparan sulfate;sialic acid;viruses
Behavioral response pregnant woman early stage COVID19 pandemic network Era China online questionnaire study,34216818,PURPOSE aim present study examine behavioral response pregnant woman early stage Coronavirus Disease 2019 COVID19 outbreak METHODS recruited 1099 woman complete online questionnaire survey February 10 February 25 2020 subject divided two group pregnant woman group control group RESULTS Concerns infection participant watched COVID19 news least day Protective behavior utilization rate pregnant woman often using various measure higher nonpregnant woman Exercise 306 pregnant woman continued exercise home control group percentage 84 Spouse relationship 388 subject relationship improved 23 thought relationship getting worse CONCLUSIONS Pregnant woman unique behavioral response different form nonpregnant woman important understand behavioral response pregnant woman network Era,covid-19;behavior;pregnant women;public health
Comparison Six SARSCoV2 Molecular Methods Correlation Cycle Threshold Distribution Clinical Specimens,34289054,BACKGROUND detection SARSCoV2 patient sample critical importance management patient monitoring transmission population However data analytical performance characteristic detection SARSCoV2 clinical specimen individual target within platform among different analytical platform limited METHODS evaluated performance six different sampletoanswer SARSCoV2 detection method Roche cobas 6800 Cepheid GeneXpert Diasorin Simplexa Luminex Aries EUA Luminex Aries RUO bioMerieux BioFire clinical specimen range viral load RESULTS positive percent agreement PPA Roche cobas 6800 GeneXpert 100 Diasorin 95 Aries EUA 74 Aries RUO 83 BioFire 97 Notably sample cycle threshold Ct value 30 E gene Roche cobas 6800 platform found 100 positive percent agreement among platform Given result examined distribution 10000 Ct value positive specimen individual institution Roche cobas platform Nearly 60 specimen asymptomatic individual PCR Ct value 30 measured using cobas 6800 assay E gene CONCLUSIONS result demonstrate performance characteristic different platform Ct value provide data regarding distribution viral RNA present positive specimen,covid-19;pcr;sars-cov-2;diagnostics
Bell s Palsy 24 Hours mRNA1273 SARSCoV2 Vaccine,34336436,Coronavirus disease 2019 COVID19 become fastestspreading pandemic 21st century Various vaccine made available via emergency use authorization Currently two mRNA vaccine offered internationally BNT162b2 mRNA1273 randomized trial vaccine incidence Bell s palsy vaccinated group statistically exceed placebo group FDA recommends increased surveillance Bell s palsy potential side effect administration vaccine among larger population globally case report Bell s palsy associated mRNA vaccine Type interferon proposed potential mechanism linking mRNA COVID19 vaccine Bell s palsy report case 36yearold previously healthy patient developed symptom Bell s palsy along leftarm numbness tingling subjective weakness masquerading subacute stroke receiving second dose mRNA1273 vaccine CT MRI brain unremarkable discharged home diagnosis Bell s palsy improved followup mRNA COVID19 vaccine may considered risk factor Bell s palsy,bell's palsy;covid-19;facial nerve;interferons;stroke;vaccine
Potential Role Extracellular Vesicles COVID19 Treatment Opportunity Challenge,34368228,SARSCoV2 infection become urgent public health concern worldwide severely affecting society economy due long incubation time high prevalence People spare effort rapid development vaccine treatment world Amongst numerous way tackling pandemic approach using extracellular vesicle EVs emerging review summarize current prevalence pathogenesis COVID19 involving combination SARSCoV2 virus receptor ACE2 endothelial dysfunction micro thrombosis together cytokine storm also discus ongoing EVsbased strategy treatment COVID19 including mesenchymal stem cell MSC EVs drugEVs vaccineEVs plateletEVs others manuscript provides foundation development targeted drug vaccine SARSCoV2 infection,ace2;covid-19;sars-cov-2;extracellular vesicles (evs);immunomodulation;mesenchymal stem cell (msc)
use prone positioning severe COVID19 outside intensive care unit,34282626,OBJECTIVES aimed demonstrate applicability prone position highflow oxygen COVID19 patient severe respiratory failure service September number case need intensive care increased MATERIAL METHODS prone position applied minimum 30minute period least four hour day patient oxygen saturation level respiration rate monitored 30 minute prone positioning RESULTS Ten patient nine male 91 MF included study Mean oxygen saturation baseline 758+1214 min 50 max 90 patient high oxygen demand oxygen saturation patient differed significantly 834+638 90+531 p 0001 prone positioning Similarly respiration rate differed significantly 239+6 214+497 p 0001 prone positioning Two patient died treatment CONCLUSION study highlight promise prone positioning performed ward condition improving oxygenation COVID19 study contains small group may provide guidance clinical management COVID19 patient prevent need intensive care challenging course therapy Tab 2 Fig 2 Ref 15,covid-19;oxygen saturation.;prone position
Role Th17 Response COVID19,34205262,COVID19 acute infectious disease respiratory system caused infection SARSCoV2 virus Severe Acute Respiratory Syndrome Coronavirus 2 Transmission SARSCoV2 infection occurs droplet contaminated object rapid wellcoordinated immune system response first line defense viral infection However disturbed overactivated immune response may counterproductive causing damage body Severely ill patient hospitalised COVID19 exhibit increased level many cytokine including Interleukin IL 1beta IL2 IL6 IL7 IL8 IL10 IL17 granulocyte colony stimulating factor GCSF monocyte chemoattractant protein 1 MCP1 tumor necrosis factor TNF Increasing evidence suggests Th17 cell play important role pathogenesis COVID19 activating cytokine cascade also inducing Th2 response inhibiting Th1 differentiation suppressing Treg cell review focus Th17 pathway course immune response COVID19 explores plausible target therapeutic intervention,covid-19 pneumonia;sars-cov-2;th17 response;cytokines
Coronavirus Disease 2019 COVID19 Key Emphasis Melatonin Safety Therapeutic Efficacy,34356384,Viral infection constitute tectonic convulsion normophysiology host current coronavirus disease 2019 COVID19 pandemic exception therefore severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection like invading microbe enacts generalized immune response virus contact body Melatonin systemic dealer overlook homeostasis disturbance consequently brings play cooperative triad antioxidant antiinflammatory immunestimulant backbone stop infective cycle SARSCoV2 endogenous exogenous threat COVID19 corporal propagation SARSCoV2 involves exacerbated oxidative activity therefore overproduction great amount reactive oxygen nitrogen specie RONS endorsement melatonin possible protective agent current pandemic indirectly supported widely demonstrated beneficial role preclinical clinical study respiratory disease addition focusing therapeutic action strengthening host protection response critical phase infective cycle make likely multitasking melatonin provide multiprotection maintaining efficacy virus variant already emerging emerge long SARSCoV2 continues circulate among u,sars-cov-2;adjuvant therapy;antioxidant;circadian rhythms;clinical trials;inflammation;melatonin;mitochondria;safety
Characterisation novel ACE2based therapeutic enhanced rather reduced activity SARSCoV2 variant,34287040,human angiotensinconverting enzyme 2 act host cell receptor SARSCoV2 member Coronaviridae family SARSCoV1 HCoVNL63 report biophysical property SARSCoV2 spike variant D614G B117 B1351 P1 affinity ACE2 receptor infectivity capacity revealing weakness developed neutralising antibody approach Furthermore report preclinical characterisation package soluble receptor decoy engineered catalytically inactive immunologically inert broad neutralisation capacity represents attractive therapeutic alternative light mutational landscape COVID19 construct efficiently neutralised four SARSCoV2 variant concern decoy also display antibodylike biophysical property manufacturability strengthening suitability firstline treatment option prophylaxis therapeutic regimen COVID19 related viral infection IMPORTANCE Mutational drift SARSCoV2 risk rendering therapeutic vaccine le effective Receptor decoy strategy utilising soluble human ACE2 may overcome risk viral mutational escape since mutation disrupting viral interaction ACE2 decoy necessity decrease virulence thereby preventing meaningful escape solution described soluble ACE2 receptor decoy significant following reason previous ACE2based therapeutic described novel feature including 1 mutation within ACE2 remove catalytical activity systemic interference reninangiotensin system 2 abrogated FcgammaR engagement reduced risk antibodydependent enhancement infection reduced risk hyperinflammation 3 streamlined antibodylike purification process scaleup manufacturability indicating receptor decoy could produced quickly easily scale Finally demonstrate ACE2based therapeutic confer broadspectrum neutralisation potency ACE2tropic virus including SARSCoV2 variant concern contrast therapeutic mAb,
Monocytedriven atypical cytokine storm aberrant neutrophil activation key mediator COVID19 disease severity,34226537,Epidemiological clinical report indicate SARSCoV2 virulence hinge upon triggering aberrant host immune response direct virusinduced cellular damage elucidate immunopathology underlying COVID19 severity perform cytokine multiplex immune profiling COVID19 patient show hypercytokinemia COVID19 differs interferongammadriven cytokine storm macrophage activation syndrome pronounced critical versus mildmoderate COVID19 Systems modelling cytokine level paired deepimmune profiling show classical monocyte drive hyperinflammatory phenotype reduction Tlymphocytes correlate disease severity CD8+ cell disproportionately affected Antigen presenting machinery expression also reduced critical disease Furthermore report neutrophil contribute disease severity local tissue damage amplification hypercytokinemia formation neutrophil extracellular trap Together finding suggest myeloiddriven immunopathology hyperactivated neutrophil ineffective adaptive immune system act mediator COVID19 disease severity,
Filtering Facepiece Respirators Healthcare Workers Protection Time COVID19 Pandemic,34285653,Protecting healthcare worker HCWs frontline time COVID19 pandemic paramount filtering facepiece respirator FFRs N95 respirator one personal protective equipment PPE used protect HCWs exposed airborne pathogen clinical practice performing aerosol generating procedure FFRs able serve intended purpose without causing additional health safety hazard HCWs following commentary provide basic information selecting correct FFRs conducting fitness test,covid-19;n95 respirators;healthcare workers;occupational health;personal protective equipment
Trends nationally notifiable sexually transmitted disease case report US COVID19 pandemic JanuaryDecember 2020,34224523,BACKGROUND describe change reported sexually transmitted disease STDs US coronavirus disease 2019 pandemic compared weekly number reported nationally notifiable STDs 2020 2019 METHODS reviewed case chlamydia gonorrhea primary secondary P syphilis reported US National Notifiable Disease Surveillance System 2020 STD compare number 2020 case reported given Morbidity Mortality Weekly Report MMWR week number 2019 case reported week expressing 2020 case percentage 2019 case also calculated percent difference 2020 2019 cumulative case total MMWR week 50 week December 9 RESULTS MMWR week 111 week December 29 2019March 11 2020 weekly number case STDs reported 2020 percentage case week 2019 similar However 2020 number much lower 2019 number week 15 week April 8 chlamydia 498 gonorrhea 712 P syphilis 637 week 50 2020 cumulative total compared 2019 140 lower chlamydia 71 higher gonorrhea 09 lower P syphilis CONCLUSION MarchApril 2020 national case reporting STDs dramatically decreased compared 2019 However resurgence reported gonorrhea syphilis case later year suggest STD reporting may increased 2020 underscoring importance continued STD prevention care activity,
national FITbased colorectal cancer screening program Netherlands COVID19 pandemic,34217421,COVID19 pandemic affected many healthcare service worldwide Like many nation Netherlands experienced large number individual affected COVID19 2020 leading increased demand hospital intensive care unit Dutch Ministry Health decided suspend Dutch biennial fecal immunochemical test FIT based colorectal cancer CRC screening program March 16 2020 FIT invitation resumed June 3 study describe shortterm effect suspension myriad relevant screening outcome result suspension quarter individual due screening March November 2020 received invitation FIT screening November 30 2020 Furthermore 578 received consecutive FIT restart November 30 2020 received outside upper limit standard screening interval 26 month Median time positive FIT colonoscopy change result pandemic Participation rate FIT screening followup colonoscopy month suspension significantly lower expected returned normal level suspension Based anticipated 2020 cohort size estimate number individual advanced neoplasia currently detected November 2020 312 lower compared would expected without pandemic Future study monitor impact longterm screening outcome result pandemic,covid-19;colorectal cancer;screening
Myocarditis COVID19 mRNA Vaccines,34281357,Myocarditis recognized rare complication coronavirus disease 2019 COVID19 mRNA vaccination especially young adult adolescent male According US Centers Disease Control Prevention myocarditispericarditis rate approximately 126 case per million dos seconddose mRNA vaccine among individual 12 39 year age reported case patient myocarditis invariably presented chest pain usually 2 3 day second dose mRNA vaccination elevated cardiac troponin level ECG abnormal ST elevation cardiac MRI suggestive myocarditis tested patient evidence acute COVID19 viral infection 1 case cardiomyopathy gene panel negative autoantibody level certain selfantigens frequency natural killer cell increased Although mechanism development myocarditis clear molecular mimicry spike protein severe acute respiratory syndrome coronavirus2 SARSCoV2 selfantigens trigger preexisting dysregulated immune pathway certain individual immune response mRNA activation immunologic pathway dysregulated cytokine expression proposed reason male predominance myocarditis case unknown possible explanation relate sex hormone difference immune response myocarditis also underdiagnosis cardiac disease woman Almost patient resolution symptom sign improvement diagnostic marker imaging without treatment Despite rare case myocarditis benefitrisk assessment COVID19 vaccination show favorable balance age sex group therefore COVID19 vaccination recommended everyone =12 year age,covid-19;covid-19 vaccines;sars-cov-2;mrna vaccine;myocarditis;pericarditis;vaccination
RiskAversion Negative Health Outcomes May Promote Individual Compliance Containment Measures Covid19 Pandemic,34220639,Firstperson experience stressful life event change individual risk attitude driving increased decreased risk perception shift riskaverse riskloving behavior may find correlate individual psychosocioemotional profile purpose aimed estimate relationship difference risktaking attitude toward possible negative health outcome psychosocioemotional dimension modulating experience lifethreatening situation context Covid19 pandemic March 2020 launched PsyCovid Study http wprnorgitem428452 ass psychosocioemotional change due Covid19 pandemic Italian population Additionally distributed 130 participant Covid19 Risk Task including monetary healthrelated stimulus estimating measure riskaversion toward health classifying participant basis riskattitude profile set psychosocioemotional variable reduced three PCA component Proactivity Isolation Inactivity individual degree riskaversion toward negative health outcome directly related Proactivity encasing empathic social support positive coping strategy may prompt individual put place selfprotection strategy toward possible negative health consequence finding indicate riskaverse profile toward possible negative health outcome may associated higher level individual prosocial proactive disposition possibly making individual compliant social hygienic guideline thus reducing exposure SARSCoV2 infection,covid-19;coping styles;empathy;loneliness;negative health outcomes;risk aversion
Impacts Side Effects BNT162b2 First Dose ChAdOx1 AntiSARSCoV2 Vaccination Work Productivity Need Medical Attention Vaccine Acceptance Multicenter Survey Healthcare Workers Referral Teaching Hospitals Republic Korea,34198562,establish successful antiSARSCoV2 vaccination strategy necessary take possible tradeoff account conducted survey vaccinated healthcare worker HCWs inthree referral teaching hospital Republic Korea investigated frequency vaccination side effect SEs impact work productivity need medical attention vaccine acceptance Three group HCWs surveyed 1406 received first dose BNT162b2 BNT162b2 1 1168 received second dose BNT162b2 BNT162b2 2 1679 received first dose ChAdOx1 ChAdOx1 1 SEs impact work productivity reported ChAdOx1 1 two group However among individual aged =40 year significant difference absence work found ChAdOx1 1 BN162b2 2 44 31699 vs 30 12405 p = 026 none hospitalized Older HCWs ChAdOx1 1 showed intention receive second dose vaccine Although incidence SEs impact greater first dose ChAdOx1 BNT162b2 young people significant impact SEs seemed rare individual aged =40 year regardless vaccine received,covid-19;sars-cov-2;side effect;vaccination
Effects COVID19 Lockdown Physical Activity Dietary Behaviors Kuwait CrossSectional Study,34208807,Coronavirus disease COVID19 pandemic brought drastic measure significantly altered norm daily living measure affected human behavior disparate way study seek understand impact pandemic physical activity dietary behavior among adult living Kuwait crosssectional survey conducted 18 June 15 July 2020 using questionnaire disseminated social medium including WhatsApp Facebook target population individual aged 21 year older living State Kuwait study included 679 respondent 579 female 677 Kuwaiti national gender reported increased consumption vegetable fruit carbohydrate decreased consumption fish sugary drink Compared male female reported eating outbreak prepandemic eating behavior 323 vs 359 p 005 Approximately onethird respondent 331 reported performing le 30 min physical activity exercise week 364 respondent rated quality sleep poor very poor rate smoking cigarette among male significantly higher female 406 vs 53 p 0001 Physical activity positively correlated vegetable consumption quality sleep Quality sleep negatively correlated consumption sweet snack consumption vegetable negatively correlated consumption sugary drink overall negative impact COVID19 pandemic Kuwait necessitates development health promotion intervention support positive physical activity dietary behavior using alternative coping strategy among resident Kuwait,covid-19;kuwait;dietary behavior;physical activity
Preventive behaviour family inequality COVID19 pandemic crosssectional study China,34284821,BACKGROUND coronavirus disease 2019 COVID19 pandemic international public health threat people s participation diseaserelated preventive behaviour key controlling infectious disease study aimed ass difference adopting preventive behaviour among population explore potential individual household factor inequality within family METHODS online survey conducted April 2020 directional stratified convenient sampling method used select 4704 participant eight province eastern central western China questionnaire included demographic information household variable five target prevention behaviour chisquared test binary multilevel model MantelHaenszel hierarchical analysis used data analysis study RESULTS Approximately 712 participant appropriate outdoor prevention 329 participant indoor protection place Sharing behaviour P 0001 education level P 0001 positively associated adopting preventive measure inhibiting effect household crowding stimulating effect high household income preventive behaviour determined study Household size negatively associated living area beta = 0057 P 005 living style beta = 0077 P 005 Household income positively associated age beta = 0023 P 005 relationship friend beta = 0053 P 005 Vulnerable group older adult woman likely inadequate preventive behaviour Older adult = 153 95 CI 109215 woman = 137 95 CI 115164 2 suspected symptom = 185 95 CI 107319 likely affected inhibiting effect household crowding stimulating effect high household income limited group CONCLUSIONS Inequalities COVID19 prevention behaviour exist family inadequate adoption prevention vulnerable group noteworthy study expands research perspective emphasizing role household factor preventive behaviour focusing family inequality government use traditional medium platform enhance resident public health knowledge Targeted additional wage subsidy investment affordable housing financial support multigenerational household temporary relocation policy may deserve attention Communities could play critical role COVID19 prevention,covid-19;china;household;preventive behaviours
Changes Domestic Energy Water Usage UK COVID19 Lockdown Using HighResolution Temporal Data,34202018,response COVID19 outbreak UK Government provided public health advice stay home 16 March 2020 followed instruction stay home full lockdown 24 March 2020 use data high temporal resolution utility sensor installed 280 home across social housing Cornwall UK test change domestic electricity gas water usage response government guidance Gas usage increased 20 following advice stay home week full lockdown although difference seen full lockdown full lockdown morning electricity usage shifted later day decreasing 6 am increasing midday change energy echoed water usage 17 increase onehour delay peak morning usage Changes consistent people getting later spending time home washing full lockdown Evidence change also observed later lockdown lockdown finding suggest compliance enforced stayathome message advice discus implication socioeconomically disadvantaged household given indication inability achieve increased energy need pandemic,covid-19;electricity usage;gas usage;sensors;water usage
RealWorld Acceptance COVID19 Vaccines among Healthcare Workers Perinatal Medicine China,34199143,Surveys showed vaccine hesitancy may influence acceptance COVID19 vaccine healthcare worker HCWs general population Currently actual acceptance COVID19 vaccination HCWs rarely reported present survey investigated realworld acceptance COVID19 vaccination HCWs perinatal medicine first threemonth period vaccination China identify main reason decline vaccination HCWs 1087 participated Chinese national symposium perinatal medicine 1618 April 2021 invited answer 27question questionnaire online total 1051 HCWs completed questionnaire 862 9061051 accepted COVID19 vaccination 138 1451051 declined vaccination vaccine hesitancy onefourth vaccinated participant accept vaccination consulted others requested employer main reason decline vaccination 145 unvaccinated HCWs concern vaccine safety result indicate vaccination request employer may promote vaccine acceptance convincing data safety COVID19 vaccine appears important increase acceptance vaccination,china;coronavirus disease 2019 (covid-19);healthcare workers;vaccine acceptance
Genomic surveillance combat COVID19 challenge opportunity,34337584,Although development increasingly widespread availability effective safe vaccine provides greatest hope future recovery increasingly devastating COVID19 pandemic preventive effort offer immediate route decreasing morbidity mortality Genomic surveillance emerging vital necessity achieve effective mitigation containment Since SARSCoV2 variant already detected crucial obtain reliable evidence whether contagious virulent resistant available COVID19 vaccine well spread throughout world Genomic surveillance leverage application nextgeneration sequencing creates availability whole genome data advance phylogenetic method method offer novel mean detect variant phenotypically antigenically different Genomic surveillance facilitate greater early anticipation well initiation effective strategy mitigate contain outbreak SARSCoV2 variant novel virus,
Inside story research development COVID19 vaccine,34222129,ongoing coronavirus threat China spread rapidly nation declared global health emergency World Health Organization pandemic resulted half world s population living condition lockdown Several academic institution pharmaceutical company different stage development plunged vaccine development race coronavirus disease 2019 COVID19 demand immediate therapy potential prevention COVID19 growing increase number individual affected due seriousness disease global dissemination lack prophylactic therapeutic challenging part need vigorous testing immunogenicity safety efficacy level protection conferred host vaccine world responds COVID19 pandemic face challenge overabundance information related virus Inaccurate information myth spread widely speed making difficult public identify verified fact advice trusted source local health authority review focus type vaccine candidate COVID19 clinical well preclinical development platform,covid-19;clinical trials;sars-cov-2;vaccine;vaccine candidate;vaccine development
Testosterone Deficiency Risk Factor Severe COVID19,34226825,Background Male sex related increased COVID19 severity fatality although confirmed infection similarly distributed men woman aim retrospective analysis investigate impact sex hormone disease progression immune activation men COVID19 Patients Methods studied effect sex hormone disease severity immune activation 377 patient 230 men 147 woman PCRconfirmed SARSCoV2 infection hospitalized Innsbruck University Hospital February December 2020 Results Men severe COVID19 concomitant higher immune system activation upon hospital admission compared woman Men severe course infection lower serum total testosterone tT level whereas luteinizing hormone LH estradiol E2 level within normal range tT deficiency associated elevated CRP r = 0567 p 0001 IL6 level r = 0563 p 0001 lower cholesterol level r = 0407 p 0001 increased morbidity mortality Men tT level 100 ngdL eighteenfold higher inhospital mortality risk 18243 95 CI 2301 144639 p = 0006 compared men tT level 230 ngdL Moreover morbidity mortality showed positive correlation E2 level admission detected negative correlation tTE2 ratio upon hospital admission Conclusion Hospitalized men COVID19 present rather low testosterone level linked advanced immune activation severe clinical manifestation translating increased risk ICU admission death underlying mechanism remain elusive may include infection driven hypogonadism well inflammation mediated cholesterol reduction causing gonadotropin suppression impaired androgen formation Finally elderly late onset hypogonadism might also contribute lower testosterone level,covid-19;sars-cov-2;disease severity;estradiol;inflammation;outcome;testosterone
Comprehensive Overview Production Vaccines PlantBased Expression Systems Scope Plant Biotechnology Combat SARSCoV2 Virus Pandemics,34203729,Many pathogenic viral pandemic caused threat global health COVID19 pandemic latest transmission growing exponentially around globe putting constraint health system worldwide novel coronavirus severe acute respiratory syndrome coronavirus2 SARSCoV2 cause pandemic Many candidate vaccine available time COVID19 massive international race underway procure many vaccine possible country However due heavy global demand strain global vaccine production use plant biotechnologybased expression system vaccine production also represents one part international effort develop plantbased heterologous expression system viruslike particle VLPs vaccines antiviral drug rapid supply antigenantibodies detecting kit plant origin bioactive compound boost immunity provide tolerance fight virus infection review look plant biotechnology platform provide best fight global pandemic,covid-19 vaccine;sars-cov-2 virus;bio-farming;respiratory disorder;vaccine
User Experiences New Zealand COVID Tracer App Thematic Analysis Interviews,34292868,BACKGROUND mobile app based COVID19 contact tracing fully effective large majority population need using app ongoing basis However paucity study user opposite potential adopter mobile contact tracing apps experience New Zealand highincome country western political culture successful managing COVID19 pandemic experience valuable informing policy response similar context OBJECTIVE study pursues following research question 1 user experience app everyday context 2 drive use app METHODS Residents New Zealand s Auckland region encompasses country s largest city approached via Facebook 34 COVID Tracer app user interviewed Interview transcript analysed using thematic analysis RESULTS Interviews ranged duration 15 50 minute Participants ranged late teen early sixty Even though half participant identified white New Zealanders European origin different ethnicity represented including New Zealanders South Pacific Indian MidEastern SouthAmerican SouthEast Asian descent Two participant identified Maori Indigenous New Zealanders broad range career represented topmiddle management health support work charity work Likewise educational background ranged broadly high school completion Master s degree Two participant unemployed recently lost job pandemic thematic analysis resulted five major theme perceived benefit pattern use privacy social influence need collective action Benefits using app society general salient participant immediate health benefit individual Use however depended alert level tended decline many participant low alert level Privacy consideration played little role shaping adoption use even though participant highly aware privacy discourse around app Participants aware need high level adoption use app control pandemic Attempts encourage others use app common although always successful CONCLUSIONS Appeals civic responsibility likely drive use mobile contact tracing app condition high threat likely scenario COVID19 remaining endemic requiring ongoing vigilance long term mechanism promoting use mobile contact tracing apps may needed offering incentive privacy important concern many user flexible privacy setting mobile contact tracing apps allowing user set optimal level privacy may appropriate,
Communitybased surveillance internally displaced people s camp urban setting complex emergency Yemen 2020,34225760,BACKGROUND need early identification coronavirus disease COVID19 case community high Yemen first wave COVID19 epidemic case presenting health facility severe Early detection case would allow early intervention interrupt transmission chain study aimed describe implementation communitybased surveillance CBS internally displaced people IDP camp urban setting Yemen 15 April 2020 30 September 2020 METHODS Following Centers Disease Control Prevention guidance evaluation surveillance system assessed usefulness acceptability CBS acceptability calculated proportion trained volunteer reported disease alert ass usefulness compared alert reported electronic disease early warning system eDEWS alert reported CBS described response activity implemented RESULTS AlMukalla City 18 1478 volunteer reported least one alert IDP camp 58 1831 volunteer reported least one alert AlMukalla City CBS detected 49 alert influenzalike illness whereas health facility detected 561 case COVID19 IDP camp CBS detected 91 alert influenzalike illness compared 10 alert detected eDEWS IDP camp CBS detected three syndrome besides influenzalike illness febrile illness outbreak suspicion acute diarrhoea skin disease IDP camp public health action implemented disease detected case reported CONCLUSIONS Yemen CBS useful detecting suspected outbreak IDP camp CBS implementation yield expected result general community urban area early stage COVID19 pandemic little known disease urban setting system failed detect suspected COVID19 case disease despite ongoing outbreak reported eDEWS Yemen country feasibility acceptability study conducted month CBS expansion urban community project expanded IDP camp creating COVID19 disease outbreak reporting site,covid-19;community-based surveillance;complex emergency;idp camps;urban settings;yemen
Geographical DetectorBased Spatial Modeling COVID19 Mortality Rate Continental United States,34202168,Investigating spatial distribution pattern disease suspected determinant could help one understand health risk study investigated potential risk factor associated COVID19 mortality continental United States collected death case COVID19 3108 county 23 January 2020 31 May 2020 Twelve variable including demographic population density percentage 65 year percentage nonHispanic White percentage Hispanic percentage nonHispanic Black percentage Asian individual air toxin PM25 climate precipitation humidity temperature behavior comorbidity smoking rate cardiovascular death rate gathered considered potential risk factor Based four geographical detector risk detector factor detector ecological detector interaction detector provided novel Geographical Detector technique assessed spatial risk pattern COVID19 mortality identified effect factor study found population density percentage nonHispanic Black individual two important factor responsible COVID19 mortality rate Additionally interactive effect pair factor even significant individual effect existing research examined role risk factor independently traditional model usually unable account interaction effect different factor Based Geographical Detector technique study s finding showed cause COVID19 mortality complex joint influence two factor substantial effect two separate factor COVID19 epidemic status still severe result study supposed beneficial providing instruction recommendation government epidemic risk response COVID19,covid-19;geographical detector;impact factor;interactive effect;spatial distribution
COVID19 Pandemic New Knowledge Impact Air Quality Spread Coronavirus Infection Cities,34366646,Suspended substance air form cluster coronavirus particle spread 10 source infection importance taking air pollution account simulating spread COVID19 pandemic due similarity health impact made coronavirus respirable fraction suspended solid Europe 66 death China 11 death COVID19 due ambient air pollution epidemiological model factor must considered along reason development coronavirus infection Russian city increased air pollution one risk factor development epidemic,coronavirus infection;atmospheric air pollution;fine particles;risk factors
Highlights Studies Presented Virtual American College Cardiology Scientific Sessions 2021 Staying Updated Latest Advancements Prevention,34226979,PURPOSE REVIEW review highlight latebreaking science presented Virtual American College Cardiology Scientific Sessions 2021 demonstrated advancement preventative cardiology introduced novel therapeutic modality management chronic kidney disease heart failure COVID19 RECENT FINDINGS study reviewed include clinical trial assessed use dapagliflozin patient respiratory failure due COVID19 DARE19 trial evinacumab patient severe hypertriglyceridemia pancreatitis effect genotypeguided oral P2y12 inhibitor v conventional clopidogrel longterm ischemic outcome percutaneous coronary intervention TAILORPCI trial anticoagulation patient hospitalized COVID19 ACTION trial atorvastatin v placebo patient COVID19 admitted ICU INSPIRATIONS trial rehabilitation therapy older acute heart failure patient REHABHF trial aspirin dosing patientcentric trial assessing benefit longterm effectiveness ADAPTABLE trial addition review result American College Cardiology Global Heart Attack Initiative GHATI Finally discus secondary analysis STRENGTH trial assessing association achieved level omega3 fatty acid level major cardiovascular outcome study presented virtual American College Cardiology Scientific Session 2021 represent remarkable contribution field cardiovascular disease prevention,aspirin;dapagliflozin;evinacumab;omega-3 fatty acid;rehabilitation;severe hypertriglyceridemia
Heattreated virus inactivation rate depends strongly treatment procedure illustration SARSCoV2,34288702,Decontamination help limit environmental transmission infectious agent required safe reuse contaminated medical laboratory personal protective equipment safe handling biological sample Heat treatment common decontamination method notably used virus show liquid specimen solution SARSCoV2 cell culture medium virus inactivation rate heat treatment 70 degree C vary almost two order magnitude depending treatment procedure halflife 086 min 95 credible interval 009 177 closed vial heat block 3700 min 1265 86982 uncovered plate dry oven finding suggest critical role evaporation virus inactivation via dry heat Placing sample open uncovered container may dramatically reduce speed efficacy heat treatment virus inactivation Given finding reviewed literature temperaturedependent coronavirus stability found specimen container whether closed covered uncovered rarely reported scientific literature Heattreatment procedure must fully specified reporting experimental study facilitate result interpretation reproducibility must carefully considered developing decontamination guideline Importance Heat powerful weapon infectious agent widely used decontamination medical laboratory personal protective equipment biological sample many method heat treatment methodological detail affect speed efficacy decontamination applied four different heattreatment procedure liquid specimen containing SARSCoV2 result show container used store specimen decontamination substantially affect inactivation rate given initial level contamination decontamination time vary minute closed vial several hour uncovered plate Reviewing literature found container choice heat treatment method rarely reported explicitly method section study show careful consideration heattreatment procedure particular choice specimen container whether covered make result consistent across study improve decontamination practice provide insight mechanism virus inactivation,
CostBenefit Analysis COVID19 Asymptomatic Mass Testing Strategy North Metropolitan Area Barcelona,34209328,BACKGROUND epidemiological situation generated COVID19 highlighted importance applying nonpharmacological measure management epidemic Mass screening asymptomatic general population established priority strategy carrying diagnostic test detect possible case isolate contact cut transmission chain thus limit spread virus OBJECTIVE evaluate economic impact mass COVID19 screening asymptomatic population first second wave epidemic Catalonia Spain METHODOLOGY CostBenefit Analysis based estimated total cost mass screening versus health gain associated health cost avoided RESULTS Excluding value monetized health BenefitCost ratio estimated 045 low value would seem advise mass screening policy However monetized health included ratio close 120 reversing interpretation word monetization health critical element tip scale favour desirability screening Results show intervention highest return maximize percentage positive detected CONCLUSION Efficient management resource policy mass screening asymptomatic population generate high social return positivity rate critically determines desirability Likewise precocity detection case cut transmission chain contagion increase economic return intervention Maximizing value resource depends screening strategy accompanied contacttracing specific focus targeting example highrisk subpopulation highest rate expected positive,covid-19;asymptomatic screening;cost benefit analysis;economic analysis;mass testing;non-pharmacological interventions;test-tracking-quarantine
LongTerm Persistence Spike Antibody Predictive Modeling Antibody Dynamics Following Infection SARSCoV2,34218284,BACKGROUND Antibodies Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 shown neutralize virus invitro prevent disease animal challenge model upon reexposure However current understanding SARSCoV2 humoral dynamic longevity conflicting METHODS CoStars study prospectively enrolled 3679 healthcare worker comprehensively characterize kinetics SARSCoV2 spike receptorbindingdomain RBD nucleoprotein N antibody parallel Participants screening seropositive serial monthly serological testing maximum 7 month Mesoscale Discovery Assay Survival analysis determined proportion seroreversion two hierarchical Gamma model predicted upper lowerbounds longterm antibody trajectory RESULTS total 1163 monthly sample provided 349 seropositive participant 200 day postsymptoms 95 participant detectable Santibodies compared 75 detectable Nantibodies Santibody predicted remain detectable 95 participant 465 day 95 CI 370575 using continuousdecay model indefinitely using decaytoplateau model account antibody secretion longlived plasma cell Santibody titer correlated strongly surrogate neutralization invitro R 2=072 Nantibodies however decayed rapidly halflife 60 day 95 CI 5268 CONCLUSIONS CoSTAR s study data presented provides evidence longterm persistence neutralizing Santibodies important implication duration functional immunity following SARSCoV2 infection contrast rapid decay Nantibodies must considered future seroprevalence study public health decisionmaking first study establish mathematical framework capable predicting longterm humoral dynamic following SARSCoV2 infection,covid-19;elisa;immunity;sars-cov-2;antibody;kinetics;neutralization;nucleoprotein;serology;virus;spike protein
Addressing vaccine hesitancy access barrier achieve persistent progress Israel s COVID19 vaccination program,34340714,March 31 2021 Israel administered 116 dos vaccine COVID19 per 100 population age far OECD country also ahead OECD country term share population received least one vaccination 61 share fully vaccinated 55 Among Israelis aged 16 comparable figure 81 74 respectively light objective article 1 describe analyze vaccination uptake end March 2021 2 identify behavioral barrier likely affected desire ability vaccinated 3 describe effort undertaken overcome barrier Israel s vaccination campaign launched December 20 within 25 week 20 Israelis received first dose Afterwards pace slowed took additional 4 week increase 20 40 yet another 6 week increase 40 60 Initially uptake low among young adult two religiouscultural minority group ultraOrthodox Jews Israeli Arabs uptake increased markedly timeIn first quarter 2021 Israel enhance access vaccine address moderate amount vaccine hesitancy general population also address intense pocket vaccine hesitancy among young adult religiouscultural minority group continued high rate infection month February March despite broad vaccination coverage time created confusion vaccine effectiveness turn contributed vaccine hesitancy Among Israeli Arabs resident smaller village encountered difficulty reaching vaccination site also slowed rate vaccinationThe challenge addressed via mix messaging incentive extension initial vaccine delivery system measure Many measure addressed general population others targeted subgroup belowaverage vaccination rate early adopter vaccinated took hard creative work increase population coverage 40 60 beyondSignificantly capacity strategy helped Israel address vaccine hesitancy geographic access barrier different enabled procure distribute administer vaccine strategy likely relevant country progress challenge securing adequate vaccine supply streamlining distribution challenge encouraging vaccine uptake,
Autoimmune hepatitis following COVID vaccination,34225251,Unprecedented loss life due COVID pandemic necessitated development several vaccine record time vaccine received approval without extensively whetted adverse effect efficacy profile adverse effect mild nonetheless serious thromboembolic event also reported Autoimmune hepatitis AIH occur predisposed individual immune mediated reaction hepatocytes triggered environmental factor Vaccines rare cause AIH report two case AIH triggered COVID Covishield vaccination one patient made uneventful recovery another succumbed liver disease first report Covishield vaccination related AIH second ever form COVID vaccination hope report deter COVID vaccination drive However also hope raise awareness potential side effect increased role pharmacovigilance guiding treatment,adverse effects;auto-immune hepatitis;covid-19;covishield;molecular mimicry;outcomes;pharmacovigilance;sars-cov-2;treatment;vaccination
Perspective Relationship Susceptibility Initial SARSCoV2 Infectivity Optimal Nasal Conditioning Inhaled Air,34360686,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 influenza virus shown spread rapidly winter Severe coronavirus disease 2019 COVID19 follow SARSCoV2 infection disproportionately affect older person male well people living temperate zone country tropical ancestry Recent evidence importance adequately warming humidifying conditioning inhaled air nasal cavity reducing SARSCoV2 infectivity upper respiratory tract URT discussed particular reference relevance airborne SARSCoV2 transmission ii nasal epithelium initial site SARSCoV2 infection iii role type 1 3 interferon preventing viral infection URT epithelial cell iv weaker innate immune response respiratory viral infection URT epithelial cell suboptimal temperature humidity v early innate immune response URT limiting eliminating SARSCoV2 infection available data consistent optimal nasal air conditioning reducing SARSCoV2 infectivity URT consequence severe COVID19 study SARSCoV2 infection rate viral load nasal cavity nasopharynx relation inhaled air temperature humidity age gender genetic background needed context Face mask used reducing airborne virus transmission also promote better nasal air conditioning cold weather Masks thereby minimise SARSCoV2 infectivity particularly relevant protecting vulnerable person severe COVID19,covid-19;sars-cov-2 infectivity;age;gender;genetic factors in sars-cov-2 susceptibility;innate immunity;nasal conditioning of inspired air;upper respiratory tract immunity
statistical model dynamic COVID19 infection case detection ratio 2020,34378235,case detection ratio coronavirus disease 2019 COVID19 infection varies time due changing testing capacity different testing strategy evolving underlying number infection note show way quantifying dynamic jointly modeling reported number detected COVID19 infection nonfatal fatal outcome proposed methodology also allows explore temporal development actual number infection detected undetected thereby shedding light infection dynamic exemplify approach analyzing German data 2020 making use data available since beginning pandemic modeling approach used quantify effect different testing strategy visualize dynamic case detection ratio time obtain information underlying true infection number thus enabling u get clearer picture course COVID19 pandemic 2020,covid-19;case detection ratio;dark figure of infections;generalized additive models;penalized splines
Changes prevalence nosocomial infection pre postCOVID19 pandemic tertiary Hospital China,34281515,BACKGROUND Nosocomial infection NIs important cause mortality increasing evidence reveals prevalence NIs reduced effective prevention control measure aim study investigate impact prevention control measure COVID19 pandemic NIs METHODS retrospective study conducted analyze prevalence NIs COVID19 pandemic 6 month Children s Hospital Soochow University RESULTS total 39914 patient 2019 34645 patient 2020 admitted hospital study 139 48134645 patient NIs 2020 significantly lower 256 102139914 patient 2019 rate critical fatal case also decreased addition rate appropriate handwashing number protective glove apron used per person number healthcare staff per patient significantly increased Except ICU prevalence nosocomial infection department decreased 2019 2020 Regarding source infection significant reduction mainly observed respiratory 099 v 042 p = 0000 digestive tract 063 v 014 p = 0000 microorganism analysis respiratory infection indicated obvious decline acinetobacters fungi significant decline pathogen gastrointestinal infection observed rotavirus comparison catheterrelated nosocomial infection 2019 2020 show significant difference CONCLUSIONS prevention control measure COVID19 pandemic reduced nosocomial infection almost department except ICU mainly regarding respiratory gastrointestinal oral infection catheterrelated infection show difference,covid-19;nosocomial infections;prevalence
Phylogenomic analysis SARSCoV2 third wave cluster Malaysia reveals dominant local lineage B1524 persistent spike mutation A701V,34362872,emergence third wave COVID19 infection Malaysia since September 2020 led imminent change public health prevention control measure high 962 registered COVID19 case 885 confirmed death Malaysia occurred third wave infection phylogenomic study 258 SARSCoV2 full genome February 2020February 2021 led discovery novel Malaysian lineage B1524 lineage contains another spike mutation A701V coexists D614G spike mutation predominant thirdwave cluster study provides vital genomic insight rapid spread SARSCoV2 variant Malaysia conjunction presence dominant SARSCoV2 lineage third wave COVID19 infection,
Coronavirus King Wanted Crown Common Highly Pathogenic SARSCoV2 Key Accessory Genes,34335504,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 emerged late 2019 etiologic agent current `` coronavirus disease 2019 COVID19 pandemic serious health implication significant global economic impact seven human coronaviruses zoonotic origin pandemic SARSCoV2 third emerging coronavirus 21st century highly pathogenic human population Previous human coronavirus outbreak SARSCoV1 MERSCoV already provided several valuable information common molecular cellular mechanism coronavirus infection well origin However meet new challenge caused SARSCoV2 detailed understanding biological specificity well knowledge origin crucial provide information viral pathogenicity transmission epidemiology enable strategy therapeutic intervention drug discovery Therefore review summarize current advance SARSCoV2 knowledge light preexisting information recently emerging coronaviruses depict specificity immune response wild bat discus current knowledge genetic diversity bathosted coronaviruses promotes viral genome expansion accessory gene acquisition addition describe basic virology coronaviruses special focus SARSCoV2 Finally highlight detail current knowledge gene accessory protein postulate major key promote virus adaptation specific host bat human contribute suppression immune response well pathogenicity,sars-cov-2;accessory proteins;biology;evolution;origin
Detection preexisting SARSCoV2reactive cell unexposed renal transplant patient,34228322,BACKGROUND Recent data demonstrate potentially protective preexisting cell reactive severe acute respiratory syndrome coronavirus 2 SARSCoV2 sample healthy blood donor collected SARSCoV2 pandemic Whether preexisting immunity also detectable immunosuppressed patient currently known METHODS Fiftyseven patient included casecontrol study compared frequency SARSCoV2reactive cell sample 20 renal transplant RTx patient 20 agegender matched nonimmunosuppressedimmune competent healthy individual collected onset SARSCoV2 pandemic Seventeen coronavirus disease 2019 COVID19 patient used positive control cell reactivity Spike Nucleocapsid Membrane SARSCoV2 protein analyzed multiparameter flow cytometry Antibodies analyzed neutralization assay RESULTS Preexisting SARSCoV2reactive cell detected majority unexposed patient healthy individual RTx patient 1320 showed CD4 + cell reactive least one SARSCoV2 protein CD8 + cell reactive least one SARSCoV2 protein demonstrated 1220 RTx patient frequency Th1 cytokine expression pattern preformed SARSCoV2 reactive cell differ RTx nonimmunosuppressed healthy individual CONCLUSIONS study show magnitude functionality preexisting SARSCoV2 reactive cell transplant patient noninferior compared immune competent cohort Although several proinflammatory cytokine produced detected cell study required prove antiviral protection,antigen-spcific t cells;immunosuppression;renal transplantation;sars-cov-2
Initial prehospital Rapid Emergency Medicine Score REMS predict outcome COVID19 patient,34223444,Objective Rapid Emergency Medicine Score REMS widely studied use predicting outcome COVID19 patient encountered prehospital setting study aimed determine whether first prehospital REMS could predict emergency department hospital disposition COVID19 patient transported emergency medical service Methods retrospective study used linked prehospital hospital record ESO Data Collaborative 911initiated transport patient hospital COVID19 diagnosis July 1 December 31 2020 calculated REMS first recorded prehospital value component calculated area receiver operating curve AUROC emergency department ED mortality ED discharge hospital mortality hospital length stay LOS determined optimal REMS cutpoints using test characteristic curve Results Among 13830 included COVID19 patient median REMS 6 interquartile range IQR 59 ED mortality 1 n = 80 REMS =9 predicted ED death AUROC 079 Onequarter patient n = 3419 discharged ED optimal REMS cutpoint =5 AUROC 072 Eighteen percent n = 1742 admitted patient died REMS =8 optimally predicted hospital mortality AUROC 072 Median hospital LOS 83 day IQR 41148 day REMS =7 predicted hospitalization =3 day AUROC 062 Conclusion Initial prehospital REMS modestly predictive ED hospital disposition patient COVID19 Prediction stronger outcome proximate first set emergency medical service EMS vital sign finding highlight potential value first prehospital REMS risk stratification individual patient system surveillance resource planning related COVID19,covid-19;emergency medical services;patient outcomes;prehospital;retrospective studies;risk stratification;scoring system;triage
Macrovascular Thrombotic Events Mayo Clinic EnterpriseWide Sample Hospitalized COVID19Positive Compared COVID19Negative Patients,34218854,OBJECTIVE determine difference rate thromboembolic complication hospitalized coronavirus disease 2019 COVID19 positive compared COVID19negative patient PATIENTS METHODS Adult patient hospitalized January 1 2020 May 8 2020 COVID19 testing polymerase chain reaction assay identified electronic health record across multiple hospital Mayo Clinic enterprise Thrombotic outcome venous arterial identified hospital problem list RESULTS identified 3790 hospitalized patient COVID19 testing across 19 hospital 102 positive test result median age lower COVIDpositive patient 62 v 67 year P=03 median duration hospitalization longer COVIDpositive patient 85 v 4 day P 001 required intensive care unit care 569 58 102 v 268 987 3688 P 001 Comorbidities including atrial fibrillationflutter heart failure chronic kidney disease malignancy observed le frequently COVIDpositive admission venous thromboembolism identified 29 COVIDpositive patient 3 102 46 COVIDnegative patient 168 3688 frequency venous arterial event different group unadjusted odds ratio COVIDpositivepatients venous thromboembolism 063 95 CI 019 202 multivariable logistic regression model evaluated death within 30 day hospital discharge neither COVID positivity adjusted 112 95 CI 054 234 thromboembolism adjusted 090 95 CI 060 132 associated death CONCLUSION Early experience patient COVID19 across multiple academic regional hospital representing different US region demonstrates lower previously reported incidence thrombotic event incidence higher contemporary COVIDnegative hospitalized comparator,
Relative COVID19 Viral Persistence Antibody Kinetics,34199240,total 15 RTPCR confirmed COVID19 patient admitted hospital initial outbreak Taiwan average time virus clearance delayed seven patient 2414 + 433 day compared 1025 + 056 day postsymptom onset PSO eight patients strong antibody response patient viral persistence pharynx peak value serum antibody 6772 + 2178 vs 7670 + 3211 patient delayed versus rapid virus clearance patient delayed viral clearance excessive antibody compromised quality early stage delay peak virus neutralization efficacy 3414 + 715 versus 1250 + 235 day PSO patient rapid virus clearance Weak antibody response patient rapid viral clearance also effective substantial comparable neutralization efficacy 3570 + 878 versus 4137 + 1149 patient delayed virus clearance Human Cytokine 48Plex Screening serial serum sample revealed elevated concentration proinflammatory cytokine chemokines deceased patient delayed virus clearance severe disease level comparatively le two patient suffered severe disease eventually survived,covid-19;cytokine profile;neutralization efficacy;serum antibody;viral persistence
Novel Face Mask Detection Technique using Machine Learning control COVID19 pandemic,34373829,COVID19 pandemic scattering speedily around world since 2019 Due pandemic human life becoming increasingly involutes complex Many people died virus lack antiviral drug one reason spreading COVID19 virus disease spreading continuously easily due common mistake people like breathing coughing sneezing infected person main symptom normal flu Therefore present condition best precaution disease face mask cover area mouth nose According government World Health Organization everyone wear face mask busy place like hospital marketplace today s environment s difficult tell someone wearing mask physical inspection impractical since add labour cost research present mask detector us machine learning facial categorization system determine whether person wearing mask may connected CCTV system verify person wearing mask allowed,alexnet;covid'19;corona virus;deep learning;neural network;sensor
Methodology Addressing Infectious Aerosol Persistence RealTime Using Sensor Network,34200380,Human exposure infectious aerosol result transmission disease influenza tuberculosis COVID19 dental procedure generate significant number aerosolized particle increasing transmission risk dental setting Since generation aerosol dentistry unavoidable many clinic started using intervention strategy areafiltration unit extraoral evacuation equipment especially relatively recent constraint pandemic However effectiveness device dental operatories studied Therefore ability dental personnel efficiently position operate instrument also limited address challenge utilized realtime sensor network assessment aerosol dynamic dental restoration cleaning producer without intervention strategy tested procedure local area HighEfficiency Particle Air HEPA filter ii ExtraOral Suction Device EOSD study conducted University Washington School Dentistry using network 13 fixed sensor positioned within operatory one wearable sensor worn dental operator sensor network provides time spaceresolved particulate matter PM data Threedimensional 3D visualization informed aerosol persistence operatory found area filter improve overall aerosol concentration dental office significant way decrease PM concentration average 16 observed EOSD equipment used procedure combination realtime sensor 3D visualization provide dental personnel facility manager actionable feedback effectively ass aerosol transmission medical setting develop evidencebased intervention strategy,aerosols;air quality;dental clinics;dispersion modeling;exposure assessment;extra-oral suction device;high-volume evacuation;infection control;particle concentration;sensor network
Dynamics COVID19 epidemic Ireland mitigation,34344318,BACKGROUND Ireland across European Union COVID19 epidemic wave driven mainly emergence new variant SARSCoV2 continued course despite various intervention government Public health intervention continue attempt control spread wait planned significant effect vaccination METHODS tackle challenge observed nonstationary aspect epidemic used modified SEIR stochastic model timevarying parameter following Brownian process enabled u reconstruct temporal evolution transmission rate COVID19 nonspecific hypothesis follows basic stochastic process constrained available data model coupled Bayesian inference particle Markov Chain Monte Carlo method parameter estimation utilized mainly welldocumented Irish hospital data RESULTS Ireland mitigation measure provided 7886 reduction transmission first wave March May 2020 second wave October 2020 reduction estimation around 20 70 third wave January 2021 third wave partly due UK variant appearing Ireland June 2020 estimated seroprevalence 20 95 CI 1235 complete accordance seroprevalence survey end April 2021 seroprevalence greater 17 due part vaccination campaign Finally demonstrate available observed confirmed case reliable analysis owing fact reporting rate expected greatly evolved CONCLUSION provide first estimation dynamic COVID19 epidemic Ireland key parameter also quantify effect mitigation measure virus transmission mitigation three wave result demonstrate Ireland significantly reduced transmission employing mitigation measure physical distancing lockdown date avoided saturation healthcare infrastructure flattened epidemic curve likely reduced mortality However await full roll vaccination programme new variant potentially transmissible andor infectious could continue emerge mitigation measure change silent transmission challenge remain,covid-19;ireland;mitigation;stochastic model;time varying parameters
Kinetics SARSCoV2 antibody response serological estimation time since infection,34282461,BACKGROUND Infection severe acute respiratory syndrome coronavirus 2 SARSCoV2 induces complex antibody response varies order magnitude individual time METHODS developed multiplex serological test measuring antibody five SARSCoV2 antigen Spike protein seasonal coronaviruses measured antibody response cohort hospitalized patient healthcare worker followed eleven month symptom mathematical model antibody kinetics used quantify duration antibody response Antibody response data used train algorithm estimating time since infection RESULTS One year symptom estimate 36 95 range 11 94 antiSpike IgG remains 31 9 89 antiRBD IgG remains 7 1 31 antiNucleocapsid IgG remains multiplex assay classified previous infection time interval 03 month 36 month 612 month method validated using data seroprevalence survey France demonstrating historical SARSCoV2 transmission reconstructed using sample single survey CONCLUSIONS addition diagnosing previous SARSCoV2 infection multiplex serological assay estimate time since infection used reconstruct past epidemic,sars-sov-2;antibody kinetics;sero-prevalence;surveillance;time since infection
impact COVID19 pandemic diagnostic imaging service Australia,34288493,INTRODUCTION COVID19 pandemic driving unprecedented change healthcare service worldwide study aimed quantify impact first wave COVID19 pandemic diagnostic imaging service Australia using interrupted time series model METHODS Monthly data extracted Australian Medicare Benefits Schedule diagnostic imaging service performed January 2016 December 2019 HoltWinters forecasting model developed total imaging service well imaging modality model used predict monthly data January 2020 June 2020 95 confidence interval P 005 Absolute percentage residual difference RD observed predicted service time period calculated RESULTS statistically significant reduction total imaging service performed March 2020 RD 332260 131 95 CI 175 84 April 2020 RD 716957 324 95 CI 362 281 May 2020 RD 571634 214 95 CI 251 173 Nuclear medicine CT service relatively le impacted general radiography ultrasound MRI service also statistically significant increase nuclear medicine CT service performed June 2020 compared predicted value CONCLUSIONS first wave COVID19 Australia significant reduction total diagnostic imaging service variable impact different imaging modality finding may significant public health implication used inform evidencebased strategy recovery phase pandemic,covid-19;sars-cov-2;coronavirus;health services;public health;radiology
Transition Simple VV VA Hybrid ECMO Configurations COVID19 ARDS,34207598,SARSCoV2 patient severe acute respiratory distress syndrome ARDS VenoVenous Extracorporeal Membrane Oxygenation VV ECMO shown provide valuable treatment reasonable survival large multicentre investigation However patient conversion modified ECMO support form may needed singlecentre retrospective registry consecutive patient receiving VV ECMO 1 March 2020 1 May 2021 included analysed patient cohort divided two group remained VV ECMO required conversion modality Seventyeight patient included fourteen case 18 requiring conversion venoarterial VA hybrid ECMO reason ECMO mode configuration change inadequate drainage 357 inadequate perfusion 143 myocardial infarction 71 hypovolemic shock 143 cardiogenic shock 143 septic shock 71 multivariable analysis use dobutamine p = 0007 shorter ICU duration p = 0047 predicted conversion 30day mortality higher converted patient logrank p = 0029 Overall 19 patient 244 survived discharge lung transplantation Adverse event common conversion included renal cardiovascular ECMOcircuit complication Conversion associated mortality multivariable analysis conclusion many 18 patient undergoing VV ECMO COVID19 ARDS may require conversion advanced ECMO support,covid-19;sars-cov-2;acute respiratory distress syndrome;cardiogenic shock;extracorporeal life support;extracorporeal membrane oxygenation
Air particulate concentration orthodontic procedure pilot study,34289851,BACKGROUND study evaluates particle dispersion involved dental procedure carried orthodontic treatment Variants temperature relative humidity dental cabinet considered METHODS Using particle counter pilot study conducted 98 consecutive recording made appointment patient undergoing orthodontic treatment Temperature relative humidity particle present beginning AR appointment BR recorded control record CR temperature relative humidity particle present made start clinical activity addition conventional statistic differential descriptive procedure used analyse result influence relative humidity particle concentration analysed statistical modelling regression equation RESULTS number particle present regardless size much higher AR CR p 001 true relative humidity ambient temperature relationship relative humidity particle number determined exponential LIMITATIONS STUDY limitation associated sample size environmental condition room lack discrimination among procedure performed CONCLUSIONS pilot study show moment patient enters dental office large number additional particle generated treatment number particle 03 micronswhich high capacity penetrate respiratory tractincreases Moreover relationship relative humidity particle formation observed study needed,bioaerosols;covid-19;dentistry;orthodontics;sars-cov-2
CT Quantification COVID19 Pneumonia Admission Predict Progression Critical Illness Retrospective Multicenter Cohort Study,34222293,Objective Early identification coronavirus disease 2019 COVID19 patient worse outcome may benefit clinical management patient aimed quantify pneumonia finding CT admission predict progression critical illness COVID19 patient Methods retrospective study included laboratoryconfirmed adult patient COVID19 patient underwent thinsection chest computed tomography CT scan showing evidence pneumonia CT image severe moving artifact excluded analysis Patients clinical laboratory data collected medical record Three quantitative CT feature pneumonia lesion automatically calculated using careai Intelligent Multidisciplinary Imaging Diagnosis Platform Intelligent Evaluation System Chest CT COVID19 denoting percentage pneumonia volume PPV groundglass opacity volume PGV consolidation volume PCV According Chinese COVID19 guideline trial version 7 patient divided noncritical critical group Critical illness defined composite admission intensive care unit respiratory failure requiring mechanical ventilation shock death performance PPV PGV PCV discrimination critical illness assessed correlation PPV laboratory variable assessed Pearson correlation analysis Results total 140 patient included mean age 586 year 85 607 male Thirtytwo 229 patient critical Using cutoff value 226 PPV highest performance predicting critical illness area curve 0868 sensitivity 813 specificity 806 PPV moderately positive correlation neutrophil r = 0535 p 0001 erythrocyte sedimentation rate r = 0567 p 0001 dDimer r = 0444 p 0001 highsensitivity Creactive protein r = 0495 p 0001 aspartate aminotransferase r = 0410 p 0001 lactate dehydrogenase r = 0644 p 0001 urea nitrogen r = 0439 p 0001 whereas PPV moderately negative correlation lymphocyte r = 0535 p 0001 Conclusions Pneumonia volume quantified initial CT noninvasively predict progression critical illness advance serve prognostic marker COVID19,covid-19;chest ct;critical illness;pneumonia;quantification
Visitor Capacity Considering Social Distancing Urban Parks AgentBased Modeling,34206436,COVID19 pandemic greatly influenced society past year Park accessibility social distancing considered important threat longterm epidemic However measure maintain park accessibility diminish virus spreading synchronously seldom studied may threaten public health major urban park globally paper proposed methodology based agentbased model analyze capacity park simulating park visitor behavior social distancing model derived historical visitor data realistic visitor behavior three park setting park capacity varied contact condition different park policy layout adjustment analyzed First congestion caused social distancing without proper visitor control found inside park Second 85 3972 square meter per person predicted safe space different park Third current result easily adjusted according various concern regarding infection distance rate Finally inferred information provision effective space design adjustment mandatory measure result guide park manager plan design park setting also helpful improving knowledge mechanism behind visitor behavior Moreover finding tested verified variety public space many contactbased illness,covid-19;environmental science and engineering;epidemiology;landscape architecture;public health;risk assessment;social distance
Study PublicInterest Short Message Service SMS China COVID19 Pandemic Mobile User Survey Content Analysis,34360208,outbreak coronavirus disease 2019 COVID19 greatly threatened global health system triggered public health emergency order manage COVID19 pandemic healthcare prevention information delivered omnimedia channel eg television radio social platform etc traditional outlet short message service SMS timely provide abundant antiepidemic alert mobile user paper aim investigate mobile user attitude toward COVID19 publicinterest SMS sent government authority explore insight messaging text collected January April 2020 China general respondent show positive attitude towards content necessity publicinterest SMS pandemic However find gender age difference affect content evaluation also influence reading forwarding behavior necessity SMS show significant difference 1825yearold 40yearold group middle elder group showing serious attitude giving higher remark youth due habit medium usage However significant difference presented female male term content category topic releasing institution analyzed respectively Due centralized response coordination prevention control China message COVID19 disposal organization eg municipal steering group provincial CDC account 70 among four city,covid-19;content analysis;demographic difference;epidemic prevention and healthcare;public-interest short message service
COVID19 model blind social determinant health systematic review protocol,34226230,INTRODUCTION Infectious disease model important tool inform public health policy decision model primarily based average population approach often ignore role social determinant predicting course pandemic impact policy intervention Ignoring social determinant model may cause exacerbate inequality limitation previously explored context current pandemic COVID19 found disproportionately affect marginalised racial ethnic socioeconomic group Therefore primary goal identify extent COVID19 model incorporate social determinant health predicting outcome pandemic METHODS ANALYSIS search MEDLINE EMBASE Cochrane Library Web Science database December 2019 August 2020 ass infectious disease modelling study inclusion social factor meet following criterion focused human spread SARSCoV2 b modelling study c interventional noninterventional study focused one following outcome COVID19related outcome eg case death nonCOVID19related outcome ie impact pandemic control policy health condition health service impact pandemic control policy economic outcome Data extracted model incorporating social factor report percentage model considered social factor indicate social factor considered describe social factor incorporated conceptualisation implementation infectious disease model extracted data also used create narrative synthesis result ETHICS DISSEMINATION Ethics approval required secondary data collected result systematic review disseminated peerreviewed publication conference proceeding PROSPERO REGISTRATION NUMBER CRD42020207706,covid-19;epidemiology;public health;social medicine
Excess allcause mortality COVID19related mortality temporal analysis 22 country January August 2020,34282450,BACKGROUND study aimed investigate overall sexspecific excess allcause mortality since inception COVID19 pandemic August 2020 among 22 country METHODS Countries reported weekly monthly allcause mortality January 2015 end June August 2020 Weekly monthly COVID19 death reported 2020 Excess mortality 2020 calculated comparing weekly monthly 2020 mortality observed death baseline mortality obtained 20152019 data week month using two method difference observed mortality rate 2020 20152019 average ii difference observed expected 2020 death RESULTS Brazil France Italy Spain Sweden UK England Wales Northern Ireland Scotland USA demonstrated excess allcause mortality whereas Australia Denmark Georgia experienced decrease allcause mortality Israel Ukraine Ireland demonstrated sexspecific change allcause mortality CONCLUSIONS Allcause mortality August 2020 higher previous year participating country Geographical location seasonality country well prompt application highstringency control measure may explain observed variability mortality change,covid-19;sars-cov-2;infection control;mortality;pandemic
Sexbased clinical immunological difference COVID19,34225644,BACKGROUND Males female differ immunological response foreign pathogen However current COVID19 clinical practice trial take sex factor consideration METHODS performed sexbased comparative analysis clinical outcome peripheral immune cell severe acute respiratory syndrome coronavirus SARSCoV2 specific antibody level 1558 male 1499 female COVID19 patient single center lymphocyte subgroup measured Flow cytometry total antibody Spike protein receptor binding domain RBD nucleoprotein N specific IgM IgG level measured chemiluminescence RESULTS found male patient approximately twofold rate ICU admission 47 vs 27 male female respectively P = 0005 mortality 3 vs 14 male female respectively P = 0004 female patient Survival analysis revealed male sex independent risk factor death COVID19 adjusted hazard ratio HR = 222 95 confidence interval CI 1336 P = 0003 level inflammatory cytokine peripheral blood higher male hospitalization renal 1021588 65 vs 631499 42 male female respectively P = 0002 hepatic abnormality 6501588 409 vs 4751499 317 P = 0003 common male patient female patient analyzing dynamic change lymphocyte subset symptom onset found percentage CD19+ B cell CD4+ cell generally higher female patient disease course COVID19 Notably protective RBDspecific IgG SARSCoV2 sharply increased reached peak fourth week symptom onset female patient gradually increased reached peak seventh week symptom onset male patient CONCLUSIONS Males unfavorable prognosis higher inflammation lower percentage lymphocyte indolent antibody response SARSCoV2 infection recovery Early medical intervention close monitoring important especially male COVID19 patient,covid-19;immunology;prognosis;sars-cov-2;sex
Synthesis gold nanoparticles reduced porous graphenemodified ITO electrode spectroelectrochemical detection SARSCoV2 spike protein,34352502,reported synthesis reduced porous graphene oxide rPGO decorated gold nanoparticles Au NPs modify ITO electrode used highly uniform Au NPs rPGO modified ITO electrode surfaceenhanced Raman spectroscopyactive surface working electrode us Au nanoparticles porous graphene enhance Raman signal electrochemical conductivity COVID19 proteinbased biosensor developed based immobilization antiCOVID19 antibody onto modified electrode us probe capturing COVID19 protein developed biosensor showed capability monitoring COVID19 protein within concentration range 100 nmolL 1 pmolL limit detection LOD 75 fmolL Furthermore COVID19 protein detected based electrochemical technique within concentration range 100 nmolL 500 fmolL showed LOD 395 fmolL Finally three concentration COVID19 protein spiked human serum investigated Thus present sensor showed high efficiency towards detection COVID19,covid-19;gold nanoparticles;reduced porous graphene oxide modified ito electrode;spectroelectrochemical biosensor;square wave voltammetry;surface enhanced-raman spectroscopy
Geographical Epidemiological Characteristics Sporadic Coronavirus Disease 2019 Outbreaks June December 2020 China Overview EnvironmentToHuman Transmission Events,34336875,China quickly brought severe acute respiratory syndrome coronavirus 2 control early stage 2020 thus generated sufficient confidence among public enabled respond several sporadic coronavirus disease 2019 outbreak article present geographical epidemiological characteristic several sporadic coronavirus disease 2019 outbreak June December 2020 China data show coronavirus disease may transmitted imported coldchain food international exchange viewpoint deserves great attention,covid-19 disease;cold-chain food;environment-to-human transmission;scientific protective measures;severe acute respiratory syndrome coronavirus 2
Inflammatory Response COVID19 Patients Resulting Interaction Inflammasome SARSCoV2,34360684,outbreak coronavirus disease 2019 COVID19 began end 2019 COVID19 caused infection severe acute respiratory syndrome coronavirus 2 SARSCoV2 patient COVID19 may exhibit poor clinical outcome patient severe COVID19 experience cytokine release syndrome CRS cytokine stormelevated level hyperactivated immune cellsand circulating proinflammatory cytokine including interleukin IL 1beta IL18 severe inflammatory response lead organ damagefailure even death inflammasome intracellular immune complex responsible secretion IL1beta IL18 various human disease Recently growing number study revealing link inflammasome COVID19 Therefore article summarizes current literature regarding inflammasome complex COVID19,coronavirus disease 2019;cytokines;inflammasome;severe acute respiratory syndrome coronavirus 2
Arterial venous thrombosis coronavirus 2019 disease Covid19 relationship mortality,34218413,BACKGROUND Patients coronavirus disease 2019 Covid19 may experience venous thrombosis data regarding arterial thrombosis sparse METHODS Prospective multicenter study 5 hospital including 373 patient Covid19related pneumonia Demographic data laboratory finding including coagulation test comorbidities reported followup arterial venous thrombotic event death registered RESULTS Among 373 patient 75 20 thrombotic event 75 20 died Thrombotic event included 41 venous thromboembolism 34 arterial thrombosis Age cardiovascular disease intensive care unit treatment white blood cell Ddimer albumin troponin blood level associated thrombotic event multivariable regression logistic model intensive care unit treatment Odds Ratio 60 95 Confidence Interval CI 28126 p 0001 coronary artery disease 24 95 CI 1450 p = 0022 albumin level 049 95 CI 028087 p = 0014 associated ischemic event Age sex chronic obstructive pulmonary disease diabetes heart failure coronary heart disease intensive care unit treatment inhospital thrombotic event Ddimer Creactive protein troponin albumin level associated mortality multivariable Cox regression analysis showed inhospital thrombotic event hazard ratio HR 272 95 CI 159465 p 0001 age HR 1035 95 CI 10141057 p = 0001 albumin HR 0447 95 CI 02770723 p = 0001 predicted morality CONCLUSIONS Covid19 patient experience equipollent rate venous arterial thrombotic event associated poor survival Early identification appropriate treatment Covid19 patient risk thrombosis may improve prognosis,covid-19;mortality;sars-cov-2;thrombosis
neurological sequela pandemic epidemic,33106890,Neurological manifestation pandemic frequently cause short longterm consequence frequently overlooked Despite advance treatment infectious disease nervous system involvement remains challenge limited treatment often available underrecognition neurological manifestation may lead increase burden acute disease well secondary complication longterm consequence Nervous system infection dysfunction pandemic common enduring consequence especially among vulnerable population frequently forgotten improved understanding possible mechanism neurological damage epidemic increased recognition possible manifestation fundamental bring insight dealing future outbreak reverse gap knowledge reviewed pandemic large important epidemic human history neurological manifestation evident described possible physiological process lead adverse sequela caused triggered pathogen,cns infections;encephalitis;meningitis;pandemics/history;peripheral neuropathies
Common antioxidant vitamin C antiinfective agent remedial role SARSCoV2 infection update,34284566,Coronavirus disease 2019 COVID19 led worldwide multifaceted crisis medical world agonizes contend problem string tested medication proven unavailing Vitamin C well described salutary antioxidant trial conclude may potential antiviral drug high dos Vitamin C alternate crucial step pathogenesis sepsis acute respiratory distress syndrome dynamic driving force behind trial around world tried immunonutrition weapon clinical entity summarize mechanism action Vitamin C role infection current literature referring potential role Vitamin C SARSCoV2 infection also contingent treatment agent,
Estimated Dissemination RatioA Practical Alternative Reproduction Number Infectious Diseases,34336770,Policymakers require consistent accessible tool monitor progress epidemic impact control measure real time One measure Estimated Dissemination Ratio EDR straightforward easily replicable robust measure trajectory outbreak used many year control infectious disease livestock simple calculate explain calculation use discussed together example current COVID19 outbreak UK application illustrate EDR demonstrate change transmission rate may clear epidemic curve Thus EDR provide early warning epidemic resuming growth allowing earlier intervention conceptual comparison EDR commonly used reproduction number also provided,covid-19;epidemics;estimated dissemination ratio;mathematical models;reproduction number r;survaillance
Chronology COVID19 Symptoms Old Patients Study Hospital Outbreak,34209409,BACKGROUND wanted better understand frequency temporal distribution symptom COVID19 old patient currently well defined METHODS observational descriptive study followed patient three geriatric convalescence rehabilitation unit COVID19 outbreak emerged unit March 2020 developed disease recorded new symptom occurring diagnosis previous 14 following 21 day group SARSCov2negative patient served control RESULTS Sixtynine 176 inpatient mean age 86 year infected SARSCov2 outbreak moment diagnosis majority patient fever 710 malaiseasthenia 246 respiratory symptom 667 However 48 patient 696 SARSCov2 positive patient also presented usually several day symptom gastrointestinal symptom 391 patient median onset eight day diagnosis IQR 9 +3 day b neurological symptom 304 patient median onset five day diagnosis IQR 11 3 day notably delirium 246 c symptom like fall unexplained decompensation chronic condition 290 patient median onset four day diagnosis IQR 10 0 None symptom observed similar proportion 25 control SARSCoV2negative patient hospitalized period CONCLUSIONS Diarrhea nauseavomiting delirium fall unexplained decompensation chronic condition first symptom COVID19 majority older patient cohort preceding typical symptom several day Recognizing early symptom could hasten diagnosis COVID19 population,covid-19;atypical symptoms;early diagnosis;older patients;temporal pattern
Respiratory Telerehabilitation Boys Young Men Duchenne Muscular Dystrophy COVID19 Pandemic,34200985,BACKGROUND COVID19 pandemic forced reorganization multidisciplinary healthcare system Duchenne muscular dystrophy Digital solution seem optimal providing rehabilitation time aim study investigate whether possible conduct respiratory physical therapy use telerehabilitation Duchenne muscular dystrophy METHODS study conducted online conference family DMD physical therapy panel showed video instruction respiratory exercise participant n = 152 asked fill online survey evaluating quality acceptance understanding instruction RESULTS survey filled 45 296 participant mean rating satisfaction 4705 intelligibility 4785 Thirtyseven 822 patient declared performed exercise caregiver declared possible perform proposed exercise time week daily two respondent replied invitation individual online session CONCLUSIONS Findings study show respiratory telerehabilitation may implemented DMD patient however interest digital rehabilitation among caregiver DMD boy Poland low reason situation require research,dmd;children;respiratory rehabilitation;telerehabilitation
Hepatic manifestation COVID19 effect remdesivir liver function patient COVID19 illness,34219928,COVID19 emerged major global health crisis since first case reported China December 2019 Remdesivir broadspectrum antiviral approved US Food Drug Administration treat hospitalized patient COVID19 infection Although adverse effect remdesivir largely unknown data randomized controlled trial demonstrated deleterious effect liver review briefly address hepatic manifestation COVID19 infection data regarding efficacy adverse effect remdesivir liver function used patient hospitalized COVID19 literature search identified five randomized controlled trial two case report one case series including total 2375 patient Although mild transaminase elevation reported feature COVID19 concern hepatotoxicity associated use remdesivir Based limited available data regarding adverse effect remdesivir hepatic function prudent exercise caution evaluating baseline liver function avoiding use potentially hepatotoxic drug closely monitoring liver function using remdesivir patient hospitalized COVID19,covid-19;coronavirus;sars-cov-2;drug-induced liver injury;elevated liver function tests;hepatic dysfunction;remdesivir
Effects Activity TrackerBased Counselling LiveWeb Exercise Breast Cancer Survivors Italy COVID19 Lockdown,34207765,BACKGROUND prevent fight increase daily sedentary time promote stimulate positive effect physical activity exercise health traditional intervention new strategy important breast cancer survivor BCS research goal compare effect weekly personal feedback based objectively measured physical activity trend daily sedentary time physical activity BCS E group intervention also including online supervised physical exercise session E + group Italy COVID19 lockdown METHODS Italian COVID19 emergency allowed possibility also observe effect social personal limitation total 51 BCS studied 18week period objective registration daytoday sedentary time physical activity sleep subsamples received weekly fortnight personal feedback Data analysed considering four key period according COVID19 emergency step RESULTS Statistical analysis showed additive effect sedentary time multiplicative effect lightto vigorous lightintensity physical activity E group high overall sedentary time different trend lightto vigorous lightintensity physical activity reduction 1st 2nd period national personal restriction showing significant rise end national restriction CONCLUSIONS use activity tracker accompanying app reception weekly tailored advice supervised online physical exercise session elicit proper physical activity recomposition BCS COVID19 era,polar loop 2;breast cancer;light-intensity physical activity;sedentary time
Echocardiographic assessment right ventricle COVID19 systematic review,34292433,Cardiac involvement frequently reported COVID19 responsible increased morbidity mortality Given importance right heart function acute chronic respiratory disease assessment SARSCoV2 infected patient may add prognostic accuracy Transthoracic echocardiography proposed early predict myocardial injury risk death hospitalized patient systematic review present uptodate sum literature regarding right ventricle ultrasound assessment evaluated commonly used echocardiographic parameter ass RV function discussed relationship pathophysiological mechanism involved COVID19 searched Medline Embase study used transthoracic echocardiography right ventricle assessment patient COVID19,echocardiography;pulmonary hypertension;right ventricle;sars-cov-2
Social Media Use SelfEfficacy Perceived Threat Preventive Behavior Times COVID19 Results CrossSectional Study Pakistan,34220597,Although role social medium infectious disease outbreak receiving increasing attention little known mechanism social medium use affect risk perception preventive behavior outbreak study aim determine whether relationship social medium use preventive behavior perceived threat coronavirus selfefficacy sociodemographic characteristic data collected 310 respondent across Pakistan using online crosssectional survey Reliability analysis performed scale structural equational modeling used identify relationship study variable found social medium use predicts selfefficacy beta = 025 p 005 perceived threat coronavirus beta = 054 p 005 R 2 = 006 ii preventive behavior predicted selfefficacy perceived threat coronavirus R = 010 p 005 Therefore result indicate importance social medium s influence healthrelated behavior finding valuable health administrator government policymakers social scientist specifically individual whose situation similar Pakistan,coronavirus;infection control;infection management;prevention;regulation;social media use
Evidencing influence prepandemic sport participation substance misuse physical activity COVID19 lockdown prospective analysis among older adolescent,33760804,OBJECTIVES physical activity level PAL significantly decreased result social distancing lockdown related COVID19 pandemic lack knowledge correlate PAL pandemic aim research examine influence prepandemic sport participation substance use misuse SUM PAL COVID19 pandemic MATERIAL METHODS study included 661 highschool student Bosnia Herzegovina aged 1518 year 292 female investigation included 2 testing wave COVID19 pandemic baseline January 2020 COVID19 lockdown followup April 2020 variable included PAL measured Physical Activity Questionnaire Adolescents sport factor SUM RESULTS Sports factor baseline positively correlated PALs baseline followup Smoking tobacco negatively affected PALs baseline followup Alcohol consumption positively correlated PAL baseline effect PAL followup CONCLUSIONS study confirmed importance sport participation maintaining PAL challenging situation COVID19 lockdown substancespecific influence SUM PAL lockdown point evident social cultural aspect SUM behavior adolescent study evidencing cumulative effect PAL decline lockdown warranted Int J Occup Med Environ Health 2021 34 2 15163,exercise;health behavior;risk factors;teenagers;tobacco;virus diseases
SARSCoV2 child cancer Brazil Results multicenter national registry,34288386,BACKGROUND Strategies mitigate impact COVID19 special population complex challenging study addressed impact COVID19 pediatric patient cancer low middleincome country METHODS Multicenter observational cohort study prospective record retrospective analysis starting April 2020 21 pediatric oncology center distributed throughout Brazil PARTICIPANTS Patients 18 year age infected SARSCoV2 virus confirmed diagnosis reverse transcriptasepolymerase chain reaction RTPCR treatment pediatric oncology center variable interest included clinical symptom diagnostic therapeutic measure repercussion SARSCoV2 infection cancer treatment general prognosis monitored RESULTS One hundred seventynine patient included median age 6 413 year 58 male 559 acute leukemia 341 solid tumor presence SARSCoV2 diagnosed RTPCR Various laboratory marker analyzed showed correlation outcome Children low high BMI age lower overall survival 714 826 respectively ageappropriate BMI 927 p = 007 severity presentation diagnosis significantly associated outcome p 001 Overall mortality presence infection 123 n = 22 CONCLUSION child cancer COVID19 lower BMI associated worse prognosis mortality group patient 123 significantly higher described pediatric population overall approximately 1,bmi;covid-19;sars-cov-2;cancer;pediatric oncology
Selfreported dietary change among Los Angeles County adult COVID19 pandemic,34217761,Poor diet historically leading cause morbidity mortality United States US causing 44000 death month Dietary pattern likely changed COVID19 pandemic due major shift crisis social economic food system study examines selfreported dietary change Los Angeles LA County COVID19 identifies factor associated making healthy unhealthy change Data Understanding Coronavirus America Study internet panel adult representative LA County household N = 1080 Multinomial logistic regression used test selfreported change diet healthiness assessed July 2020 associated socioecological factor known associated diet assessed AprilJuly 2020 half LA County resident reported making change diet 283 reported eating healthier food since beginning pandemic 248 reported eating le healthy food Individuals significantly likely report healthy change NonHispanic Black HispanicLatino vs NonHispanic White received unemployment insurance larger social network Individuals significantly likely report unhealthy change younger mixed race child household transportation barrier obesity Individuals significantly likely report healthy unhealthy change Asian experienced food insecurity challenge getting food due store closure pandemic may exacerbating dietrelated disease risk group community color among individual obesity facing transportation barrier,covid-19 pandemic;diet;eating;ecological model
Impact COVID19 Pandemic Lockdown Routine Childhood Immunization Saudi Nationwide CrossSectional Study,34222155,Background Routine childhood immunization costeffective method prevent infection decrease childhood morbidity mortality COVID19 pandemic affected access health care Saudi Arabia including mandatory vaccination young child aimed ass prevalence intentionally delayed vaccination child aged = 2 year COVID19 pandemic curfew Saudi Arabia relation caregiver fear infection identifying factor affecting caregiver decision Methods conducted crosssectional study using selfadministered survey targeted primary caregiver child aged = 2 year residing Saudi Arabia COVID19 pandemic curfew March 4July 6 2020 Results received response 577 caregiver 908 mother prevalence intentional vaccination delay 37 Upon adjusting potential confounders odds delaying scheduled childhood vaccination COVID19 pandemic fear greater among caregiver higher level fear 110 95 CI 102111 Common reason delaying vaccination COVID19 infection prevention exposure COVID19 case Conclusion Intentional vaccination delay leaf young child vulnerable preventable infectious disease Identifying child offering catchup vaccination reduces risk Campaigns increase awareness danger delaying vaccinepreventable disease must promoted caregiver addition promotion home vaccination service preparation future pandemic recommend country consider intervention control level fear anxiety provoked pandemic medium intervention improved access vaccination,covid-19;saudi arabia;children;immunization;pandemic;vaccination
Comparative bench study evaluation modified snorkeling mask used COVID19 pandemic standard interface noninvasive ventilation,34217695,PURPOSE aim bench study compare standard NIV nCPAP device Helmet H Full face mask FFM modified full face snorkeling mask used COVID19 pandemic METHODS mannequin connected active lung simulator inspiratory expiratory variation airway pressure observed high simulated effort determined relative preset CPAP level NIV applied Pressure Support Mode two simulated respiratory rate two cyclingoff flow threshold bench study measured variable defining patientventilator interaction performance RESULTS nCPAP tested interface show significant difference term Pawi Pawe NIV snorkeling mask demonstrated better patientventilator interaction compared FFM shown significantly shorter Pressurization Time Expiratory Trigger Delay p 001 significant difference found term Inspiratory Trigger Delay Time Synchrony interface tested RR 20sim snorkeling mask presented lower DeltaPtrigger p 001 moreover condition tested snorkeling mask showed longer Pressure Time Product 200 300 500 m compared FFM p 001 major limitation snorkeling mask NIV interface possible reach maximum 18 cmH2O peak inspiratory pressure CONCLUSIONS modified snorkeling mask used acceptable alternative interface nCPAP NIV emergency,ards;covid-19;mechanical ventilation;non-invasive ventilation
Serologic Responses following Single Dose SARSCov2 Vaccination Allogeneic Stem Cell Transplantation Recipients,34293520,Immunocompromised individual included formal trial SARSCoV2 mRNA vaccine Subsequent study patient hematologic malignancy solid organ transplantation recipient suggest inferior response vaccination determined antibody response single dose vaccine one vulnerable patient group allogeneic hematopoietic cell transplantation alloHCT recipient PfizerBioNTech PB AstraZeneca AZ SARSCoV2 vaccine administered least 3 month posttransplantation 55 adult alloHCT recipient found older age concurrent use immunosuppressive medication significantly associated lack antibody response vaccination 21 patient systemic immunosuppression mounted response compared 58 patient immunosuppression P = 006 also show response AZ vaccine may superior response PB vaccine cohort finding highlight need novel immunogenic vaccine formulation schedule highestrisk patient well continued public healthy safety measure protect vulnerable member society,allogeneic stem cell transplantation;covid vaccination;sars-cov-2 antibody response
Clinical characteristic outcome COVID19 patient prediabetes,34224947,BACKGROUND AIMS aimed examine clinical characteristic outcome coronavirus disease 2019 COVID19 patient prediabetes METHODS retrospective cohort study 102 COVID19 patient admitted tertiary care hospital India May October 2020 RESULTS patient poor clinical profile admission high rate invasive mechanical ventilation 48 intensive care unit admission 48 complication 726 mortality 324 CONCLUSION People prediabetes high risk poor outcome COVID19,covid-19;diabetes;hba1c;mortality;prediabetes;severity
Using Food Stress Index Emergency Food Assistance Australian Case Series Analysis COVID19 Pandemic Natural Disasters,34209708,Food insecurity increase human natural disaster Two tool developed assist effective food relief Western Australia Food Stress Index similar rental stress predicts likelihood household food insecurity geographic location basic nutritious Food Basket Recommendation quantifies type amount food meet dietary recommendation different family type study aim understand compare process impact using tool organisation client involved emergency food assistance andor disaster preparedness multiple casestudy design analysed organisation s use tool assist response COVID19 pandemic restriction catastrophic bushfires Australia Qualitative interview conducted telephone Zoom cloudbased video conferencing service JulyAugust 2020 purposeful sample eight interviewee representing seven case government food relief community organisation involved emergency food assistance andor disaster preparedness Three theme emerged analysis 1 organisation confident user tool 2 Collaborations `` Ready Go 3 Food Stress Index `` game changer Findings demonstrate intrinsic value tool provision emergency food relief normal circumstance time increased need ie COVID19 pandemic study highlight value importance ongoing intersectoral collaboration food relief food security eg Western Australian Food Relief Framework suggests upscaling Food Stress Index food basket increase effectiveness measure address food insecurity Australia,covid-19;food stress index;disaster management;emergency food assistance;food insecurity
NICEdrugch workflow rational drug design systemslevel analysis drug metabolism,34340747,discovery drug requires decade intensive research financial investment still high risk failure reduce burden developed NICEdrugch resource incorporates 250000 bioactive molecule studied enzymatic metabolic target fate toxicity NICEdrugch includes unique fingerprint identifies reactive similarity drugdrug drugmetabolite pair validated application scope performance NICEdrugch similar method field golden standard datasets describing drug metabolite sharing reactivity drug toxicity drug target use NICEdrugch evaluate inhibition toxicity anticancer drug 5fluorouracil suggest avenue alleviate side effect propose shikimate 3phosphate targeting liverstage malaria minimal impact human host cell Finally NICEdrugch suggests 1300 candidate drug food molecule target COVID19 explains inhibitory mechanism experimental screening NICEdrugch database accessible online systematically identify reactivity small molecule druggable enzyme practical application lead discovery drug repurposing,e. coli;p. falciparum;computational biology;drug clustering;drug metabolic fate;drug similarity;enzyme inhibition;human;ligand-based drug discovery;medicine;nutraceuticals;systems biology
Developing Innovative System Open Flexible PatientFamilyCentered Virtual Visiting ICU COVID19 Pandemic Collaboration Staff Patients Families Technology Companies,34291683,challenge COVID19 pandemic strike core humanity inability family sit bedside loved one battling life ICU Virtual visiting one tool help deal challenge introducing virtual visiting ICU identified 5 criterion sustainable system aligned patientfamilycentered care virtual visiting needed 1 simulate open flexible visiting 2 able accommodate difference family size dynamic cultural practice 3 utilize video conferencing platform private secure 4 easy use require special team facilitate meeting 5 increase workload ICU staff growing body literature demonstrating global movement toward virtual visiting ICU however publication describe system meet 5 criterion Importantly paper describing system virtual visiting mimic open flexible family presence bedside unable find offtheshelf video conferencing platform met criterion come solution multidisciplinary team ICU staff partnered healthcare technology adoption consultant two technology company develop innovative system called HowRU HowRU us video conferencing platform Webex integration newly designed software automates many laborious complex process HowRU cloud based supported simplified system closely simulates open flexible visiting ensuring patient family privacy dignity security demonstrated transferability HowRU implanting second ICU HowRU commercially available internationally hope HowRU improve patientfamilycentered care ICU,covid-19;howru;intensive care unit;open and flexible visiting;patient family communication;patient-family connect;patient-family-centered care;tailored system of virtual visiting;video conferencing;virtual visiting;visitor restrictions
Clinical Characteristics Outcomes COVID19 lowprevalence wellresourced setting Sydney Australia,34228387,BACKGROUND Northern Sydney Local Health District one first health region affected COVID19 Australia AIM describe clinical characteristic risk factor outcome lowprevalence Australian population METHODS retrospective analysis 517 laboratoryconfirmed COVID19 case January June 2020 Patient information collected part routine care within COVID19 Virtual Hospital system Outcomes examined death recovery 30 day intensive care unit ICU admission RESULTS case fatality rate 18 Multivariate analysis showed factor independently associated death composite outcome deathICU admission incomplete recovery 30 day age 80 presence 2 comorbidities case acquired COVID19 international 509 cruise ship travel 91 Health care worker comprised 128 cohort represented disproportionately high percentage `` unknown source group 276 median incubation period 5 day IQR 38 one patient incubation period 15 day Hospitalisation required 118 ICU admission 21 ventilation 14 RALE score CXR 10 independently associated death CONCLUSIONS low prevalence wellresourced Australian setting report overall low mortality Factors associated adverse patient outcome multivariate analysis age greater 80 presence 2 comorbidities data assist early risk stratification COVID19 patient surge capacity planning hospital article protected copyright right reserved,australia;covid-19;virtual hospital risk stratification;low-prevalence
COVID19 ShelterInPlace Orders Associated Delayed Presentation Deep Venous Thrombosis Geriatric Hip Fractures,34292806,Geriatric hip fracture benefit timely surgery onset coronavirus disease 2019 COVID19 pandemic shelterinplace SIP order mandated highrisk city author hypothesized geriatric patient hip fracture likely present hospital greater 24 hour injury SIP order retrospectively reviewed patient 65 year older presented hip fracture March 20 2020 May 24 2020 SIP group March 20 2019 May 24 2019 historical group Primary outcome incidence presentation greater 24 hour injury mean number day injury presentation Secondary outcome incidence preoperative deep venous thrombosis DVT 30 90day mortality rate Thirtythree patient comprised SIP group 50 patient comprised historical group significant difference demographic medical comorbidities SIP group likely present greater 24 hour injury P=05 presented greater number day injury P=02 significant difference incidence preoperative DVT P=03 significant difference 30 90day mortality rate Geriatric patient sustained hip fracture SIP restriction COVID19 likely present greater 24 hour injury greater number day injury presentation diagnosed preoperative DVT Orthopedics 2021 44 4 223228,
moderating effect solar radiation association human mobility COVID19 infection Europe,34342824,novel coronavirus disease 2019 COVID19 caused global pandemic study suggested negative association sunlight intensity COVID19 infection alluding belief might safe go sunny day paper examined whether solar radiation mitigated association human mobility COVID19 infection Europe using dynamic panel data model investigate effect human mobility solar radiation interaction COVID19 infection result revealed outgoing mobility positively correlated solar radiation negatively correlated COVID19 infection lag level 1 2 3 week coefficient interaction item indicated solar radiation negatively moderated relationship outgoing mobility number daily new confirmed case 2 3week lag level However moderating effect limited unable eliminate positive effect outgoing mobility COVID19 infection Thus result suggested solar radiation weakly mitigated relationship human mobility COVID19 infection providing policy implication mobility still restricted sunny day COVID19 pandemic,covid-19;human mobility;moderating effect;solar radiation
Placental pathology concerning sudden foetal demise SARSCoV2 positive asymptomatic pregnant female,34282805,AIMS Coronavirus disease 2019 responsible worldwide increase morbidity mortality relationship infection mothertochild vertical transmission elucidated yet However recent report indicate foetal death rate 3 METHODS report case sudden preterm foetal demise woman positive SARSCoV2 asymptomatic physiological course pregnancy RESULTS One possible explanation sudden foetal death may acute placental insufficiency caused SARSCoV2 placental infection development foetal inflammatory response syndrome FIRS CONCLUSION Considering potential risk foetal demise question remain regarding foetal monitoring timing labour delivery second third trimester particularly asymptomatic mild maternal SARSCoV2 infection relevant multidisciplinary team must also aware risk associated possibly fatal consequence,
Animals vaccine COVID19,34352721,Animals especially mammal played critical role COVID19 pandemic COVID19 virus originated animal virus jump back forth human animal Moreover animal central development various vaccine virus employed around world continuing long history interrelationship animal human disease transmission prevention call interdisciplinary approach medicine,animals in science;covid-19;coronaviruses;one health;vaccines
SARSCoV2 Antigenemia Confounding Factor Immunodiagnostic Assays Case Study,34198719,Humoral immunity emerged vital immune component severe acute respiratory syndrome coronavirus 2 SARSCoV2 Nevertheless subset recovered Coronavirus Disease2019 COVID19 paucisymptomaticasymptomatic individual generate antibody response constituting paradox assumed immunodiagnostic assay may operate competitive format within context antigenemia potentially explaining phenomenon present case persistent antigenemiaviremia documented least 73 day postsymptom onset using inhouse methodology progressively declined seroconversion took place late around day 55 supporting hypothesis Thus prolonged SARSCoV2 antigenemiaviremia could mask humoral response rendering certain case phenomenon nonresponders misnomer,covid-19;elisa;sars-cov-2;antibody;antigenemia;immunodiagnostics;immunoprevalence;non-responders;seroconversion;viremia
Case COVID19Related Thrombocytopenia Leukopenia Adolescent Mild Symptoms,34208610,Since beginning COVID19 pandemic numerous report review complication caused disease analyzing acute chronic consequence main symptom SARSCoV2 dry cough fever fatigue COVID19 appears affect system including renal cardiovascular circulatory respiratory system causing chronic obstructive pulmonary disease report 14yearold male adolescent presented thrombocytopenia platelet count 92 x 10 9 L leukopenia white blood count 42 x 10 3 muL observed two month ago Ten day first blood test viral infection nasal congestion runny nose reported without accompanying symptom Viral antibody screening revealed positivity three specific COVID19 antibody haematological evaluation bone marrow aspiration revealed nonspecific dysplastic feature red cell megakaryocyte progenitor Although haematological alteration due COVID19 infection available adult patient report effect COVID19 infection pediatric population underestimated first case haematological involvement Noteworthy current case impact COVID19 infection related severity disease symptom mild similar case bone marrow aspiration would performed part routine workup Thus important evaluating pediatric patient COVID19 infection search report alteration order better understand impact spectrum clinical manifestation specific viral infection child adolescent,covid-19;bone marrow;leucopenia;myelodysplastic syndromes;platelet count
Environmental scan provincial territorial planning COVID19 vaccination program Canada,34220354,Background Public health department Canada currently facing challenging task planning implementing coronavirus disease 2019 COVID19 vaccination program Objective collect synthesize information regarding COVID19 vaccination program planning province territory Canada including logistic consideration priority group vaccine safety effectiveness monitoring Methods Provincialterritorial public health leader interviewed via teleconference early planning stage COVID19 vaccination program AugustOctober 2020 collect information following topic unique factor COVID19 vaccination intention adopt National Advisory Committee Immunization NACI recommendation priority group early vaccination vaccine safety effectiveness monitoring Data grouped according common response descriptive analysis performed Results Eighteen interview occurred 25 participant 11 13 provincesterritories PTs Factors unique COVID19 vaccination included prioritizing group early vaccination n=7 public perception vaccine n=6 differing eligibility criterion n=5 Almost PTs n=10 reported reliance NACI recommendation Longterm care resident n=10 healthcare worker n=10 frequently prioritized early vaccination followed people chronic medical condition n=9 senior n=8 PTs n=9 planning routine adverse event monitoring ass vaccine safety Evaluation effectiveness anticipated occur within public health department n=3 researcher n=3 based national guidance n=4 Conclusion Plans COVID19 vaccination program PTs exhibit similarity largely consistent NACI guideline discrepancy research needed evaluate COVID19 vaccination program implemented,covid-19;pandemic;vaccination;vaccination program;vaccine
Viral load disease severity COVID19,34133005,relationship COVID19 severity viral load unknown objective ass association viral load disease severity COVID19 single center observational study adult laboratory confirmed SARSCoV2 first positive inhospital nasopharyngeal swab used calculate log10 copiesml log10 copy number CN SARSCoV2 Four category based level care modified sequential organ failure assessment score mSOFA time swab determined Median log10CN compared different level care mSOFA quartile Median log10CN compared patient receive influenza vaccine correlation log10CN Ddimer examined found 396 patient 543 male 25 major comorbidity Hospital mortality 157 Median mSOFA 2 IQR 03 Median log10CN 55 IQR 3380 Median log10CN highest nonintubated ICU patient 64 IQR 4481 lowest intubated ICU patient 36 IQR 2669 p value 001 adjusted analysis difference remained significant mean difference 116 95 CI 018214 significant difference log10CN group remaining pairwise comparison association median log10CN mSOFA either unadjusted adjusted analysis median log10CN patient without influenza immunization correlation log10CN Ddimer conclude cohort find clear association viral load disease severity COVID19 patient Though viral load higher nonintubated ICU patient intubated ICU patient significant difference viral load disease severity,covid-19;coronavirus;organ dysfunction score;rt-pcr;sars-cov-2;viral load
Measures physical performance COVID19 patient mapping review,34284976,BACKGROUND OBJECTIVE evidence short longterm impairment physical performance patient COVID19 infection verification measure physical impairment condition lacking reviewed measure used ass physical performance patient Secondary target measure exercise daily life activity induced symptom METHODS Medline CINAHL Pedro database searched January 2020 February 2021 article English language Two investigator independently conducted search screened title andor abstract based inclusion criterion independently scored study quality study evaluated two reviewer according NIH quality assessment tool observational cohort crosssectional study Discrepancies resolved consensus RESULTS 156 potentially relevant article 31 observational study 8 crosssectional 1 randomized controlled trial 1 protocol included quality 31 evaluable study judged low 11 study fair 14 study Sample size study ranged 14 20889 patient among 28 reported measure Barthel Index 424 study SixMinute Walking Distance Test 364 Short Physical Performance Battery 212 1Minute SittoStand 121 used Fifteen 36 study reported exercise induced desaturation dyspnoea performing assessment respectively exercise induced symptom fatigue pain Studies reported wide range impairment physical performance compared `` reference value range mean median reported value v `` reference value 1177 v 100 point Barthel Index 1122 v 2237 repetitionsmin 1mSTS 0579 v 114 + 13 point SPPB 45223 v 380782 6MWT respectively CONCLUSION review found wide variety functional status test used making comparison difficult study measure show impairment physical performance COVID19 patient However quality study judged low fair,dyspnoea;exercise capacity;exercise induced desaturation;exercise tests;functional status;rehabilitation
Knowledge Attitudes Practices Regarding COVID19 among Healthcare Workers Uganda CrossSectional Survey,34208959,Healthcare worker HCWs high risk COVID19 However data HCWs knowledge attitude practice KAP toward COVID19 limited September November 2020 conducted questionnairebased COVID19 KAP survey among HCWs three hospital Uganda used Bloom s cutoff =80 determine sufficient knowledge good attitude good practice multivariate Poisson regression robust variance statistical analysis 717 HCWs invited participate 657 916 agreed enrolled mean age standard deviation enrollee 332 102 year clinical HCWs 647 advanced secondary schoolother higherlevel education 578 Overall 839 sufficient knowledge 784 positive attitude 370 good practice toward COVID19 Factors associated KAP Knowledge clinical HCW aRR 112 95 CI 102123 previous participation health research aRR 110 95 CI 104117 Attitude age 35 year aRR 088 95 CI 079098 Practice clinical HCW aRR 191 95 CI 141259 HCWs Uganda good knowledge positive attitude poor practice towards COVID19 Differences COVID19 KAP clinical nonclinical HCWs could affect uptake COVID19 intervention including vaccination,covid-19;sars-cov-2;uganda;attitude;healthcare workers;knowledge;practices
Cerebral Hemodynamics Intracranial Compliance Impairment Critically Ill COVID19 Patients Pilot Study,34208937,Introduction One possible mechanism new coronavirus SARSCov2 could induce brain damage impairment cerebrovascular hemodynamics CVH intracranial compliance ICC due elevation intracranial pressure ICP main objective study ass presence CVH ICC alteration patient COVID19 evaluate association shortterm clinical outcome Methods Fifty consecutive critically ill COVID19 patient studied transcranial Doppler TCD noninvasive monitoring ICC Subjects included upon ICU admission CVH evaluated using mean flow velocity middle cerebral artery mCBFV pulsatility index PI estimated cerebral perfusion pressure eCPP ICC assessed using P2P1 ratio noninvasive ICP curve CVHICC score computed using variable primary composite outcome unsuccessful weaning respiratory support death day 7 defined UO Results first assessment n = 50 P2P1 ratio median 120 IQRs 100128 vs 100 088116 p = 003 eICP 14 1125 vs 11 715 mmHg p = 001 significantly higher among patient unfavorable outcome UO others Patients UO significantly higher CVHICC score 9 812 vs 6 57 p 0001 favorable outcome area receiver operating curve AUROC CVHICC score predict UO 086 95 CIs 075097 score 85 63 4677 sensitivity 87 6297 specificity predict UO patient undergoing second assessment n = 29 median 11 531 day measured variable similar two timepoints difference measured variable ICU nonsurvivors n = 30 survivor observed Conclusions ICC impairment CVH disturbance often present COVID19 severe illness could accurately predict early poor outcome,covid-19;cerebral perfusion pressure;cerebrovascular resistance;intracranial compliance;intracranial pressure
Impacts COVID19 Pandemic Cardiac Rehabilitation Delivery around World,34211829,Background investigated impact COVID19 cardiac rehabilitation CR delivery around globe including virtual delivery well effect provider patient Methods crosssectional study piloted survey administered CR program globally via REDCap April June 2020 50 member International Council Cardiovascular Prevention Rehabilitation ICCPR personal contact facilitated program identification Results Overall 1062 183 program response rate response received 70111 631 country response rate country world existent CR program 367 491 program reported stopped CR delivery 203 271 stopped temporarily mean = 83 + 28 week Alternative model delivered 322 397 program primarily lowtech mode n = 226193 Furthermore 353 302 respondent redeployed 276 373 felt need work due fear losing job despite perceived risk contracting COVID19 mean = 300 + 274100 Also 266 225 reported anxiety 241 204 concerned exposing family 113 97 reported increased workload transition remote delivery 105 90 juggling caregiving responsibility business hour Patients often contacting staff regarding grocery shopping hearthealthy food n = 333 284 use technology interact program n = 329 279 stop exercise place exercise n = 303 257 risk death COVID19 due preexisting cardiovascular disease n = 249 212 Respondents perceived staff n = 488 413 patient n = 453 386 personal protective equipment well COVID19 screening n = 414 352 testing n = 411 350 paramount inperson service resumption Conclusion Given estimated number CR program globally result suggest approximately 4400 CR program globally ceased temporarily stopped service delivery remain open implementing new technology ensure patient receive CR safely despite challenge Highlights COVID19 impacted cardiac rehabilitation CR delivery around globe crosssectional study survey completed 1062 183 CR program 70 631 countries pandemic resulted least temporary cessation 75 CR program others ceasing initiation new patient reducing component delivered andor changing mode delivery little opportunity planning training also significant psychosocial economic impact CR providers Alternative CR model eg homebased virtual reimbursement advocacy needed ensure safe accessible secondary prevention delivery,covid-19;cardiac rehabilitation;global health;health services;healthcare providers;survey
Influence polish national COVID19 lockdown patient characteristic outcome bariatric surgery highvolume centerA cohort study,34219035,INTRODUCTION result COVID19 pandemic health care system around world overburdened resulting significant reduction planned surgical procedure bariatric surgery primary aim study ass influence COVID19 national lockdown Poland shortterm outcome intraoperative course bariatric patient high volume IFSO certified bariatric center MATERIAL METHODS retrospective analysis 158 bariatric surgery patient underwent bariatric procedure either prior first national lockdown Poland patient categorized prelockdown group postlockdown group comprising 79 patient RESULTS postlockdown group significantly lower operative weight 10576 v 11425 p = 0012 BMI 3699 v 3993 p = 0005 compared prelockdown group primary length stay significantly longer postlockdown group 304 v 244 p = 0001 postlockdown group significantly lower mean CCI score 190 v 667 p = 0046 le shortterm readmission postdischarge 0 v 886 p = 0007 prelockdown group CONCLUSION postlockdown group found lower body weight BMI day operation operated prior lockdown finding conflicting previous research assessing weight change lockdown Since qualification criterion order operation similar predefined group possible explanation finding higher patient motivation due COVID19 fear longer preparation period due elective surgery postponement encourage bariatric center globally ass effect national lockdown patient profile well psychological behavioral impact bariatric cohort,"bariatric;lockdown;outcomes;surgery, covid-19"
Molecular determinant disease severity urinary tract infection,34131331,common lethal bacterial pathogen coevolved host Pathogens aggressor host immune system responsible defence However immune response also become destructive excessive innate immune activation major cause infectionassociated morbidity exemplified symptomatic urinary tract infection UTIs caused part excessive innate immune activation Severe kidney infection acute pyelonephritis major cause morbidity mortality painful infection urinary bladder acute cystitis become debilitating susceptible patient Disease severity controlled specific innate immune checkpoint detailed understanding function crucial strategy counter microbial aggression novel treatment prevention measure One approach use bacterial molecule reprogramme innate immune system accelerating inhibiting disease process different outcome asymptomatic bacteriuria defined low host immune responsiveness bacteria attenuated virulence observation provides rationale immunomodulation new therapeutic tool deliberately modify host susceptibility control host response avoid severe disease power innate immunity arbitrator health disease also highly relevant emerging pathogen including current COVID19 pandemic,
Simulating drug concentration PDMS microfluidic organ chip,34346471,Microfluidic organonachip Organ Chip cell culture device often fabricated using polydimethylsiloxane PDMS biocompatible transparent elastomeric oxygen permeable however hydrophobic small molecule absorb PDMS make challenging predict drug response describe combined simulation experimental approach predict spatial temporal concentration profile drug continuous dosing PDMS Organ Chip containing two parallel channel separated porous membrane lined cultured cell without prior knowledge log P value First threedimensional finite element model drug loss chip developed incorporates absorption adsorption convection diffusion simulates change drug level time space function potential PDMS diffusion coefficient log P value experimentally measuring diffusivity compound PDMS determining partition coefficient mass spectrometric analysis drug concentration channel outflow possible estimate effective log P range compound diffusion partition coefficient experimentally derived antimalarial drug potential SARSCoV2 therapeutic amodiaquine incorporated model quantitatively estimate drugspecific concentration profile time measured human lung airway chip lined bronchial epithelium interfaced pulmonary microvascular endothelium strategy applied device geometry surface treatment vitro microfluidic model simulate spatial temporal gradient drug 3D without prior knowledge partition coefficient rate diffusion PDMS Thus approach may expand use PDMS Organ Chip device various form drug testing,
AsianOrigin Approved COVID19 Vaccines Current Status COVID19 Vaccination Program Asia Critical Analysis,34199995,COVID19 vaccination started throughout globe vaccination program also begun Asian country paper analyzed Asianorigin COVID19 vaccine vaccination program status Asia till March 2021 three section first section mapped approved vaccine originated Asia technological platform collaboration vaccine development regulatory approval country found total eight Asian COVID19 vaccine originated got approval three country China India Russia second section critically evaluated recent progress COVID19 vaccination program analyzed overall vaccination status across Asian region also calculated cumulative COVID19 vaccine dos administered different Asian country vaccine rolling 7day average various Asian country COVID19 vaccine per day dos administrated several Asian country found China India vaccinated maximum number people Finally evaluated factor affecting COVID19 vaccination program Asia vaccine hesitancy basic reproduction number R0 vaccination campaign cost vaccine analysis assist implementation COVID19 vaccination program successfully Asia,asia;covid-19 vaccination;covid-19 vaccines;factors infusing covid-19 vaccination
Emergency teleradiological activity epidemiological estimator predictor covid19 pandemic mainland France,34292414,BACKGROUND COVID19 pandemic highlighted need realtime monitoring disease evolution rapidly adapt restrictive measure prospective multicentric study aimed investigating radiological marker COVID19related emergency activity global estimator pandemic evolution France incorporated two source data March November 2020 opensource epidemiological dataset collecting daily hospitalisation intensive care unit admission hospital death discharge teleradiology dataset corresponding weekly number CTscans performed 65 emergency centre interpreted remotely CTscans specifically requested COVID19 suspicion monitored Teleradiological epidemiological time series aligned relationship estimated crosscorrelation function extreme breakpoints compared Dynamic linear model trained forecast weekly hospitalisation based teleradiological activity predictor RESULTS total 100018 CTscans included 36 week 19133 19 performed within COVID19 workflow Concomitantly 227677 hospitalisation reported Teleradiological epidemiological time series almost perfectly superimposed crosscorrelation coefficient lag 0 090092 Maximal number COVID19 CTscans reached week 20200323 1 086 CTscans 1 week highest hospitalisation 23542 patient best valid forecasting model combined number COVID19 CTscans number hospitalisation prior two week provided lowest mean absolute percentage 509 testing period 20201102 20201129 CONCLUSION Monitoring COVID19 CTscan activity emergency accurately instantly predicts hospitalisation help adjust medical resource paving way complementary public health indicator,coronavirus infections;forecasting;public health;teleradiology
Autophagy Unfolded Protein Response Neuropilin1 CrossTalk SARSCoV2 Infection Learned Coronaviruses,34206057,COVID19 pandemic caused 2019nCoVSARSCoV2 virus severe acute respiratory syndrome currently global health emergency need much effort generate urgent practical treatment reduce COVID19 complication mortality human Viral infection activates various cellular response infected cell including cellular stress response unfolded protein response UPR autophagy following inhibition mTOR UPR autophagy mechanism involved cellular tissue homeostasis apoptosis innate immunity modulation clearance pathogen viral particle However evolutionary arm race virus gain ability subvert autophagy UPR benefit SARSCoV2 enter host cell binding cell surface receptor including angiotensinconverting enzyme 2 ACE2 neuropilin1 NRP1 ACE2 blockage increase autophagy mTOR inhibition leading gastrointestinal complication SARSCoV2 virus infection NRP1 also regulated mTOR pathway increased NRP1 enhance susceptibility immune system dendritic cell DCs SARSCoV2 induce cytokine storm related high COVID19 mortality Therefore signaling pathway mTOR UPR autophagy may potential therapeutic target COVID19 Hence extensive investigation required confirm potential Since currently specific treatment COVID19 infection sought review discus important role autophagy UPR mTOR mechanism regulation cellular response coronavirus infection help identify new antiviral modality SARSCoV2 virus,covid-19;sars-cov-2;autophagy;endoplasmic reticulum stress;unfolded protein response
Antibiotic prescribing respiratory tract infection patient suspected proven COVID19 result antibiotic point prevalence survey Scottish hospital,34223137,Background Bacterial coinfection infrequently observed SARSCoV2COVID19 infection outside critical care however antibiotic commonly prescribed Objectives examine factor associated antibiotic prescribing suspected respiratory tract infection RTI evaluate nature dynamic prescribing hospitalized patient suspected proven COVID19 infection Methods antibiotic point prevalence survey hospitalized adult patient conducted designated COVID19 clinical area including critical care 15 Scottish hospital Antibiotics prescribed RTI factor associated prescribing investigated Results 820 surveyed patient 272 prevalence 333 received antibiotic suspected RTI survey day 588 SARSCoV2 positive Antibiotics empirical 919 amoxicillin 246 doxycycline 205 coamoxiclav 15 frequently prescribed Oral antibiotic prescribed 545 duration recorded 767 ward median 5 day IV oral switch occurred median 2 day Prescribing RTI independently positively associated COPDchronic lung disease purulentbloody sputum abnormal chest Xray CRP = 100 mgL Probable definite hospitalacquired COVID19 diabetes associated lower odds receiving antibiotic RTI Conclusions Antibiotic prescribing suspected RTI commonly observed predominantly empirical suspected proven COVID19 Initiatives reinforce stewardship principle including clinical review effective use microbiological diagnostics better understanding role biomarkers central limit unnecessary antibiotic therapy COVID19,
Insights management anorectal disease coronavirus 2019 disease era,34290826,Coronavirus 2019 disease COVID19 created major impact public health virus plagued large population requiring hospitalization resource utilization Knowledge COVID19 virus continues grow commonly present gastrointestinal symptom initially considered atypical presentation led delay care pandemic posed serious threat care anorectal disease Urgent surgery delayed care cancer patient cancer screening disrupted added patient discomfort adverse outcome healthcare continue future better availability personal protective equipment provider standard checklist protocol operating room help minimize healthcarerelated spread virus Telehealth outpatient procedure biochemical tumor marker test help mitigation anorectaldiseaserelated problem limited literature clinical management anorectal disease pandemic performed detailed literature review guide clinician around management option anorectal disease patient also highlighted health challenge seen pandemic,coronavirus disease 2019;anorectal disease;telehealth
New quinolinetriazole conjugate Synthesis antiviral property SARSCoV2,34214752,present therapeutic option severe acute respiratory syndrome coronavirus2 SARSCoV2 limited designed synthesized three set small molecule using quinoline scaffold series quinoline conjugate 10al 11ac 12ae incorporating 123triazole synthesized via modified microwaveassisted click chemistry technique Among synthesized conjugate 4 1 2chlorophenyl 1H123triazol4yl methoxy 6fluoro2 trifluoromethyl quinoline 10g 6fluoro4 2 1 4methoxyphenyl 1H123triazol4yl ethoxy 2 trifluorometh yl quinoline 12c show high potency SARSCoV2 selectivity index SI compound 10g 12c also indicates significant efficacy compared reference drug,click chemistry;molecular docking;quinoline;sars-cov-2;triazole
Outbreak SARSCoV2 Infections Including COVID19 Vaccine Breakthrough Infections Associated Large Public Gatherings Barnstable County Massachusetts July 2021,34351882,July 2021 469 case COVID19 associated multiple summer event large public gathering town Barnstable County Massachusetts identified among Massachusetts resident vaccination coverage among eligible Massachusetts resident 69 Approximately three quarter 346 74 case occurred fully vaccinated person completed 2dose course mRNA vaccine PfizerBioNTech Moderna received single dose Janssen Johnson Johnson vaccine =14 day exposure Genomic sequencing specimen 133 patient identified B16172 Delta variant SARSCoV2 virus cause COVID19 119 89 Delta AY3 sublineage one 1 Overall 274 79 vaccinated patient breakthrough infection symptomatic Among five COVID19 patient hospitalized four fully vaccinated death reported Realtime reverse transcriptionpolymerase chain reaction RTPCR cycle threshold Ct value specimen 127 vaccinated person breakthrough case similar 84 person unvaccinated fully vaccinated whose vaccination status unknown median = 2277 2154 respectively Delta variant SARSCoV2 highly transmissible 1 vaccination important strategy prevent severe illness death July 27 CDC recommended person including fully vaccinated wear mask indoor public setting area COVID19 transmission high substantial Findings investigation suggest even jurisdiction without substantial high COVID19 transmission might consider expanding prevention strategy including masking indoor public setting regardless vaccination status given potential risk infection attendance large public gathering include traveler many area differing level transmission,
COULD COVID19 HEMOGLOBINOPATHY,34285445,world struggling deal corona pandemic Effective therapy still awaited due lack understanding pathophysiological mechanism disease Bearing recent research clinical observation mind author propose novel physiological mechanism COVID19 explain development COVID19 related acute respiratory distress syndrome ARDS secondary COVID19 related hemoglobinopathy consistent observation radiological picture COVID19 related ARDS bear resemblance high altitude pulmonary edema HAPE typical ARDS great controversy regarding proposed similarity main argument objecting comparison etiology hypoxia case HAPE inflammation COVID19 related ARDS propose considering recent bioinformatics prediction model COVID19 might first infect red blood cell via CD147 cause hemoglobin damage resulting hypoxemia may cause pulmonary hypoxic vasoconstriction leading HAPElike lung lesion introduced alveolar hypoxia exaggerates hemoglobinopathy hypoxemia leading vicious cycle review author recommend laboratory experiment prove hypothesis proposed physiological mechanism significant therapeutic implication proven author suggest use exchange transfusion adjunct therapy development antiCD147 drug,"acute respiratory distress syndrome;cd147;covid-19;high altitude pulmonary edema, pathophysiology;high altitude pulmonary embolism"
Direct Measurement B Lymphocyte Gene Expression Biomarkers Peripheral Blood Transcriptomics Enables Early Prediction Vaccine Seroconversion,34202032,Peripheral blood transcriptome highly promising area biomarker development However transcript abundance TA cell mixture sample confounded proportion component leukocyte subpopulation pose challenge clinical application cell origin change TA known without prior cell separation procedure developed framework develop celltype informative TA biomarkers enable determination TA single celltype B lymphocyte directly cell mixture sample peripheral blood eg peripheral blood mononuclear cell PBMC without need subpopulation separation applicable panel gene called B cell informative gene ratio two B cell informative gene target gene stably expressed reference gene obtained PBMC used new biomarker represent target gene expression purified B lymphocyte approach eliminates tedious procedure cell separation directly determines TA leukocyte subpopulation peripheral blood sample called Direct LSTA method method applied gene expression datasets collected influenza vaccination trial early predictive biomarkers seroconversion using TNFRSF17 TXNDC5 target gene TNFRSF13C FCRLA reference gene Direct LSTA B cell biomarkers determined directly PBMC transcriptome data highly correlated TA corresponding target gene purified B lymphocyte Vaccination responder almost 2fold higher Direct LSTA biomarker level TNFRSF17 log 2 SMD = 084 95 CI = 047121 day 7 vaccination sensitivity Direct LSTA biomarkers prediction seroconversion greater 07 areaunder curve AUC 08 many datasets paper report straightforward approach directly estimate B lymphocyte gene expression PBMC could used routine clinical setting Moreover method enables practice precision medicine prediction vaccination response importantly seroconversion could predicted early day 7 acquired immunology pathway common vaccination influenza COVID19 biomarkers could also useful predict seroconversion new COVID19 vaccine,b lymphocytes;covid-19;pbmc;biomarker;gene expression;influenza;peripheral blood;seroconversion;transcript abundance;transcriptome;vaccination
Humoral response SARSCoV2 well preserved symptom dependent kidney transplant recipient,34212497,Data immune response SARSCoV2 kidney transplant recipient scarce Thus conducted singlecenter observational study ass antiSARSCoV2 IgG seroprevalence outpatient kidney transplant recipient KTR n = 1037 healthcare worker HCW n = 512 second wave COVID19 pandemic fall 2020 evaluated clinical variable affecting antibody level Antibodies S1 S2 subunit SARSCoV2 evaluated using immunochemiluminescent assay cut 95 AUml sensitivity 912 specificity 902 AntiSARSCoV2 IgG seroprevalence lower KTR HCW 7 vs 119 p = 001 Kidney transplant recipient SARSCoV2 infection younger p = 001 received CNIbased immunosuppression frequently p = 029 seronegative KTR AntiSARSCoV2 IgG positive symptomatic KTR higher BMI p = 04 asymptomatic KTR Interestingly antiSARSCoV2 IgG level higher KTR HCW median 31 AUml IQR 1784 vs median 15 AUml IQR 1139 p 001 presence moderate severe symptom KTR found independent factor affecting IgG level Beta coefficient = 4199 95 CI 9927406 p = 011 multivariable model conclusion KTR exhibit wellpreserved symptomdependent humoral response SARSCoV2 infection,clinical research/practice;infection and infectious agents - viral;infectious disease;kidney transplantation/nephrology;patient characteristics
Characteristics immune inflammatory response among different age group pediatric patient COVID19 China,34341947,BACKGROUND Severe case coronavirus disease 2019 COVID19 among pediatric patient common child le 1 year age aim address underlying role immunity inflammation condition among different age group pediatric patient METHODS recruited pediatric patient confirmed moderate COVID19 symptom admitted Wuhan Children s Hospital January 28th April 1st 2020 Patients divided four age group = 1 16 710 1115 year Demographic information clinical characteristic laboratory result lymphocyte subset test immune inflammation related marker evaluated RESULTS Analysis included 217241 900 patient moderate clinical stage disease Average recovery time child 6 year old significantly shorter child younger 6 year P = 0001 Reduced neutrophil increased lymphocyte significantly observed among patient 1 year old P 001 CD19+ B cell significantly elevated immune cell especially among patient 1 year old cell proportion n = 12 300 P 0001 cell count n = 13 325 P 0001 low level immune related maker immunoglobulin Ig G P 0001 IgA P 0001 IgM P 0001 serum complement C3c P 0001 also mostly found among patient 1 year old together elevated level inflammation related marker tumor necrosis factor gamma P = 0007 interleukin IL 10 P = 0011 IL6 P = 0008 lactate dehydrogenase P 0001 procalcitonin P = 0007 CONCLUSION higher rate severe case long course COVID19 among child 1 year old may due lower production antibody serum complement age group,age difference;china;coronavirus disease 2019;immune;inflammation;pediatric
Computed tomography every step Long coronavirus disease,34210624,BACKGROUND patient continue experience symptom related Coronavirus disease COVID19 acute phase infection Imaging study especially computed tomography CT chest gained importance since beginning pandemic CT help diagnose COVID19 ass extent pulmonary involvement predict disease severity aimed define frequency persistent symptom correlate presence result laboratory finding severity disease based finding chest CT METHODS examined patient discharged hospital treatment COVID19 whose nasopharyngeal swab sample tested positive severe acute respiratory syndrome coronavirus 2 least 4 week initial diagnosis patient asked presence persisting symptom addition demographic data laboratory result severity level seen chest CT recorded RESULTS 116 patient included study 61 reported least one persisting symptom 525 mean age study population 4890 + 1774 year persistent symptom included shortness breath chest pain cough muscle weakness dizziness headache fatigue palpitation mean CT severity score 380 + 038 lower patient without persistent symptom CONCLUSIONS Levels Creactive protein fibrinogen anemia female sex associated persistent symptoms severity disease seen CT successful predictor disease severityprognosis also correlated prolonged COVID infection persistent symptom,crp;ct severity;d dimer;persistent symptom;post-covid
VisionBased Social Distancing Critical Density Detection System COVID19,34283141,Social distancing SD effective measure prevent spread infectious Coronavirus Disease 2019 COVID19 However lack spatial awareness may cause unintentional violation new measure backdrop propose active surveillance system slow spread COVID19 warning individual regionofinterest contribution twofold First introduce visionbased realtime system detect SD violation send nonintrusive audiovisual cue using stateoftheart deeplearning model Second define novel critical social density value show chance SD violation occurrence held near zero pedestrian density kept value proposed system also ethically fair record data target individual human supervisor present operation proposed system evaluated across realworld datasets,convolutional neural network;linear regression;pedestrian detection;social distancing
Effect coinfection intestinal parasite COVID19 severity prospective observational cohort study,34368662,Background Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection result spectrum clinical presentation Evidence Africa indicates significantly le COVID19 patient suffer serious symptom industrialized world others previously postulated partial explanation phenomenon different activated immune system due parasite infection aimed test hypothesis investigating potential correlation coinfection parasite COVID19 severity endemic area Africa Methods Ethiopian COVID19 patient enrolled screened intestinal parasite July 2020 March 2021 primary outcome proportion patient severe COVID19 Ordinal logistic regression model used estimate association parasite infection COVID19 severity Models adjusted sex age residence education level occupation body mass index comorbidities Findings 751 SARSCoV2 infected patient enrolled 284 378 intestinal parasitic infection 27255 106 severe COVID19 patient coinfected intestinal parasite 257496 518 nonsevere COVID19 patient parasite positive p 00001 Patients coinfected parasite lower odds developing severe COVID19 adjusted odds ratio aOR 023 95 CI 017030 p 00001 parasite aOR 037 95 CI 026051 p 00001 protozoa aOR 026 95 CI 019035 p 00001 helminth stratified specie coinfection Entamoeba spp Hymenolepis nana Schistosoma mansoni Trichuris trichiura implied lower probability developing severe COVID19 11 death 15 among patient without parasite p = 0009 Interpretation Parasite coinfection associated reduced risk severe COVID19 African patient Parasitedriven immunomodulatory response may mute hyperinflammation associated severe COVID19 Funding European Developing Countries Clinical Trials Partnership EDCTP European Union Joep Lange Institute JLI Netherlands Trial registration Clinicaltrialsgov NCT04473365,covid-19;severity;africa;co-infection;parasite
Efficacy Tocilizumab Therapy Different Subtypes COVID19 Cytokine Storm Syndrome,34205217,BACKGROUND Cytokine storm COVID19 heterogenous least three subtypes cytokine release syndrome CRS macrophage activation syndrome MAS sepsis METHODS retrospective study comprising 276 patient SARSCoV2 pneumonia patient tested ferritin interleukin6 DDimer fibrinogen calcitonin Creactive protein According diagnostic criterion three group patient different subtypes cytokine storm syndrome identified MAS CRS sepsis MAS CRS group treatment result assessed depending whether tocilizumab used RESULTS MAS diagnosed 91 patient examined CRS 818 sepsis 91 Median serum ferritin patient MAS significantly higher 5894 vs 984 vs 957 ngmL p 0001 CRS sepsis Hypofibrinogenemia pancytopenia also observed MAS patient CRS patient higher mortality rate observed among received tocilizumab 21 vs 10 patient p = 0043 RR = 21 95 CI 1043 MAS patient tocilizumab decreased mortality 13 vs 6 patient p = 0013 RR = 050 95 CI 025099 CONCLUSIONS Tocilizumab therapy patient COVID19 CRS associated increased mortality MAS patient contributed reduced mortality,ards;cytokine storm syndrome;inflammation;monoclonal antibodies
Persistence SARSCoV2 RNA nasopharyngeal blood urine stool sample patient COVID19 hospitalbased longitudinal study,34210325,BACKGROUND persistence severe acute respiratory syndromecoronavirus 2 SARSCoV2 RNA body fluid patient novel coronavirus disease 2019 COVID19 may increase potential risk viral transmission still uncertainty whether recommended quarantine duration sufficient reduce risk transmission study aimed investigate persistence SARSCoV2 RNA nasopharyngeal blood urine stool sample patient COVID19 METHODS hospitalbased longitudinal study 100 confirmed case COVID19 recruited March 2020 August 2020 Guilan Province north Iran Nasopharyngeal blood urine stool sample obtained participant time hospital admission upon discharge 1 week discharge every 2 week sample negative SARSCoV2 RNA reverse transcriptionpolymerase chain reaction RTPCR assay survival analysis also performed identify duration viral persistence RESULTS median duration viral RNA persistence nasopharyngeal sample 8 day first positive RTPCR result upon admission 95 CI 691909 maximum duration viral shedding 25 day admission Positive blood urine stool RTPCR result detected 24 7 6 patient respectively median duration viral persistence blood urine stool sample 7 day 95 CI 607793 6 day 95 CI 416841 13 day 95 CI 696194 respectively Also maximum duration viral persistence blood urine stool sample 17 11 42 day admission respectively CONCLUSION According present result immediately hospitalized patient discharged evidence viral genetic material found Therefore appropriate treatment selected patient hospital However recommend investigation larger sample size multicenter prospective randomized controlled trial RCTs evaluate effect different drug shedding virus body secretion,covid-19;persistence;rna;rt-pcr;sars-cov-2
Exercise Ventilatory Inefficiency PostCOVID19 Syndrome Insights Prospective Evaluation,34208271,INTRODUCTION Coronavirus disease 2019 COVID19 systemic disease characterized disproportionate inflammatory response acute phase study sought identify clinical sequela potential mechanism METHODS conducted prospective singlecenter study NCT04689490 previously hospitalized COVID19 patient without dyspnea midterm followup outpatient group also evaluated underwent serial testing cardiopulmonary exercise test CPET transthoracic echocardiogram pulmonary lung test sixminute walking test serum biomarker analysis quality life questionaries RESULTS Patients dyspnea n = 41 586 compared asymptomatic patient n = 29 414 higher proportion female 732 vs 517 p = 0065 comparable age prevalence cardiovascular risk factor significant difference transthoracic echocardiogram pulmonary function test Patients complained persistent dyspnea significant decline predicted peak VO2 consumption 778 64925 vs 99 88105 p 000 p 0001 total distance sixminute walking test 535 467600 vs 611 550650 meter p = 0001 quality life KCCQ23 601 + 186 vs 828 + 113 p 0001 Additionally abnormality CPET suggestive impaired ventilatory efficiency VEVCO2 slope 32 281374 vs 294 269314 p = 0022 high PETCO2 345 3239 vs 38 3640 p = 0025 INTERPRETATION study 50 COVID19 survivor present symptomatic functional impairment irrespective age prior hospitalization finding suggest potential ventilationperfusion mismatch hyperventilation syndrome,cardiopulmonary exercise testing;dyspnea;post-covid-19 syndrome;pulmonary function test;six-minute walking test;ventilatory inefficiency
Atrial Fibrillation Risk Factor Worse Outcomes Severe COVID19 Patients Single Center Retrospective Cohort,34285872,Introduction New onset atrial fibrillation lead worse outcome patient sepsis association new onset atrial fibrillation AF COVID19 patient COVID19 outcome lacking study aim determine whether new onset atrial fibrillation COVID19 patient admitted ICU risk factor death requirement mechanical ventilation MV Methods retrospective study conducted cohort COVID19 patient admitted Bahrain Defence Force COVID19 Field ICU April 2020 November 2020 Data extracted electronic medical record patient developed new onset AF admission compared patient remained sinus rhythm Multivariate logistic regression model used control confounders estimate effect AF outcome patient Results study included total 492 patient 30 diagnosed new onset AF AF group primary outcome occurred 667 patient n = 20 control group 171 n = 79 developed primary outcome Upon adjusting confounders multivariate regression model AF odds ratio 396 95 CI 1051498 p = 0042 primary outcome Conclusion result indicate new onset AF risk factor worse outcome patient admitted COVID19 ICU,atrial fibrillation;bahrain;covid-19;corona virus;critical care;icu;sars-cov2;arrythmia;atrial arrythmia
Increased Adherence Infection Control Practices Among Medical Laboratory Technicians COVID19 Pandemic SelfReported Survey Study,34221909,Background adherence medical laboratory technician MLT infection control guideline essential reducing risk exposure infectious agent study explored adherence MLT towards infection control practice COVID19 pandemic Method study population consisted MLT n = 444 worked private government health sector Jordan selfreported survey used collect data participant Findings 87 participant reported adherence handwashing guideline using personal protective equipment PPE interacting patient 745 handling clinical sample 700 Besides 881 482 77 reported wearing lab coat face mask goggles time respectively majority reported increased adherence infection control practice COVID19 pandemic includes increased PPE use workplace 942 increased frequency disinfection laboratory surface 924 laboratory equipment 867 increased frequency handwashinguse antiseptic 946 graduate degree significantly associated increased adherence participant daily use goggleseye protection p = 0002 use PPE handling clinical sample p = 0011 work experience 10 year associated increased adherence use PPE handling clinical sample p = 0001 Conclusion MLT reported good adherence assessed infection control practice addition reported increased conformity infection control guideline COVID19 pandemic,
Unintended consequence COVID19 social distancing among older adult kidney disease,34286836,BACKGROUND social distancing policy protect older adult advanced chronic kidney disease CKD exposure COVID19 reduced social interaction may also unintended consequence METHODS identify subgroup patient risk unintended health consequence social distancing conducted crosssectional analysis data national cohort study older Veterans advanced CKD n=223 Characteristics included activity daily living ADLs instrumental ADLs IADLs cognition score depression score social support financial stress symptom burden number chronic condition Unintended consequence social distancing included restricted Life Space mobility low willingness video telehealth reduced inperson contact caregiver food insecurity identified subgroup patient risk unintended consequence using modelbased recursive partitioning MoB RESULTS Participants mean age 779 year 646 white 969 male Overall 224 participant restricted Life Space 339 reported low willingness video telehealth 190 reported reduced caregiver contact 32 reported food insecurity Life Space restriction four subgroup partitioned ie split IADL difficulty cognition score ADL difficulty identified highest rate restricted Life Space 547 subgroup participant 3 IADL difficulty low willingness telehealth reduced caregiver contact separate model identified two subgroup split cognition score depression score respectively CONCLUSIONS Measures function cognition depressive symptom may identify older adult advanced CKD higher risk unintended health consequence social distancing,covid-19;chronic kidney disease;older adults
Impact COVID19 Mitigation Measures MosquitoBorne Diseases 2020 Queensland Australia,34208620,describe impact COVID19 mitigation measure mosquitoborne disease Queensland Australia first half 2020 Implementation restriction coincided atypical late season outbreak Ross River virus RRV characterized peak notification April 1173 May 955 greater 3fold mean observed previous four year propose limitation human movement likely resulted majority RRV infection acquired near place residence increase outdoor activity gardening bushwalking local household vicinity increased risk exposure RRVinfected mosquito contrast precipitous decline international passenger flight led reduction number imported dengue malaria case 70 60 respectively compared previous five year substantial reduction flight also reduced risk pathway importation exotic mosquito risk posed importation via sea cargo affected Overall emergence COVID19 varied impact mosquitoborne disease epidemiology Queensland need mosquito surveillance control together encouragement personal protective measure remains unchanged,australia;covid-19;ross river virus;arbovirus;mosquito;transmission
Strategies COVID19 Epidemiological Surveillance India Overall Policies Till June 2021,34368070,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 gripped entire world almost paralysing human race entirety virus rapidly transmits via humantohuman medium resulting massive increase patient COVID19 order curb spread disease immediate action complete lockdown implemented across globe India population 13 billion exception took challenge execute phasewise lockdown unlock partial lockdown activity study intend summarise different phase Government India GoI imposed fight SARSCoV2 act reference guideline help controlling future wave COVID19 similar pandemic situation India,covid-19;sars-cov-2;coronavirus;lockdown;pandemic;partial lockdown;unlock
Assessing Spatiotemporal Spread COVID19 via Compartmental Models Diffusion Italy USA Brazil,34335018,outbreak COVID19 2020 led surge interest mathematical modeling infectious disease model usually defined compartmental model population study divided compartment based qualitative characteristic different assumption nature rate transfer across compartment Though commonly formulated ordinary differential equation model compartment depend time recent work also focused partial differential equation PDE model incorporating variation epidemic space research PDE model within Susceptible Infected Exposed Recovered Deceased framework led promising result reproducing COVID19 contagion dynamic paper ass robustness modeling framework considering different geometry extended period similar study first validate code reproducing previously shown result Lombardy Italy focus US state Georgia Brazilian state Rio de Janeiro one impacted area world result show good agreement realworld epidemiological data time space region across major area across three different continent suggesting modeling approach valid robust,
Clinical Puzzles DecisionMaking Antisynthetase Syndrome,34221776,present challenging clinical case antisynthetase syndrome ASS fouryear followup disease debuted skin manifestation interstitial lung disease ILD severe Raynaud s phenomenon came fore development occlusive vasculopathy critical digital ischemia relief vascular lesion severity condition determined ILD use combined pulse therapy cyclophosphamide methylprednisolone treatment intravenous immunoglobulin made possible reduce activity ASS lung lesion progression vasculopathy However termination unplanned pregnancy patient experienced exacerbation ILD progression decided use rituximab patient s condition stabilized Clinical laboratory remission achieved maintained year half However severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic triggered reexacerbation pulmonary domain disease forced u use nintedanib positive clinical instrumental effect,antisynthetase syndrome;digital ischemia;interstitial lung disease;intravenous immunoglobulin;nintedanib;rituximab;sars-cov-2;treatment
Description preliminary experience Virtual Visit Assessment ViVA COVID19 pandemic structured virtual management protocol patient multiple sclerosis,34131815,people multiple sclerosis PwMS strict followup essential Telemedicine potential overcome many difficulty routine management Herein present structured protocol used remotely manage patient MS describing detail step taken exam needed stage working group established developed tailored protocol adapted variety setting overall protocol consisted 5 phase enrolment document sharing phase preevaluation virtual visit postvisit phase divided 14 individual step October 2020 25 virtual visit carried via Skype patient s caregiver present visit active role average duration virtual visit 24 min previsit postvisit around 15 min Overall satisfaction rated physician considered high 80 + 05 Using system usability scale SUS patient also favorably rated virtual visit 966 + 61 20 case virtual visit sufficient provide adequate information inperson clinical visit recommended described protocol potential provide benefit healthcare system well patient caregiver beyond COVID19 pandemic,covid-19;management;multiple sclerosis;protocol;telemedicine
Series case acute acquired comitant esotropia child associated excessive online class smartphone COVID19 pandemic digital eye strain among kid DESK study3,34223812,Extra time sitting front digital device required elearning child Corona virus COVID19 pandemic lead many ocular problem including digital eye strain DES view increased incidence DES child multiple study conducted central India ass eye strain child due excessive online class research project named `` Digital eye strain among kid DESK study study DESK3 aimed report series case acute acquired comitant esotropia AACE child attending online class COVID19 pandemic Children aged 618 year recent onset esotropia 1month duration without similar history past presented month JulyAugust 2020 tertiary child eye care hospital evaluated Data collection included age gender child presence absence diplopia visual acuity duration smartphone use duration online class angle deviation near distance cycloplegic refraction Total eight child AACE included study mean age child 125 + 42 year eight male mean duration smartphone use 46 + 07 hour per day child attending online class 4 hour per day smartphone average size 55 inch Five child emmetropic one myopic one pseudomyopic one hyperopic angle deviation near distance 481 + 164 PD 493 + 159 PD respectively normal ocular motility Seven child complained horizontal diplopia gaze Neurological examination CT scan brain orbit normal patient Two month lockdown one case identified compared eight lockdown Prolonged near work smart phone use elearning might lead development AACE child,acute acquired comitant esotropia;covid-19 pandemic;children;smartphone
Xray CTscanbased automated detection classification covid19 using convolutional neural network CNN,34226832,Covid19 Coronavirus Disease2019 recent coronavirusrelated disease announced pandemic World Health Organization Furthermore brought whole planet halt result worldwide introduction lockdown killed million people virus low fatality rate problem highly infectious result infected large number people putting strain healthcare system hence Covid19 identification patient become critical goal research use Xrays image computed tomography CT image introduce deep learning strategy based Convolutional Neural Network CNN automatically detect identify Covid19 disease implemented two different classification using CNN ie binary multiclass classification total 3877 image dataset CT Xray image utilised train model binary classification 1917 image Covid19 infected individual overall accuracy 9964 recall sensitivity 9958 precision 9956 F1score 9959 ROC 100 observed binary classification multiple classification model trained using total 6077 image 1917 image Covid19 infected people 1960 image normal healthy people 2200 image pneumonia infected people accuracy 9828 recall sensitivity 9825 precision 9822 F1score 9823 ROC 9987 achieved multiclass classification using proposed method currently available dataset proposed model produced desired result assist healthcare worker quickly detecting Covid19 positive patient,accuracy;cnn;deep learning;precision;roc;recall
Coinfections Bacteria Fungi Respiratory Viruses Patients SARSCoV2 Systematic Review MetaAnalysis,34202114,BACKGROUND Coinfection bacteria fungi respiratory virus SARSCoV2 particular importance due possibility increased morbidity mortality metaanalysis calculated prevalence coinfections METHODS Electronic database searched 1 December 2019 31 March 2021 Effect size prevalence pooled 95 confidence interval CIs minimize heterogeneity performed subgroup analysis RESULTS 6189 paper identified 72 article included systematic review 40 case series 32 cohort study 68 article 38 case series 30 cohort study included metaanalysis 31953 SARSCoV2 patient included metaanalysis overall pooled proportion laboratoryconfirmed bacterial infection 159 95 CI 136182 n = 1940 49 study 2 = 99 p 000001 37 95 CI 2648 n = 177 16 study 2 = 93 p 000001 fungal infection 66 95 CI 5576 n = 737 44 study 2 = 96 p 000001 respiratory virus SARSCoV2 patient ICU higher coinfections compared ICU nonICU patient follows bacterial 222 95 CI 161284 2 = 88 versus 148 95 CI 124173 2 = 99 fungal 96 95 CI 68124 2 = 74 versus 27 95 CI 0038 2 = 95 however identical respiratory viral coinfection proportion SARSCoV2 patient ICU nonICU ICU 66 95 CI 00113 2 = 58 versus 66 95 CI 5577 2 = 96 Funnel plot possible publication bias pooled effect size prevalence coinfections asymmetrical visual inspection Egger s test confirmed asymmetry p value 005 CONCLUSION Bacterial coinfection relatively high hospitalized patient SARSCoV2 little evidence S aureus playing major role Knowledge prevalence type coinfections SARSCoV2 patient may diagnostic management implication,covid-19;sars-cov-2;bacterial;co-infection;coinfection;concurrent;fungal;meta-analysis;viral
Risk Diagrams Based Primary Care Electronic Medical Records Linked RealTime PCR Data Monitor Local COVID19 Outbreaks Summer 2020 Prospective Study Including 7671862 People Catalonia,34291033,Monitoring transmission prerequisite containing COVID19 report effective potential growth EPG novel measure early identification local outbreak based primary care electronic medical record EMR PCRconfirmed case Secondly studied whether increasing EPG precedes local hospital intensive care ICU admission mortality Populationbased cohort including Catalan citizen PCR test hospitalization intensive care ICU mortality 1072020 13092020 linked EMR covering 886 Catalan population obtained Nursing home resident excluded COVID19 count ascertained based EMR PCRs separately Weekly empirical propagation rho7 14day cumulative incidence A14 95 confidence interval estimated care management area CMA level combined EPG = rho7 x A14 Overall 7607201 6798994 people 43 CMAs included PCR EMR measure respectively A14 rho7 EPG increased numerous CMAs summer 2020 EMR identified 270fold case PCRs similar trend median interquartile range 2 1 day earlier better precision Upticks EPG preceded increase local hospital admission ICU occupancy mortality Increasing EPG identified localized outbreak Catalonia preceded local hospital ICU admission subsequent mortality EMRs provided similar estimate PCR day earlier better precision EPG useful tool monitoring community transmission early identification COVID19 local outbreak,covid-19;outbreak detection;public health;sentinel;surveillance
Scaffold Hopping alphaRubromycin Enables Direct Access FDAApproved Cromoglicic Acid SARSCoV2 Pro Inhibitor,34198933,COVID19 pandemic still active around globe despite newly introduced vaccine Hence finding effective medication repurposing available one could offer great help serious situation antiCOVID19 investigation microbial natural product MNPs came across alpharubromycin antibiotic derived Streptomyces collinus ATCC19743 able suppress catalytic activity IC50 = 54 microM Ki = 322 microM one viral key enzyme ie Pro However showed high cytotoxicity toward normal human fibroblast CC50 = 167 microM reduce cytotoxicity microbial metabolite utilized number silico tool ensemble docking molecular dynamic simulation binding free energy calculation propose novel scaffold main pharmacophoric feature inhibit Pro better druglike property reducedminimal toxicity Nevertheless reaching novel scaffold synthetically timeconsuming process particularly critical time Instead scaffold used template explore similar molecule among FDAapproved medication share main pharmacophoric feature aid pharmacophorebased virtual screening software result cromoglicic acid aka cromolyn found best hit upon vitro Pro testing 45 time potent IC50 = 11 microM Ki = 068 microM alpharubromycin minimal cytotoxicity toward normal human fibroblast CC50 100 microM report highlight potential MNPs providing unprecedented scaffold wide range therapeutic efficacy also revealed importance cheminformatics tool speeding drug discovery process extremely important critical situation,covid-19;mpro;streptomyces collinus;cheminformatics;cromolyn;in silico;alpha-rubromycin
Accelerated stability study ester prodrug remdesivir Recently FDAapproved Covid19 antiviral using reversedphaseHPLC fluorimetric diode array detection,34227154,Remdesivir RDV first antiviral drug approved Food Drug Administration treat severe acute respiratory syndrome coronavirus 2 RDV relatively new chemical entity ester prodrug reported stability profile Due urgency use thus fast production important develop stabilityindicating method assay Chromatographic separation carried C18 column 250 x 46 mm 5 microm dual detection diode array 240 nm fluorescence lambdaexem 245390 nm Isocratic elution acetonitrile distilled water acidified phosphoric acid pH 4 ratio 5545 vv respectively used linearity range using HPLCdiode array detection 0115 mugmL whereas using fluorimetric detection 00515 mugmL per International Conference Harmonization guideline RDV degraded accelerated alkaline acidic neutral hydrolysis oxidative heat photolytic stress condition Possible degradation hypothesis parent molecule suggested illustrated proposed method achieved selective determination intact drug peak overlapping assumption Extensive degradation confirms threatened drug stability thermal basic hydrolytic stressing developed method fully validated proved suitable quality control routine analysis RDV raw material pharmaceutical dosage form,covid-19;degradation hypothesis;remdesivir;stability-indicating hplc;validation
Mammographic sonographic finding breast axillary tail following COVID19 vaccine,34340203,Axillary lymphadenopathy breast imaging recent coronavirus disease 2019 COVID19 vaccination reported literature immunization become widespread muscle edema injection site observed MRI secondary immune response ipsilateral breast imaging observation edema reported seen COVID19 vaccination date Mammographic finding trabecular skin thickening along increased echogenicity ultrasound seen edema secondary capillary leak poor lymphatic drainage considered possible etiology observed breast edema following recent COVID19 vaccine Inflammatory change observed breast axillary tail post vaccination described case series transient clinically relevant patient experience swelling following injection Similar evaluation suspected mastitis short interval imaging follow confirm resolution may appropriate patient ipsilateral vaccination history could potentially reduce number false positive examination clinical scenario However inflammatory breast cancer mimic inflammation infection therefore close follow resolution critical miss cancer,covid-19 vaccine;edema;focal asymmetry
Daily glucose variation influenced use corticosteroid COVID19 patient treated LimaPeru,34217143,AIM pandemic generated need COVID19 patient treated best possible however effect treatment glycemic control yet taken account article aim determine whether daily variation glucose influenced use corticosteroid COVID19 patient treated LimaPeru METHODOLOGY prospective cohort study undertook glucose measured four time day 53 patient hospitalized due COVID19 value associated use corticosteroid adjusted socioeducational variable mean PAGEE model RESULTS Nested multivariate analysis daily glucose variation found using corticosteroid increased daily average glucose well first last glucose measurement 6am 10pm respectively pvalues 0026 increase glucose level also observed diabetes pvalues 0001 contrast found decrease last glucose measurement day obese patient pvalue = 0044 CONCLUSIONS patient used corticosteroid treatment COVID19 increased average glucose per day especially first last measurement,blood glucose;covid-19;dexamethasone;glycemic variability;hyperglycemia;type 2 diabetes mellitus
HighDensity Blood Transcriptomics Reveals Precision Immune Signatures SARSCoV2 Infection Hospitalized Individuals,34335605,immune response COVID19 infection variable COVID19 influence clinical outcome hospitalized patient need understood readily obtainable biological material blood hypothesized highdensity analysis host pathogen blood RNA hospitalized patient SARSCoV2 would provide mechanistic insight heterogeneity response amongst COVID19 patient combined advanced multidimensional bioinformatics RNA enrolled 36 hospitalized COVID19 patient 11 died 15 control collecting 74 blood PAXgene RNA tube multiple timepoints one early 23 patient treatment various therapy Total RNAseq performed highdensity 160 million pairedend 150 base pair read per sample representing sequenced base per sample publicly deposited blood PAXgene tube study 770 gene significantly altered blood COVID19 patient associated antiviral defense mitotic cell cycle type interferon signaling severe viral infection Immune gene activated include associated neutrophil mechanism secretory granule neutrophil extracellular trap NETs along decreased gene expression lymphocyte clonal expansion acquired immune response Therapies convalescent serum dexamethasone reduced many blood expression signature COVID19 Severely ill deceased patient marked various secondary infection unique gene pattern dysregulated innate response peripheral organ damage otherwise found cohort Highdensity transcriptomic data offer shared gene expression signature providing unique insight immune system individualized signature patient could used understand patient s clinical condition Whole blood transcriptomics provides patientlevel insight immune activation immune repertoire secondary infection guide precision treatment,covid-19;rnaseq;sars-cov-2;blood transcriptomics;immune cell deconvolution;immune repertoire;interferon response;secondary infections
Rescue medical activity among sea migrant refugee Mediterranean region lesson learned 20142020 period,34212349,BACKGROUND Since 2014 number migrant refugee crossing Mediterranean towards Europe risen significantly due various reason state agency nongovernmental organization NGOs launched rescue mission Central Mediterranean accordance international legal obligation search rescue SAR operation distress sea aim summarise specific qualification needed maritime SAR Mediterranean term population risk equipment medical support required especially coronavirus disease 2019 COVID19 pandemic operational legal framework MATERIALS METHODS article aim summarise key point SAR effort medical perspective depicted relevant literature specific timeline period 20142020 specific part Mediterranean Sea Central Mediterranean route paper published English whose full text available included study inclusion criterion article referring sea rescue operation 2014 2020 b research focused medical preparedness assistance rescue operation Central Mediterranean route c study concerning demographic clinical feature rescue population guideline rule conduct person state participating rescue activity exclusion criterion study describing SAR operation different region world b study focusing route demographic medical support migrantsrefugees land RESULTS Three major theme identified characteristic population distress sea country origin age group presence communicable noncommunicable disease identified relevant literature research show dermatological respiratory issue major concern among sea migrant coming different country Africa Asia relatively young mostly male b medical preparedness equipment needed rescue according current guideline revised COVID19 pandemic infrastructure needed SAR operation includes equipment resuscitation personal protective equipment deck adjustment medical personnel trained function austere setting able handle vulnerable patient group child pregnant woman c medicolegal implication SAR operation knowledge legal framework encompassing SAR operation seems necessary European Union state led initiative seem withdraw proactive SAR criminalising NGO led rescue effort Operating imperative save life seems way respecting international law human value thus summary law dictate made effort keep medical worker participating operation updated CONCLUSIONS Investigation aim shed light special clinical feature sea migrant skill equipment organizational structure needed medical worker participating SAR operation well legal framework asked operate Special consideration given difficulty emerged due COVD19 pandemic,covid-19;mediterranean route;initial assessment;sea migrants;search and rescue (sar)
Overt hematochezia rare gastrointestinal presentation patient corona virus disease 2019,34334919,World health care system affected severe acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic associated disease coronavirus disease 2019 COVID19 new human pathogen mostly affect respiratory system various extrapulmonary pathology reported literature seems gastrointestinal system one target organ SARSCoV 2 Diarrhea longterm bowel symptom rare although occurrence high fever cough,co-rads score;covid-19;dysentery;hematochezia;sars-cov-2
rare case shingle COVID19 vaccine possible adverse effect,34222134,Coronavirus disease 2019 COVID19 exhibit mild moderate symptom whereas 15 COVID19 case progress pneumonia associated cutaneous finding also reported maculopapular eruption morbilliform rash urticaria chickenpoxlike lesion livedo reticularis inactivated COVID19 vaccine authorized use country including Turkey report unusual case varicellazoster virus VZV reactivation 68yearold male patient vaccinated COVID19 patient presented family medicine clinic stinging sensation pain radiating right side chest back Physical examination revealed multiple pinheaded vesicular lesion upon erythematous base occupying area right mammary region back corresponding T3T5 dermatome reported got second dose COVID19 vaccine 5 day ago COVID 19 decrease cellmediated immunity could also increase risk herpes zoster HZ Although exact reason remains unsolved vaccineinduced immunomodulation caused live attenuated vaccine attenuated alloreactivity caused inactivated vaccine may responsible mechanism reactivation HZ Epidemiological study needed clarify possible connection vaccination reactivation herpesvirus infection,covid-19 virus disease;herpes zoster virus;vaccine
Track dynamical feature mutant variant COVID19 UK,34198454,AIMS main purpose study explore whether new variant SARSCoV2 VOC 20201201 UK equipped leading underlying feature METHODS apply systematic persuasive approach reveal underlying dynamical feature variant approach utilises extracting main feature consist 3valued feature via timeseries data new case 28day death 60day death experimental sample chosen rely rolling set regional data vector whose dimension 7 day data set projected onto 3valued feature yield vector rejection minimal feature thus extracted minimal total norm map trace similarity extracted timevarying feature RESULTS finding matter preliminary followup study clearly show consistent substantial shift 3valued feature even occurrence new variant might validate efficacy current vaccine variant CONCLUSIONS Since underlying feature mutant unchanged leading feature B117 yet present might help u make lockdown decision `` choose lesser two evil pandemic economic woe validate vaccine development adopt preventive measure, 3-valued features; uk covid-19; distance tensor product; feature extraction; mutant variants
kidnapping mitochondrial function associated SARSCoV2 infection,34132382,Infection Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 lead multiorgan failure associated cytokine storm septic shock virus evades mitochondrial production interferon N protein moment hijack function organelle aim study show virus kidnaps mitochondrial machinery benefit survival leading alteration serum parameter nitrosative stress NSS prospective cohort 15 postmortem patient died COVID19 six marker mitochondrial function COX II COX IV MnSOD nitrotyrosine Bcl2 caspase9 analyzed immune colloidal gold technique sample lung heart liver Biometric laboratory result patient showed alteration hemoglobin platelet creatinine urea nitrogen glucose Creactive protein albumin Ddimer ferritin fibrinogen Ca 2 + K + lactate troponin change associated alteration mitochondrial structure function multiorgan dysfunction present COVID19 patient may caused part damage mitochondrion result inflammatory state contributes NSS activates sepsis cascade result increased mortality COVID19 patient,
20Week Study Clinical Outcomes OvertheCounter COVID19 Prophylaxis Treatment,34225463,OBJECTIVES SETTING lethal COVID19 pandemic enters second year need effective modality alleviation remains urgent includes modality readily used public reduce disease spread severity preventive measure earlystage treatment may temper immediacy demand advanced antiCOVID measure drug antibody vaccine help relieve strain also health system resource DESIGN PARTICIPANTS present result clinical study multicomponent OTC `` core formulation regimen used multiply exposed adult population Analysis clinical outcome data sample 100 subject comprised roughly equal sized regimencompliant test noncompliant control group meeting equivalent inclusion criterion demonstrates strong statistical significance favor use core formulation RESULTS group moderate size difference outcome 20week study period large stark 4 compliant test group presented flulike symptom none test group COVIDpositive whereas 20 noncompliant control group presented flulike symptom threequarters 15 overall control group COVIDpositive CONCLUSIONS Offering low cost readily implemented antiviral approach study regimen may serve least stopgap modality perhaps useful tool combatting pandemic,covid-19;otc;sars-cov-2;early-stage treatment;immunity enhancement;ionophores;prophylaxis;regimen compliance;zinc
Unprovoked serotonin syndromelike presentation SARSCoV2 infection small case series,34290872,Clinicians researcher reported array neurological abnormality coronavirus disease 2019 COVID19 serotonin excess observed unaware report central nervous system serotonin toxicity COVID19 present two case resemble serotonin syndrome COVID19 without identifiable inciting medication 54yearold multiple sclerosis diabetes mellitus presented altered mental status altered sensorium attributed diabetic ketoacidosis condition quickly deteriorated fever 105 degree Fahrenheit rigidity extremity inducible clonus hyperreflexia intubated treated possible meningitis seizure Neurologic workup negative acute pathology Despite acetaminophen core temperature remained elevated 105 degree Fahrenheit treated external cooling cyproheptadine within 48 h fever rigidity hyperreflexia clonus resolved extubated discharged home day 14 72yearold hyperlipidemia admitted tremor 4 day testing positive COVID19 symptom rapidly worsened transferred Intensive Care Unit day 3 extremis febrile 1044 degree Fahrenheit heart rate 180 beat per minute apparent whole body myoclonus intubated developed fever refractory acetaminophen requiring external cooling Extensive neurologic workup negative received cyproheptadine slowly improved extubated discharged rehab day 11 case represent unique presentation COVID19 must considered requires high index suspicion,central nervous system;coronavirus;cyproheptadine;serotonin;serotonin syndrome
Potential Improvement Rehabilitation Quality 2019 Novel Coronavirus Isometric Training System `` MuscleLung CrossTalk,34200791,novel Coronavirus Disease 2019 COVID19 crisis present 200 country started December 2019 far led 149 470968 case 3152121 death 127133013 survivor recovered 28 April 2021 COVID19 high morbidity mortality 2 average whereas people treated period time people recover COVID19 left 20 30 decreased lung function context exercise focused skeletal muscle minimal lung involvement could potentially play important role Regular exercise protects disease associated chronic lowgrade systemic inflammation longterm effect exercise may ascribed antiinflammatory response elicited acute bout exercise partly mediated musclederived myokines isometric training system seems feature system involved skeletal muscle target tissue However study examined effect exercise treatment recovery COVID19 importantly `` musclelung crosstalk mechanism COVID19 treatment suggested theoretical construct examined researcher,covid-19;anti-inflammatory treatment;chronic diseases;cytokines;exercise;fibroblast growth factor 21;immune response;myokines;oxidative stress
India s pragmatic vaccination strategy COVID19 mathematical modellingbased analysis,34215611,OBJECTIVES investigate impact targeted vaccination strategy morbidity mortality due COVID19 well incidence SARSCoV2 India DESIGN Mathematical modelling SETTINGS Indian epidemic COVID19 vulnerable population DATA SOURCES Countryspecific agesegregated pattern social contact case fatality rate demographic data obtained peerreviewed literature public domain MODEL agestructured dynamical model describing SARSCoV2 transmission India incorporating uncertainty natural history parameter constructed INTERVENTIONS Comparison different vaccine strategy targeting priority group keyworkers including healthcare professional individual comorbidities 2460 year old 60 MAIN OUTCOME MEASURES Incidence reduction averted death different scenario assuming current restriction fully lifted vaccination implemented RESULTS priority group together account 18 India s population infectionpreventing vaccine 60 efficacy covering group would reduce peak symptomatic incidence 206 95 uncertainty interval UI 167254 cumulative mortality 297 95 CrI 258338 similar vaccine ability prevent symptom infection reduce peak incidence symptomatic case 104 95 CrI 84130 cumulative mortality 329 95 CrI 286373 event insufficient vaccine supply cover priority group model projection suggest keyworkers vaccine strategy prioritise 60 subsequently individual comorbidities setting weakest transmission sparsely populated rural area comorbidities prioritised keyworkers CONCLUSIONS appropriately targeted vaccination strategy would witness substantial mitigation impact COVID19 country like India wide heterogeneity Smart vaccination based public health consideration rather mass vaccination appears prudent,covid-19;epidemiology;health policy;public health
COVID19 Vaccines ThrombosisRoadblock DeadEnd Street,34356644,Two adenovirusbased vaccine ChAdOx1 nCoV19 Ad26COV2S two mRNAbased vaccine BNT162b2 mRNA1273 approved European Medicines Agency EMA invaluable preventing reducing incidence coronavirus disease2019 COVID19 Recent report pointed thrombosis associated thrombocytopenia adverse effect occurring low frequency individual vaccination cause event may related SARSCoV2 spike protein interaction different Ctype lectin receptor heparan sulfate proteoglycans HSPGs CD147 receptor different soluble splice variant spike protein adenovirus vector interaction CD46 receptor platelet factor 4 antibody Similar finding reported several viral disease vaccine administration addition immunological mechanism elicited viral vector related cellular delivery could play relevant role individual certain genetic background Although rare potential COVID19 vaccineinduced immune thrombotic thrombocytopenia VITT requires immediate validation especially risk group elderly chronic smoker individual preexisting incidence thrombocytopenia necessary reformulation existing vaccine,covid-19;sars-cov-2;chronic smokers;thrombosis;vaccines
Nursing Interventions Increase Influenza Vaccination Quality Measures Home Telehealth Patients,34224534,BACKGROUND Influenza vaccination preventive health quality measure Home telehealth nursing staff intervention reduce influenza disease burden complication PURPOSE improve seasonal flu vaccine rate using novel home telehealth clinical technology intervention METHODS pre postintervention concurrent cohort study 513 outpatient conducted Interventions included automated 2way patient messaging using remote monitoring equipment new note template record vaccination status electronic health record flu vaccine patient education RESULTS Interventions resulted vaccination rate 704 Veterans age 19 65 year 817 Veterans 66 year older exceeding national regional local Veterans Administration target CONCLUSIONS Twoway messaging standardized documentation increased rate Declinations persisted despite education Reasons included fear side effect rarely leaving home due COVID19 pandemic Nursing intervention increase influenza vaccination quality measure primary care home telehealth patient,
Editorial Maternal SARSCoV2 Infection Pregnancy Outcomes Current Global Study Data,34219126,global COVID19 pandemic data clinical study systematic review population registry data shown compared nonpregnant woman SARSCoV2 infection pregnancy associated small increase risk mother Large cohort study registry data collected 2020 included US Surveillance Emerging Threats Mothers Babies Network SETNET COVIPREG UK Global Pregnancy Neonatal Outcomes COVID19 PANCOVID study American Academy Pediatrics AAP Section NeonatalPerinatal Medicine SONPM National Perinatal COVID19 Registry Swedish Pregnancy Register Canadian Surveillance COVID19 Pregnancy CANCOVIDPreg registry Recently published data shown maternal infection SARSCoV2 occur third trimester result small increase hospital admission admission intensive care unit ICU mechanical ventilation preterm birth increased cesarean section mother infected SARSCoV2 However currently approved vaccine given pregnancy result immune response current SARSCoV2 variant Transplacental transmission SARSCoV2 fetus occur immediate longterm effect newborn infant remain unclear Therefore woman pregnant planning pregnancy managed according current clinical guideline timely vaccination prevent infection SARSCoV2 Editorial summarizes currently known maternal SARSCoV2 infection pregnancy outcome multinational study,
Incidence Reported FluLike Syndrome Cases Brazilian Health Care Workers 2020 March June,34206062,Health care worker HCWs increased risk exposed COVID19 study aimed characterize flulike syndrome case FS HCWs notified Brazil compare FS case general community GC Brazilian protocol FS corresponds suspected case COVID19 manuscript analyzed case FS five Brazilian state estimating incidence rate case FS clinical epidemiological characteristic Registered case March June 2020 totaled 1100000 case FS HCWs represented 17 register whose incidence 2041100 vs 215100 GC FS case HCWs concentrated highest percentage age group 30 49 year 6515 among nursing staff 4686 study first interstate evaluation Brazil estimate suspected case FS COVID19 HCWs order control spread viral respiratory infection HCWs including COVID19 necessary review management health information identify many situation worker frequently exposed well profession information guide specific practical farreaching action,brazil;covid-19;sars-cov-2;flu-like syndrome;health-care workers
COVID19 Myositis Know Far,34216297,PURPOSE Myositis rare manifestation COVID19 recently reported review examines current literature COVID19induced myositis focusing etiopathogenesis clinical presentation diagnostic practice therapeutic challenge immunosuppression difficulty experienced rheumatologist established myositis COVID19 era RECENT FINDINGS COVID19 associated viral myositis attributable direct myocyte invasion induction autoimmunity COVID19induced myositis may varied presentation typical dermatomyositis rhabdomyolysis paraspinal affliction back pain may may present acute exponential elevation enzyme marker creatine kinase CK Virusmediated muscle inflammation attributed ACE2 angiotensinconverting enzyme receptormediated direct entry affliction muscle fiber leading innate adaptive immune activation greater recognition stark similarity antiMDA5positive myositis COVID19 thrown researcher alley exploration finding common etiopathogenic basis well therapeutic strategy patient established myositis chronic care disrupted pandemic several logistic challenge treatment dilemma leading high flare rate Teleconsultation bridged gap ushering era patientled care digital transition tool remote disease assessment COVID19 brought along greater insight unique manifestation COVID19related myositis ranging direct virusinduced muscle disease triggered autoimmunity etiopathogenic link explore remarkable shift mean delivering chronic care led patient caregiver worldwide embrace virtual shift teleconsultation opened doorway new era patientled care,covid-19;dermatomyositis;idiopathic inflammatory myopathy;immunopathogenesis;myasthenia;myositis;rhabdomyolysis;tele-triage;telemedicine
Adaptation respiratory service provide CPAP patient COVID19 pneumonia outside critical care setting district general hospital,34286203,Introduction Onehundred forty patient Croydon University Hospital received continuous positive airway pressure CPAP specialist respiratory ward bridge invasive mechanical ventilation IMV ceiling care COVID19 retrospective study aimed outline service expansion patient characteristic explore risk factor outcome Results Mean age patient CPAP 64 year standard deviation 12 median number day admission CPAP initiation 1 day interquartile range IQR 03 time successful wean CPAP 4 day IQR 26 Twentyeightday mortality 64 Thirtyfour per cent patient went onto require IMV 24 improved CPAP 41 palliated 28day nonsurvivor group older age statistically significant higher admission creatinine higher peak oxygen requirement Age 65 year associated higher mortality odds ratio 59 95 confidence interval 263133 Conclusion CPAP viable ceilingoftreatment option unsuitable ventilation may even avoid need ventilation others Duration CPAP may useful service provision predict resource allocation rapidity admission CPAP initiation highlight need early ceiling care established,covid-19;cpap;sars-cov-2;continuous positive airway pressure;service adaptation
COVID19 ischemic stroke,34224187,Since onset COVID19 pandemic substantial proportion COVID19 patient documented thrombotic complication ischemic stroke Several mechanism related immunemediated thrombosis renin angiotensin system effect SARSCoV2 cardiac brain tissue may contribute pathogenesis ischemic stroke patient COVID19 Simultaneously significant strain global healthcare delivery including ischemic stroke management made treatment stroke setting COVID19 particularly challenging review summarize current knowledge epidemiology clinical manifestation pathophysiology ischemic stroke patient COVID19 bridge gap bench bedside clinical practice challenging global health crisis last decade,covid-19;sars-cov-2;ischemic stroke;pathophysiology
ISIDOG Consensus Guidelines COVID19 Vaccination Women Pregnancy,34209801,INTRODUCTION SarsCoV2 infection pose particular problem pregnancy infection frequently cause severe complication unaffected pregnant woman nonpregnant woman SARSCoV2 infection vaccination available rapidly implemented worldwide question arises whether pregnant woman vaccinated whether receive priority METHODS Available scientific data available guideline vaccination SARSCoV2 collected Guideline Committee International Society Infectious Diseases Obstetrics Gynecology ISIDOG analyzed discussed summarized guideline healthcare worker caring pregnant woman Concluding statement graded according Oxford evidencebased medicine grading system RESULTS evidence consider pregnancy risk factor serious complication COVID19 infection even absence additional risk factor hypertension diabetes obesity increase risk even pregnancy Currently available data slightly favor mRNAbased vaccine vectorbased vaccine pregnancy breastfeeding safety data become available CONCLUSION ISIDOG advises policy maker society prioritize pregnant woman receive vaccination SARSCoV2 favor mRNA vaccine safety information becomes available,covid-19;sars-cov-2;maternal complications;pandemic;pregnancy complication;prevention;safety;vaccine
Implications Frailty COVID19,34292183,global coronavirus disease19 COVID19 pandemic caused severe acute respiratory distress syndrome coronavirus 2 SARSCoV2 continues cause higher mortality hospitalization rate among older adult strategy frailty screening suggested resource allocation clinical management Frailty physiologic condition characterized decreased reserve stressor associated disability hospitalization death Measuring frailty useful tool determine risk prognosis COVID19 patient acute setting provide higher quality care vulnerable individual outpatient setting literature review conducted examine current research regarding frailty COVID19 Frailty inform holistic care COVID19 patient investigation needed elucidate measuring frailty guide treatment prevention COVID19,
Estrogen Receptor Modulators Viral Infections SARSCoV2 Therapeutic Consequences,34207220,COVID19 pandemic respiratory disease caused SARSCoV2 coronavirus worldwide epidemiologic data showed higher mortality male compared female suggesting hypothesis protective effect estrogen severe disease progression ultimate end patient s death article summarizes current knowledge regarding potential effect estrogen modulators estrogen receptor COVID19 estrogen receptor activation show complex effect patient s organism influence cardiovascularpulmonaryimmune system includes lower production cytokine responsible cytokine storm receptorindependent effect directly inhibits viral replication Furthermore inhibits interaction IL6 receptor complex Interestingly addition natural hormone phytestrogens even synthetic molecule able interact estrogen receptor exhibit antiCOVID19 activity point view estrogen receptor modulators potential included antiCOVID19 therapeutic arsenal,covid-19;il-6;sars-cov-2;cytokine storm;estrogen;estrogen receptor;viral replication
Provider attitude satisfaction rapid preoperative pointofcare COVID19 testing using ID,34292525,PURPOSE Healthcare worker experienced high level anxiety COVID19 pandemic particularly caring patient unknown infection status trialled rapid preoperative pointofcare COVID19 testing using Abbott ID COVID19 clinical validation urgent surgical population single centre British Columbia Canada sought determine opinion belief operating room staff usefulness effectiveness pointofcare test workflow wellbeing METHODS descriptive study used mixedmethods crosssectional survey staff nurse anesthesiologist surgeon ancillary staff single centre using ID three month Outcomes interest included healthcare worker satisfaction ID effect workflow worry COVID19 transmission RESULTS overall response rate 56 n = 133 highest among anesthesiologist 100 n = 38 Respondents satisfied performance ID rapid COVID19 testing preoperative patient giving mean standard deviation SD rate 44 14 fivepoint scale 115128 90 recommended continued use ID asymptomatic patient active case COVID19 community Respondents felt preoperative COVID19 testing ID made safer staff mean SD rate 42 08 patient mean SD rate 40 09 CONCLUSION COVID19 pandemic important maintain physical mental wellbeing hospital staff Rapid pointofcare testing increased sense workplace safety improved morale reduced worry associated COVID19 without excessive disruption workflow,covid-19;healthcare provider morale;id now;point-of-care;satisfaction
Saliva Threat Opportunity Covid19 Pandemic,34290811,Covid19 pandemic continues world increasing number confirmed case performed test day day shown collecting nasopharyngeal sample commonly prefered method perform RTPCR disadvantage like causing discomfort bleeding patient Sample collecting procedure also render healthcare professional exposing risk transmission virus related direct contact patient disadvantage make procedure undesirable researcher force search alternative technique point saliva appears opportunity regarding high viral load hand high viral load pose threat especially profession dental practitioner much aerosol exposure Since dentistry branch health constantly need direct operation necessary protected virus much possible caring patient literature review done using electronic database `` PubMed `` Google Scholar `` Cochrane Database January 2021 Studies proposed many different preventive measure regard Therefore purpose review draw attention saliva bringing together recent research also provide information perspective dental clinician prevention potential diagnostic technique,covid-19;diagnostics;sars-cov-2;saliva
singledose J J vaccine 67 efficacy moderate severecritical COVID19 =14,34224270,SOURCE CITATION Sadoff J Gray G Vandebosch et al Safety efficacy singledose Ad26COV2S vaccine Covid19 N Engl J Med 2021 Epub ahead print 33882225,
Hypopharyngeal Ulcers COVID19 Histopathological Virological Analyses Case Report,34290701,coronavirus disease 2019 COVID19 ulcerative lesion episodically reported various segment gastrointestinal GI tract including oral cavity oropharynx esophagus stomach bowel report describe autopsy case COVID19 patient showed two undiagnosed ulcer level anterior posterior wall hypopharynx Molecular testing virus involved pharyngeal ulcer demonstrated presence severe acute respiratory syndrome coronavirus type 2 SARSCoV2 RNA together herpes simplex virus 1 DNA Histopathologic analysis demonstrated fullthickness lymphomonocytic infiltration mainly composed CD68positive cell hemorrhagic focus necrosis mucosal layer deep skeletal muscle fiber Fibrin platelet microthrombi also found Cytological sign HSV1 induced damage found Cells expressing SARSCoV2 spike subunit 1 immunohistochemically identified inflammatory infiltration Immunohistochemistry HSV1 showed general negativity inflammatory infiltration although presence positive cell Thus histopathological immunohistochemical molecular finding supported direct role SARSCoV2 producing local ulcerative damage although possible contributory role HSV1 reactivation excluded clinical perspective autopsy report two undiagnosed lesion put question ulcer along GI tract could common frequently neglected COVID19 patient,covid-19;hsv;gastrointestinal tract;histopathology;inflammation;molecular analysis;mucosal injury
Effect TrainInduced Wind Transmission COVID19 New Insight Potential Infectious Risks,34360459,unprecedented COVID19 pandemic caused traffic tieup across world addition home quarantine order travel ban social distance guideline six foot enacted reduce risk contagion However recent life gradually returning normal crisis research moving train test Gaussian puff model employed investigate impact wind raised train running transmission dispersion SARSCoV2 infected individual finding suggest 2 social distance guideline may enough traininduced wind action human respiratory diseasecarrier droplet may travel unexpected place However deficiency passenger safety guideline necessary improve quantitative research relationship traininduced wind virus transmission finding could provide fresh insight contain spread COVID19 provide basis preventing controlling pandemic virus probe strategy control disease future,covid-19;gaussian puff model;high-speed train;moving model test;train-induced wind
Application Telehealth Prenatal Care COVID19 PandemicA CrossSectional Survey Polish Women,34200723,reduce risk infection SARSCoV2 commuting clinic due contact medical staff American College Obstetricians Gynecologists recommended arranging appointment form `` telehealth aim study ass access medical care pregnancy SARSCoV2 pandemic role telehealth implementation prenatal care standard crosssectional study study group included 618 woman pregnant andor gave birth Poland COVID19 pandemic majority participant experienced difficulty accessing medical care pandemic correlation experience use hybrid healthcare model established affiliation public private healthcare irrelevant relationship healthcare privatepublic inpersonhybrid implementation prenatal care standard ensure safe access prenatal care pregnant woman recommendation hybrid pregnancy management model created detailed information regarding appointment patient must present inperson conducted remotely reduce risk associated movement interpersonal contact visit test screening take place conducted inperson appointment arranged form telehealth,covid-19;poland;sars-cov-2;cross-sectional studies;prenatal care;standard of care;telemedicine
Side effect antibody titer transition BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine Japan,34210623,BACKGROUND coronavirus disease COVID19 afflicted large population worldwide Although vaccine aroused great expectation side effect Japanese people antibody titer transition vaccination unclear METHODS side effect BNT162b2 mRNA COVID19 vaccine participant received vaccination center investigated participant also surveyed antibody titer transition RESULTS study 983 798 Japanese participant responded first second dos respectively Side effect occurred 757 770 715 participant 900 first second dos respectively Grade 4 side effect occurred second dose significantly side effect first dose p 0001 Side effect occurred second dose 571 female 921 178 male participant 801 Female participant higher incidence side effect male participant p 0001 comparison among age group showed significant difference p = 0018 frequency side effect decreased age Twentythree individual participated survey antibody titer transition second vaccine dose median antibody titer IgG IgM 376 007 AUmL respectively IgG IgM titer showed significant increase study period p 0001 CONCLUSIONS BNT162b2 mRNA COVID19 vaccine might safe Japanese people antibody titer increased two dos vaccination Larger nationwide study warranted verify finding,antibody titer;coronavirus disease;igg/igm antibody;side effect;vaccine
Early approval COVID19 vaccine Pros con,34283001,development safe effective vaccine overriding priority controlling 2019coronavirus disease COVID19 pandemic onset COVID19 caused high mortality economic loss yet also offered opportunity advance novel therapeutic DNA mRNA vaccine Although hoped swift acceptance vaccine prevent loss life rejuvenate economy restore normal life could also significant pitfall perspective provides overview future direction challenge advancing promising vaccine platform widespread therapeutic use,covid-19;dna;sars-cov-2;vaccine;mrna
Rapid Sensitive Detection Severe Acute Respiratory Syndrome Coronavirus 2 LabelFree Manner Using Micromechanical Sensors,34209484,Coronavirus COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 identified deadly pandemic genomic analysis SARSCoV2 performed using reverse transcriptionpolymerase chain reaction RTPCR technique identifying viral ribonucleic acid RNA infected patient However RTPCR diagnostic technique manually laborious expensive therefore readily accessible every laboratory Methodological simplification crucial combat ongoing pandemic introducing quick efficient affordable diagnostic method report microcantilever sensor offer promising opportunity rapid COVID19 detection first attempt capture singlestranded complementary DNA SARSCoV2 DNA hybridization Therefore microcantilever surface immobilized oligonucleotide probe detected using complementary target DNA hybridization shift microcantilever resonance frequency result show microcantilever sensor discriminate complementary noncomplementary target DNA micro nanoscale Additionally microcantilever sensor aptitude toward partial complementary DNA determines potential identify new variant coronavirus Therefore microcantilever sensing could vital tool effort extinguish spreading COVID19 pandemic,dna hybridization;sars-cov-2 detection;dynamic mode;microcantilever sensor
Randomised controlled open label multicentre clinical trial explore safety efficacy hyperbaric oxygen preventing ICU admission morbidity mortality adult patient COVID19,34226219,INTRODUCTION COVID19 may cause severe pneumonitis trigger massive inflammatory response requires ventilatory support intensive care unit ICU mortality reported high 62 Dexamethasone antiinflammatory drug tested date shown positive effect mortality aim explore treatment hyperbaric oxygen HBO safe effective patient severe COVID19 hypothesis HBO prevent ICU admission morbidity mortality attenuating inflammatory response primary objective evaluate HBO reduces number ICU admission compared best practice treatment COVID19 main secondary objective evaluate HBO reduces load ICU resource morbidity mortality evaluate HBO mitigates inflammatory reaction COVID19 METHODS ANALYSIS randomised controlled phase II open label multicentre trial 200 subject severe COVID19 least two risk factor mortality included Baseline clinical data blood sample collected randomisation repeated daily 7 day day 14 30 Subjects randomised computerbased system HBO maximum five time first 7 day plus best practice treatment best practice treatment primary endpoint ICU admission defined criterion selection ICU evaluate HBO mitigates inflammatory reaction COVID19 using molecular analysis parameter recorded electronic case report form independent Data Safety Monitoring Board review safety parameter ETHICS DISSEMINATION trial approved National Institutional Review Board Sweden 202001705 Swedish Medical Product Agency 51202036673 Positive negative inconclusive result published peerreviewed scientific journal open access TRIAL REGISTRATION NCT04327505 EudraCT number 202000134937,covid-19;immunology;infectious diseases;intensive & critical care;thoracic medicine
Significant Inactivation SARSCoV2 Vitro Green Tea Catechin CatechinDerivative Black Tea Galloylated Theaflavins,34208050,Potential effect tea constituent SARSCoV2 infection assessed vitro Infectivity SARSCoV2 decreased 1100 undetectable level treatment black tea green tea roasted green tea oolong tea 1 min addition epigallocatechin gallate EGCG significantly inactivated SARSCoV2 concentration theasinensin TSA galloylated theaflavins including theaflavin 33diOgallate TFDG remarkable antiviral activity EGCG TSA TFDG 1 mM 40 microM 60 microM respectively comparable concentration compound tea beverage significantly reduced infectivity virus viral RNA replication cell secondary virus production cell EGCG TSA TFDG significantly inhibited interaction recombinant ACE2 RBD protein result suggest potential usefulness tea prevention persontoperson transmission novel coronavirus,covid-19;catechin;novel coronavirus;polyphenol;tea;theaflavin
prolonged effect COVID19 new `` threat,34286502,Coronavirus longhaulers currently represent significant public health concern Recent report suggest persistent effect COVID19 fatigue dyspnea chest pain anxiety depression arthralgia may last month lead decline quality life Risk factor long COVID still well understood Survivors suffer ongoing symptom new entity highlight need multidisciplinary approach would enable closer monitoring affected patient implementation measure could reduce impact pandemic overall patient wellbeing resolution acute symptom,
emergence transmission COVID19 European country 20192020 comprehensive review timeline case containment,34333650,emerged late 2019 COVID19 carried via traveler Germany France Italy freedom movement accelerated transmission throughout Europe However effective nonpharmaceutical intervention introduced European government led containment rapid increase case within European nation Electronic search performed obtain number confirmed case incident rate nonpharmaceutical government measure European country spread impact nonpharmaceutical intervention throughout Europe assessed visualized Specifically heatmaps used represent number confirmed case incident rate country time addition map created showing number confirmed case incident rate Europe three different date 15 March 15 April 15 May 2020 allowed u ass geographic temporal pattern disease,covid-19;europe;sars-cov-2;non-pharmaceutical interventions;pandemic
Benefits early use highflownasalcannula HFNC patient COVID19 associated pneumonia,34218943,INTRODUCTION Severe COVID19 associated hypoxemic bilateral pneumonia lead mechanical ventilation considerable proportion patient best knowledge recommendation best time initiate high flow nasal cannula HFNC PATIENTS METHODS Retrospective study patient admitted COVID19 pneumonia required HNFO March 2020 February 2021 Patients grouped early HNFC late HNFC according modified Kirby index RESULTS 53 patient included Fortyfour included early HFNC 9 late HNFC statistically significant clinicalepidemiological difference Early use HFNC associated decrease need intubation 295 vs 666 p = 0044 hospital stay 188 vs 36 p = 0022 mortality 227 vs 555 p = 0061 CONCLUSIONS Early HFNC use associated decrease need intubation mortality overall hospital stay,covid-19;hnfc;kirby index;neumonia;onaf;pneumonia;indice de kirby
Fusobacterium nucleatum alteration oral microbiome pregnancy SARSCOV2 infection,34286500,OBJECTIVE human evolved close symbiosis ecological community commensal symbiotic pathogenic bacteria intestinal microbiome oral cavity largest diversified importance reflected local systemic disease also pregnancy since would seem influence placental microbiome MATERIALS METHODS literature review article published PubMed Fusobacterium Nucleatum implication systemic oral health adverse pregnancy outcome flavor perception interference oralnasal mucosal immunity RESULTS maintaining microbiome s homeostasis Fusobacterium nucleatum opportunistic periodontal pathogen oral cavity play crucial role bridge microorganism tongue biofilm maintaining balance different specie oralnasal mucosal immunity also taste receptor interaction also involved flavor perception detection oral microbiome child first day life suggests possible physiological role However dysbiosis determine pathogenicity local systemic consequence including pathogenesis respiratory infection CONCLUSIONS interesting evaluate possible correlation SarsCoV2 consequence microflora oral cavity promote possible broadspectrum preventive action favor subject promoting eubiosis oral microbiome defensive action could envisaged commensal patient specific comorbidities therefore already prone oral dysbiosis,
Gammairradiated SARSCoV2 vaccine candidate OZG38613 confers protection SARSCoV2 challenge human ACEIItransgenic mouse,34349145,SARSCoV2 virus caused severe pandemic around world vaccine development urgent use became crucial issue Inactivated virus formulated vaccine Hepatitis smallpox proved reliable approach immunization prolonged period study gammairradiated inactivated virus vaccine require extra purification process unlike chemically inactivated vaccine Hence novelty vaccine candidate OZG38613 nonadjuvant added gammairradiated intradermally applied inactive viral vaccine Efficiency safety dose either 10 13 10 14 viral RNA copy per dose OZG38613 initially determined BALBc mouse followed testing immunogenicity protective efficacy vaccine Human ACE2encoding transgenic mouse immunized infected SARSCoV2 virus challenge test study show vaccinated mouse lowered SARSCoV2 viral RNA copy number oropharyngeal specimen histological analysis lung tissue along humoral cellular immune response including neutralizing antibody similar shown BALBc mouse without substantial toxicity Subsequently plan made commencement Phase 1 clinical trial OZG38613 vaccine COVID19 pandemic,
SARSCoV2 Threat Marine Mammals Study Italian Seawaters,34204885,Zoonotically transmitted coronaviruses responsible Severe Acute Respiratory Syndrome Coronavirus2 SARSCoV2 causing dramatic Coronavirus Disease2019 CoViD19 pandemic affected public health economy society global scale impact SARSCoV2 pandemic permeated environment wildlife well particular concern raised viral occurrence persistence aquatic marine ecosystem discharge untreated wastewater carrying infectious SARSCoV2 natural water system home sea mammal may dramatic consequence vulnerable specie efficient transmission coronaviruses raise question regarding contribution virusreceptor interaction main receptor SARSCoV2 Angiotensin Converting Enzyme2 ACE2 serving functional receptor viral spike protein study aimed comparative analysis ACE2 receptor human one assessing susceptibility SARSCoV2 different specie marine mammal living Italian water also determined mean immunohistochemistry ACE2 receptor localization lung tissue different cetacean specie order provide preliminary characterization ACE2 expression marine mammal respiratory tract Furthermore evaluate Italian wastewater management coastal exposition extreme weather event may led susceptible marine mammal population exposed SARSCoV2 geomapping data carried overlapped result showed potential SARSCoV2 exposure marine mammal inhabiting Italian coastal water putting risk swimming feeding specific risk area Thus highlighted potential hazard reverse zoonotic transmission SARSCoV2 infection along impact marine mammal regularly inhabiting Mediterranean Sea also stressing need appropriate action order prevent damage specific vulnerable population,ace-2;italian wastewater management species;sars-cov-2;marine mammals
SARSCoV2 Variants Synopsis Vitro Efficacy Data Convalescent Plasma Currently Marketed Vaccines Monoclonal Antibodies,34201767,summarize vitro evidence efficacy convalescent plasma currently approved vaccine monoclonal antibody SARSCoV2 variant concern VOC B117 B1351 P1 B16172 variant interest VOI B1427B1429 P2 B1525 P3 B1526 B16711 strain B11298 B1258delta waiting real world clinical efficacy data provide guidance treating physician,covid-19;lycov016;regn10987;sars-cov-2;convalescent plasma;etesevimab;imdevimab;immune escape;mutations;neutralizing antibody
Protocol Cologne Corona Surveillance CoCoS Study prospective populationbased cohort study,34215236,BACKGROUND Surveillance strategy critical cope current SARSCoV2 pandemic evaluate well adjust governmentimposed countermeasure Incidence estimate widely based laboratory confirmed case reported health authority Prevalence incidence data SARSCoV2 still scarce along demographic behavioural factor associated infection risk METHODS Cologne Corona Surveillance Study conducted City Cologne fourthlargest city Germany population approximately 11 million Researchers apply selfsampling surveillance rolling cohort Cologne resident Random sample 6000 Cologne resident 18 year age older drawn registration office Upon receiving information saliva sample kit participant asked fill questionnaire online via phone sign written informed consent send back written consent well saliva sample saliva sample tested SARSCoV2 reverse PCR questionnaire administered gather information personal characteristic health status risk second round testing take place 6 week first DISCUSSION Selfadministered saliva sampling proved legitimate feasible alternative nasopharyngeal swab taken health professional However unclear whether targeted response rate 40 achieved whether result representative population TRIAL REGISTRATION DRKSde German Clinical Trials Register DRKS Identifier DRKS00024046 Registered 25 February 2021,covid-19;coronavirus;pandemic;risk behaviours;rolling cohort;socio-economic factors;surveillance
Selfassembling synthetic nanoadjuvant scaffold crosslink B cell receptor represent new platform technology therapeutic antibody production,34348905,Host antibody response pivotal providing protection infectious agent pioneered new class selfassembling micelle based pentablock copolymer enhance antibody response providing low inflammatory environment compared traditional adjuvant type `` justright immune response critical rational design vaccine older adult report mechanism enhancement antibody response pentablock copolymer micelle act scaffold antigen presentation B cell crosslink B cell receptor unlike micelleforming synthetic block copolymer exploited unique mechanism developed scaffold platform technology produce antibody vitro show novel approach used generate laboratoryscale quantity therapeutic antibody multiple antigen including associated SARSCoV2 Yersinia pestis expanding value nanomaterials rapidly develop countermeasure infectious disease,
Respiratory care critical patient 2019 novel coronavirus,34218168,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 transmitted respiratory droplet aerosol close contact Cross infection occur virus spread rapidly among human Nineteen percent 19 infected patient developed severe pneumonia acute respiratory distress syndrome ARDS Hypoxemia usually occurs patient may require oxygen therapy mechanical ventilation MV support article recently published clinical experience observational study reviewed Corresponding respiratory therapy regarding different stage infection proposed Infection control principle respiratory strategy including oxygen therapy noninvasive respiratory support NIRS intubation evaluation equipment preparation ventilator setting special maneuver comprise prone position PP recruitment maneuver RM extracorporeal membrane oxygenation ECMO weaning extubation summarized Respiratory equipment device disinfection recommendation worked expect review article could used reference healthcare worker patient care minimizing risk environmental contamination,2019 severe acute respiratory syndrome coronavirus 2 (sars-cov-2);coronavirus disease 2019 (covid-19);infection control;mechanical ventilation;oxygen therapy;respiratory care
impact repeated mass antigen testing COVID19 prevalence disease,34219976,absence effective vaccination mass testing quarantining positive case contact could help mitigate pandemic allow economy stay open investigate effect repeated mass testing COVID19 pandemic caused SARSCoV2 virus using data first ever nationwide rapid antigen testing implemented Slovakia autumn 2020 first round testing district ex ante unknown threshold test positivity retested Comparing district threshold provide evidence repeated mass antigen testing temporarily reduce number new infection result suggest mass testing coupled quarantining positive case contact could effective tool mitigating pandemic lasting effect retesting regular interval would likely necessary,antigen testing;covid-19;covid-19 policies;mass testing;non-pharmaceutical interventions
Shedding light toxicity SARSCoV2 peptide aquatic biota study involving neotropical mosquito larva Diptera Culicidae,34333265,Knowledge COVID19 pandemic affect aquatic wildlife still extremely limited effect SARSCoV2 structural constituent invertebrate model reported far Thus investigated presence 2019new coronavirus different urban wastewater sample later evaluated behavioral biochemical effect exposure Culex quinquefasciatus larva two SARSCoV2 spike protein peptide PSPD2002 PSPD2003 synthesized laboratory Initially result show contamination wastewater new coronavirus via RTqPCR viral N1 gene hand study show shortterm exposure 48 h low concentration 40 mugL synthesized peptide induced change locomotor olfactorydriven behavior C quinquefascitus larva associated increased production ROS AChE activity cholinesterase effect knowledge first study report indirect effect COVID19 pandemic larval phase freshwater invertebrate specie result raise concern ecological level observed biological effect may lead drastic consequence,contamination;developmental toxicity;insects;peptides;sars-cov-2;water
Advanced Research Development Face Masks Respirators Pre Post Coronavirus Disease 2019 COVID19 Pandemic Critical Review,34207184,outbreak COVID19 pandemic 2020 accelerated need personal protective equipment PPE mask one method reduce andor eliminate transmission coronavirus across community Despite availability different coronavirus vaccine still recommended Center Disease Control Prevention CDC World Health Organization local authority apply public safety measure including maintaining social distancing wearing face mask includes individual fully vaccinated Remarkable increase scientific study along manufacturingrelated research development investigation performed attempt provide better PPE solution pandemic Recent literature estimated filtration efficiency FE face mask respirator shedding light specific targeted parameter investigator measure detect evaluate provide reliable data consistent result review showed variability testing protocol FE evaluation method different face mask material andor brand addition safety requirement needed perform aerosol viral filtration test one main challenge researcher currently face inability simulate mimic true aerosol filtration scenario via laboratory experiment field test vitroin vivo investigation Moreover FE mask influenced different filtration mechanism environmental parameter filtration material property number layer used packing density fiber charge density fiber diameter aerosol type particle size aerosol face velocity concentration loading infectious concentration generated due different human activity parameter fully understood constrain design production efficacy efficiency face mask,sars-cov-2;aerosol;coronavirus;filtration;personal protection equipment
Management proximal femur fracture elderly current concept treatment option,34348796,one leading cause elderly patient hospitalisation proximal femur fracture PFFs present increasing socioeconomic problem near future result demographic change expressed increasing proportion elderly people society Perioperative management must handled attentively avoid complication decrease mortality rate deal exceptional need elderly development orthogeriatric centre support orthogeriatric comanagement mandatory Adequate pain medication balanced fluid management delirium prevention operative treatment choice based comorbidities individual demand biological rather chronological age deserve particular attention improve patient outcome operative management intertrochanteric subtrochanteric fracture favour intramedullary nailing femoral neck fracture Garden classification used differentiate nondisplaced displaced fracture Osteosynthesis suitable biologically young patient nondislocated fracture whereas total hip arthroplasty hemiarthroplasty main option biologically old patient displaced fracture bedridden patient osteosynthesis might option establish transferability bed chair restroom Postoperatively patient benefit early mobilisation early geriatric care COVID19 pandemic prolonged time surgery thus increased rate complication took toll frail patient PFFs review aim offer surgical guideline treatment PFFs elderly focus pitfall challenge particularly relevant frail patient,delirium prevention;frailty;garden classification;surgical management
impact 2009 influenza pandemic seasonality human respiratory syncytial virus systematic analysis,34219389,BACKGROUND Several local study showed 2009 influenza pandemic delayed RSV season However globallevel analysis available possible impact 2009 influenza pandemic RSV season OBJECTIVES aim understand impact 2009 influenza pandemic RSV season METHODS compiled data published literature systematic review online reportsdatasets previously published data global RSV seasonality conducted globallevel systematic analysis impact 2009 influenza pandemic RSV seasonality RESULTS included 354 season 45 unique site 26 country Globally influenza pandemic delayed onset first RSV season 058 month average 95 CI 042 073 maximum delay 25 month onset second RSV season lesser extent 025 month 95 CI 012 039 maximum delay 34 month delayed onset observed third RSV season delayed onset pronounced northern temperate followed southern temperate least pronounced tropic CONCLUSIONS 2009 influenza pandemic delayed RSV onset average 058 month 25 month suggests evidence viral interference well impact public health measure important implication preparedness RSV season ongoing COVID19 pandemic future pandemic,covid-19;influenza virus;pandemic;respiratory syncytial virus;seasonality
AntiSARSCoV2 Repurposing Drug Database Clinical Pharmacology Considerations,34218521,critical step evaluate potential vivo antiviral activity drug connect vivo exposure vitro antiviral activity AntiSARSCoV2 Repurposing Drug Database database includes vitro antiSARSCoV2 activity vivo pharmacokinetic data facilitate extrapolation vitro antiviral activity potential vivo antiviral activity large set drugscompounds addition serving data source vitro antiSARSCoV2 activity vivo pharmacokinetic information database also calculation tool used compare vitro antiviral activity vivo drug exposure identify potential antiSARSCoV2 drug Continuous development expansion feasible public availability database,
Monitoring new coronavirus SARSCoV2 Origin transmission food preservation method,34219846,Unfortunately limited research coronavirus survival food product also food processing knowledge physical chemical characteristic coronaviruses mostly come study SARSCoV MERSCoV physical ie thermal processing chilling freezing microwave irradiation ultraviolet light gamma irradiation high hydrostatic pressure chemical acidification use common disinfectant food industry like chlorinated derivative ozone mean could used inactive coronaviruses reduce infection method applied individually combination act better performance Thermal processing one effective method inactive coronavirus Heating 75 degree C 1560 min 65 degree C 1 min best temperature inactive SARSCoV MERS virus respectively Among irradiation method microwave UV gamma effective one UVC ray Moreover use disinfectant like chlorinated derivative appropriate way disinfect food product surface Novelty impact statement review provided updated information effective strategy inactive coronavirus used food industry SARSCoV2 new pandemic coronavirus initiated contaminated food transmitted close contact aerosol food surface Food preservation physical chemical method could decrease SARSCoV2 Probably heating UVC effective approach inactive SARSCoV2 Despite finding coronavirus inactivation discussed much research still needed development new approach overcome coronavirus,
Hashimoto s thyroiditis following SARSCoV2 infection,34373245,Infectious disease long considered one trigger autoimmune autoinflammatory disease Since appearance new coronavirus December 2019 city Wuhan China many report suggesting infection coronavirus 2 SARSCoV2 precedes appearance several autoimmune autoinflammatory disease describe case report patient infected SARSCoV2 virus later developed picture Hashimoto s thyroiditis,covid-19;endocrine system
ENDOCRINOLOGY TIME COVID19 2021 update Management Diabetes insipidus Hyponatraemia,34292875,COVID19 changed nature medical consultation emphasizing virtual patient counseling relevance patient diabetes insipidus DI hyponatremia main complication desmopressin treatment DI dilutional hyponatraemia Since plasma sodium monitoring always possible time COVID19 recommend delay desmopressin dose week aquaresis occurs allowing excess retained water excreted Patients measure body weight daily Patients DI admitted hospital COVID19 high risk mortality due volume depletion Specialists must supervise fluid replacement dosing desmopressin Patients pituitary surgery drink thirst measure body weight daily early recognize development postoperative SIAD know hyponatraemia symptom Hyponatraemia COVID19 common prevalence 20 30 mostly due SIAD hypovolemia mirror disease severity early predictor mortality Hypernatraemia may also develop COVID19 patient prevalence 35 especially ICU derives different multifactorial reason eg due insensible water loss pyrexia increased respiration rate use diuretic Hypernatraemic dehydration may contribute high risk acute kidney injury COVID19 IV fluid replacement administered caution severe case COVID19 risk pulmonary oedema,
Investigating potential mechanism depression inducedby COVID19 infection patient,34373041,new coronavirus COVID19 emerged world pandemic SARSCoV2 infection cause variant common symptom dry cough tiredness dyspnea fever myalgia chill headache chest pain conjunctivitis Different organ may affected COVID19 respiratory system gastrointestinal tract kidney CNS However information COVID19 infection CNS insufficient know virus enter central nervous system CNS via different route causing symptom dizziness headache seizure loss consciousness depression Depression common disorder among neurological symptom following COVID19 infection although mechanism COVID19induced depression yet clear aim present study investigate probable mechanism COVID19induced depression reason depression infected patient may due social pathological factor including social quarantine economic problem stress change HPA axis inflammation due entry proinflammatory cytokine CNS production inflammatory cytokine microglia mitochondrial disorder damage hippocampus malnutrition evaluating different factor involved COVID19induced depression concluded depression minimized controlling stress preventing cytokine storm appropriate antiinflammatory drug proper nutrition,covid-19;depression;stress
Personal Protective Equipment Adherence Pediatric Resuscitation Team Members COVID19 Pandemic,34353649,STUDY OBJECTIVE COVID19 pandemic health care worker highest risk infection among essential worker Although personal protective equipment PPE use associated lower infection rate appropriate use PPE variable among health care worker even setting COVID19 patient aimed evaluate pattern PPE adherence emergency department resuscitation included aerosolgenerating procedure METHODS conducted retrospective videobased review pediatric resuscitation involving one aerosolgenerating procedure first 3 month COVID19 pandemic United States March June 2020 Recommended adherence complete inadequate absent 5 PPE item headwear eyewear mask gown glove duration potential exposure evaluated individual room aerosolgenerating procedure initiation RESULTS Among 345 health care worker observed 19 resuscitation 306 887 nonadherent inadequate absent adherence recommended use least 1 PPE type time resuscitation 23 67 PPE One hundred forty health care worker 406 altered removed least 1 type PPE event aggregate time resuscitation room health care worker across event 1187 hour time provider either absent inadequate eyewear 464 hour 391 absent inadequate mask 352 hour 297 CONCLUSION Full adherence recommended PPE use limited setting increased risk SARSCoV2 virus aerosolization addition ensuring appropriate donning approach needed ensuring ongoing adherence PPE recommendation exposure,
Efficacy combined Sofosbuvir Daclatasvir treatment COVID19 patient pneumonia multicenter Egyptian study,34225541,BACKGROUND Limited experimental clinical evidence suggests potential role sofosbuvirdaclatasvir treating COVID19 aim evaluate efficacy generic sofosbuvirdaclatasvir treating COVID19 patient pneumonia RESEARCH DESIGN METHODS multicenter prospective study involved 174 patient COVID19 Patients randomized two group Group 96 patient received sofosbuvir 400 mg daclatasvir 60 mg 14 day combination conventional therapy Group B 78 patient received conventional therapy alone Clinical laboratory radiological data collected baseline 7 14 28 day therapy Primary endpoint rate clinicalvirological cure RESULTS lower mortality rate observed group 14 v 21 P = 007 1 month therapy difference found rate ICU admission oxygen therapy ventilation Additionally statistically significant shorter duration hospital stay 9 v 12 P 001 faster achievement PCR negativity day 14 84 versus 47 P 001 noticed group CONCLUSION Adding sofosbuvirdaclatasvir conventional therapy COVID19 promising use associated shorter hospital stay faster PCR negativity may reduced mortality,covid-19;daclatasvir;sofosbuvir;efficacy;safety
Association HLA genotype COVID19 susceptibility severity progression comprehensive review literature,34344463,COVID19 pandemic markedly impacted cultural political economic structure world Several aspect pathogenesis related clinical consequence yet elucidated Infection rate well morbidity mortality differed within country intriguing scientist understand patient genetics may influence outcome condition clarify aspect could related clinical variability SARSCoV2 disease reviewed study exploring role human leukocyte antigen HLA genotype individual response SARSCoV2 infection andor progression discussing also contribution immunological pattern MHCrelated March 2021 main online database accessed article investigated possible association HLA genotype related polymorphism susceptibility severity progression COVID19 considered Although genetic environmental factor certainly expected influence susceptibility protection individual HLA related polymorphism influence susceptibility progression severity SARSCoV2 infection crucial role played HLA molecule immune response especially pathogenderived peptide presentation huge molecular variability HLA allele human population could responsible different rate infection different patient following COVID19 infection,covid-19;genotypes;hla;haplotypes;mhc;polymorphisms;sars-cov-2
Machine Learning Approach Aid Early COVID19 Detection,34207437,novel coronavirus SARSCoV2 cause disease COVID19 forced u go home limit physical interaction others Economies around world come halt nonessential business forced close order prevent propagation virus Developing country difficulty due lack access diagnostic resource study present approach detecting COVID19 infection exclusively basis selfreported symptom approach great interest relatively inexpensive easy deploy either individual population scale best model delivers sensitivity score 0752 specificity score 0609 area curve receiver operating characteristic 0728 promising result justify continuing research effort towards machine learning test detecting COVID19,covid-19 detection;sars-cov-2;machine learning;symptoms-based test
Progression myopia natural cohort Chinese child COVID19 pandemic,34287693,PURPOSE determine myopia progression child COVID19 related factor associated myopia METHODS subject underwent threetimepoint ocular examination measured July 2019 January August 2020 compared change uncorrected visual acuity UCVA mydriatic spherical equivalent SE axial length AL two period COVID19 questionnaire performed investigate risk factor myopia RESULTS Compared COVID19 mean SD myopia progression COVID19 significantly higher right eye 093 065 vs 033 047 p 0001 However difference UCVA change axial elongation two period clinically insignificant logistic regressive analysis found difference SE change associated baseline AL P = 0028 95 confidence interval CI 1058 2632 online education P = 002 95 CI 1587 8665 time digital screen p 0005 95 CI 1587 4450 CONCLUSIONS Children higher risk myopia progression COVID19 associated baseline AL longtime online learning digital screen reading,covid-19;mydriatic spherical equivalent;myopia progression
Development Rheumatology Informatics System Effectiveness Learning Collaborative Improving PatientReported Outcome Collection PatientCentered Communication Adult Rheumatology,34288595,OBJECTIVE Patientreported outcome PROs integral part treattotarget approach managing rheumatoid arthritis RA clinical practice however routine collection documentation discussion PROs patient highly variable RISE LC Rheumatology Informatics System Effectiveness Learning Collaborative established develop share best practice PRO collection use across adult rheumatology practice United States METHODS goal RISE LC developed site survey inperson meeting Participants completed baseline survey PRO collection use practice RISE LC learning session focused improving communication around PROs patient enhancing shared decisionmaking treatment plan coronavirus disease 2019 COVID19 pandemic RISE LC pivoted adapt PRO tool telehealth RESULTS baseline responding site n = 15 established workflow collecting PROs site used paper form alone PRO documentation electronic health record variable half site using structured data field standardize improve use PROs participant iteratively developed Clinical Disease Activity Indexbased RA Disease Activity Communication Tool solicit treatment goal improve shared decisionmaking across site COVID19 pandemic necessitated developing tool gauge PROs via telehealth CONCLUSION RISE LC continuous structured method implementing strategy improve PRO collection use rheumatological care initially adapting Learning Collaborative model extending include feature learning network Future direction include measuring impact standardized PRO collection discussion shared decisionmaking RA outcome,
Antibacterial use age SARSCoV2,34223134,Background Balancing use antibacterial therapy selection resistance pandemic era introduced question guideline project explored prescription empirical antibacterial therapy differs without SARSCoV2 infection Methods Multivariable logistic regression used determine whether COVID19 status factor play role prescription antibacterial therapy inpatient setting large referral academic medical centre analysis conducted determine whether factor differ testing positive negative SARSCoV2 Results 405 patient cohort 175 received antibacterial therapy 296 tested positive SARSCoV2 positive SARSCoV2 test carried 03 95 CI 019 049 receiving antibacterial treatment first 48 h admission P 00001 adjusting age procalcitonin result Patients 1 3 le likely receive antibacterial every year increase age overall group among testing negative SARSCoV2 respectively Younger age found impact use antibacterial therapy overall analysis well SARSCoV2 negative subgroup P = 003 P = 001 High procalcitonin value found associated increased antibacterial therapy use overall stratified analysis Conclusions Antibacterial therapy prescription differs COVID19 disease status procalcitonin result highly associated antibacterial use across stratum,
Evaluation Clinical Decision Support Strategy Increase Seasonal Influenza Vaccination Among Hospitalized Children Inpatient Discharge,34292335,Importance Hospitalized child increased risk influenzarelated complication yet influenza vaccine coverage remains low among group Evidencebased strategy vaccination vulnerable child health care visit especially important COVID19 pandemic Objective design evaluate clinical decision support CDS strategy increase proportion eligible hospitalized child receive seasonal influenza vaccine prior inpatient discharge Design Setting Participants quality improvement study conducted among child eligible seasonal influenza vaccine hospitalized tertiary pediatric health system providing care half million patient annually 3 hospital study used sequential crossover design control intervention compared hospitalization intervention group 20192020 season use intervention order set concurrent control 20192020 season without use intervention order set historical control 20182019 season use order set underwent intervention 20192020 season Interventions CDS intervention developed usercentered design process including 1 placing default influenza vaccine order admission order set eligible patient 2 script offer vaccine using presumptive strategy 3 justintime education clinician addressing vaccine eligibility influenza order group link reference material intervention rolled stepwise fashion 20192020 influenza season Main Outcomes Measures Proportion eligible hospitalization 1 influenza vaccine administered prior discharge Results Among 17740 hospitalization 9295 boy 52 mean SD age 80 60 year patient predominantly Black n = 8943 50 White n = 7559 43 mostly public insurance n = 11274 64 10997 hospitalization eligible influenza vaccine 20192020 season 5449 50 intervention group 5548 50 concurrent control 6743 eligible hospitalization 20182019 served historical control Vaccine administration rate 31 n = 1676 intervention group 19 n = 1051 concurrent control 14 n = 912 historical control P 001 adjusted analysis odds receiving influenza vaccine 325 95 CI 294359 time higher intervention group 128 95 CI 115142 time higher concurrent control historical control Conclusions Relevance quality improvement study suggests usercentered CDS may associated significantly improved influenza vaccination rate among hospitalized child Stepwise implementation CDS intervention practical method used increase quality improvement rigor comparison historical concurrent control,
Obesity major risk factor immunity severe outcome COVID19,34350941,influenzalike virus named SARSCoV2 responsible COVID19 disease spread worldwide within short time COVID19 become significant concern public health Obesity highly prevalent worldwide considered risk factor impairing adaptive immune system Although diabetes hypertension cardiovascular disease renal failure considered risk factor COVID19 obesity yet wellconsidered study approach establishing systemic association prevalence obesity impact immunity concerning severe outcome COVID19 utilizing existing knowledge Overall study outcome documented worldwide prevalence obesity effect immunity possible underlying mechanism covering obesityrelated risk pathway severe outcome COVID19 Overall understanding present study immune system impairing factor role obesity severe outcome COVID19 worthy,ace-2;covid-19;immunity;morbidity;obesity;sars-cov-2
Impact twodose varicella immunization program incidence varicella multiyear observational study Shanghai China,34343035,BACKGROUND remains hesitant include twodose varicella vaccine VarV national routine immunization program China aimed quantify impact twodose VarV varicella incidence Shanghai RESEARCH DESIGN METHODS directly extracted data varicella case VarV dos 20132020 Shanghai estimated effect twodose VarV using Serfling model RESULTS twodose VarV immunization program extensively implemented since October 2017 become free since August 2018 Shanghai program varicella case significantly declined child P 001 whereas adult aged 18 year P = 022 Compared predicted number varicella case actual number significantly lower 8 2018 28 2019 Among child aged 46 year reduction varicella case largest Moreover significant reduction varicella case throughout 2020 P 0001 decrease due social distancing COVID19 54 CONCLUSIONS twodose VarV immunization program may reduce approximately onethird varicella case Shanghai Children 4 year adult benefit le program warrant enhancing immunization,varicella;immunization program;serfling model;varicella vaccine;varicella-zoster virus
Role Conversational Agents Substance Use Disorder Social Distancing Contexts,34286669,COVID19 pandemic related policy social distancing order affecting ability people substance use disorder SUD seek prevention treatment commentary introduce conversational agent type social technology discus role conversational agent prevention treatment SUD social distancing context potential benefit limitation designing implementing technology prevention care patient SUD,conversational agent;addiction;public health;substance use
Case report cerebral sinus venous thrombosis COVID19 patient,34220192,Background Coronavirus disease 2019 COVID19 pandemic started December 2019 still ongoing disease expanding rapidly high variety phenotype asymptomatic mild respiratory tract infection multiple organ system dysfunction death Neurological manifestation also appear patient COVID19 headache seizure decrease consciousness paralysis hypercoagulable state patient COVID19 associated thromboembolic incident including ischemic stroke venous thromboembolism pulmonary artery embolism many Cerebral sinus venous thrombosis CSVT rare neurovascular emergency often found critically ill patient report two case CSVT different onset neurologic manifestation prognosis Case presentation Two case cerebral sinus venous thrombosis COVID19 patient reported following respiratory hematology coagulation disarrangement triggered severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection first patient presented seizure hypertension diabetes mellitus comorbidities latter case comorbidity showed severe presentation COVID19 brain lung thrombosis although already several day intravenous anticoagulant administration two case also different course disease outcome interesting topic study Conclusions CSVT one neurological complication COVID19 brainstem venous drainage involved Despite successful alteration negative result SARSCoV2 rtPCR test thrombogenesis coagulation cascade continuing Therefore high level neutrophil lymphocyte ratio NLR Ddimer fibrinogen Creactive protein CRP paramount indicator poor prognosis,covid 19;csvt;coagulation cascade;thrombogenesis
Supporting Breastfeeding 2021 BeyondLessons Pandemic,34205900,COVID19 pandemic affected maternal infant health globally directly infection SARSCoV2 virus indirectly change health care resulting social economic health care policy unique country developing country share disproportionate burden maternal infant health review discus uncertainty resulting SARSCoV2 infection pregnancy vertical transmission virus effect breastfeeding newborn problem family community caring mother COVID19 impact breastfeeding newborn discussed challenge posed pandemic forced u think devise innovative solution including telemedicine help antenatal counseling breastfeeding education lactation support Optimal utilization resource technology find creative solution individual community level help facilitating maternalinfant bonding soon birth Appropriate health care policy support pregnant lactating mother go long way meeting healthy child development goal,breastfeeding during pandemic;breastfeeding future;lactation support;paid parental leave;supporting breastfeeding;telelactation
Lessons field delivering trachoma mass drug administration safely COVID19 context,34291283,first coronavirus disease 2019 COVID19 interim guidance released World Health Organization recommended suspension nonurgent community health intervention including mass drug administration MDA neglected tropical disease However end sight COVID19 pandemic crucial find way restart MDA testing measure reduce risk COVID19 transmission health worker volunteer community Consequently guideline developed delivering MDA safely COVID19 context training implementation assessed observation checklist study also gathered data feasibility using MDA platform disseminate COVID19 health education result suggest delivering MDA safely COVID19 context possible revealed significant challenge using MDA platform COVID19 education,covid-19 context;mass drug administration;neglected tropical diseases;trachoma
Social Distancing Policy Effective Controlling COVID19 Interrupted Time Series Analysis,34223186,Introduction social distancing plan one way implemented management COVID19 pandemic study aimed evaluate effect social distancing reducing daily new case death COVID19 Methods crosssectional study data daily new case daily death collected 15022020 19042020 Changes level trend daily new case daily death implementation social distancing plan evaluated using interrupted time series analysis STATA software Results postintervention trend decrease 102 new case per day 7 new death per day compared preintervention trend p 0001 Moreover postintervention period daily new case decrease 58 new case per day 2 new death per day p 0001 Conclusion Could concluded social distancing plan directly affect new daily case new daily death,covid-19;iran;physical distancing;incidence;interrupted time series analysis
Brief Overview Potential Treatments Viral Diseases Using Natural Plant Compounds Case SARSCov,34202844,COVID19 pandemic well general global increase viral disease led researcher look plant kingdom potential source antiviral compound Since ancient time herbal medicine extensively applied treatment prevention various infectious disease different traditional system purpose review highlight potential antiviral activity plant compound effective reliable agent viral infection especially virus coronavirus group Various antiviral mechanism shown crude plant extract plantderived bioactive compound discussed understanding action mechanism complex plant extract isolated plantderived compound help pave way towards combat lifethreatening disease molecular docking study silico analysis extracted compound future prospect included vitro production antiviral chemical compound plant using molecular pharming also considered Notably hairy root culture represent promising sustainable way obtain range biologically active compound may applied development novel antiviral agent,bioactive compounds;coronavirus;hairy roots;herbal medicines;molecular farming;plant extracts;respiratory diseases
Fight COVID19 MultiProtease Front Surroundings Could Early Therapeutic Approach Repositioning Drugs Prevent Disease Severity,34201505,interaction membrane spike protein severe acute respiratory syndrome coronavirus 2 SARSCoV2 transmembrane angiotensinconverting enzyme 2 ACE2 receptor human epithelial host cell first step infection critical role viral pathogenesis current coronavirus disease2019 COVID19 pandemic Following binding S1 subunit ACE2 receptor different serine protease including TMPRSS2 furin trigger participate fusion viral envelope host cell membrane basis high virulence pathogenicity SARSCoV2 receptor found involved viral binding invasiveness host cell review comprehensively discus mechanism underlying binding SARSCoV2 ACE2 putative alternative receptor role potential coreceptors protease early stage SARSCoV2 infection Given short therapeutic time window within act avoid devastating evolution disease focused potential therapeutic treatmentsselected mainly among repurposing drugsable counteract invasive front protease mild inflammatory condition order prevent severe infection Using existing approved drug advantage rapidly proceeding clinical trial low cost consequently immediate worldwide availability,ace2;covid-19;sars-cov-2;co-receptors;protease;repositioning drugs
Bacterial coinfection among coronavirus disease 2019 patient group updated systematic review metaanalysis,34226847,pandemic severe acute respiratory syndrome coronavirus 2 raised attention towards bacterial coinfection role coronavirus disease 2019 COVID19 disease study aim systematically review identify pooled prevalence bacterial coinfection related article comprehensive search conducted international database including MEDLINE Scopus Web Science Embase identify article prevalence bacterial coinfections COIVD19 patient 1 December 2019 30 December 2020 observational epidemiological study evaluated prevalence bacterial coinfections patient COVID19 included without restriction Fortytwo study including total sample size 54695 included analysis pooled estimate prevalence bacterial coinfections 2097 95 CI 15952646 pooled prevalence bacterial coinfections 520 95 CI 239891 respiratory subtype 479 95 CI 0111461 gastrointestinal subtype pooled prevalence Eastern Mediterranean Regional Office SouthEast Asia Regional Office 100 95 CI 823510000 261 95 CI 174362 rate coinfection pose great danger towards patient especially critical condition Although multiple complication adverse effect related extensive use antibiotic treat patient COVID19 seems option except applying need done carefully,covid-19;coinfection;coronavirus;meta-analysis;systematics review
Knowledge Attitudes Practices KAP toward COVID19 Vaccine Oman PreCampaign CrossSectional Study,34200001,Oman globally acknowledged wellstructured immunization program high vaccination coverage massive spread misinformation brought COVID19 pandemic well easy access various medium channel may affect acceptance vaccine despite inherent trust local system crosssectional study evaluated knowledge attitude practice KAP Oman toward COVID19 vaccine included 3000 randomly selected adult answering structured questionnaire via telephone Participants 667 Omani 76 male 837 without comorbidities mean age 3827 year SD + 1045 Knowledge COVID19 s symptom mode transmission attitude toward disease adequate 884 heard vaccine 593 would advise others take 568 would take 475 would take second dose Males CI = 237 = 200281 Omani CI = 1956 = 45952397 willing vaccinated history chronic disease source vaccine knowledge education level factor affected willingness accept vaccine Omani community s willingness take COVID19 vaccine enhanced utilizing social medium community influencers spread awareness vaccine s safety efficacy,covid-19;oman;attitude;immunization programs;knowledge;pandemics;practice;vaccines
Serological response single dose SARSCoV2 mRNA vaccine,34224753,delay production delivery COVID19 vaccine growing number fatal infection across globe raised question whether would advantageous vaccinate larger group individual one dose instead smaller one two dos group vaccinated healthcare worker describe qualitative quantitative serological response single dose BNT162b2 vaccine found second dose inoculation 953 182191 already antiSARSCoV2 IgG half antibody concentration RBD key target neutralizing antibody reached maximum value used evaluation immunoassay order improve execution vaccination program study needed ass whether individual single dose mRNA vaccine delay inoculation second dose produce sufficient immune response Additionally followup study help understanding postvaccination immunity long last relates infection reinfection,bnt162b2;multiplex imunnosassay;sars-cov-2;mrna vaccine
Disparities global COVID19 vaccination rate allocation resource country need,34336193,July 20th 2021 191 million confirmed COVIDrelated case 41 million COVIDrelated death documented across globe Vaccines initially prioritized healthcare worker HCWs elderly population provide protection highrisk individual However despite intraandinternational distribution COVID19 vaccine considerable variability vaccination rate observed worldwide example United Arab Emirates reported 166 vaccine doses100 population whereas country Africa administered 10 doses100 population inadequate supply vaccination addition lack swift distributionreallocation vaccine arrived likely contribute low vaccination rate observed Africa US many country Europe began administering vaccine December 2020 whereas majority country Africa began administering vaccine March 2021 order mitigate COVIDrelated death recommend country join effort allocating COVID vaccine country need addition recommend partial vaccination larger proportion highrisk population opposed fully vaccinating half amount However adequate supply vaccine may limited use distributed timesensitive manner recommend implementation targeted costeffective vaccine allocation distribution strategy order increase vaccination rate reserve healthcare system resource avoid preventable death associated COVID19 infection,
SARSCoV2 receptor angiotensinconverting enzyme 2 ACE2 myalgic encephalomyelitischronic fatigue syndrome metaanalysis public DNA methylation gene expression data,34341773,People myalgic encephalomyelitischronic fatigue syndrome MECFS often report high frequency viral infection flulike symptom disease course Given reporting agrees different immunological abnormality altered gene expression profile observed disease aimed answering whether expression human angiotensinconverting enzyme 2 ACE2 major cell entry receptor SARSCoV2 also altered patient particular low expression ACE2 could indicative high risk developing COVID19 performed metaanalysis public data CpG DNA methylation gene expression enzyme homologous ACE protein peripheral blood mononuclear cell related subset found patient MECFS decreased methylation level four CpG probe ACE locus cg09920557 cg19802564 cg21094739 cg10468385 another probe promoter region ACE2 gene cg08559914 also found decreased expression ACE2 ACE patient compared healthy control Accordingly newly collected data evidence significant higher proportion sample ACE2 expression limit detection patient healthy control Altogether patient MECFS higher COVID19 risk considered priority group vaccination public health authority support conclusion similar research recommended human cell entry receptor cell type namely cell targeted virus,ace2;dna methylation;gene expression;myalgic encephalomyelitis/chronic fatigue syndrome;sars-cov-2
massvaccination change COVID19 lockdown requirement Australia,34345875,Background prevent future outbreak COVID19 Australia pursuing massvaccination approach targeted group population comprising healthcare worker agedcare resident individual increased risk exposure receive highly effective priority vaccine rest population instead access le effective vaccine Methods apply largescale agentbased model COVID19 Australia investigate possible implication hybrid approach massvaccination model calibrated recent epidemiological demographic data available Australia account several component vaccine efficacy Findings Within feasible range vaccine efficacy value model support assertion complete herd immunity due vaccination likely Australian context realistic scenario herd immunity achieved simulate effect massvaccination epidemic growth rate investigate requirement lockdown measure applied curb subsequent outbreak simulation Australia s vaccination strategy feasibly reduce required lockdown intensity initial epidemic growth rate 43 52 respectively severity epidemic measured peak number daily new case decrease two order magnitude plausible massvaccination lockdown strategy Interpretation study present strong argument largescale vaccination campaign Australia would substantially reduce intensity future outbreak stringency nonpharmaceutical intervention required suppression Funding Australian Research Council National Health Medical Research Council,covid-19;sars-cov-2;agent-based modelling;computational epidemiology;epidemic growth rate;herd immunity;interventions;mass vaccination;pandemics;vaccine efficacy
Predictors Intention Vaccinate COVID19 General Public Hong Kong Findings PopulationBased CrossSectional Survey,34202016,Vaccination one effective way stop spread COVID19 Understanding factor associated intention receive COVID19 vaccine key successful vaccination programme crosssectional study explored rate vaccination intention identified predictor using health belief model HBM general population Hong Kong pandemic Data collected December 2020 January 2021 via telephone survey Hierarchical logistic regression analysis used identify factor associated intention receive COVID19 vaccine total 1255 adult 18 year 53 female completed telephone survey Overall 42 indicated intention vaccinate 315 showed vaccine hesitancy 265 reported refusal receive COVID19 vaccine Individuals men older age working past experience pandemic le concerned vaccine safety poorer knowledge COVID19 greater level perceived susceptibility selfefficacy cue action acceptance governmental preventive measure related COVID19 significantly likely report intention vaccinate low intention among Hong Kong population reflects importance developing effective vaccination promotion campaign predictor identified study,covid-19;hong kong;health belief model;intention to vaccinate
Investigating Decreased Rates Nulliparous Cesarean Deliveries COVID19 Pandemic,34282578,OBJECTIVE Preventing first cesarean delivery CD important CD rate continue rise novel coronavirus disease 2019 COVID19 pandemic quality improvement metric hospital identified lower rate CD sought investigate change identify factor may contributed decrease STUDY DESIGN compared nulliparous singleton delivery large academic hospital COVID19 pandemic April July 2020 statewide `` stayathome order month 1 year prior pandemic April July 2019 primary outcome mode delivery obtained electronic medical record system along indication CD RESULTS cohort included 1913 delivery 892 2019 1021 2020 Patient characteristic age body mass index race ethnicity insurance type differ group Median gestational age delivery group CD rate decreased significantly COVID19 pandemic compared prior 289 vs 336 p = 003 significant increase rate labor induction 457 vs 406 p = 002 difference proportion induction elective 195 vs 207 p = 066 rate CD labor unchanged 159 vs 163 p = 082 however woman attempted trial labor 870 vs 826 p = 001 Thus proportion CD without trial labor decreased 251 vs 330 p = 004 CONCLUSION statistically significant decrease CD COVID19 pandemic hospital driven decrease CD without trial labor increased rate attempted trial labor suggests presence patientlevel factor warrant investigation potential target decreasing CD rate Additionally diverse medically complex population increased rate labor induction associated increased rate CD KEY POINTS Primary CD rate fell COVID19 pandemic Decrease driven woman attempting labor Higher rate induction without rise CD rate found,
Delayed localized hypersensitivity reaction COVID19 mRNA vaccine sixmonth retrospective study,34288056,clinical trial two novel COVID19 vaccine PfizerBioNTech Moderna reported delayed local injection site reaction 12 Since vaccination rate increase awareness adverse reaction needed research letter report series delayed localized hypersensitivity reaction mRNA SARSCoV2 vaccine histopathologic confirmation,
Transport Aerosols Underground Mine Workings Terms SARSCoV2 Virus Threat,34201360,paper present method implementation result aerosol dispersion test underground mine working Numerous test carried determine potential risk SARSCoV2 coronavirus infection underground environment mine influence selected parameter mine air possibility method aerosol transmission ventilation route experimentally determined real condition concentration additional aerosol class ultrafine fine aerosol increased distance generator concentration coarse particle decreased Assuming consumption solution aerosol generated even small level 1 cm 3 min number additional aerosol several hundred particle one cubic centimeter air distance 5070 generator concentration ultrafine particle range 4020000 nm increased 122 particlescm 3 209 particlescm 3 air temperature 12 degree C relative humidity 9596 90 particlescm 3 243 particlescm 3 air temperature 17 degree C relative humidity 7682 increasing distance generator 10 50,sars-cov-2;aerosol transport;coronavirus;mining ventilation;underground mines
Spatiotemporal analysis COVID19 outbreak Wuhan China,34211038,study revealed spatial transmission characteristic COVID19 Wuhan China aimed analyze spatiotemporal spread COVID19 Wuhan influence factor Information 32682 COVID19 case reported March 18 extracted national infectious disease surveillance system Geographic information system method applied analysis transmission COVID19 influence factor different period found decrease effective reproduction number Rt COVID19 related indicator taking series effective public health measure including restricting traffic centralized quarantine strict stayat home policy distribution COVID19 case number Wuhan showed obvious global aggregation local aggregation addition analysis streetslevel suggested population density number hospital associated COVID19 case number epidemic situation showed obvious global local spatial aggregation High population density larger number hospital may account aggregation epidemic Wuhan control short time strong quarantine measure restriction movement resident implanted,
Causes Consequences COVID19Associated Bacterial Infections,34354682,COVID19 literature highlight bacterial infection common fatal case recovered case bacterial infection drive mortality COVID19 clear implication patient management However possible enrichment bacterial infection COVID19 fatality simply byproduct latestage pathology leading different advice patient management address question review current knowledge bacterial infection COVID19 ass information past viral respiratory pandemic simulate alternate causal model interaction virus bacteria mortality COVID19 model conclude currently available data sufficient discriminate alternate causal pathway highlight data required determine relative contribution bacterial infection COVID19 morbidity mortality summarize potential longterm consequence SARSCoV2 infection,covid-19;icu;bacteria;co-infection;pneumonia;secondary infection
Identification Causal Genes COVID19 Using SMR Method,34290742,Since first report COVID19 December 2019 100 million people infected SARSCoV2 Despite ongoing research still limited knowledge genetic cause COVID19 resolve problem applied SMR method analyze gene involved COVID19 pathogenesis integration multiple omics data assessed SNPs associated COVID19 risk GWAS data Spanish Italian patient lung eQTL data GTEx project GWAS eQTL data integrated summarydatabased SMR method using SNPs instrumental variable IVs result six proteincoding five nonproteincoding gene regulated nine SNPs identified significant risk factor COVID19 Functional analysis gene showed UQCRH participates cardiac muscle contraction PPA2 closely related sudden cardiac failure SCD OGT interacting gene partner PANO1 associated neurological disease Observational study show myocardial damage SCD neurological disease often occur COVID19 patient Thus finding provide potential molecular mechanism understanding complication COVID19,covid-19;gwas;ogt;pano1;ppa2;smr;uqcrh;eqtl
fully automated microfluidic PCRarray system rapid detection multiple respiratory tract infection pathogen,33492406,Rapid accurate identification respiratory tract infection pathogen utmost importance clinical diagnosis treatment well prevention pathogen transmission meet demand microfluidic chipbased PCRarray system Onestart developed Onestart system us microfluidic chip packaged reagent required waste liquid also collected stored chip readytouse system complete detection 21 pathogen fully integrated manner sample lysis nucleic acid extractionpurification realtime PCR sequentially implemented chip entire analysis process completed within 15 h system automatically generates test report lower limitofdetection LOD Onestart assay determined 10 x 10 3 copiesmL 1 interbatch variation cycle threshold Ct value ranged 008 069 intrabatch variation ranged 09 266 Analytical result reference sample mix showed 100 specificity Onestart assay analysis batched clinical sample showed consistency Onestart assay realtime PCR ability provide rapid sensitive specific detection respiratory tract infection pathogen application Onestart system facilitate timely clinical management respiratory tract infection effective prevention pathogen transmission Onestart readytouse system detect 21 pathogen fully integrated manner microchip within 15 h,automation;microfluidic;multiplex detection;point-of-care testing;rapid diagnosis;respiratory tract infection
Lessons learned SARSCoV2 measurement wastewater,34375259,Standardized protocol wastewaterbased surveillance WBS RNA SARSCoV2 virus responsible current COVID19 pandemic developed refined worldwide early detection disease outbreak report lesson learned establishing WBS program SARSCoV2 integrated human surveillance program COVID19 established WBS three campus university including student residential dormitory hospital treat COVID19 patient Lessons learned WBS program address variability water quality new detection technology range detectable viral load wastewater predictive value integrating environmental human surveillance data Data WBS program indicated water quality statistically different sewer sampling site variability observed wastewater coming individual building compared cluster building new detection technology developed based upon use novel polymerase called V2G Detectable level SARSCoV2 wastewater varied 10 2 10 6 genomic copy gc per liter raw wastewater L Integration environmental human surveillance data indicate WBS detection 100 gcL SARSCoV2 RNA wastewater associated positivity rate 4 detected human surveillance wastewater catchment area though confidence interval wide beta 899 ln 100 95 CI = 0901708 p 005 data also suggest early detection COVID19 surge based correlation viral load wastewater human disease incidence could benefit increasing wastewater sample collection frequency weekly daily Coupling simpler faster detection technology frequent sampling potential improve predictive potential using WBS SARSCoV2 early detection onset COVID19,concentration;detection;sars-cov-2;sampling;wastewater;wastewater based surveillance
FullyAutomated Method Evaluate Coronavirus Disease Progression COVID19 Cough Sounds Using Minimal Phase Information,34131828,paper focus important issue disease progression COVID19 coronavirus disease 2019 processing COVID19 cough sound proposing fullyautomated method new method based timedomain exploiting phase 1 data always available cough event proposed approach generates plausible click sequence consist click various cough sample covid19 patient click sequence extracted phase slope function input signal used calculate interclick interval ICIs thereby scoring index SI derived based coefficient variation CV extracted ICIs Moreover probability density function pdf output click sequence obtained method need adjust parameter experimental result achieved realrecorded COVID19 cough data using medically annotated Novel Coronavirus Cough Database NoCoCoDa reveal proposed timedomain method useful tool automatic cough sound processing determine disease progression coronavirus patient,automatic cough sound processing;covid-19;click sequence;coronavirus disease progression;cough sounds/samples;inter-click intervals;nococoda database
Casirivimab,34283490,Casirivimab one severe acute respiratory syndrome coronavirus 2 SARSCoV2 neutralizing antibody proposed use clinical management coronavirus disease 2019 COVID19 used combination imdevimab reduces viral load improves clinical outcome activity review indication contraindication activity adverse event key element casirivimab therapy clinical setting also highlight essential point needed member interprofessional team managing COVID19 patient,
COVID19 diagnosis patient critical limb ischemia complication clinical outcome,34211520,67yearold male diabetic patient systemic arterial hypertension admitted emergency department necrotic ulcer left external malleolus palpable popliteal pedal pulse Arterial Duplex ultrasound identified femoropopliteal occlusion popliteal refilling knee patent peroneal artery endovascular procedure performed requiring retrograde access popliteal artery reestablish blood flow deploy popliteal stent Technical success achieved patient underwent debridement wound Two day later 48 hour operation patient began exhibit respiratory symptom coughing dyspnea immediately underwent chest CT identified ground glass opacity crazypaving pattern bilateral air bronchogram lung reverse transcription polymerase chain reaction RTPCR test positive SARSCov2 patient moved intensive care unit put mechanical ventilation hydroxychloroquine azithromycin administered Despite appropriate treatment patient died 4 day diagnosed COVID19,covid-19;angioplasty;critical limb ischemia;endovascular surgery;gangrene;peripheral occlusive arterial disease
increased injury incidence German Bundesliga SARSCoV2 virus lockdown,34286365,INTRODUCTION coronavirus lockdown 2020 resulted worldwide suspension professional sport first major professional football league restart lockdown German Bundesliga study investigates whether injury incidence increased restart season 9 day regular preparation time without friendly match comparison three control period MATERIALS METHODS prospective cohort study injury analysis least 1 day absence official football match training session German Bundesliga registry standardised according Hagglund et al Br J Sports Med 39340346 2005 Fuller et al Clin J Sports Med 1697106 2006 data collection previous publication validated use medium source injury registration study period lockdown May June 20192020 season compared three control period period directly lockdown beginning 20192020 season 20182019 season final RESULTS nine match day restart 20192020 season showed overall injury incidence 49 per 1000 h football rate significantly lower previous season final 9 last match day overall injury incidence 69 per 1000 h football p 0001 increased compared rate summer break 9 match day incidence 551000 h p 005 winter break 8 match day incidence 561000 h p 005 CONCLUSION period unexpected break 20192020 season due coronavirus lockdown rapid return competition showed increase injury rate compared prelockdown period lower injury rate previous season final unintentional midseason rest potential physical recovery individual fitness training seems positive effect injury occurrence,covid-19;injury prevention;pandemic;soccer
Comparison clinical biochemical feature hospitalized COVID19 influenza pneumonia patient,34289142,severe acute respiratory syndrome coronavirus 2 influenza virus cause similar clinical presentation essential ass severely ill patient presenting viral syndrome diagnostic prognostic purpose aimed compare clinical biochemical feature pneumonia patient coronavirus disease 2019 COVID19 H1N1 Sixty patient diagnosed COVID19 pneumonia 61 patient diagnosed influenza pneumonia hospitalized October 2020January 2021 October 2017December 2019 respectively clinical data laboratory result chest computed tomography scan intensive care unit admission invasive mechanical ventilation outcome retrospectively evaluated median age 65 range 3296 year patient COVID19 diagnosis 58 range 1883 year patient influenza p = 0002 comorbidity index significantly higher patient COVID19 p = 0010 Diabetes mellitus hypertension statistically significantly common patient COVID19 p = 0019 p = 0008 respectively distribution severe disease mortality significantly different among patient COVID19 influenza patient p = 0096 p = 0049 comparison inflammation marker Creactive protein CRP level significantly higher influenza patient patient COVID19 p = 0033 presence sputum predictive influenza odds ratio 0342 95 confidence interval CI 211300899 CRP platelet also predictive COVID19 4764 95 CI 10031012 0991 95 CI 09840998 respectively conclude sputum symptom much detected influenza patient Besides lower CRP higher PLT count would discriminative COVID19,
Telemedicine Preferred Visit Modality Patients Type 1 Diabetes,34293815,BACKGROUND COVID19 pandemic limit access diabetes clinic Remote communication phone call WhatsApp message became available past year However current need avoid facetoface meeting necessitates expansion telemedicine service limited data whether option virtual meeting preferred therapeutic modality patient type 1 diabetes T1D OBJECTIVE ass cohort T1D patient preference perception telemedicine METHODS T1D patient followed hospitalaffiliated diabetes clinic asked fill structured questionnaire aimed determine attitude towards telemedicine preference virtual versus conventional visit questionnaire offered consecutive T1D patient visited clinic August October 2020 RESULTS Seventy one T1D patient fulfilled questionnaire included Median age 38 year 39 male median duration diabetes 18 year Fourteen percent participant preferred virtual visit 24 conventional visit 62 preferred combination modality Sex origin education duration diabetes mode insulin treatment distance clinic associated patient preference older patient = 61 year tended prefer conventional visit Sixtysix percent felt confident ability download data personal medical device CONCLUSIONS Patients wide range treatment modality willing use telemedicine However virtual meeting fully replace conventional visit T1D especially older age group,
Adenoviral vector vaccine platform SARSCoV2 pandemic,34354082,Adenoviral vector explored vaccine agent range infectious disease ability induce potent balanced immune response made logical candidate apply COVID19 pandemic unique molecular characteristic vector enabled rapid development vaccine advanced design capable overcoming biological challenge faced early adenoviral vector system success urgency COVID19 situation resulted flurry candidate adenoviral vector vaccine COVID19 academia industry vaccine represent lead candidate currently supported Operation Warp Speed government agency rapid translational development review detail adenoviral vector COVID19 vaccine currently human clinical trial provides overview new technology employed design vaccine formed cornerstone COVID19 global vaccination campaign review provides full consideration impact development emerging platform,
Single breath counting effective screening tool forced vital capacity ALS,34348533,Objective measure correlation single breath counting SBC forced vital capacity liter FVCL amyotrophic lateral sclerosis ALS patient define utility SBC determining patient meet threshold initiation noninvasive positive pressure ventilation FVC 50 predicted FVCpred Methods patient paced SBCpp externally paced SBCep counting along FVCL+pred standard clinical data collected Linear regression used examine SBCpp SBCep predictor FVCL Receiver operating characteristic curve analysis evaluated sensitivity specificity SBC categorically predicting FVCpred =50 Results 30 ALS patient SBC explained moderate proportion variance FVCL SBCpp R 2 = 0431 p 0001 SBCep R 2 = 0511 p 001 proportion improved including covariates SBCpp R 2 = 0635 p 001 SBCep R 2 = 0657 p 001 Patients minimal speech involvement performed similarly unadjusted SBCpp R 2 = 0511 p 001 SBCep R 2 = 0595 p 001 adjusted SBCpp R 2 = 0634 p 001 SBCep R 2 = 0650 p 001 model SBCpp 100 sensitivity 60 specificity area curve AUC = 0696 predicting FVCpred 50 SBCep 100 sensitivity 56 specificity AUC = 0696 minimal speech involvement SBCpp SBCep 100 sensitivity 761 specificity SPCpp AUC = 0845 SBCep AUC = 0857 Conclusions SBC explains moderate proportion variance FVC extremely sensitive marker poor FVC FVC obtained current COVID19 pandemic SBC helpful directing patient care,single breath count;amyotrophic lateral sclerosis;biomarker;neuromuscular disease;ventilation
COVID19 SARSCoV2 Variants Current Challenges Health Concern,34211506,ongoing coronavirus disease 2019 COVID19 outbreak Wuhan China triggered unfolded quickly throughout globe severe acute respiratory syndrome coronavirus 2 SARSCoV2 new virus transmitted primarily inhalation contact infected droplet seems contagious pathogenic incubation period varying 2 14 day epidemic ongoing public health problem challenge present global health system worldwide social economic stress observed transitional source origin transport human unknown speedy human transportation accepted extensively typical clinical symptom COVID19 almost like cold case fatality rate varying 2 3 percent small number patient may experience serious health problem even die date limited number antiviral agent vaccine treatment COVID19 occurrence pathogenicity COVID19 infection outlined comparatively analyzed given outbreak s urgency recent development diagnostics treatment marketed vaccine discussed deal viral outbreak scientist concerned appearance several variant globe efficacy vaccine variant need consistent monitoring virus epidemiology surveillance ongoing variant related disease severity,covid-19;sars-cov-2 variant;therapeutics;vaccine efficacy;wave of infection
VectoredVaccine Platforms Enabled Rapid Development Safe Effective Vaccines Response COVID19 Pandemic Situation,34358139,2019 outbreak severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent coronavirus disease COVID19 caused ongoing public health crisis,
Rintatolimod Induces Antiviral Activities Human Pancreatic Cancer Cells Opening AntiCOVID19 Opportunity Cancer Patients,34207861,Severe acute respiratory virus2 SARSCoV2 spread globally leading devastating loss life Large registry study begun shed light epidemiological clinical vulnerability cancer patient succumb endure poor outcome SARSCoV2 Specific treatment COVID19 infection cancer patient lacking demand treatment increasing Therefore explored effect Rintatolimod Ampligen R AIM ImmunoTech Ocala FL USA Tolllike receptor 3 TLR3 agonist treat uninfected human pancreatic cancer cell HPACs direct effect Rintatolimod measured targeted gene expression profiling proteomics measurement result show Rintatolimod induces antiviral effect HPACs inducing RNaseLdependent independent pathway innate immune system Treatment Rintatolimod activated interferon signaling pathway leading overexpression several cytokine chemokines epithelial cell Furthermore Rintatolimod treatment increased expression angiogenesisrelated gene without promoting fibrosis main cause death patient COVID19 conclude Rintatolimod could considered early additional treatment option cancer patient infected SARSCoV2 prevent complicated severity disease,rnase l;rintatolimod;sars-cov-2;toll-like receptor 3;cytokines;epithelial cancerous cells;interferon signaling
prolonged steroid therapy may beneficial patient COVID19 pneumonia,34221256,INTRODUCTION report introduces two case presenting absorption considerable radiological change course coronavirus pneumonia patient treated prolonged oral steroidsCASES first case concern male receiving steroid hospitalisation Infectious Disease Hospital discharge patient experienced increasing dyspnoea resulting hospitalisation Department Lung Diseases HRCT revealed progression bilateral middle basal groundglass opacity compared examination performed early stage disease supplementary oxygen therapy steroid administered followed extended prednisone consumption 2 month discharge Followup HRCT revealed almost complete absorption groundglass opacity second case concern male treated steroid hospitalisation Infectious Disease Hospital Chest CT revealed widespread bilateral groundglass opacity consolidation discharge treatment suffered severe dyspnoea exercise intolerance resulting hospitalisation 7 th day home stay Since continued steroid treatment administered resulting clinical spirometric radiological improvementCONCLUSIONS Based observation patient COVIDpneumonia may derive benefit prolonged steroid treatment Therefore class medication considered SARSCoV2 patient especially patient persistent radiological change dyspnoea requiring supplementary oxygen therapy However randomised controlled trial required establish guideline steroid treatment group patient,covid-19;chest ct abnormalities;organising pneumonia;pulmonary fibrosis;steroid therapy
COVID19 cancer screening Scotland national coordinated approach minimising harm,34217418,Screening important component cancer control internationally Scotland National Health Service Scotland provides screening programme cervical bowel breast cancer COVID19 pandemic resulted suspension programme March 2020 describe integrated approach managing impact pandemic cancer screening programme Scotland throughout 2020 outline policy context decisionmaking process leading suspension criterion framework informing subsequent staggered restart subsequent month decision suspend screening service order protect screening invitee staff manage NHS capacity made review number screening participant likely affected potential number delayed cancer diagnosis Restart principle detailed route map plan developed programme seeking ensure broad consistency approach across programme nationally Early data indicates bowel breast cervical screening participation increased since restart Primary care adapt new infection prevention control measure delivery cervical screening Cancer charity provided cancer intelligence policy brief national body Scottish Government well supporting public patient screening invitee information awareness campaign Emerging pandemic recognition need opportunity transform renew cancer screening service Scotland particular address longstanding workforce capacity problem innovation investment continue prioritise addressing health inequality,covid-19;cancer screening;impact of pandemic;monitoring impact;programmatic screening;screening restart;screening suspension
Mouthwashes CPC Reduce Infectivity SARSCoV2 Variants Vitro,34282982,Oral mouthwash decrease infectivity several respiratory virus including SARSCoV2 However precise agent antiviral activity oral rinse exact mechanism action remain unknown show cetylpyridinium chloride CPC quaternary ammonium compound many oral mouthwash reduces SARSCoV2 infectivity inhibiting viral fusion step target cell disrupting integrity viral envelope also found CPCcontaining mouth rinse decreased thousand time infectivity SARSCoV2 vitro corresponding vehicle effect activity effective different SARSCoV2 variant including B117 Alpha variant originally identified United Kingdom presence sterilized saliva CPCcontaining mouth rinse could therefore represent costeffective measure reduce SARSCoV2 infectivity saliva aiding reduce viral transmission infected individual regardless variant infected,covid-19;airborne transmission;cellular infection;coronaviruses;oral hygiene;virucide
BNT162b2 mRNA Vaccine Elicits Robust Humoral Cellular Immune Responses People Living HIV,34293114,Previous study shown certain vaccine induce suboptimal response people living HIV PLWH However response SARSCoV2 vaccine fully characterized patient show BNT162b2 vaccine induces robust immune response comparable response healthy donor,covid;plwh;sars-cov-2;mrna vaccine
Immunopathogenesis Different Emerging Viral Infections Evasion Fatal Mechanism Prevention,34335596,Different emerging viral infection may emerge different region world pose global pandemic threat high fatality Clarification immunopathogenesis different emerging viral infection provide plan crisis management prevention emerging infection perspective article describes emerging viral infection evolves microbial mutation zoonotic andor vectorborne transmission progress fatal infection due overt viremia tissuespecific cytotropic damage orand immunopathology classified immunopathogenesis common emerging viral infection 4 category 1 deficient immunity disseminated viremia eg Ebola 2 pneumocytotropism withwithout later hyperinflammation eg COVID19 3 augmented immunopathology eg Hanta 4 antibodydependent enhancement infection altered immunity eg Dengue practical guide early blocking viral evasion limiting viral load identifying fatal mechanism emerging viral infection provided prevent reduce transmission rapid diagnosis followed early treatment virus neutralization reduction morbidity mortality emerging viral infection COVID19,early diagnosis;early treatment;emerging viral infections;evasion;fatality;immunopathogenesis;prevention
POSTCOVID SYNDROME PULMONARY COMPLICATIONS,34284532,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infected million people worlwide caused pandemic still ongoing virus cause disease named COVID19 composed multi systemic manifestation pulmonary system predominance time pass dealing effect complication disease survivor shown wide variety far concern clinical outcome timeline symptom different patient Since lung involved organ postCOVID prolonged persistent effect mainly related pulmonary system crucial define predict outcome determine individual progress fibrosis loss function lung review summarizes current literature regarding pulmonary complication postCOVID syndrome management condition,mis-a;post-covid;pulmonary complications
Possible Benefit Angiotensin II Receptor Blockers COVID19 Patients Case Series,34285712,Introduction Dysfunction reninangiotensinaldosterone system RAAS observed patient coronavirus disease 2019 COVID19 presumed effect reducing interleukin6 IL6 level angiotensin II receptor blocker ARBs RAAS modulation investigated change angiotensin II IL6 level four COVID19 patient treated ARBs Case Presentation Cases 1 2 received ARBs newly administered ARBs Case 3 restarted ARBs discontinuation 7 day case 4 received increased dose ARBs mean angiotensin II level 6075 pgmL range 488850 pgmL reference range 100 pgmL Creactive protein CRP 1058 mgdL range 4451805 mgdL IL6 5578 pgmL range 128614482 pgmL reference range 7 pgmL observed admission patient Upon clinical improvement mean decrease CRP 102 mgdL range 006378 mgdL IL6 563 pgmL range 0172087 pgmL observed patient Conversely angiotensin II level gradually increased Conclusion report support potential benefit ARBs improve clinical outcome COVID19 patient controlling RAAS dysfunction,
Murine CD8 + Cell Epitope Identified ReceptorBinding Domain SARSCoV2 Spike Protein,34208032,ongoing COVID19 pandemic caused SARSCoV2 posed devastating threat worldwide receptorbinding domain RBD spike protein one important antigen SARSCoV2 vaccine analysis CD8 cytotoxic lymphocyte activity preclinical study using mouse model critical evaluating vaccine efficacy immunized C57BL6 wildtype mouse transgenic mouse expressing human angiotensinconverting enzyme 2 ACE2 SARSCoV2 RBD protein evaluate IFNgammaproducing cell splenocytes immunized mouse using overlapping peptide pool enzymelinked immunospot assay flow cytometry identified SARSCoV2 S395404 major histocompatibility complex MHC class Irestricted epitope RBDspecific CD8 cell response C57BL6 mouse,cd8 cytotoxic t lymphocyte;sars-cov-2;cell-mediated immunity;epitope;vaccine
Exploring Feasibility Multivariate Deep Learning Models Predicting COVID19 Epidemic,34291025,Background Mathematical model powerful tool study COVID19 However one fundamental challenge current modeling approach lack accurate comprehensive data Complex epidemiological system COVID19 especially challenging commonly used mechanistic model understanding pandemic rapidly refreshes Objective aim develop datadriven workflow extract process develop deep learning DL method model COVID19 epidemic provide alternative modeling approach complement current mechanistic modeling paradigm Method extensively searched extracted annotated relevant datasets 60 official press release Hubei China 2020 Multivariate long shortterm memory LSTM model developed different architecture track predict multivariate COVID19 time series 1 2 3 day ahead comparison univariate LSTMs also developed track new case total case new death Results comprehensive dataset 10 variable retrieved processed 125 day Hubei Multivariate LSTM reasonably good predictability new death hospitalization severe critical patient total discharge total monitored hospital Multivariate LSTM showed better result new total case new death 1dayahead prediction univariate counterpart 2day 3dayahead prediction Besides complex LSTM architecture seemed increase overall predictability study Conclusion study demonstrates feasibility DL model complement current mechanistic approach exact epidemiological mechanism still investigation,covid-19;deep learning;epidemic;modeling;multivariate
ACE2Independent Interaction SARSCoV2 Spike Protein Human Epithelial Cells Inhibited Unfractionated Heparin,34200372,Coronaviruses SARSCoV2 responsible COVID19 depend virus spike protein binding host cell receptor cause infection SARSCoV2 spike protein bind primarily ACE2 target cell processed membrane protease including TMPRSS2 leading viral internalisation fusion plasma membrane suggested however receptor ACE2 may involved virus binding investigated interaction recombinant version spike protein human epithelial cell line express lowvery low level ACE2 TMPRSS2 proxy assay interaction host cell tagged form spike protein containing S1 S2 region bound temperaturedependent manner cell line whereas S1 region alone receptorbinding domain RBD interacted weakly Spike protein associated cell independently ACE2 TMPRSS2 RBD required presence high level ACE2 interaction spike protein previously shown bind heparin soluble glycosaminoglycan tested effect various heparin ACE2independent spike protein interaction cell Unfractionated heparin inhibited spike protein interaction IC50 value 005 UmL whereas two lowmolecularweight heparin le effective mutant form spike protein lacking argininerich putative furin cleavage site interacted weakly cell lower affinity unfractionated lowmolecularweight heparin wildtype spike protein suggests furin cleavage site might also heparinbinding site potentially important interaction host cell glycosaminoglycans heparan sulphate dermatan sulphate chondroitin sulphate also inhibited binding spike protein indicating might bind one glycosaminoglycans surface target cell,sars-cov-2;glycosaminoglycan;heparin;spike protein
Combining SARSCoV2 Proofreading Exonuclease RNADependent RNA Polymerase Inhibitors Strategy Combat COVID19 HighThroughput silico Screening,34354677,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infected million people worldwide Currently many clinical trial search effective COVID19 drug underway Viral RNAdependent RNA polymerase RdRp remains target choice prophylactic curative treatment COVID19 Nucleoside analog promising RdRp inhibitor shown effectiveness vitro well clinical setting One limitation RdRp inhibitor removal incorporated nucleoside analog SARSCoV2 exonuclease ExoN Thus ExoN proofreading activity accomplishes resistance many RdRp inhibitor hypothesize absence highly efficient antiviral treat COVID19 combinatorial drug therapy RdRp ExoN inhibitor promising strategy combat disease repurpose drug COVID19 treatment 10397 conformers 2240 approved drug screened ExoN domain nsp14 using AutoDock VINA molecular docking approach detailed study interaction helped u identify dexamethasone metasulfobenzoate conivaptan hesperidin glycyrrhizic acid potential inhibitor ExoN activity result confirmed using molecular dynamic MD simulation molecular mechanic combined generalized Born model solvent accessibility method MMGBSA calculation Furthermore binding free energy conivaptan hesperidin estimated using MMGBSA 8586 + 068 11907 + 069 kcalmol respectively Based docking MD simulation known antiviral activity conivaptan hesperidin identified potential SARSCoV2 ExoN inhibitor recommend investigation combinational therapy using RdRp inhibitor repurposed ExoN inhibitor potential COVID19 treatment,sars-cov-2;combinatorial therapy;drug repurposing;exonuclease inhibitor;molecular docking and md simulation;nucleoside analog
seroprevalence severe acute respiratory syndrome coronavirus 2 Delhi India repeated populationbased seroepidemiological study,34339514,BACKGROUND Three round repeated crosssectional serosurvey estimate change seroprevalence severe acute respiratory syndrome coronavirus 2 SARSCoV2 conducted August October 2020 state Delhi India general population =5 age METHODS selection participant multistage sampling design 11 district 280 ward citystate multistage allocation proportional population size blood sample screened using immunoglobulin G IgG enzymelinked immunosorbent assay kit RESULTS observed total 4267 N=150 46 4311 N=17 409 3829 N=15 015 positive test indicative presence IgG antibody SARSCoV2 August September October 2020 serosurvey round respectively adjusted seroprevalence declined 2839 95 confidence interval CI 2765 2914 August 2408 95 CI 2343 2474 September 2471 95 CI 2401 2542 October adjusted analysis participant lower per caput income living slum overcrowded household diabetes comorbidity significantly higher statistical odds antibody positivity p 001 CONCLUSIONS Nearly one four resident Delhi India =5 age SARSCoV2 infection AugustOctober 2020,covid-19;sars-cov-2;serosurvey
Seroprevalence antiSARSCoV2 antibody Africa systematic review metaanalysis,34228851,estimated seroprevalence antisevere acute respiratory syndrome coronavirus 2 SARSCoV2 antibody resident African country explored associated factor searched PubMed EMBASE PsycINFO AMED CINAHL DOAJ Google Scholar database peer reviewed article preprints reported antiSARSCoV2 antibody seroprevalence general specific human population resident Africa eligible study evaluated using Joana Briggs Institute prevalence critical appraisal tool Twentythree study involving 27735 individual included paper pooled seroprevalence antiSARSCoV2 antibody Africa 22 95 CI 1431 high heterogeneity 2 = 100 p 0001 Seroprevalence highest study conducted Central Africa compared Southern Africa West Africa North Africa East Africa respectively number day first reported coronavirus disease 2019 case country seroprevalence study conducted significant moderator seroprevalence Seropositivity numerically influenced gender age participant male aged 50 year affected SARSCoV2 infection highest pooled seroprevalence Africa reported review interpreted cautiously due high heterogeneity study Continued seroprevalence surveillance warranted establish Africa s transition towards herd immunity,africa;covid-19;sars-cov-2;antibody;seroprevalence
SARSCoV2 infection risk factor early pregnancy loss ACE2 TMPRSS2 coexpression persistent replicative infection primitive trophoblast,34293134,BACKGROUND SARSCoV2 infection term placenta relatively rare However growing evidence suggests susceptibility human placenta infection may vary gestational age pathogen several viral infection susceptibility appears greatest early gestation Infections periimplantation placenta result preclinical pregnancy loss would typically go undetected Little known effect SARSCoV2 periimplantation human placenta since time pregnancy modeled vitro METHODS used human embryonic stem cellderived model periimplantation placental development ass pattern ACE2 TMPRSS2 transcription protein expression primitive trophoblast molecule involved SARSCoV2 cell entry infection infected trophoblast cell model clinical isolate SARSCoV2 documented infection dynamic RESULTS ACE2 TMPRSS2 transcribed translated stemcell derived trophoblast preferential expression syncytialized cell syncytialized cell supported replicative persistent infection SARSCoV2 nonsyncytialized trophoblast cell culture CONCLUSIONS Coexpression ACE2 TMPRSS2 early human embryonic stem cellderived trophoblast robust replicative infection limited syncytiotrophoblast equivalent support hypothesis increased viral susceptibility may defining characteristic primitive trophoblast Potential implication finding early pregnancy loss deserve investigation,ace2;covid-19;sars-cov-2;tmprss2;miscarriage;placenta;spontaneous abortion;stem cell;trophoblast
Emerging neurotropic feature SARSCoV2,34289037,prevailing coronavirus disease COVID19 caused novel severe acute respiratory syndrome coronavirus SARSCoV2 presented neurological manifestation including hyposmia hypogeusia headache stroke encephalitis GuillainBarre syndrome neuropsychiatric disorder Although several cell type brain express angiotensin converting enzyme2 ACE2 main SARSCoV2 receptor related protein remains unclear whether observed neurological manifestation attributed virus invasion brain comorbidities caused dysregulation systemic factor briefly review neurological manifestation SARSCoV2 summarize recent evidence potential neurotropism SARSCoV2 discus potential mechanism COVID19associated neurological disease,ace2;sars-cov-2;brain invasion;neurological manifestations
Singlenucleus transcriptome analysis human brain immune response patient severe COVID19,34281603,BACKGROUND Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection associated neurological neuropsychiatric illness many individual sought understanding relationship brain tropism neuroinflammation host immune response acute COVID19 case METHODS Three brain region dorsolateral prefrontal cortex medulla oblongata choroid plexus 5 patient severe COVID19 4 control examined presence virus assessed western blot viral spike protein well viral transcriptome analysis covering 99 SARSCoV2 genome potential serotypes Dropletbased singlenucleus RNA sequencing snRNAseq performed sample examine impact COVID19 transcription individual cell brain RESULTS Quantification viral spike S1 protein viral transcript detect SARSCoV2 postmortem brain tissue However analysis 68557 singlenucleus transcriptomes three distinct region brain identified increased proportion stromal cell monocyte macrophage choroid plexus COVID19 patient Furthermore differential gene expression pseudotemporal trajectory gene regulatory network analysis revealed transcriptional change cortical microglia associated range biological process including cellular activation mobility phagocytosis CONCLUSIONS Despite absence detectable SARSCoV2 brain time death finding suggest significant persistent neuroinflammation patient acute COVID19,choroid plexus;gene expression;microglia;neuroinflammation;prefrontal cortex;sars-cov-2
SARSCoV2 seroepidemiological study healthcare worker discordant result using seven different diagnostic method,34224078,aim study access SARSCoV2 antibody seroprevalence healthcare worker HCWs tertiary pediatric hospital first wave pandemic compare result among seven commercially available antibody detection assay including chemiluminescence CMIA electroluminescence ECLIA EpsilonnzymeLinked Immunosorbent Assay ELISA rapid immunochromatography RIC SARSCoV2 antibody detection performed serum sample 1216 HCWs using reference CMIA assay 81216 066 detected positive Positive serum sample tested assay however one sample positive test rest 7 case negative ECLIA ELISA gave discordant result RIC test Six month later new serum sample seropositive HCWs analyzed 7 test inconsistent result Identification reliable SARSCoV2 antibody test important determine actual number past infection duration antibody guide public health decision,antibody;covid-19;comparison;immunity;sars-cov-2;serology
Clinical phenotype outcome SARSCoV2 influenza RSV seven respiratory virus retrospective study using complete hospital data,34226206,BACKGROUND understanding difference clinical phenotype outcome COVID19 compared respiratory viral infection important optimise management patient plan healthcare Herein sought investigate difference patient positive SARSCoV2 compared influenza respiratory syncytial virus RSV respiratory virus METHODS performed retrospective cohort study hospitalised adult child =15 year tested positive SARSCoV2 influenza virus AB RSV rhinovirus enterovirus parainfluenza virus metapneumovirus seasonal coronaviruses adenovirus bocavirus respiratory sample admission 2011 2020 RESULTS total 6321 adult 1721 SARSCoV2 6379 paediatric 101 SARSCoV2 healthcare episode included study adult SARSCoV2 positivity independently associated younger age male sex overweightobesity diabetes hypertension tachypnoea well better haemodynamic measurement white cell count platelet count creatinine value Furthermore SARSCoV2 associated higher 30day mortality compared influenza adjusted HR aHR 443 95 CI 351 559 RSV aHR 381 95 CI 272 534 respiratory virus aHR 346 95 CI 261 460 well higher 90day mortality ICU admission ICU mortality pulmonary embolism adult child patient SARSCoV2 older lower prevalence chronic cardiac respiratory disease compared virus CONCLUSIONS SARSCoV2 associated severe outcome compared respiratory virus although associated specific patient clinical characteristic admission substantial overlap precludes discrimination based characteristic,covid-19;pneumonia;respiratory infection;viral infection
Knowledge attitude prevention COVID19 among community health worker Nepala crosssectional study,34281512,BACKGROUND Emerging reemerging pathogen global challenge public health pandemic Coronavirus disease 2019is reemerging case infectious disease caused Severe Acute Respiratory SyndromeCorornavirus2 Health care worker worldwide higher risk worldwide situation Nepal knowledge attitude health worker certainly mark outcome towards pandemic study aim ass knowledge attitude community health worker towards prevention COVID19 virus METHODS descriptive crosssectional study carried among community health worker various province Nepal semistructured selfadministered questionnaire prepared Google form circulated sampled health worker various social medium platform like face book messenger Instagram gmails total 650 invitation send among 420 responded among 399 provided complete response Responses containing anonymized data collected analyzed using SPSSversion20 result interpreted checked various demographic enabling factor using chisquare test logistic regression model Also ethical approval taken NHRC Nepal Health Research Council protocol registration number 3602020P prior conduction study RESULTS total sample size 450 took 399 response taking consideration inclusion criterion 399 valid response 230 476 male 169 424 female 380 952 employed participant thought wearing PPE reduce chance getting COVID19 majority participant 805 321 responded COVID19 successfully controlled staff receiving excellent support palika high knowledge level Knowledge level significantly associated enabling factor `` support palika P = 0045 459 respondent availability COVID19 response medical item prevention COVID19 respective health facility Also logistic regression analysis revealed odds knowledge level 2 time higher AOR=1913 95 CI 12662891 compared female participant Ref female CONCLUSIONS Proper adequate knowledge attitude towards COVID19 paramount prevention control SARSCOV2 Health care worker knowledgeable COVID19 proactively practicing preventive measure minimize spread infection lack optimistic attitude Hence constantly updated educational program related COVID19 surely contribute improving healthcare worker knowledge attitude towards COVID19,community health care workers (hcw's);enabling factors;knowledge and attitude;palika (rural/ urban municipalities and metropolitan city)
Statistical study impact different meteorological change spread COVID19 pandemic Egypt latitude,34222613,Abstract 1 million illness 70000 death reported due novel COVID19 end first quarter 2020 April 2020 World Health Organization declared COVID19 pandemic striking resemblance COVID19 forerunner SARS MERS well earlier finding impact meteorological condition spread SARS MERS prompted researcher investigate relationship meteorological condition spread COVID19 work statistically studied effect different meteorological parameter average temperature humidity dew point wind speed spread COVID19 pandemic Egypt latitude Algeria Egypt Iran Saudi Arabia Turkey finding revealed correlation several meteorological parameter spread COVID19 contrary popular belief virus disappear temperature rise theory either virus became active Egypt latitude temperature rose humidity became unstable temperature rose summer season loglinear quasiPoisson regression model used estimate relationship studied metrological parameter spread COVID19 finding study ramification future control prevention effort Egypt latitude Graphic abstract,average dew point;average humidity;average temperature;average wind speed;covid-19;metrological factors
Effects HomeBased Lifestyle Intervention Program Cardiometabolic Health Breast Cancer Survivors COVID19 Lockdown,34204528,study aimed evaluate cardiometabolic effect homebased lifestyle intervention LI breast cancer survivor BCSs COVID19 lockdown total 30 BCSs woman stage 0II nonmetastatic aged 535 + 76 year nonphysically active normal left ventricular systolic function risk factor recurrence underwent 3month LI based nutrition exercise Anthropometrics Mediterranean diet adherence physical activity level PAL cardiorespiratory fitness VO2max echocardiographic parameter heart rate variability average standard deviation NN interval ASDNN5 min 24 h very 24 hVLF lowfrequency 24 hLF metabolic endocrine inflammatory serum biomarkers glycemia insulin resistance progesterone testosterone highsensitivity Creactive protein hsCRP evaluated T0 T1 LI LI improvement body mass index kgm 2 T0 = 260 + 50 T1 = 255 + 47 p = 0035 diet Mediet score T0 = 69 + 23 T1 = 88 + 22 p 0001 PAL METminweek T0 = 647 + 547 T1 = 1043 + 564 p 0001 VO2max mLmin 1 kg 1 T0 = 305 + 58 T1 = 334 + 68 p 0001 sign diastolic dysfunction participant T0 = 15 T1 = 10 p = 0007 ASDNN5 min m T0 = 506 + 144 T1 = 553 + 167 p = 0032 24 hLF m 2 T0 = 589 + 391 T1 = 732 + 542 p = 0014 glycemia mgdL T0 = 1008 + 114 T1 = 917 + 110 p 0001 insulin resistance HOMAIR score T0 = 207 + 154 T1 = 153 + 111 p = 0005 testosterone ngmL T0 = 034 + 027 T1 = 024 + 020 p = 0003 hsCRP mgL T0 = 218 + 214 T1 = 175 + 174 p = 0027 parameter change Despite homeconfinement LI based exercise nutrition improved cardiometabolic health BCSs,covid-19;mediterranean diet;breast cancer survivors;cardiotoxicity;cardiovascular fitness;exercise;heart rate variability;home-based lifestyle intervention;secondary and tertiary prevention
Overcoming gap regional collaborative optimize capacity management predict length stay patient admitted COVID19,34350391,Objective Ensuring efficient response COVID19 requires degree intersystem coordination capacity management coupled accurate assessment hospital utilization including length stay LOS aimed establish optimal practice intersystem data sharing LOS modeling support patient care regional hospital operation Materials Methods completed retrospective observational study patient admitted COVID19 followed 12week prospective validation involving 36 hospital covering upper Midwest developed method sharing deidentified patient data across system analysis compared 3 approach generalized linear model GLM random forest RF aggregated system level average identify feature associated LOS compared model performance area ROC curve AUROC Results total 2068 patient included used model derivation 597 patient validation LOS overall median 50 day mean 82 day Consistent predictor LOS included age critical illness oxygen requirement weight loss nursing home admission validation cohort RF model AUROC 0890 GLM model AUROC 0864 achieved good excellent prediction LOS marginally better system average practice Conclusion Regional sharing patient data allowed effective prediction LOS across system however provided marginal improvement hospital average aggregate level federated approach sharing aggregated system capacity average LOS likely allow effective capacity management regional level,covid-19;interoperability;predictive modeling
Prevalence SingleNucleotide Variant SARSCoV2 Korea Impact Diagnostic Sensitivity Xpert Xpress SARSCoV2 Assay,34374354,sensitivity molecular diagnostics could affected nucleotide variant pathogen gene site affected variant monitored report singlenucleotide variant SNV nucleocapsid N gene severe acute respiratory syndrome coronavirus 2 SARSCoV2 ie G29179T impairs diagnostic sensitivity Xpert Xpress SARSCoV2 assay Cepheid Sunnyvale CA USA observed significant difference threshold cycle Ct value envelope E N gene confirmed SNV cause difference using Sanger sequencing SNV G29179T prevalent Korea associated B1497 virus lineage dominant Korea Clinical laboratory aware various SNVs SARSCoV2 genome consider potential effect diagnosis coronavirus disease 2019,coronavirus disease 2019 (covid-19);diagnosis;diagnostic sensitivity;korea;performance;severe acute respiratory syndrome coronavirus 2 (sars-cov-2);single nucleotide variant;xpert xpress sars-cov-2 assay
Stay Home Governance Quality Effectiveness Lockdown,34219863,order control spread COVID19 pandemic first wave pandemic numerous country decided adopt lockdown policy considerable time since measure last introduced first time implemented global scale contemporary information intensive society effectiveness measure may depend citizen perceive capacity government set implement sound policy Indeed lockdown confinement policy general binding measure people used raise serious concern among population reason governance quality could affect perception benefit related government s choice impose lockdown making citizen inclined accept restrict movement present paper empirically investigate relation efficacy lockdown governance quality measured World Governance Indicators result suggest country higher level government effectiveness rule law regulatory quality reach better result adopting lockdown measure Supplementary Information online version contains supplementary material available 101007s11205021027423,covid-19;effects of governance;lockdown;non-pharmaceutical intervention
liberal want curbside pickup conservative Contactless shopping protectionary action COVID19 pandemic,34220344,Consumers showed dramatically increased interest contactless shopping reaction COVID19 pandemic Based protection motivation theory study investigated contactless shopping grew protectionary action COVID19 Findings nationwide online survey n = 311 confirmed impact politicization pandemic consumer response contactless shopping intention significance threat coping appraisal taking protectionary action study add knowledge existing literature contactless shopping protection motivation theory Results imply retailer must invest contactless shopping provide instore shopping environment prioritizes health safety shopper employee decrease threat virus infection shopping However retailer recommended develop different marketing strategy regarding contactless shopping based consumer political orientation,covid-19;contactless shopping;curbside pickup;political orientation;protection motivation theory
forget `` traumatic experience case report transient global amnesia nasopharyngeal swab Coronavirus disease 19,34225676,BACKGROUND Transient global amnesia TGA clinical syndrome characterized temporary shortterm memory loss inability retain new memory usually lasting 2 8 h TGA may related several medical procedure including angiography general anesthesia gastroscopy CASE PRESENTATION report 58yearold woman experiencing TGA one hour execution firsttime nasopharyngeal swab COVID19 Brain MRI showed typical punctate Diffusion Weight Image DWI hippocampal lesion CONCLUSIONS first report TGA execution nasopharyngeal swab COVID19 association lengthen list medical procedure associated TGA discus possible plausible mechanism nasopharyngeal swab could trigger TGA,covid-19;case report;nasopharyngeal swab;sars-cov-2;tga
Possible Vertical Transmission Unsuspected SARSCoV2Infected Mother Newborn,34290917,Although Coronavirus Disease 2019 COVID19 found multiple route transmission limited data exist whether vertical transmission severe acute respiratory syndrome coronavirus 2 SARSCoV2 occur asymptomatic infected mother newborn pregnancy report fullterm newborn girl found positive COVID19 24 hour life subsequently symptomatic fever tachycardia tachypnea elevated lactate dehydrogenase elevated total bilirubin newborn delivered mother suspected COVID19 giving birth developed fever dyspnea five hour delivery found positive COVID19 Upon history collection mother reported recent mild nasal congestion day prior delivery case highlight vertical transmission COVID19 newborn may occur late third trimester mother suspected infection pregnant woman may need screened COVID19 symptom including nonspecific symptom prior admission labor delivery floor order perform diagnostic test recommended safety precaution keep newborn hospital personnel safe,asymptomatic;coronavirus infections;covid-19;infant;maternal-infant infection;newborn health;pregnancy;sars-cov-2;transplacental transmission;vertical infectious disease transmission
AntiPF4 testing vaccineinduced immune thrombocytopenia thrombosis heparin induced thrombocytopenia Results UK National External Quality Assessment Scheme exercise April 2021,34227230,BACKGROUND Vaccineinduced immune thrombocytopenia thrombosis VITT following administration AstraZeneca AZ ChAdOx1 nCOV19 vaccine recently reported associated clinical laboratory feature included thrombosis unusual site thrombocytopenia raised Ddimers positivity IgG antiplatelet factor 4 PF4 antibody OBJECTIVES UK National External Quality Control Assessment Scheme external quality control exercise carried distributing liquid lyophilized sample subject VITT pool sample subject classical heparininduced thrombocytopenia HIT nonVITTnonHIT case 85 center performing HIT testing METHODS Participating center employed locally validated testing method HIT assay RESULTS lyophilized liquid sample found commutable ELISA assay used detection antiPF4 antibody Aeskulisa Stago Hyphen LIFECODES antiPF4 ELISA assay successfully detected VITT antibody whereas Acustar HIT Werfen LIA Stago STIC assay CONCLUSION important clinical laboratory team aware limitation antiPF4 assay using aid diagnosis VITT syndrome,covid-19;heparin;thrombocytopenia;thrombosis;vaccine-induced
Predictors Telemedicine Utilization Pediatric Neurosurgical Population COVID19 Pandemic,34224882,OBJECTIVE wake COVID19 pandemic telemedicine become rapidly adopted neurosurgical community however study examined predictor telemedicine utilization analyze patient variable associated acceptance telemedicine encounter pediatric neurosurgical population early phase COVID19 pandemic METHODS patient seen single institution s outpatient pediatric neurosurgery clinic April 1 2020 July 31 2020 retrospectively reviewed Demographic variable collected patient s first completed encounter Patients participating telemedicine compared seen person Univariate analysis performed using Wilcoxon rank sum test continuous variable Fischer exact test categorical variable logistic regression multivariable analysis performed RESULTS included 682 patient 374 telemedicine 308 person Univariate analysis demonstrated telemedicine visit likely occur earlier study date P 0001 patient participating telemedicine visit likely established rather new patient P 0001 White Caucasian P 0001 Hispanic Latino P 0001 Englishspeaking P 0001 nonMedicareMedicaid recipient P 0001 lower noshow rate P = 0006 live farther hospital P = 0005 Multivariable analysis demonstrated older age P = 0031 earlier appointment date P 001 established patient status P 0001 Englishspeaking P 002 nonMedicareMedicaid insurance P 005 significant predictor telemedicine utilization CONCLUSIONS Significant demographic difference exist among pediatric patient participated telemedicine versus requested inperson visit institution Addressing barrier access crucial promoting health equity continued utilization telemedicine,covid-19;pediatric neurosurgery;telehealth;telemedicine
Role Chest CT COVID19,34221639,December 2019 disease attributed new severe acute respiratory syndrome coronavirus 2 named coronavirus disease 2019 COVID19 broke Wuhan China spread rapidly throughout world CT advocated selected indication tool toward rapid early diagnosis CT pattern COVID19 include ground glass opacity GGO consolidation crazy paving Additional sign include `` rounded morphology lesion vascular enlargement sign nodule fibrous stripe Signs healing organization include subpleural band reticular pattern reversed halo sign traction bronchiectasis Cavitation tree bud sign absent pleural effusion rare high incidence pulmonary embolism associated COVID19 CT finding COVID19 appear follow predictable timeline maximal involvement approximately 611 day symptom onset stage evolution include early stage day 04 GGO predominant abnormality progressive stage day 58 increasing crazy paving peak stage day 913 predominance consolidation absorption phase day 14 gradual absorption consolidation residual GGO subpleural band CT finding COVID19 high sensitivity low specificity determined 98 25 retrospective study 1014 patient low specificity CT diagnosis COVID19 pneumonia due overlap CT finding viral pneumonia infection lung involvement connective tissue disorder drug reaction pulmonary edema hemorrhage,consolidation;crazy paving;ground glass opacities;rounded consolidation;vascular enlargement sign
mass spectrometrybased targeted assay detection SARSCoV2 antigen clinical specimen,34229274,BACKGROUND COVID19 pandemic caused severe acute respiratory syndromecoronavirus 2 SARSCoV2 overwhelmed health system worldwide highlighted limitation diagnostic testing Several type diagnostic test including RTPCRbased assay antigen detection lateral flow assay strength weakness developed deployed short time METHODS describe immunoaffinity purification approach followed high resolution mass spectrometrybased targeted qualitative assay capable detecting SARSCoV2 viral antigen nasopharyngeal swab sample Based discovery experiment using purified virus recombinant viral protein nasopharyngeal swab sample COVID19 positive patient nucleocapsid protein selected target antigen developed automated antibody capturebased workflow coupled targeted highfield asymmetric waveform ion mobility spectrometry FAIMS parallel reaction monitoring PRM assay Orbitrap Exploris 480 mass spectrometer ensemble machine learningbased model determining COVID19 positive sample developed using fragment ion intensity PRM data FINDINGS optimized targeted assay used analyze 88 positive 88 negative nasopharyngeal swab sample validation resulted 98 95 CI = 09220997 8688 sensitivity 100 95 CI = 09581000 8888 specificity using RTPCRbased molecular testing reference method INTERPRETATION result demonstrate direct detection infectious agent clinical sample tandem mass spectrometrybased assay potential deployed diagnostic assay clinical laboratory hitherto limited analysis pure microbial culture FUNDING study supported DBTWellcome Trust India Alliance Margdarshi Fellowship grant IAM151502023 awarded AP generosity Eric Wendy Schmidt,covid-19;diagnostic assays;ion mobility;machine learning;mass spectrometry;sars-cov-2
Posterior reversible encephalopathy syndrome convalescence COVID19,34370958,61yearold woman severe coronavirus disease 2019 COVID2019 confirmed nasopharyngeal realtime reverse transcriptionpolymerase chain reaction RTPCR severe acute respiratory syndrome coronavirus 2 SARSCoV2 required invasive mechanical ventilation 24hours admission intensive care unit stay developed transient acute kidney injury septic shock extubated 22 day day 25 developed generalized tonicclonic seizure Magnetic resonance imaging MRI brain showed bilateral subcortical lesion parietal occipital lobe multiple microand macrobleeds consistent posterior reversible encephalopathy syndrome PRES point RTPCR SARSCoV2 respiratory specimen cerebrospinal fluid negative discharged home 35 day admission oral levetiracetam Control MRI five month discharge showed bilateral focal gliosis followup remains seizurefree levetiracetamPRES observed neurological manifestation acute COVID19 knowledge first PRES case occurring hospitalized patient already recovered COVID19 persistent proinflammatoryprothrombotic state triggered SARSCoV2 infection may lead longstanding endothelial dysfunction resulting delayed PRES patient recovering COVID19 rapid exponential increase survivor acute COVID19 clinician aware delayed postacute neurological damage including PRES,covid-19;cerebrovascular dysfunction;pres;sars-cov-2;seizures
Serial quantitative chest computed tomography imaging prognosticator coronavirus disease 2019 pneumonia,34373176,2019 large outbreak novel coronavirus disease COVID19 occurred China purpose study quantitatively analyze evolution chest computed tomography CT imaging feature COVID19 Nine patient positive realtime reversetranscriptase polymerase chain reaction result included study Totally 19 CT scan analyzed Lesion density lesion volume lesion load higher severe group mild group significantly positive correlation noted major laboratory prognosticator lesion volume load Lesion load first week disease significantly higher severe group p = 003 study revealed several CT feature significantly different severely mildly infected form COVID19 pneumonia CT lesion load value first week infection may applied outcome predictor disease,covid19;computed tomography;coronavirus;prognosticator
Impact COVID19 Admissions Management Patients Atrial Fibrillation Episodes Emergency Department,34199795,BACKGROUND COVID19 pandemic number admission emergency department ED due primary diagnosis atrial fibrillation AF decreased compared prepandemic time principal aim study ass frequency SARSCoV2 infection sinus rhythm restoration among patient arrived ED AF Secondary aim included determining whether patient arriving ED principally due AF delayed presentation whether frequency successful cardioversion AF decreased pandemic period MATERIALS METHODS retrospective analysis medical record patient admitted two hospital EDs due AF JulyDecember 2019 prepandemic period versus JulyDecember 2020 pandemic period performed RESULTS study period 601 ED visit 497 patient made due primary diagnosis AF patient aged 712+135 year 513 male duration AF episode ED admission 10 h 4530 h pandemic period vs 5 h 324 h nonpandemic period p = 0001 shorter duration AF episode ED admission associated successful restoration sinus rhythm pandemic period among patient shortlasting AF treated Phenazolinum restoration sinus rhythm frequent Copernicus Memorial Hospital University Hospital p = 0026 positive SARSCoV2 test found 5 1 patient 2 patient 05 prior diagnosis COVID19 disease noted medical history CONCLUSIONS 1 number AF episode treated two EDs lower pandemic nonpandemic period 2 patient AF appeared ED later AF onset pandemic period 3 Successful cardioversion atrial fibrillation frequent prepandemic period one two hospital 4 difference approach treatment shortlasting AF episode EDs pandemic period may exist two EDs 5 patient SARSCoV2 infection second wave COVID19 pandemic constituted small percentage patient admitted EDs due AF episode,covid-19;atrial fibrillation;cardioversion;emergency department;pandemic
Multisystem Inflammatory Syndrome Children Induction Chemotherapy Newly Diagnosed Pediatric Acute Myeloid Leukemia Concurrent COVID19,34133374,15yearold male presented fatigue weight loss 1 month petechia bruising 2 week diagnosed concurrent new acute myeloid leukemia coronavirus disease 2019 febrile chest computed tomography scan showed ground glass opacity Fever resolved 4 day Polymerase chain reaction test coronavirus disease 2019 became negative 2 day Induction chemotherapy initiated day 8 complicated multisystem inflammatory syndrome child multisystem inflammatory syndrome child managed symptomatic treatment continued chemotherapy Patient recovered end induction bone marrow showed remission leukemia,
Pilot Study Covid Autism Prevalence Clinical Presentation Vaccine Side Effects,34203463,Background Several neurobiological mechanism proposed support hypothesis higher COVID19 risk individual autism spectrum disorder ASD However realworld data available population Methods compared period prevalence MarchMay 2020 symptom presentation COVID19 infection sample individual severe ASD n = 36 staff personnel n = 35 two specialized center AntiSARSCov2 antibody positivity used proxy infection Additionally evaluated vaccine side effect group Results significant difference found prevalence COVID19 positivity autistic participant staff personnel Levels antibody spike protein receptor binding domain significantly different autistic staff participant level antibody Nterminal domain higher autistic individual significant difference prevalence symptomatic COVID19 autistic participant 91 compared staff personnel 923 frequent side effect among autistic participant light fever Conclusions present study provides preliminary data COVID19 transmission presentation ASD data support hypothesis higher susceptibility severity COVID19 people ASD,covid-19;antibody response;autism spectrum disorders;susceptibility;vaccine
Mendelian randomization analysis provides causality smoking expression ACE2 putative SARSCoV2 receptor,34227468,Background understand causal role modifiable lifestyle factor angiotensinconverting enzyme 2 ACE2 expression putative severe acute respiratory syndrome coronavirus 2 SARSCoV2 receptor across 44 human tissuesorgans coronavirus disease 2019 COVID19 susceptibility severity conducted phenomewide twosample Mendelian randomization MR study Methods 500 genetic variant used instrumental variable predict smoking alcohol consumption Inversevariance weighted approach adopted primary method estimate causal association MREgger regression weighted median MR pleiotropy residual sum outlier MRPRESSO performed identify potential horizontal pleiotropy Results found genetically predicted smoking intensity significantly increased ACE2 expression thyroid beta=1468 p=18x10 8 increased ACE2 expression adipose brain colon liver nominal significance Additionally genetically predicted smoking initiation significantly increased risk COVID19 onset odds ratio=114 p=87x10 5 statistically significant result observed alcohol consumption Conclusions work demonstrates important role smoking measured status intensity susceptibility COVID19 Funding XJ supported research grant Swedish Research Council VR201802247 Swedish Research Council Health Working Life Welfare FORTE202000884,ace2 expression;covid-19 related adverse outcomes;alcohol consumption;epidemiology;global health;human;mendelian randomization;smoking intensity;smoking status
Number Syncytial Knots VEGF Expression Placental Villi Parturient Woman COVID19 Depends Disease Severity,34292445,comparative morphological study carried analyze number syncytial knot VEGF expression placental villus parturient woman COVID19 categorized disease severity number syncytial knot assessed specimen stained hematoxylin eosin VEGF expression determined immunohistochemical analysis syncytiotrophoblast villous endothelial cell Morphological study placenta tissue parturient woman COVID19 showed increased number syncytial knot villus indicating development preplacental hypoxia High VEGF expression syncytiotrophoblast vascular endotheliocytes reflects stereotyped response hypoxia underlie development preeclampsialike syndrome number syncytial knot VEGF expression placental villus parturient woman COVID19 depended disease severity,sars-cov-2;vegf;novel coronavirus infection (covid-19);placenta;syncytial knots
Saliva Molecular Testing SARSCoV2 Surveillance Two Italian Primary Schools,34202882,BACKGROUND evidence far proven significant role school SARSCoV2 transmission negative effect closure child adolescent well documented Surveillance mean frequent student staff testing advocated order implement school safety aim report result school surveillance program early detection SARSCoV2 infection pre asymptomatic subject mean molecular salivary testing MST METHODS School surveillance two school Milan Italy carried six week participant received saliva collection kit selfperformed RESULTS 401 student 12 teacher enrolled 5 positive child 5 different class observed case asymptomatic nasopharyngeal swab positive day four case one case resulted negative day positive 3 day later one positive case whole family set surveillance positive child develop symptom family member infected CONCLUSIONS MST might represent efficient way actively survey community order detect asymptomatic case thus limiting SARSCoV2 transmission,covid-19;molecular salivary testing;school surveillance
Psychosocial intervention improving engagement care health behavioural outcome adolescent young people living HIV systematic review metaanalysis,34338417,INTRODUCTION Adolescents young people comprise growing proportion new HIV infection globally yet current approach effectively engage group adolescent HIVrelated outcome poorest among age group Providing psychosocial intervention incorporating psychological social andor behavioural approach offer potential pathway improve engagement care health behavioural outcome among adolescent young people living HIV AYPLHIV METHODS systematic search peerreviewed paper published January 2000 July 2020 conducted four electronic database Cochrane Library PsycINFO PubMed Scopus included randomized controlled trial evaluating psychosocial intervention aimed improving engagement care health behavioural outcome AYPLHIV aged 10 24 year RESULTS DISCUSSION Thirty relevant study identified Studies took place United States n = 18 60 subSaharan Africa Nigeria South Africa Uganda Zambia Zimbabwe Southeast Asia Thailand Outcomes interest included adherence antiretroviral therapy ART ART knowledge viral load data sexual risk behaviour sexual risk knowledge retention care linkage care Overall psychosocial intervention AYPLHIV showed important smalltomoderate effect adherence ART SMD = 03907 95 CI 01059 06754 21 study n = 2647 viral load SMD = 02607 95 CI 04518 00696 12 study n = 1566 psychosocial intervention reviewed demonstrate significant impact retention care n = 8 sexual risk behaviour knowledge n = 13 viral suppression n = 4 undetectable viral load n = 5 linkage care n = 1 among AYPLHIV study measured transition adult service Effective intervention employed various approach including digital lay health worker delivery hold promise scaling intervention context COVID19 CONCLUSIONS review highlight potential psychosocial intervention improving health outcome AYPLHIV However research need conducted intervention effectively reduce sexual risk behaviour AYPLHIV well strengthen engagement care investment needed ensure intervention costeffective sustainable resilient face resource constraint global challenge COVID19 pandemic,adherence to art;adolescent hiv;adolescents and young people;engagement in care;psychosocial interventions;sexual risk behaviour;viral load;viral suppression
overview Novel Coronavirus SARSCoV2 crisis Fiji Correspondence,34375769,Fiji facing second wave COVID19 recording increased number COVID19 case response Fijian Government mainly directed towards obtaining international assistance term expertise vaccination international support necessary country Fijian Government also need consider basic need affected Fijians response article provide overview current COVID19 crisis Fiji justify need reshaping current approach Fijian Government,covid-19;fijian government
SARSCoV2 COVID19 pandemic hospital insight environmental surface contamination disinfectant efficiency estimation plastic waste production,34333010,current COVID19 pandemic caused SARSCoV2 led people around globe implement preventive measure environmental cleaning using alcoholbased material social distancing order prevent minimize viral transmission via fomite role environmental surface contamination viral transmission within hospital ward still debatable especially considering spread new variant virus world present comprehensive study aim investigate environmental surface contamination different ward hospital well efficacy two common disinfectant virus inactivation try produce estimate plastic residue pollution environmental side effect pandemic regard environmental surface contamination 76 sample taken different ward hospital 40 positive sample taken contaminated environmental surface patient bed handle nursing station toilet door handle cell phone patient toilet sink toilet bowl patient s pillow regularlytouched surface pose high risk transmission virus number positive sample also reveals SARSCoV2 survive inanimate surface disinfection ethanol 70 sodium hypochlorite 0001 result correspond time VOC 20201201 lineage B117 emerged hospital considered variant could possibly different trait characteristic level persistence environment plastic waste environmental side effect pandemic also investigated confirmed amount plastic residue single RT PCR confirmatory test COVID19 diagnosis 821778 g plastic residuetest result recommended improving plastic waste management program considering challenge minimizing plastic waste pollution optimization gas control technology incinerator process redesign reduction singleuse plastic PPE etc utmost importance,covid-19;environmental surface contamination;plastic residue;sars-cov-2;voc lineage b.1.1.7
SARSCoV2 Origin Evolution Targeting Inhibition,34222046,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 caused outbreak Wuhan city China quickly spread worldwide Currently specific drug antibody claim cure severe acute respiratory disease SARSCoV2 spike protein recognizes bind angiotensin converting enzyme 2 ACE2 receptor allowing viral RNA enter host cell main protease Mpro involved proteolytic process mature nonstructural protein RNAdependent RNA polymerase RdRp responsible viral genome replication transcription process Owing pivotal physiological role viral invasion replication protein Mpro RdRp regarded main therapeutic target coronavirus disease 2019 COVID19 review carried evolutionary analysis SARSCoV2 comparison mammalinfecting coronaviruses sprung past decade described pathogenic mechanism SARSCoV2 displayed structural detail protein Mpro RdRp well complex structure different chemical inhibitor antibody Structural comparison showed neutralizing antibody small molecule inhibitor could inhibit protein Mpro RdRp Moreover analyzed structural difference SARSCoV2 ancestral protein D614G mutant led second wave infection recent pandemic context outline method might potentially help cure COVID19 provide summary effective chemical molecule neutralizing antibody,sars-cov-2;evolution;pathogenic mechanism;structure;targeting inhibition
Use nanotechnology combating coronavirus,34221822,Recent COVID19 pandemic situation caused due novel severe acute respiratory syndrome coronavirus 2 SARSCoV2 affected global health well economics global attention prevention diagnosis well treatment COVID19 infection would help easing current situation use nanotechnology nanomedicine considered promising due excellent potential managing various medical issue virus major threat Nanoparticles shown great potential various biomedical application prove great use antiviral therapy especially conventional antiviral agent review focus pathophysiology SARSCoV2 progression COVID19 disease followed currently available treatment Use nanotechnology elaborated exploiting various nanoparticles like metal metal oxide nanoparticles carbonbased nanoparticles quantum dot polymeric nanoparticles well lipidbased nanoparticles along mechanism action virus prove beneficial COVID19 therapeutic However need considered use nanotechnologybased approach COVID19 therapeutic aid human immunity fighting infection main function performed immune system combatting infection,antiviral properties;covid-19 disease;coronavirus;nanotechnology;sars-cov-2
Multicentre postimplementation assessment positivepredictive value SARSCoV2 antigenbased pointofcare test used asymptomatic screening continuing care staff,34288728,Frequent screening SARSCoV2 among asymptomatic population using antigenbased point care test APOCT occurring globally limited clinical performance data positive predictive value PPV two APOCT used asymptomatic screening SARSCoV2 among healthcare worker HCW continuing care CC site across Alberta Canada evaluated February 22 May 2 2021 CC site implemented SARSCoV2 voluntary screening asymptomatic HCW Onsite testing Abbott Panbio BD Veritor occurred weekly twice weekly basis Positive APOCT confirmed realtime reversetranscriptase polymerase chain reaction rRTPCR reference method total 71847 APOCT 17689 Veritor 54158 Panbio performed among 369 CC site Eightyseven 012 APOCT positive 39 005 confirmed true positive using rRTPCR Use Veritor Panbio resulted 766 300 false positive detection respectively p 0001 corresponded 234 700 PPV Veritor Panbio respectively Frequent screening SARSCoV2 among asymptomatic HCW CC using APOCT resulted low detection rate high detection false positive Careful assessment risk v benefit APOCT program prevalence infection population need thoroughly considered implementation,
Deceased donor liver transplantation SARSCoV2 positive donor SARSCoV2 positive recipient,34351679,Liver graft deceased donor active SARSCoV2 infection carry unknown risk transmission Recently OPTN Ad Hoc DTAC summary stated decision recover organ donor active COVID19 consider recipient s risk mortality delaying transplantation waiting suitable donor potential risk donorderived SARSCoV2 1 high likelihood persistent community transmission many deceased donor liver SARSCoV2 infected donor transplanted 2,covid-19;sars-cov-2;liver transplant
Safeguarding teenager sexual health service COVID19 pandemic,34226202,OBJECTIVES first aim examine COVID19 restriction movement impacted teenager access local sexual health service SHS second aim audit whether safeguarding assessment carried accessing service remotely METHODS AprilSeptember 2020 consultation number teenager aged 17 year compared 2019 equivalent Service safeguarding assessment standard reviewed teenager receiving telephone consultation first 6 month lockdown AprilSeptember 2020 RESULTS reduction contact service 100 aged 13 year younger 52 aged 14 15 year 31 aged 16 17 year compared month safeguarding assessment either carried service accounted partner community practitioner contact service young people 15 year younger 96 safeguarding assessment carried aged 1617 year CONCLUSIONS reduction consultation age group examined 6 month following lockdown add evidence restriction lockdown barrier young people accessing SHSs consultation safeguarding assessment consistently carried Nevertheless due reduced contact overall likely safeguarding issue remain undisclosed Multiagency safeguarding network telephone consultation low threshold promoting inperson consultation facilitated access SHS robust safeguarding pathway constraint COVID19 pandemic,covid-19;patient care management;public health;risk assessment;sexual health
Neurological manifestation mild moderate case COVID19,34366659,Background coronavirus disease due SARS COVID2 emerged Wuhan city China December 2019 rapidly spread 200 country world global health pandemic primary presentation respiratory cardiac However neurological manifestation also reported tried explore reported neurological manifestation group nonhospitalized mild moderate COVID19 patient contacted 107 patient via phone call email message within 10 day clinical presentation collected data regarded neurological nonneurological symptom disease using questionnaire collected medical information patient Results found 100 patient reported least one neurological symptom first 10 day COVID19 presentation common headache recorded 72 total anosmiadysgeusia reached 52 myalgia 44 fatigue 33 dizziness 32 le common numbness migraine loss concentration seizure Conclusion many neurological manifestation found common COVID19 patient even mild case added increasing report serious case GuillainBarre syndrome acute necrotizing encephalopathy myelitis stroke encephalitis COVID19 patient support CNS invasion virus assures importance neurological assessment COVID19 patient acute phase infection recovery potential neurological sequela,covid-19;home-isolated patients;neurological manifestations
Association Administration IL6 Antagonists Mortality Among Patients Hospitalized COVID19 Metaanalysis,34228774,Importance Clinical trial assessing efficacy IL6 antagonist patient hospitalized COVID19 variously reported benefit effect harm Objective estimate association administration IL6 antagonist compared usual care placebo 28day allcause mortality outcome Data Sources Trials identified systematic search electronic database October 2020 January 2021 Searches restricted trial status language Additional trial identified contact expert Study Selection Eligible trial randomly assigned patient hospitalized COVID19 group IL6 antagonist administered group neither IL6 antagonist immunomodulators except corticosteroid administered Among 72 potentially eligible trial 27 375 met study selection criterion Data Extraction Synthesis prospective metaanalysis risk bias assessed using Cochrane Risk Bias Assessment Tool Inconsistency among trial result assessed using I2 statistic primary analysis inverse varianceweighted fixedeffects metaanalysis odds ratio ORs 28day allcause mortality Main Outcomes Measures primary outcome measure allcause mortality 28 day randomization 9 secondary outcome including progression invasive mechanical ventilation death risk secondary infection 28 day Results total 10930 patient median age 61 year range median 5268 year 3560 33 woman participating 27 trial included 28 day 1407 death among 6449 patient randomized IL6 antagonist 1158 death among 4481 patient randomized usual care placebo summary 086 95 CI 079095 P = 003 based fixedeffects metaanalysis corresponds absolute mortality risk 22 IL6 antagonist compared assumed mortality risk 25 usual care placebo corresponding summary ORs 083 95 CI 074092 P 001 tocilizumab 108 95 CI 086136 P = 52 sarilumab summary ORs association mortality compared usual care placebo receiving corticosteroid 077 95 CI 068087 tocilizumab 092 95 CI 061138 sarilumab ORs association progression invasive mechanical ventilation death compared usual care placebo 077 95 CI 070085 IL6 antagonist 074 95 CI 066082 tocilizumab 100 95 CI 074134 sarilumab Secondary infection 28 day occurred 219 patient treated IL6 antagonist v 176 patient treated usual care placebo accounting trial sample size 099 95 CI 085116 Conclusions Relevance prospective metaanalysis clinical trial patient hospitalized COVID19 administration IL6 antagonist compared usual care placebo associated lower 28day allcause mortality Trial Registration PROSPERO Identifier CRD42021230155,
Epidemiology SARSCoV2 Qatar s primary care population aged 10 year,34225657,BACKGROUND urgent need elucidate epidemiology Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 characterize potential impact Investing characterising SARSCoV2 help plan improve response pandemic Furthermore help identify efficient way managing pandemic avoiding public health policy intervention may unduly restrictive normal activity unnecessarily costly paper describes design report finding population based epidemiological study undertaken characterise SARSCoV2 Qatar using limited resource timely manner METHODS Asymptomatic individual =10 year registered Qatar s publicly funded primary health provider eligible stratified random sampling technique utilized identify study sample Participants invited appointment completed questionnaire provided sample polymerase chain reaction Immunoglobulin G immunoassay test Data collected analyzed calculate point period prevalence sociodemographic lifestyle clinical characteristic RESULTS 18918 individual invited study 2084 participated response rate 108 overall point prevalence period prevalence estimated 16 95 CI 1122 146 95 CI 131162 respectively Period prevalence SARSCoV2 infection considerably different across age group 97198 higher male compared female 162 127 respectively significant variation observed nationality 71 222 municipality 69353 CONCLUSIONS study provides example methodologically robust approach undertaken timely manner limited resource report muchneeded epidemiological data spread SARSCoV2 Given low prevalence rate majority population Qatar remains susceptible Enhanced surveillance must continue place particularly due large number asymptomatic case observed Robust contact tracing social distancing measure key prevent future outbreak,covid-19;epidemiology;primary care;sars-cov2
Simultaneous Sudden Hearing Loss Peripheral Facial Paralysis Patient Covid19,34219500,Although peripheral facial paralysis sudden sensorineural hearing loss common anosmia reported neurological manifestation severe acute respiratory syndrome coronavirus 2 SARSCoV2 present 62yearold serologically COVID19 positive woman seventh eighth nerve involvement showed electrophysiologically Auditory Brainstem Response electroneurography radiologically internal acoustic canal magnetic resonance imaging single case report suggests possible association SARSCoV2 infection simultaneous sudden sensorineural hearing loss isolated facial paralysis However study needed determine whether relationship coincidental occasional,abr;covid-19;enog;peripheral facial paralysis;sudden sensorineural hearing loss
Temporal Relationship COVID19 Infections among Prison Staff Incarcerated Persons Larger Community United States,34206845,BACKGROUND objective examine temporal relationship COVID19 infection among prison staff incarcerated individual general population county prison located among federal prison United States METHODS employed populationstandardized regression fixed effect prison predict number active case COVID19 among incarcerated person using data Federal Bureau Prisons BOP month March December 2020 63 prison RESULTS significant relationship COVID19 prevalence among staff larger community COVID19 prevalence among incarcerated person US federal prison system staff rate low zero COVID19 incidence larger community continues association COVID19 prevalence among incarcerated person suggesting possible presymptomatic asymptomatic transmission staff Masking policy slightly reduced COVID19 prevalence among incarcerated person though association infection among staff community incarcerated person remained significant strong CONCLUSION relationship COVID19 infection among staff incarcerated person show staff vital infection control correctional administrator also focus infection containment effort staff addition incarcerated person,covid-19;correctional staff;incarcerated populations;incarceration;pandemic;prisons
Use Telehealth Orthopedic Consultations Assessments Systematic Review,34292815,result coronavirus disease 2019 COVID19 pandemic telehealth orthopedic care expanding rapidly author sought identify evidence describing effectiveness barrier clinical application telehealth orthopedic assessment consultation MEDLINE PubMed EMBASE Cochrane Library searched inception March 2020 Fortyseven study included common condition evaluated trauma related primary modality videoconferencing Available literature support use telehealth orthopedic consultation assessment yield moderatetohigh patient provider satisfaction accurate examination costeffectiveness reduced wait time commonly reported concern professional liability network security technical issue Given COVID19 pandemic rapid implementation uptake virtual assessment patient care occurred current evidence suggests telehealth capable providing prompt access quality costefficient orthopedic consultation assessment Orthopedics 2021 44 4 198 206,
COVID19 Antimicrobial Resistance Review,34376994,world continues respond coronavirus pandemic COVID19 larger hidden threat antimicrobial resistance AMR lurking behind AMR remains worrisome pathogen causing resistant infection thrive hospital medical facility putting patient risk irrespective severity medical condition compounding management COVID19 study aim provide overview early finding COVID19 AMR well provide recommendation lesson learned toward improving antimicrobial stewardship conducted rapid narrative review published article searching PubMed Google Scholar COVID19 Antimicrobial Resistance predetermined keywords Secondary bacterial infection play crucial role mortality morbidity associated COVID19 Research shown minority COVID19 patient need antibiotic treat secondary bacterial infection Current evidence reiterates need give antibiotic therapy prophylaxis patient mild COVID19 patient suspected confirmed moderate COVID19 illness unless indicated pandemic also brought fore deficiency health system around world come lot lesson one despite advance medicine remain incredibly vulnerable infection limited standard therapy worth thinking context AMR resistant pathogen evolving leading u era untreatable infection necessity continuous research understanding controlling infectious agent well development newer functional antimicrobial need strengthen antimicrobial stewardship program,2019-ncov;covid-19;sars-cov-2;antimicrobial resistance;antimicrobial stewardship;pandemic
Effects Interferon Beta COVID19 adult patient Systematic Review,34216119,BACKGROUND high rate transmission infection coronavirus disease 2019 COVID19 public health emergency major epidemiological concern definitive treatment established vaccination recently begun aim review efficacy safety Interferon Beta IFNbeta patient confirmed COVID19 diagnosis MATERIALS METHODS search PubMed Science Direct Cochrane Clinicaltrialsgov database conducted December 2019 December 2020 review efficacy safety IFNbeta adult patient COVID19 confirmed included randomized controlled trial case report experimental study Correspondences letter editorial review commentary case control crosssectional cohort study include new clinical data excluded RESULTS 66 searched study 8 included review study demonstrated although IFNbeta reduce time clinical response increase discharge rate day 14 decrease mortality day 28 time negative reverse transcription polymerase chain reaction RTPCR shown significantly shortened patient receiving IFNbeta along lower nasopharyngeal viral load patient receiving IFNbeta le significant rise IL6 IFNbeta shown decrease intensive care unit ICU admission rate requirement invasive ventilation severe case improve survival rate compared control group severe adverse event reported review found patient received early treatment IFNbeta experienced significantly reduced length hospitalization mortality ICU admission mechanical ventilation greater chance clinical improvement improved imaging study noted patient received IFNbeta reported death associated addition IFNbeta randomized trial involving significant sample size needed better understand effect IFNbeta survival COVID19 CONCLUSION review identified encouraging data outcome incorporating IFNbeta treat COVID19 patient IFNbeta shown decrease hospital stay s overall length decrease severity respiratory symptom added standard care Also study demonstrated reduce length ICU stay enhance survival rate decrease need invasive mechanical ventilation minor side effect reported neuropsychiatric symptom hypersensitivity reaction However randomized clinical trial large sample size needed ass IFNbeta s benefit precisely,beta-interferon;covid-19;coronavirus;interferon beta;sars-cov-2
Heparan Sulfate Binding Cationic Peptides Restrict SARSCoV2 Entry,34202835,novel severe acute respiratory syndrome coronavirus 2 SARSCoV2 caused global pandemic world striving treatment modality SARSCoV2 understanding virus entry mechanism may help design entry inhibitor may help limit virus spreading Owing importance cellular ACE2 heparan sulfate SARSCoV2 entry aimed evaluate efficacy cationic G1 G2 peptide virus entry inhibition silico binding affinity study revealed possible binding site G1 G2 peptide HS ACE2 required spikeHS spikeACE2 interaction Prophylactic treatment G1 G2 peptide also proved decrease cell surface HS essential virus entry receptor two mechanism confirm possible use cationic peptide inhibit entry SARSCoV2,sars-cov-2;cationic peptide;entry inhibitors;heparan sulfate;pseudotyped virus
Electron Density Analysis SARSCoV2 RNADependent RNA Polymerase Complexes,34203564,work devoted study complementarity electronic structure ligand SARSCoV2 RNAdependent RNA polymerase research methodology based determining 3D map electron density complex using original quantum freeorbital AlteQ approach observed positive relationship parameter electronic structure enzyme ligand complementarity factor enzymeligand complex proposed console application AlteQ complementarity assessment Windows Linux alteqmapenzymeligand4winexe alteqmapenzymeligand4linux available free ChemoSophia webpage,alteq;rna-dependent rna polymerase;sars-cov-2;complementarity;electron density analysis
Differential alteration peripheral lymphocyte subset COVID19 patient upregulation doublepositive doublenegative cell,34221400,Background Viral infection cause alteration total number lymphocyte subset distribution aimed study peripheral blood lymphocyte subset COVID19 patient correlate subset clinical laboratory data may help clarifying pathogenesis develop novel diagnostic prognostic biomarkers COVID19 Methods Twentysix reversetranscription polymerase chain reaction RTPCR confirmed COVID19 patient subjected medical historytaking thorough clinical examination Laboratory test included complete blood count dimer ferritin Creactive protein CRP Chest CT used diagnose COVID19 pneumonia Lymphocyte subset compared 20 healthy control using flow cytometry Results Leucopenia relative neutrophilia lymphopenia eosinopenia together marked elevation neutrophillymphocyte ratio observed COVID19 patient marked reduction observed cell including CD4 CD8 cell natural killer NK natural killer cell NKT Doublepositive DPT cell doublenegative DNT cell B cell elevated patient relative lymphocyte subset Conclusion Immuneinflammatory parameter utmost importance understanding pathogenesis provisional diagnosis COVID19 Yet adequate care must taken interpretation vast discrepancy observed study even locality study needed clarify role B cell DPT DNT cell pathogenesis control COVID19,covid-19;sars-cov-2;double-negative t cells;double-positive t cells;lymphocyte subsets
Women s consideration experience breast cancer screening surveillance COVID19 pandemic United States focus group study,34217409,COVID19 pandemic resulted numerous change delivery healthcare service including breast cancer screening surveillance Although facility implemented number strategy provide service woman s thought experience related breast cancer screening surveillance pandemic well known focus group study woman across seven state recruited Breast Cancer Surveillance Consortium aim remedy gap information Thirty woman ranging age 31 69 participated five virtual focus group eight prior breast cancer first three focus group covered range topic related screening surveillance pandemic last two group covered experience review sample communication woman screening surveillance pandemic obtain reaction recommendation half woman screening surveillance pandemic Coding analysis resulted nine theme three topic area decision factor screening experience preferred communication Themes included weighing risk COVID19 versus cancer feeling screening surveillance mostly safe barrier may heightened feeling safe undergoing screening receiving range pandemicspecific communication none lot wanting communication personalized clear concise Based finding provider facility assure woman pandemic safety measure review method content communication ass barrier screening may amplified pandemic including anxiety access,
LongTerm Longitudinal Evaluation Six Commercial Immunoassays Detection IgM IgG Antibodies SARS CoV2,34206895,number serological assay SARSCoV2 skyrocketed past year Concerns raised regarding performance characteristic depending disease severity time analysis postsymptom onset PSO Thus independent validation using unbiased sample selection required meaningful serology data interpretation aimed ass clinical performance six commercially available assay seroconversion dynamic humoral response SARSCoV2 infection study included 528 serum sample 156 patient followup visit six month PSO 161 serum sample healthy people IgGtotal antibody positive percentage increased remained 95 six month chemiluminescent immunoassay CLIA IgG antiS1S2 electrochemiluminescent assay ECLIA total antiNP used early time point PSO chemiluminescent microparticle immunoassay CMIA IgM antiS achieved best sensitivity IgM IgG appear simultaneously circumstance performed parallel sensitivity increase severe moderate clinical form significantly associated higher seropositivity percentage antibody level High specificity found evaluated assay sensitivity variable depending time PSO severity disease detection method targeted antigen,clia;cmia;covid-19;eclia;elisa;igg;igm;sars-cov-2;serological assays
COVID19related downscaling inhospital liver care decreased patient satisfaction increased liverrelated mortality,34222742,Background Aims COVID19 pandemic necessitated downscaling inhospital care prohibit spread severe acute respiratory syndromecoronavirus2 SARSCoV2 assessed patient perception quality care telesurvey cohort 1 written questionnaire cohort 2 ii analyzed trend elective nonelective admission prior 122019022020 032020052020 COVID19 pandemic Austria Methods Twohundred seventynine outpatient recruited cohort 1 138 patient cohort 2 admission 122019 052020 Division GastroenterologyHepatology Vienna General Hospital analyzed Results Thirtytwo point six percent n=91279 cohort 1 725 n=95131 cohort 2 telemedical contact 595 n=166279 682 n=90132 facetoface visit 241 n=32133 needed acute medical help healthcare restriction however 573 n=5189 reported contacting physician COVID19 difficult impossible Patientreported satisfaction treatment decreased significantly restriction cohort 1 visual analog scale VAS 01090+16 to86+22 p 0001 nonsignificantly cohort 2 VAS01089+16 to87+21 p=0182 Despite fewer hospital admission COVID19 proportion nonelective admission +63 ICUadmissions +67 increased Cirrhotic patient nonelective admission COVID19 significantly higher MELD 255 142 vs170 IQR88 p=0003 DeltaMELD difference last MELD 39+63vs87+64 p=0008 required immediate intensive care frequently 267 vs56 p=0034 significantly increased 30day liverrelated mortality 300 vs83 p=0028 Conclusions COVID19 pandemic impact quality liver care evident decreased patient satisfaction hospitalization sicker ACLD patient increased liverrelated mortality Strategies improved telemedical liver care preemptive treatment cirrhosisrelated complication needed counteract COVID19associated restriction inhospital care,covid-19;sars-cov-2;advanced chronic liver disease;cirrhosis;corona virus
Patients smoke ignore addiction take care patient,34346630,Smoking cessation yield large health gain especially time COVID19 Compared measure stop COVID19 tobacco control lagging behind studied smokingcessationcare Netherlands using qualitative interview physician N=55 questionnaire among physician healthcare provider HCPs N=883 2017 responsible Three actor emerged patient smoke end responsible quitting HCP quitadvice counseling referral government create society stimulates `` smokefree Many HCPs ask smoking advise quit taskdivision unclear smoking cause multiple disease part multiple discipline specialization HCPs see smoking serious addiction inclined ensure adequate smokingcessationcare patient Fortunately positive development well within healthcare society way contribute,
Identifying compound prevent binding SARSCoV2 Sprotein ACE2,34358993,investigated compound selected molecular docking identify specific treatment COVID19 decrease interaction angiotensinconverting enzyme 2 ACE2 receptorbinding domain RBD SARSCoV2 Five compound interact ACE2 amino acid Gln24 Asp30 His34 Tyr41 Gln42 Met82 Lys353 Arg357 evaluated using specific binding assay effect interaction ACE2 RBD compound labeled ED demonstrated favorable ACE2binding IC50 3195 muM ED cytotoxicity evaluated using PC3 cell MTT assay consistent low theoretical toxicity previously reported propose ED mainly interacts His34 Glu37 Lys353 ACE2 inhibitory effect interaction ACE2 RBD Sprotein recommend investigation develop ED potential drug adjuvant COVID19 treatment,ace2;covid-19;docking;inhibitors of ace2/rbd;sars-cov-2
Coping Oral Tongue Cancer COVID19 Infection,34220559,date April 19 2021 coronavirus disease 2019 COVID19 caused 140886773 confirmed case 3000000 death worldwide since beginning pandemic Oncology patient usually frail due fear prognosis recurrence outcome treatment Thus coping cancer complicated process necessary overcome oncological challenge even case Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 disease brief case report middleaged man affected advanced oral tongue cancer COVID19 describing experience cancer diagnosis surgical treatment rehabilitation hospital quarantine COVID19 Besides traumatic experience due functional alteration breathing eating speaking caused major surgery concurrent facial disfigurement patient face COVID19 diagnosis implied hospital social isolation aim perspective work focus role psychological support management hospital distress related COVID19 psychophysical loneliness alienation experience support anticipate patient oncological surgery treatment implemented telemedicine case isolation hospital discharge,coronavirus sars-cov-2;coping;loneliness;oral tongue cancer;psychological distress;telemedicine
Outcomes Prognostic Factors Large Cohort Hospitalized Cancer Patients COVID19,34228508,PURPOSE Patients cancer increased risk unfavorable outcome COVID19 Knowledge outcome determinant severe acute respiratory syndrome coronavirus 2 infection population essential risk stratification definition appropriate management objective evaluate prognostic factor allcause mortality patient diagnosed cancer COVID19 METHODS consecutive patient cancer hospitalized institution COVID19 included Electronic medical record reviewed clinical laboratory characteristic potentially associated outcome RESULTS Five hundred seventysix consecutive patient cancer COVID19 included present study overall inhospital mortality rate 493 demonstrated Clinical factor associated increased risk death COVID19 age 65 year Eastern Cooperative Oncology Group performance status 0 zero best supportive care primary lung cancer presence lung metastasis Laboratory finding associated higher risk unfavorable outcome neutrophilia lymphopenia elevated level Ddimer creatinine Creactive protein AST CONCLUSION high mortality rate patient cancer diagnosed COVID19 demonstrated present study emphasizing need close surveillance group patient especially unfavorable prognostic characteristic,
Telehealth COVID19 perspective alcohol drug nurse,34133036,AIM study aimed explore experience alcohol drug nurse transitioning telehealth due COVID19 pandemic BACKGROUND COVID19 caused immense disruption healthcare service reduce viral transmission many service moved offsite care delivery modality telehealth DESIGN used qualitative descriptive design study METHODS Secondary analysis semistructured interview alcohol drug nurse Australia New Zealand n = 19 conducted July August 2020 Data analysed using thematic analysis reported using COREQ guideline RESULTS Three identified facetoface contact ceased client Changing service delivery job ca nt see `` anxious shift service delivery lot Indigenous people nt like FaceTiming Challenges delivery service telehealth CONCLUSION Participants study reported challenge transitioning telehealth modality perceived loss therapeutic communication difficulty assessing risk healthcare consumer domestic violence challenge delivering telehealth care marginalized consumer cohort need overcome telehealth considered successful alcohol drug treatment However telehealth successful adjunct existing practice nurse working consumer regional remote area consumer preferred method service delivery IMPACT Nurses study described substantial issue delivery alcohol drug treatment via telehealth including perception telehealth barrier addressing risk consumer use alcohol drug difficulty working therapeutically beneficial way via telehealth Telehealth mean reduce viral transmission reduction facetoface contact although may useful service function may detrimental clinical service nurse provide,covid-19 pandemic;alcohol and other drug (aod) nursing;nursing workforce;substance use disorders;telehealth;telemedicine
Recent advance detection technology COVID19,34215093,Corona Virus Disease 2019 COVID19 highly infectious respiratory illness caused SARSCoV2 spread around world month became worldwide pandemic Quick accurate diagnosis infected patient important controlling transmission addition commonly used Realtime reversetranscription polymerase chain reaction RTPCR detection technique diagnostic technique also emerging endlessly article review current diagnostic method COVID19 discus advantage disadvantage provides important reference diagnosis COVID19,covid-19;detection technologies;sars-cov-2
Dentistry pathway coronaviruses transmission review,34337110,nCoV19 short period time lower two month spread pandemic world novel type Coronavirus show coughing sneezing fatigue respiratory symptom similar cold illness killed 100000 people However many protocol established minimize number infected people without border regardless nationality virus spread country review broad mechanistic interdisciplinary consideration dentistry pathway transmission physiology effective available drug biological inhibiting pathway discussed Among many reason caused higher rate spreading dental service surgery involve professionalpatient close contact could seen one probable pathway transmission virus According recently reported literature blueprint many individual instrumental reason dentistry could observed nCoV19 infection spreading raise concern professional efficiency conventional antiviral method result many study attributed fact superhydrophobic antiviral material surface potential candidate designing dentistry instrument antiviral property,dental;infection;transmission;virus;ncov-19
PlantBased Phytochemical Screening Targeting Main Protease SARSCoV2 Design Effective Potent Inhibitors,34206970,Currently worldwide pandemic declared response spread coronavirus disease 2019 COVID19 fatal fastspreading viral infection caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 low availability efficient vaccine treatment option resulted high mortality rate bringing world economy knee Thus mechanistic investigation drug capable counteracting disease high demand main protease pro expressed SARSCoV2 targeted development potential drug candidate due crucial role played pro viral replication transcription generated phytochemical library containing 1672 phytochemical derived 56 plant reported antiviral antibacterial antifungal activity molecular docking program used screen top three candidate compound epicatechin3Ogallate psitaraxasterol catechin gallate respective binding affinity 84 85 88 kcalmol Several active site targeted protein including Cys145 His41 Met49 Glu66 Met165 found interact top three candidate compound multiple simulation profile rootmeansquare deviation rootmeansquare fluctuation radius gyration solventaccessible surface area value supported inflexible nature docked proteincompound complex toxicity carcinogenicity profile assessed showed epicatechin3Ogallate psitaraxasterol catechin gallate favorable pharmacological property adverse effect finding suggest compound could developed part effective drug development pathway treat COVID19,admet;sars-cov-2;dynamics simulation;molecular docking;phytochemicals
Computational IntelligenceBased Model Mortality Rate Prediction COVID19 Patients,34198547,COVID19 outbreak currently one biggest challenge facing country around world Millions people lost life due COVID19 Therefore accurate early detection identification severe COVID19 case reduce mortality rate likelihood complication Machine Learning ML Deep Learning DL model shown effective detection diagnosis several disease including COVID19 study used ML algorithm Decision Tree DT Logistic Regression LR Random Forest RF Extreme Gradient Boosting XGBoost KNearest Neighbor KNN DL model containing six layer ReLU output layer sigmoid activation predict mortality rate COVID19 case Models trained using confirmed COVID19 patient 146 country Comparative analysis performed among ML DL model using reduced feature set best result achieved using proposed DL model accuracy 097 Experimental result reveal significance proposed model baseline study literature reduced feature set,covid-19;deep learning;machine learning;mortality rate;prediction
Impact COVID19 pandemic prevalence respiratory virus child lower respiratory tract infection China,34344406,BACKGROUND multifaceted nonpharmaceutical intervention NPIs taken COVID19 pandemic decrease spreading SARSCoV2 impact prevalence virus study aimed explore prevalence common respiratory virus among hospitalized child lower respiratory tract infection LRTI China COVID19 pandemic METHODS Respiratory specimen obtained child LRTI Children s Hospital Fudan University detection respiratory syncytial virus RSV adenovirus ADV parainfluenza virus PIV 1 3 influenza virus FluA influenza virus B FluB human metapneumovirus MPV rhinovirus RV data analyzed compared year 2020 COVID19 pandemic 2019 COVID19 pandemic RESULTS total 7107 patient enrolled including 4600 patient 2019 2507 patient 2020 Compared 2019 observed unprecedented reduction RSV ADV FluA FluB MPV infection 2020 despite reopening school June 2020 However RV infection significantly increased 2020 sharp increase observed especially reopening school Besides PIV infection showed resurgent characteristic September 2020 mixed infection significantly le frequent 2020 compared year 2019 CONCLUSIONS NPIs COVID19 pandemic great impact prevalence common respiratory virus China Meanwhile need cautious possible resurgence respiratory virus COVID19 restriction relaxed,covid-19;children;nonpharmaceutical interventions;prevalence;respiratory viruses
AntiCoronavirus Vaccines Past Investigations SARSCoV1 MERSCoV Approved Vaccines BioNTechPfizer Moderna OxfordAstraZeneca others Development SARSCoV2 Infection,34355678,aim review article summarize knowledge available date prophylaxis achievement fight Coronavirus work give overview reported recent literature vaccine investigation already developed like BNT162b2 mRNA1273 ChAdOx1S effective pathogenic Coronaviruses SARSCoV1 MERSCoV1 SARSCoV2 course particular attention paid development already use combat current COVID19 COronaVIrus Disease 19 pandemic main objective make contribution comprehension additionally molecular level currently ready antiSARSCoV2 prophylactic intervention well provide reader overall picture innovative approach development vaccine could general utility fight pathogenic Coronaviruses,bnt162b2;biontech/pfizer;covid-19;chadox1-s.;coronavirus;hcov;mers-cov;moderna;oxford/astrazeneca;sars-cov;sars-cov-2;coronavirus infections;mrna-1273;pandemics;vaccine
Airliquid interface culture healthy diseased human respiratory tract promise challenge future direction,34345878,Airliquid interface ALI culture model currently represent valid instrument recreate typical aspect respiratory tract vitro healthy diseased state help reducing number animal experiment therefore supporting 3R principle review discus ALI culture cocultures derived immortalized well primary cell used study common disorder respiratory tract term pathophysiology drug screening article display ALI model used simulate inflammatory lung disease chronic obstructive pulmonary disease COPD asthma cystic fibrosis lung cancer viral infection also includes focus ALI culture described literature studying respiratory virus SARSCoV2 causing global Covid19 pandemic time writing review Additionally commercially available model ALI culture presented Ultimately aim review provide detailed overview ALI model currently available critically discus context prevalent disease respiratory tract,3d co-culture models;sars cov-2;air-liquid interface;lung;pulmonary administration;respiratory tract
Establishing quality evaluation system nursing management fever clinic Delphi method,34216501,AIM aim study construct quality evaluation system fever clinic nursing management BACKGROUND Fever clinic first line defence epidemic COVID19 China METHODS study combine Delphi method analytic hierarchy process Delphi method used carry two round consultation 18 expert select revise indicator level Analytic hierarchy process used calculate weight indicator level RESULTS quality evaluation system nursing management fever clinic built using Delphi method includes five firstlevel index 14 secondlevel index 82 thirdlevel index tworound expert consultation used build indicator recovery rate expert questionnaire two round respectively 100 94 expert authority coefficient 0925 Kendall coefficient two round respectively 0205 0162 P 001 weight analysis show health management nursing staff 02803 disinfection isolation treatment medical waste 02803 important followed nursing post management personnel training 01889 configuration management equipment 01427 patient consultation management nursing 01078 CONCLUSION quality evaluation system nursing management constructed fever clinic used put forward specific objective quantifiable evaluation criterion nursing quality fever clinic management better meet need epidemic prevention control certain application promotion value IMPLICATIONS NURSING MANAGEMENT establishment improvement quality system fever clinic care management help respond outbreak COVID19,delphi method;analytic hierarchy process;fever clinic;nursing management;quality evaluation
observational study cohort citizen receiving AZD1222 vaccine SARSCoV2,34290884,retrospective study cohort 67 subject vaccinated AZD1222 retrospectively observed Consistently published finding serious adverse event reported adverse event reported fever muscle ache andor pain site injection resolved day 8 note citizen prescribed lowdose aspirin even heparin thrombosis prevention also found variation laboratory test result full blood count chemistry day 1 compared day 8 Physicians aware prevention therapy thrombosis currently recommended given low incidence side effect Additional study warranted interpret finding,azd1222;covid-19;sars-cov-2;adverse events;coagulation
variant GuillainBarre syndrome SARSCoV2 vaccination AMSAN,34370408,Introduction Coronavirus disease 2019 COVID19 respiratory infection rapidly become global pandemic vaccine SARSCoV2 developed great success article would like present patient developed GuillainBarre syndrome GBS serious complication receiving inactive SARSCoV2 vaccine CoronaVac Case report 76yearold male patient presented emergency department nine day progressive limb weakness Two week prior admission received second dose CoronaVac vaccine Motor examination revealed decreased extremity strength 35 lower extremity versus 45 upper extremity Deep tendon reflex absent four extremity Nerve conduction study showed predominantly reduced amplitude motor sensory nerve consistent AMSAN acute motor sensory axonal neuropathy Conclusion Clinicians aware neurological complication side effect associated COVID19 vaccination early treatment option,amsan;guillain-barre syndrome;sars-cov-2 vaccines
COVID19 Solid Organ Transplant Recipients Review Current Literature,34220357,Purpose review approach ongoing organ transplantation management COVID19 solid organ transplant recipient SOTR evolved tremendously since pandemic s beginning summarize current literature surrounding virology SARSCoV2 epidemiology COVID19 transplant recipient review clinical feature complication COVID19 SOTR discus safety efficacy current therapy candidate vaccine population Recent finding Despite initial suspension organ transplantation early 2020 routine donor testing decrowding hospital allowed transplant activity resume prepandemic rate COVID19associated mortality SOTR similar general population lower patient endorgan disease awaiting transplant optimal approach immunosuppression SOTR COVID19 unknown disease severity may influence management decision Many vaccine development likely safe immunocompromised host though postmarketing investigation required determine efficacy SOTR Summary Though multiple unique consideration care SOTR COVID19 immunosuppression appear detrimental impact overall outcome Organ transplantation remains lifesaving intervention safely performed despite global pandemic,covid-19;immunosuppression;sars-cov-2;solid organ transplant
Acute disseminated encephalomyelitis COVID19 systematic synthesis worldwide case,34371208,Acute disseminated encephalomyelitis ADEM reported coronavirus disease 2019 COVID19 review systematically included worldwide reported case association included 30 case report pediatric adult explored epidemiological clinical evidence described time diagnosis clinical imaging laboratory feature response treatment regimen difference regarding severity Also original case report presented Neurologists must alert occurrence multifocal neurological symptom without encephalopathy patient recovered COVID19 Timely MRI study performed establish diagnosis consider early corticosteroidbased treatment,acute disseminated encephalomyelitis (adem);autoimmune disease;central nervous system (cns);coronavirus disease 2019 (covid-19);demyelinating disease;sars-cov-2
EpitopeSpecific Response Human Milk Immunoglobulins COVID19 Recovered Women,34198820,breastfeeding infant mother infected SARSCoV2 become dramatic healthcare problem recommends infected woman abandon breastfeeding however still risk contact transmission Convalescent donor milk may provide defense aforementioned issue eliminate consequence artificial feeding Therefore vital characterize epitopespecific immunological landscape human milk woman recovered COVID19 carried comprehensive ELISAbased analysis blood serum human milk maternity patient recovered COVID19 different trimester pregnancy found patient predominantly contained SARSCoV2 Nproteinspecific immunoglobulin manifested antibody antigen tested proteinspecific timedependent manner Women recovered COVID19 trimester III showed noticeable decrease number milk sample sIgA specific Nprotein linear NTD RBDSD1 epitope showed increase sample RBD conformationdependent sIgA Santigens found solely induce sIgA1 response whereas Nprotein sIgA1 sIgA2 subclass involved 100 33 case Overall antibody immunological landscape convalescent donor milk suggests may potential defense agent COVID19 infant conferring passive immunity,n-protein;s-protein;sars-cov-2;breastfeeding;class a immunoglobulins;class g immunoglobulins;class m immunoglobulins;human milk;passive immunity;receptor-binding domain (rbd)
Intracellular Routing Recognition LipidBased mRNA Nanoparticles,34202584,Messenger RNA mRNA extensively used gene therapy vaccination due safety DNA following way lack integration risk cytoplasmic expression transient expression compatible fine regulation However clinical application mRNA limited fast degradation nuclease activation detrimental immune response Advances mRNA application recent approval COVID19 vaccine fueled optimization mRNA sequence development mRNA delivery system Although delivery system mRNA sequence optimization abundantly reviewed understanding intracellular processing mRNA mandatory improve application focus lipid nanoparticles LNPs advanced nanocarriers delivery mRNA review mRNA therapeutic potency affected interaction cellular protein intracellular distribution,intracellular routing;lipid-based nanoparticles;mrna delivery
Anaphylaxis digital medicine,34292178,PURPOSE REVIEW Digital medicine mHealth aim help patient healthcare provider HCPs improve facilitate provision patient care encompasses equipmentconnected medical device mHealth service mHealth apps apps updated review digital health anaphylaxis proposed RECENT FINDINGS anaphylaxis mHealth used electronic health record registriesIt greatly benefit new International Classification Diseases11 rule artificial intelligence Telehealth revolutionised coronavirus disease 2019 pandemic lesson learnt extended shared decision making anaphylaxis nonvalidated apps exist urgent need develop validate tool SUMMARY Although digital health appears great importance anaphylaxis still insufficiently used,
Reappraisal trifluperidol Nsp3 potential therapeutic novel COVID19 molecular docking dynamic study,34290823,Novel COVID19 highly infectious disease caused recently discovered SARSCoV2 fastspreading disease urgently requires therapeutic current study employed computational regression method target ADPribose phosphatase ADRP domain Nsp3 using FDAapproved drug Identified lead investigated using molecular dynamic simulation MDS screening MDS result suggest trifluperidol could novel inhibitor ADRP domain Nsp3 Trifluperidol could therefore used help control spread COVID19 either alone combination antiviral agent,adrp;fda drugs;nsp3;pca;sars-cov-2;molecular docking;molecular dynamic simulation
Lessons COVID19 South Africa Keeping environment clean first law health,34212751,wake coronavirus disease 2019 COVID19 pandemic link poor hygiene unclean environment human health overemphasised particularly South Africa high incidence infectious disease overburdened health system One controllable factor often overlooked poor disposal litter waste management adverse effect public health wearing mask regular handwashing sanitising well making sure neighbourhood public space clean safe spread COVID19 disease prevented,covid-19;hygiene;infection prevention;infectious disease;litter
COVID19 review current knowledge regarding exposure quarantine isolation preventive measure,34349986,Deeper understanding spread morbidity fatality development immune response associated coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 necessary order establish appropriate epidemiological clinical response Exposure control represents key part combat COVID19 effectiveness current therapeutic option remains partial Since preventive measure sufficiently able slow pandemic article explore pertinent knowledge gap overall looking effective vaccination strategy way Early strategy may need rely counting convalescent protected order speed immunization whole population,coronavirus disease 2019;epidemiology;exposure;infectivity;isolation;quarantine;severe acute respiratory syndrome coronavirus 2
Computational analysis TMPRSS2 expression normal SARSCoV2infected human tissue,34284028,transmembrane serine protease 2 TMPRSS2 key molecule SARSCoV2 invading human host cell provide insight SARSCoV2 infection various human tissue understand potential mechanism SARSCoV2 infection investigated TMPRSS2 expression various normal human tissue SARSCoV2infected human tissue Using publicly available datasets performed computational analysis TMPRSS2 expression level 30 normal human tissue compared male female younger age = 49 year older age 49 year population tissue found TMPRSS2 expression level highest prostate stomach pancreas lung small intestine salivary gland TMPRSS2 protein relatively high expression level parathyroid gland stomach small intestine pancreas kidney seminal vesicle epididymis prostate However TMPRSS2 expression level significantly different female male younger older population tissue pathway enriched TMPRSS2upregulated pantissue mainly involved immune metabolism cell growth proliferation stromal signature cancer disease Many cytokine gene displayed positive expression correlation TMPRSS2 pantissue including TNFalpha IL1 IL2 IL4 IL7 IL8 IL12 IL18 IFNalpha MCP1 GCSF IP10 analyzed TMPRSS2 expression level nasopharyngeal swab SARSCoV2infected patient TMPRSS2 expression level showed significant difference male female younger older patient However significantly lower SARSCoV2infected healthy individual patient viral acute respiratory illness Interestingly TMPRSS2 expression level positively correlated enrichment level four immune signature B cell CD8 + cell NK cell interferon response SARSCoV2infected patient likely negatively correlated normal lung tissue data may provide insight mechanism SARSCoV2 infection,gene co-expression network;gene expression profiles;immune signatures;pathway and gene ontology;sars-cov-2;transmembrane serine protease 2
SARSCoV2 Skin Pathologist s Point View,34200112,SARSCoV2 pandemic dramatically changed life habit month advanced efficient health system world overwhelmed infectious disease caused 326 million death 156 million case worldwide Although lung frequently affected organ skin also resulted target body district much suggest may real `` sentinel COVID19 disease present 17 case skin manifestation studied analyzed recent month Department immunohistochemical investigation carried sample S1 spikeprotein SARSCoV2 well electron microscopy investigation showing evidence virion within constituent cell eccrine sweat gland endothelium small blood vessel Finally conduct brief review COVIDrelated skin manifestation confirmed immunohistochemistry andor electron microscopy described literature,covid-19;sars-cov-2;eruption;skin
Cardiac Events Potentially Associated Remdesivir Analysis European Spontaneous Adverse Event Reporting System,34202350,Remdesivir recommended hospitalized patient COVID19 already reported Summary Product Characteristics remdesivir s safety concern hepatoxicity nephrotoxicity related However case raised concern regarding potential cardiac event associated remdesivir therefore Pharmacovigilance Risk Assessment Committee European Medicines Agency requested investigate available data Therefore analyzed Individual Case Safety Reports ICSRs collected EudraVigilance database focusing cardiac adverse event April December 2020 1375 ICSRs related remdesivir retrieved EudraVigilance 863 628 related male 433 adult patient total 822 AEs N = 2604 serious one third total ICSRs N = 416 303 fatal outcome frequently reported event referred hepatichepatobiliary disorder 194 renal urinary disorder 111 cardiac event 84 Among 221 cardiac ICSRs 69 reported fatal outcome drug cardiovascular disorder reported suspectedconcomitant together remdesivir 166 ICSRs 751 62 fatal Moreover mean time overall cardiac event 33 day +22 Finally disproportionality analysis showed twofold increased risk reporting cardiac adverse event associated remdesivir compared hydroxychloroquine azithromycin study showed remdesivir could associated risk cardiac event suggesting potential safety signal completely evaluated yet study needed confirm finding,cardiac events;remdesivir;safety monitoring
Repurposing colchicine s journey view drugtodrug interaction review,34285885,Colchicine s medical evolution historically bound Mediterranean basin since remarkable researcher region underscored valuable property passing year colchicine became essential pharmaceutical substance treatment rheumatologic cardiovascular disease light recent finding therapeutic value colchicine grown clinical practice colchicine remains underutilized view proven efficacy safety complex pharmacokinetics multifaceted antiinflammatory role remain investigation current review address safe administration colchicine view key drug drug interaction Finally briefly presenting colchicine s future potential application,"acs, acute coronary syndrome;cad, coronary artery disease;covid-19, coronavirus disease - 19;colchicine;doacs, direct oral anticoagulants;history;inflammation;lp-pla2, lipoprotein-associated phospholipase a2;nlrp3, nod-, lrr- and pyrin domain-containing protein 3;pharmacokinetics;rock, rho-associated protein kinase;repurposing;safety;egfr, estimated glomerular filtration rate"
prospective study COVID19 convalescent plasma donor CCP recruitment strategy resource constrained blood centre,34226835,Background Objectives COVID19 pandemic spread across 87 million people 18 million death world definite treatment modality use convalescent plasma become increasingly popular worldwide study aimed identify appropriate strategy donor recruitment evaluate appropriateness preset plasma donation guideline Material Methods prospective study conducted May September 2020 donor recruited following two circumstance Group patient postCOVID19 followup clinic Group II patient recovered COVID19 recruited mass electronic medium preset donor selection criterion laboratory investigation designed according national international guideline Approximately 500 ml COVID19 convalescent plasma CCP collected recovered individual group two different cell separator overall donor s attendance rate deferral rate adverse event donor compliance analysed compared two group Results significant difference attendance relation registration group P 00001 Donor deferral significantly higher group II compared group single frequent cause donor deferral low antibody index P = 00001 total donor adverse event rate CCP donation significantly lower compared routine plateletpheresis procedure donor s compliance blood centre s protocol satisfactory group Conclusion Recruitment patient postCOVID19 followup clinic effective general recruitment mass electronic medium convalescence plasma donation resourceconstrained blood centre,convalescent plasma;donor recruitment;plasmapheresis
Medical Oncology Patient Perceptions Telehealth Video Visits,34288697,PURPOSE Telehealth medical oncology expanded secondary COVID19 pandemic However quantitative research medical oncology telehealth use show conflicting result patient satisfaction whereas qualitative data sparse qualitative study aimed identify factor influencing patient acceptability video visit medical oncology care onset expansion telehealth COVID19 pandemic METHODS Semistructured interview conducted November 2019 April 2020 20 patient participated telehealth visit medical oncology provider Thomas Jefferson University RESULTS 20 participant 13 65 female 15 75 White mean standard deviation age 605 year 118 Patients identified convenience anxiety COVID19 provider preference positively influencing acceptability video visit however patient noted limitation provider connection physical examination visit length disadvantage Regarding receipt serious bad news preferred video visit privacy immediacy result news processing family comfort Others preferred inperson encounter provider support ability receive written information inperson referral CONCLUSION Patientperceived factor influencing general acceptability appropriateness serious bad news delivery future us telehealth unique individual shared common theme Understanding patient s perspective telehealth acceptability tailoring use preference critical continued utilization research needed understand address reason lack telehealth uptake among certain patient,
Transplacental COVID Antibodies Cytokine Storm Newborn Presence Antibodies Indicate Protection Always,34227782,Pregnant woman one important group need special attention Covid19 pandemic Women s physiological change immune system pregnancy put neonate increased risk negative outcome COVID19 infection data still scarce comment upon case asymptomatic SARSCoV2 infected mother effect neonate reported first case evidence cytokine storm neonate demonstrated presence transplacental acquired IgG antibody,
COVID19 dental care know,34377355,SARSCoV2 severe acute respiratory syndrome coronavirus 2 primarily transmitted airborne droplet spread favored close human contact thus COVID19 pandemic new challenge dental practice oral cavity considered SARSCoV2 reservoir virus detected saliva periodontal pocket infected person Therefore aside common symptom COVID19 manifest lesion oral cavity Due high risk crosscontamination dental office new precautionary measure implemented professional dental care ensure safety dental staff patient Given dynamically changing situation dental practitioner follow local guideline implement according current need available resource key success reduce risk crossinfection SARSCoV2 cost good oral health population,covid- 19;dental care;sars-cov-2;oral cavity;triage
Percutaneous Achilles tenotomy local anaesthetic clubfoot clinic safe COVID19 pandemic child parent,34218297,PURPOSE Achilles tenotomy routinely required correct equinus deformity Congenital talipes equinovarus CTEV patient part gold standard treatment using Ponseti method procedure performed clinic local anaesthetic theatre general anaesthetic COVID19 pandemic reduced theatre capacity caused delay CTEV patient treatment new standard operating procedure allowed tenotomies performed local anaesthetic clinic introduced study looking safety feasibility parent perspective procedure METHODS study prospectively registered service improvement project followed SQUIRE guideline Ogrinc et al BMJ Qual Saf 25986992 2016 consecutive patient requiring tenotomy included Data collected prospectively including demographic Pirani score carers satisfaction questionnaire RESULTS Twenty five patient 36 tenotomies included study median age 9 week patient achieved ankle dorsiflexion greater 15 degree postop None patient parent contracted COVID 19 virus parent reported positive experience 99 felt le anxious tenotomy done clinic rather theatre CONCLUSIONS new service offering clinic tenotomies found safe clinically successful study first show parent preference excellent satisfaction tenotomy performed local anaesthetic service improved allocation resource due success continue beyond pandemic,covid-19;clubfoot;local anaethesia;tenotomy
Patient s Perspective Burn Reconstructive Surgery COVID19 Pandemic,34212182,Covid19 pandemic hospital system delayed halted elective surgery outpatient care profoundly disrupting reconstructive burn treatment ranging surgery postoperative therapy study aim characterize burn patient perspective reconstructive surgery Covid19 12component questionnaire burn patient awaiting reconstructive surgery single ABA verified Burn Center administered Responses regarding willingness undergo reconstruction perceived medical personal impact Covid19 perspective telehealth gathered Surveys administered patientscaregivers phone English Spanish Inclusion criterion consisted burn patient elective reconstructive surgery delayed canceled result pandemic 51 patient met inclusion criterion 23 patient responded survey 45 Average patient age 23 43 male majority 52 pediatric 22 96 patient willing undergo reconstruction Covid19 pandemic despite perceived increased risk 43 disagreed strongly disagreed telehealth adequately enabled communication burn care provider 78 agreed strongly agreed felt susceptible Covid19 burn patient 83 agreed strongly agreed Covid19 pandemic created stressor specifically related burn care majority patient expressed strong desire return surgical therapeutic care delayed Covid19 Patients reported feeling especially vulnerable Covid19 pandemic burn patient cited difficulty obtaining care financial stressor main cause,covid-19;disparities;reconstruction;telehealth
Role Mycobacterium w Treatment COVID19 Observational Study,34227770,Background COVID19 taken big toll world term morbidity mortality disease may progress patient leading trigger `` cytokine storm shown associated adverse outcome Heat killed Mycobacterium w Mw known immunomodulator approved treatment gram negative sepsis study carried evaluate role Mw treatment COVID19 early course disease Method retrospective observational study 117 84 male 33 female COVID19 patient admitted July 3 2020 Aug 26 2020 covid ward Fortis Hiranandani hospital Mumbai enrolled Patients tested COVID19 positive RTPCR treated standard care treatment along Mw 03 ml intradermal injection per day 3 consecutive day Patients evaluated live discharge well change level inflammatory marker Results Use Mw seen associated rapid recovery 116117 patient COVID19 discharged hospital within 10 day decrease level CRP IL6 observed administration Mw decrease associated improvement patient condition use Mw seen associated systemic side effect Conclusion patient COVID19 may deteriorate due exaggerated production cytokine may result adverse outcome Mw used earlier disease effectively prevents excessive cytokine production also contribute rapid recovery Mw also found safe use Larger randomized controlled trial recommended ass role Mw COVID19,
Lung Cancer Surgery early phase acute COVID19 pneumonitis,34217692,65yearold female diagnosed earlystage lung cancer 2020 scheduled robotic assisted left upper lobectomy Unfortunately patient contracted symptomatic COVID19 resulting postponement lung resection 6 week following acute infection admitted surgery preoperative computed tomography scan showed widespread interstitial pneumonitis However surgery went ahead given concern tumour progression albeit lesser resection preserve lung tissue patient slightly hypoxic postoperative recovery uneventful discharged 5 day later Final histology confirmed fully resected stage T1cN0M0 adenocarcinoma lung,
Pandemic Hospitals Reorganizing Emergency Departments,34284534,Emergency department always first point contact hospital many situation including manmade natural disaster first place patient symptom COVID19 met health institution also emergency department Emergency department play important role diagnosing disease isolating patient hospitalization necessary process start triage outpatient admitted emergency department brought ambulance continues isolation patient appropriate area including physical evaluation management laboratory scanning process necessary providing cardiopulmonary resuscitation airway support Afterwards patient treated outpatient hospitalized treated intensive care unit line preliminary diagnosis clinical condition Disruptions may occur one stage lead crowd lengthy queue emergency department prolonging followup period patient One strength Turkey point emergency department accustomed heavy patient load experience gained condition facilitated organization prehospital emergency medical service pandemic hospital emergency department organization main goal provide uninterrupted highquality patient care personnel training personal protection measure creation physical condition Turkey s emergency department accustomed managing intensive patient flow work full capacity normal time Thanks experience emergency healthcare worker health service provided without patient turned away door emergency department COVID19 pandemic review aimed present organization pandemic hospital emergency department COVID19 pandemic made schematic representation architectural area emergency department Ankara City Hospital bed capacity 3810 256 bed emergency department,covid-19 pandemics;disasters;emergencies.;emergency treatment
Predictive Value PrecisionCut Lung Slices Susceptibility Three Animal Species SARSCoV2 Validation Refined Hamster Model,34209230,assessing specie susceptibility severe acute respiratory syndrome coronavirus 2 SARSCoV2 search appropriate animal model multiple research group around world inoculated broad range animal specie using various SARSCoV2 strain dos administration route Although silico analysis based receptor binding diverse vitro cell culture valuable exact prediction specie susceptibility based tool proved challenging assessed whether precisioncut lung slice PCLS could facilitate selection animal model thereby reducing animal experimentation Pig hamster cat PCLS incubated SARSCoV2 virus replication followed time Virus replicated efficiently PCLS hamster cat evidence replication obtained pig PCLS data corroborate finding many research group investigated susceptibility hamster pig cat towards infection SARSCoV2 finding suggest PCLS used convenient tool screening different animal specie sensitivity newly emerged virus validate result obtained PCLS employed hamster model Hamsters inoculated SARSCoV2 via intranasal route Susceptibility infection evaluated body weight loss viral load oropharyngeal swab respiratory tissue lung pathology broadly used hamster model refined including activity tracking hamster activity wheel robust sensitive parameter clinical health addition facilitate quantification pathology lung devised semiquantitative scoring system evaluating degree histological change lung inclusion additional parameter refined enriched hamster model allowing generation data single experiment,sars-cov-2;activity;hamster model;histology scores;precision-cut lung slices
Electron DonorAcceptor Capacity Selected Pharmaceuticals COVID19,34207391,year ago first case infection new coronavirus identified subsequently produced pandemic causing human death throughout world Much research published virus discovery indicate oxidative stress contributes possibility getting sick new SARSCoV2 follows free radical scavenger may useful treatment coronavirus 19 disease COVID19 report investigates antioxidant property nine antiviral two anticancer molecule one antibiotic one antioxidant found orange juice Hesperidin one anthelmintic one antiparasitic Ivermectin molecule apt scavenging free radical either electron donor electron acceptor result present show Valrubicin best electron acceptor anticancer drug three F atom structure elbasvir best electron donor antiviral chronic hepatitis C antiviral drug good electron donor meaning molecule capable reduzing molecule Ivermectin Molnupiravir two powerful COVID19 drug good electron acceptor fact effective oxidant molecule may advantage Electron acceptor molecule oxidize molecule affect condition necessary viral infection replication spread virus may also oxidize molecule essential life mean weapon used defend u COVID19 may also harm u study posit idea oxide reduction balance may help explain toxicity efficacy drug result represent advance road towards understanding action mechanism drug used possible treatment COVID19 Looking ahead clinical study needed define importance antioxidant treating COVID19,covid-19;dam;sars-cov2;coronavirus;electroaccepting power;oxidation
Population seroprevalence SARSCoV2 antibody Anambra State SouthEast Nigeria,34293489,OBJECTIVE objective study determine proportion Anambra State population infected SARSCoV2 virus developed antibody second wave METHODS WHOrecommended health facilitybased crosssectional approach adapted survey 8 th 15 th December 2020 3142 participant across 21 local government area LGAs State aged one year attending randomly selected health facility recruited Demographic symptomrelated information collected participant well whole peripheral blood tested SARSCoV2 IgG IgM rapid test kit RESULTS 425 participant tested positive IgG 74 IgM 54 positive IgG IgM Overall 553 positive recorded giving crude seroprevalence 17 6 95 CI = 16 26 18 98 ranged widely 31 9 95 CI = 24 43 40 22 Onitsha North LGA 5 4 95 CI = 2 19 10 78 Awka north Bayesian Adjustments yielded state seroprevalence 16 1 CONCLUSION One six state resident infected SARSCoV2 developed antibody second wave LGAs age group sex settlement type affected COVID19 large proportion population remained susceptible SARSCoV2,covid-19 immunity;disease surveillance;population survey;sars-cov-2 seroepidemiology
COVID19 School Open Open Question First Review Current Knowledge,34205837,COVID19 pandemic led unprecedented closure school term duration option school closure SARSCoV2 initially poorly known influenced epidemiological aspect influenza virus However school closure still debate seems unsupported sure evidence efficacy COVID19 era aim narrative review discus available literature SARSCoV2 spread among child adolescent school setting trying explain child appear le susceptible severe disease le involved viral spreading also tried define efficacy school closure overview effect choice made various country trying identify preventive measure could effective safe reopening Finally focused psychological aspect prolonged closure child adolescent SARSCoV2 child COVID19 influenza school used key word literature research updated 29 March 2021 knowledge first review summarizing whole current knowledge SARSCoV2 spreading among child adolescent school setting providing worldwide overview pandemic context,covid-19;sars-cov-2;adolescents;children;influenza virus;molecular swab;non-therapeutic intervention;psychological aspects;recommendations;secondary transmission;variants
Improper disposal face mask COVID19 unheeded public health threat,34367445,Ethiopia confirmed first case novel coronavirus COVID19 pandemic March 2020 mean tackle spread virus government opened campaign public exercise hygiene measure washing hand frequently physical distancing week later fivemonth State Emergency SOE declared several business school theatre hall closed People advised work home including permitting telecommuting many government official However mainly due fear economic crisis government forced release lockdown mass wearing face mask become requirement health professional government insist people make use facemasks also equally important give guidance dispose safely face mask disposed improperly potential spreading SARSCoV2 urgency come people s violation rule come disposing mask used Providing awareness creation program negative impact contaminated face mask health individual introducing law prohibit improper disposal used personal protective equipment PPEs among solution discussed manuscript could help reduce problem,covid-19;face mask;improper disposal;waste management
Malignant cerebral infarction ChAdOx1 nCov19 vaccination catastrophic variant vaccineinduced immune thrombotic thrombocytopenia,34341358,Vaccineinduced thrombotic thrombocytopenia cerebral venous thrombosis syndrome recently described young adult within two week first dose ChAdOx1 nCoV19 vaccine report two case malignant middle cerebral artery MCA infarct thrombocytopenia 910 day following ChAdOx1 nCoV19 vaccination two case arrived facility around time different geographical area potentially excluding epidemiological link meanwhile abnormality found respective vaccine batch Patient 1 57yearold woman underwent decompressive craniectomy despite two prior successful mechanical thrombectomy Patient 2 55yearold woman developed fatal bilateral malignant MCA infarct patient manifested pulmonary portal vein thrombosis high level antibody platelet factor 4polyanion complex None patient ever received heparin past stroke onset observation rare arterial thrombosis may contribute assessment possible adverse effect associated COVID19 vaccination,
Assessment SARSCoV2 Infection among Healthcare Workers German COVID19 Treatment Center,34281000,date 160 million people infected COVID19 worldwide present study investigated history SARSCoV2 infection among 3067 healthcare worker HCW German COVID19 treatment center early phase pandemic July 2020 based seroprevalence SARSCoV2 antibody selfreported previous PCR result result demonstrate low prevalence SARSCoV2 infection n = 107 35 increased risk employee high level patient exposure general working COVID19confined area particular suggests local hygiene standard implemented hospital first wave COVID19 pandemic effective preventing patienttoHCW transmission evidence highly mobile staff serving vector SARSCoV2 transmission could found addition impairment smell andor taste strongly associated SARSCoV2 history,covid-19;sars-cov-2;epidemiology;health care workers;infection risk;infectious disease;transmission
Dockingbased virtual screening identification potential COVID19 main protease inhibitor brown algae,34226782,COVID19 SARSCoV2 viral disease cause acute respiratory syndrome increased morbidity mortality rate throughout world World Health Organization declared COVID19 outbreak pandemic classified health emergency throughout world recent past outbreak SARS MERS shown interspecies transmission potential coronaviruses limitation already prescribed drug overcome global public health issue Therefore dire need identify new regimen targeted drug natural compound antiCOVID19 potential study aimed screening 1018 brown algal natural compound many previously reported immunomodulatory effect probable antiCOVID19 potential source compound extracted MarinLit database dedicated marine natural product screened COVID19 main protease top seven compound analysed interaction active site visualized study warrant screening potent compound virus invitro condition,covid-19;docking-based vs;seaweed;structure-based virtual screening
Insights household transmission SARSCoV2 populationbased serological survey,34131124,Understanding risk infection household communityexposures transmissibility asymptomatic infection critical SARSCoV2 control Limited previous evidence based primarily virologic testing disproportionately miss mild asymptomatic infection Serologic measure likely capture previously infected individual apply household transmission model data crosssectional householdbased population serosurvey 4534 people =5 year 2267 household enrolled AprilJune 2020 Geneva Switzerland found risk infection exposure single infected household member aged =5 year 173 137217 threetimes extrahousehold exposure first pandemic wave 51 4558 Young child lower risk infection household member Workingage adult highest extrahousehold infection risk Seropositive asymptomatic household member 694 lower odds 95 CrI318888 infecting another household member compared reporting symptom accounting 145 95 CrI 72227 household infection,
Famotidine inhibits tolllike receptor 3mediated inflammatory signaling SARSCoV2 infection,34214498,Apart prevention using vaccination management option COVID19 remain limited retrospective cohort study use famotidine specific oral H2 receptor antagonist antihistamine associated reduced risk intubation death patient hospitalized COVID19 case series nonhospitalized patient COVID19 experienced rapid symptom resolution taking famotidine molecular basis observation remains elusive show using biochemical cellular functional assay famotidine effect viral replication viral protease activity However famotidine affect histamineinduced signaling process infected Caco2 cell Specifically famotidine treatment inhibits histamineinduced expression Tolllike receptor 3 TLR3 SARSCoV2 infected cell reduce TLR3dependent signaling process culminate activation IRF3 NFkappaB pathway subsequently controlling antiviral inflammatory response SARSCoV2infected cell treated famotidine demonstrate reduced expression level inflammatory mediator CCL2 IL6 driver cytokine release syndrome precipitate poor outcome patient COVID19 Given pharmacokinetic study indicate famotidine reach concentration blood suffice antagonize histamine H2 receptor expressed mast cell neutrophil eosinophil observation explain famotidine may contribute reduced histamineinduced inflammation cytokine release thereby improving outcome patient COVID19,sars-cov-2;antiviral signaling;famotidine;histamine;toll-like receptor
Quantification SARSCoV2 spike nucleocapsid protein using isotope dilution tandem mass spectrometry,34344552,emergence subsequent global outbreak novel coronavirus SARSCoV2 prompted laboratory launch effort develop method SARSCoV2 antigen detection quantification present isotope dilution mass spectrometry method IDMS rapid accurate quantification primary antigen spike nucleocapsid protein IDMS method utilizes liquid chromatographytandem mass spectrometry LCMSMS analyze sample tryptic digest detection quantification selected conserved peptide SARSCoV2 spike nucleocapsid protein IDMS method necessary attribute successfully utilized accurate quantification SARSCoV2 proteinbased vaccine target rapid diagnostic test Absolute quantification achieved quantifying averaging 5 peptide spike protein 3 peptide S1 subunit 2 peptide S2 subunit 4 peptide nucleocapsid protein overall relative standard deviation method 367 spike protein 511 nucleocapsid protein IDMS offer speed 5 h total analysis time sensitivity LOQ 10 fmolmicroL precision quantification SARSCoV2 spike nucleocapsid protein,covid-19;coronavirus;epidemic;mass spectrometry;nucleocapsid;outbreak;pandemic;quantification;sars-cov-2;spike;vaccine
Clinicopathological feature fatal COVID19 infection preliminary experience tertiary care center North India using postmortem minimally invasive tissue sampling,34227439,OBJECTIVES study histopathology patient dying COVID19 using postmortem minimally invasive sampling technique METHODS singlecenter observational study conducted JPNATC AIIMS Thirtyseven patient died COVID19 enrolled Postmortem percutaneous biopsy taken lung heart liver kidney stained hematoxylin eosin Immunohistochemistry performed using CD61 CD163 SARSCoV2 virus detected using IHC primary antibody RESULTS mean age 487 year 595 male Lung histopathology showed diffuse alveolar damage 78 patient Associated bronchopneumonia seen 375 scattered microthrombi 21 patient Immunopositivity SARSCoV2 observed Type II pneumocytes Acute tubular injury epithelial vacuolization seen 46 renal biopsy Seventyone percent liver biopsy showed Kupffer cell hyperplasia 275 showed submassive hepatic necrosis CONCLUSIONS Predominant finding diffuse alveolar damage demonstration SARSCoV2 protein acute phase Microvascular thrombus rarely identified organ Substantial hepatocyte necrosis Kupffer cell hypertrophy microvesicular macrovesicular steatosis unrelated microvascular thrombus suggested liver might primary target COVID19,covid-19;india;diffuse alveolar damage (dad);histopathology;immunohistochemistry;minimally invasive tissue sampling (mits)
3CL pro PL pro affinity docking study fight COVID19 based 900 compound PubChem literature new drug found,34219808,spread novel coronavirus SARSCoV2 resulting COVID19 disease late 2019 transformed worldwide pandemic effectively brought world halt Proteases 3CL pro PL pro responsible proteolysis new virion represent vital inhibition target COVID19 treatment Herein report silico docking study 860 COVID19related compound PubChem database Molecular dynamic simulation carried validate conformation stability compoundligand complex best docking score MMPBSA approach employed calculate binding free energy comparison ca 50 previously reported potential SARSCoV2 s protease inhibitor show number new compound excellent binding affinity Antiinflammatory drug Montelukast Ebastine Solumedrol antimigraine drug Vazegepant antiMRSA prodrug TAK599 among many others show remarkable affinity 3CL pro known side effect present candidate immediate clinical trial study report thorough docking score summary COVID19related compound found PubChem database illustrates asset computational screening method search possible druglike candidate Several yetuntested compound show affinity par reported inhibitor warrant attention Furthermore submitted work provides reader ADME data ZINC PubChem IDs well docking score studied compound comparison,3clpro;molecular docking;plpro;pubchem;sars-cov-2
Raising awareness unintended consequence hand sanitiser child,34212752,use hand sanitisers common practice prevent spread coronavirus disease 2019 COVID19 However safety thereof requires consideration may hazardous child Recent study shown misuse increased unsupervised availability alcoholbased hand sanitisers may result adverse event child skin irritation dryness cracking peeling Unintentional intentional ingestion hand sanitisers child age 12 year may occur colour smell flavour added Consumption alcohol child may result hypoglycaemia apnoea acidosis allows invasion bacterial viral infection Children may also rub eye sanitised hand cause ocular injury Therefore use hand sanitisers general need revised child adult intervention lowering risk adverse event misuse hand sanitiser practised often include promoting washing hand sanitisers possible training child use hand sanitisers creating awareness danger ingested contact eye,covid-19;alcohol-based sanitiser;children;ocular injury;skin irritations
Recent update possible reason low incidence morbidity COVID19 case Africa,34335014,Background COVID19 respiratory illness caused SARSCoV2 major cause morbidity mortality worldwide since first reported case Wuhan China year passed since pandemic began reason different COVID19 burden variation across continent keep puzzling general public Main body abstract Since COVID19 pandemic started published research article addressed epidemiological risk factor host factor susceptibility immunity ascertain possible reason different rate COVID19 infection Africa continent summarized uptodate scientific literature identify possible argument regard Available literature suggests demographic epidemiological sociological genetic immunological factor contribute COVID19 severity susceptibly SARSCoV2 Short conclusion review summarizes existing data discus reason differential COVID19 burden across continent argument mentioned herein helpful guide future experimental study test different hypothesis,africa;burden;covid-19;sars-cov-2;severity;susceptibility
Clinical Evaluation Rapid STANDARD Q COVID19 Ag Test Screening Severe Acute Respiratory Syndrome Coronavirus 2,34374355,Standard test severe acute respiratory syndrome coronavirus 2 SARSCoV2 detect presence viral RNA using realtime reverse transcription rRT PCR Recently convenient rapid relatively inexpensive SARSCoV2 antigen Ag detection method developed STANDARD Q COVID19 Ag test SD Biosensor Inc Suwon Korea rapid immunochromatography test qualitatively detects nucleocapsid protein SARSCoV2 using gold conjugated antibody evaluated performance comparison Allplex 2019nCoV Assay Seegene Seoul Korea retrospective casecontrol study using residual sample sensitivity specificity STANDARD Q COVID19 Ag test 892 5865 960 96100 respectively Cycle threshold Ct value three target SARSCoV2 gene envelope RNAdependent RNA polymerase nucleocapsid gene included Allplex 2019nCoV Assay significantly lower Ag testpositive patient Ag testnegative patient P 0001 Ag test sensitivity higher sample Ct =30 collected one five day post symptom onset conclusion STANDARD Q COVID19 Ag test serve alternative highprevalence setting low sensitivity compensated rRTPCR test limited,allplex 2019-ncov assay;antigen;immunochromatography;nucleocapsid protein;performance;standard q covid-19 ag test;severe acute respiratory syndrome coronavirus 2
pandemic problem compliance safety measure case Egypt,34133030,Analysing data nationally representative sample 3442 interview conducted Egypt 2020 study examines influence four set factor predicting compliance advice healthcare professional combat spread COVID19 demographic knowledge value fear disease denial pandemic foreign invasion finding show higher likelihood compliance linked socioeconomic status awareness pandemic reliance plurality information source adherence liberal value fear disease male young employed religious fatalistic denial severity pandemic lower likelihood consistent result reported literature addition study highlight link compliance attribute nationalism national identity national pride perception pandemic national event willingness sacrifice one s human right combat spread disease Drawing factor paper suggests building societal consensus around theme national unity microparasitic invasion key effective strategy combat spread virus,covid-19;egypt;compliance;pandemic;religiosity;values survey
Knowledge Attitudes Perceptions COVID19 among Healthcare NonHealthcare Workers SubSaharan Africa WebBased Survey,34227870,Due current COVID19 pandemic associated high mortality subSaharan Africa panic amongst healthcare worker higher risk infected study compared knowledge attitude perception COVID19 among healthcare worker HCWs nonhealthcare worker nonHCWs examined common associated factor webbased crosssectional study 1871 respondent 430 HCWs 1441 nonHCWs conducted lockdown measure place 4 region subSaharan Africa Data obtained using validated selfadministered questionnaire via online survey platform Mean score calculated summarized using test group Multivariate linear regression analysis conducted ass unadjusted B adjusted coefficient beta confidence interval CI 95 mean score slightly higher among HCWs nonHCWs statistically significant worried contracting COVID19 common factor associated knowledge attitude perception 2 group Knowledge COVID19 associated attitude perception 2 group significant associated factor subSaharan Africa region age 29 38 year beta = 32 95 CI 004 060 knowledge among nonHCWs education beta = 43 95 CI 081 004 beta = 95 95 CI 169 022 knowledge among nonHCWs HCWs respectively practice selfisolation beta = 71 95 CI 041 102 attitude among nonHCWs HCWs beta = 97 95 CI 045 149 home quarantine due COVID19 group Policymakers healthcare provider consider factor targeting intervention COVID19 future pandemic,covid-19;frontline workers;lockdown;public health preparedness/response;risk perception
Role NonInvasive Respiratory Supports COVID19 Acute Respiratory Failure Patients Intubate Orders,34202895,current goldstandard treatment COVID19related hypoxemic respiratory failure invasive mechanical ventilation However intubate order DNI prevent use treatment case aim study evaluate noninvasive ventilatory support provide good therapeutic alternative invasive ventilation patient severe COVID19 infection DNI Data collected four centre three European country Patients severe COVID19 infection included emulated hypothetical target trial outcome compared patient DNI order treated exclusively noninvasive respiratory support patient could intubated necessary set propensity score inverse probability treatment weighting remove confounding indication Fourhundred patient included 270 eligible intubation 130 DNI order adjusted risk ratio death among patient eligible intubation 081 95 CI 046 142 median length stay acute care survivor similar group 18 1031 vs 19 13235 p = 076 use noninvasive respiratory support good compromise patient severe COVID19 intubate order,covid-19;cpap;high flow nasal cannula;mechanical ventilation;oxygenation
Contributions EURO 2020 football championship event third wave SARSCoV2 Scotland 11 June 7 July 2021,34355691,Public Health Scotland used Scottish national contact tracing data estimate European football championship EURO 2020 contribution third wave SARSCoV2 infection 11 June 7 July 2021 2632 4 63874 SARSCoV2 case selfreported attending EURO 2020 event 90 male 73 2039yearolds case attended unofficial gathering averaged contact general population Targeted guidance celebrating safely closed space key,"covid-19;sars-cov-2;coronavirus;mass gatherings;sporting events, public health response;surveillance"
Postinfection cognitive impairment cohort elderly patient COVID19,34281568,BACKGROUND Understanding longterm effect coronavirus disease 2019 COVID19 cognitive function essential monitoring cognitive decline elderly population study aim ass current cognitive status longitudinal cognitive decline elderly patient recovered COVID19 METHODS crosssectional study recruited 1539 COVID19 inpatient aged 60 year discharged three COVID19designated hospital Wuhan China February 10 April 10 2020 total 466 uninfected spouse COVID19 patient selected control current cognitive status assessed using Chinese version Telephone Interview Cognitive Status40 TICS40 longitudinal cognitive decline assessed using Informant Questionnaire Cognitive Decline Elderly IQCODE Cognitive assessment performed 6 month patient discharge RESULTS Compared control COVID19 patient lower TICS40 score higher IQCODE score TICS40 median IQR 29 25 32 vs 30 26 33 p 0001 IQCODE median IQR 319 300 363 vs 306 300 338 p 0001 Severe COVID19 patient lower TICS40 score higher IQCODE score nonsevere COVID19 patient TICS40 median IQR 24 18 28 vs 30 26 33 p 0001 IQCODE median IQR 363 313 431 vs 313 300 356 p 0001 control TICS40 median IQR 24 18 28 vs 30 26 33 p 0001 IQCODE median IQR 363 313 431 vs 306 300 338 p 0001 Severe COVID19 patient higher proportion case current cognitive impairment longitudinal cognitive decline nonsevere COVID19 patient dementia 25 1050 vs 9 069 p 0001 Mild cognitive impairment MCI 60 2521 vs 63 484 p 0001 control dementia 25 1050 vs 0 0 p 0001 MCI 60 2521 vs 20 429 p 0001 COVID19 severity delirium COPD risk factor current cognitive impairment Low education level severe COVID19 delirium hypertension COPD risk factor longitudinal cognitive decline CONCLUSIONS Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection associated increased risk longterm cognitive decline elderly population COVID19 patient especially severe patient intensively monitored postinfection cognitive decline,covid-19;cognitive impairment;coronavirus;post infection
Molecular Determinants SARSCoV2 Variants,34373192,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 evolution expected given nature virus replication Selection establishment variant human population depend viral fitness molecular immunological selection pressure discus mechanism replication recombination may contribute emergence current future variant SARSCoV2,covid-19;sars-cov-2;recombination;replication;variants
Preexisting cardiovascular disease rather cardiovascular risk factor drive mortality COVID19,34217220,BACKGROUND relative association cardiovascular CV risk factor diabetes hypertension established CV disease CVD susceptibility CV complication mortality COVID19 remains unclear METHODS conducted cohort study consecutive adult hospitalised severe COVID19 1st March 30th June 2020 Preexisting CVD CV risk factor association mortality CV complication ascertained RESULTS Among 1721 patient median age 71 year 57 male 349 203 preexisting CVD CVD 888 516 CV risk factor without CVD RFCVD 484 281 neither Patients CVD older higher burden nonCV comorbidities followup 438 255 patient died 37 CVD 257 RFCVD 165 neither CVD independently associated inhospital mortality among patient 70 year age adjusted HR 243 95 CI 116507 = 70 year aHR 114 95 CI 077169 RFCVD independently associated mortality either age group 70 aHR 121 95 CI 072201 = 70 aHR 107 95 CI 076152 CV complication occurred patient CVD 66 versus RFCVD 17 neither 11 p 0001 213 124 patient developed venous thromboembolism VTE CVD independent predictor VTE CONCLUSIONS patient hospitalised COVID19 preexisting established CVD appears important contributor mortality CV risk factor absence CVD CVDrelated hazard may mediated part new CV complication Optimal care vigilance destabilised CVD essential patient group Trial registration na,covid-19;cardiovascular disease;cardiovascular risk factors;diabetes;hypertension
PostCOVID19 Syndrome Long Haul Syndrome Description Multidisciplinary Clinic Mayo Clinic Characteristics Initial Patient Cohort,34218857,OBJECTIVE describe characteristic series patient reporting prolonged symptom infection coronavirus disease 2019 COVID19 PATIENTS METHODS study describes multidisciplinary COVID19 Activity Rehabilitation Program established Mayo Clinic evaluate treat patient postCOVID syndrome report clinical characteristic first 100 patient receiving evaluation management timeframe June 1 2020 December 31 2020 RESULTS cohort consisted 100 patient mean age 454+142 year 68 woman mean body mass index 302 kgm 2 presenting mean 93 day infection Common preexisting condition respiratory 23 mental health including depression andor anxiety 34 75 hospitalized COVID19 Common presenting symptom ware fatigue 80 respiratory complaint 59 neurological complaint 59 followed subjective cognitive impairment sleep disturbance mental health symptom onethird patient 34 reported difficulty performing basic activity daily living 1 3 patient returned unrestricted work duty time analysis patient laboratory imaging test showed abnormality nondiagnostic despite debilitating symptom patient required physical therapy occupational therapy brain rehabilitation Facetoface virtual care delivery modality feasible CONCLUSION patient COVID19related symptom severe enough require hospitalization younger 65 year likely female preexisting comorbidities severe acute respiratory syndrome coronavirus 2 infection Symptoms including mood disorder fatigue perceived cognitive impairment resulted severe negative impact resumption functional occupational activity patient experiencing prolonged effect,
Integrated singlecell analysis revealed immune dynamic Ad5nCoV immunization,34373443,Coronavirus disease 2019 COVID19 driven SARSCoV2 severe infectious disease become global health threat Vaccines among effective public health tool combating COVID19 Immune status critical evaluating safety response vaccine however evolution immune response immunization remains poorly understood Singlecell RNA sequencing scRNAseq represents powerful tool dissecting multicellular behavior discovering therapeutic antibody Herein performing scRNAV Jseq peripheral blood mononuclear cell four COVID19 vaccine trial participant longitudinally immunization revealed enhanced cellular immunity concerted cell typespecific IFN response well boosted humoral immunity SARSCoV2specific antibody Based CDR3 sequence germline enrichment able identify several potential binding antibody synthesized expressed tested 21 clone identified lineage Among one monoclonal antibody P3V61 exhibited relatively high affinity extracellular domain Spike protein might promising therapeutic reagent COVID19 Overall finding provide insight assessing vaccine novel scRNAV Jseq approach might facilitate development potent durable safe prophylactic vaccine,
Safety structural integrity N95PFF2 respirator decontamination,34229034,BACKGROUND COVID19 caused SARSCoV2 virus emerging respiratory pathogen work environment represents highrisk factor health professional Given scarcity protective personal equipment due global demand decontamination reuse study carried Thus aim study evaluate safety method decontamination N95PFF2 respirator especially regarding structural integrity METHODS N95PFF2 respirator subjected hydrogen peroxide decontamination analyzed using scanning electron microscopy thermogravimetric analysis Seven respirator brand lot used one control six subjected decontamination process sealing qualitative test applied order identify change structure could damage sealing respirator RESULTS Indicated fiber morphology layer affected six decontamination cycle Also thermal stability different layer similar Fit testing showed respiradors submitted cycle decontamination approved CONCLUSIONS Thus possible conclude hydrogen peroxide decontamination method effective since alter physical property respirator,covid-19;coronavirus;decontamination;health professional;ppe;prevention;sars-cov-2
First Molecular Characterization Serbian SARSCoV2 Isolates Unique Early Second Wave Europe,34220784,March 6 2020 considered official date beginning COVID19 epidemic Serbia late spring early summer 2020 Europe recorded decline rate SARSCoV2 infection subsiding first wave trend lasted fall second wave epidemic began appear Unlike rest Europe Serbia hit second wave epidemic month earlier Already June 2020 newly confirmed case risen exponentially COVID19 pandemic first pandemic instant sharing genomic information isolates around world aim study analyze whole SARSCoV2 viral genome Serbia identify circulating variantscladelineages explore sitespecific mutational pattern unique early second wave European epidemic analysis Serbian isolates represents first publication Balkan country demonstrates importance specificity local transmission especially preventive measure differ among country One hundred fortyeight different genome variant among 41 Serbian isolates detected study One unique seven extremely rare mutation identified locally specific continuous dominance 20D clade time amino acid substitution newly identified variant concern found isolates October 2020 Future research focused functional characterization novel mutation order understand exact role variation,covid-19;ngs;sars-cov-2;serbia;genetic diversity
Antibody status cumulative incidence SARSCoV2 infection among adult three region France following first lockdown associated risk factor multicohort study,34293141,BACKGROUND aimed estimate seropositivity antiSARSCoV2 antibody MayJune 2020 first lockdown period adult living three region France identify associated risk factor METHODS 4 May 2020 23 June 2020 16 000 participant survey COVID19 existing consortium three general adult population cohort living IledeFrance IDF Grand Est GE two region high rate COVID19 NouvelleAquitaine NA low rate randomly selected take driedblood spot antiSARSCoV2 antibody assessment three different serological method ClinicalTrial Identifier NCT04392388 primary outcome positive antiSARSCoV2 ELISA IgG result spike protein virus ELISAS Estimates adjusted using sampling weight poststratification method Multiple imputation used infer cumulative incidence SARSCoV2 infection adjustment imperfect test accuracy RESULTS analysis included 14 628 participant 983 positive ELISAS weighted estimate seropositivity cumulative incidence 100 95 confidence interval CI 91 109 114 95 CI 101 128 IDF 90 95 CI 77 102 98 95 CI 81 118 GE 31 95 CI 24 37 29 95 CI 21 38 NA respectively Seropositivity higher younger participant odds ratio = 184 95 CI 179 609 40 v 5060 year old = 056 95 CI 042 074 =70 v 5060 year old least one child adolescent lived household = 130 95 CI 111 153 lower smoker compared nonsmokers = 071 95 CI 057 049 CONCLUSIONS Seropositivity antiSARSCoV2 antibody French adult population =10 first wave Modifiable nonmodifiable risk factor identified,covid-19;sars-cov-2;cohort;general population;risk factors;seroprevalence
Impact Prior Influenza Pneumoccocal Vaccines Humoral Cellular Response SARSCoV2 BNT162b2 Vaccination,34201065,Vaccination SARSCoV2 considered effective method prevention contain pandemic highly effective SARSCoV2 vaccine applied largescale whether extent strength vaccineinduced immune response could potentiated still object debate Several report studied effect different vaccine susceptibility mortality COVID19 conflicting result aimed evaluate whether previous influenza andor pneumococcal vaccination impact specific immune response SARSCoV2 BNT162b2 mRNA vaccine study population consists 710 worker Institute completed BNT162b2 schedule tested least second dose 27 December 2020 15 April 2021 152 214 received influenza 215 303 concomitant influenza pneumococcal vaccination median 102 day second dose BNT162b2 Overall 100 worker tested antiSpike receptorbinding domain antiSRBD antibody 224 worker neutralization titer Microneutralization assay MNA 155 worker spikespecific cell interferongamma response IFNgamma level antiSRBD MNA IFNgamma evaluated compared according sex age involvement direct care COVID19 patient previous influenzapneumococcal vaccination univariate analysis statistically significant association observed regard previous influenza pneumococcal vaccination significant lower antiSRBD response observed according older age male sex MNA titer significantly associated sex age multivariable analysis worker receiving concomitant influenza pneumococcal vaccination influenza showed 58 p 001 42 p 007 increase MNA titer respectively compared receive influenzapneumococcal vaccination Female worker showed 81 MNA 44 antiSRBD increase compared male worker p 0001 Compared worker aged 21 49 year aged 50 older associated reduction antiSRBD 16 p 0005 MNA 31 p 0019 IFNg 32 immune response Maintaining influenza pneumococcal immunization program coming season COVID19 could still spreading remains strongly recommended protect vulnerable limit potential burden infection healthcare system,covid-19;sars-cov-2;immune response;influenza;pneumoccocus;vaccine
High throughput surface plasmon resonance imaging method clinical detection presence strength binding IgM IgG IgA antibody SARSCoV2 CoViD19 infection,34221910,Surface Plasmon Resonance imaging SPRi used determine presence strength binding IgG IgM IgA Receptor Binding Domain RBD SARSCoV2 serum 102 CoViD19 nonCoViD19 patient SPRi assay simultaneously measure antibody isotype level strength binding RBD ultimate 384 patient sample one run turn course disease IgG level strength binding increased generally IgM IgA level go Recovered patient show high strength binding IgG type RBD protein antiRBD immunoglobulin SPRi assay provides additional insight immune status patient recovering CoViD19 new high throughput method applied assessment quality immune reaction healthy individual SARSCoV2 mutant vaccination program Surface Plasmon Resonance imaging unprecedented technology high throughput screening antibody profiling CoViD19 patient Fingerprinting isotypes IgM IgG IgA performed 384 patient one run An affinity maturation effect shown patient recovering CoViD19,affinity;antibody isotypes;biosensor;corona;high throughput;infectious diseases;off-rate
Extended Reality Enhanced Telehealth Beyond COVID19 Viewpoint,34227992,COVID19 pandemic caused widespread challenge revealed vulnerability across global health care system response many health care provider turned telehealth solution widely embraced likely become standard modern care Immersive extended reality XR technology potential enhance telehealth greater acceptability engagement presence However numerous technical logistic clinical barrier remain incorporation XR technology telehealth practice COVID19 may accelerate union XR telehealth researcher explore novel solution close social distance viewpoint highlight research demonstration XR telehealth COVID19 pandemic discus future direction make XR next evolution remote health care,covid-19;augmented reality;extended reality;mixed reality;telehealth;telemedicine;telepresence;virtual reality
Innate Immune Response SARSCoV2 Infection Cells Soluble Mediators,34209845,vulnerability humankind SARSCoV2 absence preexisting immunity unpredictability infection outcome high transmissibility broad tissue tropism ability exploit subvert immune response pose major challenge likely perpetuating COVID19 pandemic Nevertheless peculiar infectious scenario provides researcher unique opportunity studying latest immunological technique understanding immune response SARSCoV2 naive versus recovered subject well SARSCoV2 vaccinee Interestingly current understanding COVID19 indicates combined action innate immune cell cytokine chemokines finetunes outcome SARSCoV2 infection related immunopathogenesis Indeed emerging picture clearly show excessive inflammatory response virus among main cause disease severity COVID19 patient review innate immune response SARSCoV2 infection described light capacity influence adaptive immune response towards protective phenotype also intent point multiple strategy exploited SARSCoV2 antagonize host antiviral response finally outline inborn error predisposing individual COVID19 disease severity,sars-cov-2;innate immunity;soluble and cellular mediators
Neutrophils crossroad acute viral infection severity,34284874,Neutrophils versatile immune effector cell essential mounting firstline defense invading pathogen However uncontrolled activation lead severe lifethreatening complication Neutrophils exist heterogeneous population interaction pathogen immune cell may shape outcome host immune response Diverse class virus including recently identified novel SARSCoV2 shown alter various aspect neutrophil biology offering possibility selective intervention review heterogeneity within neutrophil population highlighting functional consequence circulating phenotype critical involvement exaggerating protective pathological immune response virus discus recent finding neutrophil extracellular trap NETs COVID19 pathology cover virus neutrophil biology NETs crucial developing disease severity end also pointed area neutrophilmediated response finely tuned outline opportunity therapeutic manipulation controlling inflammation viral infection,covid-19;dengue;emergency granulopoiesis;neutrophil extracellular trap;neutrophil heterogeneity
Evidencebased approach early outpatient treatment SARSCoV2 COVID19 infection,34211257,Misinformation promotion wellintended disproved therapy COVID19 plagued evidencebased shared decisionmaking throughout COVID19 pandemic time crisis clinician may feel strong inclination prescribe potentially harmful unproven therapy behalf patient supported beneficence Clinicians mindfully identify avoid commission bias pandemic especially data accumulated assist clinically sound decisionmaking describe evidencebased approach treatment early outpatient COVID19 stressing availability Food Drug Administration emergency use authorization therapy considering plausibly beneficial nonprescription supplement generally regarded safe,covid-19;sars-cov-2;colchicine;evidence-based;ivermectin;melatonin;outpatient therapy
Impact COVID19 Pharmaceutical Care Services Role Community Pharmacists MultiCenter CrossSectional Study Ethiopia,34222654,Objectives current study aimed assessing impact COVID19 pharmaceutical care service role community pharmacist Methods crosssectional study conducted May 1st June 7 2020 community pharmacy Bahir Dar Gondar city Ethiopia Descriptive statistic Chisquare test conducted Pvalue le 005 considered declare statistical significance 95 Confidence interval CI Results total 101 community pharmacy approached one pharmacist per pharmacy 80 completed survey total pharmacy 788 encountered shortage pharmaceutical product Chisquare test revealed significant difference P = 0036 shortage personal protection equipment Gondar Bahir Dar city Face mask 55 774 followed hand glove 15 211 commonly reported personal protective equipment s short supply Conclusion Strategies place improve availability affordability various essential pharmaceutical mitigate spread disease prevent complication,covid-19;ethiopia;community pharmacy;pandemic;pharmaceutical care
Identification mapping relative quantitation SARSCoV2 Spike glycopeptides MassRetention Time Fingerprinting,34345007,describe analytical method identification mapping relative quantitation glycopeptides SARSCoV2 Spike protein method may executed using LCTOF mass spectrometer requires specialized knowledge glycan analysis exploit differential resolving power reverse phase HPLC separation technique resolve peptide high efficiency glycans resolved poorly Consequently glycopeptides consisting peptide bearing different glycan structure posse similar retention time coelute Rather disadvantage show shared retention time used map multiple glycan specie peptide location combination MSMS pseudo MS3 constructed detailed massretention time database Spike glycopeptides database allows accurate mass LCMS laboratory reliably identify quantify Spike glycopeptides single overnight elastase digest le 90 minute,
Emerging Reemerging Infections Children COVID MISC Zika Ebola Measles Varicella Pertussis Immunizations,34215396,role emergency provider lie forefront recognition treatment novel reemerging infectious disease child Familiarity disease presentation might considered rare vaccinepreventable nonendemic illness essential identifying controlling outbreak seen thus far novel coronavirus pandemic susceptibility severity transmission disease presentation unique pattern child Emergency provider also potential play public health role using lesson learned phenomenon vaccine hesitancy refusal,covid-19;emerging infections;re-emerging infections;traveler;vaccine-preventable
Seroprevalence AntiSARSCoV2 Antibodies Blood Donors Nuevo Leon State Mexico 2020 Retrospective CrossSectional Evaluation,34202849,progression distribution SARSCoV2 pandemic continuously changing time traced blood donor serological survey investigated seroprevalence antiSARSCoV2 antibody blood donor Nuevo Leon Mexico 2020 strategy rapid evaluation spread SARSCoV2 asymptomatic case detection collected residual plasma sample blood donor attended two regional donation center January December 2020 identify change antiSARSCoV2 IgG prevalence Plasma sample analyzed Abbott Architect instrument using commercial Abbott SARSCoV2 IgG chemiluminescent assay found total 99 reactive sample 2068 analyzed plasma sample resulting raw prevalence 487 Donors aged 1849 year likely seropositive compared aged 50 year p 0001 Weekly seroprevalence increased 18 early pandemic stage 2759 end year Prevalence 146fold higher female compared male Case geographical mapping showed Monterrey city recorded majority SARSCoV2 case result show growing trend seroprevalence time associated asymptomatic infection unnoticed current epidemiological surveillance protocol,covid-19;mexico;anti-sars-cov-2 igg;blood donors;seroprevalence
central nervous system drug displaying antiinflammatory activity suitable early treatment COVID19,34284539,majority COVID19 case mildly moderately symptomatic patient excessive inflammatory response becomes dominant factor disease progression advanced stage high mortality Treatment antiinflammatory drug either prevent disease progression nonsteroidal antiinflammatory drug NSAIDs colchicine recommended advanced disease stage dexamethasone Fluvoxamine amantadine drug used treat neurological psychiatric disease Fluvoxamine selective serotonin uptake inhibitor whereas amantadine old antiviral variably influencing brain neurotransmitter system repurposed Parkinson s disease drug agonist sigma1 receptor located endoplasmic reticulum effect seems responsible antiinflammatory activity Moreover amantadine found dampen expression cathepsinL lysosomal enzyme implicated SARSCoV2 virus entry target cell two small controlled clinical trial early treatment SARSCoV2infected person fluvoxamine fully prevented COVID19 symptom Anecdotal evidence show amantadine may similarly effective drug easily available inexpensive favorable safety profile Clinical trial evaluating efficacy muchneeded postexposure prophylaxis early treatment COVID19 ongoing,amantadine for covid-19.;fluvoxamine
Association blood group risk COVID19 infection morbidity mortality,34222812,OBJECTIVE aimed compare effect blood group Rh factor development coronavirus19 disease COVID19 aspect clinical course inflammatory parameter organspecific biochemical parameter significant number patient METHODS multicenter study carried retrospectively 3551 patient hospitalized diagnosis COVID19 whose blood group recorded time hospitalization control group 22133 individual medical data admitted blood bank affiliated hospital last year used difference blood group clinical characteristic analyzed RESULTS 3551 patient Rh + blood group found higher ratio case group control increased risk infected case 413 vs control 388 1113 95 CI 10361197 p=0003 Meanwhile Rh + blood group ratio significantly lower case group control group case 26 vs control 283 0862 95 CI 08230966 p=0005 significant difference blood group term admission intensive care unit mortality observed patient AB Rh + blood group greater risk intubation others 1467 95 CI 10402071 p=0028 CONCLUSION demonstrated people blood group Rh + susceptible COVID19 whereas blood group 0 Rh + protective effect infection person infected severe acute respiratory syndrome coronavirus 2 mindful patient blood group AB Rh + would prone intubation blood group,blood groups;coronavirus-19 disease;severe acute respiratory syndrome coronavirus 2
antiviral activity iota kappa lambdacarrageenan COVID19 critical review,34222718,Objective specific antiviral treatment available coronavirus disease 2019 COVID19 Among possible natural constituent carrageenan polymer derived marine algae posse variety antiviral property purpose review summarize evidence supporting carrageenan subtypes antiviral activity emerging severe acute respiratory syndrome coronavirus2 SARSCoV2 causative agent COVID19 Methods PubMedMEDLINE Google Scholar search conducted publication using term carrageenan iota carrageenan kappa carrageenan lambdacarrageenan coronavirus common cold rhinovirus SARSCoV2 search also done grey literature increase understanding search word `` carrageenan also carried publication discussed narrative Results Carrageenan shown potent antiviral activity coronaviruses coronavirus NL63 SARSCoV2 noncoronaviruses dengue virus herpes simplex virus cytomegalovirus vaccinia virus vesicular stomatitis virus sindbis virus human immunodeficiency virus influenza virus human papillomavirus rabies virus junin virus tacaribe virus African swine fever bovine herpes virus suid herpes virus rhinovirus vivo study conducted using carrageenan antiSARSCoV2 agent majority vivo research done influenza respiratory virus cause common cold together coronavirus Thus various clinical trial conducted determine transferability vitro data clinical effectiveness SARSCoV2 combined oral ivermectin nasally administered iotacarrageenan improved outcome COVID19 patient still tested clinic singledose administration Conclusion Though carrageenan exhibited potent antiviral activity SARSCoV2 used treat COVID19 emergency protocol conjunction oral medication ivermectin solid evidence clinical trial support efficacy Thus clinical trial required ass efficacy COVID19 treatment prior broad application,covid-19;carrageenan;clinical trial;iota-carrageenan;nasal spray;sars-cov-2
outlook antigenspecific adoptive immunotherapy viral infection focus COVID19,34217004,Although standardofcare yet adoptive immunotherapeutic approach gradually earned place within list antiviral therapy fatal hardtotreat viral disease maintain robust antiviral immunity effectively target viral particle virallyinfected cell immune cell capable recognizing viral antigen required conventional vaccination induce cell vivo another option prime generate antigenspecific immune cell ex vivo approach successfully trialed virulent opportunistic viral infection bone marrow transplantation Amid crisis SARSCoV2 pandemic followed success certain earlyauthorized vaccine institution company explored effect viralspecific adoptive cell transfer ACTs trial alternative treatment Aimed outlining perspective antigenspecific adoptive immunotherapy viral infection review article specifically provides appraisal ACTbased studiestrials SARSCoV2 infection,adoptive immunotherapy;antigen-specific immune cells;covid-19;sars-cov-2;virus diseases
FDAauthorized mRNA COVID19 vaccine effective per realworld evidence synthesized across multistate health system,34223401,Background Two FDAauthorized mRNA COVID19 vaccine BNT162b2 PfizerBioNTech mRNA1273 Moderna demonstrated high efficacy large Phase 3 randomized clinical trial important ass effectiveness realworld setting Methods retrospective analysis 136532 individual Mayo Clinic health system Arizona Florida Iowa Minnesota Wisconsin PCR testing data December 1 2020 April 20 2021 compared clinical outcome vaccinated cohort 68266 individual received least one dose either vaccine nBNT162b2 = 51795 nmRNA1273 = 16471 unvaccinated control cohort 68266 individual propensitymatched based relevant demographic clinical geographic feature estimated realworld vaccine effectiveness comparing incidence rate positive SARSCoV2 PCR testing COVID19 associated hospitalization ICU admission starting 7 day second vaccine dose Findings realworld vaccine effectiveness preventing SARSCoV2 infection 861 95 CI 824891 BNT162b2 933 95 CI 857974 mRNA1273 BNT162b2 mRNA1273 888 95 CI 755957 860 95 CI 716939 effective preventing COVID19 associated hospitalization vaccine 100 effective 95 CIBNT162b2 514100 95 CImRNA1273 433100 preventing COVID19 associated ICU admission Conclusions BNT162b2 mRNA1273 effective realworld setting associated reduced rate SARSCoV2 infection decreased burden COVID19 healthcare system,
Covid19 Growth HormoneInsulinLike Growth Factor 1 Study Critically NonCritically Ill Patients,34220703,Objective aimed measure insulinlike growth factor 1 IGF1 growth hormone GH critically noncritically ill patient Covid19 ass visavis clinical laboratory parameter prognostic tool Subjects Methods included patient admitted ward ICU largest Covid19 referral hospital Greece patient nonCovid19 pneumonia served control Apart routine laboratory workup Covid19 measured GH IGF1 calculated normalized IGF1 value standard deviation score SDS blood sampling upon admission ward ICU Results studied 209 critically noncritically ill patient Covid19 39 control patient Patients Covid19 ICU nonsurvivors older presented worse hematologicalbiochemical profile including white blood cell count troponin glucose aminotransferase lactate dehydrogenase compared ICU survivor Covid19 survivor ward Overall IGF1 SDS higher Covid19 survivor compared nonsurvivors 096 + 189 v 205 + 248 respectively p=0030 significant difference noted GH group Nevertheless critically ill patient Covid19 prognostic value IGF1 raw data IGF1 SDS GH survivalnonsurvival par APACHE II SOFA marginal difference GH SOFA Conclusion conclusion finding suggest might association low IGF1 possibly GH poor outcome patient Covid19,growth hormone;hospitalization;humans;insulin-like growth factor 1;pandemics;severe acute respiratory syndrome coronavirus 2
Catalytic hairpin DNA assemblybased chemiluminescent assay detection short SARSCoV2 target cDNA,34215120,Colorimetric sensor recognized promising mean target molecule detection provide rapid costeffective facile sensing visible naked eye Challenges remain though term detection sensitivity specificity shortlength target gene Herein demonstrate successful combination catalytic hairpin DNA assembly CHA approach enzymelinked immunosorbent assay ELISA mimicking technique simple sensitive sequencespecific colorimetric assay detect short SARSCoV2 target cDNA developed CHAbased chemiluminescent assay low concentration target cDNA continuously recycled amplify dimeric DNA probe two biotinylated hairpin DNA hairpin DNA completely consumed dimeric DNA probe effectively immobilized neutravidincoated microplate well capture neutravidinconjugated horseradish peroxidase via biotinneutravidin interaction resulting sensitive selective colorlesstoblue color change developed sensing system exhibit high sensitivity detection limit 1 nM target cDNA well ability precisely distinguish singlebase mismatched mutant gene within 2 h proposed system require complex protocol expensive equipment amplify target cDNA potential utilized powerful tool improve detection sensitivity target gene clinical diagnostics colorimetric detection,catalytic hairpin assembly;chemiluminescent assay;colorimetric detection;dna probe;sars-cov-2;target dna
Associations immunological feature COVID19 severity systematic review metaanalysis,34344353,BACKGROUND COVID19 spread widely worldwide causing million death aim explore association immunological feature COVID19 severity METHODS conducted metaanalysis estimate mean difference MD immune cell cytokine level COVID19 severity PubMed Web Science Scopus Cochrane Library grey literature RESULTS total 21 study 2033 COVID19 patient included Compared mild case severe case showed significantly lower level immune cell including CD3 + cell x 10 6 MD 41387 95 CI 61139 21634 CD4 + cell x 10 6 MD 20356 95 CI 27794 12918 CD8 + cell x 10 6 MD 12888 95 CI 16397 9379 B cell x 10 6 L MD 2387 95 CI 4397 378 NK cell x 10 6 L MD 5712 95 CI 8118 3306 significantly higher level cytokine including TNFalpha pgml MD 034 95 CI 009 059 IL5 pgml MD 142 95 CI 399 244 IL6 pgml MD 1307 95 CI 980 1635 IL10 pgml MD 204 95 CI 132 275 significantly higher level chemokines MCP1 SMD 341 95 CI 242 440 IP10 SMD 282 95 CI 120 445 eotaxin SMD 155 95 CI 005 305 However significant difference found indicator Treg cell x 10 6 MD 013 95 CI 140 114 CD4 + CD8 + ratio MD 026 95 CI 002 055 IFNgamma pgml MD 026 95 CI 005 056 IL2 pgml MD 005 95 CI 049 060 IL4 pgml MD 003 95 CI 068 062 GMCSF SMD 044 95 CI 046 135 RANTES SMD 094 95 CI 288 475 CONCLUSION metaanalysis revealed significantly lower level immune cell CD3 + CD4 + CD8 + B NK cell higher level cytokine TNFalpha IL5 IL6 IL10 higher level chemokines MCP1 IP10 eotaxin severe case comparison mild case COVID19 Measurement immunological feature could help ass disease severity effective triage COVID19 patient,covid-19;chemokines;cytokines;immune cells;severity;meta-analysis
Acute Kidney Injury COVID19,34360866,COVID19 mainly considered respiratory illness since SARSCoV2 us angiotensin converting enzyme 2 receptor ACE2 enter human cell kidney also target viral infection Acute kidney injury AKI alarming condition COVID19 patient Recent study confirmed direct entry SARSCoV2 renal cell namely podocytes proximal tubular cell pathomechanism kidney damage Hypovolemia cytokine storm collapsing glomerulopathy also play important role increasing number paper suggest strong association AKI development higher mortality COVID19 patient hence interest matter Although knowledge role kidney SARSCoV2 infection changing dynamically yet fully investigated present insight possible pathomechanisms AKI COVID19 clinical feature risk factor impact hospitalization possible way management via renal replacement therapy,covid-19;rrt;acute kidney injury;dialysis
SamplePooling Strategy SARSCoV2 Detection among Students Staff University Sannio,34206932,Since beginning Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 pandemic clear testing large group population key stem infection prevent effect coronavirus disease 2019 mostly among sensitive patient hand time costsustainability virus detection molecular analysis reverse transcriptasequantitative polymerase chain reaction RTqPCR may major issue testing extended large community mainly asymptomatic large community context samplepooling test grouping could offer effective solution report screening 1195 oralnasopharyngeal swab collected student staff Universita degli Studi del Sannio University Sannio Benevento Campania Italy analyzed inhouse developed multiplex RTqPCR SARSCoV2 detection simple monodimensional sample pooling strategy Overall 400 distinct pool generated within 24 h swab collection five positive sample identified four confirmed using commercially available kit suitable vitro diagnostic use IVD High accuracy sensitivity specificity also determined comparing result reference IVD assay deconvoluted sample Overall conducted 463 analysis instead 1195 reducing testing resource 60 without lengthening diagnosis time without significant loss sensitivity suggesting strategy successful recognizing positive case community asymptomatic individual minor requirement reagent time compared normal testing procedure,rt-qpcr;sars-cov-2;sample pooling
Machine Learning Analyzing NonCountermeasure Factors Affecting Early Spread COVID19,34201618,COVID19 pandemic affected whole world country impacted equally open question factor explain initial faster spread country compared others Many factor overshadowed effect countermeasure studied early phase infection countermeasure yet taken place collected diverse dataset potentially relevant factor infection metric date task Using show importance different factor factor category determined statistical method machine learning ML feature selection FS approach Factors related culture eg individualism openness development travel proved important thorough factor analysis made using novel rule discovery algorithm also show interconnected factor caution relying ML analysis isolation Importantly explore potential pitfall found methodology similar work demonstrate impact COVID19 data analysis best model using decision tree classifier predict infection class roughly 80 accuracy,covid-19;feature correlation;feature significance;machine learning;risk factors
Trust government intention vaccinate COVID19 vaccine hesitancy comparative survey five large city United States United Kingdom Australia,34218963,BACKGROUND widespread hesitancy towards COVID19 vaccine United States United Kingdom Australia OBJECTIVE identify predictor willingness vaccinate COVID19 five city varying COVID19 incidence US UK Australia DESIGN Online crosssectional survey adult Dynata s research panel JulySeptember 2020 PARTICIPANTS SETTING Adults aged 18 Sydney Melbourne London New York City Phoenix MAIN OUTCOMES MEASURES Willingness receive COVID19 vaccine reason vaccine intention STATISTICAL METHODS identify predictor intention receive COVID19 vaccine used Poisson regression robust error estimation produce prevalence ratio RESULTS proportion willing receive COVID19 vaccine 70 London 71 NYC 72 Sydney 76 Phoenix 78 Melbourne Age sociodemographic characteristic predicted willingness receive COVID19 vaccine five city Sydney Melbourne participant high confidence current government greater willingness receive vaccine PR=124 95 CI=107144 PR=138 95 CI=174162 participant high confidence current government NYC Phoenix le likely willing receive vaccine PR=078 95 CI=072085 PR=085 95 CI=076096 LIMITATIONS Consumer panel subject bias may representative general population CONCLUSIONS Success COVID19 vaccination program requires high level vaccine acceptance data suggests 25 adult may willing receive COVID19 vaccine many explicitly antivaccination thus may become willing vaccinate time Among three country surveyed appears cultural difference political influence differing experience COVID19 may affect willingness receive COVID19 vaccine,covid-19;coronavirus;sars-cov-2;vaccine hesitancy
Structurefunction relation SARSCoV2 spike protein impact mutation variant concern,34213849,review cover main feature severe acquired respiratory syndrome coronavirus 2 SARSCoV2 spike protein interaction main entry receptor human angiotensin converting enzyme 2 ACE2 subsequent membrane fusion step focus structural organization protein mechanistic aspect interaction lead cytoplasmic release viral genome potently neutralizing antibody SARSCoV2 shown interfere spikeACE2 interaction thus also review location potential impact mutation spike protein observed variant concern emerged concomitantly acquired immunity population one year virus circulation Understanding interaction affect spikeACE2 interaction subsequent spikeproteininduced membrane fusion reaction important stay one step ahead virus evolution develop efficient countermeasure,ace2 receptor;escape mutations;membrane fusion;neutralization by antibodies;sars-cov-2;spike protein;variants of concern
Organ transplantation deceased donor vaccineinduced thrombosis thrombocytopenia,34214257,,autoantibody;clinical research/practice;coagulation and hemostasis;donors and donation: donor follow-up;infection and infectious agents - viral: influenza;kidney transplantation/nephrology;liver transplantation/hepatology
Dexamethasone Severe COVID19 Work Cellular Molecular Levels,34201797,coronavirus disease 2019 COVID19 caused infection severe respiratory syndrome coronavirus2 SARSCoV2 significantly impacted human society Recently synthetic pure glucocorticoid dexamethasone identified effective compound treatment severe COVID19 However glucocorticoid generally harmful infectious disease bacterial sepsis severe influenza pneumonia develop respiratory failure systemic inflammation similar COVID19 apparent inconsistency suggests presence pathologic mechanism unique COVID19 render steroid effective review plausible mechanism advance hypothesis SARSCoV2 infection accompanied infected cellspecific glucocorticoid insensitivity reported virus alteration local glucocorticoid action interferes undesired glucocorticoid facilitate viral replication affect desired antiinflammatory property noninfected organstissues postulate virus coincidentally cause glucocorticoid insensitivity process modulating host cell activity promoting replication infected cell explore tenet focusing SARSCoV2encoding protein potential molecular mechanism supporting hypothetical glucocorticoid insensitivity unique COVID19 characteristic lifethreatening viral disease probably due difference specific virallyencoded molecule host cell activity modulated,glucocorticoid receptor (gr);glucocorticoids;inflammation;innate immunity;severe acute respiratory syndrome coronavirus-2 (sars-cov-2);type i interferons (ifns)
Effect unfavorable maternalfetal environment cause mitigation measure covid19 pandemic public maternity reference Uruguay,34219582,INTRODUCTION mitigation measure face health emergency due COVID 19 pandemic generated deep economic social psychological crisis community level effect greater people violated right relation social crisis gender perspective woman particularly affected pandemic Given disadvantaged situation woman socially economically politically selfcare diminished OBJECTIVE identify whether association classic risk factor prematurity fetal growth restriction increase pathology period MarchSeptember 2020 maternity hospital assist woman low resource MATERIALS METHODS retrospective study comparative analysis period 15 March 30 September 2019 period 2020 data obtained electronic clinical database prevalence preterm birth smallforgestational age newborn analyzed Indicators available database reflect maternal condition lead unfavorable maternal environment selected classified category RESULTS period 2019 3225 birth registered period 2020 3036 birth 2019 period 122 prematurity evidenced 2020 period 145 RR = 119 IC 95 = 105135 p = 005 relation PEG 55 first period versus 69 second RR = 126 CI 95 = 104153 p = 01 increase found indicator traditionally related etiology proposed explain increase prematurity smallforage gestational evidence increase inflammatory vascular condition CONCLUSION economic psychological social crisis 1st semester health emergency seriously affected social determinant health pregnant woman use Public Maternity reference Uruguay situation base poor perinatal result period maximum mediated mitigation pandemic,covid 19;mitigation measures;perinatal results;unfavorable maternal environment
Case Study Using Telehealth Rural Healthcare Facility Expand Services Protect Health Safety Patients Staff,34203888,case study aimed gain understanding implementation usage telehealth program COVID19 pandemic rural healthcare facility action research methodology utilizing cycle planning implementation review adaptation adopted improve use telehealth COVID19 case continued increase Data collected literature review examination existing document review gap SWOT analysis examination staffing plan helped ensuring adequate resource place start continue usage telehealth Additionally review entire process conducted program advanced various phase implementation conducting rigorous analysis reflection data informed cycle improvement telehealth program Challenges surrounding continuation usage telehealth also described paucity research use telehealth program rural healthcare facility especially pandemic study provide practical tip leader healthcare manager,covid-19;health care;leadership;pandemics;rural health;telemedicine
Racial ethnic disparity viral acute respiratory infection United States protocol systematic review,34215337,BACKGROUND COVID19 pandemic caused SARSCoV2 highlighted consistent inequity incidence disease severity mortality across racial ethnic minority population United States US beyond similar pattern observed previous viral respiratory pathogen date systematic review comprehensively documented disparity potential contributing factor response review aim synthesize data racial ethnic disparity morbidity mortality due viral acute respiratory infection ARI SARSCoV2 review focus understanding structural health social factor contextualize race ethnicity driving disparity US METHODS conduct systematic review study published January 1 2002 onward search include PubMedMEDLINE EBSCO HostCINAHL Plus PsycInfo EMBASE Cochrane Library database identify relevant article include study design describe racialethnic disparity associated viral ARI conducted US Primary outcome include incidence disease severity complication hospitalization death attributed ARI Secondary outcome include uptake preventive intervention including vaccination handwashing social distancing wearing mask Two reviewer independently screen citation fulltext article abstract relevant data Data characterizing individual community structurallevel factor associated disparity abstracted better understand underlying structural inequity contributing racial disparity ARI ass methodological quality study conduct metaanalyses using random effect model appropriate DISCUSSION Findings systematic review shed light pattern racial ethnic disparity viral ARI United States support mathematical modeling epidemic trajectory intervention impact structural driver transmission including structural racism Moreover data emerging review may reignite pandemic preparedness focused community specific vulnerability related living working condition given prevailing structural inequity thus facilitating improved future pandemic response novel endemic viral respiratory pathogen SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42020219771,acute respiratory infection;health disparities;influenza-like illness;pandemic preparedness;pandemic response;racial disparities;structural racism
Longitudinal analysis characterize class subclass antibody response recombinant receptorbinding protein RBD SARSCoV2 COVID19 patient Thailand,34375345,Serological assay detect antibody severe acute respiratory syndrome coronavirus 2 SARSCoV2 might contribute confirming suspected coronavirus disease 2019 COVID19 patient detected molecular assay Human antibody target host angiotensinconverting enzyme 2binding domain viral spike protein target serodiagnosis therapeutic study aimed characterize class subclass antibody response recombinant receptorbinding protein RBD SARSCoV2 COVID19 patient investigated reactivity antibody patient tropical infection healthy individual Thailand ELISAs IgM IgA IgG IgG subclass based RBD antigen developed tested time series 27 serum sample 15 patient COVID19 60 sample preCOVID19 outbreak including acute dengue fever murine typhus influenza leptospirosis healthy individual RBDspecific IgA IgG detected 21 COVID19 patient acute phase median IgA IgG level significantly higher convalescent serum sample compared acute serum sample P 005 observed highest correlation level IgG IgA rho = 0 92 IgG1 IgG3 major IgG subclass detected SARSCoV2 infection acute IgG3 level negatively associated viral detection based RTPCR ORF1ab gene rho = 057 median IgA IgG level convalescence serum COVID19 patient significantly higher healthy individual convalescent serum febrile infectious patient analysis antibody class subclass provide insight human immune response SARSCoV2 natural infection interpretation antibody assay,
Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities Severe Acute Respiratory Syndrome Coronavirus 2,34203977,direct evidence effectiveness repurposed FDAapproved drug Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 infection Although curcumin hesperidin quercetin broad spectrum pharmacological property antiviral activity SARSCoV2 remain unclear study aimed ass vitro antiviral activity curcumin hesperidin quercetin SARSCoV2 compared hydroxychloroquine determine mode action Vero E6 cell compound significantly inhibited virus replication mainly virucidal agent primarily indicating potential activity early stage viral infection investigate mechanism action tested compound molecular docking study carried SARSCoV2 spike main protease Mpro receptor Collectively obtained silico vitro finding suggest compound could promising SARSCoV2 Mpro inhibitor recommend preclinical clinical study studied compound find potential therapeutic targeting COVID19 near future,covid-19;sars-cov-2;antiviral;curcumin;hesperidin;molecular docking;quercetin
Clinical Course Risk Factors InHospital Mortality 205 Patients SARSCoV2 Pneumonia Como Lombardy Region Italy,34208017,aim study explore risk factor inhospital mortality describe effectiveness different treatment strategy 205 laboratoryconfirmed case infected SARSCoV2 Lombardy outbreak patient received best supportive care specific intervention included main drug tested repurposing treat COVID19 hydroxychloroquine anticoagulation antiviral drug steroid interleukin6 pathway inhibitor Clinical laboratory treatment characteristic analyzed univariate multivariate logistic regression method explore impact inhospital mortality Univariate analysis showed prognostic significance age greater 70 year presence two relevant comorbidities PF ratio le 200 presentation elevated LDH lactate dehydrogenase CRP Creactive protein value intermediate therapeuticdose anticoagulation hydroxychloroquine early antiviral therapy lopinavirritonavir short course steroid tocilizumab therapy Multivariable regression confirmed increasing odds inhospital death associated age older 70 year 326 reduction mortality patient treated anticoagulant 037 antiviral lopinavirritonavir 122 steroid 059 therapy contrast hydroxychloroquine tocilizumab confirmed significant effect treatment SARSCoV2 pneumonia Results reallife singlecenter experience agreement confirm actual literature data SARSCoV2 pneumonia term clinical risk factor inhospital mortality effectiveness different therapy proposed management COVID19 disease,sars-cov 2;coronavirus disease 2019;mortality;pneumonia;risk factors;therapy;treatment
Impact COVID19 gastric cancer treatment Japanese highvolume center JCOG stomach cancer study group survey,34286401,PURPOSES spread coronavirus disease 2019 COVID19 affected socioeconomic healthcare system many country Accordingly many individual may canceled annual healthcheck program including esophagogastroduodenoscopy would resulted lower number newly diagnosed patient gastric cancer comparison time METHODS Questionnaires distributed 62 hospital every week May 2020 August 2020 total 744 mailing list Stomach Cancer Study Group Japan Clinical Oncology Group number patient gastric cancer hospital system COVID19 pandemic surveyed RESULTS total 74 551 744 questionnaire answered analyzed early May approximately 50 hospital restrict surgical slot due COVID19 pandemic However gradually loosened restriction thereafter number gastrectomy 80 period previous year hospital Tokyo seriously affected 50 decrease number gastrectomy CONCLUSIONS number gastrectomy lower previous year multicenter followup study required evaluate longterm effect COVID19 clinical outcome patient gastric cancer,covid-19;coronavirus;gastrectomy;socioeconomic factors;stomach neoplasms
Evidence thromboembolic pathogenesis lung cavitations severely ill COVID19 patient,34362979,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 causing coronavirus disease 2019 COVID19 induces lung injury varying severity potentially causing severe acute respiratory distress syndrome ARDS Pulmonary injury pattern COVID19 patient differ patient cause ARDS aimed explore frequency pathogenesis cavitary lung lesion critically ill patient COVID19 Retrospective study 39 critically ill adult patient hospitalized severe acute respiratory syndrome coronavirus 2 including lung injury varying severity tertiary care referral center March May 2020 BerlinGermany observed lung cavitations unusually large proportion 2239 56 COVID19 patient treated intensive care unit ICU including 35 patient without mechanical ventilation Median interquartile range IQR time onset symptom ICU admission 115 6251775 day 15 patient lung cavitations already present first CT scan performed ICU admission seven patient developed subsequent median IQR observation period 48 3558 day seven patient found least one cavitation diameter 2 cm maximum 10 cm Patients developed cavitations older higher body mass index Autopsy finding three patient revealed cavitations reflected lung infarct undergoing liquefaction secondary thrombotic pulmonary artery branch occlusion Lung cavitations appear frequent complication severely ill COVID19 patient probably related prothrombotic state associated COVID19,
Recoding Peptides MHC Class Immune Display Enriching Viral Expression Virus Vulnerability Virus Evasion,34199077,Many virus especially RNA virus utilize programmed ribosomal frameshifting andor stop codon readthrough expression decoding UGA dynamically redefined specify selenocysteine recoding effectively increase viral coding capacity generate set ratio product Nterminal domain different Cterminal domain Recoding also regulatory generate product nonuniversal 21st directly encoded amino acid Selection translation speed expression many virus expense fidelity creates host immune defensive opportunity contrast host opportunism certain virus including persistent virus utilize recoding adventitious frameshifting part strategy evade immune response specific drug Several instance recoding small intensively studied virus escaped detection many year identification resolved dilemma fundamental importance ribosome ratcheting consistent initial strong view invariant triplet decoding however foresee possibility transitory anticodon codon dissociation Deep level dynamic structural understanding recoding underway high level structure relevant frameshifting required expression SARS CoV2 genome determined,drips;stopgo;bet hedging;cancer;codon redefinition;ribosomal frameshifting;ribosome structure;selenocysteine;stop codon readthrough
Ultrapotent antibody diverse highly transmissible SARSCoV2 variant,34210892,emergence highly transmissible SARSCoV2 variant concern VOC resistant therapeutic antibody highlight need continuing discovery broadly reactive antibody identify four receptorbinding domain targeting antibody three earlyoutbreak convalescent donor potent neutralizing activity 23 variant including B117 B1351 P1 B1429 B1526 B1617 VOCs Two antibody ultrapotent subnanomolar neutralization titer IC50 03 111 ngmL IC80 15 345 ngmL define structural functional determinant binding four VOCtargeting antibody show combination two antibody decrease vitro generation escape mutant suggesting potential mitigating resistance development,
Reducing risk tuberculosis transmission HCWs high incidence setting,34281623,Globally tuberculosis TB leading cause death single infectious agent Healthcare worker HCWs increased risk hospitalacquired TB infection due persistent exposure Mycobacterium tuberculosis Mtb healthcare setting World Health Organization developed international system infection prevention control IPC intervention interrupt cycle nosocomial TB transmission guideline TB IPC proposed comprehensive hierarchy three core practice comprising administrative control environmental control personal respiratory protection However implementation recommendation go beyond minimal physical organisational requirement thus appropriately introduced resourceconstrained setting area high TB incidence many low middleincome country LMICs lack knowledge expertise practice TB IPC major barrier implementation essential intervention HCWs often underestimate risk airborne Mtb dissemination tidal breathing lack required expertise funding design install maintain environmental control system lead inadequate dilution infectious particle air turn increase risk TB dissemination Insufficient supply particulate respirator lack direction reuse respiratory protection associated unsafe working practice increased risk TB transmission patient HCWs Delayed diagnosis initiation treatment commonly influenced effectiveness healthcare system identify TB patient availability rapid molecular diagnostic tool Failure recognise resistance firstline drug contributes emergence drugresistant Mtb strain including multidrugresistant extensively drugresistant Mtb Future guideline development must consider social economic cultural climatic condition ensure recommended control measure implemented highincome country importantly lowincome high TB burden setting Urgent action ambitious investment needed regional national level get back track reach global TB target especially context COVID19 pandemic,healthcare workers;lmic;mdr-tb;transmission;tuberculosis
Clinical Mortality Review COVID19 Patients Sukraraj Tropical Infectious Disease Hospital Nepal Retrospective Study,34287389,Coronavirus Disease 2019 COVID19 challenged health system worldwide including low middle income country like Nepal view rising number infection prediction multiple wave disease mortality due COVID19 need critically analyzed every possible effort could made prevent COVID19 related mortality future Main aim research study mortality due COVID19 tertiary level hospital Nepal retrospective observational study included inpatient Sukraraj Tropical Infectious Disease Hospital reverse transcriptase polymerase chain reaction positive SARSCOV2 died hospital stay January 2020 till January 2021 Medical record patient evaluated 860 total admission year 50 mortality study center 50 mortality majority male 76 male female ratio 3171 65 year age 72 two comorbidities 64 common comorbidities among patient died hospital stay hypertension 58 followed diabetes mellitus 50 chronic obstructive airway disease 24 median duration symptom onset death 18 day ranged minimum 2 day till maximum 39 day Ddimer found 1 mgL 58 case ferritin 500 ngml 42 patient presentation total 42 patient thrombocytopenia 80 patient lymphocytopenia 60 Neutrophil Lymphocyte ratio 1175 mean NLR 1838 total mortality 16 patient also showed microbiological evidence secondary infection Male gender age 65 year multiple comorbidities lymphocytopenia elevated Neutrophil lymphocyte ratio elevated inflammatory marker risk factor found majority mortality study finding could utilized early triage risk assessment COVID19 patient aggressive treatment strategy could employed earliest reduce mortality due COVID19 future,covid-19;nepal;mortality
Diagnostic Accuracy New Antigen Test SARSCoV2 Detection,34200827,BACKGROUND AIMS Quick reliable diagnostic tool play important role controlling spread SARSCov2 pandemic aim study evaluate diagnostic accuracy new cytosalivary antigen test aimed detecting presence antigen SARSCoV2 compared gold standard RTPCR lateral flow test METHODS total 433 healthy volunteer enrolled study sensitivity specificity new cytosalivary antigen test calculated compared RTPCR nasopharyngeal swab lateral flow test RESULTS total 433 sample collected tested Mediterranean Fair Palermo February 2021 April 2021 new cytosalivary antigen sensitivity 100 specificity 942 sensitivity specificity lateral flow test 55 100 respectively CONCLUSIONS new cytosalivary antigen test detected positive case RTPCR sample asymptomatic subject demonstrating promising tool sensitive diagnosis COVID19 study warranted better characterize diagnostic accuracy,elisa;rt-pcr;sars-cov-2;cyto-salivary test;lateral flow test;respiratory disease covid-19
efficient facial mask COVID19 Evaluating mask use various community one year pandemic,34284538,Face mask device worn mouth nose protect splash infectious respiratory droplet aerosol generated breathing coughing according filtering capacity Medical mask respirator cloth mask used source control protection exposed first case March 11 2020 Turkey National COVID19 Scientific Advisory Board published various content correct use mask Medical face mask used healthcare setting source control potential personal protection COVID19 pandemic Adverse event associated using mask sparse mainly associated tightfitting respirator dermatitis due prolonged use reason rejection use Studies suggest use mask mainly healthcare facility also community source control people respiratory symptom communicable disease COVID19 likely acceptable recommended particularly severe epidemic pandemic Metaanalysis case control cross sectional cohort retrospective retrospective cross sectional research randomized controlled controlled comparison study reviewed protective effect mask COVID19 laboratory evidence Optimum use face mask additional precaution found useful controlling spread respiratory virus SARSCoV2 study metaanalyses conclusion recent evidence COVID19 pandemic consistent previous study shown association face mask use decreased risk viral infection medical face mask use encouraged community healthcare facility along infection control measure hand hygiene outbreak widespread community transmission,covid-19;sars-cov-2;efficacy;face mask;pandemic
Pneumothorax due COVID19 Analysis case report,34336592,Cases pneumothoraxpneumomediastinum reported patient severe acute respiratory syndrome coronavirus 2 SARSCoV2 however time onset hospital stay rarely studied Coronavirus disease 2019 COVID19 patient complication described determine time onset associated comorbidities location duration pneumothorax search PubMed yielded simple frequency bivariate analysis death 113 confirmed case 67 article median time date hospital admission presence pneumothorax 8 day Right hemithorax frequent form pneumothorax Almost half patient required intubation invasive mechanical ventilation Although frequency phenomenon high among hospitalized patient confirmed SARSCoV2 high among developed acute respiratory distress syndrome ARDS study contributes literature present large number patient developed pneumothorax admission characterized clinical deterioration dyspnea tachypnea pleuritic chest pain subcutaneous emphysema low oxygen saturation level Pneumothoraxpneumomediastinum recommended differential diagnosis even without considering presence chronic pulmonary comorbidities invasive mechanical ventilation,covid-19;pneumomediastinum;pneumothorax;sars-cov-2
Confounding Factors Influencing Kinetics Magnitude Serological Response Following Administration BNT162b2,34205564,BACKGROUND Little known potential confounding factor influencing humoral response individual received BNT162b2 vaccine METHODS Blood sample 231 subject collected 14 28 42 day following coronavirus disease 2019 COVID19 vaccination BNT162b2 Antispike receptorbindingdomain protein antiSpikeRBD immunoglobulin G IgG antibody measured timepoint Impact age sex childbearing age status hormonal therapy blood group body mass index pasthistory severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection assessed multivariable analysis RESULTS CONCLUSIONS naive subject level antiSpikeRBD antibody gradually increased following administration first dose reach maximal response day 28 plateauing day 42 vaccinated subject previous SARSCoV2 infection plateau reached sooner ie day 14 naive population age significant negative impact antiSpikeRBD titer day 14 28 lower level observed male day 42 corrected confounding factor Body mass index BMI well B AB blood group significant impact various subgroup early response day 14 longer significant confounding factor highlighted previously infected group,bmi;bnt162b2;sars-cov-2;age;antibody;blood-group;gender;kinetic;serology;vaccine
HLAdependent heterogeneity macrophage immunoproteasome activation lung COVID19 disease,34225749,BACKGROUND worldwide pandemic caused SARSCoV2 virus characterized significant unpredictable heterogeneity symptom remains poorly understood METHODS Transcriptome single cell transcriptome COVID19 lung integrated deeplearning analysis MHC class immunopeptidome SARSCOV2 proteome RESULTS analysis transcriptomes lung sample COVID19 patient revealed activation MHC class antigen presentation tissue correlated amount SARSCoV2 RNA present Similarly positive relationship detected sample level SARSCoV2 expression genomic cluster located 6p2132 region 40 kb long inside MHCII cluster encodes constituent immunoproteasome analysis singlecell transcriptomes bronchoalveolar cell highlighted activation immunoproteasome CD68 + M1 macrophage COVID19 patient addition PSMB8based trajectory cell featured activation defense response mild case disease impairment alveolar clearance mechanism severe COVID19 examining binding affinity SARSCoV2 immunopeptidome common HLAA B C allele worldwide found higher number stronger presenter type allele Asian population could shed light disease le widespread part world CONCLUSIONS HLAdependent heterogeneity macrophage immunoproteasome activation lung COVID19 disease could implication effort predict response HLAdependent SARSCoV2 vaccine global population,antigen presentation;covid-19;hla;immunoproteasome;integrative analysis;mhc class-i;macrophage;peptidome;transcriptome
Comparison Analysis Neutralizing Antibody Levels Serum Inoculating SARSCoV2 MERSCoV SARSCoV Vaccines Humans,34199384,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 Middle East respiratory syndrome coronavirus MERSCoV severe acute respiratory syndrome coronavirus SARSCoV pose great threat humanity Every pandemic involving coronaviruses seriously affected human health economic development Currently approved therapeutic drug infection Therefore development vaccine particularly important combat coronaviruses review summarized analyzed progress vaccine SARSCoV MERSCoV SARSCoV2 including inactivated vaccine live attenuated vaccine subunit vaccine nucleic acid vaccine viral vector vaccine addition compared level neutralizing antibody serum patient three kind coronaviruses different stage ability effect SARSCoV2 MERSCoV SARSCoV review provides useful information vaccine evaluation analysis,mers-cov;sars-cov;sars-cov-2;neutralizing antibody;vaccine
Neurotransmitters Neuropeptides decrease PD1 cell healthy subject patient hepatocellular carcinoma HCC increase proliferation eradication HCC cell,34293596,cell aged people patient either cancer severe infection including COVID19 often exhausted senescent dysfunctional leading increased susceptibility complication mortality Neurotransmitters Neuropeptides bind receptor cell induce multiple beneficial cell function Yet cell different people vary expression level Neurotransmitter Neuropeptide receptor magnitude corresponding effect Therefore performed individualbased study cell 3 healthy subject 3 Hepatocellular Carcinoma HCC patient HCC usually develops due chronic inflammation inflamed liver induces reduction inhibition CD4 + cell Natural Killer NK cell Immunebased therapy HCC urgently needed tested selected Neurotransmitters Neuropeptides decrease key checkpoint protein PD1 human cell increase proliferation killing HCC cell First confirmed human cell express dopamine receptor DRs glutamate receptor GluRs AMPAGluR3 NMDAR mGluR Second discovered either Dopamine Glutamate GnRHII Neuropeptide andor CGRP 10nM well DR GluR agonist induced following effect 1 Decreased significantly PD1 + cell PD1 expression level per cell 60 decrease within 1 h 2 Increased significantly number cell proliferated presence HCC cell 7 fold increase 3 Increased significantly cell killing HCC cell 2 fold increase 4 nonconventional combination Neurotransmitters Neuropeptides surprising synergistic beneficial effect conclude Dopamine Glutamate GnRHII Neuropeptide CGRP alone combination decrease PD1 + cell PD1 expression per cell cell healthy subject HCC patient increase proliferation response HCC cell killing HCC cell Yet testing cell many cancer patient absolutely needed Based finding previous one designed novel `` Personalized Adoptive NeuroImmunotherapy calling validation safety efficacy clinical trial,cgrp;dopamine;glutamate;gnrh-ii;hepatocellular carcinoma;nerve-driven immunity;neuro-immunotherapy;neuropeptide y;pd-1;t cells
Avascular necrosis part long COVID19,34215639,Long COVID19 affect different body system present avascular necrosis AVN sequalae long COVID19 yet documented largescale use lifesaving corticosteroid COVID19 case anticipate resurgence AVN case report series three case patient developed AVN femoral head treated COVID19 infection mean dose prednisolone used case 758 mg 4001250 mg le mean cumulative dose around 2000 mg steroid documented literature causative AVN Patients symptomatic developed early AVN presentation mean 58 day COVID19 diagnosis compared literature show generally take 6 month 1 year develop AVN post steroid exposure,covid-19;drugs: musculoskeletal and joint diseases;groin pain;musculoskeletal and joint disorders;unwanted effects/adverse reactions
quantitative evaluation aerosol generation supraglottic airway insertion removal,34287820,Many guideline consider supraglottic airway use aerosolgenerating procedure status requires increased level personal protective equipment fallow time case result reduced operating theatre efficiency Aerosol generation never quantitated supraglottic airway use address evidence gap conducted realtime aerosol monitoring 0310microm diameter ultraclean operating theatre supraglottic airway insertion removal showed low background particle concentration median IQR range 16 031 040 particlesl 1 patient s tidal breathing produced higher concentration aerosol 40 13110 044 particlesl 1 p = 0048 average aerosol concentration detected supraglottic airway insertion 13 1042 062 particlesl 1 n = 11 removal 21 0175 0262 particlesl 1 n = 12 different tidal breathing p = 031 p = 084 respectively Comparison supraglottic airway insertion removal volitional cough 104 66169 33326 n = 27 demonstrated supraglottic airway insertionremoval sequence produced 4 aerosol compared single cough p 0001 transient aerosol increase recorded one complicated supraglottic airway insertion initially failed provide patent airway Detailed analysis event showed atypical particle size distribution subsequently identified multiple source nonrespiratory aerosol may produced airway management considered artefact finding demonstrate supraglottic airway insertionremoval generates bioaerosol breathing far le cough inform design infection prevention strategy anaesthetist operating theatre staff caring patient managed supraglottic airway,covid-19;sars-cov-2;aerosol-generating procedure;supraglottic airway device
Telepractice SchoolAge Children Stutter Controlled Study Evaluate Efficacy MIDASP,34345351,COVID19 pandemic necessitated general reorganization rehabilitation service Italy lockdown Italy led use telepractice delivery speech therapy including stuttering aim present work evaluate effectiveness Multidimensional Integrated Differentiated ArtMediated Stuttering Program MIDASP Tomaiuoli et al 2012 delivered online schoolage child stutter nonrandomized controlled pre posttreatment study included experimental group 11 child receiving telepractice adaptation MIDASP historical control group 11 child receiving inperson MIDASP group assessed Stuttering Severity Instrument Fourth Edition SSI4 Overall Assessment Speaker s Experience Stuttering OASESS pre posttreatment statistically significant difference found two mode delivery finding suggest MIDASP treatment delivered via telepractice effective schoolage child stutter,fluency;mida-stuttering program;stuttering;telehealth;telepractice
Giant coronary artery aneurysm feature coronavirusrelated inflammatory syndrome,34210694,5monthold female infant admitted hospital history fever rash recent coronavirus pandemic significantly elevated inflammatory marker illness respond first line broad spectrum antibiotic illness later complicated coronary artery aneurysm classified giant despite treatment intravenous immunoglobulin steroid immunomodulators infant COVID19 antibody despite initial negative COVID19 PCR test case highlight association atypical Kawasaki like illness paediatric multisystem inflammatory syndrometemporarily associated COVID19 infection,covid-19;cardiovascular medicine;paediatrics
Digital acoustic surveillance early detection respiratory disease outbreak Spain protocol observational study,34215614,INTRODUCTION Cough common symptom COVID19 respiratory illness However objectively measuring frequency evolution hindered lack reliable scalable monitoring system overcome newly developed artificial intelligence model exploit portability smartphones context ongoing COVID19 pandemic cough detection respiratory disease syndromic surveillance represents simple mean early outbreak detection disease surveillance protocol evaluate ability populationbased digital cough surveillance predict incidence respiratory disease population level Navarra Spain assessing individual determinant uptake platform METHODS ANALYSIS Participants Cendea de Cizur Zizur Mayor attending local University Navarra Pamplona invited monitor nighttime cough using smartphone app Hyfe Cough Tracker Detected cough aggregated time space Incidence COVID19 diagnosed respiratory disease within participant cohort study area population collected local health facility used carry autoregressive moving average analysis independent time series mixedmethods design explore barrier facilitator continuous digital cough monitoring evaluating participation pattern sociodemographic characteristic Participants fill acceptability questionnaire subgroup participate focus group discussion ETHICS DISSEMINATION Ethics approval obtained ethic committee Centre Hospitalier de lUniversite de Montreal Canada Medical Research Ethics Committee Navarre Spain Preliminary finding shared civil health authority reported individual participant Results submitted publication peerreviewed scientific journal international conference TRIAL REGISTRATION NUMBER NCT04762693,covid-19;epidemiology;respiratory infections
Covid19 Risk Venous Thromboembolism Ethnically Diverse Populations,34293316,BACKGROUND Limited existing data suggest novel coronavirus disease 2019 Covid19 may increase risk venous thromboembolism VTE information large ethnically diverse population appropriate control lacking RESEARCH QUESTION rate VTE among adult hospitalized Covid19 differ matched hospitalized control without Covid19 STUDY DESIGN METHODS conducted retrospective study among hospitalized adult laboratoryconfirmed Covid19 hospitalized adult without evidence Covid19 matched age gender raceethnicity acute illness severity month hospitalization FebruaryAugust 2020 two integrated healthcare delivery system 36 hospital Outcomes included VTE deep venous thrombosis pulmonary embolism ascertained using diagnosis code combined validated natural language processing algorithm applied electronic health record death cause 30 day Fine Gray hazard regression performed evaluate association Covid19 VTE accounting competing risk death residual difference group well identifying predictor VTE patient Covid19 RESULTS identified 6319 adult Covid19 6319 matched adult without Covid19 mean SD age 600 172 year 46 woman 531 Hispanic 146 AsianPacific Islander 103 Black 30day followup 313 validated VTE 160 Covid19 153 control 1172 death 817 Covid19 355 control occurred Adults Covid19 threefold adjusted risk VTE adjusted hazard ratio 348 95 Confidence Interval 203598 compared matched control Predictors VTE Covid19 patient included age =55 year Black race prior VTE diagnosed sepsis prior moderate severe liver disease body mass index =40 kgm 2 platelet count 217 kmcL INTERPRETATION Among ethnically diverse hospitalized adult Covid19 infection increased risk VTE selected patient characteristic associated higher thromboembolic risk setting Covid19,covid-19;epidemiology;risk factor;venous thromboembolism
Massively scaledup testing SARSCoV2 RNA via nextgeneration sequencing pooled barcoded nasal saliva sample,34211145,Frequent widespread testing member population asymptomatic severe acute respiratory syndrome coronavirus 2 SARSCoV2 essential mitigation transmission virus Despite recent increase testing capacity test based quantitative polymerase chain reaction qPCR assay easily deployed scale required populationwide screening show nextgeneration sequencing pooled sample tagged samplespecific molecular barcodes enables testing thousand nasal saliva sample SARSCoV2 RNA single run without need RNA extraction assay named SwabSeq incorporates synthetic RNA standard facilitates endpoint quantification calling true negative reduces requirement automation purification sampletosample normalization used SwabSeq perform 80000 test analytical sensitivity specificity comparable better traditional qPCR test le two month turnaround time le 24 h SwabSeq could rapidly adapted detection pathogen,
Impact First Wave COVID19 Pandemic HIVAIDS Programming Kenya Evidence Kibera Informal Settlement COVID19 Hotspot Counties,34205036,study sought determine impact COVID19 HIVAIDS programming Kibera informal settlement COVID19 hotspot county first wave pandemic study conducted two phase first phase entailed analysis HIV care treatment secondary data 20182020 Kenya Health Information System second phase prospective cohort study conducted among people living HIV Kibera informal settlement total 176 participant aged 18 year accessing HIV service selected healthcare facility Kibera randomly sampled facility electronic medical record followed three month Sociodemographics contact detail abstracted record telephone interview conducted consenting participant Results retrospective review HIV program data indicated 56 p 0000 95 CI 313 628 reduction uptake HIV service Clients starting antiretroviral therapy ART reduced significantly 48 p 0001 95 CI 354 77 hotspot county However preexposure prophylaxis uptake increased significantly 24 p 0019 95 CI 4 49 Kibera 14 reported missing medication onset COVID19 pandemic lack food 38 government measure 11 affected ART access 11 access health facility due fear contracting COVID19 government regulation lack personal protective equipment Socioeconomic factor food insecurity government measure affected uptake HIVAIDS service hence need scaling measure increase access HIVAIDS service onset pandemic,covid-19;hiv/aids;antiretroviral therapy;food security;lockdown measures;personal protective equipment;pre-exposure prophylaxis
Implications defective immune response SARSCoV2 vaccinated organ transplant recipient,34210786,Organ transplant patient poor immune response COVID19 vaccine thus designing vaccine strategy protect vulnerable population SARSCoV2 infection crucial,
Acute respiratory distress syndrome,34217425,Acute respiratory distress syndrome ARDS acute respiratory illness characterised bilateral chest radiographical opacity severe hypoxaemia due noncardiogenic pulmonary oedema COVID19 pandemic caused increase ARDS highlighted challenge associated syndrome including unacceptably high mortality lack effective pharmacotherapy Seminar summarise current knowledge regarding ARDS epidemiology risk factor differential diagnosis evidencebased clinical management mechanical ventilation supportive care discus area controversy ongoing research Although Seminar focus ARDS due cause also consider commonality distinction COVID19associated ARDS compared ARDS cause,
Efficacy Telemedicine Telemonitoring AtHome Monitoring Patients COVID19,34209725,AIM work aim ass telemedicine telemonitoring clinically useful safe athome monitoring Coronavirus disease 2019 COVID19 patient METHODS retrospective cohort study patient diagnosed COVID19 Galicia Northwestern Spain 26 December 2020 15 February 2021 structured proactive monitoring via telemonitoring TELEA patient considered highrisk Lugo Marina Monforte Healthcare Area ASLAM evaluated compared model remaining healthcare area Galicia RESULTS 47053 COVID19 patient 4384 93 ASLAM 1187 271 monitored via TELEA rest 3197 ASLAM 42669 rest Galicia monitored via method Patients monitored ASLAM via TELEA older consulted emergency department le frequently p = 005 hospitalized le frequently p 001 shorter hospital stay p 00001 lower mortality rate first hospitalization p = 003 athome lifethreatening emergency recorded CONCLUSIONS data suggest COVID19 patient care model involving proactive athome monitoring telemedicine telemonitoring associated reduced pressure hospital service lower mortality rate,covid-19;mortality;telemedicine
Digital surveillance online decision support tool COVID19 one year pandemic Italy observational study,34292866,BACKGROUND Italy experienced severe consequence term hospitalization death COVID19 pandemic Online decision support system selftriage application used several setting supplement recommendation health authority prevent manage COVID19 digital Italian health tech startup developed noncommercial online decision support system assist individual managing potential exposure COVID19 interpret symptom chat user interface available since early phase pandemic Italy OBJECTIVE compare trend session online support decision system COVID19 case reported national health surveillance system Italy February 2020 March 2021 METHODS analyzed number session user COVID19 positive contact user symptom compatible COVID19 number case reported National surveillance system calculate distance time series used Dynamic Time Warping algorithm also applied Symbolic Aggregate approXimation SAX encoding time series oneweek period calculated Hamming distance SAX string shifted time series session online decision support system one week ahead measured improvement Hamming distance verify hypothesis session online decision support system anticipate trend case reported official surveillance system RESULTS analyzed total 75557 session online decision support system Among 65207 session user symptom 19062 contact individual COVID19 highest number session online decision support system recorded early phase pandemic second peak observed October 2020 third peak observed March 2021 parallel surge reported case Peaks session online decision support system preceded surge COVID19 notified case approximately one week distance session user COVID 19 contact reported case calculated dynamic time warping 6123 distance session user symptom 9372 time series user COVID 19 contact consistent trend confirmed case applied Symbolic Aggregate approXimation encoding measured Hamming distance two time series applying oneweek shift Hamming distance time series session user COVID19 contact reported case improved 049 046 repeated analysis restricting time window time period July December 2020 corresponding Hamming distance 016 shifting time series improved 008 time shift CONCLUSIONS Temporal trend number session online COVID19 online decision support system may precede trend reported COVID19 case obtained traditional surveillance trend session user contact COVID19 case may better predict reported case COVID19 session user symptom Data online decision support system may represent useful information source supplement traditional surveillance support identification early warning signal COVID19 pandemic CLINICALTRIAL,
Severe Acute Respiratory Syndrome Coronavirus SARSCoV1 Middle East Respiratory Syndrome Coronavirus MERSCoV infection pregnancy overview,34218204,Severe Acute Respiratory Syndrome Coronavirus SARSCoV1 Middle East Respiratory Syndrome Coronavirus MERSCoV infection like virus affect respiratory tract cause severe maternal illness adverse pregnancy outcome highly transmissible acquired droplet Host reservoir dromedary camel MERSCoV masked palm civet SARSCoV1 critical link onset outbreak Clinically present flulike symptom therefore high index suspicion required ensure timely diagnosis tailored management Although many reported series infection pregnancy seem associated increased risk preterm delivery maternal mortality Diagnosis made PCR nasopharyngeal swab currently effective antiviral agent virus following infection various agent administered patient important aspect management early identification deterioration intensive support prevention transmission understanding evidence impact infection pregnancy suggests potential future repeat outbreak hence importance maintaining vigilance across healthcare system,coronaviruses;pregnancy;respiratory syndrome;viral infection
COVID19 Initial Presentation Intraperitoneal Hemorrhage Secondary Spontaneous Splenic Rupture,34211811,declared coronavirus disease 2019 COVID19 global pandemic early 2020 pandemic continued evolve period several month many case unusual presentation emerging pose greater challenge physician term quickly identifying COVID19 patient based initial sign symptom report present one unusual presentation patient sudden intraperitoneal hemorrhage spontaneous splenic rupture COVID19 likely etiology contributing factor patient 75yearold Caucasian woman presented emergency department ED complaint severe leftsided abdominal pain several day without preceding trauma CT abdomenpelvis revealed large amount fluid abdomen raised suspicion bleeding exploratory laparotomy revealed splenic rupture hemoperitoneum patient subsequently underwent emergent splenectomy patient s COVID19 antigen test returned positive surgery subsequently confirmed polymerase chain reaction PCR test COVID19 found result primarily respiratory symptom ability invade endothelial cell via angiotensinconverting enzyme 2 affinity speculated mechanism may cause predisposition microthromboses eventually lead manifestation large lymphoid organ thrombosis Based case presentation evolving literature severe acute respiratory syndrome coronavirus 2 SARSCoV2 spontaneous splenic rupture emergent differential diagnosis considered COVID19 patient presenting gastrointestinal complaint abdominal pain nausea,atraumatic splenic rupture;covid-19;gastro-intestinal;hemato;intra-abdominal collection
Lock Stock Barrel Role ReninAngiotensinAldosterone System Coronavirus Disease 2019,34359922,Since end 2019 medicalscientific community facing terrible pandemic caused new airborne viral agent known SARSCoV2 Already early stage pandemic following discovery virus us ACE2 cell receptor molecular target infect cell body hypothesized reninangiotensinaldosterone system involved pathogenesis disease Since numerous study published subject exact role reninangiotensinaldosterone system pathogenesis COVID19 still matter debate RAAS represents important protagonist pathogenesis COVID19 providing virus receptor entry host cell determining organotropism Furthermore following infection virus able cause increase plasma ACE2 activity compromising normal function RAAS dysfunction could contribute establishment thromboinflammatory state characteristic severe form COVID19 Drugs targeting RAAS represent promising therapeutic option COVID19 sufferer,ace inhibitors;ace2;covid-19;sars-cov2;renin-angiotensin-aldosterone system;sartans;zinc-chelating agents
Impact Recent SARSCoV2 Infection Course Severity Dengue Children Prospective Observational Study North India,34339386,2020 considerable overlap occurred COVID19 pandemic seasonal dengue transmission India study aimed evaluate effect acute recent infection SARSCoV2 course outcome dengue fever child prospectively enrolled 44 child clinical laboratory diagnosis dengue fever Assessment acute recent SARSCoV2 infection done using reverse transcriptionpolymerase chain reaction IgG antibody ELISA Children grouped based evidence SARSCoV2 exposure clinical severity outcome compared median age study cohort 96 month interquartile range IQR 69129 month Fever 98 vomiting 78 abdominal pain 68 hepatomegaly 68 edema 32 common feature twothirds N = 30 severe dengue 20 45 dengue shock Liver dysfunction 58 acute kidney injury 25 major organ dysfunction Nineteen 43 child stayed pediatric intensive care unit median duration 5 day IQR 211 day None acute SARSCoV2 infection however IgG SARSCoV2 detected 15 34 case Children recent exposure SARSCoV2 showed trend toward lower incidence acute kidney injury fewer organ dysfunction lower frequency invasive ventilation Four child 9 died none death SARSCoV2exposed group present study expose preliminary evidence dengue fever might follow le severe course child recent exposure SARSCoV2 infection However pertinent understand antigenic similarity crossprotective antibody response two virus clinical relevance,
Population surveillance approach detect respond new cluster COVID19,34220348,Background maintain control coronavirus disease 2019 COVID19 epidemic lockdown lifted crucial enhance alternative public health measure surveillance necessary detect high proportion new case quickly isolated people exposed traced quarantined introduce mathematical approach used determine many sample need collected per unit area unit time detect new cluster COVID19 case stage early enough control outbreak Methods present sample size determination method us relative weighted approach Given contribution COVID19 test result subpopulations detect disease threshold prevalence level control outbreak 1 determine expected number weekly sample provided current healthcarebased surveillance respiratory virus infection may provide sample size already adequate detect new cluster COVID19 2 determine many additional weekly sample needed volunteer sampling Results demonstration method weekly Canadian provincial territorial PT level found populous PT sufficient testing number healthcare visit respiratory illness detect COVID19 target prevalence levelassumed high enough identify control new cluster Furthermore detection COVID19 efficient fewer sample required surveillance focus healthcare symptomatic testing demand volunteer population higher contact rate higher expected prevalence level fewer sample needed detect COVID19 predetermined threshold level Conclusion study introduces targeted surveillance strategy combining passive active surveillance sample determine many sample collect per unit area unit time detect new cluster COVID19 case goal strategy allow early enough detection control outbreak,covd-19;detection;mathematical approach;outbreak;surveillance
Early long term antibody kinetics asymptomatic mild disease COVID19 patient,34215811,patient infected SARSCoV2 asymptomatic mildly symptomatic However early late antibody kinetics association antibody level clinical symptom disease phase patient yet fully defined Confirmed SARSCoV2 patient household contact evaluated period four month evaluation procedure included symptom monitoring viral load serology analysis every ten day total 1334 serum sample collected 135 patient analyzed using three assay IgGN IgGS IgM antibody study participant 97 seropositive study two distinct cluster identified cluster significantly different inflammatory related symptom Peak IgGS 400 AUml noninflammatory cluster 715 AUml inflammatory cluster P = 0006 whereas IgGN peak 43 587 P = 0023 respectively Finally decision tree model designed predict disease phase based serological titer level overall accuracy 807 specific profile seroconversion decay serum antibody used predict timecourse acute infection,
Predictors COVID19Related Perceived Improvements Dietary Health Results US CrossSectional Study,34205306,COVID19 pandemic resulted substantial lifestyle change US study identified predictor perceived dietary healthfulness change pandemic period study included analysis lifestyle dietary healthfulness change using 958 survey response US primary household food purchaser Information collected related demographic COVID19related household change healthrelated habit pandemic Binary logistic regression identified predictor perceived increase dietary healthfulness pandemic period Overall 598 164 234 participant reported eating habit likely changed may changed likely change respectively participant whose dietary habit likely may changed 641 168 19 reported healthier neither healthier le healthy le healthy eating habit respectively COVID19related income loss meal consumed household member front television increase food advertisement exposure increased perceived stress better perceived current health significant predictor perceived increase dietary healthfulness Overall dietary habit perceived become healthier pandemic predictor perceived improvement dietary healthfulness surprising indicate need study factor crisis noncrisis situation,covid-19;united states;diet;health;lifestyle;nutrition
Prone Supine 12Lead ECG Comparisons Implications Cardiac Assessment Prone Ventilation COVID19,34217662,OBJECTIVES study sought describe expected change mirrorimage prone electrocardiogram ECG compared normal supine including range cardiac condition BACKGROUND Unwell COVID19 patient risk cardiac complication Prone ventilation recommended pose practical challenge acquisition 12lead ECG effect prone positioning ECG remain unknown METHODS 100 patient underwent 3 ECGs standard supine front SF prone position precordial lead attached front PF prone precordial lead attached back mirror image front PB RESULTS Prone positioning associated QTc prolongation PF 437 + 32 m vs SF 432 + 31 m p 001 PB 436 + 34 m vs SF 432 + 31 m p = 002 lead V1 V3 PB ECG qR morphology present 90 change Twave polarity 84 patient anterior ischemia STsegment change V1 V3 supine ECG longer visible PB 100 replaced R wave V1 Bundle branch block BBB remained detectable 100 PB left BBB appearing right BBB PB 71 QRS narrowing qR V1 right BBB STsegmentTwave change limb lead arrhythmia detection largely unaffected PB CONCLUSIONS expected PB ECG unreliable detection anterior myocardial injury remains useful STsegmentTwave abnormality limb lead BBB detection rhythm monitoring prone ECG useful screening tool diagnostic utility COVID19 patient require prone ventilation,covid-19;electrocardiogram;prone;supine
Impact COVID19 pandemic routine childhood immunisation Colombia,34285000,OBJECTIVE ass impact COVID19 pandemic routine childhood vaccination coverage Colombia age group ruralurban residence state vaccine type DESIGN Ecological study official monthly vaccination record SETTING Vaccination record Colombian Ministry Health MarchOctober 2019 2020 PARTICIPANTS Aggregated data Colombian child 12 month n=676 153 1223 month n=700 319 5 year n=734 295 participating Expanded Program Immunization MAIN OUTCOME MEASURES Proportion eligible population receiving vaccination RESULTS Vaccination coverage showed overall decline approximately 144 2019 2020 2019 coverage=760 2020 coverage=616 greatest reduction proportion vaccinated observed child 12 month age pneumococcal vaccine second dose 2019 coverage=814 2020 coverage=622 20192020 absolute difference 192 95 CI 148 237 child aged 1223 month proportion vaccinated yellow fever declined 164 124 209 783 2019 618 2020 Among child 5 year age biggest decrease occurred oral polio vaccine second dose difference 114 71 157 2019 2020 731 617 2019 2020 observed statistically significant effect vaccine coverage rural versus urban area child 12 month 5 year age CONCLUSIONS Reduced uptake immunisation COVID19 pandemic pose serious risk vaccinepreventable disease outbreak Colombia middleincome country need continue monitor immunisation programme coverage disease outbreak national subnational level undertake catchup vaccination activity,covid-19;epidemiology;health services research
Factors associated mortality patient hospitalized COVID19 prospective cohort Peruvian national referral hospital,34292921,Objectives describe ass clinical characteristic factor associated mortality adult patient COVID19 admitted national referral hospital Peru Methods conducted prospective cohort study included hospitalized patient older 18 year severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection diagnosis Patients positive rapid serological test admission respiratory symptom compatible image excluded collected data clinical record Results total 813 adult included 544 669 confirmed COVID19 mean age 612 year standard deviation 150 575 705 male frequent comorbidities hypertension 341 obesity 259 admission frequent symptom dyspnea 822 cough 539 total 114 140 patient received mechanical ventilation 38 47 admitted intensive care unit 377 464 died requirement ventilatory support greater lung involvement inflammatory marker associated higher mortality found every 10year age increase risk dying increased 32 relative risk 132 95 confidence interval 125 138 admitted intensive care unit placed mechanical ventilation 139 95 confidence interval 113 169 197 95 confidence interval 169 229 time risk dying compared respectively Conclusion found high mortality rate among hospitalized patient associated older age higher inflammatory marker greater lung involvement,covid-19;peru;sars-cov-2;hospitalization;mortality;risk factors;coronavirus
Unique autoantibody prevalence longterm recovered SARSCoV2infected individual,34214763,variability resolution SARSCoV2infections individual neither comprehended longterm immunological consequence ass longterm impact SARSCoV2infection immune system conducted prospective study 80 acute former SARSCoV2 infected individual 39 unexposed donor evaluate autoantibody response immune composition Autoantibody level cyclic citrullinated peptide CCP specific predictor rheumatoid arthritis RA significantly p = 0035 elevated convalescent whereas acute COVID19 patient longterm convalescent showed critically increased level antitissue transglutaminase TG specific predictor celiac disease CD p = 0002 antiCCP antiTG antibody level still detectable 48 month post infection AntiTG antibody occurred predominantly aged patient context postSARSCoV2specific immune composition R 2 = 031 p = 0044 study show increased antiCCP antiTG autoantibody level remain longterm recovering even mildly experienced COVID19 interrelationship lung viral entry side RA CDassociated autoimmunity indicates SARSCoV2infection could relevant environmental factor pathogenesis,autoantibodies;covid-19;celiac disease;long-term;rheumatoid arthritis;sars-cov-2
Longlived macrophage reprogramming drive spike proteinmediated inflammasome activation COVID19,34133077,Innate immunity trigger responsible viral control hyperinflammation COVID19 largely unknown show SARSCoV2 spike protein Sprotein prime inflammasome formation release mature interleukin1beta IL1beta macrophage derived COVID19 patient macrophage healthy SARSCoV2 naive individual Furthermore longitudinal analysis reveal robust Sproteindriven inflammasome activation macrophage isolated convalescent COVID19 patient correlate distinct epigenetic gene expression signature suggesting innate immune memory recovery COVID19 Importantly show Sproteindriven IL1beta secretion patientderived macrophage requires nonspecific monocyte preactivation vivo trigger NLRP3inflammasome signaling finding reveal SARSCoV2 infection cause profound longlived reprogramming macrophage resulting augmented immunogenicity SARSCoV2 Sprotein major vaccine antigen potent driver adaptive innate immune signaling,nlrp3;sars-cov-2;inflammasome;innate immunity;macrophage
Facial SelfTouching Propagation COVID19 Role Gloves Dental Practice,34209991,BACKGROUND Despite facial selftouching possible source transmission SARSCoV2 role dental practice studied Factors anxiety symptom threat perception COVID19 may increase possibility contagion objective compare impact control measure glove sign reduction facial selftouching METHODS intrasubject design undertaken 150 adult patient movement waiting room monitored Microsoft Kinect software three occasion without control measure using plastic glove using advisory sign selftouching Additionally participant completed subscale STAI StateAnxiety BIPQ5 Brief Illness Perception Questionnaire blood pressure heart rate recorded RESULTS lowest incidence facial selftouching occurred experimental situation glove introduced subject elevated anxiety symptom realized facial selftouching regardless control measure However threat perception COVID19 associated negatively facial selftouching CONCLUSIONS use glove useful control measure reduction facial touching However people anxiety symptom regardless whether greater threat perception COVID19 exhibit facial touching,covid-19;sars-cov-2;anxiety;high risk;preventive measures;touch
Role Neuropilin1 NRP1 SARSCoV2 Infection Review,34202613,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 discovered 2019 responsible global coronavirus disease 19 COVID19 pandemic main protein interacts host cell receptor Spike1 S1 subunit coronavirus subunit bind receptor present host cell membrane identified several study neuropilin1 NRP1 one coreceptors SARSCoV2 entry Therefore review focus significance NRP1 SARSCoV2 infection MEDLINEPubMed database used search available literature current review report NRP1 play many important function including angiogenesis neuronal development regulation immune response Additionally presence glycoprotein host cell membrane significantly augments infection spread SARSCoV2 Literature data suggest NRP1 facilitates entry virus central nervous system olfactory epithelium nasal cavity Moreover published finding show interfering VEGFANRP1 using NRP1 inhibitor may produce analgesic effect review describes association NRP1 SARSCoV2 inter alia pathological change retina Based published finding suggest NRP1 important mediator implicated inter alia neurological manifestation SARSCoV2 infection Additionally appears use NRP1 inhibitor promising therapeutic strategy treatment SARSCoV2 infection,covid-19;nrp-1;sars-cov-2;coronavirus;host cell
Antibiotic Use Associated Risk Factors Antibiotic Prescribing COVID19 Hospitalized Patients,34291681,BACKGROUND Literature suggests antibiotic prescribing COVID19 patient high Currently insufficient data drive antibiotic prescribing practice throughout COVID19 pandemic OBJECTIVE study sought determine antibiotic use rate identify risk factor antibiotic prescribing hospitalized patient first study ass risk factor receiving 1 course antibiotic METHODS retrospective multicenter observational study Patients admitted March 1 2020 May 31 2020 treated COVID19 included primary endpoint rate antibiotic use hospitalization Secondary endpoint included risk factor associated antibiotic use risk factor associated receiving 1 antibiotic course rate microbiologically confirmed infection RESULTS total 208 encounter 198 patient included final analysis Eightythree percent patient received least 1 course antibiotic despite low rate microbiologically confirmed infection 12 Almost onethird patient 30 received 1 course antibiotic Risk factor identified antibiotic prescribing receiving 1 course antibiotic included increased hospital length stay median 12 day intensive care unit admission necessity mechanical ventilation CONCLUSION RELEVANCE high rate antibiotic prescribing low rate microbiologically confirmed bacterial coinfection Many patient received 1 course antibiotic hospitalization study highlight importance demand appropriate antibiotic stewardship practice COVID19 patient,covid-19;antibiotics;antimicrobial stewardship;bacterial infection;bacterial pneumonia
Potential Use Vitamin C Prevent Kidney Injury Patients COVID19,34203409,newly found SARSCoV2 led pandemic COVID19 caused respiratory distress syndrome even death worldwide become global public health crisis Unfortunately elder subject comorbidities high mortality rate One main feature COVID19 cytokine storm cause damage cell tissue including kidney reviewed current literature renal impairment patient COVID19 analyzed possible etiology mechanism addition investigated potential use vitamin C prevention renal injury patient appears vitamin C could helpful improve outcome patient COVID19 Lastly discussed possible protective effect vitamin C renal function COVID19 patient existing kidney condition,covid-19;acute kidney injury;inflammatory cytokine storm;oxidative stress;vitamin c
COVID19 pediatric patient undergoing chronic dialysis kidney transplantation,34218318,study aim present incidence COVID19 pediatric patient undergoing renal replacement therapy RRT compare severity outcome disease dialysis kidney transplant KTx group multicenter observational study conducted 1 April 31 December 2020 Istanbul Members Istanbul branch Turkish Pediatric Nephrology Association asked report confirmed case COVID19 RRT well number prevalent RRT patient age 20 total 46 confirmed case COVID19 reported 12 center 17 dialysis patient 29 KTx recipient Thus incidence rate COVID19 93 among dialysis patient 92 among KTx recipient 9month period Istanbul Twelve KTx recipient three dialysis patient asymptomatic p = 012 symptomatic patient dialysis KTx group mild respiratory illness two patient one group experienced severe disease course one hemodialysis patient critical illness required mechanical ventilation entire cohort one hemodialysis patient multiple comorbidities diedConclusion case asymptomatic mild disease course pediatric patient undergoing dialysis kidney transplant increased risk COVID19 Known adult population dialysis patient kidney transplant recipient increased risk severe illness COVID19 higher mortality rate Children kidney transplantation increased risk COVID19 mild disease course Data child dialysis scarce New Pediatric patient undergoing dialysis kidney transplantation increased risk COVID19 patient undergoing renal replacement therapy either dialysis transplanted develop asymptomatic mild COVID19 disease favorable outcome,covid-19;children;dialysis;kidney transplantation;pediatric;rrt;renal replacement therapy
Prognostic value neutrophiltolymphocyte ratio COVID19 patient systematic review metaanalysis,34228867,BACKGROUND Neutrophiltolymphocyte ratio NLR accessible widely used biomarker NLR may used early marker poor prognosis patient COVID19 OBJECTIVE evaluate prognostic value NLR patient diagnosed COVID19 METHODS conducted systematic review metaanalysis Observational study reported association baseline NLR value ie hospital admission severity allcause mortality COVID19 patient included quality study assessed using NewcastleOttawa Scale NOS Random effect model inverse variance method used metaanalyses effect expressed odds ratio ORs 95 confidence interval CIs Small study effect assessed Egger s test RESULTS analysed 61 study n = 15 522 patient 58 cohort 3 casecontrol study increase one unit NLR associated higher odds severity 622 95 CI 493 784 P 001 higher odds allcause mortality 126 95 CI 688 2306 P 001 sensitivity analysis found 41 study low risk bias moderate heterogeneity 2 = 53 58 maintained strong association NLR value outcome severity 536 95 CI 445 645 P 001 mortality 1042 95 CI 773 1406 P = 005 CONCLUSIONS Higher value NLR associated severity allcause mortality hospitalised COVID19 patient,
Severe COVID19 Hospitalized Carriers Single CFTR Pathogenic Variants,34203982,clinical presentation COVID19 extremely heterogeneous ranging asymptomatic severely ill patient Thus host genetic factor may involved determining disease presentation progression Given carrier single cystic fibrosis CF causing variant CFTR geneCFcarriersare susceptible respiratory tract infection aim determine likelihood undergoing severe COVID19 implemented cohort study 874 individual diagnosed COVID19 first pandemic wave Italy Whole exome sequencing performed validated CFcausing variant identified Forty subject 16 female 24 male found CFcarriers Among mechanically ventilated patient CFcarriers represented 87 significantly p 005 younger mean age 51 year compared noncarriers mean age 6142 year Furthermore whole cohort age male CFcarriers lower compared noncarriers p 005 CFcarriers relative risk presenting abnormal inflammatory response CRP = 20 mgdL 169 p 005 hazard ratio death day 14 310 p 005 multivariate regression model adjusted age sex comorbidities conclusion CFcarriers susceptible severe form COVID19 showing also higher risk 14day death,cf carrier screening;cftr;covid-19;host genetics
Brief Report Acute Kidney Injury People Living HIV Hospitalized Coronavirus Disease 2019 Clinical Characteristics Outcomes,34229329,BACKGROUND Data clinical characteristic outcome people living HIV PLWH hospitalized coronavirus disease 2019 COVID19 develop acute kidney injury AKI limited SETTING Large tertiary health care system Bronx NY METHODS performed retrospective cohort study 83 PLWH 4151 patient without HIV hospitalized COVID19 March 10 2020 May 11 2020 compared clinical characteristic outcome associated AKI HIV serostatus evaluated HIVrelated factor AKI among PLWH AKI defined staged using Kidney Disease Improving Global Outcomes criterion RESULTS incidence AKI hospitalized patient COVID19 differ significantly HIV serostatus 542 PLWH v 495 patient without HIV P = 06 Despite higher incidence stage 3 AKI 289 v 171 P = 005 PLWH compared without HIV significant difference need renal replacement therapy 222 v 134 P = 012 renal recovery 769 v 825 P = 061 dependence renal replacement therapy 77 v 38 P = 027 CD4 Tcell count HIV1 RNA viral suppression antiretroviral therapy use associated AKI AKI associated increased need invasive ventilation inhospital death HIV independent risk factor inhospital death AKI adjusted hazard ratio 101 95 CI 059 172 P = 098 CONCLUSIONS HIVrelated factor associated increased risk AKI PLWH hospitalized COVID19 PLWH hospitalized COVID19 stage 3 AKI outcome AKI similar without HIV,
Characteristics Healthcare Workers Vaccinated Influenza Era COVID19,34202867,Understanding potential impact COVID19 receiving influenza vaccination among healthcare worker HCWs utmost importance purpose present crosssectional study describe characteristic explore predictor receiving influenza vaccination among large cohort Italian HCWs hospital setting Information collected anonymous questionnaire December 2020 January 2021 General practice characteristic perceived risk seasonal influenza attitude towards efficacy safety influenza vaccination reason behind decision vaccinated influenza explored Fewer half 462 HCWs agreed influenza serious illness perceived risk getting infected influenza concern safety vaccination significant positive predictor Fewer half respondent concerned efficacy 486 safety 498 influenza vaccination 519 reported received seasonal influenza vaccine previous season mentioned reason receiving influenza vaccine current season influenza COVID19 share similar symptom Study result aid policymakers developing vaccination education program promotion trust address negative misconception achieve future high coverage among highrisk group,covid-19 pandemic;italy;healthcare workers;influenza vaccination;survey;vaccination coverage
Protracted COVID19 Treatment Facial Palsy,34211790,Neurologic manifestation increasingly reported coronavirus disease 2019 COVID19 pandemic continues report COVID19 patient Bell s palsy Case Summary 52yearold man fever malaise tested positive COVID19 week developed rightsided peripheral facial palsy treated corticosteroid conjunction antiviral treatment resulted complete recovery Discussion Concomitant treatment corticosteroid antiviral treatment decrease morbidity patient COVID19related Bell s palsy,
Postacute COVID19 syndrome,34224394,Osszefoglalo posztakut COVID19 szindroma PACS az akut betegseget koveto 412 het szubakut tunetes szakasznak valamint az ezt koveto kronikus posztCOVIDidoszaknak az egyutteset jelenti PACS kulonbozo altalanos tunetekkel e szervi pulmonalis cardiovascularis neuropszichiatriai endokrin mozgasszervi borgyogyaszati renalis manifesztaciokkal jar Ebben az osszefoglaloban attekintjuk PACS kialakulasahoz vezeto patogenetikai e rizikotenyezoket Bemutatjuk klinikumot e diagnosztikat PACS ellatasa alapvetoen haziorvosi feladat mely szervi tunetek gyogyszeres e nem gyogyszeres kezelesebol multidiszciplinaris rehabilitaciobol e gondozasbol Kiterunk haziorvos feladataira szakellatasba torteno beutalas indokaira e posztCOVIDhalozat letrehozasanak e mukodtetesenek szuksegessegere Orv Hetil 2021 162 27 10671078 Summary Postacute COVID19 syndrome PACS includes subacute symptomatic phase 412 week acute COVID19 well subsequent chronic postCOVID19 period PACS associated various general symptom organ pulmonary cardiovascular neuropsychiatric endocrine musculoskeletal dermatological renal manifestation summary review pathogenetic risk factor leading development PACS present clinical picture diagnostics PACS usually managed general practitioner management PACS includes pharmacological nonpharmacological treatment multidisciplinary rehabilitation regular followup also discus task general practitioner reason referral specialist need set operate postCOVID19 network Orv Hetil 2021 162 27 10671078,covid-19;covid-19;sars-cov-2;multidisciplinary team;multidiszciplinaris team;organ symptoms;post-covid-19 network;post-acute covid-19 syndrome;poszt-covid-19-halozat;posztakut covid-19 szindroma;szervi tunetek
Herpes zoster inactivated SARSCoV2 vaccine two healthy young adult,34363257,Coronavirus disease 2019 COVID19 cause various cutaneous manifestation identified since outbreak 1 era vaccination cutaneous side effect vaccine likely frequently encountered Mild reaction like localized redness swelling detected vaccine reaching phase 3 trial besides rarer adverse effect injection cite urticaria maculopapular rash reaction dermal filler due COVID19 vaccine reported 2,covid-19;sars-cov-2;herpes zoster;inactivated vaccine;vaccination
Understanding COVID19 impact cervical breast colorectal cancer screening among federally qualified healthcare center participating `` Back track screening quality improvement project,34217422,COVID19 pandemic contributed decrease breast colorectal cervical cancer screening 86 94 compared threeyear average postponed screening created backlog system need address healthcare facility reopen preventive care American Cancer Society leading 17month intervention 22 federally qualified health center FQHCs across United States aimed reducing cancer incidence mortality disparity alleviating additional strain caused COVID19 study describes COVIDrelated cancer screening service disruption reported participating FQHCs Selected FQHCs experienced service disruption andor preventive care cancellation due COVID19 varied severity duration Fiftynine percent stopped cancer screening completely Centers transitioned telehealth visit rescheduled future impact strategy may limited continued pandemicrelated disruption inability screening home colon cancer screening exception center resumed inperson screening limited person appointment high level community transmission may reduce FQHC ability provide catchup service FQHCs provide critical cancer prevention service vulnerable population delivery culturally competent highquality healthcare mitigate potentially reverse racial ethnic disparity cancer prevention testing treatment Ensuring expanding access care move pandemic critical preventing excess cancer incidence mortality vulnerable population,covid-19;cancer screening;fqhc
Performance Roche IL6 chemiluminescent immunoassay patient COVIDlike respiratory symptom,34214571,INTRODUCTION evaluated Roche Elecsys IL6 assay Cobas immunoassay analyser METHOD Serum IL6 144 control compared 52 sample patient COVIDlike respiratory symptom 17 SARSCoV2 RTPCR positive 25 intensive care unit ICU compared IL6 level Creactive protein CRP procalcitonin PCT level case RESULTS IL6 assay coefficientofvariation CV 23 341 pgmL 25 2225 pgmL limit quantitation 16 pgmL linear 16 4948 pgmL significant difference IL6 value patient COVIDlike respiratory symptom versus control p 0001 ROC analysis showed IL6 64 pgmL identified symptomatic case AUC 094 sensitivity 882 specificity 972 significant difference IL6 symptomatic ICUnonICU case median IL6 228 v 11 pgmL p 00001 ROC analysis showed IL6 75 pgmL sensitivity 760 specificity 889 superior CRP PCT predicting ICU admission AUC IL6 083 CRP 071 PCT 082 CONCLUSION performance Elecsys IL6 assay keeping manufacturer s claim IL6 64 pgmL differentiates healthy suspected COVID19 case appears raised earlier inflammatory marker case IL6 75 pgmL good predictor ICU admission,assay evaluation;il6;inflammatory markers;sars-cov-2
Combined noninvasive respiratory support therapy treat SARSCoV2 patient prospective Observational Study,34290078,Background role highflow nasal cannula HFNC CPAP COVID19 controversial objective study evaluate impact application noninvasive respiratory support NIRS algorithm clinical outcome COVID19 subject acute respiratory failure ARF Methods performed single center prospective observational study subject respiratory failure COVID19 managed highflow nasal cannula HFNC CPAP+HFNC combined therapy main outcome intubation rate defined failure therapy also analyzed role ROX index SpO2FiO2 respiratory rate predict need intubationResults June December 2020 113 subject COVID19 respiratory failure admitted respiratory intermediate care unit RICU HFNC applied 65 subject 5752 combined therapy 48 4247 total 83 subject 7345 successfully treated NIRS intubation rate 2654 overall mortality 1415 Mortality rate intubated subject 552 ROX index 628 12 hour predicted NIRS failure 976 sensitivity 518 specificityConclusions Data cohort managed RICU showed combined NIRS feasible favorable outcome prospective study required,covid-19;sars-cov-2;combined therapy;continuous positive airway pressure;high-flow nasal cannula;hypoxemic respiratory failure
Possible Preventive Role Physically Active Lifestyle SARSCoV2 Pandemic Might Regular ColdWater Swimming Exercise Reduce Symptom Severity COVID19,34281096,objective study investigate incidence course COVID19 risk upper respiratory tract infection group people physically active lifestyle Data collected anonymously using online survey platform December 2020 age participant ranged 18 65 year 2343 participant 115 overcame COVID19 infection Relative control group CTRL physically active coldwater swimmer PACW exhibit lower risk incidence COVID19 RR 1074 CI 95 07101625 However PACW higher chance asymptomatic course COVID19 RR 2321 CI 95 08366442 p 005 higher chance acute respiratory infection le per year CTRL RR 1923 CI 95 116412253 p 001 Furthermore PACW exhibited lower incidence acute respiratory infection occurring twice per year RR 0258 CI 95 01380483 p 001 Coldwater swimming physical activity may lessen risk COVID19 recreational athlete However physically active lifestyle might positive effect rate incidence acute respiratory infection severity COVID19 symptom,bmi;acute respiratory infection;athletes;cold-water swimming;physical activity
Transmission dynamic SARSCoV2 midsize city China,34376168,BACKGROUND outbreak pneumonia COVID19 associated severe acute respiratory syndrome coronavirus 2 SARSCoV2 emerged Wuhan city rapidly spread city Wenzhou located approximately 900 km Wuhan experiencing outbreak severe time considered modest epidemic became pandemic described epidemiological characteristic SARSCoV2 outside epicenter help understand transmission pattern midsized Chinese city METHODS investigate epidemiological clinical characteristic COVID19 described case series 473 patient confirmed COVID19 Wenzhou China January 27 March 16 2020 described public health intervention COVID19 evaluated effect intervention effective reproduction number Rt RESULTS median age patient 476 year 484 female 338 patient history residence Wuhan Fever 717 cough 431 common symptom addition three kind unconventional case observed namely 49 asymptomatic patient 76 confirmed patient link Wuhan city contact individual Wuhan without symptom time contact 129 confirmed patient unknown source transmission estimated basic reproductive number R0 275 95 CI 237323 Rt fluctuated within range 250 374 January 11 January 16 gradually reached peak 374 January 16 Rt gradually decreased January 16 decreased 100 January 30 Rt continually decreased reached lowest point 003 February 21 2020 CONCLUSION study presented possibility asymptomatic carrier affected SARSCoV2 transmission three kind unconventional patient Wenzhou may important characteristic SARSCoV2 transmission evaluation showed series multifaceted intervention proved effective controlling epidemic COVID19 finding might provide valuable example control policy country area combatting global pandemic COVID19,asymptomatic patient;covid-19;prevention and control measures;r0;rt;sars-cov-2;transmission dynamics
silico Screening Natural Phytocompounds Towards Identification Potential Lead Compounds Treat COVID19,34291081,COVID19 one member coronavirus family easily assail human 10 million people infected two million people died COVID19 globally past year several researcher made essential advance discovering potential drug efficient drug available market present study aim identify potent phytocompounds different medicinal plant Zingiber officinale Cuminum cyminum Piper nigrum Curcuma longa Allium sativum total 227 phytocompounds identified screened protein SACE2 pro structurebased virtual screening approach Based binding affinity score 30 active phytocompounds selected Amongst binding affinity betasitosterol betaelemene SACE2 showed 120 109 kcalmol respectively Meanwhile binding affinity betasitosterol betachlorogenin pro found 97 84 kcalmol respectively selected compound proceeded molecular dynamic simulation prime MMGBSA analysis ADMET property check understand stability interaction conformational change binding free energy pharmaceutical relevant parameter Moreover hotspot residue Lys31 Lys353 SACE2 catalytic dyad His41 Cys145 pro actively involved inhibition viral entry silico analysis anticipate work could valuable ongoing novel drug discovery potential treatment COVID19,covid-19;s-ace2;main protease;molecular dynamics simulation;natural medicinal plants;structure-based virtual screening
Indepth profiling COVID19 risk factor preventive measure healthcare worker,34379308,PURPOSE determine risk factor coronavirus disease 2019 COVID19 healthcare worker HCWs characterize symptom evaluate preventive measure SARSCoV2 spread hospital METHODS crosssectional study conducted May 27 August 12 2020 first wave COVID19 pandemic obtained serological epidemiological occupational well COVID19related data quaternary care multicenter hospital Munich Germany RESULTS 7554 HCWs participated 22 tested positive antiSARSCoV2 antibody Multivariate analysis revealed increased COVID19 risk nurse 31 seropositivity 95 CI 2539 p = 0012 staff working COVID19 unit 46 seropositivity 95 CI 3265 p = 0032 male 24 seropositivity 95 CI 1832 p = 0019 HCWs reporting highrisk exposure infected patient 55 seropositivity 95 CI 4075 p = 00022 outside work 120 seropositivity 95 CI 80174 p 00001 Smoking protective factor 11 seropositivity 95 CI 0718 p = 000018 symptom taste disorder strongly associated COVID19 298 seropositivity 95 CI 243358 p 00001 unbiased decision tree identified subgroup different risk profile Working home preventive measure protect SARSCoV2 infection PCRtesting strategy focused symptom highrisk exposure detected larger COVID19 outbreak CONCLUSION Awareness identified COVID19 risk factor successful surveillance strategy key protecting HCWs SARSCoV2 especially setting limited vaccination capacity reduced vaccine efficacy,covid-19;healthcare workers;prevention;risk factors;sars-cov-2
Head home implementation COVID19 pandemic,34289965,BACKGROUND Recent research suggests 20 50 paediatric head injury attending emergency department ED could safely discharged soon triage without need medical review using Head Injury Discharge Triage tool HIDAT sought implement clinical practice METHODS Paediatric ED triage staff underwent competencybased assessment HIDAT head injury presentation 1 May 31 October 2020 included analysis determined patient discharged using tool underwent CT brain whether clinically important traumatic brain injury representation ED RESULTS 1429 patient screened 610 43 screened negative 250 18 discharged nursing staff entire cohort 32 CTs performed head injury concern 6 abnormal 1 CT performed HIDAT negative group normal discharged using HIDAT four reattended two vomiting imaging admission two minor scalp wound infection Two patient screened negative declined discharge policy later medical discharge imaging admission Paediatric ED attendance 29 lower 2018 CONCLUSION successfully implemented HIDAT local clinical practice number discharged 18 lower originally described likely multifactorial relationship COVID19 paediatric ED attendance unclear decreased attendance suggest tool originally designed attending ED may accessing medicalnonmedical resource,emergency care systems;head;paediatric emergency med;paediatric injury;performance improvement;trauma
Parenteral Anticoagulation Retroperitoneal Hemorrhage COVID19 Case Report Five Patients,34222798,Since coronavirus disease 2019 COVID19 associated hypercoagulable state especially critical patient anticoagulation used thromboprophylaxis Hemorrhagic complication even uncommon one retroperitoneal hemorrhage occur following anticoagulant administration present 5 patient COVID19 whose clinical course complicated spontaneous retroperitoneal hemorrhage patient initially presented respiratory manifestation infection history evidence suggestive traumatic injury hospitalization patient received supplemental oxygen antibiotic enoxaparin heparin interferon beta1b three patient anticoagulation subcutaneous injection enoxaparin three patient heparin two patient course hospitalization patient showed suddenonset abdominal pain three case hypotension three case acute drop hemoglobin level CT scan abdomen pelvis revealed retroperitoneal hemorrhage one patient owing unstable vital sign expanding hematoma surgical intervention performed Others managed conservatively discontinuation anticoagulant intravenous IV fluid resuscitation packed red blood cell transfusion Three patient died due worsening infection respiratory failure Retroperitoneal hemorrhage could potential complication COVID19 patient receiving anticoagulation Careful monitoring vital sign blood test like hemoglobin level patient essential,covid-19;hemorrhage;retroperitoneal space;sars-cov-2
epidemic La Pampa Argentina historical perspective,34346995,article describes emergence health concern relating epidemic occurred twentieth century La Pampa province Argentina Epidemics smallpox drove policy frequently originated Buenos Aires country s capital spread many epidemic due shortage water sewage adequate refuse disposal insufficient number health care worker presence disease transmission vector mosquito ultimately poverty historical experience described text highlight importance analyzing impact SARSCoV2 beyond big city,
Antibody Status Disease History Incidence SARSCoV2 Infection Among Patients Chronic Dialysis,34215666,BACKGROUND Although reinfection severe acute respiratory syndrome coronavirus 2 SARSCoV2 rare among individual coronavirus disease 2019 COVID19 risk factor ability naturally acquired immunity prevent reinfection among patient ESKD known METHODS prospective study conducted among adult ESKD treated incenter hemodialysis ICHD United States Exposure ascribed basis presence absence IgG SARSCoV2 baseline separately history documented COVID19 study entry Outcomes assessed infectionfree period SARSCoV2 infection ie detected protocolized PCR test routine clinical surveillance clinically manifest COVID19 consisting latter RESULTS 2337 consented participant met study inclusion criterion 95 antiSARSCoV2 IgG positive baseline 36 history COVID19 6679 patientmonths followup 263 participant evidence SARSCoV2 infection including 141 clinically manifest COVID19 Presence antiSARSCoV2 IgG versus absence baseline associated lower risk SARSCoV2 infection incidence rate ratio 055 95 confidence interval 032 095 clinically manifest COVID19 021 95 confidence interval 007 067 CONCLUSION Among patient ESKD naturally acquired antiSARSCoV2 IgG positivity associated 45 lower risk subsequent SARSCoV2 infection 79 lower risk clinically manifest COVID19 natural immunity incomplete patient ESKD prioritized SARSCoV2 vaccination independent COVID19 disease history,covid-19;hemodialysis;immunity
Dendritic cell deficiency persist seven month SARSCoV2 infection,34290398,Severe Acute Respiratory Syndrome Coronavirus SARSCoV 2 infection induces exacerbated inflammation driven innate immunity component Dendritic cell DCs play key role defense viral infection instance plasmacytoid DCs pDCs capacity produce vast amount interferonalpha IFNalpha COVID19 deficit DC number IFNalpha production associated disease severity work described addition DC deficiency several DC activation homing marker altered acute COVID19 patient associated multiple inflammatory marker Remarkably previously hospitalized nonhospitalized patient remained decreased number CD1c+ myeloid DCs pDCs seven month SARSCoV2 infection Moreover expression DC marker CD86 CD4 restored previously nonhospitalized patient restoration integrin beta7 indoleamine 23dyoxigenase IDO level observed finding contribute better understanding immunological sequela COVID19,covid-19;dendritic cell;long-covid;sars-cov-2
Comparison renal replacement therapy renal recovery COVID19 pandemic single centre observational study,34337912,BACKGROUND objective describe indication management complication outcome renal replacement therapy RRT COVID19 critically ill patient contextualise finding comparison made 36 nonCOVID19 consecutive patient requiring RRT ICU METHODS conducted retrospective single centre observational cohort study patient requiring acute RRT 1st March 30th June 2020 Comparison made receiving RRT preCOVID19 period January 2019 February 2020 RESULTS 154 COVID19 patient 47 305 received continuous venovenous haemofiltration CVVHF required mechanical ventilation vasopressor support requirement RRT related fluid balance rather azotaemia Compared 36 nonCOVID19 patient COVID19 younger p=0016 lower serum creatinine hospital admission p=0049 lesser degree metabolic acidosis p 0001 lactataemia p 0001 initiation RRT addition duration RRT requirement longer p 0001 Despite lower CVVHF exchange rate higher serum creatinine level following RRT initiation COVID19 patient metabolic abnormality corrected Hospital mortality 60 among COVID19 patient requiring RRT compared 67 nonCOVID patient p=0508 renal recovery among survivor without preexisting CKD similar p=0231 CONCLUSIONS requirement RRT COVID19 patient primarily related fluid balance using lower CVVHF exchange rate effective correct metabolic abnormality Renal recovery occurred one patient 60 day 40 patient survived,
Cognitive impairment patient COVID19 hemodialysis dangerous neglect,34133066,Neurological manifestation coronavirus disease 2019 COVID19 often tragic repercussion Although many report neurological complication severe acute respiratory syndrome coronavirus 2 infection exist none patient hemodialysis fivefold greater risk stroke general population report emphasize importance vigilant mild stroke high risk populationssuch patient hemodialysiswith COVID19 since condition overlapping symptom,covid-19;cognitive impairment;encephalopathy;hemodialysis;ischemic stroke
Humoral response SARSCoV2 vaccination promise improve catastrophic prognosis hemodialysis patient result COVID19 COViNEPH Project,34351091,Introduction urgent need check efficacy SARSCoV2 vaccination among hemodialyzed HD patient known extensive disturbance acquired immunity catastrophic risk death COVID19 Objectives crosssectional study aimed ass humoral response following vaccination BNT162b2 BioNTech Pfizer Comirnaty vaccine Patients method analyzed titer magnitude IgG antibody directed spike SARSCoV2 antigen 1421 day second dose BNT162b2 vaccine group HD patient confirmed SARSCoV2 infection yet compared patient history COVID19 126 HD patient stratified based evidence previous infection SARSCOV2 confirmed viral RNA detection nucleocapsidspecific IgG antibody detection Results santigen immune response median IQR antibody titer 366 193691 UAml seen 87 91 infection naive HD patient 956 68 91 INHD patient 747 strong humoral response observed titer antiS antibody 200 UAml Older subject le likely develop Santibodies response P 0001 median Santigen antibody titer 35 previously infected PI HD patient 12fold higher INHD patient 4620 12407820 UAml P 0001 significant difference Santibody titer symptomatic asymptomatic PIHD patient Conclusions study demonstrated majority HD patient achieved high immunization rate vaccination BNT162b2 Whether translates protecting population COVID19 requires research,
Perception experience regarding COVID19 pandemic among urban young adult Bangladesh mixedmethod study,34221848,Aim study aimed exploring perception experience regard COVID19 pandemic among Bangladeshi urban young adult Subject method Using mixedmethod approach online crosssectional survey among 315 participant indepth interview IDI among 20 young adult conducted May 1 May 25 2020 Descriptive statistic chisquare test performed quantitative data along thematic analysis qualitative data Results mean + SD age participant 2654 + 305 majority male 549 816 participant reported COVID19 viral disease transmitted droplet sneezing coughing close contact another person 908 Nearly 40 participant reported news channel reliable source information COVID19 Participants male le likely aware female term mode transmission COVID19 going outside home 827 male v 908 female p 005 Male participant thought perfectly healthy reluctant agree maintaining social distance compared female participant 728 male v 901 female p 0001 Participant s satisfaction level service provided government also significantly different higher among female male participant 399 male v 535 female p 005 majority participant reported suffering due financial uncertainty psychological distress inadequate health facility Dissatisfaction reported existing health service creating several misconception lacking testing facility debasement health professional Conclusion study found better perception regarding COVID19 among young adult poor preventive practice Health education intervention rapid response implemented targeting vulnerable group improve preventive practice,bangladesh;covid-19;experiences;perception;young adults
Resolution pulmonary artery thrombosis patient moderate COVID19 disease,34211650,Novel Coronavirus disease COVID19 widely described cause proinflammatory hypercoagulable state inflammatory process involving alveolar vascular endothelium respiratory system determining factor onset primary Pulmonary Artery Thrombosis PAT even patient heparin prophylactic treatment Little known efficacy anticoagulant therapy course PAT caused COVID19 paper describe result obtained patient moderate COVID19 disease previously threated prophylactic enoxaparin received full Anticoagulant treatment diagnosis PAT three month Computed Tomography Pulmonary Angiography demonstrated complete resolution vascular obstructive lesion patient coagulation test normal,
Functions Coronavirus Accessory Proteins Overview State Art,34199223,Coronavirus accessory protein unique set protein whose gene interspersed among within gene encoding structural protein Different coronavirus genus even different specie within coronavirus genus encode varying amount accessory protein leading genus speciesspecificity Though accessory protein dispensable replication coronavirus vitro play important role regulating innate immunity viral proliferation pathogenicity function accessory protein virus infection pathogenesis area particular interest review summarize current knowledge accessory protein several representative coronaviruses infect human animal including emerging severe acute respiratory syndrome coronavirus 2 SARSCoV2 emphasis role interaction virus host mainly involving stress response innate immunity autophagy apoptosis crosstalking among pathway also discussed,accessory protein;coronavirus;infection;innate immunity;pathogenesis
COVID19 pneumonia suspected coinfection Mycoplasma pneumoniae improved early administration favipiravir ciclesonide,34377494,female nurse 40 caring patient severe coronavirus disease 2019 COVID19 pneumonia treated highflow nasal cannula HFNC presented fever cough dyspnoea Based imaging finding positive reverse transcriptionpolymerase chain reaction RTPCR severe acute respiratory syndrome coronavirus 2 SARSCoV2 COVID19 pneumonia diagnosed although cohabiting family similar symptom RTPCR test negative Laboratory result showed Mycoplasma antigen + started ciclesonide 1200 mugday favipiravir 3600 mgday first day 1600 mgday Day 2 Mycoplasma antigen positive admission family similar symptom levofloxacin 500 mgday started patient recovered discharged Day 10 patient Mycoplasma infection Mycoplasma antibody measured particle agglutination PA method increased 80 time 4 week case highlight healthcare worker wearing full personal protective equipment nevertheless acquire COVID19 patient treated HFNCs,covid-19;mycoplasma pneumoniae;ciclesonide;favipiravir;high-flow nasal cannula
Innovations automate manual ventilation Covid19 pandemic beyond,34341217,Manual ventilation compressing selfinflating bag lifesaving option respiratory support many resourcelimited setting Previous effort automate manual ventilation using mechatronic system unsuccessful Covid19 pandemic stimulated reexploration automating manual ventilation economically viable alternative address anticipated shortage mechanical ventilator Many device developed displayed lay press social medium platform However unsuitable clinical use variety reason include failure understand clinical need complex ventilatory requirement Covid19 patient lack technical specification guide innovator technical challenge delivering ventilation parameter physiological manner absence guideline bench testing innovative device lack clinical validation patient insight gained design development laboratory testing clinical validation novel device designated Artificial Breathing Capability Device shared assist innovator developing clinically usable device detailed set clinical requirement device technical specification meet requirement framework bench testing presented addition regulatory certification issue well concern related protection intellectual property highlighted insight designed foster innovation ecosystem whereby clinically useful automated manual ventilation device developed deployed meet need associated Covid19 pandemic beyond,
Conscious prone positioning pregnant patient COVID19 respiratory distress case report review,34221902,Prone positioning used decade improve oxygenation patient acute respiratory distress syndrome COVID19 pandemic growing emphasis utilization prone positioning nonintubated patient mean preventing invasive ventilation improving outcome case report patient presented acute hypoxemic respiratory failure late pregnancy experienced significant improvement oxygenation prone positioning Additionally physiology prone positioning reviewed well mechanism safety pregnancy,covid-19;pregnancy;prone positioning
Outbreak COVID19 industrial ship,34212347,BACKGROUND People ship high risk outbreak infectious disease including coronavirus disease 2019 COVID19 rapid wellcoordinated response important curb transmission severe acute respiratory syndrome coronavirus 2 SARSCoV2 studied outbreak industrial ship improve outbreak control ship coordination participating harbour partner MATERIALS METHODS Public Health Service PHS RotterdamRijnmond performed epidemiological investigation outbreak COVID19 among 77 seafarer ship port captain interviewed ship detail experience outbreak seafarer asked fill questionnaire symptom suspicious COVID19 date symptom onset Information stakeholder involved outbreak control registered RESULTS captain first contacted PHS probable case March 31st 2020 via physician ashore One crewmember hospitalised April 8th another died unexpectedly aboard April 10th Questionnaires distributed midApril 75 remaining seafarer showed 38 60 responder 63 suspicious symptom February 15th April 13th None tested total 8 crewmembers tested positive COVID19 leaving ship including hospitalised crewmember one died aboard May 5th last case left isolation quarantine ended Many different stakeholder involved outbreak response responsibility always fully clear beforehand causing coordination issue CONCLUSIONS Testing crew COVID19 symptom underpins control measure clarifies communication stakeholder Building network beforehand develop outbreak guideline tailored ship local circumstance essential control future outbreak ship,covid-19;sars-cov-2;coronavirus;harbour;outbreak;public health service;ship
importance external methodological insight external validation machine learning model medicine,34352688,Background Objective Medical machine learning ML model tend perform better data cohort new data often due overfitting covariate shift reason external validation EV necessary practice evaluation medical ML However still gap literature interpret EV result hence ass robustness ML model METHODS fill gap proposing metavalidation method ass soundness EV procedure complement usual way ass EV considering dataset cardinality similarity EV dataset respect training set investigate notion cardinality similarity used inform reliability validation procedure integrating two summative data visualization RESULTS illustrate methodology applying validation stateoftheart COVID19 diagnostic model 8 EV set collected across 3 different continent model performance moderately impacted data similarity Pearson rho = 038 p 0001 EV validated model reported good AUC average 084 acceptable calibration average 017 utility average 050 validation datasets adequate term dataset cardinality similarity thus suggesting soundness result also provide qualitative guideline evaluate reliability validation procedure discus importance proper external validation light obtained result CONCLUSIONS paper propose novel lean methodology 1 study similarity training validation set impact generalizability ML model 2 ass soundness EV evaluation along three complementary performance dimension discrimination utility calibration 3 draw conclusion robustness model validation applied methodology stateoftheart model diagnosis COVID19 routine blood test showed interpret result light presented framework,covid-19;dataset cardinality;dataset similarity;medical machine learning;validation
Development Validation Method Quantification Favipiravir COVID19 Management Spiked Human Plasma,34206357,current work simple economical accurate precise HPLC method UV detection developed quantify Favipiravir FVIR spiked human plasma using acyclovir ACVR internal standard COVID19 pandemic time FVIR ACVR well separated resolved C18 column using mobile phase blend methanol acetonitrile20 mM phosphate buffer pH 31 isocratic mode flow rate 1 mLmin proportion 301060 vvv detector wavelength set 242 nm Maximum recovery FVIR ACVR plasma obtained dichloromethane DCM extracting solvent calibration curve found linear range 31600 microgmL regression coefficient r 2 = 09976 However acceptable r 2 calibration data s heteroscedasticity observed reduced using weighted linear regression weighting factor 1x Finally method validated concerning sensitivity accuracy Inter Intraday s RSD 028 065 100 012 respectively precision recovery 8999 8909 9081 LQC MQC HQC respectively stability RSD 30day 304 171 LQC HQC respectively 20 degree C carryover USFDA guidance Bioanalytical Method Validation researcher COVID19 pandemic crisis Furthermore significant difference selectivity evaluated LLOQ concentration 3 microgmL FVIR relative blank,hplc;acyclovir;bio-analytical;favipiravir;spiked human plasma;validation
Predictive Markers Immunogenicity Efficacy Human Vaccines,34205932,Vaccines represent one major advance modern medicine Despite many success vaccination continuous effort design new vaccine needed fight `` old pandemic tuberculosis malaria well emerging pathogen Zika virus severe acute respiratory syndrome coronavirus 2 SARSCoV2 Vaccination aim reaching sterilizing immunity however assessing vaccine efficacy still challenging underscore need better understanding immune protective response Identifying reliable predictive marker immunogenicity help select develop promising vaccine candidate early preclinical study lead improved personalized vaccination strategy system biology approach increasingly adopted address major challenge using multiple highdimensional technology combined silico model Although goal develop predictive model vaccine efficacy human applying approach animal model empowers basic translational vaccine research review provide overview vaccine immune signature preclinical model well target human population also discus highthroughput technology used probe vaccineinduced response along data analysis computational methodology applied predictive modeling vaccine efficacy,high-throughput technologies;in vivo imaging;machine learning;preclinical models;predictive biomarkers;systems immunology;unsupervised analyses;vaccine signatures;vaccines
Mask RCNNbased building extraction VHR satellite data operational humanitarian action example related Covid19 response Khartoum Sudan,34220286,Within constraint operational work supporting humanitarian organization response Covid19 pandemic conducted building extraction Khartoum Sudan extracted approximately 12 million dwelling building using Mask RCNN deep learning approach Pleiades highresolution satellite image 05 pixel resolution Starting untrained network digitized hundred sample iteratively increased number sample validating initial classification result adding sample collection able strike balance need timely information accuracy result combining output three different model aiming distinctive type building postprocessing workflow obtained recall 078 precision 077 F 1 score 078 able deliver first result 10 day initial request procedure show great potential convolutional neural network framework combination GIS routine dwelling extraction even operational setting,
Prevalence Symptoms Seven Months Diagnosis Symptomatic COVID19 Outpatient Setting,34224254,BACKGROUND million SARSCoV2 infection worldwide increasing number patient coming forward longterm clinical effect disease lasting several week month OBJECTIVE characterize symptom 7 9 month diagnosis COVID19 DESIGN Selfreported survey semistructured telephone interview enrollment 30 45 day 7 9 month diagnosis SETTING 18 March 15 May 2020 symptomatic person tested positive SARSCoV2 Geneva University Hospitals followed CoviCare virtual clinical outpatient followup program Persons contacted 30 45 day 7 9 month diagnosis PARTICIPANTS Persons part CoviCare program 18 March 15 May 2020 MEASUREMENTS standardized interview symptom consistent COVID19 grading intensity RESULTS 629 participant study completed baseline interview 410 completed followup 7 9 month COVID19 diagnosis 390 reported residual symptom Fatigue 207 common symptom reported followed loss taste smell 168 dyspnea 117 headache 100 LIMITATION Limitations include generalizability missing data 348 participant CONCLUSION Residual symptom SARSCoV2 infection common among otherwise young healthy person followed outpatient setting finding contribute recognition longterm effect disease mostly counted death toll date promoting communication postacute sequela SARSCoV2 encouraging physician continue longterm monitoring patient PRIMARY FUNDING SOURCE None,
COVID19 individual herd immunity,34213845,Immunity SARSCoV2 virus ensures protection reinfection virus thanks combined action neutralizing antibody lymphocyte specific viral protein particular Spike protein must distinguished immune response ensures healing infection following contamination involves innate immunity particularly type 1 interferon followed adaptive cellular humoral immunity importance effect interferon highlighted occurrence severe form disease genetically deficient subject patient antibody neutralizing type 1 interferon Herd immunity individual biological property mathematical property qualifies fact proportion subject individual immunity high enough little chance epidemic occur level proportionthe herd immunity population computed theoretical often unrealistic hypothesis difficult ass natural condition,antibodies;covid-19;herd immunity;individual immunity;sars-cov-2;t lymphocytes
Challenges Opportunities Mass Vaccination Centers COVID19 Times Rapid Review Literature,34205891,mass vaccination center location normally used nonhealthcare activity set highvolume highspeed vaccination infectious disease emergency high contagiousness mortality COVID19 complete lack population immunity posed extraordinary threat global health aim research collect review previous experience mass vaccination center 4 April 2021 developed rapid review searching four electronic database PubMedMedline Scopus EMBASE Google Scholar medRxiv total 2312 paper 15 included current review Among one article described COVID19 vaccination center others referred vaccination particular influenza majority conducted United States simulation singleday experience practice mass vaccination bioterrorist attack Indeed published September 11 attack Regarding staff timing performance data highly heterogenous Several study used model Center Disease Control Prevention guideline Results highlighted difference around definition layout management mass vaccination center aspect considered core aspect light suggested potential definition current review answer urgency organizing mass vaccination center COVID19 pandemic highlighting important organizational aspect considered planning,covid-19;health planning organizations;mass vaccination;rapid review;vaccines
Clinical epidemiological profile Indian COVID19 patient Jaipur descriptive study,34286929,analyzed data 102 confirmed patient novel Coronavirus 2 infection COVID19 early period nationwide lockdown announced India declaration pandemic analyzed epidemiological clinical characteristic outcome hospitalization 102 patient positive result novel corona virus SARSCoV2 RNA testing traced basis history travel contact confirmed COVID19 case resident hotspot area presence symptom thus providing accurate estimate proportion asymptomatic case initial population 102 patient enrolled study 833 85102 asymptomatic 1667 17102 symptomatic Seventyseven 7549 male 2450 25102 female Eighteen 176 patient associated comorbidities prevalent diabetes mellitus 108 11102 hypertension 78 8102 chronic obstructive pulmonary disease COPD 392 4102 chronic kidney Disease CKD 098 1102 coronary artery Disease CAD 098 1102 cerebrovascular disease CVD 098 1102 clinical spectrum among symptomatic COVID19 patient varied dry cough fever respiratory failure multiorgan failure Twelve 1176 patient kept intensive care unit ICU Ninetynine 9705 patient recovered three 294 died hospital stay majority COVID19 case India asymptomatic change biochemical inflammatory profile small insignificant asymptomatic patient compared symptomatic patient Elevated NLR lymphopenia age presence comorbidities associated increased severity poor outcome,
Coronary artery calcification risk mortality adverse outcome patient COVID19 Chinese multicenter retrospective cohort study,34222797,Background Coronary artery calcification CAC independent risk factor major adverse cardiovascular event however impact CAC inhospital death adverse clinical outcome patient coronavirus disease 2019 COVID19 remains unclear Objective explore association CAC inhospital mortality adverse event patient COVID19 Methods multicenter retrospective cohort study enrolled 2067 laboratoryconfirmed COVID19 patient definitive clinical outcome death discharge admitted 22 tertiary hospital China January 3 2020 April 2 2020 Demographic clinical laboratory result chest CT finding CAC admission collected primary outcome inhospital death secondary outcome composed inhospital death admission intensive care unit ICU requiring mechanical ventilation Multivariable Cox regression analysis KaplanMeier plot used explore association CAC inhospital death adverse clinical outcome Results mean age 50 year SD16 1097 531 male total 177 patient showed high CAC level compared patient low CAC patient older mean age 49 vs 69 year P 0001 likely male 520 vs 650 P = 0001 Comorbidities including cardiovascular disease CVD 333 59177 vs 47 891890 P 0001 presented often among patient high CAC compared patient low CAC laboratory result patient high CAC higher rate increased Ddimer LDH well CKMB P 005 mean CT severity score high CAC group also higher low CAC group 126 vs 111 P = 0005 multivariable Cox regression model patient high CAC higher risk inhospital death hazard ratio HR 1731 95 CI 10102971 P = 0046 adverse clinical outcome HR 1611 95 CL 10872387 P = 0018 Conclusion High CAC risk factor associated inhospital death adverse clinical outcome patient confirmed COVID19 highlight importance calcium load testing hospitalized COVID19 patient call attention patient high CAC Supplementary Information online version contains supplementary material available 101007s42058021000724,cardiovascular disease;coronary artery calcification;coronavirus disease 2019;mortality
Extracellular Vesicles Mesenchymal Stem Cells Therapeutic Properties Discovered Extraordinary Success,34200818,Mesenchymal stem cell MSCs cell distributed stroma body known various property including replication potential various differentiation immunerelated process including inflammation two decade ago cell shown play relevant role therapy numerous disease dependent immune regulation release cytokine growth factor ensuing activation favorable enzyme process discovery induced great increase investigation Soon thereafter however became clear therapeutic action MSCs risky accompanied serious drawback defect MSC therapy therefore reduced disease replaced others extracellular vesicle MSCEVs latter vesicle recapitulate therapeutic action MSCs equal even better efficacy without serious drawback parent cell addition MSCEVs characterized many advantage among heterogeneity dependent stroma origin alleviation cell aging regulation immune response inflammation illustrate MSCEV therapeutic effect largely mediated specific miRNAs covering various disease pathological process occurring bone heart vessel kidney brain MSCEVs operate also development cancer COVID19 alleviate organ lesion induced virus Therapy MSCEVs improved combination innate potential engineering process inducing precise targeting transfer drug unique property MSCEVs explain intense study carried extraordinary success Although yet developed clinical practice perspective proximal future encouraging,adipose tissue;blood;clinical developments;clinical trials;ectosome and exosome;engineering;heterogeneity;immune reactions;inflammation;luminal cargo;mir-;mirna;protection of organs;regenerative medicine;senescence;stromas employed: from bone marrow;umbilical cord
difference various covid19 vaccine,34228411,coronavirus pandemic caused SARSCoV2 Vaccination appears offer way pandemic Vaccines virus make use SARSCoV2 s spike protein essential protein surface virus us attach host cell viral vector vaccine AstraZeneca Sputnik Johnson Johnson gene spike protein introduced adenovirus Following vaccination modified adenovirus infect cell host subsequently start produce spike protein causing immune response RNA vaccine Pfizer Moderna introduce messenger RNA spike protein host cell messenger RNA us produce spike protein Viral vector vaccine RNA vaccine faster develop safer produce traditional vaccine also easier modify new virus virus variant latter may great importance future pandemic,
Dynamic Characteristic Analysis Antibodies Patients COVID19 13Month Study,34354712,worldwide pandemic Severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection yet understanding remains limited characteristic antibody especially dynamic longterm tracking Sequential serum sample collected 416 day post onset symptom POS 102 patient hospitalized coronavirus disease 2019 COVID19 Immunoglobulin Ig G IgM IgA level targeting SARSCoV2 spike 1 receptorbinding domain S1RBD spike 2 extracellular domain S2ECD nucleocapsid protein N quantified well neutralizing activity pleasantly surprised find antibody remained detective effective year POS also found varied reaction different antibody time passed NIgA rose rapidly early stage infection S2IgG present high level long time observation study described long traceable antibody response COVID19 offered hint target screen postinfectious immunity vaccination development SARSCoV2,sars-cov-2;immunoreaction;neutralizing antibodies;nucleocapsid protein;receptor binding domain;spike glycoprotein
Impact repeated nasal sampling detection quantification SARSCoV2,34290378,impact repeated sample collection COVID19 test performance unknown FDA CDC currently recommend primary collection diagnostic sample minimize perceived risk falsenegative finding therefore evaluated association repeated sample collection test performance among 325 symptomatic patient undergoing COVID19 testing Atlanta GA High concordance found consecutively collected midturbinate sample molecular n = 74 100 concordance antigenbased n = 147 97 concordance kappa = 095 CI = 088100 diagnostic assay Repeated sample collection decrease COVID19 test performance demonstrating multiple sample collected assay validation clinical diagnosis,
Increased circulating level angiotensin 17 severely ill COVID19 patient,34350288,letter report unexpected increase ACE2 product angiotensin 17 parallel decrease substrate angiotensin II suggesting dysregulation reninangiotensin system towards angiotensin 17 formation COVID19 patient http bitly3xFXuTU,
Precautionary Behaviors Second Third Phases COVID19 Pandemic Comparative Study Latin American Population,34206907,population s behavioral response containment precautionary measure COVID19 pandemic played fundamental role controlling contagion comparative analysis precautionary behavior region carried total 1184 people Mexico Colombia Chile Cuba Guatemala participated online survey containing questionnaire sociodemographic factor precautionary behavior information COVID19 concern maintenance confinement medical symptom associated COVID19 Cubans reported highest score information COVID19 Colombians reported le frequent usage precautionary measure eg use mask greater adherence confinement recommendation general contrast low level behavior Guatemalans Chileans reported greater pandemicrelated concern highest number medical symptom associated COVID19 finding allow partial characterization Latin American population s response second third phase COVID19 pandemic highlight importance designing managing public health policy according circumstance population facing pandemic,covid-19;latin america;concerns;confinement;medical symptoms;precautionary behavior
Numerical simulation stability analysis novel reactiondiffusion COVID19 model,34219967,study novel reactiondiffusion model spread new coronavirus COVID19 investigated model spatial extension recent COVID19 SEIR model nonlinear incidence rate taking account effect random movement individual different compartment environment equilibrium point new system found diffusive nondiffusive model detailed stability analysis conducted Moreover stability region space parameter attained equilibrium point case model effect parameter explored numerical verification proposed model using finite differencebased method illustrated along consistency stability proving positivity acquired solution obtained result reveal random motion individual significant impact observed dynamic steadystate stability spread virus help presenting strategy better control,covid-19;finite difference;reaction-diffusion;stability
COVID19 Cases First Local Outbreak SARSCoV2 B117 Variant China May Present Serious Clinical Features Prospective Comparative Cohort Study,34346755,SARSCoV2 B117 variant increased sharply number worldwide reported contagious nonvariant Little known regarding detailed clinical feature B117 variant infection Data 74 COVID19 case two outbreak two district Beijing China extracted cloud database including 41 case Shunyi District Shunyi B1470 group 33 Daxing Daxing B117 group December 25 2020 January 17 2021 conducted comparison clinical characteristic Seven clinical indicator Daxing B117 group significantly higher Shunyi group including proportion fever 38 degree C level Creactive protein CRP serum amyloid SAA creatine kinase CK ddimer DD CD4 + lymphocyte CD4 + proportion groundglass opacity GGO lung P value =005 adjusting age B117 variant infection risk factor elevated CRP P = 0045 SAA P = 0011 CK P = 0034 CD4 + P = 0029 presence GGO P = 0005 median threshold cycle CT value reverse transcriptase quantitative PCR RTqPCR test N gene target Daxing B117 group significantly lower P = 0036 Shunyi B1470 group Clinical feature including serious inflammatory response pneumonia possibly higher viral load detected case infected B117 SARSCoV2 B117 variant may increased pathogenicity IMPORTANCE SARSCoV2 B117 variant first identified United Kingdom increased sharply number worldwide reported contagious nonvariant knowledge study investigating detailed clinical feature COVID19 case infected B117 variant published Local epidemic rarely occurred China occasionally small clustered outbreak triggered imported SARSCoV2 strain one chain transmission could happen late 2020 early 2021 two clustered COVID19 outbreak occurred Beijing one caused B117 variant COVID19 patient two outbreak received similar clinical test diagnosis treatment found B117 variant infection could lead serious inflammatory response acute response process severe pneumonia probably higher viral load therefore implies B117 variant may increased pathogenicity,b.1.1.7 variant;covid-19;sars-cov-2;clinical features;whole-genome analysis
Evaluation cellbased surrogate SARSCoV2 neutralization assay,34288726,Determinants protective immunity SARSCoV2 infection require development wellstandardized reproducible antibody assay need led emergence variety neutralization assay Headtohead evaluation different SARSCoV2 neutralization platform could facilitate comparison across study laboratory Five neutralization assay compared using forty plasma sample convalescent individual mildtomoderate COVID19 four cellbased system using either live recombinant SARSCoV2 pseudotyped viral particle created lentivirus LV vesicular stomatitis virus VSV packaging one surrogate ELISAbased test measure inhibition spike protein receptor binding domain RBD binding receptor human angiotensin converting enzyme 2 hACE2 Vero Vero E6 HEK293T expressing hACE2 TZMbl cell expressing hACE2 transmembrane serine protease 2 tested cellbased assay showed 50 neutralizing dilution ND50 geometric mean titer GMTs highly correlated Pearson r = 081089 ranged within 34fold livevirus assay LVpseudovirus assay HEK293ThACE2 cell showed similar mean titer 141 178 respectively ND50 titer positively correlated plasma IgG targeting SARSCoV2 spike RBD r = 063089 moderately correlated nucleoprotein IgG r = 046073 ND80 GMTs mirrored ND50 data showed similar correlation assay IgG concentration VSVpseudovirus assay LVpseudovirus assay HEK293ThACE2 cell low highthroughput version calibrated SARSCoV2 IgG standard High concordance outcome cellbased assay live pseudotyped virion enables valid crossstudy comparison using platform 249,
Effective Lockdown Role HospitalBased COVID19 Transmission Indian States Outbreak Risk Analysis,34223651,Several report India indicate hospital quarantined center COVID19 hotspot study transmission occurring hospital well community developed mechanistic model lockdown effect Using daily COVID19 case data six state overall India estimated several important parameter model Moreover provided estimation effective RT basic R0 community RC hospital RH reproduction number forecast COVID19 notified case May 3 2020 till May 20 2020 five different lockdown scenario seven location analysis suggests 65 99 new COVID19 case currently asymptomatic location Besides 116 total COVID19 transmission currently occurring hospitalbased contact percentage increase 69 location Furthermore hospitalbased transmission rate beta2 significant positive 065 08 negative 058 023 correlation R0 effectiveness lockdown respectively Therefore much larger COVID19 outbreak may trigger hospitalbased transmission location model forecast May 3 2020 till May 20 2020 indicates twotimes increase cumulative case comparison total observed case April 29 2020 Based result proposed containment policy may reduce threat larger COVID19 outbreak future,covid-19;effective lockdown policy;ensemble model forecast;hospital-based transmission;outbreak risk analysis
Bubble concept sporting tournament COVID19 pandemic Football Club World Cup,34221444,Objectives report persontostaff transmission COVID19 implementation bubble concept included testing hygiene distancing monitoring strategy mitigate risk Methods prospective case series included staff onsite involved Football Club World Cup tournament conducted within bubbles personnel travelling tournament required possession negative RTPCR test within 72 hour arrival subjected testing schedule tournament location assigned COVID19 protocol enforcement officer ensure adherence regular testing hygiene measure physical distancing daily symptom reporting via ScribePro app Results study involved 70 recruited staff combined 1321 test day symptom checker app mean number day completed symptom checker app 1887 day range 728 five question asked part daily symptom checker one answered positively 0015 individual isolated assessed within 20 min tested initial diagnosis likely nonCOVID19related viral illness testing returned three negative test remainder tournament Conclusions persontostaff transmission COVID19 tournament within sample organisation sporting tournament COVID19 pandemic possible risk mitigation strategy strategy include setting bubble regular testing hygiene measure physical distancing daily symptom reporting,covid-19;football;soccer
Burden COVID19 Italian Internal Medicine Wards Delphi SWOT Performance Analysis Two Pandemic Waves Local Health Authority `` Roma 6 Hospital Structures,34204972,Background COVID19 cause major change daytoday hospital activity due epidemiological characteristic clinical challenge pose especially internal medicine ward Therefore necessary understand manage implicated factor order maintain high standard care even subpar circumstance Methods threephase mixeddesign study Initially Delphi method allowed u analyze cause poor outcome cohort aggregate Italian COVID19 ward via Ishikawa diagram retrieved item score assigned according proscons opportunitiesthreats system Scores also assigned according potential valueperceived risk Finally performance MCs MedicineCOVID19 ward MCFs MedicineCOVID19free Internal Medicine ward unit represented via Barber s nomogram Results MCFs hospitalized 790 patient 2390 compared 2019 Internal Medicine admission main risk factor mortality patient admitted local facility +7 presence comorbidities 3 100 =5 247 total 197 25 patient treated noninvasive ventilation NIV death 5714 occurred patient admitted local facility Conclusions MedicineCOVID19 ward show higher complexity demand compared nonCOVID19 one comparable subintensive therapy ward necessary promote use NIV setting,covid-19;internal medicine ward;territorial medicine
Changes Patient Satisfaction Scores Early COVID19 Pandemic,34377775,coronavirus disease 2019 COVID19 pandemic caused rapid widespread application telemedicine service outpatient setting Prior COVID19 patient satisfaction measured Consumer Assessment Healthcare Providers Systems CAHPS Clinician Group Survey CGCAHPS measured Press Ganey telemedicine survey survey ask patient s likelihood recommend particular medical practice useful imperfect surrogate overall satisfaction purpose analysis identify change patient satisfaction score implementation telemedicine service retrospective analysis institution s experience early month COVID19 pandemic compared month immediately prior pandemic conducted percent patient `` Top box response survey question regarding likelihood recommend medical practice compared total 14 430 CGCAHPS result collected November 2019 February 2020 compared 22 009 telemedicine survey result collected March May 2020 general medical specialty incorporated telemedicine suffered decrease patient s likelihood recommend medical practice first month pandemic However magnitude decrease variable medical specialty Physical medicine rehabilitation pain medicine relatively poor score prior pandemic statistically change Oncology sole medical specialty continued unchanged high patient satisfaction score data provide insight refinement telemedicine,cg-cahps;covid-19;pandemic;retrospective;telemedicine
Quality life patient IBD COVID19 pandemic Netherlands,34215570,OBJECTIVE COVID19 put strain regular healthcare worldwide inflammatory bowel disease IBD gastrointestinal surgery postponed change treatment diagnostic procedure made abrupt change treatment regimen may result increased morbidity consequent wellbeing patient IBD aim study determine effect COVID19 pandemic healthrelated quality life HRQoL patient IBD DESIGN patient IBD completed Inflammatory Bowel Disease Questionnaire IBDQ 36Item Short Form Health Survey SF36 questionnaire 31 August 13 September 2020 included cohort study primary end point determine HRQoL patient IBD measured IBDQ SF36 questionnaire secondary end point determining factor influence HRQoL patient IBD RESULTS 582 patient IBD filled IBDQ SF36 questionnaire HRQoL study population low according questionnaire physical mental subscales addition multivariate analysis showed increased age female sex patient underwent surgery significantly lower HRQoL frequently physical domain questionnaire CONCLUSION Patients IBD overall low HRQoL COVID19 pandemic Furthermore older patient woman patient underwent surgical procedure lowest physical HRQoL,covid-19;inflammatory bowel disease;quality of life
frontline coronavirus disease 2019 pandemic healthcare personnel,34227581,PURPOSE REVIEW estimated four 11 reported coronavirus disease 2019 COVID19 case occurs healthcare personnel HCP HCP high risk acquiring transmitting severe acute respiratory syndrome coronavirus 2 SARSCoV2 given close contact individual recognized unrecognized COVID19 summarize literature date describing epidemiology identifying risk factor associated COVID19 analyzing clinical characteristic outcome SARSCoV2 infection HCP RECENT FINDINGS prevalence SARSCoV2 antibody among HCP range 07 45 Although heterogeneity seroprevalence rate reported literature HCP may increased risk SARSCoV2 infection exposure patient COVID19 literature support minimized adequate personal protective equipment PPE supply proper hand hygiene appropriate PPE use infection prevention measure addition infection HCP commonly acquired community well nonclinical care setting including break room work room SUMMARY much focus minimizing patienttoHCP transmission SARSCoV2 additional effort needed prevent exposure nonclinical care setting community,
One year clash pandemic diabetes COVID19 lesson learnt future perspective,34375500,coronavirus disease 2019 COVID19 pandemic infected 176 million people worldwide caused 38 million death 1 Diabetes mellitus another pandemic affecting around 463 million people globally Although diabetes increase risk contracting COVID19 emerged one important comorbidities affecting prognosis COVID19 patient 2,
Nanotechnology Integration SARSCoV2 Diagnosis Treatment Approach Preventing Pandemic,34361227,SARSCoV2 outbreak COVID19 disease caused massive health devastation prompting World Health Organization declare worldwide health emergency corona virus infected million people worldwide many died result lack particular medication current emergency necessitates extensive therapy order stop spread coronavirus various vaccination available validated COVID19 treatment Since outbreak many therapeutic tested including use repurposed medication nucleoside inhibitor protease inhibitor broad spectrum antiviral convalescence plasma therapy immunemodulators monoclonal antibody However approach yielded outcome mostly used alleviate symptom associated potentially fatal adverse drug reaction Nanoparticles hand may prove effective treatment COVID19 designed boost efficacy currently available antiviral medication trigger rapid immune response COVID19 last decade significant progress nanotechnology review focus virus s basic structure pathogenesis current treatment option COVID19 study address nanotechnology application diagnosis prevention treatment targeted vaccine delivery laying groundwork successful pandemic fight,covid-19;biosensors;nanotechnology;sanitizers;vaccines
Endothelial Cell Participation Inflammatory Reaction,34199319,Inflammation old concept started considered important factor infection chronic disease role leukocyte plasmatic component mediator prostaglandin cytokine recent decade endothelium completed concept inflammation process function endothelium appeared crucial regulator initiator inflammatory process Culture human endothelial cell experimental system made possible define molecular basis inflammation vascular disease diabetes mellitus atherosclerosis vasculitis thromboembolic complication Advanced glycation end product receptor RAGE present endothelial cell ECs monocyte participates activation cell inflammatory condition Inflammasome cytosolic multiprotein control response diverse microorganism positively regulated stimulator interferon response CGAMP interactor1 STING1 Angiogenesis thrombotic event dysregulated inflammation ECs appear protector also possible initiator thrombosis,sars-cov-2;angiogenesis;endothelial cells;inflammasome;inflammation;thrombosis
Effects air pollution climatology COVID19 mortality Spain,34335996,health economic social impact COVID19 significant across world objective evaluate association air pollution NO2 PM25 level COVID19 mortality Spanish province February 3 2020 July 14 2020 adjusting climatic parameter observational ecological study conducted information extracted Datadista repository Datadista 2020 Air pollutant NO2 PM25 level analyzed potential determinant COVID19 mortality Multilevel Poisson regression model used analyze risk mortality severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection Models adjusted four climatic variable hour solar radiation precipitation daily temperature wind speed population size mean level PM25 NO2 across province time Spain 87 mugm 3 SD 97 87 mugm 3 SD 62 respectively High level PM25 IRR = 1016 95 CI 10071026 NO2 IRR = 1066 95 CI 10581075 precipitation IRRNO2 = 0989 95 CI 09810997 positively associated COVID19 mortality whereas temperature IRRPM25 = 0988 95 CI 09761000 IRRNO2 = 0771 95 CI 07610782 respectively wind speed IRRNO2 = 1095 95 CI 10611131 negatively associated COVID19 mortality Air pollution key factor understand mortality rate COVID19 Spain Furthermore climatic variable could influencing COVID19 progression Thus air pollution climatology ought taken consideration order control pandemic Supplementary Information online version contains supplementary material available 101007s11869021010622,air pollution;covid-19;mortality;risk factors;sars-cov-2
Absence SARSCoV2 antibody prepandemic plasma child adult Vietnam,34339862,tested prepandemic 20152019 plasma sample 148 Vietnamese child 100 Vietnamese adult high risk zoonotic infection antibody SARSCoV2 nucleocapsid spike protein None positive data thus demonstrated evidence prior serological crossreactivity SARSCoV2 might explain low number COVID19 Vietnam Future study look preexisting B cell cell memory prepandemic sample Vietnam might shed light pathogenesis infection,covid-19;cross-reactivity;sars-cov-2;zoonosis
Feasibility assessment skeletal muscle mass single crosssectional image level fourth thoracic vertebra,34343845,BACKGROUND Skeletal muscle mass SMM determined computed tomography CT emerging novel imaging biomarker Crosssectional area CSA SMM level third lumbar vertebra L3 abdominal imaging considered clinical reference standard measuring SMM certain patient group oncological nononcological lung disease like COVID19 chest CT may available abdominal CT purpose study investigate whether determining SMM chest CT feasible alternative abdominal CT RESEARCH QUESTION correlation SMM measurement level L3 level fourth thoracic vertebra Th4 STUDY DESIGN METHODS study retrospectively analyzed abdominal thoracic series wholebody CTscans trauma patient N = 47 head neck cancer patient N = 194 abdominal muscle delineated single axial slice level L3 erector spinae levator scapula rhomboideus minor major pectoralis minor major muscle delineated single axial slice level Th4 CSA muscle Th4 L3 level compared using linear regression multivariate linear regression model established RESULTS Muscle CSA level Th4 strongly correlate L3 muscle CSA r = 0791 p 005 multivariate model incorporating patient characteristic arm positioning age sex weight achieved stronger correlation r = 0856 p 005 INTERPRETATION Skeletal muscle CSA measured level Th4 feasible alternative measurement L3 allows diagnosing low SMM using clinically available thoracic CTscans SMM measurement level Th4 may become prognostic triage tool faced mechanical ventilator shortage,computed tomography;l3;sarcopenia;skeletal muscle mass;th4
Physical Activity Sedentary Behavior WellBeing Adults Physical Disabilities andor Chronic Diseases First Wave COVID19 Pandemic Rapid Review,34208156,Background People physical disability andor chronic disease report lower level physical activity wellbeing general population potentially exacerbated COVID19 pandemic study explored international literature physical activity sedentary behavior wellbeing adult physical disability andor chronic disease first wave pandemic Method rapid review included study reporting physical activity sedentary behavior andor wellbeing adult physical disability andor chronic disease Four database Pubmed CINAHL PsycInfo Embase searched study published 30 September 2020 Results included twentynine study involving eleven different type disability health condition twentyone different country Twentysix study reported physical activity one reported increase COVID19 pandemic four study reported difference twentyone study reported decrease Thirteen study reported decline wellbeing one study measured sedentary behavior reporting increase Conclusion Despite variety method used almost study reported negative impact physical activity wellbeing people physical disability andor chronic disease first wave pandemic finding highlight importance supporting population especially time crisis,coronavirus;exercise;health;rehabilitation;vulnerable populations
chronic inflammation cause acute inflammation spiral hyperinflammation manner modulated diet gut microbiome severe Covid19,34213801,propose hyperinflammation HYPi runaway consequence acute inflammation ACUi arises easily also abates le easily host preexisting chronic inflammation CHRi factor involved generating ACUi limit viral proliferation already present underlying CHRi also ii antiinflammatory AI mechanism abatement ACUi following containment viral proliferation suppressed desensitized underlying CHRi causing ACUi spiral HYPi Stress pollution diet gut microbiomes alterable week dietary change intimate bidirectional causeeffect relationship CHRi propose avoidance CHRipromoting food adoption CHRisuppressing food could reduce susceptibility HYPi Covid19 viral disease influenza characterized episodic unpredictable HYPi,acute inflammation;chronic inflammation;covid-19;cytokine storm;diet;gut inflammation;gut microbiome;hyperinflammation;systemic inflammation
Immunohistochemical finding lung COVID19 subject evidence surfactant dysregulation,34286505,OBJECTIVE Acute respiratory distress syndrome ARDS characterized quantitative qualitative change surfactant composition leading surfactant dysregulation alveolar collapse acute respiratory hypoxic failure Recently surfactant hypothesized play relevant role COVID19 representing strong defender SARSCoV2 infection aim work study immunohistochemical surfactant expression lung patient died following SARSCoV2 ARDS order shed light possible therapeutic surfactant administration PATIENTS METHODS investigated four patient died due ARDS following SARSCOV2 infection four patient submitted lung biopsy absence SARSCoV2 infection 8 case lung specimen immunostained antisurfactant protein SPA B SPB RESULTS control subject reactivity SPB restricted type II alveolar cell Immunostaining SPA observed surface alveolar space COVID19 positive lung immunoreactivity SPB similar observed control lung SPA strongly expressed along alveolar wall Moreover dense aggregate SPA positive material observed alveolar space CONCLUSIONS immunohistochemical data show dysregulation surfactant production COVID19 patient particularly regarding SPA expression increased presence SPA condensed mass inside alveolar space could invalidate therapeutic efficacy treatment exogenous surfactant,
Complement dysregulation associated severe COVID19 illness,34289657,Severe acute respiratory syndrome coronavirus2 SARSCoV2 may manifest thrombosis stroke renal failure myocardial infarction thrombocytopenia reminiscent complementmediated disease Multiple clinical preclinical study implicated complement pathogenesis COVID19 illness previously found SARSCoV2 spike protein activates alternative pathway complement APC vitro interfering function complement factor H key negative regulator APC demonstrated serum 58 COVID19 patient 32 patient minimal oxygen requirement 7 high flow oxygen 17 requiring mechanical ventilation 2 death induce complementmediated cell death functional assay modified Ham test increase membrane attack complex C5b9 deposition cell surface positive mHam assay 20 cellkilling present 412 COVID19 patient requiring intubation n=717 63 COVID19 patient requiring minimal oxygen support n=232 C5 factor inhibition effectively mitigated complement amplification induced COVID19 patient serum Increased serum factor Bb level associated disease severity COVID19 patient suggesting APC dysregulation play important role Moreover SARSCoV2 spike protein directly block complement factor H binding heparin may lead complement dysregulation cell surface Taken together data suggest complement dysregulation contributes pathogenesis COVID19 may marker disease severity,
Healthcare worker perspective coronavirus testing availability cross sectional survey,34289840,BACKGROUND Studies impact novel SARSCoV2 virus COVID healthcare worker HCWs rarely include full spectrum hospital worker including le visible patient support role early day pandemic COVID testing preferentially available HCWs objective study understand individual experience HCWs pandemic associated perception access receipt COVID testing METHODS hospital employee n = 6736 single academic medical center Boston Massachusetts invited participate crosssectional survey regarding perceived access receipt COVID testing first wave pandemic March August 2020 Responses linked human resource data Log binomial univariate multivariable model used estimate association individual employment variable COVID testing RESULTS total 2543 employee responded survey 38 mean age 40 year + 14 Respondents female 76 white 55 worked nurse 27 administrator 22 patient support role 22 56 respondent wanted COVID testing Age RR 091 CI 088093 full time status RR 085 CI 079092 employment tenure RR 096 CI 094098 change quality life RR 094 CI 091096 change job duty RR 119 CI 103137 worry enough paid sick leave RR 121 CI 112130 associated interest testing Administrators RR 064 CI 058072 patient support staff RR 085 CI 078092 le likely nurse want testing Age RR 104 CI 101107 material hardship RR 087 CI 079096 employer sponsored insurance RR 110 CI 100122 associated receiving COVID test Among employee administrativefacilities staff le likely receive COVID testing RR 069 CI 059079 CONCLUSIONS study add understanding hospital employee view availability COVID testing Hazard pay support hospital worker may increase COVID testing rate finding may applicable perceived barrier towards vaccination receipt,access to testing;coronavirus;disparities;healthcare workers
Nondieting Approaches Treatment Obesity,34283495,body mass index =30 27 Asian descent kilogram per square meter constitutes definition obesity 1 Obesity involves complex interplay genetic sociocultural environmental behavioral factor 1997 World Health Organization declared obesity major global health issue along undernutrition climate changethe triad termed `` Global Syndemic `` 2 Today United States America USA onethird adult population obese Center Disease Control projecting 2050 60 men 40 woman USA obese 3 Obesity came focus SARSCoV2 pandemic patient obesity found increased need mechanical ventilation higher mortality 4 thought exclusive problem developed world numerous study shown developing country highest incidence obesity SouthEast Asians higher percentage body fat truncalcentral obesity insulin resistance White race counterpart prompting endorse lower cutoff point action obesity =27kgm2 Asian population 5 latest terminology introduced obesity ABCDadiposity based chronic disease shift focus chronic nature obesity comorbidities require treatment addition treatment obesity 6 well known obesity associated shortened life span increased incidence obstructive sleep apnea osteoarthritis gout polycystic ovarian syndrome metabolic syndrome prediabetes hypertension stroke nonalcoholic fatty liver disease heart failure cancer colon breast endometrium gallbladder 7 Thus treatment obesity essential along early identification complication Although article focus nondieting approach treating obesity medication gastrointestinal device bariatric surgery must emphasized diet exercise essential good cardiometabolic health obese patient,
Implementation Triage System Shortening Patient Journey Time Prevent COVID19 Transmission University Hospital Pandemic,34208858,explore characteristic patient investigation PUI route patient journey time outpatient service examined demographic data presenting symptom risk contact COVID19 case result realtime polymerase chain reaction PCR test PUI case March May 2020 contact time transfer time total journey time patient journey route hospital also explored result shown number percentage median interquartile range IQR total 334 PUI case identified triage system median IQR age 35 27 47 year Cough common presenting symptom 562 fever =375 degree C found 198 case median IQR time onset presenting symptom 3 1 5 day common risk contact COVID19 case found triage living returning outbreak area Fifteen 45 PUI case positive realtime PCR test contact time transfer time longest PUI ward Emergency Department ED PUI ward respectively Plans action shorten transfer time ED PUI ward total journey time developed,covid-19;pcr;patient journey;patient under investigation;transmission
Importance Happy Hypoxemia COVID19,34221943,Background Nowadays new coronavirus SARSCoV2 complication one main concern world One severe complication COVID19 hypoxemia Objectives study aimed ass importance happy hypoxemia COVID19 Methods systematically searched web science PubMed Google scholar database find article related COVID19 happy hypoxemia Results COVID19 cause type hypoxemia named silent happy hypoxemia atypical clinical presentation type hypoxemia noted viral pneumonia specific treatment serious complication Patients silent hypoxemia may develop severe hypoxemia without dyspnea nearnormal lung compliance patient awake calm responsive Although lung oxygenated efficiently alert cooperative condition may deteriorated rapidly without warning cause death Conclusions According finding paying attention happy hypoxemia important improving health status COVID19 patient,covid-19;coronavirus;hypoxemia
SARSCoV2 antibody dynamic transmission communitywide serological testing Italian municipality Vo,34282139,February March 2020 two mass swab testing campaign conducted Vo Italy May 2020 tested 86 Vo population three immunoassays detecting antibody spike nucleocapsid antigen neutralisation assay Polymerase Chain Reaction PCR Subjects testing positive PCR FebruaryMarch serological assay May tested November report result analysis May November survey estimate seroprevalence 35 95 Credible Interval CrI 2843 May November 988 95 Confidence Interval CI 9371000 serum tested positive May still reacted least one antigen 186 95 CI 110285 showed increase antibody neutralisation reactivity May Analysis serostatus member 1118 household indicates 260 95 CrI 172369 SusceptibleInfectious Transmission Probability Contact tracing limited impact epidemic suppression,
Realworld impact vaccination coronavirus disease 2019 COVID19 incidence healthcare personnel academic medical center,34287111,OBJECTIVE Coronavirus disease 2019 COVID19 vaccination effectiveness healthcare personnel HCP established However question remain regarding performance highrisk healthcare occupation work location describe effect COVID19 HCP vaccination campaign SARSCoV2 infection timing vaccination job type work location METHODS conducted retrospective review COVID19 vaccination acceptance incidence postvaccination COVID19 hospitalization mortality among 16156 faculty student staff large academic medical center Data collected 8 week prior start phase 1a vaccination frontline employee ended 11 week campaign onset RESULTS COVID19 incidence rate among HCP institution decreased 32 8 week prior start vaccination 038 4 week campaign initiation COVID19 risk reduced among individual received single vaccination hazard ratio HR 052 95 confidence interval CI 040068 P 0001 reduced 2 dos vaccine HR 017 95 CI 009032 P 0001 2 week second dose observed case positivity rate 004 Among phase 1a HCP observed lower risk COVID19 among physician trend toward higher risk respiratory therapist independent vaccination status Rates infection similar subgroup nurse examined work location CONCLUSIONS finding show realworld effectiveness COVID19 vaccination HCP Despite encouraging result unvaccinated HCP remain elevated risk infection highlighting need targeted outreach combat vaccine hesitancy,
Integrated multiomics approach identified molecular mechanism pathogenetic process COVID19 affect patient Parkinson s disorder,34366686,novel coronavirus named SARSCoV2 emerged end 2019 cause coronavirus disease COVID2019 Recent case report SARSCoV2 infected individual revealed onset Parkinson s disease PD symptom patient family history PD However till recently genetic impact mechanism may induce Parkinsonism inCOVID19 patient COVID19 found study aimed detect commonly dysregulated gene transcriptional regulator pathway PD SARSCoV2 infection integrated genomewide transcriptomic datasets PBMC sample COVID19 PD associated pathway study revealed 81 upregulated 48 downregulated differentially expressed gene DEGs shared PD SARSCoV2 infection dysregulated gene involved key pathway `` mitochondrion structure organization `` cell activation immune response `` signalling interleukin analysis showed RELA TP53 SP1 TFs may regulate upregulated DEGs discovered key dysregulated gene characterized biological process commonly dysregulated SARSCoV2 infection PD could used design personalized treatment PD following COVID19,"covid-19;parkinson's disorder;blood gene expression, transcriptional signatures;molecular pathways"
Copper Products Surfaces Reduce Spread Infectious Microorganisms HospitalAcquired Infections,34206230,Pathogen transfer infection built environment globally significant event leading spread disease increase subsequent morbidity mortality rate numerous strategy followed healthcare facility minimize pathogen transfer complete infection control yet achieved However based traditional use many culture introduction copper product surface significantly positively retard pathogen transmission invite investigation example many microbe rendered unviable upon contact exposure copper copper alloy either immediately within short time addition many diseasecausing bacteria E coli O157 H7 hospital superbug several virus including SARSCoV2 also susceptible exposure copper surface thus suggested replacing common touch surface healthcare facility food industry public place including public transport copper alloy copper may substantially contribute limiting transmission Subsequent hospital admission mortality rate consequently lowered concomitant saving life considerable level resource consideration significant time COVID19 pandemic upcoming epidemic becoming clear form possible infection control measure practiced order protect community wellbeing promote healthy outcome,covid-19 pandemic;coronavirus;health care;infection control;microbial infections
Assessment antiviral coating hightouch surface using human coronaviruses HCoV229E SARSCoV2,34288707,novel robust approach evaluate antiviral activity coating developed assessing three commercially available leaveon surface coating product efficacy human coronaviruses HCoV229E SARSCoV2 assessment based three criterion reflect reallife setting namely immediate antiviral effect ii effect repeated cleaning coated surface iii antiviral activity presence organic material result showed copper compoundbased coating successfully met three criterion quaternary ammonium compoundbased coating meet second criterion coating based reactive oxygen specie showed antiviral effect Moreover study demonstrated HCoV229E relevant SARSCoV2 surrogate experiment new approach allows benchmark currently available antiviral coating future coating development avoid unjustified claim deployment efficient antiviral coating offer additional measure mitigate risk transmission respiratory virus SARSCoV2 influenza virus hightouch surface Importance SARSCoV2 virus responsible COVID19 pandemic transmitted mainly persontoperson respiratory droplet whilst contribution fomite transmission le important suspected beginning pandemic Nevertheless antiviral coating solution offer additional measure mitigate risk SARSCoV2 transmission hightouch surface deployment antiviral coating new currently lacking solid scientific evidence efficacy commercially available selfdisinfecting surface reallife condition Therefore developed novel robust approach evaluate antiviral activity coating applying strict quality criterion three commercially available product test efficacy SARSCoV2 also showed HCoV229E relevant surrogate experiment approach bring significant benefit evaluate effect coating also survival nonenveloped virus known tolerant desiccation disinfectant hightouch surface play important role,
Biophysical property isolated spike protein binding helix human ACE2,34214538,entry severe acute respiratory syndrome coronavirus 2 virus human cell mediated binding surface spike protein human angiotensinconverting enzyme 2 ACE2 receptor 23residue long helical segment SBP1 binding interface human ACE2 interacts viral spike protein therefore generated considerable interest recognition element virus detection Unfortunately emerging report indicate affinity SBP1 receptorbinding domain spike protein much lower ACE2 receptor examine biophysical property SBP1 reveal factor leading low affinity spike protein Whereas SBP1 show good solubility solubility 08 mM circular dichroism spectroscopy show mostly disordered antiparallel betasheet content helicity helicity substantial 20 upon adding high concentration =20 vv 222trifluoroethanol helix promoter Fluorescence correlation spectroscopy singlemolecule photobleaching study show peptide oligomerizes concentration 50 nM hypothesized mutating hydrophobic residue F28 F32 F40 SBP1 directly interact spike protein alanine would reduce peptide oligomerization without affecting spike binding affinity Whereas mutant peptide SBP1 mod show substantially reduced oligomerization propensity show improved helicity study show failure effort far produce short SBP1 mimic high affinity spike protein due lack helicity also due heretofore unrecognized problem oligomerization,
incremental value computed tomography COVID19 pneumonia predicting ICU admission,34341411,Triage crucial patient s management estimation required intensive care unit ICU bed fundamental health system COVID19 pandemic assessed whether chest computed tomography CT COVID19 pneumonia incremental role predicting patient s admission ICU performed volumetric texture analysis area affected lung CT 115 outpatient COVID19 infection presenting emergency room dyspnea unresponsive hypoxyemia Admission blood laboratory including lymphocyte count serum lactate dehydrogenase Ddimer Creactive protein ratio arterial partial pressure oxygen inspired oxygen collected calculating area receiveroperating characteristic curve AUC compared performance blood laboratoryarterial gas analysis feature alone combined CT feature two hybrid model Hybrid radiological Hybrid radiomics predicting ICU admission Following machine learning approach 63 patient allocated training 52 validation set Twentynine 25 patient admitted ICU Hybrid radiological model comprising lung consolidation performed significantly p = 004 better predicting ICU admission validation AUC = 082 95 confidence interval 073097 set blood laboratoryarterial gas analysis feature alone AUC = 071 95 confidence interval 056086 risk calculator ICU admission derived available http githubcomcgplabcovidapp volume consolidated lung CT patient COVID19 pneumonia mild significant incremental value predicting ICU admission,
Structure Function Major SARSCoV2 SARSCoV Proteins,34220199,SARSCoV2 virus causative agent COVID19 pandemic genomic organization consisting 16 nonstructural protein nsps 4 structural protein 9 accessory protein Relative SARSCoV2 SARSCoV genomic organization similar article function structure protein SARSCoV2 SARSCoV described great detail nsps expressed single two polyproteins cleaved individual protein using two protease virus chymotrypsinlike protease papainlike protease released protein serve center virus replication transcription nsps modulate host s translation immune system others help virus evade host immune system nsps help form replicationtranscription complex doublemembrane vesicle Others including one RNAdependent RNA polymerase one exonuclease help polymerization newly synthesized RNA virus help minimize mutation rate proofreading synthesis viral RNA get capped capping consists adding GMP methylation mark called cap 0 additionally adding methyl group terminal ribose called cap1 Capping accomplished help helicase also help remove phosphate two methyltransferases scaffolding factor Among structural protein protein form receptor virus latch angiotensinconverting enzyme 2 receptor host N protein bind protects genomic RNA virus accessory protein found virus small protein immune modulatory role Besides function protein solved Xray cryogenic electron microscopy structure related function protein along comparison coronavirus homologs described article Finally rate mutation SARSCoV2 residue proteome 2020 pandemic described protein mutated often protein significance mutation rate fully understood,sars-cov;sars-cov-2;function;proteins;structure
Progression Trends Virus Influenza COVID19 Overview Recent Studies,34203647,Influenza highly known contagious viral infection responsible death many people history pandemic pandemic occurring every 10 30 year last century recent global pandemic prior COVID19 2009 influenza H1N1 pandemic decade ago H1N1 virus caused 12500 death 19 month globally world challenged another pandemic Since December 2019 first case novel coronavirus COVID19 infection detected Wuhan infection risen rapidly throughout world even World Health Organization announced COVID19 worldwide emergency ensure human health public safety review article aim discus important issue relating COVID19 including clinical epidemiological pathological feature COVID19 recent progress diagnosis treatment approach COVID19 infection also highlight key similarity difference COVID19 influenza ensure theoretical practical detail COVID19,covid-19;coronavirus;influenza a;pandemic
Impact United Kingdom Malaysia s Inherent Health Systems COVID19 Responses Comparison Containment Strategies,34226852,March 2020 outbreak COVID19 officially declared global pandemic World Health Organization Given novelty virus hence lack official guidance effective containment strategy individual country opted different containment approach ranging herd immunity strict lockdown opposing strategy followed United Kingdom former colony Malaysia stand exemplary Realtime polymerase chain reaction implemented testing county Malaysia acted strict quarantining rule infection surveillance United Kingdom followed initially lenient herdimmunity approach strict lockdown enforced week later Although based healthcare structure historically Malaysia developed unified health system compared United Kingdom suggest centralized structure could one possible explanation Malaysia able react timely efficient manner despite closer geographic proximity China explore difference testing quarantining strategy well political situation societal compliance could account discrepancy United Kingdom s versus Malaysia s relative success COVID19 containment,covid-19;community spread;inherent health system;pandemic response;public health
Comparison SaltRelated Knowledge Behaviors Status WeChat Users 2019 2020,34206633,order identify status saltrelated knowledge behavior resident active WeChat software 2019 2020 10day saltrelated survey conducted 2019 2020 based WeChat public platform China Healthy Lifestyle Campaign Distribution score saltrelated knowledge salt reduction behavior highsalt intake behavior 2019 2020 compared Data 2109 participant 2019 12732 participant 2020 left analysis Overall 882 participant 2019 willingness reduce amount cooking salt household significantly lower 902 2020 pvalue 005 2019 2020 80 participant knew fine dried noodle contain salt le 30 knew ice cream contains salt 78 participant chose 5 g 6 g maximum daily salt intake healthy adult 98 participant knew excessive salt intake would increase risk hypertension year percentage participant used salt measuring spoon asked restaurant use le salt read sodium content nutrition fact table chose food low sodium content regularly used lowsodium salt 361 450 441 403 358 2019 percentage increased significantly 464 492 508 471 434 2020 pvalue 005 percentage people regularly eating pickled mustard tuber salted vegetable sauce food using highsalt condiment also increased 2019 2020 median saltrelated knowledge score salt reduction behavior score highsalt intake behavior score 11 2 5 point 2019 10 3 5 point 2020 respectively Compared 2019 saltrelated knowledge score relatively lower salt reduction behavior score highsalt intake behavior score relatively higher 2020 Besides score saltrelated knowledge behavior differed different gender age hypertension group COVID19 epidemic may influenced saltrelated knowledge behavior status WeChat user China Promotion education saltrelated knowledge online behavior intervention still needed particularly male hypertension patient future,china healthy lifestyle for all;high salt intake;salt reduction;salt-related knowledge
Obesity Potential Risk factor Poor Prognosis COVID19,34216125,BACKGROUND Coronavirus disease 2019 COVID19 continues cause major mortality morbidity worldwide even year emergence early day hypertension diabetes cardiovascular disease noted poor prognostic factor obesity gained attention later stage present study unfavorable clinical outcome transfer intensive care unit invasive mechanical ventilation mortality investigated obese patient COVID19 MATERIALS METHODS retrospective study analyzed patient positive polymerase chain reaction test tertiary care hospital MarchMay 2020 divided 3 group according body mass index BMI normal overweight obese BMI 185 2499 kgm 2 25 2999 kgm 2 = 30 kgm 2 respectively compared clinical feature laboratory finding group recorded adverse clinical outcome Multivariate logistic analysis performed unfavorable outcome RESULTS 99 patient 35 116 41 69 patient 24 normalweight overweight obese group respectively Among patient 52 18 patient transferred intensive care unit ICU 30 11 patient received invasive mechanical ventilation IMV 22 patient 8 died Obese patient minimum 1 comorbidity normal BMI patient 73 vs 50 P = 0002 longer median interquartile range IQR duration hospitalization 8 5 12 vs 6 5 9 day P = 0006 Obese participant higher concentration serum Creactive protein procalcitonin ferritin nonobese patient P 005 multivariate analysis obesity associated ICU admission adjusted odds ratio aOR 299 95 confidence interval CI 126 704 P = 0012 Moreover IMV requirement associated obesity aOR 873 95 CI 244 3120 P = 0001 Mortality occurred 16 9 1 obese group overweight group normalweight group respectively Chisquare trend analysis P = 0002 CONCLUSION Obesity risk factor adverse outcome caused increased mortality hence requiring close followup,"body mass index;covid-19;intensive care unit;obesity, sars-cov-2"
History Heart Failure Independent Risk Factor Death Patients Admitted Coronavirus 19 Disease,34209143,AIMS association cardiovascular disease coronary artery disease hypertension worse outcome COVID19 patient previously demonstrated However effect prior diagnosis heart failure HF reduced preserved left ventricular ejection fraction COVID19 outcome yet established METHODS RESULTS retrospectively studied adult patient COVID19 admitted institution March 1st 2nd May 2020 Patients grouped based presence absence HF used competing event survival model examine association HF death need intubation need dialysis hospitalization 4043 patient admitted COVID19 335 patient 83 prior diagnosis HF Patients HF older lower body mass index significantly higher burden comorbidities compared patient without HF yet two group presented hospital similar clinical severity similar marker systemic inflammation Patients HF higher cumulative inhospital mortality compared patient without HF 490 vs 272 p 0001 remained statistically significant HR = 1383 p = 0001 adjustment age body mass index comorbidities well propensity score matching HR = 1528 p = 0001 Notably difference mortality need mechanical ventilation renal replacement therapy observed among HF patient preserved reduced ejection fraction CONCLUSIONS presence HF risk factor death substantially increasing inhospital mortality patient admitted COVID19,covid-19;cardiovascular disease;corona virus 2019;epidemiology;heart failure;risk factor
Endoscopic endonasal surgery COVID19 pandemic Management guideline,34226169,Current SARSCoV2 coronavirus pandemic challenging medical surgical activity Specifically within neurosurgery endoscopic endonasal approach pose high risk contagion healthcare personnel involved Initially recommendation avoid surgery However pandemic dragged new solution must proposed continue carrying approach safely Given lack established protocol propose following one concisely establishes measure taken urgent scheduled surgery addition new protectionaspiration device Maskpirator described,base de craneo;covid-19;cirugia endoscopica;endoscopic surgery;guideline;protocolo;sars-cov-2;skull base;sars-cov-2
Induction exacerbation subacute cutaneous lupus erythematosus following messengerRNA adenoviralvector based SARSCoV2 vaccination,34291477,Accumulating evidence exists COVID19 vaccine might induce exacerbate autoimmune rheumatic disease Currently available COVID19 vaccine include messengerRNA mRNA recombinant adenoviral AdV vector vaccine encoding SARSCoV2 spike protein production primary target neutralizing antibody herein report case subacute cutaneous lupus erythematosus SCLE following mRNA vaccination BNT162b2 summarize current literature cutaneous lupus erythematosus occurring COVID19 vaccination,
Venous thromboembolism COVID19 patient,34211527,COVID19 potentially serious respiratory disease caused SARSCoV2 virus involves increased risk venous thromboembolism VTE pathophysiology apparently related exacerbated inflammatory process coagulopathy verified increase Ddimer fibrinogen fibrin degradation product Occurrence must monitored prevented treated according existing recommendation guideline increased risk thrombosis association phenomenon severe form disease death prompted group propose aggressive prophylactic therapeutic approach However riskbenefit profile type conduct defined case must assessed individually multidisciplinary approach study review main study evidence available date diagnosis prophylaxis treatment venous thromboembolism COVID19 patient,covid-19;sars-cov-2;anticoagulant;disseminated intravascular coagulation;prophylaxis;thrombosis
Citywide Virus Testing Chinese Government s Response Preventing Controlling Second Outbreak SARSCoV2,34222164,Containing spread SARSCoV2 daunting challenge globally China well handful country part contained implementing strict policy Wuhan s citywide virustesting program present way forward preventing controlling uncertainty anxiety instability complexity face outbreak SARSCoV2 Inarguably health crisis requires timetested strategy tactic coordinating government social entity response health crisis goal toward ensuring sustained effectiveness possible recurrence SARSCoV2 Wuhan Prevention Control Headquarters Wuhan COVID19 launched massive virus testing Wuhan s 11 million resident completed within 10 day light unprecedented mass testing study applies situational crisis communication theory analyze massive virustesting process mechanism involved contain SARSCoV2 Wuhan many country still partial lockdown second outbreak Wuhan indication awaited SARSCoV2stricken country postlockdowns community restriction lifted Therefore recently implemented Wuhan control mechanism city district township may become hortatory guide world region contend consider appropriate measure control spread SARSCoV2 ensure public safety,sars-cov-2;wuhan;control mechanism;crisis management;massive virus testing
AIbased language model powering drug discovery development,34216835,discovery development new medicine expensive timeconsuming often inefficient many failure along way Powered artificial intelligence AI language model LMs changed landscape natural language processing NLP offering possibility transform treatment development effectively summarize advance AIpowered LMs potential aid drug discovery development highlight opportunity AIpowered LMs target identification clinical design regulatory decisionmaking pharmacovigilance specifically emphasize potential role AIpowered LMs developing new treatment Coronavirus 2019 COVID19 strategy including drug repurposing extrapolated infectious disease potential cause pandemic Finally set remaining challenge propose possible solution improvement,artificial intelligence;covid-19;drug development;drug discovery;language models;natural language processing
Prevalence Persistence Factors Associated SARSCoV2 IgG Seropositivity Large Cohort Healthcare Workers Tertiary Care University Hospital Northern Italy,34205134,observational study evaluated SARSCoV2 IgG seroprevalence related clinical demographic occupational factor among worker largest tertiary care UniversityHospital Northwestern Italy University Turin first pandemic wave MarchApril 2020 Overall 10000 individual tested seropositive subject retested 5 month evaluate antibody waning Among 8769 hospital worker seroprevalence 76 without significant difference related job profile among 1185 University worker 33 Selfreporting COVID19 suspected symptom significantly associated positivity Odds Ratio 207 95 CI 176244 although 27 seropositive subject reported previous symptom multivariable analysis contact work resulted increased risk 69 24 working COVID ward contact household evidenced highest risk fivefold 531 95 CI 412685 Compared never smoker active smoker inversely associated seroprevalence 060 95 CI 048076 5 month 85 previously positive subject still tested positive frequency SARSCOV2 infection among Health Care Workers comparable observed survey performed Northern Italy Europe first pandemic wave study confirms infection frequently occurred asymptomatic underline importance household exposure seroprevalence 060 95 CI 048076,covid-19 serological testing;sars-cov-2;health personnel;population surveillance;surveys and questionnaires
intranasal vaccine durably protects SARSCoV2 variant mouse,34289385,SARSCoV2 variant attenuate antibody neutralization could jeopardize vaccine efficacy recently reported protective activity intranasally administered spike proteinbased chimpanzee adenovirusvectored vaccine ChAdSARSCoV2S animal advanced human trial assessed durability dose response crossprotective activity mouse single intranasal dose ChAdSARSCoV2S induced durably high neutralizing Fc effector antibody response serum Sspecific IgG IgA secreting longlived plasma cell bone marrow Protection historical SARSCoV2 strain observed across 100fold vaccine dose range 200day period 6 week 9 month vaccination serum antibody neutralized SARSCoV2 strain B1351 B1128 B16171 spike protein conferred almost complete protection upper lower respiratory tract challenge variant virus Thus mouse intranasal immunization ChAdSARSCoV2S provides durable protection historical emerging SARSCoV2 strain,covid-19;sars-cov-2;antibody;durability;mice;mucosal immunity;pathogenesis;vaccine;variants of concern
RADIOLOGICAL FINDINGS COVID19,34365783,BACKGROUNDAIM Available information radiological finding 2019 novel coronavirus disease COVID19 constantly updated Ground glass opacity GGOs consolidation bilateral peripheral distribution reported common CT finding le typical feature also identified According reported study SARSCoV2 infection limited respiratory system also affect organ Renal dysfunction gastrointestinal complication liver dysfunction cardiac manifestation neurological abnormality among reported extrapulmonary feature review aim provide updated information radiologist clinician better understand radiological manifestation COVID19 MATERIALS METHODS Radiological finding observed SARSCoV2 virus infection explored detail PubMed Google Scholar database RESULTS typical pulmonary manifestation COVID19 pneumonia determined GGOs accompanying consolidation primarily involve periphery bilateral lower lobe common extrapulmonary finding increased resistance flow kidney thickening vascular wall fatty liver pancreas heart inflammation finding However finding specific significantly overlapped caused viral disease therefore alternative diagnosis considered patient negative diagnostic test CONCLUSION Radiological imaging play supportive role care patient COVID19 clinician radiologist need know associated pulmonary extrapulmonary finding imaging feature help diagnose manage possible complication disease early stage also familiar CT finding patient COVID19 since disease incidentally detected imaging performed indication,covid-19;computed tomography;extrapulmonary involvement;imaging;signs
system biology approach COVID19 progression population,34340771,number model mathematical epidemiology developed account control measure vaccination quarantine However COVID19 brought unprecedented social distancing measure challenge include manner explain data avoid overfitting parameter inference develop simple timedependent model social distancing effect introduced analogous coarsegrained model gene expression control system biology apply approach understand drastic difference COVID19 infection fatality count observed Hubei Wuhan Mainland China province find unintuitive data may explained interplay difference transmissibility effective protection detection efficiency Hubei province generally result demonstrate regional difference may drastically shape infection outburst obtained result demonstrate applicability developed method extract key infection parameter directly publically available data globally applied outbreak COVID19 number country Overall show application uncommon strategy method approach molecular system biology research mathematical epidemiology may significantly advance understanding COVID19 infectious disease,compartmental models;infection dynamics;mass action law;quantitative biology;regulation modeling;sars-cov-2
AngiotensinConverting Enzyme Inhibitors Angiotensin Receptor Blockers Withdrawal Associated Higher Mortality Hospitalized Patients COVID19,34204014,main aim describe effect severity ACEI angiotensinconverting enzyme inhibitor ARB angiotensin II receptor blocker COVID19 hospitalization retrospective observational multicenter study evaluating hospitalized patient COVID19 treated ACEIARB primary endpoint incidence composite outcome prognosis IMV invasive mechanical ventilation NIMV noninvasive mechanical ventilation ICU admission intensive care unit andor allcause mortality evaluated outcome patient whose treatment ACEIARB continued withdrawn February June 2020 11205 patient included mean age 67 year SD = 163 431 female 2162 patient received ACEIARB treatment ACEIARB treatment showed lower allcause mortality p 00001 Hypertensive patient ACEIARB group better result IMV ICU admission composite outcome prognosis p 00001 difference found incidence major adverse cardiovascular event Patients previously treated ACEIARB continuing treatment hospitalization lower incidence composite outcome prognosis whose treatment withdrawn RR 067 95 CI 063076 ARB associated better survival ACEI HR 077 95 CI 062096 ACEIARB treatment COVID19 hospitalization associated protection mortality benefit greater hypertensive continued treatment taking ARB,acei;arb;covid-19;mace;prognosis
ACE2 ReceptorModified AlgaeBased Microrobot Removal SARSCoV2 Wastewater,34291944,coronavirus SARSCoV2 survive wastewater several day potential risk waterborne human transmission hence posing challenge containing virus reducing spread Herein report active biohybrid microrobot system offer highly efficient capture removal target virus various aquatic medium algaebased microrobot fabricated using click chemistry functionalize microalgae angiotensinconverting enzyme 2 ACE2 receptor SARSCoV2 spike protein resulting ACE2algaerobot display fast 100 mums longlasting 24 h selfpropulsion diverse aquatic medium including drinking water river water obviating need external fuel movement ACE2algaerobot offer effective `` onthefly removal SARSCoV2 spike protein SARSCoV2 pseudovirus Specifically active biohybrid microrobot result 95 removal viral spike protein 89 removal pseudovirus significantly exceeding control group static ACE2algae bare algae result suggest considerable promise biologically functionalized algae toward removal virus environmental threat wastewater,
Musculoskeletal Changes Hemophilia Patients Subsequent COVID19 Lockdown,34207821,1 Background lockdown period due COVID19 pandemic drastically decreased level physical activity population Hemophilia characterized hemarthrosis lead chronic progressive degenerative joint deterioration 2 Methods observational study recruited 27 patient hemophilia arthropathy Knee ankle elbow joint assessed frequency clinical hemarthrosis pain intensity pressure pain threshold joint ROM evaluated 3 Results Following lockdown significant deterioration joint condition perceived joint pain range motion noted joint change frequency knee hemarthrosis frequency ankle hemarthrosis significantly reduced However frequency elbow hemarthrosis increased Depending degree hemophilia severity change pressure pain threshold elbow pain intensity range motion ankle joint According type treatment ie prophylaxis vs ondemand treatment difference joint condition elbow plantar flexion movement ankle difference knee joint based severity disease type treatment development inhibitor 4 Conclusions COVID19 lockdown musculoskeletal status patient hemophilia deteriorated Joint condition perceived pain range motion significantly affected frequency clinical hemarthrosis increase period active therapeutic model could prevent rapid deterioration patient hemophilic arthropathy prolonged sedentary period,covid-19;hemophilia;joint disease;musculoskeletal pain;physiotherapy modalities
Applications 2D 3DDynamic Representations DNARNA Sequences description genome sequence virus,34348613,aim study show graphical bioinformatics method good tool description genome sequence virus new approach identification unknown virus strain proposed METHODS Biological sequence represented graphically 2D 3DDynamic Representations DNARNA Sequences theoretical method graphical representation sequence developed u earlier approach idea classical dynamic introduced bioinformatics sequence represented set material point 2D 3D space distribution point space characteristic sequence numerical parameter descriptor characterizing sequence correspond quantity typical classical dynamic RESULTS application theoretical method reviewed briefly 2Ddynamic graph representing complete genome sequence SARSCoV2 shown CONCLUSION proved 3DDynamic Representation DNARNA Sequences coupled random forest algorithm classifies successfully subtypes influenza virus strain,graphical bioinformatics; 2d and 3d-dynamic representations of dna/rna sequences; supervised learning; machine learning; random forest; boruta algorithm.
Viral Bad News Sent EVAIL,34207152,article review current knowledge virus may utilize Extracellular Vesicle Assisted Inflammatory Load EVAIL exert pathologic activity Viruses classically considered exert pathologic action acute chronic infection followed host response host response cause release cytokine leading vascular endothelial cell dysfunction cardiovascular complication However virus may employ alternative pathway soluble cytokineinduced pathologiesby initiating release extracellular vesicle EVs including exosomes bestunderstood example alternative pathway human immunodeficiency virus HIV elicited EVs propensity harm vascular endothelial cell Specifically HIVencoded accessory protein called `` negative factor Nef demonstrated EVs body fluid HIV patient successful combined antiretroviral therapy ART also demonstrated sufficient inducing endothelial cardiovascular dysfunction review highlight HIVNef example HIV produce EVs loaded proinflammatory cargo disseminate cardiovascular pathology discus whether EV production explain SARSCoV2mediated pulmonary cardiovascular pathology,hiv;nef;sars-cov-2;antiretroviral therapy;cardiovascular disease;extracellular vesicles;viral infection
Public health adherence informationseeking people chronic condition early phase COVID19 pandemic,34218517,INTRODUCTION People chronic condition common among rehabilitation population may risk factor put higher risk severe illness due COVID19 OBJECTIVE describe compare adherence public health guideline willingness adhere public health guideline including vaccination informationseeking perceived trustworthiness information among people without chronic condition early stage COVID19 pandemic DESIGN National crosssectional online survey people without chronic health condition conducted April May 2020 PARTICIPANTS Survey respondent people without chronic condition 18 year old able read English US since January 2020 total 3109 survey response received 2572 complete unique response used analysis METHODS survey assessed demographic adherence public health measure informationseeking perceived trustworthiness information source Descriptive analysis characterized sample ttests nonparametric test used compare without chronic condition public health measure RESULTS Participants chronic condition reported high adherence public health recommendation high willingness adhere anticipated recommendation across wide range chronic condition similar without chronic condition despite advised caution people underlying health condition 708 chronic condition reported willingness vaccinated Participants reported accessing information varied source perceived trust highest healthcare provider lowest social medium CONCLUSION Participants reported high adherence public health measure regardless chronic condition status early phase COVID19 pandemic Knowledge adherence public health measure informationseeking trust information assist rehabilitation provider organization seeking mitigate disease transmission particularly chronic condition article protected copyright right reserved,covid-19;chronic condition;health care delivery;health policy;health services research;information sources;public health adherence;risk factor
Development SARSCoV2 Specific IgG VirusNeutralizing Antibodies Infection Variants Concern Vaccination,34202276,humoral immunity SARSCoV2 infection vaccination examined Convalescent serum infection variant concern VOCs B117 n = 10 B1351 n = 1 serum 100 vaccinee PfizerBioNTech BNT162b2 n = 33 Moderna mRNA1273 n = 11 AstraZeneca ChAdOx1 nCoV19AZD1222 n = 56 tested presence immunoglobulin G IgG directed viral spike protein receptorbinding domain RBD nucleoprotein N virusneutralizing antibody VNA latter surrogate assay sVNT Verocell based neutralization test cVNT used Maturity IgG determined measuring avidity immunoblot IB Past VOC infection resulted broad reactivity antiS IgG 100 antiRBD IgG 100 antiN IgG 91 latter absent 99 vaccinee Starting approximately two week first vaccine dose antiS IgG 75100 particularly antiRBD IgG 98100 detectable second dose titer increased higher convalescent sVNT showed evidence VNA 91 convalescent 80100 100 firstsecond vaccine dose respectively second dose increase VNA titer IgGs high avidity demonstrated cVNT IB respectively Revaccination contributes robust immune response,covid-19;igg;avidity;humoral immune response;titer;vaccination;virus variants;virus-neutralizing antibodies
Sociodemographic Profile COVID19 Patients Difficulties Faced Testing RTPCR Multicenter Crosssectional Study,34226470,study aimed find sociodemographic profile well difficulty Reverse transcription polymerase chain reaction RTPCR testing faced Coronavirus Disease 2019 COVID19 patient crosssectional study conducted 10th August 7th September 2020 Data collected telephone interview using predesigned questionnaire taking verbal consent participant 281 COVID19 patient 279 diagnosed RTPCR 103 asymptomatic 676 male 24 hospital staff Majority 662 noncity corporation area History recent contact known COVID19 patient present 569 case Fever 783 cough 58 common symptom One third patient faced difficulty test RTPCR COVID19 Sixteen percent patient complained difficulty getting serial testing maximum waiting time one week giving sample Thirty patient 108 wait longer usual time reaching center giving sample Hospital staff unable cooperate 25 patient difficulty managing transport hospital suspected COVID19 patient issue 22 patient Though testing difficult city corporation area p=0028 delay getting test result le p 0001 Maximum delay getting test result 10 day Finding difficulty COVID19 testing help point issue behind help take necessary step tackle matter Testing rate increased contain highly contagious virus densely populated country,
Appraisal Current Scenario Vaccine Research COVID19,34372603,recent coronavirus disease 2019 COVID19 outbreak drawn global attention affecting million disrupting economy healthcare modality high infection rate COVID19 caused colossal health crisis worldwide information comprehensive nature infectious agent SARSCoV2 still remains obscure ongoing genomic study successful identifying genomic sequence presenting antigen may serve promising potential therapeutic target effective management COVID19 attempt establish herd immunity massive effort directed driven toward developing vaccine SARSCoV2 pathogen review direction aimed providing current scenario future perspective development vaccine SARSCoV2,covid-19;sars-cov-2;immunity;therapeutic targets;vaccines
COVID19 Infection Targeting Possibilities Treatment,34348019,outbreak novel coronavirus nCoV severe acute respiratory syndrome coronavirus2 SARSCoV2 December 2019 Wuhan China posed international public health emergency worldwide forced people confined home virus highrisk category declared pandemic World Health Organization worldwide researcher various health professional working together determine best way stop spread halt virus s spread circumvent pandemic condition threatening million human life absence definitive treatment possible explore reduce virus infection enhance patient recovery Along offlabel medicine plasma therapy vaccine researcher exploit various plantsherbs constituent effectively treat nCoV infection present study aimed present brief informative salient feature numerous fact regarding SARSCoV2 including structure genomic sequence recent mutation targeting possibility various hurdle research progress offlabeled drug convalescent plasma therapy vaccine plantsherbs treatment coronavirus disease2019 COVID19 Results showed offlabeled drug hydroxychloroquine dexamethasone tocilizumab antiviral drug remdesivir favipiravir etc give positive result approved use approved restricted use country like India Future research focus possibility may allow development effective treatment COVID19,
Effect Ambient Environmental Conditions COVID19 Mortality Systematic Review,34205714,Weather condition may impact SARSCoV2 virus transmission shown seasonal influenza Virus transmission likely favor low temperature low humidity condition systematic review aimed collect evidence impact temperature humidity COVID19 mortality review registered PROSPERO registration CRD42020196055 searched Pubmed Embase Cochrane COVID19 database observational epidemiological study Two independent reviewer screened titleabstracts full text study Two reviewer also performed data extraction quality assessment 5051 identified study 11 included review Although result inconsistent study imply decrease temperature humidity contributes increase mortality establish association greater certainty future study consider accurate exposure measurement important covariates government lockdown population density sufficient lag time nonlinear association,covid-19;sars-cov-2;humidity;precipitation;seasonality;temperature
Effects Delayed Radical Prostatectomy Active Surveillance Localised Prostate CancerA Systematic Review MetaAnalysis,34208888,External factor coronavirus disease 2019 COVID19 lead cancellation backlog cancer surgery effect delay unclear study summarised evidence surrounding expectant management delay radical prostatectomy RP neoadjuvant hormone therapy NHT compared immediate RP MEDLINE EMBASE searched randomised controlled trial RCTs nonrandomised controlled study pertaining review question Risks bias RoB evaluated using RoB 20 tool NewcastleOttawa Scale total 57 study included Metaanalysis four RCTs found overall survival cancerspecific survival significantly worsened amongst intermediaterisk patient undergoing active monitoring observation watchful waiting low highrisk patient Evidence 33 observational study comparing delayed RP immediate RP contradictory However conservative estimate delay 5 month 4 month 30 day lowrisk intermediaterisk highrisk patient respectively associated significantly worse pathological oncological outcome individual study 11 RCTs 3month course NHT shown improve pathological outcome patient effect oncological outcome apparently limited,covid-19;active surveillance;prostate cancer;radical prostatectomy;surgical waiting time;treatment delay
Preventing COVID19 assisted living facility impossible task pending vaccination roll,34221853,aimed describe clinical outcome resident longterm care facility closure visitor supplier response first COVID19 pandemic February 23 June 22 2020 result facilitywide SARSCoV2 testing resident staff June 2020 partially reopening Seventyfour resident 53 member staff included present study staff underwent nasopharyngeal swab test SARSCoV2 staff resident underwent serological test detect IgG antibody SARSCoV2 result test negative Conversely 94 resident 38 member staff tested positive nasopharyngeal swab test second COVID19 pandemic wave data collected November 1 November 30 2020 experience suggests presence lifethreatening pandemic SARSCoV2 infection prompt use restrictive procedure prevent spread progression disease assisted living facility short term may fail long term especially prevalence COVID19 greatly increased outside facility enhancing risk import disease outside SARSCoV2 vaccination resident staff member would contribute controllimit prevalence spread virus,assisted living facilities;covid-19;sars-cov-2
Mobility restriction associated reduction COVID19 incidence early pandemic evidence realtime evaluation 34 country,34215764,country implemented restriction mobility prevent spread Coronavirus disease19 COVID19 entailing considerable societal cost least initially based limited evidence effectiveness asked whether mobility restriction associated change occurrence COVID19 34 OECD country plus Singapore Taiwan data source Google Global Mobility Data Source report different type mobility COVID19 case retrieved dataset curated World Data Beginning country s 100th case incorporating 14day lag account delay exposure illness examined association change mobility January 3 February 6 2020 baseline ratio number newly confirmed case given day total number case past 14 day index day potentially infective pool population per million population using LOESS regression logit regression twothirds examined country reduction 40 commuting mobility workplace transit station retailer recreation associated decreased case especially early pandemic mobility incidence brought restriction provided little additional benefit finding point importance acting early decisively pandemic,
Improving Pandemic Response Employing Mathematical Modeling Confront COVID19,34343282,Modeling complement surveillance data inform COVID19 public health decision making policy development includes use modeling improve situational awareness ass epidemiological characteristic inform evidence base prevention strategy enhance modeling utility future public health emergency Centers Disease Control Prevention CDC launched Infectious Disease Modeling Analytics Initiative initiative objective 1 strengthen leadership infectious disease modeling epidemic forecasting advanced analytic work 2 build cultivate community skilled modeling analytics practitioner consumer across CDC 3 strengthen support internal external applied modeling analytic work 4 working partner coordinate governmentwide advanced data modeling analytics infectious disease effort critical help prepare CDC country world respond effectively present future infectious disease threat,covid-19;forecasting;modeling;pandemic;public health
Transient drop neutrophil count COVID19 regardless clozapine treatment patient mental illness,34229112,,
Early Onset SARSCOV2 Antibodies First Dose BNT162b2 Correlation Age Gender BMI,34206312,BACKGROUND first goal study analyse antibody titre 21 day first dose BNT162b2 vaccine group 252 healthcare worker HCW second goal analyse antibody titre change correlation age gender body mass index BMI METHODS Participants nasopharyngeal swab SARSCoV2 assessed presence SARSCoV2 antibody baseline 21 day BNT162b2 priming dose RESULTS First dose BNT162b2 activated immune response 98 participant Five HWC increase antibody titre 21 day first dose Antibody titre greater young 38 year vs older participant 38 vs 4756 p = 0002 38 vs 56 p = 0001 Higher antibody level detected underweight vs preobesity group p = 0026 normalweight vs preobesity group p = 0007 association confirmed adjusting age p = 00001 gender p = 000001 CONCLUSIONS study demonstrates single dose BNT162b2 activates immune response young normalweight correlate positively response Larger specifically designed clinical trial needed validate result,covid-19;sars-cov-2;antibodies;obesity;serum titer;vaccine
Impact COVID19 Pandemic Patients Affected NonCommunicable Diseases Europe USA,34206293,international online patient community Carenity conducted patient study two independent wave among adult affected noncommunicable disease NCDs Europe United States America USA study aimed ass real time impact coronavirus disease 2019 COVID19 medical condition patient NCDs access health care adaptation daily life well describe source information COVID19 need specific information support pandemic 50 patient reported worsening medical condition 17 developed new disease Additionally 26 respondent reported impact pandemic regularlongterm treatment intake 54 patient felt completely socially isolated reported strong impact COVID19 pandemic stress level state mind higher level observed USA compared Europe 59 respondent wished received additional information regarding risk associated medical condition pandemic Television used source information whereas physician trusted one study describes substantial impact COVID19 pandemic NCD patient,covid-19;access;behavior;health care impact;isolation;non-communicable diseases;patient experience;source of information;stress
Responses COVID19 South Asian Association Regional Cooperation SAARC country 2020 data analysis world crisis,34376927,Coronavirus disease COVID19 caused SARSCoV2 notified Wuhan city Hubei province China mid December 2019 disease showing dynamic change pattern COVID19 confirmed case death toll low middleincome country LMICs study exponential growth EG method used calculate reproductive rate Rt initial current stage epidemic South Asian Association Regional Cooperation SAARC member country April 2020 December 2020 Time dependent TD method used calculate weekly reproduction number also presented observation COVID19 epidemiology relation health expenditure poverty BCG vaccination literacy comparison reproduction number population density understanding current scenario trend expected outcome disease SAARC country significant positive correlation noticed COVID19 death health expenditure GDP r=058 P 005 factor population density sq km literacy adult population poverty significantly correlated number COVID19 case death Among SAARC country highest reproduction number Rt observed India Rt =210 95 CI 204217 followed Bangladesh Rt =162 95 CI 159164 initial state epidemic continuous monitoring necessitated country looking medical facility available infrastructure healthcare manpower constraint may appear increased number critically ill patient situation persists longer,"covid-19;population density, poverty;reproduction number;saarc countries;sars-cov-2"
Transmission frequency COVID19 presymptomatic asymptomatic patient AJK report 201 case,34217301,BACKGROUND COVID19 pandemic catastrophic global phenomenon affecting human life way unseen since 1918 influenza pandemic Effective management threat requires halting transmission strategy requiring accurate knowledge SARSCoV2 transmission pattern METHODS retrospective contact study aiming estimate transmission rate COVID19 tracing contact symptomatic presymptomatic asymptomatic patient History patient contact 24 h appearance symptom infection confirmation traced disease transmission RESULTS Overall total 201 COVID19 patient contact 7168 people 24 h average 3566 contact per patient ranging minimum 4 maximum 87 contact meeting 7168 person met infection detected 64 089 155 symptomatic patient total 5611 contacted person traced appearance symptom presymptomatic last 24 h average 3620 meeting per patient infection transmitted 63 112 people 5548 9888 remaining uninfected 63 transmission 62 984 traced within 6 h symptom onset 1 identified 612 h timeframe symptom total 1557 person traced meetingcontacts asymptomatic case last 24 h infection confirmation 1557 person 1 found infected infection rate calculated 006 Statistically transmission rate presymptomatic patient found significantly higher transmission rate asymptomatic individual P 005 CONCLUSION studied population risk presymptomatic asymptomatic transmission COVID19 low transmission risk 112 006 respectively Presymptomatic infection becomes rare contact made longer 6 h onset symptom infection transmission traced long 9 h appearance clear symptom patient incidence rate low 002 total contact period,ajk;asymptomatic;covid-19;covid-19 patients;covid-19 transmission;pakistan;pre-symptomatic
Delayed Cutaneous Hypersensitivity Reaction Vaxzevria ChAdOx1S Vaccine SARSCoV2,34351606,Recently increasing number case delayed cutaneous reaction immunization mRNAbased vaccine severe acute respiratory syndrome coronavirus 2 SARSCoV2 reported adverse reaction considered delayedtype cellmediated hypersensitivity reaction described Moderna mRNA1273 Comirnaty PfizerBioNTech BNT162b2 vaccine describe delayed large local cutaneous reaction patient received viral vector vaccine Vaxzevria ChAdOx1S AstraZeneca time course clinical symptom delayed skin reaction mRNA vaccine similar pattern recognized patient Vaxzevria vaccination phenomenon described Vaxzevria clinical trial knowledge first report adverse reaction vectorbased SARSCoV2 vaccine hope raise awareness delayed injection site reaction also occur viral vector vaccine encourage additional reporting patient education regarding cutaneous reaction coronavirus disease 2019 COVID19 vaccination,
InTransit Migrants Asylum Seekers Inclusion Gaps Mexico s COVID19 Health Policy Response,34228514,COVID19 pandemic immigration asylum process delayed interrupted migrant asylum seeker stranded Mexico s northern border Intransit migrant asylum seeker underserved population pandemic preparedness seldom taken need account article analyze public health policy developed Mexico response COVID19 pandemic describe policy largely overlooked need vulnerable mobile population reviewed eighty publicly available document issued federal state municipal authority Mexico January September 2020 seven policy document explicitly considered intransit migrant asylum seeker health care need addition identified six major gap policy addressed would promote greater inclusion person mobility future pandemic response plan protect health migrant population,
Outcomes SARSCoV2 Infection Patients Chronic Liver Disease Cirrhosis National COVID Cohort Collaborative Study,34284037,BACKGROUND AIMS patient chronic liver disease CLD without cirrhosis existing study outcome severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection limited generalizability used National COVID Cohort Collaborative N3C harmonized electronic health record dataset 64 million describe SARSCoV2 outcome patient CLD cirrhosis METHODS identified patient CLD without cirrhosis SARSCoV2 testing N3C Data Enclave July 1 2021 used survival analysis associate SARSCoV2 infection presence cirrhosis clinical factor primary outcome 30day mortality RESULTS isolated 220727 patient CLD SARSCoV2 test status 128864 58 noncirrhosisnegative 29446 13 noncirrhosispositive 53476 24 cirrhosisnegative 8941 4 cirrhosispositive patient Thirtyday allcause mortality rate 39 cirrhosisnegative 89 cirrhosispositive patient Compared cirrhosisnegative patient cirrhosispositive patient 238 time adjusted hazard death 30 day Compared noncirrhosispositive patient cirrhosispositive patient 331 time adjusted hazard death 30 day stratified analysis among patient cirrhosis increased age obesity comorbid condition ie diabetes heart failure pulmonary disease SARSCoV2 infection associated increased adjusted hazard death CONCLUSIONS study approximately 221000 nationally representative diverse genderbalanced patient CLD found SARSCoV2 infection patient cirrhosis associated 238 time mortality hazard presence cirrhosis among patient CLD infected SARSCoV2 associated 331 time mortality hazard result provide additional impetus increasing vaccination uptake research regarding immune response vaccine patient severe liver disease,covid-19;cirrhosis;n3c;omop;sars-cov-2
Changes olfactory bulbus volume olfactory sulcus depth chronic period COVID19 infection,34289328,BACKGROUND Although limited number study investigating change olfactory bulb volume OBV olfactory sulcus depth OSD value acute subacute period COVID19 infection study conducted chronic period PURPOSE aim study reveal change OBV OSD COVID19 chronic period MATERIAL METHODS total 83 people included study including 42 normal healthy individual control group 41 patient COVID19 infection 1012 month infection RESULTS COVID19 group included 41 patient mean age 4027 + 145 year control group included 42 individual mean age 4027 + 144 mean OBV 6797 + 1427 mm 3 COVID19 group 9421 + 756 mm 3 control group mean OSD 798 + 037 mm COVID19 group 882 + 074 mm control group Left right mean OBVs OSD significantly lower patient COVID 19 control individual p 05 CONCLUSION finding show COVID19 infection cause significant decrease OBV OSD measurement chronic period,3 tesla mri;covid-19;olfactory bulbus volume;olfactory sulcus depth
Indoor Environmental Quality Dwellings Lifestyle Behaviors COVID19 Pandemic Russian Perspective,34199589,novel coronavirus COVID19 outbreak public health emergency international concern response public health authority started enforcing preventive measure like selfisolation social distancing enforcement isolation consequence may affect lifestylerelated behavior general population Quarantine encompasses range strategy used detain isolate conditionally release individual population infected exposed contagious disease tailored circumstance Interestingly medical student may represent example COVID19 pandemic form new habit change lifestyle behavior conducted webbased survey ass change lifestylerelated behavior selfisolated medical student COVID19 pandemic analyzed sanitaryhygienic regulation Russian Federation determine requirement healthy building Results showed pandemic enforcement isolation affect medical student lifestylerelated behavior accompanies increase noncommunicable disease NCDs Indoor environmental quality IEQ healthy building cuttingedge factor preventing COVID19 NCDs Russian sanitaryhygienic regulation support improving factor suitable requirement ventilation sewage waste management disinfection Herein assessing isolation possible hygienic selfisolation index,covid-19;russia;building codes;built environment;disinfection;indoor environment;lifestyle;self-isolation;sewage;ventilation
Ongoing global regional adaptive evolution SARSCoV2,34292871,Understanding trend severe acute respiratory syndrome coronavirus 2 SARSCoV2 evolution paramount control COVID19 pandemic analyzed 300000 highquality genome sequence SARSCoV2 variant available January 2021 result show ongoing evolution SARSCoV2 pandemic characterized primarily purifying selection small set site appear evolve positive selection receptorbinding domain spike protein region nucleocapsid protein associated nuclear localization signal NLS enriched positively selected amino acid replacement replacement form strongly connected network apparent epistatic interaction signature major partition SARSCoV2 phylogeny Virus diversity within geographic region steadily growing entirety pandemic analysis phylogenetic distance pair region reveals four distinct period based global partitioning tree emergence key mutation initial period rapid diversification regionspecific phylogeny ended February 2020 followed major extinction event global homogenization concomitant spread D614G spike protein ending March 2020 NLSassociated variant across multiple partition rose global prominence March July period stasis term interregional diversity Finally beginning July 2020 multiple mutation since demonstrated enable antibody evasion began emerge associated ongoing regional diversification might indicative speciation,sars-cov-2;ancestral reconstruction;epistasis;globalization;phylogeny
retrospective cohort study risk factor outcome older patient admitted innercity geriatric unit London first peak COVID19 pandemic,34228265,PURPOSE Compared younger patient coronavirus disease 2019 COVID19 clinical presentation older people heterogeneous fatal aim describe cohort older adult admitted innercity London hospital first peak pandemic METHODS retrospective observational study enrolled older adult consecutively admitted two geriatric ward suspected confirmed severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection collected sociodemographic data comorbidities symptom presentation andor admission biochemical radiological data outcome 28 day RESULTS One hundred twentyfour patient included 75 80 year old 195 COVID19 case judged hospitalacquired half presented developed typical symptom respiratory failure fatigue 468 diagnosed delirium 242 fall dysphagia present 137 mortality rate 298 higher among male 80 year patient higher grade frailty history dementia chronic kidney disease well diagnosed respiratory failure acute kidney injury hypernatremia Independent predictor mortality male sex age 80 year respiratory failure hypernatremia CONCLUSION described cohort patient SARSCoV2 infection first UK peak global pandemic found patient significant frailty multiple comorbidities high mortality increased dependency greater social care need survivor,covid-19;coronavirus pandemic;frailty;sars-cov-2
Analysis Forecasting Incidence Intensive Care Unit Admissions Projected Mortality Attributable COVID19 Portugal UK Germany Italy France Predictions 4 Weeks Ahead,34208000,use artificial neural network ANNs great contribution medical study since application forecasting concept allows analysis future disease propagation context paper present study new coronavirus SARSCOV2 focus verifying virus propagation associated mitigation procedure massive vaccination campaign two proposed methodology making prediction 28 day ahead number new case death ICU patient five European country Portugal France Italy United Kingdom Germany case study result massive immunization Israel also considered data input case death daily ICU patient normalized reduce discrepant number due country size cumulative vaccination value percentage population immunized least one dose vaccine comparative criterion calculation mean absolute error MAE prediction present best methodology targeting possibility use method proposed best architecture achieved general MAE 1to28day ahead forecast lower 30 case 06 death 25 ICU patient per million people,ann forecasting;covid-19 in europe;covid-19 in israel;covid-19 prediction icu;covid-19 prediction cases;covid-19 prediction deaths;covid-19 vaccination;covid-19 wearing of face mask;new coronavirus;time series prediction
Association diabetes severity mortality hospitalized patient COVID19 Wuhan China singlecentered retrospective study,34283900,Objective Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 spread worldwide aim study investigate association diabetes severity mortality among hospitalized patient COVID19 Wuhan China Methods retrospective singlecenter case study enrolled total 564 patient diagnosed COVID19 Seventh Hospital Wuhan City January 20 March 15 2020 Results Among 564 patient confirmed COVID19 509 851 discharged 55 98 died median age 59 year range 1093 year total 85 151 patient diagnosed diabetes admission median age 650 range 3491 year Patients diabetes significantly higher proportion critical case 24 282 vs 66 138 inhospital mortality 17 20 vs 38 79 Moreover patient diabetes presented abnormal level multiple indicator concerning lymphopenia inflammation heart liver kidney lung function admission diabetic patient group still display higher troponin TnT level approaching discharge KaplanMeier survival curve indicated trend toward poorer survival diabetic patient compared nondiabetic patient also evidenced abnormal laboratory biomarker change regarding multiple system impairment among COVID19 patient diabetes inhospital death Conclusion detailed clinical investigation 564 hospitalized patient COVID19 indicated considerable association diabetes COVID19 severity mortality Thus intensive treatment may considered COVID19 patient diabetes especially regarding cardiac injury,covid-19;clinical characteristics;diabetes;mortality
Good public health logistics resilient health system pandemic Lessons Tamil Nadu,34287195,article highlight importance strengthening public system need rapid scaling access testing appropriate therapeutic context Covid19 pandemic place robust public procurement system drug diagnostics paper draw lesson Tamil Nadu experience validates understanding investing public institution essential rapid responsiveness pandemic public health emergency ethical health system point view,
decision analytic approach social distancing policy early stage COVID19 pandemic,34219851,COVID19 pandemic become crucial public health problem world disrupted life million many country including United States study present decision analytic approach efficient tool ass effectiveness early social distancing measure community different population characteristic First empirically estimate reproduction number two different state develop agestructured compartmental simulation model disease spread demonstrate variation observed outbreak Finally analyze computational result show early trigger social distancing strategy result smaller death toll however relatively larger second wave Conversely late trigger social distancing strategy result higher initial death toll relatively smaller second wave study show decision analytic tool help policy maker simulate different social distancing scenario early stage global outbreak Policy maker expect multiple wave case result social distancing policy implemented vaccine available mass immunization appropriate antiviral treatment,covid-19;compartmental model;decision analysis;reproductive number estimation;social distancing
Hyperperception Model Partner s New Friends Inspire Jealousy Failing Use Social Distancing,34227875,hyperperception model used derive hypothesis concerning process people experience romantic jealousy observation romantic partner social network site main focus receiver component model specifies observation others interaction constrained social medium interaction appear intimate dyad also observable offline survey N = 322 conducted test component model determine model predict additional phenomenon possession signal staying home COVID19 pandemic data generally consistent hypothesis utility hyperperception model understanding effect observing romantic partner interaction social medium data also reveal importance interpersonal process obeying social distancing guideline,covid-19;facebook;hyperperception;jealousy;social distancing;social network sites
Rapid generation mouse model emerging infectious disease case severe COVID19,34379705,Since pandemic COVID19 intensely struck human society small animal model infectious disease urgent need basic pharmaceutical research Although several COVID19 animal model identified many show either minimal inadequate pathophysiology SARSCoV2 challenge describe new versatile strategy rapidly establish mouse model emerging infectious disease one month multiroute multiserotype transduction recombinant adenoassociated virus AAV vector expressing viral receptor study proposed approach enables profound enduring systemic expression SARSCoV2receptor hACE2 wildtype mouse render vulnerable SARSCoV2 infection Upon virus challenge generated AAVhACE2 mouse showed pathophysiology closely mimicking patient severe COVID19 efficacy novel therapeutic antibody cocktail RBDchAbs COVID19 tested confirmed using AAVhACE2 mouse model demonstrating successful application drug development,
Assessing Knowledge Attitudes Practices COVID19 among Quarantine Hotel Workers China,34205519,pandemic quarantine hotel worker face higher risk infection host quarantine guest overseas study s aim gain understanding knowledge attitude practice KAP quarantine hotel worker China total 170 participant took part crosssectional survey ass KAP quarantine hotel worker China COVID19 pandemic chisquare test independent ttest oneway analysis variance ANOVA descriptive analysis binary logistic regression used examine sociodemographic factor associated KAP level COVID19 pandemic result show 6241 good knowledge 947 positive attitude towards COVID19 782 good practice quarantine hotel worker 953 confident COVID19 successfully controlled China handling COVID19 crisis well 988 quarantine hotel worker also taking personal precaution avoiding crowd 806 wearing facemasks 976 result evidence quarantine hotel worker China acquired necessary knowledge positive attitude proactive practice response COVID19 pandemic result study provide reference quarantine hotel worker targeted education intervention,covid-19;attitudes;knowledge;practices;quarantine hotel workers
Determinants Postponed Cancer Screening COVID19 Pandemic Evidence Nationally Representative COVID19 Snapshot Monitoring Germany COSMO,34285614,Purpose COVID19 pandemic accompanied various challenge individual health health care system However preventive examination cancer screening postponed pandemic nationally representative study describing postponed cancer screening identifying determinant Germany lacking aim close gap knowledge Materials Methods used crosssectional data nationally representative onlinesurvey `` COVID19 Snapshot Monitoring Germany COSMO wave 17 conducted July 2020 analytical sample included 974 individual mean age 459 year SD 165 year 18 74 year outcome measure whether cancer screening postponed since March 2020 due COVID19 pandemic attended planned yes postponed Results total slightly 10 individual stated postponed cancer screening March July 2020 due COVID19 pandemic particularly woman individual aged 30 49 year likelihood postponed cancer screening positively associated higher affect regarding COVID19 165 95 CI 116235 whereas negatively associated younger age eg 18 29 year 017 95 CI 005064 compared individual 30 49 year Conclusion Study finding showed one ten individual postponed cancer screening COVID19 pandemic determined two correlate age affect regarding COVID19 Individuals increased likelihood postponed cancer screening specifically addressed,covid-19;cancer screening;corona-virus;delayed screening;postponed screening; sars-cov-2; access to health care; availability of medical care; health care use; health care utilization; health services research; postponed treatment
Prevalence COVID19 10000 sample 7853 patient Eastern Turkey positive realtime PCR,34223786,Aim COVID19 caused SARSCoV2 started December 2019 spread across world Materials method analyzed realtime PCR result 10000 sample 2 April 30 May 2020 three neighbor city located East Turkey final study population 7853 case excluding screening test Results Realtime PCR performed detect SARSCoV2specific RNAdependentRNApolymerase gene fragment number total positive sample 7853 487 however number nonrepeating positive patient 373 48 Cough fever common symptom positive case Conclusion Epidemiologic study performed prevalence SARSCoV2 infection better understand effect virus across world,covid-19;sars-cov-2;positivity rate;prevalence;real-time pcr
Therapeutic meal psychiatric day hospital child sanitary restriction Institutional psychotherapy Covid19,34219745,context COVID19 pandemic Pordegui child s hospital day psychiatric centre Montauban hospital first closed door March 2019 like many ambulatory care facility result first confinement strong impact accessibility care particularly vulnerable patient lockdown eased week respect hygiene rule barrier gesture still impact therapeutic framework institutionThis article aim document reflection effect current arrangement inherent pandemic health situation seem produce organization care psychiatric child s hospital using example therapeutic mealsThe latter taken granted even though minimal condition caring time reinstated condition include repetitive structuring reassuring framework schedule collective arrangement characterized regular presence pattern caregiver availability well feedback session form institutional meeting reopening center specific phenomenon identifiable care time noticed meal individual group patient situational analysis led based observation experience patient crossexamination institutional psychotherapy phenomenology order understand movement highlight seems irreducible meal therapeutic,covid-19;child psychiatry;clinical case;day psychiatric center;health crisis;therapeutic meals;therapeutic mediation
Telogen Effluvium SARSCoV2 Infection Series Cases Possible Pathogenetic Mechanisms,34373830,Introduction Physicians largely studied cutaneous involvement coronavirus disease 2019 COVID19 report focused telogen effluvium TE possible sequela COVID19 assessed 14 case hair loss occurring SARSCoV2 infection using trichoscopy trichogram investigate pattern related COVID19 Furthermore discussed possible mechanism involved COVID19 TE Case Presentation Fourteen individual referred postCOVID19 dermatology office complaining acute hair loss SARSCoV2 infection Clinical evaluation included pull test trichoscopy trichogram COVID19 TE occurred median 2 month range 13 month following SARSCoV2 infection median duration hair loss 5 month range 16 month Trichoscopy showed variable typical TE pattern Trichogram showed different telogenanagen ratio depending interval onset hair loss trichological visit DiscussionConclusion case showed TE 1 3 month onset SARSCoV2 infection thus earlier classic TE Trichoscopic feature trichogram showed variation classic TE Different pathogenetic mechanism including proinflammatory cytokine direct viral damage hair follicle hypothesized study larger sample needed better understand condition,coronavirus disease 2019;hair loss;hair microscopy;telogen effluvium;trichoscopy
Managing chronic disease COVID19 pandemic elearning application promote healthy lifestyle person multiple sclerosis,34130565,Ehealth application support continuing care person chronic disease multiple sclerosis MS developed webbased mobile app called VIOLA used home person MS pwMS previously participated innovative multidisciplinary rehab program purpose VIOLA reinforce participant learned healthy lifestyle keep motivated adhere rehabilitation program outbreak Covid19 pandemic severely curtailed pwMS contact usual health provider quickly updated VIOLA grant continuity care homebound patientsBy monitoring pwMS subscription individual module found definite increase national lockdown declared Subscribers rated app positivelyEncouraged positive feedback planning extend access app also pwMS prior specific learning experience would limit psychophysical consequence lockdown Furthermore VIOLA could effective maintaining proper lifestyle contributing improve quality life pwMSVIOLA potential increasing adherence pwMS rehabilitation confirming digital communication tool valuable solution homebound,covid-19;chronic disease;e-learning;lifestyle;multiple sclerosis;telehealth
Liquid Chalk Antiseptic SARSCoV2 Influenza Respiratory Viruses,34133201,COVID19 pandemic impacted enforced significant restriction within society including attendance public professional athlete gym Liquid chalk commonly used accessory gym comprised magnesium carbonate alcohol quickly evaporates hand leave layer dry chalk investigated whether liquid chalk antiseptic highly pathogenic human virus including SARSCoV2 influenza virus noroviruses Chalk applied virus inoculum recovery infectious virus determined mimic use gym observed addition chalk virus contact led significant reduction recovery infectious SARSCoV2 influenza virus little impact norovirus observation suggest use application liquid chalk effective suitable antiseptic major sporting event Olympic Games IMPORTANCE restrict potential transmission infectivity SARSCoV2 use liquid chalk requirement active gym setting However effectiveness scientifically proven show application liquid chalk virus inoculum significantly impact recovery infectious SARSCoV2 influenza virus noroviruses Thus study shown implementation application liquid chalk communal social gym setting effective reducing infectivity respiratory virus support use liquid chalk major sporting event restrict impact COVID19 community,covid-19;sars-cov-2;alcohol;antiseptic;influenza a virus;norovirus;noroviruses
Network Analysis Outpatients Identify Predictive Symptoms Combinations Symptoms Associated PositiveNegative SARSCoV2 Nasopharyngeal Swabs,34355004,Background Limited data exist early predictive clinical symptom combination symptom could included case definition coronavirus disease 2019 COVID19 particularly mildtomoderate disease outpatient setting Methods cohort study individual presenting clinical symptom one largest dedicated network COVID19 test center Geneva Switzerland March 2 April 23 2020 Individuals completed symptom questionnaire received nurseled checkup nasopharyngeal swab obtained analysis clinical feature predicting positivity negativity SARSCoV2 RTPCR test performed determine relationship symptom combination Results 3248 patient included mean age 422 year 1504 463 male 713 22 positive RTPCR 1351 416 consulted within 3 day symptom onset strongest predictor positive SARSCoV2 RTPCR anosmia particularly early disease followed fever myalgia cough Symptoms predictive negative test breathing difficulty abdominal symptom thoracic pain runny nose Three distinct network symptom identified occur together respiratory symptom systemic symptom related fever systemic symptom related anosmia Conclusions Symptoms network symptom associated positivenegative SARSCoV2 RTPCR emerging may help guide targeted testing Identification early COVID19related symptom alone combination contribute establish clinical case definition provide basis clinician public health authority distinguish respiratory virus early course disease particularly outpatient setting,covid-19;sars-cov-2;clinical features;combination of symptoms;diagnosis;outpatient;predictive symptoms
Regional Differences Epidemiological Clinical Characteristics Treatment Clinical Outcomes COVID19 Wuhan Remote Areas Hubei Province,34336881,Background Coronavirus disease 2019 COVID19 pandemic major threat global health Regional difference epidemiological clinical characteristic treatment outcome patient yet investigated study conducted investigate difference amongCOVID19 patient Hubei Province China Methods retrospective crosssectional study analyzed data 289 COVID19 patient designated hospital three region Urban Wuhan Union West Hospital Suburban area Wuhan Hannan Hospital Enshi city February 8 20 2020 final date followup December 14th 2020 outcome case fatality rate epidemiological clinical data Results Urban Wuhan experienced significantly higher case fatality rate 215 suburban Wuhan 523 rural area Enshi 351 Urban Wuhan higher proportion patient mechanical ventilation 2405 suburban Wuhan 0 rural Enshi 357 Treatment glucocorticoid equivalent urban suburban Wuhan 4684 4575 respectively higher Enshi 2500 Urban Wuhan higher proportion patient abnormal test including liver function serum electrolyte higher rate pneumonia p 001 Urban Wuhan also higher incidence respiratory failure heart disease liver disease shock compared two region p 005 Conclusions finding revealed regional difference COVID19 finding provide novel insight distribution appropriate resource prevention control treatment COVID19 global community,covid-19;sars-cov-2;clinical characteristics;mortality;regional differences
Delayed Presentation COVID19 Pandemic Leading PostMyocardial Infarction Ventricular Septal Defect,34221777,Postmyocardial infarction ventricular septal defect postMI VSD rare complication STelevation myocardial infarction STEMI incidence 1 early revascularization era present case 66yearold woman postMI VSD owing delay presentation current pandemic Patient presented worsening back pain chest pain confusion EKG positive inferior wall STEMI underwent emergent percutaneous intervention placement drugeluting stent right coronary artery developed worsening heart failure newonset heart murmur found VSD transthoracic echo poor prognosis family decided pursue comfort care patient unfortunately passed Delay seeking health care pandemic seen patient multifactorial including fear contracting infection decreased emergency medical service member concern overburdening healthcare system Lack standardized inhospital approach emergency ensuring adequate protection infection healthcare worker especially initial phase pandemic led increased doortoballoon time addition increased time first medical contact importance medium outreach ensuring availability health care emergency changing emergency response algorithm ensure safety patient healthcare provider including thrombolytic therapy delay due stringent screening delayed COVID19 testing used prevent worsening complication following STEMI,covid;post mi complications;post mi vsd;ventricular septal defect (vsd);vsd
Review COVID19 vaccine subtypes efficacy geographical distribution,34362856,1 May 2021 152 661 445 Covid19 case 3 202 256 death globally pandemic led race discover vaccine achieve herd immunity curtail damaging effect Covid19 study aim discus recent WHOapproved Covid19 vaccine subtypes status geographical scheduled update 4 May 2021 keywords `` Covid19 Vaccines Pfizer BNT162b2 AstraZeneca AZD1222 Moderna mRNA1273 Janssen Ad26COV2S typed PubMed Thirty Two relevant PubMed article included study vaccine discussed PfizerBNT162b2 Moderna VaccinemRNA1273 AstraZenecaAZD122ChAdOx1 nCoV19 Janssen vaccinesAd26COV2S well platform trial limitation geographical distribution 16 May 2021 number country approved use following vaccine Pfizer 85 Moderna 46 OxfordAstraZeneca 101 Janssen 41,covid-19;virology
LongTerm Exposure PM25 Facemask Mandates Stay Home Orders COVID19 Incidence United States,34200600,Longterm PM25 exposure might predispose population SARSCoV2 infection intervention policy might interrupt SARSCoV2 transmission reduce risk COVID19 conducted ecologic study across United States using countylevel COVID19 incidence 12 September 2020 represent first two surge US annual average PM25 2000 2016 statelevel facemask mandate stay home order fit negative binomial model ass COVID19 incidence association PM25 policy Stratified analysis facemask policy stay home policy also performed 1microgm 3 increase annual average concentration PM25 exposure associated 756 95 CI 376 1149 increase COVID19 risk Facemask mandate stay home policy inversely associated COVID19 adjusted RRs 08466 95 CI 07598 09432 09193 95 CI 08021 10537 respectively association PM25 COVID19 consistent among county without preventive policy study added evidence longterm PM25 exposure increased risk COVID19 surge cumulatively 12 September 2020 United States Although statelevel implementation facemask mandate stay home order effective preventing spread COVID19 clear effect modification observed regarding longterm exposure PM25 risk COVID19,covid-19;facemasks;nation-wide study;particulate matter;stay-home orders
Reinfection COVID19 scoping review,34334891,Reinfections COVID19 reported around world cause concern considering lot assumption modeling including vaccination related disease relied longterm immunity one first group report series 4 healthcare worker reinfected review article report scoping review available literature reinfections discussion implication reinfections,covid-19;immunity;reinfection;respiratory diseases;respiratory infections
NewOnset Type 1 Diabetes Mellitus Diabetic Ketoacidosis Pancreatitis Patient COVID19,34368517,Coronavirus Disease 2019 COVID19 struck world health economic catastrophe recently unusual autoimmune presentation including newonset Type 1 Diabetes Herein present 17yearold male patient presented Emergency room fever palpitation cough fourweek duration referred Emergency room found DKA CT chest showed groundglass opacity suggestive COVID19 pneumonia abdominal cut showed dilated intrahepatic biliary radicle pancreatic loculations suggestive pancreatitis patient admitted ICU started Intravenous fluid Insulin infusion COVID19 PCR returned positive hypothesize SARSCoV2 vital role eliciting autoimmune response triggering Type 1 Diabetes study needed confirm hypothesis SARSCOV2 may cause pancreatitis first presentation could high blood sugar DKA,covid-19;dka;diabetic ketoacidosis;new-onset;pancreatitis;type 1 diabetes mellitus
Suppression Inflammatory Cardiac Cytokine Network Rats Untreated Obesity PreDiabetes AT2 Receptor Agonist NP6A4,34220518,Obesity affect 42 United States population exacerbates heart disease leading cause death men woman Obesity also increase proinflammatory cytokine cause chronic tissue damage vital organ standardofcare sufficiently attenuate inflammatory sequela Angiotensin II receptor AT2R antiinflammatory cardiovascular protective molecule however AT2R agonist used clinic treat heart disease NP6A4 new AT2R peptide agonist FDA orphan drug designation pediatric cardiomyopathy NP6A4 increase AT2R expression mRNA protein nitric oxide generation human cardiovascular cell AT2Rantagonist PD123319 AT2RSiRNA suppress NP6A4effects indicating NP6A4 act AT2R determine whether NP6A4 would mitigate cardiac damage chronic inflammation induced untreated obesity investigated effect 2weeks NP6A4 treatment 18 mgkg delivered subcutaneously cardiac pathology male Zucker obese ZO rat display obesity prediabetes cardiac dysfunction NP6A4 attenuated cardiac diastolic systolic dysfunction cardiac fibrosis cardiomyocyte hypertrophy increased myocardial capillary density NP6A4 treatment suppressed tubulointerstitial injury marker urinary betaNAG liver injury marker alkaline phosphatase serum protective effect NP6A4 occurred presence obesity hyperinsulinemia hyperglycemia hyperlipidemia without modulating blood pressure NP6A4 increased expression AT2R consistent human cell cardioprotective erythropoietin EPO Notch1 ZO rat heart suppressed nineteen inflammatory cytokine Cardiac miRNA profiling silico analysis showed NP6A4 activated unique miRNA network may regulate expression AT2R EPO Notch1 inflammatory cytokine mitigate cardiac pathology Seventeen proinflammatory profibrotic cytokine increase lethal cytokine storm caused infection COVID19 among cytokine suppressed NP6A4 treatment ZO rat heart Thus NP6A4 activates novel antiinflammatory network comprised 21 protein heart reported previously Since NP6A4 s unique mode action suppresses proinflammatory cytokine network attenuates myocardial damage ideal adjuvant drug antiglycemic antihypertensive standardofcare drug protect heart tissue proinflammatory profibrotic cytokine attack induced obesity,at2 receptor;np-6a4;cardiac dysfunction;heart disease;inflammatory cytokines;myocardial strain;obesity
Controlling inflammation elderly BCG vaccination,34348906,tuberculosis vaccine BCG may protect inflammation elderly well offer option protection SARSCoV2 developing country,
Early Prediction COVID19 Ventilation Requirement Mortality Routinely Collected Baseline Chest Radiographs Laboratory Clinical Data Machine Learning,34354361,Background Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 emerged Wuhan China late 2019 created global pandemic overwhelmed healthcare system COVID19 July 3 2021 yielded 182 million confirmed case 39 million death globally according World Health Organization Several patient initially diagnosed mild moderate COVID19 later deteriorated reclassified severe disease type Objective aim create predictive model COVID19 ventilatory support mortality early baseline time diagnosis routinely collected data patient CXR CBC demographic patient history Methods Four common machine learning algorithm three data balancing technique feature selection used build validate predictive model COVID19 mechanical requirement mortality Baseline CXR CBC demographic clinical data retrospectively collected April 2 2020 till June 18 2020 5739 patient confirmed PCR COVID19 King Abdulaziz Medical City Riyadh However patient 1508 1513 met inclusion criterion ventilatory support mortalilty endpoint respectively Results independent test set ventilation requirement predictive model top 20 feature selected reliefF algorithm baseline radiological laboratory clinical data using support vector machine random undersampling technique attained AUC 087 balanced accuracy 081 mortality endpoint top model yielded AUC 083 balanced accuracy 080 using feature balanced random forest indicates routinely collected data model predict outcome good performance predictive ability combined data consistently outperformed data set individually intubation mortality ventilator support chest Xray severity annotation alone performed better comorbidity complete blood count age gender AUC 085 balanced accuracy 079 mortality comorbidity alone achieved AUC 080 balanced accuracy 072 higher model use either chest radiograph laboratory demographic feature Conclusion experimental result demonstrate practicality proposed COVID19 predictive tool hospital resource planning patient prioritization current COVID19 pandemic crisis,cbc;covid-19;niv;smote; machine learning;x-rays;mortality;random forest
Collaborative critical care prediction resource planning COVID19 pandemic using computer simulation modelling future urgent planning lesson,34286207,March 2020 epidemiological modelling COVID19 predicted overwhelming demand healthcare resource yet data emerged painted different picture management science health system team University Strathclyde collaborated one NHS organisation contextualise national policy predict local resource need pandemic took hold Using action research combined organisational expertise local international data healthcare system expertise create discrete event simulation model predicted concurrent resource use first 10 week pandemic realistic estimate uncertainty allowed organisation create effective strategy resource planning followed national guidance cost would unwieldy futile decentralised approach delivered valuable information timely manner case study unique healthcare literature serf example successful methodology similar crisis,covid-19;computer simulation modelling;critical care;discrete event simulation;urgent care
Silico Vitro Analyses Validate Human MicroRNAs Targeting SARSCoV2 3UTR,34198800,COVID19 pandemic caused betacoronavirus SARSCoV2 genome virus composed single strand RNA 5 3UTR flanking region proteincoding ORFs closely resembling cell mRNAs MicroRNAs endogenous posttranscriptional regulator target mRNA modulate protein expression mediate cellular function including antiviral defense present study carried bioinformatics screening search endogenous human microRNAs targeting 3UTR SARSCoV2 Results computational technique allowed u identify 10 potential candidate capacity 3 together hsamiR1385p target SARSCoV2 3UTR validated vitro gene reporter assay Available information indicates two microRNAs namely hsamiR3941 hsamiR1385p combine effective targeting SARSCoV2 genome complementary antiviral protective effect host cell make potential candidate therapeutic treatment COVID19 variant known date information obtained conducting present analysis available Open Science Framework repository,sars-cov-2 3'-utr;antiviral defense;hsa-mir-138-5p;hsa-mir-3941
Analysis First 300 Cases SARS CoV2 Infection Infection Disease Clinic Craiova Romania,34211744,COVID19 ongoing pandemic intermediate analysis first 300 case treated Infectious Diseases Clinic Craiova performed found case asymptomatic mild severity symptomatic case increase age main comorbidities associated mainly severe case high blood pressure obesity cardiac condition diabetes mellitus malignancy Inflammation coagulation metabolic disorder significantly expressed critically ill patient Fatality rate relatively low death seems associated old age,covid-19;sars cov2;intermediate analysis
Phytotherapic Drugs Covid19 Treatment Scoping Review,34225610,BACKGROUND rapid eruption Coronavirus end 2019 caused global health crisis significant loss economy social wellbeing created massive shortage advanced health facility inadequate medicinal supply deteriorating human health condition basis adverse effect ongoing pandemic review proposed evaluate antiviral efficacy plantbased therapeutic SARSCoV2 commonly called COVID19 infection highlight possible action mechanism phytotherapeutic drug coronavirus inhibition validated clinical trial herbal formula Though experimental study COVID19 treatment limited undesirable side effect herbal drug unidentified compound ignored OBJECTIVE made effort study prospective plantderived bioactive entity effectiveness treatment COVID19 emphasize safety regulatory concern phytomedicines METHODS methodology involves relevant study COVID19 treatment based herbal extract purified bioactive metabolite eliterature survey done downloading research article available PubMed National library medicine Elsevier Google scholar search engine keywords used plant metabolite natural bioactive phytotherapeutic drug clinical trial SARSCoV2 Coronavirus inhibitor herbal extract RESULTS review pay particular attention etiological study COVID19 virus inhibition using medicinal plant metabolite immunomodulatory agent application valuable bioactive like phenolic compound saponin alkaloid tannin flavonoid terpenoids preparing herbal formuladrug drug resistance bioactive compound side effect human health discussed effective phytomedicine Thus emphasizing perspective phytotherapeutic drug safe remedy boost immunomodulatory function antiviral activity COVID19 CONCLUSION Altogether review present action mechanism plant extract rich bioactive compound depicted potential antiviral activity SARSCoV2 plant bioactive compound serve lead molecule develop phytomedicine ensuring safety regulation clinical trial treat prevent COVID19 viral infection,bioactive metabolites;clinical trials;herbal extracts;medicinal plants;phytotherapic drugs;plant-derived immunomodulatory agents;sars-cov-2
Encephalitis following COVID19 disease,34370409,Shortly COVID19 appeared became clear although disease mainly characterized respiratory symptom sign frequently appeared showed involvation organ several new publication report neurological complication According data developing encephalitis could relatively frequent among symptom mostly observed concommittantly respiratory symptom critical state disease several form detected patient symptom central nervous system involvement appeared week healing COVID19 pneumonia Clinical sign imaging electroencephalograpy cerebrospinal fluid analysis confirmed diagnosis encephalitis Considering previous SARSCoV2 infection result examination think case postinfectious central nervous system disease data available regarding encephalitis Covid19 disease literature yet,covid-19 disease;sars-cov-2 virus infection;healed pneumonia;postinfectious encephalitis
Management Coronavirus Disease 2019 Patients Lung Cancer Experience Thoracic Oncology Center,34368223,Background Cancer patient appear higher risk complication coronavirus disease 2019 COVID19 Specific data related lung cancer LC patient management active treatment andor recent diagnosis still limited aimed investigate clinical presentation baseline feature clinical outcome LC patient COVID19 Methods retrospective case study performed Centro Hospitalar Universitario de Sao Joao tertiary hospital North Portugal Data LC patient diagnosed COVID19 collected first 10 month COVID19 pandemic March 2020January 2021 Results Twentyeight patient active LC diagnosed COVID19 adenocarcinoma common histological type present n = 13 464 Sixteen patient metastatic stage IV LC 615 Twentyfive patient 893 relevant comorbidities including hypertension 393 chronic obstructive pulmonary disease 321 patient undergoing antineoplastic treatment median time last chemotherapy administration COVID19 diagnosis 16 day interquartile range = 1341 day Half patient previously corticosteroid therapy Twenty patient 714 needed hospitalization 18 received oxygen therapy 643 3 107 received highflow nasal cannula good tolerability 1 36 needed noninvasive ventilation Hydroxychloroquine antibiotic given 4 143 12 429 patient respectively Seven patient 25 died median time 5 day following COVID19 diagnosis Conclusion one first study reporting adverse outcome associated COVID19 LC patient time add evidence regarding need create protocol guideline reduce infection risk patient,covid-19;clinical management;infection;lung cancer;thoracic oncology
Diabetic ketoacidosis pediatric patient type 1 type 2 diabetes COVID19 pandemic,34332999,BACKGROUND COVID19 pandemic caused family stay home cancel everyday activity Hospital admission decreased affecting change diagnosis management chronic disease child AIMS analyzed first lockdown influenced clinical presentation manifestation child diabetes mellitus DM German University Hospital METHODS March 15th October 11th 2020 data general patient information clinical symptom lab result related diabetic ketoacidosis DKA analyzed child 018years presented new onset DM poor metabolic control known DM data including frequency severity DKA compared data patient presented 2019 RESULTS Data 125 participant DM evaluated 2020 n=52 2019 n=73 2020 twelve patient 231 diagnosed new onset DM two type2 diabetes 667 presented DKA including patient T2DM 2019 245 patient new onset DM 50 presented DKA 2020 patient new onset DM younger presented severe symptom DKA stay longer hospital compared 2019 2020 six child 50 new onset DM 6years whereas 2019 child new onset DM adolescent n=7 389 CONCLUSION COVID19 lockdown aggravated complication diabetes onset therapy management including severity frequency DKA underline need health education early DKA diagnosis early identify child risk,covid-19;children;diabetes mellitus;diabetic ketoacidosis;lockdown
Correlation hemoglobin A1c outcome patient hospitalized COVID19,34284145,BACKGROUND Diabetes known risk factor severe coronavirus disease 2019 COVID19 conducted study determine correlation hemoglobin A1c HbA1c level poor outcome hospitalized patient diabetes COVID19 METHODS retrospective singlecenter observational study patient diabetes defined HbA1c = 65 known medical history diabetes confirmed case COVID19 required hospitalization patient admitted institution March 3 2020 May 5 2020 HbA1c result patient divided quartile 5167 3250 mmolmol 6875 5158 mmolmol 7689 6074 mmolmol 9 75 mmolmol primary outcome inhospital mortality Secondary outcome included admission intensive care unit invasive mechanical ventilation acute kidney injury acute thrombosis length hospital stay RESULTS Five hundred six patient included number death within quartile 1 4 30 25 37 27 34 27 24 19 respectively statistical difference primary secondary outcome quartile except acute kidney injury le frequent quartile 4 CONCLUSIONS significant association HbA1c level adverse clinical outcome patient diabetes hospitalized COVID19 HbA1c used risk stratification patient,covid-19;diabetes;hemoglobin a1c;mortality;outcomes
Neuromuscular blockade administration associated altered energy expenditure critically ill intubated patient COVID19,34130866,BACKGROUND AIMS ESPEN guideline advocate energy need critically ill patient COVID 19 assessed using indirect calorimetry safely available study described energy need intubated patient COVID19 explores whether neuromuscular blockade administration NMBAs associated altered energy expenditure METHODS Resting energy expenditure REE respiratory exchange rate RER evaluated among critically ill intubated COVID19 patient 28th day intensive care unit stay ICUS indirect calorimetry Paralysed patient defined drug induced paralysis using cicatracurium least 3 day ICUS RESULTS 34 adult COVID 19 patient 598 male 352 obese requiring mechanical ventilation assessed prospectively REE measurement suggest gradual increase energy need post 3rd day ICUS patient without obesity non ob 178 kcalkgr 293 kcalkgr actual body weight AcBW 28th day ICUS p = 0011 patient obesity ob 181 kcalkgr 301 kcalkgr adjusted body weight AjBW 28th day ICUS p = 0021 NMBAs use accompanied significant drop REE especially first 7 day hospitalization non ob 229 v 179 kcalkgr AcBW p = 0014 ob patient 225 v 195 kcalkgr ABW p = 0027 CONCLUSION identified energy need COVID19 intubated patient highlighted significant increase beyond 1st week ICU Administration NMBAs considered may impact resting energy expenditure,covid 19;neuromuscular blockade;resting energy expenditure
Knowledge skill preventive behavior regarding COVID19 among public Shahrekord Iran,34222500,BACKGROUND COVID19 serious costly problem community Observing health issue performing preventive behavior influenced knowledge skill people toward COVID19 Hence study investigated knowledge skill practice public Shahrekord toward COVID19 MATERIALS METHOD present study performed cross sectional Data collected using online questionnaire 540 Shahrekord resident selected via convenience sampling 2020 Knowledge skill practice toward COVID19 assessed using prevalidated questionnaire Collected data analyzed SPSS21 software oneway analysis variance Pearson test regression test RESULTS study 391 male 609 female 463 2025 year mean score knowledge skill preventive behavior 7569 + 1785 5387 + 2740 5997 + 2379 respectively significant direct relationship knowledge skill P = 005 r = 081 public knowledge better skill well significant association age P = 0036 education level P = 0019 job P = 0014 knowledge addition significant association job P = 0027 marital status P = 0014 skill observed Knowledge skill demographic variable predict 376 preventive behavior CONCLUSION majority participant good knowledge moderate skill relatively enough practice Government policymakers must consider knowledge level skill practice implement productive intervention preventing COVID19,behavior;covid-19;knowledge;skill
SARSCoV2 vaccine stand,34213848,Vaccination SARSCoV2 virus responsible Covid19 pandemic represents major infection control strategy absence effective treatment disease date Unprecedented mobilization led development large number project already test human several month first efficacy safety data expected coming week New vaccine technology evaluated RNA replicating nonreplicating viral vector increasing chance success criterion evaluating vaccinesdespite exceptional speed developmentmust remain rigorous enough ensure acceptance population Beyond development mass production equitable distribution raise many question Finally vaccination successfully implemented health professional population convinced validity implies particular attention quality information given method communication,adenoviral vectors;covid-19;elinical trial;messenger;sars-cov2;spike;vaccine arn
SPOT webtool enabling swift profiling transcriptomes,34289024,increasing number single cell bulk RNAseq datasets describing complex gene expression profile different organism organ cell type call intuitive tool allowing rapid comparative analysis present Swift Profiling Transcriptomes SPOT web tool allows differential expression analysis also fast ranking gene fitting transcription profile interest Based heuristic approach spot algorithm rank gene according proximity userdefined gene expression profile interest best hit visualized table bar chart dot plot exported Excel file tool generally applicable tested RNAseq data malaria parasite undergo multiple stage transformation complex life cycle well data multiple human organ development cell line infected SARSCoV2 virus SPOT enable nonbioinformaticians easily analyse available dataset AVAILABILITY SPOT freely available academic use http frischknechtlabshinyappsioSPOT http githubcomEliasFarrSPOT SUPPLEMENTARY INFORMATION Supplementary data available Bioinformatics online,
Interactive Interface GraphBased Analyses Dynamic HBond Networks Application Spike Protein,34133162,Dynamic hydrogenbond network key determinant protein conformational dynamic case macromolecular protein complex large number hydrogen bond giving rise extensive hydrogenbond network efficient algorithm required analyze interaction could important dynamic biological function complex present highly efficient standalone interface designed analysis dynamical hydrogenbond network biomolecules macromolecular complex facilitate comprehensive description protein dynamic interface includes analysis hydrophobic interaction illustrate usefulness workflow interface dissecting dynamic ectodomain SARSCoV2 protein closed conformation find protein contains numerous local cluster dynamic hydrogen bond identify hydrogen bond sampled persistently receptor binding domain spike protein host handful persistent hydrogenbond cluster suggesting structural plasticity data analysis interface released open use,
Severe Acute Respiratory Syndrome Coronavirus 2 Pregnancy Outcomes According Gestational Age Time Infection,34352196,conducted international multicenter retrospective cohort study PregOuTCOV examine effect gestational age time infection severe acute respiratory syndrome coronavirus 2 SARSCoV2 obstetric neonatal outcome included singleton pregnancy live fetus 10 week gestation pregnancy outcome known exposed group consisted patient infected SARSCoV2 whereas unexposed group consisted remaining patient period Primary outcome defined composite adverse obstetric outcome composite adverse neonatal outcome 10925 pregnant woman 393 360 infected SARSCoV2 exposed group matching possible confounders identified statistically significant increase exposed group composite adverse obstetric outcome 20 week gestation composite adverse neonatal outcome 26 week gestation p 0001 Vaccination program target woman early pregnancy conception possible,covid-19;europe;pregoutcov;sars-cov-2;coronavirus disease;high-risk pregnancy;pregnancy outcomes;propensity score matching;respiratory infections;severe acute respiratory syndrome coronavirus 2;vaccination;viruses;zoonoses
Pandemic Worry Preventive Health Behaviors COVID19 Outbreak,34222295,Objective school preparing onsite learning urgently needed characterize extent pandemic worry examine predictor adopting preventive health behavior hand washing face mask wearing maintaining social distance among student pharmacist Methods online survey sent 326 student pharmacist United States Pandemic worry measured using sevenpoint Likert scale ranging extremely afraid extremely afraid getting COVID19 health belief model HBM theoretical framework study Preventive health behavior component HBM also measured using sevenpoint Likert scale one indicated extremely unlikely seven indicated extremely likely Multivariable linear regression model used identify predictor behavior Results medium level pandemic worry = 42 SD = 192 identified female reported higher pandemic worry Respondents reported extremely likely wash hand = 68 SD = 048 maintain social distance = 66 SD = 092 moderately unlikely wear face mask = 22 SD = 151 Determinants face mask wearing included pandemic worry perceived benefit cue action selfefficacy Asian American Perceived barrier negatively associated face mask wearing Conclusion Strategies implemented reduce psychological impact COVID19 pandemic among student pharmacist Predictors identified study incorporated effort improve face mask wearing Continued monitoring pandemic worry preventive health behavior great significance university college onsite learning,covid-19;face mask wearing;hand washing;maintaining social distance;pandemic worry
Neurosurgical Considerations Regarding Decompressive Craniectomy Intracerebral Hemorrhage SARSCoV2Vaccination Vaccine Induced Thrombotic ThrombocytopeniaVITT,34202817,Given ongoing global SARSCoV2vaccination effort clinical awareness need raised regarding possibility increased incidence SARSCoV2vaccinerelated immunemediated thrombocytopenia patient intracerebral hemorrhage ICH secondary cerebral sinus vein thrombosis CVT requiring emergency neurosurgical treatment context vaccineinduced immune thrombotic thrombocytopenia VITT recently association vaccination cerebral sinus vein thrombosis described number case neurosurgical treatment warranted patient special consideration warranted addressing perioperative coagulation herein describe past management patient VITT established literatureguided algorithm treatment patient addressing impaired coagulation patient Increasing insight addressing pathophysiology SARSCoV2vaccinerelated immunemediated thrombocytopenia guide physician developing interdisciplinary algorithm taking account special consideration disease,covid-19;sars-cov-2;cerebral sinus and vein thrombosis (cvt);decompressive craniectomy;intracerebral hemorrhage (ich);vaccination;vaccine-induced immune thrombotic thrombocytopenia (vitt)
Study Plasma Buffy Coat Patients SARSCoV2 InfectionA Preliminary Report,34201967,pandemic caused SARSCoV2 infection affect many aspect public health knowledge science practice around world Several study shown SARSCoV2 RNA plasma seems associated worse prognosis COVID19 present study investigated plasma buffy RNA patient COVID19 determine prognostic value prospective study carried patient hospitalized COVID19 RNA analyzed plasma buffy coat Morphological immunohistochemical study used detect presence SARSCoV2 buffy coat COVID19 patient obtained RNA concentration plasma 4483 + 3130 ngmL patient positive plasma test SARSCoV2 4615 died COVID19 four case test revealed SARSCoV2 present buffy coat Abnormal morphology monocyte lymphocyte neutrophil found immunohistochemical study showed positivity mononuclear cell platelet result suggest SARSCoV2 present plasma facilitates viral dissemination migration specific organ SARSCoV2 infects target cell binding receptor study presence plasma SARSCoV2 RNA correlated worse prognosis,rna;sars-cov-2;blood;buffy coat;immunohistochemical;morphology;plasma
Structural Topic Model Analysis MaskWearing Issue Using International News Big Data,34198600,Media play important role acquisition health information worldwide particularly evident face COVID19 epidemic Relatedly practical desirable people wear mask health fashion religious region However depending cultural difference people naturally accept wearing mask look upon negatively 2020 COVID19 pandemic led widespread maskwearing mandate worldwide case COVID19 wearing mask strongly recommended analyzing news data spread epidemic possible see direction crisis management structured particular utilizing big data analysis international news data discourse around world analyzed deeply study collected analyzed 58061 international news item related maskwearing 1 January 2019 31 December 2020 collected dataset compared World Health Organization s pandemic declaration applying structural topic model analysis result revealed prior declaration issue related COVID19 outbreak emphasized afterward issue related movement restriction quarantine management local economic impact emerged,covid-19;international newspaper;mask-wearing;quarantine;structural topic model
COVID19 Exposure Dental Clinic Healthcare Workers Routinely Use Particulate Filtering Respirators,34208462,Asymptomaticmildly symptomatic coronavirus disease 2019 COVID19 patient produce considerable amount virus transmit severe acute respiratory syndrome virus 2 SARSCoV2 close contact Preventing inhospital transmission SARSCoV2 challenging since symptombased screening protocol may miss asymptomaticmildly symptomatic patient particular dental healthcare worker HCWs high risk exposure facetoface contact exposure oral secretion unavoidable report exposure HCWs dental procedure mild symptomatic COVID19 patient 32yearold male visited dental clinic tertiary care hospital experienced mild cough started three day dental visit report symptom entrance screening underwent several dental procedure imaging orthognathic surgery without wearing mask Seven HCWs closely exposed patient dental procedure could generated droplet aerosol One HCW close contact patient radiologic exam seven HCWs casual contact HCWs wore particulate filtering respirator 94 filter capacity glove none wore eye protection gown next day patient experienced dysgeusia diagnosed COVID19 high viral load HCWs close contact patient quarantined 14 day polymerase chain reaction antibody test SARSCoV2 negative exposure event suggests protective effect particulate filtering respirator dental clinic recommendation different level personal protective equipment PPE dental HCWs according procedure type established according planned procedure risk COVID19 infection patient outbreak situation community,covid-19;sars-cov-2;infection control dental clinic
Field Molecular Epidemiology Viral Sequencing Changed Transmission Inferences First Portuguese SARSCoV2 Infection Cluster,34200621,Field epidemiology viral sequencing provide comprehensive characterization transmission chain allow better identification superspreading event However example presented date COVID19 pandemic studied first COVID19 cluster detected Portugal 59 individual involved amongst extended family work environment following return four related individual work trip Italy first patient introduce virus would misidentified following traditional field inquiry alone shown viral sequencing isolates 23 individual result also pointed family work environment primary mode transmission,covid-19;epidemiological survey;family versus work environment;infection cluster;viral sequencing
Comprehensive Immunologic Evaluation Bronchoalveolar Lavage Samples Human Patients Moderate Severe Seasonal Influenza Severe COVID19,34348975,Infection severe acute respiratory syndrome coronavirus2 SARSCoV2 seasonal influenza may lead respiratory failure requiring intubation mechanical ventilation pathophysiology respiratory failure attributed local immune dysregulation immune response viral infection lower airway human lung differs individual respiratory failure without well understood used quantitative multiparameter flow cytometry multiplex cytokine assay evaluate matched blood bronchoalveolar lavage BAL sample control human subject subject symptomatic seasonal influenza respiratory failure subject severe seasonal influenza SARSCoV2 infection respiratory failure find severe case associated influx nonclassical monocyte activated cell plasmablast B cell lower airway Cytokine concentration elevated lower airway moderate influenza patient compared control however 28 35 measured cytokine significantly elevated severe influenza severe SARSCoV2 infection noted largest elevation IL6 IP10 MCP1 IL8 IL1 family cytokine RANTES higher severe influenza infection severe SARSCoV2 infection Interestingly concentration IP10correlated blood BAL severe infection result demonstrate inflammatory immune dysregulation lower airway severe viral pneumonia distinct lower airway response seen human patient symptomatic severe illness suggest measurement blood IP10 concentration may predict unique dysregulation,
Specialist confirmed allergic reaction COVID19 mRNA vaccine mass vaccination site,34217573,Healthcare provider play key role reaching target vaccine uptake educating public risk may severe allergic reaction COVID19 vaccine Thus important resolve report literature present conflicting data vaccine safety performed prospective study PfizerBioNTech vaccination administered Albany Community Vaccination Center potential vaccinee site screened allergic history prior triage boardcertified allergist first 14 day operation site vaccinated 14655 individual 39 personal history anaphylaxis vaccine recipient nonallergic complication none visitor suffered objective immediate allergic symptom finding indicate specialistconfirmed rate immediate allergic reaction mRNA SARSCoV2 vaccination far lower selfreported rate defined subjective unconfirmed symptom,covid-19;mass vaccination;pfizer;sars-cov-2
BType Natriuretic Peptides HighSensitive Troponin COVID19 Survival Factors One Best Performer,34205536,Increased concentration Btype natriuretic peptide BNP Nterminal proBtype natriuretic peptide NTproBNP highsensitivity troponin HsTnI COVID19 patient already reported aim study evaluate common marker cardiac disease useful predictor fatal outcome COVID19 patient One hundred seventyfour patient affected COVID19 recruited marker cardiac disease clinical history patient collected admission infectious disease unit intensive care unit NTproBNP BNP HsTnI value higher inhospital nonsurviving patient Receiver operating characteristic ROC curve analysis NTproBNP BNP HsTnI performed NTproBNP AUC = 0951 HsTnI AUC = 0947 better performer p = 001 BNP AUC = 0777 Logistic regression performed assessing relation HsTnI NTproBNP fatal outcome adjusting age gender NTproBNP significant population divided two group one higher NTproBNP value admission cutoff resulted ROC curve 511 ngL second one lower value KaplanMeier analysis showed absence fatal outcome group patient NTproBNP value lower cutoff p 0001 NTproBNP proved best prognostic tool fatal outcome among marker cardiac disease COVID19 patient,bnp;covid-19;nt-probnp;fatal outcome;prognostic markers;troponin
Modelling SARSCoV2 transmission UK university setting,34224948,Around 40 school leaver UK attend university individual university generally host thousand student academic year Bringing together student community COVID19 pandemic may require strong intervention control transmission Prior modelling analysis SARSCoV2 transmission within university using compartmental modelling approach suggest outbreak almost inevitable constructed networkbased model capture interaction student population different setting housing social study single academic term representative campusbased university ran susceptiblelatentinfectiousrecovered type epidemic process parameterised according available estimate SARSCoV2 investigated impact adherence effectiveness isolation test trace measure room isolation symptomatic student supplementary mass testing adhering test trace isolation measure found 22 7 41 student population could infected autumn term compared 69 56 76 assuming zero adherence measure Irrespective adherence isolation measure average higher proportion student resident oncampus became infected compared student resident offcampus Room isolation generated minimal benefit Regular mass testing together high adherence isolation test trace measure could substantially reduce proportion infected term compared testing finding suggest SARSCoV2 may readily transmit university setting limited adherence nonpharmaceutical intervention andor delay receiving test result Following isolation guidance effective contact tracing curbed transmission reduced expected time adhering student would spend isolation,covid-19;infectious disease model;mathematical epidemiology;sars-cov-2;universities
Predictors Clinical Outcomes Adult COVID19 Patients Admitted Tertiary Care Hospital India analytical crosssectional study,34212921,BACKGROUND outbreak ofsevere acute respiratory syndrome coronavirus 2 SARSCoV2 pandemic resulted inexponential rise number patient getting hospitalised corona virus disease 2019 COVID19 paucity data South East Asian Region related predictor clinical outcome patient formed basis conducting study METHODS analytical crosssectional study Demographic clinical radiological laboratory data 125 patient collected admission study outcome death discharge recovery univariate analysis unpaired ttest Chisquare Fisher s Exact test used Receiver operating characteristic ROC curve plotted Sequential Organ Failure Assessment SOFA score laboratory parameter Logistic regression applied multivariate analysis RESULTS Elderly age ischemic heart disease smoking significantly associated mortality Elevated level Ddimer lactate dehydrogenase LDH reduced lymphocyte count predictor mortality ROCs SOFA score curve showed cutoff value = 35 sensitivity 917 specificity 875 IL6 cutoff value = 379 sensitivity 96 specificity 78 lymphocyte count cut calculated le equal 146 x 109per litre sensitivity752 specificity 833 CONCLUSION Old age smoking history ischemic heart disease laboratory parameter including elevated Ddimer raised LDH low lymphocyte count baseline associated COVID19 mortality higher SOFA score admission poor prognosticator COVID19 patient,
Mathematical modeling dynamic analysis SIQR model delay pandemic COVID19,34198381,basis SIQR epidemic model consider impact treatment time epidemic situation present differential equation model timedelay according characteristic COVID19 Firstly analyze existence stability equilibrium modified COVID19 epidemic model Secondly analyze existence Hopf bifurcation derive normal form Hopf bifurcation using multiple time scale method determine direction Hopf bifurcation stability bifurcating periodic solution Finally carry numerical simulation verify correctness theoretical analysis actual parameter show conclusion associated critical treatment time effect epidemic treatment time, covid-19 model; hopf bifurcation; multiple time scales method; normal form; time-delay
Role Micronutrient Immunomodulation effect vaccine era COVID19,34282078,Different dietary nutrient distinct effect including enhancing immune response activity supporting mucous membrane integrity effect critical fighting pathogenic agent cover COVID19 coronavirus disease shuts globally Recent research shown micronutrient deficiency commonly associated compromised immune response respiratory tract infection even susceptibility COVID19 relationship Vit infection role mucosal epithelium integrity skin mucous membrane supplementation could option assistedtreating SARSCoV2 virus possible prevention lung infection Vit Cascorbic acid stimulates oxygen radical scavenging activity skin enhances epithelial barrier function Ascorbic acid alone natural compound baicalin theafalvin may inhibit expression angiotensin converting enzyme II human small alveolar epithelial cell limited entry SARSCoV2 Vitamin receptor VDRs expressed immune cell different immune cell macrophage monocyte dendritic cell cell B cell convert Vit active form 125 OH 2 D Oral vitamin intake readily way restrict viral infection regulation ACE2 receptor attenuate disease severity decreasing frequency cytokine storm pulmonary proinflammatory response Vit E support Tcell mediated function optimization Th1 response suppression Th2 response Vitamin E supplementation lower production superoxide may favor antioxidant benefit progress COVID19 treatment Zinc play essential role innate adaptive immune system cytokine production Zincdependent viral enzyme initiate infectious process proved Zinc level directly associated symptom relieved COVID19 Iron essential component enzyme involved activation immune cell lower iron level predispose severe symptom SARSCoV2 monitoring status predict disease severity mortality Selenium participates adaptive immune response supporting antibody production development Deficiency reduce antibody concentration decreased cytotoxicity NK cell compromised cellular immunity attenuated response vaccination COVID19 vaccine including three broad category proteinbase vaccine genebased vaccine mRNA vaccine DNA vaccine combination gene proteinbased vaccine Micronutrients involved immunity virus entering human innate immune response adaptive immune response Micronutrients indispensable immune response vaccination,
Absence Antibody Reponses Severe COVID19 Patients Hemodialysis Following mRNA Vaccination,34377727,Inpatient dialysis patient isolate resulting higher rate coronavirus disease 2019 COVID19 infection increased severity higher mortality rate 1 present 2 African American dialysis patient developed severe COVID19 infection vaccination patient mounted antibody response COVID19 vaccine hepatitis B vaccination,covid-19;esrd;hepatitis b;infection after covid vaccination;nonrespondents;vaccination
preventive measure adequate evaluation implementation COVID19 prevention control measure nursing home China,34217292,BACKGROUND novel coronavirus disease 2019 COVID19 pandemic become challenge nursing home China Nursing home particularly dangerous place term spread COVID19 given house vulnerable highrisk population several useful guideline coping COVID19 nursing home provided However actual implementation rate guideline unknown study aim document adherence nursing home Ministry Civil Affairs guideline COVID19 prevention control nursing home METHODS crosssectional study conducted among 484 nursing home 136 city 28 province China selfreport questionnaire created based Ministry Civil Affairs guideline COVID19 prevention control nursing home first edition questionnaire Transformational Leadership Public Sector Scale sent nursing home manager via Wenjuanxing app online February 7 29 2020 Ultimately 461 960 nursing home participated response rate 480 RESULTS average overall implementation rate COVID19 prevention control measure 800 14397180 average implementation rate hygienic behaviour management access management lower 753 787 respectively Number medical staff transformational leadership score nursing home s manager associated total implementation score p 005 total 698 322461 nursing home manager serious resource problem inadequate protective supply 720 staff shortage 477 two primary problem nursing home located urban large nursing home size hospitalnursing home cooperation transformational leadership score manager 60 lower risk serious resource problem CONCLUSIONS Overall implementation prevention control measure nursing home insufficient epidemic China medical staff adequate resource cooperation hospital higher transformational leadership manager required improve implementation rate urgent nursing home maintain safety resident staff,covid-2019;evaluation;implementation;nursing homes;prevention and control;prevention resource;transformational leadership
Vitamin supplementation COVID19 treatment systematic review metaanalysis,34217144,BACKGROUND VitaminD immunemodulator might linked disease severity SARSCoV2 METHODS Metaanalysis RCTs quasiexperimental study evaluating role vitaminD supplementation COVID patient done RESULTS Total 5 study 3 RCTs 2 Quasiexperimental including n = 467 patient included Vitamin nt reduce mortality RR 055 95 CI 022 139 p = 021 ICU admission rate RR 020 95 CI 001426 p = 03 need invasive ventilation RR 024 95 CI 001789 p = 042 CONCLUSION significant difference vitaminD supplementation major health related outcome COVID19 Welldesigned RCTs required addressing topic,covid pneumonia;covid-19;sars-cov-2;vitamin-d
Covid19 pandemic concomitant benefit improved hygiene habit,34218279,editorial editor explored state response pandemic collateral damage public health general also economy education Ironically also show adjustment adaptation people behavior resulted improved habit personal hygiene selfcare bad though people learned basic value handwashing preventive measure avoid disease spread germ long run going beneficial prevent repeat pandemic magnitude,hand hygiene compliance;hand washing;self-care
Identifying factor nurse consider decisionmaking process related patient care COVID19 pandemic,34214122,BACKGROUND Nurse identification patient deterioration critical particularly COVID19 pandemic patient deteriorate quickly literature shown nurse rely intuition make decision limited information source data experienced nurse utilize inform intuition objective study identify source data inform nurse decisionmaking related recognition deteriorating patient explore COVID19 impacted nurse decisionmaking METHODS qualitative study experienced nurse voluntarily participated focused interview focused interview expert nurse asked share description memorable patient encounter question posed facilitate reflection thought action hindered helped decisionmaking also asked consider impact COVID19 nursing decisionmaking Interviews transcribed verbatim study team member reviewed transcript coded response organized key finding theme RESULTS Several theme related decisionmaking identified research team including identifying patient care need workload management reflecting missed care opportunity inform learning Participants n = 10 also indicated COVID19 presented number unique barrier nurse decisionmaking CONCLUSIONS Findings study indicate experienced nurse utilize several source information inform intuition apparent demand nurse response pandemic heightened Decisionmaking theme drawn participant experience assist nurse educator training nursing student decisionmaking deteriorating patient manage potential barrier eg resource constraint lack family associated caring patient challenging time prior encountering issue clinical environment Nurse practice utilize finding increase awareness among experienced nurse recognizing pandemic situation impact decisionmaking capability,
Impact SARSCoV2 Ocular Surface Pathology Treatment Practices Review,34377601,Purpose Review ocular surface potential site ocular involvement SARSCoV2 infection performed review literature understand pathogenesis SARSCoV2 disease manifestation ocular surface well elucidate emerging treatment pattern practice change COVID19 pandemic Recent Findings ocular manifestation SARSCoV2 likely limited mild transient conjunctivitis manifestation validated larger cohort Ocular surface tissue considered potentially infectious due presence host receptor surface tissue availability donor tissue lowermiddle income country greatly impacted pandemic would benefit investigation transmissibility donor tissue Summary Transmission SARSCoV2 ocular surface yet confirmed common ocular manifestation mild conjunctivitis Ocular surface surgeon face specific challenge use donor tissue aerosolizing procedure adapted practice pattern accordingly,covid-19 eye;covid-19 ocular surface;ocular surface pathology covid-19;sars-cov-2 ocular surface
Strategies Improve Antimicrobial Utilization Special Focus Developing Countries,34200116,Antimicrobial resistance AMR high priority across country increase morbidity mortality cost Concerns AMR resulted multiple initiative internationally nationally regionally enhance appropriate antibiotic utilization across sector reduce AMR overuse antibiotic exacerbated COVID19 pandemic Effectively tackling AMR crucial country Principally narrative review ongoing activity across sector undertaken improve antimicrobial use address issue vaccine including COVID19 Point prevalence survey successful hospital identify area quality improvement program principally centering antimicrobial stewardship program include reducing prolonged antibiotic use prevent surgical site infection Multiple activity centering education successful reducing inappropriate prescribing dispensing antimicrobial ambulatory care essentially viral infection acute respiratory infection imperative develop new quality indicator ambulatory care given current concern instigate program clear public health messaging reduce misinformation essential pandemic Regular access effective treatment needed reduce resistance treatment HIV malaria tuberculosis Key stakeholder group instigate multiple initiative reduce AMR need followed,covid-19;antimicrobial resistance;antimicrobial stewardship programs;antimicrobials;healthcare-associated infections;lower- and middle-income countries;misinformation;patient initiatives;surgical site infections;vaccines
Images denoising COVID19 chest Xray based multiresolution parallel residual CNN,34219975,Chest Xray CXR medical imaging technology common economical use clinical Recently coronavirus COVID19 spread worldwide second wave rebounding strongly coming winter detrimental effect global economy health make prediagnosis COVID19 soon possible reduce work pressure medical staff making use deep learning network detect positive CXR image infected patient critical step However complex edge structure rich texture detail CXR image susceptible noise interfere diagnosis machine doctor Therefore paper proposed novel multiresolution parallel residual CNN named MPRCNN CXR image denoising special application COVID19 improve image quality core MPRCNN consists several essential module Multiresolution parallel convolution stream utilized extracting reliable spatial semantic information multiscale feature b Efficient channel spatial attention let network focus texture detail CXR image fewer parameter c adaptive multiresolution feature fusion method based attention utilized improve expression network whole MPRCNN simultaneously retain spatial information shallow layer high resolution semantic information deep layer low resolution Comprehensive experiment demonstrate MPRCNN better retain texture structure detail CXR image Additionally extensive experiment show MPRCNN positive impact CXR image classification detection COVID19 case denoised CXR image,covid-19;cxr images denoising;multi-resolution;residual cnn
COVID19 Endocrine System Comprehensive Review Theme,34209964,BACKGROUND AIM review aimed summarize advance topic endocrine disease coronavirus disease 2019 COVID19 METHODS Scientific institutional website database searched data collected organized plausible angle discussion toward following clinical issue 1 patient COVID19 higher risk developing acute lateonset endocrine disease dysfunction 2 May underlying endocrine disease dysfunction considered risk factor poor prognosis infection occurred 3 defined strategy manage endocrine disease despite pandemicrelated constraint Herein author considered relevant frequently observed endocrine disease disorder related hypothalamicpituitary region thyroid parathyroid gland calciumphosphorus homeostasis osteoporosis adrenal gland gonad Main Data highlight basis pathophysiological mechanism anatomical alteration Severe Acute Respiratory Syndrome Coronavirus 2 SARSCoV2 induced endocrine dysfunction condition adrenal insufficiency cortisol excess may risk factor worse clinical progression infection occurred atrisk population may require adequate education avoid SARSCoV2 infection adequately manage medical therapy pandemic even emergency Endocrine disease management underwent palpable restraint especially procedure requiring obligate access healthcare facility diagnostic therapeutic purpose Strategies clinical triage prioritize medical consultation laboratory instrumental evaluation digital telehealth solution implemented better deal probably longterm situation,addison disease;covid-19;cushing syndrome;sars-cov-2;adrenal gland;hypercalcemia;osteoporosis;parathyroid;pituitary;review;thyroid;vitamin d
Hybrid harmony search algorithm social network contact tracing COVID19,34220301,coronavirus disease 2019 COVID19 first reported December 2019 Wuhan China moved almost every country showing unprecedented outbreak world health organization declared COVID19 pandemic Since million people infected million lost life around globe end 2020 effective vaccine could prevent fast spread disease started loom horizon Nevertheless isolation social distancing face mask quarantine bestknown measure time fight pandemic hand contact tracing effective procedure tracking infection saving others life paper devise new approach using hybrid harmony search HHS algorithm cast problem finding strongly connected component SCCs contact tracing new approach named hybrid harmony search contact tracing HHSCT algorithm hybridization achieved integrating stochastic hill climbing operator design harmony search algorithm HHSCT algorithm compared existing algorithm finding SCCs directed graph showed superiority algorithm devised approach provides 7718 enhancement term run time exceptional average error rate 17 compared existing algorithm finding SCCs,covid-19;contact tracing;coronavirus;harmony search algorithm;hill climbing;metaheuristic approach;social networks
Bad Prognosis Critical Ill Patients COVID19 ShortTerm ICU Stay regarding Vitamin Levels,34207873,BACKGROUND AIMS Vitamin inadequacy may involved mechanism SARSCoV2 infection potential risk factor disease propagation control coronavirus disease 2019 COVID19 study assessed shortterm evolution vitamin status influence upon different clinical parameter critically ill patient COVID19 METHODS prospective analytical study 37 critically ill volunteer 41 71 year age COVID19 evaluated baseline three day intensive care unit ICU stay 25OHD3 25OHD2 analyzed liquid chromatographytandem mass spectrometry total 25OHD level calculated sum RESULTS patient presented low 25OHD level baseline decreasing total 25OHD p = 0011 mainly 25OHD2 p = 0006 level ICU stay 25OHD2 level decreased mean 416 + 896 versus 70 + 234 25OHD3 form ICU stay Patients need invasive mechanical ventilation presented higher level 25OHD2 baseline followup Lower 25OHD 25OHD3 level associated higher Ddimer baseline p = 0003 p = 0001 follow p = 0029 higher procalcitonin level p = 0002 p = 0018 follow lower percentage lymphocyte count p = 0044 p = 0040 ICU stay CONCLUSIONS Deficient vitamin status critical patient established admission worsened three day stay Lower vitamin level related key altered clinical biochemical parameter patient SARSCoV2 infection Given different response 25OHD3 25OHD2 form would useful monitor evolution critically ill patient,sars-cov-2;vitamin d;coronavirus disease 2019;critical care;intensive care patient
Carboxyhemoglobinemia Critically Ill Coronavirus Disease 2019 Patients,34205655,Carboxyhemoglobinemia common serious disorder defined increase carboxyhemoglobin level Unfortunately data carboxyhemoglobinemia coronavirus disease 2019 COVID19 patient Therefore study aimed evaluate incidence etiology carboxyhemoglobinemia COVID19 patient determine association carboxyhemoglobinemia novel coronavirus infection retrospective chart review performed academic medical center inpatient COVID19 case either single serial carboxyhemoglobin COHb level March 2020 August 2020Our study demonstrates carboxyhemoglobinemia COVID19 patient due sepsis hemolysis cytokine storm triggered novel coronavirus infection sequela directly virulence novel coronavirus Given coexisting illness critically ill COVID19 patient impossible establish coronavirus virulence culprit elevated COHb level Moreover study found high incidence carboxyhemoglobinemia critically ill COVID19 patient oxygen saturation measured pulse oximetry inaccurate unreliable however study could demonstrate uniform result discrepancy oxygen saturation measured pulse oximetry arterial blood gas study COHb level measured using COoximeter Therefore recommend monitoring COHb level routinely critically ill COVID19 patient allow effective prompt treatment,carbon monoxide;carboxyhemoglobinemia;coronavirus disease 2019;elevated carboxyhemoglobin;etiology;incidence
Comprehensive OGlycosylation Analysis SARSCoV2 Spike Protein Biomimetic TrpArg Materials,34284575,COVID19 pandemic caused severe acute respiratory syndrome coronavirus2 SARSCoV2 serious public health threat vaccine SARSCoV2 target highly glycosylated spike protein good knowledge glycosylation profile protein key successful vaccine development Unlike 22 confirmed Nglycosylation site SARSCoV2 Oglycosylation site protein reported difference mainly ascribed extremely low stoichiometry Oglycosylation Herein designed biomimetic material TrpArg WR monomergrafted silica microspheres designated WRSiO2 biomimetic material enrich N Olinked glycopeptides high selectivity WRSiO2 resist nonglycopeptides interference 100 molar fold BSA Olinked glycopeptide enrichment utilized WRSiO2 comprehensively analyze Oglycosylation profile recombinant SARSCoV2 S Twentyseven Oglycosylation site including 18 unambiguous site identified SARSCoV2 S study demonstrates biomimetic polymer offer specific selectivity Olinked glycopeptides pave way Oglycosylation research biological field Oglycosylation profile SARSCoV2 might supplement comprehensive glycosylation addition Nglycosylation SARSCoV2,
Plausibility third wave COVID19 India mathematical modelling based analysis,34213435,Background objective context India s ongoing resurgence COVID19 second wave since midFebruary 2021 following subsiding first wave September 2020 increasing speculation possibility future third wave infection posing burden healthcare system Using simple mathematical model transmission dynamic SARSCoV2 study examined condition serious third wave could occur Methods Using deterministic compartmental model SARSCoV2 transmission four potential mechanism third wave examined waning immunity restores previously exposed individual susceptible state ii emergence new viral variant capable escaping immunity previously circulating strain iii emergence new viral variant transmissible previously circulating strain iv release current lockdown affording fresh opportunity transmission Results Immunemediated mechanism waning immunity viral evolution immune escape unlikely drive severe third wave acting unless mechanism lead complete loss protection among previously exposed Likewise new transmissible variant would exceed high threshold R0 45 cause third wave However plausible mechanism third wave include new variant transmissible time capable escaping prior immunity ii lockdown highly effective limiting transmission subsequently released case third wave seems unlikely severe second wave Rapid scaleup vaccination effort could play important role mitigating future wave disease Interpretation conclusion study demonstrates plausible mechanism substantial third wave could occur also illustrating unlikely resurgence large second wave Model projection however subject several uncertainty remains important scale vaccination coverage mitigate eventuality Preparedness planning potential future wave benefit drawing upon projected number based present modelling exercise,covid-19 - mathematical modelling -;sars-cov-2 - third wave - transmission - variant;resurgence -
Clinical characteristic decision tree model predict death outcome severe COVID19 patient,34372767,BACKGROUND novel coronavirus disease 2019 COVID19 spread rapidly among people cause pandemic great clinical significance identify COVID19 patient high risk death METHODS total 2169 adult COVID19 patient enrolled Wuhan China February 10th April 15th 2020 Difference analysis medical record performed severe nonsevere group well survivor nonsurvivors addition developed decision tree model predict death outcome severe patient RESULTS 2169 COVID19 patient median age 61 year male patient accounted 48 total 646 patient diagnosed severe illness 75 patient died older median age higher proportion male patient found severe group nonsurvivors compared counterpart Significant difference clinical characteristic laboratory examination found severe nonsevere group well survivor nonsurvivors decision tree including three biomarkers neutrophiltolymphocyte ratio Creactive protein lactic dehydrogenase developed predict death outcome severe patient model performed well training test datasets accuracy model 098 datasets CONCLUSION performed comprehensive analysis COVID19 patient outbreak Wuhan China proposed simple clinically operable decision tree help clinician rapidly identify COVID19 patient high risk death priority treatment intensive care given,c-reactive protein;covid-19;decision tree;lactic dehydrogenase;neutrophil-to-lymphocyte ratio
introduction mandatory mask policy associated significantly reduced COVID19 case major metropolitan city,34288910,BACKGROUND Whilst evidence use face mask reducing COVID19 case increasing impact mandatory use across large population difficult ass Introduction mandatory mask use July 22 2020 resurgence COVID19 Melbourne Australia created situation facilitated assessment impact policy epidemic growth rate introduction occurred absence change restriction METHODS FINDINGS Exponential epidemic growth decay rate daily COVID19 diagnosis estimated using nonweighted linear regression natural logarithm daily case time using linear spline model one knot lspline package R v 363 model s two linear segment pivot around hinge day mask policy began take effect 8 day following introduction policy used two form data ass change mask usage image people wearing mask public place obtained major medium outlet populationbased survey data Potential confounding factor including daily COVID19 test number COVID19 case among population subset affected differentially mask policyeg healthcare worker examined impact result Daily case fitted exponential growth first loglinear segment k = +0042 se = 0007 fitted exponential decay second k = 0023 se = 0017 loglinear segment range reported serial interval SARSCoV2 infection growth rate correspond 2233 reduction effective reproduction ratio mandatory mask use Analysis image people public space showed mask usage rose approximately 43 97 Analysis survey data found third day policy introduction 44 participant reported `` often `` always wearing mask fourth day 100 reported `` always potentially confounding factor associated observed change growth rate CONCLUSIONS mandatory mask use policy substantially increased public use mask associated significant decline new COVID19 case introduction policy study strongly support use mask controlling epidemic broader community,
Impact COVID19 cervical cancer screening Challenges opportunity improving resilience reduce disparity,34217415,COVID19 pandemic major impact wide range health outcome Disruptions elective health service related cervical screening management abnormal screening test result treatment precancers may lead increase cervical cancer incidence exacerbate existing health disparity Modeling study suggest short delay cervical screening subject previously negative HPV result minor effect cancer outcome delay management treatment lead larger increase cervical cancer Several approach mitigate effect disruption cervical screening management HPVbased screening higher accuracy compared cytology negative HPV result provides longer reassurance cervical cancer HPV testing conducted selfcollected specimen Selfcollection expands reach screening underserved population currently participate screening Selfcollection also provide alternative screening approach pandemic testing supported telehealth specimen collected home substantially reducing patientprovider contact risk COVID19 exposure also expanding reach catchup service address backlog screening test accumulated pandemic Riskbased management allows prioritizing management patient highest risk cervical cancer extending screening interval lowest risk pandemic provides important lesson make cervical screening resilient disruption reduce cervical cancer disparity may exacerbated due disruption health service,covid-19;cervical cancer;cervical precancer;hpv;health disparities;pandemic;sars-cov-2;screening
Sepsis patient hospitalized coronavirus disease 2019 often severe,34292175,PURPOSE REVIEW discus severe COVID19 considered sepsis coinfection secondary infection aggravate condition perpetuate organ dysfunction leading high mortality rate RECENT FINDINGS severe COVID19 direct viral toxicity dysregulated host response infection Although coinfection andor secondary infection present latest greater concern mainly resourcepoor setting Patients severe COVID19 present phenotype multiorgan dysfunction lead death unacceptable high percentage patient wide variability around world Similarly endemic sepsis mortality COVID19 critically ill patient higher lowincome middleincome country compared highincome country Disparities including hospital strain resource limitation higher incidence healthcareassociated infection HAI staffing issue could part explain variability SUMMARY high mortality rate critically ill patient severe COVID19 disease related severity patient disease also modifiable factor ICU strain HAI incidence organizational aspect Therefore HAI prevention delivery best evidencebased care patient avoid additional damage important Quality improvement intervention might help improving outcome mainly resourcelimited setting,
Acquired thrombotic thrombocytopenic purpura possible association AstraZenecaOxford COVID19 vaccine,34226899,Acquired thrombotic thrombocytopenic purpura characterized microvascular aggregation platelet microangiopathic hemolytic anemia causing ischemia multiple organ including brain mainly le likely kidney heart disease caused severe reduction activity ADAMTS 13 due presence inhibitory antibody,ttp;covid-19;thrombocytopenia;vaccines
Predictive Value Comorbid Conditions COVID19 Mortality,34208640,paper aim understanding broad spectrum factor influencing survival infected patient correlation factor create predictive probabilistic score surviving COVID19 disease Initially 510 hospital admission counted study 310 patient survive prediction model developed based data using Bayesian approach Following data collection process development study second cohort patient totaling 541 built validate risk matrix previously created final model area curve 0773 predicts mortality risk SARSCoV2 infection based nine disease group considering gender age patient distinct risk group ease medical worker assessment patient created visual risk matrix based probabilistic model ranging score 1 low mortality risk 5 high mortality risk score comprises correlation existing comorbid condition number comorbid condition gender age group category clinical model generalized hospital context used identify patient high risk immediate intervention might required,covid-19;sars-cov-2;mortality risk;prediction model
Evaluation Immune Response Disease Status SLE Patients Following SARSCoV2 Vaccination,34347939,OBJECTIVE evaluate seroreactivity disease flare COVID19 vaccination multiethnicracial cohort patient systemic lupus erythematosus SLE METHODS 90 SLE patient 20 healthy control receiving complete COVID19 vaccine regimen included IgG seroreactivity SARSCoV2 spike receptorbinding domain RBD SARSCoV2 microneutralization used evaluate B cell response IFNgamma production ass cell response measured ELISpot Disease activity measured hybrid SLE disease activity index SLEDAI flare assigned SELENASLEDAI flare index RESULTS Overall fully vaccinated SLE patient produced significantly lower IgG antibody SARSCoV2 spike RBD control Twentysix SLE patient 288 generated IgG response lowest control 100 unitsml logistic regression analysis use immunosuppressant prednisone normal antidsDNA level prior vaccination associated decreased vaccine response IgG seroreactivity SARSCoV2 Spike RBD strongly correlated SARSCoV2 microneutralization titer antigenspecific IFNgamma production determined ELISpot subset patient poor antibody response IFNgamma production likewise diminished Prepostvaccination SLEDAI score similar 114 patient postvaccination flare 13 severe CONCLUSION multiethnicracial study SLE patient 29 low response COVID19 vaccine associated immunosuppression Reassuringly disease flare rare minimal protective level remain unknown data suggest protocol development needed ass efficacy booster vaccination,covid-19;immunosuppressants;seroreactivity;systemic lupus erythematosus;vaccination
Specific Treatment Exists SARSCoV2 ARDS,34200720,COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 seems difficult overcome pandemic scale seen since 1918 influenza pandemic Although predominant clinical presentation respiratory disease neurological manifestation sequela increasingly recognized observed case series rapid recovery ARDS within 24 h preliminary clinical feature COVID19 ARDSassociated neurological disease also noted 15 April 2021 SARSCoV2 ARDS Sorok Island South Korea leper living together compared dapsone s effect human considered SARSCoV2 Dapsone showed different effect brain Sorokdo National Hospital reported relationship dapsone neuroinflammasome Alzheimer s disease AD Sorok Island January 2005 June 2020 AD prevalence low leprosy patient group took dapsone regularly preliminary crosssectional study trial group 22 subject control group 22 subject Hunt Regional Hospital reported following result chisquare statistic 51836 pvalue 0022801 result considered significant p 005 result medical treatment 21 December 29 December 2020 considered mortality rate ARDS onset stage 0 dapsone administered standard COVID19 treatment 40 without dapsone administered standard COVID19 treatment respectively Based respiratory failure sudden high death rate originating involvement brainstem especially preBotzinger complex dapsone used significantly reduce incidence case acute respiratory distress syndrome illness caused SARSCoV2,brainstem;inflammasome;oral dna vaccine
Seroprevalence SARSCoV2 Symptom Profiles SeroNeutralization Suburban Area France,34200070,World Health Organisation recommends monitoring circulation severe acute respiratory syndrome coronavirus 2 SARSCoV2 investigated antiSARSCoV2 total immunoglobulin IgT antibody seroprevalence vitro seroneutralization Nancy France spring 2020 Individuals randomly sampled electoral list invited household member 5 year old tested antiSARSCoV2 IgT ie IgAIgGIgM antibody ELISA Biorad seroneutralization activity evaluated Vero CCL81 cell Among 2006 individual raw seroprevalence 21 95 confidence interval 15 29 highest 20 34yearold participant 47 23 84 within socially deprived area 25 vs 1 p = 002 without intrafamily infection p 10 6 Moreover 25 participant presented least one COVID19 symptom associated SARSCoV2 positivity p 10 13 highly discriminant anosmia ageusia odds ratio 278 139 545 163 68 307 seropositive individual asymptomatic Positive seroneutralization demonstrated vitro 3143 seropositive subject Regarding low seroprevalence preventive effect lockdown March 2020 assumed summer second COVID19 wave expected could subsequently observed poorly immunized population,covid-19;precariousness;seroprevalence;symptoms profile
Severe acquired haemophilia associated asymptomatic SARSCoV2 infection,34285024,65yearold man presented symptom severe subcutaneous bleeding arm led compartment syndrome requiring fasciotomy massive blood transfusion protocol Medical history significant history autoimmune thyroid disease Workup revealed elevated partial thromboplastin time decreased factor VIII level elevated factor VIII inhibitor level worked cause acquired haemophilia found elevated SARSCoV2 antibody level Given negative workup secondary aetiology suspect cause haemophilia SARSCoV2 infection observed previously various case report,covid-19;haematology (drugs and medicines)
Impact COVID19 Lockdown Weight Loss Body Composition Subjects Overweight Obesity Participating Nationwide WeightLoss Program Impact Remote Consultation FollowUpThe CORNPC Study,34201490,aim study ass impact nationwide total lockdown LD France weight loss body composition modification subject participating weight loss program evaluate impact remote consultation participant adherence weight loss program CORNPC study prospective multicentre cohort study including participant undergoing two six month program rate weight loss kgweek computed 15 day 99 day LD 15 day 1550 completing participant body weight decreased 871 kg IQR 770 1002 823 kg 721 943 resulting difference 479 kg 448 510 p 001 corresponding reduction waist circumference 4 cm 0 9 p 001 median weight loss 44 kg 05 94 used remote consultation 14 kg 08 57 remote consultation group p 001 large prospective cohort observed rate weight loss reduced LD reduction counterbalanced participant involved remote consultation followup doseeffect response based number remote consultation,"covid-19 pandemic;total lockdown;weight loss program, remote consultations"
Social Workers Knowledge Ability Crisis Intervention Kuwait Case COVID19,34214015,Summary main purpose current study ass whether significant difference among variable social worker familiarity crisis intervention model receiving uptodate information latest development COVID19 adequate information symptom COVID19 willingness work COVID19 patient social worker ability apply crisis intervention model working client three subscales assessing identifying problem establishing relationship formulating action plan crosssectional survey method used conduct sample study sample N = 274 used study consisted social worker KuwaitFindings result showed CIS valid reliable trusted measure level according purpose study Analysis using Ttest showed significant relationship CIS study s variable p 05Application study would help raise knowledge awareness ability social worker apply crisis intervention model COVID19 pandemic working client variable may associated,crisis intervention;health;social work;social worker;social worker practice
Rapid Inactivation SARSCoV2 Variants Continuous Intermittent Irradiation DeepUltraviolet LightEmitting Diode DUVLED Device,34203643,1 year passed since social activity restricted due spread severe acute respiratory syndrome coronavirus 2 SARSCoV2 recently novel SARSCoV2 variant spreading around world growing concern may higher transmissibility protective efficacy vaccine may weaker Immediate measure needed reduce human exposure virus study antiviral efficacy deepultraviolet lightemitting diode DUVLED irradiation 280 + 5 nm 375 mWcm 2 three SARSCoV2 variant evaluated B117 B1351 P1 variant strain irradiation virus stock 1 resulted infectious titer reduction rate 963 946 919 respectively irradiation 5 rate increased 999 999 998 respectively also tested effect pulsed DUVLED irradiation 75 mWcm 2 duty rate 50 frequency 1 kHz output condition continuous irradiation found antiviral efficacy pulsed continuous irradiation finding suggest developing optimizing DUVLED device increase output may possible instantly inactivate SARSCoV2 DUVLED irradiation,covid-19;sars-cov-2;uv-led;variants;viral inactivation
Use face mask blood donor COVID19 pandemic Impact donor hemoglobin concentration bane boon,34217601,BACKGROUND COVID19 virus caused world s deadliest pandemic Early April 2020 Delhi Government made compulsory people wear face mask going outdoors curb disease spread Prolonged use surgical mask pandemic reported cause many adverse effect Intermittent hypoxia shown activate erythropoietin EPO leading increased hemoglobin mass AIM analyze whether face mask induced intermittent hypoxia effect hemoglobin level healthy blood donor MATERIALS METHODS retrospectively analyzed donor data 1st July 201931st December 2020 hemoglobin distribution across hemoglobin range donor deferral basis hemoglobin Study population divided two cohort Group 1 1st July 201931 st March 2020 implementation mandatory face mask Group 2 1st April 202031 st December 2020 implementation mandatory face mask RESULTS Mean Hb blood donor Group 2 1501 + 11 gdl higher Group1 1449 + 115 gdl p 00001 471 group2 donor Hb 16118 gdl compared group1 384 529 group 2 donor Hb 12515 gdl compared 616 Group 1 p 005 Deferral due anemia lesser group 2 compared group 1 p 000001 Group 2 significantly higher deferral due high Hb 18 gmdl Group 1 p = 00039 CONCLUSION study including 19504 blood donor spanning one half year show prolonged use face mask blood donor may lead intermittent hypoxia consequent increase hemoglobin mass,covid-19;donor hemoglobin;erythropoietin;face mask;intermittent hypoxia;prolonged use
Risk factor infection mortality among hemodialysis patient COVID19 pandemic,34227016,PURPOSE aim study evaluate risk factor COVID19 infection mortality document relation exists 25 OH Vitamin COVID19 infection METHODS retrospective study evaluated 151 HD patient Patients infected COVID19 compared patient without infection Risk factor intensive care unit ICU stay mortality analyzed Deceased infected patient also compared patient died due cause RESULTS mean age HD patient 5715 + 1573 year 517 male mean 25 OH Vitamin level patient 1648 + 845 ngml Thirtyfive infected patient significantly older higher Charlson comorbidity index CCI score also higher number patient diabetic nephropathy cerebrovascular accident CVA coronary heart disease CHD Patients needed stay ICU higher CCI score higher number patient diabetic nephropathy pulmonary disease statistically significantly higher CRP level Deceased infected patient significantly older higher CCI score lower PTH survived infected patient Deceased infected patient lower PTH significantly lower leukocyte lymphocyte count urea level admission compared patient died due cause Patients poor prognosis lower neutrophil lymphocyte count infection admission respectively 25 OH Vitamin level related risk COVID19 infection ICU stay mortality CONCLUSION Older age higher CCI score diabetic nephropathy CHD CVA pulmonary disease lower neutrophil lymphocyte count found poor prognostic factor comparison yielded significant finding 25 OH Vitamin acetylsalicylic acid erythropoietin intravenous iron ACEI ARBs dialysis adequacy parameter,covid-19;hemodialysis;mortality;vitamin d
GuillainBarre syndrome 15 day COVID19 despite SARSCoV2 vaccination,34290962,GuillainBarre syndrome GBS following SARSCoV2 vaccination repeatedly observed GBS following SARSCoV2 infection vaccinated patient reported 69yo female developed paresthesia lower upper limb followed progressive muscle weakness history positive mild SARSCoV2 infection 15 day earlier COVID19 occurred despite first dose vectorbased SARSCoV2 vaccine 40 day prior onset GBS Since CSF investigation nerve conduction study indicative GBS subtype acute inflammatory demyelinating polyneuropathy AIDP immunoglobulin 30 gd started two week complete recovery achieved conclusion SARSCoV2 infection may develop despite full vaccination may complicated GBS Since trigger GBS could identified causal relation SARSCoV2 infection GBS suspected,adverse reaction;covid-19;polyradiculitis;sars-cov-2;side effect;vaccination
Isolation Containment Perceived Fear Infectivity Protective Behavioral Changes COVID19 Vaccination Campaign,34208729,ongoing COVID19 pandemic maintenance protective behavior continued challenge effort contain spread virus crosssectional study via internet questionnaire utilized elucidate change compliance protective behavior among Israeli population n = 1120 beginning vaccination campaign Comparison made individual previously infected virus received one dose inoculation vaccine individual neither infected vaccinated study result indicate previously infected COVID19 virus le careful mask wearing 188 social distancing 297 compared examined group regarding mask wearing 82 116 respectively regard social distancing 128 192 may require targeted risk communication campaign address population Furthermore study revealed nonJewish compared Jewish study counterpart older 19+ vigilant protective behavior 296 vs 112 respectively social distancing 296 vs 111 respectively mask wearing Despite successful initial vaccination campaign Israel public health official need engage member public unremittingly observe compliance directed health guideline ensure result previous governmental effort fighting pandemic lockdown effectively sustained road containment hastened,covid-19;infectivity;pandemic;practices;protective behavior;vaccinations
Dynamics SARSCoV2 Spike Proteins Cell Entry Control Elements AminoTerminal Domains,34340537,Selective pressure drive adaptive change coronavirus spike protein directing viruscell entry change concentrated aminoterminal domain NTDs receptorbinding domain RBDs complex modular spike protein trimer impact hypervariability virus entry often unclear particularly respect sarbecovirus NTD variation Therefore constructed indels substitution within hypervariable NTD region used severe acute respiratory syndrome coronavirus 2 SARSCoV2 viruslike particle quantitative viruscell entry assay elucidate spike structure controlling initial infection stage identified NTD variation increased SARSCoV2 spike proteinmediated membrane fusion cell entry Increased cell entry correlated greater presentation RBDs ACE2 receptor revealed significant allosteric effect change within NTDs orient RBDs effective viruscell binding Yet NTD change elevating receptor binding membrane fusion also reduced interdomain association leaving spike viruslike particle susceptible irreversible inactivation finding parallel obtained decade ago comparison murine coronavirus spike protein variant established inverse relationship membrane fusion potential virus stability Considerable hypervariability SARSCoV2 spike protein NTDs also appear driven counterbalancing pressure effective viruscell entry durable extracellular virus infectivity force may selectively amplify SARSCoV2 variant concern IMPORTANCE Adaptive change increase SARSCoV2 transmissibility may expand prolong coronavirus disease 2019 COVID19 pandemic Transmission requires metastable dynamic spike protein bind virus cell catalyze viruscell membrane fusion Using newly developed assay reflecting two essential step viruscell entry focused adaptive change SARSCoV2 spike protein found deletion aminoterminal domain reset spike protein metastability rendering virus le stable yet poised respond cellular factor prompt entry subsequent infection result identify adjustable control feature balance extracellular virus stability facile virus dynamic cell entry equilibrating element warrant attention monitoring evolution pandemic coronaviruses,sars-cov-2;coronavirus;coronavirus spike protein;membrane fusion;virus entry;virus receptors
Remdesivir Versus StandardofCare Severe Coronavirus Disease 2019 Infection Analysis 28Day Mortality,34282406,Background Remdesivir approved US Food Drug Administration treatment patient hospitalized coronavirus disease 2019 COVID19 shown shorten time recovery improve clinical outcome randomized trial Methods final day 28 comparative analysis data phase 3 randomized openlabel study comparing 2 remdesivir regimen 5 v 10 day combined analysis remdesivir cohort realworld retrospective longitudinal cohort study patient receiving standardofcare treatment nonremdesivir cohort Eligible patient aged =18 year confirmed severe acute respiratory syndrome coronavirus 2 SARSCoV2 oxygen saturation =94 room air required supplemental oxygen pulmonary infiltrates Propensity score matching 110 ratio used ensure comparable population assessed day 14 clinical recovery determined using 7point ordinal scale day 28 allcause mortality coprimary endpoint Results total 368 remdesivir 1399 nonremdesivir patient included matched analysis day 14 clinical recovery rate significantly higher among remdesivir versus nonremdesivir cohort 652 v 571 odds ratio 149 95 confidence interval CI 116190 P = 0002 day 28 mortality rate significantly lower remdesivir cohort versus nonremdesivir cohort 120 v 162 067 95 CI 04795 P = 03 Conclusions Remdesivir associated significantly higher rate day 14 clinical recovery lower day 28 mortality compared standardofcare treatment hospitalized patient COVID19 data taken together support use remdesivir improve clinical recovery decrease mortality SARSCoV2 infection,covid-19;sars-cov-2;mortality;remdesivir
Health Care Workers Knowledge Attitudes Beliefs Related COVID19 Palliative Medicine Hospice Care,34223494,Background Although coronavirus disease 2019 COVID19 impacted global scale knowledge attitude belief health care worker provide care end life evaluated Objectives ass understand palliative medicine hospice care health care worker knowledge attitude belief related COVID19 Design webbased survey created Primary outcome included attitude belief knowledge Secondary outcome included comparison health care worker described high risk versus high risk complication related COVID19 infection SettingSubjects total 1262 adult hospice worker United States invited Results total 348 worker completed survey 321 analyzed 5452 age 50 year 8474 female 4175 nurse 296 administrative staff 654 physician worker 3956 considered high risk develop complication related COVID19 infection 7446 felt neutral uncomfortable treating patient 7757 believed recommended personal protective equipment PPE adequate 8941 supported riskreduction strategy 8473 obtained information health authority 2555 social medium 3146 believed COVID19 likely created laboratory intentionally 6614 hospice worker considered high risk complication felt available PPE adequate protect compared 8505 responder consider high risk p 00001 majority respondent incorrect seven eight clinical scenario Conclusion Improving staff knowledge information related COVID19 would enhance staff safety improve patient care relieve anxiety,covid-19;attitudes;beliefs;hospice;knowledge;palliative
Probable vertical transmission severe acute respiratory syndrome coronavirus 2 infection mother neonate,34334918,pandemic spread severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection affected 188 country territory Altered physiological status pregnancy make mother vulnerable severe SARSCoV2 infection virus may transmitted mother baby antenatal period postnatal period Although primary mode transmission virus respiratory droplet emerging evidence utero transmission mother foetus rare case report describe one episode probable vertical transmission best knowledge second systematically investigated Indian case indicating utero transmission SARSCoV2 mother foetus,covid-19;mother to child transmission;rt-pcr;sars-cov-2
Spatially resolved simulation spread COVID19 three European country,34283832,explore spatial temporal spread novel SARSCoV2 virus containment measure three European country based fit data early outbreak Using data Spain Italy estimate age dependent infection fatality ratio SARSCoV2 well risk hospitalization intensive care admission use model simulates dynamic virus using age structured spatially detailed agent based approach explicitly incorporates governmental intervention change mobility contact pattern occurred COVID19 outbreak country simulation reproduce several feature spatiotemporal spread three country studied show containment measure combined high density responsible containment case within densely populated area spread le densely populated area occurred late stage first wave capability reproduce observed feature spatiotemporal dynamic SARSCoV2 make model potential candidate forecasting dynamic SARSCoV2 setting recommend application low lowermiddle income country remain understudied,
Recent Progress Metabolic Syndrome Research Therapeutics,34202257,Metabolic syndrome MetS welldefined yet difficulttomanage disease entity precipitous rise incidence due contemporary lifestyle growing heterogeneity among affected population present unprecedented challenge Moreover predisposed risk developing severe acute respiratory syndrome coronavirus 2 SARSCoV2 infection population MetS viral impact host metabolic parameter underscore need investigate mechanism thoroughly Recent investigation metabolomics proteomics revealed differentially expressed substance MetS also consequence diet consumption physical activity energy metabolism variation metabolite well protein product also influence wide spectrum host characteristic cellular behavior phenotype Research dysregulation gut microbiota resultant inflammatory status also contributed understanding underlying pathogenic mechanism stateoftheart therapy advancing depiction biomolecular landscape MetS emerged play key role individualized precision medicine Fecal microbiota transplantation aiming restore host s homeostasis targeting bile acid signaling pathway two approach combatting MetS Comprehensive molecular inquiry MetS omics measure mandatory facilitate development novel therapeutic modality,metabolic syndrome;metabolomics;microbiota;precision medicine;proteomics
Preferences Toward COVID19 Diagnostic Testing Features Results National CrossSectional Survey,34284644,PURPOSE Describe preference toward COVID19 testing feature method location hypothetical monetary incentive simulate effect monetary incentive willingness test DESIGN Online crosssectional survey administered July 2020 SUBJECTS 1505 nationally representative US respondent MEASURES Choice preferred COVID19 testing option discrete choice experiment Options differed method nasalswab saliva location hospitalclinic drivethrough athome monetary incentive 0 10 20 ANALYSIS Latent class conditional logit model classify preference mixed logit model simulate incentive effectiveness RESULTS Preferences categorized 4 group 34 n = 517 considered testing comfort saliva versus nasal swab important 27 n = 408 willing trade comfort monetary incentive 19 n = 287 would test convenient location 20 n = 293 avoided testing altogether Relative monetary incentive incentive 100 increased percent testing avoiders 16 convenience seeker 70 willing test CONCLUSION Preferences toward different COVID19 testing feature vary highlighting need match testing feature individual monitor spread COVID19,covid-19 diagnostic testing;discrete choice experiment;disease prevention;health communications;monetary incentive
Risk Covid19 infection endoscopy Efficacy personal protective equipment PPE protecting health professional,34290789,Objectives correlate compliance personal protective equipment PPE protocol risk exposure SARSCOV2 infection endoscopy staff Methods included 85 endoscopic procedure performed Lahore General Hospital May July 2020 Standard operating procedure SOPs implemented patient selection risk stratification personal protective equipment PPE use endoscopy staff Patient endoscopy staff followed Covid19 infection PPE score staff Covid19 positivity followup correlated using student s test Results Following 85 procedure included 2 23 patient became Covid19 positive PPE score 9 5 58 procedure endoscopist Covid19 developed 2 23 PPE score 9 19 223 procedure 1 st assistant 9 105 developed infection 2 nd assistant PPE score 9 19 223 endoscopy 5 59 tested positive covid19 Infectivity endoscopy staff 62 Association PPE score risk Covid19 significant p value 051 endoscopist 010 1 st assistant 009 2 nd assistant Conclusion Compliance SOPs infection control reduces risk acquiring Covid19 infection endoscopy Proper use PPE effective safety endoscopy staff,covid-19 infection;endoscopy;personal protective equipment (ppe)
Reversion Gut Microbiota Recovery Phase Patients Asymptomatic Mild COVID19 Longitudinal Study,34200249,Patients COVID19 reported experience gastrointestinal symptom well respiratory symptom effect COVID19 gut microbiota poorly understood explored gut microbiome profile associated respiratory infection SARSCoV2 recovery phase patient asymptomatic mild COVID19 longitudinal analysis performed using patient determine whether gut microbiota changed recovery COVID19 applied 16S rRNA amplicon sequencing analyze two paired fecal sample 12 patient asymptomatic mild COVID19 Fecal sample selected two time point SARSCoV2 infection infected state negative conversion viral RNA recovered state also compared microbiome data 36 healthy control Microbial evenness recovered state significantly increased compared infected state SARSCoV2 infection induced depletion Bacteroidetes abundance observed tendency rapidly reverse recovered state FirmicutesBacteroidetes ratio infected state markedly higher recovered state Gut dysbiosis observed infection even patient asymptomatic mild COVID19 composition gut microbiota recovered negative conversion SARSCoV2 RNA Modifying intestinal microbe response COVID19 might useful therapeutic alternative,covid-19;fb ratio;sars-cov2;asymptomatic;gut microbiota;microbiome;mild
Acute Myocardial Injury Following COVID19 Vaccination Case Report Review Current Evidence Vaccine Adverse Events Reporting System Database,34219532,COVID19 vaccination related adverse event evolving field present case acute myocardial injury developed result acute immune response following second dose COVID19 vaccination Moderna 67yearold man presented acute congestive heart failure clinical course improved 3 day Review Vaccine Adverse Events Reporting System VAERS Centers Disease Control Prevention website identified 37 vaccine recipient developed myocarditis adverse event following COVID19 vaccination mass expansion COVID19 vaccine administration physician need vigilant possibility new adverse event,covid-19 vaccine;adverse events;myocarditis
Hydroxychloroquine Azithromycin Treatment Hospitalized Patients Infected SARSCoV2 Senegal March October 2020,34209237,today little data available COVID19 African country case management relied mainly treatment association hydroxychloroquine HCQ azithromycin AZM study aimed understand main clinical outcome COVID19 hospitalized patient Senegal March October 20202 described clinical characteristic patient analysed clinical status alive discharged versus hospitalized died 15 day Isolation Treatment Centres ITC admission among adult patient received HCQ plus AZM receive combination total 926 patient included analysis Six hundred seventyfour 674 728 patient received combination HCQ AZM Results showed proportion patient discharge D15 significantly higher patient receiving HCQ plus AZM 163 IC 95 109243 Factors associated lower proportion patient discharged alive age = 60 year 055 IC 95 036083 least one preexisting disorder 061 IC 95 042090 high clinical risk admission following NEWS score 049 IC 95 028083 side effect reported including 2 case cardiac rhythmic disorder HCQ AZM group versus 13 without HCQ + AZM improvement clinical status 15 day found patient exposed HCQ plus AZM combination,sars-cov-2;senegal;azithromycin;hydroxychloroquine;treatment
Evaluation Management Alcohol use Disorder among Older Adults,34336549,Purpose Review prevalence alcohol use disorder AUD among older adult United States rising remains underdiagnosed underreported inadequately managed review highlight medical social cultural factor AUD older adult provides guideline screening evaluation management Recent Findings COVID19 pandemic created additional challenge barrier care older adult may disproportionate worsening anxiety depression substance use resulting increased isolation related physical distancing shelterinplace guideline Summary older adult routinely screened AUD standardized screening tool patient s screening result positive clinician conduct brief assessment may supplemented laboratory test older adult risk alcohol misuse need specialized SUD treatment benefit Screening Brief Intervention Referral Treatment SBIRT prevent substance misuse occurs Medications treatment AUD older adult include naltrexone acamprosate disulfiram gabapentin topiramate Psychosocial treatment including mutual help group equally important,alcohol use disorder;geriatrics;older adults;substance use disorders
GreenBlue Spaces Population Density versus COVID19 Cases Deaths Poland,34203108,last year connection COVID19 pandemic caused SARSCoV2 coronavirus scientific paper appeared author trying identify factor including environmental favoring spread disease paper present spatial differentiation total number COVID19 case death full year March 2020March 2021 SARSCoV2 pandemic Poland versus greenblue space greenia forest orchard meadow pasture recreational rest area biologically active arable land bluelakes artificial water reservoir river ecological area internal water population density analysis cover 380 county including 66 city study used daily report progress pandemic Poland published Ministry Health Republic Poland unique detailed data 24 type land use available Statistics Poland database Statistical relationship determined abovementioned environmental variable variable characterizing COVID19 case death Various basic type regression model analysed optimal model selected determination coefficient significance level value parameter relationship together estimation error calculated obtained result indicated higher number greenblue space individual county lower total number COVID19 infection death relationship described logarithmic homographic model turn increase population density caused increase COVID19 case death according power model result used current analysis spread pandemic including location potential outbreak turn developed model used tool forecasting development pandemic making decision implementation preventive measure,covid-19 cases and deaths;poland;green-blue spaces;population density;relationships
Declining Levels Neutralizing Antibodies SARSCoV2 Convalescent COVID19 Patients One Year Post Symptom Onset,34220870,Major advance made understanding dynamic humoral immunity briefly acute coronavirus disease 2019 COVID19 However knowledge concerning longterm kinetics antibody response convalescent patient limited oneyear period post symptom onset longitudinally collected 162 sample 76 patient quantified IgM IgG antibody recognizing nucleocapsid N protein receptor binding domain RBD spike protein one year approximately 90 recovered patient still detectable SARSCoV2specific IgG antibody recognizing N RBDS Intriguingly neutralizing activity detectable 43 patient neutralization test E484Kmutated variant concern VOC B1351 initially identified South Africa performed among patient neutralize original virus capacity neutralize even diminished 226 donor Despite declining N Sspecific IgG titer considerable fraction recovered patient detectable neutralizing activity one year infection However neutralizing capacity particular E484Kmutated VOC detectable minority patient one year symptomatic COVID19 finding shed light kinetics longterm immune response natural SARSCoV2 infection argue vaccination individual experienced natural infection protect emerging VOC,covid-19;sars-cov-2;antibody responses;humoral immunity;spike
LockdownRelated Disparities Experienced People Disabilities First Wave COVID19 Pandemic Scoping Review Thematic Analysis,34200979,People disability may disproportionally affected COVID19 pandemic synthesize literature broader health social impact people disability arising lockdownrelated measure METHODS Scoping review thematic analysis midSeptember 2020 seven scientific database three preprint server searched identify empirical perspective paper addressing lockdownrelated disparity experienced people disability Snowballing search expert consultation also occurred Two independent reviewer took eligibility decision performed data extraction RESULTS 1026 unique reference 85 addressed lockdownrelated disparity experienced people disability Ten primary two central theme identified 1 Disrupted access healthcare COVID19 2 Reduced physical activity leading health functional decline 3 physical distance inactivity social isolation loneliness 4 Disruption personal assistance community support network 5 Children disability disproportionally affected school closure 6 Psychological consequence disrupted routine activity support 7 Family informal caregiver burden stress 8 Risks maltreatment violence selfharm 9 Reduced employment andor income exacerbating disparity 10 Digital divide access health education support service Lack disabilityinclusive response emergency preparedness structural prepandemic disparity central theme CONCLUSIONS Lockdownrelated measure contain COVID19 pandemic disproportionally affect people disability broader impact health social ground Lack disabilityinclusive response emergency preparedness prepandemic disparity created structural disadvantage exacerbated pandemic structural disparity pandemic ramification require development implementation disabilityinclusive public health policy measure,covid-19;sars-cov-2;discrimination;health equity;healthcare disparities;people with disabilities;public health;social determinants of health;social inclusion;stigma
Facemasks Looming Microplastic Crisis,34281005,Singleuse disposable facemasks used preventive measure ongoing COVID19 pandemic However many researcher found evidence facemasks dumped lake river open garbage dump Facemasks potential releasing microplastic fiber environment phenomenon poorly investigated Moreover microplastic fiber composed plastic potential affecting flora fauna many ecosystem preliminary study investigate many microplastic fiber released water KFAD KF94 surgical FFP1 standard facemasks widely available facemask standard South Korea waterbody research mechanically agitated 24 48 72 h Findings showed layer facemasks composed polypropylene surgical KF94 standard facemasks released highest number microplastic fiber Furthermore research condition single facemask release least 47 microplastic fiber per day eg KFAD standard mask lead release least 1381 million microplastic fiber per day total South Korea 70 urban population us single mask every day Moreover released microplastic fiber significantly increased agitation time extended 24 48 h finding suggests number released microplastic fiber likely increase drastically,covid-19;facemasks;microplastics;solid waste management;water pollution
Risk Factors SARSCoV2 Infection Pneumonia Intubation Death Northeast Mexico,34291023,Despite social distancing mobility restriction measure implemented susceptible people around world infection death due COVID19 continued increase even first month 2021 Mexico Thus necessary find risk group benefit aggressive preventive measure highdensity population casecontrol study suspected COVID19 patient Nuevo Leon Mexico Cases 1 COVID19positive patient COVID19positive patient 2 developed pneumonia 3 intubated 4 died Controls 1 COVID19negative patient 2 COVID19positive patient without pneumonia 3 nonintubated COVID19positive patient 4 surviving COVID19positive patient = 18 year age pregnant included preexisting condition analysed risk factor age year sex male diabetes mellitus hypertension chronic obstructive pulmonary disease asthma immunosuppression obesity cardiovascular disease chronic kidney disease smoking MannWhitney U test Chi square binary logistic regression used total 56715 suspected patient analysed Nuevo Leon Mexico 626 positive COVID19 infected 14 developed pneumonia 29 intubated 81 died mean age infected 447 year complicated around 60 year Older age male sex diabetes hypertension obesity risk factor infection complication death COVID19 study highlight importance timely recognition population exposed preexisting condition prioritise preventive measure virus,covid-19;mexico;sars-cov-2;coronavirus;death;intubation endotracheal;pneumonia
NGlycosylation SARSCoV2 Receptor Binding Domain Important Functional Expression Plants,34211491,Nicotiana benthamiana used worldwide production host recombinant protein Many recombinant protein monoclonal antibody growth factor viral antigen require posttranslational modification like glycosylation function transiently expressed different variant glycosylated receptor binding domain RBD SARSCoV2 spike protein N benthamiana characterized impact variation RBDlength posttranslational modification protein expression yield functionality found truncated RBD variant RBD215 consisting amino acid Arg319Leu533 efficiently expressed secreted soluble protein Purified RBD215 mainly present monomer showed binding conformationdependent antibody CR3022 cellular receptor angiotensin converting enzyme 2 ACE2 antibody present convalescent serum Expression RBD215 glycoengineered DeltaXTFT plant resulted generation complex Nglycans Nglycosylation site sitedirected mutagenesis showed Nglycans important proper RBD folding difference Nglycan processing effect protein expression function,covid-19;sars-cov-2;glycoprotein;glycosylation;posttranslational modification;virus
Tracheostomy Timing Outcome Severe COVID19 WeanTrach Multicenter Study,34208672,BACKGROUND Tracheostomy performed safely patient coronavirus disease 2019 COVID19 However little known optimal timing effect outcome complication METHODS multicenter retrospective observational study study included 153 tracheostomized COVID19 patient 11 intensive care unit ICUs primary endpoint median time tracheostomy critically ill COVID19 patient Secondary endpoint survival rate length ICU stay posttracheostomy complication stratified tracheostomy timing early versus late technique surgical versus percutaneous RESULTS median time tracheostomy 15 164 day significant difference survival critically ill COVID19 patient received tracheostomy versus day 15 surgical percutaneous technique ICU length stay shorter early compared late tracheostomy p 0001 percutaneous compared surgical tracheostomy p = 0050 rate lower respiratory tract infection higher surgical versus percutaneous technique p = 0007 CONCLUSIONS Among critically ill patient COVID19 neither early percutaneous tracheostomy improved outcome shorten ICU stay Infectious complication le frequent percutaneous surgical tracheostomy,covid-19;sars-cov-2;coronavirus;intensive care;percutaneous;surgical technique;tracheostomy
Asthma Pregnancy Review Current Literature Recommendations,34221160,Background Asthma common respiratory disorder affecting woman pregnancy Although reversible disease may adversely affect maternal quality life perinatal outcome especially severe inappropriately managed case Conversely pregnancy influence course asthma physiological respiratory hormonal immune system change Exacerbations key feature asthma representing significant problem severe requiring aggressive medical intervention hospital even ICU admission Purpose purpose article summarize current knowledge provide comprehensive overview asthma pregnancy also want rising awareness among patient clinician importance proper asthma management pregnancy Data source comprehensive literature search PubMed Medline Taylor Francis performed searched review article well prospective retrospective study published English investigating bilateral relationship asthma pregnancy using key word mentioned bellow Manual search national international guideline well relevant journal publication topic also conducted Conclusion Optimal asthma control preventing detecting treating exacerbation utmost importance minimize adverse effect mother fetusneonate Guidelines recommend active asthma management pregnancy Strong support prior throughout pregnancy individualized treatment guided multidisciplinary team suggested Education importance antiasthmatic therapy avoiding trigger frequent accurate monitoring essential good asthma management Considering pandemic facing potential impact COVID19 asthma Global Initiative Asthma GINA guideline recommendation physician mentioned present article,
Pancreatic Injury COVID19 VaccineA Case Report,34205898,COVID19 pandemic caused 3 million death worldwide Recently developed genetically engineered vaccine critical solution controlling pandemic Clinical trial large number participant confirmed safety efficacy However growing number vaccinated people new infrequent adverse effect reported described medicinal product characteristic would like report case acute pancreatic injury occurred shortly administering Pfizer BioNTech COVID19 mRNA vaccine Comirnaty report point potential need close monitoring patient reporting abdominal pain vaccination unresponsive standard oral painkiller symptom associated acute pancreatitis,covid-19;covid-19 mrna vaccine;comirnaty;coronavirus vaccine;pancreatic injury;pancreatitis
Dynamic assessment risk airborne viral infection,34212441,paper applies Rudnick Milton method dynamic evaluation probability airborne contagion redefining parameter variable discretized form adapt calculation risk contagion real need scenario used define presence people infected subject hourly production quantum infection calculation concentration CO2 produced exhalation air Three case study discussed school office commercial activity Complex scenario include environmental sanitization variable number people possibility simulating work shift dynamic evaluation quantum infection also estimated foreseen Rudnick Milton model involves updating average value equivalent fraction indoor air improvement accuracy calculation due reduction improper peak stationary variable,coronavirus;sars-cov-2;aerosol transmission;pandemic;probability of contagion;virus airborne transmission
manage patient suspected upper tract urothelial carcinoma pandemic COVID19,34332847,BACKGROUND pandemic COVID19 disrupted clinical pathway patient suspected upper tract urothelial carcinoma UTUC aim investigate optimal management UTUC pandemic determining 1 Whether threemonth delay RNU lead worsened overall survival 2 Whether radical nephroureterectomy RNU performed without prior diagnostic ureteroscopy URS METHODS Consecutive patient RNU performed suspected UTUC four hospital Hong Kong Taiwan included Patients histologically proven UTUC RNU performed within one year dichotomized early =3 month delayed 3 month RNU group Diagnostic performance predictive model based preURS factor gross haematuria suspicious malignant urine cytology filling defect contrastenhancing mass computed tomography without URS analysed using receiver operating characteristic area curve AUC Overall survival analysed using KaplanMeier method multivariate Cox regression analysis RESULTS 2000 2019 665 patient underwent RNU 491 prior diagnostic URS early RNU group better overall survival P=0015 Early RNU associated better overall survival upon multivariate analysis HR 155 95 CI 103233 P=0035 Large tumour size multifocal tumour T2 disease positive nodal status associated poorer overall survival combination 2 3 preURS factor achieved positive predictive value 995 100 Presence 3 preURS factor achieved AUC 0851 URS AUC 0809 without URS CONCLUSIONS delay RNU 3 month associated poorer overall survival avoided despite current COVID19 also consider direct RNU based clinical factor alone also avoids URS hospitalization expedites clinical pathway UTUC,mortality;neoplasms;nephroureterectomy;pandemics;ureteroscopy
influence delayed treatment due COVID19 patient neovascular agerelated macular degeneration polypoidal choroidal vasculopathy,34221305,Purpose explore impact coronavirus disease 2019 COVID19 prognosis patient neovascular agerelated macular degeneration nAMD polypoidal choroidal vasculopathy PCV share experience managing pandemic Method retrospective study nAMD PCV patient treated Peking Union Medical College Hospital 31 December 2019 1 August 2020 Baseline demographic clinical characteristic best corrected visual acuity BCVA optical coherence tomography OCT feature duration delayed treatment number antivascular endothelial growth factor VEGF injection analyzed Results total 130 nAMD patient 155 eye 76 PCV patient 89 eye identified Compared condition COVID19 BCVA delayed case decreased significantly proportion patient presenting submacular scar significantly greater delayed treatment group p 005 BCVA nondelayed case remained stable percentage patient disease activity subretinal fluid hemorrhage fovea decreasing significantly p 005 stable case require antiVEGF treatment significantly worse baseline final BCVA patient likely chronic burnt case significantly worse anatomical structure p 005 Conclusions delayed case due pandemic suffered compromised visual function higher rate submacular scar formation visual function nondelayed case remained stable favorable anatomical outcome suggesting importance regular followup nAMD PCV patient Besides effective measure hospital pandemic crucial provide timely treatment chronic disease,covid-19;neovascular age-related macular degeneration;polypoidal choroidal vasculopathy;prognosis
Predictors COVID19 outpatient fever clinic,34288955,BACKGROUND objective study identify clinical risk factor COVID19 German outpatient fever clinic allow distinction SARSCoV2 infected patient patient flulike symptom METHODS retrospective singlecentre cohort study Patients included visiting fever clinic 4th April 2020 15th May 2020 Symptoms comorbidities sociodemographic factor recorded standardized fashion Multivariate logistic regression used identify risk factor COVID19 base model discrimination assessed using area receiver operation curve AUROC RESULTS final analysis included 930 patient 74 8 COVID19 Anosmia 1071 CI 607189 ageusia 93 CI 5361612 strongly associated COVID19 Highrisk exposure 1220 CI 6802190 especially household 414 CI 1281333 also correlated household member especially flulike symptom higher risk COVID19 Working essential workplace also associated COVID19 235 CI 140396 whereas smoking inversely correlated 019 CI 008044 model considered risk factor like anosmia ageusia concomitant symptomatic household member smoking well discriminated COVID19 patient patient flulike symptom AUROC 084 CONCLUSIONS report set four readily available clinical parameter allow identification highrisk individual COVID19 study replace molecular testing help guide containment effort waiting test result,
Acute rhabdomyolysis young woman moderate COVID19,34221896,coronavirus disease 2019 COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 serious medical social economic impact worldwide COVID19 may lead variety complication including rhabdomyolysis Although rhabdomyolysis rare complication lead severe kidney damage Recent study suggest rhabdomyolysis caused SARSCoV2 common middleaged older men severe COVID19 Herein report case rhabdomyolysis young woman moderate COVID19 habit muscle training presented moderate COVID19 acute rhabdomyolysis required large volume fluid infusion addition dexamethasone remdesivir Clinicians pay attention development rhabdomyolysis patient COVID19 especially habit strenuous exercise muscle training even young moderate COVID19,covid-19;exercise;muscle training;rhabdomyolysis;sars-cov-2
MultiEpitope Vaccine Design Using Immunoinformatic Approach SARSCoV2,34208061,4 June 2021 COVID19 caused 17284 million case infection 371 million death worldwide Due rapid dissemination high mutation rate essential develop vaccine harboring multiple epitope efficacious multiple variant prevent immune escape SARSCoV2 silico approach based viral genome applied identify 19 highimmunogenic Bcell epitope 499 human leukocyte antigen HLA restricted Tcell epitope Thirty multiepitope peptide vaccine designed iNeoSuite manufactured solidphase synthesis Docking analysis confirmed stable hydrogen bond epitope corresponding HLA allele four peptide candidate derived spike protein SARSCoV2 selected immunize mouse significantly larger amount total IgG serum well increase CD19+ cell inguinal lymph node observed peptideimmunized mouse compared control ratio IFNgammasecreting lymphocyte CD4+ CD8+ Tcells peptideimmunized mouse higher control mouse also larger number IFNgammasecreting Tcells spleen peptideimmunized mouse peptide vaccine study successfully elicited antigenspecific humoral cellular immune response mouse validate safety efficacy vaccine animal study using primate model well clinical trial human required,covid-19;sars-cov-2;epitope;immunoinformatics;peptide;vaccine
Clinical Frailty Score v Hospital Frailty Risk Score predicting mortality adverse outcome hospitalised patient COVID19 Spanish case series,34227196,OBJECTIVES Frailty used predictor adverse outcome people coronavirus disease 2019 COVID19 aim study analyse prognostic value two different frailty score patient hospitalised COVID19 MATERIAL METHODS retrospective cohort study included adult =18 year inpatient COVID19 took place 3 March 2 May 2020 Patients categorised Clinical Frailty Score CFS Hospital Frailty Risk Score HFRS primary outcome inhospital mortality secondary outcome tocilizumab treatment length hospital stay admission intensive care unit ICU need invasive mechanical ventilation Results analysed multivariable logistic regression expressed odds ratio ORs adjusting age sex kidney function comorbidity RESULTS 290 included patient 54 frail according CFS =5 point prevalence 186 95 confidence interval CI 144237 v 65 HFRS =5 point prevalence 224 95 CI 178277 Prevalence frailty increased age according measure 5064 year CFS 19 v HFRS 123 6579 year CFS 315 v HFRS 400 =80 year CFS 667 v HFRS 400 P 001 CFSdefined frailty independently associated risk death 367 95 CI 149904 le treatment tocilizumab 028 95 CI 008093 HFRSdefined frailty independently associated length hospital stay 10 day 289 95 CI 153544 ICU admission 418 95 CI 184952 invasive mechanical ventilation 593 95 CI 2331510 CONCLUSION spring 2020 wave COVID19 pandemic Spain CFSdefined frailty independent predictor death frailty measured HFRS associated length hospital stay 10 day ICU admission use invasive mechanical ventilation,
Three phase COVID19 theoretical thinking epidemic prevention control,34353108,response COVID19 outbreak evaluated analyzing literature published outbreak reviewing summarizing different stage node measure occurrence development COVID19 country draw experience reference fight COVID19 China December 2019 COVID19 first reported Wuhan China whole world continued pay close attention development COVID19 China outbreak development COVID19 lasted year Looking back process COVID19 several key stage event profound impact development COVID19 divided evolution outbreak since origin different phase policy change Chinese government different period COVID19 pandemic evaluated transformation node policy difference stage determined divided evolution outbreak three stage outbreak initial outbreak stage carrying virus people good stage nondirect contact transmission good transmission stage paper review three stage evolution response Chinese government COVID19 using phase analysis method examine different policy starting point change policy reason policy change study provides resource COVID19 policy review includes image threephase shift policy epidemic progressed summarizing describing policy change three phase response COVID19 China paper provides resource others formulating response pandemic commentary also designed provoke scholarly dialog among reader journal,covid-19 outbreak;comments;policy changes;three stages review
Comprehensive Molecular Epidemiological Analysis SARSCoV2 Infection Cyprus April 2020 January 2021 Evidence Highly Polyphyletic Evolving Epidemic,34207490,spread severe acute respiratory syndrome coronavirus 2 SARSCoV2 resulted extraordinary global public health crisis early 2020 Cyprus among European country affected SARSCoV2 epidemic adopted lockdown measure March 2020 limit initial outbreak island study performed comprehensive retrospective molecular epidemiological analysis genetic phylogenetic phylodynamic phylogeographic analysis SARSCoV2 isolates Cyprus April 2020 January 2021 covering first ten month SARSCoV2 infection epidemic island primary aim study ass transmissibility SARSCoV2 lineage Cyprus Whole SARSCoV2 genomic sequence generated 596 clinical sample nasopharyngeal swab obtained communitybased diagnostic testing center hospitalized patient phylogenetic analysis revealed total 34 different lineage Cyprus B1258 B1129 B1177 B12 B1 B117 designated Variant Concern 20201201 VOC prevalent lineage island study period Phylodynamic analysis showed highly dynamic epidemic SARSCoV2 infection three consecutive surge characterized specific lineage B1129 April June 2020 B1258 September 2020 January 2021 B117 December 2020 January 2021 Genetic analysis whole SARSCoV2 genomic sequence aforementioned lineage revealed presence mutation within protein L18F DeltaH69V70 S898F DeltaY144 S162G A222V N439K N501Y A570D D614G P681H S982A D1118H confer higher transmissibility andor antibody escape immune evasion upon virus Phylogeographic analysis indicated majority import export United Kingdom UK although many regionscountries identified southeastern Asia southern Europe eastern Europe Germany Italy Brazil Chile USA Denmark Czech Republic Slovenia Finland Switzerland Pakistan Taken together finding demonstrate SARSCoV2 infection epidemic Cyprus maintained continuous influx lineage many country resulting establishment everevolving polyphyletic virus island,covid-19;cyprus;sars-cov-2;molecular epidemiology
Higher rate SARSCoV2 IgG seropositivity hospitalbased healthcare worker compared elderly care staff Swedish lowprevalence region crosssectional study,34350813,BACKGROUND Previous seroprevalence study demonstrated higher antiSARSCoV2 IgG seroprevalence healthcare worker HCWs background population first phase 2020 COVID19 pandemic study however focussed mainly hospital employee AIM perform crosssectional study comparing seroprevalence hospitalbased HCWs employed elderly care home care nursing home METHODS Employees n = 4955 county Varmland Sweden recruited week 27 42 tested IgG antibody SARSCoV2 Serological result combined selfreported questionnaire data FINDINGS IgG seroprevalence 57 total group HCWs higher among employed hospitalbased healthcare among working elderly care 84 vs 37 p 001 employed assistant nurse working COVID19 unit exposed via coworker private acquaintance associated IgG seropositivity CONCLUSION difference seroprevalence HCWs two setting suggests profession also factor workplace environment may importance studied exposure associated IgG seropositivity asymptomatic infection detected 75 participant preventing outbreak among HCWs challenging Adequate use personal protective equipment working patient regardless COVID19 status source control situation coworker distancing possible routine enabling symptomatic staff isolate pending PCR result required prevent healthcareassociated outbreak COVID19,covid-19;igg seroprevalence;healthcare workers;hospital;nursing home
Clinical characteristic outcome invasively ventilated patient COVID19 Argentina SATICOVID prospective multicentre cohort study,34224674,BACKGROUND Although COVID19 greatly affected many lowincome middleincome country detailed information patient admitted intensive care unit ICU still scarce aim examine ventilation characteristic outcome invasively ventilated patient COVID19 Argentina upper middleincome country METHODS prospective multicentre cohort study SATICOVID enrolled patient aged 18 year older RTPCRconfirmed COVID19 invasive mechanical ventilation admitted one 63 ICUs Argentina Patient demographic clinical laboratory general management variable collected day 1 ICU admission physiological respiratory ventilation variable collected day 1 3 7 primary outcome allcause inhospital mortality patient followed death hospital hospital discharge whichever occurred first Secondary outcome ICU mortality identification independent predictor mortality duration invasive mechanical ventilation pattern change physiological respiratory mechanical ventilation variable study registered ClinicalTrialsgov NCT04611269 complete FINDINGS March 20 2020 Oct 31 2020 enrolled 1909 invasively ventilated patient COVID19 median age 62 year IQR 5270 1294 678 men hypertension obesity main comorbidities 939 492 patient required vasopressor Lungprotective ventilation widely used median duration ventilation 13 day IQR 722 Median tidal volume 61 mLkg predicted bodyweight IQR 6070 day 1 value increased significantly day 7 positive endexpiratory pressure 10 cm H2O 812 day 1 slight significant decrease day 7 Ratio partial pressure arterial oxygen PaO2 fractional inspired oxygen FiO2 160 IQR 111218 respiratory system compliance 36 mLcm H2O 2944 driving pressure 12 cm H2O 1014 FiO2 060 045080 day 1 Acute respiratory distress syndrome developed 1672 876 patient 1176 616 received prone positioning Inhospital mortality 577 11011909 patient ICU mortality 570 10881909 patient 462 438 patient died refractory hypoxaemia frequently overlapping septic shock n=174 Cox regression identified age hazard ratio 102 95 CI 101103 Charlson score 116 111123 endotracheal intubation outside ICU ie ICU admission 137 110171 vasopressor use day 1 129 107155 Ddimer concentration 102 101103 PaO2FiO2 day 1 0998 09970999 arterial pH day 1 101 100101 driving pressure day 1 105 103108 acute kidney injury 166 136203 month admission 110 103118 independent predictor mortality INTERPRETATION patient COVID19 required invasive mechanical ventilation lungprotective ventilation widely used mortality high Predictors mortality study broadly agreed identified study invasively ventilated patient highincome country sustained burden COVID19 scarce healthcare personnel might contributed high mortality course study Argentina data might help identify point improvement management patient middleincome country elsewhere FUNDING None TRANSLATION Spanish translation Summary see Supplementary Materials section,
Consensus Statement Neurorehabilitation COVID19 Times Expert Group Behalf Indian Federation Neurorehabilitation IFNR,34220054,COVID19 pandemic India causing significant morbidity disruption healthcare delivery rapidly escalating contagion straining public health system already pressure due shortage infrastructure inadequate workforce Neuro rehabilitation service still infancy country significantly interrupted last six month expert group Indian Federation Neurorehabilitation IFNR formulated guideline consensus recommendation Neurologists Physiatrists Therapists managing neurological disability COVID 19 aim consensus paper sensitize clinician therapist maintaining continuum care rehabilitation need Covid patient well non Covid patient neurological disorder ongoing COVID 19 pandemic,covid-19;disability;interventions;neurorehabilitation
Analyzing COVID19 Using Multisource Data Integrated Approach Visualization Spatial Regression Machine Learning,34377880,Coronavirus disease 2019 COVID19 caused severe acute respiratory syndrome coronavirus 2 first identified Wuhan China December 2019 number COVID19 infection death worldwide continues increase rapidly prevention control COVID19 remains urgent article aim analyze COVID19 geographical perspective information provide useful insight rapid visualization spatialtemporal epidemic information identification factor important spread COVID19 new type vitalization method called point grid map integrated calendarbased visualization show spatialtemporal variation COVID19 combination mixed geographically weighted regression mixed GWR extreme gradient boosting XGBoost used identify potential factor corresponding importance visualization result clearly reflect spatialtemporal pattern COVID19 quantified result reveal impact population outflow Wuhan important factor indicate statistically significant spatial heterogeneity result provide insight multisource big geodata employed within framework integrating visualization analytical method characterize COVID19 trend addition work help understand influential factor controlling preventing epidemic important policy design effective decisionmaking controlling COVID19 result reveal one effective way control COVID19 include controlling source infection cutting transmission route protecting vulnerable group,covid-19;xgboost;geographical perspective;mixed gwr;spatial-temporal patterns;visualization
Alveolar Air Leak Syndrome Potential Complication COVID 19ARDS Single Center Retrospective Analysis,34227771,Background Alveolar air leak comprising pneumothorax pneumomediastinum subcutaneous emphysema ongoing COVID 19 pneumonia increasingly reported literature air leak also recognized severe acute respiratory syndrome SARS Middle East respiratory syndrome MERS H1N1 viral pandemic review incidence outcome alveolar air leak 400 patient admitted tertiary care institution moderatesevere COVID19 pneumonia Methods performed retrospective audit moderate severe COVID19 case admitted hospital Patients recognized either spontaneous pneumothorax pneumomediastinum pneumopericardium subcutaneous emphysema identified clinical feature characteristic thoroughly documented clinical outcome gathered case presented brief synopsis Results audit period reviewed 670 patient 419 patient required intensive care moderate severe disease 10 patient developed Pneumothorax pneumomediastinum pneumopericardium and subcutaneous emphysema referred Alveolar Air leak syndrome incidence alveolar air leak found 239 6 patient survive resultant complication Conclusion Spontaneous alveolar air leak rare definite complication COVID19 viral pneumonia may occur absence mechanical ventilation ICU Clinicians must alert diagnosis treatment complication,
Sanger sequencing protocol SARSCoV2 Sgene,34346163,describe Sanger sequencing protocol SARSCoV2 Sgene Spike glycoprotein product composed receptorbinding S1 membrane fusion S2 segment target vaccine used combat COVID19 protocol used laboratory basic Sanger sequencing capability allows rapid `` source screening SARSCoV2 variant notably concern protocol applied surveillance clinical specimen collected either nucleic acid preservation lysismix virus transport medium research involving cultured virus yield data public health importance timely manner,s-gene;sars-cov-2;sanger sequencing;base-calling accuracy;variant detection
serum proteome signature predict mortality severe COVID19 patient,34226277,recorded serum proteome profile 33 severe COVID19 patient admitted respiratory intensive care unit respiratory failure received patient blood sample admission two later time point aim predict treatment outcome focused serum protein different abundance group survivor nonsurvivors observed small panel dozen protein significantly different abundance two group four structurally functionally related type3 cystatins AHSG FETUB histidinerich glycoprotein KNG1 abundant survivor family interalphatrypsin inhibitor ITIH1 ITIH2 ITIH3 ITIH4 found differentially abundant survivor nonsurvivors whereby ITIH1 ITIH2 abundant survivor group ITIH3 ITIH4 abundant nonsurvivors ITIH1ITIH2 ITIH3ITIH4 also showed opposite trend protein abundance disease progression defined optimal panel nine protein mortality risk assessment prediction power mortality risk panel evaluated two recent COVID19 serum proteomics study independent cohort measured laboratory different country observed perform well predicting mortality also cohort panel may unique COVID19 protein panel previously annotated mortality marker aging disease caused different pathogen including bacteria,
Active Aging Governance Challenges Local Level,34202217,International national guideline promoting active aging creating necessary mean decisionmakers relevant actor work together governance mechanism implement local active aging policy especially important present COVID19 pandemic context posing greater challenge older people tend selfisolated local actor conceptualizing active aging priority related healthy life older people governance mechanism used implement policy question addressed paper targeting Portugal southern European country mixedmethods sequential explanatory design combining survey conducted national level interview key actor NUTS III Aveiro Region employed identify understand underpinning governance mechanism Findings confirm passive organization type European politicoterritorial study tend place Portugal gap way policy formulated implemented evaluated well lack coordination Results study important impact way local government stakeholder prepare postpandemic period design implement policy addressing active aging,active aging;governance;local policies;older people healthy life;stakeholders
Multiple Tracheal Diverticula COVID19 Positive Patient,34281404,tracheal diverticulum type paratracheal air cyst usually incidental finding computed tomography scan neck thorax incidence 1 4 adult tracheal diverticulum rare entity symptomatic certain case present case COVID19 positive patient presented hospital diagnosed multiple tracheal diverticulum hospitalization,
Antiviral Activity Vitis vinifera Leaf Extract SARSCoV2 HSV1,34209556,Vitis vinifera represents important renowned source compound significant biological activity Wines winery bioproducts grape pomace skin seed rich bioactive compound wide range human pathogen including bacteria fungi virus However little known biological property vine leaf aim study evaluation phenolic composition antiviral activity Vitis vinifera leaf extract two human virus Herpes simplex virus type 1 HSV1 pandemic currently widespread severe acute respiratory syndrome coronavirus 2 SARSCoV2 40 phenolic compound identified extract HPLCMSMS analysis quercetin derivative others included derivative luteolin kaempferol apigenin isorhamnetin myricetin chrysoeriol biochanin isookanin scutellarein Leaf extract able inhibit HSV1 SARSCoV2 replication early stage infection directly blocking protein enriched viral surface low concentration 10 mugmL result promising highlight natural extract could used design antiviral drug development future vaccine,hsv-1;lc-ms;sars-cov-2;vitis vinifera;antimicrobial;antiviral;flavonoids;leaf extract;molecular networking;natural extract
Beliefs barrier associated COVID19 vaccination among general population Saudi Arabia,34289817,BACKGROUND Developing vaccine COVID19 considered key strategy end pandemic However public acceptance reliant belief perception toward vaccine Therefore study aimed ass belief barrier associated COVID19 vaccination among Saudi population METHODS online selfadministered questionnaire distributed across main region Saudi Arabia May 2020 questionnaire addressed sociodemographic variable belief toward COVID19 vaccination potential barrier may prevent participant vaccinated association COVID19 vaccine acceptance sociodemographic variable analyzed Logistic regression analysis used identify predicting variable vaccine acceptance RESULTS 3101 participant 447 accepting COVID19 vaccination available whereas 553 admitted hesitancy Younger male received seasonal influenza vaccine likely accept taking vaccine study found concern side effect key barrier vaccine acceptance Furthermore majority refusers may accept vaccine additional study confirmed safety effectiveness CONCLUSION Results utilized planning vaccination campaign waiting vaccine development,covid-19;covid-19 vaccine acceptance;saudi arabia;vaccine;vaccine hesitancy
Incidence course COVID19 hospitalization among patient familial Mediterranean fever,34293118,OBJECTIVES evaluate incidence hospitalization COVID19 patient familial Mediterranean fever FMF compared general population compare disease course FMF inpatient age sex ethnicity comorbiditymatched nonFMF COVID19 inpatient METHODS used electronic medical record EMR obtain data total number insured population number FMF patient two largest health management organization HMOs Jerusalem Clalit Meuhedet total number COVID19 inpatient Hadassah Medical Center including FMF period 1 February 2020 10 March 2021 retrieved EMR Hadassah COVID19 course compared FMF inpatient group age sex ethnicity comorbiditymatched nonFMF COVID19 inpatient FMF inpatient matched 2 nonFMF control RESULTS found statistically significant difference odds hospitalization COVID19 FMF patient nonFMF population 046 v 041 p= 073 Furthermore found similar disease severity therapeutic approach FMF COVID19 inpatient matched nonFMF COVID19 inpatient CONCLUSIONS Neither FMF baseline colchicine therapy appear affect incidence hospitalization COVID19 disease course term severity therapeutic approach,covid-19;sars-cov-2;colchicine;familial mediterranean fever;hospitalization
Knowledge attitude practice safety measure corona virus disease 19 COVID19 among general population,34290180,Objective evaluate knowledge attitude practice general population Corona virus disease 19 COVID19 Methods total 950 participant submitted online selfadministered questionnaire developed literature search validated online survey link distributed various social medium platform WhatsApp Instagram Facebook LinkedIn Twitter Snapchat Pinterest Tumblr 861 form included study checking completion relevant response participant whereas 89 form excluded data analyzed Statistical Package Social Sciences Descriptive statistic performed percentage frequency determination quantitative qualitative variable Spearman s correlation Chi square test performed control confounders association knowledge attitude practice gender education level P value 005 considered statistically significant Results two third population aware COVID19 three fourth bachelor s degree whereas 18 master level education 85 attended course awareness campaign lecture inculcate recent updated knowledge 83 believed COVID19 serious threat community hence prevention strategy adopted significant relationship p = 023 knowledge attitude practice level gender whereas significant relationship p = 001 noted education participant Similarly significant relationship p = 000 seen knowledge practice participant toward COVID19 Conclusion studied population displayed adequate knowledge attitude practice combat COVID19 However also find knowledge gap information source perception COVID19 among study participant Therefore critical need effective education widespread public campaign aiming enhance relevant contemporary information related prevention management COVID19,awareness;covid-19;general population;knowledge;safety measures
Unmasking demand mask Analytics mandating coronavirus mask,34226764,paper analytically examines demand surgical mask following recent health precaution due coronavirus Using simple linear demand curve alternatively examining impact requirement mandate wearing mask frontline worker b suggested required masking whole public c compulsory masking whole public impact different scenario price elasticity demand determined along slope rate change elasticity result differ nonlinear demand curve considered instead equilibrium mask price increase mask universally mandated whereas consumer surplus higher mask recommended mandated However ranking consumer surplus shown sensitive supply elasticity mask consideration enable structured mean view demand implication masking requirement provide food policy thought,covid-19;consumer surplus;coronavirus;demand analysis;demand complementarity;elasticity;health;market equilibrium;regulation
COVID19related Gastrointestinal Bleeding Pediatric Patient,34133380,Coronavirus disease 2019 COVID19 contagious disease caused severe acute respiratory syndrome coronavirus2 Patients hematologic malignancy shown higher risk mortality due COVID19 reported general adult population Reports acute lymphoblastic leukemia COVID child scarce present case 11yearold male patient undergoing treatment Bcell acute lymphoblastic leukemia atypical course COVID19 patient received positive result syndrome coronavirus2 polymerase chain reaction test performed due epidemiologic reason chemotherapy continued since patient clinical sign COVID19 disease started intensive gastrointestinal bleeding followed severe respiratory tract infection 2 week later,
ACE2lentiviral transduction enables mouse SARSCoV2 infection mapping receptor interaction,34214142,SARSCoV2 us human ACE2 hACE2 receptor cell attachment entry mouse ACE2 mACE2 unable support infection Herein describe ACE2lentivirus system illustrate utility vitro vivo SARSCoV2 infection model Transduction nonpermissive cell line hACE2 imparted replication competence transduction mACE2 containing N30D N31K F83Y H353K substitution match hACE2 rescued SARSCoV2 replication Intrapulmonary hACE2lentivirus transduction C57BL6J mouse permitted significant virus replication lung epithelium RNASeq histological analysis illustrated model involved acute inflammatory disease followed resolution tissue repair transcriptomic profile similar seen COVID19 patient hACE2lentivirus transduction IFNAR IL28RA mouse lung used illustrate loss type III interferon response significant effect virus replication However importance driving inflammatory response illustrated RNASeq analysis also demonstrate utility hACE2lentivirus transduction system vaccine evaluation C57BL6J mouse ACE2lentivirus system thus broad application SARSCoV2 research providing tool mutagenesis study mouse model development,
Circulating miRNAs Potential diagnostic role coronavirus disease 2019 COVID19,34343725,Nowadays coronavirus disease COVID19 pandemic caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 represents major global health problem Intensive effort employed better understand pathology develop strategy enabling early diagnosis efficient treatment study compared signature circulating miRNAs plasma COVID19 patient versus healthy donor MiRCURY LNA miRNA miRNome qPCR Panels performed miRNA signature characterization Individual quantitative realtime PCR qRTPCR carried validate miRNome qPCR result Receiveroperator characteristic ROC curve analysis applied ass diagnostic accuracy significantly deregulated miRNA potential diagnostic biomarker Eight miRNAs identified differentially expressed miR175p miR1425p downregulated whilst miR15a5p miR19a3p miR19b3p miR23a3p miR92a3p miR320a upregulated SARSCoV2infected patient ROC curve analysis revealed AUC Areas ROC Curve 0815 P=0031 0875 P=0012 0850 P=0025 miR19a3p miR19b3p miR92a3p respectively Combined ROC analysis using 3 miRNAs showed greater AUC 0917 P=00001 indicating robust diagnostic value 3 miRNAs result suggest plasma miR19a3p miR19b3p miR92a3p expression level could serve potential diagnostic biomarker andor putative therapeutic target SARSCoV2infection,biomarkers;coronavirus;plasma;severe acute respiratory syndrome;mirnas
SARSCoV2 Overview Virus Genetics Transmission Immunopathogenesis,34200934,human population currently facing third possibly worst pandemic caused human coronaviruses CoVs virus first reported Wuhan China 31 December 2019 spread within short time almost country world Genome analysis early virus isolates revealed high similarity SARSCoV hence new virus officially named SARSCoV2 Since CoVs largest genome among RNA virus adapt many point mutation recombination event particularly spike gene enable virus rapidly change evolve nature CoVs known cross specie boundary using different cellular receptor animal reservoir intermediate host SARSCoV2 still unresolved necessitate investigation current review different aspect SARSCoV2 biology pathogenicity discussed including virus genetics evolution spike protein role evolution adaptation novel host virus transmission persistence nature addition immune response developed SARSCoV2 infection demonstrated special reference interplay immune cell role disease progression believe SARSCoV2 outbreak last spillover CoVs bat continue Therefore establishing intervention approach reduce likelihood future CoVs spillover natural reservoir priority,covid-19;sars-cov-2;coronavirus;cross-species transmission;evolution;immune response
Acute Care Reimagined Home Hospital Care Support Triple Aim Reduce Health Disparities,34228685,EXECUTIVE SUMMARY Home hospital care HHC new exciting concept hold promise achieving three component Triple Aim reducing health disparity innovative care delivery model HHC substitute traditional inpatient hospital care hospital care home older patient certain condition Studies shown evidence reduced cost care improved patient satisfaction enhanced quality safety care patient treated model steady growth Medicare Advantage enrollment expansion 2020 Centers Medicare Medicaid Services CMS Hospitals Without Walls program include acute hospital care home creates opportunity hospital implement program financially rewarded reducing cost Capacity constraint exacerbated COVID19 pandemic suggest ideal time healthcare leader test advance concept HHC community,
Prevention therapy SARSCoV2 B1351 variant mouse,34289384,Improving clinical care individual infected SARSCoV2 variant global health priority Smallmolecule antiviral like remdesivir RDV biologics human monoclonal antibody mAbs demonstrated therapeutic efficacy SARSCoV2 causative agent coronavirus disease 2019 COVID19 known whether combination RDVmAb improve outcome singleagent therapy whether antibody therapy remain efficacious variant show combination two mAbs clinical trial C144 C135 potent antiviral effect even initiated 48 h infection therapeutic efficacy vivo B1351 variant concern VOC Combining RDV antibody provided modest improvement outcome compared single agent data support continued use RDV treat SARSCoV2 infection continued clinical development C144 C135 antibody combination treat patient infected SARSCoV2 variant,b.1.351;covid-19;rdv;sars-cov-2;monoclonal antibodies;remdesivir;therapy;variants
Living Donor Liver Transplantation COVID19 Pandemic Evolving Challenge,34131867,BACKGROUND Maintaining standard living donor liver transplantation LDLT challenge corona virus disease 2019 COVID19 pandemic Centerspecific protocol developed transplant society propose limiting elective LDLT looked outcome LDLT pandemic exclusively LDLT center METHODS Patients grouped preCOVID January 2019February 2020 n = 162 COVID March 2020January 2021 n = 53 cohort looked patient characteristic 30day morbidity mortality Outcomes also assessed donor recipient underwent surgery recovery COVID19 RESULTS average number transplant reduced 115month 48month Fewer patient MELD 20 underwent LDLT COVID cohort 413 versus 245 P = 003 nine patient positive pretransplant COVID19 PCR 2 223 death waiting list Seven patient underwent LT recovery COVID19 one 30day mortality due biliary sepsis Three donor positive COVID19 PCR underwent uneventful donation testing negative COVID19 significant difference 30day survival observed preCOVID COVID cohort 932 versus 906 P = 03 two recipient developed COVID19 pneumonia within 30 day LT one mortality 1year survival entire cohort MELD cutoff 20 90 84 P = 02 CONCLUSION Despite comparable outcome fewer sick patient might undergo LDLT pandemic Individuals recovered COVID19 might safely considered donation transplantation,covid-19;living donor liver transplantation;meld score;survival
COVID19 patient obesity risk worse outcome despite younger age fewer inflammatory derangement,34353740,BACKGROUND Coronavirus disease 2019 COVID19 viral pulmonary infection progress cytokine storm syndrome widespread dysregulated inflammatory response Many patient risk severe COVID19 manifestation identified preexisting condition pulmonary origin well condition impair appropriate immune response obesity OBJECTIVES aim study describe manifestation clinical course inflammatory biomarker milieu COVID19 patient obesity SETTING University Hospital Philadelphia Pennsylvania METHODS retrospective cohort study 600 patient positive COVID19 stratified World Health Organization obesity class presenting symptom disease biomarkers demographic outcome intubation rate intensive care unit ICU admission length stay LOS mortality investigated RESULTS Age inversely related obesity class patient obesity class III presented 129 year younger patient normal weight P 0001 Initial ferritin lab value negatively correlated increasing obesity class P = 0192 Normal nearnormal lymphocyte profile noted patient obesity compared patient without obesity P = 0017 Patients obesity increased rate ICU admission P = 0215 increased length stay P = 0004 difference intubation rate P = 3705 mortality P = 2486 CONCLUSION Patients obesity likely present hospital younger age reduced level COVID19 related biomarker disturbance increased LOS ICU admission rate although increased risk mortality,body mass index;covid-19;d-dimer;ferritin;inflammation;lymphopenia;obesity;sars-cov-2
Mobile PSA Novel Telehealth Tool Prostate Cancer FollowUp,34337524,prevalence prostate cancer PCa increasing prognosis PCa continues improve increasing followup requirement radical prostatectomy radiotherapy put significant pressure health care system Followup typically conducted treating urologist specialized nurse general practitioner Despite increase patient number resource likely increase proportion Furthermore ongoing COVID19 pandemic led paradigm shift thinking towards telehealth solution primarily avoid limit physical contact spare resource report novel telehealth solution PCa followup called Mobile PSA Currently 4500 PCa patient using Mobile PSA followup center Mobile PSA increase followup accuracy biochemical relapse detected timely manner significantly reduce delay reporting prostatespecific antigen result patient significantly reduce cost Patient summary assessed new telehealth information system prostate cancer followup use app 4500 prostate cancer patient center used system called Mobile PSA followup system significantly reduces delay reporting prostatespecific antigen PSA test result patient increase accuracy detecting recurrence elevated PSA reduces cost,covid-19;follow-up;prostate cancer;prostate-specific antigen;telemedicine;ehealth
Multidisciplinary Approach Coronavirus Disease COVID19,34207756,Since December 2019 humanity faced important global threat Many study published origin structure mechanism action SARSCoV2 virus treatment disease priority scientist world direct time research subject review highlight chemical study therapeutic approach overcome COVID19 seven different section section structure mechanism action SARSCoV2 immunotherapy vaccine computeraided drug design repurposing therapeutic COVID19 synthesis new molecular structure COVID19 food safetysecurity functional food component potential natural product COVID19 work aimed screen newly synthesized compound repurposing chemical covering antiviral antiinflammatory antibacterial antiparasitic anticancer antipsychotic antihistamine compound COVID19 also highlight computeraided approach develop antiCOVID19 molecule explain phytochemical dietary supplement identified antiviral bioproducts almost successfully tested COVID19 addition present immunotherapy type target immunotherapy inflammationmutations virus immune response vaccine issue,covid-19;sars-cov-2;cytokine storm;dietary supplements;immunotherapy;in-silico research;natural products;repurposing drugs;small drugs;vaccine development
Retrospective Analysis Effects NonCompliance Denosumab Changes Bone Mineral Density COVID19 Pandemic,34290494,Purpose Although denosumab safe effective treatment osteoporosis various clinical trial study investigated efficacy specific clinical situation effect noncompliance standard sixmonth dosing regimen denosumab bone mineral density BMD assessed retrospective study patient prescribed denosumab COVID19 pandemic Patients Methods February 2019 September 2020 638 patient record reviewed 236 patient meeting eligibility criterion Patients divided three group received denosumab injection five seven month initial subcutaneous injection received denosumab injection seven nine month initial subcutaneous injection received denosumab injection nine month initial subcutaneous injection multivariate regression study conducted compare BMD shift least one year apart two denosumab injection three prespecified group lumbar spine LS femoral neck FN Results difference LS BMD indicates statistical difference subject received denosumab injection 5 7 month nearstandard dosing interval 9 month P=003 FN BMD clinically significant association identified Conclusion result study show special clinical situation COVID19 pandemic clinician may flexibility prescribe denosumab interval injection exceed 9 month,covid-19;bone mineral density;compliance;denosumab;osteoporosis
Investigation management pulmonary embolism 2 specific clinical condition,34338010,Pulmonary embolism remains common potentially deadly disease despite advance diagnostic imaging treatment prevention Managing pulmonary embolism requires multifactorial approach involving risk stratification determining appropriate diagnostics selecting individualised therapy first part article reviewed pathophysiology risk factor clinical presentation diagnostic evaluation therapeutic management early outpatient management pulmonary embolism second part summarises pulmonary embolism setting pregnancy COVID19 recurrent disease chronic thromboembolic pulmonary hypertension,ambulatory management;covid-19;chronic thromboembolic pulmonary hypertension;computed tomography pulmonary angiogram;pregnancy;pulmonary embolism;ventilation/perfusion scan
Flavonoids Promising Antiviral Agents SARSCoV2 Infection Mechanistic Review,34202374,newly diagnosed coronavirus 2019 COVID19 affected human activity since discovery Flavonoids commonly found human diet attracted lot attention due remarkable biological activity paper provides comprehensive review benefit flavonoid COVID19 disease Previouslyreported effect flavonoid five RNA virus similar clinical manifestation andor pharmacological treatment including influenza human immunodeficiency virus HIV severe acute respiratory syndrome SARS Middle East respiratory syndrome MERS Ebola considered Flavonoids act via direct antiviral property inhibit different stage virus infective cycle indirect effect modulate host response viral infection subsequent complication Flavonoids shown antiviral activity via inhibition viral protease RNA polymerase mRNA virus replication infectivity compound also effective regulation interferon proinflammatory cytokine subcellular inflammatory pathway nuclear factorkappaB Jun Nterminal kinase Baicalin quercetin derivative hesperidin catechin studied flavonoid regard conclusion dietary flavonoid promising treatment option COVID19 infection however future investigation recommended ass antiviral property compound disease,antiviral;inflammation;lung;oxidative damage;polyphenol
Physical Activity among Adults Residing 11 Countries COVID19 Pandemic Lockdown,34280992,novel coronavirus COVID19 pandemic physical activity PA behavior altered worldwide due public health measure `` lockdown study described PA among adult residing 11 country COVID19 lockdown examined factor associated PA engagement conducted crosssectional anonymous survey among adult =18 year old 11 country Brazil Bulgaria China India Ireland Malaysia North Macedonia Singapore Spain Turkey United States 11775 participant 637 female 528 1834 year old 40 participant insufficiently active 439 reported decrease PA lockdown 448 Statistically significant difference observed 1 proportion participant insufficiently active 2 level PA 3 decrease PA across 11 country stringent governmental policy response associated greater likelihood insufficiently active lockdown adjusted odds ratio = 122 95 confidence interval = 103 145 Higher depression anxiety score associated greater likelihood decreased level PA lockdownWe found substantial reduction PA level COVID19 lockdown across country Countryspecific PA promotion intervention needed similar global emergency,changes in physical activity;governmental policy responses;insufficiently active
Use Antimicrobials among Suspected COVID19 Patients Selected Hospitals Bangladesh Findings First Wave COVID19 Pandemic,34207020,Antimicrobials empirically used COVID19 patient resulting increased antimicrobial resistance objective ass antimicrobial use among suspected COVID19 inpatients March August 2020 collected data inpatients 12 tertiarylevel hospital across Bangladesh identified suspected COVID19 patient collected information antimicrobial received within 24 h hospitalization tested nasopharyngeal swab SARSCoV2 using rRTPCR used descriptive statistic regression model data analysis Among 1188 suspected COVID19 patient 69 male 40 comorbidities 53 required oxygen Antibiotics used 92 patient 47 within 24 h 89 admission Patients also received antiviral 1 antiparasitic drug 3 Thirdgeneration cephalosporin use highest 708 60 followed macrolide 481 40 majority 853 78 took antibiotic SARSCoV2 negative admission 77 mild 94 moderately ill patient received antibiotic Antibiotic use admission higher among severely ill patient AOR = 117 95 CI 45301 received antibiotic within 24 h hospital admission AOR = 16 95 CI 1025 Antimicrobial use highly prevalent among suspected COVID19 inpatients Bangladesh Initiating treatment thirdgeneration cephalosporin among mild moderately ill patient common Promoting antimicrobial stewardship monitoring essential prevent blanket antibiotic use thereby mitigating antimicrobial resistance,bangladesh;covid-19;sars-cov-2;antibiotic;antimicrobial use;suspected covid-19
Epicardial adipose tissue severe Coronavirus Disease 19,34284784,BACKGROUND visceral adipose tissue epicardial adipose tissue EAT proinflammatory property former associated Coronavirus Disease 19 COVID19 severity aimed investigate whether association also exists EAT MATERIAL METHODS retrospectively measured EAT volume using computed tomography CT scan semiautomatic software inpatient COVID19 analyzed correlation EAT volume anthropometric characteristic comorbidities analyzed clinicobiological radiological parameter associated severe COVID19 O2 Formula see text 6 lmin intensive care unit ICU admission death 25 CT lung involvement three key indicator COVID19 severity RESULTS included 100 consecutive patient 63 men mean age 618 + 162 year 47 obese 54 hypertension 42 diabetes 172 cardiovascular event history Severe COVID19 n = 35 35 associated EAT volume 132 + 62 v 104 + 40 cm 3 p = 002 age ferritinemia 25 CT lung involvement ICU admission death n = 14 14 associated EAT volume 153 + 67 v 108 + 45 cm 3 p = 0015 hypertension 25 CT lung involvement association EAT volume severe COVID19 remained adjustment sex BMI ferritinemia lung involvement adjustment age Instead association EAT volume ICU admission death remained adjustment five parameter CONCLUSIONS result suggest measuring EAT volume chest CT scan hospital admission patient diagnosed COVID19 might help ass risk disease aggravation,covid-19;epicardial adipose tissue (eat);epicardial fat volume;inflammation
22yearold COVID19 positive male prior medical history presented emergency department pulmonary infarction,34211651,Rapidly growing evidence shown high incidence venous thrombosis patient severe acute respiratory syndrome secondary novel coronavirus 2 disease named COVID19 Accumulating case report series also shown higher prevalence arterial thrombosis patient well Although pathophysiology remains unknown likely multifactorial including endotheliitis direct viral damage underlying hyperinflammatory state arterial venous thrombosis occurrence appear linked underlying classic risk factor venous thromboembolism may present healthy patient without significant comorbidities present case 22yearold healthy patient COVID19 developed pulmonary embolism pulmonary infarction complication result arterial venous thrombosis pulmonary vascular supply resulting tissue necrosis,covid-19;pulmonary infarction;hypercoagulability
Vaccination PADs,34207916,Primary antibody deficiency PADs common primary immunodeficiency PIDs divided following group depending immunological feature agammaglobulinemia common variable immunodeficiency CVID isotype hyper IgM isotype light chain functional deficiency normal B cell count specific antibody deficiency normal Ig concentration normal number B cell transient hypogammaglobulinemia infancy role vaccination PADs recognized therapeutic diagnostic prognostic may used patient residual Bcell function provide humoral immunity specific infective agent According content mechanism vaccine grouped live attenuated inactivated conjugated polysaccharide mRNA replicationdeficient vector vaccine Vaccination may unsafe le effective using certain vaccine specific type immunodeficiency Inactivated vaccine administered PAD patient even could generate protective response live attenuated vaccine recommended major antibody deficiency December 2020 European Medicines Agency EMA approved vaccine COVID19 infection according ESID advises vaccination recommended patient PADs specific data available safety efficacy PAD patient,antibody deficiency;immunization;immunodeficiency;vaccination recommendations
Risk missing colorectal cancer COVIDadapted diagnostic pathway using quantitative faecal immunochemical testing,34228096,BACKGROUND COVID19 brought unprecedented challenge healthcare service author COVIDadapted pathway suspected bowel cancer combine two quantitative faecal immunochemical test qFITs standard CT scan oral preparation CT miniprep aim study estimate degree risk mitigation residual risk undiagnosed colorectal cancer METHOD Decisiontree model developed using combination data COVIDadapted pathway AprilMay 2020 local audit qFIT symptomatic patient performed since 2018 relevant data prevalence colorectal cancer sensitivity specificity diagnostic tool obtained literature local cancer data set expert opinion missing data considered diagnostic scenario included single qFIT two qFITs single qFIT CT miniprep two qFITs CT miniprep enriched pathway compared standard diagnostic pathway colonoscopy CT virtual colonoscopy CTVC RESULTS COVIDadapted pathway included 422 patient whereas audit qFIT included 5000 patient risk missing colorectal cancer present estimated high 202 per cent use single qFIT triage test Using second qFIT CT miniprep addon test reduced risk missed cancer 649 per cent tradeoff increased rate colonoscopy CTVC 287 single qFIT 418 double qFIT CT miniprep combination per 1000 patient CONCLUSION Triage using qFIT alone could lead high rate missed cancer may reduced using CT miniprep addon test triage colonoscopy CTVC,
Cardiac involvement consecutive unselected hospitalized COVID19 population Inhospital evaluation oneyear followup,34224766,BACKGROUND Cardiovascular disease CVD occur COVID19 impact clinical course Data CVD prevalence hospitalized COVID19 patient sequela survivor limited Aim prospective study carried consecutive unselected COVID19 population ass 1 CVD occurrence among hospitalized COVID19 patient 2 persistence new onset CVD onemonth oneyear followup METHODS 30 day n = 152 COVID19 patient underwent cardiovascular evaluation Standard electrocardiogram ECG Troponin echocardiography integrated test indicated Medical history arterial blood gas blood test chest computed tomography treatment recorded CVD defined occurrence new condition hospitalization COVID19 Survivors attended onemonth followup visit oneyear telephone followup RESULTS Fortytwo patient 28 experienced wide spectrum CVD acute myocarditis frequent Death occurred 32 patient 21 frequently patient developed CVD p = 0032 adjustment confounders CVD independently associated death occurrence onemonth followup visit 7 patient 9 presented persistent delayed CVD oneyear telephone followup 57 patient 48 reported persistent symptom CONCLUSION Cardiovascular evaluation COVID19 patient crucial since occurrence CVD hospitalized COVID19 patient common 28 requires specific treatment increase risk inhospital mortality Persistence delayed presentation CVD 1month 9 persistent symptom 1year followup 48 suggest need monitoring COVID19 survivor,covid-19;cardiovascular disease;cardiovascular magnetic resonance;echocardiography;follow-up;myocarditis
Codistribution Light Night LAN COVID19 incidence United States,34348695,BACKGROUND Light night LAN circadian disruption factor may affect human immune system consequently increase individual s susceptibility severity infectious disease COVID19 COVID19 infection spread differently state United States US current analysis aimed test whether association LAN COVID19 case 4 selected US state Connecticut New York California Texas METHODS analyzed clustering pattern COVID19 case ArcMap performed multiple linear regression model using data LAN COVID19 incidence adjustment confounding variable including population density percent poverty racial factor RESULTS Hotspots LAN COVID19 case located large city metrocenters 4 state LAN intensity associated cases1 k overall lockdown duration New York Connecticut P 0001 Texas California overall case rate significantly associated LAN New York P 0001 Connecticut P 0001 CONCLUSIONS observed significant positive correlation LAN intensity COVID19 casesrate1 k suggesting circadian disruption ambient light may increase COVID19 infection rate possibly affecting individual s immune function Furthermore difference demographic structure lockdown policy different state play important role COVID19 infection,covid-19;light at night (lan)
Emergency dental care adult child new coronavirus infection caused SARSCov2 outpatients dental clinic megapolis,34357735,BACKGROUND article presented data organization medical care period 10 month Municipal Public Dental clinic metropolitan city SaintPetersburg patient diagnosed new coronavirus infection AIM Organization medical ambulatory care patient diagnosed new coronavirus infection MATERIALS METHODS Layout decision utilized enabled organize reception patient infected SARSCoV2 without disrupting scheduled mode treatment dental patient Saint Petersburg Budgetary Healthcare Facility Municipal Dental Clinic N 33 provided dental service 191 patient COVID19 RESULTS Whereas 159 patient admitted treatment contagious isolation ward 89 patient consulted via use telehealth technology among 39 received telemedical assistance service Mean age patient treated isolated ward child 86+36 adult 391+138 year People active working age comprised 72 adult patient Males filed dental assistance female 54 ICD K045 established diagnosis 52 case CONCLUSIONS managed demonstrate high efficiency utilizing telehealth technology issue organizing medical dental care II level healthcare institution adult population child diagnosed new coronavirus infection COVID19 heavy populated metropolis solved,covid-19;sars-cov-2;dental care;dental practice
Title Covid19associated coagulopathy,34344026,COVID19 primarily respiratory disease considered multisystemic disease symptom severity increase Blood coagulation abnormality key feature patient severe symptom indicative high risk venous arterial thromboembolism COVID19 prothrombotic condition caused interplay infectious agent inflammation blood coagulation system referred COVID19associated coagulopathy characterized greatly increased Ddimer high fibrinogen extended prothrombin time reduced number platelet Due high thrombotic potential prophylactic anticoagulation recommended hospitalized patient However optimal dosage anticoagulation still debated article provide overview current state knowledge COVID19associated coagulopathy discus clinical therapeutic consequence,
Protective Measures COVID19 Dental Practice Infection Control,34200036,onset Coronavirus 2019 COVID19 pandemic challenged worldwide healthcare sector including dentistry highly infectious nature severe acute respiratory syndrome coronavirus 2 SARSCoV2 virus risk transmission aerosol generating procedure profoundly impacted delivery dental care service globally dental practice renewed infection control strategy preventive measure reopening `` new normal period responsibility healthcare professional constantly analyze new data limit spread COVID19 dental care setting light new variant SARSCoV2 rapidly emerging different geographic location urgent need comply ever rigorous public health measure mitigate COVID19 transmission aim article provide dental clinician essential information regarding spread SARSCoV2 virus protective measure COVID19 transmission dental facility complied provided guidance standard protocol recommended credible national international organization review serve aid navigating unprecedented time ease reviewed available literature recommended best current practice must taken dental office function safely successfully,covid-19;sars-2;coronavirus;dentistry;disinfection;infection control
Centenarians extremely old people living frailty elicit durable SARSCoV2 spike specific IgG antibody virus neutralization function following virus infection determined serological study,34222846,Background SARSCoV2 Severe Acute Respiratory Syndrome coronavirus 2 led 165 million COVID19 case 34 million death worldwide Epidemiological analysis revealed risk developing severe COVID19 increase age Despite disproportionate number older individual longterm care facility affected SARSCoV2 COVID19 little understood immune response development humoral immunity extremely old person SARSCoV2 infection conducted serological study investigate development humoral immunity centenarian following SARSCoV2 outbreak longterm care facility Methods Extreme aged individual centenarian resident longterm care facility infected exposed SARSCoV2 investigated April June 2020 development antibody SARSCoV2 Blood sample collected positive bystander individual 30 60 day original diagnosis SARSCoV2 infection Plasma used quantify IgG IgA IgM isotypes subsequent subclass antibody specific SARSCoV2 spike protein function antispike assessed virus neutralization assay native SARSCoV2 virus Findings Fifteen longterm care resident investigated SARSCoV2 infection individual Clinical Frailty scale score =5 extreme older age centenarian Six woman median age 988 year tested positive SARSCoV2 Antispike IgG antibody titer highest titer observed cohort IgG positive individual virus neutralization ability Additionally 5 6 positive participant robust IgA antiSARSCoV2 response 5 antibody detected 60 day initial diagnosis,
Inaccurate nasopharyngeal testing patient gastrointestinal COVID19 case report,33785206,,
SARSCoV2 Infects Hamster Testes,34204370,COVID19 pandemic continues affect million people worldwide Although SARSCoV2 respiratory virus growing concern disease could cause damage pathology outside lung including genital tract Studies suggest SARSCoV2 infection damage testis reduce testosterone level underlying mechanism unknown evidence virus replication testicular cell lacking infected golden Syrian hamster intranasally model mild human COVID19 detected viral RNA testis sample without histopathological change one month postinfection Using ex vivo infection model detected SARSCoV2 replication hamster testicular cell Taken together data raise possibility testis damage observed severe case COVID19 could partly explained direct SARSCoV2 infection testicular cell,sars-cov-2;sertoli;hamster;reproductive tract;testes
Coronavirus 7th C affecting 6Cs focus compassion care touch,34379479,C0VID19 pandemic challenged everyone society child longer able attend school nursery adult trying juggle working home vulnerable member society needed selfisolate NHS staff key worker also need juggle family situation many adapt practice way working address demand placed NHS time current pandemic altered nature service provided patient staff wearing personal protective equipment many redeployed ward area article considers 6Cs nursing challenge faced staff COVID19 pandemic primary focus care compassion vital role touch care patient family also considered,covid-19;compassion;fatigue;pandemic;touch
Increase Antimicrobial Consumption Tertiary Care Hospital First Phase COVID19 Pandemic,34202340,Background COVID19 pandemic pose novel challenge antimicrobial consumption metric stewardship strategy COVID19 patient became major cause hospital admission first wave pandemic often leading antimicrobial prescription upon admission treatment superinfection aim study understand antimicrobial consumption impacted beginning pandemic tertiary care hospital reference center COVID19 Materials Methods retrospective beforeandafter study done Descriptive statistic discharge patientdays antimicrobial use indicator defined daily dos DDD 100 discharge DDD100 patientdays various group calculated first three month pandemic March April May 2020 quarterly value year 20112019 annual percentage change used estimate 95 confidence interval indicator compared patient type medicalsurgical type admission urgentelective age group using Spearman s correlation coefficient Results Statistically significant increase occurred 2020 total antibacterial macrolides cephalosporin amoxicillinclavulanic acid carbapenems meropenem thirdgeneration cephalosporin reduction seen cefazolincefoxitin correlation found antibacterial consumption patient admission type 2020 unlike prepandemic year different impact DDD100 discharge DDD100 patientdays due increased lengthsofstay longer antimicrobial therapy Conclusions COVID19 pandemic led increase antimicrobial consumption different impact DDD100 discharge DDD100 patientdays highlight need use indicator simultaneously better understand cause antimicrobial consumption variation improve design effective antimicrobial stewardship intervention,covid-19;antimicrobial agents;antimicrobial consumption indicators;antimicrobial stewardship;drug utilization
Possible Link SARSCoV2 Infection Parkinson s Disease Role TollLike Receptor 4,34281186,Parkinson s disease PD common neurodegenerative motor disorder characterized selective degeneration dopaminergic neuron substantia nigra par compacta SNpc midbrain depletion dopamine DA impaired nigrostriatal pathway pathological hallmark PD includes aggregation accumulation alphasynuclein alphaSYN Although precise mechanism underlying pathogenesis PD still unknown activation tolllike receptor TLRs mainly TLR4 subsequent neuroinflammatory immune response seem play significant role Mounting evidence suggests viral infection concur precipitation PD parkinsonism recently identified coronavirus named severe acute respiratory syndrome coronavirus 2 SARSCoV2 causative agent ongoing pandemic coronavirus disease 2019 COVID19 responsible 160 million case led death three million individual worldwide Studies reported many patient COVID19 display several neurological manifestation including acute cerebrovascular disease conscious disturbance typical motor nonmotor symptom accompanying PD review neurotropic potential SARSCoV2 possible involvement pathogenesis PD discussed Specifically involvement TLR4 signaling pathway mediating virus entry well massive immune inflammatory response COVID19 patient explored binding SARSCoV2 spike protein TLR4 possible interaction SARSCoV2 alphaSYN contributing factor neuronal death also considered,covid-19;parkinson's disease;sars-cov-2;neuroinflammation;synuclein;toll-like receptor 4
SARSCoV2 screening effectiveness risk increasing transmission,34283945,Testing asymptomatic people SARSCoV2 aim reduce COVID19 transmission Screening programme effectiveness depends upon testing strategy sample handling logistics test sensitivity individual behaviour addition dynamic viral transmission interaction factor fully characterized investigated interaction factor determine optimize reduction transmission estimate idealistic assumption 70 transmission may averted realistic assumption 7 may averted show programme overwhelm laboratory capacity reduce isolation minor symptom increased transmission compared programme need designed avoid issue ineffective even counterproductive model allows optimal selection test quantifies balance accuracy timeliness quantifies potential impact behavioural intervention anticipate model used understand optimal screening strategy infectious disease substantially different dynamic,covid-19 pandemic;sars-cov-2;infection transmission;mass screening
emerging SARSCoV2 variant concern,34211709,Since emerging Wuhan China December 2019 coronavirus SARSCoV2 causing devastating severe respiratory infection human worldwide disease spreading faster medical community could contain death toll increased alarming rate worldwide causing World Health Organization officially sanction SARSCoV2 outbreak pandemic leading state worldwide lockdown majority year 2020 report new strain virus emerging various part world strain displaying even greater infectivity transmissibility Areas emerging variant concern arise country like United Kingdom South Africa Brazil India mutation carry lineage N501Y D614G N439K Y453F others globally dominated clade 20A 20B 20C literature review intends identify report SARSCoV2 variant currently evolving disease implication,501.v3;501y.v1;501y.v2;ace2;b.1.1.7;covid-19;d614g;e484k;n439k;n501y;sars-cov-2;y453f;genetic variations;spike mutations;variants of concern
Resilience COVID19 Italy Faced Pandemic Pediatric Orthopedics Traumatology,34206218,BACKGROUND aimed investigate variation medical surgical activity pediatric orthopedics Italy year COVID19 pandemic comparison data previous two year difference among first wave phase 2 second wave also analyzed METHODS conducted retrospective multicenter study regarding clinical surgical activity pediatric orthopedics pandemic prepandemic period hospital database seven tertiary referral center pediatric orthopedics traumatology queried event regarding pediatric orthopedic patient 1 March 2018 28 February 2021 Surgical procedure classified according `` SITOP Priority Panel additional classification `` highpriority `` lowpriority surgery also applied RESULTS Overall 2020 observed significant drop surgical volume compared previous two year decrease different across different class priority `` highpriority surgery le influenced decrease emergency department visit almost threefold greater decrease trauma surgery second wave lower decline surgical intervention noticeable resumption `` lowpriority surgery outpatient visit observed CONCLUSION study represents first nationwide survey quantifying impact COVID19 pandemic pediatric orthopedics traumatology first second wave,covid-19;orthopedics;pediatrics;statistics;surgery;traumatology
IMPACT COVID19 MENTAL HEALTH AGING,34377058,potential ramification COVID19 pandemic population s mental health rising global concern individual community level erratic uncertain COVID19 outbreak prospective exhibit detrimental effect psychological health aging present various measure dedicated parameter like awareness epidemiology clinical aspect mode transmission counteracting spread infection public health problem although initiative neglected critical mental health concern study investigate outbreak study level harmful effect mental health crosstalk aging Global execution preventive control measure resilience establishment challenging factor whereas reformed lifestyle lockdown coping selfisolation quarantine social distancing posttraumatic stress disorder alarming Hallmarks aging interact suggested affect healthspan aged adult possibly due attenuated immunity Among various hallmark concentrated show direct indirect interaction viral infection comprising inflammation genomic instability impaired mitochondrial function epigenetic modification telomere attrition damaged autophagy hallmark possibly contribute elicited pathophysiological response SARSCoV2 may add additive risk accelerated aging postrecovery among aged adult role antiaging drug candidate require main consideration COVID19 research discussed briefly later future emerge potential therapeutic approach treatment patient severe infection,covid-19;sars-cov-2;telomere;antiaging drug;autophagy
SARSCoV2 myocardial injury inflammation insight large clinical autopsy study,34282465,OBJECTIVE Despite growing evidence myocardial injury hospitalized COronaVIrus Disease 2019 COVID19 patient mechanism behind injury poorly understood little known association SARSCoV2mediated myocarditis Furthermore definite evidence presence role SARSCoV2 cardiomyocytes clinical scenario still lacking METHODS histologically characterized myocardial tissue 40 patient deceased severe SARSCoV2 infection first wave pandemic Clinical data also recorded analyzed case finding supportive myocardial inflammation histological analysis complemented RTPCR immunohistochemistry SARSCoV2 viral antigen situ RNA hybridization detection viral genome RESULTS chronic acute myocardial damage invariably present correlating age comorbidities population Myocarditis overt entity found one case 25 SARSCoV2 genome found cardiomyocytes patient myocarditis focally negligibly present cardiomyocytes patient known viral persistence lung sign myocardial inflammation presence myocardial injury associated myocardial inflammatory infiltrates CONCLUSIONS autopsy cohort COVID19 patient myocarditis rarely found associated SARSCoV2 presence cardiomyocytes Chronic acute form myocardial damage constantly found correlate severity COVID19 disease preexisting comorbidities,covid-19;cardiac autopsy study;myocardial injury;myocarditis;necrosis
mixedmethods study describing behavioral factor influenced general practitioner experience using triage COVID19 pandemic,34217208,BACKGROUND Early COVID19 pandemic general practice asked expand triage reduce unnecessary facetoface contact prioritizing consultation mode eg online messaging video telephone current study explores potential barrier facilitator general practitioner experienced expanding triage system attitude towards triage COVID19 pandemic METHOD mixedmethod study design used quantitative online survey conducted along qualitative interview gain nuanced appreciation practitioner experience United Kingdom survey item informed Theoretical Domains Framework would capture 14 behavioral factor may influence whether practitioner use triage system Items responded using sevenpoint Likert scale median score calculated item response participant identifying partowner nonowners ie `` partner vs `` nonpartner practitioner compared semistructured interview conducted remotely examined using Braun Clark s thematic analysis RESULTS survey completed 204 participant 66 Female participant 83 reported triaging patient item highest median score captured Knowledge Skills SocialProfessional role identity Beliefs capability domain item lowest median score captured Beliefs consequence Goals Emotions domain 14 17 item partner score higher nonpartner score qualitative interview participant relied phone triage system Six broad theme discovered patient accessibility confusion around triage uncertainty risk relationship service provider job satisfaction potential total digital triage Suggestions arose optimize triage ensuring sufficient time conduct triage accurately providing practical training use triage efficiently CONCLUSIONS Many general practitioner engaging expanded triage system though support needed achieve total triage across practice Nonpartner practitioner likely require support use triage system practice take Additionally practical support made available help practitioner manage new risk uncertainty likely experience nonfacetoface consultation,digital triage;general practice;telephone triage;theoretical domains framework;triage
Role JAKSTAT Interstitial Lung Diseases Molecular Cellular Mechanisms,34207510,Interstitial lung disease ILDs comprise different fibrotic lung disorder characterized cellular proliferation interstitial inflammation fibrosis JAKSTAT molecular pathway activated interaction broad number profibroticproinflammatory cytokine IL6 IL11 IL13 among others increased different ILDs Similarly several growth factor overexpressed ILDs plateletderived growth factor PDGF transforming growth factor beta1 TGFbeta1 fibroblast growth factor FGF activate JAKSTAT canonical noncanonical pathway indicates predominant role JAKSTAT ILDs different JAKSTAT isoforms appears JAK2STAT3 predominant initiating cellular change observed ILDs review analyzes expression distribution different JAKSTAT isoforms ILDs lung tissue different cell type related ILDs lung fibroblast alveolar epithelial type II cell analyzes JAKSTAT activation effect JAKSTAT phosphorylation cellular fibrotic process proliferation senescence autophagy endoplasmic reticulum stress epithelialfibroblast mesenchymal transition described small molecule directed inhibit JAKSTAT activation assayed vitro vivo model pulmonary fibrosis different JAK inhibitor currently approved myeloproliferative disorder Recent evidence indicates JAK inhibitor monoclonal antibody directed block IL6 used compassionate use attenuate excessive inflammation lung fibrosis related SARSCoV2 virus altogether indicate JAKSTAT pathway attractive target proven future clinical trial lung fibrotic disorder,janus kinases (jak);idiopathic pulmonary fibrosis (ipf);interstitial lung disease (ild);signal transducer and activator of transcription (stat)
Differential Kinetics Cycle Threshold Values Admission Symptoms among Patients Mild COVID19 Prospective Cohort Study,34360473,coronavirus disease 2019 COVID19 pandemic half case transmission may occur via asymptomatic individual make difficult contain However whether viral load throat admission different asymptomatic symptomatic patient well known conducting prospective cohort study patient asymptomatic mild COVID19 cycle threshold Ct value polymerase chain reaction test COVID19 examined every day admission Ct value admission increased steadily symptomatic patient febrile patient asymptomatic patient significance p = 001 p = 0004 respectively although Ct value whole significantly different two group Moreover Ct value whole higher patient dysosmiadysgeusia without p = 002 whereas lower patient headache without p = 001 Patients IgGpositive discharge maintained higher Ct value eg 35 admission IgGnegative p = 003 Assuming viral load Ct value negatively associated viral load whole change time may different symptom immune reaction ie IgGpositive discharge,covid-19;ct;pcr;sars-cov-2;afebrile;asymptomatic;coronavirus disease 2019;cycle threshold;febrile;mild
Risk Factors Infection Hospitalization Death SARSCoV2 PopulationBased Cohort Study,34199198,conducted prospective populationbased cohort study ass risk factor infection hospitalization death SARSCoV2 study comprised people covered Health Service Navarre Spain Sociodemographic variable chronic condition obtained electronic healthcare database Confirmed infection hospitalization death SARSCoV2 obtained enhanced epidemiological surveillance second SARSCoV2 epidemic surge JulyDecember 2020 diagnostic test widely available Among 643757 people 5497 confirmed infection 323 hospitalization 38 intensive care unit admission 72 death SARSCoV2 per 100000 inhabitant observed higher incidence confirmed infection associated people aged 1529 year nursing home resident healthcare worker people born Latin America Africa well diagnosed diabetes cardiovascular disease chronic obstructive pulmonary disease COPD chronic kidney disease dementia severe obesity hypertension functional dependence risk hospitalization population associated male higher age nursing home resident Latin American African origin diagnosed immunodeficiency diabetes cardiovascular disease COPD asthma kidney disease cerebrovascular disease cirrhosis dementia severe obesity hypertension functional dependence risk death associated male higher age nursing home resident Latin American origin low income level immunodeficiency diabetes cardiovascular disease COPD kidney disease dementia functional dependence study support prioritization older population nursing home resident people chronic condition functional dependence SARSCoV2 prevention vaccination highlight need additional preventive support immigrant,covid-19;covid-19 hospitalization;covid-19 severity;sars-cov-2 infection;spain;cohort study;epidemiology;inequality;mortality;risk factor
Pneumonia Caused Severe Acute Respiratory Syndrome Coronavirus 2 Influenza Virus Multicenter Comparative Study,34291119,Background Detailed difference clinical information severe acute respiratory syndrome coronavirus 2 SARSCoV2 pneumonia CP main phenotype SARSCoV2 disease influenza pneumonia IP still unclear Methods prospective multicenter cohort study conducted including patient CP hospitalized January June 2020 retrospective cohort patient IP hospitalized 2009 2020 compared clinical presentation studied prognostic factor CP IP Results Compared IP group n = 66 multivariate analysis CP group n = 362 lower percentage patient underlying asthma chronic obstructive pulmonary disease P 01 lower neutrophiltolymphocyte ratio P 01 lower systolic blood pressure P 01 higher diastolic blood pressure P 01 lower aspartate aminotransferase level P 05 higher serum sodium level P 05 frequent multilobar infiltrates P 05 diagnostic scoring system based finding showed excellent differentiation CP IP area receiver operating characteristic curve 0889 Moreover prognostic predictor different CP IP Conclusions Comprehensive difference CP IP revealed highlighting need early differentiation 2 pneumonia clinical setting,covid-19;influenza;multicenter study;pneumonia
Adverse event related COVID19 vaccine need strengthen pharmacovigilance monitoring system,34366660,Coronavirus disease 2019 COVID19 infectious disease caused new specie betacoronavirus genus named severe acute respiratory syndrome coronavirus 2 COVID19 pandemic started late 2019 continues mid2021 caused enormous damage health life globally urgent public health need led development vaccine COVID19 recordbreaking time COVID19 vaccine widely rolled mass many country following approval emergency use World Health Organization regulatory agency many country addition several COVID19 vaccine candidate undergoing clinical trial However myth fear rumor misconception persist particularly regard adverse event commentary describe adverse event associated COVID19 vaccine discus essential functional adverse event monitoring system context,
Assessment Impact Risk Exposure Portuguese Biomedical Scientists Context COVID19,34281029,Currently main public health concern worldwide COVID19 pandemic caused SARSCoV2 recently discovered described Due high pathogenicity infectiousness necessary determine risk healthcare professional face every day dealing infected patient contaminated biological sample purpose study ass Portuguese Biomedical Scientists risk COVID19 exposure related stress appraisal One hundred forty participant completed online version s Risk Assessment Management Exposure Survey Stress Appraisal Measure Participants worked mainly outpatient setting 45 emergency service 28 Twenty three percent participant exposed COVID19 community exposure 39 occupational exposure Although 95 reported using personal protective equipment PPE 836 high risk infection However use type PPE related risk exposure Participants reported moderate perception stress threat also moderate perception control situation result may contribute efficient risk management professional prevent disease transmission hospital community,covid-19;biomedical scientist;risk exposure;stress appraisal
Immune Evasion SARSCoV2 Emerging Variants Learnt Far,34206453,Despite slow evolutionary rate SARSCoV2 relative RNA virus massive rapid transmission COVID19 pandemic enabled acquire significant genetic diversity since first entered human population led emergence numerous variant recently labeled `` variant concern VOC due potential impact transmission morbiditymortality evasion neutralization antibody elicited infection vaccination therapeutic application potential evade neutralization result diversity target epitope generated accumulation mutation spike protein three globally recognized VOCs Alpha B117 Beta B1351 Gamma P1 remain sensitive neutralization albeit reduced level serum convalescent individual recipient several antiCOVID19 vaccine effect spike variability much evident neutralization capacity monoclonal antibody newly recognized VOC Delta lineage B16172 well locally accepted VOCs Epsilon B142729US B117 E484KUK indicating necessity close monitoring new variant global level VOCs characteristic mutational pattern role mutation play immune evasion summarized review,b.1.1.7;b.1.351;b.1.617;covid-19;p.1;sars-cov-2;immune escape;mutations;neutralization;variant of concern
SARSCoV2 Antigen Detection Expand Testing Capacity COVID19 Results Hospital Emergency Department Testing Site,34359294,BACKGROUND SARSCoV2 antigen detection currently expanded testing capacity COVID19 yet relies SARSCoV2 RNA RTPCR amplification OBJECTIVES report COVID19 testing algorithm tertiary care hospital emergency department ED combine antigen performed ED RTPCR performed outside ED testing METHODS December 2020 January 2021 priori designated spatially separated COVID19 nonCOVID19 ED area respectively symptomatic asymptomatic patient received SARSCoV2 antigen testing nasopharyngeal swab sample Antigen result promptly accessible guide subsequent outside performed confirmatory RTPCR testing RESULTS Overall 1083 100 1083 sample COVID19 area 1815 494 3670 sample nonCOVID19 area antigen result required confirmation RTPCR Antigen positivity rate 124 1341083 37 661815 respectively Compared RTPCR testing result sensitivity specificity positive predictive value PPV negative predictive value NPV antigen testing respectively 680 983 888 941 COVID19 area 419 973 273 986 nonCOVID19 area Practically RTPCR test avoided 506 18553670 nonCOVID19 area sample antigen negative patient otherwise would needed antigen result confirmation CONCLUSIONS algorithm value preserve RTPCR avoidable usage importantly save time translated timely RTPCR result availability COVID19 area,covid-19;sars-cov-2;antigen-based testing;emergency department;molecular-based testing
Antibiotic resistance beyond COVID19,34223149,Antibiotics underpin modern medicine increased life expectancy leading society sizeable vulnerable elderly population suffered disproportionately current COVID19 pandemic Governments responded shuttering economy limiting social interaction refocusing healthcare implication antibiotic resistance event spring 2020 COVID19stressed ICUs relaxed stewardship perhaps promoting resistance Counterpoised citizen died home total hospital antibiotic use declined reducing selection pressure Restricted travel social distancing potentially reduced community import transmission resistant bacteria though hard data lacking future depends vaccine deployed Unequivocal vaccine success allow swift return normality Vaccine failure followed extended successful nonpharmaceutical suppression may lead point delay indefinite travel restriction sustainability doubtful Alternatively failure vaccine control measure may prompt acceptance must live virus prolonged 188994 influenza coronavirus OC43 pandemic Vaccine failure scenario particularly accepting learning live virus favour increased outpatient management nonCOVID19 infection using oral long 12 antibiotic Ultimately modelsexcept envisaging societal collapsesuggest COVID19 controlled hospital revert pre2020 pattern large backlog nonCOVID19 patient awaiting treatment Clearing increase workload stress nosocomial infection antibiotic use resistance New antibiotic including cefiderocol part answer,
Effects coronavirus disease 2019 digestive system nutritional implication,34334686,PURPOSE REVIEW deluge scientific data since coronavirus disease 2019 COVID19 first reported effect COVID19 digestive system increasingly well understood article aim review current data effect COVID19 digestive system particular emphasis preexisting digestive disease implication nutrition practice RECENT FINDINGS Evidence shown Severe acute respiratory syndrome coronavirus 2 virus affect gastrointestinal GI tract pancreas hepatobiliary system resulting different GI manifestation Several preexisting digestive disease investigated study revealed special patient population group generally increased risk contract COVID19 susceptible develop increasing severity disease Aside medical therapy optimizing nutritional care beneficial role group patient SUMMARY GI manifestation COVID19 addition preexisting digestive disease impact patient s nutrition Digestion absorption transport nutrient may impaired date existing guideline nutritional management patient particular atrisk group nutrition practice based observation clinical experience Basic prepandemic nutrition care principle primarily followed often individualized based clinical judgment,
COVID19 Prevention Control Measures Workplace Settings Rapid Review MetaAnalysis,34360142,Workplaces highrisk environment SARSCoV2 outbreak subsequent community transmission Identifying understanding implementing effective workplace SARSCoV2 infection prevention control IPC measure critical protect worker family community rapid review metaanalysis conducted synthesize evidence assessing effectiveness COVID19 IPC measure implemented global workplace setting April 2021 Medline Embase PubMed Cochrane Library searched study quantitatively assessed effectiveness workplace COVID19 IPC measure included study comprised varying empirical design occupational setting Measures interest included surveillance measure outbreak investigation environmental adjustment personal protective equipment PPE change work arrangement worker education Sixtyone study healthcare nursing home meatpacking manufacturing office setting included accounting 280000 employee based Europe Asia North America Metaanalyses showed combined IPC measure resulted lower employee COVID19 positivity rate 02 positivity 95 CI 004 single measure asymptomatic PCR testing 17 95 CI 0929 universal masking 24 95 CI 34555 Modelling study showed combination timely widespread contact tracing case isolation ii facilitating smaller worker cohort iii effective use PPE reduce workplace transmission Comprehensive COVID19 IPC measure incorporating swift contact tracing case isolation PPE facility zoning effectively prevent workplace outbreak Masking alone considered sufficient protection SARSCoV2 outbreak workplace,covid-19;control measures;infection prevention;occupational health and safety;review;workers
Enzymatic Assays Explore Viral mRNA Capping Machinery,34291555,eukaryote mRNA modified addition 7methylguanosine 7 G 5 cap protect mRNA premature degradation thereby enhancing translation enabling differentiation self endogenous nonself RNAs e g viral one Viruses often develop mRNA capping pathway augment expression protein escape host innate immune response Insights capping system may provide new idea therapeutic intervention facilitate drug discovery e g virus cause pandemic outbreak betacoronaviruses SARSCoV 2002 MARSCoV 2012 recent SARSCoV2 Thus proper method screening large compound library required identify lead structure could serve basis rational antiviral drug design review summarizes method allow monitoring activity inhibition enzyme involved mRNA capping,antiviral agents;high-throughput screening;mrna;methyltransferases;viral capping
Usefulness Respiratory Mechanics Laboratory Parameter Trends Markers Early Treatment Success Mechanically Ventilated Severe Coronavirus Disease SingleCenter Pilot Study,34204119,Whether patient severe coronavirus disease COVID19 successfully liberated mechanical ventilation MV early important COVID19 pandemic study aimed characterize time course parameter outcome severe COVID19 relation timing liberation MV retrospective singlecenter observational study performed using data mechanically ventilated COVID19 patient admitted ICU 1 March 2020 15 December 2020 Early liberation ventilation EL group defined successful extubation within 10 day MV trend respiratory mechanic laboratory data visualized compared EL prolonged MV PMV group using smoothing spline linear mixed effect model 52 admitted patient 31 mechanically ventilated COVID19 patient included EL group 20 69 PMV group 11 31 patient median age 71 year inhospital mortality low 6 activity daily living ADL time hospital discharge significantly impaired PMV group compared EL group mean Barthel index range 30 7595 versus 25 0225 p = 0048 trend respiratory compliance different patient EL PMV group increasing trend ventilatory ratio MV approximately 2 week observed group interaction daily change earlier liberation significant trajectory thrombinantithrombin complex antithrombin 3 fibrinogen Creactive protein lymphocyte positive endexpiratory pressure PEEP value indicator physiological dead space increase MV trajectory marker hypercoagulation status inflammation PEEP significantly different depending timing liberation MV finding may provide insight pathophysiology COVID19 treatment critical care setting,covid-19;mechanical ventilation;respiratory failure
Descriptive Comparative Analysis Patients Cancer Referring Emergency Department Italian University Hospital Across Severe Acute Respiratory Syndrome Coronavirus 2 Waves,34228511,PURPOSE COVID19 cancer patient C19CP represent population high risk mortality whose clinical characteristic still unknown second SARSCoV2 wave aim retrospective study compare epidemiology clinical presentation C19CP referring emergency department ED institution San Luigi Gonzaga University Hospital Orbassano Turin Italy 3week observation period first second COVID19 wave starting introduction corresponding national lockdown METHODS retrieved ED admission March 9 29 2020 first wave October 24 November 13 2020 second wave collected clinical characteristic consecutive patient molecularly confirmed SARSCoV2 infection also considered untested SARSCoV2negative cancer patient referring ED reference time frame RESULTS C19CP second wave exceeded first wave despite nonsignificant difference 39 576 v 8 163 P = 5 Compared nononcological patient C19CP older median age 70 year interquartile range 6177 v 60 year interquartile range 4573 P = 02 presented often = 2 comorbidities 404 v 243 P = 02 Compared nononcological patient C19CP respiratory failure 29 47 v 321 692 P = 049 hospitalization 37 47 v 363 692 P = 0004 higher comparable frequency across wave Five 24 10 27 hospitalized cancer patient first second wave developed SARSCoV2 infection hospitalization CONCLUSION C19CP vulnerable population irrespective COVID19 wave highlight need prioritize vaccination oncological patient safeguard guarantee optimal anticancer care,
Lessons learnt COVID19 coagulopathy,34226900,coronavirus disease 2019 COVID19 pandemic already left indelible mark human life Despite havoc created pandemic also saw significant advance management infectious disease wherein worldwide collaborative effort health care professional unprecedented One commonest complication recognised early pandemic development coagulopathy review lesson learnt COVID19 coagulopathy summarised perspective future clinical research strategy include local versus systemic coagulopathy matter put Ddimers effective use exhort input identifying simple platelet activation marker rethink role fibrinogen look differently lupus anticoagulant heparininduced thrombocytopenia bring back disseminated intravascular coagulation differential diagnosis slate importantly channel funding haemostasis thrombosis research,covid-19;d-dimer;coagulopathy;fibrinogen;platelets;thrombocytopenia
NanotechnologyBased Approaches Investigational Therapeutics COVID19,34218774,Severe acute respiratory syndrome coronavirus 2 SARSCoV2 novel coronavirus currently responsible global pandemic since December 2019 class coronavirus affected 217 country around world country taken nonremedial preventive action like country lockdown work home travel ban significant one social isolation Pharmacists doctor nurse technologist healthcare professional playing pivotal role pandemic Unluckily specific drug treat patient confirmed COVID19 though favipiravir remdesivir appeared favorable antiviral drug vaccine already developed vaccination started worldwide Different nanotechnology developing stage many country preventing SARSCOV2 treating COVID19 condition article review COVID19 pandemic situation well nanotechnologybased approach investigational therapeutic COVID19,covid-19;sars-cov-2;antiviral drugs;nanotechnology;vaccines
